data_2n0t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n0t _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 75.040000000000006 110.82 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.55 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.109999999999999 111.125 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -88.47 144.63 34.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 65.239999999999995 110.864 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 132.26 22.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.684 2.256 . . . . 71.329999999999998 112.338 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -116.51 142.28 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 111.097 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.79 137.8 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -101.34 156.23 17.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 110.857 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.52 143.69 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 74.450000000000003 110.901 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.35 143.03 37.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.030000000000001 110.879 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -115.43 120.3 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.149 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 163.28 13.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 53.409999999999997 111.064 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.88 96.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 72.129999999999995 111.145 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.33 31.39 6.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.519999999999996 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.24 65.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 64.109999999999999 112.475 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -96.22 132.91 25.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.648 0.737 . . . . 74.349999999999994 110.874 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.65 65.32 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.129999999999995 112.351 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -121.97 -72.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.903 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.64 -148.24 4.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 74.340000000000003 112.526 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.75 126.6 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 74.319999999999993 110.874 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.33 125.26 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 72.430000000000007 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.1 p -113.47 159.16 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.884 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.69 126.67 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.299999999999997 110.904 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.0 tm-20 -59.46 -48.36 81.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.010000000000005 110.916 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 7.1 mt 69.51 126.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.219999999999999 110.935 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.6 74.14 8.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 110.902 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.8 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.400000000000006 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.01 -37.59 12.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.896 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -75.11 -27.7 59.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.894 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.67 68.7 81.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 72.439999999999998 111.095 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 58.87 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.698 2.265 . . . . 63.409999999999997 112.378 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.59 -72.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.3 m -58.95 -53.91 53.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 64.120000000000005 111.14 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.39 58.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 62.140000000000001 111.118 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -74.17 -24.75 59.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 110.849 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -90.5 -34.41 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.200000000000003 110.869 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.77 -28.71 9.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.36 76.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.319999999999993 110.874 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.96 -28.69 25.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 111.119 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.12 13.1 13.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.951 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -117.22 -11.99 10.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.099999999999994 110.852 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.1 p -116.63 -0.06 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 75.409999999999997 111.184 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.56 10.66 60.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.439999999999998 112.516 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.16 -36.79 85.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 74.239999999999995 110.846 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -15.23 62.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.921 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.01 -18.66 30.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.746 . . . . 45.340000000000003 112.472 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 47' ' ' GLY . 9.6 m-85 -87.42 -24.95 24.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.38 . . . . 65.530000000000001 110.841 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -30.9 135.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 64.340000000000003 112.457 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -76.46 -43.86 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.96 0.409 . . . . 72.420000000000002 110.941 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.67 93.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 72.239999999999995 110.889 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.9 63.18 0.84 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 73.140000000000001 112.462 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 53.039999999999999 110.834 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.3 p -144.7 -172.74 3.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 65.120000000000005 110.896 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.45 167.09 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.878 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -46.96 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 110.858 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -146.04 153.05 40.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.863 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -144.81 130.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.113 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -134.78 104.65 10.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 75.540000000000006 111.145 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 98.43 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 62.020000000000003 112.32 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.5 -22.51 3.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 62.210000000000001 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.27 -60.65 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 75.329999999999998 110.865 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.45 -160.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 74.439999999999998 110.902 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 65.3 m -133.36 -73.0 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 74.209999999999994 110.907 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 61.8 160.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.894 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 61.149999999999999 112.459 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.819 0.342 . . . . 75.310000000000002 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 t -132.71 137.48 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 73.019999999999996 110.843 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -70.32 -27.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 75.019999999999996 111.153 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -122.98 41.29 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.79 -136.58 5.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 63.210000000000001 112.513 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.82 -74.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.010000000000005 110.896 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 160.4 32.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.878 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 147.04 35.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.319999999999993 110.873 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.61 158.65 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 64.450000000000003 110.914 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.29 127.19 32.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.450000000000003 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -57.76 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.030000000000001 110.895 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -179.76 177.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.926 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.47 36.95 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.150000000000006 110.883 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -50.49 -25.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 70.540000000000006 111.158 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mt -73.07 122.75 22.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.019999999999996 110.92 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -77.23 160.2 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.872 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -86.53 107.23 18.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.862 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 p -142.93 164.82 29.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 71.219999999999999 111.128 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.03 144.19 4.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 71.209999999999994 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.01 27.5 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.251 . . . . 75.030000000000001 112.326 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.57 73.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 74.200000000000003 112.458 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.87 161.91 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 75.019999999999996 111.121 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -102.84 128.83 49.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.916 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.1 t -143.75 -116.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.816 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 178.24 143.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.340000000000003 110.856 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 101.67 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.040000000000006 111.095 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 -167.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 110.929 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.634 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.65 -37.29 65.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 111.05 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.5 -65.12 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 75.310000000000002 112.522 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.71 120.88 7.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.252 . . . . 75.340000000000003 112.379 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 105' ' ' PRO . 10.0 p-10 26.53 64.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 61.149999999999999 110.915 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 t -163.22 54.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 52.310000000000002 111.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -40.11 -52.29 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 75.209999999999994 110.923 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.48 -167.79 53.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 63.539999999999999 112.501 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -118.81 -20.17 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 63.109999999999999 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -51.44 150.9 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.420000000000002 110.948 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -160.47 175.03 13.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.5 110.893 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -144.98 179.02 7.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.120000000000005 110.873 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 32.8 mm -102.24 -63.73 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER 79.37 112.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.921 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 t -98.8 -13.52 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.175 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.61 159.06 30.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 111.087 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -71.51 102.62 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.9 p -121.36 70.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.439999999999998 111.184 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -84.65 22.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.841 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -103.87 9.72 36.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.896 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.29 -30.98 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.040000000000006 110.93 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.26 165.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 110.851 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.22 -24.74 30.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 72.450000000000003 112.471 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -104.9 -33.56 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 73.129999999999995 110.904 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -119.73 170.29 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.819 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.02 112.88 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 111.129 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.94 144.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 31.6 p90 -178.65 112.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 72.239999999999995 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . 144.04 -166.11 27.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 64.25 112.484 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt 172.87 -174.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 74.409999999999997 110.95 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.69 86.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 111.15 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -47.5 -74.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.865 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -150.78 146.99 26.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 71.299999999999997 110.868 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.36 26.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 74.109999999999999 112.51 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.3 -30.14 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 71.510000000000005 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -50.76 -25.94 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.030000000000001 110.864 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.2 mm -86.33 -38.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.156 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.2 t -51.32 -23.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 111.125 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.28 -43.48 15.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 75.030000000000001 110.857 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.13 -48.33 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.129999999999995 111.131 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.5 ptm -64.08 -20.15 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.46 29.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 74.530000000000001 110.873 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.69 -23.18 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 74.109999999999999 110.831 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.32 1.33 57.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 72.400000000000006 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.71 -147.29 10.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.755 -0.736 . . . . 74.549999999999997 112.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.1 134.35 6.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 74.0 110.858 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -70.59 76.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 74.010000000000005 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.71 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.239999999999995 110.859 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.54 -60.5 0.43 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 74.120000000000005 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -61.63 155.18 23.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 72.420000000000002 110.966 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 63.2 p -124.91 129.42 50.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 71.450000000000003 111.166 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.3 -31.69 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 73.140000000000001 110.893 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -169.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 75.420000000000002 110.895 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -137.88 126.07 23.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.865 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.14 127.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 71.150000000000006 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.31 43.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 111.192 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.0 142.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.088 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.57 -64.98 1.01 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 50.210000000000001 111.078 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.77 178.12 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.5 110.858 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.63 -176.34 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.420000000000002 110.914 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 137.07 -146.46 18.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 71.310000000000002 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 128.14 53.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 73.400000000000006 110.917 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.51 -56.53 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.400000000000006 110.905 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 62.130000000000003 110.923 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.807 0.337 . . . . 75.349999999999994 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.78 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.540000000000006 111.153 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.35 157.4 38.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 74.230000000000004 110.854 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.28 69.21 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.274 . . . . 74.109999999999999 112.34 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 m -130.34 55.57 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.239999999999995 111.145 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.26 147.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 75.420000000000002 111.169 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.55 163.51 32.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.010000000000005 110.876 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -141.76 146.17 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 72.120000000000005 110.882 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.98 163.32 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 110.841 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 mm -132.5 102.66 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 111.142 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.04 158.0 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 111.149 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -138.31 99.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.120000000000005 111.134 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.68 42.65 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 70.420000000000002 110.891 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.88 -8.08 67.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 71.150000000000006 112.504 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.0 tt0 -100.22 101.38 14.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.746 . . . . 73.530000000000001 110.844 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.81 126.89 13.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 74.310000000000002 112.298 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -83.87 -43.73 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.909 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.02 -151.32 20.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.420000000000002 112.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 156.83 21.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.901 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.62 76.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 111.151 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.65 165.44 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.89 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.67 122.53 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 110.897 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -47.89 137.03 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.88 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.22 120.93 43.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.948 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -76.36 57.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.847 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -28.17 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 61.25 111.067 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.75 -61.29 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.510000000000005 110.845 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.030000000000001 110.921 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 m -72.75 120.05 78.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.319999999999993 111.13 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 31' ' ' LYS . 53.5 Cg_endo -69.74 -87.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.674 2.25 . . . . 74.299999999999997 112.382 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -70.1 -44.58 68.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 73.140000000000001 110.898 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -46.07 -28.46 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 73.230000000000004 111.121 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.430000000000007 111.067 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' ARG . 15.6 tt0 -57.98 -64.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.519999999999996 110.865 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 34' ' ' GLU . 14.2 t-20 -31.53 -51.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 63.329999999999998 110.873 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.01 -40.95 62.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 110.91 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -52.62 -25.01 9.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 71.340000000000003 110.88 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.37 -43.48 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 73.200000000000003 111.109 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.73 -13.98 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 64.420000000000002 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -6.2 31.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.826 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.2 p -101.62 -21.25 14.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.126 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.76 -17.12 54.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.239999999999995 112.502 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.59 -37.13 48.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 74.430000000000007 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -23.13 35.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.519999999999996 110.865 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.33 -4.55 40.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 74.299999999999997 112.515 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -164.02 167.13 20.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 75.349999999999994 110.842 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.31 20.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 73.409999999999997 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 108.11 16.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 75.120000000000005 110.936 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -69.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 73.230000000000004 110.852 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.79 32.67 2.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.329999999999998 112.47 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.13 -168.2 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.400000000000006 110.84 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 m -114.17 -168.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.24 -173.29 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 71.209999999999994 110.913 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -102.96 -74.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -154.64 103.52 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 74.439999999999998 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.88 128.27 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 64.310000000000002 111.17 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 5.0 tt -136.11 106.85 9.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 72.540000000000006 111.144 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.76 105.72 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.697 2.265 . . . . 71.150000000000006 112.306 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.62 -49.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 42.200000000000003 112.511 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.27 -66.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 75.510000000000005 110.86 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -162.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.120000000000005 110.872 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.8 m -149.94 98.38 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.409999999999997 110.907 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -90.68 170.09 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 71.299999999999997 110.889 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 71.040000000000006 112.46 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 71.400000000000006 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 177.6 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.844 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -86.9 -34.45 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.115 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.01 72.42 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.903 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.48 -130.02 10.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 70.040000000000006 112.501 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.78 -77.5 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 73.150000000000006 110.877 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.78 -177.34 4.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 73.549999999999997 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.23 174.91 11.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 75.140000000000001 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.7 158.61 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 110.853 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 119.48 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.439999999999998 110.872 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -47.46 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.863 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.53 167.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 110.875 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.48 37.11 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.872 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.79 -22.19 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.430000000000007 111.139 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.09 90.6 4.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 71.430000000000007 110.93 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -63.23 171.98 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 70.349999999999994 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -90.29 95.25 10.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 73.129999999999995 110.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 94' ' ' GLY . 18.2 p -131.14 149.56 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 65.329999999999998 111.117 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' THR . . . 56.17 155.07 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 63.409999999999997 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.37 24.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 71.209999999999994 112.348 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.28 -10.55 60.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 74.230000000000004 112.541 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -47.67 133.51 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 75.420000000000002 111.139 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -120.97 145.9 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 72.239999999999995 110.884 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 t -149.79 -133.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.821 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mtt -145.65 112.62 6.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 75.25 110.862 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.01 74.37 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 72.430000000000007 111.132 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -107.36 -75.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.91 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 107' ' ' THR . . . -134.99 -84.62 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 65.329999999999998 111.077 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.84 -83.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 72.150000000000006 112.481 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.77 113.9 3.53 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.677 2.251 . . . . 73.310000000000002 112.351 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 34.47 46.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.896 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 103' ' ' ALA . 17.6 p -142.26 46.74 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 55.229999999999997 111.143 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.73 176.52 8.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.913 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.82 -127.04 1.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 62.130000000000003 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -101.76 -171.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 71.530000000000001 110.917 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 72.3 64.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 110.913 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -72.48 149.39 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 110.877 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 5.4 p90 -114.6 120.49 40.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.349999999999994 110.847 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.57 132.63 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 111.101 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.11 127.84 33.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 72.510000000000005 110.915 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 p -99.62 -31.35 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 65.019999999999996 111.155 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.06 24.77 5.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 72.439999999999998 111.089 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.69 135.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 74.540000000000006 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.0 p -139.97 61.25 1.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 73.099999999999994 111.137 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.06 3.61 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -86.29 1.44 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.420000000000002 110.919 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 pp -139.81 43.64 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.109999999999999 110.909 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.49 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.845 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 125' ' ' LYS . . . -50.11 140.53 17.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 70.150000000000006 112.469 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 1.0 OUTLIER 78.41 61.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.875 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -163.14 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.846 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.4 t 74.67 86.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 64.400000000000006 111.095 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.0 t -90.91 133.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.159 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.64 22.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.439999999999998 110.852 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -140.7 174.07 22.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 60.219999999999999 112.494 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.68 130.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 74.230000000000004 110.895 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.77 129.36 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.420000000000002 111.129 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 -59.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 61.219999999999999 110.844 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -139.82 140.99 36.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.888 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.7 1.78 43.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 75.439999999999998 112.445 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.8 ttt -49.56 -31.13 9.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 71.129999999999995 110.927 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -49.69 -26.72 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.89 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.34 -36.28 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 75.349999999999994 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.07 -22.75 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 71.540000000000006 111.137 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -83.75 -34.24 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 110.849 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.0 81.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.140000000000001 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.5 ptm -72.21 -11.87 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.951 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.92 25.2 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -16.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.129999999999995 110.905 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.66 -6.03 40.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.55 -166.05 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 73.400000000000006 112.452 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -140.04 -75.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 75.049999999999997 110.883 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.95 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 72.230000000000004 110.908 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -92.79 24.02 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.019999999999996 110.873 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.49 9.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 54.229999999999997 112.521 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.64 149.1 36.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 73.540000000000006 110.859 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -130.85 168.05 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 73.099999999999994 111.149 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.2 t -92.04 -2.49 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.040000000000006 110.898 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -140.95 -167.55 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.409999999999997 110.893 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.45 119.83 17.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 75.340000000000003 110.895 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.2 125.57 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 70.519999999999996 111.162 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.61 172.36 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.200000000000003 111.14 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.15 108.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.150000000000006 111.131 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -60.28 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 111.14 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -148.9 177.2 9.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 10.7 p -178.17 163.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.909 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.11 -169.61 28.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.47 117.51 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.519999999999996 110.927 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.11 -69.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.540000000000006 110.958 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 75.209999999999994 110.915 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.23 148.25 24.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 71.129999999999995 111.133 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.37 143.12 5.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 64.519999999999996 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 112.68 3.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 64.230000000000004 112.378 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -115.93 133.81 55.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 111.125 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.08 150.15 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 111.152 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -108.48 160.83 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.94 130.09 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.310000000000002 110.895 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.04 95.68 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 71.239999999999995 110.903 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.7 mt -75.62 151.91 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 74.519999999999996 111.104 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.52 168.49 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 74.140000000000001 111.051 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 109.78 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.049999999999997 111.098 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.19 34.93 2.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 110.919 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 10.99 84.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 72.310000000000002 112.457 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.3 147.53 45.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.672 0.749 . . . . 73.5 110.876 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.21 56.63 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 62.030000000000001 112.336 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 tp -132.97 8.32 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 73.400000000000006 110.969 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -166.15 12.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 55.310000000000002 112.494 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.96 151.35 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 72.120000000000005 110.888 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 25.9 m -124.95 170.2 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 52.439999999999998 111.146 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 t -122.72 151.33 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.150000000000006 110.875 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -126.4 134.43 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.239999999999995 110.916 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -108.79 105.72 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.902 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.12 138.6 31.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -90.72 83.3 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.842 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.93 0.92 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 75.530000000000001 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.2 -34.23 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 110.866 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -97.51 -27.14 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.310000000000002 110.912 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.56 79.46 24.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 74.120000000000005 111.138 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -19.25 36.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 74.239999999999995 112.336 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -43.65 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 70.099999999999994 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -53.19 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 73.400000000000006 111.122 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.65 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 75.129999999999995 111.099 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.98 -38.16 37.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 110.906 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.33 -61.86 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 72.340000000000003 110.903 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -51.51 -25.23 6.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 75.450000000000003 110.889 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -36.12 83.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.61 -21.05 35.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.239999999999995 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.29 -60.44 2.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 75.530000000000001 110.929 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 64.019999999999996 110.896 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -84.53 -12.78 53.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 44.14 83.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.8 32.03 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 73.0 110.909 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.1 32.54 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 72.319999999999993 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.68 13.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 52.119999999999997 112.482 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.75 -170.54 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 75.010000000000005 110.848 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.57 176.6 37.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 72.019999999999996 112.502 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.68 -18.07 63.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 73.409999999999997 110.894 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.38 136.55 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 64.409999999999997 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.4 58.58 8.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.719 -0.753 . . . . 64.299999999999997 112.509 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.7 p -145.07 -166.27 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 60.310000000000002 110.888 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.96 169.06 24.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.869 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -104.18 -67.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 73.329999999999998 110.86 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 59.65 20.64 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 72.219999999999999 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -146.97 115.63 6.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.23 156.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 75.530000000000001 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.97 112.88 8.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 75.209999999999994 111.112 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 86.31 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 72.430000000000007 112.384 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.75 9.05 8.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 65.120000000000005 112.487 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -69.98 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.510000000000005 110.867 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.95 -164.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.310000000000002 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.48 121.57 7.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.209999999999994 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -92.91 134.71 34.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.230000000000004 110.943 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 54.329999999999998 112.5 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.826 0.346 . . . . 72.420000000000002 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.82 -179.13 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.83 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.78 -5.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 111.156 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.99 28.1 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.9 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.0 -126.18 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 74.420000000000002 112.458 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -144.49 13.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 73.349999999999994 110.908 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -171.44 126.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -119.03 143.83 46.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 63.420000000000002 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -66.43 156.5 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 75.120000000000005 110.899 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -78.03 134.68 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.884 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -61.98 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.902 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -173.94 148.21 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.892 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.52 49.97 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.6 mm -72.5 -15.93 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 75.549999999999997 111.149 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.75 137.7 42.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.140000000000001 110.88 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -129.0 104.89 7.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 75.510000000000005 110.914 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -67.63 103.57 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.816 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.3 p -130.58 39.63 3.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.13 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.8 163.8 32.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 74.420000000000002 112.482 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 146.26 59.6 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.738 2.292 . . . . 75.109999999999999 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.02 13.71 65.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.71 -0.757 . . . . 70.329999999999998 112.474 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.27 138.61 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 63.149999999999999 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.99 114.6 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 75.140000000000001 110.896 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.66 140.29 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 64.530000000000001 110.864 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.5 mmt -69.55 145.5 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.439999999999998 110.849 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.14 139.05 39.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 61.130000000000003 111.124 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 174.63 -69.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 72.209999999999994 110.908 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -136.42 -40.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.76 -69.02 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 63.43 112.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -104.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.265 . . . . 73.109999999999999 112.356 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -90.77 62.95 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.84 68.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 111.122 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -44.66 -60.73 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 72.510000000000005 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.59 43.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 73.239999999999995 112.448 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 p -129.04 9.94 5.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 72.030000000000001 110.851 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -166.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -143.87 128.16 17.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.908 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -123.25 106.85 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.099999999999994 110.888 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 tt -120.55 103.8 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 73.040000000000006 111.181 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -85.44 153.11 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 75.019999999999996 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 28.95 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.119 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.93 165.11 5.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 111.067 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -61.78 96.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.9 62.43 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 74.230000000000004 111.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.53 25.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 110.902 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -69.9 -22.88 63.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 110.934 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.63 34.68 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.420000000000002 110.933 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -86.99 44.42 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 110.844 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.06 52.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.776 -0.726 . . . . 71.299999999999997 112.526 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -171.34 -45.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 75.439999999999998 110.894 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.49 142.34 30.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 72.450000000000003 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.78 90.61 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 63.310000000000002 111.1 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 p -82.53 143.56 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 111.151 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -176.51 134.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.875 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.31 137.99 9.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 60.350000000000001 112.487 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 172.05 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 72.219999999999999 110.907 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.96 139.04 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 74.040000000000006 111.105 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -117.9 -29.85 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 62.350000000000001 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.56 158.33 36.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.71 85.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 75.450000000000003 112.484 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.6 mmm -92.04 -24.15 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 73.140000000000001 110.848 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -80.57 -34.53 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 74.010000000000005 110.877 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 142' ' ' MET . 46.6 mm -39.42 -48.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 65.319999999999993 111.132 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.7 t -90.36 -50.8 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 60.409999999999997 111.135 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -44.68 -59.77 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 110.88 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.74 78.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 111.082 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 8.1 tmm? -50.08 -45.04 52.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 73.310000000000002 110.894 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -27.76 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 64.340000000000003 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -63.31 -25.45 68.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -90.52 21.92 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.519999999999996 110.872 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.89 -159.03 21.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 53.450000000000003 112.52 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -155.47 147.59 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 71.409999999999997 110.836 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -76.34 64.24 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 75.329999999999998 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -176.19 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 75.450000000000003 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.63 -52.47 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 71.349999999999994 112.454 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.04 112.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.049999999999997 110.905 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.1 m -77.88 127.96 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 111.166 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -46.15 -32.07 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 64.049999999999997 110.86 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -133.51 -178.56 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.450000000000003 110.871 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -98.82 107.28 19.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 71.109999999999999 110.938 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.0 mt -98.3 108.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.510000000000005 111.147 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 t -119.24 156.93 29.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 111.148 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.48 139.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.209999999999994 111.139 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.73 -59.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 111.124 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.74 161.81 41.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.64 -168.59 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 110.894 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.68 -165.58 26.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 74.439999999999998 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -113.09 138.82 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 71.25 110.944 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.36 156.2 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 75.129999999999995 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 110.852 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.797 0.332 . . . . 75.129999999999995 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.59 141.64 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.230000000000004 111.111 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.62 145.83 37.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 73.099999999999994 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 121.59 8.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 73.519999999999996 112.301 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -106.64 128.04 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 111.138 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.3 m -111.73 141.99 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.209999999999994 111.164 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -122.35 160.22 25.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.902 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -142.03 143.1 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.929 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.21 82.07 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.835 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.9 147.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.24 150.56 41.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.81 97.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 111.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.87 24.41 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.187 -0.46 . . . . 64.420000000000002 110.841 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.09 59.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 64.310000000000002 112.48 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -108.34 143.0 26.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 74.549999999999997 110.881 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 152.82 68.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.661 2.241 . . . . 75.140000000000001 112.339 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.5 tp -129.63 -0.38 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 110.905 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.48 171.71 12.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 51.509999999999998 112.508 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -105.99 127.41 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 62.439999999999998 110.855 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.18 100.18 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.310000000000002 111.137 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.8 p -102.17 142.44 33.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 71.349999999999994 110.819 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.52 104.5 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 72.349999999999994 110.891 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -51.86 167.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 72.230000000000004 110.833 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.46 126.85 53.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 74.5 110.93 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -77.33 59.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 110.899 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.06 -7.51 52.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 73.310000000000002 111.121 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.85 -65.05 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.019999999999996 110.93 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -61.22 2.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.53 83.29 2.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 74.120000000000005 111.121 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.97 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 75.209999999999994 112.351 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.31 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -47.17 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 111.11 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.31 -33.96 59.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.5 111.096 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.61 -31.75 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.510000000000005 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -77.49 -67.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.099999999999994 110.908 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.18 -43.33 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 74.239999999999995 110.849 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -29.61 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.861 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.33 20.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.131 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.98 -38.41 82.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.907 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -69.55 -47.88 62.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.109999999999999 110.893 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.1 p -72.34 -13.52 61.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 74.409999999999997 111.121 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.51 69.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 75.120000000000005 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.1 41.56 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 74.209999999999994 110.932 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -130.09 -2.63 4.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.914 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.73 -14.06 65.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 73.310000000000002 112.488 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -33.85 76.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.530000000000001 110.936 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 48' ' ' TYR . . . 85.27 -141.32 19.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 71.109999999999999 112.482 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 1.3 t80 82.56 85.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 73.329999999999998 110.884 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 -47.95 4.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.871 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -125.29 113.33 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 54.25 112.512 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 p -88.11 -168.61 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 64.099999999999994 110.833 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 p -139.52 96.0 3.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 70.239999999999995 110.911 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -81.37 107.11 13.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 71.030000000000001 110.858 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.29 29.84 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 73.530000000000001 110.873 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.05 24.4 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.209999999999994 110.887 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.43 141.73 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.107 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -131.95 110.36 14.34 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 74.349999999999994 111.15 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 89.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.657 2.238 . . . . 74.450000000000003 112.403 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.7 14.86 4.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 75.310000000000002 112.5 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 -64.51 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 110.87 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.16 -169.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 74.430000000000007 110.883 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.8 m -146.4 142.91 28.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 65.239999999999995 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 140.37 51.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.925 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 70.150000000000006 112.466 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.833 0.349 . . . . 73.109999999999999 110.874 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -87.92 -174.9 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.9 pt -80.35 -32.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 75.430000000000007 111.126 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -89.19 44.29 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 75.400000000000006 110.932 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 -109.17 2.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 64.420000000000002 112.494 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -52.56 174.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.395 . . . . 75.420000000000002 110.851 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 -172.19 2.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 73.519999999999996 110.883 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.89 145.17 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.853 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -60.61 176.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 74.019999999999996 110.882 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.4 126.4 40.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 75.209999999999994 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.27 -48.71 26.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 62.119999999999997 110.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -175.19 149.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.019999999999996 110.862 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.02 46.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.881 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -14.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.540000000000006 111.163 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.43 125.67 49.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.893 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -164.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.019999999999996 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -97.42 65.39 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 65.219999999999999 110.897 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -20.05 53.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 111.126 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.23 174.77 46.55 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.129999999999995 112.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.667 2.245 . . . . 73.030000000000001 112.379 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.02 -30.6 4.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 75.409999999999997 112.485 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 mm -62.8 158.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 74.310000000000002 111.114 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.417 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 5.8 mp -107.05 147.97 29.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 75.200000000000003 110.893 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.57 150.03 49.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 38.1 mmt -79.37 106.38 11.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.844 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.67 73.57 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 72.299999999999997 111.08 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 102' ' ' ASN . 34.3 t-20 -105.02 -81.79 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 110.924 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 176.8 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.299999999999997 111.129 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.31 171.34 38.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 65.109999999999999 112.476 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 65.25 112.335 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 65.58 32.41 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 109' ' ' GLY . 29.2 p -148.02 69.52 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 74.430000000000007 111.13 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.55 18.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.911 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 107' ' ' THR . . . -63.74 -144.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.8 -0.714 . . . . 74.409999999999997 112.434 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 t 51.68 -150.92 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 72.349999999999994 110.897 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -77.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 73.329999999999998 110.931 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.53 172.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.549999999999997 110.852 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 138.66 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 73.519999999999996 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.68 114.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 73.519999999999996 111.119 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.5 p -71.43 -27.23 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 57.53 17.08 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 62.299999999999997 111.132 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.56 137.48 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 75.010000000000005 111.09 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -51.21 129.99 25.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.6 p -131.5 59.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 64.420000000000002 111.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -51.24 -24.0 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 74.049999999999997 110.893 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -63.13 -30.29 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.914 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.8 mt -111.68 64.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 64.299999999999997 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -110.74 15.89 21.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.230000000000004 110.809 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.64 31.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 63.219999999999999 112.487 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -126.17 -62.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 73.209999999999994 110.874 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -98.0 121.72 40.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.854 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.9 t -58.45 96.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 111.095 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.79 128.22 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 72.519999999999996 111.071 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.5 43.33 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.862 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -119.19 -168.45 14.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.340000000000003 112.467 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp 178.48 150.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 74.219999999999999 110.909 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.26 85.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 74.519999999999996 111.114 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -66.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.519999999999996 110.892 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.02 123.11 13.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 63.219999999999999 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.44 73.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 44.030000000000001 112.497 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -93.55 -28.69 15.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 110.859 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -70.07 -34.91 73.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 73.310000000000002 110.903 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 142' ' ' MET . 29.1 mm -66.77 -38.01 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.350000000000001 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.46 -0.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 111.14 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -117.7 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.400000000000006 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.45 -57.94 10.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 62.409999999999997 111.072 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.4 ttm -50.7 -29.97 12.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 65.219999999999999 110.89 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.430000000000007 110.866 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -62.45 -13.47 30.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 110.856 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.18 17.1 3.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.109999999999999 110.89 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.15 -146.07 19.61 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 71.230000000000004 112.489 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -152.51 -87.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 70.310000000000002 110.883 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -156.04 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.129999999999995 110.874 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.12 19.94 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.871 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.56 -157.72 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 55.140000000000001 112.548 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.7 mttt 63.15 101.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 74.140000000000001 110.896 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -84.02 155.45 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.340000000000003 111.148 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -17.21 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 62.130000000000003 110.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -126.92 -165.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 72.219999999999999 110.883 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.55 106.24 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.4 mt -94.03 122.73 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.030000000000001 111.141 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.4 p -139.02 169.52 17.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 20.1 mt -107.04 99.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.519999999999996 111.165 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.53 8.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.127 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -133.15 168.64 18.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.200000000000003 110.845 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.1 p -176.95 -167.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.864 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.82 -152.06 16.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 44.020000000000003 112.512 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.69 129.72 55.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 74.319999999999993 110.913 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -100.06 -29.45 12.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.898 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.030000000000001 110.864 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 74.319999999999993 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.93 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.439999999999998 111.134 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -97.76 159.39 31.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 71.420000000000002 110.895 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 148.57 65.44 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 74.030000000000001 112.378 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 173.74 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 73.230000000000004 111.118 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -167.2 143.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 111.108 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -124.36 154.57 40.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 110.83 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -135.98 132.49 36.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 65.549999999999997 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.23 108.39 19.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.824 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mm -80.96 110.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.219999999999999 111.169 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.15 172.66 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 71.299999999999997 111.133 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.27 94.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.319999999999993 111.08 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 72.09 56.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.858 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.51 11.63 57.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 64.519999999999996 112.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -123.69 107.37 31.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 73.25 110.875 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 138.56 37.95 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.634 2.223 . . . . 74.530000000000001 112.349 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -103.31 -53.23 2.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.540000000000006 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.5 -154.23 9.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 75.400000000000006 112.491 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 168.12 24.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 73.329999999999998 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 -177.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.099999999999994 111.123 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -130.09 96.88 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 65.239999999999995 110.826 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -93.34 115.26 27.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 70.200000000000003 110.909 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.32 113.88 25.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.884 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.8 mt -80.25 140.01 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.549999999999997 110.894 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 82.58 6.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 71.400000000000006 110.848 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -29.86 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 75.439999999999998 111.104 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.28 -28.19 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 54.240000000000002 110.831 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 -34.55 11.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.310000000000002 110.898 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 15.5 m -131.9 88.79 40.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 73.450000000000003 111.152 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.63 12.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.661 2.241 . . . . 73.310000000000002 112.336 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.92 -48.48 11.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 21.6 m -76.7 7.93 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 73.549999999999997 111.132 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.18 -40.98 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 35' ' ' ASN . 13.5 pt-20 -90.76 -32.6 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 75.230000000000004 110.864 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' GLU . 54.4 t-20 -30.87 -70.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 110.881 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -71.44 -30.95 66.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.5 tmm_? -50.21 -43.1 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 73.510000000000005 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.34 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 111.122 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 21.56 12.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.2 t -127.61 -26.67 2.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.200000000000003 110.843 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -109.89 -16.53 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 64.140000000000001 111.098 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.63 86.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 73.340000000000003 112.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -170.23 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 73.200000000000003 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 20.73 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.120000000000005 110.9 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 -26.18 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 64.0 112.465 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -147.86 -176.34 5.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 73.230000000000004 110.871 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.92 -144.49 16.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 43.009999999999998 112.494 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.84 174.22 6.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.988 0.423 . . . . 75.049999999999997 110.918 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 14.43 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.329999999999998 110.927 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -158.82 44.36 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 72.109999999999999 112.494 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -89.99 133.53 34.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 110.873 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.7 m -51.89 172.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 73.209999999999994 110.866 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 73.37 1.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 74.010000000000005 110.838 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -70.61 175.24 5.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.540000000000006 110.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.88 104.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.827 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.1 mt -148.51 132.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 111.135 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.8 pt -154.17 109.14 2.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 74.340000000000003 111.147 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 126.69 13.61 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.654 2.236 . . . . 70.340000000000003 112.347 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.45 3.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 72.439999999999998 112.491 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.4 -75.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 75.010000000000005 110.843 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.22 -164.5 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 53.420000000000002 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.4 m -125.51 -70.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 65.37 153.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.951 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 73.420000000000002 112.527 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.827 0.346 . . . . 74.140000000000001 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 t -145.16 120.0 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 71.319999999999993 110.856 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.84 -19.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 75.310000000000002 111.102 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 -22.0 14.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.24 -112.8 0.35 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.729 -0.748 . . . . 55.450000000000003 112.501 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -108.96 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 110.872 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -159.96 155.77 26.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.882 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -112.65 171.27 7.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 110.849 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.71 142.49 30.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.878 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.62 141.84 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.200000000000003 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -102.91 -64.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 110.841 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.29 165.81 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.864 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.17 45.69 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.894 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.88 -11.27 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.230000000000004 111.123 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.18 70.12 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 64.239999999999995 110.946 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -61.35 130.32 45.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.869 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.97 90.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 110.83 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 p -99.28 31.69 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 72.450000000000003 111.163 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.69 177.47 26.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 75.340000000000003 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.24 7.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.252 . . . . 73.239999999999995 112.34 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.33 14.07 66.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.329999999999998 112.457 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -86.99 125.49 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 73.510000000000005 111.174 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.05 137.81 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 110.927 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 13.8 t -141.67 -130.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 62.130000000000003 110.826 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.9 mmt -149.94 -175.05 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 110.844 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -169.05 147.28 3.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 111.137 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.8 m-20 166.5 -78.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 71.340000000000003 110.878 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.98 -35.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 71.129999999999995 111.156 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.77 -127.19 2.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 64.219999999999999 112.499 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 149.03 66.25 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.340000000000003 112.352 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 51.5 29.3 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.099999999999994 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 108' ' ' ASN . 3.1 m -132.87 21.79 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.510000000000005 111.139 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 107' ' ' THR . 3.2 m120 29.49 -98.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.219999999999999 110.865 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.91 169.31 13.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 71.230000000000004 112.522 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.57 11.65 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 70.150000000000006 110.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -175.26 156.58 2.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.219999999999999 110.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -111.82 150.18 30.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 62.210000000000001 110.867 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 114' ' ' ILE . 18.6 p90 -108.92 67.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.540000000000006 110.886 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 113' ' ' PHE . 36.0 mt -32.19 115.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 111.148 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.0 m -84.13 149.26 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 110.843 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.4 p -113.71 18.56 17.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 74.519999999999996 111.144 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -166.19 -176.59 3.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.420000000000002 111.108 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -77.53 104.47 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.907 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -126.79 55.51 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 75.239999999999995 111.137 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 21.99 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.867 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -94.94 11.03 33.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 75.439999999999998 110.881 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.08 25.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.923 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -58.17 -65.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 75.019999999999996 110.873 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.87 83.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.140000000000001 112.464 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 179.38 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 72.049999999999997 110.863 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -126.89 162.5 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.239999999999995 110.861 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.429 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -76.26 -166.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 111.18 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.2 p -170.34 141.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 111.143 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.546 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 2.6 p90 -177.66 110.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.1 145.98 7.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 73.409999999999997 112.464 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -157.68 139.53 14.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 110.931 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.45 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 111.132 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -32.83 65.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.96 178.31 8.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 73.040000000000006 110.866 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.17 57.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 64.030000000000001 112.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 75.420000000000002 110.851 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -54.55 -22.38 12.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 34.9 mm -78.11 -41.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 62.420000000000002 111.178 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -53.75 -47.2 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 111.136 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.23 -29.09 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.98 -26.7 61.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.420000000000002 111.129 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.403 ' C ' ' H ' ' A' ' 144' ' ' ARG . 21.2 mtm -73.48 -49.3 27.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.230000000000004 110.891 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.67 39.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 72.530000000000001 110.896 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -125.53 -16.42 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 75.120000000000005 110.818 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -130.52 13.09 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.200000000000003 110.926 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.45 44.82 1.44 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.733 . . . . 52.109999999999999 112.463 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t 37.45 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 52.009999999999998 110.877 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -141.36 18.08 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -128.79 -18.54 3.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.866 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.51 -59.55 0.48 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 75.319999999999993 112.444 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.78 158.48 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.879 0.371 . . . . 73.209999999999994 110.885 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.77 154.01 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 75.140000000000001 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -21.48 59.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 110.825 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -132.28 165.93 23.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 75.439999999999998 110.877 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -108.47 124.07 49.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.881 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -97.61 107.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.549999999999997 111.135 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.54 145.1 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 64.450000000000003 111.114 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.44 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -90.29 139.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.400000000000006 111.137 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.92 -57.76 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 71.310000000000002 111.123 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -167.2 169.08 12.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.109999999999999 110.852 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.0 m -146.95 168.87 20.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 72.099999999999994 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.45 178.48 35.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 70.219999999999999 112.495 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -47.2 48.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 71.439999999999998 110.859 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 61.72 108.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 110.844 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 63.340000000000003 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.75 143.88 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 70.420000000000002 111.094 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -54.76 134.75 65.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.664 0.745 . . . . 75.340000000000003 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.510000000000005 112.323 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.2 m -115.05 138.79 50.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 111.146 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.49 147.65 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 111.136 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -107.98 146.23 32.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.21 133.12 45.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 75.409999999999997 110.879 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.82 127.6 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.89 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.34 120.15 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.230000000000004 111.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.22 37.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 54.020000000000003 111.104 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.01 106.71 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.140000000000001 111.129 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 71.17 35.44 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 74.120000000000005 110.863 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.19 -6.69 78.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 65.120000000000005 112.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -98.06 136.42 21.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 75.430000000000007 110.917 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 133.72 26.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.718 2.279 . . . . 63.210000000000001 112.333 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -116.81 -34.94 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.924 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -176.87 43.51 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 75.510000000000005 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.27 152.62 50.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 75.109999999999999 110.886 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 173.86 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 72.319999999999993 111.128 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.0 p -139.72 143.56 37.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.883 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -122.48 133.18 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 110.886 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -101.87 123.15 45.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 71.540000000000006 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.45 124.35 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.299999999999997 110.898 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -77.01 62.86 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.430000000000007 110.835 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.25 -29.36 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 63.049999999999997 111.093 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.52 -45.6 91.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.847 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -90.14 -31.19 17.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 72.400000000000006 110.915 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 129' ' ' PHE . 2.9 m -129.8 84.9 59.64 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.624 0.726 . . . . 75.450000000000003 111.092 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -31.33 20.86 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.719 2.279 . . . . 63.420000000000002 112.32 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -46.24 10.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 110.869 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -6.73 42.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.168 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.56 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 111.072 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 35' ' ' ASN . 51.6 mt-10 -92.46 -44.31 8.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 110.88 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.7 t30 -28.0 -64.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.936 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -72.0 -37.32 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 74.030000000000001 110.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.0 tmm_? -51.02 -35.64 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.409999999999997 110.863 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.72 -32.4 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.530000000000001 111.121 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -72.78 -54.31 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.019999999999996 110.882 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 m -56.37 -50.62 71.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.519999999999996 110.879 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.4 p -72.89 -26.92 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 111.171 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.75 101.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 75.319999999999993 112.482 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -149.53 34.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 110.886 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -131.7 3.55 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 71.340000000000003 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.32 15.96 63.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 71.400000000000006 112.498 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -174.69 173.96 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 75.150000000000006 110.906 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.89 -172.43 15.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 63.140000000000001 112.482 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.36 144.66 27.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.97 0.415 . . . . 75.349999999999994 110.89 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.49 -60.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.936 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.4 45.77 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 73.439999999999998 112.42 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -93.59 -171.04 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 73.239999999999995 110.831 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.8 m -87.65 -167.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 110.893 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.29 -174.09 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 71.230000000000004 110.842 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.3 -76.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.230000000000004 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.11 162.71 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.030000000000001 110.877 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.5 mt -149.83 129.9 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 73.019999999999996 111.077 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -143.94 117.94 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.641 0.734 . . . . 71.439999999999998 111.14 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 130.63 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.73 2.287 . . . . 62.43 112.349 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.68 21.7 79.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 53.340000000000003 112.48 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.62 -69.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 74.450000000000003 110.857 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.52 -170.53 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 75.510000000000005 110.904 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.51 107.72 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.847 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.41 179.74 4.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.901 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.513 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.793 0.33 . . . . 62.340000000000003 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.419 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 4.0 t -127.14 107.97 10.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.875 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 pt -56.5 -19.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.129999999999995 111.135 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.64 28.94 7.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 72.099999999999994 110.919 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.16 -137.65 5.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 44.119999999999997 112.47 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' C ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -109.95 -34.78 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.909 0.385 . . . . 74.420000000000002 110.899 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -178.91 146.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.549999999999997 110.897 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 160.39 16.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 72.430000000000007 110.903 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.7 166.58 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -59.17 -174.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 72.519999999999996 110.938 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.85 -63.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.239999999999995 110.884 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -177.74 161.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.219999999999999 110.882 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 68.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.010000000000005 110.866 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.16 -1.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 111.168 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mt -119.24 111.67 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 63.43 110.904 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.65 175.08 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 110.922 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -96.85 83.76 3.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 73.109999999999999 110.822 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 21.67 13.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 111.162 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.79 145.76 12.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 71.230000000000004 112.495 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 115' ' ' CYS . 53.2 Cg_endo -69.82 -9.64 26.58 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.239999999999995 112.315 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -100.98 -20.02 15.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 73.430000000000007 112.507 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.56 141.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 75.140000000000001 111.145 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 17.3 mt -116.17 162.94 16.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 110.891 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 t -151.48 -142.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 72.140000000000001 110.891 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -152.12 133.73 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 110.89 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.16 103.44 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 111.071 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 1.9 p30 -131.97 -179.53 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 70.129999999999995 110.863 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.562 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -64.17 -34.5 78.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 111.128 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 119.76 -62.86 0.47 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 72.239999999999995 112.471 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.9 Cg_endo -69.75 94.61 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 2.269 . . . . 72.319999999999993 112.332 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 43.17 56.64 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.049999999999997 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 109' ' ' GLY . 4.2 m -121.26 -1.68 9.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 73.450000000000003 111.117 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 47.18 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 62.439999999999998 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 115.68 126.73 4.08 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 73.120000000000005 112.486 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.15 -31.0 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.319999999999993 110.86 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.76 145.01 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 73.349999999999994 110.925 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.62 179.64 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 75.310000000000002 110.936 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -150.5 130.7 13.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.908 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 45.2 mt -48.1 -87.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 75.409999999999997 111.126 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.5 OUTLIER 160.96 -61.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 72.420000000000002 110.875 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 67.85 -1.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 71.340000000000003 111.16 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . 174.95 151.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 111.111 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -55.5 132.5 48.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 74.530000000000001 110.875 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 69.5 p -129.95 52.62 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.164 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 72.349999999999994 110.86 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.25 -36.57 81.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 110.939 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.55 74.5 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 71.120000000000005 110.927 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -157.65 55.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.855 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.56 -44.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 71.120000000000005 112.494 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -64.74 -42.98 94.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.81 0.338 . . . . 62.350000000000001 110.868 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -112.83 166.07 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 73.140000000000001 110.813 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -68.57 -149.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 65.310000000000002 111.128 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.445 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 9.2 p -171.84 157.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 111.116 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' ' O ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER 179.4 167.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.903 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 57.03 142.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 61.509999999999998 112.462 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -154.4 133.09 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 75.310000000000002 110.885 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -44.94 114.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 73.239999999999995 111.116 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -88.43 -75.23 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 72.150000000000006 110.914 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -138.14 142.63 40.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 72.010000000000005 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.47 8.8 26.32 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 74.040000000000006 112.476 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.4 ttt -48.35 -32.33 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 64.200000000000003 110.882 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -49.31 -28.52 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.1 mm -78.21 -40.55 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 75.310000000000002 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.3 t -51.0 -47.15 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 111.142 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.96 -36.24 65.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 110.929 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.24 80.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 72.140000000000001 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.9 mtm -70.88 -19.13 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -89.41 21.79 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 75.519999999999996 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 -20.49 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.875 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -102.4 -6.02 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.540000000000006 110.937 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.11 3.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 73.239999999999995 112.513 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.17 135.28 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 73.349999999999994 110.849 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -70.94 79.69 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.109999999999999 110.864 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 175.77 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.26 -61.91 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 64.099999999999994 112.474 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -74.51 -178.07 3.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 75.319999999999993 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.7 22.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.155 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -21.64 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 73.420000000000002 110.819 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -131.76 -164.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 72.209999999999994 110.876 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 119.7 19.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 75.209999999999994 110.934 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.71 101.44 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 74.450000000000003 111.121 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.8 162.75 13.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 111.169 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.43 142.92 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.530000000000001 111.102 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -102.23 -55.35 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 70.430000000000007 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -142.93 179.43 7.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -170.97 -167.01 0.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 70.129999999999995 110.906 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 137.16 -148.16 19.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 65.099999999999994 112.475 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -112.08 136.91 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.129999999999995 110.869 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 tp -54.12 -57.0 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 62.43 110.935 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.355 . . . . 71.030000000000001 110.883 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.37 158.95 31.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.656 0.741 . . . . 52.530000000000001 110.865 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.77 65.08 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.684 2.256 . . . . 72.25 112.348 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -131.44 57.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.109999999999999 111.148 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -49.05 147.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 111.151 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.25 164.99 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 110.878 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -144.84 138.35 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.510000000000005 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.79 91.27 4.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 110.883 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.4 mm -59.76 143.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 111.151 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.63 163.39 22.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 74.219999999999999 111.136 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.4 t -151.8 104.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 75.150000000000006 111.14 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 52.39 46.32 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.841 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.6 10.97 83.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 34.350000000000001 112.469 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -133.66 109.1 12.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.738 . . . . 72.219999999999999 110.903 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.3 Cg_endo -69.75 168.92 20.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 72.209999999999994 112.374 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.06 -58.45 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.927 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.24 -167.64 27.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 73.019999999999996 112.49 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -100.24 127.75 46.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 72.099999999999994 110.909 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.407 HG21 HG13 ' A' ' 138' ' ' ILE . 7.7 t -101.65 120.16 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.219999999999999 111.124 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -94.93 84.28 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.54 95.51 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -78.41 153.64 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.5 110.866 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.06 133.21 56.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.209999999999994 110.888 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -81.54 78.64 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.879 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.9 -7.0 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.549999999999997 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -61.31 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.63 -60.01 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.869 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.57 83.2 4.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.632 0.729 . . . . 75.450000000000003 111.105 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 72.299999999999997 112.342 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 179.38 -59.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 70.140000000000001 110.908 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.1 m -56.31 -48.57 76.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 65.329999999999998 111.157 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.02 87.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 71.109999999999999 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.85 -30.11 9.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.85 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.62 -61.27 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.907 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.9 -33.65 57.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 74.540000000000006 110.837 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.28 -27.97 69.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.409999999999997 110.894 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 37' ' ' ARG . . . -93.0 -38.39 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.510000000000005 111.118 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -78.12 -2.6 38.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t -98.93 -8.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.848 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.6 p -115.96 8.02 14.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.3 37.0 30.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.734 . . . . 62.240000000000002 112.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -110.02 30.96 6.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 74.409999999999997 110.92 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.27 32.13 4.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.89 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.3 -45.1 2.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 62.409999999999997 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -138.91 167.04 22.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 72.310000000000002 110.892 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.67 -108.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.758 . . . . 74.420000000000002 112.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -177.25 124.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.389 . . . . 75.099999999999994 110.965 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -26.44 13.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.889 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.68 -67.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.741 . . . . 54.409999999999997 112.494 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t 45.42 -160.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 72.5 110.844 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -166.4 162.55 17.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 71.409999999999997 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -101.78 -78.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.540000000000006 110.868 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.74 25.82 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.510000000000005 110.872 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.94 21.42 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.66 138.87 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.106 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 mt -121.24 102.72 42.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.708 . . . . 74.349999999999994 111.127 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 77.89 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.702 2.268 . . . . 72.409999999999997 112.31 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.12 -40.82 0.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 63.140000000000001 112.494 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -64.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 72.310000000000002 110.917 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.96 -167.48 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 110.88 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 t -143.45 129.56 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 74.129999999999995 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -152.92 164.28 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 74.099999999999994 110.895 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 74.420000000000002 112.54 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 72.340000000000003 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.07 -177.4 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 110.855 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.36 -38.09 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 74.5 111.144 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -80.22 -13.26 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 75.200000000000003 110.927 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.84 -172.32 45.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 74.209999999999994 112.529 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.73 -96.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.898 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -121.44 176.71 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 74.040000000000006 110.89 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -149.42 153.94 38.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 110.915 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 164.03 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.871 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.04 145.75 25.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.838 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -52.32 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.874 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -179.0 163.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 53.340000000000003 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.03 36.99 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 110.877 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mm -53.19 -26.63 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 74.420000000000002 111.172 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.36 112.59 21.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.872 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -103.04 93.83 5.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 110.926 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -64.8 108.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 73.219999999999999 110.867 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.3 p -128.09 33.81 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.58 174.63 44.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 53.5 112.487 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 160.2 50.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 74.129999999999995 112.333 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 14.54 76.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 71.099999999999994 112.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 44.7 mm -99.98 137.5 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 74.239999999999995 111.154 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.12 138.31 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.340000000000003 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.56 131.89 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.230000000000004 110.866 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.42 ' HG2' ' CE1' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -71.34 -27.17 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.902 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.67 167.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 63.350000000000001 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 169.42 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 63.409999999999997 110.867 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -106.25 -20.14 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.116 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 130.41 -58.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 62.210000000000001 112.492 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.75 83.52 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 73.439999999999998 112.366 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 27.06 82.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.200000000000003 110.926 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 t -156.87 54.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.540000000000006 111.158 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -54.33 -40.87 68.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.914 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.76 -152.0 39.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 72.019999999999996 112.459 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.9 m -134.21 65.14 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 54.450000000000003 110.866 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -155.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.540000000000006 110.947 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -177.4 75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 1.5 t80 -90.33 129.01 36.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 110.882 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.7 mt -107.55 130.59 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 111.166 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.5 t -99.98 136.71 39.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -120.39 -20.46 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 111.115 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.86 179.01 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 75.120000000000005 111.113 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 87.98 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 73.200000000000003 110.888 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.411 ' HB ' ' CE2' ' A' ' 121' ' ' TRP . 8.4 p -122.5 62.61 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.155 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 23.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 110.869 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.411 ' CE2' ' HB ' ' A' ' 119' ' ' THR . 2.2 p90 -94.65 19.5 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.1 11.2 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 73.049999999999997 110.931 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.8 -63.44 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 71.430000000000007 110.837 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.31 57.7 3.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.659 -0.781 . . . . 65.200000000000003 112.521 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -156.81 -52.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 71.040000000000006 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -113.98 148.26 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 71.129999999999995 110.867 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.8 t -90.8 107.53 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.530000000000001 111.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.22 140.61 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 72.450000000000003 111.172 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.42 ' CE1' ' HG2' ' A' ' 100' ' ' MET . 9.3 p90 -159.93 33.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -126.16 -166.88 12.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 63.229999999999997 112.456 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER 167.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 75.230000000000004 110.935 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -112.73 93.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 64.430000000000007 111.157 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -52.0 -48.1 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.891 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.67 -175.85 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 73.0 110.922 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 53.17 71.48 0.68 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 64.109999999999999 112.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.53 3.38 52.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 74.209999999999994 110.913 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -79.15 -28.46 42.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 110.87 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 HG13 HG21 ' A' ' 20' ' ' VAL . 23.4 mm -68.58 -36.62 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 73.099999999999994 111.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.68 6.06 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 71.219999999999999 111.127 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -119.13 -62.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 110.865 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.09 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.400000000000006 111.082 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.35 -37.02 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.862 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -24.48 18.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 74.400000000000006 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.97 -11.23 36.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.879 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -86.06 22.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.93 -160.0 32.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 64.310000000000002 112.467 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.7 p -151.44 -71.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 75.120000000000005 110.853 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.72 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 73.25 110.861 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -105.74 15.1 27.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.938 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.82 -38.32 3.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 70.140000000000001 112.479 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -50.44 120.56 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 73.420000000000002 110.891 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 p -95.02 158.75 15.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -15.94 57.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 110.846 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.6 170.45 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 73.319999999999993 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -98.49 123.3 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.914 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.93 130.63 57.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.450000000000003 111.154 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.2 p -138.56 157.62 45.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 71.209999999999994 111.164 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.78 93.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 111.119 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.77 -57.83 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 111.071 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.54 162.48 41.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 75.510000000000005 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.5 p -156.01 160.56 40.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 75.430000000000007 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.84 45.25 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 75.430000000000007 112.482 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.63 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.7 mt-30 -68.18 -36.56 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 75.219999999999999 110.911 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.8 mm? 73.86 -58.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 75.549999999999997 110.873 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 110.918 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 74.349999999999994 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -126.05 143.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.122 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -53.51 145.34 28.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 40.329999999999998 110.895 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 129.4 17.51 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 74.340000000000003 112.354 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 m -119.98 147.3 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 111.132 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.45 165.09 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.11 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -122.54 153.79 38.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.866 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -136.09 128.88 31.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.905 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -95.32 126.56 40.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.219999999999999 110.872 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.53 119.36 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.329999999999998 111.169 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.0 163.13 15.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 75.319999999999993 111.124 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -147.67 92.84 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.129 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.05 31.12 4.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.030000000000001 110.85 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.12 -12.99 65.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 74.040000000000006 112.512 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -97.9 126.86 39.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.652 0.739 . . . . 74.319999999999993 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.4 69.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 75.129999999999995 112.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -117.76 -67.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.319999999999993 110.916 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.8 -159.6 10.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 63.219999999999999 112.506 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -127.99 124.27 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 110.903 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.8 t -113.11 90.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 72.420000000000002 111.13 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -85.16 147.8 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.823 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.68 140.02 40.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 75.349999999999994 110.884 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -91.21 161.97 14.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.299999999999997 110.895 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.9 119.57 37.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 73.439999999999998 110.907 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -74.85 61.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 75.530000000000001 110.902 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.98 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 74.409999999999997 111.137 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.91 -65.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -74.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 65.400000000000006 110.899 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 129' ' ' PHE . 12.9 m -84.58 116.71 66.39 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 111.162 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.706 2.271 . . . . 72.450000000000003 112.331 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -66.28 -43.69 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.918 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -48.24 -27.96 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 111.152 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.17 -39.27 29.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 53.020000000000003 111.104 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.92 -156.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 61.140000000000001 110.878 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t30 69.85 -68.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 61.530000000000001 110.903 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.01 -29.03 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 110.909 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -52.03 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 71.439999999999998 110.89 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.95 -28.09 43.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.200000000000003 111.082 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.08 19.47 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.8 t -144.8 -31.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 63.210000000000001 110.881 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -103.94 -32.97 9.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 74.530000000000001 111.097 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 120.08 2.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 61.240000000000002 112.513 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.41 -47.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 71.530000000000001 110.884 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -11.37 57.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 110.907 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.77 7.52 35.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 74.530000000000001 112.515 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' C ' ' A' ' 47' ' ' GLY . 2.6 m-85 -93.02 -24.77 18.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 73.540000000000006 110.871 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -29.05 130.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 51.210000000000001 112.467 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -95.2 34.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.933 0.397 . . . . 73.519999999999996 110.915 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.98 147.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.873 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.05 62.15 4.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 72.349999999999994 112.476 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -125.82 -168.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 72.340000000000003 110.906 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 m -120.85 -169.69 1.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.299999999999997 110.896 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.06 127.75 55.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.839 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -63.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.813 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -157.58 -179.51 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 110.841 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.406 ' CG2' ' HA3' ' A' ' 146' ' ' GLY . 65.8 mt -150.55 136.22 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.349999999999994 111.142 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -140.27 105.41 6.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.573 0.701 . . . . 75.019999999999996 111.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 159.4 53.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 71.010000000000005 112.31 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.93 -34.53 3.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 64.340000000000003 112.508 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -111.18 -82.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 73.530000000000001 110.86 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.53 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 175.13 119.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.861 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.41 177.29 8.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 72.450000000000003 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.04 174.55 10.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.919 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 75.25 112.508 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 110.934 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.514 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER -83.68 5.76 23.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 110.858 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 77' ' ' SER . 2.5 mt 83.0 -43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 71.420000000000002 111.106 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -72.65 70.24 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.939 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.43 -72.25 2.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 41.109999999999999 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.0 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 65.019999999999996 110.835 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -117.75 162.94 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 75.510000000000005 110.896 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -141.22 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.150000000000006 110.865 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.79 164.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -77.85 113.04 15.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 75.340000000000003 110.858 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -56.28 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.209999999999994 110.848 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.08 149.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 72.230000000000004 110.894 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -111.84 58.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.854 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.97 -10.96 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.420000000000002 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 137.33 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 110.92 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -128.34 -172.89 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 71.299999999999997 110.892 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 94' ' ' GLY . 61.7 m-70 -95.18 -89.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 110.881 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m 76.54 -15.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.178 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 92' ' ' HIS . . . -168.34 163.22 36.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 74.540000000000006 112.485 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 118' ' ' LYS . 53.8 Cg_endo -69.79 143.19 49.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.619 2.213 . . . . 75.329999999999998 112.392 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.16 -41.28 2.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.737 -0.744 . . . . 74.340000000000003 112.457 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.6 mm -50.42 150.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 75.439999999999998 111.152 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -123.18 161.11 25.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 110.886 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.2 m -158.8 -129.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.894 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.0 mtp -142.83 -159.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 73.209999999999994 110.92 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 173.38 81.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.319999999999993 111.084 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 107' ' ' THR . 2.0 t30 -104.13 -158.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.24 42.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 52.299999999999997 111.085 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.73 168.82 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 71.200000000000003 112.468 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.67 26.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 72.109999999999999 112.335 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 56.35 34.13 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 54.039999999999999 110.871 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 102' ' ' ASN . 16.3 p -137.67 26.66 2.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 75.319999999999993 111.144 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.1 t30 50.62 -97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 74.349999999999994 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.74 -85.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.727 . . . . 62.420000000000002 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 t 71.0 36.76 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 74.219999999999999 110.872 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -92.22 -34.95 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 74.319999999999993 110.894 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.0 t80 68.57 75.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 63.399999999999999 110.908 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.401 ' CE1' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -108.49 129.67 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.47 121.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 73.409999999999997 111.169 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.5 p -73.91 136.92 43.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.902 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 t -109.89 -16.58 13.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 111.134 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.65 24.57 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 71.209999999999994 111.116 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 1.2 tmtt? 58.17 103.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.2 p -121.38 71.63 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.45 20.34 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.835 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -9.01 58.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 110.929 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -47.87 8.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 72.329999999999998 110.918 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -56.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.019999999999996 110.851 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.58 47.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.693 -0.765 . . . . 74.430000000000007 112.507 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -96.73 -31.02 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 73.329999999999998 110.932 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -132.36 124.87 29.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.129999999999995 110.825 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.8 t -49.37 111.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 111.103 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 111.156 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.436 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.6 p90 -165.66 34.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.310000000000002 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -122.41 -173.22 14.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.717 . . . . 75.230000000000004 112.508 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 174.57 144.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 71.329999999999998 110.928 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.12 90.22 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.150000000000006 111.154 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -59.96 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.519999999999996 110.856 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.55 142.0 10.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 61.439999999999998 110.863 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.48 2.99 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 75.230000000000004 112.484 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.18 -32.19 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 74.310000000000002 110.827 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -50.4 -27.95 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 72.019999999999996 110.925 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 24.5 mm -80.09 -40.81 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.141 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -48.83 -52.82 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 72.219999999999999 111.162 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.78 -30.59 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.868 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.69 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 111.121 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 19.1 mtm -62.81 -30.12 71.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.859 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.13 -55.07 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.310000000000002 110.874 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -22.5 66.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 75.099999999999994 110.84 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.94 -6.28 59.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.869 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.406 ' HA3' ' CG2' ' A' ' 56' ' ' ILE . . . -89.94 -157.35 33.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 54.450000000000003 112.537 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 p -164.49 142.59 6.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 74.209999999999994 110.86 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -74.63 73.31 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 110.922 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 175.93 -33.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.919 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.17 -67.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 73.420000000000002 112.491 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.45 159.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.299999999999997 110.92 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -131.19 156.67 44.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 111.174 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.8 t -77.41 -18.05 57.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 110.879 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -134.22 -165.67 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 75.150000000000006 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -138.63 136.08 35.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.25 110.915 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.02 119.04 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 26.5 p -106.01 163.69 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.152 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.3 mt -106.48 134.83 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.113 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.63 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.084 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.76 171.95 16.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.0 m -151.86 122.8 7.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 73.200000000000003 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -150.36 178.13 28.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 62.219999999999999 112.471 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 123.07 24.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 75.239999999999995 110.935 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 -58.88 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.049999999999997 110.887 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 55.5 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.230000000000004 110.846 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 75.439999999999998 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 75.030000000000001 111.071 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.91 157.27 39.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.729 . . . . 60.340000000000003 110.892 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.98 52.42 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 74.519999999999996 112.33 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.9 m -138.44 93.87 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 70.310000000000002 111.145 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 2.4 m -77.03 143.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 111.108 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -132.26 162.51 30.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.888 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.84 152.84 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 74.400000000000006 110.911 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -109.35 114.75 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 75.450000000000003 110.855 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 tt -86.01 147.83 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 75.140000000000001 111.125 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -141.14 164.26 30.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 111.131 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.33 105.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 73.209999999999994 111.137 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 66.88 50.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 72.420000000000002 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.19 20.6 67.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 60.399999999999999 112.496 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -134.4 107.29 11.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 75.209999999999994 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.81 141.76 45.91 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 73.239999999999995 112.306 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.63 24.9 7.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.898 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.53 -167.26 14.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.738 . . . . 52.310000000000002 112.474 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -178.72 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 75.010000000000005 110.832 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.32 161.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.093 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.6 t -114.44 91.79 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 110.832 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -83.52 102.49 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.873 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.27 111.06 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 110.892 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.4 mt -85.51 140.66 30.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 62.310000000000002 110.935 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.65 81.3 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.842 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.71 -3.69 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 111.122 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -87.47 -38.33 16.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.519999999999996 110.832 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.96 -23.76 17.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 72.420000000000002 110.921 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.59 73.06 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 75.519999999999996 111.11 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -6.81 19.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.272 . . . . 72.420000000000002 112.374 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 -51.84 5.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.902 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -53.77 7.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 61.509999999999998 111.066 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -31.41 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.239999999999995 111.079 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.44 -56.47 8.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 110.835 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HA ' HG12 ' A' ' 78' ' ' ILE . 1.8 t30 -47.86 -39.61 19.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 110.865 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -77.83 -32.77 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 72.109999999999999 110.888 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -35.98 81.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 75.099999999999994 110.858 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.31 67.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 51.409999999999997 111.124 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.3 -32.56 70.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 110.906 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -60.14 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.884 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.1 p -72.91 -17.01 61.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 111.089 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.19 44.53 93.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.722 -0.751 . . . . 71.150000000000006 112.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -28.85 69.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 74.450000000000003 110.886 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -70.72 -125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 71.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.06 18.18 3.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 62.109999999999999 112.45 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -165.57 -174.55 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 74.409999999999997 110.848 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.21 124.61 2.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 73.230000000000004 112.488 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.9 155.61 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.993 0.425 . . . . 74.510000000000005 110.907 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -157.01 -38.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 71.409999999999997 110.898 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.25 27.7 12.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 54.43 112.488 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 170.56 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 64.400000000000006 110.894 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -140.53 153.1 46.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 70.25 110.861 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.92 134.32 53.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 75.120000000000005 110.885 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.37 34.22 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.109999999999999 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -138.31 33.17 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 110.921 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 27.7 mt -82.71 140.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 75.439999999999998 111.096 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.38 113.62 23.37 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.596 0.712 . . . . 75.200000000000003 111.107 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 81.38 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 73.439999999999998 112.356 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.81 0.24 4.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.748 -0.739 . . . . 75.140000000000001 112.498 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.337 . . . . 75.329999999999998 110.852 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.25 -160.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 70.329999999999998 110.889 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 82.4 m -136.96 -41.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 64.340000000000003 110.921 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 65.28 150.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.140000000000001 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 73.420000000000002 112.512 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.793 0.33 . . . . 74.010000000000005 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.28 157.2 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.91 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -67.52 -11.84 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 70.099999999999994 111.14 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.27 13.8 20.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.47 -162.85 23.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 74.230000000000004 112.485 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.1 -42.55 60.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.939 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -177.24 173.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 70.219999999999999 110.846 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.53 168.29 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 110.866 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.69 162.6 16.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.895 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.01 149.42 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.329999999999998 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.7 -63.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 73.150000000000006 110.857 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -176.39 173.7 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 73.450000000000003 110.844 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 45.65 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 74.340000000000003 110.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.73 -25.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.94 119.28 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.937 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -100.86 112.42 24.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 71.510000000000005 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.94 99.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 61.299999999999997 110.841 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.2 p -127.45 36.25 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.329999999999998 111.159 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.11 39.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 61.039999999999999 112.533 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.62 23.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 72.439999999999998 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.01 22.58 72.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 72.230000000000004 112.481 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mm -95.39 117.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 74.439999999999998 111.15 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 tt -83.78 121.47 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 110.891 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -119.58 142.63 48.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.329999999999998 110.889 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 mmt -81.74 102.75 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 63.530000000000001 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -84.91 146.38 27.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 111.109 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER 165.97 -166.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 65.140000000000001 110.854 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.22 -52.96 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.150000000000006 111.093 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.05 -87.75 0.27 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.727 -0.749 . . . . 74.420000000000002 112.455 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 125.19 11.86 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.43 112.351 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 45.6 36.12 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.2 p -146.77 56.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.439999999999998 111.158 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -50.99 -52.91 38.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.519999999999996 110.827 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.38 -168.58 54.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 75.140000000000001 112.488 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 t -119.85 -5.7 10.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 64.0 110.835 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -64.76 156.62 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.876 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.4 162.37 40.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.219999999999999 110.874 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -160.57 140.5 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 110.869 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -91.88 125.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 75.540000000000006 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.4 m -74.49 -32.4 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 110.919 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 m 55.86 14.69 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.519999999999996 111.138 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.53 167.99 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 63.240000000000002 111.108 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -63.35 133.44 54.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.6 p -145.34 43.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 111.164 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -66.11 -10.21 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 73.019999999999996 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -75.9 -9.6 58.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 110.923 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.17 -17.98 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 72.219999999999999 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 124' ' ' GLY . 11.0 m-20 51.64 70.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.519999999999996 110.818 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.17 43.76 0.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 64.5 112.481 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -73.8 133.32 43.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.349 . . . . 74.400000000000006 110.955 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 64.53 28.95 13.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 110.851 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 60.85 -163.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 111.147 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.1 p -179.13 145.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.145 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 2.0 p90 -176.68 125.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 74.540000000000006 110.91 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.86 145.92 14.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 74.540000000000006 112.554 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -165.74 151.72 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 74.120000000000005 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -55.76 168.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 111.095 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -147.81 -39.89 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.902 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -132.26 155.37 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.879 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.24 78.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.49 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -2.22 47.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 72.530000000000001 110.901 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.26 -29.96 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.912 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.99 -43.79 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.105 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.3 t -88.2 6.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 111.156 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.06 -69.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 75.129999999999995 110.87 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.53 67.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 64.310000000000002 111.123 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -49.67 -35.44 21.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.88 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.49 54.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.299999999999997 110.836 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -141.31 0.32 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 110.859 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.69 15.96 26.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 73.5 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.12 -155.72 31.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 73.340000000000003 112.458 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.24 -169.23 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 73.540000000000006 110.881 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -77.77 -32.58 52.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.049999999999997 110.863 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -106.09 1.33 26.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.912 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.03 -146.25 16.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 61.329999999999998 112.455 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 64.78 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 65.200000000000003 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 59.3 p -82.56 146.01 29.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 64.319999999999993 111.154 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -21.99 62.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -135.19 -179.17 5.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.099999999999994 110.896 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -97.86 101.44 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.871 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mp -96.44 122.02 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.104 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.18 159.49 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.530000000000001 111.174 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.0 mt -87.88 116.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 75.310000000000002 111.143 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.28 -52.19 20.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.109999999999999 111.09 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -143.38 -179.59 6.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 65.219999999999999 110.866 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.1 p -171.23 -172.85 1.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.010000000000005 110.858 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.29 -149.21 20.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 73.040000000000006 112.455 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -127.55 141.95 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 72.530000000000001 110.926 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.82 166.6 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 73.439999999999998 110.856 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.17 156.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.329999999999998 111.101 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -93.63 157.21 38.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 75.349999999999994 110.908 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 151.83 69.13 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.678 2.252 . . . . 64.420000000000002 112.364 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -138.98 151.32 46.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 74.430000000000007 111.101 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.8 151.97 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 73.549999999999997 111.136 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.1 156.77 41.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 110.888 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -137.92 137.29 37.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.9 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.47 114.09 26.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.049999999999997 110.886 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mm -82.49 114.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 72.200000000000003 111.132 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.76 148.77 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.03 98.6 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 111.178 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.95 24.27 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.099999999999994 110.873 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.02 -21.62 45.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.019999999999996 112.471 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.36 150.2 36.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.637 0.732 . . . . 74.439999999999998 110.869 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.5 68.28 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 70.120000000000005 112.355 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 tp -125.53 -39.65 2.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.876 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.5 41.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 70.409999999999997 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.15 167.1 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 75.019999999999996 110.869 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.15 -179.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 62.409999999999997 111.106 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -131.59 95.66 3.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.831 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.78 138.15 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.019999999999996 110.854 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.45 156.06 27.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 74.340000000000003 110.884 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.08 118.07 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 72.140000000000001 110.896 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.59 77.93 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.209999999999994 110.869 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.1 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 111.083 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.02 -46.84 41.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -87.72 -18.49 29.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.885 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.44 84.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.633 0.73 . . . . 74.140000000000001 111.143 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -27.65 26.29 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 73.209999999999994 112.341 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -76.47 -57.36 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 71.25 110.89 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.7 m -51.7 -43.55 62.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.195 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.45 78.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.450000000000003 111.139 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -25.01 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 70.129999999999995 110.848 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -66.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.310000000000002 110.935 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -52.59 -39.7 61.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 110.918 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -33.8 15.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 111.138 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.13 26.12 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.109999999999999 110.959 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.3 t -121.2 -5.69 9.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 63.039999999999999 110.872 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.8 p -118.47 15.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 111.183 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.98 24.81 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 60.420000000000002 112.488 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -83.78 -21.89 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 72.340000000000003 110.884 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 17.64 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.219999999999999 110.96 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.33 -52.5 4.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 64.109999999999999 112.493 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.03 155.92 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 74.239999999999995 110.898 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 -136.69 3.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 73.329999999999998 112.507 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -22.55 17.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.393 . . . . 75.019999999999996 110.865 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.63 112.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.150000000000006 110.879 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.77 55.55 20.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 54.219999999999999 112.479 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 m -113.85 3.85 15.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 54.130000000000003 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m 50.61 -168.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 65.439999999999998 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -111.41 154.37 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 64.140000000000001 110.887 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -93.34 -64.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 75.109999999999999 110.841 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.5 148.12 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 74.299999999999997 110.922 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.2 mt -142.49 117.81 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 75.010000000000005 111.142 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.42 99.9 23.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 75.019999999999996 111.148 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 93.71 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.215 . . . . 73.319999999999993 112.384 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.43 -26.18 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 52.5 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.55 -56.54 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 73.310000000000002 110.843 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.49 ' HG2' ' N ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -174.49 -165.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.85 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.49 ' N ' ' HG2' ' A' ' 61' ' ' MET . 0.7 OUTLIER -146.32 144.9 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.834 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -94.52 -168.71 1.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.897 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.518 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.808 0.337 . . . . 74.129999999999995 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -105.03 126.39 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 64.430000000000007 110.888 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 -13.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 111.116 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.48 -16.38 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.941 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.31 -107.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 54.149999999999999 112.504 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -109.45 -55.76 2.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 71.540000000000006 110.913 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -166.74 151.09 7.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 74.230000000000004 110.904 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.09 144.13 51.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.219999999999999 110.9 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -52.98 153.52 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.876 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.04 136.38 33.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 73.420000000000002 110.865 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.14 -55.32 6.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.854 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -176.83 -173.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.861 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -132.34 38.49 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.885 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -51.34 -25.16 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.125 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.61 110.58 18.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 64.5 110.897 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -98.68 -166.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.93 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -102.09 -98.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.340000000000003 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 65.6 7.1 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 111.141 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.51 163.36 30.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 75.519999999999996 112.499 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.72 10.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 73.549999999999997 112.341 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.43 31.51 54.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.467 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.51 131.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 73.030000000000001 111.162 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.61 136.98 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 113' ' ' PHE . 5.7 t -105.95 -133.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 74.349999999999994 110.824 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.82 -34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 110.896 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 66.84 97.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.310000000000002 111.141 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.86 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 72.129999999999995 110.919 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.445 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -82.68 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 111.077 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 126.2 -63.42 0.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 71.019999999999996 112.462 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.72 -92.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.319999999999993 112.362 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -138.84 92.14 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.4 p -143.39 21.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.159 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 44.86 -91.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 72.450000000000003 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.95 -69.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 71.200000000000003 112.488 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 t 67.52 36.12 3.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 72.530000000000001 110.87 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -103.27 -97.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 110.943 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 170.3 173.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 64.340000000000003 110.911 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER 178.21 57.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.519999999999996 110.897 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.7 mt -65.47 85.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.200000000000003 111.162 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.6 m -70.96 145.68 49.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.883 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.7 p -99.51 20.13 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 111.09 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -174.56 -167.84 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.101 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -78.46 134.01 37.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.842 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -134.27 49.74 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -63.21 -11.83 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 73.299999999999997 110.899 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -60.67 -26.28 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.883 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.8 -29.92 58.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 65.049999999999997 110.924 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 124' ' ' GLY . 21.5 t0 49.83 81.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.859 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 17.31 62.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.689 -0.767 . . . . 45.219999999999999 112.505 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ASP . 22.1 tptp -103.57 -25.35 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 73.319999999999993 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 64.6 m-70 -96.83 -6.96 34.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 75.109999999999999 110.834 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 7.9 t 76.66 80.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.59 138.67 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 111.149 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -154.57 26.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.299999999999997 110.897 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.9 -179.01 15.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 52.229999999999997 112.506 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 140.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 70.439999999999998 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.4 t -86.96 80.4 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 71.340000000000003 111.148 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -43.53 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 73.430000000000007 110.858 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.43 168.24 15.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.510000000000005 110.888 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.97 -0.09 44.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 72.129999999999995 112.46 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -33.44 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 74.019999999999996 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -51.13 -29.19 12.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.140000000000001 110.901 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 24.7 mm -76.22 -40.44 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 73.319999999999993 111.09 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 65.4 t -49.49 -47.49 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 111.111 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -52.12 -33.41 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.852 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.41 82.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.209999999999994 111.099 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 12.6 mtm -77.34 -14.64 59.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 75.120000000000005 110.908 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -86.44 14.27 6.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.129999999999995 110.9 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.9 1.2 2.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 110.869 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -105.06 -5.8 20.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.400000000000006 110.868 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.41 -151.26 9.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 63.420000000000002 112.474 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.1 m -145.94 -74.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.375 . . . . 53.32 110.847 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 110.86 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.87 2.67 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.886 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.85 -44.92 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 44.109999999999999 112.482 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.7 137.56 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 72.420000000000002 110.93 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.2 p -123.56 157.57 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.299999999999997 111.139 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.3 t -81.37 -17.24 49.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.349999999999994 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -135.2 -175.73 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.019999999999996 110.869 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -125.08 130.36 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.349999999999994 110.886 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.48 129.03 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.07 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 167.81 20.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.150000000000006 111.162 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.53 111.98 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.0 -50.99 36.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.085 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.34 162.85 33.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 63.509999999999998 110.9 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.4 p -165.73 168.18 16.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.46 -175.24 36.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 64.129999999999995 112.475 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 116.49 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 73.099999999999994 110.902 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.18 -39.64 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 73.319999999999993 110.933 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.140000000000001 110.864 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.804 0.335 . . . . 75.140000000000001 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.44 145.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.450000000000003 111.137 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.2 148.51 6.12 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.605 0.716 . . . . 74.109999999999999 110.924 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 126.11 12.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 73.319999999999993 112.336 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 m -106.6 108.86 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.14 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.72 141.96 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 73.530000000000001 111.146 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -111.99 159.99 17.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.430000000000007 110.893 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.31 138.03 29.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.896 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.4 109.16 17.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 74.549999999999997 110.906 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mt -94.49 148.32 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 111.138 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.34 164.53 28.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 111.04 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 154' ' ' LYS . 91.0 t -136.44 98.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.129 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 65.69 54.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 75.150000000000006 110.882 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.39 9.91 56.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.209999999999994 112.476 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -123.72 107.24 31.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.642 0.734 . . . . 71.319999999999993 110.877 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.77 143.43 50.79 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.652 2.234 . . . . 74.420000000000002 112.379 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.84 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 74.310000000000002 110.9 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.67 -167.8 26.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 54.109999999999999 112.473 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.07 120.58 40.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 74.209999999999994 110.852 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.23 102.47 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 72.450000000000003 111.132 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -110.24 147.19 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.439999999999998 110.88 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.83 109.04 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.907 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.29 127.88 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.846 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 26.9 mt -89.28 136.12 33.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 71.219999999999999 110.972 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -78.68 65.3 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.61 66.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 62.420000000000002 111.093 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.19 -55.42 12.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 73.540000000000006 110.898 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -60.58 3.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 33.0 m -99.37 101.18 12.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.596 0.712 . . . . 74.109999999999999 111.127 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -50.48 0.46 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.677 2.252 . . . . 75.319999999999993 112.366 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -44.68 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 74.450000000000003 110.895 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -86.04 23.13 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 64.019999999999996 111.138 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.78 -47.38 15.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 62.119999999999997 111.127 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.6 mt-10 -85.68 -24.29 27.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.150000000000006 110.876 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 34' ' ' GLU . 1.6 t-20 -28.29 -72.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.510000000000005 110.913 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.28 -30.19 42.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.519999999999996 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.45 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.0 ttp180 -49.27 -44.28 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.540000000000006 110.878 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.95 66.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.219999999999999 111.145 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.11 -41.92 76.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.897 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -64.1 -45.1 90.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 74.010000000000005 111.102 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.53 88.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 74.340000000000003 112.474 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.02 31.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 74.310000000000002 110.924 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -126.27 -15.7 5.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.919 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 21.65 14.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 71.319999999999993 112.515 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -178.28 -167.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 74.230000000000004 110.844 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.89 -177.24 43.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 75.540000000000006 112.44 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 104.7 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 73.329999999999998 110.906 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 -66.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.049999999999997 110.899 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.79 26.09 7.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 53.210000000000001 112.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -76.19 -164.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 63.100000000000001 110.866 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.2 p -153.07 172.74 16.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.875 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.4 -75.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.87 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.72 23.53 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.530000000000001 110.856 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.16 17.73 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.883 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.07 143.22 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.3 mt -127.49 103.39 22.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.674 0.749 . . . . 74.150000000000006 111.119 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.71 96.5 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.3 . . . . 72.010000000000005 112.318 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.19 -21.18 4.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.76 . . . . 71.209999999999994 112.485 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.06 -60.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.906 0.384 . . . . 73.040000000000006 110.878 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -167.63 -148.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 62.200000000000003 110.875 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -131.89 -58.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 65.74 118.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.549999999999997 110.878 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 65.120000000000005 112.476 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.788 0.327 . . . . 72.230000000000004 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 p -87.02 -174.74 5.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.879 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.52 -31.51 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.129999999999995 111.173 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -87.33 42.32 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.882 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.42 -113.78 3.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 73.219999999999999 112.48 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.37 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 74.530000000000001 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.07 -171.08 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 73.439999999999998 110.894 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -131.44 169.53 15.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.88 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.71 169.85 11.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -61.38 -167.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 65.430000000000007 110.844 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -152.59 -55.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 63.310000000000002 110.839 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.38 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 65.030000000000001 110.898 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.17 56.5 1.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.833 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.6 -0.45 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 73.400000000000006 111.111 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.67 132.4 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 74.150000000000006 110.923 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.69 126.68 40.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 72.430000000000007 110.931 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -53.44 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 63.140000000000001 110.882 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -95.02 4.61 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.319999999999993 111.166 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.02 -175.38 46.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.749 -0.739 . . . . 62.329999999999998 112.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 158.75 55.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.281 . . . . 65.230000000000004 112.347 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.15 -28.21 9.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 55.399999999999999 112.463 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.1 mm -57.81 124.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 71.530000000000001 111.14 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.883 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 112' ' ' PHE . 4.8 t -142.77 -152.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 63.509999999999998 110.857 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.4 mmt -141.11 135.34 30.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 110.858 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.903 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.91 -163.43 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 111.089 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.903 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 4.0 m120 116.61 -176.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 70.239999999999995 110.888 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.485 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -52.28 -41.28 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.340000000000003 111.053 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.58 -64.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 74.409999999999997 112.47 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 111.96 2.96 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.599 2.199 . . . . 62.25 112.353 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 42.47 61.56 1.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.0 p -152.5 54.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.176 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -43.38 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.109999999999999 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.24 -164.32 19.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 71.019999999999996 112.489 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 -31.76 5.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 73.209999999999994 110.867 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -55.51 149.02 14.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 74.099999999999994 110.9 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -160.95 158.05 27.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.861 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.4 -173.07 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 75.400000000000006 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.3 mt -113.51 -57.45 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 111.121 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.22 127.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -133.19 34.38 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 71.150000000000006 111.106 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.37 159.18 37.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 73.120000000000005 111.093 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -67.11 88.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.926 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 p -111.12 54.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.174 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.29 15.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 110.877 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 11.33 27.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 110.946 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 4.1 mt -109.26 -33.24 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 122' ' ' LEU . 4.3 t0 78.19 -42.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.857 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.61 2.78 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 75.340000000000003 112.515 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -62.94 -14.94 53.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 73.319999999999993 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -92.51 16.54 11.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.894 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 t 72.41 85.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.167 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.31 126.46 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 111.147 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.425 ' CG ' HG22 ' A' ' 29' ' ' VAL . 5.1 p90 -157.93 128.49 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.892 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 115.81 121.61 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 72.209999999999994 112.545 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -129.72 159.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 74.329999999999998 110.905 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.25 158.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 111.119 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -62.59 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 74.209999999999994 110.865 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.16 173.6 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 73.209999999999994 110.877 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.44 81.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 73.329999999999998 112.478 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -7.09 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 73.319999999999993 110.865 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -30.86 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.865 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 142' ' ' MET . 50.1 mm -65.69 -36.14 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.138 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.04 1.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 111.123 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -115.62 -64.0 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.854 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.25 -52.61 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 61.299999999999997 111.065 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 14.0 tmm? -51.9 -45.78 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 72.239999999999995 110.868 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -23.12 3.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 110.845 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.4 ttm-85 -63.28 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 75.510000000000005 110.877 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -92.91 20.13 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.885 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.73 68.14 0.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.540000000000006 112.447 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -27.35 135.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 72.430000000000007 110.837 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 13.6 mmm-85 -46.16 -63.68 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 75.510000000000005 110.903 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.81 -31.35 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 63.149999999999999 110.879 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.8 -167.69 22.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 75.530000000000001 112.521 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 mttt 61.72 103.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 73.219999999999999 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.5 p -77.68 144.35 37.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 74.150000000000006 111.15 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 p -60.9 -19.05 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 110.83 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -129.88 -168.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.905 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.4 108.46 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.894 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.95 99.87 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.143 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.15 157.1 23.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.32 111.121 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.12 126.01 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 75.239999999999995 111.185 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.31 -63.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.230000000000004 111.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -127.31 168.95 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.150000000000006 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.05 -176.1 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.349999999999994 110.847 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.97 -152.22 20.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.759 -0.734 . . . . 74.219999999999999 112.499 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.07 138.33 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.366 . . . . 72.319999999999993 110.854 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.92 143.98 45.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.963 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.85 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 110.882 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.43 144.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 111.153 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -52.2 141.73 30.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.618 0.723 . . . . 75.099999999999994 110.862 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 128.44 16.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 73.420000000000002 112.351 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -115.52 125.95 53.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 73.319999999999993 111.197 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.22 156.74 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 72.010000000000005 111.142 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -127.46 165.65 19.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.833 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.63 143.98 33.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 64.510000000000005 110.888 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.04 136.26 38.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 71.239999999999995 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mm -107.19 136.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 111.127 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.86 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 111.095 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -153.1 101.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.430000000000007 111.167 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 65.4 56.64 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 72.510000000000005 110.888 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.4 13.08 48.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.718 . . . . 54.340000000000003 112.512 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -124.04 113.42 28.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 75.340000000000003 110.903 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 153.32 68.87 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.348 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -112.51 -60.49 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.62 -164.33 27.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 65.200000000000003 112.468 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -108.99 121.49 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 75.230000000000004 110.853 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -119.37 111.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 71.25 111.119 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 p -111.09 152.61 26.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.869 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 112.9 15.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.329999999999998 110.889 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.33 137.39 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 72.310000000000002 110.881 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.5 113.35 26.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 110.92 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -85.99 70.79 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.86 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -1.88 43.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 111.112 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.36 -48.22 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.209999999999994 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -62.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.874 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.35 77.67 5.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.64 0.733 . . . . 74.409999999999997 111.117 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 72.85 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 74.439999999999998 112.371 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HG2' ' N ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -177.11 -42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.140000000000001 110.892 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.565 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -82.55 -61.85 1.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 64.310000000000002 111.127 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.43 22.17 4.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 75.209999999999994 111.115 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.37 12.67 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.876 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -121.5 -28.03 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 64.549999999999997 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -54.26 -26.75 30.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 110.883 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.23 -30.79 39.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 75.019999999999996 110.876 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.0 -26.67 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 111.077 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.08 19.44 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.349999999999994 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -118.02 -8.06 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.86 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -115.95 12.71 15.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 111.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.11 31.55 33.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 62.210000000000001 112.461 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.95 -34.18 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 74.230000000000004 110.898 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -19.97 62.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 65.340000000000003 110.914 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.88 18.8 60.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 71.340000000000003 112.473 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.8 151.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 73.430000000000007 110.902 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.49 -179.58 16.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 72.230000000000004 112.485 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.13 102.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 74.150000000000006 110.9 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 -51.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.92 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.94 32.73 2.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 43.350000000000001 112.475 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.32 -169.46 2.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 73.120000000000005 110.893 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.1 p -152.86 148.77 27.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 65.150000000000006 110.864 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.82 -177.61 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.439999999999998 110.898 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -171.87 60.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.831 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -137.23 29.54 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 110.883 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.49 143.27 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 75.420000000000002 111.141 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.5 mt -139.77 96.5 8.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.622 0.725 . . . . 75.230000000000004 111.108 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 85.13 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.255 . . . . 73.200000000000003 112.314 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.47 -40.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 71.519999999999996 112.486 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -58.19 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 73.409999999999997 110.867 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.97 -158.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 65.239999999999995 110.838 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.4 m -139.56 142.55 37.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 63.520000000000003 110.879 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -126.9 157.39 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 75.310000000000002 110.953 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 74.040000000000006 112.486 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.805 0.336 . . . . 74.329999999999998 110.871 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.663 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 40.5 t -118.74 10.83 12.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.861 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER 75.4 -8.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 111.092 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -110.28 -18.12 13.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 71.230000000000004 110.938 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.37 -134.38 2.01 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 73.340000000000003 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -123.98 -33.84 3.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 74.219999999999999 110.888 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.42 163.95 10.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.879 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -144.28 135.6 25.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.299999999999997 110.883 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -51.02 162.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.209999999999994 110.903 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -75.29 92.67 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 73.129999999999995 110.882 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -51.67 51.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 177.51 167.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 110.891 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.340000000000003 110.907 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.38 -28.08 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 72.040000000000006 111.143 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.75 122.3 31.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 110.892 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -108.39 -166.55 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.891 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -99.88 -88.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.219999999999999 110.837 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.6 m 69.46 7.64 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.448 . . . . 74.510000000000005 111.121 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.22 168.78 30.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.019999999999996 112.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 171.34 14.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.269 . . . . 74.439999999999998 112.322 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.26 50.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.150000000000006 112.526 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.7 mm -95.31 139.4 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 71.129999999999995 111.127 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.54 142.29 36.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 110.905 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 m -116.89 -138.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.408 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 7.3 mmt -155.13 -59.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 110.872 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 65.04 146.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.45 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER 177.81 -73.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 75.530000000000001 110.882 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.43 -28.8 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 71.099999999999994 111.12 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.11 -76.72 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.72 -0.752 . . . . 41.020000000000003 112.429 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.79 107.62 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 73.230000000000004 112.331 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' PRO . 70.9 m-80 35.41 69.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.349999999999994 110.873 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 2.7 m -134.68 16.68 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 111.165 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.5 t30 39.45 -97.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.9 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 133.65 174.48 13.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 62.219999999999999 112.512 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 63.6 m -144.68 -43.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 71.340000000000003 110.901 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -91.47 92.55 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 63.009999999999998 110.889 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -82.91 147.06 28.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.129999999999995 110.858 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -111.46 131.73 55.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.911 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.51 123.17 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 111.1 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 68.1 m -74.72 130.97 40.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 62.119999999999997 110.862 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.9 p -91.71 -27.77 17.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 111.173 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.53 169.67 15.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 55.130000000000003 111.117 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -61.86 96.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 110.895 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 29.6 p -121.33 59.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 25.0 1.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 73.129999999999995 110.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 10.5 21.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.945 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.44 -41.56 7.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 73.349999999999994 110.89 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -58.37 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 74.349999999999994 110.899 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.23 59.99 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.702 -0.761 . . . . 74.310000000000002 112.468 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -103.33 -22.66 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 70.349999999999994 110.87 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.485 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 18.6 m-70 -119.32 -20.78 7.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.120000000000005 110.891 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 16.1 t 80.74 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 111.104 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.2 t -102.43 137.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 70.230000000000004 111.143 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.6 29.63 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 74.040000000000006 110.884 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.64 140.17 6.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 62.149999999999999 112.451 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -124.04 -165.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 72.519999999999996 110.904 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -96.68 134.13 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 111.13 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -90.62 -63.37 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.109999999999999 110.862 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -162.07 142.6 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 72.340000000000003 110.892 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.63 4.71 13.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 73.340000000000003 112.523 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.6 ttt -49.41 -33.24 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 74.310000000000002 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.1 -28.44 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.239999999999995 110.931 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.0 mm -79.39 -38.4 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.030000000000001 111.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.8 t -48.08 -53.31 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 111.172 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.98 -32.02 14.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.12 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 111.119 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.7 mtm -77.14 -17.15 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.409999999999997 110.858 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -90.16 29.47 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 110.899 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.882 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -129.15 17.43 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.86 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -136.65 46.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 74.120000000000005 112.469 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 146' ' ' GLY . 37.8 m 33.42 -100.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.340000000000003 110.856 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -161.52 -40.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 73.150000000000006 110.86 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.58 -7.03 57.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.200000000000003 110.903 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 109.34 -137.18 14.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.310000000000002 112.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 75.47 -55.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.35 140.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 111.156 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 0.33 20.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 70.5 110.859 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.14 161.04 36.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.878 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.48 112.76 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 55.450000000000003 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.5 mt -98.35 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.219999999999999 111.168 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.66 174.2 6.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 74.150000000000006 111.122 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.36 145.12 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 111.14 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.21 -62.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 111.102 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -157.06 164.8 37.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.299999999999997 110.787 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.7 m -146.23 -165.55 2.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.863 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.34 28.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 73.239999999999995 112.489 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -108.65 136.48 48.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.353 . . . . 74.010000000000005 110.919 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 mt -73.12 -41.04 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.5 110.909 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 71.340000000000003 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.362 . . . . 72.230000000000004 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.26 155.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -92.96 152.87 41.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 72.239999999999995 110.882 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 147.11 62.07 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.686 2.257 . . . . 70.409999999999997 112.356 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -140.01 165.8 26.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.329999999999998 111.173 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.96 132.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 73.010000000000005 111.136 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.5 162.86 13.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 71.319999999999993 110.906 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -143.67 138.58 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.310000000000002 110.884 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.41 71.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 71.230000000000004 110.827 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -50.47 136.09 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 64.219999999999999 111.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -108.37 152.69 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 111.126 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.27 94.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.159 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.01 32.33 21.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 74.030000000000001 110.896 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.47 -24.71 25.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.310000000000002 112.511 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -121.79 119.68 28.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.67 0.748 . . . . 71.439999999999998 110.884 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.1 Cg_endo -69.72 162.67 41.16 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.732 2.288 . . . . 74.209999999999994 112.365 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.11 20.98 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 73.519999999999996 110.891 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.4 ' HA3' HD13 ' A' ' 138' ' ' ILE . . . 133.9 -164.33 24.43 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 73.239999999999995 112.49 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 174.47 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 75.230000000000004 110.866 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 m -136.78 177.12 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.116 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -129.61 100.86 5.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 75.019999999999996 110.893 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -86.62 114.04 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.430000000000007 110.877 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.55 124.85 50.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.510000000000005 110.898 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.1 mt -88.19 126.66 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.937 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -76.38 67.08 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.099999999999994 110.888 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.03 -30.1 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 111.138 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -53.06 -56.46 16.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 64.430000000000007 110.874 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -81.95 -35.55 28.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.841 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.32 80.35 72.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 70.519999999999996 111.129 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.07 17.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.27 . . . . 73.219999999999999 112.356 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.59 -69.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.420000000000002 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -42.26 -39.62 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 111.166 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.55 -67.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.071 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' ARG . 6.8 tt0 -41.62 -61.06 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 61.030000000000001 110.862 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -35.83 -43.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.881 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -75.24 -41.85 56.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.019999999999996 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' GLU . 9.0 tmm_? -51.62 -30.32 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.838 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.55 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 111.113 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.19 -41.44 81.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.923 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.9 p -58.88 -46.09 88.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.439999999999998 110.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -16.93 64.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.340000000000003 111.129 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.56 86.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.230000000000004 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -143.74 39.95 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 110.92 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 21.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.926 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.91 -33.69 3.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.486 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -126.09 -167.53 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 75.400000000000006 110.865 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.6 -144.21 13.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.733 . . . . 72.510000000000005 112.496 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 -18.69 15.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 74.239999999999995 110.968 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.59 113.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 74.5 110.88 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -131.19 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 61.109999999999999 112.498 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t 49.32 -166.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 65.329999999999998 110.817 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.7 p -143.52 -168.58 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -179.44 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 110.87 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -116.13 -57.52 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.099999999999994 110.855 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -145.79 164.6 31.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.909 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -153.42 124.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 111.171 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.62 126.82 18.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.652 0.739 . . . . 73.519999999999996 111.132 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 138.44 37.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.622 2.215 . . . . 74.030000000000001 112.348 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.43 30.86 77.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 60.32 112.486 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.96 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 74.519999999999996 110.898 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -163.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 110.893 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 m -137.02 -69.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 70.129999999999995 110.865 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 62.81 148.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 65.329999999999998 110.897 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 74.310000000000002 112.469 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.76 0.314 . . . . 72.329999999999998 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ILE . 47.6 p -77.87 137.46 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 61.420000000000002 110.861 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -33.59 -46.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 111.153 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 8.2 p90 -112.84 106.21 14.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 71.209999999999994 110.88 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.57 -168.86 51.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 73.430000000000007 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -71.33 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 74.010000000000005 110.902 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 155.56 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 73.230000000000004 110.913 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 179.41 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.230000000000004 110.881 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 173.96 9.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 65.439999999999998 110.848 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -71.79 179.96 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 74.219999999999999 110.883 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.72 -63.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.835 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.86 158.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.855 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 60.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.049999999999997 110.924 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -78.98 -3.34 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 75.349999999999994 111.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.94 71.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 110.882 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 154.57 24.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.310000000000002 110.866 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -63.82 83.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 71.120000000000005 110.845 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -77.08 -8.81 58.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 72.209999999999994 111.13 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.95 -174.35 45.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 64.310000000000002 112.492 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.07 66.68 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.329 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -27.96 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 72.549999999999997 112.496 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.18 120.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 72.420000000000002 111.131 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 4.1 tt -91.96 143.16 26.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.909 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.0 t -148.83 -166.58 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.824 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.81 148.52 25.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 75.540000000000006 110.872 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 107' ' ' THR . 3.1 t30 -145.5 -160.54 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.519999999999996 110.927 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.602 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -46.16 -45.59 16.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 75.239999999999995 111.081 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.04 -65.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 64.040000000000006 112.527 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 112.21 3.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.233 . . . . 72.230000000000004 112.333 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' PRO . 51.7 m-20 34.42 46.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.901 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 19.7 p -154.08 34.31 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.299999999999997 111.16 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -79.73 4.01 17.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.07 133.1 43.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 74.25 112.467 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.22 166.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 74.409999999999997 110.891 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 67.52 138.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 70.25 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -153.91 177.49 10.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 73.239999999999995 110.91 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.47 162.91 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 75.25 110.874 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.4 pt -145.39 134.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.540000000000006 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 14.0 t -96.58 156.89 16.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 73.299999999999997 110.873 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -124.9 27.74 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 111.125 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.62 27.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 71.400000000000006 111.102 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.0 142.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.878 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.57 48.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.129999999999995 111.195 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.72 -20.82 23.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 71.109999999999999 110.849 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -62.51 -22.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.904 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.41 -37.46 57.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 61.329999999999998 110.919 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t0 47.09 86.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 73.299999999999997 110.828 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.79 37.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 73.25 112.508 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -55.03 -32.91 62.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 74.319999999999993 110.911 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -145.57 43.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.871 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.462 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER 67.13 -153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 111.12 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.462 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 14.2 p -176.94 144.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.200000000000003 111.122 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 4.1 p90 -176.5 95.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.881 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 132.54 161.48 9.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 54.409999999999997 112.468 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt 175.18 131.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 75.510000000000005 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.69 136.36 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 111.124 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -114.54 -39.41 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 75.519999999999996 110.883 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.24 160.94 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.329999999999998 110.896 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.05 81.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.299999999999997 112.473 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -12.29 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 72.150000000000006 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -75.06 -24.54 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 74.530000000000001 110.88 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.4 HD13 ' HA3' ' A' ' 18' ' ' GLY . 17.6 mm -64.19 -44.11 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 t -93.38 5.62 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 111.166 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -112.58 -64.36 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 70.219999999999999 110.849 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.27 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 111.077 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.34 -44.45 54.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.230000000000004 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.93 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 60.530000000000001 110.907 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.37 -29.97 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.37 -2.81 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 72.319999999999993 110.884 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.95 -152.75 14.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 71.0 112.44 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 t -161.92 156.13 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 75.540000000000006 110.858 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -71.53 -7.47 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.409999999999997 110.837 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -106.21 -19.61 13.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.862 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.15 -44.27 1.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 61.240000000000002 112.495 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -44.55 129.63 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.450000000000003 110.914 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 49.2 p -98.62 118.17 34.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 111.118 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 p -54.2 -26.27 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 110.82 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 -163.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.230000000000004 110.943 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -131.0 127.75 38.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.943 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.2 mp -98.84 125.21 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 73.040000000000006 111.145 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 141.69 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 75.200000000000003 111.139 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.07 100.53 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 111.185 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.31 -59.82 3.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.093 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.5 170.41 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.873 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -170.2 154.36 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.928 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.79 179.89 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.747 . . . . 51.43 112.478 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 1.1 mt-30 -82.62 -49.92 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 75.209999999999994 110.898 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.7 mm? 65.04 115.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 75.230000000000004 110.936 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 110.917 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.889 0.376 . . . . 71.349999999999994 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.85 156.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 75.530000000000001 111.139 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -92.64 160.1 35.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.623 0.725 . . . . 75.209999999999994 110.859 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.52 69.02 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 64.349999999999994 112.349 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.1 m -136.18 150.13 48.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 75.5 111.142 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.92 137.24 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.150000000000006 111.079 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -113.32 157.87 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 110.867 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -141.66 136.34 30.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.219999999999999 110.878 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.55 119.75 35.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.912 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.02 142.41 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.12 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.54 170.76 15.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.219999999999999 111.067 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.99 96.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.25 111.092 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.74 36.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.030000000000001 110.857 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -12.42 66.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 65.120000000000005 112.486 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.56 131.55 30.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 73.439999999999998 110.921 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 153.18 69.08 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.257 . . . . 75.230000000000004 112.333 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -117.53 -68.21 0.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.329999999999998 110.912 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.58 28.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 60.119999999999997 112.528 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.76 134.26 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 75.319999999999993 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.59 139.99 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 111.076 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -123.53 152.66 41.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 73.450000000000003 110.87 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.54 -175.48 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 74.230000000000004 110.874 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -144.48 117.57 8.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 73.200000000000003 110.927 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.46 130.21 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 110.913 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.48 75.86 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.86 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -28.11 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.420000000000002 111.126 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -37.72 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -86.44 -31.97 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.889 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 129' ' ' PHE . 7.9 m -132.84 84.98 48.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 74.230000000000004 111.11 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -40.38 5.37 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.228 . . . . 60.509999999999998 112.38 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -83.08 -44.89 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 110.864 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -81.84 17.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 63.420000000000002 111.163 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.79 -44.14 12.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.25 111.139 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.4 mt-10 -81.81 -31.37 31.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 75.400000000000006 110.85 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 8.4 t30 -27.18 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 110.896 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -77.51 -34.21 54.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.869 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 1.8 ttp180 -47.83 -40.27 20.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.917 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.21 60.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 111.079 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 13.16 14.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.420000000000002 110.942 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -129.67 -20.29 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.8 p -101.19 -25.08 14.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 73.319999999999993 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.17 62.11 1.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.230000000000004 112.45 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.63 27.08 1.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 71.129999999999995 110.865 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -123.6 -11.03 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.86 -25.94 25.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 52.130000000000003 112.539 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -140.57 166.65 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 64.530000000000001 110.89 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.87 -176.68 41.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 74.030000000000001 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.58 3.29 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.956 0.408 . . . . 73.209999999999994 110.937 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -54.19 150.41 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 73.430000000000007 110.894 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.51 63.61 3.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 74.530000000000001 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 m -153.6 -95.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 65.329999999999998 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 p -176.5 -172.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.099999999999994 110.899 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -124.18 -174.51 3.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 75.310000000000002 110.9 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.26 177.02 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 71.430000000000007 110.87 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 51.17 27.09 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.030000000000001 110.872 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mt -71.27 119.44 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.4 111.32 8.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 72.230000000000004 111.168 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 93.45 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.672 2.248 . . . . 71.230000000000004 112.335 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.96 -30.89 2.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 71.530000000000001 112.461 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -108.56 -65.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.519999999999996 110.9 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -171.82 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 72.319999999999993 110.849 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -121.17 -67.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 64.530000000000001 110.906 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 64.15 162.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.209999999999994 112.504 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.786 0.327 . . . . 74.430000000000007 110.871 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -125.31 129.31 49.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 63.530000000000001 110.856 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pt -61.75 -15.0 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.439999999999998 111.172 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.0 21.85 6.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.923 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 77' ' ' SER . . . 157.12 -136.15 4.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 75.340000000000003 112.495 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 77' ' ' SER . 27.2 mm-40 -104.57 -47.71 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.956 0.407 . . . . 73.219999999999999 110.883 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 175.01 10.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 71.549999999999997 110.866 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.51 175.0 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 110.897 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.97 152.12 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 75.030000000000001 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -56.61 166.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 110.864 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.37 -64.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 71.349999999999994 110.888 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.36 153.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 62.409999999999997 110.909 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 62.69 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 110.853 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.9 -4.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.340000000000003 111.177 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.49 77.38 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.902 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -58.82 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.939 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 86.29 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.549999999999997 110.861 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 p -108.33 17.78 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 111.113 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.62 164.97 31.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 73.549999999999997 112.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.63 30.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.265 . . . . 75.329999999999998 112.312 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . 75.98 26.38 64.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.729 . . . . 72.430000000000007 112.517 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -91.86 118.85 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 72.540000000000006 111.152 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.37 143.31 26.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 64.439999999999998 110.961 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 t -146.22 -127.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 63.100000000000001 110.821 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.61 118.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.79 88.87 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 61.299999999999997 111.089 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -153.74 95.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.219999999999999 110.873 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 71.26 -66.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 64.530000000000001 111.052 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.15 -73.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 74.209999999999994 112.491 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.3 Cg_endo -69.72 123.54 10.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 73.239999999999995 112.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' PRO . 4.2 m-20 31.06 60.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 75.430000000000007 110.901 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 108' ' ' ASN . 1.2 p -145.05 31.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 70.0 111.132 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.581 ' C ' ' O ' ' A' ' 107' ' ' THR . 35.6 t30 22.14 -100.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 75.299999999999997 110.911 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.96 145.12 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 72.239999999999995 112.514 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -121.4 -10.43 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 61.149999999999999 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -81.25 53.66 2.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 75.409999999999997 110.902 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -52.95 143.17 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 62.420000000000002 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.491 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -112.95 64.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 75.329999999999998 110.876 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 113' ' ' PHE . 55.5 mt -29.82 99.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 74.430000000000007 111.155 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -64.97 152.88 42.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.886 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.3 p -118.55 -1.82 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.115 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.46 159.4 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 75.409999999999997 111.129 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -53.73 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.030000000000001 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.2 p -105.15 63.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.240000000000002 111.131 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 4.87 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -84.21 7.52 18.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.933 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.37 -57.69 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 110.938 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.04 83.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 110.89 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.06 36.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 61.420000000000002 112.489 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tmtp? -73.56 -30.31 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 64.030000000000001 110.93 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -146.14 34.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 110.864 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 56.21 -154.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 111.119 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p 178.89 147.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.030000000000001 111.129 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 15.4 p90 -177.5 115.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 64.109999999999999 110.876 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.86 141.71 11.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 73.099999999999994 112.48 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -158.76 148.24 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.409999999999997 110.901 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.6 t -51.91 148.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 72.510000000000005 111.108 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -118.27 -60.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.906 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.5 125.61 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.150000000000006 110.893 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 112.16 65.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.7 mmm -84.26 -0.47 52.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 73.430000000000007 110.877 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -30.39 63.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.848 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 142' ' ' MET . 13.1 mm -72.21 -37.17 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 111.154 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.69 20.48 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 111.144 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -139.28 -55.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.310000000000002 110.9 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.4 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 70.140000000000001 111.152 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 10.2 tmm? -48.0 -36.38 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 64.010000000000005 110.888 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.11 -32.69 55.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 74.049999999999997 110.885 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -59.01 -18.41 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 75.319999999999993 110.869 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 144' ' ' ARG . 50.0 m-85 -82.59 1.12 39.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.889 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.79 -157.7 33.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 55.340000000000003 112.528 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 t -159.45 169.7 23.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 75.200000000000003 110.836 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -61.28 -48.5 81.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 110.888 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -5.66 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.349999999999994 110.909 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.46 -39.96 2.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 74.129999999999995 112.523 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -48.88 158.22 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 72.530000000000001 110.883 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.1 p -126.25 157.62 37.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 74.299999999999997 111.176 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.4 t -85.64 1.44 49.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 73.230000000000004 110.892 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.3 -168.67 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 75.099999999999994 110.893 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.16 120.48 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.439999999999998 110.939 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -84.55 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 111.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.38 136.68 51.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.299999999999997 111.202 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.65 132.97 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 75.420000000000002 111.165 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.03 -58.23 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 74.400000000000006 111.129 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -167.79 168.45 12.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 54.340000000000003 110.896 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.7 m -146.81 164.48 32.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 71.549999999999997 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.51 171.83 44.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.761 . . . . 75.120000000000005 112.502 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -68.18 -35.7 78.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.887 0.375 . . . . 61.130000000000003 110.929 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.5 mm? 71.83 -60.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.929 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.885 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.818 0.342 . . . . 75.439999999999998 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.92 146.06 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 111.14 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.84 141.12 14.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 71.230000000000004 110.91 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.72 26.28 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.649 2.233 . . . . 74.409999999999997 112.364 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -112.78 112.07 23.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 111.144 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 16.1 m -88.57 155.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 111.096 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.55 151.75 39.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.219999999999999 110.866 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 137.64 23.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -109.96 148.28 31.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -120.13 134.44 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 74.120000000000005 111.146 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.27 156.35 42.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.129 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.27 120.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.439999999999998 111.159 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.71 41.34 7.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.875 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.44 62.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 54.130000000000003 112.472 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.07 125.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.657 0.741 . . . . 75.140000000000001 110.856 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 131.6 21.67 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.702 2.268 . . . . 71.510000000000005 112.372 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.76 -19.51 10.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.400000000000006 110.926 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.47 -179.58 39.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.747 . . . . 74.030000000000001 112.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -144.0 167.0 23.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.353 . . . . 74.319999999999993 110.854 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.4 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 22.6 m -127.15 173.52 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 111.074 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 t -117.75 94.71 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.349999999999994 110.87 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 12.5 m-85 -84.21 120.34 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 73.299999999999997 110.848 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.91 146.47 26.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.120000000000005 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -112.26 121.35 44.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.931 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.99 68.85 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.841 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.21 57.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.420000000000002 111.129 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.93 -65.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.109999999999999 110.852 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.43 -62.13 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 110.887 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.63 84.78 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.113 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 76.48 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 71.120000000000005 112.329 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 179.66 -65.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 73.439999999999998 110.85 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.1 m -50.92 -41.55 58.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 74.239999999999995 111.152 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.27 -26.24 51.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 64.450000000000003 111.085 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.14 -24.08 66.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 73.099999999999994 110.907 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -80.75 -66.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -49.57 -41.21 41.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.140000000000001 110.888 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -62.13 -33.46 74.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.230000000000004 110.889 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.4 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 111.067 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.87 -51.04 36.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 m -57.06 -48.12 79.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 110.859 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -79.25 -5.41 54.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 73.329999999999998 111.168 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.25 64.96 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 41.240000000000002 112.505 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -112.22 37.53 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 73.310000000000002 110.883 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -131.64 17.02 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.299999999999997 110.884 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.62 63.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 74.109999999999999 112.51 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.92 164.78 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 74.439999999999998 110.858 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.78 141.2 5.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 63.409999999999997 112.5 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 138.66 9.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 74.450000000000003 110.925 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 -47.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.129999999999995 110.927 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.48 30.22 6.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.731 . . . . 75.099999999999994 112.455 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -112.48 -164.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 73.400000000000006 110.887 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.0 p -103.23 -178.8 3.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.874 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -88.54 177.32 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 75.109999999999999 110.851 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.36 -61.54 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 74.150000000000006 110.888 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -164.33 145.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 70.400000000000006 110.903 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.43 145.66 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.430000000000007 111.122 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -139.16 123.04 11.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 74.319999999999993 111.131 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.71 28.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.632 2.221 . . . . 75.239999999999995 112.338 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.17 24.44 68.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 72.340000000000003 112.505 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 -71.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 71.439999999999998 110.918 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.5 -163.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 72.420000000000002 110.88 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.57 143.34 16.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.319999999999993 110.893 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.41 152.27 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.875 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 64.019999999999996 112.491 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.781 0.324 . . . . 74.230000000000004 110.906 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -71.18 174.41 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.549999999999997 110.846 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -83.45 -32.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 111.139 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -81.36 3.12 25.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.22 -120.46 3.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.739 -0.744 . . . . 73.439999999999998 112.521 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -60.47 -164.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 61.240000000000002 110.89 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.97 164.27 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.55 146.66 47.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 110.876 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.38 172.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 72.329999999999998 110.862 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 124.19 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 75.420000000000002 110.863 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.12 -55.35 14.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.859 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.3 p30 179.65 172.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.319999999999993 110.886 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.41 41.05 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.510000000000005 110.863 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.54 -33.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.409999999999997 111.157 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.99 118.97 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 110.945 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.4 111.11 23.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 110.902 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 92.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 73.040000000000006 110.881 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 p -115.43 25.66 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 74.519999999999996 111.166 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.61 171.0 43.94 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 73.150000000000006 112.527 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 150.37 67.84 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.743 2.295 . . . . 75.099999999999994 112.36 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 -30.35 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 75.219999999999999 112.468 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -51.49 145.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.420000000000002 111.113 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -104.82 133.07 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 75.200000000000003 110.881 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.75 137.34 54.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 71.340000000000003 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.9 mmt -88.07 178.48 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 110.864 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . 176.11 174.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 71.319999999999993 111.111 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 33.7 t-20 178.21 -66.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 53.119999999999997 110.837 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -157.34 23.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 72.150000000000006 111.081 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.73 -153.55 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 44.229999999999997 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.03 66.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 73.409999999999997 112.303 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 64.91 27.14 12.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 75.200000000000003 110.936 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -147.11 67.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 62.420000000000002 111.122 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -88.21 7.21 33.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.959 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.85 130.74 36.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 63.539999999999999 112.501 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.1 p 48.13 -158.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 65.129999999999995 110.823 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 49.77 93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.932 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.69 163.77 18.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.299999999999997 110.841 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -138.85 139.98 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 73.140000000000001 110.858 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.84 -41.65 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 75.239999999999995 111.093 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.6 m 70.78 99.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.88 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.9 p -91.83 27.42 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 111.146 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -173.04 -173.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 62.109999999999999 111.088 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 138.06 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 75.120000000000005 110.929 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.7 p -81.27 -150.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.131 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 168.65 -67.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -64.76 -19.87 66.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 72.5 110.949 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.16 140.24 29.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.916 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -154.98 -48.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.873 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.99 51.39 0.82 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 61.310000000000002 112.472 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 29.74 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 74.450000000000003 110.92 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.472 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 29.3 m-70 -156.11 -50.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.859 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 15.8 t 80.04 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 111.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.0 133.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 75.540000000000006 111.154 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.01 17.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 71.430000000000007 110.889 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -135.29 -166.55 11.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 72.549999999999997 112.47 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 175.08 172.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 73.129999999999995 110.89 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.94 100.38 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 75.150000000000006 111.144 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -39.87 90.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 179.71 -168.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.915 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.68 14.69 51.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 42.219999999999999 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.58 -22.02 20.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 74.010000000000005 110.902 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -50.28 -30.26 11.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 71.150000000000006 110.886 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.7 mm -73.32 -39.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.219999999999999 111.147 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.3 t -48.33 -44.05 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 62.43 111.135 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.72 -47.4 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.530000000000001 110.892 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -27.51 62.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.540000000000006 111.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 46.3 mtm -80.32 -39.76 28.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.852 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.44 30.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.219999999999999 110.878 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -122.48 -13.54 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.319999999999993 110.884 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -128.84 24.13 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.851 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -120.73 73.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 75.430000000000007 112.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 146' ' ' GLY . 24.0 p -24.37 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 75.109999999999999 110.87 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -49.62 -36.13 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.310000000000002 110.869 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -54.08 -25.6 22.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.917 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.57 -45.16 1.26 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.791 -0.719 . . . . 72.230000000000004 112.512 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 116.1 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 74.030000000000001 110.905 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -78.96 133.13 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 111.138 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -23.25 67.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 74.230000000000004 110.838 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.23 -169.33 2.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 74.299999999999997 110.908 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 134.39 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 73.540000000000006 110.885 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -115.25 87.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 111.129 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.0 p -102.38 168.77 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 111.174 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.4 118.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.340000000000003 111.162 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.33 -70.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 111.136 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -119.1 173.24 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 53.140000000000001 110.863 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.2 p -171.9 178.57 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 110.833 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.69 -143.9 15.4 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 63.229999999999997 112.517 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.5 tt0 -107.29 132.95 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 110.924 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -59.78 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.902 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 110.884 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.795 0.331 . . . . 72.540000000000006 110.851 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.68 142.47 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.099999999999994 111.129 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.89 162.13 0.83 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 74.549999999999997 110.89 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 149.23 66.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 73.329999999999998 112.345 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.0 m -136.94 86.21 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 61.450000000000003 111.126 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.98 159.85 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 111.107 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 161.35 36.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 71.310000000000002 110.928 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.64 137.55 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.400000000000006 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.42 100.16 9.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 110.858 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mm -75.44 144.88 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.540000000000006 111.18 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.7 154.1 41.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.131 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -129.16 98.84 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.239999999999995 111.121 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.54 54.98 8.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.099999999999994 110.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.08 7.93 52.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 62.210000000000001 112.469 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -140.05 95.76 8.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 75.319999999999993 110.856 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 161.65 45.12 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 70.150000000000006 112.289 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.31 25.94 5.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.916 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -162.69 21.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 75.439999999999998 112.441 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 -176.92 5.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 74.140000000000001 110.885 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.19 163.91 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -116.5 94.82 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.150000000000006 110.868 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.63 116.79 28.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 75.230000000000004 110.881 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.34 113.68 26.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.340000000000003 110.923 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.94 139.71 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 75.540000000000006 110.941 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -86.97 60.22 6.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.433 . . . . 70.420000000000002 110.886 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.53 -25.26 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 111.087 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.9 -61.06 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.239999999999995 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -19.12 62.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 110.875 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.99 82.7 8.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.682 0.753 . . . . 71.239999999999995 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.62 24.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 65.129999999999995 112.3 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -58.52 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.925 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 m -52.0 -45.09 64.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 111.115 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.22 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 111.081 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.47 -23.18 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.926 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.51 -71.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 110.874 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -48.72 -44.23 38.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.230000000000004 110.857 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.18 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 74.120000000000005 110.837 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.73 -38.79 28.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.450000000000003 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.408 ' HB2' HD11 ' A' ' 78' ' ' ILE . 1.1 tt -89.33 20.06 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 74.430000000000007 110.922 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -112.39 -15.18 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.019999999999996 110.864 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 p -117.52 4.68 12.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 111.132 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.96 30.13 66.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 74.129999999999995 112.491 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -38.6 50.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.968 0.413 . . . . 63.25 110.906 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -17.05 54.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 110.9 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.72 -26.36 24.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 73.230000000000004 112.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.34 159.61 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 71.450000000000003 110.843 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.3 -78.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 65.329999999999998 112.491 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -167.44 -64.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 73.109999999999999 110.96 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tptt 59.77 166.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 70.299999999999997 110.882 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 118.67 14.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 71.310000000000002 112.479 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 m -159.14 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 72.420000000000002 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -142.88 119.14 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 110.879 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.23 122.54 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.894 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.92 70.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 110.848 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.43 39.49 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 74.400000000000006 110.855 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 mt -96.26 140.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.230000000000004 111.139 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.436 HG13 ' HD2' ' A' ' 58' ' ' PRO . 2.0 tt -135.05 133.02 20.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.587 0.708 . . . . 64.010000000000005 111.184 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.8 125.21 11.86 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 51.140000000000001 112.375 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.33 26.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 75.010000000000005 112.514 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -156.73 -82.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 73.010000000000005 110.855 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -179.96 -150.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 110.848 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.9 m -146.79 144.22 29.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 73.099999999999994 110.91 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.49 164.64 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 110.878 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.769 -0.729 . . . . 54.43 112.454 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.804 0.335 . . . . 75.430000000000007 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -133.15 15.26 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 110.819 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.47 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER 83.9 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 75.400000000000006 111.184 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.93 -23.25 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 62.200000000000003 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.04 -156.68 26.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 64.409999999999997 112.503 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.95 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 71.040000000000006 110.908 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -155.84 155.34 32.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 74.219999999999999 110.917 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -119.55 145.91 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 75.099999999999994 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -64.57 152.98 40.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 72.540000000000006 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.8 93.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 75.109999999999999 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -58.56 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 75.510000000000005 110.885 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 175.44 175.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.400000000000006 110.909 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.58 43.52 2.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.921 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mm -46.23 -32.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 74.150000000000006 111.147 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.0 147.71 22.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.439999999999998 110.924 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -126.33 -166.37 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.510000000000005 110.884 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -98.65 -88.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.209999999999994 110.873 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.35 10.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.329999999999998 111.163 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.59 141.07 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 71.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 156.68 62.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 75.230000000000004 112.318 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.52 -28.8 9.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 60.340000000000003 112.475 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.82 147.87 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 72.019999999999996 111.102 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -99.1 148.8 23.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.49 176.96 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 110.845 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.474 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 4.8 mmt -82.52 170.72 14.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.926 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 100.12 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 61.119999999999997 111.083 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -161.0 -169.86 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.420000000000002 110.923 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.471 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -53.38 -32.84 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.150000000000006 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.23 -68.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 74.549999999999997 112.445 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.73 120.52 7.3 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.200000000000003 112.345 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 11.9 m-20 32.96 58.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 75.340000000000003 110.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.555 ' O ' ' C ' ' A' ' 108' ' ' ASN . 19.2 p -139.71 33.12 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.099999999999994 111.161 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 107' ' ' THR . 2.4 p30 23.89 -101.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 73.230000000000004 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 100' ' ' MET . . . 166.08 -165.25 38.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 63.310000000000002 112.468 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.45 13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 110.854 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 70.36 72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 75.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 175.59 122.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 71.530000000000001 110.87 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 112' ' ' PHE . 11.4 t80 178.83 47.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 75.140000000000001 110.847 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.91 94.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.540000000000006 111.117 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.5 p -83.28 133.22 34.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.87 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -91.05 -10.38 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.145 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.16 149.43 47.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.400000000000006 111.079 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.16 131.98 46.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.530000000000001 110.895 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.05 47.14 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 65.540000000000006 111.093 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.02 -15.45 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 110.872 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -57.81 -20.21 34.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 70.319999999999993 110.955 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.28 -46.32 28.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.944 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.99 -58.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.540000000000006 110.851 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.0 64.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.43 112.508 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -105.47 -28.45 10.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.23 125.5 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.899 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.01 114.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 73.200000000000003 111.152 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -98.42 139.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 111.133 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -176.26 123.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.38 134.85 8.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.733 . . . . 62.229999999999997 112.491 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -152.02 165.26 35.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 72.409999999999997 110.873 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.84 159.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 111.158 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 -47.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.430000000000007 110.879 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.39 178.51 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 70.439999999999998 110.839 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 51.44 69.5 1.12 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.778 -0.725 . . . . 62.310000000000002 112.471 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.52 -1.16 40.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.333 . . . . 74.019999999999996 110.898 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -77.71 -27.12 50.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.859 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.34 -44.38 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 111.152 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.11 9.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 111.13 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.89 -66.38 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 72.299999999999997 110.868 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.83 -51.51 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 73.519999999999996 111.111 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.0 ttm -50.95 -44.43 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 110.875 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -52.8 -27.11 16.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.892 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -62.63 -23.09 66.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 63.539999999999999 110.909 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -78.65 2.46 19.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.120000000000005 110.904 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.16 -161.37 6.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 72.099999999999994 112.5 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.9 m -142.15 -77.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 71.439999999999998 110.849 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.893 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -92.94 14.93 16.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.150000000000006 110.938 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.41 -42.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.742 -0.742 . . . . 74.209999999999994 112.542 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 155.67 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 73.340000000000003 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.0 p -130.24 157.85 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 72.409999999999997 111.175 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.1 p -79.01 -16.49 56.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 110.88 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.39 -169.72 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 72.329999999999998 110.912 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.55 40.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.893 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.51 127.39 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 75.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 143.49 47.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 111.134 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.91 104.97 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 75.109999999999999 111.157 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -59.95 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 111.073 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -144.33 171.1 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 65.349999999999994 110.869 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.3 p -175.58 145.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.0 -178.92 36.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 64.439999999999998 112.529 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -81.4 122.78 27.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 70.010000000000005 110.88 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.92 -30.68 14.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.030000000000001 110.936 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.916 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.19 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.319999999999993 111.115 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -89.58 144.27 31.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 75.120000000000005 110.902 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 124.57 11.23 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.273 . . . . 74.209999999999994 112.349 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -117.1 145.99 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 74.299999999999997 111.133 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.36 148.75 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 65.019999999999996 111.105 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -110.0 154.47 23.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.14 137.47 42.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.549999999999997 110.861 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.36 124.0 44.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.888 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.89 129.05 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.549999999999997 111.092 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.9 168.54 12.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 74.230000000000004 111.085 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.5 t -152.39 107.23 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 111.155 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.25 25.23 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.439999999999998 110.845 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.63 -14.04 65.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.030000000000001 112.499 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.82 139.28 21.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.73 . . . . 71.319999999999993 110.905 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.49 64.97 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.722 2.281 . . . . 74.040000000000006 112.374 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -66.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 73.299999999999997 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.29 -174.83 36.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 64.340000000000003 112.459 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -118.76 126.09 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 71.120000000000005 110.877 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -121.14 119.72 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.173 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.3 p -107.14 148.93 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.895 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.3 105.72 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 73.109999999999999 110.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.93 162.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 74.329999999999998 110.909 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.94 119.24 35.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 72.450000000000003 110.909 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.85 84.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.010000000000005 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.91 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.430000000000007 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.59 -28.71 37.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 110.888 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -71.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.903 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 29' ' ' VAL . 30.7 m -101.46 99.5 11.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.56 0.695 . . . . 74.150000000000006 111.133 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.678 2.252 . . . . 72.150000000000006 112.361 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -43.22 66.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.9 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.422 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 6.4 m -85.8 21.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 64.230000000000004 111.125 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.31 20.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 61.439999999999998 111.122 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ASN . 86.9 tt0 -83.57 -24.21 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 72.150000000000006 110.89 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -30.79 -70.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 62.030000000000001 110.896 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.01 -32.42 63.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.926 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -50.82 -37.9 45.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 72.219999999999999 110.863 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.57 -29.99 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.098 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.94 -51.65 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.912 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -65.35 -47.83 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 54.549999999999997 110.863 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -68.83 -24.07 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 64.450000000000003 111.171 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.49 83.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 75.120000000000005 112.482 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 33.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.396 . . . . 74.019999999999996 110.895 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -124.73 27.58 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 110.887 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.09 14.34 68.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 62.310000000000002 112.502 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -174.91 173.86 2.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 75.340000000000003 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.61 153.93 7.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 51.039999999999999 112.484 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.97 137.88 41.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.947 0.403 . . . . 74.329999999999998 110.944 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -41.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.010000000000005 110.912 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.03 43.35 0.55 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 53.439999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.26 31.67 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.430000000000007 110.885 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.0 m 62.96 174.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.894 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -168.2 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 110.855 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 -59.75 1.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.878 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -155.68 -169.99 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -168.4 141.84 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 111.166 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.6 mt -134.87 95.89 15.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.66 0.743 . . . . 72.310000000000002 111.128 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.14 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.346 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.45 -27.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 51.329999999999998 112.474 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -51.46 2.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.439999999999998 110.931 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.97 -159.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 75.319999999999993 110.853 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 36.8 m -129.46 -66.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.230000000000004 110.917 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 62' ' ' CYS . 14.6 tt0 64.34 136.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.9 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 70.439999999999998 112.495 180.0 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.754 0.311 . . . . 73.329999999999998 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -102.61 157.65 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 71.319999999999993 110.903 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -39.38 -38.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 111.159 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.78 49.96 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 74.409999999999997 110.935 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.45 -120.58 7.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.769 -0.729 . . . . 72.540000000000006 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.98 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 110.93 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.26 176.34 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 110.893 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.54 175.23 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.349999999999994 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.36 173.69 10.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.834 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.4 158.43 28.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 110.822 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.98 -58.59 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.049999999999997 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.97 150.93 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 74.150000000000006 110.893 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -125.01 68.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 71.400000000000006 110.9 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.6 mt -83.19 0.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 111.119 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -121.56 83.18 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 71.239999999999995 110.941 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -70.17 141.14 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 74.140000000000001 110.899 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -55.7 91.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.838 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.1 p -86.9 7.62 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 73.299999999999997 111.171 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.45 -165.32 30.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 73.319999999999993 112.438 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 166.04 28.91 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 75.129999999999995 112.358 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.06 84.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 74.0 112.502 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.1 mm -83.18 141.43 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 74.5 111.148 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER -116.29 141.4 48.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 71.030000000000001 110.95 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.819 ' O ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -150.22 30.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 62.109999999999999 110.86 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.819 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 ptp 34.1 120.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 75.019999999999996 110.891 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -46.91 170.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.239999999999995 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -174.49 174.77 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.904 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.0 24.7 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 62.520000000000003 111.089 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.5 -178.41 21.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 72.129999999999995 112.5 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.95 41.69 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.662 2.242 . . . . 71.340000000000003 112.357 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 67.63 27.87 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 p -150.55 50.92 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 70.519999999999996 111.156 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -80.88 1.81 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 65.540000000000006 110.914 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.93 88.58 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 73.140000000000001 112.468 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 m -145.75 -145.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.349 . . . . 74.109999999999999 110.833 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 4.4 tp-100 -109.77 -80.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 110.923 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 p90 178.94 137.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 72.319999999999993 110.868 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' ' C ' ' A' ' 114' ' ' ILE . 5.7 p90 -131.26 45.29 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.019999999999996 110.876 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 113' ' ' PHE . 79.1 mt -28.07 130.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 75.409999999999997 111.14 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 77.5 m -83.07 148.09 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 110.832 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.4 p -117.88 22.98 11.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 61.420000000000002 111.124 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.58 175.76 6.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 111.124 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 86.57 4.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 74.019999999999996 110.904 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.0 p -112.11 52.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.125 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -87.26 23.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 71.239999999999995 110.871 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 8.67 39.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 64.519999999999996 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.43 1.41 51.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 62.310000000000002 110.935 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 49.3 66.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 75.439999999999998 110.863 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 41.19 36.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 55.340000000000003 112.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -57.21 -32.87 66.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 75.549999999999997 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -108.67 156.82 19.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.420000000000002 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.56 94.49 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 111.097 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 49.6 t -74.46 136.07 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 111.156 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -163.84 26.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.936 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.54 -178.34 15.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 44.130000000000003 112.461 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.33 147.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 74.439999999999998 110.817 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -72.21 103.8 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 111.163 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -53.58 25.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.884 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -166.8 157.55 12.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 110.88 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.93 6.05 54.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.120000000000005 112.48 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.8 ttt -49.66 -31.15 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 110.886 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -52.04 -24.04 6.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 mt -81.84 -39.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.019999999999996 111.113 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.96 -44.65 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.340000000000003 111.159 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.62 -29.48 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.896 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.47 67.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 71.129999999999995 111.104 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -23.35 57.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 73.219999999999999 110.847 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.56 29.21 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.913 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.73 3.75 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 110.821 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.16 13.5 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 110.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.06 -160.91 36.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.744 . . . . 60.210000000000001 112.514 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.1 t -154.13 18.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.519999999999996 110.849 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 46.91 59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 71.420000000000002 110.871 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -177.34 -36.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 65.239999999999995 110.93 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.75 -56.98 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 74.400000000000006 112.485 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.95 116.29 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 75.439999999999998 110.877 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 p -90.28 158.47 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 74.25 111.134 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 t -68.57 -21.66 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 75.329999999999998 110.866 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.47 -168.0 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.230000000000004 110.834 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.47 124.43 34.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.909 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 mp -100.17 104.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 111.166 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 175.8 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 64.219999999999999 111.19 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.74 143.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 72.120000000000005 111.118 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.35 -59.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.0 111.098 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -154.78 164.5 38.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 75.040000000000006 110.845 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.0 m -144.79 -162.97 1.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.209999999999994 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.92 -155.54 22.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 34.240000000000002 112.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.24 134.9 50.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.346 . . . . 70.129999999999995 110.886 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 tp -55.35 -59.07 5.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.892 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.209999999999994 110.913 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 72.319999999999993 110.892 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.61 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 65.099999999999994 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.8 160.72 35.59 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 54.439999999999998 110.895 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 152.9 69.43 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.387 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 m -123.75 43.87 2.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 73.319999999999993 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -50.67 143.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.549999999999997 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.41 175.9 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.913 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -146.14 145.66 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.87 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -102.23 135.21 44.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 63.399999999999999 110.876 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.04 131.0 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 71.25 111.142 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.26 167.8 13.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.329999999999998 111.081 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.27 98.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.129999999999995 111.131 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 70.519999999999996 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.33 -12.09 70.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.513 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -95.84 131.81 28.44 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 74.439999999999998 110.894 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 145.57 57.87 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.754 2.302 . . . . 73.549999999999997 112.342 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tp -114.9 -67.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 64.400000000000006 110.861 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.23 177.5 41.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 71.420000000000002 112.477 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 135.92 49.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.450000000000003 110.907 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.12 129.48 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 74.430000000000007 111.131 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.3 t -90.84 96.5 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.836 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.83 81.82 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.409999999999997 110.871 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -57.51 143.49 40.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 73.129999999999995 110.897 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 mt -109.6 117.47 34.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 72.299999999999997 110.895 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.69 72.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.310000000000002 110.851 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.18 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 72.239999999999995 111.096 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -54.03 -60.33 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 70.519999999999996 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -61.93 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.921 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.08 94.2 46.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 74.329999999999998 111.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -22.83 31.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 71.219999999999999 112.315 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -66.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 73.230000000000004 110.905 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -52.84 -40.93 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 111.123 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.88 -71.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 63.240000000000002 111.079 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 37' ' ' ARG . 34.2 tt0 -40.66 -65.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 75.239999999999995 110.898 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.6 t30 -34.18 -45.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.884 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.11 -38.92 51.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 73.230000000000004 110.894 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -51.89 -29.84 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 72.430000000000007 110.865 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.06 55.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.122 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.8 mt -67.82 -54.45 18.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.129999999999995 110.877 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 t -52.91 -41.89 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.439999999999998 110.874 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -71.08 -21.6 62.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 74.400000000000006 111.143 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.78 91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.010000000000005 112.495 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 35.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 110.861 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -144.0 12.43 1.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 110.926 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.27 17.33 74.27 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 71.140000000000001 112.45 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -175.26 -166.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 71.450000000000003 110.926 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 130.77 -149.08 19.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 74.510000000000005 112.489 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -98.08 -26.16 14.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 75.430000000000007 110.93 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.32 139.33 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.856 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.69 60.23 5.94 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 74.400000000000006 112.531 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -137.49 -165.93 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.88 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -157.21 168.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.240000000000002 110.869 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -81.47 120.69 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.905 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -93.69 -17.53 23.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -145.26 137.76 25.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.873 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.5 mt -150.33 121.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 111.128 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt -137.76 108.14 8.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.400000000000006 111.132 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 107.64 1.91 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 74.329999999999998 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 130.82 -34.13 2.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 72.409999999999997 112.537 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.22 -68.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 75.049999999999997 110.871 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -165.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 110.83 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.66 137.32 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.884 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -100.15 140.98 33.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.932 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 74.510000000000005 112.465 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.831 0.348 . . . . 75.420000000000002 110.839 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.03 -173.72 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.219999999999999 110.832 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -87.36 -32.03 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 111.157 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.37 82.36 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 70.120000000000005 110.943 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.29 -125.87 8.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 65.040000000000006 112.463 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -116.61 -85.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 73.540000000000006 110.903 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 175.0 9.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.74 155.26 40.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 110.832 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 168.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 74.450000000000003 110.898 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.29 130.62 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 70.430000000000007 110.869 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -50.31 18.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 73.099999999999994 110.869 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.76 159.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.908 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.4 29.84 6.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.875 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.0 mm -51.31 -27.53 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 73.230000000000004 111.134 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.15 103.3 15.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.530000000000001 110.893 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.7 107.34 19.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 71.239999999999995 110.883 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.42 98.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 110.847 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 42.36 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 111.115 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.33 178.93 23.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 75.239999999999995 112.521 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.29 19.25 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.241 . . . . 74.5 112.329 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.17 -34.75 3.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 61.219999999999999 112.503 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.91 137.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 73.510000000000005 111.137 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.7 tt -98.38 128.64 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.510000000000005 110.93 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.42 -171.07 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 72.150000000000006 110.834 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.5 mmt -116.63 -173.4 2.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 70.040000000000006 110.877 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 102' ' ' ASN . . . -101.35 -48.77 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 61.149999999999999 111.053 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 101' ' ' ALA . 5.4 p-10 39.73 -165.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 65.409999999999997 110.906 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -158.86 22.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 111.103 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.3 -67.92 0.34 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 75.430000000000007 112.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.534 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.75 -156.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 74.140000000000001 112.315 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.22 87.31 7.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 75.230000000000004 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -153.75 51.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 111.167 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -71.64 -4.88 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 110.895 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.65 76.04 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 74.510000000000005 112.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.0 p -127.3 -140.88 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 73.109999999999999 110.871 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -77.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.95 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 170.89 148.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 110.842 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.78 122.58 14.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.010000000000005 110.886 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.0 tt -123.95 137.46 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 71.129999999999995 111.124 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.83 148.48 22.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.140000000000001 110.888 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -92.68 -18.74 22.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.409999999999997 111.094 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.0 179.89 5.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 75.439999999999998 111.125 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -65.7 90.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 p -116.9 59.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 64.209999999999994 111.187 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.09 28.06 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.856 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.81 10.63 27.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.91 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -23.65 17.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 72.510000000000005 110.913 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.8 OUTLIER 56.72 85.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 60.25 110.87 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.589 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 20.18 61.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 42.149999999999999 112.461 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -104.66 -14.36 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 75.420000000000002 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -110.99 -8.94 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.400000000000006 110.848 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.6 t 65.74 96.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.133 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.12 130.36 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.109999999999999 111.139 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.11 27.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.888 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -152.72 -179.67 28.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 75.25 112.523 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.09 136.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 74.510000000000005 110.915 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.32 119.07 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.400000000000006 111.165 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -42.28 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 110.904 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.39 156.01 13.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.908 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.65 1.96 57.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.763 . . . . 71.349999999999994 112.51 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -29.1 8.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.93 -22.32 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.2 mm -89.84 -35.67 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 72.409999999999997 111.11 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.4 t -52.62 -22.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 111.149 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -84.29 -35.38 23.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.340000000000003 110.888 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.02 94.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 72.5 111.1 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.3 ptm -71.39 -37.15 71.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.893 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.04 34.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 110.922 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -10.86 6.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 75.129999999999995 110.912 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.17 14.59 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.450000000000003 110.861 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -106.77 71.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.707 -0.759 . . . . 73.319999999999993 112.525 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.553 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.73 131.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 71.099999999999994 110.843 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -46.25 -46.54 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 73.040000000000006 110.901 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -47.0 -37.9 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.200000000000003 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.07 -47.67 0.92 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 63.5 112.463 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 110.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 75.310000000000002 110.889 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.1 t -82.62 145.12 29.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 75.030000000000001 111.182 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -22.46 52.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 72.299999999999997 110.874 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -136.31 163.91 29.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.952 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.14 130.8 51.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.230000000000004 110.878 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.82 120.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 111.169 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.6 p -119.31 165.41 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.450000000000003 111.181 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.629 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 3.9 mp -90.37 -64.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 111.144 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 158' ' ' ILE . . . 93.93 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 64.150000000000006 111.127 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.59 147.08 15.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.874 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.2 p -176.24 -174.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.510000000000005 110.889 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.0 -163.73 28.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 62.549999999999997 112.484 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -81.39 120.07 24.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 74.109999999999999 110.908 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mt -91.91 -23.97 19.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 110.943 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.333 . . . . 73.109999999999999 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 89.1 t 62.38 104.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 73.010000000000005 111.137 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -60.19 151.93 64.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 63.140000000000001 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 117.25 4.97 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 65.319999999999993 112.34 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.7 m -110.35 132.12 54.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 72.329999999999998 111.132 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.99 160.48 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.151 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -127.92 160.04 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 63.130000000000003 110.911 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -135.84 126.98 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.019999999999996 110.914 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.27 72.08 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.865 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.16 135.12 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.310000000000002 111.133 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -123.27 151.38 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 111.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.6 t -133.31 100.85 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t0 54.06 55.73 7.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 64.319999999999993 110.897 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.31 12.27 55.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 75.310000000000002 112.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -142.87 94.22 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.645 0.736 . . . . 72.319999999999993 110.887 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.2 Cg_endo -69.7 167.13 25.27 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.271 . . . . 74.049999999999997 112.386 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.78 30.05 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 71.049999999999997 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.0 -164.02 22.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 70.299999999999997 112.481 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 164.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 75.430000000000007 110.818 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.8 171.8 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 74.120000000000005 111.107 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -149.84 148.58 29.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.858 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.32 154.05 42.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 71.409999999999997 110.868 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -94.15 -53.28 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 62.539999999999999 110.874 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mt 73.81 122.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 110.936 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.75 69.04 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.530000000000001 110.875 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.49 48.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 111.098 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.95 -34.25 26.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 61.420000000000002 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -31.42 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 65.530000000000001 110.879 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.8 67.6 79.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 71.040000000000006 111.138 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 61.64 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 72.420000000000002 112.355 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.68 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 75.209999999999994 110.875 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -75.2 -60.5 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.400000000000006 111.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.43 -1.32 57.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.239999999999995 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -82.19 -19.99 38.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 110.886 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -101.28 -27.86 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 72.450000000000003 110.859 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -50.95 -29.47 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.899 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -31.17 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.409999999999997 110.869 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.2 -30.64 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 64.549999999999997 111.129 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -84.47 5.46 27.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.954 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 m -108.15 -2.67 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 70.530000000000001 110.83 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -117.16 13.21 14.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 74.319999999999993 111.146 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.58 26.58 10.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.010000000000005 112.47 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -33.47 28.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 110.93 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -17.97 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.9 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.09 -63.27 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 52.130000000000003 112.463 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -102.29 148.99 24.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 64.109999999999999 110.828 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.63 151.45 6.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 74.129999999999995 112.491 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -49.56 103.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 64.239999999999995 110.921 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -139.55 -47.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 110.846 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.69 33.76 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 74.340000000000003 112.457 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -172.83 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 73.140000000000001 110.858 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.2 m -89.51 -172.09 3.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 75.329999999999998 110.874 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -75.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.019999999999996 110.876 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 41.42 -160.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.842 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.35 19.35 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.219999999999999 110.84 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.06 139.94 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 75.340000000000003 111.099 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -139.87 108.58 7.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 75.299999999999997 111.157 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 92.35 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 63.130000000000003 112.345 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.11 21.27 2.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.150000000000006 112.474 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.05 -66.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 73.329999999999998 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptp -163.54 -168.94 1.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.239999999999995 110.857 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.73 97.09 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 110.841 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.68 141.48 36.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.540000000000006 110.942 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 54.149999999999999 112.525 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.79 0.329 . . . . 73.530000000000001 110.932 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 148.84 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.409999999999997 110.879 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.14 -55.31 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 111.142 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -128.3 26.62 5.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 74.329999999999998 110.966 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.04 -167.25 17.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 64.420000000000002 112.485 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -118.24 -29.59 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 75.030000000000001 110.879 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -168.88 136.36 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.942 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -112.03 158.78 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.61 161.68 22.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.430000000000007 110.899 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -79.39 108.04 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.230000000000004 110.831 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.5 -52.64 12.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.450000000000003 110.857 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -178.9 168.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 72.439999999999998 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.91 72.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.936 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.83 -3.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 73.150000000000006 111.139 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.53 91.64 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 110.897 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -75.47 -167.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.0 110.901 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -95.05 72.54 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 74.129999999999995 110.858 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 p -69.63 -17.92 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 111.133 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.06 -177.11 43.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.240000000000002 112.476 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.82 52.08 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 63.210000000000001 112.326 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.35 8.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 54.219999999999999 112.476 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mm -99.36 137.25 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 73.040000000000006 111.153 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mt -111.11 148.18 33.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 72.409999999999997 110.898 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.664 ' O ' ' C ' ' A' ' 100' ' ' MET . 1.8 p -163.69 55.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 64.150000000000006 110.869 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.664 ' C ' ' O ' ' A' ' 99' ' ' SER . 3.0 mmt 7.96 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 63.530000000000001 110.861 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.07 110.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 54.049999999999997 111.095 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -142.54 -164.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.888 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -47.99 -51.85 22.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 73.310000000000002 111.126 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 124.96 -61.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 62.509999999999998 112.498 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.3 Cg_endo -69.76 100.0 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 71.010000000000005 112.335 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 63.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 73.140000000000001 110.919 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.9 p -134.73 13.59 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.153 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 42.28 -100.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.928 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.94 166.52 10.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 75.540000000000006 112.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.75 22.75 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 75.099999999999994 110.824 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.86 90.3 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.120000000000005 110.938 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -72.44 155.7 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 73.019999999999996 110.894 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 10.1 p90 -120.96 107.3 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.519999999999996 110.9 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.27 111.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 111.108 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.88 136.85 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.903 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.84 13.17 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 111.145 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.5 11.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.28 138.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 70.120000000000005 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.1 p -139.34 46.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.340000000000003 111.085 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -54.06 -25.39 21.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -62.43 -18.53 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.949 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.8 mt -82.58 -34.97 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.938 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.78 -10.0 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.879 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.18 52.46 1.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.777 -0.725 . . . . 75.230000000000004 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 -29.74 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 74.450000000000003 110.912 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -112.36 154.97 24.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.874 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -50.08 109.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 111.095 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.58 153.79 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 73.450000000000003 111.143 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 130' ' ' GLY . 4.8 p90 -177.02 178.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.884 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 43.61 114.15 0.0 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 73.310000000000002 112.516 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -119.53 35.41 4.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 75.420000000000002 110.913 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t 60.23 162.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 111.075 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -136.63 -58.08 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 73.010000000000005 110.923 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 175.29 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.934 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.37 81.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.705 -0.759 . . . . 70.340000000000003 112.446 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.9 tpt -91.62 -25.94 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 74.310000000000002 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.42 -30.72 53.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.030000000000001 110.892 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 142' ' ' MET . 43.6 mm -44.07 -39.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 111.169 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.1 -52.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 61.229999999999997 111.134 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -45.83 -49.99 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.11 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.094 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 9.6 ttm -50.3 -31.42 14.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 73.519999999999996 110.855 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 72.310000000000002 110.918 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -62.61 -14.21 40.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 110.883 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.87 3.65 47.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.28 -156.09 31.06 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 64.450000000000003 112.503 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 -165.99 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 63.409999999999997 110.9 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -84.4 -48.35 9.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 71.099999999999994 110.87 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -94.68 10.55 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.884 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.19 -150.77 17.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 54.420000000000002 112.481 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 65.04 142.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.91 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 p -114.41 141.46 47.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 111.082 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -18.0 63.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.838 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.12 -162.42 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 72.120000000000005 110.896 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -116.41 93.88 4.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 73.430000000000007 110.888 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.83 117.69 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.310000000000002 111.13 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.8 t -136.77 -178.36 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.25 111.143 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 35.5 mm -105.22 115.88 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 111.121 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.91 -62.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 111.117 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.06 167.27 20.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.409999999999997 110.834 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.13 -174.63 4.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 73.230000000000004 110.888 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.45 -160.93 24.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 74.140000000000001 112.49 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.35 137.01 48.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 73.25 110.925 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -47.91 -60.97 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 110.895 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 75.129999999999995 110.873 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.788 0.328 . . . . 75.25 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -139.44 146.23 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.319999999999993 111.156 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.51 156.55 1.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 65.140000000000001 110.924 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 151.16 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.667 2.245 . . . . 73.400000000000006 112.353 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -141.98 145.74 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.095 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.9 m -136.82 163.21 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.329999999999998 111.107 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 162.71 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.219999999999999 110.881 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -139.32 131.79 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.340000000000003 110.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.58 75.54 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.872 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.1 146.36 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 111.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -138.94 164.77 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 63.399999999999999 111.118 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -139.81 104.76 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 63.43 111.093 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 63.21 52.54 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 110.891 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.05 17.46 61.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 44.140000000000001 112.498 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -132.19 106.56 13.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 73.109999999999999 110.893 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.3 Cg_endo -69.75 138.85 38.82 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.664 2.243 . . . . 73.049999999999997 112.313 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.76 18.33 13.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.892 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.75 167.22 13.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 73.209999999999994 112.495 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.75 175.67 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.88 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m -122.39 -176.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 111.114 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -134.77 86.31 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -84.83 127.23 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 63.109999999999999 110.88 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -104.03 145.42 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.5 110.914 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.11 113.65 26.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 73.409999999999997 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.81 67.46 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 71.400000000000006 110.926 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.97 77.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 111.062 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.9 -54.77 14.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.319999999999993 110.845 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.21 -60.83 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.14 95.89 48.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 73.209999999999994 111.097 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -23.13 31.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.253 . . . . 65.209999999999994 112.358 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -78.55 -51.19 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 110.955 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.1 m -64.85 -30.94 71.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 111.126 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.66 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 111.115 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.0 tt0 -56.47 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 70.400000000000006 110.948 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -29.29 -54.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 75.5 110.888 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -77.07 -39.32 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 110.905 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -50.04 -31.75 13.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.420000000000002 110.901 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.91 -36.86 72.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 111.124 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.7 mt -64.58 -43.86 92.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 110.899 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -59.16 -50.63 73.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.883 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -74.91 -18.8 60.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 111.182 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.86 83.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 73.409999999999997 112.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.35 31.95 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 65.340000000000003 110.88 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -122.78 26.93 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.844 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 2.32 55.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 71.140000000000001 112.503 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -163.28 178.67 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.38 . . . . 73.099999999999994 110.885 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.34 131.96 3.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.461 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 161.43 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 73.430000000000007 110.924 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.96 -40.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 71.239999999999995 110.896 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.91 43.54 1.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 74.219999999999999 112.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.53 165.08 24.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.519999999999996 110.849 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -131.01 -179.56 5.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 110.831 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -113.63 -69.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 110.904 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.61 20.25 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.885 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -138.03 29.93 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.85 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.9 144.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.124 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 mm -134.52 107.39 10.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 74.430000000000007 111.118 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 98.51 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.727 2.284 . . . . 73.120000000000005 112.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.13 -28.95 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 53.329999999999998 112.493 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.94 -63.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 73.150000000000006 110.913 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -176.94 -157.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 75.109999999999999 110.87 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 t -144.41 137.06 26.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 72.340000000000003 110.902 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 167.61 21.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.885 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 74.439999999999998 112.478 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.793 0.33 . . . . 72.129999999999995 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t -85.62 146.72 26.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.129999999999995 110.835 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.26 -41.87 74.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 111.15 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.07 -5.64 37.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.955 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 -143.33 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 55.43 112.437 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -118.9 -25.58 6.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 73.109999999999999 110.877 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -170.75 141.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -108.8 154.1 22.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.049999999999997 110.916 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -88.29 164.43 15.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 73.400000000000006 110.896 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.01 116.32 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 65.140000000000001 110.899 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.68 -49.58 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 110.871 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.93 140.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.924 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.15 70.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.530000000000001 110.917 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.38 4.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 64.129999999999995 111.103 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.32 121.77 45.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 110.913 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 92' ' ' HIS . 14.3 mttp -123.81 82.85 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.019999999999996 110.891 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.458 ' O ' ' CB ' ' A' ' 93' ' ' THR . 5.0 m80 38.78 -160.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 75.239999999999995 110.863 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.458 ' CB ' ' O ' ' A' ' 92' ' ' HIS . 1.2 t 161.8 -38.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 111.16 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.7 -163.6 33.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 75.049999999999997 112.486 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 128.54 16.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 75.340000000000003 112.372 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.17 -5.44 15.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 70.239999999999995 112.487 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.401 HG22 HG12 ' A' ' 128' ' ' VAL . 1.7 mm -61.88 139.87 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.352 . . . . 74.340000000000003 111.108 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.86 125.97 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.963 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.78 125.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.859 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -33.77 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 74.109999999999999 110.852 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 62.84 155.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.124 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p30 172.0 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.340000000000003 110.888 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.429 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -78.18 -22.51 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.209999999999994 111.081 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.8 -64.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 54.530000000000001 112.506 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.1 Cg_endo -69.68 87.45 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 71.349999999999994 112.367 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 32.55 78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 72.019999999999996 110.87 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.94 15.53 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 111.175 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 43.73 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.871 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 73.56 132.97 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 70.430000000000007 112.448 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.9 p -129.18 77.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 62.520000000000003 110.825 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.85 -31.92 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.150000000000006 110.904 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 71.97 69.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 110.86 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -90.82 111.03 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.908 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -102.89 111.31 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 75.519999999999996 111.107 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.24 160.02 29.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 71.530000000000001 110.87 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.6 p -133.65 27.83 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 111.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.31 32.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.104 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.2 tttt 62.39 146.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.868 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 38.4 p -141.97 58.65 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 73.400000000000006 111.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 92' ' ' HIS . 8.1 tm-20 -49.56 -24.7 2.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 65.030000000000001 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -60.02 -36.03 76.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 75.299999999999997 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.57 106.32 18.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.905 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -43.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.040000000000006 110.859 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.23 -38.26 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 54.420000000000002 112.497 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -59.94 -35.83 75.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 72.239999999999995 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -131.81 140.13 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.83 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.786 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 72.7 t -74.14 -81.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 111.078 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.786 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 72.4 t 103.08 127.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 111.168 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.55 18.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 110.854 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.27 146.43 16.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 64.450000000000003 112.458 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -156.42 140.05 15.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 75.409999999999997 110.861 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -48.65 109.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 111.152 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 -36.03 24.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 75.530000000000001 110.865 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.01 175.37 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 61.25 110.862 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 48.69 73.09 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 71.340000000000003 112.485 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -3.53 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.77 0.319 . . . . 75.109999999999999 110.88 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.25 -34.64 23.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.84 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 142' ' ' MET . 50.2 mm -42.47 -41.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.168 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.79 -49.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.135 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -46.5 -50.27 17.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 110.873 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.48 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 4.9 ttm -50.38 -38.51 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.835 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.99 -27.62 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 110.909 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -62.66 -14.89 48.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 72.530000000000001 110.863 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -89.51 13.22 14.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 110.922 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.02 -156.34 28.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 55.25 112.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.5 t -166.87 169.79 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 71.140000000000001 110.828 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -54.0 -47.31 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 73.400000000000006 110.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 3.29 53.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.140000000000001 110.886 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.36 13.25 79.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 62.130000000000003 112.476 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.576 ' O ' ' CG2' ' A' ' 152' ' ' THR . 4.9 tppp? -45.55 -29.14 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.383 . . . . 75.340000000000003 110.957 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.576 ' CG2' ' O ' ' A' ' 151' ' ' LYS . 0.6 OUTLIER 86.73 -169.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 111.136 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 152' ' ' THR . 23.3 t -137.7 -52.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.299999999999997 110.895 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 -168.09 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.892 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.67 111.13 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.519999999999996 110.9 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.4 mt -107.24 101.76 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.164 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.4 p -113.64 168.66 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 111.132 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.95 106.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 111.162 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -54.57 41.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 51.299999999999997 111.113 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.24 167.97 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.897 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -156.5 160.87 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.853 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.84 179.83 46.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 53.329999999999998 112.481 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 7.3 mt-30 -74.89 -37.89 62.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 74.409999999999997 110.902 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.5 mm? 71.41 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 75.540000000000006 110.951 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.219999999999999 110.881 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.829 0.347 . . . . 74.439999999999998 110.863 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.03 152.64 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.310000000000002 111.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -67.48 137.63 93.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.597 0.713 . . . . 73.400000000000006 110.885 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.54 51.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 74.239999999999995 112.343 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -127.75 148.38 50.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 111.136 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.44 160.04 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 111.135 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.5 162.25 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 110.829 -179.95 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -139.32 136.43 34.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 71.019999999999996 110.889 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.77 69.85 1.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 110.897 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -51.52 129.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 75.209999999999994 111.105 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.48 163.12 16.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 52.119999999999997 111.093 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -140.89 104.99 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.530000000000001 111.125 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t0 51.49 53.23 13.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 64.530000000000001 110.875 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.15 10.09 55.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 74.430000000000007 112.43 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -142.57 96.52 6.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.635 0.731 . . . . 72.209999999999994 110.903 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 157.69 59.66 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 74.450000000000003 112.343 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.84 21.0 8.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.928 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.64 169.42 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 74.540000000000006 112.489 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.03 172.68 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 74.319999999999993 110.886 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.59 158.77 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.129999999999995 111.154 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.8 p -140.83 143.75 34.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 73.430000000000007 110.884 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -125.88 123.54 38.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 64.310000000000002 110.874 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -47.01 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.019999999999996 110.901 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 75.27 117.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 71.340000000000003 110.914 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -83.67 57.58 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 110.835 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.33 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 111.134 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.1 -59.34 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 71.209999999999994 110.83 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -50.24 -57.73 7.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 110.88 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -110.48 90.21 9.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.638 0.732 . . . . 71.450000000000003 111.142 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -19.33 36.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 2.24 . . . . 74.140000000000001 112.393 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -79.84 -58.25 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.873 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 t -87.11 25.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 111.173 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -42.25 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.420000000000002 111.093 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -76.85 -10.01 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.917 -179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -42.41 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.349999999999994 110.891 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -81.42 -32.16 32.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.863 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 5.5 ttp85 -55.1 -39.98 69.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 110.839 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.52 -37.06 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 64.310000000000002 111.106 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 33.46 1.03 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.896 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 t -151.2 -22.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.0 m -84.47 -42.14 15.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 73.129999999999995 111.163 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 151.28 -31.1 0.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 73.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 42' ' ' GLY . 8.4 tp10 -33.46 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 75.209999999999994 110.882 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 141.42 30.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.450000000000003 110.93 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.29 -30.49 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 73.120000000000005 112.458 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -47.07 -36.1 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 72.120000000000005 110.863 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.85 -146.37 3.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 75.140000000000001 112.486 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 136.45 43.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 75.25 110.915 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -162.62 -39.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 64.310000000000002 110.904 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.54 43.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 63.409999999999997 112.495 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.0 m -120.74 168.43 11.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 75.430000000000007 110.838 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -58.96 163.44 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 73.200000000000003 110.871 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.38 -70.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 71.540000000000006 110.89 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -163.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 71.219999999999999 110.823 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 51.82 35.74 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 74.549999999999997 110.899 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.11 135.38 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.230000000000004 111.146 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 tt -141.15 115.94 7.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 72.140000000000001 111.156 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.73 69.14 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.72 2.28 . . . . 71.209999999999994 112.326 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.54 69.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 52.219999999999999 112.495 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.61 -71.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 110.868 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -166.72 -159.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.230000000000004 110.851 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.45 -49.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.319999999999993 110.889 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 67.99 145.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.450000000000003 110.953 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 54.329999999999998 112.484 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.805 0.336 . . . . 73.439999999999998 110.899 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 p -85.11 144.21 28.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 71.219999999999999 110.851 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.45 -13.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 71.120000000000005 111.078 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -20.34 13.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 75.219999999999999 110.959 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.72 -131.76 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.329999999999998 112.514 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -95.42 -36.52 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.926 0.393 . . . . 72.25 110.916 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.04 157.07 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 62.240000000000002 110.891 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -147.97 138.98 23.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 74.430000000000007 110.889 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 64.209999999999994 110.939 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.51 158.65 20.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.847 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -54.51 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.62 145.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.894 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -104.83 57.32 0.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.877 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.4 mm -74.32 -24.61 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.049999999999997 111.127 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.17 133.81 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.929 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.22 78.33 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 74.040000000000006 110.919 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' LYS . 21.9 m80 33.23 -140.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 75.310000000000002 110.837 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 168.29 -51.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 63.399999999999999 111.106 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.08 -153.65 13.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 70.25 112.507 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 109.59 2.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 72.510000000000005 112.341 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.06 -22.85 4.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 62.210000000000001 112.491 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mm -50.82 141.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 73.549999999999997 111.097 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.97 132.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 71.439999999999998 110.918 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.34 33.84 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.855 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 43.71 -159.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.430000000000007 110.901 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -170.52 138.98 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 74.400000000000006 111.143 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.4 m-20 166.39 -74.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 64.310000000000002 110.91 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.68 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -171.79 122.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 111.101 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.803 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.43 -37.78 61.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 71.010000000000005 112.49 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.803 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.8 84.91 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 71.549999999999997 112.324 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.6 m120 43.52 62.09 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 110.908 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -154.13 57.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 65.549999999999997 111.156 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.99 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.921 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.29 173.42 37.13 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.681 -0.771 . . . . 70.150000000000006 112.46 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.09 13.35 12.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.439999999999998 110.852 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -165.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.948 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -155.64 93.62 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.310000000000002 110.894 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.46 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 110.888 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mt -121.54 138.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 111.128 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 m -83.38 162.16 21.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 73.040000000000006 110.868 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -135.18 15.58 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 111.165 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.75 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.117 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 61.88 156.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 110.861 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 36.7 p -108.35 -141.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 111.125 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 119' ' ' THR . 0.3 OUTLIER 161.7 -51.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 110.864 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -7.05 53.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 72.019999999999996 110.933 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.71 10.16 16.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 75.310000000000002 110.893 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.87 127.5 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.886 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.56 32.62 61.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 75.510000000000005 112.483 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 -66.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 75.140000000000001 110.904 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -125.4 160.43 29.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.857 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.06 117.89 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 73.230000000000004 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.82 138.36 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 72.340000000000003 111.131 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -178.94 111.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.894 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.7 134.96 6.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 70.319999999999993 112.42 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -155.2 147.9 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 72.140000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.2 m -53.17 125.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.142 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -89.01 -49.09 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 110.872 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 172.59 11.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.866 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.35 0.83 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 63.340000000000003 112.495 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -84.58 3.83 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 73.109999999999999 110.901 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -32.9 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.921 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 142' ' ' MET . 45.8 mm -65.28 -38.45 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 73.319999999999993 111.093 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 t -91.57 13.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 73.349999999999994 111.088 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -128.57 -66.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.019999999999996 110.854 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.92 15.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 75.239999999999995 111.11 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.522 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 8.5 tmm? -48.49 -36.95 16.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 60.229999999999997 110.923 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -53.85 -31.63 50.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 75.049999999999997 110.848 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -16.9 40.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.886 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -82.08 4.89 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 73.299999999999997 110.858 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.05 -163.86 34.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 63.039999999999999 112.469 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -157.98 20.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 70.209999999999994 110.819 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 47.05 60.97 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.83 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 t30 174.96 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.865 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.22 -56.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 65.549999999999997 112.505 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 132.06 39.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 110.879 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.2 p -111.67 144.85 40.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 111.157 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 110.895 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -159.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.931 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -132.73 137.79 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.91 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.44 136.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.129999999999995 111.107 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 159.15 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 71.219999999999999 111.136 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.7 mm -83.12 104.84 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.310000000000002 111.145 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.23 -56.58 7.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 62.030000000000001 111.099 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.13 175.39 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 54.310000000000002 110.867 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.1 p -174.45 154.41 2.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 73.530000000000001 110.825 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.27 -176.57 46.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.450000000000003 112.498 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.8 OUTLIER -73.62 -38.34 65.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 74.540000000000006 110.901 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.2 mm? 71.29 -65.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.349999999999994 110.934 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.510000000000005 110.918 179.913 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 75.430000000000007 110.883 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.83 156.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 111.147 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.88 126.88 57.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 75.25 110.852 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 145.41 57.19 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.701 2.267 . . . . 73.430000000000007 112.374 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -132.64 123.41 26.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 75.430000000000007 111.132 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 m -100.42 151.06 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.118 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.23 153.54 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.519999999999996 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 138.79 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 110.888 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.42 152.59 20.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.888 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.51 135.75 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.101 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 157.56 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 111.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.94 111.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.200000000000003 111.14 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.27 25.56 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 70.200000000000003 110.913 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.97 -14.2 65.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.752 -0.737 . . . . 74.239999999999995 112.498 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.69 140.85 23.2 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 73.019999999999996 110.9 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.83 68.51 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.633 2.222 . . . . 75.400000000000006 112.356 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 -66.2 1.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 110.921 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.42 -148.19 5.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 73.5 112.459 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 127.41 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 73.129999999999995 110.901 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -100.28 144.89 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.230000000000004 111.11 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -107.25 94.71 5.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 74.030000000000001 110.831 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -88.21 126.3 35.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.883 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -107.8 145.87 32.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 110.906 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -114.93 119.28 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.93 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -82.75 81.66 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 72.099999999999994 110.909 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.38 -2.66 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 111.12 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -80.02 -42.13 24.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 72.099999999999994 110.858 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -97.11 -24.22 15.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 110.89 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -140.44 82.74 15.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.682 0.753 . . . . 74.239999999999995 111.086 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -49.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.634 2.223 . . . . 74.519999999999996 112.343 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -55.95 11.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.329999999999998 110.89 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -50.77 -48.97 59.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 111.116 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -27.94 64.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.107 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -61.42 -31.02 70.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.861 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.27 -71.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 53.439999999999998 110.881 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -48.54 -30.43 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.86 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -57.23 -40.94 78.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.299999999999997 110.836 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.52 45.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 111.107 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -76.46 -40.47 50.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.892 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -72.22 -46.51 55.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 54.009999999999998 110.828 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -82.51 8.17 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 111.166 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.55 40.79 11.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 75.340000000000003 112.459 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.96 -27.36 43.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 75.010000000000005 110.891 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -113.46 -6.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.329999999999998 110.903 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 40.8 32.88 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 71.200000000000003 112.451 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -121.1 -18.75 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 73.230000000000004 110.873 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.58 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 64.510000000000005 112.496 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -156.09 15.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.942 0.401 . . . . 73.25 110.911 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -60.76 127.63 32.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 71.329999999999998 110.897 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.93 67.6 1.85 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 72.319999999999993 112.519 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 m -164.29 -94.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.7 p -172.3 -168.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 71.530000000000001 110.853 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -178.21 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 70.219999999999999 110.893 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -114.02 -50.17 2.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.84 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -179.07 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.847 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 175.03 122.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.310000000000002 111.107 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.7 mt -133.47 112.91 13.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 64.519999999999996 111.129 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 82.08 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 74.349999999999994 112.363 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.19 -32.81 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.129999999999995 112.525 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -59.41 1.71 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 73.109999999999999 110.845 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.8 -166.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.919 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.1 129.0 19.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 71.030000000000001 110.903 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 132.62 51.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 110.914 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 61.439999999999998 112.544 -179.995 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.796 0.332 . . . . 65.200000000000003 110.856 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -124.04 26.33 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.873 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 77' ' ' SER . 57.0 mt 87.56 -59.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.340000000000003 111.185 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.46 28.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 61.420000000000002 110.912 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.93 166.69 13.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 75.319999999999993 112.488 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.71 -84.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.387 . . . . 63.340000000000003 110.877 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 152.22 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.530000000000001 110.914 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -115.26 168.58 9.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.907 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -86.39 159.68 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.89 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.83 116.01 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 71.299999999999997 110.854 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 -47.87 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 75.019999999999996 110.908 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 p30 175.52 174.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 74.129999999999995 110.875 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.74 38.21 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.349999999999994 110.91 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.65 -26.73 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.25 111.121 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.45 118.51 30.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.924 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -110.6 167.75 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.040000000000006 110.871 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.26 96.21 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 64.430000000000007 110.918 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -96.01 4.21 52.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 111.17 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 -161.25 23.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 74.530000000000001 112.536 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -57.14 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.662 2.241 . . . . 62.32 112.407 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -66.25 142.61 43.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.120000000000005 112.526 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -161.85 118.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 74.310000000000002 111.141 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 121.11 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 72.150000000000006 110.937 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 p -150.84 -161.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.825 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 mtp -112.63 99.66 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 75.329999999999998 110.865 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.58 73.0 10.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 111.095 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.65 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.87 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.53 -92.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.107 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 169.8 -61.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.409999999999997 112.484 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 54.1 Cg_endo -69.73 90.46 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.717 2.278 . . . . 74.409999999999997 112.359 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 37.82 42.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 110.902 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p -139.17 39.63 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 70.219999999999999 111.123 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.73 177.34 6.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.120000000000005 110.935 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.43 -117.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 23.23 112.477 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.3 p -107.16 -165.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 61.240000000000002 110.861 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 73.07 63.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 110.935 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.87 -178.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.540000000000006 110.888 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.71 129.97 8.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.92 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.75 109.28 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 111.101 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.478 ' C ' ' H ' ' A' ' 117' ' ' ALA . 84.3 m -51.61 -33.64 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.91 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.51 -33.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.549999999999997 111.171 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . -138.63 173.57 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 111.099 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -69.39 88.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.895 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.6 p -92.17 65.09 4.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 111.135 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -5.55 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.349999999999994 110.847 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.9 -5.13 39.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 110.918 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.4 mt -89.35 -48.48 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.929 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.8 -85.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 110.847 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -118.49 109.34 1.75 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.686 -0.769 . . . . 75.409999999999997 112.472 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.48 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 73.120000000000005 110.911 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -119.97 134.04 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.510000000000005 110.828 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.55 97.21 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 111.146 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.27 131.63 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 54.329999999999998 111.126 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.445 ' HA ' HG21 ' A' ' 29' ' ' VAL . 22.8 p90 -136.33 4.51 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 65.019999999999996 110.877 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.82 -161.33 9.11 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 55.439999999999998 112.459 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 177.2 -169.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 75.540000000000006 110.925 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.83 88.8 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 111.104 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -40.78 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.888 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.08 163.96 3.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 70.400000000000006 110.894 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.26 11.58 44.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 64.439999999999998 112.479 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -30.76 9.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 63.32 110.861 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -51.06 -26.42 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.926 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mm -78.83 -45.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.239999999999995 111.11 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -50.22 -44.03 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 111.126 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.35 -29.68 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 110.904 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.43 -31.91 60.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.230000000000004 111.063 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 8.1 mtm -75.67 -35.07 60.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 75.109999999999999 110.888 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -84.13 31.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 73.310000000000002 110.85 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -126.42 -13.26 6.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.906 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.35 17.65 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.61 -156.58 30.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.219999999999999 112.513 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.76 -64.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 72.450000000000003 110.888 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.39 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.9 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.28 11.79 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.915 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.27 15.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 62.32 112.446 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 75.53 -58.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 74.010000000000005 110.9 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 m 71.12 145.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.349999999999994 111.145 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.45 1.83 56.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 110.876 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -141.01 165.71 26.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 74.129999999999995 110.916 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -106.23 115.92 31.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 75.349999999999994 110.916 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.96 105.87 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 72.140000000000001 111.126 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -106.93 167.85 9.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.209999999999994 111.093 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 83.0 mt -121.33 138.52 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 71.329999999999998 111.155 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.59 -56.4 3.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 111.118 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -158.81 166.92 30.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 73.450000000000003 110.844 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -145.72 -163.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.892 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 141.4 -150.37 21.82 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 65.329999999999998 112.496 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -106.25 134.38 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 72.030000000000001 110.909 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -57.78 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.540000000000006 110.94 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 75.219999999999999 110.876 179.915 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.839 0.352 . . . . 73.230000000000004 110.916 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.98 156.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 111.103 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -87.66 148.31 43.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.723 . . . . 74.140000000000001 110.903 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 122.73 9.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.271 . . . . 75.400000000000006 112.367 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.5 m -114.01 135.92 53.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.150000000000006 111.157 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 26.1 m -121.33 157.66 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.103 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.1 p90 -122.55 160.34 25.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 110.823 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -137.54 136.52 37.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.040000000000006 110.897 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.74 112.03 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 71.340000000000003 110.858 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -85.26 126.12 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 74.219999999999999 111.155 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.98 165.15 14.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.420000000000002 111.09 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.19 93.84 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 71.349999999999994 111.111 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.78 35.08 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.882 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -13.17 67.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.539999999999999 112.522 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.76 130.28 33.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.652 0.739 . . . . 73.310000000000002 110.917 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 151.61 69.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 74.140000000000001 112.332 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -118.74 -67.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.924 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.92 -141.15 3.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 42.219999999999999 112.492 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -150.53 127.29 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 62.229999999999997 110.908 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.85 122.3 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.150000000000006 111.164 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 68.9 p -104.13 150.4 24.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.450000000000003 110.888 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -118.25 178.17 4.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 110.939 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 127.0 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 110.875 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.43 106.21 18.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.918 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -72.68 75.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 73.439999999999998 110.888 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.91 -34.35 62.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 111.087 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.868 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.5 -65.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.872 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.44 93.07 30.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.588 0.709 . . . . 73.209999999999994 111.146 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -25.27 29.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.709 2.273 . . . . 60.119999999999997 112.364 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -78.74 -57.9 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 110.912 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 m -61.4 -26.08 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 64.019999999999996 111.177 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.58 -56.29 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.540000000000006 111.094 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.7 tt0 -62.66 -56.98 12.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.827 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.1 t-20 -28.07 -56.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 72.400000000000006 110.879 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.37 -40.57 62.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.929 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -48.3 -32.75 7.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 75.010000000000005 110.903 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.25 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.094 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 73.209999999999994 110.938 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.2 m -76.3 -44.56 36.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 71.510000000000005 110.894 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -79.52 -0.55 33.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 74.230000000000004 111.162 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.87 78.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.787 -0.72 . . . . 54.310000000000002 112.451 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.21 0.86 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 73.150000000000006 110.9 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -127.51 -0.4 6.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.299999999999997 110.96 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 41.32 29.32 0.38 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 72.0 112.52 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.03 -33.15 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 73.439999999999998 110.859 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 74.109999999999999 112.44 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.88 149.68 21.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 71.239999999999995 110.929 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.9 119.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 75.519999999999996 110.93 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.87 22.18 76.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 74.25 112.479 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 p -94.17 -166.87 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.899 0.38 . . . . 74.450000000000003 110.881 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.3 m -99.2 -168.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.58 126.14 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.856 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -51.2 -62.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 74.230000000000004 110.863 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -149.57 167.28 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.859 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.86 127.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.329999999999998 111.125 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -140.48 90.92 9.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.653 0.74 . . . . 73.510000000000005 111.115 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 108.65 2.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.238 . . . . 74.549999999999997 112.398 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.62 -45.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 55.25 112.424 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 -71.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 110.876 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.81 -174.74 4.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.871 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.97 117.87 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 65.310000000000002 110.891 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -136.58 166.39 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.92 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.79 -0.719 . . . . 53.509999999999998 112.51 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.773 0.32 . . . . 73.310000000000002 110.902 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 130.19 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.832 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -48.03 -34.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 71.209999999999994 111.122 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.58 19.87 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.901 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.79 -140.99 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 72.409999999999997 112.479 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -122.99 -25.69 4.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 75.299999999999997 110.903 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -168.69 160.23 10.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 63.43 110.918 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -132.95 162.97 30.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.896 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -80.34 156.97 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.886 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.97 105.09 13.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 72.540000000000006 110.883 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.72 -41.57 97.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 110.887 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 175.07 171.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.884 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -130.4 32.62 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.905 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -19.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 75.129999999999995 111.164 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.9 128.31 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.921 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -121.29 179.39 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.894 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -78.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.340000000000003 110.821 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 61.96 11.37 4.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 111.186 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.86 166.63 34.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.219999999999999 112.544 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 163.09 39.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 75.140000000000001 112.34 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.98 9.87 79.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 74.230000000000004 112.529 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -97.57 150.08 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 74.099999999999994 111.168 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 1.7 tt -107.53 142.92 36.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.971 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -128.78 132.23 47.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.869 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.8 mmt -64.25 -45.73 86.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.901 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 46.62 72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 111.127 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -104.0 -163.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.230000000000004 110.891 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.406 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -51.41 -32.4 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 111.095 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.563 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 132.76 -54.46 0.78 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 72.129999999999995 112.499 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.6 Cg_endo -69.8 -100.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 73.219999999999999 112.291 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.2 91.46 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.924 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.7 p -150.22 28.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.162 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.89 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.349999999999994 110.864 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.92 -90.75 0.22 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 73.319999999999993 112.45 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.7 t 76.54 33.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 73.420000000000002 110.86 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -90.0 -34.46 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.510000000000005 110.921 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 t80 79.92 65.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 63.450000000000003 110.86 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.413 ' HB3' ' CB ' ' A' ' 99' ' ' SER . 27.5 t80 -96.74 95.11 7.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 63.299999999999997 110.843 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.63 136.81 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 75.439999999999998 111.14 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.5 m -103.05 133.57 47.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.230000000000004 110.897 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.8 p -111.75 17.12 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 74.0 111.158 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.14 175.51 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.010000000000005 111.088 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.8 78.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.519999999999996 110.902 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -117.34 67.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 65.349999999999994 111.134 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.26 25.2 4.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.915 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.419 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -93.58 17.87 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.019999999999996 110.885 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -132.61 14.35 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.439999999999998 110.947 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.92 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.129999999999995 110.838 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.97 57.53 3.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 75.540000000000006 112.543 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -163.97 -52.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 73.129999999999995 110.915 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -104.83 133.41 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.400000000000006 110.839 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.32 101.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 75.040000000000006 111.126 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.02 138.68 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 111.138 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -161.82 25.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.889 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -118.65 -165.83 13.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 71.319999999999993 112.488 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 1.6 tttp 162.22 120.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 71.109999999999999 110.871 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.13 88.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 65.340000000000003 111.105 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -71.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 75.519999999999996 110.945 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.54 159.13 44.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 71.239999999999995 110.847 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.22 42.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 62.100000000000001 112.492 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -30.41 13.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.200000000000003 110.885 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -53.62 -25.8 19.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 63.210000000000001 110.881 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.9 mm -90.23 -39.13 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 111.135 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.13 -23.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.17 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.05 -27.81 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 73.040000000000006 110.906 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.91 71.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 71.519999999999996 111.119 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.6 ptm -76.8 -15.61 59.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.919 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.99 27.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.310000000000002 110.856 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.11 0.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.040000000000006 110.902 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -121.08 6.86 10.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.329999999999998 110.913 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -117.28 45.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 75.439999999999998 112.476 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' GLY . 7.3 t 36.16 -147.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 64.019999999999996 110.834 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -139.59 7.92 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 73.400000000000006 110.905 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -16.96 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.851 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.54 -57.5 0.53 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.129999999999995 112.46 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.89 133.88 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 71.129999999999995 110.904 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.415 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 70.6 p -113.19 138.68 49.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 75.329999999999998 111.18 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -24.16 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 74.099999999999994 110.836 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -165.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.916 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -126.65 125.03 41.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 110.901 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.4 105.94 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.329999999999998 111.129 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.07 171.86 7.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 111.157 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.93 147.16 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 75.409999999999997 111.129 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.69 -59.05 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 65.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.81 167.41 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 110.889 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.1 m -145.61 -166.11 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 73.519999999999996 110.855 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.06 -177.73 16.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 62.310000000000002 112.546 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.1 pt20 -94.52 136.36 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 72.209999999999994 110.911 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 1.5 pt? -112.49 -34.81 5.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.917 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.412 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.87 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.856 0.36 . . . . 73.549999999999997 110.865 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -139.77 142.24 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 53.530000000000001 111.159 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -55.16 159.83 3.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 73.420000000000002 110.893 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 149.09 66.42 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.236 . . . . 74.120000000000005 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.71 49.84 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 75.010000000000005 111.107 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -42.31 140.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 111.166 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CE1' ' HA ' ' A' ' 161' ' ' CYS . 0.1 OUTLIER -124.85 165.28 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.892 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -142.5 137.73 30.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.905 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.56 86.22 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.836 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.7 mm -57.71 145.06 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.147 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.04 155.87 46.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 65.209999999999994 111.09 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.4 t -134.99 109.51 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 111.086 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 t0 57.98 52.41 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 75.519999999999996 110.923 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.53 12.63 56.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.010000000000005 112.505 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.51 107.82 26.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.637 0.732 . . . . 72.349999999999994 110.899 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.5 Cg_endo -69.75 143.41 50.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 72.230000000000004 112.348 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 21.44 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.897 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.37 166.39 20.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.807 -0.711 . . . . 61.350000000000001 112.519 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -175.32 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 74.430000000000007 110.852 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.8 175.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 111.148 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 t -117.39 84.41 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.847 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -81.85 88.32 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 74.120000000000005 110.846 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.83 137.13 36.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 72.409999999999997 110.883 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.2 mt -111.82 144.99 40.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.92 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -91.59 67.24 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.239999999999995 110.872 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.66 -10.57 8.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 111.106 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -92.23 -35.08 14.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 54.020000000000003 110.864 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -86.92 -30.34 21.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 73.230000000000004 110.917 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' CG ' ' A' ' 129' ' ' PHE . 4.5 m -128.52 69.0 78.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.605 0.717 . . . . 73.109999999999999 111.14 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 60.08 1.62 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.696 2.264 . . . . 73.439999999999998 112.385 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.81 -63.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 72.109999999999999 110.896 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.93 -55.72 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 75.430000000000007 111.086 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.63 -12.99 59.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 111.051 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.29 -35.74 81.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 74.310000000000002 110.875 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.26 -31.48 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.450000000000003 110.883 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.9 -27.28 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 110.876 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -62.26 -30.91 71.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 75.019999999999996 110.901 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.21 -24.81 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 74.530000000000001 111.125 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.58 26.61 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 72.450000000000003 110.887 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.93 -21.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 75.439999999999998 110.846 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -89.79 -30.64 17.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 53.439999999999998 111.135 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 135.32 -20.42 3.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 73.310000000000002 112.475 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -32.6 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 72.239999999999995 110.876 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 153.82 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 110.86 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.16 -33.01 0.43 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 71.019999999999996 112.466 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -55.05 -28.56 53.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 74.239999999999995 110.897 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -77.48 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 63.409999999999997 112.506 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 124.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.409999999999997 110.915 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -93.71 -77.45 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 74.120000000000005 110.89 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.6 -54.1 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 72.200000000000003 112.441 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.7 -164.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 110.841 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.8 p -157.0 134.45 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 71.409999999999997 110.946 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.77 123.76 38.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 72.109999999999999 110.901 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.94 32.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.5 110.84 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -133.02 27.17 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.862 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.8 138.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 72.310000000000002 111.102 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.92 111.13 17.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.613 0.721 . . . . 73.319999999999993 111.16 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 90.33 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 73.209999999999994 112.366 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.28 4.86 13.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 52.109999999999999 112.455 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.72 -66.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 72.129999999999995 110.868 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.15 -166.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 72.329999999999998 110.867 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.1 t -152.89 108.51 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.099999999999994 110.886 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -97.42 163.6 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 62.310000000000002 110.919 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 60.539999999999999 112.491 -179.944 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.795 0.331 . . . . 73.319999999999993 110.896 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m -79.52 -171.81 2.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 61.509999999999998 110.881 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.8 pt -92.85 -40.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.340000000000003 111.116 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -86.76 85.12 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 75.450000000000003 110.887 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.36 -107.77 3.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 70.319999999999993 112.44 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -91.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 74.099999999999994 110.869 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 150.58 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 64.329999999999998 110.855 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 154.41 39.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 75.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 pm0 -62.87 160.5 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 65.140000000000001 110.853 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.7 -169.47 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 52.439999999999998 110.907 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -132.96 -59.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 75.099999999999994 110.877 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -171.2 149.86 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 71.430000000000007 110.851 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.3 64.41 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 110.902 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.1 mt -78.16 2.31 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 74.010000000000005 111.147 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.74 132.65 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 74.219999999999999 110.942 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -110.06 123.34 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.129999999999995 110.88 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.19 91.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 75.040000000000006 110.877 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.9 p -129.58 21.9 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 64.030000000000001 111.183 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.26 167.48 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 71.129999999999995 112.445 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -44.94 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 64.310000000000002 112.308 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.79 40.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.26 141.7 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.439999999999998 111.162 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.57 130.46 35.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 75.019999999999996 110.872 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 -147.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 110.845 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tpt -152.43 143.14 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.019999999999996 110.868 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -117.73 149.16 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 73.549999999999997 111.121 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 161.75 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.881 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.6 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -55.63 -36.87 67.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 62.210000000000001 111.106 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.7 -65.15 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 74.120000000000005 112.521 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.6 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 106.86 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.717 2.278 . . . . 71.420000000000002 112.321 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.0 p30 42.76 56.87 3.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.908 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.99 33.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 111.156 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -74.29 -0.71 17.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.918 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.9 119.63 19.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 33.350000000000001 112.484 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 8.9 t 54.86 -166.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 74.439999999999998 110.852 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 110' ' ' SER . 3.9 mm-40 64.04 118.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 75.540000000000006 110.905 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.4 156.87 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.855 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.76 154.6 36.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 110.882 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.17 105.5 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 75.349999999999994 111.153 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.24 146.38 53.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 110.86 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 p -96.14 19.99 10.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.111 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.24 177.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 75.540000000000006 111.138 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 131.63 51.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 73.340000000000003 110.902 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.16 41.05 3.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 71.129999999999995 111.145 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -49.02 -25.43 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 73.099999999999994 110.916 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -58.21 -32.62 68.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.952 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 mt -118.5 61.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.913 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -126.63 56.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.150000000000006 110.844 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 53.310000000000002 112.506 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 73.340000000000003 110.901 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -105.09 -16.35 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 74.549999999999997 110.843 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t 71.84 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.530000000000001 111.116 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 p -79.22 153.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.097 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.414 ' CG ' HG22 ' A' ' 29' ' ' VAL . 44.1 p90 -176.91 129.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.340000000000003 110.836 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.39 149.21 12.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 74.209999999999994 112.513 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -162.6 162.96 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 74.120000000000005 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 m -83.76 107.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 111.153 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -41.03 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.019999999999996 110.871 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 178.9 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 110.896 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.67 74.58 0.32 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 74.420000000000002 112.5 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -84.35 -18.39 36.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 73.329999999999998 110.87 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.94 -36.83 24.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.913 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 142' ' ' MET . 37.9 mm -40.39 -45.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.519999999999996 111.109 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.9 t -89.09 -50.66 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 73.0 111.124 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -49.33 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 70.5 110.88 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.86 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 42.210000000000001 111.106 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 4.5 ttm -50.84 -45.71 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 64.430000000000007 110.874 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -52.07 -23.74 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.898 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -63.77 -26.29 68.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.852 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.28 8.28 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.549999999999997 110.945 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.25 -146.25 20.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 63.119999999999997 112.451 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.01 161.36 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 64.219999999999999 110.835 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -50.76 -56.66 11.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 75.510000000000005 110.871 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -6.74 59.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 73.510000000000005 110.863 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.46 -150.37 16.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 64.129999999999995 112.476 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mttp 61.43 104.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 74.310000000000002 110.871 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.1 p -82.18 155.84 24.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 73.120000000000005 111.155 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -2.99 58.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 71.109999999999999 110.842 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -138.83 -175.43 4.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.905 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.68 104.93 13.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 75.439999999999998 110.904 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.3 mt -95.34 127.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 72.329999999999998 111.122 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -139.72 159.16 42.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 111.119 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.3 mm -84.86 105.22 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 111.112 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.59 -56.57 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 75.200000000000003 111.104 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.0 177.16 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 54.32 110.831 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . 0.421 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 17.0 p -176.88 155.74 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 72.340000000000003 110.891 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 -169.48 40.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.747 . . . . 72.400000000000006 112.5 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.27 126.26 35.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 74.209999999999994 110.891 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.81 138.26 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.897 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 110.853 179.935 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 73.340000000000003 110.878 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.61 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 111.119 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -95.82 151.76 38.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 75.400000000000006 110.895 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 134.69 28.55 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.65 2.233 . . . . 71.420000000000002 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m -122.16 140.44 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 75.030000000000001 111.119 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.19 159.46 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 111.104 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.447 ' HB3' HD22 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -133.44 155.08 50.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.873 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.2 134.36 40.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.549999999999997 110.866 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.66 108.91 20.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 73.299999999999997 110.828 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.05 119.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 64.25 111.133 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.93 167.58 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 61.450000000000003 111.099 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -150.68 91.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 111.121 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.1 32.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.816 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.19 -12.24 69.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 54.340000000000003 112.478 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.81 130.35 25.48 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.667 0.746 . . . . 62.200000000000003 110.891 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 152.95 69.43 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.683 2.255 . . . . 72.209999999999994 112.336 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.52 -65.42 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.120000000000005 110.929 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.74 -178.01 36.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 72.349999999999994 112.464 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.7 125.98 54.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 72.25 110.832 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.52 143.97 38.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 74.430000000000007 111.12 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 23.3 p -129.99 155.26 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.888 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.7 165.57 18.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.329999999999998 110.913 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -120.97 124.69 45.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.888 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.6 mt -93.42 126.82 38.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 75.099999999999994 110.936 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -83.07 82.31 8.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.917 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -4.59 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 60.32 111.087 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.23 -34.11 16.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 110.858 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -91.44 -28.48 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.917 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.55 79.31 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.625 0.726 . . . . 70.340000000000003 111.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.14 13.43 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 71.25 112.294 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -45.72 9.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 72.25 110.874 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -52.4 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 73.200000000000003 111.161 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.11 -77.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 75.310000000000002 111.113 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 29.7 tt0 -48.34 -66.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 75.409999999999997 110.876 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 19.8 t30 -28.23 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 72.120000000000005 110.916 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' GLU . 85.3 t80 -85.53 -42.0 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 110.87 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -54.52 -31.24 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.877 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.01 -43.57 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 111.11 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.11 -39.2 86.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 73.239999999999995 110.905 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -35.26 76.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.04 -12.74 61.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.165 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 4.13 63.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.788 -0.72 . . . . 63.310000000000002 112.446 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.96 -1.65 36.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 72.519999999999996 110.933 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -93.39 37.57 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 70.25 110.916 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.09 -45.46 3.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 74.010000000000005 112.502 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -155.89 -166.38 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 74.450000000000003 110.854 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 -107.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 65.150000000000006 112.511 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -162.84 123.49 2.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.414 . . . . 65.310000000000002 110.919 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -106.9 -26.74 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.909 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.94 -62.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.741 . . . . 74.510000000000005 112.489 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.65 -169.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.340000000000003 110.869 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 p -166.11 111.21 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 61.240000000000002 110.876 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -73.4 123.98 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.892 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -120.32 17.99 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.120000000000005 110.867 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -136.84 119.09 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 110.855 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.0 mt -143.53 137.28 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 111.075 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.3 mt -146.8 95.38 4.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.666 0.746 . . . . 75.299999999999997 111.111 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 96.34 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 72.230000000000004 112.347 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.69 -35.17 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.47 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.32 -64.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 72.140000000000001 110.849 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -158.39 -169.5 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 72.230000000000004 110.895 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.32 -75.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 70.409999999999997 110.858 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 63.32 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.030000000000001 110.926 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 62.310000000000002 112.479 179.999 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.847 0.356 . . . . 74.319999999999993 110.842 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 t -81.69 160.78 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 64.349999999999994 110.874 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 pp -88.35 -32.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 111.126 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -85.01 -6.29 59.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.9 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -121.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 73.319999999999993 112.512 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -112.34 -83.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 74.200000000000003 110.927 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.92 168.05 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.887 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.0 165.52 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.898 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -62.45 163.32 8.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 110.846 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -80.33 161.41 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 62.210000000000001 110.886 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 -50.65 3.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 110.89 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p30 178.74 157.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.549999999999997 110.898 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.73 66.73 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.859 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.0 mt -83.91 7.78 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 72.219999999999999 111.156 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -127.29 127.53 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.936 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.28 133.28 56.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 71.109999999999999 110.904 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -59.05 91.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.0 110.874 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.2 p -118.95 19.4 13.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 74.299999999999997 111.197 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.96 26.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.340000000000003 112.525 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -2.93 10.99 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.430000000000007 112.331 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.41 29.01 6.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.420000000000002 112.501 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.66 127.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 74.219999999999999 111.165 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.3 124.13 34.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.420000000000002 110.874 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 42.9 t -115.5 160.73 19.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 71.230000000000004 110.854 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.76 115.24 29.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 110.874 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.97 150.53 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 62.130000000000003 111.11 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.72 -163.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 71.010000000000005 110.884 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -12.68 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 62.32 111.083 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 121.69 -135.02 10.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 72.239999999999995 112.47 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 54.2 Cg_endo -69.71 147.52 63.35 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.735 2.29 . . . . 73.150000000000006 112.337 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.93 23.07 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.903 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.653 ' O ' ' C ' ' A' ' 108' ' ' ASN . 7.7 p -141.23 33.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.310000000000002 111.2 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER 11.49 -87.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 71.049999999999997 110.913 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 107.16 140.15 9.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 75.430000000000007 112.486 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -97.86 -33.33 11.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.334 . . . . 75.129999999999995 110.816 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -63.43 152.46 38.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.94 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' SER . 17.1 p90 -145.08 146.55 31.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 71.540000000000006 110.891 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -127.84 114.86 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 65.310000000000002 110.889 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.6 mt -67.02 101.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.519999999999996 111.149 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 54.7 m -57.85 126.98 29.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.901 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -88.19 -31.25 19.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 64.219999999999999 111.105 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.9 155.02 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 111.111 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -57.01 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.400000000000006 110.888 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 p -117.6 69.52 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.519999999999996 111.134 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.52 21.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.867 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.441 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 5.3 p90 -101.14 15.19 29.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 73.349999999999994 110.941 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 13.3 mt -129.73 17.05 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 110.937 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -63.15 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.540000000000006 110.862 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -46.75 -28.78 3.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 73.409999999999997 112.505 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -74.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 75.510000000000005 110.925 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -86.67 141.25 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.549999999999997 110.851 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.58 129.73 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 64.439999999999998 111.133 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.31 137.67 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 111.147 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.07 -32.87 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.129999999999995 110.902 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -109.92 161.05 13.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 75.120000000000005 112.495 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -155.57 148.68 24.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.349 . . . . 75.340000000000003 110.919 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.45 126.49 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 72.540000000000006 111.153 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -68.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 110.874 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 143.71 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.844 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.72 9.21 21.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 63.119999999999997 112.514 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.0 ttm -49.62 -28.03 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.409999999999997 110.884 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -50.63 -27.25 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 75.209999999999994 110.89 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.85 -35.72 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 73.540000000000006 111.113 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.78 -23.41 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 111.144 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.01 -25.14 32.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.906 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.29 57.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 111.12 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.8 ptm -76.97 -30.37 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 72.230000000000004 110.907 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -89.85 33.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 110.856 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 17.2 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.25 110.865 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -97.73 33.3 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.87 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.601 ' O ' ' C ' ' A' ' 147' ' ' SER . . . 64.88 -92.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 75.040000000000006 112.483 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.601 ' C ' ' O ' ' A' ' 146' ' ' GLY . 88.7 p 17.86 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 110.874 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -91.51 -24.62 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.519999999999996 110.888 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -105.01 -7.53 19.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 110.931 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.95 -39.81 2.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.759 . . . . 75.239999999999995 112.453 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -64.5 101.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 71.239999999999995 110.891 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 147' ' ' SER . 1.9 m -90.56 154.15 19.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 60.32 111.162 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.73 -17.76 63.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 74.400000000000006 110.848 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.26 -175.87 4.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.866 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -120.05 144.17 47.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 110.899 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.41 134.51 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.126 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -129.33 166.86 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 111.136 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.06 106.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 111.128 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.2 -57.23 11.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 111.13 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -160.26 174.63 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.310000000000002 110.859 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 11.4 p -175.35 169.6 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.230000000000004 110.894 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.02 -160.52 28.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 71.239999999999995 112.493 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -72.25 109.36 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 110.883 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -66.66 -48.33 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.519999999999996 110.914 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 110.878 179.943 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.351 . . . . 73.030000000000001 110.868 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.65 153.82 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 111.158 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -50.44 153.31 2.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.943 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 141.07 44.29 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 61.240000000000002 112.332 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.9 m -126.29 101.55 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.299999999999997 111.135 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 5.8 m -96.42 149.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.319999999999993 111.123 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.95 162.72 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 55.109999999999999 110.889 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.01 133.51 21.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.886 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.25 108.52 16.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.891 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.7 mm -87.48 139.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.340000000000003 111.161 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -120.7 155.87 32.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.123 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.0 96.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 72.439999999999998 111.125 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.87 56.04 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 71.430000000000007 110.884 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.75 11.63 54.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 74.430000000000007 112.446 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -142.44 92.17 7.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 74.519999999999996 110.886 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.76 156.17 64.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.358 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.61 23.93 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 110.866 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.66 -161.74 21.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 44.450000000000003 112.463 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 170.37 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 74.329999999999998 110.868 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.15 172.47 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 72.349999999999994 111.147 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -127.89 90.69 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.409999999999997 110.87 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -81.73 72.98 8.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.540000000000006 110.94 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.92 143.53 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 110.851 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 mt -105.53 119.81 40.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.93 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -76.62 57.23 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.340000000000003 110.856 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -31.3 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.510000000000005 111.103 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.87 -63.14 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 74.219999999999999 110.893 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.29 -74.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.93 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 2.4 m -85.15 110.77 31.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 65.209999999999994 111.107 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 74.299999999999997 112.344 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -57.67 -47.02 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.874 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -45.77 -41.9 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 111.142 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -107.5 21.72 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 111.086 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -93.16 -28.37 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.856 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -85.19 -41.08 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 75.120000000000005 110.88 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -32.75 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.905 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.96 -39.55 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 74.340000000000003 110.85 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.46 -17.97 26.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.164 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.02 9.98 13.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.895 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.4 m -126.35 -3.42 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.019999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.6 p -124.82 -4.98 7.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 111.143 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.15 71.85 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 73.109999999999999 112.485 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.27 34.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 73.230000000000004 110.861 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.6 -42.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.219999999999999 110.863 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 46' ' ' PHE . . . -137.67 30.53 2.58 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 75.030000000000001 112.44 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' CG ' ' C ' ' A' ' 45' ' ' GLY . 2.1 p90 40.11 63.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 74.099999999999994 110.879 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.94 21.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 75.450000000000003 112.497 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.17 -179.81 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.393 . . . . 74.120000000000005 110.885 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -166.24 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 64.340000000000003 110.875 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.75 44.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 71.239999999999995 112.507 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.15 155.17 32.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 63.530000000000001 110.826 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.67 127.52 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 74.109999999999999 110.898 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -148.61 122.08 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.409999999999997 110.87 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -140.81 73.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.129999999999995 110.869 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -121.18 21.86 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.88 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.64 136.35 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.139 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.11 113.05 32.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 72.230000000000004 111.193 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 86.73 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 73.5 112.362 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.64 2.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 75.109999999999999 112.501 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.27 -72.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 73.329999999999998 110.917 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -178.22 -158.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.140000000000001 110.871 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.2 t -143.24 135.9 27.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.409999999999997 110.869 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 153.42 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.927 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 74.439999999999998 112.505 -179.982 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.754 0.312 . . . . 74.450000000000003 110.873 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.06 120.38 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.85 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 pt -49.18 -37.01 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 73.200000000000003 111.159 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.22 36.92 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.904 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.51 15.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 75.010000000000005 112.458 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -122.4 -24.15 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 73.340000000000003 110.895 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -169.36 147.1 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.040000000000006 110.903 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.94 158.16 34.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.943 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.92 162.52 28.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.099999999999994 110.926 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.63 108.39 13.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.886 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.52 -51.73 47.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.239999999999995 110.882 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t30 175.27 175.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.881 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.45 40.81 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.871 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.52 -27.12 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.430000000000007 111.115 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.59 133.62 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 73.329999999999998 110.913 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -114.19 -175.69 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 75.340000000000003 110.942 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -99.49 -86.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 73.230000000000004 110.868 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 67.09 6.32 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 111.104 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.37 159.48 20.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 72.030000000000001 112.483 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.416 ' CB ' ' HA ' ' A' ' 116' ' ' THR . 53.6 Cg_endo -69.71 169.69 18.26 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 75.409999999999997 112.354 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.26 8.85 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.743 . . . . 65.549999999999997 112.482 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 mm -69.9 158.28 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 73.120000000000005 111.121 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.36 162.72 23.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.934 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -160.49 43.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 110.883 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.402 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 4.2 mmt 48.65 -166.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.883 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.61 78.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 60.299999999999997 111.105 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.34 -76.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 73.430000000000007 110.91 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.07 -41.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 55.219999999999999 111.127 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -75.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 73.209999999999994 112.51 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 102.2 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 73.400000000000006 112.312 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.59 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 73.409999999999997 110.851 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -154.55 59.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.119 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.578 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -80.37 -0.68 37.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 70.219999999999999 110.901 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 21.0 -136.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.758 . . . . 75.409999999999997 112.518 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 m -153.91 65.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.331 . . . . 73.129999999999995 110.87 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -93.71 -45.41 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 74.209999999999994 110.91 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.402 ' H ' ' HA ' ' A' ' 100' ' ' MET . 0.0 OUTLIER 67.63 130.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.864 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.41 134.76 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 110.885 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.55 143.99 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 74.030000000000001 111.155 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 p -115.55 161.23 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 73.450000000000003 110.906 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' THR . . . . . 0.416 ' HA ' ' CB ' ' A' ' 95' ' ' PRO . 3.2 m -127.91 30.63 5.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 111.088 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.24 22.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.230000000000004 111.11 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.12 134.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.219999999999999 110.916 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 68.1 p -131.45 41.47 3.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 71.129999999999995 111.122 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -48.97 -26.42 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 61.210000000000001 110.863 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -60.35 -36.77 78.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.912 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.27 31.99 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.934 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -114.63 41.92 2.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.897 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.15 30.9 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 75.329999999999998 112.501 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.34 -39.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 110.936 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -97.33 156.88 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 110.879 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.53 99.18 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 111.109 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 91.9 t -63.64 124.93 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 70.209999999999994 111.156 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.615 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 1.4 t80 -155.43 81.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.91 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.56 166.5 39.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 43.350000000000001 112.476 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp 177.97 153.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 72.549999999999997 110.911 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -105.39 87.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 111.151 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -51.35 -46.24 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 74.129999999999995 110.917 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 174.22 11.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 110.866 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.8 77.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 64.510000000000005 112.491 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -24.36 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.758 0.313 . . . . 74.420000000000002 110.9 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -76.53 -34.65 58.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 110.854 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.0 mm -45.4 -39.8 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 111.12 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.4 -52.23 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 111.149 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -49.39 -67.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.889 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -51.62 -54.42 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 111.099 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 11.6 ttm -51.12 -41.28 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.914 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -23.22 12.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 72.409999999999997 110.89 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -65.55 -25.94 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 75.239999999999995 110.847 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -87.42 9.0 22.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 73.120000000000005 110.838 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.14 -171.14 40.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 62.009999999999998 112.501 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -158.5 149.39 20.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 70.129999999999995 110.832 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -49.89 -56.09 11.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.876 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -22.23 57.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.430000000000007 110.879 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.96 -36.2 3.94 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 73.030000000000001 112.479 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -50.55 160.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 63.439999999999998 110.866 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.9 p -121.22 156.98 31.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 72.200000000000003 111.13 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -26.47 62.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 61.109999999999999 110.879 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.29 -168.19 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 72.010000000000005 110.888 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -113.43 96.82 6.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.886 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 19.6 mt -90.61 101.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.349999999999994 111.114 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 t -117.63 164.87 14.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 111.141 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.4 mt -88.53 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 111.144 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.62 -64.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 111.113 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -135.1 166.33 23.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 73.140000000000001 110.856 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -153.72 -174.84 5.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.834 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.9 -147.77 18.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 74.420000000000002 112.462 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.6 pt20 -126.61 136.73 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.875 0.369 . . . . 73.349999999999994 110.901 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -35.39 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 65.430000000000007 110.969 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 75.099999999999994 110.893 179.905 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.321 . . . . 73.340000000000003 110.879 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.1 t -109.95 134.48 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 111.178 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -59.28 159.14 16.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.603 0.716 . . . . 71.519999999999996 110.918 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 154.0 68.45 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 74.239999999999995 112.35 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 m -122.14 44.64 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 75.010000000000005 111.145 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -47.83 140.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 63.409999999999997 111.141 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.57 175.87 9.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.129999999999995 110.892 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -148.64 142.59 25.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 73.540000000000006 110.902 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.29 131.8 42.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 74.5 110.826 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.8 137.34 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.239999999999995 111.106 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.76 167.07 22.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 73.239999999999995 111.092 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.92 95.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.030000000000001 111.121 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 71.14 33.49 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.901 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.27 70.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 71.409999999999997 112.549 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -93.17 131.7 32.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.691 0.757 . . . . 74.319999999999993 110.849 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 147.33 62.18 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 64.540000000000006 112.323 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.37 -67.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.120000000000005 110.88 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.21 -146.66 4.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 73.150000000000006 112.5 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.27 125.86 12.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 75.540000000000006 110.864 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.45 135.24 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 111.158 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -88.76 100.61 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.841 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -87.81 73.6 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 72.400000000000006 110.852 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -51.47 151.78 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 110.878 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.41 123.75 47.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 74.299999999999997 110.932 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.74 70.77 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.864 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.95 -8.68 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 111.084 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.23 -56.13 4.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 71.109999999999999 110.894 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -54.91 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.894 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.53 83.24 53.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.613 0.721 . . . . 73.230000000000004 111.103 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 63.11 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.23 . . . . 74.439999999999998 112.359 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -159.77 -67.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.914 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 m -53.33 -48.06 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 75.310000000000002 111.154 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.02 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 54.43 111.132 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -55.63 -28.27 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.904 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -54.2 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 72.140000000000001 110.922 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.09 -36.52 81.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.862 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -27.23 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 70.430000000000007 110.871 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.41 -35.03 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.310000000000002 111.133 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.84 5.22 25.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.898 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -105.31 -13.99 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 71.530000000000001 110.869 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -116.59 8.23 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 71.109999999999999 111.159 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.03 21.72 39.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 71.239999999999995 112.487 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -34.31 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 73.319999999999993 110.893 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -13.35 62.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.881 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.62 -12.48 59.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 71.340000000000003 112.5 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 47' ' ' GLY . 19.5 m-85 -92.34 -28.08 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 75.340000000000003 110.842 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -35.51 125.89 0.74 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 72.129999999999995 112.472 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -100.48 33.13 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 75.510000000000005 110.979 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 146.74 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 74.299999999999997 110.898 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.05 -95.91 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 60.109999999999999 112.476 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 121.72 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 74.420000000000002 110.862 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.0 p -174.21 -166.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 61.210000000000001 110.882 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 63.51 86.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 64.450000000000003 110.902 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -116.47 17.28 15.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 75.25 110.885 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -134.37 151.68 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 110.862 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 179.54 131.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.519999999999996 111.17 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.06 109.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.674 0.75 . . . . 73.329999999999998 111.146 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.27 . . . . 74.109999999999999 112.333 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.96 -31.6 1.73 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 74.129999999999995 112.489 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.47 -64.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 73.25 110.863 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -158.42 -156.32 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 110.908 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.2 m -131.44 -44.04 1.02 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 74.310000000000002 110.872 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.09 119.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 71.299999999999997 110.947 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 50.109999999999999 112.487 -179.973 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.882 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -128.38 15.27 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 110.888 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . 0.467 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER 82.75 -19.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 111.11 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -20.29 15.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 72.219999999999999 110.934 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.41 -88.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.310000000000002 112.462 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -138.69 -54.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 75.5 110.898 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -168.81 145.17 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.239999999999995 110.895 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.48 144.55 49.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.299999999999997 110.882 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.73 170.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 71.510000000000005 110.857 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.2 146.45 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.010000000000005 110.85 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -58.79 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 75.230000000000004 110.846 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 178.75 156.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 110.889 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -112.55 60.14 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.868 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.7 mm -78.51 -20.52 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.010000000000005 111.181 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 99.06 10.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 72.299999999999997 110.889 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.24 114.33 26.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 110.926 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.44 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -51.16 -95.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 75.450000000000003 110.83 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.5 OUTLIER 66.72 5.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 111.167 -179.86 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.84 153.27 24.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 50.130000000000003 112.49 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.72 63.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.264 . . . . 73.420000000000002 112.326 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.64 -17.95 58.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 53.140000000000001 112.482 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -64.45 140.91 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 72.120000000000005 111.167 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.79 126.67 36.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.230000000000004 110.894 179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -122.72 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 70.319999999999993 110.846 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 mtm -69.17 175.29 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.878 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -166.92 147.38 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.310000000000002 111.103 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.6 m-20 163.5 -64.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.934 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.75 -106.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 111.103 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.534 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -156.59 -60.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 75.129999999999995 112.479 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.534 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.79 -104.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.262 . . . . 72.329999999999998 112.297 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -121.0 72.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.852 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.69 10.42 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.115 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.86 179.51 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 62.539999999999999 110.832 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.17 24.53 2.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 75.439999999999998 112.473 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.49 -52.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 65.409999999999997 110.906 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.14 155.81 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 72.310000000000002 110.9 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -149.87 171.63 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.872 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -159.28 166.48 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 63.119999999999997 110.886 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.5 mt -121.4 114.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.439999999999998 111.12 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.8 p -65.15 -28.03 69.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 60.409999999999997 110.849 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 49.31 22.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 71.420000000000002 111.141 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.4 176.14 6.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 72.239999999999995 111.077 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 104.63 12.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.874 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.2 p -132.45 63.8 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.209999999999994 111.16 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -90.13 22.63 3.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 62.520000000000003 110.881 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -93.33 5.91 49.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.150000000000006 110.933 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.59 -4.96 36.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.899 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.14 68.42 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.91 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.57 37.36 0.83 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.79 -0.719 . . . . 70.140000000000001 112.454 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -55.46 -34.33 64.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 72.049999999999997 110.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -110.38 156.2 21.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.099999999999994 110.827 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.07 85.07 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 111.105 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -65.25 118.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 111.109 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 17.96 4.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 74.409999999999997 110.869 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.74 178.2 28.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 75.010000000000005 112.503 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 170.09 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 75.200000000000003 110.934 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.4 t -97.75 84.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 75.400000000000006 111.11 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -62.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.908 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 75.409999999999997 110.829 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.29 10.46 68.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.209999999999994 112.467 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.64 27.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 74.310000000000002 110.856 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.55 -26.92 14.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 72.099999999999994 110.886 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.4 mm -80.02 -41.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 72.150000000000006 111.124 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 38.1 t -50.17 -45.19 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 75.319999999999993 111.115 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -32.77 67.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 71.310000000000002 110.85 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.77 92.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 75.319999999999993 111.079 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.1 mtm -71.62 -26.09 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 72.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.5 14.18 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 73.010000000000005 110.883 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -16.26 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.209999999999994 110.89 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -104.24 -8.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.239999999999995 110.864 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.53 -150.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 73.420000000000002 112.447 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -169.41 152.87 4.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 73.540000000000006 110.857 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -73.24 69.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.349999999999994 110.851 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 177.51 -26.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 110.86 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.4 -48.14 0.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 45.439999999999998 112.497 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.84 160.9 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.439999999999998 110.895 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -137.71 171.4 14.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 111.119 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 p -86.55 -4.01 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.842 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -137.85 -165.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 75.239999999999995 110.888 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.33 125.31 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 71.439999999999998 110.903 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.04 131.18 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 111.148 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 163.85 22.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.120000000000005 111.152 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.97 94.47 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 111.132 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.55 -48.63 76.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.209999999999994 111.1 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.64 -178.48 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 74.140000000000001 110.877 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.0 p -176.55 157.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.89 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.48 176.67 45.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 75.200000000000003 112.488 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.6 mt-30 -69.29 -36.71 77.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.854 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.3 mm? 71.9 -21.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 110.898 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 163' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 70.109999999999999 110.846 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.815 0.341 . . . . 74.340000000000003 110.9 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.04 154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.131 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -89.79 151.32 45.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 75.5 110.826 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 109.27 2.28 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.671 2.247 . . . . 73.329999999999998 112.344 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -113.42 141.46 47.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 61.329999999999998 111.121 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.9 148.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.209999999999994 111.141 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -118.69 147.79 43.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.209999999999994 110.908 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -129.06 131.41 47.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.895 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.12 75.54 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 72.319999999999993 110.892 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mm -49.74 141.41 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.146 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -132.92 151.49 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 74.400000000000006 111.111 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.6 t -134.19 108.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 72.200000000000003 111.181 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t0 51.47 52.25 15.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.430000000000007 110.919 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.22 50.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 71.200000000000003 112.463 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -139.29 94.57 9.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.651 0.738 . . . . 73.129999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.83 157.75 59.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.309 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pp -126.37 22.88 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 70.430000000000007 110.955 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.85 160.4 9.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 65.409999999999997 112.495 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 -179.68 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 74.420000000000002 110.917 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.61 168.99 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.111 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -145.64 144.27 30.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 110.823 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.68 138.62 52.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 72.030000000000001 110.904 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -111.36 113.56 26.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.896 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 mt -80.2 129.74 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 110.903 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 72.16 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.43 110.868 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.51 -27.19 15.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 72.420000000000002 111.116 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.57 -44.01 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.845 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.51 -32.84 18.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.906 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 m -131.24 87.19 48.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.329999999999998 111.147 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.27 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 73.150000000000006 112.364 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -41.89 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 70.349999999999994 110.897 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -3.1 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 111.18 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.62 -37.47 56.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.329999999999998 111.141 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 35' ' ' ASN . 80.3 tt0 -92.79 -37.88 12.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 65.040000000000006 110.885 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -29.32 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.861 -179.904 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.45 -32.75 74.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.219999999999999 110.857 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -51.75 -34.7 40.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.885 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.49 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 111.113 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.4 mt -75.63 -52.02 11.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 75.200000000000003 110.856 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.9 m -59.39 -54.01 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.862 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.6 p -73.19 -27.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.340000000000003 111.15 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.96 92.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.722 . . . . 72.319999999999993 112.495 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.72 36.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 74.120000000000005 110.901 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -133.72 26.81 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.299999999999997 110.947 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.06 4.76 60.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 74.450000000000003 112.454 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -164.56 178.05 7.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 75.230000000000004 110.875 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.52 117.01 2.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 70.400000000000006 112.45 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.11 150.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 63.420000000000002 110.912 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -76.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 73.299999999999997 110.92 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.01 44.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 73.019999999999996 112.516 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -26.46 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.420000000000002 110.848 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p 178.13 176.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 65.439999999999998 110.931 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -103.2 -77.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.876 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.12 -80.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.549999999999997 110.9 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -164.82 110.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 110.878 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.71 135.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 111.131 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -131.74 103.5 14.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 74.120000000000005 111.087 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.53 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 75.25 112.385 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.46 8.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 41.340000000000003 112.476 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.56 -66.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 73.239999999999995 110.94 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -168.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 73.5 110.875 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.15 133.22 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.519999999999996 110.895 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.04 154.81 18.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.939 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 61.310000000000002 112.525 -179.976 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.797 0.332 . . . . 74.099999999999994 110.885 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 142.27 27.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 71.430000000000007 110.852 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -40.67 -38.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.120000000000005 111.081 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -85.89 49.24 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.877 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.16 -113.82 4.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 73.040000000000006 112.47 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.96 -161.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.393 . . . . 74.400000000000006 110.862 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -178.51 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 65.030000000000001 110.87 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -131.66 162.13 31.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 74.430000000000007 110.913 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -91.28 172.5 8.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 73.310000000000002 110.866 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.71 105.9 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 71.120000000000005 110.821 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -58.21 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 73.439999999999998 110.861 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -177.92 165.52 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 110.883 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.1 55.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 110.839 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mt -48.93 -26.32 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 75.030000000000001 111.194 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.3 mt -93.39 155.08 17.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 110.905 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -117.93 178.29 4.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.908 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -105.08 76.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.849 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 t -122.34 22.39 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 111.162 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.72 160.12 15.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.76 -0.733 . . . . 73.409999999999997 112.505 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.26 24.27 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 72.430000000000007 112.375 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.42 71.11 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 74.400000000000006 112.491 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.42 143.4 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 75.310000000000002 111.119 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.03 152.67 34.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.140000000000001 110.887 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.9 m -154.89 -101.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.877 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -176.4 124.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 74.540000000000006 110.874 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 80.76 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 53.229999999999997 111.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -137.32 -64.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 71.209999999999994 110.919 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.676 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -178.17 121.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 51.5 111.118 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.883 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -72.61 -29.48 65.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 71.230000000000004 112.482 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.883 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.7 Cg_endo -69.78 80.99 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.232 . . . . 72.099999999999994 112.367 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.29 53.96 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.519999999999996 110.892 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.03 39.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.200000000000003 111.142 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -74.77 160.27 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.941 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.99 -110.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.530000000000001 112.507 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.25 -162.14 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 72.319999999999993 110.851 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 74.75 50.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 75.519999999999996 110.896 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 41.0 p90 -50.25 142.71 9.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.836 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 114' ' ' ILE . 27.9 p90 -103.98 59.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 72.340000000000003 110.871 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 113' ' ' PHE . 9.3 tt -34.79 121.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.5 111.106 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.7 m -90.53 159.01 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 64.109999999999999 110.898 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -111.67 -9.69 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 71.040000000000006 111.163 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.87 161.38 40.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 62.219999999999999 111.085 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.24 115.92 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.150000000000006 110.9 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.8 p -115.7 47.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 75.209999999999994 111.153 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.71 -17.54 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 74.540000000000006 110.926 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -55.65 -21.91 20.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 71.310000000000002 110.934 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.33 -56.25 5.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.923 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 73.03 -61.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.897 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.83 61.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.685 -0.769 . . . . 73.530000000000001 112.491 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -98.02 -27.79 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.430000000000007 110.913 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -143.44 138.1 29.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.812 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.4 t -51.37 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.14 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.2 143.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 75.329999999999998 111.133 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -178.78 119.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.129999999999995 110.855 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.42 123.33 4.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 74.409999999999997 112.485 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -139.23 162.03 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 74.519999999999996 110.892 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 t -54.83 100.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 111.136 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -46.85 41.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 75.430000000000007 110.888 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -148.06 118.2 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.865 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.33 84.42 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 64.230000000000004 112.474 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 tpt -91.26 -21.52 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 110.873 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -30.74 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 73.0 110.885 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 142' ' ' MET . 38.2 mm -64.49 -41.76 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.239999999999995 111.117 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.65 11.39 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 111.085 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.8 -64.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 110.855 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.63 -57.28 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 111.083 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.7 tmm? -52.81 -37.86 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 70.420000000000002 110.888 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -24.59 32.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.878 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -68.39 -12.57 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.010000000000005 110.839 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -94.78 26.09 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 75.510000000000005 110.884 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.503 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -124.92 44.04 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 70.400000000000006 112.53 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 146' ' ' GLY . 29.8 t 29.57 -102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.384 . . . . 74.329999999999998 110.834 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -173.5 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 73.019999999999996 110.86 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -87.74 -6.45 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.420000000000002 110.895 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.68 -55.81 0.76 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 74.409999999999997 112.464 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 110.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.84 0.352 . . . . 74.230000000000004 110.848 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.0 p -84.11 138.33 33.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 111.154 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.31 -28.92 63.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 65.530000000000001 110.854 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -137.07 -179.62 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 110.903 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 135.4 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 110.888 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.17 87.66 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.040000000000006 111.128 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -108.68 157.16 18.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 111.175 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.4 mt -93.22 146.06 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.188 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.55 -61.22 1.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 111.114 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.09 154.6 48.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.0 m -146.16 -167.5 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 73.439999999999998 110.892 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.66 -162.93 23.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 72.25 112.501 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -112.54 133.82 54.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 75.239999999999995 110.901 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.24 144.48 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 62.439999999999998 110.943 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.25 110.895 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.838 0.351 . . . . 75.219999999999999 110.896 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.9 t 59.62 99.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 73.409999999999997 111.127 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -58.59 154.91 32.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.540000000000006 110.907 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 154.8 67.33 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.233 . . . . 75.439999999999998 112.365 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -120.55 163.01 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 64.349999999999994 111.109 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 t -144.11 140.68 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 111.176 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.416 ' HB3' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -126.34 144.36 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 65.430000000000007 110.864 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.67 139.58 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 71.299999999999997 110.862 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.02 109.86 22.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 65.239999999999995 110.799 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.3 136.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.478 . . . . 74.329999999999998 111.157 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.32 161.91 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.340000000000003 111.099 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.2 t -146.45 93.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.019999999999996 111.161 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.2 27.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.83 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.88 57.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 64.430000000000007 112.536 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.15 139.22 21.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.605 0.717 . . . . 72.409999999999997 110.891 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 152.93 69.49 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 71.439999999999998 112.401 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.07 -68.39 0.92 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 73.129999999999995 110.929 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.81 -144.67 4.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 61.140000000000001 112.518 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.31 135.91 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.450000000000003 110.847 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.64 129.73 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 111.145 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 95.54 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.450000000000003 110.821 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.5 m-85 -87.56 119.81 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 110.875 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -101.07 147.88 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.917 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.06 120.18 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 65.140000000000001 110.911 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.63 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.100000000000001 110.904 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.67 -2.47 56.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 65.530000000000001 111.104 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.05 -51.03 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 110.867 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -26.32 16.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.209999999999994 110.862 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.58 74.57 65.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 111.142 179.858 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -44.6 1.98 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.251 . . . . 73.340000000000003 112.382 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -62.85 -50.22 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.92 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -39.33 93.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 111.138 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.81 -68.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 111.07 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' ARG . 27.2 tt0 -48.42 -65.61 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.932 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 34' ' ' GLU . 4.2 t30 -29.93 -52.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 65.120000000000005 110.867 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.12 -41.56 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 75.349999999999994 110.885 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 5.0 ttm180 -52.06 -29.52 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.540000000000006 110.834 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -32.55 73.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 111.098 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.01 35.3 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 110.877 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -113.22 -12.29 13.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 110.853 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 p -121.32 18.14 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 111.159 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.34 27.8 8.39 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.747 -0.739 . . . . 64.209999999999994 112.528 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.04 -40.41 53.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.392 . . . . 75.239999999999995 110.882 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -17.27 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 110.895 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.26 -66.24 3.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 63.030000000000001 112.492 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -93.3 148.02 22.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 75.5 110.917 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.8 -168.04 25.14 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.756 -0.735 . . . . 54.229999999999997 112.48 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.11 139.7 30.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.931 0.396 . . . . 74.310000000000002 110.941 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -42.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 73.200000000000003 110.918 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.2 45.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 55.020000000000003 112.473 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.5 t -95.43 45.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 72.510000000000005 110.854 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.27 -176.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 70.540000000000006 110.881 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -176.53 134.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 110.859 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.22 66.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 73.519999999999996 110.862 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 8.26 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.230000000000004 110.86 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.457 HG21 ' HA3' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -57.75 150.63 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 111.125 179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 3.9 mt -140.29 95.64 8.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 75.329999999999998 111.14 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.77 87.6 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 74.239999999999995 112.332 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 71.409999999999997 112.516 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -59.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 72.340000000000003 110.908 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -157.22 -150.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.888 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.6 t -121.01 -53.68 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 74.109999999999999 110.896 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.08 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 72.519999999999996 110.943 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.728 -0.748 . . . . 65.540000000000006 112.5 -179.976 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.797 0.332 . . . . 74.329999999999998 110.893 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 167.01 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.400000000000006 110.826 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -42.96 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 111.126 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.75 46.02 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.966 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.55 -95.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.749 . . . . 42.420000000000002 112.495 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -54.64 178.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 70.140000000000001 110.904 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.92 -172.07 2.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.150000000000006 110.9 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.11 164.46 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 73.019999999999996 110.866 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.27 179.33 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.859 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.89 129.73 34.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.430000000000007 110.84 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -88.24 -46.57 9.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.510000000000005 110.877 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 p30 177.68 156.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.119999999999997 110.913 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.84 63.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.884 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 2.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 71.299999999999997 111.164 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.8 mt -133.68 136.74 44.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.120000000000005 110.907 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -162.91 1.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.897 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -102.19 97.07 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 65.209999999999994 110.867 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -79.19 -21.43 46.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 111.154 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.02 -125.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 62.350000000000001 112.483 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.14 47.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.616 2.211 . . . . 65.5 112.345 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 67.05 121.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 72.310000000000002 112.47 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -176.4 130.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 71.040000000000006 111.135 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -106.61 122.84 47.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.888 179.888 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.51 -155.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 75.540000000000006 110.908 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.1 mmt -134.23 116.34 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.905 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.38 80.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.209999999999994 111.083 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.5 p30 39.14 -157.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 72.209999999999994 110.912 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.554 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -141.44 10.99 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 111.11 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.9 -65.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 64.319999999999993 112.512 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.554 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.78 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 60.439999999999998 112.314 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -82.34 81.05 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.510000000000005 110.888 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -153.22 56.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 111.111 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.89 -44.51 19.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 71.109999999999999 110.898 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 48.18 -164.74 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 44.520000000000003 112.452 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.96 87.82 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 110.866 -179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -161.15 51.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.924 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -59.83 -172.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.898 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.62 106.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.099999999999994 110.927 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.8 mt -48.17 123.36 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 111.122 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 89.7 m -84.29 116.5 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 110.868 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -88.18 -30.69 19.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.109999999999999 111.155 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.13 161.02 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 71.209999999999994 111.085 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -62.22 102.3 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 110.921 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -113.89 46.0 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 71.129999999999995 111.175 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -16.79 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 72.530000000000001 110.827 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.12 -15.51 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.939 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.99 78.29 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.150000000000006 110.942 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.92 -47.79 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 64.450000000000003 110.871 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.87 45.17 3.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 72.209999999999994 112.499 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -145.25 -53.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 71.439999999999998 110.906 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -101.68 134.76 44.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 110.802 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.47 104.83 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 111.119 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 90.8 t -78.41 132.5 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 111.131 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 29' ' ' VAL . 19.5 p90 -152.94 26.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 110.884 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -161.4 -170.53 26.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.701 -0.762 . . . . 72.239999999999995 112.466 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp 178.73 -169.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 75.400000000000006 110.926 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -116.35 81.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 73.340000000000003 111.139 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -49.2 -34.56 15.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 74.349999999999994 110.919 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -171.02 168.28 6.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.540000000000006 110.873 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.83 -1.6 58.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.714 -0.755 . . . . 71.019999999999996 112.466 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -33.54 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 74.230000000000004 110.934 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -50.58 -27.03 6.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 71.019999999999996 110.905 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 mm -81.58 -45.61 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 73.540000000000006 111.145 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.06 -51.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.121 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.01 -27.74 14.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 70.239999999999995 110.891 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.57 52.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 75.5 111.109 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.1 mtm -62.96 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.863 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 6.3 mm-40 -51.42 -71.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.898 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -60.0 -16.68 32.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.883 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -92.51 2.16 56.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 72.040000000000006 110.854 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.457 ' HA3' HG21 ' A' ' 56' ' ' ILE . . . -127.62 46.77 1.06 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 75.239999999999995 112.504 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 146' ' ' GLY . 8.1 t 34.89 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 110.886 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.9 mmm-85 -133.62 -35.44 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.409999999999997 110.903 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -99.45 -8.3 24.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.010000000000005 110.926 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.57 80.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 63.439999999999998 112.483 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -60.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 75.049999999999997 110.874 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 66.43 133.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 63.210000000000001 111.126 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -9.02 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.230000000000004 110.877 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.48 156.65 47.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 73.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.76 118.64 32.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.891 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mt -88.59 134.47 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 111.15 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.16 170.45 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 71.430000000000007 111.145 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.7 111.36 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 111.156 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.96 39.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.131 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -167.6 168.84 12.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 75.519999999999996 110.908 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.3 p -156.49 163.76 39.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 65.319999999999993 110.867 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.72 -178.85 47.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 74.319999999999993 112.456 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.517 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 9.5 mt-30 -69.32 -37.23 77.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 71.209999999999994 110.94 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.5 mm? 71.14 -62.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 65.450000000000003 110.885 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.099999999999994 110.877 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 75.150000000000006 110.852 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.9 155.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 61.049999999999997 111.104 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.37 149.25 37.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 75.340000000000003 110.9 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.81 19.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.681 2.254 . . . . 70.450000000000003 112.366 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 m -119.6 124.91 47.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.450000000000003 111.132 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -104.95 144.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 75.25 111.108 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -105.05 154.94 19.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 73.530000000000001 110.866 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.33 131.52 26.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 75.219999999999999 110.89 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.52 95.07 5.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.400000000000006 110.885 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mt -78.92 141.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 64.409999999999997 111.144 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.83 159.94 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.099999999999994 111.122 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.31 106.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 75.239999999999995 111.095 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 51.45 55.44 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 63.299999999999997 110.879 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.51 9.84 33.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 63.439999999999998 112.512 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -136.0 93.84 14.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.685 0.755 . . . . 74.099999999999994 110.87 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.83 156.02 64.22 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.694 2.262 . . . . 64.549999999999997 112.313 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.18 26.99 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.942 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.9 169.28 12.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 63.520000000000003 112.488 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.58 171.52 12.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.019999999999996 110.845 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.3 -176.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.439999999999998 111.158 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.7 p -148.11 154.77 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.824 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.36 134.1 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 110.878 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.1 tt0 -73.98 -55.03 6.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.099999999999994 110.888 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mt 76.8 124.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.961 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -81.76 55.28 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.877 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -36.52 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.430000000000007 111.113 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.44 -51.61 66.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 110.878 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -60.49 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 110.891 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.55 82.51 6.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 74.200000000000003 111.135 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 60.94 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 62.450000000000003 112.355 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 -71.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 74.010000000000005 110.874 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.3 m -58.34 -53.71 55.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 70.030000000000001 111.149 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.83 9.52 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.106 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -88.95 -24.54 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 61.509999999999998 110.872 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.57 -29.76 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.859 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -50.59 -28.4 8.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.868 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -56.66 -30.71 63.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.420000000000002 110.861 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.79 -31.79 19.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.420000000000002 111.081 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.19 -47.85 75.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 70.510000000000005 110.962 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -65.22 -37.41 87.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 110.857 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.4 p -73.88 -19.66 60.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 74.310000000000002 111.184 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.6 91.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.741 . . . . 64.519999999999996 112.457 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.66 36.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.901 0.381 . . . . 73.150000000000006 110.886 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.99 6.63 2.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 9.7 84.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 75.519999999999996 112.526 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -174.16 -169.17 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 72.409999999999997 110.886 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.53 -80.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.507 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -176.8 110.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 74.329999999999998 110.889 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -179.03 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 74.540000000000006 110.938 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -45.2 104.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 61.240000000000002 112.507 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -159.74 54.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 62.219999999999999 110.865 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.8 m 52.3 -173.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.908 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -168.84 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.839 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -115.56 -77.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 75.409999999999997 110.857 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -135.44 143.38 45.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.875 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.6 mt -143.78 125.86 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 72.219999999999999 111.134 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.28 114.11 12.46 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 70.219999999999999 111.15 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.8 108.99 2.21 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.682 2.255 . . . . 73.150000000000006 112.334 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.2 -31.28 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 54.229999999999997 112.516 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -63.2 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 75.109999999999999 110.854 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.81 -165.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.853 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.3 m -142.19 115.04 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.100000000000001 110.925 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -99.36 151.06 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 64.430000000000007 110.908 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 72.349999999999994 112.433 -179.911 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 77' ' ' SER . 16.6 ptpt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.312 . . . . 72.019999999999996 110.921 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 61.2 p -87.75 -167.94 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.811 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.85 11.19 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 75.319999999999993 111.121 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -7.71 25.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 72.430000000000007 110.919 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.05 -84.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 75.109999999999999 112.451 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.4 -68.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 71.349999999999994 110.864 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -167.78 163.58 14.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 65.120000000000005 110.883 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.6 144.15 51.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.856 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.13 159.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 110.878 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -64.6 -167.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.863 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -148.36 -67.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.409999999999997 110.893 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -176.93 171.88 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 72.540000000000006 110.935 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.97 43.35 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 71.409999999999997 110.868 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.7 mt -51.01 -27.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.450000000000003 111.132 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.6 137.39 35.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.899 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.93 114.09 17.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.917 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -55.97 102.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.129999999999995 110.837 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.2 p -113.76 42.45 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.409999999999997 111.153 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.89 156.67 14.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 50.32 112.517 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 128.08 15.49 Favored 'Trans proline' 0 N--CA 1.466 -0.103 0 C-N-CA 122.69 2.26 . . . . 73.209999999999994 112.33 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.9 -22.1 8.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 63.409999999999997 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.9 mm -65.82 152.05 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 72.430000000000007 111.117 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.0 mt -96.12 132.18 41.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.400000000000006 110.941 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.0 m -119.67 138.66 53.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.816 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.428 ' HB2' HG12 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -77.57 172.48 13.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 72.109999999999999 110.86 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.561 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -166.13 -175.07 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 111.094 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 12.0 t30 88.6 95.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.887 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.571 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . 66.18 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 111.08 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 121.49 -59.96 0.56 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.708 -0.758 . . . . 71.430000000000007 112.462 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.571 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 100.15 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 74.5 112.301 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.8 56.33 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.84 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -132.0 7.14 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.200000000000003 111.116 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 41.29 -92.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.913 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 97.43 139.16 10.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 55.140000000000001 112.472 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 p -100.61 -8.89 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 70.340000000000003 110.896 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 129.82 35.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 75.019999999999996 110.934 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.05 138.69 48.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.219999999999999 110.903 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -120.2 121.64 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.200000000000003 110.883 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mt -92.35 119.26 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 111.107 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -76.27 150.97 36.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.84 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -126.55 23.75 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.420000000000002 111.124 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.72 20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 65.349999999999994 111.111 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 64.97 135.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.200000000000003 110.891 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.8 p -148.95 68.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 71.150000000000006 111.129 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -84.37 14.3 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.868 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -91.39 0.33 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.955 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.56 31.88 1.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 54.520000000000003 110.871 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 92' ' ' HIS . 22.5 p-10 -96.26 78.81 3.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.329999999999998 110.847 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.79 -41.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 44.329999999999998 112.485 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -35.75 73.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 73.120000000000005 110.898 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -117.37 159.3 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 64.129999999999995 110.831 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 128' ' ' VAL . 1.1 p -81.05 -159.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.087 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.524 ' N ' ' CG1' ' A' ' 127' ' ' VAL . 0.9 OUTLIER -165.36 144.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 72.140000000000001 111.128 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 27.7 p90 -175.99 115.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 71.209999999999994 110.905 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 114.87 114.5 3.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 73.409999999999997 112.488 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.39 143.14 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 64.040000000000006 110.861 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.53 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 111.126 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -56.78 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 61.210000000000001 110.899 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.09 170.8 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.872 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.37 82.45 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.463 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 8.7 tpt -89.17 11.09 19.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 75.109999999999999 110.832 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.69 -34.3 16.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 72.420000000000002 110.905 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 142' ' ' MET . 39.4 mm -60.18 -38.38 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 111.116 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 t -90.63 -3.01 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.122 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -110.66 -71.83 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.439999999999998 110.9 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.75 -52.07 34.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 72.540000000000006 111.119 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.425 ' C ' ' H ' ' A' ' 144' ' ' ARG . 13.7 tmm? -51.43 -29.16 15.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.862 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.418 ' CG ' ' HA ' ' A' ' 58' ' ' PRO . 1.4 tm-20 -79.54 29.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 71.239999999999995 110.854 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 142' ' ' MET . 15.6 ttp85 -113.51 -14.39 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.884 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -105.77 -2.46 23.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.89 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -157.46 1.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 74.019999999999996 112.483 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 t -163.79 141.77 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 74.230000000000004 110.868 -179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -57.46 -20.15 28.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 110.855 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.09 -17.87 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.902 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.93 -42.0 1.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.708 -0.758 . . . . 70.010000000000005 112.506 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -46.41 131.6 10.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 73.219999999999999 110.882 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.7 p -96.52 112.66 24.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.144 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -49.8 -28.1 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 64.299999999999997 110.841 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -125.11 -162.26 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.939 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -128.37 129.25 45.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 70.129999999999995 110.909 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.36 92.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 111.133 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.0 p -103.17 148.66 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 63.350000000000001 111.142 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.8 mt -88.82 130.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 111.134 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.89 -64.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.08 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -127.02 170.63 12.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 110.816 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.48 -174.89 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.862 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.36 -148.59 19.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 75.329999999999998 112.44 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.74 133.91 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 74.409999999999997 110.9 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 tp -56.78 -57.09 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 110.866 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.120000000000005 110.912 179.95 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.809 0.337 . . . . 75.019999999999996 110.887 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.35 138.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 64.319999999999993 111.121 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.41 157.28 13.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.65 0.738 . . . . 73.409999999999997 110.882 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 122.0 8.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 74.349999999999994 112.318 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -100.85 55.99 0.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 111.128 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -52.26 154.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.519999999999996 111.077 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.56 170.8 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.861 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.0 143.88 33.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 74.049999999999997 110.902 -179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.45 115.95 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.349999999999994 110.86 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -85.73 123.07 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 75.310000000000002 111.129 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.19 13.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 111.097 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.7 m -144.21 101.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.049999999999997 111.109 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 3.7 t0 76.71 45.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 70.549999999999997 110.901 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 24.02 70.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 72.319999999999993 112.452 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -135.27 148.7 67.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 74.239999999999995 110.92 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 140.13 41.91 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.68 2.253 . . . . 74.319999999999993 112.358 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tp -127.39 -38.12 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.913 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.24 -178.51 45.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 51.409999999999997 112.482 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 162.25 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.510000000000005 110.847 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.54 147.6 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 73.25 111.119 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.23 97.82 11.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 74.099999999999994 110.911 -179.867 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -85.0 59.61 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 110.846 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.79 115.45 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.430000000000007 110.865 -179.9 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 mt -81.83 133.2 35.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.109999999999999 110.927 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -75.8 67.31 2.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 110.855 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.18 -14.82 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 73.439999999999998 111.095 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.09 -60.26 2.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.854 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -67.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 75.540000000000006 110.924 -179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.509 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 3.2 m -105.95 114.46 62.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 64.140000000000001 111.107 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' LYS . 53.7 Cg_endo -69.77 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 73.030000000000001 112.319 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' PRO . 7.9 mtmm -38.33 -54.68 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 110.849 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.509 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 55.8 m -39.51 -58.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 73.400000000000006 111.145 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.98 30.85 4.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 70.030000000000001 111.074 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -97.24 -30.64 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.846 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.03 -35.53 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.129999999999995 110.9 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -31.62 6.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 110.932 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -35.82 70.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.872 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.29 -21.75 27.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 63.229999999999997 111.133 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.7 mt -70.23 -51.36 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 72.150000000000006 110.892 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -68.18 -44.69 75.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 74.120000000000005 110.885 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -74.96 -24.07 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 73.420000000000002 111.157 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.34 94.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.230000000000004 112.486 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.76 47.53 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.948 0.404 . . . . 61.049999999999997 110.933 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 33.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 75.200000000000003 110.868 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.63 -3.4 49.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 74.530000000000001 112.495 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -163.0 -168.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 73.450000000000003 110.862 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.69 137.39 4.81 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.679 -0.772 . . . . 75.340000000000003 112.468 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -85.21 144.27 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.951 0.405 . . . . 74.25 110.94 -179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -57.66 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 75.510000000000005 110.869 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -114.26 -76.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 71.510000000000005 112.513 179.916 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t 68.82 123.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 75.310000000000002 110.841 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.51 -171.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.549999999999997 110.849 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -104.81 -170.82 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 65.040000000000006 110.922 -179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -60.09 1.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.349999999999994 110.828 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -151.66 160.14 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.230000000000004 110.842 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.1 mt -136.82 130.52 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -130.22 110.23 16.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.601 0.715 . . . . 75.530000000000001 111.149 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.7 Cg_endo -69.83 101.72 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.609 2.206 . . . . 73.319999999999993 112.337 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.62 22.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.697 -0.764 . . . . 53.409999999999997 112.511 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.5 -63.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 110.912 -179.878 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -168.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.846 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.0 m -150.04 131.5 14.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.92 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -111.92 139.57 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 74.040000000000006 110.899 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.762 -0.732 . . . . 63.299999999999997 112.519 -179.989 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.771 0.32 . . . . 64.519999999999996 110.926 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.61 -179.44 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.843 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.5 pt -81.26 -39.17 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 75.299999999999997 111.134 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -96.68 93.93 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 63.210000000000001 110.941 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.36 -119.51 5.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 61.219999999999999 112.453 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -84.5 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 63.240000000000002 110.903 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 152.66 44.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.299999999999997 110.926 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.71 148.81 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.924 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -49.17 157.77 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 73.510000000000005 110.892 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.08 144.17 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 61.32 110.892 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -61.24 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.0 110.858 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.64 167.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 74.409999999999997 110.902 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.46 60.6 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.010000000000005 110.875 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 mm -73.37 -6.86 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 111.165 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.99 81.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 70.299999999999997 110.922 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -66.93 161.54 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.882 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -71.41 75.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.834 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -70.93 -12.28 61.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 111.153 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.14 -170.09 43.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 72.150000000000006 112.483 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 128.04 15.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.694 2.263 . . . . 74.439999999999998 112.339 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.88 -31.4 3.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 74.040000000000006 112.511 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.0 mm -61.27 139.54 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.366 . . . . 73.239999999999995 111.129 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 50.6 mt -108.28 159.64 16.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 72.439999999999998 110.938 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 m -158.96 33.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.240000000000002 110.858 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 47.17 -167.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.150000000000006 110.877 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -172.46 75.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 111.165 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -116.23 -73.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.88 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.507 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -147.64 -36.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.200000000000003 111.122 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.06 -69.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 61.109999999999999 112.512 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.507 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.6 Cg_endo -69.74 108.53 2.1 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 73.219999999999999 112.33 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 45.52 38.39 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 73.109999999999999 110.879 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -138.04 56.79 1.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 63.030000000000001 111.152 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -39.34 -57.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.893 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.8 -170.84 50.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.129999999999995 112.46 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.2 t -144.68 25.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 61.140000000000001 110.826 -179.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -79.65 -100.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.420000000000002 110.88 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 170.66 179.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.510000000000005 110.888 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.62 38.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.905 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.0 tt -58.27 91.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.200000000000003 111.14 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.9 142.11 54.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 74.150000000000006 110.907 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.4 p -111.4 22.34 15.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.154 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -176.75 161.24 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 54.240000000000002 111.116 179.88 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 95.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.420000000000002 110.914 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.5 p -125.12 59.46 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 44.219999999999999 111.119 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.22 30.63 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.200000000000003 110.929 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.47 7.27 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.400000000000006 110.902 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.11 -10.16 28.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 71.299999999999997 110.915 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.59 78.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 75.120000000000005 110.876 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 38.82 50.54 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 71.129999999999995 112.481 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -58.27 -33.01 68.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 74.099999999999994 110.886 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -143.85 177.68 8.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 71.239999999999995 110.877 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.404 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -61.91 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 73.150000000000006 111.12 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 2.6 p -174.47 138.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 111.149 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 3.7 p90 178.6 102.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 74.010000000000005 110.843 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.56 127.11 3.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 62.420000000000002 112.485 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.71 21.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 74.310000000000002 110.892 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 m -49.56 159.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 111.138 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -160.86 -39.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.530000000000001 110.904 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -63.54 1.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 110.881 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.19 105.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.109999999999999 112.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -6.78 33.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.776 0.322 . . . . 73.040000000000006 110.869 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -57.61 -20.39 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 70.120000000000005 110.87 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.8 mm -91.74 -45.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.409999999999997 111.105 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.71 -20.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.120000000000005 111.115 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -83.92 -32.88 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 63.100000000000001 110.925 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.59 -31.28 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 111.123 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -86.02 -9.48 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 110.88 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.88 28.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.869 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -145.17 8.04 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.891 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.66 2.28 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 110.903 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.17 72.57 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.769 -0.729 . . . . 73.329999999999998 112.516 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.564 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.7 134.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 74.400000000000006 110.877 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 27.2 mmm-85 -47.96 -44.91 30.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.340000000000003 110.857 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -49.11 -27.45 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 110.867 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.46 -37.59 2.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.723 . . . . 75.230000000000004 112.507 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.66 140.39 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 74.510000000000005 110.916 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.1 p -118.13 147.92 42.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 73.329999999999998 111.134 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -21.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 65.25 110.815 -179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -131.9 -168.35 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.239999999999995 110.853 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -132.14 132.15 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.922 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 127.38 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 111.128 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.86 168.75 18.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 111.136 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.404 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.4 mt -129.26 113.62 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.139 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.53 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 65.349999999999994 111.073 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.92 -178.44 6.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.846 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.62 178.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.520000000000003 110.925 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.4 -163.63 33.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.409999999999997 112.476 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.56 123.3 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 72.319999999999993 110.946 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.93 -74.84 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 110.892 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.099999999999994 110.919 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.805 0.336 . . . . 74.430000000000007 110.858 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.78 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 111.124 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.9 150.85 48.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 71.25 110.875 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 153.19 69.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 74.120000000000005 112.34 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.49 162.7 32.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 111.161 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.05 132.91 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.156 179.886 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -110.98 161.9 15.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.884 179.98 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -143.52 133.06 23.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 73.439999999999998 110.85 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.25 82.29 2.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.350000000000001 110.88 179.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.7 142.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.540000000000006 111.098 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -139.31 159.94 40.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 111.124 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -137.64 99.63 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 74.519999999999996 111.124 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.29 33.61 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.439999999999998 110.862 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.45 -15.0 64.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.732 . . . . 62.520000000000003 112.467 -179.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.52 109.66 51.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.597 0.713 . . . . 64.420000000000002 110.912 -179.909 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 145.04 55.83 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.671 2.247 . . . . 64.319999999999993 112.358 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.88 -66.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 74.109999999999999 110.857 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.82 -172.03 30.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 63.020000000000003 112.491 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 121.76 42.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 75.25 110.849 -179.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.45 105.86 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 72.120000000000005 111.112 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 79.1 p -98.84 142.06 30.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.826 -179.829 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.61 162.87 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 75.329999999999998 110.874 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -106.61 139.97 40.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.120000000000005 110.896 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.05 107.37 16.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 75.049999999999997 110.935 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -85.22 71.61 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.230000000000004 110.878 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.3 -24.55 64.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 111.082 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.57 -34.44 76.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 64.200000000000003 110.912 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -103.31 -32.16 9.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.329999999999998 110.917 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.4 67.19 75.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 65.150000000000006 111.161 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -3.37 11.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.667 2.245 . . . . 73.200000000000003 112.371 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -42.87 8.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.6 p -85.59 -41.09 15.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 74.109999999999999 111.164 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.97 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 64.329999999999998 111.082 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.7 tt0 -53.15 -64.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.893 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 34' ' ' GLU . 7.2 t30 -31.66 -46.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.409999999999997 110.905 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -78.75 -43.29 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 110.893 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -55.38 -33.23 63.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 72.120000000000005 110.884 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.68 77.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 62.420000000000002 111.153 179.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.98 39.24 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 110.927 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p -112.98 -15.15 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 75.329999999999998 110.808 -179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.2 p -123.17 10.52 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.119999999999997 111.135 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.46 61.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 72.420000000000002 112.467 179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -81.07 -26.49 36.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.93 0.395 . . . . 72.200000000000003 110.89 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -67.56 -10.14 49.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.925 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.29 -18.51 36.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 72.120000000000005 112.472 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -85.74 -31.03 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 75.25 110.854 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.32 -176.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 54.109999999999999 112.496 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.514 ' O ' ' C ' ' A' ' 49' ' ' LYS . 2.4 t80 -175.48 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.932 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 48' ' ' TYR . 6.1 ptmt -27.08 111.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.863 179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.94 -60.99 0.57 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.445 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 42.62 -159.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 65.230000000000004 110.84 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 35.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 74.219999999999999 110.898 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -59.37 132.55 54.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 110.878 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -129.51 63.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.831 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.0 tpm_? -119.05 -92.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.873 -179.935 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' ARG . 6.3 mm 55.82 115.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 111.148 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 tt -143.28 102.0 5.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 75.510000000000005 111.153 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.6 Cg_endo -69.81 98.64 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 74.140000000000001 112.305 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.99 -56.11 0.29 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.704 -0.76 . . . . 64.349999999999994 112.448 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -105.46 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 63.310000000000002 110.899 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -159.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.9 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.11 -56.44 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 72.519999999999996 110.92 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 65.6 151.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.861 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.754 . . . . 73.030000000000001 112.476 -179.929 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.777 0.322 . . . . 75.219999999999999 110.935 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -97.94 161.95 13.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 72.540000000000006 110.885 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -8.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 73.219999999999999 111.08 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.46 20.6 5.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 64.540000000000006 110.905 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.26 -132.11 2.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.409999999999997 112.477 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -114.06 -33.2 5.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 73.530000000000001 110.893 -179.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.34 177.53 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 75.409999999999997 110.887 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.31 165.6 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 73.239999999999995 110.832 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -85.64 -176.14 5.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 110.879 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -91.61 122.97 34.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 73.010000000000005 110.853 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -40.81 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 110.843 -179.882 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.6 p30 177.94 161.38 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 110.844 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -113.33 34.3 4.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.5 110.876 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 mt -62.53 -22.42 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 71.340000000000003 111.141 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.12 110.72 22.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 74.109999999999999 110.917 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -109.31 -174.65 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.945 179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -98.4 -77.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 75.409999999999997 110.898 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.1 16.89 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 70.150000000000006 111.124 -179.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.28 -168.72 36.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.340000000000003 112.499 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.667 2.244 . . . . 60.340000000000003 112.346 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 66.08 117.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.329999999999998 112.486 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -168.19 122.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 74.219999999999999 111.082 -179.96 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 tt -97.91 116.0 29.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.897 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.38 176.7 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 65.049999999999997 110.85 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -115.36 104.93 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 72.109999999999999 110.844 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.3 152.29 45.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 42.2 p-10 -179.8 -168.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 73.510000000000005 110.915 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.511 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -84.38 -20.76 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 45.25 111.1 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 123.49 -62.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.714 -0.755 . . . . 65.349999999999994 112.496 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.68 96.42 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 75.209999999999994 112.37 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 25.37 78.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.219999999999999 110.875 -179.979 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -155.27 30.13 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.183 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 3.3 p30 -97.19 178.97 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.925 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.53 42.22 2.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 70.439999999999998 112.517 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -138.97 -90.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 73.230000000000004 110.863 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.71 171.39 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 72.519999999999996 110.91 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -138.93 147.39 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.439999999999998 110.891 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -117.65 141.07 48.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 110.884 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.3 136.64 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.112 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.35 123.99 34.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.400000000000006 110.861 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 p -99.24 -25.81 14.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 73.200000000000003 111.133 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.22 23.12 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 62.329999999999998 111.09 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.36 136.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 72.510000000000005 110.896 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.7 p -131.01 51.65 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 111.172 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.04 -19.0 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.925 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -57.79 -19.71 30.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 72.439999999999998 110.925 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -63.0 1.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.924 179.949 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.78 -59.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 71.219999999999999 110.837 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.99 49.89 0.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 75.430000000000007 112.515 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -105.44 -24.36 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 73.219999999999999 110.932 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -139.32 139.57 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.400000000000006 110.87 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.3 t -77.71 104.37 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 64.200000000000003 111.159 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -90.36 135.28 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 111.147 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.65 16.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.874 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.3 -169.76 16.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.729 . . . . 51.229999999999997 112.485 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -179.81 -165.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 72.150000000000006 110.85 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.99 98.92 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.135 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -55.59 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.884 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.71 160.73 38.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 110.879 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.33 33.93 42.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 72.439999999999998 112.479 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.1 mmm -50.08 -28.79 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.34 . . . . 63.420000000000002 110.88 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.329999999999998 110.916 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 142' ' ' MET . 45.6 mm -42.24 -37.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 111.163 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.45 -51.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.400000000000006 111.131 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -48.64 -49.87 35.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.828 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.6 -52.63 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 111.088 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.505 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 6.8 ttm -50.71 -46.3 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 110.848 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 58' ' ' PRO . 3.0 pt-20 -52.03 -23.06 4.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 73.340000000000003 110.85 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -63.39 -22.98 67.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.129999999999995 110.912 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -85.6 14.71 5.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.887 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.76 -155.4 31.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.718 . . . . 74.0 112.435 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.78 -168.5 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 110.855 -179.76 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -80.13 -43.97 20.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 71.25 110.862 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -101.21 -7.84 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.340000000000003 110.874 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.11 -152.02 17.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 72.420000000000002 112.477 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 60.43 101.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 75.209999999999994 110.905 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 p -80.63 159.47 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.12 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.61 -19.91 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 74.239999999999995 110.866 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -138.29 -179.44 5.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 73.430000000000007 110.864 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.83 106.07 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 110.947 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.35 102.78 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 73.219999999999999 111.13 179.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.7 p -117.07 167.65 10.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 111.099 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.3 mt -90.95 134.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 75.010000000000005 111.107 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.34 -62.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.094 179.789 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -140.17 165.07 28.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.433 . . . . 71.230000000000004 110.827 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 33.4 m -142.67 166.27 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.884 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.82 179.8 46.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 71.209999999999994 112.452 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -93.61 -57.65 2.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 75.310000000000002 110.924 -179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.99 150.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 74.450000000000003 110.945 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.888 179.916 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 72.230000000000004 110.874 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.39 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.109 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.83 153.46 47.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 73.340000000000003 110.882 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.64 2.227 . . . . 62.240000000000002 112.317 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.4 m -126.96 142.07 51.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 75.299999999999997 111.165 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.37 157.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 73.040000000000006 111.082 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -114.0 154.84 26.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.549999999999997 110.906 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.25 138.62 35.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 110.898 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.62 113.12 26.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 55.310000000000002 110.887 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.43 121.73 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.149 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.71 163.01 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 70.439999999999998 111.088 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -153.07 105.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 111.115 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.79 31.71 9.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.530000000000001 110.842 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.65 -17.42 52.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 62.210000000000001 112.493 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.5 136.5 23.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.679 0.752 . . . . 64.420000000000002 110.844 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 155.03 66.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 73.340000000000003 112.296 -179.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.04 -60.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.439999999999998 110.967 179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.61 -170.94 35.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.732 -0.746 . . . . 72.409999999999997 112.494 179.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -124.64 127.51 47.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 74.219999999999999 110.874 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 t -129.87 129.85 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.159 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 p -109.19 154.49 22.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.25 110.878 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 135.06 52.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.409999999999997 110.848 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.36 131.95 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 75.519999999999996 110.868 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.18 118.51 32.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.937 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -80.12 55.33 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 110.88 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.35 -28.24 11.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 75.140000000000001 111.094 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.63 -47.47 70.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 75.040000000000006 110.894 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -95.78 -32.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.867 179.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.428 HG21 ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -124.22 74.64 59.59 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.667 0.746 . . . . 74.140000000000001 111.168 179.877 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -51.14 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.698 2.265 . . . . 74.310000000000002 112.32 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -43.22 84.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.894 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -69.01 -60.89 2.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 71.329999999999998 111.119 -179.987 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -33.76 -67.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.219999999999999 111.141 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' ARG . 79.3 tt0 -58.67 -58.79 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.230000000000004 110.874 -179.953 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.0 t30 -32.85 -53.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.150000000000006 110.912 -179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -79.2 -29.07 42.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.913 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 4.7 ttp180 -52.31 -32.99 40.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 75.430000000000007 110.859 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.25 -25.14 61.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 111.082 179.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 27.31 3.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.916 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -152.5 -25.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.87 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 p -81.82 -43.99 17.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.081 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 155.05 -27.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.109999999999999 112.455 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 42' ' ' GLY . 1.1 mt-10 -30.71 -74.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 72.209999999999994 110.897 -179.851 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.64 144.38 31.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.409999999999997 110.9 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.79 22.1 7.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.722 -0.752 . . . . 75.129999999999995 112.513 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.52 -8.0 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 74.540000000000006 110.896 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.97 -101.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 72.310000000000002 112.489 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 70.409999999999997 110.876 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? 57.6 169.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 74.439999999999998 110.912 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.54 118.53 8.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 73.530000000000001 112.506 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.6 p -159.33 -82.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 74.409999999999997 110.812 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -177.57 173.82 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 61.119999999999997 110.883 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.36 -171.24 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 110.834 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.74 -55.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 65.340000000000003 110.855 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.92 144.01 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.540000000000006 110.844 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -152.36 120.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 111.158 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.46 109.07 19.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.72 . . . . 72.430000000000007 111.183 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 97.92 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.655 2.236 . . . . 74.510000000000005 112.39 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.45 -5.06 23.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 71.340000000000003 112.526 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -66.52 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 74.430000000000007 110.835 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.06 -168.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.837 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.7 m -142.74 128.93 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 110.862 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -123.67 157.15 34.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.924 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.109999999999999 112.459 -179.968 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.329 . . . . 73.439999999999998 110.896 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.61 177.68 8.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 65.209999999999994 110.871 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.17 -34.06 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.430000000000007 111.102 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.29 -7.3 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.882 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.19 -169.72 42.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 54.119999999999997 112.455 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.42 -90.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 71.129999999999995 110.877 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 72.239999999999995 110.9 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -154.66 160.33 41.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.549999999999997 110.857 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.9 175.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 71.340000000000003 110.914 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.19 149.13 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 73.400000000000006 110.902 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -94.83 -46.68 6.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.887 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 157.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 62.420000000000002 110.875 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.22 37.25 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.876 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.4 mm -55.39 -22.67 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.430000000000007 111.139 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.57 116.62 23.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.903 179.904 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -107.0 104.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.926 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.33 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.89 179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.8 p -113.78 26.88 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 111.177 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 163.64 35.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 51.100000000000001 112.492 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 140.7 43.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.712 2.275 . . . . 61.229999999999997 112.349 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.95 45.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 72.129999999999995 112.465 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.45 146.21 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 65.25 111.096 -179.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.0 mt -121.27 166.0 14.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.903 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.51 -170.99 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.510000000000005 110.891 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.407 ' HE3' ' CD1' ' A' ' 129' ' ' PHE . 1.9 tpp -92.55 114.15 26.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.420000000000002 110.863 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -101.49 140.0 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 70.409999999999997 111.085 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.2 m-20 168.09 -75.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 74.010000000000005 110.915 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.46 29.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 111.109 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.51 -172.52 14.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 62.149999999999999 112.523 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -49.69 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.675 2.25 . . . . 61.530000000000001 112.327 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -48.7 -20.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.030000000000001 110.879 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.671 ' O ' ' C ' ' A' ' 108' ' ' ASN . 29.8 p -124.05 44.36 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 62.310000000000002 111.097 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.671 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.9 OUTLIER 1.96 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 72.450000000000003 110.901 179.98 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.49 91.56 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 65.349999999999994 112.491 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.91 121.47 34.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 72.329999999999998 110.893 -179.754 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -64.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.929 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.82 167.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.86 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -176.11 66.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.881 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.6 mt -78.3 108.5 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 71.129999999999995 111.089 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.7 m -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 110.86 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p 60.62 10.57 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 111.176 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.66 -170.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.129999999999995 111.116 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -79.78 125.32 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 110.911 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 t -142.45 45.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 65.420000000000002 111.134 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.75 -10.75 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 72.219999999999999 110.906 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -57.93 -26.74 62.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.540000000000006 110.904 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.68 49.82 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 70.450000000000003 110.906 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -71.57 -40.76 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.897 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.1 81.73 0.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 62.329999999999998 112.549 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -160.17 -57.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 65.439999999999998 110.873 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -112.08 142.06 44.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.319999999999993 110.834 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.4 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 81.5 t -65.71 100.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 65.329999999999998 111.179 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.26 136.51 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 111.115 179.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.428 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -177.46 128.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 74.349999999999994 110.888 179.951 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 120.69 4.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 71.010000000000005 112.524 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 152.23 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.88 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.3 t -44.35 141.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 72.530000000000001 111.133 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -132.79 -41.79 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.891 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -66.23 -78.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 110.879 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.79 115.77 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 60.039999999999999 112.49 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.68 -9.23 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.140000000000001 110.885 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -50.3 -25.06 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 63.420000000000002 110.861 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.99 -45.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.084 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.4 t -54.86 -20.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 111.09 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.65 -28.08 24.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.86 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -33.63 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 61.5 111.117 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptm -73.79 -21.19 60.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.92 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.38 26.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.881 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 -20.7 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.898 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.83 15.37 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 110.877 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.08 -142.81 9.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 72.540000000000006 112.462 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 p -162.61 147.91 12.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 63.149999999999999 110.832 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -75.7 68.51 2.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 71.299999999999997 110.899 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.1 p30 179.62 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.862 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.62 -60.47 0.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 62.409999999999997 112.483 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 107.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.209999999999994 110.931 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -79.97 139.44 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 111.176 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -27.82 67.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 65.319999999999993 110.875 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.13 -165.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 74.099999999999994 110.906 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tppm? -131.57 112.09 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.230000000000004 110.871 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.43 128.8 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 111.146 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.9 p -133.3 175.08 9.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 73.239999999999995 111.165 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -118.63 106.36 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.144 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.15 -61.5 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 73.010000000000005 111.121 179.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -134.9 179.32 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.81 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.1 p -172.81 -179.31 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 65.519999999999996 110.866 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 146.8 -169.46 27.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 74.540000000000006 112.546 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.11 138.79 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.150000000000006 110.895 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -50.27 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 110.943 179.969 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 75.010000000000005 110.865 179.947 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.341 . . . . 75.439999999999998 110.868 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.33 142.6 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 111.134 179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.68 161.06 0.92 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.601 0.715 . . . . 72.129999999999995 110.861 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 146.53 60.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.234 . . . . 74.450000000000003 112.322 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -130.4 72.28 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 72.219999999999999 111.144 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.43 151.9 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 62.229999999999997 111.108 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -130.76 162.06 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 110.862 179.97 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -136.6 132.9 35.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 74.530000000000001 110.861 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.44 87.82 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 73.420000000000002 110.886 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.7 mm -71.02 150.42 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.109999999999999 111.111 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.41 163.68 29.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 62.130000000000003 111.115 179.762 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.9 96.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 75.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t0 68.8 53.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.519999999999996 110.851 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.48 14.77 62.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 45.520000000000003 112.495 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -128.59 105.27 19.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 72.310000000000002 110.894 -179.821 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.74 138.82 38.79 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.734 2.289 . . . . 75.109999999999999 112.304 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.87 28.57 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.230000000000004 110.89 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.41 -158.71 14.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 72.230000000000004 112.489 179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.1 179.99 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 74.510000000000005 110.919 -179.89 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.44 170.08 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 111.142 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -118.43 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.891 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -79.8 63.98 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.530000000000001 110.865 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -49.27 133.92 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.895 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -104.16 132.31 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.957 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -75.77 82.51 2.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.239999999999995 110.864 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -8.84 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 70.25 111.127 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.21 -57.37 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 71.120000000000005 110.797 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -57.22 -65.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 71.540000000000006 110.914 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.99 95.14 22.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 53.210000000000001 111.106 179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -19.24 35.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.694 2.263 . . . . 75.120000000000005 112.304 179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -61.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.928 179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -57.3 -26.12 60.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 72.019999999999996 111.128 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.34 2.38 44.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.230000000000004 111.06 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -91.01 -22.62 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.876 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' OD1' ' A' ' 35' ' ' ASN . 12.3 t-20 -79.89 -68.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 110.898 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.74 -45.68 19.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.869 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -54.47 -32.32 57.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 73.510000000000005 110.888 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.36 -35.15 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 111.134 179.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.57 -28.78 68.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.109999999999999 110.869 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -38.1 82.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 53.539999999999999 110.855 -179.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.7 p -86.38 11.42 12.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 111.164 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 41.2 51.29 4.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 73.299999999999997 112.506 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.59 32.79 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 74.049999999999997 110.941 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 10.34 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.239999999999995 110.893 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.31 30.63 8.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 64.099999999999994 112.495 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.44 158.63 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 73.329999999999998 110.855 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.35 159.08 12.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.319999999999993 112.467 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.95 103.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.397 . . . . 73.340000000000003 110.971 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 -44.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 72.030000000000001 110.858 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.92 31.97 2.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 73.400000000000006 112.496 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 t -100.28 -169.69 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 71.409999999999997 110.904 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -80.85 -166.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.89 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 -167.09 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 73.209999999999994 110.851 -179.823 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -74.92 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.886 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -173.39 91.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.853 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.08 144.35 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.139 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tt -149.91 100.29 3.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 71.219999999999999 111.062 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.71 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.714 2.276 . . . . 72.430000000000007 112.311 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.52 -46.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 71.049999999999997 112.444 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -69.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 110.919 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER -155.07 -148.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 71.230000000000004 110.903 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.5 m -132.53 -49.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 55.049999999999997 110.895 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.9 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 52.210000000000001 112.483 -179.974 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 73.040000000000006 110.863 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.46 125.92 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.109999999999999 110.89 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 pp -45.3 -40.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 111.115 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -117.44 29.73 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.040000000000006 110.898 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -147.64 7.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.49 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.56 -33.61 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.961 0.41 . . . . 74.25 110.884 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.31 137.92 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.896 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -118.65 161.56 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 72.450000000000003 110.88 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.2 160.54 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.861 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.79 168.23 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.903 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -132.64 -68.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 110.863 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.18 163.26 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.140000000000001 110.929 -179.954 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 65.030000000000001 110.84 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.9 mt -77.53 -7.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.140000000000001 111.162 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 2.2 mt -114.42 139.09 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.5 110.898 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -171.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.540000000000006 110.853 179.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -115.01 91.18 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 110.904 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -107.19 21.75 17.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.519999999999996 111.143 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.72 -163.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 63.020000000000003 112.509 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 96' ' ' GLY . 53.9 Cg_endo -69.74 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 72.019999999999996 112.356 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -49.65 151.42 4.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 52.140000000000001 112.46 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER 172.6 124.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 63.310000000000002 111.149 -179.955 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.87 105.25 17.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.887 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 100' ' ' MET . 1.3 t -121.19 22.89 10.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 110.875 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.56 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.9 mmt 53.06 123.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 71.319999999999993 110.906 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.4 68.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 73.530000000000001 111.085 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -115.9 -82.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.906 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -133.72 -70.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 111.102 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.67 -125.26 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 52.350000000000001 112.522 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.53 6.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.739 2.292 . . . . 73.549999999999997 112.349 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.94 23.42 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.019999999999996 110.86 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p -154.75 46.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.151 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.554 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -88.28 11.65 16.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.299999999999997 110.873 179.995 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 24.67 -122.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 72.120000000000005 112.498 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.75 31.19 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 62.039999999999999 110.887 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -167.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.450000000000003 110.897 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -165.87 127.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 110.881 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -111.46 34.53 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.319999999999993 110.857 -179.917 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.576 ' C ' ' O ' ' A' ' 113' ' ' PHE . 24.7 mt -21.6 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 111.124 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 61' ' ' MET . 14.1 m -82.57 162.46 21.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 55.420000000000002 110.837 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 -17.48 11.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 74.349999999999994 111.14 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.63 146.81 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 75.439999999999998 111.081 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.43 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.891 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 p -114.27 69.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 75.430000000000007 111.094 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.42 17.02 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 75.329999999999998 110.889 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -98.83 1.02 45.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.049999999999997 110.9 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.06 28.21 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 110.906 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -105.4 95.71 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 70.310000000000002 110.888 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.35 -42.59 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 75.530000000000001 112.459 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -31.74 25.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 73.299999999999997 110.929 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -98.16 139.73 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 65.209999999999994 110.795 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.14 176.74 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 111.123 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -168.82 146.19 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 75.140000000000001 111.133 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -179.19 38.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.879 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.89 175.28 35.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.729 -0.748 . . . . 74.329999999999998 112.506 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -179.17 -166.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 75.420000000000002 110.879 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -121.73 125.03 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 111.107 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -111.02 -37.51 5.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 73.510000000000005 110.867 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -132.1 142.18 49.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.329999999999998 110.875 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.32 37.06 5.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 74.310000000000002 112.447 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -29.21 27.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 65.329999999999998 110.856 -179.966 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.52 -39.53 18.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 65.319999999999993 110.869 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.2 mm -39.63 -41.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 111.115 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.3 t -88.18 -51.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 71.040000000000006 111.074 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -50.59 -59.92 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 110.883 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.76 -58.94 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.157 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.63 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 5.8 ttm -50.55 -39.0 48.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.941 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -53.65 -24.89 15.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 72.349999999999994 110.919 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -65.48 -12.26 50.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 74.150000000000006 110.83 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -84.22 4.44 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 110.854 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.02 -158.14 28.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 65.109999999999999 112.483 -179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -148.77 -89.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 74.450000000000003 110.84 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -154.98 -52.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 110.864 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.52 13.89 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 60.549999999999997 110.877 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.85 -162.77 12.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 71.420000000000002 112.465 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 66.73 140.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 75.510000000000005 110.897 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.3 p -123.48 154.35 39.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 75.530000000000001 111.127 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.48 -3.86 57.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.239999999999995 110.874 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.68 165.24 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 110.888 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.77 114.82 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.329999999999998 110.874 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.5 mt -103.36 106.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.150000000000006 111.099 179.848 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 156.24 24.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 72.25 111.129 179.961 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 mm -84.12 148.26 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.131 179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 -59.28 1.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 60.509999999999998 111.072 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -167.55 163.25 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.010000000000005 110.838 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.0 m -147.68 176.6 9.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 110.887 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.55 -168.24 41.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 65.109999999999999 112.49 -179.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.2 mt-30 -87.27 -38.95 15.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 73.409999999999997 110.91 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.8 mm? 75.31 -54.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 75.319999999999993 110.886 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.409999999999997 110.871 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mmm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.342 . . . . 72.109999999999999 110.92 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 61.34 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 72.450000000000003 111.143 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.85 156.57 36.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 72.299999999999997 110.856 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 147.42 62.91 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.707 2.272 . . . . 75.25 112.314 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -147.18 141.27 26.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 64.519999999999996 111.142 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.55 147.74 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.142 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -111.78 145.64 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 110.892 -179.95 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -138.27 139.63 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.140000000000001 110.866 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -108.44 119.62 40.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.239999999999995 110.851 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.8 mm -89.03 116.6 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 111.135 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.68 154.58 17.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.117 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.89 104.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 111.112 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.21 37.06 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 75.319999999999993 110.861 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.23 80.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 73.510000000000005 112.48 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 149.63 71.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 71.329999999999998 110.884 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 150.93 68.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.653 2.235 . . . . 72.430000000000007 112.34 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.11 -57.59 1.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 73.230000000000004 110.879 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 -147.19 5.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 64.519999999999996 112.44 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -149.77 124.82 10.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 75.099999999999994 110.841 -179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.37 141.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 111.094 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -121.69 146.25 47.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 73.530000000000001 110.893 -179.859 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.66 136.16 48.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 71.299999999999997 110.894 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.17 111.14 23.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 110.87 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 129' ' ' PHE . 86.1 mt -82.7 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 75.120000000000005 110.899 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -83.17 79.68 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 110.893 179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.59 -1.36 24.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.115 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.52 -47.68 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.349999999999994 110.899 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -83.88 -27.89 28.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.898 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.53 73.84 35.02 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.578 0.704 . . . . 72.230000000000004 111.127 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -9.58 26.45 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.63 2.22 . . . . 74.349999999999994 112.362 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -53.66 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 110.867 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -58.18 -51.48 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 74.420000000000002 111.168 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.7 -26.32 67.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 63.149999999999999 111.096 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.9 -34.57 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.897 -179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.01 -57.74 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 72.209999999999994 110.885 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -50.89 -38.84 52.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.872 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.12 70.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 73.409999999999997 110.925 -179.922 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.36 -33.68 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 71.209999999999994 111.118 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.43 23.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.923 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -118.29 -8.45 10.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 55.140000000000001 110.871 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -117.96 7.48 12.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 73.049999999999997 111.16 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.67 29.59 54.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 73.129999999999995 112.477 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -34.98 26.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.381 . . . . 71.129999999999995 110.93 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.32 47.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 74.209999999999994 110.899 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.53 56.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 74.120000000000005 112.467 179.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -179.8 153.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.383 . . . . 75.420000000000002 110.849 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.2 -140.34 6.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 34.420000000000002 112.447 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -101.88 -27.99 12.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.973 0.416 . . . . 70.420000000000002 110.93 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.38 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 75.549999999999997 110.909 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.27 40.38 45.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 52.420000000000002 112.481 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 t -122.56 -171.2 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 41.240000000000002 110.874 -179.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -167.38 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 75.040000000000006 110.859 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.41 170.49 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.892 -179.842 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -118.09 -69.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 61.219999999999999 110.853 179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 172.35 13.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 110.876 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -154.58 147.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 111.114 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 120.83 16.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.662 0.744 . . . . 75.239999999999995 111.133 179.872 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 109.06 2.21 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.340000000000003 112.355 179.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 25.32 18.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 64.109999999999999 112.527 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.34 -63.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 74.5 110.871 -179.868 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -177.74 -166.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 74.219999999999999 110.897 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.86 -70.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.430000000000007 110.887 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 64.86 126.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 72.530000000000001 110.878 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 73.109999999999999 112.495 -179.955 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.344 . . . . 74.25 110.906 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.94 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 70.310000000000002 110.873 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -46.84 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.145 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -122.38 49.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.915 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.62 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 74.310000000000002 112.453 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.05 -75.82 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 73.519999999999996 110.915 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.474 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -130.21 168.46 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 73.510000000000005 110.901 179.902 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -145.48 151.66 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.129999999999995 110.873 179.969 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -54.8 157.91 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.430000000000007 110.872 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.55 112.78 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 70.530000000000001 110.84 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.51 -46.89 85.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 75.209999999999994 110.884 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -177.06 168.66 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 74.040000000000006 110.877 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.31 42.6 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.889 179.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.39 -23.49 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 111.113 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.67 145.95 24.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.958 179.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -122.06 -174.93 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 75.239999999999995 110.892 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -116.17 79.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 75.540000000000006 110.816 179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -119.99 24.9 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 72.049999999999997 111.17 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.51 150.34 20.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 63.530000000000001 112.465 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -3.5 12.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.735 2.29 . . . . 72.010000000000005 112.34 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.45 49.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 73.129999999999995 112.477 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.68 135.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 71.420000000000002 111.173 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.05 122.78 33.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 73.299999999999997 110.933 179.926 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 t -123.67 164.83 18.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.848 -179.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.4 mtp -104.78 124.31 49.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.898 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.1 122.55 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.078 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 8.2 t30 175.85 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.894 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.443 ' HB1' ' OG1' ' A' ' 107' ' ' THR . . . -59.72 -164.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.091 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.481 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -108.34 -66.91 0.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.522 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.565 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.74 130.91 20.2 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.662 2.241 . . . . 71.239999999999995 112.356 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.5 p30 22.84 67.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 65.340000000000003 110.91 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.474 HG22 ' HG3' ' A' ' 82' ' ' LYS . 6.9 p -150.62 52.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 74.420000000000002 111.151 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -50.48 -56.04 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 75.310000000000002 110.89 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.4 -172.62 52.06 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 74.209999999999994 112.518 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.1 p -112.77 -21.86 10.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 74.150000000000006 110.864 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -60.3 145.22 48.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 72.400000000000006 110.873 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.36 162.72 34.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.831 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -148.84 132.02 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 74.299999999999997 110.913 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.73 121.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 111.161 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.69 128.76 33.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 110.878 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 p -90.43 -14.37 33.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 111.219 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.06 160.16 43.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 111.164 179.833 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -53.29 132.97 39.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 64.140000000000001 110.885 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.2 p -138.35 52.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.030000000000001 111.13 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -50.63 -22.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 61.310000000000002 110.891 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -58.73 -35.79 73.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 70.340000000000003 110.894 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.24 101.62 14.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.887 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -151.09 -79.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.837 179.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.74 -27.95 29.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 65.540000000000006 112.477 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -73.42 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 73.120000000000005 110.926 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -99.5 149.77 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 64.420000000000002 110.836 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.2 t -64.37 -151.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 111.126 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.466 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 2.4 p 175.94 141.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 111.138 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 3.1 p90 -175.51 124.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.887 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.12 153.47 17.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 73.019999999999996 112.504 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -171.77 151.92 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 73.420000000000002 110.911 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.5 112.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 62.520000000000003 111.176 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.62 -49.97 8.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.932 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -159.45 145.32 16.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.898 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.95 16.56 27.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 71.299999999999997 112.481 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -29.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.340000000000003 110.852 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -49.57 -29.96 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 110.953 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.51 -50.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.420000000000002 111.099 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.61 -45.92 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 111.123 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -51.37 -40.45 59.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.891 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.33 -34.19 77.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 70.430000000000007 111.101 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.52 -29.13 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.9 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.59 26.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.030000000000001 110.872 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -134.43 -23.79 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.855 -179.883 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.402 ' N ' ' HG3' ' A' ' 144' ' ' ARG . 60.8 m-85 -100.77 6.35 43.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 74.030000000000001 110.856 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -154.94 29.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 71.340000000000003 112.494 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 t -167.51 150.85 6.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 63.530000000000001 110.806 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -77.9 65.78 3.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 110.853 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 167.82 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.896 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.3 172.75 13.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 65.510000000000005 112.473 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.51 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.420000000000002 110.879 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -91.06 41.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.109999999999999 111.134 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 74.01 -50.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.84 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.26 -168.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.921 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.55 134.77 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 74.120000000000005 110.924 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.38 104.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 71.120000000000005 111.114 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.49 178.56 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 74.239999999999995 111.133 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.6 mm -128.38 143.94 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 111.083 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.17 -65.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.116 179.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.47 164.17 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 110.88 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 59.1 m -144.9 -173.61 4.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 44.149999999999999 110.882 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.52 -158.31 26.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.040000000000006 112.482 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 136.33 47.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.861 0.362 . . . . 75.030000000000001 110.914 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 tt -93.06 -44.34 8.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 72.319999999999993 110.889 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 71.310000000000002 110.888 179.961 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.807 0.337 . . . . 71.430000000000007 110.865 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -98.34 133.92 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.125 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -53.99 158.59 3.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.677 0.751 . . . . 74.230000000000004 110.852 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 120.71 7.45 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.68 2.253 . . . . 74.430000000000007 112.313 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -107.86 68.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 111.171 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -47.86 155.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 73.219999999999999 111.159 179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.66 160.21 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.129999999999995 110.889 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -144.94 135.05 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 110.849 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -97.42 78.44 2.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 110.877 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -56.72 146.21 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 75.019999999999996 111.162 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -134.65 170.48 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.409999999999997 111.076 179.861 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.5 t -146.66 96.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 64.450000000000003 111.116 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t0 65.84 41.98 3.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.881 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.05 -16.19 52.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 73.109999999999999 112.523 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -97.42 110.02 52.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.65 0.738 . . . . 73.200000000000003 110.91 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.75 144.85 55.43 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 63.409999999999997 112.328 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mt -81.29 -44.54 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.952 179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.8 35.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 61.020000000000003 112.489 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 62.39 147.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 74.430000000000007 110.826 -179.893 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 21' ' ' SER . 36.5 t -105.41 -103.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 63.509999999999998 111.079 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 164.64 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.858 -179.859 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.85 111.68 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 65.200000000000003 110.932 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -88.22 144.46 26.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.888 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 113.18 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 110.868 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -76.53 66.28 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.892 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.23 77.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 111.075 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.57 -65.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 70.140000000000001 110.894 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -78.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.120000000000005 110.891 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.493 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 17.4 m -72.13 117.72 60.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 73.109999999999999 111.1 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -87.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 74.510000000000005 112.33 179.942 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -36.79 84.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 110.849 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -4.46 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 64.120000000000005 111.112 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -76.9 -48.54 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 111.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' C ' ' A' ' 35' ' ' ASN . 22.2 pt-20 -78.2 -38.12 44.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.849 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -28.97 -67.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.898 -179.935 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.91 -34.71 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.909 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 2.6 ttp180 -49.36 -38.68 29.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 72.109999999999999 110.843 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.55 -35.1 70.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 73.140000000000001 111.119 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 mt -68.5 -45.35 72.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 110.911 179.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.38 94.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.030000000000001 110.868 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -72.41 -15.52 61.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 73.420000000000002 111.168 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 54.17 82.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 75.409999999999997 112.463 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.54 31.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 74.439999999999998 110.947 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -138.87 22.62 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.109999999999999 110.93 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 -40.42 3.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 74.209999999999994 112.486 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -127.98 -164.01 1.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.230000000000004 110.889 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.92 145.71 11.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 64.019999999999996 112.515 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.72 102.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 73.120000000000005 110.947 -179.781 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.77 -61.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 71.010000000000005 110.876 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.47 30.13 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.230000000000004 112.477 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -76.08 -171.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 74.209999999999994 110.87 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.0 m -87.03 -174.44 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 62.310000000000002 110.885 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.59 -167.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.887 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.73 -92.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 71.239999999999995 110.842 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -135.01 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 110.872 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.6 mt 61.19 104.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.189 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 44.2 mt -139.72 98.78 7.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.582 0.706 . . . . 72.430000000000007 111.1 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.3 Cg_endo -69.84 96.13 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.652 2.235 . . . . 74.329999999999998 112.321 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.77 -46.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 55.030000000000001 112.489 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -67.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.87 -179.84 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.61 -153.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 110.887 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 p -150.74 153.39 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 74.239999999999995 110.924 -179.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -88.25 -168.84 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 75.400000000000006 110.944 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.510000000000005 112.493 -179.979 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.761 0.315 . . . . 73.310000000000002 110.892 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.74 179.31 7.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.814 -179.861 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 pt -96.63 -36.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.030000000000001 111.1 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -87.6 -20.21 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.549999999999997 110.889 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.22 -173.53 26.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 65.510000000000005 112.505 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -19.45 37.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 62.340000000000003 110.923 -179.916 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -175.91 149.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.964 179.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -117.03 166.48 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.893 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.41 159.66 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.409999999999997 110.853 -179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -71.42 141.56 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.150000000000006 110.871 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -57.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 110.902 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -173.0 145.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 110.86 -179.951 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.39 52.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 110.843 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mt -82.69 3.86 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 74.420000000000002 111.093 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.51 97.73 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.92 179.909 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 131.02 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.883 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -53.81 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 70.439999999999998 110.882 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -84.27 -12.63 54.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 111.118 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.64 -170.09 43.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.040000000000006 112.5 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.43 47.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.627 2.218 . . . . 71.230000000000004 112.375 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.74 -21.24 25.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.787 -0.72 . . . . 71.420000000000002 112.478 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.37 149.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 74.049999999999997 111.142 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 2.8 mt -119.84 145.96 46.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.945 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.8 35.23 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 110.877 -179.884 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.434 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 22.9 mmt 39.2 -149.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 65.010000000000005 110.899 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 100' ' ' MET . . . 166.63 86.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 71.439999999999998 111.062 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -110.1 -71.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.855 -179.942 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.43 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -146.02 -39.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.349999999999994 111.108 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 128.31 -61.14 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.751 . . . . 74.150000000000006 112.516 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.78 100.06 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 75.010000000000005 112.325 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.548 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER 25.28 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.873 179.972 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.6 t -140.63 29.32 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 70.010000000000005 111.139 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 t30 51.59 -99.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.895 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 102' ' ' ASN . . . 146.47 -85.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.340000000000003 112.457 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.56 20.98 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 64.239999999999995 110.873 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.52 -38.25 16.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.881 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' H ' ' HA ' ' A' ' 100' ' ' MET . 66.3 t80 68.65 84.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.929 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.0 129.1 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.872 -179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.39 118.65 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 111.127 179.992 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 18.9 p -86.0 147.01 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.881 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -107.78 33.81 3.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 111.151 -179.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -170.2 -177.92 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.084 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -82.68 90.98 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.882 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.0 p -116.39 64.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 72.209999999999994 111.185 179.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 18.61 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 72.319999999999993 110.912 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.45 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 6.4 p90 -97.9 13.8 29.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 75.430000000000007 110.921 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 3.5 mt -125.01 -4.25 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 72.519999999999996 110.908 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -79.97 53.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 110.862 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.32 26.17 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 74.310000000000002 112.485 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -168.79 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 75.409999999999997 110.93 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.94 154.51 17.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 110.903 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.95 107.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.510000000000005 111.117 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.7 t -93.5 135.02 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.120000000000005 111.106 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.93 58.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.876 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -128.93 179.32 16.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 64.319999999999993 112.483 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 176.31 147.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 73.040000000000006 110.871 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -112.28 94.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.109999999999999 111.087 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -75.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 110.909 179.894 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.17 -166.2 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 110.872 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.84 69.03 1.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 74.510000000000005 112.43 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -7.1 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.758 0.314 . . . . 73.219999999999999 110.866 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -31.31 61.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 70.109999999999999 110.846 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 142' ' ' MET . 21.2 mm -73.74 -39.19 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 111.133 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.36 -1.48 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 70.109999999999999 111.169 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -118.24 -59.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 72.540000000000006 110.909 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.81 -56.13 22.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 111.128 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 2.0 ttm -51.43 -49.47 61.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 74.319999999999993 110.9 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -24.61 28.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.420000000000002 110.91 -179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -66.67 -13.64 61.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 75.150000000000006 110.871 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -90.36 19.5 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.861 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.78 -158.75 31.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.743 . . . . 74.340000000000003 112.482 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -146.82 -77.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 74.219999999999999 110.852 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.912 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.1 -14.68 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.88 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.27 -34.41 2.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.25 112.479 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 127.84 15.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 74.049999999999997 110.872 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -110.01 149.56 29.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.519999999999996 111.121 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -68.9 -25.27 64.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.150000000000006 110.849 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.02 -166.92 1.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 74.140000000000001 110.909 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.83 116.9 25.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 75.420000000000002 110.908 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.37 128.34 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 75.109999999999999 111.114 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.4 p -138.59 149.53 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 111.081 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.99 105.94 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 63.439999999999998 111.144 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.08 76.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 64.010000000000005 111.102 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -156.61 177.99 10.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.530000000000001 110.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.3 p -174.54 159.81 3.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.239999999999995 110.873 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.51 -179.95 37.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 75.319999999999993 112.49 -179.942 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.57 -43.81 22.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 110.904 -179.85 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.86 -172.46 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 73.319999999999993 110.913 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 64.430000000000007 110.877 179.889 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.813 0.339 . . . . 75.319999999999993 110.872 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.4 t -142.24 145.83 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 75.349999999999994 111.069 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.71 140.87 97.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.623 0.725 . . . . 73.239999999999995 110.911 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.73 69.36 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 74.400000000000006 112.321 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.0 m -138.59 90.29 2.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 72.019999999999996 111.147 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -74.22 162.56 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.349999999999994 111.103 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -133.45 157.24 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 73.040000000000006 110.909 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -140.87 139.99 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.91 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -95.46 99.53 11.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.927 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 mm -71.7 113.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 74.129999999999995 111.125 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.46 161.33 15.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 111.1 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.91 110.93 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.13 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.7 43.87 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 110.855 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.82 9.11 65.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 70.230000000000004 112.497 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -114.91 132.29 23.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.594 0.712 . . . . 71.340000000000003 110.912 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.28 11.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 71.310000000000002 112.328 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.58 -36.92 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 73.040000000000006 110.919 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.21 -137.89 4.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.756 . . . . 75.120000000000005 112.471 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.87 149.74 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.851 0.358 . . . . 73.549999999999997 110.837 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 t -148.91 136.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.134 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -114.78 161.66 17.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.869 -179.834 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.76 149.51 46.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.099999999999994 110.905 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -92.0 107.9 19.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.877 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.06 130.18 34.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 75.010000000000005 110.875 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -84.73 63.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.902 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.19 -2.48 31.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.439999999999998 111.096 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.89 -55.04 3.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.845 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.299999999999997 110.937 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -110.84 80.48 2.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.587 0.708 . . . . 75.120000000000005 111.131 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 56.25 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 74.450000000000003 112.387 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -161.7 -67.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.915 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -72.48 -16.58 61.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 111.139 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.47 -36.39 26.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 71.510000000000005 111.106 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -63.98 -156.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.886 -179.929 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 65.37 -73.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 62.210000000000001 110.876 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.6 t80 -50.07 -34.41 21.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 110.881 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.68 71.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 110.876 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.2 -41.47 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.010000000000005 111.134 179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.76 -19.32 63.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 110.912 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -101.18 -7.67 22.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 75.299999999999997 110.887 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 99.8 m -105.69 -22.65 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 75.319999999999993 111.179 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 69.74 1.36 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 42.409999999999997 112.5 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.96 34.16 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 64.450000000000003 110.87 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 18.85 2.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.530000000000001 110.902 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.13 -32.04 5.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 73.439999999999998 112.448 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.85 -177.55 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.362 . . . . 75.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.47 39.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.733 . . . . 72.219999999999999 112.536 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.71 -69.26 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 73.329999999999998 110.907 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 55.5 179.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 110.845 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -37.97 100.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 53.520000000000003 112.506 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 154.17 42.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 73.209999999999994 110.824 -179.729 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.8 p -65.76 161.17 21.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 74.409999999999997 110.885 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.88 174.97 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 75.329999999999998 110.888 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.91 166.37 17.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.874 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 65.68 112.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.828 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.8 mt -151.05 122.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 75.450000000000003 111.136 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 7.1 mt -130.6 103.76 16.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 71.549999999999997 111.098 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.5 Cg_endo -69.69 85.76 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.67 2.246 . . . . 71.450000000000003 112.379 179.817 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.46 -17.08 2.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 64.129999999999995 112.519 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.87 -57.89 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 75.109999999999999 110.905 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -162.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.140000000000001 110.874 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.93 -72.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 65.420000000000002 110.867 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 62.87 153.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.030000000000001 110.913 -179.9 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 71.239999999999995 112.467 -179.943 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.804 0.335 . . . . 74.140000000000001 110.918 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.1 p -81.92 -167.4 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 64.140000000000001 110.881 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.55 12.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 111.173 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -129.61 20.74 5.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.911 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.46 -122.34 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 74.120000000000005 112.505 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.99 -20.0 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.239999999999995 110.892 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -176.11 -175.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 75.219999999999999 110.927 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -151.52 154.27 36.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.885 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -71.2 163.26 27.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.8 123.96 33.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 75.329999999999998 110.896 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -48.8 55.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 54.009999999999998 110.849 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.3 p30 179.38 175.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 110.891 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.52 37.6 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.927 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -56.55 -23.36 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 111.11 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mt -104.02 134.58 47.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.894 179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -120.04 -172.34 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.400000000000006 110.92 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -97.47 80.34 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.892 179.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.7 p -60.68 -22.53 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.137 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.91 -149.1 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 62.43 112.494 179.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 162.7 41.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.625 2.217 . . . . 74.340000000000003 112.332 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.33 23.02 76.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 73.340000000000003 112.495 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.05 116.83 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 72.510000000000005 111.125 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.38 136.07 33.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.540000000000006 110.888 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -133.77 -153.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 73.010000000000005 110.866 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mmt -153.59 158.08 40.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 71.019999999999996 110.895 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -108.5 -169.42 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 111.103 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 32.4 t30 89.43 102.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 63.43 110.893 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.51 -108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.530000000000001 111.087 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 168.86 -62.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 64.140000000000001 112.538 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.8 Cg_endo -69.82 99.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.679 2.253 . . . . 74.420000000000002 112.331 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.21 47.0 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 74.349999999999994 110.914 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.73 71.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.129999999999995 111.166 -179.966 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -91.39 31.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 110.908 179.975 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . -27.57 -95.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 64.120000000000005 112.499 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 t -151.66 -167.6 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 70.219999999999999 110.857 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.13 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 75.109999999999999 110.89 -179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -101.69 139.46 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.867 -179.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -111.35 104.6 13.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 74.5 110.893 -179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.39 136.18 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 75.010000000000005 111.094 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.19 153.75 20.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 73.439999999999998 110.866 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -130.53 -33.87 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 63.43 111.166 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.41 15.76 26.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 111.085 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 126.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 75.439999999999998 110.852 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -143.05 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 41.329999999999998 111.127 179.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.36 17.14 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.209999999999994 110.89 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -29.22 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 110.926 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.4 23.72 8.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.949 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -89.72 42.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.877 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.21 33.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 55.310000000000002 112.515 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.19 -49.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 73.439999999999998 110.901 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -96.55 158.09 15.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 110.845 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.502 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.5 t -81.8 -168.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.299999999999997 111.143 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.502 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 2.4 p -172.39 103.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 73.230000000000004 111.165 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.68 82.38 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.92 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 140.03 135.73 3.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 75.010000000000005 112.49 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.99 144.49 31.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 73.319999999999993 110.976 -179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.43 115.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 73.530000000000001 111.106 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -64.49 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.140000000000001 110.911 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.73 146.41 36.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 73.409999999999997 110.945 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.9 10.29 35.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 75.430000000000007 112.515 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 ttt -50.07 -28.69 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 70.409999999999997 110.848 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -51.5 -25.08 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 74.129999999999995 110.936 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.72 -37.34 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.142 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -53.97 -21.77 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 111.136 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -85.91 -34.32 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.877 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.22 -47.24 83.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 75.540000000000006 111.125 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.9 ptm -69.36 -22.11 63.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.91 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -88.45 23.34 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 65.530000000000001 110.891 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 -11.46 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.109999999999999 110.877 -179.922 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.6 11.47 33.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 110.877 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.1 -142.18 11.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 62.340000000000003 112.484 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t -159.16 139.63 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 74.129999999999995 110.843 -179.724 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.69 80.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.859 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 173.81 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.140000000000001 110.881 -179.975 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.02 -61.79 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 54.329999999999998 112.509 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.23 143.95 10.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 74.519999999999996 110.869 -179.973 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.4 p -116.04 133.89 55.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 71.120000000000005 111.147 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.17 -1.6 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.868 -179.898 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -136.78 -171.15 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 75.040000000000006 110.913 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -133.35 153.82 51.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.905 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mt -135.39 118.97 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 111.129 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.4 p -115.04 169.32 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 111.168 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.407 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 39.6 mm -110.38 133.33 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.450000000000003 111.089 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.67 -58.49 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 111.112 179.779 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.19 170.67 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 63.340000000000003 110.873 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 66.8 m -150.09 166.65 29.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 63.210000000000001 110.896 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.17 -178.32 48.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 62.210000000000001 112.45 -179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.2 mt-30 -80.08 -32.52 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 73.120000000000005 110.955 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER 73.49 -60.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.916 179.971 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 55.200000000000003 110.831 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.327 . . . . 74.040000000000006 110.922 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.27 156.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 73.099999999999994 111.132 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.61 128.98 94.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.65 21.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 63.030000000000001 112.334 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -126.19 145.04 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 111.123 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 10.5 m -125.15 147.53 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.530000000000001 111.139 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -103.62 148.56 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.839 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.06 130.64 20.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.903 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.6 t0 -108.59 119.94 41.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.849 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -101.82 149.25 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 111.097 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.73 26.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 72.219999999999999 111.143 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 58.9 t -139.1 101.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 111.117 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.6 t0 78.68 27.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.849 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.21 -15.63 62.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.795 -0.716 . . . . 70.299999999999997 112.518 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 136.71 21.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 73.540000000000006 110.859 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 162.95 40.12 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.673 2.249 . . . . 62.100000000000001 112.319 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -110.23 -52.79 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 61.240000000000002 110.895 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 19' ' ' ARG . . . 162.29 -15.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 74.310000000000002 112.481 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 71.52 147.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.906 0.384 . . . . 74.430000000000007 110.846 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' N ' ' HG2' ' A' ' 19' ' ' ARG . 26.4 m -115.8 -176.17 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 111.094 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 133' ' ' LYS . 3.7 m -123.67 87.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.400000000000006 110.845 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -84.32 121.63 27.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.928 -179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.04 153.26 20.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 64.329999999999998 110.85 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 mt -119.99 126.81 51.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 74.409999999999997 110.937 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -89.34 70.48 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.430000000000007 110.856 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -22.75 67.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 111.107 179.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.25 -61.08 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 75.310000000000002 110.888 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -33.07 30.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.400000000000006 110.933 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.39 79.4 70.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 75.340000000000003 111.165 179.876 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -45.41 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 74.239999999999995 112.368 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -59.38 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.400000000000006 110.904 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -55.15 -61.88 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 64.430000000000007 111.128 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -36.41 11.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 111.122 179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -67.13 -52.15 45.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 73.530000000000001 110.933 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.18 -39.88 31.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 65.450000000000003 110.934 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -76.24 -29.66 57.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.319999999999993 110.875 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -44.05 97.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.885 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.46 -25.87 62.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 111.071 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -76.72 -55.63 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 74.430000000000007 110.921 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -56.75 -48.96 76.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.129999999999995 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.0 p -77.44 -13.99 59.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 75.329999999999998 111.111 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.17 71.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 72.239999999999995 112.48 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.08 33.51 5.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.408 . . . . 74.340000000000003 110.927 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.39 0.51 6.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.908 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.0 -2.88 58.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 74.329999999999998 112.529 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -166.56 171.98 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 74.510000000000005 110.88 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.78 -172.0 24.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 75.329999999999998 112.476 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -82.1 129.34 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 74.140000000000001 110.915 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -134.93 -48.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 71.200000000000003 110.894 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -166.61 51.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 63.149999999999999 112.487 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' CYS . 16.5 t -71.41 -92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 75.209999999999994 110.861 -179.707 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 51' ' ' SER . 0.6 OUTLIER 167.52 139.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.915 -179.914 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.3 162.22 29.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 73.209999999999994 110.905 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -178.09 52.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 73.150000000000006 110.833 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -135.06 35.44 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.319999999999993 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -87.55 148.08 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 111.153 179.97 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.97 110.91 5.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.627 0.727 . . . . 72.109999999999999 111.108 179.842 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 53.7 Cg_endo -69.76 118.88 5.95 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 71.439999999999998 112.361 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.44 -30.27 7.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 64.310000000000002 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.08 -66.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 75.530000000000001 110.855 -179.885 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -176.52 -152.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.857 179.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.402 ' HB2' HG13 ' A' ' 56' ' ' ILE . 1.8 t -145.77 137.91 25.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 110.886 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.48 157.21 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.040000000000006 110.943 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 74.510000000000005 112.463 -179.984 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.741 0.305 . . . . 75.409999999999997 110.916 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 m -105.69 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.150000000000006 110.826 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.17 -44.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.109999999999999 111.127 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -101.28 75.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 110.934 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.49 -127.77 8.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 71.140000000000001 112.494 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -111.19 -85.25 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 74.409999999999997 110.913 -179.932 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -123.48 145.92 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 110.875 179.966 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.43 171.02 7.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.899 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.48 161.5 27.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.904 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -69.27 152.88 44.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 73.040000000000006 110.899 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.44 -56.67 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 70.230000000000004 110.894 -179.888 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.46 143.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.5 110.875 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.15 41.91 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 75.030000000000001 110.885 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -75.27 -22.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 64.140000000000001 111.147 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 99.46 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 72.200000000000003 110.88 179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.1 101.5 13.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.9 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.402 ' CB ' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.34 95.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.510000000000005 110.858 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.7 37.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 60.229999999999997 111.155 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.16 158.87 18.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 73.299999999999997 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 135.81 31.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.661 2.241 . . . . 63.049999999999997 112.326 -179.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.84 -22.15 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 64.120000000000005 112.498 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.402 HG13 ' CB ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -50.62 152.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 75.109999999999999 111.154 -179.976 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -118.87 126.85 52.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 110.938 179.886 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 82.1 p -153.47 86.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.200000000000003 110.826 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -38.45 155.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 72.530000000000001 110.858 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.77 19.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.129999999999995 111.042 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.873 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.12 -24.91 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 63.43 111.054 179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.421 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . 117.13 -78.46 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 61.409999999999997 112.495 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.488 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.8 128.58 16.2 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 71.099999999999994 112.348 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' PRO . 19.5 m-20 29.24 55.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 73.519999999999996 110.921 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.683 ' O ' ' C ' ' A' ' 108' ' ' ASN . 18.4 p -140.98 42.66 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 111.121 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.683 ' C ' ' O ' ' A' ' 107' ' ' THR . 23.4 t30 0.83 -82.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.883 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 119.44 168.42 13.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 55.229999999999997 112.507 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -132.88 -39.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 54.020000000000003 110.839 -179.75 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -84.05 72.71 10.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 73.200000000000003 110.897 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HB2' HD21 ' A' ' 98' ' ' LEU . 5.8 p90 -63.94 -171.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.874 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.91 150.7 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 110.893 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.8 mt -106.37 114.72 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 71.439999999999998 111.144 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.7 m -75.8 132.9 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.861 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.8 p -99.45 11.99 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 75.150000000000006 111.151 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.25 179.28 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 61.140000000000001 111.107 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -74.43 119.63 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 110.902 179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 73.3 p -132.34 59.03 1.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 111.149 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.47 -11.87 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.91 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.448 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 41.8 p90 -82.99 5.75 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 73.230000000000004 110.894 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 82.0 mt -122.51 34.91 5.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 110.93 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.11 -86.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 63.130000000000003 110.86 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.95 78.08 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.741 . . . . 42.420000000000002 112.495 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -45.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 75.219999999999999 110.881 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . 0.444 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 36.7 m-70 -112.57 -25.53 9.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 72.120000000000005 110.859 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 24.9 t 73.6 95.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 72.540000000000006 111.102 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.428 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 99.0 t -75.32 140.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 111.119 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -139.01 -29.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 73.439999999999998 110.88 -179.95 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.78 -168.33 43.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.340000000000003 112.489 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 170.01 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.325 . . . . 74.140000000000001 110.907 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.67 141.14 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.19 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' SER . 13.3 tppt? -118.07 -37.22 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 73.329999999999998 110.87 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.87 175.57 13.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.430000000000007 110.881 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.15 78.8 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 72.319999999999993 112.475 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.29 -24.11 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 73.150000000000006 110.88 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 138' ' ' ILE . 26.1 m120 -77.64 -39.49 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 74.319999999999993 110.846 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 142' ' ' MET . 50.0 mm -38.1 -46.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 73.510000000000005 111.177 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -88.79 -51.48 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 75.450000000000003 111.132 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -46.66 -57.0 5.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 110.855 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.98 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 53.43 111.074 179.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 4.5 ttm -52.86 -43.98 66.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 74.109999999999999 110.894 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -55.46 -19.77 10.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 71.129999999999995 110.884 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -66.7 -20.06 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.861 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -90.89 15.13 11.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.239999999999995 110.879 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -94.18 -159.06 33.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 63.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.42 169.7 21.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 110.871 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -57.08 -36.96 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.420000000000002 110.859 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.27 12.94 19.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 61.409999999999997 110.878 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.85 -85.7 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 75.409999999999997 112.443 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 152' ' ' THR . 4.3 mttp 62.6 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 73.349999999999994 110.914 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 151' ' ' LYS . 1.4 t 163.29 67.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 74.519999999999996 111.117 179.979 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -48.16 82.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.866 -179.873 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -126.37 177.44 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 75.120000000000005 110.912 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 75.430000000000007 110.89 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.1 pt -131.6 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 70.140000000000001 111.133 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 159.41 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 111.134 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.422 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 47.0 mt -91.85 115.92 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.109999999999999 111.16 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.76 -53.54 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 61.43 111.087 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -141.37 175.56 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 110.85 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.8 p -166.53 175.34 8.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 110.912 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.33 -156.44 26.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 61.130000000000003 112.431 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 1.6 tt0 -103.97 144.55 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 73.010000000000005 110.898 -179.842 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -62.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 75.200000000000003 110.912 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.439999999999998 110.931 179.865 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 74.439999999999998 110.852 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.6 t -140.4 142.31 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 111.136 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.66 153.24 42.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 74.530000000000001 110.913 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 154.52 67.8 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.726 2.284 . . . . 72.310000000000002 112.35 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -128.36 45.93 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.140000000000001 111.157 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.69 144.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.340000000000003 111.173 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' HD22 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -128.87 164.94 22.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.5 110.86 -179.939 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.82 148.56 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 75.120000000000005 110.907 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -108.57 157.22 18.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.889 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -129.97 129.69 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 61.32 111.156 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.44 167.39 15.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 111.084 179.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 m -152.85 106.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.135 179.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.02 23.03 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 64.400000000000006 110.88 179.894 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 -10.32 65.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 54.240000000000002 112.494 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.54 138.56 19.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 63.409999999999997 110.916 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 151.99 69.0 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 62.329999999999998 112.337 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -121.02 -70.97 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.929 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.41 179.2 35.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 74.430000000000007 112.463 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 73.420000000000002 110.91 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.85 84.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 65.310000000000002 111.079 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -66.07 94.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.5 110.834 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 25.9 p90 -106.83 114.28 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 74.349999999999994 110.899 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.91 146.7 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 61.509999999999998 110.869 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 20.2 mt -108.13 128.41 54.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 75.230000000000004 110.943 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -70.84 79.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.889 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . . . -73.44 -11.18 60.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.116 179.92 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.38 -58.96 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 65.340000000000003 110.883 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.936 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.501 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 5.0 m -66.04 128.36 93.77 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 53.009999999999998 111.131 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 53.9 Cg_endo -69.74 -88.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.686 2.257 . . . . 60.240000000000002 112.358 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -40.91 64.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 71.150000000000006 110.939 179.887 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 54.9 m -57.12 -11.28 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.319999999999993 111.144 179.961 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 30' ' ' PRO . . . -74.93 -45.43 42.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 75.099999999999994 111.1 179.872 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 35' ' ' ASN . 28.9 tt0 -91.42 -49.18 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 72.049999999999997 110.917 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.549 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -25.63 -51.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 74.310000000000002 110.924 -179.948 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -81.54 -45.04 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 110.875 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' GLU . 2.9 ptt85 -51.21 -27.16 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 110.913 -179.946 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.69 -49.2 19.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 62.200000000000003 111.11 179.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.32 -10.67 60.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.936 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -8.2 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.879 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -102.22 -13.75 17.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 64.140000000000001 111.155 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 45.83 8.65 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 60.520000000000003 112.526 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -98.38 -21.75 16.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 75.430000000000007 110.903 -179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -89.27 17.97 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 71.299999999999997 110.923 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.45 26.01 63.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 75.450000000000003 112.473 179.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 178.68 168.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 65.030000000000001 110.832 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.38 -129.59 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 61.219999999999999 112.478 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -93.92 -72.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 75.109999999999999 110.918 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 1.7 tptt 59.62 166.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 64.219999999999999 110.882 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.99 104.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 62.530000000000001 112.492 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 m -132.53 -108.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 71.540000000000006 110.872 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.7 p 172.77 150.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 64.409999999999997 110.867 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -90.53 -71.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.874 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.75 5.82 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.87 -179.971 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 94.79 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 110.877 -179.872 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mt -147.77 139.84 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.540000000000006 111.187 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.07 139.37 21.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.609 0.719 . . . . 54.539999999999999 111.118 179.913 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 128.4 15.98 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.677 2.251 . . . . 75.25 112.335 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.18 48.22 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 73.430000000000007 112.513 179.98 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.06 -80.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 74.150000000000006 110.862 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -165.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.140000000000001 110.899 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.46 28.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 70.120000000000005 110.864 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.66 127.36 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.209999999999994 110.911 -179.886 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.738 -0.744 . . . . 71.420000000000002 112.489 -179.948 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.793 0.33 . . . . 64.140000000000001 110.902 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.5 m -81.18 143.79 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.861 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.4 pt -83.88 -39.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 111.153 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -88.83 -6.78 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 72.329999999999998 110.92 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.73 -138.18 2.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.768 -0.73 . . . . 71.010000000000005 112.493 179.96 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -122.6 -29.59 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.419 . . . . 73.349999999999994 110.896 -179.851 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -174.67 137.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 73.140000000000001 110.924 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.43 138.43 54.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.881 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 175.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 70.120000000000005 110.886 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.46 -168.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.129999999999995 110.846 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.17 -61.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.853 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -171.22 154.01 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 71.319999999999993 110.888 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.02 79.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.873 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mm -86.77 14.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 74.450000000000003 111.136 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -131.33 99.69 4.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 110.906 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.09 125.74 33.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 110.868 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.406 ' HA ' HG13 ' A' ' 97' ' ' ILE . 1.3 m80 -49.03 97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 110.838 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -116.39 22.71 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.109 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 166.22 26.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.430000000000007 112.462 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 132.81 24.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 73.400000000000006 112.4 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.7 -23.74 7.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 63.439999999999998 112.51 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 92' ' ' HIS . 33.3 mm -57.58 149.99 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.341 . . . . 73.530000000000001 111.136 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.86 143.14 49.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 110.913 179.908 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -156.08 39.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 72.200000000000003 110.851 -179.926 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.01 168.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.519999999999996 110.862 179.936 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.64 76.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.299999999999997 111.1 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -144.04 -80.09 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.884 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -125.81 -146.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 111.123 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.542 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -140.29 -64.18 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 74.019999999999996 112.516 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.5 Cg_endo -69.8 106.08 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 74.150000000000006 112.368 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 39.86 68.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.530000000000001 110.884 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.656 ' O ' ' C ' ' A' ' 108' ' ' ASN . 0.3 OUTLIER -152.78 35.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 111.173 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.656 ' C ' ' O ' ' A' ' 107' ' ' THR . 1.6 m120 7.46 -87.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.539999999999999 110.94 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 128.8 -41.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.200000000000003 112.5 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.3 OUTLIER 76.68 -39.03 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.319999999999993 110.856 -179.734 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -62.67 -159.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 75.450000000000003 110.905 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -170.72 140.87 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 110.86 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 4.3 p90 -131.29 102.11 5.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.927 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.4 mt -64.59 103.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.157 -179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.6 m -60.47 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 54.100000000000001 110.888 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.94 13.83 27.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 73.420000000000002 111.124 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -169.63 153.86 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 72.010000000000005 111.101 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -56.91 99.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.942 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.6 p -117.7 63.19 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 111.117 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 2.14 5.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 65.439999999999998 110.882 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -91.78 2.99 56.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 63.409999999999997 110.938 -179.953 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.65 37.97 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.540000000000006 110.887 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -125.87 70.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.886 179.851 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.08 -49.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 71.230000000000004 112.471 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.13 -31.99 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 75.019999999999996 110.87 -179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.25 145.15 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 110.846 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.0 109.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 111.177 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.35 144.61 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.540000000000006 111.133 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 2.0 t80 174.5 100.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 75.329999999999998 110.884 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 123.74 144.08 6.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 63.5 112.479 -179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -154.72 -179.77 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 75.25 110.911 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.36 85.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 111.136 179.88 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.83 -50.3 68.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 110.921 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.9 163.56 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.109999999999999 110.859 179.961 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.17 -4.44 64.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 73.340000000000003 112.52 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.37 -34.38 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 74.129999999999995 110.869 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.93 -24.24 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.89 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.21 -41.06 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.299999999999997 111.078 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.03 -37.96 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 111.121 179.852 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.85 -20.87 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 72.519999999999996 110.853 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.17 -38.97 26.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 75.129999999999995 111.143 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -65.23 -29.8 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 110.886 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.64 -50.32 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 75.239999999999995 110.906 -179.965 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -17.05 52.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 74.209999999999994 110.912 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.3 -16.47 29.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 75.420000000000002 110.906 -179.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.99 -158.97 21.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 72.219999999999999 112.491 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.57 -162.2 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 74.340000000000003 110.804 -179.705 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -92.45 -42.74 9.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 110.892 -179.908 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -101.01 15.28 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.935 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.68 -157.87 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 61.439999999999998 112.463 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm 60.85 159.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.916 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -133.26 161.37 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 111.152 179.965 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.39 -19.26 43.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 74.349999999999994 110.817 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -135.37 161.08 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.889 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.86 128.18 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.919 179.875 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mt -101.16 134.92 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 72.120000000000005 111.133 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 p -136.59 163.89 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 75.340000000000003 111.175 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -124.71 132.89 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.409999999999997 111.094 179.923 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.06 -58.34 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 111.122 179.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -151.81 179.03 8.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 71.5 110.881 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.9 p -176.15 165.44 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 142.83 -171.59 24.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 75.400000000000006 112.428 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -68.7 118.51 11.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 72.430000000000007 110.933 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.402 HD22 ' CD1' ' A' ' 7' ' ' PHE . 1.4 mm? -92.32 -44.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.916 -179.964 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.873 179.897 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 74.120000000000005 110.867 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.14 155.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.519999999999996 111.126 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.47 141.37 42.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 110.848 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 127.79 15.11 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 73.319999999999993 112.347 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -102.19 148.78 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 62.329999999999998 111.144 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.21 139.02 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 111.158 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -117.42 143.95 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.849 -179.936 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -140.07 127.63 21.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 110.855 -179.929 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.0 79.6 2.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 74.239999999999995 110.858 179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.32 139.11 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.430000000000007 111.116 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.17 158.66 36.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 111.091 179.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.34 97.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 111.09 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t0 54.61 54.96 8.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.319999999999993 110.891 179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.82 13.06 60.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 62.32 112.456 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -142.48 93.02 7.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.684 0.754 . . . . 72.099999999999994 110.862 -179.885 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 152.43 69.28 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.688 2.259 . . . . 72.019999999999996 112.316 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.74 25.13 9.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.906 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.21 -173.68 20.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 72.340000000000003 112.504 179.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 170.3 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 71.340000000000003 110.846 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 35.2 m -137.33 177.6 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 111.119 179.957 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 p -136.63 138.79 41.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.020000000000003 110.894 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -114.52 149.55 36.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.349999999999994 110.878 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.52 128.63 53.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 74.239999999999995 110.916 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 116.79 29.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 74.010000000000005 110.915 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 11.1 m-85 -82.61 67.47 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 74.409999999999997 110.893 179.92 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 71.239999999999995 111.072 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -36.54 74.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 62.409999999999997 110.919 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -89.83 -28.39 19.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 64.530000000000001 110.946 179.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.24 83.69 7.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.638 0.732 . . . . 73.0 111.138 179.834 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.28 37.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 75.209999999999994 112.348 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -34.75 19.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.925 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -75.07 -53.74 8.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.119 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.17 -37.95 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.450000000000003 111.148 179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.64 -30.66 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.349999999999994 110.869 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.32 -61.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.851 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.01 -29.8 9.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 110.871 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.95 85.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.420000000000002 110.826 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.32 -19.03 43.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 72.319999999999993 111.132 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.9 -61.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 74.540000000000006 110.924 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -51.48 -45.65 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 72.109999999999999 110.886 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.43 -9.87 56.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 74.430000000000007 111.089 -179.902 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.12 73.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 63.229999999999997 112.528 -179.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -47.8 -53.47 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.383 . . . . 64.549999999999997 110.876 -179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -167.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.903 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.98 17.38 55.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 75.219999999999999 112.512 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -146.35 -168.32 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 74.230000000000004 110.89 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.72 144.02 7.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 70.120000000000005 112.508 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.22 120.67 5.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 75.109999999999999 110.96 -179.81 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -41.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 110.9 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 30.64 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 73.299999999999997 112.508 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -77.21 162.12 27.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 72.219999999999999 110.84 -179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 m -75.06 -168.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 75.010000000000005 110.914 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.16 135.74 32.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.876 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.12 -179.11 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.040000000000006 110.858 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.83 20.69 10.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.879 -179.875 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mt -69.45 123.47 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 111.118 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -138.92 103.44 7.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 75.040000000000006 111.155 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 76.08 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 73.340000000000003 112.337 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.02 -25.63 0.31 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 73.040000000000006 112.489 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.34 -64.19 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.310000000000002 110.876 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 -161.57 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.899 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.5 m -137.47 -64.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 110.882 -179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.97 152.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.904 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 55.539999999999999 112.448 -179.976 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 73.439999999999998 110.881 . . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -116.55 131.91 56.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 73.129999999999995 110.839 -179.884 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.35 -34.15 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.420000000000002 111.171 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -128.31 55.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 73.200000000000003 110.923 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.82 -139.7 8.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 74.439999999999998 112.448 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.94 -82.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.385 . . . . 72.310000000000002 110.893 -179.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.29 -177.42 4.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 64.329999999999998 110.89 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.52 179.74 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.549999999999997 110.91 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 160.43 22.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.895 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -74.14 111.2 9.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.903 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.31 -52.35 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.450000000000003 110.917 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 178.8 165.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.861 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.05 40.22 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.864 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.6 mt -52.48 -29.02 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.219999999999999 111.116 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.69 118.07 31.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.230000000000004 110.917 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -105.43 171.1 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.885 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.8 95.35 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.420000000000002 110.851 179.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 p -112.11 34.63 4.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 111.106 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.85 41.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.715 -0.755 . . . . 71.400000000000006 112.481 179.952 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 150.31 67.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 74.209999999999994 112.348 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.0 128.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 73.239999999999995 112.482 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -178.0 131.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 75.549999999999997 111.146 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 2.0 tt -89.36 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 74.140000000000001 110.899 179.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.1 p -109.74 -152.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 72.439999999999998 110.841 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 4.2 mtt -160.51 104.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 75.439999999999998 110.899 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.89 161.76 13.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.126 179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.14 -45.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.019999999999996 110.868 -179.936 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.434 ' CB ' ' OG1' ' A' ' 107' ' ' THR . . . -172.21 -34.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 71.25 111.084 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.15 -80.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.743 -0.741 . . . . 43.140000000000001 112.494 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 120.4 7.19 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 73.510000000000005 112.323 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.401 ' C ' HG21 ' A' ' 107' ' ' THR . 2.6 m-80 39.65 36.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 73.540000000000006 110.876 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.434 ' OG1' ' CB ' ' A' ' 103' ' ' ALA . 69.6 p -144.81 61.55 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 74.109999999999999 111.122 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 109' ' ' GLY . 3.0 m-80 -82.16 -6.38 59.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 110.907 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 29.45 -138.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 72.439999999999998 112.492 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 m -147.7 29.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 74.430000000000007 110.856 -179.711 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -107.18 83.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 110.95 -179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -80.66 176.98 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.299999999999997 110.878 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.64 -175.83 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.400000000000006 110.884 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.73 117.11 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.439999999999998 111.112 179.986 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.41 153.51 21.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 75.439999999999998 110.878 179.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.3 p -131.16 12.24 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 111.155 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.76 6.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 73.010000000000005 111.096 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.62 131.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.893 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.6 p -142.03 54.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.409999999999997 111.153 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.19 -17.88 5.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 65.540000000000006 110.919 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' TRP . . . . . 0.481 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 20.4 p90 -69.1 -18.47 63.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.922 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 50.7 mt -89.8 -6.8 55.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.902 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -47.77 -51.68 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 74.230000000000004 110.884 179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.02 52.23 3.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 53.409999999999997 112.512 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -159.65 -50.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 73.219999999999999 110.868 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -110.13 143.25 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.209999999999994 110.827 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 76.4 t -48.97 -87.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 64.400000000000006 111.142 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 17.1 t 82.77 123.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 111.135 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 14.6 p90 -161.35 36.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 70.310000000000002 110.858 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.76 173.3 36.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 75.099999999999994 112.485 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -173.83 156.23 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 110.907 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.1 t -51.05 108.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.400000000000006 111.139 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -34.06 54.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.310000000000002 110.935 179.89 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -151.51 169.77 21.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.864 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 78.97 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 71.540000000000006 112.508 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.5 tpt -87.17 0.87 54.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 62.140000000000001 110.881 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -88.59 -34.32 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 71.409999999999997 110.891 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 142' ' ' MET . 30.7 mm -60.95 -40.28 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 72.099999999999994 111.143 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.32 0.13 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.131 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -112.78 -69.71 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.893 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.06 -51.6 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 111.131 179.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 142' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 5.3 tmm? -44.31 -39.95 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.902 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.02 59.64 1.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 65.109999999999999 110.874 -179.914 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.94 -12.4 4.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 71.140000000000001 110.898 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.0 21.65 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.430000000000007 110.876 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -97.93 65.11 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 45.229999999999997 112.501 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.603 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.8 OUTLIER -18.64 120.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 72.200000000000003 110.867 -179.721 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -47.54 -43.31 24.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.855 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -45.68 -35.34 4.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.881 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.1 -60.86 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.719 . . . . 74.120000000000005 112.482 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 125.94 19.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 64.329999999999998 110.87 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.2 m -85.89 139.94 30.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 65.239999999999995 111.135 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -67.66 -22.72 65.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 64.319999999999993 110.829 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -164.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.239999999999995 110.916 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 112.16 13.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 74.230000000000004 110.913 179.872 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 mt -99.06 90.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 111.154 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.14 153.61 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 65.430000000000007 111.114 -179.976 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.3 mm -94.22 128.28 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.5 111.124 179.902 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.13 -63.08 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 111.106 179.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.26 162.17 41.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 75.510000000000005 110.873 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.06 -179.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 64.340000000000003 110.921 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.46 -156.63 25.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 62.210000000000001 112.492 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -120.02 140.58 50.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 74.409999999999997 110.874 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.08 132.66 53.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 110.913 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 72.549999999999997 110.959 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 75.040000000000006 110.82 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.55 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.109999999999999 111.125 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.0 m-20 -88.47 144.63 34.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 65.239999999999995 110.864 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 132.26 22.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.684 2.256 . . . . 71.329999999999998 112.338 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.6 m -116.51 142.28 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 75.239999999999995 111.097 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.79 137.8 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -101.34 156.23 17.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 75.430000000000007 110.857 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.52 143.69 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 74.450000000000003 110.901 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.35 143.03 37.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.030000000000001 110.879 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -115.43 120.3 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.319999999999993 111.149 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 163.28 13.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 53.409999999999997 111.064 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.88 96.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 72.129999999999995 111.145 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.33 31.39 6.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.519999999999996 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.24 65.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 64.109999999999999 112.475 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -96.22 132.91 25.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.648 0.737 . . . . 74.349999999999994 110.874 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.65 65.32 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.129999999999995 112.351 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 tp -121.97 -72.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.903 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.64 -148.24 4.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 74.340000000000003 112.526 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.75 126.6 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 74.319999999999993 110.874 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.33 125.26 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 72.430000000000007 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.1 p -113.47 159.16 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.884 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.69 126.67 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 75.299999999999997 110.904 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.0 tm-20 -59.46 -48.36 81.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 74.010000000000005 110.916 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 7.1 mt 69.51 126.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.219999999999999 110.935 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -88.6 74.14 8.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.239999999999995 110.902 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.8 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.400000000000006 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.01 -37.59 12.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.430000000000007 110.896 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -75.11 -27.7 59.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.894 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.7 m -131.67 68.7 81.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 72.439999999999998 111.095 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 58.87 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.698 2.265 . . . . 63.409999999999997 112.378 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.59 -72.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 86.3 m -58.95 -53.91 53.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 64.120000000000005 111.14 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.42 -9.39 58.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 62.140000000000001 111.118 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -74.17 -24.75 59.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 75.420000000000002 110.849 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -90.5 -34.41 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.200000000000003 110.869 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -50.77 -28.71 9.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 71.420000000000002 110.928 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.36 76.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 73.319999999999993 110.874 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.96 -28.69 25.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 111.119 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.12 13.1 13.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.951 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -117.22 -11.99 10.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 73.099999999999994 110.852 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 71.1 p -116.63 -0.06 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 75.409999999999997 111.184 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.56 10.66 60.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.439999999999998 112.516 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.16 -36.79 85.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 74.239999999999995 110.846 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -15.23 62.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 74.299999999999997 110.921 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.01 -18.66 30.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.746 . . . . 45.340000000000003 112.472 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 47' ' ' GLY . 9.6 m-85 -87.42 -24.95 24.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.38 . . . . 65.530000000000001 110.841 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -30.9 135.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 64.340000000000003 112.457 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -76.46 -43.86 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.96 0.409 . . . . 72.420000000000002 110.941 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.67 93.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 72.239999999999995 110.889 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.9 63.18 0.84 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 73.140000000000001 112.462 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 53.039999999999999 110.834 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.3 p -144.7 -172.74 3.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 65.120000000000005 110.896 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.45 167.09 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 73.230000000000004 110.878 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -46.96 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 110.858 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -146.04 153.05 40.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 110.863 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.5 mt -144.81 130.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.113 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.1 mt -134.78 104.65 10.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 75.540000000000006 111.145 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 98.43 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 62.020000000000003 112.32 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.5 -22.51 3.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 62.210000000000001 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.27 -60.65 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 75.329999999999998 110.865 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.45 -160.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 74.439999999999998 110.902 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 65.3 m -133.36 -73.0 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 74.209999999999994 110.907 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 61.8 160.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 71.230000000000004 110.894 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.71 55.09 0.46 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 61.149999999999999 112.459 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.0 122.73 2.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 65.209999999999994 112.43 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -151.08 -172.16 4.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 75.120000000000005 110.91 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -154.77 47.26 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 74.030000000000001 110.843 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 59.6 p -79.7 122.92 27.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 73.040000000000006 111.134 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.02 171.86 9.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.867 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 71' ' ' ASN . 27.5 p-80 -67.58 -35.0 78.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.430000000000007 110.882 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' HIS . 23.5 t-20 -32.41 -78.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 75.400000000000006 110.867 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.7 42.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 53.009999999999998 112.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 53.7 p -117.86 -51.56 2.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 75.120000000000005 111.165 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.73 176.65 22.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 72.129999999999995 112.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.05 112.65 4.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 73.239999999999995 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.89 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 75.310000000000002 110.931 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 t -132.71 137.48 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 73.019999999999996 110.843 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -70.32 -27.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 75.019999999999996 111.153 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -122.98 41.29 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.79 -136.58 5.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 63.210000000000001 112.513 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.82 -74.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 74.010000000000005 110.896 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 160.4 32.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.878 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.461 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 147.04 35.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.319999999999993 110.873 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.61 158.65 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 64.450000000000003 110.914 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.29 127.19 32.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.450000000000003 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -57.76 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.030000000000001 110.895 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -179.76 177.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 75.140000000000001 110.926 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.47 36.95 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.150000000000006 110.883 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -50.49 -25.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 70.540000000000006 111.158 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.6 mt -73.07 122.75 22.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.019999999999996 110.92 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -77.23 160.2 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.200000000000003 110.872 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.439 ' CD2' ' HB2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -86.53 107.23 18.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.862 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 p -142.93 164.82 29.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 71.219999999999999 111.128 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.03 144.19 4.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 71.209999999999994 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.01 27.5 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.251 . . . . 75.030000000000001 112.326 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.57 73.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 74.200000000000003 112.458 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -84.87 161.91 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 75.019999999999996 111.121 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.408 ' CB ' ' HA3' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -102.84 128.83 49.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.916 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 47.1 t -143.75 -116.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 110.816 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 178.24 143.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.340000000000003 110.856 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 101.67 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.040000000000006 111.095 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 -167.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 74.200000000000003 110.929 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.634 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.65 -37.29 65.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 111.05 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.5 -65.12 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 75.310000000000002 112.522 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.634 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.71 120.88 7.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.252 . . . . 75.340000000000003 112.379 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 105' ' ' PRO . 10.0 p-10 26.53 64.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 61.149999999999999 110.915 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.5 t -163.22 54.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 52.310000000000002 111.124 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -40.11 -52.29 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 75.209999999999994 110.923 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.48 -167.79 53.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 63.539999999999999 112.501 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -118.81 -20.17 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 63.109999999999999 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -51.44 150.9 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 74.420000000000002 110.948 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -160.47 175.03 13.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.5 110.893 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -144.98 179.02 7.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.120000000000005 110.873 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 32.8 mm -102.24 -63.73 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 73.25 111.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER 79.37 112.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.921 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 t -98.8 -13.52 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.175 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.61 159.06 30.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 72.420000000000002 111.087 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -71.51 102.62 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 65.129999999999995 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.9 p -121.36 70.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.439999999999998 111.184 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.439 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -84.65 22.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 110.841 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.9 p90 -103.87 9.72 36.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 75.209999999999994 110.896 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.29 -30.98 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.040000000000006 110.93 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.26 165.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 75.129999999999995 110.851 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.22 -24.74 30.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 72.450000000000003 112.471 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -104.9 -33.56 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 73.129999999999995 110.904 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -119.73 170.29 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.819 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.02 112.88 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 72.420000000000002 111.129 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.6 p -84.94 144.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 111.149 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.401 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 31.6 p90 -178.65 112.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 72.239999999999995 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . 144.04 -166.11 27.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 64.25 112.484 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt 172.87 -174.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 74.409999999999997 110.95 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.69 86.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 111.15 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -47.5 -74.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.865 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -150.78 146.99 26.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 71.299999999999997 110.868 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.36 26.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 74.109999999999999 112.51 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.3 -30.14 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 71.510000000000005 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -50.76 -25.94 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.030000000000001 110.864 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.2 mm -86.33 -38.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.099999999999994 111.156 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.2 t -51.32 -23.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 111.125 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.28 -43.48 15.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 75.030000000000001 110.857 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.13 -48.33 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.129999999999995 111.131 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.5 ptm -64.08 -20.15 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 73.239999999999995 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.46 29.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 74.530000000000001 110.873 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.69 -23.18 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 74.109999999999999 110.831 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.32 1.33 57.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 72.400000000000006 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.71 -147.29 10.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.755 -0.736 . . . . 74.549999999999997 112.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.1 134.35 6.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 74.0 110.858 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -70.59 76.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 74.010000000000005 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.71 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.239999999999995 110.859 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.54 -60.5 0.43 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 74.120000000000005 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -61.63 155.18 23.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 72.420000000000002 110.966 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 63.2 p -124.91 129.42 50.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 71.450000000000003 111.166 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.3 -31.69 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 73.140000000000001 110.893 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -169.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 75.420000000000002 110.895 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -137.88 126.07 23.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.865 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.14 127.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 71.150000000000006 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.31 43.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 111.192 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.0 142.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 111.088 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.57 -64.98 1.01 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 50.210000000000001 111.078 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.77 178.12 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.5 110.858 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.63 -176.34 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.420000000000002 110.914 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 137.07 -146.46 18.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 71.310000000000002 112.477 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 128.14 53.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 73.400000000000006 110.917 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.6 tp -54.51 -56.53 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.400000000000006 110.905 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 62.130000000000003 110.923 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.807 0.337 . . . . 75.349999999999994 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.78 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.540000000000006 111.153 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.35 157.4 38.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 74.230000000000004 110.854 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.28 69.21 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.274 . . . . 74.109999999999999 112.34 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.8 m -130.34 55.57 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.239999999999995 111.145 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.4 m -49.26 147.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 75.420000000000002 111.169 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.55 163.51 32.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 74.010000000000005 110.876 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -141.76 146.17 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 72.120000000000005 110.882 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -93.98 163.32 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 71.329999999999998 110.841 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 mm -132.5 102.66 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.120000000000005 111.142 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -105.04 158.0 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 111.149 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.5 t -138.31 99.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.120000000000005 111.134 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.68 42.65 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 70.420000000000002 110.891 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.88 -8.08 67.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 71.150000000000006 112.504 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.0 tt0 -100.22 101.38 14.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.746 . . . . 73.530000000000001 110.844 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.81 126.89 13.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 74.310000000000002 112.298 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -83.87 -43.73 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 72.120000000000005 110.909 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.02 -151.32 20.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.420000000000002 112.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 156.83 21.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.901 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.62 76.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 74.030000000000001 111.151 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.65 165.44 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 70.129999999999995 110.89 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -152.67 122.53 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.299999999999997 110.897 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -47.89 137.03 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 74.219999999999999 110.88 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -108.22 120.93 43.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.948 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -76.36 57.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.847 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -28.17 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 61.25 111.067 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.75 -61.29 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.510000000000005 110.845 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.030000000000001 110.921 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.4 m -72.75 120.05 78.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.319999999999993 111.13 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HG2' ' H ' ' A' ' 31' ' ' LYS . 53.5 Cg_endo -69.74 -87.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.674 2.25 . . . . 74.299999999999997 112.382 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -70.1 -44.58 68.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 73.140000000000001 110.898 179.862 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -46.07 -28.46 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 73.230000000000004 111.121 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.87 -63.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 64.430000000000007 111.067 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' ARG . 15.6 tt0 -57.98 -64.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.519999999999996 110.865 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 34' ' ' GLU . 14.2 t-20 -31.53 -51.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 63.329999999999998 110.873 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.01 -40.95 62.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 74.540000000000006 110.91 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -52.62 -25.01 9.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 71.340000000000003 110.88 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.37 -43.48 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 73.200000000000003 111.109 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.73 -13.98 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 64.420000000000002 110.914 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -6.2 31.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.826 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.2 p -101.62 -21.25 14.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 74.010000000000005 111.126 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.76 -17.12 54.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 73.239999999999995 112.502 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.59 -37.13 48.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 74.430000000000007 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -23.13 35.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.519999999999996 110.865 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.33 -4.55 40.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 74.299999999999997 112.515 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -164.02 167.13 20.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 75.349999999999994 110.842 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.31 20.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 73.409999999999997 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 108.11 16.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 75.120000000000005 110.936 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -69.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 73.230000000000004 110.852 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.79 32.67 2.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.329999999999998 112.47 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.13 -168.2 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 75.400000000000006 110.84 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 m -114.17 -168.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.24 -173.29 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 71.209999999999994 110.913 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -102.96 -74.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 73.349999999999994 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -154.64 103.52 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 74.439999999999998 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.88 128.27 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 64.310000000000002 111.17 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.413 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 5.0 tt -136.11 106.85 9.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 72.540000000000006 111.144 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.76 105.72 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.697 2.265 . . . . 71.150000000000006 112.306 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.62 -49.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 42.200000000000003 112.511 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.27 -66.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 75.510000000000005 110.86 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -162.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.120000000000005 110.872 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.8 m -149.94 98.38 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 73.409999999999997 110.907 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -90.68 170.09 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 71.299999999999997 110.889 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.43 -160.25 31.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 71.040000000000006 112.46 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.64 -4.17 79.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.751 . . . . 71.200000000000003 112.465 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.14 110.75 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 74.239999999999995 110.89 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -119.37 13.68 12.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 65.299999999999997 110.837 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.1 t -177.79 35.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 72.25 111.122 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -40.7 14.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -77.24 56.74 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 74.540000000000006 110.86 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.12 -55.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 75.349999999999994 110.896 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.29 17.55 56.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.803 -0.713 . . . . 61.439999999999998 112.438 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m 44.21 64.72 1.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 75.510000000000005 111.139 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.16 133.84 7.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 61.229999999999997 112.46 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.44 -161.14 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 55.119999999999997 112.499 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -174.96 -177.71 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 71.400000000000006 110.903 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 177.6 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.844 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.1 pt -86.9 -34.45 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 111.115 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.01 72.42 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.903 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.48 -130.02 10.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 70.040000000000006 112.501 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.78 -77.5 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 73.150000000000006 110.877 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.78 -177.34 4.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 73.549999999999997 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.23 174.91 11.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 75.140000000000001 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.7 158.61 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 75.349999999999994 110.853 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 119.48 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.439999999999998 110.872 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -47.46 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.040000000000006 110.863 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.53 167.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.120000000000005 110.875 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.48 37.11 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.040000000000006 110.872 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.79 -22.19 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.430000000000007 111.139 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 70.3 mt -98.09 90.6 4.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 71.430000000000007 110.93 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -63.23 171.98 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 70.349999999999994 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -90.29 95.25 10.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 73.129999999999995 110.86 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 94' ' ' GLY . 18.2 p -131.14 149.56 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 65.329999999999998 111.117 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' THR . . . 56.17 155.07 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 63.409999999999997 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.37 24.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 71.209999999999994 112.348 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.28 -10.55 60.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 74.230000000000004 112.541 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 6.2 mm -47.67 133.51 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 75.420000000000002 111.139 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -120.97 145.9 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 72.239999999999995 110.884 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 t -149.79 -133.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 74.219999999999999 110.821 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.2 mtt -145.65 112.62 6.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 75.25 110.862 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -95.01 74.37 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 72.430000000000007 111.132 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -107.36 -75.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.209999999999994 110.91 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.427 ' HB2' ' HB ' ' A' ' 107' ' ' THR . . . -134.99 -84.62 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 65.329999999999998 111.077 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.84 -83.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 72.150000000000006 112.481 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.443 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.77 113.9 3.53 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.677 2.251 . . . . 73.310000000000002 112.351 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 34.47 46.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 72.450000000000003 110.896 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 103' ' ' ALA . 17.6 p -142.26 46.74 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 55.229999999999997 111.143 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.73 176.52 8.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 72.430000000000007 110.913 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.82 -127.04 1.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 62.130000000000003 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -101.76 -171.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 71.530000000000001 110.917 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 72.3 64.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.319999999999993 110.913 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -72.48 149.39 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 75.230000000000004 110.877 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 5.4 p90 -114.6 120.49 40.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 72.349999999999994 110.847 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.57 132.63 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 74.319999999999993 111.101 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.11 127.84 33.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 72.510000000000005 110.915 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 p -99.62 -31.35 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 65.019999999999996 111.155 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.06 24.77 5.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 72.439999999999998 111.089 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.69 135.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 74.540000000000006 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.0 p -139.97 61.25 1.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 73.099999999999994 111.137 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.06 3.61 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -86.29 1.44 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 73.420000000000002 110.919 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 pp -139.81 43.64 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.109999999999999 110.909 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.49 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.845 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 125' ' ' LYS . . . -50.11 140.53 17.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 70.150000000000006 112.469 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 1.0 OUTLIER 78.41 61.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.875 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -163.14 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 75.319999999999993 110.846 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.4 t 74.67 86.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 64.400000000000006 111.095 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 25.0 t -90.91 133.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 74.329999999999998 111.159 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -151.64 22.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.439999999999998 110.852 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -140.7 174.07 22.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 60.219999999999999 112.494 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.68 130.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 74.230000000000004 110.895 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.7 t -51.77 129.36 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.420000000000002 111.129 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 -59.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 61.219999999999999 110.844 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -139.82 140.99 36.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.888 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.7 1.78 43.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 75.439999999999998 112.445 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.8 ttt -49.56 -31.13 9.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 71.129999999999995 110.927 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -49.69 -26.72 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.89 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.34 -36.28 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 75.349999999999994 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.07 -22.75 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 71.540000000000006 111.137 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -83.75 -34.24 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 74.409999999999997 110.849 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.0 81.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 73.140000000000001 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.5 ptm -72.21 -11.87 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.951 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.92 25.2 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -16.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 73.129999999999995 110.905 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.66 -6.03 40.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.55 -166.05 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 73.400000000000006 112.452 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -140.04 -75.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 75.049999999999997 110.883 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -179.95 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 72.230000000000004 110.908 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -92.79 24.02 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 72.019999999999996 110.873 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.49 9.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 54.229999999999997 112.521 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.64 149.1 36.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 73.540000000000006 110.859 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -130.85 168.05 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 73.099999999999994 111.149 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.2 t -92.04 -2.49 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.040000000000006 110.898 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -140.95 -167.55 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 73.409999999999997 110.893 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.45 119.83 17.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 75.340000000000003 110.895 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.2 125.57 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 70.519999999999996 111.162 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.61 172.36 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 73.200000000000003 111.14 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.15 108.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.150000000000006 111.131 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -60.28 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.239999999999995 111.14 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -148.9 177.2 9.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 71.319999999999993 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 10.7 p -178.17 163.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.030000000000001 110.909 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.11 -169.61 28.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.47 117.51 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 72.519999999999996 110.927 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -99.11 -69.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.540000000000006 110.958 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 75.209999999999994 110.915 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 73.400000000000006 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.23 148.25 24.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 71.129999999999995 111.133 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.37 143.12 5.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 64.519999999999996 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 112.68 3.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 64.230000000000004 112.378 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.7 m -115.93 133.81 55.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 111.125 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 m -124.08 150.15 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 111.152 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -108.48 160.83 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.530000000000001 110.87 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.94 130.09 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.310000000000002 110.895 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.04 95.68 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 71.239999999999995 110.903 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.7 mt -75.62 151.91 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 74.519999999999996 111.104 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -129.52 168.49 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 74.140000000000001 111.051 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.73 109.78 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.049999999999997 111.098 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.19 34.93 2.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.230000000000004 110.919 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 10.99 84.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 72.310000000000002 112.457 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -120.3 147.53 45.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.672 0.749 . . . . 73.5 110.876 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.21 56.63 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 62.030000000000001 112.336 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.7 tp -132.97 8.32 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 73.400000000000006 110.969 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -166.15 12.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 55.310000000000002 112.494 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.96 151.35 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 72.120000000000005 110.888 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.417 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 25.9 m -124.95 170.2 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 52.439999999999998 111.146 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.0 t -122.72 151.33 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.150000000000006 110.875 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -126.4 134.43 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 72.239999999999995 110.916 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -108.79 105.72 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 63.439999999999998 110.902 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.12 138.6 31.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -90.72 83.3 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.030000000000001 110.842 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.93 0.92 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 75.530000000000001 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.2 -34.23 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.150000000000006 110.866 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mttm -97.51 -27.14 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 72.310000000000002 110.912 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.56 79.46 24.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 74.120000000000005 111.138 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -19.25 36.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 74.239999999999995 112.336 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -43.65 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 70.099999999999994 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.65 -53.19 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 73.400000000000006 111.122 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.65 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 75.129999999999995 111.099 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.98 -38.16 37.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 74.530000000000001 110.906 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.33 -61.86 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 72.340000000000003 110.903 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -51.51 -25.23 6.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 75.450000000000003 110.889 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -36.12 83.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.340000000000003 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.61 -21.05 35.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.239999999999995 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.29 -60.44 2.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 75.530000000000001 110.929 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 64.019999999999996 110.896 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -84.53 -12.78 53.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.329999999999998 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 44.14 83.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.8 32.03 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 73.0 110.909 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.1 32.54 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 72.319999999999993 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.68 13.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 52.119999999999997 112.482 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.75 -170.54 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 75.010000000000005 110.848 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.57 176.6 37.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 72.019999999999996 112.502 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.68 -18.07 63.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 73.409999999999997 110.894 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.38 136.55 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 64.409999999999997 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.4 58.58 8.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.719 -0.753 . . . . 64.299999999999997 112.509 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 82.7 p -145.07 -166.27 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 60.310000000000002 110.888 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.96 169.06 24.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 73.329999999999998 110.869 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -104.18 -67.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 73.329999999999998 110.86 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 59.65 20.64 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 72.219999999999999 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -146.97 115.63 6.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.23 156.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 75.530000000000001 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.97 112.88 8.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 75.209999999999994 111.112 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 86.31 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 72.430000000000007 112.384 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.75 9.05 8.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 65.120000000000005 112.487 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -69.98 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.510000000000005 110.867 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.95 -164.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 72.310000000000002 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.0 t -151.48 121.57 7.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.209999999999994 110.869 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -92.91 134.71 34.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.230000000000004 110.943 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.38 -50.59 61.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 54.329999999999998 112.5 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.72 -91.87 2.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 72.430000000000007 112.461 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 p30 177.36 65.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 74.409999999999997 110.828 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.68 -74.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 75.510000000000005 110.887 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 99.6 m -55.61 114.27 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 74.099999999999994 111.166 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -113.62 -27.48 7.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 73.129999999999995 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 177.41 35.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.896 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -177.03 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 71.310000000000002 110.888 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.68 139.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 53.200000000000003 112.517 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -110.2 -33.74 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 65.319999999999993 111.116 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.07 -163.01 18.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 75.340000000000003 112.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . 159.03 -21.25 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 72.049999999999997 112.502 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 66.9 139.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 72.420000000000002 110.854 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.82 -179.13 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 75.219999999999999 110.83 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.78 -5.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 111.156 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.99 28.1 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.510000000000005 110.9 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.0 -126.18 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 74.420000000000002 112.458 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -144.49 13.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 73.349999999999994 110.908 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -171.44 126.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 75.409999999999997 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -119.03 143.83 46.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 63.420000000000002 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -66.43 156.5 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 75.120000000000005 110.899 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -78.03 134.68 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 74.010000000000005 110.884 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -61.98 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.310000000000002 110.902 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -173.94 148.21 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.892 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.52 49.97 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.6 mm -72.5 -15.93 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 75.549999999999997 111.149 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.75 137.7 42.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.140000000000001 110.88 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -129.0 104.89 7.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 75.510000000000005 110.914 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -67.63 103.57 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 73.400000000000006 110.816 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.3 p -130.58 39.63 3.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 73.420000000000002 111.13 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.8 163.8 32.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 74.420000000000002 112.482 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 146.26 59.6 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.738 2.292 . . . . 75.109999999999999 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.02 13.71 65.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.71 -0.757 . . . . 70.329999999999998 112.474 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 28.6 mm -89.27 138.61 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 63.149999999999999 111.123 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.1 tt -93.99 114.6 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 75.140000000000001 110.896 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.66 140.29 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 64.530000000000001 110.864 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.5 mmt -69.55 145.5 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.439999999999998 110.849 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -138.14 139.05 39.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 61.130000000000003 111.124 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 174.63 -69.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 72.209999999999994 110.908 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -136.42 -40.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 71.319999999999993 111.114 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.76 -69.02 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 63.43 112.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -104.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.265 . . . . 73.109999999999999 112.356 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -90.77 62.95 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.120000000000005 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.84 68.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.200000000000003 111.122 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -44.66 -60.73 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 72.510000000000005 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.59 43.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 73.239999999999995 112.448 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 2.7 p -129.04 9.94 5.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 72.030000000000001 110.851 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -72.26 -166.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.931 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -143.87 128.16 17.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.908 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -123.25 106.85 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 75.099999999999994 110.888 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.5 tt -120.55 103.8 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 73.040000000000006 111.181 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -85.44 153.11 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 75.019999999999996 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 28.95 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.349999999999994 111.119 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.93 165.11 5.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 72.530000000000001 111.067 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -61.78 96.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.9 62.43 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 74.230000000000004 111.155 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.53 25.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.299999999999997 110.902 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 4.2 m-90 -69.9 -22.88 63.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 110.934 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.0 mt -116.63 34.68 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.420000000000002 110.933 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -86.99 44.42 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 110.844 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.06 52.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.776 -0.726 . . . . 71.299999999999997 112.526 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -171.34 -45.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 75.439999999999998 110.894 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -98.49 142.34 30.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 72.450000000000003 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.78 90.61 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 63.310000000000002 111.1 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 p -82.53 143.56 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.140000000000001 111.151 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -176.51 134.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.875 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.31 137.99 9.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 60.350000000000001 112.487 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.37 172.05 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 72.219999999999999 110.907 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.96 139.04 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 74.040000000000006 111.105 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -117.9 -29.85 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 62.350000000000001 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.56 158.33 36.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 71.340000000000003 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.71 85.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 75.450000000000003 112.484 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.6 mmm -92.04 -24.15 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 73.140000000000001 110.848 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -80.57 -34.53 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 74.010000000000005 110.877 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.423 ' O ' ' HB2' ' A' ' 142' ' ' MET . 46.6 mm -39.42 -48.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 65.319999999999993 111.132 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.7 t -90.36 -50.8 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 60.409999999999997 111.135 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -44.68 -59.77 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.140000000000001 110.88 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.74 78.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.030000000000001 111.082 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 8.1 tmm? -50.08 -45.04 52.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 73.310000000000002 110.894 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -27.76 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 64.340000000000003 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -63.31 -25.45 68.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.409999999999997 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -90.52 21.92 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 73.519999999999996 110.872 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.89 -159.03 21.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 53.450000000000003 112.52 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -155.47 147.59 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 71.409999999999997 110.836 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -76.34 64.24 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 75.329999999999998 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -176.19 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 75.450000000000003 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.63 -52.47 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 71.349999999999994 112.454 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.04 112.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 73.049999999999997 110.905 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 28.1 m -77.88 127.96 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 74.049999999999997 111.166 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -46.15 -32.07 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 64.049999999999997 110.86 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -133.51 -178.56 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 73.450000000000003 110.871 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -98.82 107.28 19.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 71.109999999999999 110.938 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.0 mt -98.3 108.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.510000000000005 111.147 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 t -119.24 156.93 29.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 111.148 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.5 mp -83.48 139.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.209999999999994 111.139 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.73 -59.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.219999999999999 111.124 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.74 161.81 41.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 73.329999999999998 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.64 -168.59 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.319999999999993 110.894 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.68 -165.58 26.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 74.439999999999998 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -113.09 138.82 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 71.25 110.944 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.36 156.2 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 75.129999999999995 110.913 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 110.852 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.797 0.332 . . . . 75.129999999999995 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.59 141.64 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.230000000000004 111.111 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.62 145.83 37.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 73.099999999999994 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 121.59 8.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 73.519999999999996 112.301 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.8 m -106.64 128.04 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 111.138 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.3 m -111.73 141.99 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 64.209999999999994 111.164 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -122.35 160.22 25.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.902 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -142.03 143.1 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.929 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.21 82.07 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.835 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.9 147.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.230000000000004 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.24 150.56 41.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -135.81 97.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 74.439999999999998 111.121 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.87 24.41 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.187 -0.46 . . . . 64.420000000000002 110.841 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.09 59.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 64.310000000000002 112.48 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -108.34 143.0 26.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 74.549999999999997 110.881 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 152.82 68.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.661 2.241 . . . . 75.140000000000001 112.339 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 17.5 tp -129.63 -0.38 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 110.905 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 138.48 171.71 12.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 51.509999999999998 112.508 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -105.99 127.41 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 62.439999999999998 110.855 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 t -113.18 100.18 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.310000000000002 111.137 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.8 p -102.17 142.44 33.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 71.349999999999994 110.819 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.52 104.5 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 72.349999999999994 110.891 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -51.86 167.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 72.230000000000004 110.833 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.46 126.85 53.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 74.5 110.93 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -77.33 59.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 110.899 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.06 -7.51 52.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 73.310000000000002 111.121 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.85 -65.05 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.019999999999996 110.93 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -61.22 2.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 m -109.53 83.29 2.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 74.120000000000005 111.121 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.97 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 75.209999999999994 112.351 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.31 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -47.17 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 72.120000000000005 111.11 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.31 -33.96 59.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.5 111.096 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.61 -31.75 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.510000000000005 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -77.49 -67.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.099999999999994 110.908 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.18 -43.33 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 74.239999999999995 110.849 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.36 -29.61 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 75.209999999999994 110.861 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.89 -43.33 20.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 75.430000000000007 111.131 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.98 -38.41 82.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.409999999999997 110.907 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -69.55 -47.88 62.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 71.109999999999999 110.893 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.1 p -72.34 -13.52 61.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 74.409999999999997 111.121 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.51 69.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 75.120000000000005 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.1 41.56 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 74.209999999999994 110.932 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.9 mtpm? -130.09 -2.63 4.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 110.914 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.73 -14.06 65.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 73.310000000000002 112.488 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -33.85 76.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.530000000000001 110.936 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 48' ' ' TYR . . . 85.27 -141.32 19.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 71.109999999999999 112.482 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 1.3 t80 82.56 85.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 73.329999999999998 110.884 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 -47.95 4.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 73.319999999999993 110.871 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -125.29 113.33 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 54.25 112.512 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 p -88.11 -168.61 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 64.099999999999994 110.833 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 p -139.52 96.0 3.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 70.239999999999995 110.911 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 34.2 m-85 -81.37 107.11 13.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 71.030000000000001 110.858 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.29 29.84 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 73.530000000000001 110.873 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.05 24.4 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.209999999999994 110.887 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.43 141.73 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.129999999999995 111.107 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -131.95 110.36 14.34 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 74.349999999999994 111.15 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 89.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.657 2.238 . . . . 74.450000000000003 112.403 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.7 14.86 4.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 75.310000000000002 112.5 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 -64.51 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 75.340000000000003 110.87 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.16 -169.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 74.430000000000007 110.883 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.8 m -146.4 142.91 28.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 65.239999999999995 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 140.37 51.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 110.925 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 65' ' ' GLY . . . -116.93 109.16 1.86 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 70.150000000000006 112.466 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' GLY . . . 37.47 43.62 1.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 73.030000000000001 112.498 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -53.25 137.99 33.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 72.310000000000002 110.848 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.36 175.01 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 75.510000000000005 110.93 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 p -90.57 -81.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 73.549999999999997 111.176 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.88 92.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 72.349999999999994 110.872 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -47.24 102.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 73.420000000000002 110.861 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.68 -53.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.150000000000006 110.925 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.85 -71.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 64.540000000000006 112.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.9 m -110.32 -41.07 4.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 74.219999999999999 111.157 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.43 161.34 21.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 65.5 112.475 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.27 114.81 1.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 51.539999999999999 112.481 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -111.57 174.78 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 73.109999999999999 110.874 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -87.92 -174.9 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 27.9 pt -80.35 -32.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 75.430000000000007 111.126 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -89.19 44.29 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 75.400000000000006 110.932 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 -109.17 2.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 64.420000000000002 112.494 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -52.56 174.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.395 . . . . 75.420000000000002 110.851 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.3 -172.19 2.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 73.519999999999996 110.883 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.89 145.17 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.853 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -60.61 176.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 74.019999999999996 110.882 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.4 126.4 40.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 75.209999999999994 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.27 -48.71 26.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 62.119999999999997 110.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -175.19 149.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 72.019999999999996 110.862 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.02 46.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.430000000000007 110.881 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -14.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.540000000000006 111.163 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.43 125.67 49.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 65.400000000000006 110.893 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -164.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 73.019999999999996 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -97.42 65.39 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 65.219999999999999 110.897 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -20.05 53.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.209999999999994 111.126 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.23 174.77 46.55 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.129999999999995 112.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.667 2.245 . . . . 73.030000000000001 112.379 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.02 -30.6 4.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 75.409999999999997 112.485 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.1 mm -62.8 158.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 74.310000000000002 111.114 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.417 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 5.8 mp -107.05 147.97 29.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 75.200000000000003 110.893 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.57 150.03 49.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 38.1 mmt -79.37 106.38 11.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.099999999999994 110.844 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.67 73.57 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 72.299999999999997 111.08 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' C ' ' OD1' ' A' ' 102' ' ' ASN . 34.3 t-20 -105.02 -81.79 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.209999999999994 110.924 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 176.8 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 64.299999999999997 111.129 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.31 171.34 38.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 65.109999999999999 112.476 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 65.25 112.335 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 65.58 32.41 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 109' ' ' GLY . 29.2 p -148.02 69.52 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 74.430000000000007 111.13 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.55 18.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 73.209999999999994 110.911 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.476 ' H ' ' C ' ' A' ' 107' ' ' THR . . . -63.74 -144.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.8 -0.714 . . . . 74.409999999999997 112.434 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 t 51.68 -150.92 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 72.349999999999994 110.897 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -77.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 73.329999999999998 110.931 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 176.53 172.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 72.549999999999997 110.852 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 138.66 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 73.519999999999996 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.68 114.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 73.519999999999996 111.119 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.5 p -71.43 -27.23 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 57.53 17.08 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 62.299999999999997 111.132 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.56 137.48 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 75.010000000000005 111.09 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -51.21 129.99 25.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 73.010000000000005 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.6 p -131.5 59.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 64.420000000000002 111.144 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -51.24 -24.0 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 74.049999999999997 110.893 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -63.13 -30.29 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 73.129999999999995 110.914 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.8 mt -111.68 64.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 64.299999999999997 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -110.74 15.89 21.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.230000000000004 110.809 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.64 31.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 63.219999999999999 112.487 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -126.17 -62.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 73.209999999999994 110.874 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -98.0 121.72 40.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 74.230000000000004 110.854 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 29.9 t -58.45 96.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.319999999999993 111.095 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.0 t -86.79 128.22 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 72.519999999999996 111.071 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -158.5 43.33 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.862 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -119.19 -168.45 14.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.340000000000003 112.467 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.5 ttpp 178.48 150.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 74.219999999999999 110.909 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 79.4 t -92.26 85.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 74.519999999999996 111.114 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -66.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.519999999999996 110.892 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.02 123.11 13.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 63.219999999999999 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.44 73.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 44.030000000000001 112.497 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -93.55 -28.69 15.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 110.859 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -70.07 -34.91 73.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 73.310000000000002 110.903 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 142' ' ' MET . 29.1 mm -66.77 -38.01 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.350000000000001 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.0 t -81.46 -0.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 74.340000000000003 111.14 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -117.7 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 71.400000000000006 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.45 -57.94 10.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 62.409999999999997 111.072 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.464 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.4 ttm -50.7 -29.97 12.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 65.219999999999999 110.89 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.430000000000007 110.866 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -62.45 -13.47 30.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.409999999999997 110.856 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.18 17.1 3.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.109999999999999 110.89 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.15 -146.07 19.61 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 71.230000000000004 112.489 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -152.51 -87.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 70.310000000000002 110.883 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -156.04 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.129999999999995 110.874 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.12 19.94 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.871 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.56 -157.72 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 55.140000000000001 112.548 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.7 mttt 63.15 101.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 74.140000000000001 110.896 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -84.02 155.45 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.340000000000003 111.148 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -17.21 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 62.130000000000003 110.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -126.92 -165.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 72.219999999999999 110.883 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.55 106.24 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 16.4 mt -94.03 122.73 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 74.030000000000001 111.141 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.4 p -139.02 169.52 17.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 20.1 mt -107.04 99.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.519999999999996 111.165 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.53 8.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 111.127 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -133.15 168.64 18.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.200000000000003 110.845 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.1 p -176.95 -167.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 73.209999999999994 110.864 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.82 -152.06 16.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 44.020000000000003 112.512 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.69 129.72 55.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 74.319999999999993 110.913 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -100.06 -29.45 12.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 74.430000000000007 110.898 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.030000000000001 110.864 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 74.319999999999993 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.93 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 72.439999999999998 111.134 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -97.76 159.39 31.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 71.420000000000002 110.895 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 148.57 65.44 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 74.030000000000001 112.378 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.51 173.74 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 73.230000000000004 111.118 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -167.2 143.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 111.108 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -124.36 154.57 40.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.340000000000003 110.83 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -135.98 132.49 36.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 65.549999999999997 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.23 108.39 19.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.120000000000005 110.824 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mm -80.96 110.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.219999999999999 111.169 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.15 172.66 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 71.299999999999997 111.133 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.27 94.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.319999999999993 111.08 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 72.09 56.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 110.858 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.51 11.63 57.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 64.519999999999996 112.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -123.69 107.37 31.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 73.25 110.875 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 138.56 37.95 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.634 2.223 . . . . 74.530000000000001 112.349 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -103.31 -53.23 2.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.540000000000006 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.5 -154.23 9.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 75.400000000000006 112.491 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 168.12 24.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 73.329999999999998 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 -177.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 73.099999999999994 111.123 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -130.09 96.88 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 65.239999999999995 110.826 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -93.34 115.26 27.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 70.200000000000003 110.909 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.32 113.88 25.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.884 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.8 mt -80.25 140.01 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.549999999999997 110.894 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.0 m-85 -88.37 82.58 6.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 71.400000000000006 110.848 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -29.86 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 75.439999999999998 111.104 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.28 -28.19 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 54.240000000000002 110.831 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.0 mmtt -96.88 -34.55 11.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.310000000000002 110.898 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.482 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 15.5 m -131.9 88.79 40.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 73.450000000000003 111.152 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.63 12.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.661 2.241 . . . . 73.310000000000002 112.336 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.92 -48.48 11.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.482 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 21.6 m -76.7 7.93 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 73.549999999999997 111.132 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.18 -40.98 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 75.0 111.125 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 35' ' ' ASN . 13.5 pt-20 -90.76 -32.6 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 75.230000000000004 110.864 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' GLU . 54.4 t-20 -30.87 -70.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 110.881 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -71.44 -30.95 66.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 64.019999999999996 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.5 tmm_? -50.21 -43.1 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 73.510000000000005 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.34 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 71.420000000000002 111.122 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.8 21.56 12.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 110.903 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.2 t -127.61 -26.67 2.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.200000000000003 110.843 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -109.89 -16.53 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 64.140000000000001 111.098 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.63 86.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 73.340000000000003 112.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -170.23 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 73.200000000000003 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 20.73 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.120000000000005 110.9 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 -26.18 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 64.0 112.465 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -147.86 -176.34 5.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 73.230000000000004 110.871 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.92 -144.49 16.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 43.009999999999998 112.494 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.84 174.22 6.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.988 0.423 . . . . 75.049999999999997 110.918 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 14.43 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 75.329999999999998 110.927 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.44 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -158.82 44.36 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 72.109999999999999 112.494 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -89.99 133.53 34.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 73.140000000000001 110.873 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.7 m -51.89 172.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 73.209999999999994 110.866 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 73.37 1.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 74.010000000000005 110.838 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -70.61 175.24 5.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.540000000000006 110.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.88 104.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.827 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.1 mt -148.51 132.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 111.135 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.8 pt -154.17 109.14 2.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 74.340000000000003 111.147 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 126.69 13.61 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.654 2.236 . . . . 70.340000000000003 112.347 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.45 3.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 72.439999999999998 112.491 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.4 -75.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 75.010000000000005 110.843 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.22 -164.5 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 53.420000000000002 110.927 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.4 m -125.51 -70.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 65.37 153.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 63.340000000000003 110.951 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.82 -154.9 25.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 73.420000000000002 112.527 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.83 65.21 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 71.329999999999998 112.456 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.3 162.92 24.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 71.420000000000002 110.895 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.464 ' O ' ' OG1' ' A' ' 68' ' ' THR . 0.1 OUTLIER -145.35 -170.43 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.239999999999995 110.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 67' ' ' PHE . 3.3 p 68.44 36.84 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 72.409999999999997 111.147 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 -69.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 75.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -74.61 -18.67 60.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 75.5 110.905 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.71 -54.87 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 65.329999999999998 110.886 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.23 4.93 23.56 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.771 -0.728 . . . . 73.219999999999999 112.494 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 5.1 t -125.26 156.22 38.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 72.349999999999994 111.154 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.53 -36.18 1.74 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.73 -0.748 . . . . 72.349999999999994 112.444 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.05 74.87 1.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 63.030000000000001 112.473 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt 178.42 -98.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 74.140000000000001 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 t -145.16 120.0 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 71.319999999999993 110.856 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -55.84 -19.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 75.310000000000002 111.102 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 -22.0 14.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 74.420000000000002 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.24 -112.8 0.35 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.729 -0.748 . . . . 55.450000000000003 112.501 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -108.96 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 75.430000000000007 110.872 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -159.96 155.77 26.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.882 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -112.65 171.27 7.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 73.329999999999998 110.849 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.71 142.49 30.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 72.239999999999995 110.878 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.62 141.84 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.200000000000003 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -102.91 -64.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.450000000000003 110.841 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.29 165.81 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.140000000000001 110.864 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.17 45.69 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.120000000000005 110.894 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.88 -11.27 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.230000000000004 111.123 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.0 mt -98.18 70.12 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 64.239999999999995 110.946 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -61.35 130.32 45.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 75.310000000000002 110.869 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.97 90.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 75.209999999999994 110.83 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 p -99.28 31.69 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 72.450000000000003 111.163 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.69 177.47 26.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 75.340000000000003 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.24 7.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.252 . . . . 73.239999999999995 112.34 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.33 14.07 66.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.329999999999998 112.457 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -86.99 125.49 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 73.510000000000005 111.174 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tt -93.05 137.81 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 73.310000000000002 110.927 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 13.8 t -141.67 -130.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 62.130000000000003 110.826 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.9 mmt -149.94 -175.05 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 73.450000000000003 110.844 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -169.05 147.28 3.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 111.137 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.8 m-20 166.5 -78.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 71.340000000000003 110.878 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.98 -35.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 71.129999999999995 111.156 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.77 -127.19 2.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 64.219999999999999 112.499 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 149.03 66.25 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.340000000000003 112.352 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 51.5 29.3 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.099999999999994 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 108' ' ' ASN . 3.1 m -132.87 21.79 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 74.510000000000005 111.139 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 107' ' ' THR . 3.2 m120 29.49 -98.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.219999999999999 110.865 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.91 169.31 13.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 71.230000000000004 112.522 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.57 11.65 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 70.150000000000006 110.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -175.26 156.58 2.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 71.219999999999999 110.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 13.6 p90 -111.82 150.18 30.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 62.210000000000001 110.867 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 114' ' ' ILE . 18.6 p90 -108.92 67.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.540000000000006 110.886 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 113' ' ' PHE . 36.0 mt -32.19 115.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.439999999999998 111.148 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.0 m -84.13 149.26 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 72.430000000000007 110.843 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.4 p -113.71 18.56 17.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 74.519999999999996 111.144 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -166.19 -176.59 3.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.420000000000002 111.108 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -77.53 104.47 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.450000000000003 110.907 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -126.79 55.51 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 75.239999999999995 111.137 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 21.99 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 74.450000000000003 110.867 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -94.94 11.03 33.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 75.439999999999998 110.881 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.08 25.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 72.120000000000005 110.923 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -58.17 -65.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 75.019999999999996 110.873 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.87 83.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.140000000000001 112.464 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 179.38 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 72.049999999999997 110.863 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -126.89 162.5 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.239999999999995 110.861 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.429 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -76.26 -166.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 75.209999999999994 111.18 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.434 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.2 p -170.34 141.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 111.143 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.546 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 2.6 p90 -177.66 110.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 121.1 145.98 7.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 73.409999999999997 112.464 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -157.68 139.53 14.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 74.409999999999997 110.931 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.2 t -58.45 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 111.132 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -32.83 65.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.96 178.31 8.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 73.040000000000006 110.866 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.17 57.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 64.030000000000001 112.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 75.420000000000002 110.851 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -54.55 -22.38 12.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 34.9 mm -78.11 -41.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 62.420000000000002 111.178 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -53.75 -47.2 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 111.136 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.23 -29.09 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 71.420000000000002 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.98 -26.7 61.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.420000000000002 111.129 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.403 ' C ' ' H ' ' A' ' 144' ' ' ARG . 21.2 mtm -73.48 -49.3 27.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 75.230000000000004 110.891 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.67 39.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 72.530000000000001 110.896 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' A' ' 142' ' ' MET . 0.0 OUTLIER -125.53 -16.42 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 75.120000000000005 110.818 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -130.52 13.09 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 75.200000000000003 110.926 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.45 44.82 1.44 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.733 . . . . 52.109999999999999 112.463 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t 37.45 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 52.009999999999998 110.877 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -141.36 18.08 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 75.319999999999993 110.892 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -128.79 -18.54 3.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 74.120000000000005 110.866 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.51 -59.55 0.48 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 75.319999999999993 112.444 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.78 158.48 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.879 0.371 . . . . 73.209999999999994 110.885 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.77 154.01 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 75.140000000000001 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -21.48 59.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 73.439999999999998 110.825 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -132.28 165.93 23.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 75.439999999999998 110.877 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -108.47 124.07 49.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 74.420000000000002 110.881 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -97.61 107.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.549999999999997 111.135 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.54 145.1 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 64.450000000000003 111.114 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.44 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -90.29 139.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.400000000000006 111.137 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.92 -57.76 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 71.310000000000002 111.123 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -167.2 169.08 12.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.109999999999999 110.852 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.0 m -146.95 168.87 20.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 72.099999999999994 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.45 178.48 35.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 70.219999999999999 112.495 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -47.2 48.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 71.439999999999998 110.859 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 61.72 108.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 75.310000000000002 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 73.340000000000003 110.844 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 63.340000000000003 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.75 143.88 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 70.420000000000002 111.094 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -54.76 134.75 65.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.664 0.745 . . . . 75.340000000000003 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 74.510000000000005 112.323 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 62.2 m -115.05 138.79 50.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 111.146 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.49 147.65 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 74.439999999999998 111.136 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -107.98 146.23 32.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 74.109999999999999 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.21 133.12 45.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 75.409999999999997 110.879 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.82 127.6 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 74.510000000000005 110.89 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.34 120.15 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.230000000000004 111.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.35 158.22 37.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 54.020000000000003 111.104 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.01 106.71 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.140000000000001 111.129 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 71.17 35.44 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 74.120000000000005 110.863 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.19 -6.69 78.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 65.120000000000005 112.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -98.06 136.42 21.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 75.430000000000007 110.917 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 133.72 26.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.718 2.279 . . . . 63.210000000000001 112.333 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.3 tp -116.81 -34.94 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.310000000000002 110.924 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -176.87 43.51 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 75.510000000000005 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.27 152.62 50.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 75.109999999999999 110.886 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 173.86 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 72.319999999999993 111.128 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.0 p -139.72 143.56 37.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.883 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.0 m-85 -122.48 133.18 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 75.310000000000002 110.886 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -101.87 123.15 45.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 71.540000000000006 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 mt -88.45 124.35 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 75.299999999999997 110.898 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -77.01 62.86 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.430000000000007 110.835 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.25 -29.36 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 63.049999999999997 111.093 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.52 -45.6 91.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.219999999999999 110.847 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -90.14 -31.19 17.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 72.400000000000006 110.915 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 129' ' ' PHE . 2.9 m -129.8 84.9 59.64 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.624 0.726 . . . . 75.450000000000003 111.092 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -31.33 20.86 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.719 2.279 . . . . 63.420000000000002 112.32 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -46.24 10.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 74.219999999999999 110.869 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -6.73 42.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.010000000000005 111.168 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.08 -40.56 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 111.072 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 35' ' ' ASN . 51.6 mt-10 -92.46 -44.31 8.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 110.88 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.7 t30 -28.0 -64.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.936 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -72.0 -37.32 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 74.030000000000001 110.887 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.0 tmm_? -51.02 -35.64 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.409999999999997 110.863 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.72 -32.4 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.530000000000001 111.121 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 mt -72.78 -54.31 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 75.019999999999996 110.882 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 m -56.37 -50.62 71.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.519999999999996 110.879 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.4 p -72.89 -26.92 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 74.109999999999999 111.171 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.75 101.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 75.319999999999993 112.482 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -149.53 34.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 110.886 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -131.7 3.55 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 71.340000000000003 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.32 15.96 63.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 71.400000000000006 112.498 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -174.69 173.96 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 75.150000000000006 110.906 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.89 -172.43 15.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 63.140000000000001 112.482 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.36 144.66 27.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.97 0.415 . . . . 75.349999999999994 110.89 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.49 -60.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.936 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.4 45.77 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 73.439999999999998 112.42 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -93.59 -171.04 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 73.239999999999995 110.831 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.8 m -87.65 -167.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 73.329999999999998 110.893 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.29 -174.09 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 71.230000000000004 110.842 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.3 -76.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 74.230000000000004 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.11 162.71 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.030000000000001 110.877 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 48.5 mt -149.83 129.9 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 73.019999999999996 111.077 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -143.94 117.94 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.641 0.734 . . . . 71.439999999999998 111.14 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 130.63 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.73 2.287 . . . . 62.43 112.349 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.68 21.7 79.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 53.340000000000003 112.48 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -137.62 -69.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 74.450000000000003 110.857 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -170.52 -170.53 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 75.510000000000005 110.904 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.51 107.72 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.847 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.41 179.74 4.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 110.901 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.64 175.78 44.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 63.32 112.513 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.37 58.66 8.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.409999999999997 112.463 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -67.9 84.53 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 73.120000000000005 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.8 -176.13 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.340000000000003 110.879 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m 64.19 44.88 4.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 74.200000000000003 111.118 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.28 -175.65 3.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 75.030000000000001 110.867 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.484 ' O ' ' C ' ' A' ' 71' ' ' ASN . 6.9 p80 -50.92 -29.68 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.439999999999998 110.827 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 70' ' ' HIS . 13.3 t30 -30.47 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 72.219999999999999 110.904 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.16 -83.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 71.219999999999999 112.474 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.3 m -120.47 124.4 45.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 61.140000000000001 111.136 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.2 -48.37 0.48 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.749 . . . . 75.349999999999994 112.47 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.55 -87.21 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.736 . . . . 73.400000000000006 112.521 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.84 -75.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 62.340000000000003 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.419 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 4.0 t -127.14 107.97 10.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.875 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.2 pt -56.5 -19.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.129999999999995 111.135 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.64 28.94 7.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 72.099999999999994 110.919 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.16 -137.65 5.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 44.119999999999997 112.47 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' C ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -109.95 -34.78 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.909 0.385 . . . . 74.420000000000002 110.899 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -178.91 146.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.549999999999997 110.897 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 160.39 16.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 72.430000000000007 110.903 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.7 166.58 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.329999999999998 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -59.17 -174.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 72.519999999999996 110.938 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.85 -63.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 74.239999999999995 110.884 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -177.74 161.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.219999999999999 110.882 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 68.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.010000000000005 110.866 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.7 mt -78.16 -1.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 111.168 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mt -119.24 111.67 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 63.43 110.904 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.65 175.08 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 110.922 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -96.85 83.76 3.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 73.109999999999999 110.822 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 21.67 13.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 111.162 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.79 145.76 12.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 71.230000000000004 112.495 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.402 ' HA ' ' HB3' ' A' ' 115' ' ' CYS . 53.2 Cg_endo -69.82 -9.64 26.58 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 74.239999999999995 112.315 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -100.98 -20.02 15.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 73.430000000000007 112.507 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.56 141.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 75.140000000000001 111.145 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 130' ' ' GLY . 17.3 mt -116.17 162.94 16.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 110.891 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 t -151.48 -142.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 72.140000000000001 110.891 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -152.12 133.73 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 110.89 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.16 103.44 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 74.209999999999994 111.071 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.424 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 1.9 p30 -131.97 -179.53 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 70.129999999999995 110.863 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.562 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -64.17 -34.5 78.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 63.210000000000001 111.128 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.403 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 119.76 -62.86 0.47 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 72.239999999999995 112.471 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.562 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.9 Cg_endo -69.75 94.61 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 2.269 . . . . 72.319999999999993 112.332 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 43.17 56.64 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.049999999999997 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 109' ' ' GLY . 4.2 m -121.26 -1.68 9.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 73.450000000000003 111.117 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 47.18 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 62.439999999999998 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 115.68 126.73 4.08 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 73.120000000000005 112.486 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.15 -31.0 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.319999999999993 110.86 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.76 145.01 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 73.349999999999994 110.925 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -131.62 179.64 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 75.310000000000002 110.936 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -150.5 130.7 13.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 110.908 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 45.2 mt -48.1 -87.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 75.409999999999997 111.126 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.489 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.5 OUTLIER 160.96 -61.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 72.420000000000002 110.875 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 67.85 -1.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 71.340000000000003 111.16 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . 174.95 151.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 73.409999999999997 111.111 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -55.5 132.5 48.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 74.530000000000001 110.875 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 69.5 p -129.95 52.62 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.164 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 72.349999999999994 110.86 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.25 -36.57 81.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 110.939 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.55 74.5 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 71.120000000000005 110.927 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -157.65 55.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 63.140000000000001 110.855 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.56 -44.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 71.120000000000005 112.494 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -64.74 -42.98 94.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.81 0.338 . . . . 62.350000000000001 110.868 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -112.83 166.07 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 73.140000000000001 110.813 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.445 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -68.57 -149.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 65.310000000000002 111.128 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.445 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 9.2 p -171.84 157.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 111.116 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' ' O ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER 179.4 167.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.903 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 57.03 142.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 61.509999999999998 112.462 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.415 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -154.4 133.09 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 75.310000000000002 110.885 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -44.94 114.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 73.239999999999995 111.116 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -88.43 -75.23 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 72.150000000000006 110.914 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -138.14 142.63 40.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 72.010000000000005 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.47 8.8 26.32 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 74.040000000000006 112.476 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.4 ttt -48.35 -32.33 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 64.200000000000003 110.882 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -49.31 -28.52 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 73.430000000000007 110.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.1 mm -78.21 -40.55 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 75.310000000000002 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.3 t -51.0 -47.15 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 72.400000000000006 111.142 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.96 -36.24 65.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.240000000000002 110.929 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.24 80.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 72.140000000000001 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.9 mtm -70.88 -19.13 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -89.41 21.79 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 75.519999999999996 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 -20.49 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 74.430000000000007 110.875 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -102.4 -6.02 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.540000000000006 110.937 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.11 3.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 73.239999999999995 112.513 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.17 135.28 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 73.349999999999994 110.849 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.5 mmm-85 -70.94 79.69 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 74.109999999999999 110.864 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 175.77 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 71.349999999999994 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.26 -61.91 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 64.099999999999994 112.474 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -74.51 -178.07 3.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 75.319999999999993 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.7 22.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.155 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -21.64 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 73.420000000000002 110.819 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -131.76 -164.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 72.209999999999994 110.876 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 119.7 19.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 75.209999999999994 110.934 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.7 mt -92.71 101.44 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 74.450000000000003 111.121 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.8 162.75 13.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.450000000000003 111.169 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.43 142.92 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.530000000000001 111.102 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -102.23 -55.35 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 70.430000000000007 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -142.93 179.43 7.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -170.97 -167.01 0.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 70.129999999999995 110.906 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 137.16 -148.16 19.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 65.099999999999994 112.475 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -112.08 136.91 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.129999999999995 110.869 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 tp -54.12 -57.0 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 72.409999999999997 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 62.43 110.935 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.355 . . . . 71.030000000000001 110.883 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 75.0 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.37 158.95 31.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.656 0.741 . . . . 52.530000000000001 110.865 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.77 65.08 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.684 2.256 . . . . 72.25 112.348 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -131.44 57.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.109999999999999 111.148 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 m -49.05 147.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.400000000000006 111.151 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -138.25 164.99 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 75.140000000000001 110.878 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -144.84 138.35 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.510000000000005 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -101.79 91.27 4.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 110.883 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.4 mm -59.76 143.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 111.151 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.63 163.39 22.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 74.219999999999999 111.136 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.4 t -151.8 104.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 75.150000000000006 111.14 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 52.39 46.32 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.430000000000007 110.841 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.6 10.97 83.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 34.350000000000001 112.469 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -133.66 109.1 12.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.738 . . . . 72.219999999999999 110.903 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.3 Cg_endo -69.75 168.92 20.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 72.209999999999994 112.374 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.06 -58.45 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.150000000000006 110.927 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.24 -167.64 27.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 73.019999999999996 112.49 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -100.24 127.75 46.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 72.099999999999994 110.909 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 HG21 HG13 ' A' ' 138' ' ' ILE . 7.7 t -101.65 120.16 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.219999999999999 111.124 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -94.93 84.28 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.54 95.51 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 74.299999999999997 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -78.41 153.64 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.5 110.866 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.3 mt -115.06 133.21 56.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 71.209999999999994 110.888 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -81.54 78.64 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.879 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.9 -7.0 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 73.549999999999997 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -61.31 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 63.420000000000002 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.63 -60.01 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 75.140000000000001 110.869 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.57 83.2 4.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.632 0.729 . . . . 75.450000000000003 111.105 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 72.299999999999997 112.342 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 179.38 -59.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 70.140000000000001 110.908 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 51.1 m -56.31 -48.57 76.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 65.329999999999998 111.157 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.02 87.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 71.109999999999999 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.85 -30.11 9.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.85 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.62 -61.27 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 72.25 110.907 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.9 -33.65 57.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 74.540000000000006 110.837 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -62.28 -27.97 69.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.409999999999997 110.894 -179.941 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.4 ' N ' ' HG3' ' A' ' 37' ' ' ARG . . . -93.0 -38.39 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 72.510000000000005 111.118 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 tt -78.12 -2.6 38.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.924 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t -98.93 -8.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 74.140000000000001 110.848 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.6 p -115.96 8.02 14.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.340000000000003 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.3 37.0 30.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.734 . . . . 62.240000000000002 112.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -110.02 30.96 6.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 74.409999999999997 110.92 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.27 32.13 4.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.89 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.3 -45.1 2.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 62.409999999999997 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -138.91 167.04 22.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 72.310000000000002 110.892 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.67 -108.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.758 . . . . 74.420000000000002 112.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -177.25 124.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.389 . . . . 75.099999999999994 110.965 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -26.44 13.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.889 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.68 -67.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.741 . . . . 54.409999999999997 112.494 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t 45.42 -160.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 72.5 110.844 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -166.4 162.55 17.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 71.409999999999997 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -101.78 -78.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.540000000000006 110.868 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.74 25.82 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.510000000000005 110.872 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.94 21.42 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.66 138.87 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 73.140000000000001 111.106 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 11.7 mt -121.24 102.72 42.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.708 . . . . 74.349999999999994 111.127 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 77.89 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.702 2.268 . . . . 72.409999999999997 112.31 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.12 -40.82 0.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 63.140000000000001 112.494 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -64.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 72.310000000000002 110.917 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -161.96 -167.48 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.209999999999994 110.88 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 t -143.45 129.56 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 74.129999999999995 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -152.92 164.28 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 74.099999999999994 110.895 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.21 39.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 74.420000000000002 112.54 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.19 8.73 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 52.009999999999998 112.516 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.57 156.5 29.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 65.150000000000006 110.854 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -50.67 168.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.456 . . . . 74.239999999999995 110.862 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 t -101.07 30.85 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 64.530000000000001 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.19 -164.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.72 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 72.400000000000006 110.864 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.33 -55.05 15.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.140000000000001 110.863 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -161.62 160.23 32.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.678 -0.773 . . . . 73.239999999999995 112.411 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.4 p 66.22 32.83 7.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 74.329999999999998 111.145 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.01 76.07 1.05 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.728 -0.749 . . . . 72.430000000000007 112.469 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.95 53.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 72.099999999999994 112.496 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.12 -179.78 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.340000000000003 110.901 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.07 -177.4 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.349999999999994 110.855 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 25.2 pt -93.36 -38.09 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 74.5 111.144 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -80.22 -13.26 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 75.200000000000003 110.927 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.84 -172.32 45.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 74.209999999999994 112.529 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.73 -96.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.898 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.422 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -121.44 176.71 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 74.040000000000006 110.89 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -149.42 153.94 38.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 110.915 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 164.03 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.871 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.04 145.75 25.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 75.329999999999998 110.838 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -52.32 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 74.340000000000003 110.874 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -179.0 163.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 53.340000000000003 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.03 36.99 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 110.877 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.6 mm -53.19 -26.63 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 74.420000000000002 111.172 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.36 112.59 21.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 75.129999999999995 110.872 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -103.04 93.83 5.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 110.926 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -64.8 108.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 73.219999999999999 110.867 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.3 p -128.09 33.81 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.109999999999999 111.159 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.58 174.63 44.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 53.5 112.487 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 160.2 50.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 74.129999999999995 112.333 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 14.54 76.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 71.099999999999994 112.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 44.7 mm -99.98 137.5 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 74.239999999999995 111.154 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.1 tt -100.12 138.31 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.340000000000003 110.889 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -121.56 131.89 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.230000000000004 110.866 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.42 ' HG2' ' CE1' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -71.34 -27.17 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.430000000000007 110.902 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.67 167.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 63.350000000000001 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 169.42 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 63.409999999999997 110.867 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -106.25 -20.14 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.116 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.476 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 130.41 -58.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 62.210000000000001 112.492 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.75 83.52 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 73.439999999999998 112.366 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 27.06 82.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.200000000000003 110.926 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.422 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 1.8 t -156.87 54.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.540000000000006 111.158 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -54.33 -40.87 68.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 75.409999999999997 110.914 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.76 -152.0 39.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 72.019999999999996 112.459 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.9 m -134.21 65.14 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 54.450000000000003 110.866 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -155.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.540000000000006 110.947 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -177.4 75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.91 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 1.5 t80 -90.33 129.01 36.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 73.530000000000001 110.882 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 61.7 mt -107.55 130.59 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.400000000000006 111.166 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.5 t -99.98 136.71 39.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 74.540000000000006 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -120.39 -20.46 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 111.115 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.86 179.01 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 75.120000000000005 111.113 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 87.98 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 73.200000000000003 110.888 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.411 ' HB ' ' CE2' ' A' ' 121' ' ' TRP . 8.4 p -122.5 62.61 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 73.430000000000007 111.155 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 23.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.239999999999995 110.869 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.411 ' CE2' ' HB ' ' A' ' 119' ' ' THR . 2.2 p90 -94.65 19.5 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.1 11.2 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 73.049999999999997 110.931 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.8 -63.44 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 71.430000000000007 110.837 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.31 57.7 3.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.659 -0.781 . . . . 65.200000000000003 112.521 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -156.81 -52.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 71.040000000000006 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -113.98 148.26 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 71.129999999999995 110.867 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.8 t -90.8 107.53 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.530000000000001 111.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 35.7 t -83.22 140.61 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 72.450000000000003 111.172 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.42 ' CE1' ' HG2' ' A' ' 100' ' ' MET . 9.3 p90 -159.93 33.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.140000000000001 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -126.16 -166.88 12.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 63.229999999999997 112.456 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER 167.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 75.230000000000004 110.935 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 44.9 t -112.73 93.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 64.430000000000007 111.157 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -52.0 -48.1 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.510000000000005 110.891 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.67 -175.85 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 73.0 110.922 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 53.17 71.48 0.68 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 64.109999999999999 112.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -89.53 3.38 52.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 74.209999999999994 110.913 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -79.15 -28.46 42.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 72.340000000000003 110.87 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 HG13 HG21 ' A' ' 20' ' ' VAL . 23.4 mm -68.58 -36.62 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 73.099999999999994 111.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 t -94.68 6.06 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 71.219999999999999 111.127 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -119.13 -62.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 72.329999999999998 110.865 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.09 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 64.400000000000006 111.082 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.35 -37.02 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.519999999999996 110.862 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -24.48 18.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 74.400000000000006 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.97 -11.23 36.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.879 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -86.06 22.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.230000000000004 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.93 -160.0 32.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 64.310000000000002 112.467 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.7 p -151.44 -71.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 75.120000000000005 110.853 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.72 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 73.25 110.861 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -105.74 15.1 27.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 110.938 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.82 -38.32 3.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 70.140000000000001 112.479 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -50.44 120.56 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 73.420000000000002 110.891 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 p -95.02 158.75 15.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -15.94 57.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 110.846 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.6 170.45 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 73.319999999999993 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -98.49 123.3 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 75.329999999999998 110.914 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.93 130.63 57.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.450000000000003 111.154 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 67.2 p -138.56 157.62 45.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 71.209999999999994 111.164 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.2 mp -90.78 93.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.319999999999993 111.119 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -50.77 -57.83 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 75.409999999999997 111.071 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.54 162.48 41.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 75.510000000000005 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.5 p -156.01 160.56 40.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 75.430000000000007 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.84 45.25 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 75.430000000000007 112.482 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.63 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.7 mt-30 -68.18 -36.56 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 75.219999999999999 110.911 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.63 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.8 mm? 73.86 -58.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 75.549999999999997 110.873 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 74.299999999999997 110.918 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 74.349999999999994 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -126.05 143.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 73.120000000000005 111.122 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -53.51 145.34 28.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 40.329999999999998 110.895 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 129.4 17.51 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 74.340000000000003 112.354 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 m -119.98 147.3 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 73.310000000000002 111.132 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.45 165.09 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 63.420000000000002 111.11 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.6 p90 -122.54 153.79 38.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.866 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -136.09 128.88 31.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.905 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -95.32 126.56 40.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.219999999999999 110.872 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.53 119.36 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.329999999999998 111.169 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.0 163.13 15.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 75.319999999999993 111.124 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -147.67 92.84 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.129 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.05 31.12 4.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.030000000000001 110.85 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.12 -12.99 65.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 74.040000000000006 112.512 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -97.9 126.86 39.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.652 0.739 . . . . 74.319999999999993 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.4 69.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 75.129999999999995 112.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -117.76 -67.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 74.319999999999993 110.916 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.8 -159.6 10.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 63.219999999999999 112.506 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -127.99 124.27 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 74.420000000000002 110.903 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.8 t -113.11 90.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 72.420000000000002 111.13 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -85.16 147.8 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 110.823 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.68 140.02 40.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 75.349999999999994 110.884 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -91.21 161.97 14.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.299999999999997 110.895 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.2 mt -114.9 119.57 37.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 73.439999999999998 110.907 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -74.85 61.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 75.530000000000001 110.902 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.98 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 74.409999999999997 111.137 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.91 -65.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.239999999999995 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -74.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 65.400000000000006 110.899 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.436 ' CG2' ' HB2' ' A' ' 129' ' ' PHE . 12.9 m -84.58 116.71 66.39 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 74.329999999999998 111.162 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.706 2.271 . . . . 72.450000000000003 112.331 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -66.28 -43.69 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 75.120000000000005 110.918 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -48.24 -27.96 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 111.152 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.17 -39.27 29.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 53.020000000000003 111.104 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.92 -156.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 61.140000000000001 110.878 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 t30 69.85 -68.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 61.530000000000001 110.903 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.01 -29.03 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 72.430000000000007 110.909 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -52.03 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 71.439999999999998 110.89 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.95 -28.09 43.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.200000000000003 111.082 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.08 19.47 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.319999999999993 110.929 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 31.8 t -144.8 -31.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 63.210000000000001 110.881 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -103.94 -32.97 9.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 74.530000000000001 111.097 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 120.08 2.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 61.240000000000002 112.513 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 177.41 -47.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 71.530000000000001 110.884 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.85 -11.37 57.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 72.099999999999994 110.907 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.77 7.52 35.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 74.530000000000001 112.515 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' C ' ' A' ' 47' ' ' GLY . 2.6 m-85 -93.02 -24.77 18.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 73.540000000000006 110.871 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -29.05 130.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 51.210000000000001 112.467 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -95.2 34.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.933 0.397 . . . . 73.519999999999996 110.915 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.98 147.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 74.310000000000002 110.873 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.05 62.15 4.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 72.349999999999994 112.476 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -125.82 -168.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 72.340000000000003 110.906 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 m -120.85 -169.69 1.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.299999999999997 110.896 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.06 127.75 55.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.839 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -63.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 73.120000000000005 110.813 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -157.58 -179.51 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.450000000000003 110.841 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.406 ' CG2' ' HA3' ' A' ' 146' ' ' GLY . 65.8 mt -150.55 136.22 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 73.349999999999994 111.142 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -140.27 105.41 6.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.573 0.701 . . . . 75.019999999999996 111.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 159.4 53.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 71.010000000000005 112.31 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.93 -34.53 3.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 64.340000000000003 112.508 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -111.18 -82.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 73.530000000000001 110.86 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.53 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 175.13 119.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.310000000000002 110.861 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.41 177.29 8.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 72.450000000000003 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.04 174.55 10.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 73.140000000000001 110.919 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.18 150.3 18.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 75.25 112.508 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.32 114.79 4.67 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 72.409999999999997 112.5 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.64 -167.06 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.875 0.369 . . . . 75.540000000000006 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -96.68 -173.58 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.219999999999999 110.881 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.76 -71.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 111.138 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -98.5 132.9 43.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.349999999999994 110.86 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -35.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.75 -33.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 74.420000000000002 110.881 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.55 76.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 74.230000000000004 112.47 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m 71.91 43.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 73.0 111.145 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 124.8 162.56 11.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 71.340000000000003 112.454 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.54 138.46 15.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 72.310000000000002 112.484 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -169.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.792 0.329 . . . . 74.409999999999997 110.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.514 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.3 OUTLIER -83.68 5.76 23.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.329999999999998 110.858 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.514 ' HB ' ' O ' ' A' ' 77' ' ' SER . 2.5 mt 83.0 -43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 71.420000000000002 111.106 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -72.65 70.24 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.939 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.43 -72.25 2.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 41.109999999999999 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.0 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 65.019999999999996 110.835 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -117.75 162.94 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 75.510000000000005 110.896 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -141.22 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.150000000000006 110.865 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.79 164.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.439999999999998 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -77.85 113.04 15.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 75.340000000000003 110.858 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -56.28 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.209999999999994 110.848 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.08 149.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 72.230000000000004 110.894 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -111.84 58.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.854 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.97 -10.96 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.420000000000002 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.11 137.33 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 74.219999999999999 110.92 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -128.34 -172.89 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 71.299999999999997 110.892 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.422 ' C ' ' H ' ' A' ' 94' ' ' GLY . 61.7 m-70 -95.18 -89.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 73.349999999999994 110.881 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m 76.54 -15.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 73.409999999999997 111.178 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 92' ' ' HIS . . . -168.34 163.22 36.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 74.540000000000006 112.485 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HD3' ' HB2' ' A' ' 118' ' ' LYS . 53.8 Cg_endo -69.79 143.19 49.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.619 2.213 . . . . 75.329999999999998 112.392 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.16 -41.28 2.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.737 -0.744 . . . . 74.340000000000003 112.457 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.6 mm -50.42 150.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 75.439999999999998 111.152 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.3 OUTLIER -123.18 161.11 25.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 110.886 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.2 m -158.8 -129.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 74.129999999999995 110.894 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.0 mtp -142.83 -159.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 73.209999999999994 110.92 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 173.38 81.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.319999999999993 111.084 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB3' ' OG1' ' A' ' 107' ' ' THR . 2.0 t30 -104.13 -158.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 73.319999999999993 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.24 42.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 52.299999999999997 111.085 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.73 168.82 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 71.200000000000003 112.468 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.72 166.67 26.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 72.109999999999999 112.335 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 56.35 34.13 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 54.039999999999999 110.871 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 102' ' ' ASN . 16.3 p -137.67 26.66 2.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 75.319999999999993 111.144 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.1 t30 50.62 -97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 74.349999999999994 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.74 -85.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.727 . . . . 62.420000000000002 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 t 71.0 36.76 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 74.219999999999999 110.872 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -92.22 -34.95 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 74.319999999999993 110.894 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 60.0 t80 68.57 75.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 63.399999999999999 110.908 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.401 ' CE1' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -108.49 129.67 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.219999999999999 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.47 121.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 73.409999999999997 111.169 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.5 p -73.91 136.92 43.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 63.439999999999998 110.902 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.1 t -109.89 -16.58 13.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 72.510000000000005 111.134 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.65 24.57 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 71.209999999999994 111.116 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 1.2 tmtt? 58.17 103.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.2 p -121.38 71.63 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 73.230000000000004 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.45 20.34 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.409999999999997 110.835 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -9.01 58.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 110.929 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.51 -47.87 8.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 72.329999999999998 110.918 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -56.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.019999999999996 110.851 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.58 47.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.693 -0.765 . . . . 74.430000000000007 112.507 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -96.73 -31.02 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 73.329999999999998 110.932 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -132.36 124.87 29.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 74.129999999999995 110.825 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.8 t -49.37 111.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 111.103 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.9 t -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.310000000000002 111.156 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.436 ' HB2' ' CG2' ' A' ' 29' ' ' VAL . 19.6 p90 -165.66 34.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.310000000000002 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.488 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -122.41 -173.22 14.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.717 . . . . 75.230000000000004 112.508 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 174.57 144.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 71.329999999999998 110.928 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.12 90.22 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.150000000000006 111.154 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.92 -59.96 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.519999999999996 110.856 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.55 142.0 10.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 61.439999999999998 110.863 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.48 2.99 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 75.230000000000004 112.484 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.18 -32.19 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 74.310000000000002 110.827 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -50.4 -27.95 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 72.019999999999996 110.925 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 24.5 mm -80.09 -40.81 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 74.310000000000002 111.141 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -48.83 -52.82 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 72.219999999999999 111.162 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.78 -30.59 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.200000000000003 110.868 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.98 -42.69 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 71.209999999999994 111.121 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 19.1 mtm -62.81 -30.12 71.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.859 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -58.13 -55.07 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.310000000000002 110.874 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -22.5 66.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 75.099999999999994 110.84 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.94 -6.28 59.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 75.519999999999996 110.869 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.406 ' HA3' ' CG2' ' A' ' 56' ' ' ILE . . . -89.94 -157.35 33.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 54.450000000000003 112.537 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 p -164.49 142.59 6.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 74.209999999999994 110.86 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -74.63 73.31 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.420000000000002 110.922 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 175.93 -33.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.450000000000003 110.919 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.17 -67.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 73.420000000000002 112.491 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.45 159.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 75.299999999999997 110.92 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -131.19 156.67 44.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 111.174 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.8 t -77.41 -18.05 57.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 75.230000000000004 110.879 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -134.22 -165.67 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 75.150000000000006 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -138.63 136.08 35.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.25 110.915 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mt -106.02 119.04 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.329999999999998 111.128 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 26.5 p -106.01 163.69 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.439999999999998 111.152 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.3 mt -106.48 134.83 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 111.113 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.63 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 72.340000000000003 111.084 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.76 171.95 16.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 74.329999999999998 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.0 m -151.86 122.8 7.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 73.200000000000003 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -150.36 178.13 28.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 62.219999999999999 112.471 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 123.07 24.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 75.239999999999995 110.935 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.04 -58.88 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 73.049999999999997 110.887 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 55.5 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 75.230000000000004 110.846 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 75.439999999999998 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 75.030000000000001 111.071 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.91 157.27 39.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.729 . . . . 60.340000000000003 110.892 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.98 52.42 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 74.519999999999996 112.33 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 96.9 m -138.44 93.87 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 70.310000000000002 111.145 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 2.4 m -77.03 143.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 111.108 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -132.26 162.51 30.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 110.888 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.84 152.84 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 74.400000000000006 110.911 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -109.35 114.75 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 75.450000000000003 110.855 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 tt -86.01 147.83 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 75.140000000000001 111.125 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -141.14 164.26 30.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.510000000000005 111.131 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.33 105.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 73.209999999999994 111.137 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 66.88 50.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 72.420000000000002 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.19 20.6 67.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 60.399999999999999 112.496 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -134.4 107.29 11.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 75.209999999999994 110.886 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.81 141.76 45.91 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 73.239999999999995 112.306 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.63 24.9 7.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 75.219999999999999 110.898 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.53 -167.26 14.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.738 . . . . 52.310000000000002 112.474 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -178.72 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 75.010000000000005 110.832 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.9 m -137.32 161.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.209999999999994 111.093 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 30.6 t -114.44 91.79 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 73.140000000000001 110.832 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -83.52 102.49 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 73.340000000000003 110.873 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.27 111.06 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 73.140000000000001 110.892 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 27.4 mt -85.51 140.66 30.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 62.310000000000002 110.935 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.65 81.3 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.340000000000003 110.842 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.71 -3.69 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.040000000000006 111.122 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -87.47 -38.33 16.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.519999999999996 110.832 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.96 -23.76 17.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 72.420000000000002 110.921 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.59 73.06 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 75.519999999999996 111.11 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -6.81 19.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.272 . . . . 72.420000000000002 112.374 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 -51.84 5.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 110.902 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -53.77 7.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 61.509999999999998 111.066 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -31.41 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.239999999999995 111.079 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.44 -56.47 8.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 70.430000000000007 110.835 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HA ' HG12 ' A' ' 78' ' ' ILE . 1.8 t30 -47.86 -39.61 19.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 75.040000000000006 110.865 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -77.83 -32.77 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 72.109999999999999 110.888 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -35.98 81.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 75.099999999999994 110.858 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.31 67.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 51.409999999999997 111.124 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 46.1 mt -70.3 -32.56 70.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 110.906 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -60.14 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.340000000000003 110.884 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.1 p -72.91 -17.01 61.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 111.089 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.19 44.53 93.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.722 -0.751 . . . . 71.150000000000006 112.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -28.85 69.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 74.450000000000003 110.886 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -70.72 -125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 71.0 110.882 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.06 18.18 3.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 62.109999999999999 112.45 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -165.57 -174.55 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 74.409999999999997 110.848 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.21 124.61 2.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 73.230000000000004 112.488 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.9 155.61 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.993 0.425 . . . . 74.510000000000005 110.907 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -157.01 -38.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 71.409999999999997 110.898 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.25 27.7 12.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 54.43 112.488 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 170.56 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 64.400000000000006 110.894 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -140.53 153.1 46.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 70.25 110.861 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.92 134.32 53.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 75.120000000000005 110.885 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -141.37 34.22 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.109999999999999 110.869 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -138.31 33.17 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 75.349999999999994 110.921 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 27.7 mt -82.71 140.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 75.439999999999998 111.096 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.38 113.62 23.37 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.596 0.712 . . . . 75.200000000000003 111.107 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 81.38 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 73.439999999999998 112.356 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.81 0.24 4.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.748 -0.739 . . . . 75.140000000000001 112.498 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.337 . . . . 75.329999999999998 110.852 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.25 -160.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 70.329999999999998 110.889 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 82.4 m -136.96 -41.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 64.340000000000003 110.921 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 65.28 150.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.140000000000001 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.22 88.63 0.45 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 73.420000000000002 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.13 87.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 64.439999999999998 112.507 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -169.93 80.55 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 71.099999999999994 110.883 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -50.56 -71.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 75.450000000000003 110.915 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 115.44 10.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 74.420000000000002 111.166 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -99.73 51.89 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.519999999999996 110.881 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -70.62 78.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 74.25 110.88 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 70.91 -72.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.519999999999996 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.7 86.6 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.716 -0.754 . . . . 73.230000000000004 112.455 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 p -114.48 119.93 38.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 75.430000000000007 111.172 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.53 -131.48 4.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 64.239999999999995 112.467 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.02 -177.15 16.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.702 -0.761 . . . . 75.219999999999999 112.486 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -62.72 166.29 5.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 74.010000000000005 110.876 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.28 157.2 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 72.409999999999997 110.91 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -67.52 -11.84 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 70.099999999999994 111.14 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.27 13.8 20.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 75.519999999999996 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.47 -162.85 23.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 74.230000000000004 112.485 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.1 -42.55 60.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 74.340000000000003 110.939 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -177.24 173.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 70.219999999999999 110.846 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.53 168.29 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 73.530000000000001 110.866 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.69 162.6 16.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.895 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.01 149.42 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 72.329999999999998 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.7 -63.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 73.150000000000006 110.857 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -176.39 173.7 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 73.450000000000003 110.844 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 45.65 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 74.340000000000003 110.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.73 -25.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.9 mt -91.94 119.28 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.937 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.9 mtpp -100.86 112.42 24.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 71.510000000000005 110.852 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.94 99.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 61.299999999999997 110.841 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.2 p -127.45 36.25 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 72.329999999999998 111.159 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.11 39.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 61.039999999999999 112.533 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.62 23.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 72.439999999999998 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.01 22.58 72.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 72.230000000000004 112.481 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.4 mm -95.39 117.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 74.439999999999998 111.15 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.7 tt -83.78 121.47 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 110.891 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.0 t -119.58 142.63 48.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.329999999999998 110.889 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.6 mmt -81.74 102.75 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 63.530000000000001 110.882 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -84.91 146.38 27.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.310000000000002 111.109 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER 165.97 -166.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 65.140000000000001 110.854 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -47.22 -52.96 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 75.150000000000006 111.093 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.05 -87.75 0.27 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.727 -0.749 . . . . 74.420000000000002 112.455 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 125.19 11.86 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 63.43 112.351 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 45.6 36.12 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 75.0 110.85 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 1.2 p -146.77 56.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 75.439999999999998 111.158 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -50.99 -52.91 38.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.519999999999996 110.827 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.38 -168.58 54.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 75.140000000000001 112.488 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 t -119.85 -5.7 10.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 64.0 110.835 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -64.76 156.62 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.876 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.4 162.37 40.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 75.219999999999999 110.874 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -160.57 140.5 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 110.869 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.7 mt -91.88 125.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 75.540000000000006 111.122 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.4 m -74.49 -32.4 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 110.919 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 m 55.86 14.69 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.519999999999996 111.138 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.53 167.99 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 63.240000000000002 111.108 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -63.35 133.44 54.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 73.420000000000002 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 5.6 p -145.34 43.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 111.164 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -66.11 -10.21 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 73.019999999999996 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.8 p90 -75.9 -9.6 58.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 110.923 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.17 -17.98 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 72.219999999999999 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 124' ' ' GLY . 11.0 m-20 51.64 70.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.519999999999996 110.818 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.17 43.76 0.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 64.5 112.481 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -73.8 133.32 43.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.349 . . . . 74.400000000000006 110.955 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 64.53 28.95 13.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.319999999999993 110.851 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 60.85 -163.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.150000000000006 111.147 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 13.1 p -179.13 145.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.420000000000002 111.145 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.447 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 2.0 p90 -176.68 125.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 74.540000000000006 110.91 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.86 145.92 14.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 74.540000000000006 112.554 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -165.74 151.72 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 74.120000000000005 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.3 p -55.76 168.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 111.095 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.2 tptp -147.81 -39.89 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 73.239999999999995 110.902 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -132.26 155.37 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 110.879 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.24 78.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 63.140000000000001 112.49 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -2.22 47.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 72.530000000000001 110.901 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.26 -29.96 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.019999999999996 110.912 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.99 -43.79 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.105 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 9.3 t -88.2 6.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 111.156 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.06 -69.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 75.129999999999995 110.87 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.53 67.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 64.310000000000002 111.123 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 15.6 tmm? -49.67 -35.44 21.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 71.329999999999998 110.88 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.49 54.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.299999999999997 110.836 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -141.31 0.32 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 75.340000000000003 110.859 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.69 15.96 26.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 73.5 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.12 -155.72 31.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 73.340000000000003 112.458 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.24 -169.23 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 73.540000000000006 110.881 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -77.77 -32.58 52.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 74.049999999999997 110.863 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -106.09 1.33 26.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 72.230000000000004 110.912 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.03 -146.25 16.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 61.329999999999998 112.455 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 64.78 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 65.200000000000003 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 59.3 p -82.56 146.01 29.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 64.319999999999993 111.154 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -21.99 62.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.439999999999998 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -135.19 -179.17 5.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.099999999999994 110.896 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -97.86 101.44 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 75.430000000000007 110.871 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mp -96.44 122.02 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.219999999999999 111.104 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.18 159.49 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.530000000000001 111.174 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.0 mt -87.88 116.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 75.310000000000002 111.143 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.28 -52.19 20.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.109999999999999 111.09 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -143.38 -179.59 6.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 65.219999999999999 110.866 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 5.1 p -171.23 -172.85 1.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 71.010000000000005 110.858 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.29 -149.21 20.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 73.040000000000006 112.455 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -127.55 141.95 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 72.530000000000001 110.926 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -128.82 166.6 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 73.439999999999998 110.856 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 74.400000000000006 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 74.439999999999998 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.17 156.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.329999999999998 111.101 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -93.63 157.21 38.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 75.349999999999994 110.908 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 151.83 69.13 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.678 2.252 . . . . 64.420000000000002 112.364 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -138.98 151.32 46.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 74.430000000000007 111.101 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -141.8 151.97 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 73.549999999999997 111.136 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.1 156.77 41.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 75.219999999999999 110.888 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -137.92 137.29 37.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 110.9 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -92.47 114.09 26.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.049999999999997 110.886 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.3 mm -82.49 114.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 72.200000000000003 111.132 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.76 148.77 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 74.049999999999997 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.03 98.6 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 72.409999999999997 111.178 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.95 24.27 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.099999999999994 110.873 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.02 -21.62 45.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 73.019999999999996 112.471 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.36 150.2 36.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.637 0.732 . . . . 74.439999999999998 110.869 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.5 68.28 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 70.120000000000005 112.355 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 tp -125.53 -39.65 2.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 74.340000000000003 110.876 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.73 -176.5 41.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 70.409999999999997 112.455 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.15 167.1 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 75.019999999999996 110.869 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -130.15 -179.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 62.409999999999997 111.106 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -131.59 95.66 3.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.831 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -91.78 138.15 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 75.019999999999996 110.854 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -116.45 156.06 27.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 74.340000000000003 110.884 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.08 118.07 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 72.140000000000001 110.896 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -78.59 77.93 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.209999999999994 110.869 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.1 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 72.349999999999994 111.083 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.02 -46.84 41.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.140000000000001 110.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -87.72 -18.49 29.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 110.885 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -155.44 84.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.633 0.73 . . . . 74.140000000000001 111.143 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -27.65 26.29 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 73.209999999999994 112.341 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -76.47 -57.36 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 71.25 110.89 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.7 m -51.7 -43.55 62.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 111.195 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.45 78.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.450000000000003 111.139 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.96 -25.01 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 70.129999999999995 110.848 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -66.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.310000000000002 110.935 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -52.59 -39.7 61.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 110.918 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 74.239999999999995 110.877 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.48 -33.8 15.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 74.129999999999995 111.138 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -92.13 26.12 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.109999999999999 110.959 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 34.3 t -121.2 -5.69 9.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 63.039999999999999 110.872 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.8 p -118.47 15.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.129999999999995 111.183 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.98 24.81 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 60.420000000000002 112.488 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -83.78 -21.89 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 72.340000000000003 110.884 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 17.64 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.219999999999999 110.96 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.33 -52.5 4.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 64.109999999999999 112.493 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.03 155.92 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 74.239999999999995 110.898 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 -136.69 3.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 73.329999999999998 112.507 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -22.55 17.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.393 . . . . 75.019999999999996 110.865 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.63 112.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 75.150000000000006 110.879 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.77 55.55 20.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 54.219999999999999 112.479 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 m -113.85 3.85 15.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 54.130000000000003 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m 50.61 -168.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 65.439999999999998 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -111.41 154.37 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 64.140000000000001 110.887 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -93.34 -64.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 75.109999999999999 110.841 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.5 148.12 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 74.299999999999997 110.922 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 55.2 mt -142.49 117.81 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 75.010000000000005 111.142 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 59.5 mt -128.42 99.9 23.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 75.019999999999996 111.148 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 93.71 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.215 . . . . 73.319999999999993 112.384 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.43 -26.18 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 52.5 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.55 -56.54 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 73.310000000000002 110.843 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.49 ' HG2' ' N ' ' A' ' 62' ' ' CYS . 0.0 OUTLIER -174.49 -165.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 74.409999999999997 110.85 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.49 ' N ' ' HG2' ' A' ' 61' ' ' MET . 0.7 OUTLIER -146.32 144.9 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 73.219999999999999 110.834 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -94.52 -168.71 1.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.897 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.84 -73.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 74.25 112.518 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.22 -144.42 11.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.769 . . . . 53.140000000000001 112.466 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -147.35 -169.51 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.361 . . . . 61.229999999999997 110.852 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -174.77 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.540000000000006 110.901 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.6 t -54.07 132.44 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 74.329999999999998 111.162 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 57.88 178.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.129999999999995 110.901 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -69.11 -32.74 72.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 73.129999999999995 110.848 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -82.46 -77.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.430000000000007 110.913 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 138.58 -104.72 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 65.329999999999998 112.434 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p 60.33 34.14 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 70.310000000000002 111.109 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 128.71 -175.94 18.49 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 62.450000000000003 112.493 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.78 136.76 10.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 74.230000000000004 112.489 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -162.84 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 74.129999999999995 110.879 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -105.03 126.39 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 64.430000000000007 110.888 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -63.88 -13.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 73.129999999999995 111.116 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.48 -16.38 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.941 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.31 -107.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 54.149999999999999 112.504 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -109.45 -55.76 2.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 71.540000000000006 110.913 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -166.74 151.09 7.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 74.230000000000004 110.904 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.09 144.13 51.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.219999999999999 110.9 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -52.98 153.52 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.876 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.04 136.38 33.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 73.420000000000002 110.865 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.14 -55.32 6.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.854 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -176.83 -173.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.861 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -132.34 38.49 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 74.200000000000003 110.885 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 4.3 mt -51.34 -25.16 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.125 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -84.61 110.58 18.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 64.5 110.897 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -98.68 -166.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.439999999999998 110.93 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -102.09 -98.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.340000000000003 110.865 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 65.6 7.1 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 73.310000000000002 111.141 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.51 163.36 30.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 75.519999999999996 112.499 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.72 10.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 73.549999999999997 112.341 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.43 31.51 54.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 73.329999999999998 112.467 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.5 mm -94.51 131.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 73.030000000000001 111.162 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.61 136.98 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.868 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.502 ' HB3' ' HB2' ' A' ' 113' ' ' PHE . 5.7 t -105.95 -133.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 74.349999999999994 110.824 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.82 -34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.219999999999999 110.896 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 66.84 97.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 74.310000000000002 111.141 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.86 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 72.129999999999995 110.919 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.445 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -82.68 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 111.077 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 126.2 -63.42 0.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 71.019999999999996 112.462 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.445 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.72 -92.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.319999999999993 112.362 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -138.84 92.14 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.473 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.4 p -143.39 21.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.159 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 44.86 -91.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 72.450000000000003 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.95 -69.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 71.200000000000003 112.488 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 t 67.52 36.12 3.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 72.530000000000001 110.87 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -103.27 -97.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 73.120000000000005 110.943 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 0.0 OUTLIER 170.3 173.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 64.340000000000003 110.911 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.502 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER 178.21 57.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.519999999999996 110.897 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 66.7 mt -65.47 85.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.200000000000003 111.162 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.6 m -70.96 145.68 49.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.883 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 34.7 p -99.51 20.13 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.510000000000005 111.09 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -174.56 -167.84 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 73.209999999999994 111.101 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -78.46 134.01 37.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.842 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -134.27 49.74 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -63.21 -11.83 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 73.299999999999997 110.899 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -60.67 -26.28 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.883 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 mt -75.8 -29.92 58.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 65.049999999999997 110.924 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 124' ' ' GLY . 21.5 t0 49.83 81.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 71.019999999999996 110.859 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 17.31 62.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.689 -0.767 . . . . 45.219999999999999 112.505 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ASP . 22.1 tptp -103.57 -25.35 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 73.319999999999993 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.404 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 64.6 m-70 -96.83 -6.96 34.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 75.109999999999999 110.834 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 7.9 t 76.66 80.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.59 138.67 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 111.149 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -154.57 26.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.299999999999997 110.897 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.9 -179.01 15.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 52.229999999999997 112.506 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 140.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 70.439999999999998 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 85.4 t -86.96 80.4 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 71.340000000000003 111.148 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -43.53 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 73.430000000000007 110.858 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.43 168.24 15.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.510000000000005 110.888 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.97 -0.09 44.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 72.129999999999995 112.46 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -33.44 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 74.019999999999996 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -51.13 -29.19 12.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.140000000000001 110.901 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 24.7 mm -76.22 -40.44 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 73.319999999999993 111.09 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 65.4 t -49.49 -47.49 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 75.420000000000002 111.111 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -52.12 -33.41 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.109999999999999 110.852 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.41 82.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.209999999999994 111.099 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 12.6 mtm -77.34 -14.64 59.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 75.120000000000005 110.908 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -86.44 14.27 6.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.129999999999995 110.9 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.9 1.2 2.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 110.869 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -105.06 -5.8 20.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 74.400000000000006 110.868 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.41 -151.26 9.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 63.420000000000002 112.474 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.1 m -145.94 -74.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.375 . . . . 53.32 110.847 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 75.540000000000006 110.86 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.87 2.67 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.886 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.85 -44.92 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 44.109999999999999 112.482 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.7 137.56 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 72.420000000000002 110.93 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.2 p -123.56 157.57 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 73.299999999999997 111.139 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.3 t -81.37 -17.24 49.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.349999999999994 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -135.2 -175.73 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.019999999999996 110.869 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -125.08 130.36 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 72.349999999999994 110.886 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.48 129.03 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 75.239999999999995 111.07 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 167.81 20.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 71.150000000000006 111.162 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.53 111.98 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.209999999999994 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.0 -50.99 36.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 74.239999999999995 111.085 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.34 162.85 33.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 63.509999999999998 110.9 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.4 p -165.73 168.18 16.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.239999999999995 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.46 -175.24 36.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 64.129999999999995 112.475 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 116.49 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 73.099999999999994 110.902 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -91.18 -39.64 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 73.319999999999993 110.933 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.140000000000001 110.864 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.804 0.335 . . . . 75.140000000000001 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.44 145.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.450000000000003 111.137 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.2 148.51 6.12 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.605 0.716 . . . . 74.109999999999999 110.924 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 126.11 12.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 73.319999999999993 112.336 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.3 m -106.6 108.86 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 73.340000000000003 111.14 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.72 141.96 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 73.530000000000001 111.146 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -111.99 159.99 17.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 75.430000000000007 110.893 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.31 138.03 29.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.896 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.4 109.16 17.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 74.549999999999997 110.906 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mt -94.49 148.32 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 71.439999999999998 111.138 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.34 164.53 28.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 71.430000000000007 111.04 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 154' ' ' LYS . 91.0 t -136.44 98.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.129 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 65.69 54.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 75.150000000000006 110.882 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.39 9.91 56.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.209999999999994 112.476 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 76.4 tt0 -123.72 107.24 31.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.642 0.734 . . . . 71.319999999999993 110.877 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.77 143.43 50.79 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.652 2.234 . . . . 74.420000000000002 112.379 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.8 mp -98.84 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 74.310000000000002 110.9 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.67 -167.8 26.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 54.109999999999999 112.473 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.07 120.58 40.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 74.209999999999994 110.852 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 38.4 t -109.23 102.47 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 72.450000000000003 111.132 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -110.24 147.19 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.439999999999998 110.88 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.83 109.04 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.439999999999998 110.907 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.29 127.88 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 73.109999999999999 110.846 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HA ' ' HA2' ' A' ' 130' ' ' GLY . 26.9 mt -89.28 136.12 33.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 71.219999999999999 110.972 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -78.68 65.3 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.61 66.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 62.420000000000002 111.093 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.19 -55.42 12.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 73.540000000000006 110.898 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.03 -60.58 3.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 110.911 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' A' ' 29' ' ' VAL . 33.0 m -99.37 101.18 12.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.596 0.712 . . . . 74.109999999999999 111.127 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -50.48 0.46 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.677 2.252 . . . . 75.319999999999993 112.366 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -44.68 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 74.450000000000003 110.895 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.6 m -86.04 23.13 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 64.019999999999996 111.138 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.78 -47.38 15.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 62.119999999999997 111.127 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.6 mt-10 -85.68 -24.29 27.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.150000000000006 110.876 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 34' ' ' GLU . 1.6 t-20 -28.29 -72.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.510000000000005 110.913 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -79.28 -30.19 42.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.519999999999996 110.876 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.45 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.0 ttp180 -49.27 -44.28 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.540000000000006 110.878 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.95 66.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 74.219999999999999 111.145 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.2 mt -69.11 -41.92 76.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 110.897 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -64.1 -45.1 90.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.120000000000005 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 33.0 p -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 74.010000000000005 111.102 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.53 88.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 74.340000000000003 112.474 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.02 31.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 74.310000000000002 110.924 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -126.27 -15.7 5.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.519999999999996 110.919 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 21.65 14.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 71.319999999999993 112.515 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -178.28 -167.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 74.230000000000004 110.844 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.89 -177.24 43.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 75.540000000000006 112.44 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 104.7 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 73.329999999999998 110.906 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 -66.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.049999999999997 110.899 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.79 26.09 7.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 53.210000000000001 112.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -76.19 -164.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 63.100000000000001 110.866 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.2 p -153.07 172.74 16.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 75.140000000000001 110.875 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.4 -75.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.349999999999994 110.87 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.72 23.53 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 74.530000000000001 110.856 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.16 17.73 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 110.883 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.07 143.22 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 24.3 mt -127.49 103.39 22.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.674 0.749 . . . . 74.150000000000006 111.119 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.71 96.5 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.3 . . . . 72.010000000000005 112.318 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.19 -21.18 4.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.76 . . . . 71.209999999999994 112.485 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.06 -60.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.906 0.384 . . . . 73.040000000000006 110.878 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -167.63 -148.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 62.200000000000003 110.875 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -131.89 -58.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 65.74 118.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.549999999999997 110.878 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.81 151.08 17.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 65.120000000000005 112.476 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.13 175.59 19.35 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.763 -0.732 . . . . 71.439999999999998 112.481 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -118.7 59.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 72.129999999999995 110.864 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -174.62 -175.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.869 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -175.42 61.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 73.230000000000004 111.132 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.73 65.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.25 110.909 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -49.82 -72.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 110.851 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -94.02 35.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 65.109999999999999 110.859 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.16 57.69 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 72.239999999999995 112.486 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m 68.14 44.54 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 75.099999999999994 111.123 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.8 -174.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 72.219999999999999 112.474 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 127.84 28.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.737 . . . . 75.030000000000001 112.53 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -83.48 -178.19 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.327 . . . . 72.230000000000004 110.868 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 4.9 p -87.02 -174.74 5.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 110.879 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.52 -31.51 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 74.129999999999995 111.173 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -87.33 42.32 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.882 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.42 -113.78 3.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 73.219999999999999 112.48 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.37 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 74.530000000000001 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.07 -171.08 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 73.439999999999998 110.894 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -131.44 169.53 15.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.88 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.71 169.85 11.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.239999999999995 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -61.38 -167.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 65.430000000000007 110.844 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -152.59 -55.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 63.310000000000002 110.839 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.38 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 65.030000000000001 110.898 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.17 56.5 1.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.833 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.6 -0.45 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 73.400000000000006 111.111 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.9 mt -114.67 132.4 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 74.150000000000006 110.923 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.69 126.68 40.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 72.430000000000007 110.931 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -53.44 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 63.140000000000001 110.882 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -95.02 4.61 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.319999999999993 111.166 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.02 -175.38 46.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.749 -0.739 . . . . 62.329999999999998 112.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 158.75 55.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.281 . . . . 65.230000000000004 112.347 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.15 -28.21 9.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 55.399999999999999 112.463 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.1 mm -57.81 124.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 71.530000000000001 111.14 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mp -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 73.040000000000006 110.883 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.485 ' O ' ' HB2' ' A' ' 112' ' ' PHE . 4.8 t -142.77 -152.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 63.509999999999998 110.857 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.4 mmt -141.11 135.34 30.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 73.430000000000007 110.858 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.903 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.91 -163.43 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.519999999999996 111.089 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.903 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 4.0 m120 116.61 -176.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 70.239999999999995 110.888 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.485 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -52.28 -41.28 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 75.340000000000003 111.053 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.58 -64.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 74.409999999999997 112.47 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.485 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 111.96 2.96 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.599 2.199 . . . . 62.25 112.353 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 42.47 61.56 1.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 16.0 p -152.5 54.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.430000000000007 111.176 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.01 -43.38 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 71.109999999999999 110.912 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.24 -164.32 19.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 71.019999999999996 112.489 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.65 -31.76 5.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 73.209999999999994 110.867 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -55.51 149.02 14.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 74.099999999999994 110.9 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -160.95 158.05 27.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.209999999999994 110.861 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -114.4 -173.07 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 75.400000000000006 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.3 mt -113.51 -57.45 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 111.121 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.22 127.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.450000000000003 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -133.19 34.38 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 71.150000000000006 111.106 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.37 159.18 37.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 73.120000000000005 111.093 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -67.11 88.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.319999999999993 110.926 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 p -111.12 54.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 74.319999999999993 111.174 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.29 15.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.450000000000003 110.877 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 11.33 27.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 110.946 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 4.1 mt -109.26 -33.24 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 122' ' ' LEU . 4.3 t0 78.19 -42.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.420000000000002 110.857 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.61 2.78 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 75.340000000000003 112.515 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -62.94 -14.94 53.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 73.319999999999993 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -92.51 16.54 11.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 72.510000000000005 110.894 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 7.0 t 72.41 85.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 72.319999999999993 111.167 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 4.4 p -86.31 126.46 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.329999999999998 111.147 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.425 ' CG ' HG22 ' A' ' 29' ' ' VAL . 5.1 p90 -157.93 128.49 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 110.892 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 115.81 121.61 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 72.209999999999994 112.545 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -129.72 159.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 74.329999999999998 110.905 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.25 158.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 111.119 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -62.59 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 74.209999999999994 110.865 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.16 173.6 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 73.209999999999994 110.877 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.44 81.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 73.329999999999998 112.478 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -7.09 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 73.319999999999993 110.865 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -30.86 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.865 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 142' ' ' MET . 50.1 mm -65.69 -36.14 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 75.109999999999999 111.138 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 11.4 t -89.04 1.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 74.400000000000006 111.123 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -115.62 -64.0 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 63.32 110.854 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.25 -52.61 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 61.299999999999997 111.065 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 14.0 tmm? -51.9 -45.78 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 72.239999999999995 110.868 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -23.12 3.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 72.430000000000007 110.845 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.4 ttm-85 -63.28 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 75.510000000000005 110.877 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -92.91 20.13 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.420000000000002 110.885 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.73 68.14 0.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.540000000000006 112.447 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -27.35 135.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 72.430000000000007 110.837 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 13.6 mmm-85 -46.16 -63.68 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 75.510000000000005 110.903 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.81 -31.35 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 63.149999999999999 110.879 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.8 -167.69 22.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 75.530000000000001 112.521 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 mttt 61.72 103.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 73.219999999999999 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.5 p -77.68 144.35 37.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 74.150000000000006 111.15 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 p -60.9 -19.05 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 75.219999999999999 110.83 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.413 ' HB3' HG12 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -129.88 -168.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.905 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.4 108.46 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 73.420000000000002 110.894 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.95 99.87 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 73.420000000000002 111.143 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.15 157.1 23.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.32 111.121 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.12 126.01 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 75.239999999999995 111.185 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.31 -63.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 75.230000000000004 111.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -127.31 168.95 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 64.150000000000006 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.05 -176.1 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.349999999999994 110.847 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.97 -152.22 20.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.759 -0.734 . . . . 74.219999999999999 112.499 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.07 138.33 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.366 . . . . 72.319999999999993 110.854 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -116.92 143.98 45.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.963 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.85 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 110.882 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.43 144.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 74.439999999999998 111.153 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -52.2 141.73 30.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.618 0.723 . . . . 75.099999999999994 110.862 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 128.44 16.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 73.420000000000002 112.351 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -115.52 125.95 53.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 73.319999999999993 111.197 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.9 m -113.22 156.74 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 72.010000000000005 111.142 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -127.46 165.65 19.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.200000000000003 110.833 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.63 143.98 33.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 64.510000000000005 110.888 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.04 136.26 38.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 71.239999999999995 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.7 mm -107.19 136.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 74.439999999999998 111.127 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -143.26 162.86 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 73.150000000000006 111.095 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 76.1 t -153.1 101.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.430000000000007 111.167 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 65.4 56.64 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 72.510000000000005 110.888 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.4 13.08 48.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.718 . . . . 54.340000000000003 112.512 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -124.04 113.42 28.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 75.340000000000003 110.903 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 153.32 68.87 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.674 2.249 . . . . 73.530000000000001 112.348 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -112.51 -60.49 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.62 -164.33 27.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 65.200000000000003 112.468 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -108.99 121.49 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 75.230000000000004 110.853 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.7 t -119.37 111.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 71.25 111.119 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 p -111.09 152.61 26.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.869 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 112.9 15.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 75.329999999999998 110.889 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.33 137.39 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 72.310000000000002 110.881 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.5 113.35 26.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 110.92 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -85.99 70.79 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 74.310000000000002 110.86 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -1.88 43.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 111.112 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.36 -48.22 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 74.209999999999994 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.52 -62.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 75.5 110.874 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -115.35 77.67 5.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.64 0.733 . . . . 74.409999999999997 111.117 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 72.85 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 74.439999999999998 112.371 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' HG2' ' N ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -177.11 -42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.140000000000001 110.892 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.565 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -82.55 -61.85 1.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 64.310000000000002 111.127 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -91.43 22.17 4.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 75.209999999999994 111.115 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.37 12.67 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.876 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -121.5 -28.03 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 64.549999999999997 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -54.26 -26.75 30.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 74.099999999999994 110.883 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.23 -30.79 39.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 75.019999999999996 110.876 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.0 -26.67 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.030000000000001 111.077 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.08 19.44 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 75.349999999999994 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -118.02 -8.06 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.340000000000003 110.86 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -115.95 12.71 15.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 74.209999999999994 111.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.11 31.55 33.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 62.210000000000001 112.461 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.95 -34.18 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 74.230000000000004 110.898 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.49 -19.97 62.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 65.340000000000003 110.914 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.88 18.8 60.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 71.340000000000003 112.473 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.8 151.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 73.430000000000007 110.902 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.49 -179.58 16.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 72.230000000000004 112.485 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.13 102.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 74.150000000000006 110.9 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 -51.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 74.140000000000001 110.92 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.94 32.73 2.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 43.350000000000001 112.475 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.32 -169.46 2.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 73.120000000000005 110.893 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.1 p -152.86 148.77 27.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 65.150000000000006 110.864 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.82 -177.61 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.439999999999998 110.898 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -171.87 60.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.831 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -137.23 29.54 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.010000000000005 110.883 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.49 143.27 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 75.420000000000002 111.141 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 14.5 mt -139.77 96.5 8.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.622 0.725 . . . . 75.230000000000004 111.108 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 85.13 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.255 . . . . 73.200000000000003 112.314 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.47 -40.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 71.519999999999996 112.486 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -58.19 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 73.409999999999997 110.867 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.97 -158.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 65.239999999999995 110.838 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.4 m -139.56 142.55 37.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 63.520000000000003 110.879 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -126.9 157.39 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 75.310000000000002 110.953 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.63 99.86 0.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 74.040000000000006 112.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.82 -132.58 11.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 74.510000000000005 112.491 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.9 -169.71 1.78 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.834 0.35 . . . . 74.439999999999998 110.918 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.38 132.83 29.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 75.450000000000003 110.893 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.1 t -117.24 -33.68 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 63.539999999999999 111.172 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -106.18 44.62 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.120000000000005 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 174.19 115.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 71.120000000000005 110.867 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 47.77 34.27 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 64.239999999999995 110.878 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.69 153.97 32.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.74 . . . . 75.019999999999996 112.487 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 p -142.55 141.13 31.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 74.530000000000001 111.183 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.16 173.07 30.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.030000000000001 112.499 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.71 -93.73 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 71.319999999999993 112.505 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt 64.68 152.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.805 0.336 . . . . 74.329999999999998 110.871 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.663 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 40.5 t -118.74 10.83 12.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.420000000000002 110.861 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER 75.4 -8.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 74.319999999999993 111.092 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -110.28 -18.12 13.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 71.230000000000004 110.938 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.37 -134.38 2.01 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 73.340000000000003 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -123.98 -33.84 3.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 74.219999999999999 110.888 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.42 163.95 10.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.879 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -144.28 135.6 25.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.299999999999997 110.883 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -51.02 162.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.209999999999994 110.903 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -75.29 92.67 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 73.129999999999995 110.882 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -51.67 51.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 177.51 167.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 110.891 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.340000000000003 110.907 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.38 -28.08 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 72.040000000000006 111.143 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.75 122.3 31.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.430000000000007 110.892 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -108.39 -166.55 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 73.439999999999998 110.891 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -99.88 -88.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.219999999999999 110.837 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.6 m 69.46 7.64 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.448 . . . . 74.510000000000005 111.121 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.22 168.78 30.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.019999999999996 112.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 171.34 14.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.269 . . . . 74.439999999999998 112.322 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.05 28.26 50.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.150000000000006 112.526 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 37.7 mm -95.31 139.4 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 71.129999999999995 111.127 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 12.3 mt -106.54 142.29 36.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 74.140000000000001 110.905 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 m -116.89 -138.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 74.319999999999993 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.408 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 7.3 mmt -155.13 -59.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 73.319999999999993 110.872 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 65.04 146.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 72.239999999999995 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.45 ' OD1' ' HA2' ' A' ' 109' ' ' GLY . 0.2 OUTLIER 177.81 -73.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 75.530000000000001 110.882 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -147.43 -28.8 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 71.099999999999994 111.12 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.11 -76.72 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.72 -0.752 . . . . 41.020000000000003 112.429 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.79 107.62 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 73.230000000000004 112.331 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' PRO . 70.9 m-80 35.41 69.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.349999999999994 110.873 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' A' ' 102' ' ' ASN . 2.7 m -134.68 16.68 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 71.319999999999993 111.165 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.5 t30 39.45 -97.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.329999999999998 110.9 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 133.65 174.48 13.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 62.219999999999999 112.512 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 63.6 m -144.68 -43.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 71.340000000000003 110.901 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -91.47 92.55 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 63.009999999999998 110.889 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -82.91 147.06 28.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 73.129999999999995 110.858 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -111.46 131.73 55.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.430000000000007 110.911 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.51 123.17 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 111.1 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 68.1 m -74.72 130.97 40.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 62.119999999999997 110.862 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.9 p -91.71 -27.77 17.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 72.510000000000005 111.173 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -130.53 169.67 15.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 55.130000000000003 111.117 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -61.86 96.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 74.430000000000007 110.895 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 29.6 p -121.33 59.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.430000000000007 111.145 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 25.0 1.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 73.129999999999995 110.872 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -89.22 10.5 21.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.945 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 10.9 mt -98.44 -41.56 7.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 73.349999999999994 110.89 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -58.37 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 74.349999999999994 110.899 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.23 59.99 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.702 -0.761 . . . . 74.310000000000002 112.468 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -103.33 -22.66 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 70.349999999999994 110.87 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.485 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 18.6 m-70 -119.32 -20.78 7.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 75.120000000000005 110.891 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 16.1 t 80.74 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 73.129999999999995 111.104 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 77.2 t -102.43 137.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 70.230000000000004 111.143 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -157.6 29.63 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 74.040000000000006 110.884 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.64 140.17 6.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 62.149999999999999 112.451 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -124.04 -165.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 72.519999999999996 110.904 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.7 t -96.68 134.13 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 111.13 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -90.62 -63.37 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.109999999999999 110.862 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -162.07 142.6 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 72.340000000000003 110.892 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.63 4.71 13.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 73.340000000000003 112.523 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.6 ttt -49.41 -33.24 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 74.310000000000002 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.1 -28.44 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 75.239999999999995 110.931 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.0 mm -79.39 -38.4 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.030000000000001 111.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.8 t -48.08 -53.31 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 111.172 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.98 -32.02 14.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.02 -41.12 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 61.229999999999997 111.119 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 43.7 mtm -77.14 -17.15 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.409999999999997 110.858 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -90.16 29.47 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.129999999999995 110.899 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 75.120000000000005 110.882 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -129.15 17.43 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.510000000000005 110.86 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -136.65 46.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 74.120000000000005 112.469 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 146' ' ' GLY . 37.8 m 33.42 -100.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 74.340000000000003 110.856 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -161.52 -40.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 73.150000000000006 110.86 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.58 -7.03 57.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.200000000000003 110.903 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 109.34 -137.18 14.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.310000000000002 112.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 75.47 -55.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.35 140.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.400000000000006 111.156 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 0.33 20.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 70.5 110.859 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.14 161.04 36.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.878 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.48 112.76 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 55.450000000000003 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.5 mt -98.35 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 73.219999999999999 111.168 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.66 174.2 6.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 74.150000000000006 111.122 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.36 145.12 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.310000000000002 111.14 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.21 -62.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.510000000000005 111.102 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -157.06 164.8 37.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.299999999999997 110.787 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.7 m -146.23 -165.55 2.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.863 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.34 28.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 73.239999999999995 112.489 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -108.65 136.48 48.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.353 . . . . 74.010000000000005 110.919 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 41.7 mt -73.12 -41.04 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.5 110.909 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 71.340000000000003 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.362 . . . . 72.230000000000004 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.26 155.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -92.96 152.87 41.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 72.239999999999995 110.882 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 147.11 62.07 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.686 2.257 . . . . 70.409999999999997 112.356 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -140.01 165.8 26.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.329999999999998 111.173 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.96 132.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 73.010000000000005 111.136 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.5 162.86 13.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 71.319999999999993 110.906 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -143.67 138.58 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 74.310000000000002 110.884 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -101.41 71.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 71.230000000000004 110.827 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.7 mm -50.47 136.09 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 64.219999999999999 111.145 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -108.37 152.69 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 75.439999999999998 111.126 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 t -127.27 94.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 111.159 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.01 32.33 21.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 74.030000000000001 110.896 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.47 -24.71 25.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 71.310000000000002 112.511 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -121.79 119.68 28.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.67 0.748 . . . . 71.439999999999998 110.884 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.1 Cg_endo -69.72 162.67 41.16 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.732 2.288 . . . . 74.209999999999994 112.365 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.11 20.98 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 73.519999999999996 110.891 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.4 ' HA3' HD13 ' A' ' 138' ' ' ILE . . . 133.9 -164.33 24.43 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 73.239999999999995 112.49 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 174.47 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 75.230000000000004 110.866 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.9 m -136.78 177.12 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 111.116 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -129.61 100.86 5.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 75.019999999999996 110.893 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -86.62 114.04 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.430000000000007 110.877 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.55 124.85 50.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.510000000000005 110.898 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.1 mt -88.19 126.66 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.420000000000002 110.937 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -76.38 67.08 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.099999999999994 110.888 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.03 -30.1 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 71.219999999999999 111.138 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -53.06 -56.46 16.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 64.430000000000007 110.874 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 4.6 mptp? -81.95 -35.55 28.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.319999999999993 110.841 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.32 80.35 72.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 70.519999999999996 111.129 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.07 17.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.27 . . . . 73.219999999999999 112.356 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.59 -69.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 72.420000000000002 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -42.26 -39.62 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 111.166 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.55 -67.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 73.420000000000002 111.071 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' ARG . 6.8 tt0 -41.62 -61.06 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 61.030000000000001 110.862 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -35.83 -43.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 74.409999999999997 110.881 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -75.24 -41.85 56.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.019999999999996 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' GLU . 9.0 tmm_? -51.62 -30.32 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.838 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.55 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.239999999999995 111.113 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.19 -41.44 81.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 110.923 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.9 p -58.88 -46.09 88.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.439999999999998 110.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -16.93 64.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.340000000000003 111.129 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.56 86.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 73.230000000000004 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -143.74 39.95 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 74.340000000000003 110.92 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 21.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.926 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.91 -33.69 3.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.486 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -126.09 -167.53 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 75.400000000000006 110.865 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.6 -144.21 13.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.733 . . . . 72.510000000000005 112.496 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 -18.69 15.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 74.239999999999995 110.968 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.59 113.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 74.5 110.88 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -131.19 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 61.109999999999999 112.498 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.2 t 49.32 -166.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 65.329999999999998 110.817 -179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.7 p -143.52 -168.58 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -179.44 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.340000000000003 110.87 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -116.13 -57.52 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.099999999999994 110.855 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -145.79 164.6 31.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.209999999999994 110.909 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -153.42 124.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 72.120000000000005 111.171 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 pt -134.62 126.82 18.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.652 0.739 . . . . 73.519999999999996 111.132 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 138.44 37.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.622 2.215 . . . . 74.030000000000001 112.348 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.43 30.86 77.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 60.32 112.486 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.96 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 74.519999999999996 110.898 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -163.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 64.319999999999993 110.893 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 m -137.02 -69.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 70.129999999999995 110.865 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 62.81 148.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 65.329999999999998 110.897 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.61 167.18 21.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 74.310000000000002 112.469 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.44 -90.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 51.109999999999999 112.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.76 -168.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 62.539999999999999 110.865 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -134.75 32.92 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.913 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 90.2 m -58.98 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 65.25 111.131 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 65.31 -152.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 75.519999999999996 110.875 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -152.9 27.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 75.099999999999994 110.839 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.86 -17.58 56.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 71.340000000000003 110.836 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.83 15.36 2.91 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.732 -0.746 . . . . 73.25 112.497 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 81.3 m -128.51 -51.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 72.209999999999994 111.14 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.95 178.02 43.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 54.420000000000002 112.451 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -79.11 109.25 2.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 70.109999999999999 112.504 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.37 -165.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.76 0.314 . . . . 72.329999999999998 110.914 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ILE . 47.6 p -77.87 137.46 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 61.420000000000002 110.861 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -33.59 -46.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 74.219999999999999 111.153 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 8.2 p90 -112.84 106.21 14.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 71.209999999999994 110.88 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.57 -168.86 51.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 73.430000000000007 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -71.33 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 74.010000000000005 110.902 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 155.56 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 73.230000000000004 110.913 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 179.41 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.230000000000004 110.881 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 173.96 9.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 65.439999999999998 110.848 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -71.79 179.96 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 74.219999999999999 110.883 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.72 -63.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.835 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.86 158.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.230000000000004 110.855 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 60.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 72.049999999999997 110.924 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -78.98 -3.34 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 75.349999999999994 111.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.94 71.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.099999999999994 110.882 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 154.57 24.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 75.310000000000002 110.866 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -63.82 83.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 71.120000000000005 110.845 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -77.08 -8.81 58.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 72.209999999999994 111.13 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.95 -174.35 45.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 64.310000000000002 112.492 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.07 66.68 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 73.319999999999993 112.329 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -27.96 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 72.549999999999997 112.496 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.18 120.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 72.420000000000002 111.131 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.435 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 4.1 tt -91.96 143.16 26.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 75.319999999999993 110.909 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.0 t -148.83 -166.58 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 72.120000000000005 110.824 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.81 148.52 25.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 75.540000000000006 110.872 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 107' ' ' THR . 3.1 t30 -145.5 -160.54 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.519999999999996 110.927 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.602 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -46.16 -45.59 16.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 75.239999999999995 111.081 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.04 -65.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 64.040000000000006 112.527 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.602 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 112.21 3.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.233 . . . . 72.230000000000004 112.333 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' PRO . 51.7 m-20 34.42 46.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 110.901 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.485 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 19.7 p -154.08 34.31 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.299999999999997 111.16 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -79.73 4.01 17.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.07 133.1 43.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 74.25 112.467 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.22 166.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 74.409999999999997 110.891 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 67.52 138.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 70.25 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -153.91 177.49 10.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 73.239999999999995 110.91 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.47 162.91 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 75.25 110.874 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.4 pt -145.39 134.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.540000000000006 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 14.0 t -96.58 156.89 16.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 73.299999999999997 110.873 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -124.9 27.74 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 73.219999999999999 111.125 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.62 27.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 71.400000000000006 111.102 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.0 142.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 75.319999999999993 110.878 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.57 48.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.129999999999995 111.195 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.72 -20.82 23.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 71.109999999999999 110.849 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -62.51 -22.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.904 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.2 mp -76.41 -37.46 57.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 61.329999999999998 110.919 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t0 47.09 86.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 73.299999999999997 110.828 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.79 37.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 73.25 112.508 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -55.03 -32.91 62.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 74.319999999999993 110.911 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -145.57 43.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.871 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.462 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER 67.13 -153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.319999999999993 111.12 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.462 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 14.2 p -176.94 144.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 75.200000000000003 111.122 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.529 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 4.1 p90 -176.5 95.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.881 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 132.54 161.48 9.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 54.409999999999997 112.468 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt 175.18 131.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 75.510000000000005 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.69 136.36 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 111.124 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -114.54 -39.41 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 75.519999999999996 110.883 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.24 160.94 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.329999999999998 110.896 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.05 81.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.299999999999997 112.473 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -12.29 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 72.150000000000006 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -75.06 -24.54 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 74.530000000000001 110.88 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.4 HD13 ' HA3' ' A' ' 18' ' ' GLY . 17.6 mm -64.19 -44.11 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 74.530000000000001 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.7 t -93.38 5.62 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 111.166 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -112.58 -64.36 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 70.219999999999999 110.849 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.27 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 111.077 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.34 -44.45 54.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.230000000000004 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.93 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 60.530000000000001 110.907 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.37 -29.97 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 110.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.37 -2.81 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 72.319999999999993 110.884 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.95 -152.75 14.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 71.0 112.44 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.7 t -161.92 156.13 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 75.540000000000006 110.858 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -71.53 -7.47 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 74.409999999999997 110.837 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -106.21 -19.61 13.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 74.129999999999995 110.862 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.15 -44.27 1.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 61.240000000000002 112.495 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -44.55 129.63 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.450000000000003 110.914 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 49.2 p -98.62 118.17 34.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 111.118 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 p -54.2 -26.27 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.420000000000002 110.82 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -127.43 -163.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.230000000000004 110.943 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -131.0 127.75 38.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.943 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.2 mp -98.84 125.21 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 73.040000000000006 111.145 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.13 141.69 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 75.200000000000003 111.139 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.07 100.53 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 75.340000000000003 111.185 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.31 -59.82 3.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.093 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.5 170.41 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.873 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -170.2 154.36 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.928 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.79 179.89 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.747 . . . . 51.43 112.478 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 1.1 mt-30 -82.62 -49.92 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 75.209999999999994 110.898 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.7 mm? 65.04 115.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 75.230000000000004 110.936 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.109999999999999 110.917 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.889 0.376 . . . . 71.349999999999994 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.85 156.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 75.530000000000001 111.139 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -92.64 160.1 35.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.623 0.725 . . . . 75.209999999999994 110.859 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.52 69.02 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 64.349999999999994 112.349 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.1 m -136.18 150.13 48.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 75.5 111.142 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.92 137.24 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.150000000000006 111.079 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HB3' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -113.32 157.87 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.329999999999998 110.867 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -141.66 136.34 30.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.219999999999999 110.878 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.55 119.75 35.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 110.912 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 13.3 mm -95.02 142.41 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.12 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.54 170.76 15.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 73.219999999999999 111.067 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.6 m -146.99 96.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.25 111.092 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.74 36.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.030000000000001 110.857 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -12.42 66.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 65.120000000000005 112.486 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.56 131.55 30.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 73.439999999999998 110.921 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 153.18 69.08 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.257 . . . . 75.230000000000004 112.333 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -117.53 -68.21 0.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.329999999999998 110.912 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.58 28.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 60.119999999999997 112.528 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.76 134.26 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 75.319999999999993 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -136.59 139.99 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.310000000000002 111.076 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -123.53 152.66 41.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 73.450000000000003 110.87 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.54 -175.48 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 74.230000000000004 110.874 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -144.48 117.57 8.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 73.200000000000003 110.927 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.46 130.21 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 73.450000000000003 110.913 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -79.48 75.86 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.86 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -28.11 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.420000000000002 111.126 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -37.72 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 63.43 110.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -86.44 -31.97 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 74.109999999999999 110.889 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 129' ' ' PHE . 7.9 m -132.84 84.98 48.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 74.230000000000004 111.11 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -40.38 5.37 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.228 . . . . 60.509999999999998 112.38 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -83.08 -44.89 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 110.864 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.7 m -81.84 17.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 63.420000000000002 111.163 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.79 -44.14 12.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 73.25 111.139 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.4 mt-10 -81.81 -31.37 31.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 75.400000000000006 110.85 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 8.4 t30 -27.18 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 110.896 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -77.51 -34.21 54.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.450000000000003 110.869 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.415 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 1.8 ttp180 -47.83 -40.27 20.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 110.917 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.21 60.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.319999999999993 111.079 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 13.16 14.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.420000000000002 110.942 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -129.67 -20.29 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.8 p -101.19 -25.08 14.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 73.319999999999993 111.106 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.17 62.11 1.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.230000000000004 112.45 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.63 27.08 1.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 71.129999999999995 110.865 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -123.6 -11.03 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 72.319999999999993 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.86 -25.94 25.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 52.130000000000003 112.539 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -140.57 166.65 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 64.530000000000001 110.89 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.87 -176.68 41.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 74.030000000000001 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -99.58 3.29 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.956 0.408 . . . . 73.209999999999994 110.937 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -54.19 150.41 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 73.430000000000007 110.894 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 49.51 63.61 3.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 74.530000000000001 112.544 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 m -153.6 -95.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 65.329999999999998 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 p -176.5 -172.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.099999999999994 110.899 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -124.18 -174.51 3.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 75.310000000000002 110.9 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.26 177.02 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 71.430000000000007 110.87 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 51.17 27.09 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.030000000000001 110.872 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mt -71.27 119.44 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 75.310000000000002 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.4 111.32 8.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 72.230000000000004 111.168 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 93.45 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.672 2.248 . . . . 71.230000000000004 112.335 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.96 -30.89 2.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 71.530000000000001 112.461 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -108.56 -65.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.519999999999996 110.9 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -171.82 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 72.319999999999993 110.849 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -121.17 -67.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 64.530000000000001 110.906 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 64.15 162.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.85 168.27 20.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.209999999999994 112.504 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.44 -92.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 62.530000000000001 112.48 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -178.9 -155.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 72.329999999999998 110.859 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -158.37 -39.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.885 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p 47.7 -101.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 64.230000000000004 111.123 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -121.95 -176.09 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 71.329999999999998 110.86 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.62 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 71.239999999999995 110.81 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.65 -51.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 60.130000000000003 110.902 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 46.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 73.0 112.495 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.4 m -120.21 -48.88 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.369 . . . . 74.530000000000001 111.169 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.63 153.19 9.41 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.756 -0.735 . . . . 70.409999999999997 112.521 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.62 -155.52 31.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 72.120000000000005 112.456 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.93 -68.07 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 74.430000000000007 110.871 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -125.31 129.31 49.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 63.530000000000001 110.856 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pt -61.75 -15.0 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 73.439999999999998 111.172 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.0 21.85 6.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 75.0 110.923 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 77' ' ' SER . . . 157.12 -136.15 4.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 75.340000000000003 112.495 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.417 ' C ' ' HB2' ' A' ' 77' ' ' SER . 27.2 mm-40 -104.57 -47.71 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.956 0.407 . . . . 73.219999999999999 110.883 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 175.01 10.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 71.549999999999997 110.866 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.51 175.0 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 110.897 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.97 152.12 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 75.030000000000001 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -56.61 166.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 73.310000000000002 110.864 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.37 -64.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 71.349999999999994 110.888 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.36 153.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 62.409999999999997 110.909 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 62.69 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 74.329999999999998 110.853 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -81.9 -4.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.340000000000003 111.177 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.49 77.38 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.902 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -58.82 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.939 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 86.29 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.549999999999997 110.861 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 p -108.33 17.78 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 111.113 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.62 164.97 31.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 73.549999999999997 112.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.63 30.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.265 . . . . 75.329999999999998 112.312 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . 75.98 26.38 64.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.729 . . . . 72.430000000000007 112.517 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -91.86 118.85 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 72.540000000000006 111.152 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 mt -94.37 143.31 26.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 64.439999999999998 110.961 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 t -146.22 -127.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 63.100000000000001 110.821 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -162.61 118.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.420000000000002 110.868 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -106.79 88.87 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 61.299999999999997 111.089 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -153.74 95.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 72.219999999999999 110.873 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 71.26 -66.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 64.530000000000001 111.052 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.15 -73.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 74.209999999999994 112.491 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.3 Cg_endo -69.72 123.54 10.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 73.239999999999995 112.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' PRO . 4.2 m-20 31.06 60.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 75.430000000000007 110.901 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 108' ' ' ASN . 1.2 p -145.05 31.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 70.0 111.132 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.581 ' C ' ' O ' ' A' ' 107' ' ' THR . 35.6 t30 22.14 -100.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 75.299999999999997 110.911 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.96 145.12 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 72.239999999999995 112.514 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -121.4 -10.43 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 61.149999999999999 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -81.25 53.66 2.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 75.409999999999997 110.902 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -52.95 143.17 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 62.420000000000002 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.491 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -112.95 64.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 75.329999999999998 110.876 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 113' ' ' PHE . 55.5 mt -29.82 99.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 74.430000000000007 111.155 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -64.97 152.88 42.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 74.319999999999993 110.886 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.3 p -118.55 -1.82 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.115 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.46 159.4 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 75.409999999999997 111.129 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -53.73 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.030000000000001 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.2 p -105.15 63.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.240000000000002 111.131 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 4.87 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 6.5 p90 -84.21 7.52 18.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 75.340000000000003 110.933 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.37 -57.69 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 110.938 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.04 83.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.340000000000003 110.89 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.06 36.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 61.420000000000002 112.489 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tmtp? -73.56 -30.31 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 64.030000000000001 110.93 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.2 m-70 -146.14 34.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.450000000000003 110.864 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 56.21 -154.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 111.119 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 7.1 p 178.89 147.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 74.030000000000001 111.129 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 15.4 p90 -177.5 115.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 64.109999999999999 110.876 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 102.86 141.71 11.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 73.099999999999994 112.48 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -158.76 148.24 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.409999999999997 110.901 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.6 t -51.91 148.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 72.510000000000005 111.108 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -118.27 -60.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 73.129999999999995 110.906 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -128.5 125.61 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.150000000000006 110.893 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 112.16 65.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 63.32 112.49 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.7 mmm -84.26 -0.47 52.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 73.430000000000007 110.877 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -30.39 63.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 74.150000000000006 110.848 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 142' ' ' MET . 13.1 mm -72.21 -37.17 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 111.154 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.0 t -91.69 20.48 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.510000000000005 111.144 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -139.28 -55.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 74.310000000000002 110.9 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.4 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 70.140000000000001 111.152 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.486 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 10.2 tmm? -48.0 -36.38 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 64.010000000000005 110.888 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.11 -32.69 55.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 74.049999999999997 110.885 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.408 ' HG3' ' CD1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -59.01 -18.41 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 75.319999999999993 110.869 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.408 ' CD1' ' HG3' ' A' ' 144' ' ' ARG . 50.0 m-85 -82.59 1.12 39.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 74.329999999999998 110.889 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.79 -157.7 33.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 55.340000000000003 112.528 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 t -159.45 169.7 23.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 75.200000000000003 110.836 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -61.28 -48.5 81.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 74.230000000000004 110.888 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -5.66 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.349999999999994 110.909 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.46 -39.96 2.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 74.129999999999995 112.523 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -48.88 158.22 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 72.530000000000001 110.883 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.1 p -126.25 157.62 37.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 74.299999999999997 111.176 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.4 t -85.64 1.44 49.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 73.230000000000004 110.892 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.3 -168.67 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 75.099999999999994 110.893 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.16 120.48 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 75.439999999999998 110.939 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -84.55 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 74.340000000000003 111.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.38 136.68 51.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.299999999999997 111.202 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.65 132.97 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 75.420000000000002 111.165 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -88.03 -58.23 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 74.400000000000006 111.129 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -167.79 168.45 12.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 54.340000000000003 110.896 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.7 m -146.81 164.48 32.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 71.549999999999997 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.51 171.83 44.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.761 . . . . 75.120000000000005 112.502 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.589 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -68.18 -35.7 78.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.887 0.375 . . . . 61.130000000000003 110.929 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.589 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.5 mm? 71.83 -60.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 110.929 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.885 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.818 0.342 . . . . 75.439999999999998 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.92 146.06 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 75.010000000000005 111.14 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.84 141.12 14.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 71.230000000000004 110.91 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.72 26.28 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.649 2.233 . . . . 74.409999999999997 112.364 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -112.78 112.07 23.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 111.144 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.455 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 16.1 m -88.57 155.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 75.409999999999997 111.096 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.55 151.75 39.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.219999999999999 110.866 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 137.64 23.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 74.239999999999995 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -109.96 148.28 31.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 72.319999999999993 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.8 mt -120.13 134.44 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 74.120000000000005 111.146 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.27 156.35 42.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 111.129 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.1 t -135.27 120.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.439999999999998 111.159 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.71 41.34 7.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.400000000000006 110.875 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.44 62.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 54.130000000000003 112.472 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.07 125.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.657 0.741 . . . . 75.140000000000001 110.856 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 131.6 21.67 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.702 2.268 . . . . 71.510000000000005 112.372 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -115.76 -19.51 10.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.400000000000006 110.926 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.47 -179.58 39.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.747 . . . . 74.030000000000001 112.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -144.0 167.0 23.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.353 . . . . 74.319999999999993 110.854 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.4 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 22.6 m -127.15 173.52 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 75.450000000000003 111.074 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 t -117.75 94.71 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.349999999999994 110.87 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CZ ' HG23 ' A' ' 20' ' ' VAL . 12.5 m-85 -84.21 120.34 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 73.299999999999997 110.848 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.91 146.47 26.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.120000000000005 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -112.26 121.35 44.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 110.931 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -79.99 68.85 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.329999999999998 110.841 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.21 57.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.420000000000002 111.129 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.93 -65.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.109999999999999 110.852 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.43 -62.13 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 110.887 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.63 84.78 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 72.409999999999997 111.113 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 76.48 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 71.120000000000005 112.329 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 179.66 -65.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 73.439999999999998 110.85 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 52.1 m -50.92 -41.55 58.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 74.239999999999995 111.152 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.27 -26.24 51.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 64.450000000000003 111.085 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.14 -24.08 66.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 73.099999999999994 110.907 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -80.75 -66.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 74.319999999999993 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -49.57 -41.21 41.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.140000000000001 110.888 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -62.13 -33.46 74.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.230000000000004 110.889 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.4 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 71.420000000000002 111.067 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.87 -51.04 36.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 m -57.06 -48.12 79.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.430000000000007 110.859 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -79.25 -5.41 54.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 73.329999999999998 111.168 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.25 64.96 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 41.240000000000002 112.505 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -112.22 37.53 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 73.310000000000002 110.883 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -131.64 17.02 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.299999999999997 110.884 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.62 63.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 74.109999999999999 112.51 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.92 164.78 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 74.439999999999998 110.858 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.78 141.2 5.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 63.409999999999997 112.5 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -48.45 138.66 9.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 74.450000000000003 110.925 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 -47.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 74.129999999999995 110.927 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.48 30.22 6.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.731 . . . . 75.099999999999994 112.455 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -112.48 -164.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 73.400000000000006 110.887 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.0 p -103.23 -178.8 3.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 110.874 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -88.54 177.32 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 75.109999999999999 110.851 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.36 -61.54 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 74.150000000000006 110.888 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -164.33 145.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 70.400000000000006 110.903 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -133.43 145.66 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.430000000000007 111.122 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -139.16 123.04 11.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 74.319999999999993 111.131 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.71 28.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.632 2.221 . . . . 75.239999999999995 112.338 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.17 24.44 68.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 72.340000000000003 112.505 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.94 -71.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 71.439999999999998 110.918 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -174.5 -163.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 72.420000000000002 110.88 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.57 143.34 16.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.319999999999993 110.893 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.41 152.27 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.875 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.49 146.48 16.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 64.019999999999996 112.491 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.86 156.93 7.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 62.219999999999999 112.503 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -70.07 69.08 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 75.349999999999994 110.884 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -150.93 67.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.858 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 t -83.26 -0.7 50.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 71.420000000000002 111.166 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -87.48 -72.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 74.099999999999994 110.855 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.86 -177.5 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.873 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.07 134.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 65.519999999999996 110.913 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.53 89.52 0.51 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 73.109999999999999 112.495 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.1 p -115.09 140.65 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.342 . . . . 74.010000000000005 111.154 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.52 151.85 5.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.793 -0.718 . . . . 73.209999999999994 112.521 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.33 106.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 73.040000000000006 112.513 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt 177.46 131.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.781 0.324 . . . . 74.230000000000004 110.906 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -71.18 174.41 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.549999999999997 110.846 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -83.45 -32.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 72.439999999999998 111.139 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -81.36 3.12 25.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.22 -120.46 3.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.739 -0.744 . . . . 73.439999999999998 112.521 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -60.47 -164.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 61.240000000000002 110.89 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.97 164.27 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 110.902 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.55 146.66 47.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.420000000000002 110.876 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.38 172.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 72.329999999999998 110.862 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 124.19 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 75.420000000000002 110.863 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.12 -55.35 14.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.129999999999995 110.859 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.3 p30 179.65 172.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.319999999999993 110.886 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.41 41.05 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.510000000000005 110.863 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.8 mt -46.54 -33.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 75.409999999999997 111.157 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 22.0 mt -91.99 118.97 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 110.945 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.4 111.11 23.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 73.319999999999993 110.902 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.01 92.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 73.040000000000006 110.881 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 p -115.43 25.66 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 74.519999999999996 111.166 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.61 171.0 43.94 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 73.150000000000006 112.527 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 150.37 67.84 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.743 2.295 . . . . 75.099999999999994 112.36 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 -30.35 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 75.219999999999999 112.468 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 mm -51.49 145.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.420000000000002 111.113 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.7 tt -104.82 133.07 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 75.200000000000003 110.881 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.75 137.34 54.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 71.340000000000003 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 2.9 mmt -88.07 178.48 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.140000000000001 110.864 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . 176.11 174.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 71.319999999999993 111.111 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 33.7 t-20 178.21 -66.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 53.119999999999997 110.837 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -157.34 23.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 72.150000000000006 111.081 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.73 -153.55 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 44.229999999999997 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.03 66.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 73.409999999999997 112.303 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 64.91 27.14 12.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 75.200000000000003 110.936 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 26.3 p -147.11 67.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 62.420000000000002 111.122 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -88.21 7.21 33.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.530000000000001 110.959 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.85 130.74 36.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 63.539999999999999 112.501 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.1 p 48.13 -158.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 65.129999999999995 110.823 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 49.77 93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.932 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.69 163.77 18.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.299999999999997 110.841 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -138.85 139.98 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 73.140000000000001 110.858 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -81.84 -41.65 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 75.239999999999995 111.093 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.6 m 70.78 99.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 74.200000000000003 110.88 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.9 p -91.83 27.42 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 111.146 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -173.04 -173.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 62.109999999999999 111.088 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 138.06 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 75.120000000000005 110.929 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.7 p -81.27 -150.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 73.109999999999999 111.131 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 168.65 -67.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.510000000000005 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -64.76 -19.87 66.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 72.5 110.949 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 25.5 mt -88.16 140.24 29.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.25 110.916 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -154.98 -48.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.209999999999994 110.873 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.99 51.39 0.82 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 61.310000000000002 112.472 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.5 29.74 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 74.450000000000003 110.92 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.472 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 29.3 m-70 -156.11 -50.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.310000000000002 110.859 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 15.8 t 80.04 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.239999999999995 111.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.0 133.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 75.540000000000006 111.154 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -151.01 17.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 71.430000000000007 110.889 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -135.29 -166.55 11.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 72.549999999999997 112.47 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 175.08 172.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 73.129999999999995 110.89 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.94 100.38 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 75.150000000000006 111.144 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -39.87 90.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 75.239999999999995 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 179.71 -168.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.915 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.68 14.69 51.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 42.219999999999999 112.507 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -55.58 -22.02 20.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 74.010000000000005 110.902 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -50.28 -30.26 11.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 71.150000000000006 110.886 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 16.7 mm -73.32 -39.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 71.219999999999999 111.147 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.3 t -48.33 -44.05 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 62.43 111.135 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.72 -47.4 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.530000000000001 110.892 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -27.51 62.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.540000000000006 111.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 46.3 mtm -80.32 -39.76 28.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 72.140000000000001 110.852 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -87.44 30.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.219999999999999 110.878 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -122.48 -13.54 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.319999999999993 110.884 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -128.84 24.13 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.851 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -120.73 73.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 75.430000000000007 112.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 146' ' ' GLY . 24.0 p -24.37 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 75.109999999999999 110.87 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -49.62 -36.13 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.310000000000002 110.869 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -54.08 -25.6 22.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.450000000000003 110.917 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.57 -45.16 1.26 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.791 -0.719 . . . . 72.230000000000004 112.512 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 116.1 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 74.030000000000001 110.905 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -78.96 133.13 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 111.138 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -23.25 67.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 74.230000000000004 110.838 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.23 -169.33 2.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 74.299999999999997 110.908 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.08 134.39 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 73.540000000000006 110.885 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -115.25 87.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.219999999999999 111.129 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.0 p -102.38 168.77 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 111.174 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.8 mp -113.4 118.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.340000000000003 111.162 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.33 -70.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 111.136 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -119.1 173.24 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 53.140000000000001 110.863 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.2 p -171.9 178.57 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 110.833 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.69 -143.9 15.4 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 63.229999999999997 112.517 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.455 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.5 tt0 -107.29 132.95 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.862 0.363 . . . . 73.409999999999997 110.924 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -59.78 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 73.209999999999994 110.902 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.200000000000003 110.884 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.795 0.331 . . . . 72.540000000000006 110.851 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.68 142.47 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 72.099999999999994 111.129 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.89 162.13 0.83 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 74.549999999999997 110.89 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 149.23 66.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 73.329999999999998 112.345 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.0 m -136.94 86.21 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 61.450000000000003 111.126 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.98 159.85 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 111.107 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -137.33 161.35 36.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 71.310000000000002 110.928 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.64 137.55 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.400000000000006 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.42 100.16 9.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 73.140000000000001 110.858 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mm -75.44 144.88 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 74.540000000000006 111.18 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.7 154.1 41.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.131 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.8 t -129.16 98.84 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.239999999999995 111.121 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.54 54.98 8.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.099999999999994 110.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.08 7.93 52.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 62.210000000000001 112.469 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -140.05 95.76 8.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 75.319999999999993 110.856 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 161.65 45.12 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 70.150000000000006 112.289 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.31 25.94 5.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.916 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -162.69 21.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 75.439999999999998 112.441 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 -176.92 5.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 74.140000000000001 110.885 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.7 m -135.19 163.91 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 75.540000000000006 111.123 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -116.5 94.82 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.150000000000006 110.868 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -89.63 116.79 28.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 75.230000000000004 110.881 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.34 113.68 26.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.340000000000003 110.923 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 23.6 mt -79.94 139.71 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 75.540000000000006 110.941 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -86.97 60.22 6.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.433 . . . . 70.420000000000002 110.886 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.53 -25.26 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.230000000000004 111.087 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.9 -61.06 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.239999999999995 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -19.12 62.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.219999999999999 110.875 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.99 82.7 8.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.682 0.753 . . . . 71.239999999999995 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.62 24.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 65.129999999999995 112.3 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -58.52 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 74.430000000000007 110.925 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.7 m -52.0 -45.09 64.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 111.115 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.22 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.239999999999995 111.081 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -57.47 -23.18 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 110.926 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.51 -71.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.409999999999997 110.874 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -48.72 -44.23 38.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.230000000000004 110.857 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.73 -33.18 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 74.120000000000005 110.837 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.73 -38.79 28.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.450000000000003 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.408 ' HB2' HD11 ' A' ' 78' ' ' ILE . 1.1 tt -89.33 20.06 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 74.430000000000007 110.922 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -112.39 -15.18 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 73.019999999999996 110.864 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 p -117.52 4.68 12.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 74.400000000000006 111.132 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.96 30.13 66.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 74.129999999999995 112.491 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -38.6 50.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.968 0.413 . . . . 63.25 110.906 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.82 -17.05 54.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 110.9 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.72 -26.36 24.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 73.230000000000004 112.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.34 159.61 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 71.450000000000003 110.843 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.3 -78.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 65.329999999999998 112.491 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -167.44 -64.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 73.109999999999999 110.96 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tptt 59.77 166.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 70.299999999999997 110.882 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 118.67 14.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 71.310000000000002 112.479 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.8 m -159.14 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 72.420000000000002 110.811 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -142.88 119.14 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 74.140000000000001 110.879 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.23 122.54 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.219999999999999 110.894 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.92 70.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 72.319999999999993 110.848 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.43 39.49 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 74.400000000000006 110.855 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 mt -96.26 140.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.230000000000004 111.139 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.436 HG13 ' HD2' ' A' ' 58' ' ' PRO . 2.0 tt -135.05 133.02 20.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.587 0.708 . . . . 64.010000000000005 111.184 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.436 ' HD2' HG13 ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.8 125.21 11.86 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 51.140000000000001 112.375 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.33 26.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 75.010000000000005 112.514 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -156.73 -82.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 73.010000000000005 110.855 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -179.96 -150.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.340000000000003 110.848 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.9 m -146.79 144.22 29.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 73.099999999999994 110.91 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.49 164.64 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.329999999999998 110.878 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.22 -79.33 0.7 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.769 -0.729 . . . . 54.43 112.454 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.99 -150.66 22.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 71.340000000000003 112.488 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.11 155.07 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 74.109999999999999 110.884 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 62.77 158.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 74.049999999999997 110.902 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.38 -67.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 75.120000000000005 111.065 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -119.7 48.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 75.519999999999996 110.85 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' ARG . 11.1 m170 38.07 51.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.858 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -152.42 121.08 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 64.310000000000002 110.893 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.67 102.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 75.349999999999994 112.486 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 54.0 p -98.3 -64.03 1.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.841 0.353 . . . . 74.519999999999996 111.168 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.35 -92.37 0.97 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 75.150000000000006 112.505 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.47 23.61 1.69 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 63.240000000000002 112.516 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -56.91 -177.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 75.430000000000007 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -133.15 15.26 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 74.340000000000003 110.819 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.47 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.0 OUTLIER 83.9 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 75.400000000000006 111.184 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.93 -23.25 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 62.200000000000003 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.04 -156.68 26.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 64.409999999999997 112.503 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.95 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 71.040000000000006 110.908 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -155.84 155.34 32.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 74.219999999999999 110.917 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -119.55 145.91 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 75.099999999999994 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -64.57 152.98 40.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 72.540000000000006 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.8 93.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 75.109999999999999 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -58.56 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 75.510000000000005 110.885 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 175.44 175.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.400000000000006 110.909 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.58 43.52 2.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 73.340000000000003 110.921 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 mm -46.23 -32.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 74.150000000000006 111.147 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.5 mt -91.0 147.71 22.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.439999999999998 110.924 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -126.33 -166.37 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.510000000000005 110.884 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -98.65 -88.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.209999999999994 110.873 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.35 10.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.329999999999998 111.163 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.59 141.07 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 71.0 112.488 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 156.68 62.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 75.230000000000004 112.318 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.52 -28.8 9.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 60.340000000000003 112.475 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 50.3 mm -62.82 147.87 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 72.019999999999996 111.102 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -99.1 148.8 23.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 74.420000000000002 110.877 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -145.49 176.96 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.420000000000002 110.845 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.474 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 4.8 mmt -82.52 170.72 14.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.409999999999997 110.926 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -140.38 100.12 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 61.119999999999997 111.083 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -161.0 -169.86 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.420000000000002 110.923 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.471 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -53.38 -32.84 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.150000000000006 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.23 -68.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 74.549999999999997 112.445 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.73 120.52 7.3 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.200000000000003 112.345 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 11.9 m-20 32.96 58.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 75.340000000000003 110.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.555 ' O ' ' C ' ' A' ' 108' ' ' ASN . 19.2 p -139.71 33.12 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.099999999999994 111.161 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 107' ' ' THR . 2.4 p30 23.89 -101.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 73.230000000000004 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 100' ' ' MET . . . 166.08 -165.25 38.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 63.310000000000002 112.468 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.45 13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 73.319999999999993 110.854 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 70.36 72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 75.0 110.941 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 113' ' ' PHE . 0.4 OUTLIER 175.59 122.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 71.530000000000001 110.87 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 112' ' ' PHE . 11.4 t80 178.83 47.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 75.140000000000001 110.847 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.91 94.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.540000000000006 111.117 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.5 p -83.28 133.22 34.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.140000000000001 110.87 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -91.05 -10.38 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 72.340000000000003 111.145 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.16 149.43 47.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.400000000000006 111.079 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.16 131.98 46.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 74.530000000000001 110.895 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.05 47.14 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 65.540000000000006 111.093 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.02 -15.45 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 73.239999999999995 110.872 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -57.81 -20.21 34.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 70.319999999999993 110.955 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.28 -46.32 28.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 73.129999999999995 110.944 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.99 -58.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 73.540000000000006 110.851 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.0 64.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.43 112.508 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -105.47 -28.45 10.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 75.140000000000001 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.23 125.5 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 110.899 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.01 114.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 73.200000000000003 111.152 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -98.42 139.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 73.129999999999995 111.133 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -176.26 123.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 73.430000000000007 110.904 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.38 134.85 8.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.733 . . . . 62.229999999999997 112.491 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -152.02 165.26 35.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 72.409999999999997 110.873 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.8 p -72.84 159.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 111.158 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.49 -47.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.430000000000007 110.879 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.39 178.51 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 70.439999999999998 110.839 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 51.44 69.5 1.12 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.778 -0.725 . . . . 62.310000000000002 112.471 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.52 -1.16 40.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.333 . . . . 74.019999999999996 110.898 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -77.71 -27.12 50.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.859 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.34 -44.38 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 111.152 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.7 t -90.11 9.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.519999999999996 111.13 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.89 -66.38 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 72.299999999999997 110.868 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.83 -51.51 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 73.519999999999996 111.111 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.0 ttm -50.95 -44.43 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 74.430000000000007 110.875 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -52.8 -27.11 16.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 73.400000000000006 110.892 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -62.63 -23.09 66.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 63.539999999999999 110.909 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -78.65 2.46 19.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.120000000000005 110.904 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.16 -161.37 6.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 72.099999999999994 112.5 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.9 m -142.15 -77.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 71.439999999999998 110.849 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.893 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -92.94 14.93 16.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 73.150000000000006 110.938 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.41 -42.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.742 -0.742 . . . . 74.209999999999994 112.542 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 155.67 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 73.340000000000003 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.0 p -130.24 157.85 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 72.409999999999997 111.175 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.1 p -79.01 -16.49 56.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 64.219999999999999 110.88 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.39 -169.72 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 72.329999999999998 110.912 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.55 40.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.129999999999995 110.893 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.51 127.39 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 75.0 111.146 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.13 143.49 47.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 111.134 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.91 104.97 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 75.109999999999999 111.157 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.25 -59.95 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 73.209999999999994 111.073 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -144.33 171.1 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 65.349999999999994 110.869 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.3 p -175.58 145.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.329999999999998 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.0 -178.92 36.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 64.439999999999998 112.529 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -81.4 122.78 27.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 70.010000000000005 110.88 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mt -94.92 -30.68 14.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.030000000000001 110.936 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.109999999999999 110.916 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.812 0.339 . . . . 73.329999999999998 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.19 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.319999999999993 111.115 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -89.58 144.27 31.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 75.120000000000005 110.902 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 124.57 11.23 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.273 . . . . 74.209999999999994 112.349 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -117.1 145.99 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 74.299999999999997 111.133 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.36 148.75 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 65.019999999999996 111.105 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -110.0 154.47 23.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 74.310000000000002 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.14 137.47 42.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.549999999999997 110.861 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.36 124.0 44.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 110.888 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.89 129.05 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.549999999999997 111.092 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.9 168.54 12.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 74.230000000000004 111.085 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.5 t -152.39 107.23 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 62.310000000000002 111.155 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.25 25.23 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 73.439999999999998 110.845 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.63 -14.04 65.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.030000000000001 112.499 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.82 139.28 21.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.73 . . . . 71.319999999999993 110.905 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.49 64.97 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.722 2.281 . . . . 74.040000000000006 112.374 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -66.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 73.299999999999997 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.29 -174.83 36.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 64.340000000000003 112.459 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -118.76 126.09 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 71.120000000000005 110.877 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.2 t -121.14 119.72 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.173 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.3 p -107.14 148.93 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.040000000000006 110.895 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.3 105.72 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 73.109999999999999 110.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.93 162.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 74.329999999999998 110.909 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.94 119.24 35.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 72.450000000000003 110.909 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.85 84.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.010000000000005 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.91 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.430000000000007 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.59 -28.71 37.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 73.219999999999999 110.888 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.45 -71.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 75.230000000000004 110.903 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 29' ' ' VAL . 30.7 m -101.46 99.5 11.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.56 0.695 . . . . 74.150000000000006 111.133 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.678 2.252 . . . . 72.150000000000006 112.361 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -43.22 66.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.9 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.422 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 6.4 m -85.8 21.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 64.230000000000004 111.125 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.05 -45.31 20.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 61.439999999999998 111.122 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ASN . 86.9 tt0 -83.57 -24.21 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 72.150000000000006 110.89 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -30.79 -70.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 62.030000000000001 110.896 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -74.01 -32.42 63.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 75.430000000000007 110.926 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -50.82 -37.9 45.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 72.219999999999999 110.863 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.57 -29.99 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.098 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 mt -66.94 -51.65 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.912 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -65.35 -47.83 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 54.549999999999997 110.863 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 80.8 p -68.83 -24.07 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 64.450000000000003 111.171 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.49 83.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 75.120000000000005 112.482 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 33.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.396 . . . . 74.019999999999996 110.895 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -124.73 27.58 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 72.140000000000001 110.887 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.09 14.34 68.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 62.310000000000002 112.502 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -174.91 173.86 2.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 75.340000000000003 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.61 153.93 7.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 51.039999999999999 112.484 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.97 137.88 41.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.947 0.403 . . . . 74.329999999999998 110.944 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -41.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 74.010000000000005 110.912 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.03 43.35 0.55 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 53.439999999999998 112.489 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.26 31.67 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.430000000000007 110.885 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.0 m 62.96 174.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.894 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -168.2 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 110.855 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 -59.75 1.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.140000000000001 110.878 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -155.68 -169.99 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 74.340000000000003 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -168.4 141.84 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.310000000000002 111.166 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.6 mt -134.87 95.89 15.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.66 0.743 . . . . 72.310000000000002 111.128 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 81.14 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.346 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.45 -27.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 51.329999999999998 112.474 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -51.46 2.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.439999999999998 110.931 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.97 -159.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 75.319999999999993 110.853 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 36.8 m -129.46 -66.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.230000000000004 110.917 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 62' ' ' CYS . 14.6 tt0 64.34 136.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.9 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.75 161.9 13.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 70.439999999999998 112.495 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.17 91.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 73.230000000000004 112.512 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -108.38 -161.9 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 74.420000000000002 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -122.25 174.6 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 72.549999999999997 110.854 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 178.49 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 74.549999999999997 111.144 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 73.53 -154.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.019999999999996 110.902 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -175.69 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.439999999999998 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -23.32 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.931 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.56 -77.36 1.04 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 74.120000000000005 112.499 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 p -115.79 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 75.239999999999995 111.135 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.41 41.22 1.79 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 72.439999999999998 112.474 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 152.14 14.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 72.510000000000005 112.482 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.19 151.23 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 73.329999999999998 110.911 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -102.61 157.65 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 71.319999999999993 110.903 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -39.38 -38.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 73.209999999999994 111.159 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.78 49.96 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 74.409999999999997 110.935 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.45 -120.58 7.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.769 -0.729 . . . . 72.540000000000006 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.98 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 74.209999999999994 110.93 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.26 176.34 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.349999999999994 110.893 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.54 175.23 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.349999999999994 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.36 173.69 10.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.834 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.4 158.43 28.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 73.310000000000002 110.822 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.98 -58.59 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.049999999999997 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.97 150.93 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 74.150000000000006 110.893 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -125.01 68.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 71.400000000000006 110.9 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.6 mt -83.19 0.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 72.310000000000002 111.119 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 32.9 mt -121.56 83.18 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 71.239999999999995 110.941 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.9 mttm -70.17 141.14 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 74.140000000000001 110.899 179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -55.7 91.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 110.838 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 48.1 p -86.9 7.62 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 73.299999999999997 111.171 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.45 -165.32 30.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 73.319999999999993 112.438 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 166.04 28.91 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 75.129999999999995 112.358 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 80.13 -0.06 84.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 74.0 112.502 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.1 mm -83.18 141.43 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 74.5 111.148 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 0.1 OUTLIER -116.29 141.4 48.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 71.030000000000001 110.95 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.819 ' O ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -150.22 30.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 62.109999999999999 110.86 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.819 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 ptp 34.1 120.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 75.019999999999996 110.891 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -46.91 170.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.239999999999995 111.117 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -174.49 174.77 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.140000000000001 110.904 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.0 24.7 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 62.520000000000003 111.089 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.5 -178.41 21.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 72.129999999999995 112.5 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.95 41.69 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.662 2.242 . . . . 71.340000000000003 112.357 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 67.63 27.87 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 p -150.55 50.92 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 70.519999999999996 111.156 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -80.88 1.81 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 65.540000000000006 110.914 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.93 88.58 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 73.140000000000001 112.468 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 m -145.75 -145.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.349 . . . . 74.109999999999999 110.833 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 4.4 tp-100 -109.77 -80.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 110.923 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HB3' ' O ' ' A' ' 111' ' ' GLN . 8.2 p90 178.94 137.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 72.319999999999993 110.868 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' ' C ' ' A' ' 114' ' ' ILE . 5.7 p90 -131.26 45.29 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.019999999999996 110.876 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 113' ' ' PHE . 79.1 mt -28.07 130.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 75.409999999999997 111.14 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 77.5 m -83.07 148.09 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.230000000000004 110.832 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.4 p -117.88 22.98 11.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 61.420000000000002 111.124 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.58 175.76 6.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.140000000000001 111.124 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 86.57 4.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 74.019999999999996 110.904 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.0 p -112.11 52.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 72.25 111.125 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -87.26 23.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 71.239999999999995 110.871 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 8.67 39.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 64.519999999999996 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.43 1.41 51.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 62.310000000000002 110.935 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 49.3 66.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 75.439999999999998 110.863 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 41.19 36.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 55.340000000000003 112.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -57.21 -32.87 66.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 75.549999999999997 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -108.67 156.82 19.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 75.420000000000002 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.56 94.49 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 111.097 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 49.6 t -74.46 136.07 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.530000000000001 111.156 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -163.84 26.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.936 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.54 -178.34 15.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 44.130000000000003 112.461 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.33 147.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 74.439999999999998 110.817 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 6.6 t -72.21 103.8 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 74.530000000000001 111.163 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -53.58 25.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 110.884 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -166.8 157.55 12.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 71.200000000000003 110.88 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.93 6.05 54.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.120000000000005 112.48 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.8 ttt -49.66 -31.15 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 74.120000000000005 110.886 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -52.04 -24.04 6.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 74.319999999999993 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 6.5 mt -81.84 -39.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 74.019999999999996 111.113 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.96 -44.65 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.340000000000003 111.159 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.62 -29.48 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.340000000000003 110.896 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.47 67.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 71.129999999999995 111.104 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -23.35 57.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 73.219999999999999 110.847 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -89.56 29.21 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.450000000000003 110.913 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.73 3.75 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.109999999999999 110.821 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.16 13.5 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.340000000000003 110.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.06 -160.91 36.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.744 . . . . 60.210000000000001 112.514 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.1 t -154.13 18.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.519999999999996 110.849 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 46.91 59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 71.420000000000002 110.871 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -177.34 -36.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 65.239999999999995 110.93 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.75 -56.98 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 74.400000000000006 112.485 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.95 116.29 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 75.439999999999998 110.877 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 19.6 p -90.28 158.47 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 74.25 111.134 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 t -68.57 -21.66 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 75.329999999999998 110.866 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.47 -168.0 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 73.230000000000004 110.834 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.47 124.43 34.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.909 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.7 mp -100.17 104.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 71.430000000000007 111.166 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.92 175.8 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 64.219999999999999 111.19 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.74 143.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 72.120000000000005 111.118 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.35 -59.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.0 111.098 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -154.78 164.5 38.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 75.040000000000006 110.845 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.0 m -144.79 -162.97 1.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.209999999999994 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.92 -155.54 22.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 34.240000000000002 112.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.24 134.9 50.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.346 . . . . 70.129999999999995 110.886 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 tp -55.35 -59.07 5.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 74.219999999999999 110.892 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.209999999999994 110.913 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 72.319999999999993 110.892 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.61 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 65.099999999999994 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.8 160.72 35.59 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 54.439999999999998 110.895 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 152.9 69.43 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 73.400000000000006 112.387 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 m -123.75 43.87 2.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 73.319999999999993 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -50.67 143.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.549999999999997 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -135.41 175.9 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.340000000000003 110.913 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -146.14 145.66 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.239999999999995 110.87 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -102.23 135.21 44.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 63.399999999999999 110.876 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.04 131.0 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 71.25 111.142 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.26 167.8 13.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.329999999999998 111.081 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -148.27 98.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.129999999999995 111.131 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 70.519999999999996 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.33 -12.09 70.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 71.420000000000002 112.513 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -95.84 131.81 28.44 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 74.439999999999998 110.894 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 145.57 57.87 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.754 2.302 . . . . 73.549999999999997 112.342 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.0 tp -114.9 -67.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 64.400000000000006 110.861 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.23 177.5 41.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 71.420000000000002 112.477 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 135.92 49.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.450000000000003 110.907 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.12 129.48 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 74.430000000000007 111.131 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.3 t -90.84 96.5 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 74.109999999999999 110.836 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.83 81.82 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.409999999999997 110.871 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -57.51 143.49 40.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 73.129999999999995 110.897 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.3 mt -109.6 117.47 34.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 72.299999999999997 110.895 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.69 72.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.310000000000002 110.851 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.82 -30.18 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 72.239999999999995 111.096 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -54.03 -60.33 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 70.519999999999996 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.69 -61.93 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.921 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.08 94.2 46.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 74.329999999999998 111.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -22.83 31.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 71.219999999999999 112.315 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -66.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 73.230000000000004 110.905 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 60.5 p -52.84 -40.93 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.099999999999994 111.123 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.88 -71.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 63.240000000000002 111.079 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 37' ' ' ARG . 34.2 tt0 -40.66 -65.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 75.239999999999995 110.898 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.6 t30 -34.18 -45.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 71.129999999999995 110.884 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -77.11 -38.92 51.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 73.230000000000004 110.894 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -51.89 -29.84 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 72.430000000000007 110.865 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.06 55.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 72.25 111.122 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.8 mt -67.82 -54.45 18.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.129999999999995 110.877 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 t -52.91 -41.89 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.439999999999998 110.874 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.3 p -71.08 -21.6 62.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 74.400000000000006 111.143 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.78 91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.010000000000005 112.495 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 35.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 110.861 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -144.0 12.43 1.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 110.926 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.27 17.33 74.27 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 71.140000000000001 112.45 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -175.26 -166.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 71.450000000000003 110.926 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 130.77 -149.08 19.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 74.510000000000005 112.489 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -98.08 -26.16 14.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 75.430000000000007 110.93 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.32 139.33 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 110.856 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.69 60.23 5.94 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 74.400000000000006 112.531 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t -137.49 -165.93 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 72.420000000000002 110.88 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -157.21 168.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.240000000000002 110.869 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -81.47 120.69 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 75.219999999999999 110.905 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -93.69 -17.53 23.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -145.26 137.76 25.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.873 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.5 mt -150.33 121.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 74.209999999999994 111.128 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt -137.76 108.14 8.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 71.400000000000006 111.132 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 107.64 1.91 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 74.329999999999998 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 130.82 -34.13 2.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 72.409999999999997 112.537 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.22 -68.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 75.049999999999997 110.871 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -165.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 73.150000000000006 110.83 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.66 137.32 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.409999999999997 110.884 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -100.15 140.98 33.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.932 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.54 -43.97 9.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 74.510000000000005 112.465 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.67 -139.92 7.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.693 -0.765 . . . . 75.109999999999999 112.449 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 t0 179.4 136.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 72.209999999999994 110.84 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.93 29.8 7.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 110.858 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.3 m -150.48 -72.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 65.239999999999995 111.139 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.83 -163.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 74.219999999999999 110.884 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -173.45 -50.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 110.873 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -103.27 91.76 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 110.868 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.4 -50.54 0.89 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.751 . . . . 74.25 112.495 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.5 p -142.96 167.09 22.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.344 . . . . 74.530000000000001 111.145 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.25 175.0 21.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.734 -0.746 . . . . 60.299999999999997 112.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -133.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 72.450000000000003 112.531 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -175.5 176.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 75.420000000000002 110.839 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.03 -173.72 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.219999999999999 110.832 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -87.36 -32.03 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 73.430000000000007 111.157 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.37 82.36 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 70.120000000000005 110.943 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.29 -125.87 8.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 65.040000000000006 112.463 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -116.61 -85.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 73.540000000000006 110.903 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 175.0 9.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 73.319999999999993 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.74 155.26 40.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.329999999999998 110.832 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 168.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 74.450000000000003 110.898 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.29 130.62 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 70.430000000000007 110.869 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -50.31 18.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 73.099999999999994 110.869 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.76 159.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.908 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -105.4 29.84 6.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 73.329999999999998 110.875 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 22.0 mm -51.31 -27.53 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 73.230000000000004 111.134 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.15 103.3 15.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.530000000000001 110.893 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.7 107.34 19.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 71.239999999999995 110.883 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.42 98.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 110.847 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 42.36 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 74.109999999999999 111.115 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.33 178.93 23.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 75.239999999999995 112.521 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.29 19.25 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.241 . . . . 74.5 112.329 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.17 -34.75 3.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 61.219999999999999 112.503 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.6 mm -50.91 137.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 73.510000000000005 111.137 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.432 ' HB3' ' HA3' ' A' ' 130' ' ' GLY . 2.7 tt -98.38 128.64 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.510000000000005 110.93 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.42 -171.07 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 72.150000000000006 110.834 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 9.5 mmt -116.63 -173.4 2.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 70.040000000000006 110.877 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 102' ' ' ASN . . . -101.35 -48.77 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 61.149999999999999 111.053 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' ' 101' ' ' ALA . 5.4 p-10 39.73 -165.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 65.409999999999997 110.906 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -158.86 22.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 72.340000000000003 111.103 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.3 -67.92 0.34 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 75.430000000000007 112.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.75 -156.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 74.140000000000001 112.315 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.22 87.31 7.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 75.230000000000004 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 7.2 t -153.75 51.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.329999999999998 111.167 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -71.64 -4.88 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 71.299999999999997 110.895 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.65 76.04 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 74.510000000000005 112.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.0 p -127.3 -140.88 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 73.109999999999999 110.871 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -77.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.95 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 170.89 148.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 110.842 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.78 122.58 14.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.010000000000005 110.886 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.0 tt -123.95 137.46 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 71.129999999999995 111.124 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.83 148.48 22.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.140000000000001 110.888 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -92.68 -18.74 22.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.409999999999997 111.094 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.0 179.89 5.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 75.439999999999998 111.125 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -65.7 90.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 75.049999999999997 110.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 27.2 p -116.9 59.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 64.209999999999994 111.187 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.09 28.06 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 74.310000000000002 110.856 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -91.81 10.63 27.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 110.91 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -23.65 17.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 72.510000000000005 110.913 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.8 OUTLIER 56.72 85.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 60.25 110.87 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.589 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 20.18 61.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 42.149999999999999 112.461 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -104.66 -14.36 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 75.420000000000002 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 -110.99 -8.94 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.400000000000006 110.848 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 42.6 t 65.74 96.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 111.133 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.8 t -83.12 130.36 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.109999999999999 111.139 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.11 27.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.888 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.432 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -152.72 -179.67 28.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 75.25 112.523 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.09 136.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 74.510000000000005 110.915 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 1.4 t -63.32 119.07 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.400000000000006 111.165 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.47 -42.28 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 74.439999999999998 110.904 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.39 156.01 13.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 74.019999999999996 110.908 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.65 1.96 57.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.763 . . . . 71.349999999999994 112.51 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -29.1 8.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.329999999999998 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.93 -22.32 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.239999999999995 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.2 mm -89.84 -35.67 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 72.409999999999997 111.11 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.4 t -52.62 -22.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.120000000000005 111.149 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -84.29 -35.38 23.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.340000000000003 110.888 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.02 94.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 72.5 111.1 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.3 ptm -71.39 -37.15 71.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 74.120000000000005 110.893 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.04 34.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 74.450000000000003 110.922 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -10.86 6.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 75.129999999999995 110.912 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.17 14.59 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.450000000000003 110.861 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -106.77 71.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.707 -0.759 . . . . 73.319999999999993 112.525 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.553 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.73 131.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 71.099999999999994 110.843 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -46.25 -46.54 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 73.040000000000006 110.901 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -47.0 -37.9 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 75.200000000000003 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.07 -47.67 0.92 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 63.5 112.463 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 110.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 75.310000000000002 110.889 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.1 t -82.62 145.12 29.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 75.030000000000001 111.182 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -22.46 52.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 72.299999999999997 110.874 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -136.31 163.91 29.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 75.340000000000003 110.952 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.14 130.8 51.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.230000000000004 110.878 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.82 120.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 111.169 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.6 p -119.31 165.41 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.450000000000003 111.181 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.629 ' O ' ' CB ' ' A' ' 159' ' ' ALA . 3.9 mp -90.37 -64.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 72.430000000000007 111.144 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.629 ' CB ' ' O ' ' A' ' 158' ' ' ILE . . . 93.93 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 64.150000000000006 111.127 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.59 147.08 15.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 74.420000000000002 110.874 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.2 p -176.24 -174.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.510000000000005 110.889 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.0 -163.73 28.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 62.549999999999997 112.484 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -81.39 120.07 24.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 74.109999999999999 110.908 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.2 mt -91.91 -23.97 19.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.92 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 110.943 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.333 . . . . 73.109999999999999 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 89.1 t 62.38 104.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 73.010000000000005 111.137 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -60.19 151.93 64.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 63.140000000000001 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 117.25 4.97 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 65.319999999999993 112.34 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 48.7 m -110.35 132.12 54.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 72.329999999999998 111.132 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -123.99 160.48 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 111.151 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -127.92 160.04 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 63.130000000000003 110.911 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -135.84 126.98 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.019999999999996 110.914 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.27 72.08 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.865 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.16 135.12 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.310000000000002 111.133 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -123.27 151.38 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.120000000000005 111.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.6 t -133.31 100.85 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t0 54.06 55.73 7.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 64.319999999999993 110.897 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.31 12.27 55.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 75.310000000000002 112.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -142.87 94.22 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.645 0.736 . . . . 72.319999999999993 110.887 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.2 Cg_endo -69.7 167.13 25.27 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.271 . . . . 74.049999999999997 112.386 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.78 30.05 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 71.049999999999997 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.0 -164.02 22.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 70.299999999999997 112.481 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 164.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 75.430000000000007 110.818 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.3 m -128.8 171.8 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 74.120000000000005 111.107 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -149.84 148.58 29.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.858 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -125.32 154.05 42.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 71.409999999999997 110.868 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -94.15 -53.28 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 62.539999999999999 110.874 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.9 mt 73.81 122.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 110.936 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -88.75 69.04 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.530000000000001 110.875 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.49 48.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 64.109999999999999 111.098 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.95 -34.25 26.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 61.420000000000002 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -31.42 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 65.530000000000001 110.879 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.8 67.6 79.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 71.040000000000006 111.138 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 61.64 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 72.420000000000002 112.355 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.68 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 75.209999999999994 110.875 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -75.2 -60.5 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.400000000000006 111.152 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.43 -1.32 57.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.239999999999995 111.128 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.8 tm-20 -82.19 -19.99 38.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 74.239999999999995 110.886 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -101.28 -27.86 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 72.450000000000003 110.859 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -50.95 -29.47 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.899 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -31.17 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.409999999999997 110.869 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.2 -30.64 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 64.549999999999997 111.129 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.5 tt -84.47 5.46 27.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.954 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 m -108.15 -2.67 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 70.530000000000001 110.83 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -117.16 13.21 14.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 74.319999999999993 111.146 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.58 26.58 10.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.010000000000005 112.47 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -33.47 28.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 74.319999999999993 110.93 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -17.97 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.9 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.09 -63.27 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 52.130000000000003 112.463 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -102.29 148.99 24.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 64.109999999999999 110.828 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.63 151.45 6.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 74.129999999999995 112.491 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -49.56 103.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 64.239999999999995 110.921 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -139.55 -47.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 110.846 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.69 33.76 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 74.340000000000003 112.457 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -172.83 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 73.140000000000001 110.858 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.2 m -89.51 -172.09 3.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 75.329999999999998 110.874 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -75.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.019999999999996 110.876 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 41.42 -160.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.842 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.35 19.35 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.219999999999999 110.84 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.06 139.94 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 75.340000000000003 111.099 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -139.87 108.58 7.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 75.299999999999997 111.157 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 92.35 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 63.130000000000003 112.345 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.11 21.27 2.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.150000000000006 112.474 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.05 -66.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 73.329999999999998 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptp -163.54 -168.94 1.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.239999999999995 110.857 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.73 97.09 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 110.841 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.68 141.48 36.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 74.540000000000006 110.942 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.03 -50.22 70.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 54.149999999999999 112.525 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.03 109.05 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 73.340000000000003 112.506 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.59 6.69 22.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 60.310000000000002 110.893 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.5 t80 48.59 33.49 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 75.049999999999997 110.879 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.27 171.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 72.310000000000002 111.152 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 68.25 -179.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 71.230000000000004 110.901 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.66 48.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 73.5 110.885 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.09 -31.11 44.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 72.409999999999997 110.837 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.96 29.61 0.94 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 74.150000000000006 112.503 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -139.9 41.6 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 64.040000000000006 111.176 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.38 -69.01 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 72.530000000000001 112.461 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.65 -155.31 6.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 64.340000000000003 112.489 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -176.1 -163.78 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 73.530000000000001 110.932 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 148.84 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.409999999999997 110.879 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -44.14 -55.31 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.239999999999995 111.142 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -128.3 26.62 5.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 74.329999999999998 110.966 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.04 -167.25 17.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 64.420000000000002 112.485 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -118.24 -29.59 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 75.030000000000001 110.879 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -168.88 136.36 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 73.230000000000004 110.942 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -112.03 158.78 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.129999999999995 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.61 161.68 22.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.430000000000007 110.899 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -79.39 108.04 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.230000000000004 110.831 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.5 -52.64 12.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 73.450000000000003 110.857 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -178.9 168.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 72.439999999999998 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.91 72.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.936 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 16.4 mt -76.83 -3.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 73.150000000000006 111.139 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -120.53 91.64 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 74.010000000000005 110.897 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -75.47 -167.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 73.0 110.901 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -95.05 72.54 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 74.129999999999995 110.858 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 p -69.63 -17.92 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 73.129999999999995 111.133 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.06 -177.11 43.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.240000000000002 112.476 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.82 52.08 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 63.210000000000001 112.326 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 104.12 22.35 8.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 54.219999999999999 112.476 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.8 mm -99.36 137.25 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 73.040000000000006 111.153 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 7.1 mt -111.11 148.18 33.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 72.409999999999997 110.898 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.664 ' O ' ' C ' ' A' ' 100' ' ' MET . 1.8 p -163.69 55.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 64.150000000000006 110.869 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.664 ' C ' ' O ' ' A' ' 99' ' ' SER . 3.0 mmt 7.96 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 63.530000000000001 110.861 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.07 110.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 54.049999999999997 111.095 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -142.54 -164.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 75.109999999999999 110.888 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -47.99 -51.85 22.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 73.310000000000002 111.126 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 124.96 -61.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 62.509999999999998 112.498 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.474 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.3 Cg_endo -69.76 100.0 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 71.010000000000005 112.335 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 63.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 73.140000000000001 110.919 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 39.9 p -134.73 13.59 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 72.299999999999997 111.153 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 42.28 -100.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 72.420000000000002 110.928 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.94 166.52 10.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 75.540000000000006 112.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.75 22.75 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 75.099999999999994 110.824 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.86 90.3 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 74.120000000000005 110.938 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -72.44 155.7 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 73.019999999999996 110.894 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 10.1 p90 -120.96 107.3 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.519999999999996 110.9 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.27 111.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 111.108 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.88 136.85 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 74.310000000000002 110.903 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.84 13.17 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 111.145 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.5 11.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.049999999999997 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.28 138.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 70.120000000000005 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 71.1 p -139.34 46.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.340000000000003 111.085 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -54.06 -25.39 21.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.219999999999999 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 21.0 p90 -62.43 -18.53 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.239999999999995 110.949 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 33.8 mt -82.58 -34.97 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.129999999999995 110.938 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.78 -10.0 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 75.420000000000002 110.879 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.18 52.46 1.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.777 -0.725 . . . . 75.230000000000004 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 -29.74 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 74.450000000000003 110.912 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -112.36 154.97 24.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.874 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 6.6 p -50.08 109.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.010000000000005 111.095 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.1 p -76.58 153.79 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 73.450000000000003 111.143 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 130' ' ' GLY . 4.8 p90 -177.02 178.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 72.140000000000001 110.884 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 43.61 114.15 0.0 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 73.310000000000002 112.516 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -119.53 35.41 4.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 75.420000000000002 110.913 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 3.6 t 60.23 162.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 111.075 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -136.63 -58.08 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 73.010000000000005 110.923 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 175.29 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.934 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.37 81.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.705 -0.759 . . . . 70.340000000000003 112.446 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.9 tpt -91.62 -25.94 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 74.310000000000002 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.42 -30.72 53.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.030000000000001 110.892 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.499 ' O ' ' HB2' ' A' ' 142' ' ' MET . 43.6 mm -44.07 -39.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 111.169 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.1 -52.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 61.229999999999997 111.134 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -45.83 -49.99 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 73.219999999999999 110.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.11 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 72.430000000000007 111.094 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.499 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 9.6 ttm -50.3 -31.42 14.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 73.519999999999996 110.855 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 72.310000000000002 110.918 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -62.61 -14.21 40.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 110.883 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.87 3.65 47.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.400000000000006 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.28 -156.09 31.06 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 64.450000000000003 112.503 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 -165.99 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 63.409999999999997 110.9 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -84.4 -48.35 9.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 71.099999999999994 110.87 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -94.68 10.55 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 74.120000000000005 110.884 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.19 -150.77 17.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 54.420000000000002 112.481 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 65.04 142.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.120000000000005 110.91 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 p -114.41 141.46 47.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 73.450000000000003 111.082 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -18.0 63.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 75.25 110.838 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.12 -162.42 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 72.120000000000005 110.896 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -116.41 93.88 4.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 73.430000000000007 110.888 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.83 117.69 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.310000000000002 111.13 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.8 t -136.77 -178.36 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 72.25 111.143 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 35.5 mm -105.22 115.88 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 75.530000000000001 111.121 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.91 -62.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 72.420000000000002 111.117 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.06 167.27 20.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.409999999999997 110.834 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.13 -174.63 4.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 73.230000000000004 110.888 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.45 -160.93 24.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 74.140000000000001 112.49 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -110.35 137.01 48.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 73.25 110.925 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -47.91 -60.97 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 72.200000000000003 110.895 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 75.129999999999995 110.873 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.788 0.328 . . . . 75.25 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -139.44 146.23 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.319999999999993 111.156 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.51 156.55 1.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 65.140000000000001 110.924 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 151.16 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.667 2.245 . . . . 73.400000000000006 112.353 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -141.98 145.74 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.095 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.9 m -136.82 163.21 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 75.329999999999998 111.107 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -135.8 162.71 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.219999999999999 110.881 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -139.32 131.79 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.340000000000003 110.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -101.58 75.54 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.219999999999999 110.872 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.1 146.36 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.310000000000002 111.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -138.94 164.77 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 63.399999999999999 111.118 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 83.8 t -139.81 104.76 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 63.43 111.093 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 63.21 52.54 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 110.891 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.05 17.46 61.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 44.140000000000001 112.498 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -132.19 106.56 13.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 73.109999999999999 110.893 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.3 Cg_endo -69.75 138.85 38.82 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.664 2.243 . . . . 73.049999999999997 112.313 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.76 18.33 13.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 110.892 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.75 167.22 13.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 73.209999999999994 112.495 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.75 175.67 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 72.329999999999998 110.88 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m -122.39 -176.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 111.114 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -134.77 86.31 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.85 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -84.83 127.23 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 63.109999999999999 110.88 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -104.03 145.42 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 74.5 110.914 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 mt -110.11 113.65 26.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 73.409999999999997 110.908 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 15.9 m-85 -73.81 67.46 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 71.400000000000006 110.926 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.97 77.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.530000000000001 111.062 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.9 -54.77 14.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.319999999999993 110.845 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.2 mptp? -69.21 -60.83 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 74.409999999999997 110.891 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -121.14 95.89 48.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 73.209999999999994 111.097 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -23.13 31.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.253 . . . . 65.209999999999994 112.358 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -78.55 -51.19 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 75.120000000000005 110.955 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.1 m -64.85 -30.94 71.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 75.439999999999998 111.126 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.66 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 72.129999999999995 111.115 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.0 tt0 -56.47 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 70.400000000000006 110.948 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -29.29 -54.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 75.5 110.888 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -77.07 -39.32 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.400000000000006 110.905 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -50.04 -31.75 13.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.420000000000002 110.901 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.91 -36.86 72.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 72.209999999999994 111.124 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 30.7 mt -64.58 -43.86 92.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 71.209999999999994 110.899 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -59.16 -50.63 73.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.450000000000003 110.883 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.7 p -74.91 -18.8 60.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 74.409999999999997 111.182 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.86 83.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 73.409999999999997 112.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.35 31.95 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 65.340000000000003 110.88 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -122.78 26.93 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.510000000000005 110.844 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 2.32 55.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 71.140000000000001 112.503 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -163.28 178.67 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.38 . . . . 73.099999999999994 110.885 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.34 131.96 3.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 74.310000000000002 112.461 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 161.43 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 73.430000000000007 110.924 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.96 -40.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 71.239999999999995 110.896 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.91 43.54 1.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 74.219999999999999 112.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.53 165.08 24.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.519999999999996 110.849 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -131.01 -179.56 5.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 74.230000000000004 110.831 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -113.63 -69.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 110.904 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 61.61 20.25 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 73.349999999999994 110.885 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -138.03 29.93 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.439999999999998 110.85 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.9 144.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 73.409999999999997 111.124 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.6 mm -134.52 107.39 10.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 74.430000000000007 111.118 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 98.51 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.727 2.284 . . . . 73.120000000000005 112.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.13 -28.95 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 53.329999999999998 112.493 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.94 -63.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 73.150000000000006 110.913 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -176.94 -157.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 75.109999999999999 110.87 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 t -144.41 137.06 26.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 72.340000000000003 110.902 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 167.61 21.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 110.885 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.23 159.8 24.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 74.439999999999998 112.478 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 90.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 64.439999999999998 112.464 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.5 81.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 71.319999999999993 110.876 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -81.99 171.13 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.549999999999997 110.878 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.23 -49.18 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 75.019999999999996 111.172 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.5 tpt85 -88.93 -43.07 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 73.299999999999997 110.819 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -58.9 -164.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 72.040000000000006 110.839 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -34.47 78.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 73.340000000000003 110.869 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.27 145.43 37.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 73.239999999999995 112.468 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -131.55 -169.35 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 71.329999999999998 111.158 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.08 -24.74 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 71.530000000000001 112.487 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.91 76.99 0.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 75.140000000000001 112.493 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -118.79 179.6 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 72.129999999999995 110.88 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t -85.62 146.72 26.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.129999999999995 110.835 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -71.26 -41.87 74.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 73.439999999999998 111.15 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -97.07 -5.64 37.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.955 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 -143.33 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 55.43 112.437 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -118.9 -25.58 6.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 73.109999999999999 110.877 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -170.75 141.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -108.8 154.1 22.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.049999999999997 110.916 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -88.29 164.43 15.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 73.400000000000006 110.896 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.01 116.32 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 65.140000000000001 110.899 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.68 -49.58 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.420000000000002 110.871 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.93 140.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.310000000000002 110.924 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.15 70.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.530000000000001 110.917 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 19.4 mm -80.38 4.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 64.129999999999995 111.103 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -108.32 121.77 45.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 110.913 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 92' ' ' HIS . 14.3 mttp -123.81 82.85 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.019999999999996 110.891 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.458 ' O ' ' CB ' ' A' ' 93' ' ' THR . 5.0 m80 38.78 -160.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 75.239999999999995 110.863 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.458 ' CB ' ' O ' ' A' ' 92' ' ' HIS . 1.2 t 161.8 -38.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 73.040000000000006 111.16 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 158.7 -163.6 33.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 75.049999999999997 112.486 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 128.54 16.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 75.340000000000003 112.372 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.17 -5.44 15.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 70.239999999999995 112.487 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.401 HG22 HG12 ' A' ' 128' ' ' VAL . 1.7 mm -61.88 139.87 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.352 . . . . 74.340000000000003 111.108 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.6 tt -100.86 125.97 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.120000000000005 110.963 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.78 125.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 72.129999999999995 110.859 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -33.77 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 74.109999999999999 110.852 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 62.84 155.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 111.124 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p30 172.0 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 75.340000000000003 110.888 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.429 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -78.18 -22.51 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.209999999999994 111.081 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.8 -64.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 54.530000000000001 112.506 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.1 Cg_endo -69.68 87.45 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 71.349999999999994 112.367 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 32.55 78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 72.019999999999996 110.87 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.94 15.53 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 111.175 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 43.73 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.409999999999997 110.871 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 73.56 132.97 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 70.430000000000007 112.448 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.9 p -129.18 77.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 62.520000000000003 110.825 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -93.85 -31.92 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 73.150000000000006 110.904 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 71.97 69.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 73.439999999999998 110.86 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -90.82 111.03 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.120000000000005 110.908 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.5 mt -102.89 111.31 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 75.519999999999996 111.107 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.24 160.02 29.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 71.530000000000001 110.87 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.6 p -133.65 27.83 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.129999999999995 111.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.31 32.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 72.239999999999995 111.104 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.2 tttt 62.39 146.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 73.420000000000002 110.868 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 38.4 p -141.97 58.65 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 73.400000000000006 111.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.404 ' HA ' ' CD2' ' A' ' 92' ' ' HIS . 8.1 tm-20 -49.56 -24.7 2.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 65.030000000000001 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -60.02 -36.03 76.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 75.299999999999997 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.57 106.32 18.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 72.340000000000003 110.905 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -43.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.040000000000006 110.859 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.23 -38.26 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 54.420000000000002 112.497 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -59.94 -35.83 75.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 72.239999999999995 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -131.81 140.13 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.129999999999995 110.83 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.786 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 72.7 t -74.14 -81.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.209999999999994 111.078 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.786 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 72.4 t 103.08 127.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 72.439999999999998 111.168 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -147.55 18.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.420000000000002 110.854 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.27 146.43 16.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 64.450000000000003 112.458 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -156.42 140.05 15.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 75.409999999999997 110.861 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -48.65 109.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 111.152 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 -36.03 24.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 75.530000000000001 110.865 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.01 175.37 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 61.25 110.862 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 48.69 73.09 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 71.340000000000003 112.485 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -3.53 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.77 0.319 . . . . 75.109999999999999 110.88 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -84.25 -34.64 23.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 71.319999999999993 110.84 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 142' ' ' MET . 50.2 mm -42.47 -41.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 111.168 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.79 -49.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.135 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -46.5 -50.27 17.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.329999999999998 110.873 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.48 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.030000000000001 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 4.9 ttm -50.38 -38.51 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.835 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.99 -27.62 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.129999999999995 110.909 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -62.66 -14.89 48.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 72.530000000000001 110.863 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -89.51 13.22 14.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.200000000000003 110.922 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.02 -156.34 28.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 55.25 112.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.5 t -166.87 169.79 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 71.140000000000001 110.828 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -54.0 -47.31 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 73.400000000000006 110.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 3.29 53.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.140000000000001 110.886 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.36 13.25 79.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 62.130000000000003 112.476 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.576 ' O ' ' CG2' ' A' ' 152' ' ' THR . 4.9 tppp? -45.55 -29.14 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.383 . . . . 75.340000000000003 110.957 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.576 ' CG2' ' O ' ' A' ' 151' ' ' LYS . 0.6 OUTLIER 86.73 -169.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 74.349999999999994 111.136 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.559 ' N ' ' CG2' ' A' ' 152' ' ' THR . 23.3 t -137.7 -52.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.299999999999997 110.895 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 -168.09 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 110.892 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.67 111.13 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 75.519999999999996 110.9 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.4 mt -107.24 101.76 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.109999999999999 111.164 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.4 p -113.64 168.66 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.219999999999999 111.132 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.95 106.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 111.162 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -55.0 -54.57 41.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 51.299999999999997 111.113 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.24 167.97 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.897 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -156.5 160.87 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 74.329999999999998 110.853 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.84 179.83 46.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 53.329999999999998 112.481 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 7.3 mt-30 -74.89 -37.89 62.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 74.409999999999997 110.902 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.58 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.5 mm? 71.41 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 75.540000000000006 110.951 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 72.219999999999999 110.881 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.829 0.347 . . . . 74.439999999999998 110.863 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.03 152.64 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.310000000000002 111.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -67.48 137.63 93.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.597 0.713 . . . . 73.400000000000006 110.885 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.54 51.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 74.239999999999995 112.343 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -127.75 148.38 50.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 72.209999999999994 111.136 -179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.44 160.04 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 74.430000000000007 111.135 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.425 ' CD1' ' CD2' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.5 162.25 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 75.439999999999998 110.829 -179.95 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -139.32 136.43 34.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 71.019999999999996 110.889 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.77 69.85 1.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 110.897 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.2 mm -51.52 129.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 75.209999999999994 111.105 -179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.48 163.12 16.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 52.119999999999997 111.093 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.5 t -140.89 104.99 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.530000000000001 111.125 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t0 51.49 53.23 13.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 64.530000000000001 110.875 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.15 10.09 55.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 74.430000000000007 112.43 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -142.57 96.52 6.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.635 0.731 . . . . 72.209999999999994 110.903 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.69 157.69 59.66 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 74.450000000000003 112.343 -180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.84 21.0 8.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.928 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.64 169.42 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 74.540000000000006 112.489 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.03 172.68 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 74.319999999999993 110.886 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 4.5 m -138.59 158.77 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.129999999999995 111.154 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.8 p -140.83 143.75 34.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 73.430000000000007 110.884 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -125.88 123.54 38.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 64.310000000000002 110.874 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -47.01 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 73.019999999999996 110.901 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 75.27 117.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 71.340000000000003 110.914 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -83.67 57.58 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 71.219999999999999 110.835 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.24 -26.33 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.209999999999994 111.134 179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.1 -59.34 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 71.209999999999994 110.83 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -50.24 -57.73 7.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 110.88 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -110.48 90.21 9.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.638 0.732 . . . . 71.450000000000003 111.142 179.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -19.33 36.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 2.24 . . . . 74.140000000000001 112.393 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -79.84 -58.25 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.120000000000005 110.873 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.2 t -87.11 25.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 72.409999999999997 111.173 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.21 -42.25 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.420000000000002 111.093 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' HA ' ' HB3' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -76.85 -10.01 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 110.917 -179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -42.41 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.349999999999994 110.891 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -81.42 -32.16 32.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 73.430000000000007 110.863 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 5.5 ttp85 -55.1 -39.98 69.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 110.839 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.52 -37.06 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 64.310000000000002 111.106 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.74 33.46 1.03 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.239999999999995 110.896 -179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 t -151.2 -22.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 90.0 m -84.47 -42.14 15.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 73.129999999999995 111.163 -179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 151.28 -31.1 0.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 73.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 42' ' ' GLY . 8.4 tp10 -33.46 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 75.209999999999994 110.882 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 141.42 30.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 75.450000000000003 110.93 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.29 -30.49 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 73.120000000000005 112.458 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -47.07 -36.1 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 72.120000000000005 110.863 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.85 -146.37 3.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 75.140000000000001 112.486 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 136.45 43.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 75.25 110.915 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -162.62 -39.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 64.310000000000002 110.904 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.54 43.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 63.409999999999997 112.495 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.0 m -120.74 168.43 11.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 75.430000000000007 110.838 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -58.96 163.44 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 73.200000000000003 110.871 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.38 -70.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 71.540000000000006 110.89 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -163.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 71.219999999999999 110.823 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 51.82 35.74 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 74.549999999999997 110.899 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 86.0 mt -90.11 135.38 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.230000000000004 111.146 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 tt -141.15 115.94 7.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 72.140000000000001 111.156 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.73 69.14 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.72 2.28 . . . . 71.209999999999994 112.326 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.54 69.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 52.219999999999999 112.495 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.61 -71.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 71.319999999999993 110.868 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -166.72 -159.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.230000000000004 110.851 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.45 -49.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.319999999999993 110.889 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 67.99 145.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.450000000000003 110.953 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.44 -67.12 1.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 54.329999999999998 112.484 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.15 -151.73 20.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 72.329999999999998 112.501 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.81 -166.72 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.885 0.374 . . . . 60.100000000000001 110.874 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -167.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.150000000000006 110.823 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 t -125.53 -46.71 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.349999999999994 111.142 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -116.65 31.84 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 73.530000000000001 110.87 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.31 149.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 75.450000000000003 110.88 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -145.63 158.39 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.299999999999997 110.925 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.07 27.3 19.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 43.509999999999998 112.519 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.4 p -121.84 -54.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 72.109999999999999 111.172 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.98 -148.06 18.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.747 -0.74 . . . . 71.540000000000006 112.468 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.31 36.99 3.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.754 . . . . 72.129999999999995 112.509 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -49.51 166.7 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 73.439999999999998 110.899 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.9 p -85.11 144.21 28.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 71.219999999999999 110.851 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.8 pp -58.45 -13.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 71.120000000000005 111.078 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -20.34 13.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 75.219999999999999 110.959 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.72 -131.76 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.329999999999998 112.514 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -95.42 -36.52 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.926 0.393 . . . . 72.25 110.916 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.04 157.07 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 62.240000000000002 110.891 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -147.97 138.98 23.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 74.430000000000007 110.889 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 64.209999999999994 110.939 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.51 158.65 20.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 75.310000000000002 110.847 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -54.51 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.310000000000002 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.62 145.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 110.894 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -104.83 57.32 0.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.439999999999998 110.877 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.4 mm -74.32 -24.61 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.049999999999997 111.127 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.4 mt -95.17 133.81 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.929 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.22 78.33 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 74.040000000000006 110.919 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' LYS . 21.9 m80 33.23 -140.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 75.310000000000002 110.837 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 168.29 -51.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 63.399999999999999 111.106 -179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.08 -153.65 13.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 70.25 112.507 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 109.59 2.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 72.510000000000005 112.341 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.06 -22.85 4.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 62.210000000000001 112.491 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 5.0 mm -50.82 141.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 73.549999999999997 111.097 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.97 132.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 71.439999999999998 110.918 179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.34 33.84 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.329999999999998 110.855 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 43.71 -159.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.430000000000007 110.901 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.425 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -170.52 138.98 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 74.400000000000006 111.143 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.4 m-20 166.39 -74.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 64.310000000000002 110.91 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.68 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -171.79 122.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 111.101 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.803 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.43 -37.78 61.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 71.010000000000005 112.49 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.803 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.8 84.91 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 71.549999999999997 112.324 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.6 m120 43.52 62.09 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 110.908 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.413 ' HB ' ' CB ' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -154.13 57.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 65.549999999999997 111.156 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.99 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.921 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.29 173.42 37.13 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.681 -0.771 . . . . 70.150000000000006 112.46 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.09 13.35 12.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 75.439999999999998 110.852 -179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -63.88 -165.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 73.430000000000007 110.948 179.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -155.64 93.62 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.310000000000002 110.894 -179.94 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.46 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 72.140000000000001 110.888 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 2.6 mt -121.54 138.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 74.209999999999994 111.128 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 m -83.38 162.16 21.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 73.040000000000006 110.868 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -135.18 15.58 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 73.150000000000006 111.165 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.75 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.120000000000005 111.117 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 61.88 156.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.299999999999997 110.861 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 36.7 p -108.35 -141.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 74.120000000000005 111.125 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 119' ' ' THR . 0.3 OUTLIER 161.7 -51.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.409999999999997 110.864 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -7.05 53.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 72.019999999999996 110.933 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.71 10.16 16.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 75.310000000000002 110.893 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.87 127.5 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.219999999999999 110.886 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.56 32.62 61.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 75.510000000000005 112.483 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 -66.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 75.140000000000001 110.904 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -125.4 160.43 29.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 75.129999999999995 110.857 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.5 t -61.06 117.89 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 73.230000000000004 111.129 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 2.8 p -101.82 138.36 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 72.340000000000003 111.131 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -178.94 111.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 110.894 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.7 134.96 6.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 70.319999999999993 112.42 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -155.2 147.9 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 72.140000000000001 110.877 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.2 m -53.17 125.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.329999999999998 111.142 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -89.01 -49.09 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 110.872 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 172.59 11.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.866 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.35 0.83 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 63.340000000000003 112.495 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -84.58 3.83 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 73.109999999999999 110.901 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -32.9 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.921 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.522 ' O ' ' HB3' ' A' ' 142' ' ' MET . 45.8 mm -65.28 -38.45 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 73.319999999999993 111.093 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.2 t -91.57 13.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 73.349999999999994 111.088 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -128.57 -66.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.019999999999996 110.854 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.92 15.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 75.239999999999995 111.11 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.522 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 8.5 tmm? -48.49 -36.95 16.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 60.229999999999997 110.923 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -53.85 -31.63 50.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 75.049999999999997 110.848 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -16.9 40.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.886 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -82.08 4.89 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 73.299999999999997 110.858 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.05 -163.86 34.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 63.039999999999999 112.469 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -157.98 20.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 70.209999999999994 110.819 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 47.05 60.97 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.83 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 t30 174.96 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.865 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.22 -56.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 65.549999999999997 112.505 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 132.06 39.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.867 0.365 . . . . 74.310000000000002 110.879 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.2 p -111.67 144.85 40.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.540000000000006 111.157 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 110.895 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -159.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.931 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -132.73 137.79 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 61.32 110.91 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.3 pt -126.44 136.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.129999999999995 111.107 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 159.15 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 71.219999999999999 111.136 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.7 mm -83.12 104.84 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.310000000000002 111.145 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.23 -56.58 7.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 62.030000000000001 111.099 179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.13 175.39 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 54.310000000000002 110.867 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.1 p -174.45 154.41 2.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 73.530000000000001 110.825 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.27 -176.57 46.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.450000000000003 112.498 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.8 OUTLIER -73.62 -38.34 65.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 74.540000000000006 110.901 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.549 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.2 mm? 71.29 -65.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 75.349999999999994 110.934 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.510000000000005 110.918 179.913 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 75.430000000000007 110.883 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.83 156.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.439999999999998 111.147 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.88 126.88 57.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 75.25 110.852 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 145.41 57.19 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.701 2.267 . . . . 73.430000000000007 112.374 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -132.64 123.41 26.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 75.430000000000007 111.132 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 m -100.42 151.06 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.430000000000007 111.118 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.23 153.54 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.519999999999996 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 138.79 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 75.129999999999995 110.888 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -101.42 152.59 20.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 74.420000000000002 110.888 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -129.51 135.75 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.101 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 157.56 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.120000000000005 111.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 m -140.94 111.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 72.200000000000003 111.14 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.27 25.56 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 70.200000000000003 110.913 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.97 -14.2 65.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.752 -0.737 . . . . 74.239999999999995 112.498 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -93.69 140.85 23.2 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 73.019999999999996 110.9 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.83 68.51 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.633 2.222 . . . . 75.400000000000006 112.356 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.47 -66.2 1.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 74.439999999999998 110.921 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.42 -148.19 5.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 73.5 112.459 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 127.41 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 73.129999999999995 110.901 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -100.28 144.89 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.230000000000004 111.11 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -107.25 94.71 5.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 74.030000000000001 110.831 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -88.21 126.3 35.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 110.883 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -107.8 145.87 32.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 110.906 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -114.93 119.28 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 73.109999999999999 110.93 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -82.75 81.66 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 72.099999999999994 110.909 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.38 -2.66 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 75.109999999999999 111.12 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -80.02 -42.13 24.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 72.099999999999994 110.858 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -97.11 -24.22 15.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 110.89 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -140.44 82.74 15.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.682 0.753 . . . . 74.239999999999995 111.086 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -49.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.634 2.223 . . . . 74.519999999999996 112.343 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -55.95 11.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.329999999999998 110.89 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -50.77 -48.97 59.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 111.116 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -27.94 64.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.107 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -61.42 -31.02 70.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 110.861 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -66.27 -71.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 53.439999999999998 110.881 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.6 t80 -48.54 -30.43 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 110.86 -179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -57.23 -40.94 78.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.299999999999997 110.836 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.51 -21.52 45.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 73.120000000000005 111.107 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.1 mt -76.46 -40.47 50.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.040000000000006 110.892 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -72.22 -46.51 55.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 54.009999999999998 110.828 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -82.51 8.17 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 75.209999999999994 111.166 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.55 40.79 11.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 75.340000000000003 112.459 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -54.96 -27.36 43.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 75.010000000000005 110.891 -179.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.8 mtpm? -113.46 -6.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.329999999999998 110.903 179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 40.8 32.88 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 71.200000000000003 112.451 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -121.1 -18.75 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 73.230000000000004 110.873 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.58 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 64.510000000000005 112.496 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -156.09 15.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.942 0.401 . . . . 73.25 110.911 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -60.76 127.63 32.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 71.329999999999998 110.897 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.93 67.6 1.85 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 72.319999999999993 112.519 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 m -164.29 -94.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.795 0.331 . . . . 73.25 110.822 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.7 p -172.3 -168.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 71.530000000000001 110.853 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -178.21 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 70.219999999999999 110.893 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -114.02 -50.17 2.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 72.439999999999998 110.84 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -179.07 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.847 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 175.03 122.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.310000000000002 111.107 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 30.7 mt -133.47 112.91 13.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 64.519999999999996 111.129 179.892 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 82.08 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 74.349999999999994 112.363 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.19 -32.81 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.129999999999995 112.525 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -59.41 1.71 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 73.109999999999999 110.845 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.8 -166.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.919 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.1 129.0 19.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 71.030000000000001 110.903 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 132.62 51.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.299999999999997 110.914 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.96 141.65 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 61.439999999999998 112.544 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.78 165.25 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 71.109999999999999 112.472 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 177.15 86.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 42.32 110.846 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -116.49 178.46 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 110.826 -179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.403 ' HA ' ' CA ' ' A' ' 75' ' ' GLY . 0.1 OUTLIER -173.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 111.176 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -103.87 144.48 31.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 73.430000000000007 110.859 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 172.12 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 72.439999999999998 110.865 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p30 171.83 33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 75.010000000000005 110.884 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.06 23.6 77.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.734 . . . . 71.120000000000005 112.458 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -145.89 115.87 7.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.37 . . . . 62.219999999999999 111.135 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.58 -169.52 0.51 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 70.019999999999996 112.489 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 68' ' ' THR . . . -59.12 172.21 4.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 72.450000000000003 112.497 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.37 172.45 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 65.200000000000003 110.856 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.605 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -124.04 26.33 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 110.873 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.605 ' HB ' ' O ' ' A' ' 77' ' ' SER . 57.0 mt 87.56 -59.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 75.340000000000003 111.185 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.46 28.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 61.420000000000002 110.912 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.93 166.69 13.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 75.319999999999993 112.488 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.71 -84.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.387 . . . . 63.340000000000003 110.877 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 152.22 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 73.530000000000001 110.914 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -115.26 168.58 9.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 74.409999999999997 110.907 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -86.39 159.68 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.329999999999998 110.89 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.83 116.01 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 71.299999999999997 110.854 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 -47.87 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 75.019999999999996 110.908 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 p30 175.52 174.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 74.129999999999995 110.875 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.74 38.21 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.349999999999994 110.91 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.65 -26.73 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 75.25 111.121 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.45 118.51 30.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.924 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -110.6 167.75 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.040000000000006 110.871 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.26 96.21 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 64.430000000000007 110.918 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -96.01 4.21 52.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 111.17 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 -161.25 23.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 74.530000000000001 112.536 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -57.14 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.662 2.241 . . . . 62.32 112.407 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -66.25 142.61 43.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.120000000000005 112.526 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -161.85 118.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 74.310000000000002 111.141 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.18 121.11 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 72.150000000000006 110.937 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 p -150.84 -161.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.329999999999998 110.825 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 mtp -112.63 99.66 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 75.329999999999998 110.865 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -83.58 73.0 10.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 63.130000000000003 111.095 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.65 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.87 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.53 -92.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 111.107 179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 169.8 -61.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.409999999999997 112.484 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 54.1 Cg_endo -69.73 90.46 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.717 2.278 . . . . 74.409999999999997 112.359 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 37.82 42.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.219999999999999 110.902 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 22.5 p -139.17 39.63 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 70.219999999999999 111.123 -179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.73 177.34 6.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.120000000000005 110.935 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.43 -117.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 23.23 112.477 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 94.3 p -107.16 -165.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 61.240000000000002 110.861 -179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 73.07 63.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.219999999999999 110.935 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.87 -178.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.540000000000006 110.888 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.71 129.97 8.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 75.109999999999999 110.92 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 59.0 mt -84.75 109.28 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 73.120000000000005 111.101 -179.976 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.478 ' C ' ' H ' ' A' ' 117' ' ' ALA . 84.3 m -51.61 -33.64 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.91 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.51 -33.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 73.549999999999997 111.171 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.478 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . -138.63 173.57 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 111.099 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -69.39 88.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 74.409999999999997 110.895 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 31.6 p -92.17 65.09 4.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.329999999999998 111.135 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -5.55 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.349999999999994 110.847 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.9 -5.13 39.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 73.239999999999995 110.918 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 98.4 mt -89.35 -48.48 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.929 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.8 -85.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 73.140000000000001 110.847 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -118.49 109.34 1.75 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.686 -0.769 . . . . 75.409999999999997 112.472 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.48 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 73.120000000000005 110.911 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -119.97 134.04 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.510000000000005 110.828 179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.55 97.21 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.319999999999993 111.146 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.27 131.63 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 54.329999999999998 111.126 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.445 ' HA ' HG21 ' A' ' 29' ' ' VAL . 22.8 p90 -136.33 4.51 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 65.019999999999996 110.877 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.82 -161.33 9.11 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 55.439999999999998 112.459 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 177.2 -169.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 75.540000000000006 110.925 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.9 t -103.83 88.8 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 111.104 179.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -40.78 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 74.510000000000005 110.888 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.08 163.96 3.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 70.400000000000006 110.894 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.26 11.58 44.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 64.439999999999998 112.479 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -30.76 9.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 63.32 110.861 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -51.06 -26.42 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.140000000000001 110.926 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mm -78.83 -45.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.239999999999995 111.11 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 45.9 t -50.22 -44.03 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 72.219999999999999 111.126 179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.35 -29.68 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 70.340000000000003 110.904 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.43 -31.91 60.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 74.230000000000004 111.063 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 8.1 mtm -75.67 -35.07 60.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 75.109999999999999 110.888 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -84.13 31.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 73.310000000000002 110.85 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -126.42 -13.26 6.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.109999999999999 110.906 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.35 17.65 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 74.219999999999999 110.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.61 -156.58 30.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.219999999999999 112.513 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.76 -64.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 72.450000000000003 110.888 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.39 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 72.430000000000007 110.9 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.28 11.79 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 74.209999999999994 110.915 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.27 15.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 62.32 112.446 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 75.53 -58.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 74.010000000000005 110.9 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.5 m 71.12 145.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.349999999999994 111.145 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.45 1.83 56.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 110.876 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -141.01 165.71 26.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 74.129999999999995 110.916 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -106.23 115.92 31.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 75.349999999999994 110.916 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.3 mp -87.96 105.87 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 72.140000000000001 111.126 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -106.93 167.85 9.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 75.209999999999994 111.093 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 83.0 mt -121.33 138.52 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 71.329999999999998 111.155 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.59 -56.4 3.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 75.239999999999995 111.118 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -158.81 166.92 30.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 73.450000000000003 110.844 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -145.72 -163.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.409999999999997 110.892 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 141.4 -150.37 21.82 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 65.329999999999998 112.496 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -106.25 134.38 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 72.030000000000001 110.909 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -57.78 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 74.540000000000006 110.94 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 75.219999999999999 110.876 179.915 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.839 0.352 . . . . 73.230000000000004 110.916 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.98 156.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 75.430000000000007 111.103 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -87.66 148.31 43.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.723 . . . . 74.140000000000001 110.903 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 122.73 9.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.271 . . . . 75.400000000000006 112.367 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 37.5 m -114.01 135.92 53.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.150000000000006 111.157 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 26.1 m -121.33 157.66 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 74.329999999999998 111.103 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 28.1 p90 -122.55 160.34 25.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.109999999999999 110.823 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -137.54 136.52 37.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.040000000000006 110.897 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.74 112.03 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 71.340000000000003 110.858 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -85.26 126.12 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 74.219999999999999 111.155 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.98 165.15 14.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.420000000000002 111.09 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.19 93.84 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 71.349999999999994 111.111 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.78 35.08 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 73.409999999999997 110.882 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -13.17 67.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.539999999999999 112.522 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.76 130.28 33.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.652 0.739 . . . . 73.310000000000002 110.917 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 151.61 69.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 74.140000000000001 112.332 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.2 tp -118.74 -67.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.924 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.92 -141.15 3.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 42.219999999999999 112.492 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -150.53 127.29 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 62.229999999999997 110.908 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.85 122.3 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.150000000000006 111.164 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 68.9 p -104.13 150.4 24.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 73.450000000000003 110.888 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -118.25 178.17 4.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.129999999999995 110.939 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 127.0 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 110.875 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.5 mt -95.43 106.21 18.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 75.040000000000006 110.918 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -72.68 75.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 73.439999999999998 110.888 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.91 -34.35 62.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 73.140000000000001 111.087 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.868 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.5 -65.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.439999999999998 110.872 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.44 93.07 30.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.588 0.709 . . . . 73.209999999999994 111.146 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -25.27 29.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.709 2.273 . . . . 60.119999999999997 112.364 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -78.74 -57.9 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 74.450000000000003 110.912 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 m -61.4 -26.08 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 64.019999999999996 111.177 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.58 -56.29 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.540000000000006 111.094 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.7 tt0 -62.66 -56.98 12.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.109999999999999 110.827 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.1 t-20 -28.07 -56.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 72.400000000000006 110.879 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.37 -40.57 62.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 71.430000000000007 110.929 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -48.3 -32.75 7.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 75.010000000000005 110.903 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.7 -43.25 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.094 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 73.209999999999994 110.938 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.2 m -76.3 -44.56 36.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 71.510000000000005 110.894 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -79.52 -0.55 33.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 74.230000000000004 111.162 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.87 78.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.787 -0.72 . . . . 54.310000000000002 112.451 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -99.21 0.86 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 73.150000000000006 110.9 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -127.51 -0.4 6.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.299999999999997 110.96 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 41.32 29.32 0.38 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 72.0 112.52 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.03 -33.15 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 73.439999999999998 110.859 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 74.109999999999999 112.44 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.88 149.68 21.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 71.239999999999995 110.929 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.9 119.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 75.519999999999996 110.93 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.87 22.18 76.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 74.25 112.479 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 p -94.17 -166.87 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.899 0.38 . . . . 74.450000000000003 110.881 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.3 m -99.2 -168.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.58 126.14 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.856 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -51.2 -62.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 74.230000000000004 110.863 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -149.57 167.28 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 75.209999999999994 110.859 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.7 mt -141.86 127.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 64.329999999999998 111.125 179.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 46.6 mt -140.48 90.92 9.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.653 0.74 . . . . 73.510000000000005 111.115 179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 108.65 2.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.238 . . . . 74.549999999999997 112.398 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.62 -45.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 55.25 112.424 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 -71.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 74.299999999999997 110.876 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -146.81 -174.74 4.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 74.299999999999997 110.871 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.97 117.87 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 65.310000000000002 110.891 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -136.58 166.39 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.200000000000003 110.92 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.76 29.98 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.79 -0.719 . . . . 53.509999999999998 112.51 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.89 137.1 8.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 74.120000000000005 112.477 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 170.35 132.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 75.150000000000006 110.913 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -60.17 163.73 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.540000000000006 110.861 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.77 -39.89 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 74.340000000000003 111.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -101.8 -25.11 13.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 74.549999999999997 110.878 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -66.24 -9.88 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.150000000000006 110.854 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 67.73 92.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 110.852 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.4 170.49 36.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 71.230000000000004 112.483 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 74.0 p -141.63 95.41 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 75.430000000000007 111.144 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.19 -25.63 3.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 72.109999999999999 112.487 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.14 -151.07 18.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 75.540000000000006 112.5 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.47 -167.51 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 73.310000000000002 110.902 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 130.19 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.832 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -48.03 -34.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 71.209999999999994 111.122 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.58 19.87 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 73.319999999999993 110.901 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.79 -140.99 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 72.409999999999997 112.479 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -122.99 -25.69 4.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 75.299999999999997 110.903 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -168.69 160.23 10.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 63.43 110.918 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -132.95 162.97 30.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.896 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -80.34 156.97 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 72.129999999999995 110.886 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.97 105.09 13.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 72.540000000000006 110.883 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.72 -41.57 97.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 75.420000000000002 110.887 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 175.07 171.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 74.109999999999999 110.884 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -130.4 32.62 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 110.905 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -19.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 75.129999999999995 111.164 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.9 128.31 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 110.921 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -121.29 179.39 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.894 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -78.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.340000000000003 110.821 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 61.96 11.37 4.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 75.310000000000002 111.186 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.86 166.63 34.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.219999999999999 112.544 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 163.09 39.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 75.140000000000001 112.34 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.98 9.87 79.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 74.230000000000004 112.529 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -97.57 150.08 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 74.099999999999994 111.168 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 1.7 tt -107.53 142.92 36.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 75.120000000000005 110.971 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 113' ' ' PHE . 0.4 OUTLIER -128.78 132.23 47.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.869 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.8 mmt -64.25 -45.73 86.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 74.120000000000005 110.901 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 46.62 72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.340000000000003 111.127 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -104.0 -163.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.230000000000004 110.891 -179.924 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.406 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -51.41 -32.4 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 111.095 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.563 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 132.76 -54.46 0.78 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 72.129999999999995 112.499 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.6 Cg_endo -69.8 -100.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 73.219999999999999 112.291 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.2 91.46 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.340000000000003 110.924 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.7 p -150.22 28.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 111.162 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.89 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.349999999999994 110.864 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.92 -90.75 0.22 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 73.319999999999993 112.45 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.7 t 76.54 33.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 73.420000000000002 110.86 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -90.0 -34.46 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.510000000000005 110.921 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.446 ' CB ' ' O ' ' A' ' 111' ' ' GLN . 3.9 t80 79.92 65.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 63.450000000000003 110.86 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.413 ' HB3' ' CB ' ' A' ' 99' ' ' SER . 27.5 t80 -96.74 95.11 7.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 63.299999999999997 110.843 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 19.4 mt -90.63 136.81 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 75.439999999999998 111.14 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.5 m -103.05 133.57 47.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.230000000000004 110.897 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 47.8 p -111.75 17.12 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 74.0 111.158 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.14 175.51 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 74.010000000000005 111.088 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.8 78.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 75.519999999999996 110.902 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 16.6 p -117.34 67.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 65.349999999999994 111.134 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.26 25.2 4.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 75.420000000000002 110.915 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.419 ' HD1' ' HG ' ' A' ' 122' ' ' LEU . 2.2 p90 -93.58 17.87 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.019999999999996 110.885 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -132.61 14.35 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 74.439999999999998 110.947 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.92 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.129999999999995 110.838 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.97 57.53 3.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 75.540000000000006 112.543 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -163.97 -52.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 73.129999999999995 110.915 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -104.83 133.41 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.400000000000006 110.839 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.32 101.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 75.040000000000006 111.126 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.02 138.68 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 74.540000000000006 111.138 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -161.82 25.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.889 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -118.65 -165.83 13.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 71.319999999999993 112.488 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 1.6 tttp 162.22 120.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 71.109999999999999 110.871 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.13 88.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 65.340000000000003 111.105 179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -71.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 75.519999999999996 110.945 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.54 159.13 44.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 71.239999999999995 110.847 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.22 42.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 62.100000000000001 112.492 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -30.41 13.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 72.200000000000003 110.885 -179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -53.62 -25.8 19.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 63.210000000000001 110.881 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.9 mm -90.23 -39.13 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 72.129999999999995 111.135 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.13 -23.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.400000000000006 111.17 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.05 -27.81 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 73.040000000000006 110.906 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.91 71.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 71.519999999999996 111.119 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.6 ptm -76.8 -15.61 59.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.919 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -88.99 27.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.310000000000002 110.856 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.11 0.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.040000000000006 110.902 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -121.08 6.86 10.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.329999999999998 110.913 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -117.28 45.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 75.439999999999998 112.476 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' GLY . 7.3 t 36.16 -147.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 64.019999999999996 110.834 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -139.59 7.92 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 73.400000000000006 110.905 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -16.96 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.319999999999993 110.851 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.54 -57.5 0.53 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.129999999999995 112.46 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.89 133.88 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 71.129999999999995 110.904 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.415 ' HA ' ' HA2' ' A' ' 146' ' ' GLY . 70.6 p -113.19 138.68 49.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 75.329999999999998 111.18 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -24.16 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 74.099999999999994 110.836 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -165.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 73.530000000000001 110.916 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -126.65 125.03 41.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 110.901 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.5 mp -99.4 105.94 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.329999999999998 111.129 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.07 171.86 7.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 74.099999999999994 111.157 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.93 147.16 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 75.409999999999997 111.129 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.69 -59.05 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 65.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.81 167.41 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 74.439999999999998 110.889 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.1 m -145.61 -166.11 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 73.519999999999996 110.855 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.06 -177.73 16.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 62.310000000000002 112.546 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.1 pt20 -94.52 136.36 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 72.209999999999994 110.911 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.412 ' HG ' ' N ' ' A' ' 165' ' ' GLU . 1.5 pt? -112.49 -34.81 5.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 63.140000000000001 110.917 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.412 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.239999999999995 110.87 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.856 0.36 . . . . 73.549999999999997 110.865 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -139.77 142.24 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 53.530000000000001 111.159 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -55.16 159.83 3.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 73.420000000000002 110.893 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 149.09 66.42 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.236 . . . . 74.120000000000005 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.71 49.84 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 75.010000000000005 111.107 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 m -42.31 140.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 75.340000000000003 111.166 179.841 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CE1' ' HA ' ' A' ' 161' ' ' CYS . 0.1 OUTLIER -124.85 165.28 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 74.140000000000001 110.892 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -142.5 137.73 30.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 72.439999999999998 110.905 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.56 86.22 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.836 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.7 mm -57.71 145.06 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.147 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.04 155.87 46.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 65.209999999999994 111.09 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.4 t -134.99 109.51 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 72.340000000000003 111.086 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 t0 57.98 52.41 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 75.519999999999996 110.923 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.53 12.63 56.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.010000000000005 112.505 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.51 107.82 26.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.637 0.732 . . . . 72.349999999999994 110.899 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.5 Cg_endo -69.75 143.41 50.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 72.230000000000004 112.348 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 21.44 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 74.129999999999995 110.897 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.37 166.39 20.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.807 -0.711 . . . . 61.350000000000001 112.519 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -175.32 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 74.430000000000007 110.852 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.8 m -138.8 175.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.340000000000003 111.148 179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 t -117.39 84.41 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.439999999999998 110.847 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -81.85 88.32 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 74.120000000000005 110.846 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.83 137.13 36.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 72.409999999999997 110.883 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.2 mt -111.82 144.99 40.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 75.310000000000002 110.92 179.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -91.59 67.24 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.239999999999995 110.872 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.66 -10.57 8.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.140000000000001 111.106 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -92.23 -35.08 14.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 54.020000000000003 110.864 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -86.92 -30.34 21.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 73.230000000000004 110.917 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG22 ' CG ' ' A' ' 129' ' ' PHE . 4.5 m -128.52 69.0 78.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.605 0.717 . . . . 73.109999999999999 111.14 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 60.08 1.62 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.696 2.264 . . . . 73.439999999999998 112.385 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.81 -63.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 72.109999999999999 110.896 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.93 -55.72 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 75.430000000000007 111.086 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -79.63 -12.99 59.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 73.439999999999998 111.051 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.29 -35.74 81.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 74.310000000000002 110.875 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.26 -31.48 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.450000000000003 110.883 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -50.9 -27.28 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.510000000000005 110.876 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -62.26 -30.91 71.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 75.019999999999996 110.901 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.21 -24.81 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 74.530000000000001 111.125 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.58 26.61 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 72.450000000000003 110.887 -179.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.93 -21.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 75.439999999999998 110.846 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -89.79 -30.64 17.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 53.439999999999998 111.135 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 135.32 -20.42 3.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 73.310000000000002 112.475 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -32.6 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 72.239999999999995 110.876 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 153.82 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 75.209999999999994 110.86 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.16 -33.01 0.43 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 71.019999999999996 112.466 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -55.05 -28.56 53.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 74.239999999999995 110.897 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -77.48 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 63.409999999999997 112.506 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 124.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.409999999999997 110.915 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -93.71 -77.45 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 74.120000000000005 110.89 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.6 -54.1 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 72.200000000000003 112.441 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.7 -164.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 72.129999999999995 110.841 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.8 p -157.0 134.45 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 71.409999999999997 110.946 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -94.77 123.76 38.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 72.109999999999999 110.901 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.94 32.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 75.5 110.84 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -133.02 27.17 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 72.430000000000007 110.862 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.8 138.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 72.310000000000002 111.102 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.92 111.13 17.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.613 0.721 . . . . 73.319999999999993 111.16 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 90.33 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 73.209999999999994 112.366 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.28 4.86 13.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 52.109999999999999 112.455 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.72 -66.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 72.129999999999995 110.868 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.15 -166.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 72.329999999999998 110.867 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.1 t -152.89 108.51 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.099999999999994 110.886 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -97.42 163.6 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 62.310000000000002 110.919 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -142.31 144.95 14.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 60.539999999999999 112.491 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.6 84.96 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 61.210000000000001 112.487 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -144.34 46.13 1.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 61.240000000000002 110.86 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.59 -53.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 75.129999999999995 110.887 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.409 ' HB ' ' HA2' ' A' ' 72' ' ' GLY . 5.2 p -93.99 39.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 75.230000000000004 111.138 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.0 -68.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 74.109999999999999 110.908 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -179.43 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.847 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -88.0 -65.51 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 74.310000000000002 110.878 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' HA2' ' HB ' ' A' ' 68' ' ' THR . . . 121.89 48.35 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 32.350000000000001 112.526 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -119.55 -23.03 6.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 72.299999999999997 111.115 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -119.08 -21.12 3.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 74.140000000000001 112.511 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -46.88 164.71 0.12 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 50.149999999999999 112.452 -179.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.89 -171.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 73.319999999999993 110.896 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m -79.52 -171.81 2.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 61.509999999999998 110.881 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 16.8 pt -92.85 -40.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.340000000000003 111.116 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -86.76 85.12 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 75.450000000000003 110.887 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.36 -107.77 3.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 70.319999999999993 112.44 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -91.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 74.099999999999994 110.869 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 150.58 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 64.329999999999998 110.855 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 154.41 39.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 75.0 110.853 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 20.7 pm0 -62.87 160.5 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 65.140000000000001 110.853 -179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.7 -169.47 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 52.439999999999998 110.907 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -132.96 -59.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 75.099999999999994 110.877 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -171.2 149.86 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 71.430000000000007 110.851 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.3 64.41 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.540000000000006 110.902 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.1 mt -78.16 2.31 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 74.010000000000005 111.147 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.74 132.65 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 74.219999999999999 110.942 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -110.06 123.34 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 72.129999999999995 110.88 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.19 91.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 75.040000000000006 110.877 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.9 p -129.58 21.9 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 64.030000000000001 111.183 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.26 167.48 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 71.129999999999995 112.445 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -44.94 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 64.310000000000002 112.308 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.79 40.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.030000000000001 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.26 141.7 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.439999999999998 111.162 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 tt -89.57 130.46 35.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 75.019999999999996 110.872 179.955 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.7 t -128.41 -147.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.420000000000002 110.845 -179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tpt -152.43 143.14 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.019999999999996 110.868 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -117.73 149.16 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 73.549999999999997 111.121 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 161.75 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.430000000000007 110.881 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.6 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -55.63 -36.87 67.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 62.210000000000001 111.106 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.7 -65.15 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 74.120000000000005 112.521 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.6 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 106.86 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.717 2.278 . . . . 71.420000000000002 112.321 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 6.0 p30 42.76 56.87 3.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.908 -179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.99 33.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 111.156 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -74.29 -0.71 17.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.450000000000003 110.918 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.9 119.63 19.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 33.350000000000001 112.484 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 8.9 t 54.86 -166.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 74.439999999999998 110.852 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 110' ' ' SER . 3.9 mm-40 64.04 118.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 75.540000000000006 110.905 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.4 156.87 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.855 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.76 154.6 36.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 74.430000000000007 110.882 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.17 105.5 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 75.349999999999994 111.153 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.24 146.38 53.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.430000000000007 110.86 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 p -96.14 19.99 10.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.111 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.24 177.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 75.540000000000006 111.138 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 131.63 51.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 73.340000000000003 110.902 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.16 41.05 3.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 71.129999999999995 111.145 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -49.02 -25.43 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 73.099999999999994 110.916 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -58.21 -32.62 68.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 64.409999999999997 110.952 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 mt -118.5 61.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 74.409999999999997 110.913 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -126.63 56.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.150000000000006 110.844 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 53.310000000000002 112.506 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 73.340000000000003 110.901 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -105.09 -16.35 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 74.549999999999997 110.843 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t 71.84 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.530000000000001 111.116 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 p -79.22 153.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.097 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.414 ' CG ' HG22 ' A' ' 29' ' ' VAL . 44.1 p90 -176.91 129.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.340000000000003 110.836 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.39 149.21 12.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 74.209999999999994 112.513 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -162.6 162.96 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 74.120000000000005 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 m -83.76 107.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.109999999999999 111.153 179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -41.03 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 73.019999999999996 110.871 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 178.9 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.219999999999999 110.896 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.67 74.58 0.32 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 74.420000000000002 112.5 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -84.35 -18.39 36.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 73.329999999999998 110.87 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.94 -36.83 24.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 73.409999999999997 110.913 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.524 ' O ' ' HB2' ' A' ' 142' ' ' MET . 37.9 mm -40.39 -45.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.519999999999996 111.109 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.9 t -89.09 -50.66 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 73.0 111.124 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -49.33 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 70.5 110.88 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.86 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 42.210000000000001 111.106 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.524 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 4.5 ttm -50.84 -45.71 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 64.430000000000007 110.874 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -52.07 -23.74 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.230000000000004 110.898 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -63.77 -26.29 68.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.852 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.28 8.28 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.549999999999997 110.945 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.25 -146.25 20.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 63.119999999999997 112.451 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.01 161.36 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 64.219999999999999 110.835 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -50.76 -56.66 11.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 75.510000000000005 110.871 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -6.74 59.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 73.510000000000005 110.863 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.46 -150.37 16.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 64.129999999999995 112.476 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mttp 61.43 104.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 74.310000000000002 110.871 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.1 p -82.18 155.84 24.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 73.120000000000005 111.155 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -2.99 58.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 71.109999999999999 110.842 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -138.83 -175.43 4.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.905 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.68 104.93 13.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 75.439999999999998 110.904 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 8.3 mt -95.34 127.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 72.329999999999998 111.122 179.887 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -139.72 159.16 42.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 73.409999999999997 111.119 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.3 mm -84.86 105.22 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 74.219999999999999 111.112 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.59 -56.57 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 75.200000000000003 111.104 179.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.0 177.16 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 54.32 110.831 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . 0.421 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 17.0 p -176.88 155.74 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 72.340000000000003 110.891 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 -169.48 40.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.747 . . . . 72.400000000000006 112.5 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.27 126.26 35.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 74.209999999999994 110.891 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.81 138.26 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.340000000000003 110.897 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 110.853 179.935 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 73.340000000000003 110.878 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.61 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 73.340000000000003 111.119 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -95.82 151.76 38.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 75.400000000000006 110.895 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 134.69 28.55 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.65 2.233 . . . . 71.420000000000002 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.9 m -122.16 140.44 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 75.030000000000001 111.119 -179.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -125.19 159.46 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 74.239999999999995 111.104 179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.447 ' HB3' HD22 ' A' ' 164' ' ' LEU . 0.3 OUTLIER -133.44 155.08 50.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.873 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -135.2 134.36 40.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.549999999999997 110.866 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.66 108.91 20.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 73.299999999999997 110.828 179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.05 119.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 64.25 111.133 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.93 167.58 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 61.450000000000003 111.099 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -150.68 91.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.340000000000003 111.121 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.1 32.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.230000000000004 110.816 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.19 -12.24 69.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 54.340000000000003 112.478 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.81 130.35 25.48 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.667 0.746 . . . . 62.200000000000003 110.891 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 152.95 69.43 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.683 2.255 . . . . 72.209999999999994 112.336 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.7 tp -114.52 -65.42 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.120000000000005 110.929 -179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.74 -178.01 36.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 72.349999999999994 112.464 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.7 125.98 54.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 72.25 110.832 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.52 143.97 38.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 74.430000000000007 111.12 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.42 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 23.3 p -129.99 155.26 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.888 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.7 165.57 18.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.329999999999998 110.913 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -120.97 124.69 45.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.340000000000003 110.888 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.6 mt -93.42 126.82 38.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 75.099999999999994 110.936 -179.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -83.07 82.31 8.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.917 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -4.59 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 60.32 111.087 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.23 -34.11 16.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 110.858 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -91.44 -28.48 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.917 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.55 79.31 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.625 0.726 . . . . 70.340000000000003 111.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.14 13.43 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 71.25 112.294 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -45.72 9.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 72.25 110.874 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -52.4 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 73.200000000000003 111.161 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.11 -77.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 75.310000000000002 111.113 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 29.7 tt0 -48.34 -66.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 75.409999999999997 110.876 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 19.8 t30 -28.23 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 72.120000000000005 110.916 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' GLU . 85.3 t80 -85.53 -42.0 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 71.219999999999999 110.87 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -54.52 -31.24 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.519999999999996 110.877 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.01 -43.57 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 111.11 179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.11 -39.2 86.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 73.239999999999995 110.905 -179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -35.26 76.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 74.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.04 -12.74 61.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 74.420000000000002 111.165 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 4.13 63.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.788 -0.72 . . . . 63.310000000000002 112.446 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.96 -1.65 36.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 72.519999999999996 110.933 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -93.39 37.57 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 70.25 110.916 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.09 -45.46 3.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 74.010000000000005 112.502 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -155.89 -166.38 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 74.450000000000003 110.854 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 -107.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 65.150000000000006 112.511 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -162.84 123.49 2.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.414 . . . . 65.310000000000002 110.919 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -106.9 -26.74 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 73.409999999999997 110.909 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.94 -62.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.741 . . . . 74.510000000000005 112.489 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.65 -169.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.340000000000003 110.869 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 p -166.11 111.21 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 61.240000000000002 110.876 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -73.4 123.98 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.530000000000001 110.892 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -120.32 17.99 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.120000000000005 110.867 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -136.84 119.09 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 110.855 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 88.0 mt -143.53 137.28 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 111.075 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.3 mt -146.8 95.38 4.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.666 0.746 . . . . 75.299999999999997 111.111 179.814 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 96.34 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 72.230000000000004 112.347 179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.69 -35.17 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.47 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.32 -64.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 72.140000000000001 110.849 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -158.39 -169.5 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 72.230000000000004 110.895 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.32 -75.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 70.409999999999997 110.858 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 63.32 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 73.030000000000001 110.926 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.68 117.83 3.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 62.310000000000002 112.479 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.38 -131.08 4.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 62.229999999999997 112.478 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -126.69 156.2 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.861 0.362 . . . . 75.239999999999995 110.851 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -175.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.510000000000005 110.869 -179.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.82 -55.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 73.0 111.144 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.34 15.3 9.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.89 -80.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.310000000000002 110.851 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -151.02 23.05 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.230000000000004 110.932 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.43 104.8 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 64.140000000000001 112.462 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -114.52 112.4 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 74.420000000000002 111.128 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.01 -141.96 12.46 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 74.329999999999998 112.508 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . -103.4 -112.34 3.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 72.530000000000001 112.478 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 0.8 OUTLIER 179.96 168.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 74.319999999999993 110.842 179.972 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 t -81.69 160.78 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 64.349999999999994 110.874 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 pp -88.35 -32.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 72.439999999999998 111.126 179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.4 m-85 -85.01 -6.29 59.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 75.239999999999995 110.9 -179.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -121.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 73.319999999999993 112.512 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -112.34 -83.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 74.200000000000003 110.927 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.92 168.05 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 74.340000000000003 110.887 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.0 165.52 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.319999999999993 110.898 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -62.45 163.32 8.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 71.209999999999994 110.846 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -80.33 161.41 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 62.210000000000001 110.886 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 -50.65 3.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 70.239999999999995 110.89 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p30 178.74 157.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.549999999999997 110.898 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.73 66.73 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.310000000000002 110.859 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 14.0 mt -83.91 7.78 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 72.219999999999999 111.156 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -127.29 127.53 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 64.409999999999997 110.936 179.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.28 133.28 56.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 71.109999999999999 110.904 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -59.05 91.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.0 110.874 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.2 p -118.95 19.4 13.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 74.299999999999997 111.197 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.96 26.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 72.340000000000003 112.525 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -2.93 10.99 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.430000000000007 112.331 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.41 29.01 6.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.420000000000002 112.501 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -90.66 127.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 74.219999999999999 111.165 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 2.1 tt -90.3 124.13 34.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.420000000000002 110.874 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 42.9 t -115.5 160.73 19.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 71.230000000000004 110.854 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.76 115.24 29.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.329999999999998 110.874 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.97 150.53 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 62.130000000000003 111.11 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.72 -163.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 71.010000000000005 110.884 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.06 -12.68 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 62.32 111.083 179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.4 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 121.69 -135.02 10.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 72.239999999999995 112.47 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.4 ' HD2' ' HA3' ' A' ' 104' ' ' GLY . 54.2 Cg_endo -69.71 147.52 63.35 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.735 2.29 . . . . 73.150000000000006 112.337 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.93 23.07 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.340000000000003 110.903 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.653 ' O ' ' C ' ' A' ' 108' ' ' ASN . 7.7 p -141.23 33.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.310000000000002 111.2 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER 11.49 -87.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 71.049999999999997 110.913 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 107.16 140.15 9.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 75.430000000000007 112.486 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -97.86 -33.33 11.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.334 . . . . 75.129999999999995 110.816 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -63.43 152.46 38.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 71.430000000000007 110.94 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 99' ' ' SER . 17.1 p90 -145.08 146.55 31.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 71.540000000000006 110.891 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -127.84 114.86 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 65.310000000000002 110.889 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.6 mt -67.02 101.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 73.519999999999996 111.149 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 54.7 m -57.85 126.98 29.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 74.420000000000002 110.901 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -88.19 -31.25 19.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 64.219999999999999 111.105 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.9 155.02 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.239999999999995 111.111 179.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -57.01 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.400000000000006 110.888 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.8 p -117.6 69.52 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 75.519999999999996 111.134 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.52 21.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.129999999999995 110.867 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.441 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 5.3 p90 -101.14 15.19 29.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 73.349999999999994 110.941 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 13.3 mt -129.73 17.05 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 74.420000000000002 110.937 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -63.15 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.540000000000006 110.862 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -46.75 -28.78 3.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 73.409999999999997 112.505 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -74.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 75.510000000000005 110.925 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -86.67 141.25 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.549999999999997 110.851 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.58 129.73 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 64.439999999999998 111.133 179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.31 137.67 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 74.530000000000001 111.147 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -129.07 -32.87 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.129999999999995 110.902 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -109.92 161.05 13.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 75.120000000000005 112.495 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -155.57 148.68 24.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.349 . . . . 75.340000000000003 110.919 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.45 126.49 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 72.540000000000006 111.153 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -68.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 110.874 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 143.71 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.844 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.72 9.21 21.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 63.119999999999997 112.514 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.0 ttm -49.62 -28.03 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 74.409999999999997 110.884 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -50.63 -27.25 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 75.209999999999994 110.89 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.85 -35.72 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 73.540000000000006 111.113 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.78 -23.41 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.319999999999993 111.144 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.01 -25.14 32.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.120000000000005 110.906 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.29 57.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 73.109999999999999 111.12 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.8 ptm -76.97 -30.37 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 72.230000000000004 110.907 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -89.85 33.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 74.540000000000006 110.856 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 17.2 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.25 110.865 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -97.73 33.3 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 74.450000000000003 110.87 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.601 ' O ' ' C ' ' A' ' 147' ' ' SER . . . 64.88 -92.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 75.040000000000006 112.483 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.601 ' C ' ' O ' ' A' ' 146' ' ' GLY . 88.7 p 17.86 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 74.010000000000005 110.874 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -91.51 -24.62 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.519999999999996 110.888 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -105.01 -7.53 19.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.340000000000003 110.931 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.95 -39.81 2.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.759 . . . . 75.239999999999995 112.453 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -64.5 101.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 71.239999999999995 110.891 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 147' ' ' SER . 1.9 m -90.56 154.15 19.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 60.32 111.162 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.73 -17.76 63.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 74.400000000000006 110.848 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.26 -175.87 4.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.439999999999998 110.866 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -120.05 144.17 47.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 73.230000000000004 110.899 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mp -110.41 134.51 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 111.126 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -129.33 166.86 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 111.136 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 30.9 mm -112.06 106.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 111.128 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -54.2 -57.23 11.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 111.13 179.807 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -160.26 174.63 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.310000000000002 110.859 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 11.4 p -175.35 169.6 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.230000000000004 110.894 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.02 -160.52 28.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 71.239999999999995 112.493 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -72.25 109.36 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 73.120000000000005 110.883 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.447 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -66.66 -48.33 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.519999999999996 110.914 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 110.878 179.943 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.351 . . . . 73.030000000000001 110.868 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.65 153.82 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 72.129999999999995 111.158 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -50.44 153.31 2.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.595 0.712 . . . . 75.109999999999999 110.943 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 141.07 44.29 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 61.240000000000002 112.332 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.9 m -126.29 101.55 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.299999999999997 111.135 -179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 5.8 m -96.42 149.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.319999999999993 111.123 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.95 162.72 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 55.109999999999999 110.889 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.01 133.51 21.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 75.450000000000003 110.886 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.25 108.52 16.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.019999999999996 110.891 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 15.7 mm -87.48 139.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.340000000000003 111.161 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -120.7 155.87 32.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 72.109999999999999 111.123 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.0 96.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 72.439999999999998 111.125 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.87 56.04 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 71.430000000000007 110.884 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.75 11.63 54.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 74.430000000000007 112.446 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -142.44 92.17 7.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 74.519999999999996 110.886 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.76 156.17 64.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 73.109999999999999 112.358 179.961 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.61 23.93 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 74.099999999999994 110.866 -179.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.66 -161.74 21.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 44.450000000000003 112.463 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 170.37 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 74.329999999999998 110.868 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.2 m -132.15 172.47 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 72.349999999999994 111.147 179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -127.89 90.69 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.409999999999997 110.87 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -81.73 72.98 8.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.540000000000006 110.94 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.92 143.53 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 75.420000000000002 110.851 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.5 mt -105.53 119.81 40.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 110.93 179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -76.62 57.23 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.340000000000003 110.856 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -31.3 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.510000000000005 111.103 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.87 -63.14 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 74.219999999999999 110.893 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.29 -74.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.140000000000001 110.93 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 2.4 m -85.15 110.77 31.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 65.209999999999994 111.107 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 74.299999999999997 112.344 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -57.67 -47.02 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 72.129999999999995 110.874 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -45.77 -41.9 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 71.400000000000006 111.142 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -107.5 21.72 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 72.140000000000001 111.086 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -93.16 -28.37 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 74.319999999999993 110.856 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -85.19 -41.08 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 75.120000000000005 110.88 -179.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -32.75 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.905 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.96 -39.55 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 74.340000000000003 110.85 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.46 -17.97 26.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.164 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 50.4 mt -85.02 9.98 13.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 74.5 110.895 -179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.4 m -126.35 -3.42 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.019999999999996 110.879 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.6 p -124.82 -4.98 7.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 75.099999999999994 111.143 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.15 71.85 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 73.109999999999999 112.485 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.27 34.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 73.230000000000004 110.861 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.6 -42.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.219999999999999 110.863 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 46' ' ' PHE . . . -137.67 30.53 2.58 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 75.030000000000001 112.44 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' CG ' ' C ' ' A' ' 45' ' ' GLY . 2.1 p90 40.11 63.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 74.099999999999994 110.879 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.94 21.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 75.450000000000003 112.497 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.17 -179.81 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.393 . . . . 74.120000000000005 110.885 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -166.24 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 64.340000000000003 110.875 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.75 44.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 71.239999999999995 112.507 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.15 155.17 32.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 63.530000000000001 110.826 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.67 127.52 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 74.109999999999999 110.898 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -148.61 122.08 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 65.409999999999997 110.87 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -140.81 73.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.129999999999995 110.869 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -121.18 21.86 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.430000000000007 110.88 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 4.7 mt -59.64 136.35 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 75.239999999999995 111.139 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.11 113.05 32.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 72.230000000000004 111.193 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 86.73 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 73.5 112.362 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.64 2.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 75.109999999999999 112.501 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.27 -72.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 73.329999999999998 110.917 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -178.22 -158.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 74.140000000000001 110.871 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.2 t -143.24 135.9 27.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.409999999999997 110.869 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 153.42 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.230000000000004 110.927 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -142.33 147.67 19.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 74.439999999999998 112.505 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.75 85.72 1.49 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 73.349999999999994 112.483 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 60.219999999999999 110.895 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 p90 -99.76 -176.45 3.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 74.329999999999998 110.871 -179.889 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.76 -68.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.439999999999998 111.124 -179.857 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -103.87 154.55 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 75.040000000000006 110.851 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 171.22 -39.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.219999999999999 110.843 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 -35.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 62.439999999999998 110.89 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.76 -7.09 64.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 71.209999999999994 112.516 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m 72.26 36.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 74.319999999999993 111.134 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.55 151.87 7.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 70.430000000000007 112.527 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.65 -118.53 3.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 73.109999999999999 112.523 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.6 -71.95 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.312 . . . . 74.450000000000003 110.873 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.06 120.38 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 73.310000000000002 110.85 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 11.2 pt -49.18 -37.01 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 73.200000000000003 111.159 179.924 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.22 36.92 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.904 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.51 15.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 75.010000000000005 112.458 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -122.4 -24.15 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 73.340000000000003 110.895 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -169.36 147.1 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.040000000000006 110.903 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.94 158.16 34.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 73.129999999999995 110.943 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.92 162.52 28.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.099999999999994 110.926 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.63 108.39 13.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.886 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.52 -51.73 47.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 74.239999999999995 110.882 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t30 175.27 175.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 73.099999999999994 110.881 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.45 40.81 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 75.310000000000002 110.871 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.52 -27.12 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.430000000000007 111.115 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.59 133.62 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 73.329999999999998 110.913 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -114.19 -175.69 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 75.340000000000003 110.942 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -99.49 -86.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 73.230000000000004 110.868 179.91 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 67.09 6.32 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 74.140000000000001 111.104 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.37 159.48 20.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 72.030000000000001 112.483 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.416 ' CB ' ' HA ' ' A' ' 116' ' ' THR . 53.6 Cg_endo -69.71 169.69 18.26 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 75.409999999999997 112.354 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.26 8.85 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.743 . . . . 65.549999999999997 112.482 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 10.6 mm -69.9 158.28 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 73.120000000000005 111.121 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 10.9 mt -124.36 162.72 23.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.310000000000002 110.934 179.875 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -160.49 43.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.399999999999999 110.883 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.402 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 4.2 mmt 48.65 -166.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 110.883 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -179.61 78.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 60.299999999999997 111.105 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.34 -76.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 73.430000000000007 110.91 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -137.07 -41.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 55.219999999999999 111.127 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -75.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 73.209999999999994 112.51 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 102.2 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 73.400000000000006 112.312 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.59 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 73.409999999999997 110.851 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 3.0 m -154.55 59.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.140000000000001 111.119 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.578 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -80.37 -0.68 37.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 70.219999999999999 110.901 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 21.0 -136.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.758 . . . . 75.409999999999997 112.518 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 m -153.91 65.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.331 . . . . 73.129999999999995 110.87 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -93.71 -45.41 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 74.209999999999994 110.91 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.402 ' H ' ' HA ' ' A' ' 100' ' ' MET . 0.0 OUTLIER 67.63 130.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.864 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -153.41 134.76 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 110.885 -179.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.55 143.99 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 74.030000000000001 111.155 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 p -115.55 161.23 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 73.450000000000003 110.906 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.416 ' HA ' ' CB ' ' A' ' 95' ' ' PRO . 3.2 m -127.91 30.63 5.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 111.088 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.24 22.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.230000000000004 111.11 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.12 134.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.219999999999999 110.916 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 68.1 p -131.45 41.47 3.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 71.129999999999995 111.122 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -48.97 -26.42 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 61.210000000000001 110.863 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -60.35 -36.77 78.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.912 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.27 31.99 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.340000000000003 110.934 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -114.63 41.92 2.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.209999999999994 110.897 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.15 30.9 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 75.329999999999998 112.501 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.34 -39.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 71.310000000000002 110.936 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -97.33 156.88 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 72.340000000000003 110.879 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.53 99.18 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 111.109 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 91.9 t -63.64 124.93 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 70.209999999999994 111.156 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.615 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 1.4 t80 -155.43 81.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.91 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.56 166.5 39.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 43.350000000000001 112.476 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp 177.97 153.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 72.549999999999997 110.911 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.9 p -105.39 87.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 73.310000000000002 111.151 179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -51.35 -46.24 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 74.129999999999995 110.917 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 174.22 11.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 73.420000000000002 110.866 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.8 77.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 64.510000000000005 112.491 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -24.36 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.758 0.313 . . . . 74.420000000000002 110.9 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -76.53 -34.65 58.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 110.854 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.564 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.0 mm -45.4 -39.8 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.409999999999997 111.12 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.4 -52.23 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 72.319999999999993 111.149 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -49.39 -67.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 75.530000000000001 110.889 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -51.62 -54.42 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 111.099 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.564 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 11.6 ttm -51.12 -41.28 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.914 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.95 -23.22 12.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 72.409999999999997 110.89 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -65.55 -25.94 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 75.239999999999995 110.847 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -87.42 9.0 22.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 73.120000000000005 110.838 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.14 -171.14 40.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 62.009999999999998 112.501 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -158.5 149.39 20.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 70.129999999999995 110.832 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -49.89 -56.09 11.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.340000000000003 110.876 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -22.23 57.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 71.430000000000007 110.879 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.96 -36.2 3.94 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 73.030000000000001 112.479 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -50.55 160.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 63.439999999999998 110.866 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.9 p -121.22 156.98 31.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 72.200000000000003 111.13 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -26.47 62.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 61.109999999999999 110.879 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.29 -168.19 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 72.010000000000005 110.888 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -113.43 96.82 6.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 110.886 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 19.6 mt -90.61 101.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.349999999999994 111.114 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 t -117.63 164.87 14.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 111.141 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.4 mt -88.53 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 111.144 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.62 -64.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 64.209999999999994 111.113 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -135.1 166.33 23.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 73.140000000000001 110.856 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -153.72 -174.84 5.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.834 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.9 -147.77 18.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 74.420000000000002 112.462 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.6 pt20 -126.61 136.73 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.875 0.369 . . . . 73.349999999999994 110.901 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.17 -35.39 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 65.430000000000007 110.969 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 75.099999999999994 110.893 179.905 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.321 . . . . 73.340000000000003 110.879 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.1 t -109.95 134.48 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 73.409999999999997 111.178 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -59.28 159.14 16.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.603 0.716 . . . . 71.519999999999996 110.918 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 154.0 68.45 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 74.239999999999995 112.35 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 m -122.14 44.64 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 75.010000000000005 111.145 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.8 m -47.83 140.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 63.409999999999997 111.141 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -136.57 175.87 9.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.129999999999995 110.892 179.996 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -148.64 142.59 25.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 73.540000000000006 110.902 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.29 131.8 42.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 74.5 110.826 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.8 137.34 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 75.239999999999995 111.106 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.76 167.07 22.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 73.239999999999995 111.092 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.92 95.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.030000000000001 111.121 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 71.14 33.49 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.901 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.27 70.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 71.409999999999997 112.549 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -93.17 131.7 32.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.691 0.757 . . . . 74.319999999999993 110.849 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 147.33 62.18 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 64.540000000000006 112.323 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 tp -113.37 -67.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 74.120000000000005 110.88 -179.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.21 -146.66 4.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 73.150000000000006 112.5 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.27 125.86 12.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 75.540000000000006 110.864 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.8 t -116.45 135.24 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 111.158 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -88.76 100.61 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.841 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -87.81 73.6 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 72.400000000000006 110.852 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -51.47 151.78 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 73.239999999999995 110.878 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -117.41 123.75 47.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 74.299999999999997 110.932 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.74 70.77 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.864 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.95 -8.68 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 74.420000000000002 111.084 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.23 -56.13 4.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 71.109999999999999 110.894 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -54.91 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 75.340000000000003 110.894 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.53 83.24 53.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.613 0.721 . . . . 73.230000000000004 111.103 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 63.11 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.23 . . . . 74.439999999999998 112.359 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -159.77 -67.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 74.120000000000005 110.914 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 m -53.33 -48.06 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 75.310000000000002 111.154 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.02 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 54.43 111.132 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -55.63 -28.27 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.230000000000004 110.904 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -54.2 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 72.140000000000001 110.922 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.09 -36.52 81.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.862 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -27.23 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 70.430000000000007 110.871 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.41 -35.03 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.310000000000002 111.133 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.84 5.22 25.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.898 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -105.31 -13.99 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 71.530000000000001 110.869 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -116.59 8.23 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 71.109999999999999 111.159 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.03 21.72 39.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 71.239999999999995 112.487 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -34.31 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 73.319999999999993 110.893 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -13.35 62.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.881 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.62 -12.48 59.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 71.340000000000003 112.5 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 47' ' ' GLY . 19.5 m-85 -92.34 -28.08 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 75.340000000000003 110.842 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -35.51 125.89 0.74 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 72.129999999999995 112.472 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -100.48 33.13 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 75.510000000000005 110.979 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 146.74 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 74.299999999999997 110.898 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 119.05 -95.91 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 60.109999999999999 112.476 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.96 121.72 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 74.420000000000002 110.862 -179.707 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.0 p -174.21 -166.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 61.210000000000001 110.882 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 63.51 86.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 64.450000000000003 110.902 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -116.47 17.28 15.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 75.25 110.885 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -134.37 151.68 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 75.340000000000003 110.862 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 179.54 131.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.519999999999996 111.17 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 pt -138.06 109.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.674 0.75 . . . . 73.329999999999998 111.146 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.27 . . . . 74.109999999999999 112.333 179.895 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.96 -31.6 1.73 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 74.129999999999995 112.489 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.47 -64.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 73.25 110.863 -179.831 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -158.42 -156.32 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.120000000000005 110.908 179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.2 m -131.44 -44.04 1.02 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 74.310000000000002 110.872 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.09 119.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 71.299999999999997 110.947 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.78 11.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 50.109999999999999 112.487 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.25 -157.61 27.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 74.510000000000005 112.498 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.3 -177.31 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 73.209999999999994 110.856 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -176.08 121.11 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 73.010000000000005 110.897 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.3 -76.01 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 74.340000000000003 111.123 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -144.43 116.35 8.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 74.299999999999997 110.858 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.4 20.41 2.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.839 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.81 50.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 74.319999999999993 110.854 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.63 24.62 2.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 73.340000000000003 112.471 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p 48.08 88.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.848 0.356 . . . . 72.540000000000006 111.105 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.54 56.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.752 . . . . 73.109999999999999 112.513 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 101.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.739 . . . . 74.340000000000003 112.452 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 172.98 2.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 74.099999999999994 110.882 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -128.38 15.27 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 73.329999999999998 110.888 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' CB ' ' O ' ' A' ' 77' ' ' SER . 0.1 OUTLIER 82.75 -19.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 111.11 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -20.29 15.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 72.219999999999999 110.934 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.41 -88.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.310000000000002 112.462 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -138.69 -54.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 75.5 110.898 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 pttp -168.81 145.17 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.239999999999995 110.895 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.48 144.55 49.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.299999999999997 110.882 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.73 170.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 71.510000000000005 110.857 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.2 146.45 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 73.010000000000005 110.85 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -58.79 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 75.230000000000004 110.846 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 178.75 156.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 110.889 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -112.55 60.14 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 110.868 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.7 mm -78.51 -20.52 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 74.010000000000005 111.181 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.51 99.06 10.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 72.299999999999997 110.889 179.928 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.24 114.33 26.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 75.450000000000003 110.926 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.44 ' O ' HG23 ' A' ' 93' ' ' THR . 0.1 OUTLIER -51.16 -95.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 75.450000000000003 110.83 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 92' ' ' HIS . 0.5 OUTLIER 66.72 5.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 111.167 -179.86 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.84 153.27 24.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 50.130000000000003 112.49 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.72 63.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.264 . . . . 73.420000000000002 112.326 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 94.64 -17.95 58.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 53.140000000000001 112.482 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 12.7 mm -64.45 140.91 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 72.120000000000005 111.167 -179.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 tt -90.79 126.67 36.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 75.230000000000004 110.894 179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -122.72 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 70.319999999999993 110.846 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 mtm -69.17 175.29 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 75.219999999999999 110.878 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -166.92 147.38 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.310000000000002 111.103 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.6 m-20 163.5 -64.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 73.409999999999997 110.934 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.75 -106.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 74.319999999999993 111.103 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.534 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -156.59 -60.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 75.129999999999995 112.479 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.534 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.79 -104.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.262 . . . . 72.329999999999998 112.297 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -121.0 72.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 71.409999999999997 110.852 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.69 10.42 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.115 -179.939 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -99.86 179.51 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 62.539999999999999 110.832 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.17 24.53 2.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 75.439999999999998 112.473 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.49 -52.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 65.409999999999997 110.906 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -84.14 155.81 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 72.310000000000002 110.9 -179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -149.87 171.63 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.230000000000004 110.872 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -159.28 166.48 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 63.119999999999997 110.886 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.5 mt -121.4 114.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 75.439999999999998 111.12 179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.8 p -65.15 -28.03 69.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 60.409999999999997 110.849 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 49.31 22.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 71.420000000000002 111.141 -179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.4 176.14 6.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 72.239999999999995 111.077 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 104.63 12.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.874 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 66.2 p -132.45 63.8 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.209999999999994 111.16 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.406 ' HB3' ' HA ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -90.13 22.63 3.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 62.520000000000003 110.881 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -93.33 5.91 49.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.150000000000006 110.933 -179.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.4 mt -97.59 -4.96 36.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.430000000000007 110.899 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.14 68.42 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 110.91 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.57 37.36 0.83 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.79 -0.719 . . . . 70.140000000000001 112.454 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.9 mmtp -55.46 -34.33 64.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 72.049999999999997 110.899 179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -110.38 156.2 21.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.099999999999994 110.827 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.07 85.07 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.219999999999999 111.105 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 17.5 t -65.25 118.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.030000000000001 111.109 179.951 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 17.96 4.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 74.409999999999997 110.869 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.74 178.2 28.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 75.010000000000005 112.503 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 170.09 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 75.200000000000003 110.934 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 94.4 t -97.75 84.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 75.400000000000006 111.11 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -62.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.908 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 75.409999999999997 110.829 -179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.29 10.46 68.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.209999999999994 112.467 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.64 27.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 74.310000000000002 110.856 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.55 -26.92 14.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 72.099999999999994 110.886 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.4 mm -80.02 -41.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 72.150000000000006 111.124 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 38.1 t -50.17 -45.19 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 75.319999999999993 111.115 179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -32.77 67.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 71.310000000000002 110.85 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.77 92.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 75.319999999999993 111.079 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.1 mtm -71.62 -26.09 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 72.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.5 14.18 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 73.010000000000005 110.883 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -16.26 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.209999999999994 110.89 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -104.24 -8.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.239999999999995 110.864 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.53 -150.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 73.420000000000002 112.447 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -169.41 152.87 4.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 73.540000000000006 110.857 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -73.24 69.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 71.349999999999994 110.851 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 177.51 -26.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 110.86 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.4 -48.14 0.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 45.439999999999998 112.497 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.84 160.9 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 74.439999999999998 110.895 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -137.71 171.4 14.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.340000000000003 111.119 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 p -86.55 -4.01 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.310000000000002 110.842 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -137.85 -165.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 75.239999999999995 110.888 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.33 125.31 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 71.439999999999998 110.903 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.04 131.18 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.409999999999997 111.148 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.67 163.85 22.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 75.120000000000005 111.152 179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.8 mm -120.97 94.47 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.540000000000006 111.132 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.55 -48.63 76.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 74.209999999999994 111.1 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.64 -178.48 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 74.140000000000001 110.877 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.0 p -176.55 157.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.89 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.48 176.67 45.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 75.200000000000003 112.488 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.584 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.6 mt-30 -69.29 -36.71 77.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.813 0.339 . . . . 74.209999999999994 110.854 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.584 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.3 mm? 71.9 -21.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.019999999999996 110.898 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.542 ' H ' ' C ' ' A' ' 163' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 70.109999999999999 110.846 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.815 0.341 . . . . 74.340000000000003 110.9 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.04 154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 75.209999999999994 111.131 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -89.79 151.32 45.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 75.5 110.826 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 109.27 2.28 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.671 2.247 . . . . 73.329999999999998 112.344 179.914 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 6.4 m -113.42 141.46 47.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 61.329999999999998 111.121 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.4 m -126.9 148.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.209999999999994 111.141 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 11.5 p90 -118.69 147.79 43.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.209999999999994 110.908 -179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -129.06 131.41 47.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 110.895 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -97.12 75.54 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 72.319999999999993 110.892 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mm -49.74 141.41 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 74.239999999999995 111.146 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -132.92 151.49 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 74.400000000000006 111.111 179.854 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.6 t -134.19 108.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 72.200000000000003 111.181 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t0 51.47 52.25 15.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.430000000000007 110.919 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.22 50.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 71.200000000000003 112.463 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -139.29 94.57 9.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.651 0.738 . . . . 73.129999999999995 110.878 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.4 Cg_endo -69.83 157.75 59.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.251 . . . . 65.439999999999998 112.309 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 pp -126.37 22.88 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 70.430000000000007 110.955 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.85 160.4 9.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 65.409999999999997 112.495 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 -179.68 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 74.420000000000002 110.917 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.6 m -146.61 168.99 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 73.430000000000007 111.111 179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -145.64 144.27 30.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 73.439999999999998 110.823 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -127.68 138.62 52.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 72.030000000000001 110.904 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -111.36 113.56 26.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.896 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.6 mt -80.2 129.74 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 73.120000000000005 110.903 -179.918 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 72.16 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.43 110.868 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.51 -27.19 15.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 72.420000000000002 111.116 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.57 -44.01 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.845 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.51 -32.84 18.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.140000000000001 110.906 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.5 m -131.24 87.19 48.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 74.329999999999998 111.147 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.27 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 73.150000000000006 112.364 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -41.89 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 70.349999999999994 110.897 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -3.1 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 111.18 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -76.62 -37.47 56.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.329999999999998 111.141 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 35' ' ' ASN . 80.3 tt0 -92.79 -37.88 12.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 65.040000000000006 110.885 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -29.32 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.209999999999994 110.861 -179.904 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -64.45 -32.75 74.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.219999999999999 110.857 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -51.75 -34.7 40.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 75.310000000000002 110.885 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.49 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 61.240000000000002 111.113 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 13.4 mt -75.63 -52.02 11.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 75.200000000000003 110.856 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.9 m -59.39 -54.01 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.120000000000005 110.862 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.6 p -73.19 -27.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.340000000000003 111.15 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.96 92.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.722 . . . . 72.319999999999993 112.495 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.72 36.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 74.120000000000005 110.901 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -133.72 26.81 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 75.299999999999997 110.947 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.06 4.76 60.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 74.450000000000003 112.454 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -164.56 178.05 7.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 75.230000000000004 110.875 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.52 117.01 2.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 70.400000000000006 112.45 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.11 150.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 63.420000000000002 110.912 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -76.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 73.299999999999997 110.92 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.01 44.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 73.019999999999996 112.516 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -26.46 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 72.420000000000002 110.848 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p 178.13 176.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 65.439999999999998 110.931 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -103.2 -77.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.876 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.12 -80.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.549999999999997 110.9 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -164.82 110.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.209999999999994 110.878 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.1 mt -95.71 135.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 74.430000000000007 111.131 179.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.7 mt -131.74 103.5 14.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 74.120000000000005 111.087 179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 104.53 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 75.25 112.385 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.46 8.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 41.340000000000003 112.476 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.56 -66.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 73.239999999999995 110.94 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.17 -168.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 73.5 110.875 179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 87.8 m -149.15 133.22 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.519999999999996 110.895 -179.938 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.04 154.81 18.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.420000000000002 110.939 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.15 -179.92 38.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 61.310000000000002 112.525 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.35 44.66 5.52 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.738 . . . . 74.230000000000004 112.518 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -102.82 177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.863 0.363 . . . . 70.120000000000005 110.871 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -169.82 29.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 72.040000000000006 110.875 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.31 -168.08 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 72.209999999999994 111.134 -179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -96.58 -90.47 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.924 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.52 -76.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.439999999999998 110.85 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 p30 179.65 -32.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 64.120000000000005 110.859 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.31 30.62 1.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 71.239999999999995 112.496 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.9 p -99.94 -32.27 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 72.099999999999994 111.171 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.7 -123.83 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 71.319999999999993 112.482 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.5 120.45 4.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 71.150000000000006 112.485 -179.922 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -175.73 177.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 74.099999999999994 110.885 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 142.27 27.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 71.430000000000007 110.852 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -40.67 -38.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 71.120000000000005 111.081 179.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -85.89 49.24 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.877 -179.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.16 -113.82 4.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 73.040000000000006 112.47 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.96 -161.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.393 . . . . 74.400000000000006 110.862 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.08 -178.51 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 65.030000000000001 110.87 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -131.66 162.13 31.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 74.430000000000007 110.913 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -91.28 172.5 8.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 73.310000000000002 110.866 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.71 105.9 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 71.120000000000005 110.821 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -58.21 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 73.439999999999998 110.861 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -177.92 165.52 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 75.129999999999995 110.883 -179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.1 55.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 72.319999999999993 110.839 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mt -48.93 -26.32 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 75.030000000000001 111.194 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 73.3 mt -93.39 155.08 17.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 110.905 179.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -117.93 178.29 4.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 74.239999999999995 110.908 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -105.08 76.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 72.219999999999999 110.849 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 t -122.34 22.39 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.409999999999997 111.162 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -120.72 160.12 15.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.76 -0.733 . . . . 73.409999999999997 112.505 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.26 24.27 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 72.430000000000007 112.375 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.42 71.11 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 74.400000000000006 112.491 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 42.5 mm -91.42 143.4 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 75.310000000000002 111.119 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 8.0 mt -117.03 152.67 34.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.140000000000001 110.887 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 56.9 m -154.89 -101.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 74.25 110.877 -179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -176.4 124.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 74.540000000000006 110.874 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -102.58 80.76 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 53.229999999999997 111.136 179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -137.32 -64.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 71.209999999999994 110.919 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.676 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -178.17 121.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 51.5 111.118 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.883 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -72.61 -29.48 65.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 71.230000000000004 112.482 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.883 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.7 Cg_endo -69.78 80.99 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.232 . . . . 72.099999999999994 112.367 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 39.29 53.96 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.519999999999996 110.892 -179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.03 39.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.200000000000003 111.142 -179.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -74.77 160.27 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.310000000000002 110.941 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.99 -110.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.530000000000001 112.507 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.25 -162.14 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 72.319999999999993 110.851 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 74.75 50.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 75.519999999999996 110.896 -179.965 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 41.0 p90 -50.25 142.71 9.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.409999999999997 110.836 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 114' ' ' ILE . 27.9 p90 -103.98 59.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 72.340000000000003 110.871 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.419 ' C ' ' O ' ' A' ' 113' ' ' PHE . 9.3 tt -34.79 121.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.5 111.106 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 69.7 m -90.53 159.01 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 64.109999999999999 110.898 179.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -111.67 -9.69 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 71.040000000000006 111.163 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.87 161.38 40.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 62.219999999999999 111.085 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.24 115.92 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.150000000000006 110.9 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 15.8 p -115.7 47.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 75.209999999999994 111.153 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.71 -17.54 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 74.540000000000006 110.926 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -55.65 -21.91 20.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 71.310000000000002 110.934 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -73.33 -56.25 5.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 72.019999999999996 110.923 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 73.03 -61.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.200000000000003 110.897 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.83 61.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.685 -0.769 . . . . 73.530000000000001 112.491 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -98.02 -27.79 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.430000000000007 110.913 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -143.44 138.1 29.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 71.109999999999999 110.812 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 55.4 t -51.37 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 73.450000000000003 111.14 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 1.4 p -84.2 143.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 75.329999999999998 111.133 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -178.78 119.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.129999999999995 110.855 -179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.42 123.33 4.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 74.409999999999997 112.485 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -139.23 162.03 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 74.519999999999996 110.892 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 t -54.83 100.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.120000000000005 111.136 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -46.85 41.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 75.430000000000007 110.888 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -148.06 118.2 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.120000000000005 110.865 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.33 84.42 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 64.230000000000004 112.474 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 tpt -91.26 -21.52 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 110.873 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -30.74 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 73.0 110.885 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 142' ' ' MET . 38.2 mm -64.49 -41.76 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 75.239999999999995 111.117 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 3.7 t -91.65 11.39 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.240000000000002 111.085 179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.8 -64.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 64.439999999999998 110.855 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.63 -57.28 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 111.083 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.473 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.7 tmm? -52.81 -37.86 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 70.420000000000002 110.888 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -24.59 32.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.878 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -68.39 -12.57 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.010000000000005 110.839 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -94.78 26.09 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 75.510000000000005 110.884 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.503 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -124.92 44.04 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 70.400000000000006 112.53 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 146' ' ' GLY . 29.8 t 29.57 -102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.384 . . . . 74.329999999999998 110.834 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -173.5 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 73.019999999999996 110.86 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -87.74 -6.45 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.420000000000002 110.895 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.68 -55.81 0.76 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 74.409999999999997 112.464 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 110.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.84 0.352 . . . . 74.230000000000004 110.848 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 40.0 p -84.11 138.33 33.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.010000000000005 111.154 179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.31 -28.92 63.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 65.530000000000001 110.854 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -137.07 -179.62 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.120000000000005 110.903 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 135.4 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 110.888 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 20.5 mt -117.17 87.66 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.040000000000006 111.128 179.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -108.68 157.16 18.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.129999999999995 111.175 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.4 mt -93.22 146.06 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 72.109999999999999 111.188 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.55 -61.22 1.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 73.510000000000005 111.114 179.862 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.09 154.6 48.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.0 m -146.16 -167.5 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 73.439999999999998 110.892 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.66 -162.93 23.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 72.25 112.501 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -112.54 133.82 54.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 75.239999999999995 110.901 -179.844 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.24 144.48 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 62.439999999999998 110.943 179.988 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 74.25 110.895 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.838 0.351 . . . . 75.219999999999999 110.896 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.9 t 59.62 99.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 73.409999999999997 111.127 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -58.59 154.91 32.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 74.540000000000006 110.907 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 154.8 67.33 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.233 . . . . 75.439999999999998 112.365 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -120.55 163.01 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 64.349999999999994 111.109 -179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' PHE . 1.3 t -144.11 140.68 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.230000000000004 111.176 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.416 ' HB3' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER -126.34 144.36 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 65.430000000000007 110.864 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -138.67 139.58 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 71.299999999999997 110.862 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -98.02 109.86 22.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 65.239999999999995 110.799 -179.969 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.3 136.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.478 . . . . 74.329999999999998 111.157 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.32 161.91 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 73.340000000000003 111.099 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.2 t -146.45 93.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.019999999999996 111.161 179.95 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.2 27.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 73.129999999999995 110.83 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.88 57.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 64.430000000000007 112.536 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.15 139.22 21.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.605 0.717 . . . . 72.409999999999997 110.891 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 152.93 69.49 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 71.439999999999998 112.401 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.07 -68.39 0.92 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 73.129999999999995 110.929 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.81 -144.67 4.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 61.140000000000001 112.518 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.31 135.91 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.450000000000003 110.847 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.64 129.73 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.319999999999993 111.145 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 95.54 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.450000000000003 110.821 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.401 ' HB2' ' HB ' ' A' ' 6' ' ' VAL . 5.5 m-85 -87.56 119.81 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 73.439999999999998 110.875 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -101.07 147.88 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 110.917 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -121.06 120.18 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 65.140000000000001 110.911 -179.919 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.63 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.100000000000001 110.904 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.67 -2.47 56.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 65.530000000000001 111.104 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.05 -51.03 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 110.867 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -26.32 16.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.209999999999994 110.862 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG23 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.58 74.57 65.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.64 0.733 . . . . 74.329999999999998 111.142 179.858 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -44.6 1.98 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.251 . . . . 73.340000000000003 112.382 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -62.85 -50.22 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.239999999999995 110.92 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.03 -39.33 93.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 71.120000000000005 111.138 179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.81 -68.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 74.010000000000005 111.07 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' ARG . 27.2 tt0 -48.42 -65.61 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 73.120000000000005 110.932 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 34' ' ' GLU . 4.2 t30 -29.93 -52.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 65.120000000000005 110.867 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.12 -41.56 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 75.349999999999994 110.885 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.514 ' N ' ' O ' ' A' ' 34' ' ' GLU . 5.0 ttm180 -52.06 -29.52 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 75.540000000000006 110.834 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.55 -32.55 73.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 72.420000000000002 111.098 179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.01 35.3 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 110.877 -179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.7 t -113.22 -12.29 13.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 74.040000000000006 110.853 -179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 p -121.32 18.14 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.120000000000005 111.159 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.34 27.8 8.39 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.747 -0.739 . . . . 64.209999999999994 112.528 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.04 -40.41 53.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.392 . . . . 75.239999999999995 110.882 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -17.27 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 73.329999999999998 110.895 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.26 -66.24 3.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 63.030000000000001 112.492 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -93.3 148.02 22.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 75.5 110.917 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.8 -168.04 25.14 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.756 -0.735 . . . . 54.229999999999997 112.48 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.11 139.7 30.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.931 0.396 . . . . 74.310000000000002 110.941 -179.821 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -42.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 73.200000000000003 110.918 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.2 45.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 55.020000000000003 112.473 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.5 t -95.43 45.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 72.510000000000005 110.854 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.27 -176.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 70.540000000000006 110.881 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -176.53 134.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 72.200000000000003 110.859 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.22 66.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 73.519999999999996 110.862 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 8.26 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 73.230000000000004 110.86 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.457 HG21 ' HA3' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -57.75 150.63 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 73.140000000000001 111.125 179.991 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 3.9 mt -140.29 95.64 8.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 75.329999999999998 111.14 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.77 87.6 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 74.239999999999995 112.332 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 71.409999999999997 112.516 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -59.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 72.340000000000003 110.908 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -157.22 -150.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 72.439999999999998 110.888 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.6 t -121.01 -53.68 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 74.109999999999999 110.896 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.08 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 72.519999999999996 110.943 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.26 -152.58 21.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.728 -0.748 . . . . 65.540000000000006 112.5 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.65 43.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 54.130000000000003 112.471 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.24 121.63 14.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.85 0.357 . . . . 64.109999999999999 110.866 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 178.65 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 110.883 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.7 p -126.54 100.17 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 73.319999999999993 111.159 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.89 169.46 8.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 74.439999999999998 110.896 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -51.03 -32.87 22.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.863 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -179.36 103.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 71.230000000000004 110.845 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -165.97 26.84 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 71.430000000000007 112.494 179.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.3 p 62.99 26.43 15.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 73.439999999999998 111.143 -179.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.81 -116.22 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 74.230000000000004 112.512 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.43 -26.42 1.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 75.430000000000007 112.48 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.01 -157.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 74.329999999999998 110.893 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 167.01 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 71.400000000000006 110.826 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -42.96 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 111.126 179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.75 46.02 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.966 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.55 -95.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.749 . . . . 42.420000000000002 112.495 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -54.64 178.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 70.140000000000001 110.904 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.92 -172.07 2.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.150000000000006 110.9 179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.11 164.46 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 73.019999999999996 110.866 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.27 179.33 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 73.310000000000002 110.859 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.89 129.73 34.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.430000000000007 110.84 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -88.24 -46.57 9.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.510000000000005 110.877 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 p30 177.68 156.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 63.119999999999997 110.913 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.84 63.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.409999999999997 110.884 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.82 2.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 71.299999999999997 111.164 179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.8 mt -133.68 136.74 44.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.120000000000005 110.907 179.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -162.91 1.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 74.310000000000002 110.897 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -102.19 97.07 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 65.209999999999994 110.867 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -79.19 -21.43 46.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 111.154 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.02 -125.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 62.350000000000001 112.483 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.14 47.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.616 2.211 . . . . 65.5 112.345 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.447 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 67.05 121.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 72.310000000000002 112.47 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -176.4 130.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 71.040000000000006 111.135 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 0.8 OUTLIER -106.61 122.84 47.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.888 179.888 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -133.51 -155.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 75.540000000000006 110.908 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.1 mmt -134.23 116.34 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 110.905 179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.46 -46.38 80.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 74.209999999999994 111.083 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.5 p30 39.14 -157.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 72.209999999999994 110.912 -179.918 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.554 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -141.44 10.99 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 74.329999999999998 111.11 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.9 -65.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 64.319999999999993 112.512 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.554 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.78 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 60.439999999999998 112.314 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -82.34 81.05 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 70.510000000000005 110.888 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 5.3 t -153.22 56.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 111.111 -179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.89 -44.51 19.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 71.109999999999999 110.898 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 48.18 -164.74 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 44.520000000000003 112.452 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.96 87.82 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 72.040000000000006 110.866 -179.733 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -161.15 51.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.924 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -59.83 -172.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 110.898 -179.959 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.62 106.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.099999999999994 110.927 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 76.8 mt -48.17 123.36 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 74.519999999999996 111.122 -179.992 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 89.7 m -84.29 116.5 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.120000000000005 110.868 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -88.18 -30.69 19.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.109999999999999 111.155 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.13 161.02 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 71.209999999999994 111.085 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -62.22 102.3 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 110.921 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 18.6 p -113.89 46.0 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 71.129999999999995 111.175 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -16.79 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 72.530000000000001 110.827 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -64.12 -15.51 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 74.209999999999994 110.939 -179.942 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.99 78.29 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.150000000000006 110.942 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.92 -47.79 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 64.450000000000003 110.871 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.87 45.17 3.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 72.209999999999994 112.499 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -145.25 -53.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 71.439999999999998 110.906 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -101.68 134.76 44.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.230000000000004 110.802 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.47 104.83 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 71.219999999999999 111.119 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 90.8 t -78.41 132.5 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 111.131 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.405 ' HA ' HG23 ' A' ' 29' ' ' VAL . 19.5 p90 -152.94 26.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.219999999999999 110.884 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.412 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -161.4 -170.53 26.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.701 -0.762 . . . . 72.239999999999995 112.466 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp 178.73 -169.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 75.400000000000006 110.926 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -116.35 81.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 73.340000000000003 111.139 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -49.2 -34.56 15.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 74.349999999999994 110.919 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -171.02 168.28 6.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.540000000000006 110.873 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.83 -1.6 58.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.714 -0.755 . . . . 71.019999999999996 112.466 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -33.54 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 74.230000000000004 110.934 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -50.58 -27.03 6.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 71.019999999999996 110.905 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 17.6 mm -81.58 -45.61 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 73.540000000000006 111.145 179.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.06 -51.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.121 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.01 -27.74 14.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 70.239999999999995 110.891 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.57 52.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 75.5 111.109 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 62.1 mtm -62.96 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 75.310000000000002 110.863 -179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.418 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 6.3 mm-40 -51.42 -71.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 75.219999999999999 110.898 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -60.0 -16.68 32.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 74.219999999999999 110.883 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -92.51 2.16 56.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 72.040000000000006 110.854 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.457 ' HA3' HG21 ' A' ' 56' ' ' ILE . . . -127.62 46.77 1.06 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 75.239999999999995 112.504 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 146' ' ' GLY . 8.1 t 34.89 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 73.239999999999995 110.886 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.9 mmm-85 -133.62 -35.44 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 75.409999999999997 110.903 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -99.45 -8.3 24.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.010000000000005 110.926 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.57 80.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 63.439999999999998 112.483 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -60.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 75.049999999999997 110.874 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 66.43 133.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 63.210000000000001 111.126 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -9.02 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 72.230000000000004 110.877 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.48 156.65 47.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 73.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.76 118.64 32.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 75.299999999999997 110.891 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 12.7 mt -88.59 134.47 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 73.239999999999995 111.15 179.857 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.16 170.45 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 71.430000000000007 111.145 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 67.1 mt -118.7 111.36 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 75.030000000000001 111.156 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.59 -54.96 39.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 74.319999999999993 111.131 179.828 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -167.6 168.84 12.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 75.519999999999996 110.908 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.3 p -156.49 163.76 39.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 65.319999999999993 110.867 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.72 -178.85 47.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 74.319999999999993 112.456 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.517 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 9.5 mt-30 -69.32 -37.23 77.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 71.209999999999994 110.94 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.5 mm? 71.14 -62.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 65.450000000000003 110.885 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.099999999999994 110.877 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 75.150000000000006 110.852 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.9 155.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 61.049999999999997 111.104 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.37 149.25 37.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 75.340000000000003 110.9 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.81 19.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.681 2.254 . . . . 70.450000000000003 112.366 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 57.4 m -119.6 124.91 47.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.450000000000003 111.132 -179.94 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 m -104.95 144.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 75.25 111.108 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -105.05 154.94 19.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 73.530000000000001 110.866 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.33 131.52 26.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 75.219999999999999 110.89 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.52 95.07 5.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.400000000000006 110.885 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mt -78.92 141.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 64.409999999999997 111.144 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -122.83 159.94 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.099999999999994 111.122 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.31 106.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 75.239999999999995 111.095 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 51.45 55.44 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 63.299999999999997 110.879 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.51 9.84 33.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 63.439999999999998 112.512 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -136.0 93.84 14.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.685 0.755 . . . . 74.099999999999994 110.87 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.83 156.02 64.22 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.694 2.262 . . . . 64.549999999999997 112.313 -179.942 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.18 26.99 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 74.239999999999995 110.942 179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.9 169.28 12.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 63.520000000000003 112.488 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.58 171.52 12.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 74.019999999999996 110.845 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.6 m -143.3 -176.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.439999999999998 111.158 179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.7 p -148.11 154.77 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.530000000000001 110.824 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.36 134.1 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 75.340000000000003 110.878 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.1 tt0 -73.98 -55.03 6.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 73.099999999999994 110.888 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mt 76.8 124.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 73.409999999999997 110.961 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -81.76 55.28 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.877 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -36.52 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.430000000000007 111.113 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.44 -51.61 66.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.319999999999993 110.878 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -60.49 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.150000000000006 110.891 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.55 82.51 6.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 74.200000000000003 111.135 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 60.94 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 62.450000000000003 112.355 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 -71.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 74.010000000000005 110.874 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 27.3 m -58.34 -53.71 55.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 70.030000000000001 111.149 179.999 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.83 9.52 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.106 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -88.95 -24.54 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 61.509999999999998 110.872 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.57 -29.76 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 74.340000000000003 110.859 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -50.59 -28.4 8.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.400000000000006 110.868 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -56.66 -30.71 63.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 72.420000000000002 110.861 -179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.79 -31.79 19.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.420000000000002 111.081 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 67.1 mt -65.19 -47.85 75.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 70.510000000000005 110.962 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -65.22 -37.41 87.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 74.420000000000002 110.857 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.4 p -73.88 -19.66 60.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 74.310000000000002 111.184 -179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.6 91.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.741 . . . . 64.519999999999996 112.457 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.66 36.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.901 0.381 . . . . 73.150000000000006 110.886 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.99 6.63 2.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.319999999999993 110.886 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 9.7 84.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 75.519999999999996 112.526 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -174.16 -169.17 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 72.409999999999997 110.886 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.53 -80.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 71.510000000000005 112.507 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -176.8 110.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 74.329999999999998 110.889 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -179.03 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 74.540000000000006 110.938 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.403 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -45.2 104.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 61.240000000000002 112.507 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -159.74 54.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 62.219999999999999 110.865 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.8 m 52.3 -173.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 72.510000000000005 110.908 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -168.84 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 74.430000000000007 110.839 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -115.56 -77.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 75.409999999999997 110.857 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -135.44 143.38 45.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.875 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.6 mt -143.78 125.86 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 72.219999999999999 111.134 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -134.28 114.11 12.46 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 70.219999999999999 111.15 179.831 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HA ' ' CG ' ' A' ' 143' ' ' GLU . 53.9 Cg_endo -69.8 108.99 2.21 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.682 2.255 . . . . 73.150000000000006 112.334 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.2 -31.28 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 54.229999999999997 112.516 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -99.96 -63.2 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 75.109999999999999 110.854 -179.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.81 -165.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 75.120000000000005 110.853 179.975 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.3 m -142.19 115.04 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.100000000000001 110.925 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -99.36 151.06 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 64.430000000000007 110.908 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.48 159.9 18.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 72.349999999999994 112.433 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.66 1.76 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.723 -0.751 . . . . 70.319999999999993 112.486 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 150.72 40.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 73.439999999999998 110.854 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 60.79 164.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 72.25 110.862 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 p -146.64 34.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 63.109999999999999 111.12 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 65.63 34.08 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 110.873 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -51.81 -38.98 57.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 75.430000000000007 110.897 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.52 40.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 73.120000000000005 110.915 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.49 168.06 39.93 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 75.340000000000003 112.483 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -115.02 92.02 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 64.030000000000001 111.168 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.23 179.91 17.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 72.129999999999995 112.529 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.12 159.24 15.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 65.109999999999999 112.474 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 77' ' ' SER . 16.6 ptpt -176.86 -173.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 72.019999999999996 110.921 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 61.2 p -87.75 -167.94 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 73.340000000000003 110.811 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -111.85 11.19 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 75.319999999999993 111.121 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -7.71 25.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 72.430000000000007 110.919 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.05 -84.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 75.109999999999999 112.451 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.4 -68.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 71.349999999999994 110.864 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -167.78 163.58 14.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 65.120000000000005 110.883 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.6 144.15 51.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.856 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.13 159.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 73.010000000000005 110.878 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -64.6 -167.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.329999999999998 110.863 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -148.36 -67.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.409999999999997 110.893 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -176.93 171.88 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 72.540000000000006 110.935 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.97 43.35 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 71.409999999999997 110.868 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.7 mt -51.01 -27.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 72.450000000000003 111.132 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.8 mt -96.6 137.39 35.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.109999999999999 110.899 179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.93 114.09 17.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.519999999999996 110.917 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.44 ' CE1' ' HB3' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -55.97 102.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.129999999999995 110.837 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.2 p -113.76 42.45 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.409999999999997 111.153 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.89 156.67 14.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 50.32 112.517 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 128.08 15.49 Favored 'Trans proline' 0 N--CA 1.466 -0.103 0 C-N-CA 122.69 2.26 . . . . 73.209999999999994 112.33 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.9 -22.1 8.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 63.409999999999997 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.9 mm -65.82 152.05 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 72.430000000000007 111.117 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 32.0 mt -96.12 132.18 41.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.400000000000006 110.941 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.0 m -119.67 138.66 53.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 110.816 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.428 ' HB2' HG12 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -77.57 172.48 13.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 72.109999999999999 110.86 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.561 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -166.13 -175.07 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.409999999999997 111.094 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 12.0 t30 88.6 95.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.887 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.571 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . 66.18 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 111.08 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 121.49 -59.96 0.56 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.708 -0.758 . . . . 71.430000000000007 112.462 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.571 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 100.15 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 74.5 112.301 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.8 56.33 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.409999999999997 110.84 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -132.0 7.14 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.200000000000003 111.116 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 41.29 -92.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.239999999999995 110.913 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 97.43 139.16 10.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 55.140000000000001 112.472 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 p -100.61 -8.89 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 70.340000000000003 110.896 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 129.82 35.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 75.019999999999996 110.934 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.05 138.69 48.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 72.219999999999999 110.903 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -120.2 121.64 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.200000000000003 110.883 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mt -92.35 119.26 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 111.107 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -76.27 150.97 36.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 74.450000000000003 110.84 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -126.55 23.75 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.420000000000002 111.124 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.72 20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 65.349999999999994 111.111 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 64.97 135.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 72.200000000000003 110.891 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 21.8 p -148.95 68.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 71.150000000000006 111.129 -179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -84.37 14.3 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.868 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.2 p90 -91.39 0.33 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.955 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.56 31.88 1.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 54.520000000000003 110.871 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.44 ' HB3' ' CE1' ' A' ' 92' ' ' HIS . 22.5 p-10 -96.26 78.81 3.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.329999999999998 110.847 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.79 -41.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 44.329999999999998 112.485 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -35.75 73.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 73.120000000000005 110.898 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -117.37 159.3 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 64.129999999999995 110.831 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' ' 128' ' ' VAL . 1.1 p -81.05 -159.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 74.140000000000001 111.087 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.524 ' N ' ' CG1' ' A' ' 127' ' ' VAL . 0.9 OUTLIER -165.36 144.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 72.140000000000001 111.128 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.413 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 27.7 p90 -175.99 115.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 71.209999999999994 110.905 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 24' ' ' LEU . . . 114.87 114.5 3.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 73.409999999999997 112.488 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.39 143.14 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 64.040000000000006 110.861 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.5 t -52.53 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.439999999999998 111.126 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -56.78 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 61.210000000000001 110.899 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.09 170.8 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.872 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 63.37 82.45 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 63.109999999999999 112.463 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 8.7 tpt -89.17 11.09 19.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 75.109999999999999 110.832 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.69 -34.3 16.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 72.420000000000002 110.905 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.42 ' O ' ' HB3' ' A' ' 142' ' ' MET . 39.4 mm -60.18 -38.38 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.239999999999995 111.116 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.5 t -90.63 -3.01 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 74.200000000000003 111.122 179.866 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -110.66 -71.83 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.439999999999998 110.9 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.75 -52.07 34.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 72.540000000000006 111.119 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.425 ' C ' ' H ' ' A' ' 144' ' ' ARG . 13.7 tmm? -51.43 -29.16 15.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.209999999999994 110.862 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.418 ' CG ' ' HA ' ' A' ' 58' ' ' PRO . 1.4 tm-20 -79.54 29.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 71.239999999999995 110.854 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.425 ' H ' ' C ' ' A' ' 142' ' ' MET . 15.6 ttp85 -113.51 -14.39 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 73.310000000000002 110.884 -179.914 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -105.77 -2.46 23.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.89 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -157.46 1.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 74.019999999999996 112.483 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.8 t -163.79 141.77 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 74.230000000000004 110.868 -179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -57.46 -20.15 28.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 74.230000000000004 110.855 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.09 -17.87 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 75.120000000000005 110.902 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.93 -42.0 1.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.708 -0.758 . . . . 70.010000000000005 112.506 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -46.41 131.6 10.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 73.219999999999999 110.882 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.7 p -96.52 112.66 24.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 111.144 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -49.8 -28.1 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 64.299999999999997 110.841 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -125.11 -162.26 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 74.530000000000001 110.939 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -128.37 129.25 45.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 70.129999999999995 110.909 179.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.3 mp -112.36 92.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 111.133 179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.0 p -103.17 148.66 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 63.350000000000001 111.142 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.403 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.8 mt -88.82 130.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 111.134 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.89 -64.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.340000000000003 111.08 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -127.02 170.63 12.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.349999999999994 110.816 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.48 -174.89 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.530000000000001 110.862 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.36 -148.59 19.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 75.329999999999998 112.44 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.74 133.91 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 74.409999999999997 110.9 -179.866 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.2 tp -56.78 -57.09 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 74.140000000000001 110.866 -179.976 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.120000000000005 110.912 179.95 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.809 0.337 . . . . 75.019999999999996 110.887 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.35 138.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 64.319999999999993 111.121 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.41 157.28 13.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.65 0.738 . . . . 73.409999999999997 110.882 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 122.0 8.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 74.349999999999994 112.318 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.4 m -100.85 55.99 0.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 71.219999999999999 111.128 -179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -52.26 154.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.519999999999996 111.077 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -136.56 170.8 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.120000000000005 110.861 -179.988 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -142.0 143.88 33.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 74.049999999999997 110.902 -179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.45 115.95 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.349999999999994 110.86 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -85.73 123.07 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 75.310000000000002 111.129 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.19 13.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.310000000000002 111.097 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.7 m -144.21 101.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.049999999999997 111.109 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 3.7 t0 76.71 45.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 70.549999999999997 110.901 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 24.02 70.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 72.319999999999993 112.452 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -135.27 148.7 67.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 74.239999999999995 110.92 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 140.13 41.91 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.68 2.253 . . . . 74.319999999999993 112.358 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 tp -127.39 -38.12 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.913 179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.24 -178.51 45.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 51.409999999999997 112.482 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 162.25 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.510000000000005 110.847 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.54 147.6 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 73.25 111.119 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.23 97.82 11.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 74.099999999999994 110.911 -179.867 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -85.0 59.61 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.219999999999999 110.846 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.79 115.45 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 72.430000000000007 110.865 -179.9 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 mt -81.83 133.2 35.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.109999999999999 110.927 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -75.8 67.31 2.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.030000000000001 110.855 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.18 -14.82 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 73.439999999999998 111.095 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.09 -60.26 2.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.854 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -67.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 75.540000000000006 110.924 -179.995 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.509 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 3.2 m -105.95 114.46 62.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 64.140000000000001 111.107 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' LYS . 53.7 Cg_endo -69.77 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 73.030000000000001 112.319 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' PRO . 7.9 mtmm -38.33 -54.68 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 75.010000000000005 110.849 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.509 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 55.8 m -39.51 -58.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 73.400000000000006 111.145 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.98 30.85 4.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 70.030000000000001 111.074 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -97.24 -30.64 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.409999999999997 110.846 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.03 -35.53 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.129999999999995 110.9 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -31.62 6.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 65.340000000000003 110.932 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -35.82 70.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 75.430000000000007 110.872 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.29 -21.75 27.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 63.229999999999997 111.133 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 73.7 mt -70.23 -51.36 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 72.150000000000006 110.892 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -68.18 -44.69 75.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 74.120000000000005 110.885 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -74.96 -24.07 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 73.420000000000002 111.157 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.34 94.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.230000000000004 112.486 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.76 47.53 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.948 0.404 . . . . 61.049999999999997 110.933 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 33.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 75.200000000000003 110.868 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.63 -3.4 49.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 74.530000000000001 112.495 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -163.0 -168.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 73.450000000000003 110.862 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.69 137.39 4.81 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.679 -0.772 . . . . 75.340000000000003 112.468 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -85.21 144.27 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.951 0.405 . . . . 74.25 110.94 -179.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -57.66 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 75.510000000000005 110.869 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.404 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -114.26 -76.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 71.510000000000005 112.513 179.916 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t 68.82 123.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 75.310000000000002 110.841 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.51 -171.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 75.549999999999997 110.849 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -104.81 -170.82 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 65.040000000000006 110.922 -179.928 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -60.09 1.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 73.349999999999994 110.828 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -151.66 160.14 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.230000000000004 110.842 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.1 mt -136.82 130.52 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 74.5 111.151 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -130.22 110.23 16.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.601 0.715 . . . . 75.530000000000001 111.149 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.7 Cg_endo -69.83 101.72 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.609 2.206 . . . . 73.319999999999993 112.337 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.62 22.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.697 -0.764 . . . . 53.409999999999997 112.511 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -138.5 -63.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 74.230000000000004 110.912 -179.878 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -168.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 73.230000000000004 110.846 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 9.0 m -150.04 131.5 14.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.549999999999997 110.92 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -111.92 139.57 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 74.040000000000006 110.899 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.61 -159.31 27.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.762 -0.732 . . . . 63.299999999999997 112.519 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.51 20.03 76.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 72.420000000000002 112.516 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.74 102.39 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 73.430000000000007 110.864 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -100.83 40.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 75.219999999999999 110.861 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.07 150.34 48.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.299999999999997 111.189 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 70' ' ' HIS . 0.0 OUTLIER 70.86 2.32 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 65.319999999999993 110.919 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 69' ' ' ARG . 73.0 t60 -37.13 -67.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 73.310000000000002 110.89 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -172.62 70.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.510000000000005 110.873 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.76 35.54 92.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 72.349999999999994 112.506 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.7 p -128.29 -58.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 73.230000000000004 111.149 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.96 -176.82 45.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.777 -0.725 . . . . 72.209999999999994 112.469 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.36 110.7 3.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 72.349999999999994 112.492 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.19 -167.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.771 0.32 . . . . 64.519999999999996 110.926 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.61 -179.44 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.843 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.5 pt -81.26 -39.17 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 75.299999999999997 111.134 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -96.68 93.93 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 63.210000000000001 110.941 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.36 -119.51 5.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 61.219999999999999 112.453 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -84.5 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 63.240000000000002 110.903 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 152.66 44.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.299999999999997 110.926 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.71 148.81 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.924 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -49.17 157.77 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 73.510000000000005 110.892 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.08 144.17 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 61.32 110.892 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -61.24 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.0 110.858 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.64 167.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 74.409999999999997 110.902 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.46 60.6 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.010000000000005 110.875 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 30.6 mm -73.37 -6.86 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 73.120000000000005 111.165 179.929 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -117.99 81.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 70.299999999999997 110.922 179.911 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -66.93 161.54 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.882 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -71.41 75.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 74.120000000000005 110.834 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -70.93 -12.28 61.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.409999999999997 111.153 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.14 -170.09 43.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 72.150000000000006 112.483 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 128.04 15.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.694 2.263 . . . . 74.439999999999998 112.339 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.88 -31.4 3.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 74.040000000000006 112.511 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.0 mm -61.27 139.54 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.366 . . . . 73.239999999999995 111.129 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.413 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 50.6 mt -108.28 159.64 16.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 72.439999999999998 110.938 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 m -158.96 33.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.240000000000002 110.858 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 47.17 -167.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.150000000000006 110.877 179.928 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -172.46 75.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 75.329999999999998 111.165 179.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -116.23 -73.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.430000000000007 110.88 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.507 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -147.64 -36.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.200000000000003 111.122 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.06 -69.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 61.109999999999999 112.512 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.507 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.6 Cg_endo -69.74 108.53 2.1 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 73.219999999999999 112.33 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 45.52 38.39 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 73.109999999999999 110.879 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.1 p -138.04 56.79 1.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 63.030000000000001 111.152 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -39.34 -57.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 73.230000000000004 110.893 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.8 -170.84 50.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.129999999999995 112.46 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 34.2 t -144.68 25.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 61.140000000000001 110.826 -179.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -79.65 -100.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 74.420000000000002 110.88 -179.976 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 170.66 179.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 70.510000000000005 110.888 -179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.62 38.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 110.905 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.0 tt -58.27 91.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 75.200000000000003 111.14 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.9 142.11 54.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 74.150000000000006 110.907 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.4 p -111.4 22.34 15.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 73.420000000000002 111.154 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -176.75 161.24 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 54.240000000000002 111.116 179.88 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 95.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.420000000000002 110.914 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 34.5 p -125.12 59.46 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 44.219999999999999 111.119 -179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.22 30.63 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.200000000000003 110.929 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -92.47 7.27 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.400000000000006 110.902 -179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.11 -10.16 28.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 71.299999999999997 110.915 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.59 78.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 75.120000000000005 110.876 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 38.82 50.54 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 71.129999999999995 112.481 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -58.27 -33.01 68.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 74.099999999999994 110.886 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -143.85 177.68 8.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 71.239999999999995 110.877 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.404 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -61.91 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 73.150000000000006 111.12 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.432 ' O ' ' HB3' ' A' ' 129' ' ' PHE . 2.6 p -174.47 138.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.430000000000007 111.149 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 3.7 p90 178.6 102.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 74.010000000000005 110.843 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.56 127.11 3.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 62.420000000000002 112.485 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.71 21.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 74.310000000000002 110.892 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 25.5 m -49.56 159.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 73.120000000000005 111.138 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -160.86 -39.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.530000000000001 110.904 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -63.54 1.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 72.239999999999995 110.881 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.19 105.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 71.109999999999999 112.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -6.78 33.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.776 0.322 . . . . 73.040000000000006 110.869 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -57.61 -20.39 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 70.120000000000005 110.87 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.8 mm -91.74 -45.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.409999999999997 111.105 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.9 t -54.71 -20.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.120000000000005 111.115 179.927 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -83.92 -32.88 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 63.100000000000001 110.925 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.59 -31.28 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 111.123 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -86.02 -9.48 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 75.230000000000004 110.88 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -89.88 28.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 71.340000000000003 110.869 -179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -145.17 8.04 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.891 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.66 2.28 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.019999999999996 110.903 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.564 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.17 72.57 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.769 -0.729 . . . . 73.329999999999998 112.516 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.564 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.7 134.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 74.400000000000006 110.877 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.42 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 27.2 mmm-85 -47.96 -44.91 30.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.340000000000003 110.857 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -49.11 -27.45 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 64.230000000000004 110.867 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.46 -37.59 2.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.723 . . . . 75.230000000000004 112.507 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.66 140.39 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 74.510000000000005 110.916 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.1 p -118.13 147.92 42.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 73.329999999999998 111.134 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -21.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 65.25 110.815 -179.807 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -131.9 -168.35 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 74.239999999999995 110.853 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -132.14 132.15 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.922 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 127.38 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 75.129999999999995 111.128 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.86 168.75 18.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 111.136 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.404 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.4 mt -129.26 113.62 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 72.230000000000004 111.139 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.53 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 65.349999999999994 111.073 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.92 -178.44 6.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 72.409999999999997 110.846 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.62 178.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.520000000000003 110.925 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.4 -163.63 33.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 73.409999999999997 112.476 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.56 123.3 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 72.319999999999993 110.946 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.93 -74.84 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 71.230000000000004 110.892 -179.942 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 75.099999999999994 110.919 179.942 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.805 0.336 . . . . 74.430000000000007 110.858 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.78 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 111.124 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.9 150.85 48.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 71.25 110.875 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.79 153.19 69.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 74.120000000000005 112.34 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.49 162.7 32.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.430000000000007 111.161 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.05 132.91 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 73.150000000000006 111.156 179.886 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.424 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -110.98 161.9 15.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.884 179.98 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -143.52 133.06 23.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 73.439999999999998 110.85 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -98.25 82.29 2.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.350000000000001 110.88 179.936 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.7 142.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.540000000000006 111.098 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -139.31 159.94 40.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 75.209999999999994 111.124 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 96.9 t -137.64 99.63 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 74.519999999999996 111.124 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.29 33.61 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 75.439999999999998 110.862 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.45 -15.0 64.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.732 . . . . 62.520000000000003 112.467 -179.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.52 109.66 51.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.597 0.713 . . . . 64.420000000000002 110.912 -179.909 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 145.04 55.83 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.671 2.247 . . . . 64.319999999999993 112.358 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.88 -66.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 74.109999999999999 110.857 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.82 -172.03 30.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 63.020000000000003 112.491 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 121.76 42.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 75.25 110.849 -179.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.3 t -109.45 105.86 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 72.120000000000005 111.112 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.424 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 79.1 p -98.84 142.06 30.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.826 -179.829 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.61 162.87 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 75.329999999999998 110.874 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -106.61 139.97 40.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 75.120000000000005 110.896 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 41.3 mt -111.05 107.37 16.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 75.049999999999997 110.935 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -85.22 71.61 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 73.230000000000004 110.878 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.3 -24.55 64.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 64.319999999999993 111.082 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.57 -34.44 76.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 64.200000000000003 110.912 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -103.31 -32.16 9.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.329999999999998 110.917 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.4 67.19 75.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 65.150000000000006 111.161 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -3.37 11.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.667 2.245 . . . . 73.200000000000003 112.371 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -42.87 8.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 75.409999999999997 110.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.6 p -85.59 -41.09 15.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 74.109999999999999 111.164 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.97 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 64.329999999999998 111.082 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.7 tt0 -53.15 -64.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 71.150000000000006 110.893 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 34' ' ' GLU . 7.2 t30 -31.66 -46.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.409999999999997 110.905 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -78.75 -43.29 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.040000000000006 110.893 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -55.38 -33.23 63.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 72.120000000000005 110.884 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.68 77.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 62.420000000000002 111.153 179.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.98 39.24 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 75.019999999999996 110.927 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p -112.98 -15.15 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 75.329999999999998 110.808 -179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.2 p -123.17 10.52 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.119999999999997 111.135 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.46 61.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 72.420000000000002 112.467 179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -81.07 -26.49 36.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.93 0.395 . . . . 72.200000000000003 110.89 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -67.56 -10.14 49.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 64.420000000000002 110.925 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.29 -18.51 36.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 72.120000000000005 112.472 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -85.74 -31.03 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 75.25 110.854 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.32 -176.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 54.109999999999999 112.496 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.514 ' O ' ' C ' ' A' ' 49' ' ' LYS . 2.4 t80 -175.48 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.946 0.403 . . . . 75.239999999999995 110.932 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 48' ' ' TYR . 6.1 ptmt -27.08 111.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 74.430000000000007 110.863 179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.94 -60.99 0.57 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 71.329999999999998 112.445 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 42.62 -159.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 65.230000000000004 110.84 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 35.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 74.219999999999999 110.898 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -59.37 132.55 54.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.230000000000004 110.878 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -129.51 63.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.030000000000001 110.831 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.0 tpm_? -119.05 -92.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.340000000000003 110.873 -179.935 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' ARG . 6.3 mm 55.82 115.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 75.140000000000001 111.148 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.1 tt -143.28 102.0 5.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 75.510000000000005 111.153 179.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.6 Cg_endo -69.81 98.64 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 74.140000000000001 112.305 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.99 -56.11 0.29 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.704 -0.76 . . . . 64.349999999999994 112.448 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -105.46 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 63.310000000000002 110.899 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.3 -159.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 72.329999999999998 110.9 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.11 -56.44 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 72.519999999999996 110.92 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 65.6 151.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.230000000000004 110.861 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 149.74 15.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.754 . . . . 73.030000000000001 112.476 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.29 39.6 59.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 74.239999999999995 112.496 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.86 37.74 1.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.25 110.874 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.2 t80 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.109999999999999 110.908 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -113.3 37.19 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.120000000000005 111.118 -179.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -97.49 -82.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 62.340000000000003 110.932 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -37.94 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 71.319999999999993 110.899 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.92 -64.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 73.450000000000003 110.896 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.8 81.06 0.33 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 75.150000000000006 112.437 179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.4 p 50.69 58.42 5.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 73.140000000000001 111.123 -179.909 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.76 -150.05 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 74.329999999999998 112.461 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.71 -166.03 35.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 74.450000000000003 112.477 -179.927 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -172.87 171.08 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 75.219999999999999 110.935 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -97.94 161.95 13.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 72.540000000000006 110.885 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -8.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 73.219999999999999 111.08 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.46 20.6 5.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 64.540000000000006 110.905 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.26 -132.11 2.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.409999999999997 112.477 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -114.06 -33.2 5.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 73.530000000000001 110.893 -179.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.34 177.53 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 75.409999999999997 110.887 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.31 165.6 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 73.239999999999995 110.832 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -85.64 -176.14 5.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 74.409999999999997 110.879 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -91.61 122.97 34.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 73.010000000000005 110.853 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -40.81 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.420000000000002 110.843 -179.882 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.6 p30 177.94 161.38 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 110.844 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -113.33 34.3 4.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.5 110.876 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 mt -62.53 -22.42 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 71.340000000000003 111.141 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.12 110.72 22.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 74.109999999999999 110.917 179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.2 mtpp -109.31 -174.65 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.945 179.772 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -98.4 -77.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 75.409999999999997 110.898 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.1 16.89 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 70.150000000000006 111.124 -179.947 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.28 -168.72 36.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.340000000000003 112.499 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.667 2.244 . . . . 60.340000000000003 112.346 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.546 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 66.08 117.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 73.329999999999998 112.486 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.6 OUTLIER -168.19 122.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 74.219999999999999 111.082 -179.96 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 tt -97.91 116.0 29.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.340000000000003 110.897 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.38 176.7 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 65.049999999999997 110.85 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 5.3 mmt -115.36 104.93 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 72.109999999999999 110.844 179.994 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.3 152.29 45.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.105 179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 108' ' ' ASN . 42.2 p-10 -179.8 -168.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 73.510000000000005 110.915 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.511 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -84.38 -20.76 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 45.25 111.1 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.425 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 123.49 -62.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.714 -0.755 . . . . 65.349999999999994 112.496 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.68 96.42 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 75.209999999999994 112.37 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 25.37 78.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.219999999999999 110.875 -179.979 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.492 ' OG1' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -155.27 30.13 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.183 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 3.3 p30 -97.19 178.97 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.925 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.53 42.22 2.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 70.439999999999998 112.517 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -138.97 -90.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 73.230000000000004 110.863 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.71 171.39 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 72.519999999999996 110.91 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -138.93 147.39 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.439999999999998 110.891 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -117.65 141.07 48.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.439999999999998 110.884 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.3 136.64 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 111.112 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.35 123.99 34.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.400000000000006 110.861 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 p -99.24 -25.81 14.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 73.200000000000003 111.133 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.22 23.12 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 62.329999999999998 111.09 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.36 136.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 72.510000000000005 110.896 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.7 p -131.01 51.65 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 65.310000000000002 111.172 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.04 -19.0 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 74.129999999999995 110.925 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -57.79 -19.71 30.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 72.439999999999998 110.925 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -76.27 -63.0 1.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 74.040000000000006 110.924 179.949 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.78 -59.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 71.219999999999999 110.837 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.99 49.89 0.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 75.430000000000007 112.515 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -105.44 -24.36 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 73.219999999999999 110.932 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -139.32 139.57 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.400000000000006 110.87 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.3 t -77.71 104.37 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 64.200000000000003 111.159 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 78.4 t -90.36 135.28 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.420000000000002 111.147 179.908 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -150.65 16.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 110.874 -179.943 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.3 -169.76 16.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.729 . . . . 51.229999999999997 112.485 -179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -179.81 -165.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 72.150000000000006 110.85 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.99 98.92 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.140000000000001 111.135 179.9 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -55.59 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.884 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.71 160.73 38.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 110.879 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.33 33.93 42.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 72.439999999999998 112.479 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 10.1 mmm -50.08 -28.79 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.34 . . . . 63.420000000000002 110.88 -179.992 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.329999999999998 110.916 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 142' ' ' MET . 45.6 mm -42.24 -37.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 74.239999999999995 111.163 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.45 -51.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 72.400000000000006 111.131 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -48.64 -49.87 35.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 75.439999999999998 110.828 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.6 -52.63 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 111.088 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.505 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 6.8 ttm -50.71 -46.3 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 71.140000000000001 110.848 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.447 ' HG3' ' HB3' ' A' ' 58' ' ' PRO . 3.0 pt-20 -52.03 -23.06 4.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 73.340000000000003 110.85 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -63.39 -22.98 67.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.129999999999995 110.912 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -85.6 14.71 5.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.887 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.76 -155.4 31.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.718 . . . . 74.0 112.435 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.78 -168.5 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.904 0.383 . . . . 75.310000000000002 110.855 -179.76 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -80.13 -43.97 20.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 71.25 110.862 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -101.21 -7.84 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 74.340000000000003 110.874 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.11 -152.02 17.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 72.420000000000002 112.477 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 60.43 101.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 75.209999999999994 110.905 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 p -80.63 159.47 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 74.230000000000004 111.12 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.61 -19.91 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 74.239999999999995 110.866 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -138.29 -179.44 5.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 73.430000000000007 110.864 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.83 106.07 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 73.209999999999994 110.947 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 61.8 mt -92.35 102.78 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 73.219999999999999 111.13 179.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.7 p -117.07 167.65 10.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 73.299999999999997 111.099 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.3 mt -90.95 134.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 75.010000000000005 111.107 179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.34 -62.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 73.010000000000005 111.094 179.789 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -140.17 165.07 28.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.433 . . . . 71.230000000000004 110.827 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 33.4 m -142.67 166.27 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.329999999999998 110.884 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.82 179.8 46.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 71.209999999999994 112.452 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -93.61 -57.65 2.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 75.310000000000002 110.924 -179.897 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.99 150.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 74.450000000000003 110.945 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.230000000000004 110.888 179.916 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 72.230000000000004 110.874 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.39 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 111.109 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.83 153.46 47.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 73.340000000000003 110.882 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.64 2.227 . . . . 62.240000000000002 112.317 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.4 m -126.96 142.07 51.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 75.299999999999997 111.165 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -124.37 157.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 73.040000000000006 111.082 179.937 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -114.0 154.84 26.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.549999999999997 110.906 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.25 138.62 35.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 73.510000000000005 110.898 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.62 113.12 26.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 55.310000000000002 110.887 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.43 121.73 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 75.109999999999999 111.149 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.71 163.01 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 70.439999999999998 111.088 179.823 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -153.07 105.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.120000000000005 111.115 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.79 31.71 9.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.530000000000001 110.842 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.65 -17.42 52.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 62.210000000000001 112.493 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.5 136.5 23.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.679 0.752 . . . . 64.420000000000002 110.844 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 155.03 66.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 73.340000000000003 112.296 -179.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.04 -60.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.439999999999998 110.967 179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.61 -170.94 35.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.732 -0.746 . . . . 72.409999999999997 112.494 179.889 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -124.64 127.51 47.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 74.219999999999999 110.874 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 8.0 t -129.87 129.85 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 73.209999999999994 111.159 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 p -109.19 154.49 22.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 74.25 110.878 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 135.06 52.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.409999999999997 110.848 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.36 131.95 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 75.519999999999996 110.868 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 36.5 mt -96.18 118.51 32.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 72.120000000000005 110.937 -179.998 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -80.12 55.33 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 74.510000000000005 110.88 179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.35 -28.24 11.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 75.140000000000001 111.094 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.63 -47.47 70.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 75.040000000000006 110.894 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -95.78 -32.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 75.439999999999998 110.867 179.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 HG21 ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -124.22 74.64 59.59 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.667 0.746 . . . . 74.140000000000001 111.168 179.877 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -51.14 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.698 2.265 . . . . 74.310000000000002 112.32 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -43.22 84.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 110.894 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -69.01 -60.89 2.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 71.329999999999998 111.119 -179.987 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -33.76 -67.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.219999999999999 111.141 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' ARG . 79.3 tt0 -58.67 -58.79 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.230000000000004 110.874 -179.953 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.0 t30 -32.85 -53.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.150000000000006 110.912 -179.971 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -79.2 -29.07 42.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.913 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 4.7 ttp180 -52.31 -32.99 40.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 75.430000000000007 110.859 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.25 -25.14 61.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.540000000000006 111.082 179.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 27.31 3.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 73.340000000000003 110.916 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -152.5 -25.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.140000000000001 110.87 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.5 p -81.82 -43.99 17.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 74.010000000000005 111.081 -179.925 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 155.05 -27.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.109999999999999 112.455 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 42' ' ' GLY . 1.1 mt-10 -30.71 -74.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 72.209999999999994 110.897 -179.851 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.64 144.38 31.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 74.409999999999997 110.9 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.79 22.1 7.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.722 -0.752 . . . . 75.129999999999995 112.513 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.52 -8.0 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 74.540000000000006 110.896 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.97 -101.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 72.310000000000002 112.489 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 70.409999999999997 110.876 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? 57.6 169.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 74.439999999999998 110.912 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.54 118.53 8.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 73.530000000000001 112.506 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.6 p -159.33 -82.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 74.409999999999997 110.812 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -177.57 173.82 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 61.119999999999997 110.883 -179.921 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.36 -171.24 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 73.430000000000007 110.834 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.74 -55.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 65.340000000000003 110.855 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.92 144.01 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.540000000000006 110.844 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -152.36 120.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 74.340000000000003 111.158 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.46 109.07 19.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.72 . . . . 72.430000000000007 111.183 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 97.92 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.655 2.236 . . . . 74.510000000000005 112.39 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.45 -5.06 23.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 71.340000000000003 112.526 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -66.52 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 74.430000000000007 110.835 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.06 -168.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 74.400000000000006 110.837 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.7 m -142.74 128.93 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.099999999999994 110.862 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -123.67 157.15 34.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 74.409999999999997 110.924 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.65 -157.57 30.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.109999999999999 112.459 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.78 37.56 16.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 73.25 112.45 -179.908 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.14 82.33 2.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 51.340000000000003 110.865 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -99.91 44.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 74.120000000000005 110.891 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.65 -75.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.240000000000002 111.193 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 155.0 31.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 65.120000000000005 110.859 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -72.46 -5.45 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 75.349999999999994 110.817 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -166.56 33.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 73.430000000000007 110.927 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -118.4 -22.14 3.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 73.109999999999999 112.461 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p 50.83 76.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.818 0.342 . . . . 75.450000000000003 111.168 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.83 -83.46 1.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 71.310000000000002 112.527 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.99 143.28 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 55.329999999999998 112.467 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -176.49 179.49 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.792 0.329 . . . . 73.439999999999998 110.896 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.61 177.68 8.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 65.209999999999994 110.871 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.17 -34.06 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 74.430000000000007 111.102 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.29 -7.3 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.882 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.19 -169.72 42.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 54.119999999999997 112.455 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.42 -90.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 71.129999999999995 110.877 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 72.239999999999995 110.9 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -154.66 160.33 41.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.549999999999997 110.857 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.9 175.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 71.340000000000003 110.914 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.19 149.13 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 73.400000000000006 110.902 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -94.83 -46.68 6.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.887 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 157.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 62.420000000000002 110.875 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.22 37.25 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.319999999999993 110.876 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 23.4 mm -55.39 -22.67 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.430000000000007 111.139 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -85.57 116.62 23.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.903 179.904 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -107.0 104.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 73.239999999999995 110.926 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.33 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.89 179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.8 p -113.78 26.88 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 74.209999999999994 111.177 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 163.64 35.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 51.100000000000001 112.492 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 140.7 43.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.712 2.275 . . . . 61.229999999999997 112.349 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.95 45.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 72.129999999999995 112.465 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.45 146.21 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 65.25 111.096 -179.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.0 mt -121.27 166.0 14.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.903 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.51 -170.99 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 75.510000000000005 110.891 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.407 ' HE3' ' CD1' ' A' ' 129' ' ' PHE . 1.9 tpp -92.55 114.15 26.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.420000000000002 110.863 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -101.49 140.0 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 70.409999999999997 111.085 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.2 m-20 168.09 -75.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 74.010000000000005 110.915 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.46 29.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.120000000000005 111.109 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.51 -172.52 14.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 62.149999999999999 112.523 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -49.69 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.675 2.25 . . . . 61.530000000000001 112.327 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -48.7 -20.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.030000000000001 110.879 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.671 ' O ' ' C ' ' A' ' 108' ' ' ASN . 29.8 p -124.05 44.36 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 62.310000000000002 111.097 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.671 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.9 OUTLIER 1.96 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 72.450000000000003 110.901 179.98 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 79.49 91.56 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 65.349999999999994 112.491 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.91 121.47 34.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 72.329999999999998 110.893 -179.754 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -64.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 75.120000000000005 110.929 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.82 167.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 73.219999999999999 110.86 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -176.11 66.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.881 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.6 mt -78.3 108.5 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 71.129999999999995 111.089 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.7 m -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 73.430000000000007 110.86 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.8 p 60.62 10.57 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 74.530000000000001 111.176 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.66 -170.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.129999999999995 111.116 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -79.78 125.32 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.430000000000007 110.911 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 9.7 t -142.45 45.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 65.420000000000002 111.134 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.75 -10.75 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 72.219999999999999 110.906 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -57.93 -26.74 62.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.540000000000006 110.904 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.68 49.82 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 70.450000000000003 110.906 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -71.57 -40.76 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.340000000000003 110.897 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.1 81.73 0.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 62.329999999999998 112.549 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -160.17 -57.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 65.439999999999998 110.873 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -112.08 142.06 44.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.319999999999993 110.834 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' HB ' ' HE2' ' A' ' 100' ' ' MET . 81.5 t -65.71 100.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 65.329999999999998 111.179 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.26 136.51 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 74.140000000000001 111.115 179.93 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.428 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -177.46 128.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 74.349999999999994 110.888 179.951 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 120.69 4.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 71.010000000000005 112.524 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 152.23 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.88 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 34.3 t -44.35 141.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 72.530000000000001 111.133 179.903 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -132.79 -41.79 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 74.019999999999996 110.891 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -66.23 -78.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.450000000000003 110.879 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.79 115.77 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 60.039999999999999 112.49 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.68 -9.23 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.140000000000001 110.885 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -50.3 -25.06 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 63.420000000000002 110.861 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.99 -45.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.084 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.4 t -54.86 -20.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.239999999999995 111.09 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.65 -28.08 24.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.86 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -33.63 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 61.5 111.117 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptm -73.79 -21.19 60.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 75.439999999999998 110.92 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.38 26.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 110.881 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 -20.7 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.420000000000002 110.898 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.83 15.37 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 110.877 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.08 -142.81 9.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 72.540000000000006 112.462 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 p -162.61 147.91 12.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 63.149999999999999 110.832 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -75.7 68.51 2.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 71.299999999999997 110.899 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.1 p30 179.62 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.862 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.62 -60.47 0.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 62.409999999999997 112.483 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 107.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 75.209999999999994 110.931 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -79.97 139.44 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 74.209999999999994 111.176 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -27.82 67.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 65.319999999999993 110.875 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.13 -165.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 74.099999999999994 110.906 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tppm? -131.57 112.09 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.230000000000004 110.871 179.868 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -92.43 128.8 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 111.146 179.848 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.9 p -133.3 175.08 9.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 73.239999999999995 111.165 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -118.63 106.36 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 72.310000000000002 111.144 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.15 -61.5 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 73.010000000000005 111.121 179.825 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -134.9 179.32 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.439999999999998 110.81 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.1 p -172.81 -179.31 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 65.519999999999996 110.866 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 146.8 -169.46 27.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 74.540000000000006 112.546 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -95.11 138.79 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 73.150000000000006 110.895 -179.838 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -50.27 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 75.430000000000007 110.943 179.969 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 75.010000000000005 110.865 179.947 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.341 . . . . 75.439999999999998 110.868 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.33 142.6 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 111.134 179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.68 161.06 0.92 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.601 0.715 . . . . 72.129999999999995 110.861 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 146.53 60.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.234 . . . . 74.450000000000003 112.322 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -130.4 72.28 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 72.219999999999999 111.144 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.43 151.9 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 62.229999999999997 111.108 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.425 ' CD1' ' C ' ' A' ' 7' ' ' PHE . 0.0 OUTLIER -130.76 162.06 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 72.010000000000005 110.862 179.97 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -136.6 132.9 35.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 74.530000000000001 110.861 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -107.44 87.82 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 73.420000000000002 110.886 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.7 mm -71.02 150.42 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.109999999999999 111.111 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.41 163.68 29.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 62.130000000000003 111.115 179.762 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.9 96.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 75.0 111.168 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t0 68.8 53.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.519999999999996 110.851 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.48 14.77 62.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 45.520000000000003 112.495 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -128.59 105.27 19.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 72.310000000000002 110.894 -179.821 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.74 138.82 38.79 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.734 2.289 . . . . 75.109999999999999 112.304 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.87 28.57 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.230000000000004 110.89 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.41 -158.71 14.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 72.230000000000004 112.489 179.863 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.1 179.99 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 74.510000000000005 110.919 -179.89 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.44 170.08 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 75.209999999999994 111.142 179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -118.43 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.129999999999995 110.891 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -79.8 63.98 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 74.530000000000001 110.865 -179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -49.27 133.92 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 71.310000000000002 110.895 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.9 mt -104.16 132.31 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.200000000000003 110.957 179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -75.77 82.51 2.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.239999999999995 110.864 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -8.84 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 70.25 111.127 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.21 -57.37 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 71.120000000000005 110.797 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -57.22 -65.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 71.540000000000006 110.914 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.99 95.14 22.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 53.210000000000001 111.106 179.913 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.84 -19.24 35.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.694 2.263 . . . . 75.120000000000005 112.304 179.983 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -61.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.928 179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -57.3 -26.12 60.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 72.019999999999996 111.128 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.34 2.38 44.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 64.230000000000004 111.06 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -91.01 -22.62 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.876 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.411 ' C ' ' OD1' ' A' ' 35' ' ' ASN . 12.3 t-20 -79.89 -68.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.450000000000003 110.898 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -46.74 -45.68 19.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 74.430000000000007 110.869 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.3 ppt_? -54.47 -32.32 57.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 73.510000000000005 110.888 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.36 -35.15 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 63.439999999999998 111.134 179.88 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.7 mt -66.57 -28.78 68.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 72.109999999999999 110.869 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -38.1 82.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 53.539999999999999 110.855 -179.93 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.7 p -86.38 11.42 12.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.420000000000002 111.164 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 41.2 51.29 4.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 73.299999999999997 112.506 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.59 32.79 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 74.049999999999997 110.941 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 10.34 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.239999999999995 110.893 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.31 30.63 8.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 64.099999999999994 112.495 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.44 158.63 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 73.329999999999998 110.855 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.35 159.08 12.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.319999999999993 112.467 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.95 103.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.397 . . . . 73.340000000000003 110.971 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 -44.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 72.030000000000001 110.858 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.92 31.97 2.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 73.400000000000006 112.496 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 t -100.28 -169.69 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 71.409999999999997 110.904 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -80.85 -166.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 72.430000000000007 110.89 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -94.95 -167.09 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 73.209999999999994 110.851 -179.823 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -74.92 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 72.409999999999997 110.886 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -173.39 91.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.409999999999997 110.853 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.08 144.35 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 74.439999999999998 111.139 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.3 tt -149.91 100.29 3.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 71.219999999999999 111.062 179.849 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.71 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.714 2.276 . . . . 72.430000000000007 112.311 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.52 -46.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 71.049999999999997 112.444 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -69.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 74.310000000000002 110.919 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 115' ' ' CYS . 0.0 OUTLIER -155.07 -148.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 71.230000000000004 110.903 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.5 m -132.53 -49.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 55.049999999999997 110.895 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.450000000000003 110.9 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.37 148.87 20.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 52.210000000000001 112.483 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.64 174.83 18.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 61.109999999999999 112.467 -179.911 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -104.38 -48.12 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.372 . . . . 71.239999999999995 110.861 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -125.62 -84.97 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.519999999999996 110.911 -179.892 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 69.66 -70.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 74.409999999999997 111.167 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -38.17 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.409999999999997 110.843 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -50.89 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.209999999999994 110.819 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.78 38.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 74.239999999999995 110.849 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.81 -148.96 35.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 55.149999999999999 112.502 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.409 ' O ' ' CG2' ' A' ' 73' ' ' THR . 0.4 OUTLIER 72.73 4.36 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 72.430000000000007 111.155 -179.89 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -78.46 -158.63 12.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.758 . . . . 74.230000000000004 112.466 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.2 96.47 1.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 61.340000000000003 112.524 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.33 -166.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 73.040000000000006 110.863 -179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.46 125.92 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.109999999999999 110.89 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 pp -45.3 -40.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 74.140000000000001 111.115 179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -117.44 29.73 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.040000000000006 110.898 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -147.64 7.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 71.239999999999995 112.49 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.56 -33.61 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.961 0.41 . . . . 74.25 110.884 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.31 137.92 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 75.340000000000003 110.896 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -118.65 161.56 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 72.450000000000003 110.88 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.2 160.54 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.430000000000007 110.861 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.79 168.23 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.903 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -132.64 -68.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 110.863 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.18 163.26 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.140000000000001 110.929 -179.954 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 65.030000000000001 110.84 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.9 mt -77.53 -7.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.140000000000001 111.162 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.412 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 2.2 mt -114.42 139.09 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 75.5 110.898 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -171.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 75.540000000000006 110.853 179.852 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -115.01 91.18 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.019999999999996 110.904 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -107.19 21.75 17.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.519999999999996 111.143 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.72 -163.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 63.020000000000003 112.509 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HG2' ' H ' ' A' ' 96' ' ' GLY . 53.9 Cg_endo -69.74 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 72.019999999999996 112.356 -179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.416 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -49.65 151.42 4.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 52.140000000000001 112.46 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER 172.6 124.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 63.310000000000002 111.149 -179.955 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.87 105.25 17.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 110.887 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 100' ' ' MET . 1.3 t -121.19 22.89 10.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.019999999999996 110.875 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.56 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.9 mmt 53.06 123.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 71.319999999999993 110.906 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -107.4 68.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 73.530000000000001 111.085 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -115.9 -82.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.906 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -133.72 -70.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 74.310000000000002 111.102 179.882 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.67 -125.26 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 52.350000000000001 112.522 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.53 6.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.739 2.292 . . . . 73.549999999999997 112.349 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.94 23.42 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 75.019999999999996 110.86 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 17.9 p -154.75 46.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.140000000000001 111.151 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.554 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -88.28 11.65 16.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 75.299999999999997 110.873 179.995 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 24.67 -122.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 72.120000000000005 112.498 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.75 31.19 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 62.039999999999999 110.887 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -167.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.450000000000003 110.897 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -165.87 127.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.150000000000006 110.881 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.576 ' O ' ' C ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -111.46 34.53 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.319999999999993 110.857 -179.917 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.576 ' C ' ' O ' ' A' ' 113' ' ' PHE . 24.7 mt -21.6 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 111.124 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 61' ' ' MET . 14.1 m -82.57 162.46 21.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 55.420000000000002 110.837 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 -17.48 11.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 74.349999999999994 111.14 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -126.63 146.81 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 75.439999999999998 111.081 179.915 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.43 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 74.420000000000002 110.891 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 61.4 p -114.27 69.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 75.430000000000007 111.094 -179.978 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.42 17.02 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 75.329999999999998 110.889 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 p90 -98.83 1.02 45.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.049999999999997 110.9 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.06 28.21 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.230000000000004 110.906 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -105.4 95.71 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 70.310000000000002 110.888 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.35 -42.59 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 75.530000000000001 112.459 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -31.74 25.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 73.299999999999997 110.929 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -98.16 139.73 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 65.209999999999994 110.795 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -60.14 176.74 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 75.109999999999999 111.123 179.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.412 ' CG1' ' HB2' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -168.82 146.19 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 75.140000000000001 111.133 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -179.19 38.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.879 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.89 175.28 35.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.729 -0.748 . . . . 74.329999999999998 112.506 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -179.17 -166.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 75.420000000000002 110.879 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -121.73 125.03 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 111.107 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -111.02 -37.51 5.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 73.510000000000005 110.867 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -132.1 142.18 49.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.329999999999998 110.875 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.32 37.06 5.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 74.310000000000002 112.447 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -29.21 27.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 65.329999999999998 110.856 -179.966 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.52 -39.53 18.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 65.319999999999993 110.869 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.63 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.2 mm -39.63 -41.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 111.115 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.3 t -88.18 -51.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 71.040000000000006 111.074 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -50.59 -59.92 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 110.883 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.76 -58.94 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 72.219999999999999 111.157 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.63 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 5.8 ttm -50.55 -39.0 48.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 74.439999999999998 110.941 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -53.65 -24.89 15.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 72.349999999999994 110.919 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -65.48 -12.26 50.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 74.150000000000006 110.83 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -84.22 4.44 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 75.439999999999998 110.854 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.02 -158.14 28.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 65.109999999999999 112.483 -179.969 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -148.77 -89.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 74.450000000000003 110.84 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -154.98 -52.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 73.219999999999999 110.864 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.52 13.89 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 60.549999999999997 110.877 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.85 -162.77 12.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 71.420000000000002 112.465 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 66.73 140.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 75.510000000000005 110.897 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.3 p -123.48 154.35 39.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 75.530000000000001 111.127 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.48 -3.86 57.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.239999999999995 110.874 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.68 165.24 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 75.109999999999999 110.888 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.77 114.82 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.329999999999998 110.874 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.5 mt -103.36 106.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.150000000000006 111.099 179.848 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 156.24 24.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 72.25 111.129 179.961 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 mm -84.12 148.26 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 74.420000000000002 111.131 179.893 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -97.86 -59.28 1.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 60.509999999999998 111.072 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -167.55 163.25 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 72.010000000000005 110.838 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.0 m -147.68 176.6 9.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 74.030000000000001 110.887 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.55 -168.24 41.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 65.109999999999999 112.49 -179.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.606 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.2 mt-30 -87.27 -38.95 15.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 73.409999999999997 110.91 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.8 mm? 75.31 -54.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 75.319999999999993 110.886 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.409999999999997 110.871 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mmm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.342 . . . . 72.109999999999999 110.92 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 61.34 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 72.450000000000003 111.143 179.977 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.85 156.57 36.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 72.299999999999997 110.856 -179.932 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 147.42 62.91 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.707 2.272 . . . . 75.25 112.314 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -147.18 141.27 26.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 64.519999999999996 111.142 -179.942 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.55 147.74 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 74.200000000000003 111.142 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -111.78 145.64 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 74.409999999999997 110.892 -179.95 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -138.27 139.63 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.140000000000001 110.866 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -108.44 119.62 40.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.239999999999995 110.851 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.8 mm -89.03 116.6 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 74.230000000000004 111.135 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.68 154.58 17.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.310000000000002 111.117 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.89 104.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 111.112 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.21 37.06 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 75.319999999999993 110.861 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.23 80.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 73.510000000000005 112.48 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 149.63 71.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 71.329999999999998 110.884 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 150.93 68.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.653 2.235 . . . . 72.430000000000007 112.34 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.11 -57.59 1.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 73.230000000000004 110.879 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 -147.19 5.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 64.519999999999996 112.44 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -149.77 124.82 10.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 75.099999999999994 110.841 -179.796 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.6 m -113.37 141.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 74.310000000000002 111.094 179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -121.69 146.25 47.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 73.530000000000001 110.893 -179.859 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -130.66 136.16 48.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 71.299999999999997 110.894 -179.933 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.17 111.14 23.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 73.219999999999999 110.87 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD21 ' CD2' ' A' ' 129' ' ' PHE . 86.1 mt -82.7 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 75.120000000000005 110.899 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -83.17 79.68 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 75.420000000000002 110.893 179.939 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.59 -1.36 24.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 111.115 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.52 -47.68 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.349999999999994 110.899 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -83.88 -27.89 28.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.898 179.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.53 73.84 35.02 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.578 0.704 . . . . 72.230000000000004 111.127 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -9.58 26.45 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.63 2.22 . . . . 74.349999999999994 112.362 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -53.66 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.340000000000003 110.867 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -58.18 -51.48 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 74.420000000000002 111.168 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.7 -26.32 67.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 63.149999999999999 111.096 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.9 -34.57 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 74.430000000000007 110.897 -179.922 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.01 -57.74 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 72.209999999999994 110.885 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -50.89 -38.84 52.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.872 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.12 70.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 73.409999999999997 110.925 -179.922 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.36 -33.68 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 71.209999999999994 111.118 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.43 23.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.219999999999999 110.923 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -118.29 -8.45 10.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 55.140000000000001 110.871 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.8 p -117.96 7.48 12.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 73.049999999999997 111.16 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.67 29.59 54.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 73.129999999999995 112.477 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -34.98 26.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.381 . . . . 71.129999999999995 110.93 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.32 47.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 74.209999999999994 110.899 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.53 56.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 74.120000000000005 112.467 179.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -179.8 153.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.383 . . . . 75.420000000000002 110.849 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.2 -140.34 6.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 34.420000000000002 112.447 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -101.88 -27.99 12.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.973 0.416 . . . . 70.420000000000002 110.93 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.38 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 75.549999999999997 110.909 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.27 40.38 45.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 52.420000000000002 112.481 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 t -122.56 -171.2 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 41.240000000000002 110.874 -179.746 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -167.38 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 75.040000000000006 110.859 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -109.41 170.49 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.430000000000007 110.892 -179.842 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -118.09 -69.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 61.219999999999999 110.853 179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 172.35 13.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 110.876 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -154.58 147.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 72.409999999999997 111.114 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.75 120.83 16.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.662 0.744 . . . . 75.239999999999995 111.133 179.872 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 109.06 2.21 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.340000000000003 112.355 179.879 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 25.32 18.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 64.109999999999999 112.527 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.34 -63.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 74.5 110.871 -179.868 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -177.74 -166.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 74.219999999999999 110.897 179.925 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.86 -70.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.430000000000007 110.887 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 64.86 126.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 72.530000000000001 110.878 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.09 -173.82 20.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 73.109999999999999 112.495 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.16 69.09 1.39 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 73.409999999999997 112.462 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -122.94 71.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 73.140000000000001 110.88 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 t80 177.18 -69.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 73.400000000000006 110.874 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 54.8 m 61.47 -85.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 71.310000000000002 111.124 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.94 -179.2 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.109999999999999 110.859 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -43.76 -76.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 74.349999999999994 110.836 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -121.72 -78.72 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.120000000000005 110.876 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -74.9 177.77 47.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 72.25 112.521 179.944 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.5 p 65.15 39.09 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 71.349999999999994 111.167 -179.852 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.93 -92.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 74.030000000000001 112.467 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . -77.95 100.76 1.63 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.726 . . . . 74.409999999999997 112.515 -179.898 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.2 ptpt 176.38 -169.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 74.25 110.906 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.94 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 70.310000000000002 110.873 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -42.17 -46.84 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 111.145 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -122.38 49.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.915 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.62 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 74.310000000000002 112.453 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.05 -75.82 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 73.519999999999996 110.915 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.474 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -130.21 168.46 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 73.510000000000005 110.901 179.902 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -145.48 151.66 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.129999999999995 110.873 179.969 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -54.8 157.91 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.430000000000007 110.872 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.55 112.78 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 70.530000000000001 110.84 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.51 -46.89 85.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 75.209999999999994 110.884 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -177.06 168.66 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 74.040000000000006 110.877 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.31 42.6 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.409999999999997 110.889 179.994 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -53.39 -23.49 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 111.113 179.955 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.4 mt -94.67 145.95 24.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.958 179.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -122.06 -174.93 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 75.239999999999995 110.892 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -116.17 79.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 75.540000000000006 110.816 179.924 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -119.99 24.9 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 72.049999999999997 111.17 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.51 150.34 20.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 63.530000000000001 112.465 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -3.5 12.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.735 2.29 . . . . 72.010000000000005 112.34 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.45 49.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 73.129999999999995 112.477 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.68 135.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 71.420000000000002 111.173 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 5.4 tt -90.05 122.78 33.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 73.299999999999997 110.933 179.926 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.2 t -123.67 164.83 18.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.848 -179.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.4 mtp -104.78 124.31 49.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.129999999999995 110.898 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.1 122.55 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.078 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 8.2 t30 175.85 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.894 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.443 ' HB1' ' OG1' ' A' ' 107' ' ' THR . . . -59.72 -164.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 73.439999999999998 111.091 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.481 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -108.34 -66.91 0.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.522 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.565 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.74 130.91 20.2 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.662 2.241 . . . . 71.239999999999995 112.356 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.5 p30 22.84 67.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 65.340000000000003 110.91 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.474 HG22 ' HG3' ' A' ' 82' ' ' LYS . 6.9 p -150.62 52.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 74.420000000000002 111.151 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -50.48 -56.04 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 75.310000000000002 110.89 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.4 -172.62 52.06 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 74.209999999999994 112.518 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.1 p -112.77 -21.86 10.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 74.150000000000006 110.864 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -60.3 145.22 48.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 72.400000000000006 110.873 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.36 162.72 34.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 73.319999999999993 110.831 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -148.84 132.02 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 74.299999999999997 110.913 -179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.73 121.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.409999999999997 111.161 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.69 128.76 33.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 110.878 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 p -90.43 -14.37 33.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.140000000000001 111.219 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.06 160.16 43.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 73.019999999999996 111.164 179.833 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -53.29 132.97 39.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 64.140000000000001 110.885 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.2 p -138.35 52.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.030000000000001 111.13 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -50.63 -22.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 61.310000000000002 110.891 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -58.73 -35.79 73.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 70.340000000000003 110.894 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.24 101.62 14.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.887 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -151.09 -79.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 73.209999999999994 110.837 179.831 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.74 -27.95 29.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 65.540000000000006 112.477 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -73.42 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 73.120000000000005 110.926 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -99.5 149.77 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 64.420000000000002 110.836 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.466 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.2 t -64.37 -151.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 74.430000000000007 111.126 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.466 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 2.4 p 175.94 141.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.510000000000005 111.138 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.427 ' O ' ' CG ' ' A' ' 129' ' ' PHE . 3.1 p90 -175.51 124.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.019999999999996 110.887 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 108.12 153.47 17.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 73.019999999999996 112.504 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -171.77 151.92 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 73.420000000000002 110.911 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.5 112.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 62.520000000000003 111.176 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.62 -49.97 8.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.129999999999995 110.932 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -159.45 145.32 16.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.219999999999999 110.898 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.95 16.56 27.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 71.299999999999997 112.481 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -29.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.340000000000003 110.852 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -49.57 -29.96 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 72.120000000000005 110.953 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.51 -50.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.420000000000002 111.099 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.61 -45.92 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 111.123 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -51.37 -40.45 59.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.319999999999993 110.891 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.33 -34.19 77.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 70.430000000000007 111.101 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.52 -29.13 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.9 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.59 26.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.030000000000001 110.872 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 145' ' ' PHE . 0.0 OUTLIER -134.43 -23.79 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.855 -179.883 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.402 ' N ' ' HG3' ' A' ' 144' ' ' ARG . 60.8 m-85 -100.77 6.35 43.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 74.030000000000001 110.856 -179.92 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -154.94 29.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 71.340000000000003 112.494 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 t -167.51 150.85 6.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 63.530000000000001 110.806 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -77.9 65.78 3.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.420000000000002 110.853 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 167.82 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 65.140000000000001 110.896 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.3 172.75 13.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 65.510000000000005 112.473 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.51 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.420000000000002 110.879 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -91.06 41.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 74.109999999999999 111.134 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 74.01 -50.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.84 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.26 -168.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.921 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.55 134.77 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 74.120000000000005 110.924 179.861 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.38 104.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 71.120000000000005 111.114 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.49 178.56 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 74.239999999999995 111.133 179.971 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.6 mm -128.38 143.94 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 75.540000000000006 111.083 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.17 -65.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.116 179.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.47 164.17 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 71.400000000000006 110.88 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 59.1 m -144.9 -173.61 4.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 44.149999999999999 110.882 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.52 -158.31 26.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.040000000000006 112.482 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 136.33 47.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.861 0.362 . . . . 75.030000000000001 110.914 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.7 tt -93.06 -44.34 8.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 72.319999999999993 110.889 -179.957 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 71.310000000000002 110.888 179.961 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.807 0.337 . . . . 71.430000000000007 110.865 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -98.34 133.92 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 75.340000000000003 111.125 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -53.99 158.59 3.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.677 0.751 . . . . 74.230000000000004 110.852 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 120.71 7.45 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.68 2.253 . . . . 74.430000000000007 112.313 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -107.86 68.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 74.340000000000003 111.171 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -47.86 155.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 73.219999999999999 111.159 179.885 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.66 160.21 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.129999999999995 110.889 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -144.94 135.05 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 110.849 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -97.42 78.44 2.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 110.877 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -56.72 146.21 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 75.019999999999996 111.162 -179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -134.65 170.48 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.409999999999997 111.076 179.861 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 79.5 t -146.66 96.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 64.450000000000003 111.116 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t0 65.84 41.98 3.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.881 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.05 -16.19 52.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 73.109999999999999 112.523 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -97.42 110.02 52.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.65 0.738 . . . . 73.200000000000003 110.91 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.75 144.85 55.43 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 63.409999999999997 112.328 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 mt -81.29 -44.54 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.952 179.958 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.8 35.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 61.020000000000003 112.489 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.44 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 62.39 147.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 74.430000000000007 110.826 -179.893 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' O ' ' CB ' ' A' ' 21' ' ' SER . 36.5 t -105.41 -103.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 63.509999999999998 111.079 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 164.64 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 75.129999999999995 110.858 -179.859 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.85 111.68 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 65.200000000000003 110.932 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -88.22 144.46 26.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 75.319999999999993 110.888 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 113.18 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 110.868 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -76.53 66.28 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 74.420000000000002 110.892 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.23 77.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.099999999999994 111.075 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.57 -65.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 70.140000000000001 110.894 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.91 -78.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 73.120000000000005 110.891 179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.493 ' O ' ' HB1' ' A' ' 33' ' ' ALA . 17.4 m -72.13 117.72 60.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 73.109999999999999 111.1 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -87.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 74.510000000000005 112.33 179.942 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -36.79 84.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 110.849 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -4.46 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 64.120000000000005 111.112 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -76.9 -48.54 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 73.409999999999997 111.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' C ' ' A' ' 35' ' ' ASN . 22.2 pt-20 -78.2 -38.12 44.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.340000000000003 110.849 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -28.97 -67.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.340000000000003 110.898 -179.935 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -74.91 -34.71 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.909 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.452 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 2.6 ttp180 -49.36 -38.68 29.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 72.109999999999999 110.843 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.55 -35.1 70.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 73.140000000000001 111.119 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.0 mt -68.5 -45.35 72.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 110.911 179.999 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.38 94.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.030000000000001 110.868 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -72.41 -15.52 61.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 73.420000000000002 111.168 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 54.17 82.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 75.409999999999997 112.463 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.54 31.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 74.439999999999998 110.947 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -138.87 22.62 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.109999999999999 110.93 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 -40.42 3.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 74.209999999999994 112.486 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -127.98 -164.01 1.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.230000000000004 110.889 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.92 145.71 11.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 64.019999999999996 112.515 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.72 102.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 73.120000000000005 110.947 -179.781 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.77 -61.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 71.010000000000005 110.876 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.47 30.13 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.230000000000004 112.477 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -76.08 -171.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 74.209999999999994 110.87 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.0 m -87.03 -174.44 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 62.310000000000002 110.885 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.59 -167.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 73.310000000000002 110.887 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.73 -92.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 71.239999999999995 110.842 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -135.01 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 75.129999999999995 110.872 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.6 mt 61.19 104.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.540000000000006 111.189 -179.929 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.414 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 44.2 mt -139.72 98.78 7.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.582 0.706 . . . . 72.430000000000007 111.1 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.3 Cg_endo -69.84 96.13 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.652 2.235 . . . . 74.329999999999998 112.321 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.77 -46.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 55.030000000000001 112.489 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -67.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 64.239999999999995 110.87 -179.84 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.61 -153.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 110.887 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 p -150.74 153.39 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 74.239999999999995 110.924 -179.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -88.25 -168.84 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 75.400000000000006 110.944 -179.913 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.24 -65.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.510000000000005 112.493 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.5 66.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 75.510000000000005 112.501 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -79.41 168.24 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 65.519999999999996 110.889 -179.969 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.0 34.66 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 74.329999999999998 110.892 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.3 p -112.01 -75.11 0.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 74.099999999999994 111.125 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.0 165.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 73.319999999999993 110.852 -179.988 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 72.68 43.35 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.882 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.33 -74.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 71.400000000000006 110.898 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 134.64 65.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 74.5 112.474 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.3 p -133.9 -164.4 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 74.310000000000002 111.143 -179.898 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.09 -178.92 15.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 64.140000000000001 112.453 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.7 -118.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 75.400000000000006 112.448 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -158.9 170.72 21.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 73.310000000000002 110.892 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.74 179.31 7.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.814 -179.861 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 23.2 pt -96.63 -36.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.030000000000001 111.1 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -87.6 -20.21 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.549999999999997 110.889 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.22 -173.53 26.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 65.510000000000005 112.505 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -19.45 37.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 62.340000000000003 110.923 -179.916 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -175.91 149.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.964 179.967 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -117.03 166.48 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.893 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -90.41 159.66 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.409999999999997 110.853 -179.937 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -71.42 141.56 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.150000000000006 110.871 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -57.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.430000000000007 110.902 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -173.0 145.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 74.349999999999994 110.86 -179.951 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.39 52.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.340000000000003 110.843 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mt -82.69 3.86 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 74.420000000000002 111.093 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -113.51 97.73 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 72.129999999999995 110.92 179.909 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 131.02 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 75.5 110.883 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -53.81 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 70.439999999999998 110.882 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -84.27 -12.63 54.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 75.209999999999994 111.118 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.64 -170.09 43.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.040000000000006 112.5 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 142.43 47.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.627 2.218 . . . . 71.230000000000004 112.375 -179.984 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.74 -21.24 25.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.787 -0.72 . . . . 71.420000000000002 112.478 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.37 149.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 74.049999999999997 111.142 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.438 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 2.8 mt -119.84 145.96 46.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.340000000000003 110.945 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.8 35.23 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 64.430000000000007 110.877 -179.884 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.434 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 22.9 mmt 39.2 -149.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 65.010000000000005 110.899 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 100' ' ' MET . . . 166.63 86.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 71.439999999999998 111.062 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -110.1 -71.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 73.430000000000007 110.855 -179.942 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.43 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -146.02 -39.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.349999999999994 111.108 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 128.31 -61.14 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.751 . . . . 74.150000000000006 112.516 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.78 100.06 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 75.010000000000005 112.325 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.548 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER 25.28 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 110.873 179.972 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.6 t -140.63 29.32 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 70.010000000000005 111.139 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 t30 51.59 -99.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 74.129999999999995 110.895 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 102' ' ' ASN . . . 146.47 -85.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.340000000000003 112.457 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.56 20.98 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 64.239999999999995 110.873 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.52 -38.25 16.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 72.120000000000005 110.881 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' H ' ' HA ' ' A' ' 100' ' ' MET . 66.3 t80 68.65 84.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.929 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.0 129.1 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 110.872 -179.888 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -117.39 118.65 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 111.127 179.992 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 18.9 p -86.0 147.01 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 73.109999999999999 110.881 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -107.78 33.81 3.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.329999999999998 111.151 -179.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -170.2 -177.92 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 111.084 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -82.68 90.98 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.409999999999997 110.882 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 33.0 p -116.39 64.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 72.209999999999994 111.185 179.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 18.61 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 72.319999999999993 110.912 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.45 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 6.4 p90 -97.9 13.8 29.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 75.430000000000007 110.921 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 3.5 mt -125.01 -4.25 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 72.519999999999996 110.908 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -79.97 53.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.349999999999994 110.862 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.32 26.17 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 74.310000000000002 112.485 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -168.79 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 75.409999999999997 110.93 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.94 154.51 17.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 73.400000000000006 110.903 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 53.9 t -86.95 107.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 75.510000000000005 111.117 -179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 39.7 t -93.5 135.02 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 72.120000000000005 111.106 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -170.93 58.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.099999999999994 110.876 179.986 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -128.93 179.32 16.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 64.319999999999993 112.483 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 176.31 147.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 73.040000000000006 110.871 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -112.28 94.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.109999999999999 111.087 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -75.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 75.209999999999994 110.909 179.894 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.17 -166.2 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 110.872 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.84 69.03 1.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 74.510000000000005 112.43 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -7.1 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.758 0.314 . . . . 73.219999999999999 110.866 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -31.31 61.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 70.109999999999999 110.846 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.407 ' O ' ' HB3' ' A' ' 142' ' ' MET . 21.2 mm -73.74 -39.19 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 75.109999999999999 111.133 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 15.5 t -82.36 -1.48 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 70.109999999999999 111.169 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -118.24 -59.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 72.540000000000006 110.909 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.81 -56.13 22.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.510000000000005 111.128 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.407 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 2.0 ttm -51.43 -49.47 61.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 74.319999999999993 110.9 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -24.61 28.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.420000000000002 110.91 -179.963 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -66.67 -13.64 61.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 75.150000000000006 110.871 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -90.36 19.5 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 72.400000000000006 110.861 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.78 -158.75 31.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.743 . . . . 74.340000000000003 112.482 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -146.82 -77.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 74.219999999999999 110.852 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 75.209999999999994 110.912 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.1 -14.68 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.88 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.27 -34.41 2.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.25 112.479 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 127.84 15.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 74.049999999999997 110.872 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -110.01 149.56 29.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.519999999999996 111.121 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -68.9 -25.27 64.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 64.150000000000006 110.849 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.02 -166.92 1.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 74.140000000000001 110.909 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -121.83 116.9 25.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 75.420000000000002 110.908 179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.1 mp -95.37 128.34 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 75.109999999999999 111.114 179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 82.4 p -138.59 149.53 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.109999999999999 111.081 179.991 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.99 105.94 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 63.439999999999998 111.144 179.91 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.08 76.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 64.010000000000005 111.102 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -156.61 177.99 10.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.530000000000001 110.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.3 p -174.54 159.81 3.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.239999999999995 110.873 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.51 -179.95 37.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 75.319999999999993 112.49 -179.942 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.57 -43.81 22.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 74.340000000000003 110.904 -179.85 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.86 -172.46 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 73.319999999999993 110.913 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 64.430000000000007 110.877 179.889 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.813 0.339 . . . . 75.319999999999993 110.872 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.4 t -142.24 145.83 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 75.349999999999994 111.069 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.71 140.87 97.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.623 0.725 . . . . 73.239999999999995 110.911 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.73 69.36 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 74.400000000000006 112.321 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 58.0 m -138.59 90.29 2.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 72.019999999999996 111.147 -179.965 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -74.22 162.56 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 74.349999999999994 111.103 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -133.45 157.24 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 73.040000000000006 110.909 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -140.87 139.99 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 74.329999999999998 110.91 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -95.46 99.53 11.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.450000000000003 110.927 179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 mm -71.7 113.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 74.129999999999995 111.125 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.46 161.33 15.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 74.310000000000002 111.1 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.91 110.93 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 72.430000000000007 111.13 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.7 43.87 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.340000000000003 110.855 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.82 9.11 65.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 70.230000000000004 112.497 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -114.91 132.29 23.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.594 0.712 . . . . 71.340000000000003 110.912 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.28 11.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 71.310000000000002 112.328 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.58 -36.92 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 73.040000000000006 110.919 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.21 -137.89 4.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.756 . . . . 75.120000000000005 112.471 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.87 149.74 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.851 0.358 . . . . 73.549999999999997 110.837 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.4 t -148.91 136.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 72.319999999999993 111.134 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -114.78 161.66 17.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.869 -179.834 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.76 149.51 46.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 74.099999999999994 110.905 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -92.0 107.9 19.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.549999999999997 110.877 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.06 130.18 34.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 75.010000000000005 110.875 -179.969 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -84.73 63.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 74.5 110.902 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.19 -2.48 31.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.439999999999998 111.096 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.89 -55.04 3.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.845 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.299999999999997 110.937 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.7 m -110.84 80.48 2.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.587 0.708 . . . . 75.120000000000005 111.131 179.865 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 56.25 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 74.450000000000003 112.387 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -161.7 -67.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 75.439999999999998 110.915 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.0 t -72.48 -16.58 61.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 74.329999999999998 111.139 179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -82.47 -36.39 26.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 71.510000000000005 111.106 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -63.98 -156.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.019999999999996 110.886 -179.929 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 65.37 -73.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 62.210000000000001 110.876 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.6 t80 -50.07 -34.41 21.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.120000000000005 110.881 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.68 71.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.450000000000003 110.876 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.2 -41.47 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 64.010000000000005 111.134 179.887 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.76 -19.32 63.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 110.912 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -101.18 -7.67 22.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 75.299999999999997 110.887 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 99.8 m -105.69 -22.65 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 75.319999999999993 111.179 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 69.74 1.36 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 42.409999999999997 112.5 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.96 34.16 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 64.450000000000003 110.87 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 18.85 2.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.530000000000001 110.902 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.13 -32.04 5.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 73.439999999999998 112.448 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.85 -177.55 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.362 . . . . 75.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.47 39.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.733 . . . . 72.219999999999999 112.536 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.71 -69.26 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 73.329999999999998 110.907 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 55.5 179.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.450000000000003 110.845 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.407 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -37.97 100.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 53.520000000000003 112.506 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 154.17 42.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 73.209999999999994 110.824 -179.729 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.8 p -65.76 161.17 21.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 74.409999999999997 110.885 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.88 174.97 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 75.329999999999998 110.888 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.91 166.37 17.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.874 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 65.68 112.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.828 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.8 mt -151.05 122.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 75.450000000000003 111.136 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.403 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 7.1 mt -130.6 103.76 16.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 71.549999999999997 111.098 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.5 Cg_endo -69.69 85.76 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.67 2.246 . . . . 71.450000000000003 112.379 179.817 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.46 -17.08 2.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 64.129999999999995 112.519 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.87 -57.89 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 75.109999999999999 110.905 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -162.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 74.140000000000001 110.874 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.93 -72.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 65.420000000000002 110.867 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 62.87 153.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.030000000000001 110.913 -179.9 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.26 179.38 16.2 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 71.239999999999995 112.467 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.71 120.71 6.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 63.130000000000003 112.477 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -149.86 155.1 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.373 . . . . 74.030000000000001 110.846 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 179.85 175.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 110.907 -179.925 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.0 t -176.84 59.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.510000000000005 111.131 -179.929 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.58 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.340000000000003 110.839 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -47.05 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.329999999999998 110.851 -179.997 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.21 40.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 72.439999999999998 110.871 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.69 -137.8 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 75.540000000000006 112.49 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -144.53 135.29 24.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 74.310000000000002 111.12 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.6 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 65.150000000000006 112.476 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.01 -9.73 54.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 54.340000000000003 112.522 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -93.29 171.79 8.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 74.140000000000001 110.918 179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.1 p -81.92 -167.4 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 64.140000000000001 110.881 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.55 12.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.439999999999998 111.173 179.895 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -129.61 20.74 5.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.911 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.46 -122.34 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 74.120000000000005 112.505 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.99 -20.0 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 73.239999999999995 110.892 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -176.11 -175.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 75.219999999999999 110.927 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -151.52 154.27 36.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.239999999999995 110.885 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -71.2 163.26 27.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 73.0 110.854 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.8 123.96 33.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 75.329999999999998 110.896 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -48.8 55.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 54.009999999999998 110.849 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.3 p30 179.38 175.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.439999999999998 110.891 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.52 37.6 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.927 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -56.55 -23.36 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 71.129999999999995 111.11 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mt -104.02 134.58 47.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 72.310000000000002 110.894 179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -120.04 -172.34 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 73.400000000000006 110.92 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -97.47 80.34 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 73.209999999999994 110.892 179.866 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.7 p -60.68 -22.53 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.420000000000002 111.137 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.91 -149.1 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 62.43 112.494 179.945 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 162.7 41.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.625 2.217 . . . . 74.340000000000003 112.332 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.33 23.02 76.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 73.340000000000003 112.495 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.05 116.83 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 72.510000000000005 111.125 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 mt -86.38 136.07 33.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 74.540000000000006 110.888 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -133.77 -153.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 73.010000000000005 110.866 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mmt -153.59 158.08 40.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 71.019999999999996 110.895 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -108.5 -169.42 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 111.103 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 32.4 t30 89.43 102.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 63.43 110.893 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . 52.51 -108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.530000000000001 111.087 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.409 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 168.86 -62.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 64.140000000000001 112.538 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.8 Cg_endo -69.82 99.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.679 2.253 . . . . 74.420000000000002 112.331 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.21 47.0 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 74.349999999999994 110.914 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.73 71.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.129999999999995 111.166 -179.966 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.505 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -91.39 31.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 73.409999999999997 110.908 179.975 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . -27.57 -95.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 64.120000000000005 112.499 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 t -151.66 -167.6 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 70.219999999999999 110.857 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.13 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 75.109999999999999 110.89 -179.998 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -101.69 139.46 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 75.120000000000005 110.867 -179.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -111.35 104.6 13.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 74.5 110.893 -179.937 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.39 136.18 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 75.010000000000005 111.094 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.19 153.75 20.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 73.439999999999998 110.866 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -130.53 -33.87 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 63.43 111.166 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.41 15.76 26.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 75.400000000000006 111.085 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 126.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 75.439999999999998 110.852 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -143.05 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 41.329999999999998 111.127 179.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.36 17.14 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.209999999999994 110.89 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -29.22 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 110.926 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.4 23.72 8.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.949 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -89.72 42.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.877 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.21 33.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 55.310000000000002 112.515 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.19 -49.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 73.439999999999998 110.901 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -96.55 158.09 15.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 75.129999999999995 110.845 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.502 ' CG1' ' H ' ' A' ' 128' ' ' VAL . 1.5 t -81.8 -168.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.299999999999997 111.143 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.502 ' H ' ' CG1' ' A' ' 127' ' ' VAL . 2.4 p -172.39 103.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 73.230000000000004 111.165 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.68 82.38 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.92 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 140.03 135.73 3.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 75.010000000000005 112.49 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.99 144.49 31.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 73.319999999999993 110.976 -179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.43 115.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 73.530000000000001 111.106 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -64.49 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 75.140000000000001 110.911 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -141.73 146.41 36.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 73.409999999999997 110.945 179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.9 10.29 35.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 75.430000000000007 112.515 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 ttt -50.07 -28.69 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 70.409999999999997 110.848 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -51.5 -25.08 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 74.129999999999995 110.936 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.72 -37.34 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 111.142 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -53.97 -21.77 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 75.209999999999994 111.136 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -85.91 -34.32 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 73.409999999999997 110.877 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.22 -47.24 83.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 75.540000000000006 111.125 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.9 ptm -69.36 -22.11 63.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.91 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -88.45 23.34 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 65.530000000000001 110.891 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 -11.46 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.109999999999999 110.877 -179.922 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.6 11.47 33.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.030000000000001 110.877 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.1 -142.18 11.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 62.340000000000003 112.484 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t -159.16 139.63 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 74.129999999999995 110.843 -179.724 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.69 80.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.319999999999993 110.859 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 173.81 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 71.140000000000001 110.881 -179.975 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.02 -61.79 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 54.329999999999998 112.509 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.23 143.95 10.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 74.519999999999996 110.869 -179.973 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.4 p -116.04 133.89 55.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 71.120000000000005 111.147 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.17 -1.6 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.868 -179.898 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -136.78 -171.15 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 75.040000000000006 110.913 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -133.35 153.82 51.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 74.25 110.905 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mt -135.39 118.97 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 111.129 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.4 p -115.04 169.32 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 72.099999999999994 111.168 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.407 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 39.6 mm -110.38 133.33 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.450000000000003 111.089 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -82.67 -58.49 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 111.112 179.779 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.19 170.67 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 63.340000000000003 110.873 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 66.8 m -150.09 166.65 29.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 63.210000000000001 110.896 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.17 -178.32 48.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 62.210000000000001 112.45 -179.931 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.2 mt-30 -80.08 -32.52 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 73.120000000000005 110.955 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.611 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER 73.49 -60.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 73.140000000000001 110.916 179.971 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 55.200000000000003 110.831 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.327 . . . . 74.040000000000006 110.922 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.27 156.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 73.099999999999994 111.132 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.61 128.98 94.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.65 21.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 63.030000000000001 112.334 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -126.19 145.04 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 73.219999999999999 111.123 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 10.5 m -125.15 147.53 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 73.530000000000001 111.139 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -103.62 148.56 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.349999999999994 110.839 -179.945 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.06 130.64 20.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.430000000000007 110.903 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.6 t0 -108.59 119.94 41.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.010000000000005 110.849 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.2 mm -101.82 149.25 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.430000000000007 111.097 -179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.73 26.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 72.219999999999999 111.143 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 58.9 t -139.1 101.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 74.120000000000005 111.117 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.6 t0 78.68 27.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.849 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.21 -15.63 62.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.795 -0.716 . . . . 70.299999999999997 112.518 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 136.71 21.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 73.540000000000006 110.859 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 162.95 40.12 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.673 2.249 . . . . 62.100000000000001 112.319 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -110.23 -52.79 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 61.240000000000002 110.895 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' O ' ' HB3' ' A' ' 19' ' ' ARG . . . 162.29 -15.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 74.310000000000002 112.481 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.557 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 71.52 147.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.906 0.384 . . . . 74.430000000000007 110.846 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.469 ' N ' ' HG2' ' A' ' 19' ' ' ARG . 26.4 m -115.8 -176.17 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 74.219999999999999 111.094 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 133' ' ' LYS . 3.7 m -123.67 87.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.400000000000006 110.845 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -84.32 121.63 27.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 75.25 110.928 -179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.04 153.26 20.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 64.329999999999998 110.85 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 mt -119.99 126.81 51.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 74.409999999999997 110.937 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -89.34 70.48 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.430000000000007 110.856 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -22.75 67.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.129999999999995 111.107 179.914 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.25 -61.08 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 75.310000000000002 110.888 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -33.07 30.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 75.400000000000006 110.933 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.39 79.4 70.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 75.340000000000003 111.165 179.876 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -45.41 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 74.239999999999995 112.368 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -59.38 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 73.400000000000006 110.904 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.5 m -55.15 -61.88 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 64.430000000000007 111.128 179.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -36.41 11.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 74.219999999999999 111.122 179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -67.13 -52.15 45.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 73.530000000000001 110.933 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.18 -39.88 31.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 65.450000000000003 110.934 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -76.24 -29.66 57.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.319999999999993 110.875 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -44.05 97.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 73.540000000000006 110.885 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.46 -25.87 62.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 111.071 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.0 mt -76.72 -55.63 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 74.430000000000007 110.921 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -56.75 -48.96 76.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.129999999999995 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.0 p -77.44 -13.99 59.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 75.329999999999998 111.111 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.17 71.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 72.239999999999995 112.48 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.08 33.51 5.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.408 . . . . 74.340000000000003 110.927 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.39 0.51 6.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.908 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.0 -2.88 58.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 74.329999999999998 112.529 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -166.56 171.98 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 74.510000000000005 110.88 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.78 -172.0 24.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 75.329999999999998 112.476 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -82.1 129.34 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 74.140000000000001 110.915 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -134.93 -48.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 71.200000000000003 110.894 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -166.61 51.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 63.149999999999999 112.487 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.406 ' O ' ' CB ' ' A' ' 52' ' ' CYS . 16.5 t -71.41 -92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 75.209999999999994 110.861 -179.707 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 51' ' ' SER . 0.6 OUTLIER 167.52 139.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 110.915 -179.914 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -130.3 162.22 29.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 73.209999999999994 110.905 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -178.09 52.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 73.150000000000006 110.833 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -135.06 35.44 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.319999999999993 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.402 HG13 ' HB2' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -87.55 148.08 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.420000000000002 111.153 179.97 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.5 tt -143.97 110.91 5.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.627 0.727 . . . . 72.109999999999999 111.108 179.842 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 53.7 Cg_endo -69.76 118.88 5.95 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 71.439999999999998 112.361 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.44 -30.27 7.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 64.310000000000002 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.08 -66.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 75.530000000000001 110.855 -179.885 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -176.52 -152.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 74.329999999999998 110.857 179.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.402 ' HB2' HG13 ' A' ' 56' ' ' ILE . 1.8 t -145.77 137.91 25.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 64.510000000000005 110.886 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.48 157.21 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.040000000000006 110.943 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.39 35.08 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 74.510000000000005 112.463 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.89 29.82 8.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 71.439999999999998 112.497 -179.87 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.66 83.37 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.81 0.338 . . . . 71.510000000000005 110.859 -179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -94.66 31.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.540000000000006 110.849 -179.888 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.11 108.76 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 74.25 111.144 -179.923 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 tpt85 68.76 142.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.409999999999997 110.868 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -87.32 25.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 72.120000000000005 110.863 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.59 -39.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.866 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.24 54.48 0.41 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.697 -0.764 . . . . 72.530000000000001 112.455 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.4 p -112.35 3.88 17.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 63.340000000000003 111.133 -179.899 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.15 -137.57 6.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.681 -0.771 . . . . 62.140000000000001 112.479 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.85 71.58 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.747 . . . . 60.520000000000003 112.47 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 141.3 32.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 75.409999999999997 110.916 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 m -105.69 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.150000000000006 110.826 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.17 -44.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.109999999999999 111.127 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -101.28 75.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 73.329999999999998 110.934 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.49 -127.77 8.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 71.140000000000001 112.494 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -111.19 -85.25 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 74.409999999999997 110.913 -179.932 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.426 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -123.48 145.92 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 73.329999999999998 110.875 179.966 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.43 171.02 7.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 74.329999999999998 110.899 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.48 161.5 27.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 74.530000000000001 110.904 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -69.27 152.88 44.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 73.040000000000006 110.899 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.44 -56.67 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 70.230000000000004 110.894 -179.888 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.46 143.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.5 110.875 -179.968 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.15 41.91 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 75.030000000000001 110.885 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 9.2 mt -75.27 -22.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 64.140000000000001 111.147 179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.31 99.46 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 72.200000000000003 110.88 179.89 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.1 101.5 13.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 110.9 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.402 ' CB ' HG13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.34 95.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 72.510000000000005 110.858 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.7 37.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 60.229999999999997 111.155 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.16 158.87 18.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 73.299999999999997 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 135.81 31.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.661 2.241 . . . . 63.049999999999997 112.326 -179.913 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.84 -22.15 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 64.120000000000005 112.498 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.402 HG13 ' CB ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -50.62 152.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 75.109999999999999 111.154 -179.976 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -118.87 126.85 52.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.219999999999999 110.938 179.886 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 82.1 p -153.47 86.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.200000000000003 110.826 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -38.45 155.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 72.530000000000001 110.858 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.77 19.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.129999999999995 111.042 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 75.340000000000003 110.873 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.12 -24.91 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 63.43 111.054 179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.421 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . 117.13 -78.46 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 61.409999999999997 112.495 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.488 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.8 128.58 16.2 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 71.099999999999994 112.348 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' PRO . 19.5 m-20 29.24 55.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 73.519999999999996 110.921 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.683 ' O ' ' C ' ' A' ' 108' ' ' ASN . 18.4 p -140.98 42.66 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 72.209999999999994 111.121 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.683 ' C ' ' O ' ' A' ' 107' ' ' THR . 23.4 t30 0.83 -82.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 74.120000000000005 110.883 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 119.44 168.42 13.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 55.229999999999997 112.507 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -132.88 -39.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 54.020000000000003 110.839 -179.75 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -84.05 72.71 10.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 73.200000000000003 110.897 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.403 ' HB2' HD21 ' A' ' 98' ' ' LEU . 5.8 p90 -63.94 -171.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 75.519999999999996 110.874 -179.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.91 150.7 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 73.219999999999999 110.893 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.8 mt -106.37 114.72 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 71.439999999999998 111.144 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.7 m -75.8 132.9 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.861 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.8 p -99.45 11.99 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 75.150000000000006 111.151 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.25 179.28 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 61.140000000000001 111.107 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -74.43 119.63 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 73.400000000000006 110.902 179.976 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 73.3 p -132.34 59.03 1.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 72.230000000000004 111.149 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.47 -11.87 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 72.409999999999997 110.91 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.448 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 41.8 p90 -82.99 5.75 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 73.230000000000004 110.894 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.448 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 82.0 mt -122.51 34.91 5.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 110.93 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.11 -86.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 63.130000000000003 110.86 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.95 78.08 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.741 . . . . 42.420000000000002 112.495 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -45.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 75.219999999999999 110.881 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . 0.444 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 36.7 m-70 -112.57 -25.53 9.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 72.120000000000005 110.859 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 24.9 t 73.6 95.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 72.540000000000006 111.102 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.428 ' HA ' ' HB3' ' A' ' 99' ' ' SER . 99.0 t -75.32 140.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 73.140000000000001 111.119 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -139.01 -29.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 73.439999999999998 110.88 -179.95 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.78 -168.33 43.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.340000000000003 112.489 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 170.01 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.325 . . . . 74.140000000000001 110.907 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.67 141.14 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.409999999999997 111.19 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.417 ' HB3' ' HB2' ' A' ' 21' ' ' SER . 13.3 tppt? -118.07 -37.22 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 73.329999999999998 110.87 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.87 175.57 13.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.430000000000007 110.881 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.15 78.8 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 72.319999999999993 112.475 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.29 -24.11 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 73.150000000000006 110.88 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 138' ' ' ILE . 26.1 m120 -77.64 -39.49 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 74.319999999999993 110.846 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.48 ' O ' ' HB2' ' A' ' 142' ' ' MET . 50.0 mm -38.1 -46.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 73.510000000000005 111.177 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -88.79 -51.48 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 75.450000000000003 111.132 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -46.66 -57.0 5.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.239999999999995 110.855 -179.978 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.98 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 53.43 111.074 179.964 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 4.5 ttm -52.86 -43.98 66.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 74.109999999999999 110.894 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -55.46 -19.77 10.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 71.129999999999995 110.884 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -66.7 -20.06 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.219999999999999 110.861 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -90.89 15.13 11.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 75.239999999999995 110.879 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.422 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -94.18 -159.06 33.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 63.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.42 169.7 21.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.219999999999999 110.871 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.1 mmm180 -57.08 -36.96 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.420000000000002 110.859 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.27 12.94 19.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 61.409999999999997 110.878 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.85 -85.7 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 75.409999999999997 112.443 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' O ' ' HB ' ' A' ' 152' ' ' THR . 4.3 mttp 62.6 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 73.349999999999994 110.914 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 151' ' ' LYS . 1.4 t 163.29 67.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 74.519999999999996 111.117 179.979 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -48.16 82.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 74.209999999999994 110.866 -179.873 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -126.37 177.44 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 75.120000000000005 110.912 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 75.430000000000007 110.89 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 21.1 pt -131.6 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 70.140000000000001 111.133 179.875 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.3 m -134.34 159.41 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 111.134 179.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.422 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 47.0 mt -91.85 115.92 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.109999999999999 111.16 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.76 -53.54 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 61.43 111.087 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -141.37 175.56 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.340000000000003 110.85 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.8 p -166.53 175.34 8.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 73.109999999999999 110.912 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.33 -156.44 26.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 61.130000000000003 112.431 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 1.6 tt0 -103.97 144.55 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 73.010000000000005 110.898 -179.842 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.71 -62.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 75.200000000000003 110.912 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 73.439999999999998 110.931 179.865 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 74.439999999999998 110.852 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.6 t -140.4 142.31 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 72.420000000000002 111.136 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.66 153.24 42.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 74.530000000000001 110.913 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 154.52 67.8 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.726 2.284 . . . . 72.310000000000002 112.35 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -128.36 45.93 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 73.140000000000001 111.157 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.69 144.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.340000000000003 111.173 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.402 ' CD1' HD22 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -128.87 164.94 22.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 75.5 110.86 -179.939 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.82 148.56 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 75.120000000000005 110.907 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -108.57 157.22 18.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 64.310000000000002 110.889 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -129.97 129.69 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 61.32 111.156 179.977 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.44 167.39 15.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.150000000000006 111.084 179.821 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.8 m -152.85 106.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 73.239999999999995 111.135 179.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.02 23.03 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 64.400000000000006 110.88 179.894 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 -10.32 65.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 54.240000000000002 112.494 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -101.54 138.56 19.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 63.409999999999997 110.916 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 151.99 69.0 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 62.329999999999998 112.337 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.8 tp -121.02 -70.97 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 75.030000000000001 110.929 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.41 179.2 35.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 74.430000000000007 112.463 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 73.420000000000002 110.91 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.85 84.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 65.310000000000002 111.079 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -66.07 94.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.5 110.834 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 25.9 p90 -106.83 114.28 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 74.349999999999994 110.899 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.91 146.7 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 61.509999999999998 110.869 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' HB3' ' CE1' ' A' ' 129' ' ' PHE . 20.2 mt -108.13 128.41 54.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 75.230000000000004 110.943 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -70.84 79.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.889 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.407 ' HA ' ' CB ' ' A' ' 33' ' ' ALA . . . -73.44 -11.18 60.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 74.230000000000004 111.116 179.92 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.38 -58.96 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 65.340000000000003 110.883 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.65 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.936 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.501 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 5.0 m -66.04 128.36 93.77 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 53.009999999999998 111.131 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.432 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 53.9 Cg_endo -69.74 -88.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.686 2.257 . . . . 60.240000000000002 112.358 179.95 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -40.91 64.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 71.150000000000006 110.939 179.887 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 54.9 m -57.12 -11.28 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 75.319999999999993 111.144 179.961 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 30' ' ' PRO . . . -74.93 -45.43 42.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 75.099999999999994 111.1 179.872 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 35' ' ' ASN . 28.9 tt0 -91.42 -49.18 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 72.049999999999997 110.917 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.549 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -25.63 -51.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 74.310000000000002 110.924 -179.948 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -81.54 -45.04 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 72.439999999999998 110.875 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' GLU . 2.9 ptt85 -51.21 -27.16 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.409999999999997 110.913 -179.946 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.69 -49.2 19.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 62.200000000000003 111.11 179.899 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -71.32 -10.67 60.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 74.109999999999999 110.936 -179.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -8.2 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.109999999999999 110.879 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.8 p -102.22 -13.75 17.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 64.140000000000001 111.155 -179.922 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 45.83 8.65 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 60.520000000000003 112.526 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -98.38 -21.75 16.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 75.430000000000007 110.903 -179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -89.27 17.97 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 71.299999999999997 110.923 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.45 26.01 63.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 75.450000000000003 112.473 179.945 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 178.68 168.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 65.030000000000001 110.832 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.38 -129.59 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 61.219999999999999 112.478 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -93.92 -72.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 75.109999999999999 110.918 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 1.7 tptt 59.62 166.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 64.219999999999999 110.882 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.99 104.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 62.530000000000001 112.492 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 m -132.53 -108.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 71.540000000000006 110.872 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.7 p 172.77 150.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 64.409999999999997 110.867 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -90.53 -71.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.219999999999999 110.874 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.75 5.82 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.439999999999998 110.87 -179.971 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 94.79 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 75.019999999999996 110.877 -179.872 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mt -147.77 139.84 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.540000000000006 111.187 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -140.07 139.37 21.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.609 0.719 . . . . 54.539999999999999 111.118 179.913 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 128.4 15.98 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.677 2.251 . . . . 75.25 112.335 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 67.18 48.22 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 73.430000000000007 112.513 179.98 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.06 -80.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 74.150000000000006 110.862 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -165.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.140000000000001 110.899 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.59 147.46 28.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 70.120000000000005 110.864 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.66 127.36 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.209999999999994 110.911 -179.886 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -38.28 -67.56 0.51 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.738 -0.744 . . . . 71.420000000000002 112.489 -179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.87 134.03 1.91 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 73.129999999999995 112.505 -179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.14 78.16 1.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 74.219999999999999 110.875 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -94.28 36.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.868 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.38 100.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 74.430000000000007 111.117 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -35.38 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.519999999999996 110.884 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -48.76 -46.3 41.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.150000000000006 110.817 -179.98 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.46 -33.09 13.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.019999999999996 110.862 -179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.24 -133.63 7.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 71.230000000000004 112.463 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.3 p -136.02 136.02 39.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 61.399999999999999 111.172 -179.886 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.19 -95.67 1.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 65.109999999999999 112.5 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.4 125.21 5.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 71.319999999999993 112.472 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -176.23 -173.88 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 64.140000000000001 110.902 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.5 m -81.18 143.79 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.239999999999995 110.861 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.4 pt -83.88 -39.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 111.153 179.936 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -88.83 -6.78 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 72.329999999999998 110.92 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.73 -138.18 2.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.768 -0.73 . . . . 71.010000000000005 112.493 179.96 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -122.6 -29.59 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.419 . . . . 73.349999999999994 110.896 -179.851 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -174.67 137.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 73.140000000000001 110.924 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.43 138.43 54.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.510000000000005 110.881 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 175.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 70.120000000000005 110.886 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.46 -168.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 75.129999999999995 110.846 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.17 -61.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 74.439999999999998 110.853 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -171.22 154.01 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 71.319999999999993 110.888 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.02 79.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.430000000000007 110.873 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mm -86.77 14.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 74.450000000000003 111.136 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 5.7 mt -131.33 99.69 4.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 74.340000000000003 110.906 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.09 125.74 33.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 74.349999999999994 110.868 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.406 ' HA ' HG13 ' A' ' 97' ' ' ILE . 1.3 m80 -49.03 97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.010000000000005 110.838 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -116.39 22.71 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 75.239999999999995 111.109 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 166.22 26.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.430000000000007 112.462 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 132.81 24.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 73.400000000000006 112.4 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.7 -23.74 7.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 63.439999999999998 112.51 -179.931 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.406 HG13 ' HA ' ' A' ' 92' ' ' HIS . 33.3 mm -57.58 149.99 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.341 . . . . 73.530000000000001 111.136 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.86 143.14 49.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.140000000000001 110.913 179.908 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.4 ' HB2' ' CE1' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -156.08 39.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 72.200000000000003 110.851 -179.926 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 59.01 168.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.519999999999996 110.862 179.936 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.64 76.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 75.299999999999997 111.1 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -144.04 -80.09 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 73.129999999999995 110.884 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.467 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -125.81 -146.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 71.310000000000002 111.123 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.542 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -140.29 -64.18 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 74.019999999999996 112.516 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.542 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.5 Cg_endo -69.8 106.08 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 74.150000000000006 112.368 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 39.86 68.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 72.530000000000001 110.884 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.656 ' O ' ' C ' ' A' ' 108' ' ' ASN . 0.3 OUTLIER -152.78 35.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 73.319999999999993 111.173 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.656 ' C ' ' O ' ' A' ' 107' ' ' THR . 1.6 m120 7.46 -87.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.539999999999999 110.94 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 128.8 -41.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.200000000000003 112.5 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.3 OUTLIER 76.68 -39.03 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.319999999999993 110.856 -179.734 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.433 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -62.67 -159.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 75.450000000000003 110.905 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -170.72 140.87 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 74.200000000000003 110.86 -179.998 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' O ' ' CG ' ' A' ' 113' ' ' PHE . 4.3 p90 -131.29 102.11 5.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.927 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 12.4 mt -64.59 103.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 75.230000000000004 111.157 -179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.6 m -60.47 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 54.100000000000001 110.888 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.94 13.83 27.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 73.420000000000002 111.124 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -169.63 153.86 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 72.010000000000005 111.101 179.877 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -56.91 99.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.120000000000005 110.942 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 30.6 p -117.7 63.19 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 111.117 -179.959 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 2.14 5.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 65.439999999999998 110.882 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 26.0 p90 -91.78 2.99 56.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 63.409999999999997 110.938 -179.953 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.65 37.97 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.540000000000006 110.887 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -125.87 70.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.886 179.851 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.08 -49.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 71.230000000000004 112.471 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.13 -31.99 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 75.019999999999996 110.87 -179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.25 145.15 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.230000000000004 110.846 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 26.1 m -79.0 109.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 75.409999999999997 111.177 179.954 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 9.0 p -75.35 144.61 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.540000000000006 111.133 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.446 ' CE1' ' HB3' ' A' ' 24' ' ' LEU . 2.0 t80 174.5 100.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 75.329999999999998 110.884 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 123.74 144.08 6.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 63.5 112.479 -179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -154.72 -179.77 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 75.25 110.911 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.1 t -108.36 85.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 74.420000000000002 111.136 179.88 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.83 -50.3 68.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 75.439999999999998 110.921 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.9 163.56 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.109999999999999 110.859 179.961 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.17 -4.44 64.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 73.340000000000003 112.52 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.37 -34.38 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 74.129999999999995 110.869 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.93 -24.24 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 73.099999999999994 110.89 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.21 -41.06 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.299999999999997 111.078 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.03 -37.96 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 111.121 179.852 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.85 -20.87 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 72.519999999999996 110.853 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.17 -38.97 26.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 75.129999999999995 111.143 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -65.23 -29.8 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 72.519999999999996 110.886 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.64 -50.32 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 75.239999999999995 110.906 -179.965 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -17.05 52.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 74.209999999999994 110.912 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.3 -16.47 29.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 75.420000000000002 110.906 -179.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.99 -158.97 21.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 72.219999999999999 112.491 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.57 -162.2 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 74.340000000000003 110.804 -179.705 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -92.45 -42.74 9.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 75.239999999999995 110.892 -179.908 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -101.01 15.28 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.219999999999999 110.935 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.68 -157.87 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 61.439999999999998 112.463 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm 60.85 159.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 74.319999999999993 110.916 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -133.26 161.37 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.310000000000002 111.152 179.965 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.39 -19.26 43.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 74.349999999999994 110.817 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -135.37 161.08 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.319999999999993 110.889 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.86 128.18 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.209999999999994 110.919 179.875 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mt -101.16 134.92 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 72.120000000000005 111.133 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.2 p -136.59 163.89 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 75.340000000000003 111.175 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 2.1 mp -124.71 132.89 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.409999999999997 111.094 179.923 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.06 -58.34 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 74.349999999999994 111.122 179.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -151.81 179.03 8.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 71.5 110.881 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.9 p -176.15 165.44 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 142.83 -171.59 24.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 75.400000000000006 112.428 -179.912 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -68.7 118.51 11.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 72.430000000000007 110.933 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.402 HD22 ' CD1' ' A' ' 7' ' ' PHE . 1.4 mm? -92.32 -44.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 75.109999999999999 110.916 -179.964 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.873 179.897 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 74.120000000000005 110.867 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.14 155.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.519999999999996 111.126 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.47 141.37 42.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 74.120000000000005 110.848 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 127.79 15.11 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 73.319999999999993 112.347 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -102.19 148.78 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 62.329999999999998 111.144 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.21 139.02 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 64.129999999999995 111.158 179.868 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -117.42 143.95 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.439999999999998 110.849 -179.936 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -140.07 127.63 21.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 72.230000000000004 110.855 -179.929 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.0 79.6 2.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 74.239999999999995 110.858 179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.32 139.11 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 73.430000000000007 111.116 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -127.17 158.66 36.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.430000000000007 111.091 179.763 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.34 97.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 74.140000000000001 111.09 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t0 54.61 54.96 8.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.319999999999993 110.891 179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.82 13.06 60.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 62.32 112.456 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -142.48 93.02 7.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.684 0.754 . . . . 72.099999999999994 110.862 -179.885 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.2 Cg_endo -69.77 152.43 69.28 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.688 2.259 . . . . 72.019999999999996 112.316 -179.985 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.74 25.13 9.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.319999999999993 110.906 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.21 -173.68 20.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 72.340000000000003 112.504 179.912 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 170.3 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 71.340000000000003 110.846 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.408 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 35.2 m -137.33 177.6 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 111.119 179.957 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 p -136.63 138.79 41.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 55.020000000000003 110.894 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -114.52 149.55 36.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 72.349999999999994 110.878 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.52 128.63 53.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 74.239999999999995 110.916 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -94.85 116.79 29.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 74.010000000000005 110.915 -179.964 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 11.1 m-85 -82.61 67.47 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 74.409999999999997 110.893 179.92 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 71.239999999999995 111.072 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -36.54 74.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 62.409999999999997 110.919 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -89.83 -28.39 19.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 64.530000000000001 110.946 179.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -147.24 83.69 7.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.638 0.732 . . . . 73.0 111.138 179.834 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.28 37.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 75.209999999999994 112.348 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -34.75 19.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.329999999999998 110.925 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -75.07 -53.74 8.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 111.119 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.17 -37.95 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.450000000000003 111.148 179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.64 -30.66 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.349999999999994 110.869 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.32 -61.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 74.439999999999998 110.851 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.01 -29.8 9.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 73.209999999999994 110.871 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.95 85.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.420000000000002 110.826 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.32 -19.03 43.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 72.319999999999993 111.132 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 87.8 mt -78.9 -61.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 74.540000000000006 110.924 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -51.48 -45.65 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 72.109999999999999 110.886 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.43 -9.87 56.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 74.430000000000007 111.089 -179.902 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.12 73.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 63.229999999999997 112.528 -179.973 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -47.8 -53.47 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.383 . . . . 64.549999999999997 110.876 -179.868 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -167.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 110.903 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.98 17.38 55.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 75.219999999999999 112.512 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -146.35 -168.32 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 74.230000000000004 110.89 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.72 144.02 7.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 70.120000000000005 112.508 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.22 120.67 5.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 75.109999999999999 110.96 -179.81 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -41.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.010000000000005 110.9 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 30.64 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 73.299999999999997 112.508 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -77.21 162.12 27.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 72.219999999999999 110.84 -179.723 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 m -75.06 -168.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 75.010000000000005 110.914 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -140.16 135.74 32.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.409999999999997 110.876 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.12 -179.11 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.040000000000006 110.858 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 66.83 20.69 10.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 73.430000000000007 110.879 -179.875 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 18.6 mt -69.45 123.47 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 74.200000000000003 111.118 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.9 mp -138.92 103.44 7.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 75.040000000000006 111.155 179.858 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 76.08 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 73.340000000000003 112.337 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.02 -25.63 0.31 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 73.040000000000006 112.489 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.34 -64.19 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.310000000000002 110.876 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 -161.57 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 74.040000000000006 110.899 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.5 m -137.47 -64.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 72.120000000000005 110.882 -179.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.97 152.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.904 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.13 -179.93 48.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 55.539999999999999 112.448 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.35 29.38 16.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 74.099999999999994 112.514 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -65.72 120.12 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 73.450000000000003 110.915 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.33 -167.84 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.040000000000006 110.871 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.2 -52.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 71.0 111.126 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.02 162.37 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 73.340000000000003 110.853 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.94 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 71.400000000000006 110.872 -179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -129.52 -161.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 55.5 110.9 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.89 41.32 2.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 62.43 112.491 179.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.6 p -129.79 -49.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 75.329999999999998 111.145 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.43 138.11 9.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.77 . . . . 75.510000000000005 112.467 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.25 -153.17 3.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 73.030000000000001 112.494 -179.851 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.16 -70.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 73.439999999999998 110.881 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -116.55 131.91 56.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 73.129999999999995 110.839 -179.884 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -49.35 -34.15 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.420000000000002 111.171 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -128.31 55.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 73.200000000000003 110.923 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.82 -139.7 8.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 74.439999999999998 112.448 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.94 -82.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.385 . . . . 72.310000000000002 110.893 -179.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.415 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.29 -177.42 4.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 64.329999999999998 110.89 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.52 179.74 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.549999999999997 110.91 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 160.43 22.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.329999999999998 110.895 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -74.14 111.2 9.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.340000000000003 110.903 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.31 -52.35 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.450000000000003 110.917 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 178.8 165.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 72.129999999999995 110.861 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.05 40.22 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 72.120000000000005 110.864 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.6 mt -52.48 -29.02 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 74.219999999999999 111.116 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.69 118.07 31.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.230000000000004 110.917 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -105.43 171.1 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 73.439999999999998 110.885 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.8 95.35 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.420000000000002 110.851 179.882 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 p -112.11 34.63 4.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.310000000000002 111.106 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.85 41.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.715 -0.755 . . . . 71.400000000000006 112.481 179.952 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 150.31 67.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 74.209999999999994 112.348 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.0 128.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 73.239999999999995 112.482 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -178.0 131.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 75.549999999999997 111.146 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 128' ' ' VAL . 2.0 tt -89.36 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 74.140000000000001 110.899 179.913 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 31.1 p -109.74 -152.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 72.439999999999998 110.841 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.402 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 4.2 mtt -160.51 104.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 75.439999999999998 110.899 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.89 161.76 13.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.439999999999998 111.126 179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 172.14 -45.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.019999999999996 110.868 -179.936 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.434 ' CB ' ' OG1' ' A' ' 107' ' ' THR . . . -172.21 -34.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 71.25 111.084 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.15 -80.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.743 -0.741 . . . . 43.140000000000001 112.494 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 120.4 7.19 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 73.510000000000005 112.323 -179.927 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.401 ' C ' HG21 ' A' ' 107' ' ' THR . 2.6 m-80 39.65 36.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 73.540000000000006 110.876 179.994 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.434 ' OG1' ' CB ' ' A' ' 103' ' ' ALA . 69.6 p -144.81 61.55 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 74.109999999999999 111.122 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 109' ' ' GLY . 3.0 m-80 -82.16 -6.38 59.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 74.319999999999993 110.907 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 29.45 -138.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 72.439999999999998 112.492 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 9.2 m -147.7 29.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 74.430000000000007 110.856 -179.711 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -107.18 83.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.299999999999997 110.95 -179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -80.66 176.98 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 74.299999999999997 110.878 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.64 -175.83 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.400000000000006 110.884 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.73 117.11 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.439999999999998 111.112 179.986 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.41 153.51 21.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 75.439999999999998 110.878 179.953 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.3 p -131.16 12.24 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 74.439999999999998 111.155 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.76 6.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 73.010000000000005 111.096 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.62 131.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 74.239999999999995 110.893 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 28.6 p -142.03 54.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 64.409999999999997 111.153 179.985 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.19 -17.88 5.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 65.540000000000006 110.919 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' TRP . . . . . 0.481 ' CD1' ' HG ' ' A' ' 122' ' ' LEU . 20.4 p90 -69.1 -18.47 63.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 110.922 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.481 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 50.7 mt -89.8 -6.8 55.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.420000000000002 110.902 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -47.77 -51.68 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 74.230000000000004 110.884 179.84 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.02 52.23 3.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 53.409999999999997 112.512 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -159.65 -50.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 73.219999999999999 110.868 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -110.13 143.25 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.209999999999994 110.827 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 76.4 t -48.97 -87.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 64.400000000000006 111.142 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 17.1 t 82.77 123.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 111.135 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.409 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . 14.6 p90 -161.35 36.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 70.310000000000002 110.858 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.76 173.3 36.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 75.099999999999994 112.485 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -173.83 156.23 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 110.907 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.1 t -51.05 108.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.400000000000006 111.139 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -34.06 54.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.310000000000002 110.935 179.89 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -151.51 169.77 21.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 73.230000000000004 110.864 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 78.97 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 71.540000000000006 112.508 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.5 tpt -87.17 0.87 54.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 62.140000000000001 110.881 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -88.59 -34.32 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 71.409999999999997 110.891 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 142' ' ' MET . 30.7 mm -60.95 -40.28 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 72.099999999999994 111.143 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 13.9 t -87.32 0.13 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 74.230000000000004 111.131 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -112.78 -69.71 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.329999999999998 110.893 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.06 -51.6 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 75.329999999999998 111.131 179.942 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.445 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 5.3 tmm? -44.31 -39.95 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 73.340000000000003 110.902 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.02 59.64 1.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 65.109999999999999 110.874 -179.914 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.94 -12.4 4.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 71.140000000000001 110.898 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.0 21.65 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.430000000000007 110.876 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -97.93 65.11 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 45.229999999999997 112.501 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.603 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.8 OUTLIER -18.64 120.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 72.200000000000003 110.867 -179.721 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -47.54 -43.31 24.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.420000000000002 110.855 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -45.68 -35.34 4.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 75.209999999999994 110.881 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.1 -60.86 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.719 . . . . 74.120000000000005 112.482 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 125.94 19.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 64.329999999999998 110.87 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.2 m -85.89 139.94 30.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 65.239999999999995 111.135 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -67.66 -22.72 65.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 64.319999999999993 110.829 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.59 -164.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 72.239999999999995 110.916 179.906 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 112.16 13.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 74.230000000000004 110.913 179.872 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 mt -99.06 90.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.239999999999995 111.154 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.14 153.61 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 65.430000000000007 111.114 -179.976 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.3 mm -94.22 128.28 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.5 111.124 179.902 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.13 -63.08 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.409999999999997 111.106 179.804 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.26 162.17 41.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 75.510000000000005 110.873 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.06 -179.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 64.340000000000003 110.921 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.46 -156.63 25.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 62.210000000000001 112.492 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -120.02 140.58 50.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 74.409999999999997 110.874 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.08 132.66 53.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.310000000000002 110.913 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 72.549999999999997 110.959 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 75.04 110.82 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.5 OUTLIER 62.55 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.11 111.125 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' VAL . 13.0 m-20 -88.47 144.63 34.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 64.55 110.864 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 132.26 22.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.684 2.256 . . . . 63.0 112.338 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.442 HG21 HD22 ' A' ' 164' ' ' LEU . 21.6 m -116.51 142.28 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 75.24 111.097 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.79 137.8 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -101.34 156.23 17.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.857 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.52 143.69 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.901 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.35 143.03 37.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.879 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -115.43 120.3 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.149 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 163.28 13.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 53.25 111.064 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.653 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.88 96.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 72.13 111.145 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.33 31.39 6.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.14 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.24 65.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 63.34 112.475 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -96.22 132.91 25.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.648 0.737 . . . . 74.35 110.874 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.65 65.32 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 72.13 112.351 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.6 tp -121.97 -72.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.903 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.64 -148.24 4.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 74.34 112.526 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.75 126.6 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 63.52 110.874 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.33 125.26 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 70.24 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.1 p -113.47 159.16 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.884 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.69 126.67 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.904 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.0 tm-20 -59.46 -48.36 81.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 71.01 110.916 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 7.1 mt 69.51 126.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.22 110.935 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CG ' HD21 ' A' ' 90' ' ' LEU . 81.8 m-85 -88.6 74.14 8.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.902 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.8 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.4 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.01 -37.59 12.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.896 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 3.2 mmtp -75.11 -27.7 59.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 129' ' ' PHE . 2.7 m -131.67 68.7 81.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 52.22 111.095 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 58.87 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.698 2.265 . . . . 34.11 112.378 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.59 -72.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.31 110.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 86.3 m -58.95 -53.91 53.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 64.12 111.14 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -77.42 -9.39 58.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 62.13 111.118 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -74.17 -24.75 59.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.849 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.5 -34.41 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.869 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' HD2' HD11 ' A' ' 24' ' ' LEU . 3.8 t80 -50.77 -28.71 9.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.928 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.36 76.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 62.42 110.874 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.96 -28.69 25.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.12 111.119 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.12 13.1 13.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.951 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -117.22 -11.99 10.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 51.42 110.852 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.491 HG22 ' HA2' ' A' ' 162' ' ' GLY . 71.1 p -116.63 -0.06 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.184 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.56 10.66 60.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.44 112.516 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.16 -36.79 85.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 74.24 110.846 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -15.23 62.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 71.24 110.921 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.01 -18.66 30.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.746 . . . . 34.44 112.472 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 47' ' ' GLY . 9.6 m-85 -87.42 -24.95 24.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.38 . . . . 64.53 110.841 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -30.9 135.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 64.34 112.457 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -76.46 -43.86 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.96 0.409 . . . . 65.24 110.941 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.67 93.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 72.24 110.889 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.9 63.18 0.84 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 73.14 112.462 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 53.04 110.834 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.3 p -144.7 -172.74 3.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 65.12 110.896 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.45 167.09 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 70.43 110.878 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -46.96 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.858 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -146.04 153.05 40.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.863 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 HG21 ' A' ' 152' ' ' THR . 63.5 mt -144.81 130.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.12 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.458 HD12 ' HE3' ' A' ' 61' ' ' MET . 3.1 mt -134.78 104.65 10.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 75.54 111.145 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.76 98.43 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 62.02 112.32 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.5 -22.51 3.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 62.21 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.27 -60.65 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 65.22 110.865 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.458 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -173.45 -160.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 61.34 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 65.3 m -133.36 -73.0 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 74.21 110.907 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 61.8 160.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.894 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 53.35 112.459 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.819 0.342 . . . . 75.31 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 t -132.71 137.48 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 73.02 110.843 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -70.32 -27.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 73.25 111.153 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -122.98 41.29 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.79 -136.58 5.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 63.21 112.513 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.82 -74.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 63.04 110.896 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 160.4 32.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.878 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 147.04 35.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.873 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.61 158.65 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 64.33 110.914 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.29 127.19 32.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.45 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -57.76 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.03 110.895 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -179.76 177.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.47 36.95 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.883 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -50.49 -25.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 64.33 111.158 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 28' ' ' LYS . 2.6 mt -73.07 122.75 22.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.92 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -77.23 160.2 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.04 110.872 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -86.53 107.23 18.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.862 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 p -142.93 164.82 29.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.128 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.03 144.19 4.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 62.45 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.01 27.5 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.251 . . . . 73.45 112.326 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.57 73.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 33.35 112.458 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -84.87 161.91 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 75.02 111.121 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.44 HD21 ' CD2' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -102.84 128.83 49.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.916 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 128' ' ' VAL . 47.1 t -143.75 -116.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.816 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.427 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 0.8 OUTLIER 178.24 143.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.34 110.856 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 101.67 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.04 111.095 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 -167.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 74.2 110.929 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 1.057 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -54.65 -37.29 65.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.05 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 107' ' ' THR . . . 114.5 -65.12 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 75.31 112.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.655 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.71 120.88 7.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.252 . . . . 75.34 112.379 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 105' ' ' PRO . 10.0 p-10 26.53 64.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 61.01 110.915 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 1.057 HG21 ' HB3' ' A' ' 103' ' ' ALA . 5.5 t -163.22 54.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 52.31 111.124 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 82.4 m-20 -40.11 -52.29 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.23 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.48 -167.79 53.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 63.54 112.501 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -118.81 -20.17 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 45.22 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -51.44 150.9 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.15 110.948 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' CD2' HD21 ' A' ' 98' ' ' LEU . 1.9 p90 -160.47 175.03 13.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.5 110.893 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -144.98 179.02 7.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.12 110.873 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 32.8 mm -102.24 -63.73 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 63.31 111.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER 79.37 112.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.2 110.921 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 t -98.8 -13.52 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 75.34 111.175 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.61 159.06 30.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 70.02 111.087 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -71.51 102.62 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.66 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 34.9 p -121.36 70.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.44 111.184 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -84.65 22.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.841 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 119' ' ' THR . 3.9 p90 -103.87 9.72 36.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.29 -30.98 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.04 110.93 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.26 165.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.851 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.22 -24.74 30.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 65.33 112.471 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -104.9 -33.56 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 73.13 110.904 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -119.73 170.29 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.819 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.02 112.88 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 64.02 111.129 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.449 ' CG2' HD13 ' A' ' 97' ' ' ILE . 9.6 p -84.94 144.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.41 111.149 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 31.6 p90 -178.65 112.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.41 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 144.04 -166.11 27.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 64.25 112.484 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt 172.87 -174.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 54.52 110.95 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.69 86.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.35 111.15 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -47.5 -74.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.865 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -150.78 146.99 26.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 71.3 110.868 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.36 26.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 41.4 112.51 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.3 -30.14 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 64.01 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -50.76 -25.94 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.03 110.864 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.2 mm -86.33 -38.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.156 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.2 t -51.32 -23.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.2 111.125 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.28 -43.48 15.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.857 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.13 -48.33 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.13 111.131 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.5 ptm -64.08 -20.15 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.46 29.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 74.53 110.873 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.69 -23.18 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.831 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.32 1.33 57.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 72.4 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.71 -147.29 10.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.755 -0.736 . . . . 44.44 112.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.1 134.35 6.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 72.13 110.858 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -70.59 76.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 71.45 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.71 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.21 110.859 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.54 -60.5 0.43 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 72.2 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -61.63 155.18 23.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 64.31 110.966 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 56' ' ' ILE . 63.2 p -124.91 129.42 50.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 70.42 111.166 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.3 -31.69 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 73.14 110.893 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -169.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.895 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -137.88 126.07 23.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 70.13 110.865 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.14 127.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 71.15 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.31 43.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.3 111.192 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.0 142.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.088 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.57 -64.98 1.01 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 31.33 111.078 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.77 178.12 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.5 110.858 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.63 -176.34 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.914 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 137.07 -146.46 18.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 63.3 112.477 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 128.14 53.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 73.4 110.917 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 5' ' ' THR . 1.6 tp -54.51 -56.53 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.905 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 53.12 110.923 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.807 0.337 . . . . 75.35 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.78 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.153 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.35 157.4 38.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 73.32 110.854 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.28 69.21 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.274 . . . . 74.11 112.34 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 13.8 m -130.34 55.57 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.145 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 24' ' ' LEU . 15.4 m -49.26 147.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.169 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -140.55 163.51 32.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 73.41 110.876 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -141.76 146.17 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 72.12 110.882 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -93.98 163.32 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.841 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 mm -132.5 102.66 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.12 111.142 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -105.04 158.0 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 63.13 111.149 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 12' ' ' VAL . 22.5 t -138.31 99.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.34 111.134 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.68 42.65 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.891 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.88 -8.08 67.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 33.55 112.504 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.0 tt0 -100.22 101.38 14.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.746 . . . . 73.53 110.844 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.81 126.89 13.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 74.31 112.298 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -83.87 -43.73 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 71.4 110.909 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.02 -151.32 20.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.42 112.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 156.83 21.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.812 0.339 . . . . 74.1 110.901 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.62 76.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 74.03 111.151 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.65 165.44 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.14 110.89 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -152.67 122.53 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.897 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 39.7 tt0 -47.89 137.03 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 61.31 110.88 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -108.22 120.93 43.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 74.5 110.948 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -76.36 57.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 53.11 110.847 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -28.17 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 22.3 111.067 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.75 -61.29 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.51 110.845 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.921 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.928 HG23 ' HB2' ' A' ' 33' ' ' ALA . 5.4 m -72.75 120.05 78.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.32 111.13 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -87.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.674 2.25 . . . . 74.3 112.382 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -44.58 68.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.898 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -46.07 -28.46 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 73.23 111.121 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.928 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -79.87 -63.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 53.21 111.067 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' ARG . 15.6 tt0 -57.98 -64.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.865 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 34' ' ' GLU . 14.2 t-20 -31.53 -51.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.873 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.01 -40.95 62.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.91 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -52.62 -25.01 9.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.2 110.88 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.37 -43.48 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 35.41 111.109 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 39' ' ' LEU . 8.0 tt -64.73 -13.98 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 64.42 110.914 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -6.2 31.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 54.25 110.826 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.2 p -101.62 -21.25 14.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.53 111.126 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.76 -17.12 54.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 65.52 112.502 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.59 -37.13 48.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 72.43 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -23.13 35.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.865 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.33 -4.55 40.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 72.23 112.515 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -164.02 167.13 20.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 70.43 110.842 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.31 20.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 73.41 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 108.11 16.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 75.12 110.936 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -69.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.852 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.79 32.67 2.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.33 112.47 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.13 -168.2 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 73.3 110.84 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 m -114.17 -168.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.24 -173.29 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 71.21 110.913 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -102.96 -74.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -154.64 103.52 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 74.32 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.88 128.27 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 61.44 111.17 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 148' ' ' ARG . 5.0 tt -136.11 106.85 9.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 72.31 111.144 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.76 105.72 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.697 2.265 . . . . 71.15 112.306 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.62 -49.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 42.2 112.511 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.27 -66.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 75.15 110.86 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -162.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.12 110.872 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.8 m -149.94 98.38 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 62.52 110.907 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -90.68 170.09 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 71.3 110.889 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 71.04 112.46 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 71.4 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 177.6 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.844 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 35' ' ' ASN . 30.1 pt -86.9 -34.45 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 54.13 111.115 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.01 72.42 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.903 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.48 -130.02 10.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 70.04 112.501 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.78 -77.5 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 73.15 110.877 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.801 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -136.78 -177.34 4.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 64.22 110.903 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.23 174.91 11.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.22 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.7 158.61 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 61.2 110.853 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 119.48 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.44 110.872 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -47.46 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.863 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.53 167.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.12 110.875 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.48 37.11 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.872 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.79 -22.19 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.43 111.139 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 128' ' ' VAL . 70.3 mt -98.09 90.6 4.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.93 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -63.23 171.98 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 70.35 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.408 ' CD2' HG21 ' A' ' 97' ' ' ILE . 21.5 m80 -90.29 95.25 10.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 72.1 110.86 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 94' ' ' GLY . 18.2 p -131.14 149.56 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 60.33 111.117 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' THR . . . 56.17 155.07 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 41.13 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.37 24.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 64.41 112.348 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 84.28 -10.55 60.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 72.42 112.541 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 92' ' ' HIS . 6.2 mm -47.67 133.51 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 64.43 111.139 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -120.97 145.9 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 63.34 110.884 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 t -149.79 -133.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.821 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.542 ' HE3' HG23 ' A' ' 32' ' ' THR . 5.2 mtt -145.65 112.62 6.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 74.03 110.862 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -95.01 74.37 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 72.43 111.132 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -107.36 -75.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.91 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -134.99 -84.62 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 65.33 111.077 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.84 -83.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 43.12 112.481 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 107' ' ' THR . 53.9 Cg_endo -69.77 113.9 3.53 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.677 2.251 . . . . 63.12 112.351 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 34.47 46.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.32 110.896 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.6 p -142.26 46.74 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 55.23 111.143 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.73 176.52 8.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.13 110.913 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.82 -127.04 1.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 62.13 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -101.76 -171.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 63.44 110.917 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.2 mt-30 72.3 64.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.32 110.913 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -72.48 149.39 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.877 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 5.4 p90 -114.6 120.49 40.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.54 110.847 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.57 132.63 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.101 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.11 127.84 33.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 71.4 110.915 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 p -99.62 -31.35 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 65.02 111.155 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.06 24.77 5.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 72.44 111.089 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.69 135.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.547 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 67.0 p -139.97 61.25 1.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.137 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.06 3.61 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.547 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -86.29 1.44 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.14 110.919 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 pp -139.81 43.64 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.909 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.49 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.845 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 125' ' ' LYS . . . -50.11 140.53 17.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 70.15 112.469 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 1.0 OUTLIER 78.41 61.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.13 110.875 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.431 ' C ' HG23 ' A' ' 127' ' ' VAL . 2.3 m-70 -163.14 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.23 110.846 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.431 HG23 ' C ' ' A' ' 126' ' ' HIS . 5.4 t 74.67 86.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 64.4 111.095 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.482 ' O ' HD12 ' A' ' 90' ' ' LEU . 25.0 t -90.91 133.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.159 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.642 ' CB ' HG21 ' A' ' 29' ' ' VAL . 46.8 p90 -151.64 22.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.44 110.852 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -140.7 174.07 22.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 54.53 112.494 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.68 130.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 53.03 110.895 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' CA ' ' A' ' 96' ' ' GLY . 44.7 t -51.77 129.36 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.42 111.129 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -112.28 -59.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.844 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -139.82 140.99 36.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.888 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.7 1.78 43.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 75.44 112.445 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.56 -31.13 9.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 54.33 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -49.69 -26.72 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.89 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.34 -36.28 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 75.35 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.07 -22.75 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 62.45 111.137 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -83.75 -34.24 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 71.13 110.849 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.0 81.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.5 ptm -72.21 -11.87 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.51 110.951 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.92 25.2 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -16.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 71.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.66 -6.03 40.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.55 -166.05 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 73.4 112.452 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -140.04 -75.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 63.13 110.883 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -179.95 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 72.23 110.908 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -92.79 24.02 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.35 110.873 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.49 9.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 51.1 112.521 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.64 149.1 36.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 61.04 110.859 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -130.85 168.05 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 73.1 111.149 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.2 t -92.04 -2.49 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -140.95 -167.55 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 72.23 110.893 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.45 119.83 17.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 64.51 110.895 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.2 125.57 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 62.44 111.162 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -119.61 172.36 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 70.5 111.14 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.15 108.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.131 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -63.43 -60.28 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.14 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -148.9 177.2 9.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 64.22 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 10.7 p -178.17 163.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.909 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 147.11 -169.61 28.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.47 117.51 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 70.11 110.927 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.5 mm? -99.11 -69.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.54 110.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 1.2 tm-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 62.23 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 73.13 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.23 148.25 24.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 52.03 111.133 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -47.37 143.12 5.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 62.54 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 112.68 3.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 64.23 112.378 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.632 HG22 HD21 ' A' ' 164' ' ' LEU . 24.7 m -115.93 133.81 55.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 72.4 111.125 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG12 ' HG3' ' A' ' 163' ' ' GLN . 17.2 m -124.08 150.15 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 72.2 111.152 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.738 ' HB3' HD22 ' A' ' 164' ' ' LEU . 35.0 p90 -108.48 160.83 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.53 110.87 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.94 130.09 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.31 110.895 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.04 95.68 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 71.24 110.903 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.556 HD12 HG22 ' A' ' 138' ' ' ILE . 15.7 mt -75.62 151.91 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 63.42 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -129.52 168.49 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.01 111.051 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 17' ' ' LEU . 2.9 m -149.73 109.78 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.098 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.19 34.93 2.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.919 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 10.99 84.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 24.15 112.457 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.4 pt-20 -120.3 147.53 45.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.672 0.749 . . . . 62.25 110.876 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.21 56.63 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 62.03 112.336 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 12' ' ' VAL . 18.7 tp -132.97 8.32 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.11 110.969 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -166.15 12.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 24.34 112.494 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.96 151.35 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 72.12 110.888 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 25.9 m -124.95 170.2 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 52.44 111.146 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.436 ' OG ' HD21 ' A' ' 164' ' ' LEU . 14.0 t -122.72 151.33 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.15 110.875 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 5' ' ' THR . 20.0 m-85 -126.4 134.43 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 53.35 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -108.79 105.72 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.902 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.12 138.6 31.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -90.72 83.3 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.842 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.93 0.92 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.2 -34.23 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.15 110.866 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.2 mttm -97.51 -27.14 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 70.25 110.912 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.56 79.46 24.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 73.21 111.138 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -19.25 36.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 72.03 112.336 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -43.65 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 52.22 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.492 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -74.65 -53.19 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 73.4 111.122 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.65 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 75.13 111.099 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.98 -38.16 37.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.906 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.33 -61.86 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 72.34 110.903 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -51.51 -25.23 6.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.21 110.889 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -36.12 83.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.61 -21.05 35.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 110' ' ' SER . 83.1 mt -75.29 -60.44 2.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.929 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 64.02 110.896 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -84.53 -12.78 53.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 44.14 83.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 51.11 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.8 32.03 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 73.0 110.909 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.1 32.54 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 61.34 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.68 13.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 52.12 112.482 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.75 -170.54 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 75.01 110.848 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.57 176.6 37.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 72.02 112.502 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.68 -18.07 63.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 73.41 110.894 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.38 136.55 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 64.41 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.4 58.58 8.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.443 ' OG ' HD13 ' A' ' 158' ' ' ILE . 82.7 p -145.07 -166.27 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 44.11 110.888 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.96 169.06 24.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.869 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.56 ' CE1' HD11 ' A' ' 158' ' ' ILE . 53.6 m-85 -104.18 -67.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.35 110.86 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 59.65 20.64 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.23 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -146.97 115.63 6.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.23 156.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.97 112.88 8.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 75.21 111.112 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 86.31 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 71.31 112.384 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.75 9.05 8.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 65.12 112.487 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -69.98 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.51 110.867 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.95 -164.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 55.22 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.608 ' HB3' HG23 ' A' ' 114' ' ' ILE . 19.0 t -151.48 121.57 7.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.869 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -92.91 134.71 34.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.943 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 52.54 112.5 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.826 0.346 . . . . 72.42 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.82 -179.13 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.83 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.78 -5.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 64.51 111.156 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.99 28.1 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.41 110.9 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.0 -126.18 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 74.42 112.458 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -144.49 13.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 73.24 110.908 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -171.44 126.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -119.03 143.83 46.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.1 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -66.43 156.5 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.899 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -78.03 134.68 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.35 110.884 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -61.98 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.14 110.902 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -173.94 148.21 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.892 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.52 49.97 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 28' ' ' LYS . 32.6 mm -72.5 -15.93 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.149 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -104.75 137.7 42.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.14 110.88 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -129.0 104.89 7.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.914 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.706 ' CB ' HG21 ' A' ' 97' ' ' ILE . 11.9 p80 -67.63 103.57 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.816 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.3 p -130.58 39.63 3.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 73.42 111.13 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.8 163.8 32.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.482 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 146.26 59.6 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.738 2.292 . . . . 74.3 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.02 13.71 65.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.71 -0.757 . . . . 70.33 112.474 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.754 HD13 ' HB3' ' A' ' 131' ' ' LYS . 28.6 mm -89.27 138.61 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 63.15 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 98' ' ' LEU . 6.1 tt -93.99 114.6 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 75.14 110.896 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -113.66 140.29 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 64.53 110.864 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.451 ' HE3' ' CG2' ' A' ' 32' ' ' THR . 3.5 mmt -69.55 145.5 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.44 110.849 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -138.14 139.05 39.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 50.24 111.124 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' OD1' HG22 ' A' ' 107' ' ' THR . 0.4 OUTLIER 174.63 -69.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 72.21 110.908 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -136.42 -40.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 64.54 111.114 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.76 -69.02 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 52.34 112.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -104.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.265 . . . . 71.5 112.356 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -90.77 62.95 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -156.84 68.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.2 111.122 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -44.66 -60.73 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 62.32 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.59 43.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 63.34 112.448 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.422 ' HB2' HD13 ' A' ' 39' ' ' LEU . 2.7 p -129.04 9.94 5.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 72.03 110.851 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -72.26 -166.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.11 110.931 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD12 ' A' ' 98' ' ' LEU . 1.9 t80 -143.87 128.16 17.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.908 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 99' ' ' SER . 32.8 t80 -123.25 106.85 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 63.55 110.888 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 62' ' ' CYS . 7.5 tt -120.55 103.8 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 71.42 111.181 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -85.44 153.11 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 61.01 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 28.95 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.119 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.93 165.11 5.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 43.23 111.067 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -61.78 96.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -122.9 62.43 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 71.11 111.155 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.53 25.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.3 110.902 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 119' ' ' THR . 4.2 m-90 -69.9 -22.88 63.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.934 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.512 HD13 ' NE2' ' A' ' 126' ' ' HIS . 63.0 mt -116.63 34.68 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -86.99 44.42 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 73.12 110.844 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.06 52.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.776 -0.726 . . . . 71.3 112.526 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -171.34 -45.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 72.41 110.894 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.512 ' NE2' HD13 ' A' ' 122' ' ' LEU . 2.0 m-70 -98.49 142.34 30.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 61.12 110.863 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.78 90.61 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 63.31 111.1 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 90' ' ' LEU . 2.8 p -82.53 143.56 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.151 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.492 ' CZ ' HG22 ' A' ' 32' ' ' THR . 2.5 p90 -176.51 134.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.875 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.31 137.99 9.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 54.03 112.487 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.754 ' HB3' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -149.37 172.05 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 54.31 110.907 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.96 139.04 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 72.2 111.105 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -117.9 -29.85 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 54.01 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.56 158.33 36.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 58.71 85.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 55.24 112.484 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.6 mmm -92.04 -24.15 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 72.54 110.848 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 1.9 p-10 -80.57 -34.53 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.52 110.877 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 10' ' ' ILE . 46.6 mm -39.42 -48.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 65.32 111.132 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 114' ' ' ILE . 91.7 t -90.36 -50.8 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 60.41 111.135 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 12.1 mm-40 -44.68 -59.77 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.88 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.74 78.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.03 111.082 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.522 ' SD ' HD13 ' A' ' 156' ' ' ILE . 8.1 tmm? -50.08 -45.04 52.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 73.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -27.76 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 64.34 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -63.31 -25.45 68.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -90.52 21.92 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.1 110.872 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.89 -159.03 21.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 53.21 112.52 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -155.47 147.59 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 71.41 110.836 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -76.34 64.24 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.43 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -176.19 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.63 -52.47 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 71.35 112.454 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.04 112.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 61.11 110.905 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 154' ' ' LYS . 28.1 m -77.88 127.96 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 62.3 111.166 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -46.15 -32.07 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 33.33 110.86 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.589 ' H ' HG22 ' A' ' 152' ' ' THR . 2.8 mttt -133.51 -178.56 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 61.04 110.871 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -98.82 107.28 19.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 55.45 110.938 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.0 mt -98.3 108.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.43 111.147 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.1 t -119.24 156.93 29.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.34 111.148 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 53' ' ' PHE . 3.5 mp -83.48 139.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.73 -59.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.124 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.74 161.81 41.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.64 -168.59 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.32 110.894 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.68 -165.58 26.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 74.44 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.765 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.2 mt-30 -113.09 138.82 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 62.43 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -121.36 156.2 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.913 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.852 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.797 0.332 . . . . 40.53 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.59 141.64 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.23 111.111 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.62 145.83 37.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 72.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 121.59 8.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 72.42 112.301 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 164' ' ' LEU . 37.8 m -106.64 128.04 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.557 ' CG1' HD11 ' A' ' 24' ' ' LEU . 3.3 m -111.73 141.99 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.23 111.164 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.809 ' HB3' HD22 ' A' ' 164' ' ' LEU . 4.8 p90 -122.35 160.22 25.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.902 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 161' ' ' CYS . 11.3 m-85 -142.03 143.1 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.929 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.21 82.07 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.835 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.9 147.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.24 150.56 41.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.32 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 17' ' ' LEU . 67.0 t -135.81 97.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 73.1 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.87 24.41 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.187 -0.46 . . . . 45.04 110.841 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.09 59.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.48 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -108.34 143.0 26.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 74.55 110.881 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 152.82 68.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.661 2.241 . . . . 75.14 112.339 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 12' ' ' VAL . 17.5 tp -129.63 -0.38 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.31 110.905 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.588 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 138.48 171.71 12.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 51.51 112.508 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -105.99 127.41 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 60.3 110.855 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 138' ' ' ILE . 34.0 t -113.18 100.18 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.31 111.137 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.8 p -102.17 142.44 33.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.819 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.52 104.5 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.891 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -51.86 167.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 72.21 110.833 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD11 ' CG1' ' A' ' 6' ' ' VAL . 59.9 mt -117.46 126.85 53.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 74.5 110.93 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 90' ' ' LEU . 23.0 m-85 -77.33 59.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.899 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.06 -7.51 52.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 73.31 111.121 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.85 -65.05 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.02 110.93 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -61.22 2.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.2 m -109.53 83.29 2.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 55.32 111.121 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.97 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 52.42 112.351 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.31 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -47.17 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.52 111.11 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.31 -33.96 59.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.5 111.096 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.61 -31.75 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.51 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' HG23 ' A' ' 78' ' ' ILE . 7.0 t30 -77.49 -67.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.1 110.908 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.18 -43.33 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.849 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HB3' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -63.36 -29.61 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.22 110.861 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.89 -43.33 20.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 35.24 111.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.98 -38.41 82.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.907 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -69.55 -47.88 62.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 51.1 110.893 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.1 p -72.34 -13.52 61.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 72.25 111.121 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.51 69.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 75.12 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.1 41.56 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 74.21 110.932 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 78' ' ' ILE . 5.9 mtpm? -130.09 -2.63 4.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.914 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.73 -14.06 65.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 73.31 112.488 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -33.85 76.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 65.53 110.936 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 48' ' ' TYR . . . 85.27 -141.32 19.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 71.11 112.482 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 1.3 t80 82.56 85.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 72.2 110.884 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 -47.95 4.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -125.29 113.33 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.53 112.512 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 p -88.11 -168.61 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 64.1 110.833 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 p -139.52 96.0 3.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 64.14 110.911 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HZ ' HD11 ' A' ' 158' ' ' ILE . 34.2 m-85 -81.37 107.11 13.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.11 110.858 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.29 29.84 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 73.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.05 24.4 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.21 110.887 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.43 141.73 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.13 111.107 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HE3' ' A' ' 61' ' ' MET . 4.4 mt -131.95 110.36 14.34 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 74.35 111.15 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 89.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.657 2.238 . . . . 74.45 112.403 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.7 14.86 4.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 75.31 112.5 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 -64.51 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 75.34 110.87 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.559 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -177.16 -169.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 72.14 110.883 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.8 m -146.4 142.91 28.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 62.22 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 140.37 51.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.925 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 44.32 112.466 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.833 0.349 . . . . 73.11 110.874 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -87.92 -174.9 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 62.14 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 44' ' ' LYS . 27.9 pt -80.35 -32.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 75.43 111.126 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -89.19 44.29 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 71.22 110.932 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 -109.17 2.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 52.51 112.494 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -52.56 174.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.395 . . . . 75.42 110.851 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -97.3 -172.19 2.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 71.42 110.883 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.89 145.17 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.853 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -60.61 176.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 74.02 110.882 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.4 126.4 40.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 72.53 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.27 -48.71 26.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -175.19 149.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 71.42 110.862 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.02 46.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.881 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -62.37 -14.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 64.03 111.163 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -119.43 125.67 49.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 65.4 110.893 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -164.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.24 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.437 ' CE1' HG21 ' A' ' 128' ' ' VAL . 65.6 m80 -97.42 65.39 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 65.22 110.897 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -20.05 53.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.21 111.126 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.23 174.77 46.55 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.667 2.245 . . . . 61.22 112.379 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 126.02 -30.6 4.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 41.24 112.485 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 98' ' ' LEU . 14.1 mm -62.8 158.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 70.4 111.114 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.615 HD23 ' CD2' ' A' ' 112' ' ' PHE . 5.8 mp -107.05 147.97 29.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.893 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.57 150.03 49.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 38.1 mmt -79.37 106.38 11.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.1 110.844 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.67 73.57 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.08 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 34.3 t-20 -105.02 -81.79 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.924 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 102' ' ' ASN . . . 176.8 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 61.5 111.129 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.31 171.34 38.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 65.11 112.476 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 54.11 112.335 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 65.58 32.41 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.456 HG22 ' HG3' ' A' ' 82' ' ' LYS . 29.2 p -148.02 69.52 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 72.12 111.13 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.55 18.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 73.21 110.911 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 107' ' ' THR . . . -63.74 -144.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.8 -0.714 . . . . 74.41 112.434 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 t 51.68 -150.92 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 72.35 110.897 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -116.52 -77.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 64.15 110.931 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.615 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 176.53 172.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 70.03 110.852 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 138.66 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.68 114.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 64.12 111.119 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.5 p -71.43 -27.23 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 61.45 110.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 57.53 17.08 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 62.3 111.132 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 119' ' ' THR . . . -167.56 137.48 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 75.01 111.09 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -51.21 129.99 25.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 63.14 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 117' ' ' ALA . 71.6 p -131.5 59.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 64.42 111.144 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -51.24 -24.0 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 63.32 110.893 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -63.13 -30.29 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 64.51 110.914 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.8 mt -111.68 64.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -110.74 15.89 21.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.809 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.64 31.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 63.22 112.487 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -126.17 -62.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 72.54 110.874 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -98.0 121.72 40.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 72.32 110.854 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 127' ' ' VAL . 29.9 t -58.45 96.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.32 111.095 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 98' ' ' LEU . 40.0 t -86.79 128.22 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 72.52 111.071 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HA ' HD22 ' A' ' 90' ' ' LEU . 12.5 p90 -158.5 43.33 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.862 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -119.19 -168.45 14.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.34 112.467 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.463 ' H ' HD13 ' A' ' 98' ' ' LEU . 17.5 ttpp 178.48 150.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 74.22 110.909 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 96' ' ' GLY . 79.4 t -92.26 85.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 74.52 111.114 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -66.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.52 110.892 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.02 123.11 13.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.44 73.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 44.03 112.497 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -93.55 -28.69 15.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 60.43 110.859 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -70.07 -34.91 73.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 73.31 110.903 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.588 HD11 ' HA3' ' A' ' 18' ' ' GLY . 29.1 mm -66.77 -38.01 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.35 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.0 t -81.46 -0.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 54.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -117.7 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 41.41 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.45 -57.94 10.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 54.21 111.072 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.4 ttm -50.7 -29.97 12.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 65.22 110.89 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.866 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -62.45 -13.47 30.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.856 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.18 17.1 3.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.11 110.89 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.15 -146.07 19.61 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.489 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -152.51 -87.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 70.31 110.883 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -156.04 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.874 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -115.12 19.94 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.44 110.871 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.56 -157.72 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 44.42 112.548 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.7 mttt 63.15 101.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 63.24 110.896 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.582 HG21 HD12 ' A' ' 156' ' ' ILE . 33.8 p -84.02 155.45 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.34 111.148 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -17.21 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 62.13 110.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -126.92 -165.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.883 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.55 106.24 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 44.24 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' THR . 16.4 mt -94.03 122.73 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 73.04 111.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.4 p -139.02 169.52 17.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HZ ' ' A' ' 53' ' ' PHE . 20.1 mt -107.04 99.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.52 111.165 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.53 8.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 45.05 111.127 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -133.15 168.64 18.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.2 110.845 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.405 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 14.1 p -176.95 -167.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 61.3 110.864 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.82 -152.06 16.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 44.02 112.512 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.69 129.72 55.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 72.53 110.913 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 5' ' ' THR . 1.5 pt? -100.06 -29.45 12.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.898 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.03 110.864 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 74.32 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.93 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 64.13 111.134 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -97.76 159.39 31.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 71.4 110.895 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 148.57 65.44 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 71.21 112.378 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.472 ' C ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.51 173.74 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 61.33 111.118 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -167.2 143.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -124.36 154.57 40.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.83 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -135.98 132.49 36.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 65.55 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.23 108.39 19.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.824 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mm -80.96 110.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.22 111.169 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -113.15 172.66 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 70.41 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.27 94.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.32 111.08 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 72.09 56.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.858 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.51 11.63 57.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 52.04 112.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -123.69 107.37 31.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 53.44 110.875 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.81 138.56 37.95 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.634 2.223 . . . . 74.53 112.349 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -103.31 -53.23 2.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.5 -154.23 9.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 75.4 112.491 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 168.12 24.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 71.43 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 -177.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.21 111.123 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -130.09 96.88 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 65.24 110.826 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -93.34 115.26 27.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 70.2 110.909 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -113.32 113.88 25.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 42.2 110.884 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 129' ' ' PHE . 23.8 mt -80.25 140.01 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.55 110.894 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 29' ' ' VAL . 45.0 m-85 -88.37 82.58 6.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.3 110.848 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -29.86 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.41 111.104 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.28 -28.19 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 54.24 110.831 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.845 ' HG3' HD21 ' A' ' 90' ' ' LEU . 5.0 mmtt -96.88 -34.55 11.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.898 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 129' ' ' PHE . 15.5 m -131.9 88.79 40.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 71.24 111.152 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.63 12.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.661 2.241 . . . . 73.31 112.336 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.92 -48.48 11.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 32' ' ' THR . 21.6 m -76.7 7.93 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 73.55 111.132 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -81.18 -40.98 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 72.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 35' ' ' ASN . 13.5 pt-20 -90.76 -32.6 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 61.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' GLU . 54.4 t-20 -30.87 -70.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.881 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -71.44 -30.95 66.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 63.23 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.5 tmm_? -50.21 -43.1 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 73.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -68.06 -32.34 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 71.32 111.122 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.746 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.8 21.56 12.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.903 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.573 ' OG ' HG11 ' A' ' 6' ' ' VAL . 36.2 t -127.61 -26.67 2.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.2 110.843 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -109.89 -16.53 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 64.14 111.098 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.63 86.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 72.53 112.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -170.23 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 73.2 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 20.73 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.12 110.9 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 -26.18 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 64.0 112.465 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -147.86 -176.34 5.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 73.23 110.871 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.92 -144.49 16.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 43.01 112.494 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.84 174.22 6.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.988 0.423 . . . . 73.23 110.918 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 14.43 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.927 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -158.82 44.36 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 72.11 112.494 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -89.99 133.53 34.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 73.14 110.873 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.7 m -51.89 172.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 73.21 110.866 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 73.37 1.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.838 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -70.61 175.24 5.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.54 110.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.88 104.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.827 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.1 mt -148.51 132.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.33 111.135 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' SD ' ' A' ' 61' ' ' MET . 7.8 pt -154.17 109.14 2.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 73.33 111.147 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 126.69 13.61 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.654 2.236 . . . . 61.12 112.347 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.45 3.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 72.44 112.491 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.4 -75.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 75.01 110.843 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.551 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.22 -164.5 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 53.42 110.927 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.4 m -125.51 -70.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 51.25 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 65.37 153.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 63.34 110.951 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 73.42 112.527 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.827 0.346 . . . . 74.14 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 t -145.16 120.0 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 71.32 110.856 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 pp -55.84 -19.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 75.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 -22.0 14.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.24 -112.8 0.35 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.729 -0.748 . . . . 55.45 112.501 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -108.96 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 73.43 110.872 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -159.96 155.77 26.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.882 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -112.65 171.27 7.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 70.44 110.849 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.71 142.49 30.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 51.45 110.878 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.62 141.84 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.2 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -102.91 -64.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.841 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.29 165.81 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.864 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.17 45.69 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.894 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.9 mt -68.88 -11.27 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.23 111.123 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 28' ' ' LYS . 8.0 mt -98.18 70.12 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -61.35 130.32 45.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.869 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.97 90.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 74.15 110.83 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 p -99.28 31.69 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 54.21 111.163 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.69 177.47 26.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 54.13 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.24 7.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.252 . . . . 62.03 112.34 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.33 14.07 66.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.33 112.457 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -86.99 125.49 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 73.51 111.174 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 129' ' ' PHE . 3.1 tt -93.05 137.81 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.53 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 98' ' ' LEU . 13.8 t -141.67 -130.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 55.32 110.826 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 5.9 mmt -149.94 -175.05 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.13 110.844 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -169.05 147.28 3.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.137 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.8 m-20 166.5 -78.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 54.11 110.878 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.98 -35.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 71.13 111.156 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.77 -127.19 2.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 64.22 112.499 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 149.03 66.25 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.34 112.352 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 51.5 29.3 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 103' ' ' ALA . 3.1 m -132.87 21.79 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.139 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 107' ' ' THR . 3.2 m120 29.49 -98.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.865 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.91 169.31 13.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 71.23 112.522 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.57 11.65 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 70.15 110.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -175.26 156.58 2.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 52.42 110.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' HE2' HD11 ' A' ' 114' ' ' ILE . 13.6 p90 -111.82 150.18 30.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.45 110.867 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 114' ' ' ILE . 18.6 p90 -108.92 67.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.54 110.886 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 113' ' ' PHE . 36.0 mt -32.19 115.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.44 111.148 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.0 m -84.13 149.26 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.843 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.4 p -113.71 18.56 17.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.144 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -166.19 -176.59 3.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.42 111.108 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -77.53 104.47 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.45 110.907 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -126.79 55.51 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 73.52 111.137 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 21.99 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.867 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -94.94 11.03 33.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 75.44 110.881 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.08 25.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 70.12 110.923 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -58.17 -65.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.873 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.87 83.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.14 112.464 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 179.38 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 62.11 110.863 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -126.89 162.5 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.861 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -76.26 -166.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.18 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.688 ' H ' HG12 ' A' ' 127' ' ' VAL . 8.2 p -170.34 141.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.32 111.143 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.813 ' O ' HD22 ' A' ' 98' ' ' LEU . 2.6 p90 -177.66 110.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . 121.1 145.98 7.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 73.41 112.464 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -157.68 139.53 14.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.689 HG11 ' HG2' ' A' ' 136' ' ' MET . 25.2 t -58.45 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.132 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -32.83 65.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.96 178.31 8.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 73.04 110.866 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.17 57.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 53.42 112.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.689 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 75.42 110.851 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -54.55 -22.38 12.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 35.23 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 34.9 mm -78.11 -41.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 50.32 111.178 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -53.75 -47.2 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.25 111.136 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.23 -29.09 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.98 -26.7 61.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.42 111.129 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.2 mtm -73.48 -49.3 27.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.67 39.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 72.53 110.896 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -16.42 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.818 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -130.52 13.09 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 54.32 110.926 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.45 44.82 1.44 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.733 . . . . 45.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t 37.45 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 52.01 110.877 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.464 ' C ' HG22 ' A' ' 57' ' ' ILE . 13.3 mmm-85 -141.36 18.08 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.892 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -128.79 -18.54 3.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 64.24 110.866 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.51 -59.55 0.48 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 75.32 112.444 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.78 158.48 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.879 0.371 . . . . 73.21 110.885 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.77 154.01 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 75.14 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -21.48 59.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 64.3 110.825 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -132.28 165.93 23.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 75.44 110.877 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -108.47 124.07 49.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 74.42 110.881 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 4.4 mp -97.61 107.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.55 111.135 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.647 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -105.54 145.1 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 64.45 111.114 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.444 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -90.29 139.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.4 111.137 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.92 -57.76 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 52.23 111.123 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -167.2 169.08 12.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.11 110.852 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.0 m -146.95 168.87 20.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 72.1 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.45 178.48 35.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 70.22 112.495 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -47.2 48.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 71.44 110.859 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 61.72 108.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 73.34 110.844 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 62.34 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.75 143.88 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 70.42 111.094 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -54.76 134.75 65.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.664 0.745 . . . . 75.34 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 73.55 112.323 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 22' ' ' PHE . 62.2 m -115.05 138.79 50.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.146 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.49 147.65 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.136 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -107.98 146.23 32.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.21 133.12 45.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.33 110.879 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.82 127.6 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 64.05 110.89 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.34 120.15 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 71.23 111.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -127.35 158.22 37.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 45.4 111.104 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.9 m -129.01 106.71 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.14 111.129 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 71.17 35.44 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 74.12 110.863 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.19 -6.69 78.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 65.12 112.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 10.4 tp10 -98.06 136.42 21.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 75.43 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 133.72 26.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.718 2.279 . . . . 51.33 112.333 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.3 tp -116.81 -34.94 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.31 110.924 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -176.87 43.51 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 75.51 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.27 152.62 50.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 75.11 110.886 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 173.86 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 51.22 111.128 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.0 p -139.72 143.56 37.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.883 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 5' ' ' THR . 3.0 m-85 -122.48 133.18 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.886 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -101.87 123.15 45.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 55.44 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 33' ' ' ALA . 12.2 mt -88.45 124.35 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 70.34 110.898 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 90' ' ' LEU . 25.2 m-85 -77.01 62.86 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.835 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.25 -29.36 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 63.05 111.093 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.52 -45.6 91.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.22 110.847 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HD2' HD12 ' A' ' 89' ' ' ILE . 34.0 mmtm -90.14 -31.19 17.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 53.31 110.915 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.9 m -129.8 84.9 59.64 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.624 0.726 . . . . 75.45 111.092 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -31.33 20.86 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.719 2.279 . . . . 63.42 112.32 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -46.24 10.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 61.34 110.869 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -6.73 42.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.01 111.168 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.761 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -77.08 -40.56 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.31 111.072 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 35' ' ' ASN . 51.6 mt-10 -92.46 -44.31 8.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 72.23 110.88 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.7 t30 -28.0 -64.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.936 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.777 ' HA ' HD12 ' A' ' 39' ' ' LEU . 66.5 t80 -72.0 -37.32 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.0 tmm_? -51.02 -35.64 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.863 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -66.72 -32.4 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 61.2 111.121 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 36' ' ' PHE . 8.2 mt -72.78 -54.31 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 51.34 110.882 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 m -56.37 -50.62 71.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.879 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 62.4 p -72.89 -26.92 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.14 111.171 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.75 101.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 75.32 112.482 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -149.53 34.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 72.4 110.886 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -131.7 3.55 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 65.2 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.32 15.96 63.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 71.4 112.498 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -174.69 173.96 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 72.22 110.906 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.89 -172.43 15.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 43.21 112.482 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.36 144.66 27.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.97 0.415 . . . . 63.22 110.89 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.49 -60.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.936 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.4 45.77 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 73.44 112.42 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -93.59 -171.04 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 70.3 110.831 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.8 m -87.65 -167.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.893 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.29 -174.09 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 71.23 110.842 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.3 -76.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 65.41 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.11 162.71 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.877 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.667 HD11 HD12 ' A' ' 156' ' ' ILE . 48.5 mt -149.83 129.9 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 63.35 111.077 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 60' ' ' PHE . 1.2 pt -143.94 117.94 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.641 0.734 . . . . 71.44 111.14 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.8 Cg_endo -69.69 130.63 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.73 2.287 . . . . 62.43 112.349 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.68 21.7 79.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 53.34 112.48 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -137.62 -69.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 74.41 110.857 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.541 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.52 -170.53 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 70.32 110.904 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.51 107.72 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 62.34 110.847 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.41 179.74 4.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 64.21 110.901 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 33.21 112.513 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.793 0.33 . . . . 62.22 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 4.0 t -127.14 107.97 10.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.875 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 35' ' ' ASN . 8.2 pt -56.5 -19.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.13 111.135 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.64 28.94 7.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 72.1 110.919 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.16 -137.65 5.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 34.44 112.47 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.443 ' C ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -109.95 -34.78 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.909 0.385 . . . . 70.53 110.899 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -178.91 146.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.55 110.897 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 160.39 16.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 72.43 110.903 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.7 166.58 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -59.17 -174.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 63.4 110.938 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.85 -63.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 71.54 110.884 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -177.74 161.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.882 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 68.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.866 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 28' ' ' LYS . 12.7 mt -78.16 -1.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.15 111.168 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB2' HG11 ' A' ' 128' ' ' VAL . 1.1 mt -119.24 111.67 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 53.55 110.904 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.65 175.08 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 44.21 110.922 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -96.85 83.76 3.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 63.15 110.822 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 21.67 13.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.24 111.162 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.79 145.76 12.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 70.32 112.495 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 115' ' ' CYS . 53.2 Cg_endo -69.82 -9.64 26.58 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 72.51 112.315 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -100.98 -20.02 15.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 73.11 112.507 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.56 141.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 63.34 111.145 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 114' ' ' ILE . 17.3 mt -116.17 162.94 16.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.25 110.891 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 t -151.48 -142.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.891 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -152.12 133.73 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.21 110.89 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.16 103.44 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.071 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 1.9 p30 -131.97 -179.53 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 70.13 110.863 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.585 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -64.17 -34.5 78.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.128 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 119.76 -62.86 0.47 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 60.33 112.471 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.9 Cg_endo -69.75 94.61 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 2.269 . . . . 54.23 112.332 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 43.17 56.64 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 109' ' ' GLY . 4.2 m -121.26 -1.68 9.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 65.43 111.117 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 47.18 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 62.44 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 115.68 126.73 4.08 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 71.53 112.486 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.15 -31.0 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.32 110.86 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.76 145.01 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.925 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CE2' HD13 ' A' ' 98' ' ' LEU . 2.8 p90 -131.62 179.64 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 75.31 110.936 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -150.5 130.7 13.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 64.43 110.908 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 45.2 mt -48.1 -87.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 75.41 111.126 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.49 ' C ' HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER 160.96 -61.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 63.54 110.875 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 115' ' ' CYS . 1.4 p 67.85 -1.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 54.03 111.16 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.95 151.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 53.43 111.111 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -55.5 132.5 48.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.875 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -129.95 52.62 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.164 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 64.42 110.86 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.25 -36.57 81.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.939 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.55 74.5 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.927 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -157.65 55.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.855 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.56 -44.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 70.04 112.494 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -64.74 -42.98 94.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.81 0.338 . . . . 51.03 110.868 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -112.83 166.07 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.813 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -68.57 -149.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 44.41 111.128 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.643 ' O ' HG11 ' A' ' 29' ' ' VAL . 9.2 p -171.84 157.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.21 111.116 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' ' O ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER 179.4 167.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.903 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 57.03 142.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 61.51 112.462 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -154.4 133.09 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 73.25 110.885 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -44.94 114.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.116 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -88.43 -75.23 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 72.15 110.914 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -138.14 142.63 40.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 72.01 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.47 8.8 26.32 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 74.04 112.476 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.4 ttt -48.35 -32.33 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 61.11 110.882 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -49.31 -28.52 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 71.03 110.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.1 mm -78.21 -40.55 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 75.31 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.3 t -51.0 -47.15 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 64.13 111.142 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.96 -36.24 65.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.24 110.929 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.24 80.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 50.13 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.9 mtm -70.88 -19.13 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -89.41 21.79 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 -20.49 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 72.14 110.875 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -102.4 -6.02 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.54 110.937 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.11 3.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 60.34 112.513 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.17 135.28 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 72.13 110.849 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 36.5 mmm-85 -70.94 79.69 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.01 110.864 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 175.77 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.26 -61.91 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 64.1 112.474 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -74.51 -178.07 3.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 50.12 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.7 22.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 73.2 111.155 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -21.64 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.819 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -131.76 -164.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 55.24 110.876 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 119.7 19.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.52 110.934 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.667 HD12 HD11 ' A' ' 56' ' ' ILE . 49.7 mt -92.71 101.44 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 71.22 111.121 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.8 162.75 13.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.169 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.43 142.92 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.53 111.102 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -102.23 -55.35 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 70.43 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -142.93 179.43 7.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -170.97 -167.01 0.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 70.13 110.906 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 41' ' ' THR . . . 137.16 -148.16 19.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 51.55 112.475 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -112.08 136.91 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.13 110.869 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 tp -54.12 -57.0 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 70.31 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 62.43 110.935 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.355 . . . . 51.54 110.883 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 60.14 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -98.37 158.95 31.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.656 0.741 . . . . 52.2 110.865 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.77 65.08 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.684 2.256 . . . . 70.41 112.348 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -131.44 57.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.11 111.148 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.427 HG13 HD12 ' A' ' 24' ' ' LEU . 5.4 m -49.05 147.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.151 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -138.25 164.99 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.878 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -144.84 138.35 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.51 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.694 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.2 t0 -101.79 91.27 4.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 156' ' ' ILE . 9.4 mm -59.76 143.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.53 111.151 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.63 163.39 22.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.136 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.4 t -151.8 104.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 73.13 111.14 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 52.39 46.32 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.841 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.6 10.97 83.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 34.35 112.469 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -133.66 109.1 12.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.738 . . . . 72.22 110.903 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.3 Cg_endo -69.75 168.92 20.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 63.45 112.374 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.06 -58.45 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.927 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.24 -167.64 27.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 41.41 112.49 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -100.24 127.75 46.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 61.35 110.909 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 138' ' ' ILE . 7.7 t -101.65 120.16 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.124 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -94.93 84.28 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.32 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.54 95.51 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 55.12 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -78.41 153.64 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.5 110.866 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 129' ' ' PHE . 18.3 mt -115.06 133.21 56.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 55.11 110.888 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -81.54 78.64 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.13 110.879 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.9 -7.0 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 51.11 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -61.31 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 63.42 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.63 -60.01 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.57 83.2 4.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.632 0.729 . . . . 75.45 111.105 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 60.23 112.342 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 179.38 -59.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 70.14 110.908 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.547 HG23 ' CE ' ' A' ' 100' ' ' MET . 51.1 m -56.31 -48.57 76.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.02 87.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.33 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.85 -30.11 9.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.85 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.62 -61.27 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 64.42 110.907 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.9 -33.65 57.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.837 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.97 69.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.32 110.894 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.39 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 70.22 111.118 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.2 tt -78.12 -2.6 38.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t -98.93 -8.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 61.23 110.848 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.6 p -115.96 8.02 14.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.3 37.0 30.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.734 . . . . 62.24 112.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -110.02 30.96 6.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 74.41 110.92 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.675 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -128.27 32.13 4.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 52.51 110.89 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.3 -45.1 2.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.45 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -138.91 167.04 22.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 72.31 110.892 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.67 -108.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.758 . . . . 74.42 112.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -177.25 124.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.389 . . . . 75.1 110.965 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -26.44 13.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.889 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.68 -67.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.741 . . . . 35.04 112.494 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 157' ' ' THR . 3.4 t 45.42 -160.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 63.21 110.844 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -166.4 162.55 17.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 33.21 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HE1' HD11 ' A' ' 158' ' ' ILE . 22.8 m-85 -101.78 -78.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.868 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.74 25.82 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.872 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.94 21.42 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.66 138.87 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.106 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 HD12 ' CE ' ' A' ' 61' ' ' MET . 11.7 mt -121.24 102.72 42.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.708 . . . . 74.35 111.127 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 77.89 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.702 2.268 . . . . 72.41 112.31 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.12 -40.82 0.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 63.14 112.494 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -64.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 72.31 110.917 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.4 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.96 -167.48 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.88 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 t -143.45 129.56 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.92 164.28 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 60.42 110.895 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 64.41 112.54 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 72.34 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.07 -177.4 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.35 110.855 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.675 HD12 ' HD2' ' A' ' 44' ' ' LYS . 25.2 pt -93.36 -38.09 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.41 111.144 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -80.22 -13.26 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.927 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.84 -172.32 45.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 72.33 112.529 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.73 -96.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 65.11 110.898 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -121.44 176.71 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.89 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -149.42 153.94 38.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.915 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 164.03 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.871 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.04 145.75 25.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 75.05 110.838 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -52.32 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.874 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -179.0 163.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 53.34 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.03 36.99 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.877 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.6 mm -53.19 -26.63 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 71.41 111.172 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.36 112.59 21.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 74.23 110.872 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 93' ' ' THR . 4.7 mmtt -103.04 93.83 5.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 75.1 110.926 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.816 ' HB3' HG21 ' A' ' 97' ' ' ILE . 4.6 p80 -64.8 108.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 54.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' LYS . 13.3 p -128.09 33.81 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.11 111.159 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.58 174.63 44.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 53.5 112.487 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 160.2 50.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 74.13 112.333 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 14.54 76.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 65.04 112.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 92' ' ' HIS . 44.7 mm -99.98 137.5 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 62.32 111.154 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 99' ' ' SER . 3.1 tt -100.12 138.31 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.889 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.667 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -121.56 131.89 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.866 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.547 ' CE ' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.34 -27.17 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.902 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.67 167.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 60.13 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER 169.42 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 63.41 110.867 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' H ' HG23 ' A' ' 107' ' ' THR . . . -106.25 -20.14 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 62.4 111.116 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 130.41 -58.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.492 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.75 83.52 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 73.44 112.366 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 27.06 82.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.2 110.926 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 103' ' ' ALA . 1.8 t -156.87 54.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.54 111.158 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -54.33 -40.87 68.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 60.42 110.914 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.76 -152.0 39.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 63.32 112.459 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.9 m -134.21 65.14 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 42.02 110.866 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -155.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.54 110.947 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 29.9 t80 -177.4 75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.41 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 1.5 t80 -90.33 129.01 36.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 73.33 110.882 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 61.7 mt -107.55 130.59 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.166 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.5 t -99.98 136.71 39.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -120.39 -20.46 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 71.14 111.115 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.86 179.01 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 64.35 111.113 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 87.98 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 73.1 110.888 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.534 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 8.4 p -122.5 62.61 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.155 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 23.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 50.53 110.869 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.534 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -94.65 19.5 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.1 11.2 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 65.11 110.931 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.8 -63.44 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 53.4 110.837 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.31 57.7 3.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.659 -0.781 . . . . 64.13 112.521 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -156.81 -52.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 61.54 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -113.98 148.26 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.01 110.867 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.8 t -90.8 107.53 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.53 111.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 92' ' ' HIS . 35.7 t -83.22 140.61 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 72.45 111.172 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 24' ' ' LEU . 9.3 p90 -159.93 33.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -126.16 -166.88 12.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 63.23 112.456 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER 167.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 75.23 110.935 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG11 ' HG2' ' A' ' 136' ' ' MET . 44.9 t -112.73 93.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.157 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -52.0 -48.1 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.891 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.67 -175.85 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 73.0 110.922 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 53.17 71.48 0.68 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 64.11 112.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.415 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -89.53 3.38 52.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 74.21 110.913 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -79.15 -28.46 42.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.87 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.71 HG21 ' CG2' ' A' ' 20' ' ' VAL . 23.4 mm -68.58 -36.62 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 73.1 111.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -94.68 6.06 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.127 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -119.13 -62.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.865 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.09 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.31 111.082 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.5 tmm? -52.35 -37.02 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.862 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -24.48 18.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.97 -11.23 36.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.879 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -86.06 22.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 64.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.93 -160.0 32.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 64.31 112.467 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.7 p -151.44 -71.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 75.12 110.853 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.72 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 70.41 110.861 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -105.74 15.1 27.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.21 110.938 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.82 -38.32 3.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 70.14 112.479 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -50.44 120.56 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 73.42 110.891 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 p -95.02 158.75 15.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 30.12 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -15.94 57.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.846 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.6 170.45 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 54.01 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -98.49 123.3 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.914 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 10' ' ' ILE . 3.7 mp -105.93 130.63 57.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.45 111.154 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 51' ' ' SER . 67.2 p -138.56 157.62 45.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.164 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 ' HE1' ' A' ' 53' ' ' PHE . 4.2 mp -90.78 93.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.119 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -50.77 -57.83 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 75.41 111.071 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.54 162.48 41.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 75.51 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.5 p -156.01 160.56 40.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 75.43 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.84 45.25 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 75.43 112.482 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.7 mt-30 -68.18 -36.56 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 54.14 110.911 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.8 mm? 73.86 -58.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 75.1 110.873 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.11 110.918 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 51.3 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -126.05 143.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.1 111.122 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -53.51 145.34 28.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 34.01 110.895 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.4 Cg_endo -69.77 129.4 17.51 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 74.11 112.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 m -119.98 147.3 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.25 111.132 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -128.45 165.09 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 44.45 111.11 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CD1' HD21 ' A' ' 164' ' ' LEU . 5.6 p90 -122.54 153.79 38.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.866 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 158' ' ' ILE . 5.5 t80 -136.09 128.88 31.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.905 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 34.7 m-20 -95.32 126.56 40.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.872 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.508 HD12 ' HE1' ' A' ' 142' ' ' MET . 4.2 mm -99.53 119.36 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.33 111.169 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.0 163.13 15.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 65.43 111.124 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -147.67 92.84 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.03 111.129 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.05 31.12 4.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.85 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.12 -12.99 65.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 74.04 112.512 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -97.9 126.86 39.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.652 0.739 . . . . 74.32 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.4 69.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 74.2 112.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.76 -67.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.916 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.8 -159.6 10.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 63.22 112.506 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -127.99 124.27 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 74.42 110.903 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.8 t -113.11 90.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 72.42 111.13 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 77.8 p -85.16 147.8 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.823 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CD2' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.68 140.02 40.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 74.32 110.884 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 6.1 tt0 -91.21 161.97 14.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.895 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 4' ' ' PRO . 61.2 mt -114.9 119.57 37.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.907 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 90' ' ' LEU . 16.9 m-85 -74.85 61.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 75.53 110.902 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.98 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 74.41 111.137 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.91 -65.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -74.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 65.4 110.899 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 33' ' ' ALA . 12.9 m -84.58 116.71 66.39 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 72.04 111.162 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.706 2.271 . . . . 72.45 112.331 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -66.28 -43.69 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.918 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -48.24 -27.96 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.152 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -80.17 -39.27 29.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 53.02 111.104 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.92 -156.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 61.14 110.878 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.85 -68.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.31 110.903 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.01 -29.03 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.909 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -52.03 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.89 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 43' ' ' GLU . . . -78.95 -28.09 43.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.41 111.082 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -89.08 19.47 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.929 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' HG11 ' A' ' 6' ' ' VAL . 31.8 t -144.8 -31.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 61.14 110.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -103.94 -32.97 9.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 74.53 111.097 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 120.08 2.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 53.15 112.513 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 177.41 -47.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 55.42 110.884 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -83.85 -11.37 57.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.907 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.77 7.52 35.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 74.53 112.515 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' C ' ' A' ' 47' ' ' GLY . 2.6 m-85 -93.02 -24.77 18.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 64.44 110.871 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -29.05 130.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 50.51 112.467 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -95.2 34.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.933 0.397 . . . . 73.12 110.915 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.98 147.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.873 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.05 62.15 4.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 62.31 112.476 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -125.82 -168.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 72.34 110.906 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 m -120.85 -169.69 1.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.3 110.896 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.06 127.75 55.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 65.5 110.839 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -63.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.813 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -157.58 -179.51 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.45 110.841 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 152' ' ' THR . 65.8 mt -150.55 136.22 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.142 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -140.27 105.41 6.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.573 0.701 . . . . 75.02 111.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.4 Cg_endo -69.77 159.4 53.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 62.02 112.31 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.93 -34.53 3.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.508 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -111.18 -82.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 73.53 110.86 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 175.13 119.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.861 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.41 177.29 8.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.04 174.55 10.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 51.23 110.919 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 64.03 112.508 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 74.41 110.934 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -83.68 5.76 23.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.33 110.858 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 39' ' ' LEU . 2.5 mt 83.0 -43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 71.42 111.106 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -72.65 70.24 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.939 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.43 -72.25 2.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 32.34 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.0 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 65.02 110.835 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.75 162.94 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 72.45 110.896 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -141.22 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.01 110.865 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.79 164.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 63.31 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -77.85 113.04 15.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 51.13 110.858 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -56.28 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.848 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.08 149.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 64.24 110.894 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -111.84 58.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.854 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.97 -10.96 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.42 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -104.11 137.33 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.92 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -128.34 -172.89 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 71.3 110.892 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -95.18 -89.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 73.11 110.881 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m 76.54 -15.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 44.44 111.178 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.34 163.22 36.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 74.54 112.485 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 118' ' ' LYS . 53.8 Cg_endo -69.79 143.19 49.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.619 2.213 . . . . 70.22 112.392 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.16 -41.28 2.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.737 -0.744 . . . . 74.34 112.457 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.6 mm -50.42 150.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 71.43 111.152 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -123.18 161.11 25.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.13 110.886 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.746 ' OG ' HG22 ' A' ' 128' ' ' VAL . 4.2 m -158.8 -129.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 73.23 110.894 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.0 mtp -142.83 -159.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 54.34 110.92 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . 173.38 81.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.32 111.084 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 107' ' ' THR . 2.0 t30 -104.13 -158.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.24 42.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 52.3 111.085 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.73 168.82 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 71.2 112.468 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.72 166.67 26.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 72.11 112.335 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 56.35 34.13 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 54.04 110.871 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 105' ' ' PRO . 16.3 p -137.67 26.66 2.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.1 t30 50.62 -97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 73.33 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.74 -85.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.727 . . . . 62.42 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 t 71.0 36.76 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 74.22 110.872 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 9.1 tp-100 -92.22 -34.95 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 74.32 110.894 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.627 ' CE2' HD11 ' A' ' 114' ' ' ILE . 60.0 t80 68.57 75.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 63.4 110.908 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -108.49 129.67 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -120.47 121.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 73.41 111.169 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' MET . 6.5 p -73.91 136.92 43.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.14 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.577 HG21 ' OE1' ' A' ' 143' ' ' GLU . 13.1 t -109.89 -16.58 13.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 64.02 111.134 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.65 24.57 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 42.11 111.116 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 1.2 tmtt? 58.17 103.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.2 p -121.38 71.63 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 72.4 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.45 20.34 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.835 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -9.01 58.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.929 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -86.51 -47.87 8.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 72.33 110.918 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -56.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.851 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.58 47.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.693 -0.765 . . . . 74.43 112.507 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -96.73 -31.02 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 70.55 110.932 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -132.36 124.87 29.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.825 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.8 t -49.37 111.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.23 111.103 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.746 HG22 ' OG ' ' A' ' 99' ' ' SER . 20.9 t -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.24 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.718 ' HB2' HG21 ' A' ' 29' ' ' VAL . 19.6 p90 -165.66 34.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.31 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -122.41 -173.22 14.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.717 . . . . 53.34 112.508 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 174.57 144.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 62.25 110.928 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.12 90.22 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.15 111.154 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -50.92 -59.96 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.52 110.856 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.55 142.0 10.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 61.44 110.863 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.48 2.99 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.484 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.18 -32.19 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 74.31 110.827 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -50.4 -27.95 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 72.02 110.925 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 24.5 mm -80.09 -40.81 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.25 111.141 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -48.83 -52.82 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.23 111.162 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.78 -30.59 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.2 110.868 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -70.98 -42.69 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 62.13 111.121 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.508 ' HE1' HD12 ' A' ' 10' ' ' ILE . 19.1 mtm -62.81 -30.12 71.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.859 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.577 ' OE1' HG21 ' A' ' 116' ' ' THR . 14.7 mm-40 -58.13 -55.07 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.31 110.874 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -22.5 66.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.84 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.94 -6.28 59.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.869 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.427 ' HA3' ' CG2' ' A' ' 56' ' ' ILE . . . -89.94 -157.35 33.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 54.45 112.537 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 p -164.49 142.59 6.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 74.21 110.86 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 38.5 mmm-85 -74.63 73.31 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.922 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 175.93 -33.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.919 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.17 -67.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 73.42 112.491 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.45 159.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 74.13 110.92 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 56' ' ' ILE . 77.0 p -131.19 156.67 44.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.8 t -77.41 -18.05 57.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 70.21 110.879 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -134.22 -165.67 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 75.15 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -138.63 136.08 35.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.915 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.49 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.4 mt -106.02 119.04 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 65.14 111.128 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 26.5 p -106.01 163.69 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.152 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.55 HG23 ' CE1' ' A' ' 8' ' ' PHE . 4.3 mt -106.48 134.83 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.24 111.113 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -89.63 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.03 111.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.76 171.95 16.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.0 m -151.86 122.8 7.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 72.21 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -150.36 178.13 28.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 40.2 112.471 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 123.07 24.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 75.24 110.935 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -95.04 -58.88 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.11 110.887 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 55.5 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.846 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.34 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 62.53 111.071 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.91 157.27 39.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.729 . . . . 60.34 110.892 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.98 52.42 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 73.33 112.33 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 164' ' ' LEU . 96.9 m -138.44 93.87 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 70.31 111.145 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 2.4 m -77.03 143.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.108 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.525 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -132.26 162.51 30.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.888 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.56 ' HD1' HG23 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -149.84 152.84 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 62.31 110.911 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -109.35 114.75 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.855 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 tt -86.01 147.83 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.125 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -141.14 164.26 30.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.51 111.131 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 156' ' ' ILE . 61.6 t -138.33 105.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.137 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 66.88 50.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 60.14 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.19 20.6 67.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 60.4 112.496 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 tt0 -134.4 107.29 11.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 54.11 110.886 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.81 141.76 45.91 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 62.31 112.306 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.63 24.9 7.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.3 110.898 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.53 -167.26 14.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.738 . . . . 52.31 112.474 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -178.72 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 75.01 110.832 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG12 ' HB ' ' A' ' 138' ' ' ILE . 2.9 m -137.32 161.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.21 111.093 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 133' ' ' LYS . 30.6 t -114.44 91.79 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 70.5 110.832 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 13.8 m-85 -83.52 102.49 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 72.24 110.873 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.27 111.06 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.892 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.745 HD22 ' CE2' ' A' ' 129' ' ' PHE . 27.4 mt -85.51 140.66 30.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 62.31 110.935 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.65 81.3 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.842 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.71 -3.69 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.04 111.122 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -87.47 -38.33 16.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.52 110.832 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.96 -23.76 17.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 62.35 110.921 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.59 73.06 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 75.45 111.11 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -6.81 19.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.272 . . . . 45.4 112.374 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 -51.84 5.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 62.04 110.902 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.54 HG22 ' HE2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -77.96 -53.77 7.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 61.51 111.066 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -31.41 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.24 111.079 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.44 -56.47 8.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.835 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HA ' HG12 ' A' ' 78' ' ' ILE . 1.8 t30 -47.86 -39.61 19.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 71.45 110.865 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 39' ' ' LEU . 1.4 t80 -77.83 -32.77 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 71.4 110.888 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -35.98 81.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.858 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.31 67.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 51.03 111.124 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 36' ' ' PHE . 46.1 mt -70.3 -32.56 70.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.14 110.906 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -60.14 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.884 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.1 p -72.91 -17.01 61.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.34 111.089 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.19 44.53 93.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.722 -0.751 . . . . 71.15 112.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -28.85 69.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 74.45 110.886 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -70.72 -125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 64.54 110.882 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.06 18.18 3.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 44.44 112.45 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -165.57 -174.55 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 74.41 110.848 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.21 124.61 2.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 73.23 112.488 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.9 155.61 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.993 0.425 . . . . 74.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -157.01 -38.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 64.01 110.898 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.25 27.7 12.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 54.43 112.488 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 170.56 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 51.3 110.894 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -140.53 153.1 46.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 70.25 110.861 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.92 134.32 53.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.885 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.1 OUTLIER -141.37 34.22 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.869 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -138.31 33.17 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.921 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 27.7 mt -82.71 140.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.42 111.096 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.38 113.62 23.37 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.596 0.712 . . . . 63.44 111.107 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 54.2 Cg_endo -69.73 81.38 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 73.44 112.356 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.81 0.24 4.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.748 -0.739 . . . . 75.14 112.498 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.337 . . . . 74.21 110.852 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.25 -160.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 63.1 110.889 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 82.4 m -136.96 -41.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 64.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 65.28 150.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 61.42 112.512 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.793 0.33 . . . . 74.01 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.28 157.2 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 45.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -67.52 -11.84 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 64.11 111.14 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.27 13.8 20.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 75.52 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.47 -162.85 23.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.485 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.1 -42.55 60.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 74.34 110.939 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -177.24 173.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 65.11 110.846 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.53 168.29 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.866 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.69 162.6 16.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.895 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.01 149.42 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.7 -63.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.857 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -176.39 173.7 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.844 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 45.65 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.73 -25.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 71.31 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.644 ' O ' HG11 ' A' ' 128' ' ' VAL . 5.9 mt -91.94 119.28 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 71.02 110.937 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.782 ' O ' HG23 ' A' ' 93' ' ' THR . 7.9 mtpp -100.86 112.42 24.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.852 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -58.94 99.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 61.3 110.841 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 91' ' ' LYS . 6.2 p -127.45 36.25 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.159 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.11 39.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 61.04 112.533 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.62 23.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 72.44 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.01 22.58 72.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 64.22 112.481 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 92' ' ' HIS . 23.4 mm -95.39 117.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 70.23 111.15 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 112' ' ' PHE . 4.7 tt -83.78 121.47 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.891 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 8.0 t -119.58 142.63 48.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.33 110.889 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.54 ' HE2' HG22 ' A' ' 32' ' ' THR . 2.6 mmt -81.74 102.75 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 61.41 110.882 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -84.91 146.38 27.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.15 111.109 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER 165.97 -166.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 61.44 110.854 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.22 -52.96 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.093 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.05 -87.75 0.27 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.727 -0.749 . . . . 63.21 112.455 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 125.19 11.86 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 55.01 112.351 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 45.6 36.12 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.85 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -146.77 56.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 52.32 111.158 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -50.99 -52.91 38.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.52 110.827 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.38 -168.58 54.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 64.22 112.488 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 t -119.85 -5.7 10.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 60.22 110.835 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -64.76 156.62 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.876 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -149.4 162.37 40.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.874 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -160.57 140.5 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 62.41 110.869 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.729 HG21 ' CG1' ' A' ' 139' ' ' VAL . 3.7 mt -91.88 125.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 63.34 111.122 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.4 m -74.49 -32.4 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 72.42 110.919 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 m 55.86 14.69 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.52 111.138 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.53 167.99 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 63.24 111.108 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -63.35 133.44 54.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 5.6 p -145.34 43.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.164 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -66.11 -10.21 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 52.43 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.857 ' CZ2' HG22 ' A' ' 119' ' ' THR . 9.8 p90 -75.9 -9.6 58.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.923 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.17 -17.98 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 64.32 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 124' ' ' GLY . 11.0 m-20 51.64 70.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.818 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.17 43.76 0.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 51.14 112.481 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -73.8 133.32 43.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.349 . . . . 74.4 110.955 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.589 ' C ' HG23 ' A' ' 127' ' ' VAL . 4.9 m-70 64.53 28.95 13.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.32 110.851 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 60.85 -163.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.147 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 90' ' ' LEU . 13.1 p -179.13 145.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.745 ' CE2' HD22 ' A' ' 24' ' ' LEU . 2.0 p90 -176.68 125.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.91 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.86 145.92 14.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.554 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -165.74 151.72 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.23 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 133' ' ' LYS . 1.3 p -55.76 168.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 42.53 111.095 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 132' ' ' VAL . 2.2 tptp -147.81 -39.89 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.01 110.902 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -132.26 155.37 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.879 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.24 78.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 63.14 112.49 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -2.22 47.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 72.53 110.901 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.26 -29.96 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.912 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 20' ' ' VAL . 47.4 mm -63.99 -43.79 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.729 ' CG1' HG21 ' A' ' 114' ' ' ILE . 9.3 t -88.2 6.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 23.45 111.156 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.06 -69.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.87 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.53 67.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 55.41 111.123 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 15.6 tmm? -49.67 -35.44 21.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.88 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.49 54.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.3 110.836 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -141.31 0.32 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.859 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.69 15.96 26.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 63.55 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -95.12 -155.72 31.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 73.34 112.458 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.24 -169.23 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 73.54 110.881 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -77.77 -32.58 52.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.863 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -106.09 1.33 26.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.34 110.912 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.03 -146.25 16.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 61.33 112.455 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 64.78 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 63.5 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 54' ' ' HIS . 59.3 p -82.56 146.01 29.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 64.32 111.154 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -21.99 62.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -135.19 -179.17 5.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.1 110.896 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -97.86 101.44 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 73.12 110.871 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 12' ' ' VAL . 4.5 mp -96.44 122.02 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.104 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.18 159.49 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.53 111.174 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.56 HG23 ' HD1' ' A' ' 8' ' ' PHE . 42.0 mt -87.88 116.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 70.53 111.143 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.28 -52.19 20.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 52.32 111.09 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -143.38 -179.59 6.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 65.22 110.866 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 5.1 p -171.23 -172.85 1.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.23 110.858 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.29 -149.21 20.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 34.42 112.455 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -127.55 141.95 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 72.53 110.926 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.1 pt? -128.82 166.6 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 45.14 110.856 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 61.53 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 74.44 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.17 156.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.33 111.101 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -93.63 157.21 38.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 62.32 110.908 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 151.83 69.13 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.678 2.252 . . . . 64.42 112.364 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -138.98 151.32 46.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 74.43 111.101 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.574 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -141.8 151.97 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 73.55 111.136 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -127.1 156.77 41.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.888 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -137.92 137.29 37.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 64.12 110.9 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -92.47 114.09 26.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.886 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' A' ' 142' ' ' MET . 7.3 mm -82.49 114.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.32 111.132 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.76 148.77 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 72.41 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.03 98.6 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.178 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.95 24.27 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.873 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.02 -21.62 45.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.471 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.36 150.2 36.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.637 0.732 . . . . 64.45 110.869 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.5 68.28 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 70.12 112.355 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 17' ' ' LEU . 4.1 tp -125.53 -39.65 2.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 40.21 110.876 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 165.73 -176.5 41.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 70.41 112.455 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.15 167.1 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 63.31 110.869 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 27.2 m -130.15 -179.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 62.41 111.106 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -131.59 95.66 3.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.831 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' HE1' HG22 ' A' ' 132' ' ' VAL . 15.7 m-85 -91.78 138.15 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.854 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' C ' HD23 ' A' ' 24' ' ' LEU . 24.2 tt0 -116.45 156.06 27.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 74.34 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -116.08 118.07 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.896 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . 23.9 m-85 -78.59 77.93 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.21 110.869 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.1 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 72.35 111.083 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.02 -46.84 41.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 50.13 110.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.535 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.4 mttt -87.72 -18.49 29.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.885 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -155.44 84.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.633 0.73 . . . . 73.25 111.143 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -27.65 26.29 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 73.21 112.341 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -76.47 -57.36 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 71.25 110.89 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.7 m -51.7 -43.55 62.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.34 111.195 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.45 78.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.45 111.139 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -53.96 -25.01 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.4 110.848 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -66.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.935 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HD2' HD22 ' A' ' 24' ' ' LEU . 5.9 t80 -52.59 -39.7 61.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.918 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 64.31 110.877 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -90.48 -33.8 15.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 64.43 111.138 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -92.13 26.12 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.959 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.574 ' OG ' HG11 ' A' ' 6' ' ' VAL . 34.3 t -121.2 -5.69 9.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 63.04 110.872 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.8 p -118.47 15.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.13 111.183 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.98 24.81 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 60.42 112.488 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -83.78 -21.89 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 72.34 110.884 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 17.64 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.22 110.96 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.33 -52.5 4.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 53.23 112.493 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.03 155.92 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 74.24 110.898 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 -136.69 3.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 72.2 112.507 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -22.55 17.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.393 . . . . 55.15 110.865 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.63 112.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 74.51 110.879 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.77 55.55 20.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 54.22 112.479 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 m -113.85 3.85 15.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 44.25 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m 50.61 -168.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 65.44 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 56' ' ' ILE . 2.8 m-85 -111.41 154.37 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 64.14 110.887 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -93.34 -64.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.841 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.5 148.12 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 74.3 110.922 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CD2' ' A' ' 53' ' ' PHE . 55.2 mt -142.49 117.81 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 75.01 111.142 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.758 HD12 ' CE ' ' A' ' 61' ' ' MET . 59.5 mt -128.42 99.9 23.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 75.02 111.148 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.79 93.71 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.215 . . . . 73.32 112.384 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.43 -26.18 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 51.31 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.55 -56.54 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 73.31 110.843 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.758 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -174.49 -165.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 53.42 110.85 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 61' ' ' MET . 0.7 OUTLIER -146.32 144.9 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 54.43 110.834 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -94.52 -168.71 1.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 71.41 110.897 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 54.05 112.518 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.808 0.337 . . . . 73.23 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.405 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 5.2 t -105.03 126.39 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 42.32 110.888 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.839 HD13 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -63.88 -13.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.116 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.48 -16.38 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.941 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.31 -107.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 54.15 112.504 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' C ' ' HB3' ' A' ' 77' ' ' SER . 1.1 pt-20 -109.45 -55.76 2.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 71.54 110.913 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -166.74 151.09 7.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.904 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.09 144.13 51.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.9 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -52.98 153.52 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.876 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.04 136.38 33.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 73.42 110.865 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.14 -55.32 6.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.854 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.613 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.9 p30 -176.83 -173.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -132.34 38.49 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 54.25 110.885 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.535 HG21 ' HG2' ' A' ' 28' ' ' LYS . 4.3 mt -51.34 -25.16 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.31 111.125 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD23 ' CD ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -84.61 110.58 18.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 64.5 110.897 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -98.68 -166.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.93 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.527 ' CE1' HG21 ' A' ' 97' ' ' ILE . 88.3 m-70 -102.09 -98.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.34 110.865 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 65.6 7.1 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.55 111.141 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.51 163.36 30.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 75.52 112.499 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.72 10.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 51.02 112.341 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.43 31.51 54.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.467 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.527 HG21 ' CE1' ' A' ' 92' ' ' HIS . 29.5 mm -94.51 131.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 50.32 111.162 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 112' ' ' PHE . 1.2 tt -101.61 136.98 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 71.15 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 113' ' ' PHE . 5.7 t -105.95 -133.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 74.35 110.824 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -171.82 -34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.896 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 100' ' ' MET . . . 66.84 97.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.11 111.141 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.86 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.919 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.689 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -82.68 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.077 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 126.2 -63.42 0.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.462 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.72 -92.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.32 112.362 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -138.84 92.14 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.689 HG21 ' HB3' ' A' ' 103' ' ' ALA . 1.4 p -143.39 21.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.159 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 44.86 -91.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 52.43 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.95 -69.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 71.2 112.488 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 t 67.52 36.12 3.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 72.53 110.87 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -103.27 -97.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 73.12 110.943 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HE2' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.3 173.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 64.34 110.911 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER 178.21 57.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.897 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' A' ' 112' ' ' PHE . 66.7 mt -65.47 85.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.2 111.162 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.6 m -70.96 145.68 49.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.883 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.698 HG21 ' CD ' ' A' ' 143' ' ' GLU . 34.7 p -99.51 20.13 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.51 111.09 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -174.56 -167.84 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 72.21 111.101 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -78.46 134.01 37.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.842 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -134.27 49.74 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 53.11 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -63.21 -11.83 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.899 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -60.67 -26.28 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.883 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.403 HD22 ' NE2' ' A' ' 126' ' ' HIS . 25.5 mt -75.8 -29.92 58.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 60.25 110.924 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 124' ' ' GLY . 21.5 t0 49.83 81.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 71.02 110.859 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 17.31 62.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.689 -0.767 . . . . 25.31 112.505 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ASP . 22.1 tptp -103.57 -25.35 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 72.31 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.439 ' C ' HG23 ' A' ' 127' ' ' VAL . 64.6 m-70 -96.83 -6.96 34.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.834 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 87' ' ' ASN . 7.9 t 76.66 80.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.59 138.67 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.43 111.149 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -154.57 26.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 53.55 110.897 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.9 -179.01 15.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.506 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 140.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 62.22 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 22' ' ' PHE . 85.4 t -86.96 80.4 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 43.24 111.148 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -43.53 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 65.11 110.858 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.43 168.24 15.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.888 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 103.97 -0.09 44.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 51.14 112.46 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -33.44 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 61.3 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -51.13 -29.19 12.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 18' ' ' GLY . 24.7 mm -76.22 -40.44 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 60.51 111.09 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 65.4 t -49.49 -47.49 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.111 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -52.12 -33.41 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.11 110.852 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.41 82.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.21 111.099 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.619 ' HE2' HG21 ' A' ' 10' ' ' ILE . 12.6 mtm -77.34 -14.64 59.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.908 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.698 ' CD ' HG21 ' A' ' 116' ' ' THR . 17.9 mm-40 -86.44 14.27 6.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.9 1.2 2.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.869 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -105.06 -5.8 20.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.868 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.665 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -82.41 -151.26 9.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.54 112.474 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.1 m -145.94 -74.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.375 . . . . 43.01 110.847 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 75.54 110.86 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.87 2.67 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.886 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.85 -44.92 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 44.11 112.482 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.7 137.56 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 72.42 110.93 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.665 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.2 p -123.56 157.57 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.42 111.139 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.3 t -81.37 -17.24 49.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -135.2 -175.73 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.02 110.869 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -125.08 130.36 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 62.11 110.886 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.48 129.03 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 63.14 111.07 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 167.81 20.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 63.45 111.162 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.53 111.98 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.21 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -70.0 -50.99 36.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 51.0 111.085 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.34 162.85 33.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 63.51 110.9 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.4 p -165.73 168.18 16.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.24 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.46 -175.24 36.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 64.13 112.475 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 116.49 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 72.15 110.902 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.9 mm? -91.18 -39.64 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.933 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.864 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.804 0.335 . . . . 74.23 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.44 145.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.137 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.2 148.51 6.12 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.605 0.716 . . . . 55.24 110.924 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 126.11 12.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 63.15 112.336 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 164' ' ' LEU . 51.3 m -106.6 108.86 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 73.34 111.14 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.493 HG12 ' HG3' ' A' ' 163' ' ' GLN . 2.5 m -88.72 141.96 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.13 111.146 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.528 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -111.99 159.99 17.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 73.15 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.31 138.03 29.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.896 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.4 109.16 17.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.906 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.745 HD12 HG21 ' A' ' 138' ' ' ILE . 13.3 mt -94.49 148.32 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 71.44 111.138 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.34 164.53 28.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 71.43 111.04 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 17' ' ' LEU . 91.0 t -136.44 98.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.129 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 65.69 54.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.54 110.882 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.39 9.91 56.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.21 112.476 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 76.4 tt0 -123.72 107.24 31.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.642 0.734 . . . . 63.21 110.877 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.77 143.43 50.79 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.652 2.234 . . . . 72.34 112.379 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 12' ' ' VAL . 5.8 mp -98.84 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.9 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.67 -167.8 26.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 51.34 112.473 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.07 120.58 40.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 74.14 110.852 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 138' ' ' ILE . 38.4 t -109.23 102.47 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 72.45 111.132 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -110.24 147.19 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.88 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.83 109.04 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.907 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.29 127.88 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.846 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 129' ' ' PHE . 26.9 mt -89.28 136.12 33.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 54.54 110.972 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -78.68 65.3 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.61 66.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.093 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.19 -55.42 12.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 73.54 110.898 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -54.03 -60.58 3.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.911 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.0 m -99.37 101.18 12.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.596 0.712 . . . . 72.34 111.127 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -50.48 0.46 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.677 2.252 . . . . 70.01 112.366 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -44.68 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.895 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' ND2' ' A' ' 108' ' ' ASN . 3.6 m -86.04 23.13 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.138 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.78 -47.38 15.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 62.12 111.127 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.6 mt-10 -85.68 -24.29 27.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.15 110.876 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 34' ' ' GLU . 1.6 t-20 -28.29 -72.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.913 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 64.3 t80 -79.28 -30.19 42.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.52 110.876 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.0 ttp180 -49.27 -44.28 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.54 110.878 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.95 66.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 72.02 111.145 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 79.2 mt -69.11 -41.92 76.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.897 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -64.1 -45.1 90.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' OE1' ' A' ' 163' ' ' GLN . 33.0 p -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 62.11 111.102 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.53 88.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 74.34 112.474 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.02 31.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 74.31 110.924 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -126.27 -15.7 5.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.919 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 21.65 14.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 71.32 112.515 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -178.28 -167.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 72.12 110.844 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.89 -177.24 43.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 75.54 112.44 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 104.7 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 73.33 110.906 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 -66.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.05 110.899 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.79 26.09 7.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 43.2 112.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -76.19 -164.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 61.34 110.866 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.2 p -153.07 172.74 16.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 53.5 110.875 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.4 -75.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.87 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.72 23.53 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.856 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -139.16 17.73 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.883 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.07 143.22 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 55' ' ' ARG . 24.3 mt -127.49 103.39 22.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.674 0.749 . . . . 63.14 111.119 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.71 96.5 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.3 . . . . 63.14 112.318 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.19 -21.18 4.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.76 . . . . 71.21 112.485 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.06 -60.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.906 0.384 . . . . 72.4 110.878 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -167.63 -148.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 62.2 110.875 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -131.89 -58.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 65.74 118.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.878 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 65.12 112.476 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.788 0.327 . . . . 72.23 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . 4.9 p -87.02 -174.74 5.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.43 110.879 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.52 -31.51 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 72.11 111.173 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -87.33 42.32 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.882 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.42 -113.78 3.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 73.22 112.48 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.37 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 71.42 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -103.07 -171.08 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 64.33 110.894 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -131.44 169.53 15.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.88 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.71 169.85 11.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -61.38 -167.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.43 110.844 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -152.59 -55.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 61.44 110.839 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.38 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 63.22 110.898 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.17 56.5 1.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.833 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.6 -0.45 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 64.11 111.111 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 48.9 mt -114.67 132.4 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.923 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.69 126.68 40.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 72.43 110.931 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -53.44 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 63.14 110.882 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -95.02 4.61 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.166 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.02 -175.38 46.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.749 -0.739 . . . . 62.33 112.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 158.75 55.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.281 . . . . 63.52 112.347 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.15 -28.21 9.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 52.32 112.463 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.1 mm -57.81 124.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 64.31 111.14 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 113' ' ' PHE . 1.4 mp -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.883 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 112' ' ' PHE . 4.8 t -142.77 -152.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 63.51 110.857 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.4 mmt -141.11 135.34 30.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 63.42 110.858 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.881 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.91 -163.43 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.089 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.881 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 4.0 m120 116.61 -176.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.888 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.509 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -52.28 -41.28 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.12 111.053 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.58 -64.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 53.54 112.47 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 111.96 2.96 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.599 2.199 . . . . 62.25 112.353 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 42.47 61.56 1.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 42.23 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.418 HG22 ' HG3' ' A' ' 82' ' ' LYS . 16.0 p -152.5 54.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 70.14 111.176 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -45.01 -43.38 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 65.51 110.912 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.24 -164.32 19.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 71.02 112.489 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.445 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -117.65 -31.76 5.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 73.21 110.867 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.746 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 17.7 pt20 -55.51 149.02 14.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 64.24 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -160.95 158.05 27.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.861 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.0 p90 -114.4 -173.07 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 65.01 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.3 mt -113.51 -57.45 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.34 111.121 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.22 127.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -133.19 34.38 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.106 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.37 159.18 37.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 71.53 111.093 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -67.11 88.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.926 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 p -111.12 54.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.33 111.174 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.29 15.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.877 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 11.33 27.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 75.43 110.946 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 4.1 mt -109.26 -33.24 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 122' ' ' LEU . 4.3 t0 78.19 -42.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.857 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.61 2.78 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 72.21 112.515 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -62.94 -14.94 53.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 72.42 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -92.51 16.54 11.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.894 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.428 HG11 ' OD1' ' A' ' 108' ' ' ASN . 7.0 t 72.41 85.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.167 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 4.4 p -86.31 126.46 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.147 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE2' HD22 ' A' ' 24' ' ' LEU . 5.1 p90 -157.93 128.49 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.892 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 115.81 121.61 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 72.21 112.545 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -129.72 159.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 52.15 110.905 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.25 158.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 75.32 111.119 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -62.59 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.865 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.16 173.6 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 73.21 110.877 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.44 81.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 65.5 112.478 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -7.09 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 62.44 110.865 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -30.86 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.865 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.745 HG21 HD12 ' A' ' 10' ' ' ILE . 50.1 mm -65.69 -36.14 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 72.23 111.138 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 11.4 t -89.04 1.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 62.31 111.123 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -115.62 -64.0 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 60.44 110.854 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.25 -52.61 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 52.25 111.065 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 14.0 tmm? -51.9 -45.78 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 64.43 110.868 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -23.12 3.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.845 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.4 ttm-85 -63.28 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 75.51 110.877 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -92.91 20.13 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.885 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.73 68.14 0.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.1 112.447 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -27.35 135.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 72.43 110.837 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 13.6 mmm-85 -46.16 -63.68 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 71.5 110.903 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.81 -31.35 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 63.15 110.879 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.8 -167.69 22.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 75.53 112.521 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 mttt 61.72 103.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 72.3 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.5 p -77.68 144.35 37.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 65.24 111.15 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 p -60.9 -19.05 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.83 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -129.88 -168.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 61.41 110.905 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.4 108.46 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.44 110.894 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.95 99.87 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 73.42 111.143 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.15 157.1 23.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.32 111.121 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.12 126.01 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 65.42 111.185 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.31 -63.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.33 111.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -127.31 168.95 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 62.44 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.05 -176.1 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.35 110.847 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.97 -152.22 20.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.499 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -125.07 138.33 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.366 . . . . 71.54 110.854 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -116.92 143.98 45.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.963 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.85 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.814 0.34 . . . . 73.32 110.882 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.43 144.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.33 111.153 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -52.2 141.73 30.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.618 0.723 . . . . 75.1 110.862 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 128.44 16.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 63.52 112.351 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -115.52 125.95 53.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 73.32 111.197 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.9 m -113.22 156.74 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 72.01 111.142 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HB3' HD21 ' A' ' 164' ' ' LEU . 9.2 p90 -127.46 165.65 19.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.833 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.63 143.98 33.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 61.41 110.888 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.04 136.26 38.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 ' HB ' ' A' ' 20' ' ' VAL . 3.7 mm -107.19 136.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 71.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -143.26 162.86 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.12 111.095 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 156' ' ' ILE . 76.1 t -153.1 101.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.167 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 65.4 56.64 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.888 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.4 13.08 48.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.718 . . . . 54.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -124.04 113.42 28.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 72.32 110.903 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.8 153.32 68.87 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.674 2.249 . . . . 73.53 112.348 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HB3' HD12 ' A' ' 138' ' ' ILE . 1.7 mm? -112.51 -60.49 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.911 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.62 -164.33 27.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 43.35 112.468 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -108.99 121.49 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 75.23 110.853 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.796 ' HB ' HD11 ' A' ' 10' ' ' ILE . 74.7 t -119.37 111.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 65.2 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 p -111.09 152.61 26.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.11 110.869 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 112.9 15.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.889 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.33 137.39 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 53.22 110.881 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.783 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.5 113.35 26.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.92 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE2' HD11 ' A' ' 90' ' ' LEU . 4.2 m-85 -85.99 70.79 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 55.22 110.86 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -1.88 43.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.112 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.36 -48.22 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 65.3 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG2' HD23 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -60.52 -62.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.874 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -115.35 77.67 5.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.64 0.733 . . . . 70.34 111.117 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 72.85 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 74.44 112.371 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -177.11 -42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.14 110.892 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.547 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -82.55 -61.85 1.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 64.31 111.127 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . . . -91.43 22.17 4.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 75.21 111.115 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.37 12.67 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.876 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -121.5 -28.03 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 64.55 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -54.26 -26.75 30.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.883 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.23 -30.79 39.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 74.24 110.876 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.0 -26.67 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.03 111.077 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.08 19.44 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -118.02 -8.06 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.1 110.86 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -115.95 12.71 15.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 70.43 111.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.11 31.55 33.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 62.21 112.461 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.95 -34.18 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 54.33 110.898 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -61.49 -19.97 62.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 65.34 110.914 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.88 18.8 60.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 61.41 112.473 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.8 151.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 73.43 110.902 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.49 -179.58 16.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 41.5 112.485 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.13 102.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 74.15 110.9 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 -51.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.92 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.94 32.73 2.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 43.35 112.475 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.32 -169.46 2.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 72.22 110.893 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.1 p -152.86 148.77 27.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 65.15 110.864 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.82 -177.61 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.898 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -171.87 60.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 62.0 110.831 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.654 ' NH2' HD11 ' A' ' 57' ' ' ILE . 13.1 mmm180 -137.23 29.54 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.883 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.49 143.27 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 71.35 111.141 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.654 HD11 ' NH2' ' A' ' 55' ' ' ARG . 14.5 mt -139.77 96.5 8.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.622 0.725 . . . . 71.44 111.108 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.77 85.13 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.255 . . . . 73.2 112.314 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.47 -40.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 71.52 112.486 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -58.19 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 73.41 110.867 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.558 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.0 OUTLIER -173.97 -158.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 61.25 110.838 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.4 m -139.56 142.55 37.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.879 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -126.9 157.39 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.953 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 74.04 112.486 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' N ' ' HG ' ' A' ' 110' ' ' SER . 4.7 ttpt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.805 0.336 . . . . 45.43 110.871 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.663 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 40.5 t -118.74 10.83 12.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.861 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER 75.4 -8.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.53 111.092 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -110.28 -18.12 13.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 62.03 110.938 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.37 -134.38 2.01 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 73.34 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -123.98 -33.84 3.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 74.22 110.888 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.42 163.95 10.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.879 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -144.28 135.6 25.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.2 110.883 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -51.02 162.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.21 110.903 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -75.29 92.67 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.882 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -51.67 51.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 177.51 167.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.891 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.34 110.907 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.38 -28.08 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 72.04 111.143 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -87.75 122.3 31.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.43 110.892 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -108.39 -166.55 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 70.25 110.891 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.456 ' CE1' HD12 ' A' ' 122' ' ' LEU . 11.8 m170 -99.88 -88.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.22 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.6 m 69.46 7.64 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.448 . . . . 74.51 111.121 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.22 168.78 30.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.02 112.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 171.34 14.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.269 . . . . 70.11 112.322 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 80.05 28.26 50.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.15 112.526 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 128' ' ' VAL . 37.7 mm -95.31 139.4 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 53.12 111.127 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.741 HD22 ' CE1' ' A' ' 112' ' ' PHE . 12.3 mt -106.54 142.29 36.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.905 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 m -116.89 -138.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 44.32 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.406 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 7.3 mmt -155.13 -59.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 62.04 110.872 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 65.04 146.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 53.31 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.584 ' CG ' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER 177.81 -73.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 75.53 110.882 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.506 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.43 -28.8 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 71.1 111.12 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.11 -76.72 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.72 -0.752 . . . . 41.02 112.429 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.79 107.62 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 73.23 112.331 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' PRO . 70.9 m-80 35.41 69.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.873 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.584 HG22 ' CG ' ' A' ' 102' ' ' ASN . 2.7 m -134.68 16.68 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 71.32 111.165 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.5 t30 39.45 -97.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.9 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 133.65 174.48 13.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 53.15 112.512 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 76' ' ' LYS . 63.6 m -144.68 -43.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 71.34 110.901 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -91.47 92.55 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 63.01 110.889 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.741 ' CE1' HD22 ' A' ' 98' ' ' LEU . 32.7 p90 -82.91 147.06 28.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.53 110.858 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -111.46 131.73 55.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.51 123.17 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.1 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 68.1 m -74.72 130.97 40.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 54.11 110.862 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 61' ' ' MET . 28.9 p -91.71 -27.77 17.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.173 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 119' ' ' THR . . . -130.53 169.67 15.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 55.13 111.117 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -61.86 96.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 73.12 110.895 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.556 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 29.6 p -121.33 59.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.145 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -88.63 25.0 1.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 73.13 110.872 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.556 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.7 OUTLIER -89.22 10.5 21.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.945 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.456 HD12 ' CE1' ' A' ' 92' ' ' HIS . 10.9 mt -98.44 -41.56 7.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 71.21 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -58.37 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 74.35 110.899 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.23 59.99 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.702 -0.761 . . . . 72.31 112.468 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -103.33 -22.66 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 65.13 110.87 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.486 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 12.7 m80 -119.32 -20.78 7.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 63.43 110.891 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 16.1 t 80.74 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 55.43 111.104 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 97' ' ' ILE . 77.2 t -102.43 137.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 70.23 111.143 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.839 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -157.6 29.63 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 74.04 110.884 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.64 140.17 6.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.0 112.451 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -124.04 -165.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 70.11 110.904 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.465 HG23 ' CA ' ' A' ' 96' ' ' GLY . 21.7 t -96.68 134.13 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 75.41 111.13 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -90.62 -63.37 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.11 110.862 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -162.07 142.6 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.892 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.63 4.71 13.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 62.21 112.523 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.6 ttt -49.41 -33.24 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 54.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.1 -28.44 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.931 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 17' ' ' LEU . 31.0 mm -79.39 -38.4 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.03 111.115 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.8 t -48.08 -53.31 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.172 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.98 -32.02 14.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -66.02 -41.12 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.119 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.458 ' SD ' HD13 ' A' ' 156' ' ' ILE . 43.7 mtm -77.14 -17.15 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.41 110.858 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -90.16 29.47 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.882 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -129.15 17.43 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.4 110.86 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -136.65 46.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 74.12 112.469 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 146' ' ' GLY . 37.8 m 33.42 -100.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.04 110.856 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' ILE . 7.5 mmm-85 -161.52 -40.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 73.15 110.86 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.58 -7.03 57.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.2 110.903 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 109.34 -137.18 14.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.31 112.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 75.47 -55.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 65.41 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.35 140.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.4 111.156 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 0.33 20.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 70.5 110.859 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.14 161.04 36.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.878 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.48 112.76 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 43.43 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 11' ' ' ALA . 41.5 mt -98.35 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 72.24 111.168 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.66 174.2 6.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.122 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.36 145.12 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.14 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.21 -62.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.51 111.102 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -157.06 164.8 37.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.787 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.7 m -146.23 -165.55 2.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.863 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.34 28.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 72.54 112.489 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 mt-30 -108.65 136.48 48.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.353 . . . . 74.01 110.919 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 7' ' ' PHE . 41.7 mt -73.12 -41.04 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.11 110.909 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 71.34 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.362 . . . . 61.23 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.26 155.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.54 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -92.96 152.87 41.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 72.24 110.882 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 54.2 Cg_endo -69.77 147.11 62.07 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.686 2.257 . . . . 61.32 112.356 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 6' ' ' VAL . 1.9 m -140.01 165.8 26.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.33 111.173 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.96 132.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 65.13 111.136 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.5 162.86 13.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 63.34 110.906 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -143.67 138.58 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.884 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -101.41 71.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 60.44 110.827 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 156' ' ' ILE . 42.7 mm -50.47 136.09 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 63.42 111.145 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.37 152.69 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 52.41 111.126 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD23 ' A' ' 17' ' ' LEU . 2.0 t -127.27 94.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.24 111.159 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.01 32.33 21.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 74.03 110.896 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.47 -24.71 25.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 62.12 112.511 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -121.79 119.68 28.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.67 0.748 . . . . 71.44 110.884 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 162.67 41.16 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.732 2.288 . . . . 74.21 112.365 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' CG2' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -126.11 20.98 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 44.23 110.891 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 133.9 -164.33 24.43 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 60.1 112.49 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 174.47 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 75.23 110.866 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 135' ' ' GLY . 31.9 m -136.78 177.12 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.52 111.116 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -129.61 100.86 5.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.893 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -86.62 114.04 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.877 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.55 124.85 50.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.51 110.898 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 32.1 mt -88.19 126.66 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.937 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -76.38 67.08 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.1 110.888 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.03 -30.1 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.45 111.138 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -53.06 -56.46 16.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.874 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 90' ' ' LEU . 4.6 mptp? -81.95 -35.55 28.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.841 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 129' ' ' PHE . 16.6 m -128.32 80.35 72.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 63.31 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.07 17.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.27 . . . . 60.43 112.356 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.59 -69.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 61.4 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -42.26 -39.62 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 53.01 111.166 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -63.55 -67.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 53.4 111.071 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' ARG . 6.8 tt0 -41.62 -61.06 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 53.21 110.862 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -35.83 -43.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 44.21 110.881 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -75.24 -41.85 56.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.02 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' GLU . 9.0 tmm_? -51.62 -30.32 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 61.45 110.838 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.55 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.24 111.113 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.19 -41.44 81.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.923 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.9 p -58.88 -46.09 88.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.44 110.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -16.93 64.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.129 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.56 86.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 55.41 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -143.74 39.95 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 74.34 110.92 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 21.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.13 110.926 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.91 -33.69 3.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 64.33 112.486 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -126.09 -167.53 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 72.2 110.865 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.6 -144.21 13.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.733 . . . . 72.51 112.496 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 -18.69 15.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 74.24 110.968 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.59 113.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 65.1 110.88 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -131.19 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 50.42 112.498 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.697 ' O ' HG22 ' A' ' 157' ' ' THR . 6.2 t 49.32 -166.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 65.33 110.817 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.7 p -143.52 -168.58 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -179.44 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.87 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -116.13 -57.52 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.1 110.855 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -145.79 164.6 31.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.15 110.909 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' A' ' 152' ' ' THR . 67.0 mt -153.42 124.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 72.12 111.171 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 1.3 pt -134.62 126.82 18.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.652 0.739 . . . . 61.42 111.132 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 138.44 37.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.622 2.215 . . . . 63.03 112.348 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.43 30.86 77.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 54.34 112.486 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.96 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 74.52 110.898 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -163.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.893 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 m -137.02 -69.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 61.42 110.865 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 62.81 148.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 65.33 110.897 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 53.2 112.469 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.76 0.314 . . . . 61.3 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ILE . 47.6 p -77.87 137.46 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 43.31 110.861 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -33.59 -46.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.153 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 8.2 p90 -112.84 106.21 14.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 71.21 110.88 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.57 -168.86 51.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 73.43 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -71.33 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 74.01 110.902 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.06 155.56 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 53.4 110.913 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 179.41 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.881 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 173.96 9.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.848 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -71.79 179.96 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.883 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.72 -63.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.835 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.86 158.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.855 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 60.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 54.5 110.924 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -78.98 -3.34 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 70.14 111.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -115.94 71.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.882 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 154.57 24.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 53.04 110.866 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -63.82 83.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.845 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -77.08 -8.81 58.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 71.25 111.13 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.95 -174.35 45.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.54 112.492 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.07 66.68 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 71.42 112.329 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -27.96 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 53.43 112.496 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.18 120.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 72.42 111.131 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 99' ' ' SER . 4.1 tt -91.96 143.16 26.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.909 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.711 ' N ' HD23 ' A' ' 98' ' ' LEU . 21.0 t -148.83 -166.58 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 62.34 110.824 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.0 OUTLIER -101.81 148.52 25.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 75.54 110.872 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 107' ' ' THR . 3.1 t30 -145.5 -160.54 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.927 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.16 -45.59 16.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 75.24 111.081 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.04 -65.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 64.04 112.527 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 112.21 3.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.233 . . . . 64.2 112.333 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' PRO . 51.7 m-20 34.42 46.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 54.1 110.901 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 19.7 p -154.08 34.31 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.3 111.16 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -79.73 4.01 17.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.07 133.1 43.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 62.24 112.467 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.22 166.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 52.02 110.891 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 67.52 138.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 70.25 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -153.91 177.49 10.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 61.42 110.91 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.47 162.91 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.874 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.4 pt -145.39 134.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.507 ' SG ' HG23 ' A' ' 119' ' ' THR . 14.0 t -96.58 156.89 16.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 73.3 110.873 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -124.9 27.74 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 73.1 111.125 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.62 27.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 71.4 111.102 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.0 142.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.878 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.507 HG23 ' SG ' ' A' ' 115' ' ' CYS . 0.2 OUTLIER -140.57 48.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.13 111.195 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.72 -20.82 23.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 64.21 110.849 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -62.51 -22.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.904 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.455 HD22 ' HB ' ' A' ' 119' ' ' THR . 4.2 mp -76.41 -37.46 57.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.919 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t0 47.09 86.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 73.3 110.828 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.79 37.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 31.32 112.508 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -55.03 -32.91 62.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 74.32 110.911 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.621 ' C ' HG23 ' A' ' 127' ' ' VAL . 87.3 m-70 -145.57 43.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.871 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER 67.13 -153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.12 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 127' ' ' VAL . 14.2 p -176.94 144.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.22 111.122 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.619 ' CB ' HG21 ' A' ' 29' ' ' VAL . 4.1 p90 -176.5 95.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 63.02 110.881 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 132.54 161.48 9.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 54.41 112.468 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt 175.18 131.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 73.52 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.69 136.36 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.124 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -114.54 -39.41 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 75.52 110.883 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.24 160.94 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.33 110.896 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.655 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 59.05 81.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.3 112.473 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -12.29 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 70.43 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -75.06 -24.54 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 74.53 110.88 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.458 HD11 ' HA3' ' A' ' 18' ' ' GLY . 17.6 mm -64.19 -44.11 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 74.53 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -93.38 5.62 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.55 111.166 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -112.58 -64.36 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 70.22 110.849 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.27 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.23 111.077 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.34 -44.45 54.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.23 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.93 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 54.45 110.907 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.37 -29.97 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.37 -2.81 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 62.41 110.884 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.95 -152.75 14.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 52.44 112.44 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.7 t -161.92 156.13 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 72.42 110.858 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -71.53 -7.47 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 73.1 110.837 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -106.21 -19.61 13.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.862 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.15 -44.27 1.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 61.24 112.495 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -44.55 129.63 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.45 110.914 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 56' ' ' ILE . 49.2 p -98.62 118.17 34.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 53.01 111.118 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 p -54.2 -26.27 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 110.82 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -127.43 -163.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.943 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -131.0 127.75 38.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 64.53 110.943 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 10' ' ' ILE . 2.2 mp -98.84 125.21 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 73.04 111.145 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.13 141.69 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 75.2 111.139 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.07 100.53 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.185 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -66.31 -59.82 3.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.093 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.5 170.41 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.873 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -170.2 154.36 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.928 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.79 179.89 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.747 . . . . 51.43 112.478 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 1.1 mt-30 -82.62 -49.92 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 51.25 110.898 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 164' ' ' LEU . 2.7 mm? 65.04 115.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 64.33 110.936 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.11 110.917 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.889 0.376 . . . . 70.14 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.85 156.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.139 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -92.64 160.1 35.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.623 0.725 . . . . 71.1 110.859 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.52 69.02 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 61.21 112.349 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.1 m -136.18 150.13 48.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 50.2 111.142 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.92 137.24 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.15 111.079 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.625 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -113.32 157.87 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.867 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -141.66 136.34 30.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.878 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.1 m-20 -96.55 119.75 35.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 138' ' ' ILE . 13.3 mm -95.02 142.41 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.12 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.54 170.76 15.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 42.51 111.067 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 17' ' ' LEU . 2.6 m -146.99 96.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.25 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.74 36.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.03 110.857 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -12.42 66.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 65.12 112.486 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.56 131.55 30.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 73.44 110.921 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 153.18 69.08 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.257 . . . . 75.23 112.333 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.715 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.53 -68.21 0.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.58 28.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 50.05 112.528 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.76 134.26 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 70.34 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.603 HG22 ' HA3' ' A' ' 135' ' ' GLY . 53.3 t -136.59 139.99 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.076 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -123.53 152.66 41.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 53.12 110.87 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 132' ' ' VAL . 1.3 m-85 -119.54 -175.48 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 72.34 110.874 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -144.48 117.57 8.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 72.22 110.927 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.46 130.21 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 61.31 110.913 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 29' ' ' VAL . 67.6 m-85 -79.48 75.86 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.86 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -28.11 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.42 111.126 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -37.72 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 50.14 110.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HD2' HD12 ' A' ' 89' ' ' ILE . 19.0 mmtp -86.44 -31.97 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 65.22 110.889 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 7.9 m -132.84 84.98 48.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 73.22 111.11 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -40.38 5.37 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.228 . . . . 50.44 112.38 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -83.08 -44.89 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.864 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.415 HG21 ' CE ' ' A' ' 100' ' ' MET . 2.7 m -81.84 17.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 63.42 111.163 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -85.79 -44.14 12.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.41 111.139 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.4 mt-10 -81.81 -31.37 31.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 61.34 110.85 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 8.4 t30 -27.18 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 72.21 110.896 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -77.51 -34.21 54.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.869 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.426 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 1.8 ttp180 -47.83 -40.27 20.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 54.02 110.917 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.21 60.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.32 111.079 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 13.16 14.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.42 110.942 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -129.67 -20.29 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.8 p -101.19 -25.08 14.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 72.41 111.106 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.17 62.11 1.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.45 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.63 27.08 1.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 71.13 110.865 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -123.6 -11.03 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 61.35 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.86 -25.94 25.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 52.13 112.539 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -140.57 166.65 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 64.53 110.89 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.87 -176.68 41.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 73.01 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -99.58 3.29 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.956 0.408 . . . . 73.21 110.937 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -54.19 150.41 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 64.24 110.894 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 158' ' ' ILE . . . 49.51 63.61 3.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 74.53 112.544 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 m -153.6 -95.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 65.33 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 p -176.5 -172.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.899 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -124.18 -174.51 3.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.9 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.26 177.02 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 70.34 110.87 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 51.17 27.09 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.872 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mt -71.27 119.44 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.53 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.4 111.32 8.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 65.41 111.168 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 93.45 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.672 2.248 . . . . 71.23 112.335 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.96 -30.89 2.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 71.3 112.461 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -108.56 -65.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.52 110.9 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -171.82 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 72.32 110.849 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -121.17 -67.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.906 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 64.15 162.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.504 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.786 0.327 . . . . 74.43 110.871 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.444 ' HB2' ' C ' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -125.31 129.31 49.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.856 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pt -61.75 -15.0 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 63.33 111.172 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.0 21.85 6.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 72.41 110.923 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 77' ' ' SER . . . 157.12 -136.15 4.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.495 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.408 ' C ' ' HB2' ' A' ' 77' ' ' SER . 27.2 mm-40 -104.57 -47.71 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.956 0.407 . . . . 60.23 110.883 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 175.01 10.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 54.33 110.866 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.51 175.0 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.897 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.97 152.12 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -56.61 166.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.864 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.37 -64.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 71.35 110.888 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.36 153.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 62.41 110.909 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 62.69 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.853 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 28' ' ' LYS . 1.5 mt -81.9 -4.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.34 111.177 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.734 ' O ' HG11 ' A' ' 128' ' ' VAL . 4.2 mt -120.49 77.38 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -58.82 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.939 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 86.29 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.861 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 p -108.33 17.78 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.41 111.113 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.62 164.97 31.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 61.43 112.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.63 30.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.265 . . . . 75.33 112.312 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . 75.98 26.38 64.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.729 . . . . 60.43 112.517 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -91.86 118.85 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 72.54 111.152 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 131' ' ' LYS . 1.2 mt -94.37 143.31 26.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.13 110.961 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 t -146.22 -127.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 61.35 110.821 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.61 118.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.42 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -106.79 88.87 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 61.3 111.089 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 49.5 t30 -153.74 95.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 71.13 110.873 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 71.26 -66.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 64.53 111.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.15 -73.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 60.32 112.491 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.3 Cg_endo -69.72 123.54 10.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 63.14 112.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' PRO . 4.2 m-20 31.06 60.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 54.54 110.901 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 108' ' ' ASN . 1.2 p -145.05 31.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 55.31 111.132 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.581 ' C ' ' O ' ' A' ' 107' ' ' THR . 35.6 t30 22.14 -100.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.41 110.911 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.96 145.12 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 72.24 112.514 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -121.4 -10.43 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 45.54 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.595 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.8 mt-30 -81.25 53.66 2.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 75.41 110.902 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -52.95 143.17 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.15 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -112.95 64.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 72.45 110.876 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 113' ' ' PHE . 55.5 mt -29.82 99.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.155 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -64.97 152.88 42.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 63.2 110.886 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.3 p -118.55 -1.82 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.115 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 119' ' ' THR . . . -149.46 159.4 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.129 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -53.73 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.03 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 117' ' ' ALA . 33.2 p -105.15 63.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.01 111.131 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 4.87 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.725 ' CH2' HG22 ' A' ' 119' ' ' THR . 6.5 p90 -84.21 7.52 18.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.933 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -93.37 -57.69 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.03 110.938 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.04 83.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.89 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.06 36.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 61.42 112.489 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tmtp? -73.56 -30.31 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 64.03 110.93 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.485 ' C ' HG23 ' A' ' 127' ' ' VAL . 19.2 m-70 -146.14 34.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 64.51 110.864 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER 56.21 -154.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.119 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.734 HG11 ' O ' ' A' ' 90' ' ' LEU . 7.1 p 178.89 147.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 70.44 111.129 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.798 ' HB2' HG21 ' A' ' 29' ' ' VAL . 15.4 p90 -177.5 115.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.876 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 102.86 141.71 11.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 63.53 112.48 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -158.76 148.24 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.41 110.901 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 22' ' ' PHE . 94.6 t -51.91 148.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 71.22 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -118.27 -60.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.34 110.906 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -128.5 125.61 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.15 110.893 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 20' ' ' VAL . . . 112.16 65.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 45.3 112.49 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.7 mmm -84.26 -0.47 52.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 73.43 110.877 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -30.39 63.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.848 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 142' ' ' MET . 13.1 mm -72.21 -37.17 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.3 111.154 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.0 t -91.69 20.48 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.51 111.144 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -139.28 -55.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 61.41 110.9 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.4 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 70.14 111.152 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 10.2 tmm? -48.0 -36.38 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 42.53 110.888 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.11 -32.69 55.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 72.04 110.885 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ARG . . . . . 0.423 ' HG3' ' CD1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -59.01 -18.41 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.869 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 144' ' ' ARG . 50.0 m-85 -82.59 1.12 39.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 74.33 110.889 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.819 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -90.79 -157.7 33.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 55.34 112.528 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 t -159.45 169.7 23.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 75.2 110.836 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -61.28 -48.5 81.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.888 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -5.66 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.35 110.909 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.46 -39.96 2.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.523 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -48.88 158.22 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 72.53 110.883 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.819 HG22 ' HA2' ' A' ' 146' ' ' GLY . 64.1 p -126.25 157.62 37.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 73.11 111.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.4 t -85.64 1.44 49.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.892 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.3 -168.67 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 64.24 110.893 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.16 120.48 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.22 110.939 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -84.55 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 73.12 111.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.38 136.68 51.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.3 111.202 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.619 HD11 ' CE2' ' A' ' 48' ' ' TYR . 5.7 mt -85.65 132.97 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 75.42 111.165 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -88.03 -58.23 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 74.4 111.129 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -167.79 168.45 12.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.896 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.7 m -146.81 164.48 32.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 61.42 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.51 171.83 44.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.761 . . . . 75.12 112.502 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -68.18 -35.7 78.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.887 0.375 . . . . 61.13 110.929 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.83 -60.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.24 110.929 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 73.25 110.885 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.818 0.342 . . . . 75.44 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.92 146.06 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.14 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.84 141.12 14.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 52.01 110.91 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.72 26.28 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.649 2.233 . . . . 74.41 112.364 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -112.78 112.07 23.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 111.144 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 24' ' ' LEU . 16.1 m -88.57 155.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.11 111.096 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.55 151.75 39.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.866 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 137.64 23.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 62.22 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -109.96 148.28 31.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.669 HD12 ' CG2' ' A' ' 138' ' ' ILE . 3.8 mt -120.13 134.44 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 62.41 111.146 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.27 156.35 42.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.129 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD23 ' A' ' 17' ' ' LEU . 59.1 t -135.27 120.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.44 111.159 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.71 41.34 7.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.875 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.44 62.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 24.23 112.472 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.07 125.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.657 0.741 . . . . 73.44 110.856 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 131.6 21.67 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.702 2.268 . . . . 71.51 112.372 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.76 -19.51 10.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.4 110.926 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.47 -179.58 39.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.747 . . . . 74.03 112.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -144.0 167.0 23.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.353 . . . . 71.22 110.854 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 135' ' ' GLY . 22.6 m -127.15 173.52 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.074 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 t -117.75 94.71 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.35 110.87 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.737 ' CE1' HD11 ' A' ' 114' ' ' ILE . 12.5 m-85 -84.21 120.34 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.848 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.91 146.47 26.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 62.33 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.68 HD11 HG11 ' A' ' 6' ' ' VAL . 11.4 mt -112.26 121.35 44.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.931 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 90' ' ' LEU . 3.9 m-85 -79.99 68.85 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.841 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.21 57.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.129 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.93 -65.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.11 110.852 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -52.43 -62.13 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.887 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.63 84.78 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 52.05 111.113 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 76.48 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 65.34 112.329 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 179.66 -65.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 62.1 110.85 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' CE2' ' A' ' 129' ' ' PHE . 52.1 m -50.92 -41.55 58.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 74.24 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.27 -26.24 51.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.085 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.14 -24.08 66.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.907 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -80.75 -66.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 65.31 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -49.57 -41.21 41.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.888 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -62.13 -33.46 74.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.889 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.4 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 60.14 111.067 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.87 -51.04 36.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 64.23 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 m -57.06 -48.12 79.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.859 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -79.25 -5.41 54.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 73.33 111.168 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.25 64.96 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 41.24 112.505 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -112.22 37.53 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 73.31 110.883 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.635 ' HD2' HD12 ' A' ' 78' ' ' ILE . 2.1 mtpm? -131.64 17.02 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.3 110.884 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.62 63.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 74.11 112.51 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.92 164.78 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 74.32 110.858 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.78 141.2 5.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 54.41 112.5 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HE1' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.45 138.66 9.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 61.35 110.925 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 -47.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.927 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.48 30.22 6.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.731 . . . . 75.1 112.455 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -112.48 -164.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 73.4 110.887 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.0 p -103.23 -178.8 3.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 70.43 110.874 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 158' ' ' ILE . 2.0 m-85 -88.54 177.32 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 74.32 110.851 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.36 -61.54 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 72.2 110.888 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -164.33 145.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 65.24 110.903 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -133.43 145.66 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.43 111.122 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -139.16 123.04 11.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 53.42 111.131 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.71 28.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.632 2.221 . . . . 74.11 112.338 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.17 24.44 68.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 72.34 112.505 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.94 -71.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 71.44 110.918 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.58 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -174.5 -163.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 72.42 110.88 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.57 143.34 16.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.32 110.893 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.41 152.27 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.875 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 64.02 112.491 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.634 ' N ' ' HG ' ' A' ' 110' ' ' SER . 5.1 ptpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.781 0.324 . . . . 71.41 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -71.18 174.41 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.846 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.635 HD12 ' HD2' ' A' ' 44' ' ' LYS . 20.0 pt -83.45 -32.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 72.44 111.139 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -81.36 3.12 25.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.22 -120.46 3.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.739 -0.744 . . . . 73.44 112.521 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -60.47 -164.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 61.24 110.89 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -107.97 164.27 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.902 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.55 146.66 47.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.876 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.38 172.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 72.33 110.862 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 124.19 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 54.04 110.863 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.12 -55.35 14.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.859 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.3 p30 179.65 172.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.32 110.886 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.41 41.05 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.51 110.863 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.522 HG21 ' HG3' ' A' ' 28' ' ' LYS . 3.8 mt -46.54 -33.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 71.54 111.157 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.76 HD11 ' CD2' ' A' ' 25' ' ' PHE . 22.0 mt -91.99 118.97 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 62.24 110.945 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.4 111.11 23.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.902 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.681 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -61.01 92.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 52.53 110.881 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 p -115.43 25.66 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.166 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.61 171.0 43.94 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 73.15 112.527 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 150.37 67.84 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.743 2.295 . . . . 75.1 112.36 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 -30.35 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 75.22 112.468 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 92' ' ' HIS . 43.9 mm -51.49 145.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.42 111.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 ' CE1' ' A' ' 129' ' ' PHE . 1.7 tt -104.82 133.07 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 75.2 110.881 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.75 137.34 54.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 71.32 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.9 mmt -88.07 178.48 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.864 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . 176.11 174.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 71.32 111.111 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 33.7 t-20 178.21 -66.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 53.12 110.837 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -157.34 23.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.23 111.081 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.73 -153.55 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 44.23 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.03 66.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 72.43 112.303 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 64.91 27.14 12.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 75.2 110.936 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 82' ' ' LYS . 26.3 p -147.11 67.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 62.42 111.122 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -88.21 7.21 33.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.959 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.85 130.74 36.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 63.54 112.501 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.634 ' HG ' ' N ' ' A' ' 76' ' ' LYS . 55.1 p 48.13 -158.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 33.02 110.823 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 49.77 93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.932 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.69 163.77 18.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.1 110.841 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -138.85 139.98 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.858 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.737 HD11 ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -81.84 -41.65 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 75.24 111.093 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.6 m 70.78 99.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.88 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.9 p -91.83 27.42 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.146 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -173.04 -173.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 62.11 111.088 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 138.06 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.929 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.7 p -81.27 -150.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.131 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 168.65 -67.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -64.76 -19.87 66.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.949 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 126' ' ' HIS . 25.5 mt -88.16 140.24 29.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.916 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -154.98 -48.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.873 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.99 51.39 0.82 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 43.44 112.472 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HD2' HD22 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.5 29.74 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 72.45 110.92 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.493 ' CD2' HD13 ' A' ' 122' ' ' LEU . 29.3 m-70 -156.11 -50.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.859 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 15.8 t 80.04 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.0 133.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 65.02 111.154 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.53 ' CE1' HD22 ' A' ' 98' ' ' LEU . 4.6 p90 -151.01 17.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.889 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -135.29 -166.55 11.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 71.02 112.47 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER 175.08 172.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 72.41 110.89 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.634 HG11 ' HB2' ' A' ' 136' ' ' MET . 21.3 t -107.94 100.38 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.53 111.144 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -39.87 90.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 179.71 -168.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 110.915 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.714 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 62.68 14.69 51.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 42.22 112.507 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.634 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -55.58 -22.02 20.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 62.11 110.902 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -50.28 -30.26 11.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 51.24 110.886 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.669 ' CG2' HD12 ' A' ' 10' ' ' ILE . 16.7 mm -73.32 -39.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 61.13 111.147 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.671 HG12 ' OE1' ' A' ' 143' ' ' GLU . 53.3 t -48.33 -44.05 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 34.42 111.135 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.72 -47.4 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.53 110.892 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -27.51 62.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.2 111.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 10' ' ' ILE . 46.3 mtm -80.32 -39.76 28.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.671 ' OE1' HG12 ' A' ' 139' ' ' VAL . 2.5 pt-20 -87.44 30.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.22 110.878 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -122.48 -13.54 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.884 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -128.84 24.13 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.851 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -120.73 73.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 75.43 112.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 146' ' ' GLY . 24.0 p -24.37 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 75.11 110.87 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -49.62 -36.13 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.31 110.869 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -54.08 -25.6 22.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.917 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.57 -45.16 1.26 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.791 -0.719 . . . . 44.54 112.512 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 116.1 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 72.21 110.905 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -78.96 133.13 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 74.44 111.138 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -23.25 67.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 74.23 110.838 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.23 -169.33 2.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 73.21 110.908 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.1 OUTLIER -106.08 134.39 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 63.24 110.885 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -115.25 87.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.129 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.701 HG23 ' HD2' ' A' ' 155' ' ' LYS . 2.0 p -102.38 168.77 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.23 111.174 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.596 HD11 ' HE1' ' A' ' 53' ' ' PHE . 1.8 mp -113.4 118.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.11 111.162 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.33 -70.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 61.42 111.136 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -119.1 173.24 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 53.14 110.863 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.2 p -171.9 178.57 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.833 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.69 -143.9 15.4 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 63.23 112.517 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.5 tt0 -107.29 132.95 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.862 0.363 . . . . 73.14 110.924 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -59.78 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 70.2 110.902 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.884 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.795 0.331 . . . . 72.34 110.851 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.68 142.47 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 63.53 111.129 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.89 162.13 0.83 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 74.55 110.89 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 149.23 66.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 73.22 112.345 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.0 m -136.94 86.21 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 43.1 111.126 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.98 159.85 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.107 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.33 161.35 36.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.928 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.64 137.55 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.5 OUTLIER -110.42 100.16 9.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.858 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mm -75.44 144.88 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 72.4 111.18 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -124.7 154.1 41.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.35 111.131 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.577 HG21 HD23 ' A' ' 17' ' ' LEU . 4.8 t -129.16 98.84 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.24 111.121 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.54 54.98 8.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.1 110.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.08 7.93 52.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 62.21 112.469 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -140.05 95.76 8.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 74.12 110.856 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 161.65 45.12 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 70.15 112.289 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -128.31 25.94 5.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.916 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -162.69 21.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 75.44 112.441 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 -176.92 5.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 74.14 110.885 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 3.7 m -135.19 163.91 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 60.1 111.123 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -116.5 94.82 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.868 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.2 m-85 -89.63 116.79 28.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 63.42 110.881 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.34 113.68 26.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.923 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 129' ' ' PHE . 23.6 mt -79.94 139.71 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 75.1 110.941 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CG ' HD11 ' A' ' 90' ' ' LEU . 17.6 m-85 -86.97 60.22 6.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.433 . . . . 70.42 110.886 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.53 -25.26 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.087 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.9 -61.06 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -19.12 62.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.875 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.99 82.7 8.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.682 0.753 . . . . 64.22 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.62 24.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 63.14 112.3 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -58.52 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 73.22 110.925 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.524 HG21 ' CG1' ' A' ' 127' ' ' VAL . 12.7 m -52.0 -45.09 64.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 73.43 111.115 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.22 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.081 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.6 tp10 -57.47 -23.18 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.926 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.51 -71.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.874 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -48.72 -44.23 38.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.857 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.73 -33.18 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.837 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.73 -38.79 28.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.45 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.1 tt -89.33 20.06 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.922 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -112.39 -15.18 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 55.21 110.864 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 p -117.52 4.68 12.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 74.4 111.132 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.96 30.13 66.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 74.13 112.491 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -38.6 50.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.968 0.413 . . . . 63.25 110.906 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.82 -17.05 54.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 51.22 110.9 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.72 -26.36 24.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.34 159.61 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 71.45 110.843 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.636 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 176.3 -78.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 51.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -167.44 -64.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 73.11 110.96 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tptt 59.77 166.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 62.34 110.882 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 118.67 14.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 71.31 112.479 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 157' ' ' THR . 36.8 m -159.14 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 72.42 110.811 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -142.88 119.14 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 44.45 110.879 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.23 122.54 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.22 110.894 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.92 70.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.848 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.43 39.49 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 72.23 110.855 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 mt -96.26 140.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.23 111.139 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.438 HG13 ' HD2' ' A' ' 58' ' ' PRO . 2.0 tt -135.05 133.02 20.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.587 0.708 . . . . 63.14 111.184 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.8 125.21 11.86 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 50.11 112.375 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.33 26.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 75.01 112.514 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -156.73 -82.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 73.01 110.855 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -179.96 -150.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.34 110.848 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.9 m -146.79 144.22 29.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 72.01 110.91 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.49 164.64 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.878 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.769 -0.729 . . . . 31.22 112.454 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.804 0.335 . . . . 75.43 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -133.15 15.26 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 52.2 110.819 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER 83.9 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 73.15 111.184 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.93 -23.25 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 61.12 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.04 -156.68 26.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 64.41 112.503 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.95 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 71.04 110.908 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -155.84 155.34 32.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 71.05 110.917 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -119.55 145.91 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -64.57 152.98 40.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 72.54 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.8 93.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -58.56 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 75.51 110.885 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 175.44 175.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.4 110.909 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.58 43.52 2.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.3 mm -46.23 -32.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 53.33 111.147 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 25' ' ' PHE . 14.5 mt -91.0 147.71 22.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -126.33 -166.37 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.51 110.884 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -98.65 -88.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.35 10.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.163 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.59 141.07 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 63.45 112.488 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 156.68 62.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.31 112.318 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.52 -28.8 9.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 41.01 112.475 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 131' ' ' LYS . 50.3 mm -62.82 147.87 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 72.02 111.102 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 99' ' ' SER . 1.6 tm? -99.1 148.8 23.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.877 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.679 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -145.49 176.96 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.845 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.481 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 4.8 mmt -82.52 170.72 14.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.41 110.926 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' PHE . . . -140.38 100.12 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 61.12 111.083 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -161.0 -169.86 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.923 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -53.38 -32.84 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.23 -68.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 74.55 112.445 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' O ' HG23 ' A' ' 107' ' ' THR . 53.7 Cg_endo -69.73 120.52 7.3 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.2 112.345 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 11.9 m-20 32.96 58.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.52 110.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 105' ' ' PRO . 19.2 p -139.71 33.12 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.24 111.161 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 107' ' ' THR . 2.4 p30 23.89 -101.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 73.23 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 100' ' ' MET . . . 166.08 -165.25 38.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 63.31 112.468 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.45 13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 64.42 110.854 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 70.36 72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 63.21 110.941 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.703 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 175.59 122.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 61.54 110.87 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 112' ' ' PHE . 11.4 t80 178.83 47.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 73.02 110.847 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.59 HG12 HD23 ' A' ' 98' ' ' LEU . 58.8 mt -72.91 94.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.54 111.117 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.5 p -83.28 133.22 34.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.87 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -91.05 -10.38 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 34.42 111.145 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.16 149.43 47.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.16 131.98 46.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.4 110.895 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.05 47.14 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 61.22 111.093 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.02 -15.45 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.872 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -57.81 -20.21 34.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.955 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.28 -46.32 28.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 63.23 110.944 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.99 -58.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 63.51 110.851 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.0 64.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.43 112.508 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -105.47 -28.45 10.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 74.12 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.23 125.5 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.899 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 32' ' ' THR . 53.1 t -51.01 114.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 73.2 111.152 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -98.42 139.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 54.34 111.133 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.2 p90 -176.26 123.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.904 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.38 134.85 8.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.733 . . . . 62.23 112.491 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HB2' HD13 ' A' ' 97' ' ' ILE . 22.2 pttm -152.02 165.26 35.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 70.01 110.873 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 133' ' ' LYS . 9.8 p -72.84 159.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.158 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -124.49 -47.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.15 110.879 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.39 178.51 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 70.44 110.839 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 51.44 69.5 1.12 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.778 -0.725 . . . . 42.53 112.471 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.52 -1.16 40.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.333 . . . . 63.12 110.898 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -77.71 -27.12 50.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.859 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.492 ' HB ' HG12 ' A' ' 20' ' ' VAL . 35.0 mm -65.34 -44.38 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 139' ' ' VAL . 4.7 t -90.11 9.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.52 111.13 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.89 -66.38 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 72.22 110.868 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.83 -51.51 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 53.54 111.111 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.0 ttm -50.95 -44.43 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.875 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -52.8 -27.11 16.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.892 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -62.63 -23.09 66.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 62.02 110.909 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -78.65 2.46 19.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.12 110.904 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -73.16 -161.37 6.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 72.1 112.5 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.9 m -142.15 -77.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 71.44 110.849 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.893 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -92.94 14.93 16.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.938 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.41 -42.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.742 -0.742 . . . . 73.33 112.542 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 155.67 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 70.4 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 146' ' ' GLY . 75.0 p -130.24 157.85 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 53.31 111.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.1 p -79.01 -16.49 56.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.88 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.39 -169.72 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.912 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.55 40.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.893 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.51 127.39 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.23 111.146 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -134.13 143.49 47.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.134 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.91 104.97 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.1 111.157 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -64.25 -59.95 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.13 111.073 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -144.33 171.1 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 65.35 110.869 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.3 p -175.58 145.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.33 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.0 -178.92 36.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 63.13 112.529 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -81.4 122.78 27.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 70.01 110.88 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.817 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -94.92 -30.68 14.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.936 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.916 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.812 0.339 . . . . 71.12 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.19 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.32 111.115 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -89.58 144.27 31.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 75.12 110.902 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 124.57 11.23 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.273 . . . . 62.42 112.349 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -117.1 145.99 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.133 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.36 148.75 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 64.23 111.105 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -110.0 154.47 23.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.14 137.47 42.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.861 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.36 124.0 44.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.888 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.89 129.05 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.55 111.092 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -123.9 168.54 12.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.085 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.5 t -152.39 107.23 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 62.12 111.155 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.25 25.23 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 62.43 110.845 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.63 -14.04 65.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.03 112.499 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.82 139.28 21.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.73 . . . . 71.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.49 64.97 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.722 2.281 . . . . 74.04 112.374 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -66.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 63.52 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.29 -174.83 36.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 64.34 112.459 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -118.76 126.09 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 71.12 110.877 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 138' ' ' ILE . 24.2 t -121.14 119.72 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.173 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.3 p -107.14 148.93 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.895 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.3 105.72 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.93 162.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 74.33 110.909 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.94 119.24 35.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 51.21 110.909 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.85 84.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.91 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.43 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.59 -28.71 37.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.888 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' NZ ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -82.45 -71.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.903 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.7 m -101.46 99.5 11.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.56 0.695 . . . . 71.4 111.133 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.678 2.252 . . . . 63.15 112.361 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -43.22 66.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.9 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 32' ' ' THR . 6.4 m -85.8 21.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 44.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.05 -45.31 20.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 61.14 111.122 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ASN . 86.9 tt0 -83.57 -24.21 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.53 110.89 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' GLU . 15.6 t-20 -30.79 -70.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 53.1 110.896 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 39' ' ' LEU . 65.2 t80 -74.01 -32.42 63.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.1 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 2.7 ttm180 -50.82 -37.9 45.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 70.23 110.863 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.57 -29.99 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.718 HD12 ' HA ' ' A' ' 36' ' ' PHE . 63.6 mt -66.94 -51.65 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.912 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -65.35 -47.83 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 52.41 110.863 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 163' ' ' GLN . 80.8 p -68.83 -24.07 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 62.31 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.49 83.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 55.31 112.482 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 33.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.396 . . . . 74.02 110.895 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -124.73 27.58 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 23.41 110.887 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.09 14.34 68.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 53.54 112.502 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -174.91 173.86 2.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 71.13 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.61 153.93 7.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 51.04 112.484 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.97 137.88 41.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.947 0.403 . . . . 74.33 110.944 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -41.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.912 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.03 43.35 0.55 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 53.44 112.489 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.26 31.67 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.2 110.885 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.0 m 62.96 174.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.894 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -168.2 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 74.43 110.855 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 -59.75 1.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.14 110.878 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -155.68 -169.99 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 61.31 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -168.4 141.84 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.166 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 17.6 mt -134.87 95.89 15.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.66 0.743 . . . . 71.31 111.128 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.74 81.14 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.245 . . . . 65.42 112.346 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.45 -27.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 41.34 112.474 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -51.46 2.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.44 110.931 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.97 -159.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.853 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 36.8 m -129.46 -66.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.23 110.917 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 62' ' ' CYS . 14.6 tt0 64.34 136.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.9 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 65.43 112.495 180.0 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.754 0.311 . . . . 63.31 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -102.61 157.65 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 71.32 110.903 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -39.38 -38.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 64.32 111.159 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.78 49.96 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 62.32 110.935 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.45 -120.58 7.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.769 -0.729 . . . . 72.54 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.98 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 73.34 110.93 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.26 176.34 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.893 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.54 175.23 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.35 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.36 173.69 10.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 60.42 110.834 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.4 158.43 28.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.822 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.98 -58.59 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.05 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.97 150.93 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.893 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -125.01 68.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.9 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 89' ' ' ILE . 14.6 mt -83.19 0.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 43.13 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.453 HD21 ' NZ ' ' A' ' 28' ' ' LYS . 32.9 mt -121.56 83.18 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 53.13 110.941 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' THR . 33.9 mttm -70.17 141.14 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.899 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -55.7 91.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.838 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 91' ' ' LYS . 48.1 p -86.9 7.62 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 54.13 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.45 -165.32 30.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 52.53 112.438 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 166.04 28.91 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 71.41 112.358 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 80.13 -0.06 84.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 74.0 112.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.1 mm -83.18 141.43 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 71.24 111.148 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -116.29 141.4 48.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 71.03 110.95 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.819 ' O ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -150.22 30.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 53.11 110.86 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.819 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 ptp 34.1 120.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.11 110.891 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 110' ' ' SER . . . -46.91 170.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.117 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -174.49 174.77 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.904 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.0 24.7 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 62.52 111.089 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.5 -178.41 21.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.5 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.95 41.69 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.662 2.242 . . . . 65.05 112.357 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 67.63 27.87 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 p -150.55 50.92 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 64.4 111.156 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.88 1.81 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.914 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.93 88.58 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.468 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 5.0 m -145.75 -145.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.349 . . . . 72.23 110.833 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.527 ' OE1' HD13 ' A' ' 39' ' ' LEU . 4.4 tp-100 -109.77 -80.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 72.01 110.923 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.472 ' HB2' HD21 ' A' ' 98' ' ' LEU . 8.2 p90 178.94 137.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 64.34 110.868 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' ' C ' ' A' ' 114' ' ' ILE . 5.7 p90 -131.26 45.29 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.02 110.876 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 113' ' ' PHE . 79.1 mt -28.07 130.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 73.13 111.14 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 77.5 m -83.07 148.09 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.832 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.628 HG21 ' OE2' ' A' ' 143' ' ' GLU . 5.4 p -117.88 22.98 11.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 53.12 111.124 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.58 175.76 6.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.124 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 86.57 4.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.904 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.0 p -112.11 52.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 55.42 111.125 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -87.26 23.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 64.21 110.871 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 8.67 39.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 62.05 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.43 1.41 51.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 62.31 110.935 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 49.3 66.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 73.51 110.863 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 41.19 36.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 55.34 112.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -57.21 -32.87 66.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 75.21 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -108.67 156.82 19.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 71.43 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.56 94.49 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.097 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 49.6 t -74.46 136.07 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.156 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -163.84 26.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.936 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.54 -178.34 15.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 33.34 112.461 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.33 147.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 72.12 110.817 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' HA2' ' A' ' 96' ' ' GLY . 6.6 t -72.21 103.8 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.163 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -53.58 25.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.884 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -166.8 157.55 12.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.88 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.93 6.05 54.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.12 112.48 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.4 ' HB2' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.66 -31.15 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 61.14 110.886 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -52.04 -24.04 6.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.492 HD12 HG22 ' A' ' 20' ' ' VAL . 6.5 mt -81.84 -39.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 64.23 111.113 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.96 -44.65 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.34 111.159 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.62 -29.48 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.47 67.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 31.23 111.104 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -75.31 -23.35 57.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.847 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -89.56 29.21 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.73 3.75 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.821 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.16 13.5 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.822 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -89.06 -160.91 36.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.744 . . . . 51.34 112.514 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.1 t -154.13 18.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.52 110.849 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 46.91 59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 61.01 110.871 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -177.34 -36.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.93 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.75 -56.98 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 74.4 112.485 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.95 116.29 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 75.44 110.877 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.822 HG22 ' HA2' ' A' ' 146' ' ' GLY . 19.6 p -90.28 158.47 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.41 111.134 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 t -68.57 -21.66 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 75.33 110.866 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.47 -168.0 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 65.03 110.834 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.47 124.43 34.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.909 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 11' ' ' ALA . 2.7 mp -100.17 104.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 61.41 111.166 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -96.92 175.8 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 44.43 111.19 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.74 143.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 62.55 111.118 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.35 -59.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.0 111.098 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -154.78 164.5 38.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 75.04 110.845 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.0 m -144.79 -162.97 1.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.92 -155.54 22.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 34.24 112.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -108.24 134.9 50.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.346 . . . . 64.31 110.886 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 tp -55.35 -59.07 5.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.892 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.21 110.913 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 63.22 110.892 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.61 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 65.1 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.617 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -116.8 160.72 35.59 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 54.44 110.895 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 152.9 69.43 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 73.4 112.387 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 m -123.75 43.87 2.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 71.23 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -50.67 143.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.55 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -135.41 175.9 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.913 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -146.14 145.66 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.87 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -102.23 135.21 44.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 54.41 110.876 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.04 131.0 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 71.25 111.142 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.26 167.8 13.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.33 111.081 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.691 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -148.27 98.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.13 111.131 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.33 -12.09 70.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 61.13 112.513 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -95.84 131.81 28.44 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 74.44 110.894 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 145.57 57.87 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.754 2.302 . . . . 73.55 112.342 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.691 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.0 tp -114.9 -67.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.861 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.23 177.5 41.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 71.42 112.477 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 135.92 49.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.03 110.907 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.12 129.48 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 72.02 111.131 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.3 t -90.84 96.5 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.836 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.83 81.82 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.14 110.871 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 9.7 tt0 -57.51 143.49 40.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 73.01 110.897 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD21 ' HD2' ' A' ' 36' ' ' PHE . 11.3 mt -109.6 117.47 34.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 61.34 110.895 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.69 72.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.851 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 3' ' ' ASN . . . -76.82 -30.18 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 72.24 111.096 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -54.03 -60.33 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -64.69 -61.93 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.31 110.921 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.08 94.2 46.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 74.13 111.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -22.83 31.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 71.22 112.315 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -66.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 65.45 110.905 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 127' ' ' VAL . 60.5 p -52.84 -40.93 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.1 111.123 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.88 -71.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 61.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 37' ' ' ARG . 34.2 tt0 -40.66 -65.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.898 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.6 t30 -34.18 -45.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.884 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 39' ' ' LEU . 89.4 t80 -77.11 -38.92 51.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.894 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -51.89 -29.84 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 71.25 110.865 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.06 55.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 54.23 111.122 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 36' ' ' PHE . 57.8 mt -67.82 -54.45 18.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 63.4 110.877 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 t -52.91 -41.89 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.44 110.874 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 62.3 p -71.08 -21.6 62.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 73.43 111.143 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.78 91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.01 112.495 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 35.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 72.55 110.861 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -144.0 12.43 1.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.926 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.27 17.33 74.27 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 42.12 112.45 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -175.26 -166.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 65.53 110.926 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 130.77 -149.08 19.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.489 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -98.08 -26.16 14.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 75.43 110.93 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.32 139.33 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.856 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.69 60.23 5.94 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 73.32 112.531 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.463 ' H ' HD13 ' A' ' 158' ' ' ILE . 5.3 t -137.49 -165.93 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 72.41 110.88 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -157.21 168.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.24 110.869 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 156' ' ' ILE . 20.5 m-85 -81.47 120.69 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 53.52 110.905 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -93.69 -17.53 23.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -145.26 137.76 25.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.873 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.5 mt -150.33 121.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 71.12 111.128 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt -137.76 108.14 8.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 70.31 111.132 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 107.64 1.91 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 74.33 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 130.82 -34.13 2.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.537 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.22 -68.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 73.31 110.871 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -165.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 71.24 110.83 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.66 137.32 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.884 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -100.15 140.98 33.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.932 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 74.51 112.465 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.831 0.348 . . . . 75.42 110.839 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.03 -173.72 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.832 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -87.36 -32.03 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 65.45 111.157 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.37 82.36 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 54.44 110.943 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.29 -125.87 8.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 65.04 112.463 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -116.61 -85.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 73.54 110.903 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 175.0 9.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 64.01 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.74 155.26 40.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.25 110.832 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 168.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.898 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.29 130.62 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 70.43 110.869 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -50.31 18.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.869 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.76 159.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.908 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -105.4 29.84 6.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.875 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.636 HG21 ' HG3' ' A' ' 28' ' ' LYS . 22.0 mm -51.31 -27.53 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.15 103.3 15.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.893 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.7 107.34 19.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 64.02 110.883 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.63 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -58.42 98.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 74.31 110.847 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 42.36 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.115 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.33 178.93 23.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 41.5 112.521 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.29 19.25 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.241 . . . . 72.31 112.329 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA2' HD11 ' A' ' 114' ' ' ILE . . . 87.17 -34.75 3.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 43.04 112.503 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.63 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.6 mm -50.91 137.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 73.51 111.137 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 99' ' ' SER . 2.7 tt -98.38 128.64 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 64.43 110.93 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.549 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -134.42 -171.07 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 72.15 110.834 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.428 ' H ' ' HB3' ' A' ' 126' ' ' HIS . 9.5 mmt -116.63 -173.4 2.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 70.04 110.877 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 102' ' ' ASN . . . -101.35 -48.77 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 61.15 111.053 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HA ' HG23 ' A' ' 107' ' ' THR . 5.4 p-10 39.73 -165.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 62.01 110.906 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.557 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -158.86 22.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 72.34 111.103 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.3 -67.92 0.34 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 41.24 112.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.557 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.75 -156.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 74.14 112.315 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.22 87.31 7.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 102' ' ' ASN . 7.2 t -153.75 51.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.167 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -71.64 -4.88 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 70.43 110.895 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.65 76.04 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 74.51 112.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.0 p -127.3 -140.88 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 73.11 110.871 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -77.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.95 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.89 148.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.842 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.78 122.58 14.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.886 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' HA2' ' A' ' 96' ' ' GLY . 13.0 tt -123.95 137.46 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 71.13 111.124 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.83 148.48 22.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.888 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -92.68 -18.74 22.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 73.34 111.094 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.0 179.89 5.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 75.44 111.125 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -65.7 90.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.63 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.2 p -116.9 59.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 64.21 111.187 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.09 28.06 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.31 110.856 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.4 OUTLIER -91.81 10.63 27.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.91 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -23.65 17.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.913 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.8 OUTLIER 56.72 85.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 60.25 110.87 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.589 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 20.18 61.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 42.15 112.461 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -104.66 -14.36 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 75.42 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HB3' ' H ' ' A' ' 100' ' ' MET . 32.5 m-70 -110.99 -8.94 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.4 110.848 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 32' ' ' THR . 42.6 t 65.74 96.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 73.14 111.133 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 97' ' ' ILE . 24.8 t -83.12 130.36 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.139 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.11 27.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.888 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -152.72 -179.67 28.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 65.11 112.523 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.09 136.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 74.33 110.915 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . 1.4 t -63.32 119.07 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.165 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -89.47 -42.28 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 72.23 110.904 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.39 156.01 13.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 74.02 110.908 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.65 1.96 57.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.763 . . . . 71.35 112.51 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -29.1 8.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.33 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.93 -22.32 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.24 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.2 mm -89.84 -35.67 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 72.41 111.11 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.4 t -52.62 -22.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.12 111.149 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -84.29 -35.38 23.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.888 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.02 94.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 72.5 111.1 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.3 ptm -71.39 -37.15 71.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.893 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.04 34.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 74.45 110.922 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -10.86 6.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.912 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.17 14.59 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.861 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -106.77 71.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.707 -0.759 . . . . 71.35 112.525 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.553 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.73 131.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 52.45 110.843 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -46.25 -46.54 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.901 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -47.0 -37.9 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.07 -47.67 0.92 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 61.35 112.463 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 110.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 64.51 110.889 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.1 t -82.62 145.12 29.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 45.44 111.182 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -22.46 52.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.874 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -136.31 163.91 29.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.952 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.14 130.8 51.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.878 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 53' ' ' PHE . 3.8 mp -109.82 120.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.42 111.169 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.6 p -119.31 165.41 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 62.42 111.181 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 3.9 mp -90.37 -64.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 71.23 111.144 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 158' ' ' ILE . . . 93.93 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 55.42 111.127 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.59 147.08 15.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.24 110.874 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.2 p -176.24 -174.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.51 110.889 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.0 -163.73 28.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 62.55 112.484 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -81.39 120.07 24.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 64.11 110.908 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -91.91 -23.97 19.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.51 110.943 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.333 . . . . 73.11 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 89.1 t 62.38 104.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 73.01 111.137 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -60.19 151.93 64.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 63.14 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.728 ' O ' HD12 ' A' ' 24' ' ' LEU . 54.1 Cg_endo -69.73 117.25 4.97 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 65.32 112.34 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 22' ' ' PHE . 48.7 m -110.35 132.12 54.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 62.3 111.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.4 m -123.99 160.48 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 60.33 111.151 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -127.92 160.04 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.911 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HD2' HD12 ' A' ' 158' ' ' ILE . 5.9 m-85 -135.84 126.98 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.02 110.914 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.27 72.08 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.865 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.16 135.12 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.133 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -123.27 151.38 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 45.14 111.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.6 t -133.31 100.85 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t0 54.06 55.73 7.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.897 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.31 12.27 55.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 64.15 112.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 35.2 tt0 -142.87 94.22 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.645 0.736 . . . . 70.23 110.887 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.7 167.13 25.27 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.271 . . . . 74.05 112.386 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.78 30.05 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 70.53 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.0 -164.02 22.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 70.3 112.481 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 164.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 74.23 110.818 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 138' ' ' ILE . 32.3 m -128.8 171.8 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 74.12 111.107 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -149.84 148.58 29.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.04 110.858 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 5' ' ' THR . 3.9 m-85 -125.32 154.05 42.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.868 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -94.15 -53.28 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 62.54 110.874 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 4' ' ' PRO . 7.9 mt 73.81 122.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.936 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.722 ' CE2' HD22 ' A' ' 90' ' ' LEU . 60.4 m-85 -88.75 69.04 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.875 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.49 48.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 45.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.95 -34.25 26.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 61.42 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -31.42 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 65.53 110.879 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.8 67.6 79.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 61.11 111.138 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 54.2 Cg_endo -69.76 61.64 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 43.14 112.355 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.68 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 73.1 110.875 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.56 ' OG1' HG11 ' A' ' 127' ' ' VAL . 17.6 m -75.2 -60.5 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.4 111.152 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -88.43 -1.32 57.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.128 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 14.8 tm-20 -82.19 -19.99 38.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.886 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' HG21 ' A' ' 78' ' ' ILE . 8.2 p30 -101.28 -27.86 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 72.45 110.859 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -50.95 -29.47 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 45.44 110.899 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -31.17 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.869 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.2 -30.64 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 64.55 111.129 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.423 HD11 ' HA3' ' A' ' 47' ' ' GLY . 2.5 tt -84.47 5.46 27.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.954 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 m -108.15 -2.67 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 70.53 110.83 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -117.16 13.21 14.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 74.32 111.146 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.58 26.58 10.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.01 112.47 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -33.47 28.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -17.97 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 62.55 110.9 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.09 -63.27 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 41.51 112.463 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -102.29 148.99 24.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 62.44 110.828 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 39' ' ' LEU . . . 135.63 151.45 6.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.491 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 158' ' ' ILE . 8.1 t80 -49.56 103.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 64.24 110.921 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -139.55 -47.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.846 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.69 33.76 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 74.34 112.457 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -172.83 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 73.14 110.858 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.2 m -89.51 -172.09 3.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 75.33 110.874 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -75.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.02 110.876 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 41.42 -160.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.842 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.35 19.35 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.22 110.84 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.06 139.94 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 75.34 111.099 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -139.87 108.58 7.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 74.05 111.157 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 92.35 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 51.15 112.345 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.11 21.27 2.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.15 112.474 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.05 -66.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 73.33 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptp -163.54 -168.94 1.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.857 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.73 97.09 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.841 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.68 141.48 36.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.942 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 54.15 112.525 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.79 0.329 . . . . 73.53 110.932 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 148.84 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 44.44 110.879 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -44.14 -55.31 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.142 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -128.3 26.62 5.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 74.33 110.966 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.04 -167.25 17.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 24.43 112.485 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -118.24 -29.59 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 75.03 110.879 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -168.88 136.36 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.942 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -112.03 158.78 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.61 161.68 22.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.43 110.899 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -79.39 108.04 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.831 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.5 -52.64 12.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.857 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -178.9 168.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 71.1 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.91 72.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 64.05 110.936 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.4 mt -76.83 -3.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 72.34 111.139 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD22 ' CE2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -120.53 91.64 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.897 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -75.47 -167.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.901 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -95.05 72.54 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 74.13 110.858 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 p -69.63 -17.92 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 32.24 111.133 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.06 -177.11 43.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.24 112.476 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.82 52.08 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 61.23 112.326 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 104.12 22.35 8.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 52.14 112.476 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.539 ' C ' HD23 ' A' ' 98' ' ' LEU . 24.8 mm -99.36 137.25 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 62.21 111.153 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 112' ' ' PHE . 7.1 mt -111.11 148.18 33.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 54.33 110.898 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.664 ' O ' ' C ' ' A' ' 100' ' ' MET . 1.8 p -163.69 55.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.869 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.664 ' C ' ' O ' ' A' ' 99' ' ' SER . 3.0 mmt 7.96 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 61.14 110.861 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.07 110.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 54.05 111.095 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -142.54 -164.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.725 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -47.99 -51.85 22.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 43.12 111.126 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 124.96 -61.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 62.51 112.498 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 107' ' ' THR . 54.3 Cg_endo -69.76 100.0 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 45.21 112.335 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 63.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.919 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 103' ' ' ALA . 39.9 p -134.73 13.59 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.153 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.7 t30 42.28 -100.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 24.34 110.928 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.94 166.52 10.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 64.4 112.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.75 22.75 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 75.1 110.824 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.86 90.3 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 70.21 110.938 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.674 ' CD1' HD22 ' A' ' 98' ' ' LEU . 33.1 p90 -72.44 155.7 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.894 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 10.1 p90 -120.96 107.3 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 64.2 110.9 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.27 111.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.108 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.88 136.85 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 61.12 110.903 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.84 13.17 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.21 111.145 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.5 11.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.05 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.28 138.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 70.12 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.753 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.1 p -139.34 46.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 111.085 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -54.06 -25.39 21.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.753 ' CZ2' HG22 ' A' ' 119' ' ' THR . 21.0 p90 -62.43 -18.53 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 119' ' ' THR . 33.8 mt -82.58 -34.97 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.78 -10.0 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.879 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.18 52.46 1.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.777 -0.725 . . . . 75.23 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 -29.74 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 74.45 110.912 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -112.36 154.97 24.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 64.43 110.874 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.56 HG11 ' OG1' ' A' ' 32' ' ' THR . 6.6 p -50.08 109.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.095 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 90' ' ' LEU . 9.1 p -76.58 153.79 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 130' ' ' GLY . 4.8 p90 -177.02 178.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.5 110.884 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 43.61 114.15 0.0 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 73.31 112.516 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -119.53 35.41 4.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 73.24 110.913 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 96' ' ' GLY . 3.6 t 60.23 162.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 61.01 111.075 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 132' ' ' VAL . 5.4 tppt? -136.63 -58.08 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 71.15 110.923 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 175.29 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.934 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.37 81.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.705 -0.759 . . . . 70.34 112.446 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.9 tpt -91.62 -25.94 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 70.02 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.42 -30.72 53.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.03 110.892 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 20' ' ' VAL . 43.6 mm -44.07 -39.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.14 111.169 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.1 -52.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 61.12 111.134 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -45.83 -49.99 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.11 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 70.43 111.094 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 156' ' ' ILE . 9.6 ttm -50.3 -31.42 14.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 70.11 110.855 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.918 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -62.61 -14.21 40.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.883 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.87 3.65 47.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.28 -156.09 31.06 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 61.43 112.503 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 -165.99 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 63.41 110.9 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -84.4 -48.35 9.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.32 110.87 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -94.68 10.55 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.884 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.19 -150.77 17.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 51.1 112.481 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 65.04 142.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.12 110.91 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 p -114.41 141.46 47.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.082 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -18.0 63.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.838 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.12 -162.42 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.896 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -116.41 93.88 4.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.41 110.888 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' SD ' ' A' ' 142' ' ' MET . 6.6 mt -88.83 117.69 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 52.55 111.13 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.8 t -136.77 -178.36 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 54.22 111.143 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' OH ' ' A' ' 48' ' ' TYR . 35.5 mm -105.22 115.88 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -76.91 -62.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 70.45 111.117 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.06 167.27 20.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.41 110.834 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.13 -174.63 4.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 53.24 110.888 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.45 -160.93 24.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 73.01 112.49 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.0 mt-30 -110.35 137.01 48.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 71.31 110.925 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 5' ' ' THR . 3.6 mm? -47.91 -60.97 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 60.04 110.895 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.873 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.788 0.328 . . . . 75.25 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -139.44 146.23 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.32 111.156 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.51 156.55 1.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 65.14 110.924 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 151.16 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.667 2.245 . . . . 73.4 112.353 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -141.98 145.74 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 71.03 111.095 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 24' ' ' LEU . 22.9 m -136.82 163.21 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 60.21 111.107 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -135.8 162.71 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.881 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -139.32 131.79 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 15.2 t0 -101.58 75.54 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.872 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.1 146.36 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.31 111.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -138.94 164.77 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 42.13 111.118 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 156' ' ' ILE . 83.8 t -139.81 104.76 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 63.43 111.093 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 63.21 52.54 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.891 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.05 17.46 61.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 43.24 112.498 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.3 mm-40 -132.19 106.56 13.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 64.23 110.893 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.3 Cg_endo -69.75 138.85 38.82 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.664 2.243 . . . . 52.51 112.313 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.76 18.33 13.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 63.12 110.892 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.75 167.22 13.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 34.23 112.495 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.75 175.67 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 72.33 110.88 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 24.8 m -122.39 -176.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 63.05 111.114 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -134.77 86.31 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.85 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -84.83 127.23 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 63.11 110.88 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -104.03 145.42 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 61.4 110.914 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 6' ' ' VAL . 1.4 mt -110.11 113.65 26.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.908 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD2' HD21 ' A' ' 90' ' ' LEU . 15.9 m-85 -73.81 67.46 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 71.4 110.926 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.97 77.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.53 111.062 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.9 -54.77 14.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.32 110.845 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' HG21 ' A' ' 89' ' ' ILE . 3.2 mptp? -69.21 -60.83 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 62.23 110.891 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -121.14 95.89 48.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 52.3 111.097 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -23.13 31.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.253 . . . . 40.22 112.358 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -78.55 -51.19 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.02 110.955 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.508 HG22 ' CE1' ' A' ' 129' ' ' PHE . 18.1 m -64.85 -30.94 71.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.126 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.66 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.11 111.115 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.0 tt0 -56.47 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.948 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -29.29 -54.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.01 110.888 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 39' ' ' LEU . 34.0 t80 -77.07 -39.32 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.905 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -50.04 -31.75 13.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.42 110.901 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.91 -36.86 72.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 71.51 111.124 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 36' ' ' PHE . 30.7 mt -64.58 -43.86 92.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.899 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -59.16 -50.63 73.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.883 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 163' ' ' GLN . 30.7 p -74.91 -18.8 60.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 74.41 111.182 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.86 83.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 73.41 112.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.35 31.95 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 62.43 110.88 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -122.78 26.93 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.844 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 2.32 55.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 62.22 112.503 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -163.28 178.67 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.38 . . . . 73.1 110.885 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.34 131.96 3.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.461 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 161.43 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 73.43 110.924 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.96 -40.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.896 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.91 43.54 1.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 74.22 112.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.53 165.08 24.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.52 110.849 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -131.01 -179.56 5.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.831 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -113.63 -69.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.904 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.546 ' NE2' HG21 ' A' ' 152' ' ' THR . 0.0 OUTLIER 61.61 20.25 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.35 110.885 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -138.03 29.93 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.85 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -79.9 144.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 45.15 111.124 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 56' ' ' ILE . 16.6 mm -134.52 107.39 10.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 74.43 111.118 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 98.51 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.727 2.284 . . . . 43.21 112.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.13 -28.95 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 41.53 112.493 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.94 -63.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 73.15 110.913 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -176.94 -157.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 70.25 110.87 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 t -144.41 137.06 26.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 54.23 110.902 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 167.61 21.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.885 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 42.34 112.478 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.793 0.33 . . . . 70.44 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t -85.62 146.72 26.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 70.1 110.835 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 79' ' ' TYR . 2.1 pp -71.26 -41.87 74.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 44.35 111.15 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.41 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -97.07 -5.64 37.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.955 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 -143.33 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 55.43 112.437 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -118.9 -25.58 6.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 71.14 110.877 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -170.75 141.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -108.8 154.1 22.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.05 110.916 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -88.29 164.43 15.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.01 116.32 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 65.14 110.899 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.68 -49.58 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.871 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.93 140.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.924 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.15 70.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.53 110.917 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.4 mm -80.38 4.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 62.51 111.103 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -108.32 121.77 45.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.913 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 92' ' ' HIS . 14.3 mttp -123.81 82.85 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.891 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 93' ' ' THR . 5.0 m80 38.78 -160.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 65.4 110.863 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 97' ' ' ILE . 1.2 t 161.8 -38.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 73.04 111.16 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . 158.7 -163.6 33.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 71.54 112.486 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 128.54 16.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.31 112.372 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.17 -5.44 15.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 70.24 112.487 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 128' ' ' VAL . 1.7 mm -61.88 139.87 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.352 . . . . 74.34 111.108 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.6 tt -100.86 125.97 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.963 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.552 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -111.78 125.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.859 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -33.77 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 74.11 110.852 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . . . 62.84 155.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.124 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p30 172.0 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.888 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -78.18 -22.51 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.21 111.081 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.8 -64.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 54.53 112.506 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.1 Cg_endo -69.68 87.45 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 71.35 112.367 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 32.55 78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.87 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.94 15.53 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.5 111.175 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 43.73 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.871 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 73.56 132.97 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 70.43 112.448 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.9 p -129.18 77.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 44.01 110.825 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.55 ' OE1' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -93.85 -31.92 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 53.23 110.904 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER 71.97 69.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 62.52 110.86 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -90.82 111.03 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.908 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.538 HD11 ' CE1' ' A' ' 112' ' ' PHE . 96.5 mt -102.89 111.31 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 75.44 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.24 160.02 29.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.87 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.6 p -133.65 27.83 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.31 32.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 72.24 111.104 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 4.2 tttt 62.39 146.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 38.4 p -141.97 58.65 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 73.33 111.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 92' ' ' HIS . 8.1 tm-20 -49.56 -24.7 2.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 64.42 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -60.02 -36.03 76.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 74.2 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.57 106.32 18.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.905 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -43.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 72.53 110.859 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.23 -38.26 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 54.42 112.497 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -59.94 -35.83 75.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 72.24 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -131.81 140.13 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.83 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.79 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 72.7 t -74.14 -81.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.078 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.79 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 72.4 t 103.08 127.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 71.21 111.168 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.508 ' CE1' HG22 ' A' ' 32' ' ' THR . 29.5 p90 -147.55 18.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.27 146.43 16.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 64.45 112.458 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -156.42 140.05 15.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 75.41 110.861 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -48.65 109.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 74.51 111.152 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 -36.03 24.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.05 110.865 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.01 175.37 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 60.31 110.862 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 48.69 73.09 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 62.11 112.485 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -3.53 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.77 0.319 . . . . 75.11 110.88 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 88.6 m-20 -84.25 -34.64 23.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 71.32 110.84 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 50.2 mm -42.47 -41.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 62.31 111.168 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.79 -49.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.135 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 7.4 mm-40 -46.5 -50.27 17.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.873 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.48 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.59 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.9 ttm -50.38 -38.51 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 64.22 110.835 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.99 -27.62 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.909 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -62.66 -14.89 48.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.863 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -89.51 13.22 14.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.922 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.02 -156.34 28.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 34.12 112.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.5 t -166.87 169.79 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 71.14 110.828 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -54.0 -47.31 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 55.15 110.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 3.29 53.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.886 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.36 13.25 79.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 44.33 112.476 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.79 ' O ' HG22 ' A' ' 152' ' ' THR . 4.9 tppp? -45.55 -29.14 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.383 . . . . 75.34 110.957 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.795 HG23 ' N ' ' A' ' 153' ' ' SER . 0.6 OUTLIER 86.73 -169.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.136 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.795 ' N ' HG23 ' A' ' 152' ' ' THR . 23.3 t -137.7 -52.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.895 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 -168.09 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.3 110.892 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.67 111.13 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 74.24 110.9 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.59 HD13 ' SD ' ' A' ' 142' ' ' MET . 40.4 mt -107.24 101.76 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.1 111.164 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.4 p -113.64 168.66 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.22 111.132 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.95 106.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 63.33 111.162 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -55.0 -54.57 41.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 44.34 111.113 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.24 167.97 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.897 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -156.5 160.87 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 64.43 110.853 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.84 179.83 46.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 53.33 112.481 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 7.3 mt-30 -74.89 -37.89 62.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 74.41 110.902 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.41 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 63.33 110.951 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.881 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.829 0.347 . . . . 73.41 110.863 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.03 152.64 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -67.48 137.63 93.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.597 0.713 . . . . 70.33 110.885 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.54 51.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 61.4 112.343 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 86.6 m -127.75 148.38 50.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.43 111.136 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.44 160.04 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.33 111.135 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.5 162.25 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.829 -179.95 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.534 ' HD2' HD12 ' A' ' 158' ' ' ILE . 26.8 m-85 -139.32 136.43 34.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 63.05 110.889 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.77 69.85 1.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.897 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 158' ' ' ILE . 26.2 mm -51.52 129.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.0 111.105 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.48 163.12 16.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 52.12 111.093 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.856 HG22 HG22 ' A' ' 156' ' ' ILE . 53.5 t -140.89 104.99 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.125 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t0 51.49 53.23 13.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 53.14 110.875 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.15 10.09 55.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 72.24 112.43 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.2 tm-20 -142.57 96.52 6.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.635 0.731 . . . . 72.21 110.903 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.69 157.69 59.66 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 73.35 112.343 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.84 21.0 8.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.928 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.64 169.42 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 62.32 112.489 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.03 172.68 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 61.31 110.886 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.423 ' CG1' HG21 ' A' ' 138' ' ' ILE . 4.5 m -138.59 158.77 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.13 111.154 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.8 p -140.83 143.75 34.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 70.04 110.884 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -125.88 123.54 38.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 62.13 110.874 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -47.01 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.11 110.901 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 75.27 117.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 55.45 110.914 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -83.67 57.58 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.835 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -65.24 -26.33 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.134 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.1 -59.34 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 64.11 110.83 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -50.24 -57.73 7.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 62.43 110.88 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.767 ' HB ' HG22 ' A' ' 32' ' ' THR . 3.0 m -110.48 90.21 9.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.638 0.732 . . . . 71.31 111.142 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -19.33 36.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 2.24 . . . . 71.41 112.393 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -79.84 -58.25 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 63.43 110.873 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 29' ' ' VAL . 6.2 t -87.11 25.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 72.41 111.173 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -80.21 -42.25 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.42 111.093 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -76.85 -10.01 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.917 -179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' O ' HG21 ' A' ' 78' ' ' ILE . 29.7 t30 -42.41 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.35 110.891 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -81.42 -32.16 32.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 70.45 110.863 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.42 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 5.5 ttp85 -55.1 -39.98 69.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.839 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.52 -37.06 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 64.31 111.106 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.875 HD12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -91.74 33.46 1.03 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.896 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 t -151.2 -22.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' HG2' ' A' ' 163' ' ' GLN . 90.0 m -84.47 -42.14 15.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.52 111.163 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 151.28 -31.1 0.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 73.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 42' ' ' GLY . 8.4 tp10 -33.46 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 75.21 110.882 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 141.42 30.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.93 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.29 -30.49 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 73.12 112.458 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -47.07 -36.1 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 71.43 110.863 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.85 -146.37 3.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 53.0 112.486 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 136.45 43.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 75.25 110.915 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -162.62 -39.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 64.31 110.904 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.54 43.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 63.41 112.495 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.0 m -120.74 168.43 11.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 65.01 110.838 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -58.96 163.44 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 72.44 110.871 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.38 -70.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.89 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -163.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 71.22 110.823 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 51.82 35.74 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.899 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 156' ' ' ILE . 86.0 mt -90.11 135.38 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.146 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 tt -141.15 115.94 7.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 71.31 111.156 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.73 69.14 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.72 2.28 . . . . 54.32 112.326 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.54 69.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 52.22 112.495 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.61 -71.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 60.14 110.868 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -166.72 -159.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.23 110.851 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.45 -49.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.32 110.889 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 67.99 145.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.45 110.953 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 54.33 112.484 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.805 0.336 . . . . 62.41 110.899 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 110' ' ' SER . 1.9 p -85.11 144.21 28.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.851 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 39' ' ' LEU . 1.8 pp -58.45 -13.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.13 111.078 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -20.34 13.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 75.22 110.959 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.72 -131.76 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.33 112.514 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -95.42 -36.52 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.926 0.393 . . . . 72.25 110.916 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.04 157.07 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 62.24 110.891 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -147.97 138.98 23.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.889 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 54.24 110.939 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.51 158.65 20.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 74.4 110.847 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -54.51 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.62 145.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.894 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -104.83 57.32 0.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.4 mm -74.32 -24.61 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.05 111.127 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HB2' HG13 ' A' ' 128' ' ' VAL . 8.4 mt -95.17 133.81 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.32 110.929 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.22 78.33 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 60.54 110.919 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' LYS . 19.9 m-70 33.23 -140.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 72.12 110.837 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 168.29 -51.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 62.1 111.106 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 93' ' ' THR . . . 178.08 -153.65 13.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 63.04 112.507 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 109.59 2.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 72.51 112.341 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 132' ' ' VAL . . . 132.06 -22.85 4.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 62.21 112.491 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 128' ' ' VAL . 5.0 mm -50.82 141.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 73.55 111.097 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.551 HD11 ' HD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -106.97 132.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 71.44 110.918 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.34 33.84 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.855 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 43.71 -159.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.32 110.901 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -170.52 138.98 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 74.4 111.143 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.4 m-20 166.39 -74.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 64.31 110.91 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.828 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -171.79 122.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 21.21 111.101 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.824 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.43 -37.78 61.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 53.01 112.49 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.824 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.8 84.91 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 71.55 112.324 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.6 m120 43.52 62.09 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.908 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.828 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -154.13 57.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 52.01 111.156 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.99 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.921 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.29 173.42 37.13 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.681 -0.771 . . . . 64.44 112.46 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -120.09 13.35 12.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 64.25 110.852 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -63.88 -165.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.948 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 114' ' ' ILE . 36.9 t80 -155.64 93.62 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.894 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.46 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.888 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 2.6 mt -121.54 138.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.128 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 m -83.38 162.16 21.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.868 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -135.18 15.58 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 73.15 111.165 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.75 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 53.14 111.117 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 61.88 156.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.861 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 36.7 p -108.35 -141.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 64.53 111.125 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 119' ' ' THR . 0.3 OUTLIER 161.7 -51.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.41 110.864 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -7.05 53.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 72.02 110.933 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.71 10.16 16.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.893 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.87 127.5 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.886 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.56 32.62 61.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.02 112.483 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 -66.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 70.22 110.904 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -125.4 160.43 29.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.857 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.723 HG11 HG21 ' A' ' 32' ' ' THR . 57.5 t -61.06 117.89 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 62.01 111.129 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.8 p -101.82 138.36 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 70.4 111.131 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -178.94 111.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.894 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.7 134.96 6.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 70.32 112.42 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -155.2 147.9 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 72.14 110.877 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.642 HG11 HG21 ' A' ' 139' ' ' VAL . 16.2 m -53.17 125.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.142 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -89.01 -49.09 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 63.53 110.872 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 172.59 11.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.866 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.35 0.83 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 52.12 112.495 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.416 ' HE1' HG21 ' A' ' 132' ' ' VAL . 7.0 tpt -84.58 3.83 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 73.11 110.901 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -32.9 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.921 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 142' ' ' MET . 45.8 mm -65.28 -38.45 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 73.32 111.093 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 132' ' ' VAL . 4.2 t -91.57 13.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 73.35 111.088 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -128.57 -66.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.02 110.854 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.92 15.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 75.24 111.11 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 8.5 tmm? -48.49 -36.95 16.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 55.32 110.923 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -53.85 -31.63 50.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 75.05 110.848 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -16.9 40.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.886 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -82.08 4.89 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 73.3 110.858 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.05 -163.86 34.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 63.04 112.469 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -157.98 20.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 70.21 110.819 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 47.05 60.97 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.83 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 174.96 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.865 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.22 -56.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 65.55 112.505 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 132.06 39.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.867 0.365 . . . . 74.31 110.879 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 56' ' ' ILE . 40.2 p -111.67 144.85 40.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.54 111.157 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 50.24 110.895 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -159.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.03 110.931 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -132.73 137.79 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 55.03 110.91 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.856 HG22 HG22 ' A' ' 12' ' ' VAL . 9.3 pt -126.44 136.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.13 111.107 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 159.15 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 63.35 111.136 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 10' ' ' ILE . 46.7 mm -83.12 104.84 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.31 111.145 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.23 -56.58 7.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 62.03 111.099 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.13 175.39 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 51.51 110.867 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.1 p -174.45 154.41 2.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 73.53 110.825 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.27 -176.57 46.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.45 112.498 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -73.62 -38.34 65.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 74.54 110.901 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mm? 71.29 -65.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.934 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.918 179.913 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 75.43 110.883 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.83 156.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.147 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.88 126.88 57.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 71.42 110.852 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 145.41 57.19 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.701 2.267 . . . . 51.4 112.374 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -132.64 123.41 26.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 75.43 111.132 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 m -100.42 151.06 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.118 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.23 153.54 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 138.79 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.888 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.747 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -101.42 152.59 20.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.888 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 9' ' ' ASP . 5.9 mm -129.51 135.75 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.101 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 157.56 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 HD23 ' A' ' 17' ' ' LEU . 15.0 m -140.94 111.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 62.14 111.14 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.27 25.56 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 65.3 110.913 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.97 -14.2 65.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.498 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' HG2' HG23 ' A' ' 12' ' ' VAL . 2.3 pt-20 -93.69 140.85 23.2 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 54.55 110.9 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.83 68.51 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.633 2.222 . . . . 75.4 112.356 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.726 HD23 HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -118.47 -66.2 1.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 61.24 110.921 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.42 -148.19 5.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 73.5 112.459 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 127.41 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 73.13 110.901 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -100.28 144.89 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.11 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -107.25 94.71 5.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 74.03 110.831 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.555 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 12.4 m-85 -88.21 126.3 35.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.883 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -107.8 145.87 32.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 110.906 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -114.93 119.28 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 62.02 110.93 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 m-85 -82.75 81.66 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 72.1 110.909 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.38 -2.66 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.12 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -80.02 -42.13 24.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.858 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -97.11 -24.22 15.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.89 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -140.44 82.74 15.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.682 0.753 . . . . 73.34 111.086 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -49.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.634 2.223 . . . . 74.52 112.343 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -55.95 11.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.33 110.89 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' CD2' ' A' ' 129' ' ' PHE . 1.3 m -50.77 -48.97 59.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 74.11 111.116 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -27.94 64.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 45.14 111.107 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -61.42 -31.02 70.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.861 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.27 -71.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HA ' HD12 ' A' ' 39' ' ' LEU . 46.6 t80 -48.54 -30.43 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.86 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -57.23 -40.94 78.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.3 110.836 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.729 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -79.51 -21.52 45.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 60.15 111.107 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 36' ' ' PHE . 74.1 mt -76.46 -40.47 50.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.04 110.892 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -72.22 -46.51 55.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 51.25 110.828 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -82.51 8.17 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 70.41 111.166 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.55 40.79 11.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 75.34 112.459 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 5.1 mm-40 -54.96 -27.36 43.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 75.01 110.891 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.844 ' HD2' HG23 ' A' ' 78' ' ' ILE . 6.8 mtpm? -113.46 -6.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.33 110.903 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 40.8 32.88 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 71.2 112.451 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -121.1 -18.75 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 62.52 110.873 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.58 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 64.51 112.496 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -156.09 15.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.942 0.401 . . . . 73.25 110.911 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -60.76 127.63 32.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 71.33 110.897 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.93 67.6 1.85 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 35.12 112.519 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 m -164.29 -94.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.795 0.331 . . . . 71.52 110.822 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.7 p -172.3 -168.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 71.53 110.853 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -178.21 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 64.24 110.893 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -114.02 -50.17 2.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.01 110.84 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -179.07 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.847 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER 175.03 122.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.31 111.107 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.697 HD12 ' CE ' ' A' ' 61' ' ' MET . 30.7 mt -133.47 112.91 13.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 63.43 111.129 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 82.08 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 74.35 112.363 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.19 -32.81 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.13 112.525 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -59.41 1.71 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 72.13 110.845 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.697 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -178.8 -166.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 64.54 110.919 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.1 129.0 19.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 71.03 110.903 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 132.62 51.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.914 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 61.44 112.544 -179.995 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.796 0.332 . . . . 64.03 110.856 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.613 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -124.04 26.33 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.873 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.844 HG23 ' HD2' ' A' ' 44' ' ' LYS . 57.0 mt 87.56 -59.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.185 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.46 28.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 61.42 110.912 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.93 166.69 13.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 25.34 112.488 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.71 -84.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.387 . . . . 63.34 110.877 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -124.51 152.22 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 72.01 110.914 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -115.26 168.58 9.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -86.39 159.68 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 71.24 110.89 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.83 116.01 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 65.43 110.854 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 -47.87 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 75.02 110.908 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 p30 175.52 174.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 74.13 110.875 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.74 38.21 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.35 110.91 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.65 -26.73 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 50.34 111.121 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.45 118.51 30.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.924 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -110.6 167.75 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.04 110.871 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.26 96.21 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 64.43 110.918 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -96.01 4.21 52.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.34 111.17 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 -161.25 23.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 64.24 112.536 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -57.14 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.662 2.241 . . . . 62.32 112.407 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -66.25 142.61 43.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 55.11 112.526 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -161.85 118.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.12 111.141 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -103.18 121.11 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 60.21 110.937 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 p -150.84 -161.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.825 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 mtp -112.63 99.66 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.865 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -83.58 73.0 10.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 55.04 111.095 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.65 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.87 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -141.53 -92.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 33.02 111.107 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 169.8 -61.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.41 112.484 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 107' ' ' THR . 54.1 Cg_endo -69.73 90.46 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.717 2.278 . . . . 74.41 112.359 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 37.82 42.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.22 110.902 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.5 p -139.17 39.63 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 54.14 111.123 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -92.73 177.34 6.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.12 110.935 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.43 -117.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 23.23 112.477 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.511 ' HB2' HD11 ' A' ' 39' ' ' LEU . 94.3 p -107.16 -165.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 61.04 110.861 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.712 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 mt-30 73.07 63.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.935 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -61.87 -178.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.888 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.71 129.97 8.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.92 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.555 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 59.0 mt -84.75 109.28 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 45.11 111.101 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.444 ' C ' ' H ' ' A' ' 117' ' ' ALA . 84.3 m -51.61 -33.64 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.51 -33.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 44.13 111.171 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . -138.63 173.57 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.44 111.099 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -69.39 88.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.3 110.895 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 115' ' ' CYS . 31.6 p -92.17 65.09 4.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.33 111.135 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -5.55 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.35 110.847 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.9 -5.13 39.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.918 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 126' ' ' HIS . 98.4 mt -89.35 -48.48 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.929 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.8 -85.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 73.14 110.847 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -118.49 109.34 1.75 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.686 -0.769 . . . . 74.44 112.472 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.48 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 73.12 110.911 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.692 ' CD2' HD13 ' A' ' 122' ' ' LEU . 4.3 m-70 -119.97 134.04 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.51 110.828 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.55 97.21 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.32 111.146 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.27 131.63 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 54.33 111.126 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.62 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.8 p90 -136.33 4.51 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 65.02 110.877 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.82 -161.33 9.11 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 51.44 112.459 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 177.2 -169.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 75.54 110.925 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.439 HG23 ' HA3' ' A' ' 96' ' ' GLY . 55.9 t -103.83 88.8 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 55.03 111.104 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -40.78 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.888 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.08 163.96 3.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 70.4 110.894 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.26 11.58 44.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 61.15 112.479 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -30.76 9.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 63.32 110.861 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -51.06 -26.42 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.926 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mm -78.83 -45.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.24 111.11 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 143' ' ' GLU . 45.9 t -50.22 -44.03 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.54 111.126 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.35 -29.68 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 70.34 110.904 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.43 -31.91 60.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 111.063 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 10' ' ' ILE . 8.1 mtm -75.67 -35.07 60.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.888 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.424 ' OE1' HG12 ' A' ' 139' ' ' VAL . 4.6 pt-20 -84.13 31.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.85 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -126.42 -13.26 6.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.906 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.35 17.65 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.61 -156.58 30.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.22 112.513 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.76 -64.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 71.05 110.888 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.39 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 72.22 110.9 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.28 11.79 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 70.22 110.915 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.27 15.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 54.25 112.446 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 75.53 -58.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 41.4 110.9 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 154' ' ' LYS . 2.5 m 71.12 145.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.35 111.145 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.45 1.83 56.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 63.22 110.876 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.544 ' H ' HG22 ' A' ' 152' ' ' THR . 1.8 mttt -141.01 165.71 26.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.916 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -106.23 115.92 31.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 64.1 110.916 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 156' ' ' ILE . 1.3 mp -87.96 105.87 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 55.33 111.126 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -106.93 167.85 9.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 62.31 111.093 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 83.0 mt -121.33 138.52 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 64.22 111.155 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.59 -56.4 3.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.02 111.118 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -158.81 166.92 30.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 73.45 110.844 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -145.72 -163.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.892 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 141.4 -150.37 21.82 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 65.33 112.496 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -106.25 134.38 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 72.03 110.909 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -57.78 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.01 110.94 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 75.22 110.876 179.915 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.839 0.352 . . . . 73.15 110.916 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.98 156.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 61.33 111.103 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -87.66 148.31 43.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.723 . . . . 74.14 110.903 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB2' HD12 ' A' ' 24' ' ' LEU . 54.3 Cg_endo -69.68 122.73 9.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.271 . . . . 75.4 112.367 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.601 HG22 HD21 ' A' ' 164' ' ' LEU . 37.5 m -114.01 135.92 53.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 61.4 111.157 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 26.1 m -121.33 157.66 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 51.43 111.103 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 164' ' ' LEU . 28.1 p90 -122.55 160.34 25.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.11 110.823 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -137.54 136.52 37.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.74 112.03 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 62.23 110.858 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -85.26 126.12 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 53.15 111.155 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.98 165.15 14.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.42 111.09 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.19 93.84 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 60.53 111.111 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.78 35.08 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.882 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -13.17 67.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.54 112.522 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.76 130.28 33.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.652 0.739 . . . . 73.31 110.917 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 151.61 69.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 74.14 112.332 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.662 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -118.74 -67.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 64.44 110.924 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.92 -141.15 3.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 32.03 112.492 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -150.53 127.29 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 60.22 110.908 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.85 122.3 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.13 111.164 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 68.9 p -104.13 150.4 24.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 71.3 110.888 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.519 ' O ' HG23 ' A' ' 5' ' ' THR . 5.2 m-85 -118.25 178.17 4.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.939 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 127.0 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.14 110.875 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 4' ' ' PRO . 96.5 mt -95.43 106.21 18.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 71.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 90' ' ' LEU . 13.7 m-85 -72.68 75.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 73.44 110.888 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.91 -34.35 62.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 64.52 111.087 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 51.11 110.868 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.5 -65.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.872 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.44 93.07 30.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.588 0.709 . . . . 72.0 111.146 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -25.27 29.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.709 2.273 . . . . 44.12 112.364 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -78.74 -57.9 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.912 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 m -61.4 -26.08 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 61.44 111.177 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.58 -56.29 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.094 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.7 tt0 -62.66 -56.98 12.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.827 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.1 t-20 -28.07 -56.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.879 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.37 -40.57 62.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.929 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -48.3 -32.75 7.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 75.01 110.903 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.638 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -71.7 -43.25 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 53.21 111.094 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.938 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.2 m -76.3 -44.56 36.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 71.51 110.894 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -79.52 -0.55 33.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 74.23 111.162 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.87 78.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.787 -0.72 . . . . 54.31 112.451 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 10.3 pt-20 -99.21 0.86 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 73.15 110.9 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -127.51 -0.4 6.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.96 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 41.32 29.32 0.38 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 63.05 112.52 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.03 -33.15 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 73.44 110.859 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 74.11 112.44 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.88 149.68 21.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 63.55 110.929 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.9 119.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 74.2 110.93 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.87 22.18 76.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 73.43 112.479 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 p -94.17 -166.87 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.899 0.38 . . . . 74.45 110.881 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.3 m -99.2 -168.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.58 126.14 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 64.22 110.856 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -51.2 -62.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 74.23 110.863 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 150' ' ' GLY . 26.3 ttm180 -149.57 167.28 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 65.32 110.859 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 156' ' ' ILE . 58.7 mt -141.86 127.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 60.24 111.125 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.604 HD12 ' CE ' ' A' ' 61' ' ' MET . 46.6 mt -140.48 90.92 9.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.653 0.74 . . . . 73.44 111.115 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 108.65 2.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.238 . . . . 74.55 112.398 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.62 -45.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 55.25 112.424 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 -71.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 74.3 110.876 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.604 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.81 -174.74 4.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.871 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.97 117.87 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 54.2 110.891 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -136.58 166.39 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.92 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.79 -0.719 . . . . 42.44 112.51 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.773 0.32 . . . . 73.31 110.902 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 130.19 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.832 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 38' ' ' ALA . 2.3 pp -48.03 -34.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 71.21 111.122 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.58 19.87 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.901 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.79 -140.99 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 71.44 112.479 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -122.99 -25.69 4.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 75.3 110.903 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -168.69 160.23 10.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 63.43 110.918 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -132.95 162.97 30.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 65.02 110.896 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -80.34 156.97 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.886 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.97 105.09 13.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 72.54 110.883 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.72 -41.57 97.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.887 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 175.07 171.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.884 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -130.4 32.62 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.905 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -19.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 75.13 111.164 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.688 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -90.9 128.31 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.921 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -121.29 179.39 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.894 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -78.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.34 110.821 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 61.96 11.37 4.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.186 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.86 166.63 34.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.22 112.544 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 163.09 39.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 73.41 112.34 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.98 9.87 79.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 73.41 112.529 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -97.57 150.08 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 74.1 111.168 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 99' ' ' SER . 1.7 tt -107.53 142.92 36.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.971 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.655 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.78 132.23 47.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.869 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.8 mmt -64.25 -45.73 86.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 70.03 110.901 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 46.62 72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.127 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 13.0 p-10 -104.0 -163.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.891 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -51.41 -32.4 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.095 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 132.76 -54.46 0.78 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 72.13 112.499 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.6 Cg_endo -69.8 -100.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.32 112.291 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.2 91.46 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.924 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.7 p -150.22 28.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.162 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 0.9 OUTLIER 54.89 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.35 110.864 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.92 -90.75 0.22 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 73.32 112.45 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.7 t 76.54 33.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 73.42 110.86 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -90.0 -34.46 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.51 110.921 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 3.9 t80 79.92 65.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 63.45 110.86 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 99' ' ' SER . 27.5 t80 -96.74 95.11 7.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 63.3 110.843 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 19.4 mt -90.63 136.81 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 50.1 111.14 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.5 m -103.05 133.57 47.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.897 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.803 HG21 ' OE2' ' A' ' 143' ' ' GLU . 47.8 p -111.75 17.12 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.24 111.158 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.14 175.51 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 64.3 111.088 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.8 78.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 51.52 110.902 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.614 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 16.6 p -117.34 67.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 42.43 111.134 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.26 25.2 4.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.55 110.915 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.614 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -93.58 17.87 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.02 110.885 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -132.61 14.35 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 72.3 110.947 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.92 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.838 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.97 57.53 3.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 75.54 112.543 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -163.97 -52.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 64.3 110.915 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -104.83 133.41 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.4 110.839 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.32 101.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 53.21 111.126 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.02 138.68 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.138 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -161.82 25.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.889 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -118.65 -165.83 13.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 71.32 112.488 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 1.6 tttp 162.22 120.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 71.11 110.871 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.674 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.5 t -65.13 88.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 65.34 111.105 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -71.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 75.52 110.945 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.54 159.13 44.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 63.15 110.847 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.22 42.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 62.1 112.492 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.674 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.71 -30.41 13.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 65.1 110.885 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -53.62 -25.8 19.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 61.51 110.881 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.9 mm -90.23 -39.13 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.33 111.135 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.13 -23.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.4 111.17 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.05 -27.81 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 73.04 110.906 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.91 71.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 53.23 111.119 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.6 ptm -76.8 -15.61 59.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 50.22 110.919 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.803 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -88.99 27.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.31 110.856 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.11 0.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.04 110.902 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -121.08 6.86 10.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.33 110.913 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -117.28 45.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 63.34 112.476 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' GLY . 7.3 t 36.16 -147.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 64.02 110.834 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -139.59 7.92 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 65.31 110.905 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -16.96 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.851 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 55' ' ' ARG . . . 144.54 -57.5 0.53 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.13 112.46 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.89 133.88 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 54.21 110.904 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.6 p -113.19 138.68 49.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 63.33 111.18 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -24.16 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.836 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -165.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.916 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -126.65 125.03 41.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 70.25 110.901 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.574 HD13 HD11 ' A' ' 56' ' ' ILE . 3.5 mp -99.4 105.94 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.33 111.129 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.07 171.86 7.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 63.34 111.157 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.93 147.16 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 75.41 111.129 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.69 -59.05 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 65.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.81 167.41 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 62.42 110.889 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.1 m -145.61 -166.11 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.41 110.855 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.06 -177.73 16.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 62.31 112.546 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.1 pt20 -94.52 136.36 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.31 110.911 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.708 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.5 pt? -112.49 -34.81 5.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 61.35 110.917 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.87 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.856 0.36 . . . . 73.55 110.865 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -139.77 142.24 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 51.32 111.159 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -55.16 159.83 3.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 73.42 110.893 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 149.09 66.42 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.236 . . . . 74.12 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.71 49.84 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 74.51 111.107 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 6' ' ' VAL . 5.1 m -42.31 140.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 75.34 111.166 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 161' ' ' CYS . 0.1 OUTLIER -124.85 165.28 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 65.22 110.892 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -142.5 137.73 30.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 72.44 110.905 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -101.56 86.22 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.836 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.7 mm -57.71 145.06 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.147 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.04 155.87 46.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 41.52 111.09 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.4 t -134.99 109.51 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 54.1 111.086 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 t0 57.98 52.41 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 75.52 110.923 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.53 12.63 56.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.01 112.505 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.51 107.82 26.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.637 0.732 . . . . 65.11 110.899 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.5 Cg_endo -69.75 143.41 50.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 62.24 112.348 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 21.44 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.24 110.897 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.37 166.39 20.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.807 -0.711 . . . . 40.44 112.519 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -175.32 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 64.24 110.852 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 32.8 m -138.8 175.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.34 111.148 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 t -117.39 84.41 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.847 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -81.85 88.32 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 74.12 110.846 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.83 137.13 36.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 72.41 110.883 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.617 HD11 ' HD2' ' A' ' 36' ' ' PHE . 46.2 mt -111.82 144.99 40.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 29' ' ' VAL . 14.9 m-85 -91.59 67.24 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.24 110.872 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.66 -10.57 8.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.14 111.106 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -92.23 -35.08 14.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 42.52 110.864 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -86.92 -30.34 21.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 73.23 110.917 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.594 HG21 ' CG ' ' A' ' 129' ' ' PHE . 4.5 m -128.52 69.0 78.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.605 0.717 . . . . 73.11 111.14 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 60.08 1.62 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.696 2.264 . . . . 73.44 112.385 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.81 -63.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 71.33 110.896 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.93 -55.72 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 62.5 111.086 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . . . -79.63 -12.99 59.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.22 111.051 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.29 -35.74 81.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 62.31 110.875 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.26 -31.48 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.883 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' HD2' HD11 ' A' ' 24' ' ' LEU . 1.1 t80 -50.9 -27.28 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.876 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -62.26 -30.91 71.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 73.55 110.901 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.21 -24.81 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 74.53 111.125 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -99.58 26.61 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 72.45 110.887 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.93 -21.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.846 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -89.79 -30.64 17.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 35.24 111.135 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 135.32 -20.42 3.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 73.14 112.475 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -32.6 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 72.24 110.876 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 153.82 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.86 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.16 -33.01 0.43 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.466 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -55.05 -28.56 53.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 74.24 110.897 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -77.48 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 63.41 112.506 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 124.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.41 110.915 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -93.71 -77.45 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 71.32 110.89 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.6 -54.1 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 43.12 112.441 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.7 -164.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 72.13 110.841 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.695 ' HB3' HG22 ' A' ' 157' ' ' THR . 9.8 p -157.0 134.45 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 65.33 110.946 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CE1' HD11 ' A' ' 158' ' ' ILE . 12.7 m-85 -94.77 123.76 38.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 72.02 110.901 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.94 32.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 65.53 110.84 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -133.02 27.17 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.862 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.8 138.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.92 111.13 17.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.613 0.721 . . . . 72.24 111.16 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 90.33 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 72.53 112.366 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.28 4.86 13.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 52.11 112.455 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.72 -66.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 72.13 110.868 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.15 -166.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 63.11 110.867 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.1 t -152.89 108.51 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.1 110.886 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -97.42 163.6 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 54.13 110.919 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 60.54 112.491 -179.944 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.795 0.331 . . . . 61.15 110.896 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m -79.52 -171.81 2.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 52.25 110.881 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 38' ' ' ALA . 16.8 pt -92.85 -40.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.34 111.116 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -86.76 85.12 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 70.12 110.887 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.36 -107.77 3.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 63.34 112.44 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -91.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 74.1 110.869 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 150.58 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 63.15 110.855 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 154.41 39.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.853 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 106' ' ' ASN . 20.7 pm0 -62.87 160.5 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.23 110.853 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.7 -169.47 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 51.41 110.907 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -132.96 -59.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 75.1 110.877 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -171.2 149.86 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 71.43 110.851 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.3 64.41 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.902 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' ILE . 10.1 mt -78.16 2.31 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 72.53 111.147 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.74 132.65 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 74.22 110.942 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -110.06 123.34 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.88 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.19 91.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.877 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.9 p -129.58 21.9 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 61.21 111.183 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.26 167.48 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 71.13 112.445 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -44.94 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 54.22 112.308 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.79 40.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.26 141.7 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.44 111.162 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 99' ' ' SER . 4.2 tt -89.57 130.46 35.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.872 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 98' ' ' LEU . 1.7 t -128.41 -147.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.845 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tpt -152.43 143.14 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.02 110.868 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -117.73 149.16 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 54.12 111.121 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 161.75 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.881 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -55.63 -36.87 67.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 55.25 111.106 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.7 -65.15 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 44.05 112.521 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 106.86 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.717 2.278 . . . . 71.42 112.321 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 84' ' ' GLU . 2.2 p-10 42.76 56.87 3.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.908 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.99 33.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.156 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -74.29 -0.71 17.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.918 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.9 119.63 19.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 24.24 112.484 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 8.9 t 54.86 -166.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 71.52 110.852 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' SER . 3.9 mm-40 64.04 118.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 75.54 110.905 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.4 156.87 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.2 110.855 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.76 154.6 36.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.882 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.17 105.5 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 75.35 111.153 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.24 146.38 53.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.86 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 p -96.14 19.99 10.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.35 111.111 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.24 177.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 75.54 111.138 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 131.63 51.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 62.02 110.902 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.16 41.05 3.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 71.13 111.145 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -49.02 -25.43 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 64.2 110.916 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -58.21 -32.62 68.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 64.41 110.952 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 mt -118.5 61.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 61.41 110.913 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -126.63 56.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.844 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 53.31 112.506 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 63.31 110.901 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -105.09 -16.35 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.843 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t 71.84 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.53 111.116 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 p -79.22 153.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.1 111.097 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 29' ' ' VAL . 44.1 p90 -176.91 129.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.34 110.836 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.39 149.21 12.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 63.25 112.513 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -162.6 162.96 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 73.13 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 132' ' ' VAL . 15.0 m -83.76 107.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.153 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -41.03 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 44.34 110.871 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 178.9 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.22 110.896 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.67 74.58 0.32 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 74.41 112.5 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -84.35 -18.39 36.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 43.15 110.87 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.94 -36.83 24.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 63.33 110.913 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 37.9 mm -40.39 -45.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.52 111.109 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.9 t -89.09 -50.66 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.3 111.124 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -49.33 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 70.5 110.88 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.86 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 32.22 111.106 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.593 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.5 ttm -50.84 -45.71 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 63.22 110.874 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -52.07 -23.74 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.898 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -63.77 -26.29 68.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.852 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.28 8.28 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.945 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.25 -146.25 20.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 63.12 112.451 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.01 161.36 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 62.23 110.835 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -50.76 -56.66 11.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 70.3 110.871 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -6.74 59.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.863 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.46 -150.37 16.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 54.14 112.476 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mttp 61.43 104.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 74.31 110.871 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.1 p -82.18 155.84 24.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 62.45 111.155 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -2.99 58.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.44 110.842 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -138.83 -175.43 4.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.905 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.68 104.93 13.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.904 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.593 HD13 ' SD ' ' A' ' 142' ' ' MET . 8.3 mt -95.34 127.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 63.31 111.122 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 52' ' ' CYS . 29.1 p -139.72 159.16 42.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.119 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.5 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -84.86 105.22 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.112 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -61.59 -56.57 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.104 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.0 177.16 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 54.32 110.831 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 17.0 p -176.88 155.74 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.42 110.891 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 -169.48 40.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.747 . . . . 72.4 112.5 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.27 126.26 35.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 72.41 110.891 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.81 138.26 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.897 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.853 179.935 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 64.3 110.878 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.61 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 62.34 111.119 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -95.82 151.76 38.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 75.4 110.895 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 134.69 28.55 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.65 2.233 . . . . 71.42 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 22' ' ' PHE . 6.9 m -122.16 140.44 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.119 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 3.2 m -125.19 159.46 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.01 111.104 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -133.44 155.08 50.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.873 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 158' ' ' ILE . 13.7 m-85 -135.2 134.36 40.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.866 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -90.66 108.91 20.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.828 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.05 119.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 45.33 111.133 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.93 167.58 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 61.45 111.099 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.61 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -150.68 91.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.121 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.1 32.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.816 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.19 -12.24 69.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 42.43 112.478 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.81 130.35 25.48 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.667 0.746 . . . . 62.2 110.891 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 152.95 69.43 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.683 2.255 . . . . 72.21 112.336 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.7 tp -114.52 -65.42 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.929 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.74 -178.01 36.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 33.04 112.464 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.7 125.98 54.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 72.25 110.832 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.52 143.97 38.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 74.43 111.12 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 23.3 p -129.99 155.26 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.888 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -125.7 165.57 18.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.913 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -120.97 124.69 45.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.888 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 129' ' ' PHE . 8.6 mt -93.42 126.82 38.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.936 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -83.07 82.31 8.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.917 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -4.59 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 60.32 111.087 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.23 -34.11 16.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 54.5 110.858 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.4 mttm -91.44 -28.48 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.917 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.55 79.31 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.625 0.726 . . . . 65.4 111.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.14 13.43 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 70.22 112.294 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -45.72 9.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 72.25 110.874 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -52.4 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 65.35 111.161 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.11 -77.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.113 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 29.7 tt0 -48.34 -66.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.876 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 19.8 t30 -28.23 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 65.54 110.916 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' GLU . 85.3 t80 -85.53 -42.0 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.87 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -54.52 -31.24 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.877 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.641 ' HB1' ' HE2' ' A' ' 44' ' ' LYS . . . -76.01 -43.57 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.23 111.11 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 39' ' ' LEU . 3.2 tm? -67.11 -39.2 86.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 73.24 110.905 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -35.26 76.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.857 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.04 -12.74 61.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 73.42 111.165 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 4.13 63.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.788 -0.72 . . . . 62.21 112.446 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.96 -1.65 36.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 61.54 110.933 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 2.1 mmtm -93.39 37.57 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 65.31 110.916 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.09 -45.46 3.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 40.33 112.502 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -155.89 -166.38 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 74.45 110.854 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 -107.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 65.15 112.511 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -162.84 123.49 2.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.414 . . . . 53.5 110.919 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -106.9 -26.74 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 73.41 110.909 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.94 -62.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.741 . . . . 74.51 112.489 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.65 -169.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.34 110.869 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 p -166.11 111.21 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 41.4 110.876 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -73.4 123.98 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.53 110.892 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -120.32 17.99 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.867 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -136.84 119.09 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HD13 ' A' ' 156' ' ' ILE . 88.0 mt -143.53 137.28 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.075 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 90.3 mt -146.8 95.38 4.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.666 0.746 . . . . 73.35 111.111 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.72 96.34 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 72.23 112.347 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.69 -35.17 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.47 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.32 -64.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 71.43 110.849 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.451 ' HE1' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -158.39 -169.5 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 70.04 110.895 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.32 -75.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 65.33 110.858 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 64.1 tt0 63.32 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.926 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 62.31 112.479 179.999 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.847 0.356 . . . . 74.32 110.842 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 t -81.69 160.78 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 43.35 110.874 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' A' ' 44' ' ' LYS . 2.0 pp -88.35 -32.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 72.44 111.126 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 78' ' ' ILE . 30.4 m-85 -85.01 -6.29 59.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 75.24 110.9 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -121.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 63.11 112.512 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -112.34 -83.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 74.2 110.927 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.92 168.05 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.887 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.0 165.52 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 61.12 110.898 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -62.45 163.32 8.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 62.32 110.846 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 127' ' ' VAL . 25.6 t0 -80.33 161.41 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 62.21 110.886 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 -50.65 3.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.89 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p30 178.74 157.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.898 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.73 66.73 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.859 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.644 ' C ' HD22 ' A' ' 90' ' ' LEU . 14.0 mt -83.91 7.78 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.156 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.644 HD22 ' C ' ' A' ' 89' ' ' ILE . 4.1 mm? -127.29 127.53 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 64.31 110.936 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.28 133.28 56.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 65.34 110.904 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.464 ' HA ' HG21 ' A' ' 97' ' ' ILE . 3.0 m-70 -59.05 91.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.0 110.874 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.2 p -118.95 19.4 13.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 74.3 111.197 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.96 26.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.525 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -2.93 10.99 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.43 112.331 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.41 29.01 6.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.42 112.501 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 92' ' ' HIS . 20.8 mm -90.66 127.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 70.42 111.165 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.1 tt -90.3 124.13 34.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.874 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 42.9 t -115.5 160.73 19.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 71.23 110.854 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.76 115.24 29.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.874 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.97 150.53 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 62.13 111.11 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.465 ' ND2' ' HA2' ' A' ' 109' ' ' GLY . 0.4 OUTLIER 173.72 -163.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.21 110.884 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -62.06 -12.68 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 41.33 111.083 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 121.69 -135.02 10.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 72.24 112.47 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 107' ' ' THR . 54.2 Cg_endo -69.71 147.52 63.35 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.735 2.29 . . . . 73.15 112.337 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.93 23.07 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.903 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.661 HG21 ' HB3' ' A' ' 103' ' ' ALA . 7.7 p -141.23 33.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.22 111.2 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER 11.49 -87.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.913 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 107.16 140.15 9.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 73.31 112.486 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -97.86 -33.33 11.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.334 . . . . 75.13 110.816 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -63.43 152.46 38.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.94 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 99' ' ' SER . 17.1 p90 -145.08 146.55 31.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 71.54 110.891 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -127.84 114.86 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 63.24 110.889 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.6 mt -67.02 101.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 52.13 111.149 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 54.7 m -57.85 126.98 29.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 72.51 110.901 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -88.19 -31.25 19.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 64.22 111.105 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 119' ' ' THR . . . -120.9 155.02 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.24 111.111 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -57.01 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.4 110.888 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.8 p -117.6 69.52 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 54.14 111.134 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.52 21.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.867 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.682 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.3 p90 -101.14 15.19 29.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 73.35 110.941 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 13.3 mt -129.73 17.05 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.34 110.937 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -63.15 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.54 110.862 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -46.75 -28.78 3.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 54.5 112.505 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -74.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 75.51 110.925 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -86.67 141.25 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.55 110.851 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.667 HG21 ' OD1' ' A' ' 85' ' ' ASP . 94.9 t -103.58 129.73 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 43.31 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -104.31 137.67 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.147 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 31.2 p90 -129.07 -32.87 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.902 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -109.92 161.05 13.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 75.12 112.495 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -155.57 148.68 24.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.349 . . . . 73.31 110.919 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.45 126.49 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 72.54 111.153 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -68.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.874 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 143.71 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 61.33 110.844 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.72 9.21 21.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 63.12 112.514 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.0 ttm -49.62 -28.03 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 62.3 110.884 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -50.63 -27.25 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.89 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.85 -35.72 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 73.54 111.113 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.78 -23.41 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.32 111.144 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.01 -25.14 32.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.906 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.29 57.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 62.01 111.12 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.8 ptm -76.97 -30.37 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 65.41 110.907 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -89.85 33.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.856 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 17.2 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.25 110.865 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -97.73 33.3 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 72.4 110.87 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.601 ' O ' ' C ' ' A' ' 147' ' ' SER . . . 64.88 -92.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 75.04 112.483 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.601 ' C ' ' O ' ' A' ' 146' ' ' GLY . 88.7 p 17.86 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 74.01 110.874 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -91.51 -24.62 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.52 110.888 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -105.01 -7.53 19.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.34 110.931 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.95 -39.81 2.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.759 . . . . 41.22 112.453 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -64.5 101.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 71.2 110.891 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 147' ' ' SER . 1.9 m -90.56 154.15 19.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 50.1 111.162 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.73 -17.76 63.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 74.4 110.848 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.26 -175.87 4.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.866 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -120.05 144.17 47.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.899 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 56' ' ' ILE . 2.5 mp -110.41 134.51 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.126 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -129.33 166.86 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.136 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 8' ' ' PHE . 30.9 mm -112.06 106.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 61.51 111.128 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -54.2 -57.23 11.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 51.3 111.13 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -160.26 174.63 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.859 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 11.4 p -175.35 169.6 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.894 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.02 -160.52 28.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 71.24 112.493 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -72.25 109.36 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.13 110.883 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.66 -48.33 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.52 110.914 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 70.42 110.878 179.943 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.351 . . . . 62.33 110.868 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.65 153.82 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 62.25 111.158 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -50.44 153.31 2.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.595 0.712 . . . . 75.11 110.943 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 141.07 44.29 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 54.31 112.332 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.728 HG22 HD21 ' A' ' 164' ' ' LEU . 49.9 m -126.29 101.55 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.54 111.135 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 24' ' ' LEU . 5.8 m -96.42 149.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.123 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.95 162.72 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.889 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.01 133.51 21.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.886 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.25 108.52 16.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.02 110.891 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 142' ' ' MET . 15.7 mm -87.48 139.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.34 111.161 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -120.7 155.87 32.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 60.31 111.123 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.0 96.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 52.41 111.125 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.87 56.04 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.884 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.75 11.63 54.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 72.14 112.446 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -142.44 92.17 7.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 74.41 110.886 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.17 64.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 73.11 112.358 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -115.61 23.93 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.866 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.66 -161.74 21.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 44.45 112.463 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 170.37 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 74.33 110.868 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG13 HG21 ' A' ' 138' ' ' ILE . 33.2 m -132.15 172.47 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.147 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -127.89 90.69 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.41 110.87 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -81.73 72.98 8.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.54 110.94 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.92 143.53 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.851 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 6' ' ' VAL . 16.5 mt -105.53 119.81 40.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 52.52 110.93 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -76.62 57.23 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.856 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -31.3 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.51 111.103 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.87 -63.14 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 74.21 110.893 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.29 -74.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.93 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 129' ' ' PHE . 2.4 m -85.15 110.77 31.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 63.3 111.107 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 74.12 112.344 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -57.67 -47.02 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.874 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -45.77 -41.9 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 61.13 111.142 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' CB ' HG23 ' A' ' 29' ' ' VAL . . . -107.5 21.72 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.086 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -93.16 -28.37 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.856 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HA ' HD13 ' A' ' 78' ' ' ILE . 26.8 p-10 -85.19 -41.08 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 65.51 110.88 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -32.75 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 61.2 110.905 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.96 -39.55 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.85 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.46 -17.97 26.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.13 111.164 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 78' ' ' ILE . 50.4 mt -85.02 9.98 13.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 71.23 110.895 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.4 m -126.35 -3.42 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.879 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.6 p -124.82 -4.98 7.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.24 111.143 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.15 71.85 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 73.11 112.485 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.27 34.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 73.23 110.861 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.6 -42.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.22 110.863 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 46' ' ' PHE . . . -137.67 30.53 2.58 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 75.03 112.44 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' CG ' ' C ' ' A' ' 45' ' ' GLY . 2.1 p90 40.11 63.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 74.1 110.879 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.94 21.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 70.22 112.497 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.17 -179.81 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.393 . . . . 62.12 110.885 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -166.24 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 64.24 110.875 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.75 44.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.507 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.15 155.17 32.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 61.13 110.826 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.67 127.52 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 74.11 110.898 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -148.61 122.08 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 53.22 110.87 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -140.81 73.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.13 110.869 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -121.18 21.86 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.88 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 ' HA ' ' A' ' 143' ' ' GLU . 4.7 mt -59.64 136.35 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.0 111.139 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.11 113.05 32.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 65.43 111.193 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 86.73 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 73.33 112.362 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.64 2.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 75.11 112.501 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.27 -72.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 73.1 110.917 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -178.22 -158.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.871 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.2 t -143.24 135.9 27.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.41 110.869 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 153.42 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.927 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 73.52 112.505 -179.982 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.754 0.312 . . . . 74.45 110.873 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.06 120.38 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 51.11 110.85 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.2 pt -49.18 -37.01 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 73.2 111.159 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.22 36.92 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.904 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.51 15.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 75.01 112.458 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -122.4 -24.15 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 73.34 110.895 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -169.36 147.1 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.903 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.94 158.16 34.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 61.23 110.943 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.92 162.52 28.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.1 110.926 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.63 108.39 13.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.886 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.52 -51.73 47.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.882 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t30 175.27 175.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.881 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.45 40.81 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.871 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.52 -27.12 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.115 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.59 133.62 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 55.32 110.913 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -114.19 -175.69 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 72.33 110.942 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.492 ' C ' HG23 ' A' ' 93' ' ' THR . 32.1 m170 -99.49 -86.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 73.23 110.868 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 67.09 6.32 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 42.54 111.104 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.37 159.48 20.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 51.04 112.483 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.429 ' CB ' ' HA ' ' A' ' 116' ' ' THR . 53.6 Cg_endo -69.71 169.69 18.26 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 75.41 112.354 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.26 8.85 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.743 . . . . 31.34 112.482 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 98' ' ' LEU . 10.6 mm -69.9 158.28 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 64.21 111.121 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 112' ' ' PHE . 10.9 mt -124.36 162.72 23.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.934 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -160.49 43.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.4 110.883 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 4.2 mmt 48.65 -166.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.883 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -179.61 78.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 54.2 111.105 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.521 ' HB3' HG22 ' A' ' 107' ' ' THR . 0.7 OUTLIER -123.34 -76.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.91 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -137.07 -41.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 55.22 111.127 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -75.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 73.21 112.51 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 102.2 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 54.34 112.312 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.59 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 73.41 110.851 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.0 m -154.55 59.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.119 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.578 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -80.37 -0.68 37.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 65.3 110.901 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 21.0 -136.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.758 . . . . 75.21 112.518 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 m -153.91 65.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.331 . . . . 72.31 110.87 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.738 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.0 tp-100 -93.71 -45.41 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 74.21 110.91 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.569 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 67.63 130.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 75.34 110.864 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -153.41 134.76 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.35 110.885 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.55 143.99 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 74.03 111.155 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 p -115.55 161.23 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 72.54 110.906 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 95' ' ' PRO . 3.2 m -127.91 30.63 5.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.34 111.088 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.24 22.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.23 111.11 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.12 134.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.916 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 68.1 p -131.45 41.47 3.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 71.13 111.122 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -48.97 -26.42 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 61.21 110.863 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -60.35 -36.77 78.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.912 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.27 31.99 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.934 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -114.63 41.92 2.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.897 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.15 30.9 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.501 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.34 -39.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 70.33 110.936 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -97.33 156.88 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.12 110.879 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.53 99.18 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.32 111.109 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 98' ' ' LEU . 91.9 t -63.64 124.93 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 70.21 111.156 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.664 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.4 t80 -155.43 81.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.91 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.56 166.5 39.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 43.35 112.476 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp 177.97 153.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 72.55 110.911 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 132' ' ' VAL . 2.9 p -105.39 87.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.2 111.151 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -51.35 -46.24 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 63.23 110.917 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 174.22 11.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.866 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.8 77.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 52.33 112.491 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -24.36 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.758 0.313 . . . . 70.24 110.9 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -76.53 -34.65 58.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.11 110.854 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.656 HG21 HG13 ' A' ' 20' ' ' VAL . 48.0 mm -45.4 -39.8 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.35 111.12 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.4 -52.23 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 71.3 111.149 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -49.39 -67.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.53 110.889 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -51.62 -54.42 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.51 111.099 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.701 ' SD ' HD13 ' A' ' 156' ' ' ILE . 11.6 ttm -51.12 -41.28 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 75.41 110.914 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.42 ' HA ' HG21 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -53.95 -23.22 12.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 72.41 110.89 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -65.55 -25.94 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.847 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -87.42 9.0 22.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 73.12 110.838 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.14 -171.14 40.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 62.01 112.501 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -158.5 149.39 20.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 42.43 110.832 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -49.89 -56.09 11.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.876 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -22.23 57.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.879 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.96 -36.2 3.94 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 73.03 112.479 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -50.55 160.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 55.31 110.866 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.9 p -121.22 156.98 31.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 62.54 111.13 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -26.47 62.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 45.15 110.879 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.29 -168.19 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 71.52 110.888 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -113.43 96.82 6.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.886 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.701 HD13 ' SD ' ' A' ' 142' ' ' MET . 19.6 mt -90.61 101.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.114 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 7.2 t -117.63 164.87 14.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.4 111.141 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.4 mt -88.53 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.144 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.62 -64.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.34 111.113 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -135.1 166.33 23.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.856 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -153.72 -174.84 5.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.834 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.9 -147.77 18.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.462 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.6 pt20 -126.61 136.73 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.875 0.369 . . . . 73.35 110.901 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.728 HD21 HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -80.17 -35.39 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 63.51 110.969 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 70.34 110.893 179.905 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.321 . . . . 53.23 110.879 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.1 t -109.95 134.48 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 51.25 111.178 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -59.28 159.14 16.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.603 0.716 . . . . 71.52 110.918 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 154.0 68.45 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 71.23 112.35 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 m -122.14 44.64 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 75.01 111.145 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' CG1' HD12 ' A' ' 24' ' ' LEU . 3.8 m -47.83 140.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 61.1 111.141 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -136.57 175.87 9.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.13 110.892 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -148.64 142.59 25.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 73.54 110.902 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' HD13 ' A' ' 158' ' ' ILE . 5.9 t70 -96.29 131.8 42.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 63.23 110.826 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.8 137.34 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 53.15 111.106 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.76 167.07 22.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 73.24 111.092 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -143.92 95.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.03 111.121 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 71.14 33.49 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.901 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.27 70.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 71.41 112.549 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -93.17 131.7 32.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.691 0.757 . . . . 74.32 110.849 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 147.33 62.18 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 64.14 112.323 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 12' ' ' VAL . 1.3 tp -113.37 -67.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 65.42 110.88 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.21 -146.66 4.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.5 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.27 125.86 12.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 72.51 110.864 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG1' HG13 ' A' ' 132' ' ' VAL . 22.8 t -116.45 135.24 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.158 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -88.76 100.61 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.841 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -87.81 73.6 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 72.4 110.852 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -51.47 151.78 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.878 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 ' CG1' ' A' ' 6' ' ' VAL . 5.4 mt -117.41 123.75 47.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 74.3 110.932 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.74 70.77 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 70.23 110.864 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.95 -8.68 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 73.14 111.084 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.23 -56.13 4.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 71.11 110.894 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -54.91 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 73.12 110.894 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.53 83.24 53.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.613 0.721 . . . . 72.14 111.103 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 63.11 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.23 . . . . 74.44 112.359 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -159.77 -67.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 62.2 110.914 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 m -53.33 -48.06 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 75.31 111.154 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.02 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 53.14 111.132 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -55.63 -28.27 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.23 110.904 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -54.2 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 60.23 110.922 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.09 -36.52 81.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 51.4 110.862 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -27.23 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 70.43 110.871 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.41 -35.03 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.31 111.133 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.3 tt -83.84 5.22 25.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.898 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -105.31 -13.99 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.869 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -116.59 8.23 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 71.11 111.159 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.03 21.72 39.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 71.24 112.487 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -34.31 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 73.32 110.893 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -13.35 62.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 62.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.62 -12.48 59.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 71.34 112.5 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 47' ' ' GLY . 19.5 m-85 -92.34 -28.08 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 64.22 110.842 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -35.51 125.89 0.74 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 55.22 112.472 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -100.48 33.13 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 75.51 110.979 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 146.74 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 53.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 157' ' ' THR . . . 119.05 -95.91 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 44.35 112.476 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.568 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -101.96 121.72 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 70.22 110.862 -179.707 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.0 p -174.21 -166.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 61.21 110.882 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 63.51 86.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 62.53 110.902 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -116.47 17.28 15.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.885 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -134.37 151.68 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 70.21 110.862 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 179.54 131.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.52 111.17 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 61' ' ' MET . 1.2 pt -138.06 109.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.674 0.75 . . . . 73.33 111.146 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.27 . . . . 54.34 112.333 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.96 -31.6 1.73 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.489 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CB ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.47 -64.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 73.25 110.863 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.433 ' HG2' HD11 ' A' ' 57' ' ' ILE . 3.6 ptt? -158.42 -156.32 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.908 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.2 m -131.44 -44.04 1.02 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 54.44 110.872 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.09 119.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 65.13 110.947 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 50.11 112.487 -179.973 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 74.1 110.882 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -128.38 15.27 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 65.32 110.888 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 82.75 -19.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 53.42 111.11 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -20.29 15.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.934 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.41 -88.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.31 112.462 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -138.69 -54.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 75.5 110.898 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 9.2 pttp -168.81 145.17 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.895 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.48 144.55 49.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.3 110.882 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.73 170.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 65.35 110.857 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.2 146.45 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.85 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -58.79 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 62.41 110.846 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 178.75 156.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.889 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -112.55 60.14 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.868 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.7 mm -78.51 -20.52 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.45 111.181 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -96.51 99.06 10.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 72.3 110.889 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.24 114.33 26.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 63.11 110.926 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.633 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -51.16 -95.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 73.3 110.83 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 93' ' ' THR . 0.5 OUTLIER 66.72 5.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.31 111.167 -179.86 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.84 153.27 24.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 50.13 112.49 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.72 63.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.264 . . . . 73.42 112.326 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 94.64 -17.95 58.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 51.02 112.482 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.633 HG21 ' HB3' ' A' ' 92' ' ' HIS . 12.7 mm -64.45 140.91 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 65.43 111.167 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.8 tt -90.79 126.67 36.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.894 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -122.72 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 mtm -69.17 175.29 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 52.55 110.878 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -166.92 147.38 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.31 111.103 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.6 m-20 163.5 -64.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 71.15 110.934 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.75 -106.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 74.32 111.103 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.606 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -156.59 -60.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 75.13 112.479 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.79 -104.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.262 . . . . 72.33 112.297 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -121.0 72.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 55.45 110.852 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -144.69 10.42 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.44 111.115 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 102' ' ' ASN . 9.4 p30 -99.86 179.51 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 52.32 110.832 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.17 24.53 2.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 75.44 112.473 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.49 -52.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 64.21 110.906 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -84.14 155.81 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 71.04 110.9 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -149.87 171.63 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.872 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -159.28 166.48 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 63.12 110.886 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 116' ' ' THR . 37.5 mt -121.4 114.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.51 111.12 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.8 p -65.15 -28.03 69.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 60.41 110.849 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 114' ' ' ILE . 1.4 p 49.31 22.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 71.42 111.141 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.4 176.14 6.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 71.21 111.077 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 104.63 12.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 65.31 110.874 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.795 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 66.2 p -132.45 63.8 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.21 111.16 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -90.13 22.63 3.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 62.52 110.881 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.795 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.5 OUTLIER -93.33 5.91 49.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.933 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 4.4 mt -97.59 -4.96 36.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.14 68.42 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.21 110.91 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.57 37.36 0.83 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.79 -0.719 . . . . 70.14 112.454 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 3.9 mmtp -55.46 -34.33 64.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 71.45 110.899 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -110.38 156.2 21.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.1 110.827 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.07 85.07 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.22 111.105 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 90' ' ' LEU . 17.5 t -65.25 118.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.03 111.109 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 17.96 4.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 74.41 110.869 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.74 178.2 28.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.503 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 170.09 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 74.05 110.934 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.64 HG13 ' CG1' ' A' ' 20' ' ' VAL . 94.4 t -97.75 84.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 74.22 111.11 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -62.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.14 110.908 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -138.02 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.829 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.29 10.46 68.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.21 112.467 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.64 27.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 74.31 110.856 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.55 -26.92 14.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 62.42 110.886 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.4 mm -80.02 -41.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 71.53 111.124 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 116' ' ' THR . 38.1 t -50.17 -45.19 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.115 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -32.77 67.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 52.21 110.85 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.77 92.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 64.13 111.079 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.1 mtm -71.62 -26.09 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 72.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.5 14.18 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 70.13 110.883 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -16.26 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.21 110.89 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -104.24 -8.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.864 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.53 -150.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 73.42 112.447 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -169.41 152.87 4.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 63.4 110.857 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -73.24 69.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 65.2 110.851 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 177.51 -26.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.86 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.4 -48.14 0.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 41.53 112.497 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.84 160.9 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 62.22 110.895 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -137.71 171.4 14.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.41 111.119 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 p -86.55 -4.01 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.842 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -137.85 -165.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 55.14 110.888 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.33 125.31 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 54.15 110.903 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.04 131.18 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.41 111.148 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -126.67 163.85 22.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 43.04 111.152 179.993 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 9' ' ' ASP . 41.8 mm -120.97 94.47 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.132 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.55 -48.63 76.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.4 111.1 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.64 -178.48 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.877 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 161' ' ' CYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 6.0 p -176.55 157.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.89 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.48 176.67 45.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 53.31 112.488 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.6 mt-30 -69.29 -36.71 77.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.813 0.339 . . . . 64.02 110.854 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.3 mm? 71.9 -21.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.898 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 163' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.846 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.815 0.341 . . . . 72.11 110.9 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.04 154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 52.41 111.131 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -89.79 151.32 45.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 75.5 110.826 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.81 109.27 2.28 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.671 2.247 . . . . 73.12 112.344 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.664 HG22 HD21 ' A' ' 164' ' ' LEU . 6.4 m -113.42 141.46 47.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 61.12 111.121 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 163' ' ' GLN . 6.4 m -126.9 148.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 70.41 111.141 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.794 ' HB3' HD22 ' A' ' 164' ' ' LEU . 11.5 p90 -118.69 147.79 43.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.908 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -129.06 131.41 47.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 63.25 110.895 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -97.12 75.54 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 61.12 110.892 179.991 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mm -49.74 141.41 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.146 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.92 151.49 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 70.23 111.111 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.6 t -134.19 108.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 72.2 111.181 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t0 51.47 52.25 15.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.919 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.22 50.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 63.01 112.463 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mm-40 -139.29 94.57 9.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.651 0.738 . . . . 73.13 110.878 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.83 157.75 59.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.251 . . . . 53.03 112.309 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -126.37 22.88 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 44.3 110.955 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.85 160.4 9.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 65.41 112.495 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 -179.68 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 64.33 110.917 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 138' ' ' ILE . 17.6 m -146.61 168.99 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 71.43 111.111 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -145.64 144.27 30.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.823 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 5' ' ' THR . 2.0 m-85 -127.68 138.62 52.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.904 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -111.36 113.56 26.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 53.23 110.896 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 33' ' ' ALA . 10.6 mt -80.2 129.74 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.903 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 72.16 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.43 110.868 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.51 -27.19 15.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.43 111.116 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.57 -44.01 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.845 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.51 -32.84 18.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.906 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.778 HG21 ' CB ' ' A' ' 129' ' ' PHE . 11.5 m -131.24 87.19 48.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 71.12 111.147 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.27 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 73.15 112.364 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -41.89 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -3.1 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 71.03 111.18 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -76.62 -37.47 56.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.33 111.141 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 35' ' ' ASN . 80.3 tt0 -92.79 -37.88 12.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 65.04 110.885 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -29.32 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.861 -179.904 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HA ' HD12 ' A' ' 39' ' ' LEU . 37.3 t80 -64.45 -32.75 74.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.857 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -51.75 -34.7 40.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.885 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.49 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.113 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' PHE . 13.4 mt -75.63 -52.02 11.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 63.53 110.856 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.9 m -59.39 -54.01 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.862 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.6 p -73.19 -27.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.34 111.15 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.96 92.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.722 . . . . 72.32 112.495 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.72 36.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 61.11 110.901 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -133.72 26.81 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.947 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.06 4.76 60.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 74.45 112.454 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -164.56 178.05 7.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 64.14 110.875 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.52 117.01 2.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 70.4 112.45 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.11 150.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 61.31 110.912 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -76.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 63.54 110.92 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.01 44.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 72.11 112.516 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -26.46 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 63.32 110.848 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p 178.13 176.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 65.44 110.931 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -103.2 -77.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.876 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.12 -80.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.55 110.9 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -164.82 110.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.878 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.716 HD12 ' CD1' ' A' ' 156' ' ' ILE . 5.1 mt -95.71 135.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 74.05 111.131 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.564 HD12 ' CE ' ' A' ' 61' ' ' MET . 12.7 mt -131.74 103.5 14.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 74.03 111.087 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.77 104.53 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 74.54 112.385 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.46 8.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 23.1 112.476 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.56 -66.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 70.21 110.94 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.564 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -179.17 -168.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 73.5 110.875 179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.871 ' HB2' HG23 ' A' ' 114' ' ' ILE . 87.8 m -149.15 133.22 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.895 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.04 154.81 18.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.939 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 53.05 112.525 -179.976 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.797 0.332 . . . . 74.1 110.885 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 142.27 27.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 70.45 110.852 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 79' ' ' TYR . 2.1 pp -40.67 -38.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 65.33 111.081 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' CD2' HD11 ' A' ' 78' ' ' ILE . 4.5 m-85 -85.89 49.24 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.877 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.16 -113.82 4.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 73.04 112.47 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.96 -161.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.393 . . . . 74.4 110.862 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.3 OUTLIER -101.08 -178.51 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 65.03 110.87 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -131.66 162.13 31.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.913 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -91.28 172.5 8.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 55.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.71 105.9 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 71.12 110.821 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -58.21 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 73.33 110.861 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 p30 -177.92 165.52 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.883 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.1 55.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 54.11 110.839 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mt -48.93 -26.32 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.5 111.194 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 73.3 mt -93.39 155.08 17.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.905 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -117.93 178.29 4.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 63.54 110.908 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -105.08 76.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 70.33 110.849 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 t -122.34 22.39 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.162 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' HD11 ' A' ' 97' ' ' ILE . . . -120.72 160.12 15.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.76 -0.733 . . . . 72.35 112.505 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.26 24.27 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 72.43 112.375 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.42 71.11 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 60.42 112.491 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HA3' ' A' ' 94' ' ' GLY . 42.5 mm -91.42 143.4 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 73.51 111.119 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 97' ' ' ILE . 8.0 mt -117.03 152.67 34.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.887 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 56.9 m -154.89 -101.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 70.14 110.877 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -176.4 124.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 74.54 110.874 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -102.58 80.76 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 53.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -137.32 -64.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.44 110.919 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -178.17 121.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 51.5 111.118 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.906 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -72.61 -29.48 65.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 60.34 112.482 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.906 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.7 Cg_endo -69.78 80.99 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.232 . . . . 71.21 112.367 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 p-10 39.29 53.96 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.892 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -159.03 39.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.2 111.142 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.77 160.27 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.941 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.99 -110.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.53 112.507 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.25 -162.14 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 72.32 110.851 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 mt-30 74.75 50.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 75.52 110.896 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 41.0 p90 -50.25 142.71 9.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.836 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 27.9 p90 -103.98 59.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.871 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 62' ' ' CYS . 9.3 tt -34.79 121.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.5 111.106 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 119' ' ' THR . 69.7 m -90.53 159.01 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 61.3 110.898 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -111.67 -9.69 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 71.04 111.163 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.87 161.38 40.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 62.22 111.085 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.24 115.92 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.15 110.9 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 122' ' ' LEU . 15.8 p -115.7 47.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 74.41 111.153 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.71 -17.54 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.926 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -55.65 -21.91 20.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 71.31 110.934 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.522 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -73.33 -56.25 5.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 72.02 110.923 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 73.03 -61.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.2 110.897 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.83 61.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.685 -0.769 . . . . 70.03 112.491 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -98.02 -27.79 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.43 110.913 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -143.44 138.1 29.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 61.34 110.812 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 87' ' ' ASN . 55.4 t -51.37 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.14 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.4 p -84.2 143.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 75.1 111.133 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.778 ' CB ' HG21 ' A' ' 29' ' ' VAL . 37.2 p90 -178.78 119.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.13 110.855 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.42 123.33 4.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 74.41 112.485 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -139.23 162.03 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 74.52 110.892 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 t -54.83 100.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.136 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -46.85 41.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 64.54 110.888 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -148.06 118.2 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.33 84.42 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 64.23 112.474 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 tpt -91.26 -21.52 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.789 0.328 . . . . 64.41 110.873 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -30.74 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 73.0 110.885 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 20' ' ' VAL . 38.2 mm -64.49 -41.76 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.31 111.117 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.7 t -91.65 11.39 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.085 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.8 -64.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 64.44 110.855 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.63 -57.28 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.33 111.083 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.7 tmm? -52.81 -37.86 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 55.44 110.888 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -24.59 32.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.878 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -68.39 -12.57 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.839 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -94.78 26.09 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 75.51 110.884 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -124.92 44.04 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 70.4 112.53 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 146' ' ' GLY . 29.8 t 29.57 -102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.384 . . . . 44.42 110.834 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -173.5 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 64.12 110.86 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -87.74 -6.45 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.895 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.68 -55.81 0.76 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.464 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 110.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.84 0.352 . . . . 73.22 110.848 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 146' ' ' GLY . 40.0 p -84.11 138.33 33.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.154 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.31 -28.92 63.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 65.53 110.854 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -137.07 -179.62 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.12 110.903 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 135.4 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.888 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.716 ' CD1' HD12 ' A' ' 56' ' ' ILE . 20.5 mt -117.17 87.66 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.04 111.128 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -108.68 157.16 18.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.02 111.175 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.4 mt -93.22 146.06 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 72.11 111.188 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -96.55 -61.22 1.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.114 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.09 154.6 48.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.0 m -146.16 -167.5 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 73.44 110.892 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.66 -162.93 23.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 72.25 112.501 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.646 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.3 tt0 -112.54 133.82 54.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 72.22 110.901 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.794 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -109.24 144.48 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 62.34 110.943 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.895 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.838 0.351 . . . . 64.42 110.896 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.9 t 59.62 99.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 70.52 111.127 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -58.59 154.91 32.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 73.4 110.907 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 154.8 67.33 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.233 . . . . 74.4 112.365 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 6' ' ' VAL . 2.8 m -120.55 163.01 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 61.45 111.109 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.587 ' CG2' HD11 ' A' ' 24' ' ' LEU . 1.3 t -144.11 140.68 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.23 111.176 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -126.34 144.36 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 62.11 110.864 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 8.0 m-85 -138.67 139.58 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 71.3 110.862 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.02 109.86 22.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 65.24 110.799 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.3 136.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.478 . . . . 70.41 111.157 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.32 161.91 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.099 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 17' ' ' LEU . 61.2 t -146.45 93.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 54.34 111.161 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.2 27.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.83 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.88 57.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 63.01 112.536 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.15 139.22 21.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.605 0.717 . . . . 64.53 110.891 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 152.93 69.49 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 64.23 112.401 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.5 tp -116.07 -68.39 0.92 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 73.13 110.929 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.81 -144.67 4.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 42.32 112.518 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.31 135.91 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.45 110.847 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.64 129.73 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.32 111.145 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 95.54 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.45 110.821 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 5.5 m-85 -87.56 119.81 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.54 110.875 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -101.07 147.88 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.917 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 37' ' ' ARG . 0.8 OUTLIER -121.06 120.18 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 65.14 110.911 -179.919 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.63 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.1 110.904 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.67 -2.47 56.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 65.34 111.104 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.05 -51.03 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.867 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -26.32 16.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.862 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.58 74.57 65.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.64 0.733 . . . . 74.33 111.142 179.858 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -44.6 1.98 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.251 . . . . 73.34 112.382 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -62.85 -50.22 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.92 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.504 ' OG1' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -65.03 -39.33 93.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 71.12 111.138 179.986 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.81 -68.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 74.01 111.07 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' ARG . 27.2 tt0 -48.42 -65.61 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.932 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 34' ' ' GLU . 4.2 t30 -29.93 -52.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 65.12 110.867 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.12 -41.56 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.53 110.885 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.589 ' HG3' HD13 ' A' ' 24' ' ' LEU . 5.0 ttm180 -52.06 -29.52 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 64.32 110.834 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -62.55 -32.55 73.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 44.32 111.098 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -94.01 35.3 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.877 -179.923 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.7 t -113.22 -12.29 13.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 74.04 110.853 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 p -121.32 18.14 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.159 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.34 27.8 8.39 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.747 -0.739 . . . . 64.21 112.528 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.04 -40.41 53.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.392 . . . . 75.24 110.882 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -62.08 -17.27 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.895 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.26 -66.24 3.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 63.03 112.492 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -93.3 148.02 22.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 75.5 110.917 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.8 -168.04 25.14 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.756 -0.735 . . . . 33.45 112.48 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' O ' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -86.11 139.7 30.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.931 0.396 . . . . 74.31 110.941 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -42.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.918 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.2 45.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 34.15 112.473 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.5 t -95.43 45.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 72.51 110.854 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.27 -176.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 70.45 110.881 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -176.53 134.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.859 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 66.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.862 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 8.26 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.2 110.86 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.63 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -57.75 150.63 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 73.14 111.125 179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 148' ' ' ARG . 3.9 mt -140.29 95.64 8.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 54.4 111.14 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.77 87.6 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 53.42 112.332 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 71.41 112.516 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -59.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 72.34 110.908 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -157.22 -150.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 72.44 110.888 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.6 t -121.01 -53.68 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.32 110.896 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.08 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 71.03 110.943 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.728 -0.748 . . . . 64.05 112.5 -179.976 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.797 0.332 . . . . 71.22 110.893 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 167.01 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 61.2 110.826 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -51.41 -42.96 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.42 111.126 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.75 46.02 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 70.53 110.966 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.55 -95.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.749 . . . . 33.43 112.495 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -54.64 178.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 53.25 110.904 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' CD ' ' H ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -95.92 -172.07 2.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.9 179.962 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.11 164.46 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 71.11 110.866 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.27 179.33 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.13 110.859 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.89 129.73 34.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.43 110.84 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -88.24 -46.57 9.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.877 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.68 156.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 61.11 110.913 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.84 63.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.884 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.585 ' O ' HD23 ' A' ' 90' ' ' LEU . 24.0 mm -80.82 2.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.43 111.164 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 89' ' ' ILE . 59.8 mt -133.68 136.74 44.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.12 110.907 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -162.91 1.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.897 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -102.19 97.07 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 65.21 110.867 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -79.19 -21.43 46.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.44 111.154 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.02 -125.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 61.24 112.483 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.14 47.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.616 2.211 . . . . 35.44 112.345 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 67.05 121.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 64.25 112.47 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -176.4 130.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 71.04 111.135 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CB ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -106.61 122.84 47.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 63.51 110.888 179.888 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HE3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -133.51 -155.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 75.54 110.908 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.444 ' HE3' ' O ' ' A' ' 99' ' ' SER . 1.1 mmt -134.23 116.34 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.905 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . -56.46 -46.38 80.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 44.52 111.083 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 107' ' ' THR . 21.5 p30 39.14 -157.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 62.23 110.912 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.577 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -141.44 10.99 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.24 111.11 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.9 -65.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 64.32 112.512 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.577 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.78 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 53.55 112.314 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' A' ' 105' ' ' PRO . 79.6 m-20 -82.34 81.05 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 64.23 110.888 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 102' ' ' ASN . 5.3 t -153.22 56.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 51.43 111.111 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -46.89 -44.51 19.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 32.04 110.898 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 48.18 -164.74 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 33.25 112.452 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.96 87.82 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 72.04 110.866 -179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 25.2 tt0 -161.15 51.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.924 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CB ' HD23 ' A' ' 98' ' ' LEU . 2.8 p90 -59.83 -172.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 70.1 110.898 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.62 106.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.927 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.464 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 76.8 mt -48.17 123.36 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.122 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 89.7 m -84.29 116.5 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.868 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -88.18 -30.69 19.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.11 111.155 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.13 161.02 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 71.21 111.085 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -62.22 102.3 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 50.03 110.921 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.823 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 18.6 p -113.89 46.0 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 71.13 111.175 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -16.79 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 72.53 110.827 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.823 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -64.12 -15.51 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.939 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.99 78.29 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.02 110.942 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.92 -47.79 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 54.33 110.871 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.87 45.17 3.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 45.41 112.499 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -145.25 -53.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 70.35 110.906 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -101.68 134.76 44.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.802 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.47 104.83 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 71.22 111.119 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 90.8 t -78.41 132.5 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.12 111.131 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.536 ' HA ' HG21 ' A' ' 29' ' ' VAL . 19.5 p90 -152.94 26.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.884 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -161.4 -170.53 26.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.466 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp 178.73 -169.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 64.32 110.926 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -116.35 81.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 73.22 111.139 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -49.2 -34.56 15.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.919 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -171.02 168.28 6.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.873 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.83 -1.6 58.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.714 -0.755 . . . . 71.02 112.466 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -33.54 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.22 110.934 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -50.58 -27.03 6.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 71.02 110.905 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 17.6 mm -81.58 -45.61 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.25 111.145 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.06 -51.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.121 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.01 -27.74 14.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 70.24 110.891 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -71.83 -47.57 52.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 75.5 111.109 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 156' ' ' ILE . 62.1 mtm -62.96 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 64.34 110.863 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 6.3 mm-40 -51.42 -71.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 75.22 110.898 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -60.0 -16.68 32.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.883 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 142' ' ' MET . 11.8 m-85 -92.51 2.16 56.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 72.01 110.854 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 56' ' ' ILE . . . -127.62 46.77 1.06 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 75.24 112.504 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 146' ' ' GLY . 8.1 t 34.89 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 61.12 110.886 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.9 mmm-85 -133.62 -35.44 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.14 110.903 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -99.45 -8.3 24.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.926 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.57 80.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 61.43 112.483 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -60.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 75.05 110.874 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 66.43 133.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 50.01 111.126 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -9.02 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.03 110.877 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.48 156.65 47.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 73.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.76 118.64 32.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 64.3 110.891 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.454 HD13 ' SD ' ' A' ' 142' ' ' MET . 12.7 mt -88.59 134.47 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 73.24 111.15 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.16 170.45 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 71.43 111.145 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 67.1 mt -118.7 111.36 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.156 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -60.59 -54.96 39.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 63.11 111.131 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -167.6 168.84 12.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.908 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.3 p -156.49 163.76 39.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 65.1 110.867 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.72 -178.85 47.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 74.32 112.456 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 9.5 mt-30 -69.32 -37.23 77.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 61.55 110.94 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.546 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.14 -62.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 65.22 110.885 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.1 110.877 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 64.33 110.852 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.9 155.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 51.15 111.104 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.37 149.25 37.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 75.34 110.9 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.81 19.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.681 2.254 . . . . 54.1 112.366 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.632 HG21 HD22 ' A' ' 164' ' ' LEU . 57.4 m -119.6 124.91 47.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.132 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.2 m -104.95 144.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 75.25 111.108 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -105.05 154.94 19.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.866 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.33 131.52 26.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.89 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.52 95.07 5.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.885 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.753 HD12 ' CG2' ' A' ' 138' ' ' ILE . 17.3 mt -78.92 141.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 62.42 111.144 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -122.83 159.94 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.1 111.122 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.31 106.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 75.24 111.095 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 51.45 55.44 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 62.2 110.879 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.51 9.84 33.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 22.41 112.512 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -136.0 93.84 14.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.685 0.755 . . . . 72.34 110.87 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 156.02 64.22 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.694 2.262 . . . . 64.12 112.313 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.18 26.99 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 71.52 110.942 179.972 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.9 169.28 12.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.488 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.58 171.52 12.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 72.04 110.845 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 138' ' ' ILE . 17.6 m -143.3 -176.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.44 111.158 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.7 p -148.11 154.77 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.824 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.36 134.1 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.1 tt0 -73.98 -55.03 6.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 70.1 110.888 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mt 76.8 124.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.961 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD2' HD13 ' A' ' 90' ' ' LEU . 81.6 m-85 -81.76 55.28 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 71.14 110.877 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -36.52 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.113 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.44 -51.61 66.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.878 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -60.49 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.891 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.55 82.51 6.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 74.2 111.135 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 60.94 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 41.23 112.355 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 -71.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 62.23 110.874 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.444 HG23 ' HE1' ' A' ' 100' ' ' MET . 27.3 m -58.34 -53.71 55.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 53.34 111.149 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -86.83 9.52 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.106 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -88.95 -24.54 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 61.51 110.872 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.57 -29.76 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.859 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' A' ' 39' ' ' LEU . 7.7 t80 -50.59 -28.4 8.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.868 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 41' ' ' THR . 15.0 ptp180 -56.66 -30.71 63.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 71.25 110.861 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.79 -31.79 19.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.42 111.081 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 78' ' ' ILE . 67.1 mt -65.19 -47.85 75.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 65.4 110.962 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -65.22 -37.41 87.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.857 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' ARG . 65.4 p -73.88 -19.66 60.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 73.13 111.184 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.6 91.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.741 . . . . 64.52 112.457 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.66 36.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.901 0.381 . . . . 64.51 110.886 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.99 6.63 2.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.32 110.886 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 9.7 84.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.22 112.526 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -174.16 -169.17 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 72.41 110.886 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.53 -80.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 65.33 112.507 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -176.8 110.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 74.33 110.889 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -179.03 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.938 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.425 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -45.2 104.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 34.12 112.507 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -159.74 54.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 62.22 110.865 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' H ' HG22 ' A' ' 157' ' ' THR . 18.8 m 52.3 -173.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 62.2 110.908 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -168.84 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.839 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -115.56 -77.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 72.14 110.857 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -135.44 143.38 45.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 54.35 110.875 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.6 mt -143.78 125.86 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.32 111.134 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.698 HD11 ' CE ' ' A' ' 61' ' ' MET . 1.1 pt -134.28 114.11 12.46 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 70.22 111.15 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 108.99 2.21 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.682 2.255 . . . . 73.15 112.334 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.2 -31.28 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 54.23 112.516 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.599 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -99.96 -63.2 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 75.11 110.854 -179.852 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.698 ' CE ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 179.81 -165.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.853 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.3 m -142.19 115.04 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.1 110.925 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -99.36 151.06 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 54.3 110.908 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 72.35 112.433 -179.911 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' SER . 16.6 ptpt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.312 . . . . 72.02 110.921 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 61.2 p -87.75 -167.94 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.811 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 39' ' ' LEU . 2.6 pp -111.85 11.19 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.4 111.121 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -7.71 25.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.919 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.05 -84.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 75.11 112.451 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.4 -68.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 71.35 110.864 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -167.78 163.58 14.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 52.21 110.883 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.453 ' O ' ' ND2' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -130.6 144.15 51.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.856 -179.972 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.13 159.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.878 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -64.6 -167.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.863 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -148.36 -67.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.41 110.893 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 127' ' ' VAL . 6.4 p30 -176.93 171.88 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 64.33 110.935 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.97 43.35 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.868 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.7 mt -51.01 -27.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 50.34 111.132 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 128' ' ' VAL . 3.8 mt -96.6 137.39 35.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 70.24 110.899 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.93 114.09 17.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.917 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.403 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -55.97 102.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.837 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.2 p -113.76 42.45 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.3 111.153 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.89 156.67 14.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 43.11 112.517 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 128.08 15.49 Favored 'Trans proline' 0 N--CA 1.466 -0.103 0 C-N-CA 122.69 2.26 . . . . 73.21 112.33 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.9 -22.1 8.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 63.41 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.9 mm -65.82 152.05 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 52.31 111.117 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.78 HD12 ' HA3' ' A' ' 130' ' ' GLY . 32.0 mt -96.12 132.18 41.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.4 110.941 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.0 m -119.67 138.66 53.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.816 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.522 ' CG ' HG12 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -77.57 172.48 13.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 62.01 110.86 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.592 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . . . -166.13 -175.07 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 52.44 111.094 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 12.0 t30 88.6 95.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.887 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . 66.18 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.08 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 121.49 -59.96 0.56 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.708 -0.758 . . . . 71.43 112.462 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.599 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 100.15 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 64.11 112.301 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.8 56.33 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.84 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -132.0 7.14 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.2 111.116 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 1.3 m-80 41.29 -92.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.913 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 97.43 139.16 10.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 55.14 112.472 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 p -100.61 -8.89 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 65.22 110.896 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 129.82 35.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.934 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.05 138.69 48.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 62.41 110.903 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.592 ' HE1' ' HB2' ' A' ' 101' ' ' ALA . 14.2 p90 -120.2 121.64 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.2 110.883 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mt -92.35 119.26 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.107 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -76.27 150.97 36.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.84 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -126.55 23.75 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.42 111.124 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.72 20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 65.13 111.111 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 64.97 135.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.891 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.518 HG22 ' CZ3' ' A' ' 121' ' ' TRP . 21.8 p -148.95 68.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 71.15 111.129 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -84.37 14.3 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.868 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.518 ' CZ3' HG22 ' A' ' 119' ' ' THR . 3.2 p90 -91.39 0.33 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 75.44 110.955 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.56 31.88 1.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 54.52 110.871 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -96.26 78.81 3.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.02 110.847 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.79 -41.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 34.41 112.485 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -35.75 73.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 64.21 110.898 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -117.37 159.3 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 62.11 110.831 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.797 HG13 ' N ' ' A' ' 128' ' ' VAL . 1.1 p -81.05 -159.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 54.23 111.087 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.797 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -165.36 144.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 54.25 111.128 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 27.7 p90 -175.99 115.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.905 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.78 ' HA3' HD12 ' A' ' 98' ' ' LEU . . . 114.87 114.5 3.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 71.25 112.488 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.39 143.14 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 52.41 110.861 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 139' ' ' VAL . 69.5 t -52.53 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.126 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -56.78 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 55.04 110.899 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.09 170.8 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.872 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 63.37 82.45 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 42.41 112.463 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 8.7 tpt -89.17 11.09 19.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 73.45 110.832 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.69 -34.3 16.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 71.2 110.905 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.753 ' CG2' HD12 ' A' ' 10' ' ' ILE . 39.4 mm -60.18 -38.38 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.116 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.5 t -90.63 -3.01 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 63.42 111.122 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -110.66 -71.83 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.44 110.9 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.75 -52.07 34.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 72.54 111.119 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.7 tmm? -51.43 -29.16 15.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.862 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.54 29.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 71.24 110.854 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -113.51 -14.39 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.884 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -105.77 -2.46 23.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -157.46 1.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 62.12 112.483 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 57' ' ' ILE . 4.8 t -163.79 141.77 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 60.14 110.868 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -57.46 -20.15 28.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.855 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.09 -17.87 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 63.45 110.902 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.93 -42.0 1.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.708 -0.758 . . . . 70.01 112.506 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -46.41 131.6 10.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 73.22 110.882 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.7 p -96.52 112.66 24.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.21 111.144 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -49.8 -28.1 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 33.22 110.841 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -125.11 -162.26 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 62.34 110.939 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.3 tppm? -128.37 129.25 45.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 63.01 110.909 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 10' ' ' ILE . 3.3 mp -112.36 92.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.42 111.133 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 25.0 p -103.17 148.66 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 55.03 111.142 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.425 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.8 mt -88.82 130.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.134 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.89 -64.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.08 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -127.02 170.63 12.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.35 110.816 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.48 -174.89 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.862 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.36 -148.59 19.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.74 133.91 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 73.24 110.9 -179.866 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.632 HD22 HG21 ' A' ' 5' ' ' THR . 3.2 tp -56.78 -57.09 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.2 110.866 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.12 110.912 179.95 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.809 0.337 . . . . 73.42 110.887 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.35 138.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 50.21 111.121 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -57.41 157.28 13.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.65 0.738 . . . . 73.41 110.882 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 122.0 8.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 74.35 112.318 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 14.4 m -100.85 55.99 0.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 71.22 111.128 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -52.26 154.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.077 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -136.56 170.8 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.861 -179.988 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -142.0 143.88 33.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.902 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.45 115.95 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.35 110.86 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -85.73 123.07 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 43.15 111.129 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.19 13.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.31 111.097 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.7 m -144.21 101.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.05 111.109 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 3.7 t0 76.71 45.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.901 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 24.02 70.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 72.32 112.452 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -135.27 148.7 67.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 73.52 110.92 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 140.13 41.91 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.68 2.253 . . . . 43.12 112.358 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.4 tp -127.39 -38.12 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.913 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.24 -178.51 45.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 43.45 112.482 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 162.25 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.51 110.847 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.54 147.6 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 73.25 111.119 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.23 97.82 11.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.911 -179.867 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -85.0 59.61 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.12 110.846 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.79 115.45 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.865 -179.9 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.542 HD21 ' CD2' ' A' ' 36' ' ' PHE . 5.9 mt -81.83 133.2 35.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.927 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 90' ' ' LEU . 71.2 m-85 -75.8 67.31 2.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.855 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.18 -14.82 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 73.44 111.095 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.09 -60.26 2.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.854 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -67.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 51.53 110.924 -179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 3.2 m -105.95 114.46 62.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 64.14 111.107 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' LYS . 53.7 Cg_endo -69.77 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 63.53 112.319 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' PRO . 7.9 mtmm -38.33 -54.68 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.849 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 55.8 m -39.51 -58.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 73.4 111.145 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.98 30.85 4.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 70.03 111.074 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -97.24 -30.64 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.846 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.03 -35.53 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.13 110.9 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CD2' HD21 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.22 -31.62 6.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.932 179.981 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -35.82 70.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.872 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.29 -21.75 27.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 53.52 111.133 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 36' ' ' PHE . 73.7 mt -70.23 -51.36 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 63.43 110.892 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -68.18 -44.69 75.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 74.12 110.885 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -74.96 -24.07 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 41.45 111.157 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.34 94.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.486 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.76 47.53 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.948 0.404 . . . . 61.05 110.933 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 33.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 75.2 110.868 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.63 -3.4 49.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 74.53 112.495 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -163.0 -168.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 73.13 110.862 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.69 137.39 4.81 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.679 -0.772 . . . . 73.1 112.468 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -85.21 144.27 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.951 0.405 . . . . 74.25 110.94 -179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -57.66 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.869 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -114.26 -76.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 71.51 112.513 179.916 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t 68.82 123.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 43.22 110.841 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.51 -171.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 72.24 110.849 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 152' ' ' THR . 27.1 p90 -104.81 -170.82 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 62.23 110.922 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -60.09 1.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.11 110.828 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -151.66 160.14 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.842 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.1 mt -136.82 130.52 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 73.13 111.151 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -130.22 110.23 16.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.601 0.715 . . . . 75.22 111.149 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.7 Cg_endo -69.83 101.72 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.609 2.206 . . . . 73.32 112.337 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.62 22.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.697 -0.764 . . . . 53.41 112.511 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HG21 ' A' ' 119' ' ' THR . 0.1 OUTLIER -138.5 -63.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 74.23 110.912 -179.878 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -168.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 60.53 110.846 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.796 ' HB2' HG23 ' A' ' 114' ' ' ILE . 9.0 m -150.04 131.5 14.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.92 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -111.92 139.57 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.899 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.762 -0.732 . . . . 53.02 112.519 -179.989 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.771 0.32 . . . . 64.52 110.926 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.61 -179.44 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 71.23 110.843 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.5 pt -81.26 -39.17 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 64.31 111.134 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -96.68 93.93 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 63.21 110.941 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.36 -119.51 5.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 24.42 112.453 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -84.5 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 63.24 110.903 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 152.66 44.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.926 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.71 148.81 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.924 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -49.17 157.77 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 73.51 110.892 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.08 144.17 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 61.32 110.892 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -61.24 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.0 110.858 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.64 167.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.02 110.902 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.46 60.6 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.01 110.875 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 89' ' ' ILE . 30.6 mm -73.37 -6.86 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 72.12 111.165 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -117.99 81.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 70.3 110.922 179.911 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -66.93 161.54 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.882 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -71.41 75.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.834 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -70.93 -12.28 61.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.41 111.153 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.14 -170.09 43.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 70.45 112.483 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 128.04 15.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.694 2.263 . . . . 74.44 112.339 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.88 -31.4 3.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 73.43 112.511 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.0 mm -61.27 139.54 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.366 . . . . 70.32 111.129 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 112' ' ' PHE . 50.6 mt -108.28 159.64 16.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.938 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 m -158.96 33.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.858 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.493 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.6 OUTLIER 47.17 -167.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.15 110.877 179.928 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.544 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -172.46 75.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 60.42 111.165 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -116.23 -73.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.88 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.64 -36.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.2 111.122 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.06 -69.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 61.11 112.512 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.6 Cg_endo -69.74 108.53 2.1 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 73.22 112.33 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 45.52 38.39 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 73.11 110.879 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p -138.04 56.79 1.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 63.03 111.152 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -39.34 -57.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 73.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.8 -170.84 50.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.13 112.46 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.493 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 34.2 t -144.68 25.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 61.14 110.826 -179.722 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.7 tt0 -79.65 -100.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 73.13 110.88 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 170.66 179.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 52.51 110.888 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.62 38.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 61.23 110.905 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 62' ' ' CYS . 8.0 tt -58.27 91.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 65.4 111.14 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.9 142.11 54.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.907 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.624 HG21 ' CD ' ' A' ' 143' ' ' GLU . 11.4 p -111.4 22.34 15.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 64.23 111.154 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 119' ' ' THR . . . -176.75 161.24 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 54.24 111.116 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 95.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.42 110.914 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 117' ' ' ALA . 34.5 p -125.12 59.46 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 34.44 111.119 -179.971 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.22 30.63 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.2 110.929 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.479 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.6 OUTLIER -92.47 7.27 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.4 110.902 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.11 -10.16 28.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 71.01 110.915 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.59 78.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 75.12 110.876 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 38.82 50.54 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 63.23 112.481 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -58.27 -33.01 68.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 72.14 110.886 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -143.85 177.68 8.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.877 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -61.91 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 73.15 111.12 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.666 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.6 p -174.47 138.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.149 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 3.7 p90 178.6 102.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 73.25 110.843 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.56 127.11 3.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 62.42 112.485 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.71 21.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 63.31 110.892 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.644 HG11 HG21 ' A' ' 139' ' ' VAL . 25.5 m -49.56 159.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 61.52 111.138 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -160.86 -39.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.35 110.904 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -63.54 1.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.881 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.19 105.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 50.41 112.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -6.78 33.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.776 0.322 . . . . 71.52 110.869 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -57.61 -20.39 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.87 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.8 mm -91.74 -45.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.41 111.105 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.644 HG21 HG11 ' A' ' 132' ' ' VAL . 95.9 t -54.71 -20.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.12 111.115 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -83.92 -32.88 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 63.1 110.925 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.59 -31.28 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.123 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -86.02 -9.48 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.88 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.624 ' CD ' HG21 ' A' ' 116' ' ' THR . 4.0 mm-40 -89.88 28.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.869 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -145.17 8.04 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.891 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.66 2.28 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.903 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -110.17 72.57 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.769 -0.729 . . . . 73.33 112.516 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.564 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.7 134.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 50.14 110.877 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 27.2 mmm-85 -47.96 -44.91 30.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.34 110.857 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -49.11 -27.45 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 51.33 110.867 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.46 -37.59 2.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.723 . . . . 75.23 112.507 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.66 140.39 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 71.14 110.916 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.626 HG22 ' HA2' ' A' ' 146' ' ' GLY . 68.1 p -118.13 147.92 42.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 60.44 111.134 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -21.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 54.03 110.815 -179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -131.9 -168.35 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 55.13 110.853 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -132.14 132.15 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 60.3 110.922 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 127.38 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.04 111.128 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.86 168.75 18.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 42.23 111.136 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mt -129.26 113.62 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 65.15 111.139 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.53 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 54.44 111.073 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.92 -178.44 6.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.846 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.62 178.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.52 110.925 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.4 -163.63 33.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 62.4 112.476 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.56 123.3 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 72.32 110.946 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -98.93 -74.84 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 63.22 110.892 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.919 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.805 0.336 . . . . 73.42 110.858 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.78 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.03 111.124 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.9 150.85 48.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 71.25 110.875 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.79 153.19 69.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 74.12 112.34 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.49 162.7 32.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.161 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 0.1 OUTLIER -150.05 132.91 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 53.42 111.156 179.886 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -110.98 161.9 15.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.884 179.98 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.1 m-85 -143.52 133.06 23.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 73.44 110.85 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -98.25 82.29 2.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.35 110.88 179.936 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.7 142.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.54 111.098 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -139.31 159.94 40.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.124 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 156' ' ' ILE . 96.9 t -137.64 99.63 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 44.44 111.124 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.29 33.61 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.54 110.862 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.45 -15.0 64.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.732 . . . . 62.52 112.467 -179.955 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.52 109.66 51.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.597 0.713 . . . . 64.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 145.04 55.83 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.671 2.247 . . . . 64.32 112.358 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.88 -66.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 61.2 110.857 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.82 -172.03 30.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 63.02 112.491 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 121.76 42.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 75.25 110.849 -179.816 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.892 HG22 HG21 ' A' ' 138' ' ' ILE . 1.3 t -109.45 105.86 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 54.15 111.112 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 79.1 p -98.84 142.06 30.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 72.45 110.826 -179.829 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.61 162.87 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.874 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 56.9 tt0 -106.61 139.97 40.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 54.35 110.896 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 41.3 mt -111.05 107.37 16.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 55.42 110.935 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -85.22 71.61 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 62.52 110.878 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.3 -24.55 64.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 64.22 111.082 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.57 -34.44 76.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 64.2 110.912 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -103.31 -32.16 9.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.917 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -128.4 67.19 75.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 65.15 111.161 179.888 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -3.37 11.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.667 2.245 . . . . 73.2 112.371 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -42.87 8.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.6 p -85.59 -41.09 15.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.164 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.97 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 60.14 111.082 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.7 tt0 -53.15 -64.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 64.11 110.893 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 34' ' ' GLU . 7.2 t30 -31.66 -46.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.41 110.905 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -78.75 -43.29 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.893 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -55.38 -33.23 63.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.884 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.68 77.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 62.42 111.153 179.896 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -85.98 39.24 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.927 179.997 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p -112.98 -15.15 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 75.33 110.808 -179.872 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.2 p -123.17 10.52 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.12 111.135 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.46 61.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 72.42 112.467 179.983 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -81.07 -26.49 36.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.93 0.395 . . . . 55.35 110.89 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -67.56 -10.14 49.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.55 110.925 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.29 -18.51 36.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 72.12 112.472 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -85.74 -31.03 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 75.25 110.854 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.32 -176.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 45.22 112.496 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.733 ' HB2' HD11 ' A' ' 39' ' ' LEU . 2.4 t80 -175.48 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.946 0.403 . . . . 75.24 110.932 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 48' ' ' TYR . 6.1 ptmt -27.08 111.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 50.25 110.863 179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.94 -60.99 0.57 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 71.33 112.445 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 42.62 -159.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 62.32 110.84 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 35.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.898 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -59.37 132.55 54.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.878 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -129.51 63.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.831 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.0 tpm_? -119.05 -92.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.43 110.873 -179.935 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' ARG . 6.3 mm 55.82 115.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.12 111.148 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 61' ' ' MET . 8.1 tt -143.28 102.0 5.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 74.25 111.153 179.872 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.6 Cg_endo -69.81 98.64 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 74.14 112.305 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.99 -56.11 0.29 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.704 -0.76 . . . . 63.42 112.448 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -105.46 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 54.31 110.899 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -144.3 -159.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 53.01 110.9 179.939 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.11 -56.44 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 72.52 110.92 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 65.6 151.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.861 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.754 . . . . 70.53 112.476 -179.929 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.777 0.322 . . . . 54.33 110.935 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -97.94 161.95 13.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 62.54 110.885 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -8.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 72.41 111.08 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.46 20.6 5.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 63.21 110.905 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.26 -132.11 2.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.41 112.477 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -114.06 -33.2 5.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 73.23 110.893 -179.911 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.34 177.53 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 55.04 110.887 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.31 165.6 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 61.14 110.832 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -85.64 -176.14 5.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.879 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -91.61 122.97 34.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 73.01 110.853 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -40.81 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.843 -179.882 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.6 p30 177.94 161.38 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.844 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -113.33 34.3 4.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.876 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 mt -62.53 -22.42 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 71.34 111.141 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.662 HD12 ' CG1' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -94.12 110.72 22.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.917 179.883 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.502 ' O ' HD11 ' A' ' 97' ' ' ILE . 2.2 mtpp -109.31 -174.65 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.945 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -98.4 -77.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 73.5 110.898 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.1 16.89 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.124 -179.947 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.28 -168.72 36.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.34 112.499 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.667 2.244 . . . . 60.34 112.346 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 66.08 117.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 60.33 112.486 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.662 HD12 HG11 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -168.19 122.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 74.22 111.082 -179.96 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 tt -97.91 116.0 29.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.897 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.38 176.7 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 65.05 110.85 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 5.3 mmt -115.36 104.93 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 64.51 110.844 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -69.3 152.29 45.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.105 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.677 ' HB2' HG23 ' A' ' 107' ' ' THR . 42.2 p-10 -179.8 -168.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 73.51 110.915 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -84.38 -20.76 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 44.14 111.1 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 123.49 -62.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.496 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.68 96.42 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 75.21 112.37 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 25.37 78.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.22 110.875 -179.979 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -155.27 30.13 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 71.02 111.183 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 3.3 p30 -97.19 178.97 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.925 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.53 42.22 2.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 70.44 112.517 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -138.97 -90.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 51.52 110.863 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.785 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -93.71 171.39 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.11 110.91 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -138.93 147.39 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.44 110.891 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -117.65 141.07 48.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.884 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.3 136.64 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.112 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.35 123.99 34.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.4 110.861 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 p -99.24 -25.81 14.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 111.133 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.22 23.12 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 62.33 111.09 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.36 136.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 72.05 110.896 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.623 ' HB ' HD22 ' A' ' 122' ' ' LEU . 1.7 p -131.01 51.65 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 65.31 111.172 179.963 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.04 -19.0 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 63.45 110.925 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -57.79 -19.71 30.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 70.23 110.925 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.623 HD22 ' HB ' ' A' ' 119' ' ' THR . 0.0 OUTLIER -76.27 -63.0 1.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.924 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.78 -59.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.837 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.99 49.89 0.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 72.34 112.515 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -105.44 -24.36 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.14 110.932 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -139.32 139.57 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.4 110.87 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.3 t -77.71 104.37 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 64.2 111.159 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.662 ' CG1' HD12 ' A' ' 90' ' ' LEU . 78.4 t -90.36 135.28 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.147 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.465 ' CB ' HG21 ' A' ' 29' ' ' VAL . 33.6 p90 -150.65 16.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.874 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . -150.3 -169.76 16.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.729 . . . . 51.23 112.485 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -179.81 -165.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 65.12 110.85 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 136' ' ' MET . 75.0 t -100.99 98.92 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.135 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -55.59 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.71 160.73 38.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.14 110.879 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.33 33.93 42.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 72.44 112.479 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' MET . . . . . 0.498 ' HA ' HG11 ' A' ' 132' ' ' VAL . 10.1 mmm -50.08 -28.79 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.34 . . . . 63.42 110.88 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.33 110.916 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.892 HG21 HG22 ' A' ' 20' ' ' VAL . 45.6 mm -42.24 -37.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 74.24 111.163 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.45 -51.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 53.34 111.131 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -48.64 -49.87 35.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.828 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.6 -52.63 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 73.53 111.088 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.663 ' SD ' HD13 ' A' ' 156' ' ' ILE . 6.8 ttm -50.71 -46.3 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 71.14 110.848 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 58' ' ' PRO . 3.0 pt-20 -52.03 -23.06 4.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 73.34 110.85 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -63.39 -22.98 67.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.912 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -85.6 14.71 5.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.887 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.76 -155.4 31.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.718 . . . . 63.44 112.435 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.78 -168.5 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.904 0.383 . . . . 70.52 110.855 -179.76 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -80.13 -43.97 20.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 71.1 110.862 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -101.21 -7.84 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 71.52 110.874 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.11 -152.02 17.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.477 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 60.43 101.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 75.21 110.905 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 p -80.63 159.47 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.12 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.61 -19.91 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 74.24 110.866 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -138.29 -179.44 5.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 73.43 110.864 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.83 106.07 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 71.32 110.947 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' A' ' 142' ' ' MET . 61.8 mt -92.35 102.78 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 70.54 111.13 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.7 p -117.07 167.65 10.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 73.3 111.099 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.3 mt -90.95 134.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 75.01 111.107 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.34 -62.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 65.31 111.094 179.789 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -140.17 165.07 28.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.433 . . . . 61.31 110.827 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 33.4 m -142.67 166.27 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.884 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.82 179.8 46.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 51.23 112.452 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.2 mt-30 -93.61 -57.65 2.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 75.31 110.924 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.99 150.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.945 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.888 179.916 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 72.23 110.874 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.39 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.109 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.83 153.46 47.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 73.34 110.882 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 24' ' ' LEU . 53.5 Cg_endo -69.75 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.64 2.227 . . . . 62.24 112.317 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.4 m -126.96 142.07 51.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.165 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 163' ' ' GLN . 5.0 m -124.37 157.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 62.15 111.082 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -114.0 154.84 26.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.906 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.25 138.62 35.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 63.02 110.898 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.62 113.12 26.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 52.43 110.887 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.43 121.73 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.149 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -108.71 163.01 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.088 179.823 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -153.07 105.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.115 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.79 31.71 9.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.842 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.65 -17.42 52.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.493 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.5 136.5 23.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.679 0.752 . . . . 61.24 110.844 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 155.03 66.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 50.55 112.296 -179.989 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.04 -60.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.967 179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.61 -170.94 35.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.732 -0.746 . . . . 20.23 112.494 179.889 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -124.64 127.51 47.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 74.22 110.874 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.618 ' CG1' HG13 ' A' ' 132' ' ' VAL . 8.0 t -129.87 129.85 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.159 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 p -109.19 154.49 22.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.878 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 135.06 52.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.41 110.848 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.36 131.95 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.51 110.868 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 4' ' ' PRO . 36.5 mt -96.18 118.51 32.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 52.04 110.937 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 90' ' ' LEU . 47.6 m-85 -80.12 55.33 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.88 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.35 -28.24 11.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 63.13 111.094 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.63 -47.47 70.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 70.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 89' ' ' ILE . 1.1 mttt -95.78 -32.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.867 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -124.22 74.64 59.59 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.667 0.746 . . . . 74.14 111.168 179.877 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -51.14 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.698 2.265 . . . . 71.41 112.32 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -43.22 84.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.894 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.496 HG21 ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -69.01 -60.89 2.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.119 -179.987 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -33.76 -67.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.22 111.141 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' ARG . 79.3 tt0 -58.67 -58.79 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.874 -179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.0 t30 -32.85 -53.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.912 -179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -79.2 -29.07 42.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 63.34 110.913 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 4.7 ttp180 -52.31 -32.99 40.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.859 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.25 -25.14 61.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.082 179.944 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 27.31 3.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.916 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -152.5 -25.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.87 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.5 p -81.82 -43.99 17.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 65.43 111.081 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 155.05 -27.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.11 112.455 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 42' ' ' GLY . 1.1 mt-10 -30.71 -74.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 63.24 110.897 -179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.64 144.38 31.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 60.41 110.9 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.79 22.1 7.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.722 -0.752 . . . . 75.13 112.513 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.52 -8.0 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 74.42 110.896 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.97 -101.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.489 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 63.43 110.876 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? 57.6 169.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 74.44 110.912 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.54 118.53 8.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 73.53 112.506 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.6 p -159.33 -82.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 74.41 110.812 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 155' ' ' LYS . 5.9 p -177.57 173.82 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 61.12 110.883 -179.921 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.36 -171.24 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.834 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.74 -55.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 65.34 110.855 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.92 144.01 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.844 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -152.36 120.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.34 111.158 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.46 109.07 19.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.72 . . . . 72.43 111.183 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 97.92 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.655 2.236 . . . . 73.31 112.39 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.45 -5.06 23.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.526 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -66.52 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 74.43 110.835 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.06 -168.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 73.24 110.837 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.7 m -142.74 128.93 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.862 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -123.67 157.15 34.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 64.44 110.924 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.11 112.459 -179.968 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.329 . . . . 73.44 110.896 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.61 177.68 8.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 65.21 110.871 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.17 -34.06 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 73.31 111.102 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.29 -7.3 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.882 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.19 -169.72 42.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 45.31 112.455 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.42 -90.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 40.11 110.877 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.9 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -154.66 160.33 41.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.857 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.9 175.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 71.34 110.914 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.19 149.13 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.902 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -94.83 -46.68 6.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.887 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.93 157.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 62.42 110.875 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.22 37.25 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.876 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.71 HG21 ' HG2' ' A' ' 28' ' ' LYS . 23.4 mm -55.39 -22.67 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.43 111.139 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.503 HD11 ' CD2' ' A' ' 25' ' ' PHE . 4.4 mm? -85.57 116.62 23.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.903 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -107.0 104.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.926 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.712 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.33 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 179.882 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.8 p -113.78 26.88 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 72.32 111.177 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 163.64 35.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 51.1 112.492 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 140.7 43.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.712 2.275 . . . . 61.01 112.349 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.95 45.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 72.13 112.465 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 92' ' ' HIS . 13.0 mm -70.45 146.21 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 65.25 111.096 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.0 mt -121.27 166.0 14.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.903 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.51 -170.99 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.891 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.496 ' HE1' HG21 ' A' ' 32' ' ' THR . 1.9 tpp -92.55 114.15 26.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.863 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -101.49 140.0 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 70.41 111.085 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 1.2 m-20 168.09 -75.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.915 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.46 29.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.109 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.51 -172.52 14.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 54.32 112.523 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -49.69 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.675 2.25 . . . . 54.53 112.327 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -48.7 -20.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.03 110.879 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.671 ' O ' ' C ' ' A' ' 108' ' ' ASN . 29.8 p -124.05 44.36 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.097 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.671 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.9 OUTLIER 1.96 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 72.45 110.901 179.98 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 79.49 91.56 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 52.44 112.491 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.91 121.47 34.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 72.33 110.893 -179.754 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -64.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 64.52 110.929 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.82 167.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.86 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -176.11 66.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.34 110.881 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.496 HG22 HG22 ' A' ' 116' ' ' THR . 6.6 mt -78.3 108.5 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 65.43 111.089 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.7 m -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 73.43 110.86 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.496 HG22 HG22 ' A' ' 114' ' ' ILE . 1.8 p 60.62 10.57 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 74.53 111.176 -179.812 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.66 -170.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.116 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -79.78 125.32 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.911 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.553 HG23 ' CD2' ' A' ' 92' ' ' HIS . 9.7 t -142.45 45.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 65.42 111.134 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.75 -10.75 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 62.03 110.906 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -57.93 -26.74 62.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.54 110.904 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.68 49.82 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 70.45 110.906 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -71.57 -40.76 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.897 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.1 81.73 0.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 50.31 112.549 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -160.17 -57.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 62.43 110.873 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -112.08 142.06 44.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.834 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.424 ' HB ' ' HE3' ' A' ' 100' ' ' MET . 81.5 t -65.71 100.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 64.12 111.179 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.26 136.51 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 52.1 111.115 179.93 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -177.46 128.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.888 179.951 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 120.69 4.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 62.04 112.524 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 152.23 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 72.53 110.88 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.618 HG13 ' CG1' ' A' ' 20' ' ' VAL . 34.3 t -44.35 141.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 53.42 111.133 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -132.79 -41.79 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.891 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -66.23 -78.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.879 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.79 115.77 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 60.04 112.49 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.68 -9.23 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.14 110.885 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -50.3 -25.06 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 63.42 110.861 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.99 -45.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 71.31 111.084 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.4 t -54.86 -20.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.24 111.09 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.65 -28.08 24.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.02 110.86 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -33.63 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 61.5 111.117 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptm -73.79 -21.19 60.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 50.04 110.92 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.38 26.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 54.44 110.881 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 -20.7 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.898 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.83 15.37 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.12 110.877 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.08 -142.81 9.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 72.54 112.462 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 p -162.61 147.91 12.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 55.43 110.832 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -75.7 68.51 2.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 52.52 110.899 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 179.62 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.862 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.62 -60.47 0.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 53.13 112.483 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 107.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 74.41 110.931 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -79.97 139.44 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.176 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -27.82 67.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 52.11 110.875 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.13 -165.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.906 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 52' ' ' CYS . 2.8 tppm? -131.57 112.09 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.871 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.6 mp -92.43 128.8 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.146 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 7.9 p -133.3 175.08 9.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 53.34 111.165 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -118.63 106.36 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.24 111.144 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.15 -61.5 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.121 179.825 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -134.9 179.32 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.81 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.1 p -172.81 -179.31 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 54.33 110.866 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 146.8 -169.46 27.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 74.54 112.546 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.418 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.8 mt-30 -95.11 138.79 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 61.51 110.895 -179.838 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -50.27 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.943 179.969 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.865 179.947 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.341 . . . . 74.14 110.868 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.33 142.6 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.134 179.974 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.68 161.06 0.92 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.601 0.715 . . . . 54.31 110.861 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 146.53 60.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.234 . . . . 74.45 112.322 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -130.4 72.28 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 72.22 111.144 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.43 151.9 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.11 111.108 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.477 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -130.76 162.06 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.862 179.97 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -136.6 132.9 35.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.861 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 14.1 t70 -107.44 87.82 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.31 110.886 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.559 HG21 ' HE1' ' A' ' 142' ' ' MET . 17.7 mm -71.02 150.42 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.11 111.111 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.41 163.68 29.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 52.14 111.115 179.762 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.9 96.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 54.02 111.168 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t0 68.8 53.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.52 110.851 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.48 14.77 62.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 24.11 112.495 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -128.59 105.27 19.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 64.3 110.894 -179.821 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.74 138.82 38.79 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.734 2.289 . . . . 72.3 112.304 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.87 28.57 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.89 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.41 -158.71 14.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 72.23 112.489 179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.1 179.99 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 73.54 110.919 -179.89 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 11.4 m -139.44 170.08 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 75.21 111.142 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -118.43 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.891 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.7 m-85 -79.8 63.98 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 65.14 110.865 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -49.27 133.92 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.895 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 129' ' ' PHE . 12.9 mt -104.16 132.31 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.957 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -75.77 82.51 2.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.24 110.864 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -8.84 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 54.52 111.127 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.21 -57.37 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 71.12 110.797 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -57.22 -65.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.914 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 129' ' ' PHE . 2.9 m -110.99 95.14 22.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 23.53 111.106 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 53.8 Cg_endo -69.84 -19.24 35.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.694 2.263 . . . . 75.12 112.304 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -61.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 41.41 110.928 179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -57.3 -26.12 60.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 62.22 111.128 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.34 2.38 44.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 63.54 111.06 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.2 tt0 -91.01 -22.62 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.876 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.5 ' ND2' HG23 ' A' ' 78' ' ' ILE . 12.3 t-20 -79.89 -68.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 60.45 110.898 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -46.74 -45.68 19.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 65.05 110.869 179.988 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 3.3 ppt_? -54.47 -32.32 57.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.888 -179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.36 -35.15 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.134 179.88 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 78' ' ' ILE . 86.7 mt -66.57 -28.78 68.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 64.45 110.869 -179.914 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -38.1 82.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 53.54 110.855 -179.93 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.7 p -86.38 11.42 12.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.42 111.164 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 41.2 51.29 4.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 52.15 112.506 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.59 32.79 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 71.32 110.941 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 10.34 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.893 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.31 30.63 8.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 60.12 112.495 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.44 158.63 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 62.25 110.855 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.35 159.08 12.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.32 112.467 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.95 103.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.397 . . . . 73.34 110.971 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 -44.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 71.54 110.858 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.92 31.97 2.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 63.22 112.496 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 t -100.28 -169.69 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 71.41 110.904 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -80.85 -166.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 72.43 110.89 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -94.95 -167.09 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.851 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -74.92 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 72.41 110.886 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -173.39 91.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 62.01 110.853 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.738 HD12 ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -77.08 144.35 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.139 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 61' ' ' MET . 6.3 tt -149.91 100.29 3.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 71.22 111.062 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.71 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.714 2.276 . . . . 41.41 112.311 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.52 -46.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 71.05 112.444 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -69.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 74.31 110.919 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.526 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -155.07 -148.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 42.42 110.903 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.5 m -132.53 -49.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 55.05 110.895 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.9 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 50.31 112.483 -179.974 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 72.23 110.863 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.46 125.92 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.11 110.89 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.5 HG23 ' ND2' ' A' ' 35' ' ' ASN . 2.0 pp -45.3 -40.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 74.13 111.115 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -117.44 29.73 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -147.64 7.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 71.24 112.49 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.56 -33.61 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.961 0.41 . . . . 74.25 110.884 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.31 137.92 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.896 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.602 ' HE2' HD21 ' A' ' 108' ' ' ASN . 28.0 p90 -118.65 161.56 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.88 179.981 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.2 160.54 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.861 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.79 168.23 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.903 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.43 ' HG3' ' ND2' ' A' ' 87' ' ' ASN . 1.2 tp10 -132.64 -68.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.45 110.863 -179.914 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.43 ' ND2' ' HG3' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -172.18 163.26 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.929 -179.954 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.84 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 89' ' ' ILE . 15.9 mt -77.53 -7.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.14 111.162 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.423 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 2.2 mt -114.42 139.09 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.43 110.898 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -171.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 179.852 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -115.01 91.18 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.02 110.904 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -107.19 21.75 17.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.44 111.143 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.72 -163.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 63.02 112.509 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 62.14 112.356 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -49.65 151.42 4.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 52.14 112.46 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER 172.6 124.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 53.1 111.149 -179.955 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -96.87 105.25 17.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.887 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 100' ' ' MET . 1.3 t -121.19 22.89 10.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.875 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.56 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.9 mmt 53.06 123.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 71.32 110.906 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -107.4 68.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 73.53 111.085 179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -115.9 -82.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.906 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -133.72 -70.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 72.24 111.102 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.67 -125.26 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 23.13 112.522 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.53 6.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.739 2.292 . . . . 73.55 112.349 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.94 23.42 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 62.22 110.86 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.564 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.9 p -154.75 46.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.151 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.602 HD21 ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.28 11.65 16.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.873 179.995 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 24.67 -122.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 72.12 112.498 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.75 31.19 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 62.04 110.887 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -167.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.45 110.897 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -165.87 127.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.881 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.753 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -111.46 34.53 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.32 110.857 -179.917 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.576 ' C ' ' O ' ' A' ' 113' ' ' PHE . 24.7 mt -21.6 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 52.14 111.124 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' MET . 14.1 m -82.57 162.46 21.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 55.42 110.837 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 -17.48 11.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.14 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 119' ' ' THR . . . -126.63 146.81 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 75.34 111.081 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.43 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 52.44 110.891 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 117' ' ' ALA . 61.4 p -114.27 69.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.094 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.42 17.02 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 75.33 110.889 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.712 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.7 p90 -98.83 1.02 45.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.05 110.9 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.06 28.21 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.906 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -105.4 95.71 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 70.31 110.888 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.35 -42.59 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 75.53 112.459 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -31.74 25.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 73.15 110.929 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -98.16 139.73 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 65.21 110.795 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -60.14 176.74 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 75.11 111.123 179.963 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.561 ' H ' HG22 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -168.82 146.19 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 75.14 111.133 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 4.4 p90 -179.19 38.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.879 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.89 175.28 35.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.729 -0.748 . . . . 74.33 112.506 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -179.17 -166.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 64.53 110.879 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -121.73 125.03 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.11 111.107 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -111.02 -37.51 5.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.867 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -132.1 142.18 49.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.33 110.875 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.32 37.06 5.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 74.31 112.447 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -29.21 27.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 65.33 110.856 -179.966 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.52 -39.53 18.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 65.32 110.869 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.2 mm -39.63 -41.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.41 111.115 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.3 t -88.18 -51.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 71.04 111.074 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -50.59 -59.92 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.883 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.76 -58.94 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 60.14 111.157 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.649 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 5.8 ttm -50.55 -39.0 48.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.941 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -53.65 -24.89 15.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 72.35 110.919 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -65.48 -12.26 50.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.83 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -84.22 4.44 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 62.02 110.854 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.02 -158.14 28.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 65.11 112.483 -179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -148.77 -89.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 74.45 110.84 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -154.98 -52.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.03 110.864 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.52 13.89 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 60.55 110.877 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.85 -162.77 12.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 40.24 112.465 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 66.73 140.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 75.51 110.897 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.3 p -123.48 154.35 39.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 75.53 111.127 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.48 -3.86 57.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.874 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.68 165.24 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 53.34 110.888 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.77 114.82 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.33 110.874 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.591 HD13 ' SD ' ' A' ' 142' ' ' MET . 43.5 mt -103.36 106.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 61.34 111.099 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 156.24 24.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 55.2 111.129 179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 mm -84.12 148.26 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 74.42 111.131 179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -97.86 -59.28 1.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 60.25 111.072 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -167.55 163.25 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 52.35 110.838 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.0 m -147.68 176.6 9.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.887 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.55 -168.24 41.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 63.55 112.49 -179.857 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.2 mt-30 -87.27 -38.95 15.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 61.44 110.91 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.8 mm? 75.31 -54.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 71.13 110.886 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.871 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mmm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.342 . . . . 72.11 110.92 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 165' ' ' GLU . 0.4 OUTLIER 61.34 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.143 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 3' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m-20 -96.85 156.57 36.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 61.34 110.856 -179.932 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 147.42 62.91 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.707 2.272 . . . . 54.33 112.314 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 22' ' ' PHE . 8.0 m -147.18 141.27 26.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 63.52 111.142 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.55 147.74 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 71.13 111.142 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -111.78 145.64 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.892 -179.95 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 m-85 -138.27 139.63 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.14 110.866 -179.928 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -108.44 119.62 40.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.21 110.851 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.8 mm -89.03 116.6 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 70.21 111.135 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.68 154.58 17.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.31 111.117 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.89 104.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 72.32 111.112 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.21 37.06 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 71.21 110.861 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.23 80.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 43.31 112.48 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 149.63 71.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 71.33 110.884 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 150.93 68.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.653 2.235 . . . . 72.43 112.34 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.11 -57.59 1.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 62.02 110.879 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 -147.19 5.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 44.44 112.44 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -149.77 124.82 10.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 75.1 110.841 -179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 8' ' ' PHE . 35.6 m -113.37 141.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 70.43 111.094 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -121.69 146.25 47.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 73.24 110.893 -179.859 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' THR . 7.8 m-85 -130.66 136.16 48.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.32 110.894 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.17 111.14 23.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.87 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 129' ' ' PHE . 86.1 mt -82.7 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 43.12 110.899 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 26.1 m-85 -83.17 79.68 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.893 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.59 -1.36 24.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 34.45 111.115 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.52 -47.68 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.899 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.9 mttt -83.88 -27.89 28.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.898 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.53 73.84 35.02 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.578 0.704 . . . . 64.03 111.127 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -9.58 26.45 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.63 2.22 . . . . 62.5 112.362 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -53.66 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.867 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -58.18 -51.48 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.168 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.7 -26.32 67.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.3 111.096 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.9 -34.57 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.897 -179.922 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.01 -57.74 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.885 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -50.89 -38.84 52.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.872 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.12 70.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 73.12 110.925 -179.922 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.36 -33.68 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 71.21 111.118 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD11 ' HA2' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -87.43 23.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.42 110.923 -179.943 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -118.29 -8.45 10.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 55.14 110.871 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 162' ' ' GLY . 17.8 p -117.96 7.48 12.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 63.11 111.16 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.67 29.59 54.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 54.01 112.477 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -34.98 26.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.381 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.32 47.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 74.21 110.899 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.53 56.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 74.12 112.467 179.977 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -179.8 153.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.383 . . . . 64.23 110.849 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 166.2 -140.34 6.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 24.33 112.447 -179.963 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -101.88 -27.99 12.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.973 0.416 . . . . 70.42 110.93 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.38 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.909 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.27 40.38 45.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 52.42 112.481 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 t -122.56 -171.2 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 41.24 110.874 -179.746 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -167.38 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.859 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 156' ' ' ILE . 0.8 OUTLIER -109.41 170.49 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.892 -179.842 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -118.09 -69.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 61.22 110.853 179.955 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 172.35 13.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 65.43 110.876 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -154.58 147.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 52.02 111.114 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.716 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -132.75 120.83 16.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.662 0.744 . . . . 75.24 111.133 179.872 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 109.06 2.21 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.34 112.355 179.879 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 25.32 18.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 64.11 112.527 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.34 -63.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 74.5 110.871 -179.868 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.485 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -177.74 -166.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.897 179.925 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.86 -70.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.887 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 64.86 126.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.878 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 73.11 112.495 -179.955 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.344 . . . . 72.14 110.906 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.94 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 70.31 110.873 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -42.17 -46.84 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.145 179.964 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.468 ' N ' HG23 ' A' ' 78' ' ' ILE . 19.1 m-85 -122.38 49.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.915 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.62 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 65.41 112.453 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.05 -75.82 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 73.52 110.915 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.716 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -130.21 168.46 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 71.44 110.901 179.902 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -145.48 151.66 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.13 110.873 179.969 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -54.8 157.91 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.872 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.55 112.78 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.84 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.51 -46.89 85.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.884 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -177.06 168.66 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 61.41 110.877 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.31 42.6 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.41 110.889 179.994 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -53.39 -23.49 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.41 111.113 179.955 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 128' ' ' VAL . 10.4 mt -94.67 145.95 24.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.958 179.873 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -122.06 -174.93 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 54.5 110.892 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -116.17 79.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.816 179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -119.99 24.9 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 72.05 111.17 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.51 150.34 20.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 63.53 112.465 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -3.5 12.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.735 2.29 . . . . 72.01 112.34 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.45 49.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 73.13 112.477 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.68 135.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 71.41 111.173 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 129' ' ' PHE . 5.4 tt -90.05 122.78 33.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 65.53 110.933 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.478 ' HG ' ' HE2' ' A' ' 113' ' ' PHE . 13.2 t -123.67 164.83 18.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.848 -179.862 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.4 mtp -104.78 124.31 49.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.898 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -91.1 122.55 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 42.42 111.078 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 107' ' ' THR . 8.2 t30 175.85 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 73.53 110.894 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -59.72 -164.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.091 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -108.34 -66.91 0.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.51 112.522 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.581 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.74 130.91 20.2 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.662 2.241 . . . . 65.41 112.356 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.5 p30 22.84 67.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 65.34 110.91 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.847 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 6.9 p -150.62 52.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 74.42 111.151 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 83' ' ' PHE . 4.6 m-20 -50.48 -56.04 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.89 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.4 -172.62 52.06 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 61.54 112.518 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.1 p -112.77 -21.86 10.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 74.15 110.864 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.4 mm-40 -60.3 145.22 48.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 72.4 110.873 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.36 162.72 34.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.831 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' A' ' 99' ' ' SER . 15.1 p90 -148.84 132.02 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.45 110.913 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.73 121.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.41 111.161 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.69 128.76 33.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 55.21 110.878 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 116' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 61' ' ' MET . 6.9 p -90.43 -14.37 33.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.219 -179.91 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.06 160.16 43.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.164 179.833 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -53.29 132.97 39.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 64.14 110.885 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.2 p -138.35 52.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.03 111.13 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -50.63 -22.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 54.22 110.891 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -58.73 -35.79 73.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 61.42 110.894 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.24 101.62 14.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.887 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -151.09 -79.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.837 179.831 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.74 -27.95 29.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 52.4 112.477 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -73.42 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 73.12 110.926 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -99.5 149.77 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 64.24 110.836 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.2 t -64.37 -151.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.13 111.126 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.4 p 175.94 141.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.51 111.138 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.665 ' O ' HD22 ' A' ' 98' ' ' LEU . 3.1 p90 -175.51 124.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.887 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 98' ' ' LEU . . . 108.12 153.47 17.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.504 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -171.77 151.92 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 71.21 110.911 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.5 112.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 55.32 111.176 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.62 -49.97 8.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.932 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -159.45 145.32 16.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.898 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.95 16.56 27.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 42.33 112.481 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -29.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.34 110.852 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -49.57 -29.96 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 52.14 110.953 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.51 -50.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.41 111.099 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.61 -45.92 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 53.53 111.123 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -51.37 -40.45 59.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.891 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.33 -34.19 77.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 40.14 111.101 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.52 -29.13 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.9 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.59 26.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.03 110.872 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.43 -23.79 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.855 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -100.77 6.35 43.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 60.55 110.856 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -154.94 29.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 71.34 112.494 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 t -167.51 150.85 6.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 63.53 110.806 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -77.9 65.78 3.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.42 110.853 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.9 p30 167.82 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 65.14 110.896 -179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.3 172.75 13.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 65.51 112.473 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.51 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.42 110.879 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -91.06 41.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 52.3 111.134 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 74.01 -50.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.84 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.26 -168.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 65.1 110.921 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HE2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -110.55 134.77 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 70.12 110.924 179.861 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 53' ' ' PHE . 17.8 mt -100.38 104.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 53.24 111.114 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.601 HG23 ' HE2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -97.49 178.56 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 73.45 111.133 179.971 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.6 mm -128.38 143.94 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 51.13 111.083 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.17 -65.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.116 179.771 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.47 164.17 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 71.4 110.88 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 59.1 m -144.9 -173.61 4.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 34.21 110.882 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 140.52 -158.31 26.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.04 112.482 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.99 136.33 47.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.861 0.362 . . . . 63.42 110.914 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 164' ' ' LEU . 3.7 tt -93.06 -44.34 8.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 61.32 110.889 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 2' ' ' VAL . 6.9 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 61.32 110.888 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.807 0.337 . . . . 43.3 110.865 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -98.34 133.92 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 63.35 111.125 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -53.99 158.59 3.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.677 0.751 . . . . 64.35 110.852 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 120.71 7.45 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.68 2.253 . . . . 33.31 112.313 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -107.86 68.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 71.14 111.171 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -47.86 155.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 61.41 111.159 179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.66 160.21 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.889 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -144.94 135.05 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.849 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -97.42 78.44 2.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 72.02 110.877 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 17' ' ' LEU . 2.7 mm -56.72 146.21 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.55 111.162 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -134.65 170.48 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.076 179.861 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 156' ' ' ILE . 79.5 t -146.66 96.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 64.45 111.116 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t0 65.84 41.98 3.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.05 -16.19 52.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 73.11 112.523 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -97.42 110.02 52.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.65 0.738 . . . . 73.2 110.91 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.75 144.85 55.43 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 63.41 112.328 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.671 HD13 HG23 ' A' ' 138' ' ' ILE . 4.1 mt -81.29 -44.54 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 53.22 110.952 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.8 35.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 61.02 112.489 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 62.39 147.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 74.43 110.826 -179.893 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 138' ' ' ILE . 36.5 t -105.41 -103.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 63.51 111.079 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 164.64 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.858 -179.859 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.85 111.68 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 64.41 110.932 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -88.22 144.46 26.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 113.18 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.868 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -76.53 66.28 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.892 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.23 77.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.1 111.075 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.57 -65.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.894 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.612 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -51.91 -78.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 65.02 110.891 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 129' ' ' PHE . 17.4 m -72.13 117.72 60.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 53.42 111.1 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -87.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 74.51 112.33 179.942 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -36.79 84.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.849 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -4.46 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 64.12 111.112 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -76.9 -48.54 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' C ' ' A' ' 35' ' ' ASN . 22.2 pt-20 -78.2 -38.12 44.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.849 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -28.97 -67.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.898 -179.935 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HA ' HD12 ' A' ' 39' ' ' LEU . 71.9 t80 -74.91 -34.71 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.909 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 2.6 ttp180 -49.36 -38.68 29.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.843 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -71.55 -35.1 70.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 55.33 111.119 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 36' ' ' PHE . 14.0 mt -68.5 -45.35 72.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.03 110.911 179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.38 94.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.868 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -72.41 -15.52 61.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.168 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 54.17 82.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.463 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.54 31.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 74.44 110.947 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -138.87 22.62 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.11 110.93 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 -40.42 3.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 74.21 112.486 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -127.98 -164.01 1.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.23 110.889 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.92 145.71 11.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 64.02 112.515 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -50.72 102.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 65.32 110.947 -179.781 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.77 -61.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 50.23 110.876 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.47 30.13 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.477 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -76.08 -171.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 74.21 110.87 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.0 m -87.03 -174.44 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 62.31 110.885 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.59 -167.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.887 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -115.73 -92.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 71.24 110.842 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.638 ' HD3' HD11 ' A' ' 57' ' ' ILE . 13.1 ttm180 -135.01 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 72.3 110.872 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 156' ' ' ILE . 70.6 mt 61.19 104.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.54 111.189 -179.929 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' HD3' ' A' ' 55' ' ' ARG . 44.2 mt -139.72 98.78 7.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.582 0.706 . . . . 64.43 111.1 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.3 Cg_endo -69.84 96.13 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.652 2.235 . . . . 72.22 112.321 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.77 -46.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 55.03 112.489 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -67.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 62.31 110.87 -179.84 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.61 -153.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 54.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 p -150.74 153.39 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 74.24 110.924 -179.94 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 1.3 tp60 -88.25 -168.84 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.51 112.493 -179.979 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.761 0.315 . . . . 65.35 110.892 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.74 179.31 7.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.814 -179.861 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' ALA . 23.2 pt -96.63 -36.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.03 111.1 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -87.6 -20.21 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.889 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.22 -173.53 26.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 63.22 112.505 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -19.45 37.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 53.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -175.91 149.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.964 179.967 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -117.03 166.48 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.893 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 4.1 pt-20 -90.41 159.66 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.853 -179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -71.42 141.56 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.15 110.871 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -57.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.902 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -173.0 145.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.43 110.86 -179.951 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.39 52.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.34 110.843 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mt -82.69 3.86 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 73.14 111.093 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD21 ' HG2' ' A' ' 28' ' ' LYS . 2.7 mm? -113.51 97.73 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.92 179.909 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 131.02 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.883 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -53.81 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 70.44 110.882 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -84.27 -12.63 54.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.118 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.64 -170.09 43.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 72.45 112.5 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 53.8 Cg_endo -69.75 142.43 47.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.627 2.218 . . . . 55.03 112.375 -179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.74 -21.24 25.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.787 -0.72 . . . . 64.31 112.478 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.37 149.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 63.22 111.142 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.692 HD12 ' CA ' ' A' ' 130' ' ' GLY . 2.8 mt -119.84 145.96 46.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.945 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -155.8 35.23 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 60.24 110.877 -179.884 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.9 mmt 39.2 -149.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 62.42 110.899 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 100' ' ' MET . . . 166.63 86.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.32 111.062 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -110.1 -71.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.855 -179.942 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -146.02 -39.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.35 111.108 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 128.31 -61.14 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.751 . . . . 74.15 112.516 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.78 100.06 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 75.01 112.325 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.548 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER 25.28 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.873 179.972 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' ALA . 6.6 t -140.63 29.32 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 70.01 111.139 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 t30 51.59 -99.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 54.14 110.895 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 102' ' ' ASN . . . 146.47 -85.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.457 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.56 20.98 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 64.24 110.873 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -87.52 -38.25 16.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 62.02 110.881 -179.965 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 114' ' ' ILE . 66.3 t80 68.65 84.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.929 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.0 129.1 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.872 -179.888 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -117.39 118.65 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.25 111.127 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 115' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 18.9 p -86.0 147.01 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 35.53 110.881 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -107.78 33.81 3.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.33 111.151 -179.897 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -170.2 -177.92 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 54.11 111.084 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -82.68 90.98 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.882 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.603 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.0 p -116.39 64.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 72.21 111.185 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 18.61 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 72.32 110.912 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -97.9 13.8 29.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.921 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 3.5 mt -125.01 -4.25 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 72.03 110.908 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -79.97 53.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.862 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.32 26.17 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 74.31 112.485 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -168.79 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 75.41 110.93 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.94 154.51 17.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 55.41 110.903 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 129' ' ' PHE . 53.9 t -86.95 107.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 65.21 111.117 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.719 HG22 ' HB3' ' A' ' 99' ' ' SER . 39.7 t -93.5 135.02 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 64.13 111.106 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 29' ' ' VAL . 11.6 p90 -170.93 58.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 63.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.692 ' CA ' HD12 ' A' ' 98' ' ' LEU . . . -128.93 179.32 16.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 64.32 112.483 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 176.31 147.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 73.04 110.871 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -112.28 94.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.087 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -75.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.909 179.894 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.17 -166.2 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.872 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.84 69.03 1.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.43 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -7.1 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.758 0.314 . . . . 73.22 110.866 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -31.31 61.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 52.45 110.846 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.684 HG21 HG22 ' A' ' 20' ' ' VAL . 21.2 mm -73.74 -39.19 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 54.44 111.133 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 139' ' ' VAL . 15.5 t -82.36 -1.48 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 70.11 111.169 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -118.24 -59.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 65.03 110.909 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.81 -56.13 22.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.51 111.128 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 2.0 ttm -51.43 -49.47 61.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.9 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -24.61 28.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.42 110.91 -179.963 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -66.67 -13.64 61.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 75.15 110.871 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -90.36 19.5 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.43 110.861 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.78 -158.75 31.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.743 . . . . 74.34 112.482 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -146.82 -77.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 62.43 110.852 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.35 110.912 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.1 -14.68 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.88 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.27 -34.41 2.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.25 112.479 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 127.84 15.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 72.04 110.872 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -110.01 149.56 29.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.52 111.121 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -68.9 -25.27 64.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 43.45 110.849 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.02 -166.92 1.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 40.21 110.909 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.9 OUTLIER -121.83 116.9 25.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 74.01 110.908 179.917 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.615 HD13 ' CD1' ' A' ' 56' ' ' ILE . 4.1 mp -95.37 128.34 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 63.05 111.114 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 155' ' ' LYS . 82.4 p -138.59 149.53 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.081 179.991 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.669 HD13 ' CE1' ' A' ' 48' ' ' TYR . 3.0 mp -88.99 105.94 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 61.34 111.144 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.08 76.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 62.02 111.102 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -156.61 177.99 10.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.53 110.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.3 p -174.54 159.81 3.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.24 110.873 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.51 -179.95 37.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.54 112.49 -179.942 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.57 -43.81 22.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 73.02 110.904 -179.85 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.86 -172.46 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 62.3 110.913 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 64.43 110.877 179.889 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.813 0.339 . . . . 75.32 110.872 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.4 t -142.24 145.83 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 62.04 111.069 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -65.71 140.87 97.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.623 0.725 . . . . 73.24 110.911 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.73 69.36 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 60.0 112.321 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 58.0 m -138.59 90.29 2.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 33.2 111.147 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -74.22 162.56 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 63.31 111.103 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -133.45 157.24 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 71.4 110.909 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -140.87 139.99 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.43 110.91 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.635 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 6.7 m-20 -95.46 99.53 11.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.45 110.927 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 mm -71.7 113.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.125 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.46 161.33 15.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.1 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.91 110.93 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 61.52 111.13 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.7 43.87 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.855 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.82 9.11 65.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 51.53 112.497 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -114.91 132.29 23.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.594 0.712 . . . . 71.34 110.912 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.28 11.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 64.1 112.328 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.58 -36.92 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.919 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.21 -137.89 4.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.756 . . . . 75.12 112.471 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.87 149.74 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.851 0.358 . . . . 64.55 110.837 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 134' ' ' GLU . 5.4 t -148.91 136.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.134 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -114.78 161.66 17.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.869 -179.834 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.76 149.51 46.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.905 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -92.0 107.9 19.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.877 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.664 HD12 ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -81.06 130.18 34.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.875 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -84.73 63.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.44 110.902 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.19 -2.48 31.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.44 111.096 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.89 -55.04 3.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.845 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.3 110.937 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 33' ' ' ALA . 4.7 m -110.84 80.48 2.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.587 0.708 . . . . 75.12 111.131 179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 56.25 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 74.45 112.387 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -161.7 -67.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.915 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.682 HG21 HG11 ' A' ' 127' ' ' VAL . 10.0 t -72.48 -16.58 61.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 54.52 111.139 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 24' ' ' LEU . . . -82.47 -36.39 26.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 71.2 111.106 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -63.98 -156.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.886 -179.929 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 65.37 -73.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 33.11 110.876 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.6 t80 -50.07 -34.41 21.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.881 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.68 71.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.45 110.876 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.2 -41.47 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 55.22 111.134 179.887 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.76 -19.32 63.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 63.51 110.912 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -101.18 -7.67 22.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 75.3 110.887 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 99.8 m -105.69 -22.65 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 75.32 111.179 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 69.74 1.36 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 42.41 112.5 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.96 34.16 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 64.45 110.87 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 18.85 2.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.53 110.902 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.13 -32.04 5.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 54.51 112.448 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.85 -177.55 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.362 . . . . 75.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.47 39.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.733 . . . . 62.24 112.536 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.71 -69.26 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 73.33 110.907 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 55.5 179.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.845 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -37.97 100.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 53.52 112.506 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 154.17 42.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 73.21 110.824 -179.729 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.8 p -65.76 161.17 21.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 74.41 110.885 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.88 174.97 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.888 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.91 166.37 17.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.874 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 65.68 112.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.828 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.8 mt -151.05 122.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 75.45 111.136 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 7.1 mt -130.6 103.76 16.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 71.55 111.098 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.5 Cg_endo -69.69 85.76 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.67 2.246 . . . . 71.45 112.379 179.817 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.46 -17.08 2.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 52.44 112.519 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.87 -57.89 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 62.44 110.905 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -162.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.33 110.874 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.93 -72.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 65.42 110.867 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 62.87 153.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.913 -179.9 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 41.43 112.467 -179.943 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.804 0.335 . . . . 74.14 110.918 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.1 p -81.92 -167.4 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 63.14 110.881 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.3 pp -109.55 12.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.173 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -129.61 20.74 5.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.911 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.46 -122.34 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 74.12 112.505 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.99 -20.0 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.33 110.892 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -176.11 -175.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 63.3 110.927 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -151.52 154.27 36.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.885 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -71.2 163.26 27.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.854 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.8 123.96 33.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 75.33 110.896 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -48.8 55.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 51.12 110.849 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.3 p30 179.38 175.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.891 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.52 37.6 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -56.55 -23.36 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 55.01 111.11 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HG13 ' A' ' 128' ' ' VAL . 7.2 mt -104.02 134.58 47.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 45.21 110.894 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -120.04 -172.34 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 70.14 110.92 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -97.47 80.34 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 70.32 110.892 179.866 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.7 p -60.68 -22.53 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.42 111.137 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.91 -149.1 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 50.11 112.494 179.945 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 162.7 41.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.625 2.217 . . . . 74.34 112.332 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.33 23.02 76.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 73.2 112.495 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.05 116.83 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 72.22 111.125 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 130' ' ' GLY . 1.4 mt -86.38 136.07 33.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.888 179.948 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -133.77 -153.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 44.52 110.866 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mmt -153.59 158.08 40.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 61.02 110.895 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -108.5 -169.42 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 50.34 111.103 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 32.4 t30 89.43 102.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 63.43 110.893 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.52 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 52.51 -108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.087 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 168.86 -62.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 64.14 112.538 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.8 Cg_endo -69.82 99.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.679 2.253 . . . . 74.42 112.331 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.21 47.0 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 64.3 110.914 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -147.73 71.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.13 111.166 -179.966 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.552 ' CG ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -91.39 31.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 53.45 110.908 179.975 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . -27.57 -95.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 64.12 112.499 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 t -151.66 -167.6 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 70.22 110.857 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.13 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.89 -179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -101.69 139.46 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.867 -179.936 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -111.35 104.6 13.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.893 -179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.39 136.18 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 75.01 111.094 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.19 153.75 20.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.866 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -130.53 -33.87 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 62.23 111.166 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.41 15.76 26.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.085 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 126.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 75.44 110.852 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -143.05 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 41.33 111.127 179.994 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.36 17.14 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.01 110.89 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -29.22 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 64.44 110.926 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -99.4 23.72 8.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.949 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -89.72 42.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 65.22 110.877 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.21 33.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 55.31 112.515 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.19 -49.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 73.44 110.901 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -96.55 158.09 15.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.845 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.5 t -81.8 -168.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.143 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.4 p -172.39 103.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 73.23 111.165 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.68 82.38 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.92 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.558 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 140.03 135.73 3.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 75.01 112.49 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.99 144.49 31.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 73.32 110.976 -179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.43 115.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 73.53 111.106 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -64.49 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 55.51 110.911 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -141.73 146.41 36.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 73.41 110.945 179.905 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.9 10.29 35.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.515 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 ttt -50.07 -28.69 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 70.41 110.848 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -51.5 -25.08 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.936 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.72 -37.34 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.142 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -53.97 -21.77 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 75.21 111.136 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -85.91 -34.32 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.877 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.22 -47.24 83.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 52.21 111.125 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.9 ptm -69.36 -22.11 63.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.91 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -88.45 23.34 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 65.53 110.891 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 -11.46 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.877 -179.922 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.6 11.47 33.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.03 110.877 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.1 -142.18 11.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 53.14 112.484 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t -159.16 139.63 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 64.13 110.843 -179.724 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.69 80.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.13 110.859 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 173.81 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 64.11 110.881 -179.975 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.02 -61.79 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 54.33 112.509 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.23 143.95 10.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 73.52 110.869 -179.973 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.4 p -116.04 133.89 55.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 71.12 111.147 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.17 -1.6 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.41 110.868 -179.898 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -136.78 -171.15 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.33 110.913 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -133.35 153.82 51.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mt -135.39 118.97 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.55 111.129 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.4 p -115.04 169.32 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 51.21 111.168 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.405 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 39.6 mm -110.38 133.33 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.45 111.089 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.635 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -82.67 -58.49 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.52 111.112 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.19 170.67 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 62.14 110.873 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 66.8 m -150.09 166.65 29.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 63.21 110.896 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.17 -178.32 48.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 21.2 112.45 -179.931 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.2 mt-30 -80.08 -32.52 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 73.12 110.955 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER 73.49 -60.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 60.14 110.916 179.971 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 55.2 110.831 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.327 . . . . 71.11 110.922 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.27 156.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 54.13 111.132 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -66.61 128.98 94.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.65 21.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 63.03 112.334 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -126.19 145.04 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 71.23 111.123 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 10.5 m -125.15 147.53 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 55.12 111.139 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.6 p90 -103.62 148.56 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.839 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.06 130.64 20.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.903 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.6 t0 -108.59 119.94 41.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.849 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' CE ' ' A' ' 142' ' ' MET . 12.2 mm -101.82 149.25 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.43 111.097 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.73 26.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.143 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 156' ' ' ILE . 58.9 t -139.1 101.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 63.53 111.117 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.6 t0 78.68 27.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.849 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.21 -15.63 62.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.795 -0.716 . . . . 24.11 112.518 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 136.71 21.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 73.44 110.859 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 162.95 40.12 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.673 2.249 . . . . 62.1 112.319 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -110.23 -52.79 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 53.5 110.895 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 19' ' ' ARG . . . 162.29 -15.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 74.31 112.481 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 71.52 147.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.906 0.384 . . . . 74.43 110.846 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.553 HG13 HG21 ' A' ' 138' ' ' ILE . 26.4 m -115.8 -176.17 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 71.51 111.094 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 133' ' ' LYS . 3.7 m -123.67 87.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.4 110.845 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -84.32 121.63 27.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 63.54 110.928 -179.993 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.04 153.26 20.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 64.33 110.85 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 mt -119.99 126.81 51.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 74.41 110.937 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE2' HD11 ' A' ' 90' ' ' LEU . 21.0 m-85 -89.34 70.48 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.856 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -22.75 67.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.13 111.107 179.914 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.25 -61.08 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.888 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -33.07 30.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.933 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -126.39 79.4 70.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 75.34 111.165 179.876 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -45.41 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 74.24 112.368 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -59.38 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.1 110.904 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' OD1' ' A' ' 108' ' ' ASN . 1.5 m -55.15 -61.88 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 64.42 111.128 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -36.41 11.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 72.32 111.122 179.867 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -67.13 -52.15 45.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 71.32 110.933 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.18 -39.88 31.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.934 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 10.4 t80 -76.24 -29.66 57.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.875 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -44.05 97.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.885 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.46 -25.87 62.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.3 111.071 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 43.0 mt -76.72 -55.63 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 73.22 110.921 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -56.75 -48.96 76.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.0 p -77.44 -13.99 59.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 71.31 111.111 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.17 71.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 72.24 112.48 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.08 33.51 5.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.408 . . . . 62.03 110.927 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.39 0.51 6.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.908 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.0 -2.88 58.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 74.33 112.529 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -166.56 171.98 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 74.51 110.88 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.78 -172.0 24.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 75.33 112.476 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -82.1 129.34 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 72.22 110.915 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -134.93 -48.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 70.42 110.894 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -166.61 51.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 63.15 112.487 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 157' ' ' THR . 16.5 t -71.41 -92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 75.21 110.861 -179.707 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 51' ' ' SER . 0.6 OUTLIER 167.52 139.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 62.35 110.915 -179.914 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -130.3 162.22 29.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 54.44 110.905 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.09 52.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 60.41 110.833 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -135.06 35.44 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.32 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.55 148.08 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.153 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 148' ' ' ARG . 1.5 tt -143.97 110.91 5.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.627 0.727 . . . . 72.11 111.108 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 53.7 Cg_endo -69.76 118.88 5.95 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 71.44 112.361 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.44 -30.27 7.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 61.31 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.08 -66.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.3 110.855 -179.885 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.4 ' H ' HG23 ' A' ' 57' ' ' ILE . 1.7 ptt? -176.52 -152.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 61.55 110.857 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.77 137.91 25.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 44.41 110.886 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.48 157.21 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.04 110.943 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 74.51 112.463 -179.984 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.741 0.305 . . . . 63.41 110.916 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 m -105.69 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.15 110.826 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.17 -44.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.11 111.127 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -101.28 75.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 73.33 110.934 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.49 -127.77 8.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 71.14 112.494 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -111.19 -85.25 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 60.34 110.913 -179.932 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -123.48 145.92 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.875 179.966 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.43 171.02 7.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 72.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.48 161.5 27.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.904 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -69.27 152.88 44.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 73.04 110.899 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.44 -56.67 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 70.23 110.894 -179.888 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -177.46 143.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.5 110.875 -179.968 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.15 41.91 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.885 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 87' ' ' ASN . 9.2 mt -75.27 -22.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 60.32 111.147 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.653 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.31 99.46 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 72.2 110.88 179.89 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.1 101.5 13.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.9 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CB ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.34 95.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.54 110.858 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.7 37.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 60.23 111.155 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 173.16 158.87 18.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 73.3 112.484 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 135.81 31.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.661 2.241 . . . . 63.05 112.326 -179.913 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.84 -22.15 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 64.12 112.498 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 ' CB ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -50.62 152.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 75.11 111.154 -179.976 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -118.87 126.85 52.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.938 179.886 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 128' ' ' VAL . 82.1 p -153.47 86.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.2 110.826 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -38.45 155.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 63.41 110.858 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.77 19.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.13 111.042 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.873 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.809 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.12 -24.91 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 63.43 111.054 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . 117.13 -78.46 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 61.41 112.495 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 107' ' ' THR . 53.4 Cg_endo -69.8 128.58 16.2 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 62.41 112.348 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' PRO . 19.5 m-20 29.24 55.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 73.52 110.921 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 103' ' ' ALA . 18.4 p -140.98 42.66 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 72.21 111.121 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.683 ' C ' ' O ' ' A' ' 107' ' ' THR . 23.4 t30 0.83 -82.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.883 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 119.44 168.42 13.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 54.21 112.507 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -132.88 -39.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 51.5 110.839 -179.75 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -84.05 72.71 10.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 64.52 110.897 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.94 -171.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 75.52 110.874 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.91 150.7 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.893 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.8 mt -106.37 114.72 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 60.33 111.144 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.7 m -75.8 132.9 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.861 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.8 p -99.45 11.99 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.2 111.151 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.25 179.28 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.107 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -74.43 119.63 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 73.4 110.902 179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.744 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 73.3 p -132.34 59.03 1.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 72.23 111.149 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.47 -11.87 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.91 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.744 ' CZ2' HG22 ' A' ' 119' ' ' THR . 41.8 p90 -82.99 5.75 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 73.23 110.894 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 82.0 mt -122.51 34.91 5.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.93 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.11 -86.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 63.13 110.86 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.95 78.08 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.741 . . . . 42.42 112.495 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -45.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 73.12 110.881 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 126' ' ' HIS . . . . . 0.444 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 36.7 m-70 -112.57 -25.53 9.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.859 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 24.9 t 73.6 95.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 72.24 111.102 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 99' ' ' SER . 99.0 t -75.32 140.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.119 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CB ' HG21 ' A' ' 29' ' ' VAL . 43.4 p90 -139.01 -29.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 72.41 110.88 -179.95 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.78 -168.33 43.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.489 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 170.01 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.325 . . . . 65.32 110.907 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.67 141.14 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.12 111.19 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 21' ' ' SER . 13.3 tppt? -118.07 -37.22 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.87 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.87 175.57 13.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.881 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.15 78.8 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 63.33 112.475 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.29 -24.11 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 61.22 110.88 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 138' ' ' ILE . 26.1 m120 -77.64 -39.49 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 74.12 110.846 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.553 HG21 HG13 ' A' ' 20' ' ' VAL . 50.0 mm -38.1 -46.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 73.44 111.177 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -88.79 -51.48 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.03 111.132 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 20.5 mm-40 -46.66 -57.0 5.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.855 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.98 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 53.43 111.074 179.964 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.581 ' CE ' HG21 ' A' ' 10' ' ' ILE . 4.5 ttm -52.86 -43.98 66.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 74.11 110.894 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -55.46 -19.77 10.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 64.14 110.884 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -66.7 -20.06 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.861 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -90.89 15.13 11.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.23 110.879 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -94.18 -159.06 33.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 63.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.42 169.7 21.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.22 110.871 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 57' ' ' ILE . 25.1 mmm180 -57.08 -36.96 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.27 12.94 19.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 61.41 110.878 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.85 -85.7 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 22.33 112.443 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 152' ' ' THR . 4.3 mttp 62.6 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 52.43 110.914 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 151' ' ' LYS . 1.4 t 163.29 67.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 72.41 111.117 179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -48.16 82.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.866 -179.873 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -126.37 177.44 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.912 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.89 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 12' ' ' VAL . 21.1 pt -131.6 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 44.31 111.133 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 51' ' ' SER . 1.3 m -134.34 159.41 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.134 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 53' ' ' PHE . 47.0 mt -91.85 115.92 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.11 111.16 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.76 -53.54 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 45.03 111.087 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -141.37 175.56 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.34 110.85 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.8 p -166.53 175.34 8.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.912 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.33 -156.44 26.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 61.13 112.431 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 1.6 tt0 -103.97 144.55 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 72.03 110.898 -179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -57.71 -62.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.912 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 64.5 110.931 179.865 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 74.44 110.852 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.6 t -140.4 142.31 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 72.42 111.136 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.66 153.24 42.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 72.25 110.913 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 154.52 67.8 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.726 2.284 . . . . 72.31 112.35 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -128.36 45.93 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 63.15 111.157 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.69 144.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.34 111.173 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.631 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -128.87 164.94 22.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.22 110.86 -179.939 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.82 148.56 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 75.12 110.907 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.748 ' O ' HD13 ' A' ' 10' ' ' ILE . 25.6 m-20 -108.57 157.22 18.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 64.31 110.889 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 9' ' ' ASP . 8.6 mm -129.97 129.69 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 55.04 111.156 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.44 167.39 15.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.1 111.084 179.821 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 15' ' ' GLU . 12.8 m -152.85 106.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 72.33 111.135 179.946 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.02 23.03 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.35 110.88 179.894 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 -10.32 65.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 51.1 112.494 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HG2' HG23 ' A' ' 12' ' ' VAL . 4.0 pt-20 -101.54 138.56 19.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 62.13 110.916 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 151.99 69.0 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 62.33 112.337 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.8 tp -121.02 -70.97 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.54 110.929 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.41 179.2 35.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 74.43 112.463 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 73.2 110.91 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.85 84.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.31 111.079 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -66.07 94.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.5 110.834 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 25.9 p90 -106.83 114.28 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 74.35 110.899 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.91 146.7 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 33.31 110.869 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' A' ' 129' ' ' PHE . 20.2 mt -108.13 128.41 54.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 75.23 110.943 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -70.84 79.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.889 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.696 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . . . -73.44 -11.18 60.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 51.12 111.116 179.92 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.38 -58.96 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 65.34 110.883 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -50.65 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.936 179.966 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 5.0 m -66.04 128.36 93.77 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 52.45 111.131 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.686 2.257 . . . . 60.24 112.358 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -40.91 64.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 61.51 110.939 179.887 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 54.9 m -57.12 -11.28 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 71.22 111.144 179.961 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 26' ' ' ALA . . . -74.93 -45.43 42.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 75.1 111.1 179.872 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 35' ' ' ASN . 28.9 tt0 -91.42 -49.18 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 70.33 110.917 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.549 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -25.63 -51.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 65.4 110.924 -179.948 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -81.54 -45.04 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.875 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' GLU . 2.9 ptt85 -51.21 -27.16 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.913 -179.946 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.609 ' HB1' ' CD ' ' A' ' 43' ' ' GLU . . . -75.69 -49.2 19.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 62.2 111.11 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.8 tm? -71.32 -10.67 60.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 62.4 110.936 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -8.2 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.879 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 37' ' ' ARG . 19.8 p -102.22 -13.75 17.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 55.42 111.155 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 45.83 8.65 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 60.52 112.526 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.609 ' CD ' ' HB1' ' A' ' 38' ' ' ALA . 8.4 pt-20 -98.38 -21.75 16.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 75.43 110.903 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -89.27 17.97 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 71.3 110.923 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.45 26.01 63.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 75.45 112.473 179.945 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 178.68 168.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 62.24 110.832 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.38 -129.59 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 61.22 112.478 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -93.92 -72.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 75.11 110.918 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 1.7 tptt 59.62 166.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 62.04 110.882 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -36.99 104.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 62.53 112.492 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 m -132.53 -108.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 71.54 110.872 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.7 p 172.77 150.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 51.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -90.53 -71.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.874 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.75 5.82 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.44 110.87 -179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 94.79 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 75.02 110.877 -179.872 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 62' ' ' CYS . 2.5 mt -147.77 139.84 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.54 111.187 179.931 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -140.07 139.37 21.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.609 0.719 . . . . 54.54 111.118 179.913 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 128.4 15.98 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.677 2.251 . . . . 54.13 112.335 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 117' ' ' ALA . . . 67.18 48.22 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.06 -80.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 61.42 110.862 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -165.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.899 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.404 ' HB2' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -149.59 147.46 28.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.31 110.864 -179.991 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.66 127.36 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.911 -179.886 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.489 -179.948 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.716 ' N ' ' HG ' ' A' ' 110' ' ' SER . 17.6 ptpt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.793 0.33 . . . . 63.04 110.902 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.5 m -81.18 143.79 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.861 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 39' ' ' LEU . 15.4 pt -83.88 -39.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.153 179.936 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -88.83 -6.78 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.73 -138.18 2.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.768 -0.73 . . . . 71.01 112.493 179.96 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -122.6 -29.59 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.419 . . . . 73.35 110.896 -179.851 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -174.67 137.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 73.14 110.924 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.43 138.43 54.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.881 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 175.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.886 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.46 -168.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.846 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.17 -61.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.853 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -171.22 154.01 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 71.32 110.888 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.02 79.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.873 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.621 ' O ' HD23 ' A' ' 90' ' ' LEU . 10.4 mm -86.77 14.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.136 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 89' ' ' ILE . 5.7 mt -131.33 99.69 4.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 73.4 110.906 179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.09 125.74 33.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.868 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.423 ' HA ' HG13 ' A' ' 97' ' ' ILE . 1.3 m80 -49.03 97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.838 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -116.39 22.71 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 75.24 111.109 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 166.22 26.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.43 112.462 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 132.81 24.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 73.4 112.4 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 121.7 -23.74 7.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.51 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 92' ' ' HIS . 33.3 mm -57.58 149.99 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.341 . . . . 63.45 111.136 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 112' ' ' PHE . 6.7 mp -120.86 143.14 49.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.913 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.08 39.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.851 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.497 ' SD ' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER 59.01 168.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.1 110.862 179.936 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.64 76.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.1 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -144.04 -80.09 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 73.13 110.884 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -125.81 -146.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 63.33 111.123 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.622 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -140.29 -64.18 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 61.12 112.516 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.5 Cg_endo -69.8 106.08 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.21 112.368 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 39.86 68.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.884 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -152.78 35.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.173 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.656 ' C ' ' O ' ' A' ' 107' ' ' THR . 1.6 m120 7.46 -87.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.54 110.94 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 128.8 -41.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.2 112.5 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.716 ' HG ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 76.68 -39.03 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.32 110.856 -179.734 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -62.67 -159.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.02 110.905 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.761 ' HB2' HD23 ' A' ' 98' ' ' LEU . 11.8 p90 -170.72 140.87 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 65.03 110.86 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 4.3 p90 -131.29 102.11 5.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.927 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.446 HG23 ' HA2' ' A' ' 96' ' ' GLY . 12.4 mt -64.59 103.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 73.43 111.157 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.6 m -60.47 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 54.1 110.888 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.94 13.83 27.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 51.14 111.124 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 119' ' ' THR . . . -169.63 153.86 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 71.2 111.101 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -56.91 99.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.12 110.942 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.6 p -117.7 63.19 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 72.45 111.117 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 2.14 5.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 64.22 110.882 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.466 ' CZ2' HG22 ' A' ' 119' ' ' THR . 26.0 p90 -91.78 2.99 56.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.938 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.65 37.97 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.54 110.887 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -125.87 70.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.886 179.851 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.08 -49.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 71.2 112.471 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.13 -31.99 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 73.22 110.87 -179.935 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.25 145.15 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.846 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.1 m -79.0 109.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 74.32 111.177 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 90' ' ' LEU . 9.0 p -75.35 144.61 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.54 111.133 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.758 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 2.0 t80 174.5 100.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.884 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.616 ' C ' HD13 ' A' ' 98' ' ' LEU . . . 123.74 144.08 6.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 63.5 112.479 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -154.72 -179.77 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 75.25 110.911 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 12.1 t -108.36 85.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 74.42 111.136 179.88 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.83 -50.3 68.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.921 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.9 163.56 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.859 179.961 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.17 -4.44 64.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.52 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.37 -34.38 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 74.13 110.869 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.93 -24.24 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 62.24 110.89 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.21 -41.06 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.21 111.078 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.03 -37.96 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 74.41 111.121 179.852 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.85 -20.87 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 72.52 110.853 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.17 -38.97 26.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -65.23 -29.8 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.886 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.64 -50.32 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.906 -179.965 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -17.05 52.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.3 -16.47 29.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.906 -179.946 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.99 -158.97 21.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 72.22 112.491 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -149.57 -162.2 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 74.13 110.804 -179.705 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -92.45 -42.74 9.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.892 -179.908 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -101.01 15.28 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.12 110.935 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.68 -157.87 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 61.44 112.463 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm 60.85 159.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 74.32 110.916 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -133.26 161.37 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.31 111.152 179.965 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.39 -19.26 43.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 73.21 110.817 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -135.37 161.08 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.32 110.889 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -90.86 128.18 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.919 179.875 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mt -101.16 134.92 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 72.12 111.133 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 155' ' ' LYS . 4.2 p -136.59 163.89 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 75.31 111.175 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.1 mp -124.71 132.89 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.094 179.923 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.06 -58.34 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 74.35 111.122 179.799 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -151.81 179.03 8.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.34 110.881 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.9 p -176.15 165.44 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 142.83 -171.59 24.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 75.4 112.428 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -68.7 118.51 11.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 72.43 110.933 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.4 mm? -92.32 -44.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.916 -179.964 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.873 179.897 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 74.12 110.867 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.14 155.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 54.03 111.126 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.47 141.37 42.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 74.12 110.848 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.7 Cg_endo -69.75 127.79 15.11 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 73.32 112.347 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -102.19 148.78 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 55.32 111.144 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -120.21 139.02 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 53.12 111.158 179.868 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -117.42 143.95 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.849 -179.936 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -140.07 127.63 21.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 65.21 110.855 -179.929 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 34.6 t0 -101.0 79.6 2.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.858 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.32 139.11 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.5 111.116 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -127.17 158.66 36.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 111.091 179.763 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.34 97.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.09 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t0 54.61 54.96 8.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.32 110.891 179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.82 13.06 60.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 62.32 112.456 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -142.48 93.02 7.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.684 0.754 . . . . 72.1 110.862 -179.885 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 152.43 69.28 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.688 2.259 . . . . 72.02 112.316 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.74 25.13 9.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.906 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.21 -173.68 20.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.504 179.912 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 170.3 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 71.24 110.846 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG13 HG13 ' A' ' 138' ' ' ILE . 35.2 m -137.33 177.6 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.119 179.957 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 p -136.63 138.79 41.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 23.54 110.894 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -114.52 149.55 36.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.878 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.52 128.63 53.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 74.24 110.916 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 6' ' ' VAL . 6.6 mt -94.85 116.79 29.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 54.31 110.915 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 11.1 m-85 -82.61 67.47 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.893 179.92 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.072 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -36.54 74.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 62.41 110.919 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -89.83 -28.39 19.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 64.12 110.946 179.965 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -147.24 83.69 7.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.638 0.732 . . . . 73.0 111.138 179.834 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.28 37.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 54.44 112.348 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -34.75 19.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.925 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -75.07 -53.74 8.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.119 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.17 -37.95 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.45 111.148 179.887 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.64 -30.66 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.35 110.869 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.32 -61.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.851 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.01 -29.8 9.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.13 110.871 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.95 85.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.826 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.912 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -81.32 -19.03 43.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 53.4 111.132 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 110' ' ' SER . 87.8 mt -78.9 -61.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 65.41 110.924 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -51.48 -45.65 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.886 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.43 -9.87 56.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 74.43 111.089 -179.902 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.12 73.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.528 -179.973 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -47.8 -53.47 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.383 . . . . 64.55 110.876 -179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -167.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 63.01 110.903 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.98 17.38 55.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.512 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -146.35 -168.32 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 74.23 110.89 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.72 144.02 7.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 42.12 112.508 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.22 120.67 5.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 75.11 110.96 -179.81 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -41.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.01 110.9 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 30.64 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 62.22 112.508 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -77.21 162.12 27.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 72.22 110.84 -179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 m -75.06 -168.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.914 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.692 ' CE1' HD11 ' A' ' 158' ' ' ILE . 2.2 m-85 -140.16 135.74 32.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.876 -179.864 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.12 -179.11 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.04 110.858 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER 66.83 20.69 10.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.45 110.879 -179.875 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.475 HD12 ' OG1' ' A' ' 152' ' ' THR . 18.6 mt -69.45 123.47 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 74.2 111.118 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 55' ' ' ARG . 2.9 mp -138.92 103.44 7.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 60.24 111.155 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 76.08 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 45.31 112.337 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.02 -25.63 0.31 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 62.4 112.489 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.34 -64.19 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.05 110.876 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 -161.57 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 62.54 110.899 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.5 m -137.47 -64.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 40.5 110.882 -179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.97 152.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.904 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 55.54 112.448 -179.976 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 64.24 110.881 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -116.55 131.91 56.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 55.12 110.839 -179.884 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.912 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -49.35 -34.15 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.171 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD12 ' A' ' 78' ' ' ILE . 7.5 m-85 -128.31 55.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 71.23 110.923 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.82 -139.7 8.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.448 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.94 -82.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.385 . . . . 65.11 110.893 -179.846 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.797 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.29 -177.42 4.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 52.41 110.89 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.52 179.74 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.91 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 160.43 22.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.895 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -74.14 111.2 9.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.903 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.31 -52.35 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.917 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 178.8 165.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.861 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.05 40.22 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.864 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.6 mt -52.48 -29.02 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.52 111.116 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.69 118.07 31.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.917 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -105.43 171.1 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.885 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.8 95.35 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.851 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 p -112.11 34.63 4.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.85 41.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.715 -0.755 . . . . 71.4 112.481 179.952 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 150.31 67.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 74.21 112.348 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.0 128.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 52.2 112.482 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -178.0 131.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 75.55 111.146 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.0 tt -89.36 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 61.41 110.899 179.913 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 128' ' ' VAL . 31.1 p -109.74 -152.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.841 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 4.2 mtt -160.51 104.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.899 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.89 161.76 13.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.126 179.915 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER 172.14 -45.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.868 -179.936 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.909 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -172.21 -34.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 71.25 111.084 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.15 -80.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.743 -0.741 . . . . 43.14 112.494 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.623 ' O ' HG23 ' A' ' 107' ' ' THR . 53.6 Cg_endo -69.78 120.4 7.19 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 73.51 112.323 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 39.65 36.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 73.54 110.876 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.909 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 69.6 p -144.81 61.55 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 74.11 111.122 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 109' ' ' GLY . 3.0 m120 -82.16 -6.38 59.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 61.31 110.907 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 29.45 -138.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 72.44 112.492 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 39' ' ' LEU . 9.2 m -147.7 29.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 74.43 110.856 -179.711 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -107.18 83.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.3 110.95 -179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -80.66 176.98 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.878 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.64 -175.83 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.4 110.884 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.73 117.11 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.44 111.112 179.986 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.41 153.51 21.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 75.44 110.878 179.953 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.3 p -131.16 12.24 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 111.155 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.76 6.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 50.32 111.096 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.62 131.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.893 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.615 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.6 p -142.03 54.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 61.44 111.153 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.19 -17.88 5.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 62.35 110.919 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 121' ' ' TRP . . . . . 0.615 ' CZ2' HG22 ' A' ' 119' ' ' THR . 20.4 p90 -69.1 -18.47 63.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 72.14 110.922 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 50.7 mt -89.8 -6.8 55.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.902 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -47.77 -51.68 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 74.23 110.884 179.84 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.02 52.23 3.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 52.53 112.512 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -159.65 -50.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 50.22 110.868 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -110.13 143.25 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.827 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 76.4 t -48.97 -87.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 64.4 111.142 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 ' NE2' ' A' ' 92' ' ' HIS . 17.1 t 82.77 123.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 51.41 111.135 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.464 ' HB3' HG21 ' A' ' 29' ' ' VAL . 14.6 p90 -161.35 36.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 70.31 110.858 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.76 173.3 36.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 41.31 112.485 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -173.83 156.23 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 74.41 110.907 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.1 t -51.05 108.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.4 111.139 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -34.06 54.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.31 110.935 179.89 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -151.51 169.77 21.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 73.23 110.864 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 78.97 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 52.41 112.508 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.5 tpt -87.17 0.87 54.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 62.14 110.881 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -88.59 -34.32 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 71.41 110.891 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.572 HG13 HG13 ' A' ' 20' ' ' VAL . 30.7 mm -60.95 -40.28 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 72.1 111.143 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 139' ' ' VAL . 13.9 t -87.32 0.13 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 43.25 111.131 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -112.78 -69.71 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.893 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.06 -51.6 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 63.22 111.131 179.942 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 142' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 5.3 tmm? -44.31 -39.95 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.45 110.902 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.02 59.64 1.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 65.11 110.874 -179.914 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.94 -12.4 4.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.1 110.898 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.0 21.65 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.876 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 146' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -97.93 65.11 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 25.41 112.501 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.603 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.8 OUTLIER -18.64 120.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 52.34 110.867 -179.721 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -47.54 -43.31 24.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.855 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -45.68 -35.34 4.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.1 -60.86 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.719 . . . . 63.22 112.482 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 125.94 19.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 53.04 110.87 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.497 HG23 ' HA2' ' A' ' 146' ' ' GLY . 2.2 m -85.89 139.94 30.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 65.24 111.135 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -67.66 -22.72 65.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.829 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -124.59 -164.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 54.11 110.916 179.906 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 112.16 13.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 74.23 110.913 179.872 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 mt -99.06 90.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.24 111.154 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -91.14 153.61 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 65.43 111.114 -179.976 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -94.22 128.28 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.124 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.13 -63.08 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.41 111.106 179.804 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.26 162.17 41.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 74.1 110.873 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.06 -179.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 63.41 110.921 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.46 -156.63 25.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 62.21 112.492 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -120.02 140.58 50.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 74.41 110.874 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.08 132.66 53.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.1 110.913 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 64.44 110.959 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 75.04 110.82 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.5 OUTLIER 62.55 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.11 111.125 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' VAL . 13.0 m-20 -88.47 144.63 34.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 64.55 110.864 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 132.26 22.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.684 2.256 . . . . 63.0 112.338 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.442 HG21 HD22 ' A' ' 164' ' ' LEU . 21.6 m -116.51 142.28 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 75.24 111.097 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.79 137.8 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -101.34 156.23 17.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.857 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.52 143.69 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.901 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.35 143.03 37.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.879 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -115.43 120.3 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.149 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 163.28 13.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 53.25 111.064 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.653 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.88 96.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 72.13 111.145 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.33 31.39 6.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.14 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.24 65.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 63.34 112.475 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -96.22 132.91 25.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.648 0.737 . . . . 74.35 110.874 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.65 65.32 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 72.13 112.351 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.6 tp -121.97 -72.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.903 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.64 -148.24 4.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 74.34 112.526 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.75 126.6 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 63.52 110.874 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.33 125.26 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 70.24 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.1 p -113.47 159.16 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.884 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.69 126.67 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.904 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.0 tm-20 -59.46 -48.36 81.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 71.01 110.916 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 7.1 mt 69.51 126.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.22 110.935 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CG ' HD21 ' A' ' 90' ' ' LEU . 81.8 m-85 -88.6 74.14 8.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.902 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.8 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.4 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.01 -37.59 12.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.896 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 3.2 mmtp -75.11 -27.7 59.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 129' ' ' PHE . 2.7 m -131.67 68.7 81.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 52.22 111.095 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 58.87 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.698 2.265 . . . . 34.11 112.378 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.59 -72.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.31 110.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 86.3 m -58.95 -53.91 53.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 64.12 111.14 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -77.42 -9.39 58.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 62.13 111.118 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -74.17 -24.75 59.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.849 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -90.5 -34.41 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.869 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' HD2' HD11 ' A' ' 24' ' ' LEU . 3.8 t80 -50.77 -28.71 9.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.928 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.36 76.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 62.42 110.874 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.96 -28.69 25.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.12 111.119 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD11 ' CE2' ' A' ' 67' ' ' PHE . 1.1 tt -89.12 13.1 13.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.951 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -117.22 -11.99 10.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 51.42 110.852 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.491 HG22 ' HA2' ' A' ' 162' ' ' GLY . 71.1 p -116.63 -0.06 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.184 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.56 10.66 60.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.44 112.516 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.16 -36.79 85.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 74.24 110.846 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -15.23 62.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 71.24 110.921 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.01 -18.66 30.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.746 . . . . 34.44 112.472 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.764 ' CG ' HG21 ' A' ' 73' ' ' THR . 9.6 m-85 -87.42 -24.95 24.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.38 . . . . 64.53 110.841 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -30.9 135.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 64.34 112.457 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -76.46 -43.86 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.96 0.409 . . . . 65.24 110.941 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.67 93.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 72.24 110.889 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.9 63.18 0.84 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 73.14 112.462 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 53.04 110.834 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.3 p -144.7 -172.74 3.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 65.12 110.896 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.45 167.09 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 70.43 110.878 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -46.96 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.858 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -146.04 153.05 40.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.863 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 HG21 ' A' ' 152' ' ' THR . 63.5 mt -144.81 130.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.12 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.458 HD12 ' HE3' ' A' ' 61' ' ' MET . 3.1 mt -134.78 104.65 10.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 75.54 111.145 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.76 98.43 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 62.02 112.32 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.5 -22.51 3.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 62.21 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.27 -60.65 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 65.22 110.865 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.458 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -173.45 -160.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 61.34 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 65.3 m -133.36 -73.0 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 74.21 110.907 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 61.8 160.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.894 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.71 55.09 0.46 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 53.35 112.459 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.0 122.73 2.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 61.41 112.43 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -151.08 -172.16 4.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 74.4 110.91 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.497 ' CE2' HD11 ' A' ' 39' ' ' LEU . 14.5 p90 -154.77 47.26 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.25 110.843 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 75' ' ' GLY . 59.6 p -79.7 122.92 27.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 71.32 111.134 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.02 171.86 9.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 73.13 110.867 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 71' ' ' ASN . 27.5 p-80 -67.58 -35.0 78.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.882 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' HIS . 23.5 t-20 -32.41 -78.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.51 110.867 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.7 42.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 30.15 112.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.764 HG21 ' CG ' ' A' ' 46' ' ' PHE . 53.7 p -117.86 -51.56 2.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 75.12 111.165 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.73 176.65 22.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 72.13 112.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 68' ' ' THR . . . -94.05 112.65 4.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 62.21 112.512 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.89 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 75.31 110.931 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 t -132.71 137.48 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 73.02 110.843 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -70.32 -27.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 73.25 111.153 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -122.98 41.29 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.79 -136.58 5.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 63.21 112.513 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.82 -74.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 63.04 110.896 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 160.4 32.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.878 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 147.04 35.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.873 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.61 158.65 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 64.33 110.914 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.29 127.19 32.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.45 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -57.76 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.03 110.895 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -179.76 177.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.47 36.95 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.883 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -50.49 -25.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 64.33 111.158 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 28' ' ' LYS . 2.6 mt -73.07 122.75 22.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.92 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -77.23 160.2 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.04 110.872 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -86.53 107.23 18.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.862 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 p -142.93 164.82 29.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.128 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.03 144.19 4.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 62.45 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.01 27.5 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.251 . . . . 73.45 112.326 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.57 73.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 33.35 112.458 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -84.87 161.91 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 75.02 111.121 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.44 HD21 ' CD2' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -102.84 128.83 49.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.916 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 128' ' ' VAL . 47.1 t -143.75 -116.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.816 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.427 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 0.8 OUTLIER 178.24 143.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.34 110.856 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 101.67 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.04 111.095 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 -167.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 74.2 110.929 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 1.057 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -54.65 -37.29 65.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.05 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 107' ' ' THR . . . 114.5 -65.12 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 75.31 112.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.655 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.71 120.88 7.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.252 . . . . 75.34 112.379 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 105' ' ' PRO . 10.0 p-10 26.53 64.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 61.01 110.915 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 1.057 HG21 ' HB3' ' A' ' 103' ' ' ALA . 5.5 t -163.22 54.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 52.31 111.124 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 82.4 m-20 -40.11 -52.29 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.23 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.48 -167.79 53.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 63.54 112.501 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -118.81 -20.17 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 45.22 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -51.44 150.9 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.15 110.948 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' CD2' HD21 ' A' ' 98' ' ' LEU . 1.9 p90 -160.47 175.03 13.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.5 110.893 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -144.98 179.02 7.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.12 110.873 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 32.8 mm -102.24 -63.73 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 63.31 111.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER 79.37 112.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.2 110.921 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 t -98.8 -13.52 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 75.34 111.175 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.61 159.06 30.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 70.02 111.087 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -71.51 102.62 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.66 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 34.9 p -121.36 70.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.44 111.184 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -84.65 22.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.841 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 119' ' ' THR . 3.9 p90 -103.87 9.72 36.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.29 -30.98 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.04 110.93 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.26 165.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.851 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.22 -24.74 30.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 65.33 112.471 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -104.9 -33.56 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 73.13 110.904 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -119.73 170.29 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.819 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.02 112.88 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 64.02 111.129 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.449 ' CG2' HD13 ' A' ' 97' ' ' ILE . 9.6 p -84.94 144.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.41 111.149 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 31.6 p90 -178.65 112.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.41 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 144.04 -166.11 27.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 64.25 112.484 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt 172.87 -174.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 54.52 110.95 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.69 86.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.35 111.15 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -47.5 -74.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.865 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -150.78 146.99 26.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 71.3 110.868 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.36 26.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 41.4 112.51 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.3 -30.14 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 64.01 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -50.76 -25.94 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.03 110.864 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.2 mm -86.33 -38.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.156 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.2 t -51.32 -23.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.2 111.125 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.28 -43.48 15.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.857 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.13 -48.33 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.13 111.131 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.5 ptm -64.08 -20.15 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.46 29.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 74.53 110.873 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.69 -23.18 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.831 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.32 1.33 57.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 72.4 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.71 -147.29 10.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.755 -0.736 . . . . 44.44 112.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.1 134.35 6.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 72.13 110.858 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -70.59 76.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 71.45 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.71 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.21 110.859 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.54 -60.5 0.43 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 72.2 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -61.63 155.18 23.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 64.31 110.966 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 56' ' ' ILE . 63.2 p -124.91 129.42 50.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 70.42 111.166 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.3 -31.69 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 73.14 110.893 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -169.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.895 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -137.88 126.07 23.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 70.13 110.865 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.14 127.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 71.15 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.31 43.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.3 111.192 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.0 142.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.088 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.57 -64.98 1.01 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 31.33 111.078 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.77 178.12 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.5 110.858 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.63 -176.34 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.914 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 137.07 -146.46 18.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 63.3 112.477 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 128.14 53.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 73.4 110.917 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 5' ' ' THR . 1.6 tp -54.51 -56.53 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.905 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 53.12 110.923 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.807 0.337 . . . . 75.35 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.78 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.153 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.35 157.4 38.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 73.32 110.854 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.28 69.21 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.274 . . . . 74.11 112.34 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 13.8 m -130.34 55.57 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.145 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 24' ' ' LEU . 15.4 m -49.26 147.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.169 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -140.55 163.51 32.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 73.41 110.876 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -141.76 146.17 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 72.12 110.882 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -93.98 163.32 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.841 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 mm -132.5 102.66 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.12 111.142 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -105.04 158.0 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 63.13 111.149 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 12' ' ' VAL . 22.5 t -138.31 99.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.34 111.134 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.68 42.65 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.891 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.88 -8.08 67.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 33.55 112.504 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.0 tt0 -100.22 101.38 14.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.746 . . . . 73.53 110.844 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.81 126.89 13.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 74.31 112.298 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -83.87 -43.73 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 71.4 110.909 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.02 -151.32 20.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.42 112.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 156.83 21.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.812 0.339 . . . . 74.1 110.901 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.62 76.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 74.03 111.151 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.65 165.44 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.14 110.89 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -152.67 122.53 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.897 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 39.7 tt0 -47.89 137.03 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 61.31 110.88 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -108.22 120.93 43.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 74.5 110.948 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -76.36 57.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 53.11 110.847 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -28.17 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 22.3 111.067 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.75 -61.29 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.51 110.845 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.921 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.928 HG23 ' HB2' ' A' ' 33' ' ' ALA . 5.4 m -72.75 120.05 78.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.32 111.13 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -87.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.674 2.25 . . . . 74.3 112.382 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -44.58 68.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.898 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -46.07 -28.46 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 73.23 111.121 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.928 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -79.87 -63.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 53.21 111.067 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' ARG . 15.6 tt0 -57.98 -64.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.865 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 34' ' ' GLU . 14.2 t-20 -31.53 -51.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.873 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.01 -40.95 62.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.91 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -52.62 -25.01 9.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.2 110.88 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.37 -43.48 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 35.41 111.109 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 8.0 tt -64.73 -13.98 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 64.42 110.914 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -6.2 31.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 54.25 110.826 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.2 p -101.62 -21.25 14.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.53 111.126 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.76 -17.12 54.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 65.52 112.502 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.59 -37.13 48.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 72.43 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -23.13 35.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.865 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.33 -4.55 40.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 72.23 112.515 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -164.02 167.13 20.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 70.43 110.842 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.31 20.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 73.41 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 108.11 16.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 75.12 110.936 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -69.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.852 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.79 32.67 2.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.33 112.47 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.13 -168.2 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 73.3 110.84 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 m -114.17 -168.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.24 -173.29 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 71.21 110.913 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -102.96 -74.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -154.64 103.52 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 74.32 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.88 128.27 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 61.44 111.17 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 148' ' ' ARG . 5.0 tt -136.11 106.85 9.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 72.31 111.144 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.76 105.72 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.697 2.265 . . . . 71.15 112.306 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.62 -49.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 42.2 112.511 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.27 -66.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 75.15 110.86 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -162.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.12 110.872 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.8 m -149.94 98.38 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 62.52 110.907 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -90.68 170.09 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 71.3 110.889 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.43 -160.25 31.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 71.04 112.46 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.64 -4.17 79.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.751 . . . . 71.11 112.465 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.14 110.75 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 74.24 110.89 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 52.8 p90 -119.37 13.68 12.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 61.55 110.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.454 HG23 ' HA2' ' A' ' 75' ' ' GLY . 12.1 t -177.79 35.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 51.43 111.122 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -40.7 14.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 63.14 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -77.24 56.74 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 51.44 110.86 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.12 -55.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 75.35 110.896 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.29 17.55 56.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.803 -0.713 . . . . 61.44 112.438 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m 44.21 64.72 1.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 75.51 111.139 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.16 133.84 7.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 61.23 112.46 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 68' ' ' THR . . . -62.44 -161.14 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 52.11 112.499 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -174.96 -177.71 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 71.4 110.903 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 177.6 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.844 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 35' ' ' ASN . 30.1 pt -86.9 -34.45 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 54.13 111.115 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.01 72.42 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.903 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.48 -130.02 10.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 70.04 112.501 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.78 -77.5 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 73.15 110.877 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.801 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -136.78 -177.34 4.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 64.22 110.903 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.23 174.91 11.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.22 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.7 158.61 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 61.2 110.853 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 119.48 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.44 110.872 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -47.46 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.863 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.53 167.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.12 110.875 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.48 37.11 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.872 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.79 -22.19 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.43 111.139 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 128' ' ' VAL . 70.3 mt -98.09 90.6 4.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.93 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -63.23 171.98 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 70.35 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.408 ' CD2' HG21 ' A' ' 97' ' ' ILE . 21.5 m80 -90.29 95.25 10.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 72.1 110.86 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 94' ' ' GLY . 18.2 p -131.14 149.56 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 60.33 111.117 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' THR . . . 56.17 155.07 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 41.13 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.37 24.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 64.41 112.348 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 84.28 -10.55 60.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 72.42 112.541 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 92' ' ' HIS . 6.2 mm -47.67 133.51 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 64.43 111.139 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -120.97 145.9 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 63.34 110.884 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 t -149.79 -133.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.821 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.542 ' HE3' HG23 ' A' ' 32' ' ' THR . 5.2 mtt -145.65 112.62 6.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 74.03 110.862 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -95.01 74.37 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 72.43 111.132 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -107.36 -75.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.91 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -134.99 -84.62 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 65.33 111.077 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.84 -83.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 43.12 112.481 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 107' ' ' THR . 53.9 Cg_endo -69.77 113.9 3.53 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.677 2.251 . . . . 63.12 112.351 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 34.47 46.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.32 110.896 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.6 p -142.26 46.74 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 55.23 111.143 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.73 176.52 8.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.13 110.913 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.82 -127.04 1.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 62.13 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -101.76 -171.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 63.44 110.917 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.2 mt-30 72.3 64.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.32 110.913 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -72.48 149.39 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.877 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 5.4 p90 -114.6 120.49 40.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.54 110.847 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.57 132.63 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.101 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.11 127.84 33.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 71.4 110.915 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 p -99.62 -31.35 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 65.02 111.155 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.06 24.77 5.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 72.44 111.089 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.69 135.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.547 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 67.0 p -139.97 61.25 1.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.137 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.06 3.61 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.547 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -86.29 1.44 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.14 110.919 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 pp -139.81 43.64 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.909 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.49 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.845 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 125' ' ' LYS . . . -50.11 140.53 17.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 70.15 112.469 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 1.0 OUTLIER 78.41 61.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.13 110.875 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.431 ' C ' HG23 ' A' ' 127' ' ' VAL . 2.3 m-70 -163.14 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.23 110.846 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.431 HG23 ' C ' ' A' ' 126' ' ' HIS . 5.4 t 74.67 86.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 64.4 111.095 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.482 ' O ' HD12 ' A' ' 90' ' ' LEU . 25.0 t -90.91 133.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.159 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.642 ' CB ' HG21 ' A' ' 29' ' ' VAL . 46.8 p90 -151.64 22.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.44 110.852 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -140.7 174.07 22.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 54.53 112.494 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.68 130.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 53.03 110.895 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' CA ' ' A' ' 96' ' ' GLY . 44.7 t -51.77 129.36 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.42 111.129 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -112.28 -59.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.844 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -139.82 140.99 36.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.888 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.7 1.78 43.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 75.44 112.445 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.56 -31.13 9.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 54.33 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -49.69 -26.72 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.89 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.34 -36.28 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 75.35 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.07 -22.75 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 62.45 111.137 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -83.75 -34.24 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 71.13 110.849 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.0 81.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.5 ptm -72.21 -11.87 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.51 110.951 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.92 25.2 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -16.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 71.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.66 -6.03 40.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.55 -166.05 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 73.4 112.452 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -140.04 -75.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 63.13 110.883 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -179.95 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 72.23 110.908 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -92.79 24.02 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.35 110.873 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.49 9.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 51.1 112.521 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.64 149.1 36.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 61.04 110.859 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -130.85 168.05 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 73.1 111.149 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.2 t -92.04 -2.49 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -140.95 -167.55 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 72.23 110.893 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.45 119.83 17.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 64.51 110.895 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.2 125.57 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 62.44 111.162 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -119.61 172.36 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 70.5 111.14 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.15 108.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.131 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -63.43 -60.28 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.14 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -148.9 177.2 9.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 64.22 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 10.7 p -178.17 163.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.909 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 147.11 -169.61 28.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.47 117.51 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 70.11 110.927 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.5 mm? -99.11 -69.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.54 110.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 1.2 tm-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 62.23 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 73.13 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.23 148.25 24.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 52.03 111.133 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 35.4 m-20 -47.37 143.12 5.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 62.54 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 112.68 3.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 64.23 112.378 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.632 HG22 HD21 ' A' ' 164' ' ' LEU . 24.7 m -115.93 133.81 55.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 72.4 111.125 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG12 ' HG3' ' A' ' 163' ' ' GLN . 17.2 m -124.08 150.15 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 72.2 111.152 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.738 ' HB3' HD22 ' A' ' 164' ' ' LEU . 35.0 p90 -108.48 160.83 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.53 110.87 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.94 130.09 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.31 110.895 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.04 95.68 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 71.24 110.903 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.556 HD12 HG22 ' A' ' 138' ' ' ILE . 15.7 mt -75.62 151.91 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 63.42 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -129.52 168.49 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.01 111.051 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 17' ' ' LEU . 2.9 m -149.73 109.78 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.098 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.19 34.93 2.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.919 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 10.99 84.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 24.15 112.457 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.4 pt-20 -120.3 147.53 45.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.672 0.749 . . . . 62.25 110.876 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.21 56.63 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 62.03 112.336 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 12' ' ' VAL . 18.7 tp -132.97 8.32 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.11 110.969 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -166.15 12.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 24.34 112.494 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.96 151.35 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 72.12 110.888 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 25.9 m -124.95 170.2 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 52.44 111.146 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.436 ' OG ' HD21 ' A' ' 164' ' ' LEU . 14.0 t -122.72 151.33 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.15 110.875 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 5' ' ' THR . 20.0 m-85 -126.4 134.43 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 53.35 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -108.79 105.72 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.902 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.12 138.6 31.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -90.72 83.3 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.842 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.93 0.92 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.2 -34.23 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.15 110.866 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.2 mttm -97.51 -27.14 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 70.25 110.912 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.56 79.46 24.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 73.21 111.138 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -19.25 36.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 72.03 112.336 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -43.65 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 52.22 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.492 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -74.65 -53.19 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 73.4 111.122 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.65 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 75.13 111.099 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.98 -38.16 37.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.906 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.33 -61.86 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 72.34 110.903 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -51.51 -25.23 6.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.21 110.889 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -36.12 83.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.61 -21.05 35.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 110' ' ' SER . 83.1 mt -75.29 -60.44 2.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.929 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 64.02 110.896 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -84.53 -12.78 53.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 44.14 83.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 51.11 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.8 32.03 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 73.0 110.909 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.1 32.54 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 61.34 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.68 13.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 52.12 112.482 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.75 -170.54 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 75.01 110.848 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.57 176.6 37.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 72.02 112.502 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.68 -18.07 63.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 73.41 110.894 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.38 136.55 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 64.41 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.4 58.58 8.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.443 ' OG ' HD13 ' A' ' 158' ' ' ILE . 82.7 p -145.07 -166.27 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 44.11 110.888 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.96 169.06 24.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.869 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' CE1' HD11 ' A' ' 158' ' ' ILE . 53.6 m-85 -104.18 -67.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.35 110.86 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 59.65 20.64 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.23 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -146.97 115.63 6.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.23 156.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.97 112.88 8.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 75.21 111.112 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 86.31 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 71.31 112.384 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.75 9.05 8.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 65.12 112.487 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -69.98 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.51 110.867 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.95 -164.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 55.22 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.608 ' HB3' HG23 ' A' ' 114' ' ' ILE . 19.0 t -151.48 121.57 7.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.869 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -92.91 134.71 34.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.943 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.38 -50.59 61.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 52.54 112.5 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.72 -91.87 2.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 72.43 112.461 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 p30 177.36 65.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 74.41 110.828 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.68 -74.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.12 110.887 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.421 HG21 ' HB1' ' A' ' 101' ' ' ALA . 99.6 m -55.61 114.27 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 74.1 111.166 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -113.62 -27.48 7.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 61.13 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 177.41 35.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.896 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -177.03 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 71.31 110.888 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.68 139.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 40.31 112.517 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -110.2 -33.74 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 64.51 111.116 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.07 -163.01 18.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 75.34 112.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . 159.03 -21.25 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 70.14 112.502 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 66.9 139.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 72.42 110.854 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.82 -179.13 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.83 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.78 -5.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 64.51 111.156 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.99 28.1 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.41 110.9 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.0 -126.18 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 74.42 112.458 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -144.49 13.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 73.24 110.908 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -171.44 126.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -119.03 143.83 46.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.1 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -66.43 156.5 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.899 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -78.03 134.68 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.35 110.884 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -61.98 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.14 110.902 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -173.94 148.21 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.892 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.52 49.97 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 28' ' ' LYS . 32.6 mm -72.5 -15.93 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.149 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -104.75 137.7 42.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.14 110.88 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -129.0 104.89 7.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.914 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.706 ' CB ' HG21 ' A' ' 97' ' ' ILE . 11.9 p80 -67.63 103.57 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.816 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.3 p -130.58 39.63 3.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 73.42 111.13 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.8 163.8 32.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.482 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 146.26 59.6 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.738 2.292 . . . . 74.3 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.02 13.71 65.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.71 -0.757 . . . . 70.33 112.474 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.754 HD13 ' HB3' ' A' ' 131' ' ' LYS . 28.6 mm -89.27 138.61 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 63.15 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 98' ' ' LEU . 6.1 tt -93.99 114.6 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 75.14 110.896 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -113.66 140.29 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 64.53 110.864 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.451 ' HE3' ' CG2' ' A' ' 32' ' ' THR . 3.5 mmt -69.55 145.5 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.44 110.849 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -138.14 139.05 39.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 50.24 111.124 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' OD1' HG22 ' A' ' 107' ' ' THR . 0.4 OUTLIER 174.63 -69.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 72.21 110.908 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -136.42 -40.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 64.54 111.114 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.76 -69.02 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 52.34 112.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -104.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.265 . . . . 71.5 112.356 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -90.77 62.95 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -156.84 68.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.2 111.122 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -44.66 -60.73 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 62.32 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.59 43.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 63.34 112.448 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.422 ' HB2' HD13 ' A' ' 39' ' ' LEU . 2.7 p -129.04 9.94 5.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 72.03 110.851 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -72.26 -166.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.11 110.931 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD12 ' A' ' 98' ' ' LEU . 1.9 t80 -143.87 128.16 17.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.908 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 99' ' ' SER . 32.8 t80 -123.25 106.85 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 63.55 110.888 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 62' ' ' CYS . 7.5 tt -120.55 103.8 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 71.42 111.181 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -85.44 153.11 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 61.01 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 28.95 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.119 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.93 165.11 5.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 43.23 111.067 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -61.78 96.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -122.9 62.43 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 71.11 111.155 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.53 25.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.3 110.902 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 119' ' ' THR . 4.2 m-90 -69.9 -22.88 63.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.934 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.512 HD13 ' NE2' ' A' ' 126' ' ' HIS . 63.0 mt -116.63 34.68 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -86.99 44.42 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 73.12 110.844 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.06 52.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.776 -0.726 . . . . 71.3 112.526 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -171.34 -45.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 72.41 110.894 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.512 ' NE2' HD13 ' A' ' 122' ' ' LEU . 2.0 m-70 -98.49 142.34 30.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 61.12 110.863 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.78 90.61 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 63.31 111.1 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 90' ' ' LEU . 2.8 p -82.53 143.56 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.151 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.492 ' CZ ' HG22 ' A' ' 32' ' ' THR . 2.5 p90 -176.51 134.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.875 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.31 137.99 9.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 54.03 112.487 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.754 ' HB3' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -149.37 172.05 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 54.31 110.907 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.96 139.04 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 72.2 111.105 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -117.9 -29.85 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 54.01 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.56 158.33 36.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 58.71 85.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 55.24 112.484 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.6 mmm -92.04 -24.15 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 72.54 110.848 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 1.9 p-10 -80.57 -34.53 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.52 110.877 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 10' ' ' ILE . 46.6 mm -39.42 -48.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 65.32 111.132 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 114' ' ' ILE . 91.7 t -90.36 -50.8 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 60.41 111.135 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 12.1 mm-40 -44.68 -59.77 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.88 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.74 78.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.03 111.082 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.522 ' SD ' HD13 ' A' ' 156' ' ' ILE . 8.1 tmm? -50.08 -45.04 52.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 73.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -27.76 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 64.34 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -63.31 -25.45 68.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -90.52 21.92 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.1 110.872 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.89 -159.03 21.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 53.21 112.52 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -155.47 147.59 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 71.41 110.836 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -76.34 64.24 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.43 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -176.19 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.63 -52.47 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 71.35 112.454 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.04 112.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 61.11 110.905 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 154' ' ' LYS . 28.1 m -77.88 127.96 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 62.3 111.166 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -46.15 -32.07 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 33.33 110.86 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.589 ' H ' HG22 ' A' ' 152' ' ' THR . 2.8 mttt -133.51 -178.56 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 61.04 110.871 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -98.82 107.28 19.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 55.45 110.938 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.0 mt -98.3 108.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.43 111.147 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.1 t -119.24 156.93 29.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.34 111.148 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 53' ' ' PHE . 3.5 mp -83.48 139.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.73 -59.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.124 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.74 161.81 41.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.64 -168.59 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.32 110.894 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.68 -165.58 26.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 74.44 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.765 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.2 mt-30 -113.09 138.82 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 62.43 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -121.36 156.2 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.913 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.852 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.797 0.332 . . . . 40.53 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.59 141.64 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.23 111.111 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.62 145.83 37.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 72.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 121.59 8.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 72.42 112.301 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 164' ' ' LEU . 37.8 m -106.64 128.04 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.557 ' CG1' HD11 ' A' ' 24' ' ' LEU . 3.3 m -111.73 141.99 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.23 111.164 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.809 ' HB3' HD22 ' A' ' 164' ' ' LEU . 4.8 p90 -122.35 160.22 25.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.902 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 161' ' ' CYS . 11.3 m-85 -142.03 143.1 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.929 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.21 82.07 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.835 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.9 147.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.24 150.56 41.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.32 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 17' ' ' LEU . 67.0 t -135.81 97.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 73.1 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.87 24.41 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.187 -0.46 . . . . 45.04 110.841 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.09 59.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.48 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -108.34 143.0 26.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 74.55 110.881 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 152.82 68.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.661 2.241 . . . . 75.14 112.339 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 12' ' ' VAL . 17.5 tp -129.63 -0.38 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.31 110.905 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.588 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 138.48 171.71 12.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 51.51 112.508 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -105.99 127.41 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 60.3 110.855 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 138' ' ' ILE . 34.0 t -113.18 100.18 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.31 111.137 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.8 p -102.17 142.44 33.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.819 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.52 104.5 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.891 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -51.86 167.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 72.21 110.833 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD11 ' CG1' ' A' ' 6' ' ' VAL . 59.9 mt -117.46 126.85 53.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 74.5 110.93 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 90' ' ' LEU . 23.0 m-85 -77.33 59.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.899 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.06 -7.51 52.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 73.31 111.121 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.85 -65.05 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.02 110.93 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -61.22 2.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.2 m -109.53 83.29 2.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 55.32 111.121 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.97 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 52.42 112.351 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.31 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -47.17 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.52 111.11 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.31 -33.96 59.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.5 111.096 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.61 -31.75 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.51 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' HG23 ' A' ' 78' ' ' ILE . 7.0 t30 -77.49 -67.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.1 110.908 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.18 -43.33 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.849 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HB3' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -63.36 -29.61 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.22 110.861 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.89 -43.33 20.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 35.24 111.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.98 -38.41 82.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.907 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -69.55 -47.88 62.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 51.1 110.893 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.1 p -72.34 -13.52 61.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 72.25 111.121 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.51 69.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 75.12 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.1 41.56 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 74.21 110.932 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 78' ' ' ILE . 5.9 mtpm? -130.09 -2.63 4.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.914 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.73 -14.06 65.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 73.31 112.488 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -33.85 76.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 65.53 110.936 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 48' ' ' TYR . . . 85.27 -141.32 19.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 71.11 112.482 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 1.3 t80 82.56 85.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 72.2 110.884 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 -47.95 4.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -125.29 113.33 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.53 112.512 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 p -88.11 -168.61 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 64.1 110.833 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 p -139.52 96.0 3.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 64.14 110.911 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HZ ' HD11 ' A' ' 158' ' ' ILE . 34.2 m-85 -81.37 107.11 13.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.11 110.858 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.29 29.84 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 73.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.05 24.4 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.21 110.887 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.43 141.73 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.13 111.107 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HE3' ' A' ' 61' ' ' MET . 4.4 mt -131.95 110.36 14.34 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 74.35 111.15 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 89.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.657 2.238 . . . . 74.45 112.403 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.7 14.86 4.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 75.31 112.5 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 -64.51 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 75.34 110.87 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.559 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -177.16 -169.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 72.14 110.883 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.8 m -146.4 142.91 28.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 62.22 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 140.37 51.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.925 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 65' ' ' GLY . . . -116.93 109.16 1.86 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 44.32 112.466 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' GLY . . . 37.47 43.62 1.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 73.03 112.498 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -53.25 137.99 33.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 72.31 110.848 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.36 175.01 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.93 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 p -90.57 -81.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 62.24 111.176 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.88 92.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 52.41 110.872 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -47.24 102.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 73.42 110.861 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.68 -53.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.925 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.85 -71.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 64.54 112.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.9 m -110.32 -41.07 4.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 74.22 111.157 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.43 161.34 21.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 65.11 112.475 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.27 114.81 1.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 51.54 112.481 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -111.57 174.78 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 73.11 110.874 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -87.92 -174.9 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 62.14 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 44' ' ' LYS . 27.9 pt -80.35 -32.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 75.43 111.126 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -89.19 44.29 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 71.22 110.932 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 -109.17 2.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 52.51 112.494 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -52.56 174.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.395 . . . . 75.42 110.851 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -97.3 -172.19 2.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 71.42 110.883 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.89 145.17 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.853 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -60.61 176.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 74.02 110.882 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.4 126.4 40.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 72.53 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.27 -48.71 26.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -175.19 149.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 71.42 110.862 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.02 46.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.881 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -62.37 -14.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 64.03 111.163 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -119.43 125.67 49.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 65.4 110.893 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -164.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.24 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.437 ' CE1' HG21 ' A' ' 128' ' ' VAL . 65.6 m80 -97.42 65.39 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 65.22 110.897 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -20.05 53.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.21 111.126 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.23 174.77 46.55 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.667 2.245 . . . . 61.22 112.379 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 126.02 -30.6 4.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 41.24 112.485 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 98' ' ' LEU . 14.1 mm -62.8 158.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 70.4 111.114 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.615 HD23 ' CD2' ' A' ' 112' ' ' PHE . 5.8 mp -107.05 147.97 29.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.893 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.57 150.03 49.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 38.1 mmt -79.37 106.38 11.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.1 110.844 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.67 73.57 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.08 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 34.3 t-20 -105.02 -81.79 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.924 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 102' ' ' ASN . . . 176.8 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 61.5 111.129 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.31 171.34 38.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 65.11 112.476 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 54.11 112.335 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 65.58 32.41 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.456 HG22 ' HG3' ' A' ' 82' ' ' LYS . 29.2 p -148.02 69.52 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 72.12 111.13 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.55 18.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 73.21 110.911 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 107' ' ' THR . . . -63.74 -144.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.8 -0.714 . . . . 74.41 112.434 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 t 51.68 -150.92 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 72.35 110.897 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -116.52 -77.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 64.15 110.931 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.615 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 176.53 172.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 70.03 110.852 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 138.66 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.68 114.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 64.12 111.119 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.5 p -71.43 -27.23 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 61.45 110.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 57.53 17.08 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 62.3 111.132 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 119' ' ' THR . . . -167.56 137.48 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 75.01 111.09 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -51.21 129.99 25.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 63.14 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 117' ' ' ALA . 71.6 p -131.5 59.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 64.42 111.144 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -51.24 -24.0 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 63.32 110.893 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -63.13 -30.29 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 64.51 110.914 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.8 mt -111.68 64.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -110.74 15.89 21.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.809 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.64 31.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 63.22 112.487 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -126.17 -62.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 72.54 110.874 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -98.0 121.72 40.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 72.32 110.854 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 127' ' ' VAL . 29.9 t -58.45 96.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.32 111.095 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 98' ' ' LEU . 40.0 t -86.79 128.22 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 72.52 111.071 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HA ' HD22 ' A' ' 90' ' ' LEU . 12.5 p90 -158.5 43.33 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.862 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -119.19 -168.45 14.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.34 112.467 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.463 ' H ' HD13 ' A' ' 98' ' ' LEU . 17.5 ttpp 178.48 150.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 74.22 110.909 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 96' ' ' GLY . 79.4 t -92.26 85.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 74.52 111.114 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -66.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.52 110.892 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.02 123.11 13.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.44 73.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 44.03 112.497 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -93.55 -28.69 15.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 60.43 110.859 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -70.07 -34.91 73.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 73.31 110.903 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.588 HD11 ' HA3' ' A' ' 18' ' ' GLY . 29.1 mm -66.77 -38.01 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.35 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.0 t -81.46 -0.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 54.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -117.7 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 41.41 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.45 -57.94 10.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 54.21 111.072 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.4 ttm -50.7 -29.97 12.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 65.22 110.89 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.866 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -62.45 -13.47 30.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.856 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.18 17.1 3.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.11 110.89 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.15 -146.07 19.61 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.489 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -152.51 -87.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 70.31 110.883 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -156.04 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.874 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -115.12 19.94 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.44 110.871 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.56 -157.72 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 44.42 112.548 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.7 mttt 63.15 101.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 63.24 110.896 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.582 HG21 HD12 ' A' ' 156' ' ' ILE . 33.8 p -84.02 155.45 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.34 111.148 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -17.21 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 62.13 110.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -126.92 -165.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.883 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.55 106.24 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 44.24 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' THR . 16.4 mt -94.03 122.73 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 73.04 111.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.4 p -139.02 169.52 17.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HZ ' ' A' ' 53' ' ' PHE . 20.1 mt -107.04 99.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.52 111.165 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.53 8.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 45.05 111.127 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -133.15 168.64 18.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.2 110.845 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.405 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 14.1 p -176.95 -167.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 61.3 110.864 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.82 -152.06 16.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 44.02 112.512 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.69 129.72 55.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 72.53 110.913 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 5' ' ' THR . 1.5 pt? -100.06 -29.45 12.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.898 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.03 110.864 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 74.32 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.93 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 64.13 111.134 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -97.76 159.39 31.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 71.4 110.895 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 148.57 65.44 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 71.21 112.378 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 ' C ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.51 173.74 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 61.33 111.118 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -167.2 143.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -124.36 154.57 40.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.83 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -135.98 132.49 36.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 65.55 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.23 108.39 19.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.824 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mm -80.96 110.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.22 111.169 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -113.15 172.66 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 70.41 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.27 94.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.32 111.08 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 72.09 56.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.858 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.51 11.63 57.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 52.04 112.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -123.69 107.37 31.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 53.44 110.875 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.81 138.56 37.95 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.634 2.223 . . . . 74.53 112.349 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -103.31 -53.23 2.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.5 -154.23 9.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 75.4 112.491 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 168.12 24.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 71.43 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 -177.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.21 111.123 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -130.09 96.88 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 65.24 110.826 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -93.34 115.26 27.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 70.2 110.909 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -113.32 113.88 25.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 42.2 110.884 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 129' ' ' PHE . 23.8 mt -80.25 140.01 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.55 110.894 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 29' ' ' VAL . 45.0 m-85 -88.37 82.58 6.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.3 110.848 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -29.86 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.41 111.104 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.28 -28.19 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 54.24 110.831 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.845 ' HG3' HD21 ' A' ' 90' ' ' LEU . 5.0 mmtt -96.88 -34.55 11.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.898 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 129' ' ' PHE . 15.5 m -131.9 88.79 40.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 71.24 111.152 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.63 12.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.661 2.241 . . . . 73.31 112.336 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.92 -48.48 11.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 32' ' ' THR . 21.6 m -76.7 7.93 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 73.55 111.132 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -81.18 -40.98 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 72.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 35' ' ' ASN . 13.5 pt-20 -90.76 -32.6 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 61.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' GLU . 54.4 t-20 -30.87 -70.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.881 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -71.44 -30.95 66.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 63.23 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.5 tmm_? -50.21 -43.1 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 73.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -68.06 -32.34 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 71.32 111.122 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.746 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.8 21.56 12.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.903 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.573 ' OG ' HG11 ' A' ' 6' ' ' VAL . 36.2 t -127.61 -26.67 2.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.2 110.843 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -109.89 -16.53 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 64.14 111.098 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.63 86.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 72.53 112.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -170.23 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 73.2 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 20.73 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.12 110.9 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 -26.18 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 64.0 112.465 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -147.86 -176.34 5.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 73.23 110.871 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.92 -144.49 16.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 43.01 112.494 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.84 174.22 6.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.988 0.423 . . . . 73.23 110.918 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 14.43 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.927 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -158.82 44.36 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 72.11 112.494 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -89.99 133.53 34.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 73.14 110.873 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.7 m -51.89 172.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 73.21 110.866 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 73.37 1.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.838 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -70.61 175.24 5.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.54 110.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.88 104.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.827 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.1 mt -148.51 132.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.33 111.135 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' SD ' ' A' ' 61' ' ' MET . 7.8 pt -154.17 109.14 2.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 73.33 111.147 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 126.69 13.61 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.654 2.236 . . . . 61.12 112.347 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.45 3.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 72.44 112.491 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.4 -75.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 75.01 110.843 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.551 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.22 -164.5 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 53.42 110.927 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.4 m -125.51 -70.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 51.25 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 65.37 153.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 63.34 110.951 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.82 -154.9 25.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 73.42 112.527 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.83 65.21 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.456 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.3 162.92 24.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 61.52 110.895 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.648 ' CD1' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -145.35 -170.43 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.24 110.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 73' ' ' THR . 3.3 p 68.44 36.84 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 63.42 111.147 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 -69.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 75.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -74.61 -18.67 60.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 74.23 110.905 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -115.71 -54.87 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 65.25 110.886 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.23 4.93 23.56 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.771 -0.728 . . . . 72.13 112.494 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.744 ' C ' HG22 ' A' ' 68' ' ' THR . 5.1 t -125.26 156.22 38.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 44.33 111.154 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.53 -36.18 1.74 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.73 -0.748 . . . . 61.43 112.444 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.05 74.87 1.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 63.03 112.473 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt 178.42 -98.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 74.14 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 t -145.16 120.0 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 71.32 110.856 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 pp -55.84 -19.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 75.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 -22.0 14.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.24 -112.8 0.35 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.729 -0.748 . . . . 55.45 112.501 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -108.96 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 73.43 110.872 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -159.96 155.77 26.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.882 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -112.65 171.27 7.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 70.44 110.849 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.71 142.49 30.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 51.45 110.878 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.62 141.84 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.2 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -102.91 -64.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.841 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.29 165.81 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.864 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.17 45.69 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.894 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.9 mt -68.88 -11.27 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.23 111.123 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 28' ' ' LYS . 8.0 mt -98.18 70.12 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -61.35 130.32 45.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.869 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.97 90.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 74.15 110.83 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 p -99.28 31.69 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 54.21 111.163 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.69 177.47 26.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 54.13 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.24 7.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.252 . . . . 62.03 112.34 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.33 14.07 66.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.33 112.457 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -86.99 125.49 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 73.51 111.174 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 129' ' ' PHE . 3.1 tt -93.05 137.81 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.53 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 98' ' ' LEU . 13.8 t -141.67 -130.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 55.32 110.826 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 5.9 mmt -149.94 -175.05 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.13 110.844 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -169.05 147.28 3.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.137 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.8 m-20 166.5 -78.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 54.11 110.878 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.98 -35.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 71.13 111.156 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.77 -127.19 2.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 64.22 112.499 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 149.03 66.25 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.34 112.352 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 51.5 29.3 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 103' ' ' ALA . 3.1 m -132.87 21.79 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.139 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 107' ' ' THR . 3.2 m120 29.49 -98.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.865 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.91 169.31 13.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 71.23 112.522 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.57 11.65 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 70.15 110.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -175.26 156.58 2.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 52.42 110.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' HE2' HD11 ' A' ' 114' ' ' ILE . 13.6 p90 -111.82 150.18 30.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.45 110.867 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 114' ' ' ILE . 18.6 p90 -108.92 67.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.54 110.886 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 113' ' ' PHE . 36.0 mt -32.19 115.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.44 111.148 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.0 m -84.13 149.26 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.843 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.4 p -113.71 18.56 17.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.144 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -166.19 -176.59 3.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.42 111.108 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -77.53 104.47 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.45 110.907 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -126.79 55.51 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 73.52 111.137 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 21.99 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.867 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -94.94 11.03 33.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 75.44 110.881 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.08 25.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 70.12 110.923 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -58.17 -65.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.873 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.87 83.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.14 112.464 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 179.38 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 62.11 110.863 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -126.89 162.5 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.861 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -76.26 -166.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.18 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.688 ' H ' HG12 ' A' ' 127' ' ' VAL . 8.2 p -170.34 141.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.32 111.143 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.813 ' O ' HD22 ' A' ' 98' ' ' LEU . 2.6 p90 -177.66 110.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . 121.1 145.98 7.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 73.41 112.464 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -157.68 139.53 14.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.689 HG11 ' HG2' ' A' ' 136' ' ' MET . 25.2 t -58.45 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.132 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -32.83 65.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.96 178.31 8.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 73.04 110.866 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.17 57.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 53.42 112.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.689 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 75.42 110.851 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -54.55 -22.38 12.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 35.23 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 34.9 mm -78.11 -41.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 50.32 111.178 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -53.75 -47.2 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.25 111.136 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.23 -29.09 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.98 -26.7 61.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.42 111.129 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.2 mtm -73.48 -49.3 27.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.67 39.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 72.53 110.896 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -16.42 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.818 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -130.52 13.09 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 54.32 110.926 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.45 44.82 1.44 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.733 . . . . 45.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t 37.45 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 52.01 110.877 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.464 ' C ' HG22 ' A' ' 57' ' ' ILE . 13.3 mmm-85 -141.36 18.08 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.892 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -128.79 -18.54 3.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 64.24 110.866 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.51 -59.55 0.48 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 75.32 112.444 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.78 158.48 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.879 0.371 . . . . 73.21 110.885 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.77 154.01 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 75.14 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -21.48 59.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 64.3 110.825 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -132.28 165.93 23.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 75.44 110.877 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -108.47 124.07 49.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 74.42 110.881 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 4.4 mp -97.61 107.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.55 111.135 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.647 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -105.54 145.1 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 64.45 111.114 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.444 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -90.29 139.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.4 111.137 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.92 -57.76 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 52.23 111.123 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -167.2 169.08 12.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.11 110.852 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.0 m -146.95 168.87 20.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 72.1 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.45 178.48 35.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 70.22 112.495 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -47.2 48.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 71.44 110.859 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 61.72 108.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 73.34 110.844 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 62.34 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.75 143.88 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 70.42 111.094 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -54.76 134.75 65.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.664 0.745 . . . . 75.34 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 73.55 112.323 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 22' ' ' PHE . 62.2 m -115.05 138.79 50.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.146 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.49 147.65 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.136 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -107.98 146.23 32.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.21 133.12 45.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.33 110.879 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.82 127.6 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 64.05 110.89 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.34 120.15 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 71.23 111.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -127.35 158.22 37.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 45.4 111.104 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.9 m -129.01 106.71 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.14 111.129 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 71.17 35.44 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 74.12 110.863 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.19 -6.69 78.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 65.12 112.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 10.4 tp10 -98.06 136.42 21.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 75.43 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 133.72 26.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.718 2.279 . . . . 51.33 112.333 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.3 tp -116.81 -34.94 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.31 110.924 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -176.87 43.51 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 75.51 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.27 152.62 50.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 75.11 110.886 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 173.86 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 51.22 111.128 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.0 p -139.72 143.56 37.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.883 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 5' ' ' THR . 3.0 m-85 -122.48 133.18 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.886 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -101.87 123.15 45.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 55.44 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 33' ' ' ALA . 12.2 mt -88.45 124.35 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 70.34 110.898 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 90' ' ' LEU . 25.2 m-85 -77.01 62.86 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.835 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.25 -29.36 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 63.05 111.093 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.52 -45.6 91.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.22 110.847 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HD2' HD12 ' A' ' 89' ' ' ILE . 34.0 mmtm -90.14 -31.19 17.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 53.31 110.915 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.9 m -129.8 84.9 59.64 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.624 0.726 . . . . 75.45 111.092 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -31.33 20.86 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.719 2.279 . . . . 63.42 112.32 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -46.24 10.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 61.34 110.869 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -6.73 42.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.01 111.168 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.761 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -77.08 -40.56 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.31 111.072 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 35' ' ' ASN . 51.6 mt-10 -92.46 -44.31 8.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 72.23 110.88 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.7 t30 -28.0 -64.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.936 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.777 ' HA ' HD12 ' A' ' 39' ' ' LEU . 66.5 t80 -72.0 -37.32 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.0 tmm_? -51.02 -35.64 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.863 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -66.72 -32.4 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 61.2 111.121 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 36' ' ' PHE . 8.2 mt -72.78 -54.31 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 51.34 110.882 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 m -56.37 -50.62 71.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.879 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 62.4 p -72.89 -26.92 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.14 111.171 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.75 101.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 75.32 112.482 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -149.53 34.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 72.4 110.886 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -131.7 3.55 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 65.2 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.32 15.96 63.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 71.4 112.498 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -174.69 173.96 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 72.22 110.906 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.89 -172.43 15.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 43.21 112.482 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.36 144.66 27.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.97 0.415 . . . . 63.22 110.89 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.49 -60.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.936 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.4 45.77 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 73.44 112.42 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -93.59 -171.04 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 70.3 110.831 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.8 m -87.65 -167.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.893 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.29 -174.09 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 71.23 110.842 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.3 -76.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 65.41 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.11 162.71 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.877 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.667 HD11 HD12 ' A' ' 156' ' ' ILE . 48.5 mt -149.83 129.9 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 63.35 111.077 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 60' ' ' PHE . 1.2 pt -143.94 117.94 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.641 0.734 . . . . 71.44 111.14 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.8 Cg_endo -69.69 130.63 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.73 2.287 . . . . 62.43 112.349 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.68 21.7 79.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 53.34 112.48 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -137.62 -69.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 74.41 110.857 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.541 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.52 -170.53 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 70.32 110.904 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.51 107.72 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 62.34 110.847 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.41 179.74 4.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 64.21 110.901 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.64 175.78 44.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 33.21 112.513 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.37 58.66 8.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.41 112.463 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -67.9 84.53 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 65.1 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.8 -176.13 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.879 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m 64.19 44.88 4.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 74.2 111.118 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.28 -175.65 3.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.867 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.484 ' O ' ' C ' ' A' ' 71' ' ' ASN . 6.9 p80 -50.92 -29.68 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.44 110.827 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 70' ' ' HIS . 13.3 t30 -30.47 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 72.22 110.904 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.16 -83.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 71.22 112.474 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.3 m -120.47 124.4 45.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 43.25 111.136 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.2 -48.37 0.48 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.749 . . . . 74.23 112.47 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.55 -87.21 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.736 . . . . 73.4 112.521 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.84 -75.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 62.22 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 4.0 t -127.14 107.97 10.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.875 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 35' ' ' ASN . 8.2 pt -56.5 -19.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.13 111.135 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.64 28.94 7.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 72.1 110.919 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.16 -137.65 5.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 34.44 112.47 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' C ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -109.95 -34.78 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.909 0.385 . . . . 70.53 110.899 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -178.91 146.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.55 110.897 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 160.39 16.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 72.43 110.903 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.7 166.58 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -59.17 -174.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 63.4 110.938 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.85 -63.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 71.54 110.884 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -177.74 161.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.882 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 68.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.866 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 28' ' ' LYS . 12.7 mt -78.16 -1.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.15 111.168 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB2' HG11 ' A' ' 128' ' ' VAL . 1.1 mt -119.24 111.67 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 53.55 110.904 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.65 175.08 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 44.21 110.922 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -96.85 83.76 3.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 63.15 110.822 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 21.67 13.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.24 111.162 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.79 145.76 12.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 70.32 112.495 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 115' ' ' CYS . 53.2 Cg_endo -69.82 -9.64 26.58 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 72.51 112.315 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -100.98 -20.02 15.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 73.11 112.507 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.56 141.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 63.34 111.145 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 114' ' ' ILE . 17.3 mt -116.17 162.94 16.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.25 110.891 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 t -151.48 -142.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.891 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -152.12 133.73 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.21 110.89 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.16 103.44 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.071 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 1.9 p30 -131.97 -179.53 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 70.13 110.863 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.585 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -64.17 -34.5 78.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.128 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 119.76 -62.86 0.47 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 60.33 112.471 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.9 Cg_endo -69.75 94.61 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 2.269 . . . . 54.23 112.332 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 43.17 56.64 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 109' ' ' GLY . 4.2 m -121.26 -1.68 9.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 65.43 111.117 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 47.18 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 62.44 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 115.68 126.73 4.08 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 71.53 112.486 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.15 -31.0 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.32 110.86 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.76 145.01 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.925 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CE2' HD13 ' A' ' 98' ' ' LEU . 2.8 p90 -131.62 179.64 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 75.31 110.936 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -150.5 130.7 13.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 64.43 110.908 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 45.2 mt -48.1 -87.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 75.41 111.126 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.49 ' C ' HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER 160.96 -61.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 63.54 110.875 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 115' ' ' CYS . 1.4 p 67.85 -1.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 54.03 111.16 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.95 151.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 53.43 111.111 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -55.5 132.5 48.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.875 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -129.95 52.62 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.164 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 64.42 110.86 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.25 -36.57 81.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.939 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.55 74.5 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.927 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -157.65 55.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.855 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.56 -44.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 70.04 112.494 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -64.74 -42.98 94.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.81 0.338 . . . . 51.03 110.868 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -112.83 166.07 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.813 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -68.57 -149.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 44.41 111.128 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.643 ' O ' HG11 ' A' ' 29' ' ' VAL . 9.2 p -171.84 157.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.21 111.116 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' ' O ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER 179.4 167.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.903 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 57.03 142.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 61.51 112.462 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -154.4 133.09 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 73.25 110.885 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -44.94 114.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.116 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -88.43 -75.23 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 72.15 110.914 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -138.14 142.63 40.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 72.01 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.47 8.8 26.32 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 74.04 112.476 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.4 ttt -48.35 -32.33 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 61.11 110.882 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -49.31 -28.52 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 71.03 110.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.1 mm -78.21 -40.55 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 75.31 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.3 t -51.0 -47.15 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 64.13 111.142 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.96 -36.24 65.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.24 110.929 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.24 80.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 50.13 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.9 mtm -70.88 -19.13 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -89.41 21.79 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 -20.49 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 72.14 110.875 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -102.4 -6.02 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.54 110.937 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.11 3.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 60.34 112.513 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.17 135.28 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 72.13 110.849 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 36.5 mmm-85 -70.94 79.69 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.01 110.864 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 175.77 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.26 -61.91 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 64.1 112.474 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -74.51 -178.07 3.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 50.12 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.7 22.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 73.2 111.155 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -21.64 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.819 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -131.76 -164.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 55.24 110.876 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 119.7 19.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.52 110.934 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.667 HD12 HD11 ' A' ' 56' ' ' ILE . 49.7 mt -92.71 101.44 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 71.22 111.121 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.8 162.75 13.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.169 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.43 142.92 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.53 111.102 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -102.23 -55.35 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 70.43 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -142.93 179.43 7.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -170.97 -167.01 0.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 70.13 110.906 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 41' ' ' THR . . . 137.16 -148.16 19.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 51.55 112.475 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -112.08 136.91 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.13 110.869 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 tp -54.12 -57.0 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 70.31 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 62.43 110.935 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.355 . . . . 51.54 110.883 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 60.14 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -98.37 158.95 31.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.656 0.741 . . . . 52.2 110.865 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.77 65.08 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.684 2.256 . . . . 70.41 112.348 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -131.44 57.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.11 111.148 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.427 HG13 HD12 ' A' ' 24' ' ' LEU . 5.4 m -49.05 147.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.151 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -138.25 164.99 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.878 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -144.84 138.35 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.51 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.694 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.2 t0 -101.79 91.27 4.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 156' ' ' ILE . 9.4 mm -59.76 143.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.53 111.151 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.63 163.39 22.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.136 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.4 t -151.8 104.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 73.13 111.14 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 52.39 46.32 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.841 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.6 10.97 83.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 34.35 112.469 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -133.66 109.1 12.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.738 . . . . 72.22 110.903 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.3 Cg_endo -69.75 168.92 20.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 63.45 112.374 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.06 -58.45 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.927 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.24 -167.64 27.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 41.41 112.49 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -100.24 127.75 46.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 61.35 110.909 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 138' ' ' ILE . 7.7 t -101.65 120.16 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.124 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -94.93 84.28 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.32 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.54 95.51 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 55.12 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -78.41 153.64 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.5 110.866 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 129' ' ' PHE . 18.3 mt -115.06 133.21 56.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 55.11 110.888 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -81.54 78.64 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.13 110.879 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.9 -7.0 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 51.11 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -61.31 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 63.42 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.63 -60.01 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.57 83.2 4.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.632 0.729 . . . . 75.45 111.105 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 60.23 112.342 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 179.38 -59.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 70.14 110.908 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.547 HG23 ' CE ' ' A' ' 100' ' ' MET . 51.1 m -56.31 -48.57 76.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.02 87.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.33 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.85 -30.11 9.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.85 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.62 -61.27 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 64.42 110.907 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.9 -33.65 57.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.837 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.97 69.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.32 110.894 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.39 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 70.22 111.118 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.2 tt -78.12 -2.6 38.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t -98.93 -8.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 61.23 110.848 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.6 p -115.96 8.02 14.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.3 37.0 30.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.734 . . . . 62.24 112.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -110.02 30.96 6.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 74.41 110.92 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.675 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -128.27 32.13 4.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 52.51 110.89 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.3 -45.1 2.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.45 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -138.91 167.04 22.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 72.31 110.892 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.67 -108.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.758 . . . . 74.42 112.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -177.25 124.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.389 . . . . 75.1 110.965 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -26.44 13.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.889 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.68 -67.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.741 . . . . 35.04 112.494 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 157' ' ' THR . 3.4 t 45.42 -160.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 63.21 110.844 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -166.4 162.55 17.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 33.21 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HE1' HD11 ' A' ' 158' ' ' ILE . 22.8 m-85 -101.78 -78.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.868 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.74 25.82 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.872 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.94 21.42 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.66 138.87 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.106 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 HD12 ' CE ' ' A' ' 61' ' ' MET . 11.7 mt -121.24 102.72 42.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.708 . . . . 74.35 111.127 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 77.89 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.702 2.268 . . . . 72.41 112.31 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.12 -40.82 0.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 63.14 112.494 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -64.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 72.31 110.917 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.4 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.96 -167.48 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.88 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 t -143.45 129.56 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -152.92 164.28 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 60.42 110.895 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.21 39.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 64.41 112.54 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.19 8.73 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 45.03 112.516 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.57 156.5 29.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 65.15 110.854 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -50.67 168.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.862 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 t -101.07 30.85 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 64.53 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.19 -164.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.72 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.1 110.864 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.33 -55.05 15.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.863 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 73' ' ' THR . . . -161.62 160.23 32.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.678 -0.773 . . . . 73.24 112.411 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.4 p 66.22 32.83 7.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 73.43 111.145 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.01 76.07 1.05 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.728 -0.749 . . . . 61.4 112.469 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.95 53.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 72.1 112.496 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.12 -179.78 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.34 110.901 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.07 -177.4 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.35 110.855 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.675 HD12 ' HD2' ' A' ' 44' ' ' LYS . 25.2 pt -93.36 -38.09 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.41 111.144 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -80.22 -13.26 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.927 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.84 -172.32 45.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 72.33 112.529 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.73 -96.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 65.11 110.898 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -121.44 176.71 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.89 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -149.42 153.94 38.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.915 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 164.03 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.871 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.04 145.75 25.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 75.05 110.838 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -52.32 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.874 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -179.0 163.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 53.34 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.03 36.99 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.877 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.6 mm -53.19 -26.63 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 71.41 111.172 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.36 112.59 21.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 74.23 110.872 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 93' ' ' THR . 4.7 mmtt -103.04 93.83 5.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 75.1 110.926 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.816 ' HB3' HG21 ' A' ' 97' ' ' ILE . 4.6 p80 -64.8 108.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 54.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' LYS . 13.3 p -128.09 33.81 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.11 111.159 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.58 174.63 44.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 53.5 112.487 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 160.2 50.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 74.13 112.333 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 14.54 76.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 65.04 112.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 92' ' ' HIS . 44.7 mm -99.98 137.5 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 62.32 111.154 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 99' ' ' SER . 3.1 tt -100.12 138.31 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.889 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.667 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -121.56 131.89 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.866 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.547 ' CE ' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.34 -27.17 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.902 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.67 167.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 60.13 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER 169.42 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 63.41 110.867 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' H ' HG23 ' A' ' 107' ' ' THR . . . -106.25 -20.14 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 62.4 111.116 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 130.41 -58.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.492 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.75 83.52 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 73.44 112.366 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 27.06 82.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.2 110.926 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 103' ' ' ALA . 1.8 t -156.87 54.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.54 111.158 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -54.33 -40.87 68.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 60.42 110.914 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.76 -152.0 39.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 63.32 112.459 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.9 m -134.21 65.14 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 42.02 110.866 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -155.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.54 110.947 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 29.9 t80 -177.4 75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.41 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 1.5 t80 -90.33 129.01 36.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 73.33 110.882 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 61.7 mt -107.55 130.59 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.166 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.5 t -99.98 136.71 39.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -120.39 -20.46 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 71.14 111.115 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.86 179.01 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 64.35 111.113 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 87.98 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 73.1 110.888 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.534 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 8.4 p -122.5 62.61 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.155 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 23.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 50.53 110.869 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.534 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -94.65 19.5 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.1 11.2 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 65.11 110.931 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.8 -63.44 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 53.4 110.837 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.31 57.7 3.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.659 -0.781 . . . . 64.13 112.521 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -156.81 -52.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 61.54 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -113.98 148.26 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.01 110.867 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.8 t -90.8 107.53 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.53 111.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 92' ' ' HIS . 35.7 t -83.22 140.61 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 72.45 111.172 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 24' ' ' LEU . 9.3 p90 -159.93 33.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -126.16 -166.88 12.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 63.23 112.456 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER 167.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 75.23 110.935 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG11 ' HG2' ' A' ' 136' ' ' MET . 44.9 t -112.73 93.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.157 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -52.0 -48.1 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.891 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.67 -175.85 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 73.0 110.922 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 53.17 71.48 0.68 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 64.11 112.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.415 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -89.53 3.38 52.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 74.21 110.913 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -79.15 -28.46 42.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.87 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.71 HG21 ' CG2' ' A' ' 20' ' ' VAL . 23.4 mm -68.58 -36.62 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 73.1 111.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -94.68 6.06 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.127 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -119.13 -62.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.865 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.09 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.31 111.082 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.5 tmm? -52.35 -37.02 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.862 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -24.48 18.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.97 -11.23 36.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.879 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -86.06 22.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 64.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.93 -160.0 32.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 64.31 112.467 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.7 p -151.44 -71.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 75.12 110.853 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.72 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 70.41 110.861 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -105.74 15.1 27.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.21 110.938 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.82 -38.32 3.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 70.14 112.479 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -50.44 120.56 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 73.42 110.891 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 p -95.02 158.75 15.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 30.12 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -15.94 57.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.846 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.6 170.45 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 54.01 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -98.49 123.3 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.914 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 10' ' ' ILE . 3.7 mp -105.93 130.63 57.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.45 111.154 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 51' ' ' SER . 67.2 p -138.56 157.62 45.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.164 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 ' HE1' ' A' ' 53' ' ' PHE . 4.2 mp -90.78 93.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.119 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -50.77 -57.83 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 75.41 111.071 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.54 162.48 41.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 75.51 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.5 p -156.01 160.56 40.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 75.43 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.84 45.25 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 75.43 112.482 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.7 mt-30 -68.18 -36.56 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 54.14 110.911 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.8 mm? 73.86 -58.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 75.1 110.873 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.11 110.918 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 51.3 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -126.05 143.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.1 111.122 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -53.51 145.34 28.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 34.01 110.895 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.4 Cg_endo -69.77 129.4 17.51 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 74.11 112.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 m -119.98 147.3 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.25 111.132 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -128.45 165.09 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 44.45 111.11 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CD1' HD21 ' A' ' 164' ' ' LEU . 5.6 p90 -122.54 153.79 38.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.866 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 158' ' ' ILE . 5.5 t80 -136.09 128.88 31.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.905 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 34.7 m-20 -95.32 126.56 40.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.872 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.508 HD12 ' HE1' ' A' ' 142' ' ' MET . 4.2 mm -99.53 119.36 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.33 111.169 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.0 163.13 15.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 65.43 111.124 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -147.67 92.84 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.03 111.129 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.05 31.12 4.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.85 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.12 -12.99 65.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 74.04 112.512 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -97.9 126.86 39.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.652 0.739 . . . . 74.32 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.4 69.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 74.2 112.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.76 -67.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.916 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.8 -159.6 10.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 63.22 112.506 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -127.99 124.27 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 74.42 110.903 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.8 t -113.11 90.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 72.42 111.13 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 77.8 p -85.16 147.8 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.823 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CD2' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.68 140.02 40.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 74.32 110.884 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 6.1 tt0 -91.21 161.97 14.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.895 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 4' ' ' PRO . 61.2 mt -114.9 119.57 37.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.907 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 90' ' ' LEU . 16.9 m-85 -74.85 61.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 75.53 110.902 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.98 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 74.41 111.137 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.91 -65.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -74.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 65.4 110.899 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 33' ' ' ALA . 12.9 m -84.58 116.71 66.39 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 72.04 111.162 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.706 2.271 . . . . 72.45 112.331 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -66.28 -43.69 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.918 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -48.24 -27.96 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.152 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -80.17 -39.27 29.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 53.02 111.104 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.92 -156.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 61.14 110.878 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.85 -68.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.31 110.903 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.01 -29.03 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.909 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -52.03 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.89 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 43' ' ' GLU . . . -78.95 -28.09 43.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.41 111.082 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -89.08 19.47 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.929 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' HG11 ' A' ' 6' ' ' VAL . 31.8 t -144.8 -31.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 61.14 110.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -103.94 -32.97 9.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 74.53 111.097 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 120.08 2.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 53.15 112.513 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 177.41 -47.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 55.42 110.884 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -83.85 -11.37 57.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.907 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.77 7.52 35.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 74.53 112.515 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' C ' ' A' ' 47' ' ' GLY . 2.6 m-85 -93.02 -24.77 18.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 64.44 110.871 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -29.05 130.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 50.51 112.467 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -95.2 34.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.933 0.397 . . . . 73.12 110.915 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.98 147.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.873 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.05 62.15 4.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 62.31 112.476 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -125.82 -168.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 72.34 110.906 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 m -120.85 -169.69 1.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.3 110.896 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.06 127.75 55.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 65.5 110.839 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -63.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.813 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -157.58 -179.51 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.45 110.841 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 152' ' ' THR . 65.8 mt -150.55 136.22 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.142 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -140.27 105.41 6.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.573 0.701 . . . . 75.02 111.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.4 Cg_endo -69.77 159.4 53.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 62.02 112.31 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.93 -34.53 3.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.508 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -111.18 -82.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 73.53 110.86 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 175.13 119.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.861 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.41 177.29 8.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.04 174.55 10.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 51.23 110.919 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.18 150.3 18.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 64.03 112.508 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.32 114.79 4.67 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 61.44 112.5 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.64 -167.06 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.875 0.369 . . . . 71.24 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.496 ' CE1' HD11 ' A' ' 39' ' ' LEU . 54.8 p90 -96.68 -173.58 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.22 110.881 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -170.76 -71.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 73.14 111.138 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -98.5 132.9 43.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.35 110.86 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -35.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.75 -33.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 71.04 110.881 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.55 76.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.47 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m 71.91 43.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 65.41 111.145 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 124.8 162.56 11.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 71.34 112.454 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.565 ' H ' HG22 ' A' ' 68' ' ' THR . . . -86.54 138.46 15.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 64.35 112.484 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -169.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.792 0.329 . . . . 74.41 110.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -83.68 5.76 23.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.33 110.858 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 39' ' ' LEU . 2.5 mt 83.0 -43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 71.42 111.106 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -72.65 70.24 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.939 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.43 -72.25 2.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 32.34 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.0 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 65.02 110.835 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.75 162.94 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 72.45 110.896 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -141.22 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.01 110.865 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.79 164.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 63.31 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -77.85 113.04 15.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 51.13 110.858 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -56.28 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.848 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.08 149.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 64.24 110.894 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -111.84 58.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.854 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.97 -10.96 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.42 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -104.11 137.33 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.92 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -128.34 -172.89 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 71.3 110.892 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -95.18 -89.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 73.11 110.881 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m 76.54 -15.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 44.44 111.178 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.34 163.22 36.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 74.54 112.485 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 118' ' ' LYS . 53.8 Cg_endo -69.79 143.19 49.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.619 2.213 . . . . 70.22 112.392 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.16 -41.28 2.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.737 -0.744 . . . . 74.34 112.457 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.6 mm -50.42 150.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 71.43 111.152 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -123.18 161.11 25.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.13 110.886 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.746 ' OG ' HG22 ' A' ' 128' ' ' VAL . 4.2 m -158.8 -129.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 73.23 110.894 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.0 mtp -142.83 -159.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 54.34 110.92 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . 173.38 81.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.32 111.084 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 107' ' ' THR . 2.0 t30 -104.13 -158.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.24 42.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 52.3 111.085 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.73 168.82 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 71.2 112.468 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.72 166.67 26.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 72.11 112.335 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 56.35 34.13 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 54.04 110.871 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 105' ' ' PRO . 16.3 p -137.67 26.66 2.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.1 t30 50.62 -97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 73.33 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.74 -85.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.727 . . . . 62.42 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 t 71.0 36.76 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 74.22 110.872 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 9.1 tp-100 -92.22 -34.95 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 74.32 110.894 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.627 ' CE2' HD11 ' A' ' 114' ' ' ILE . 60.0 t80 68.57 75.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 63.4 110.908 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -108.49 129.67 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -120.47 121.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 73.41 111.169 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' MET . 6.5 p -73.91 136.92 43.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.14 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.577 HG21 ' OE1' ' A' ' 143' ' ' GLU . 13.1 t -109.89 -16.58 13.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 64.02 111.134 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.65 24.57 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 42.11 111.116 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 1.2 tmtt? 58.17 103.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.2 p -121.38 71.63 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 72.4 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.45 20.34 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.835 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -9.01 58.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.929 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -86.51 -47.87 8.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 72.33 110.918 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -56.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.851 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.58 47.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.693 -0.765 . . . . 74.43 112.507 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -96.73 -31.02 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 70.55 110.932 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -132.36 124.87 29.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.825 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.8 t -49.37 111.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.23 111.103 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.746 HG22 ' OG ' ' A' ' 99' ' ' SER . 20.9 t -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.24 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.718 ' HB2' HG21 ' A' ' 29' ' ' VAL . 19.6 p90 -165.66 34.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.31 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -122.41 -173.22 14.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.717 . . . . 53.34 112.508 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 174.57 144.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 62.25 110.928 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.12 90.22 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.15 111.154 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -50.92 -59.96 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.52 110.856 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.55 142.0 10.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 61.44 110.863 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.48 2.99 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.484 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.18 -32.19 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 74.31 110.827 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -50.4 -27.95 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 72.02 110.925 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 24.5 mm -80.09 -40.81 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.25 111.141 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -48.83 -52.82 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.23 111.162 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.78 -30.59 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.2 110.868 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -70.98 -42.69 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 62.13 111.121 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.508 ' HE1' HD12 ' A' ' 10' ' ' ILE . 19.1 mtm -62.81 -30.12 71.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.859 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.577 ' OE1' HG21 ' A' ' 116' ' ' THR . 14.7 mm-40 -58.13 -55.07 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.31 110.874 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -22.5 66.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.84 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.94 -6.28 59.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.869 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' HA3' ' CG2' ' A' ' 56' ' ' ILE . . . -89.94 -157.35 33.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 54.45 112.537 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 p -164.49 142.59 6.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 74.21 110.86 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 38.5 mmm-85 -74.63 73.31 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.922 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 175.93 -33.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.919 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.17 -67.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 73.42 112.491 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.45 159.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 74.13 110.92 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 56' ' ' ILE . 77.0 p -131.19 156.67 44.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.8 t -77.41 -18.05 57.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 70.21 110.879 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -134.22 -165.67 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 75.15 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -138.63 136.08 35.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.915 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.49 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.4 mt -106.02 119.04 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 65.14 111.128 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 26.5 p -106.01 163.69 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.152 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.55 HG23 ' CE1' ' A' ' 8' ' ' PHE . 4.3 mt -106.48 134.83 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.24 111.113 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -89.63 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.03 111.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.76 171.95 16.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.0 m -151.86 122.8 7.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 72.21 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -150.36 178.13 28.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 40.2 112.471 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 123.07 24.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 75.24 110.935 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -95.04 -58.88 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.11 110.887 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 55.5 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.846 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.34 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 62.53 111.071 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.91 157.27 39.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.729 . . . . 60.34 110.892 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.98 52.42 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 73.33 112.33 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 164' ' ' LEU . 96.9 m -138.44 93.87 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 70.31 111.145 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 2.4 m -77.03 143.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.108 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -132.26 162.51 30.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.888 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.56 ' HD1' HG23 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -149.84 152.84 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 62.31 110.911 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -109.35 114.75 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.855 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 tt -86.01 147.83 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.125 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -141.14 164.26 30.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.51 111.131 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 156' ' ' ILE . 61.6 t -138.33 105.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.137 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 66.88 50.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 60.14 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.19 20.6 67.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 60.4 112.496 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 tt0 -134.4 107.29 11.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 54.11 110.886 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.81 141.76 45.91 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 62.31 112.306 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.63 24.9 7.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.3 110.898 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.53 -167.26 14.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.738 . . . . 52.31 112.474 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -178.72 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 75.01 110.832 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG12 ' HB ' ' A' ' 138' ' ' ILE . 2.9 m -137.32 161.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.21 111.093 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 133' ' ' LYS . 30.6 t -114.44 91.79 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 70.5 110.832 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 13.8 m-85 -83.52 102.49 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 72.24 110.873 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.27 111.06 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.892 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.745 HD22 ' CE2' ' A' ' 129' ' ' PHE . 27.4 mt -85.51 140.66 30.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 62.31 110.935 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.65 81.3 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.842 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.71 -3.69 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.04 111.122 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -87.47 -38.33 16.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.52 110.832 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.96 -23.76 17.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 62.35 110.921 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.59 73.06 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 75.45 111.11 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -6.81 19.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.272 . . . . 45.4 112.374 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 -51.84 5.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 62.04 110.902 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.54 HG22 ' HE2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -77.96 -53.77 7.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 61.51 111.066 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -31.41 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.24 111.079 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.44 -56.47 8.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.835 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HA ' HG12 ' A' ' 78' ' ' ILE . 1.8 t30 -47.86 -39.61 19.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 71.45 110.865 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 39' ' ' LEU . 1.4 t80 -77.83 -32.77 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 71.4 110.888 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -35.98 81.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.858 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.31 67.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 51.03 111.124 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 36' ' ' PHE . 46.1 mt -70.3 -32.56 70.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.14 110.906 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -60.14 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.884 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.1 p -72.91 -17.01 61.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.34 111.089 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.19 44.53 93.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.722 -0.751 . . . . 71.15 112.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -28.85 69.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 74.45 110.886 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -70.72 -125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 64.54 110.882 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.06 18.18 3.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 44.44 112.45 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -165.57 -174.55 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 74.41 110.848 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.21 124.61 2.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 73.23 112.488 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.9 155.61 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.993 0.425 . . . . 74.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -157.01 -38.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 64.01 110.898 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.25 27.7 12.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 54.43 112.488 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 170.56 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 51.3 110.894 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -140.53 153.1 46.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 70.25 110.861 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.92 134.32 53.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.885 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -141.37 34.22 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.869 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -138.31 33.17 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.921 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 27.7 mt -82.71 140.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.42 111.096 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.38 113.62 23.37 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.596 0.712 . . . . 63.44 111.107 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 54.2 Cg_endo -69.73 81.38 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 73.44 112.356 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.81 0.24 4.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.748 -0.739 . . . . 75.14 112.498 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.337 . . . . 74.21 110.852 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.25 -160.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 63.1 110.889 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 82.4 m -136.96 -41.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 64.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 65.28 150.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.22 88.63 0.45 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 61.42 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.13 87.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 52.21 112.507 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -169.93 80.55 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 44.42 110.883 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -50.56 -71.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 75.45 110.915 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 115.44 10.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 70.34 111.166 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -99.73 51.89 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.52 110.881 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -70.62 78.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.88 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 70.91 -72.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.52 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.7 86.6 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.716 -0.754 . . . . 73.23 112.455 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 p -114.48 119.93 38.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 75.43 111.172 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.53 -131.48 4.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 51.45 112.467 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.02 -177.15 16.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.702 -0.761 . . . . 75.22 112.486 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -62.72 166.29 5.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 74.01 110.876 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.28 157.2 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 45.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -67.52 -11.84 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 64.11 111.14 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.27 13.8 20.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 75.52 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.47 -162.85 23.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.485 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.1 -42.55 60.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 74.34 110.939 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -177.24 173.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 65.11 110.846 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.53 168.29 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.866 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.69 162.6 16.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.895 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.01 149.42 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.7 -63.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.857 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -176.39 173.7 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.844 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 45.65 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.73 -25.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 71.31 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.644 ' O ' HG11 ' A' ' 128' ' ' VAL . 5.9 mt -91.94 119.28 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 71.02 110.937 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.782 ' O ' HG23 ' A' ' 93' ' ' THR . 7.9 mtpp -100.86 112.42 24.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.852 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -58.94 99.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 61.3 110.841 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 91' ' ' LYS . 6.2 p -127.45 36.25 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.159 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.11 39.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 61.04 112.533 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.62 23.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 72.44 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.01 22.58 72.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 64.22 112.481 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 92' ' ' HIS . 23.4 mm -95.39 117.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 70.23 111.15 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 112' ' ' PHE . 4.7 tt -83.78 121.47 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.891 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 8.0 t -119.58 142.63 48.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.33 110.889 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.54 ' HE2' HG22 ' A' ' 32' ' ' THR . 2.6 mmt -81.74 102.75 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 61.41 110.882 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -84.91 146.38 27.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.15 111.109 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER 165.97 -166.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 61.44 110.854 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.22 -52.96 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.093 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.05 -87.75 0.27 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.727 -0.749 . . . . 63.21 112.455 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 125.19 11.86 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 55.01 112.351 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 45.6 36.12 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.85 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -146.77 56.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 52.32 111.158 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -50.99 -52.91 38.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.52 110.827 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.38 -168.58 54.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 64.22 112.488 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 t -119.85 -5.7 10.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 60.22 110.835 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -64.76 156.62 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.876 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -149.4 162.37 40.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.874 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -160.57 140.5 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 62.41 110.869 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.729 HG21 ' CG1' ' A' ' 139' ' ' VAL . 3.7 mt -91.88 125.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 63.34 111.122 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.4 m -74.49 -32.4 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 72.42 110.919 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 m 55.86 14.69 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.52 111.138 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.53 167.99 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 63.24 111.108 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -63.35 133.44 54.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 5.6 p -145.34 43.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.164 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -66.11 -10.21 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 52.43 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.857 ' CZ2' HG22 ' A' ' 119' ' ' THR . 9.8 p90 -75.9 -9.6 58.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.923 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.17 -17.98 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 64.32 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 124' ' ' GLY . 11.0 m-20 51.64 70.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.818 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.17 43.76 0.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 51.14 112.481 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -73.8 133.32 43.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.349 . . . . 74.4 110.955 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.589 ' C ' HG23 ' A' ' 127' ' ' VAL . 4.9 m-70 64.53 28.95 13.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.32 110.851 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 60.85 -163.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.147 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 90' ' ' LEU . 13.1 p -179.13 145.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.745 ' CE2' HD22 ' A' ' 24' ' ' LEU . 2.0 p90 -176.68 125.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.91 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.86 145.92 14.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.554 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -165.74 151.72 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.23 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 133' ' ' LYS . 1.3 p -55.76 168.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 42.53 111.095 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 132' ' ' VAL . 2.2 tptp -147.81 -39.89 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.01 110.902 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -132.26 155.37 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.879 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.24 78.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 63.14 112.49 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -2.22 47.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 72.53 110.901 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.26 -29.96 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.912 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 20' ' ' VAL . 47.4 mm -63.99 -43.79 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.729 ' CG1' HG21 ' A' ' 114' ' ' ILE . 9.3 t -88.2 6.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 23.45 111.156 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.06 -69.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.87 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.53 67.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 55.41 111.123 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 15.6 tmm? -49.67 -35.44 21.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.88 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.49 54.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.3 110.836 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -141.31 0.32 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.859 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.69 15.96 26.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 63.55 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -95.12 -155.72 31.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 73.34 112.458 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.24 -169.23 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 73.54 110.881 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -77.77 -32.58 52.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.863 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -106.09 1.33 26.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.34 110.912 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.03 -146.25 16.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 61.33 112.455 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 64.78 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 63.5 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 54' ' ' HIS . 59.3 p -82.56 146.01 29.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 64.32 111.154 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -21.99 62.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -135.19 -179.17 5.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.1 110.896 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -97.86 101.44 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 73.12 110.871 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 12' ' ' VAL . 4.5 mp -96.44 122.02 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.104 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.18 159.49 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.53 111.174 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.56 HG23 ' HD1' ' A' ' 8' ' ' PHE . 42.0 mt -87.88 116.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 70.53 111.143 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.28 -52.19 20.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 52.32 111.09 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -143.38 -179.59 6.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 65.22 110.866 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 5.1 p -171.23 -172.85 1.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.23 110.858 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.29 -149.21 20.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 34.42 112.455 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -127.55 141.95 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 72.53 110.926 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.1 pt? -128.82 166.6 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 45.14 110.856 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 61.53 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 74.44 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.17 156.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.33 111.101 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -93.63 157.21 38.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 62.32 110.908 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 151.83 69.13 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.678 2.252 . . . . 64.42 112.364 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -138.98 151.32 46.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 74.43 111.101 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.574 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -141.8 151.97 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 73.55 111.136 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -127.1 156.77 41.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.888 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -137.92 137.29 37.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 64.12 110.9 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -92.47 114.09 26.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.886 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' A' ' 142' ' ' MET . 7.3 mm -82.49 114.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.32 111.132 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.76 148.77 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 72.41 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.03 98.6 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.178 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.95 24.27 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.873 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.02 -21.62 45.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.471 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.36 150.2 36.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.637 0.732 . . . . 64.45 110.869 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.5 68.28 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 70.12 112.355 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 17' ' ' LEU . 4.1 tp -125.53 -39.65 2.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 40.21 110.876 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 165.73 -176.5 41.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 70.41 112.455 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.15 167.1 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 63.31 110.869 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 27.2 m -130.15 -179.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 62.41 111.106 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -131.59 95.66 3.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.831 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' HE1' HG22 ' A' ' 132' ' ' VAL . 15.7 m-85 -91.78 138.15 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.854 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' C ' HD23 ' A' ' 24' ' ' LEU . 24.2 tt0 -116.45 156.06 27.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 74.34 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -116.08 118.07 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.896 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . 23.9 m-85 -78.59 77.93 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.21 110.869 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.1 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 72.35 111.083 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.02 -46.84 41.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 50.13 110.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.535 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.4 mttt -87.72 -18.49 29.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.885 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -155.44 84.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.633 0.73 . . . . 73.25 111.143 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -27.65 26.29 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 73.21 112.341 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -76.47 -57.36 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 71.25 110.89 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.7 m -51.7 -43.55 62.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.34 111.195 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.45 78.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.45 111.139 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -53.96 -25.01 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.4 110.848 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -66.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.935 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HD2' HD22 ' A' ' 24' ' ' LEU . 5.9 t80 -52.59 -39.7 61.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.918 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 64.31 110.877 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -90.48 -33.8 15.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 64.43 111.138 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -92.13 26.12 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.959 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.574 ' OG ' HG11 ' A' ' 6' ' ' VAL . 34.3 t -121.2 -5.69 9.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 63.04 110.872 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.8 p -118.47 15.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.13 111.183 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.98 24.81 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 60.42 112.488 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -83.78 -21.89 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 72.34 110.884 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 17.64 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.22 110.96 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.33 -52.5 4.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 53.23 112.493 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.03 155.92 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 74.24 110.898 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 -136.69 3.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 72.2 112.507 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -22.55 17.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.393 . . . . 55.15 110.865 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.63 112.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 74.51 110.879 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.77 55.55 20.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 54.22 112.479 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 m -113.85 3.85 15.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 44.25 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m 50.61 -168.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 65.44 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 56' ' ' ILE . 2.8 m-85 -111.41 154.37 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 64.14 110.887 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -93.34 -64.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.841 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.5 148.12 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 74.3 110.922 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CD2' ' A' ' 53' ' ' PHE . 55.2 mt -142.49 117.81 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 75.01 111.142 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.758 HD12 ' CE ' ' A' ' 61' ' ' MET . 59.5 mt -128.42 99.9 23.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 75.02 111.148 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.79 93.71 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.215 . . . . 73.32 112.384 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.43 -26.18 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 51.31 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.55 -56.54 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 73.31 110.843 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.758 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -174.49 -165.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 53.42 110.85 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 61' ' ' MET . 0.7 OUTLIER -146.32 144.9 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 54.43 110.834 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -94.52 -168.71 1.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 71.41 110.897 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.84 -73.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 54.05 112.518 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.22 -144.42 11.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.769 . . . . 53.14 112.466 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -147.35 -169.51 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.361 . . . . 61.23 110.852 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -174.77 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.54 110.901 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 74' ' ' GLY . 10.6 t -54.07 132.44 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 57.88 178.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.901 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -69.11 -32.74 72.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 63.43 110.848 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -82.46 -77.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 63.51 110.913 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 138.58 -104.72 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 65.33 112.434 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p 60.33 34.14 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 62.04 111.109 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 68' ' ' THR . . . 128.71 -175.94 18.49 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 62.45 112.493 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.78 136.76 10.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 54.1 112.489 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -162.84 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 73.23 110.879 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.405 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 5.2 t -105.03 126.39 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 42.32 110.888 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.839 HD13 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -63.88 -13.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.116 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.48 -16.38 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.941 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.31 -107.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 54.15 112.504 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' C ' ' HB3' ' A' ' 77' ' ' SER . 1.1 pt-20 -109.45 -55.76 2.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 71.54 110.913 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -166.74 151.09 7.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.904 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.09 144.13 51.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.9 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -52.98 153.52 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.876 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.04 136.38 33.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 73.42 110.865 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.14 -55.32 6.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.854 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.613 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.9 p30 -176.83 -173.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -132.34 38.49 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 54.25 110.885 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.535 HG21 ' HG2' ' A' ' 28' ' ' LYS . 4.3 mt -51.34 -25.16 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.31 111.125 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD23 ' CD ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -84.61 110.58 18.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 64.5 110.897 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -98.68 -166.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.93 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.527 ' CE1' HG21 ' A' ' 97' ' ' ILE . 88.3 m-70 -102.09 -98.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.34 110.865 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 65.6 7.1 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.55 111.141 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.51 163.36 30.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 75.52 112.499 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.72 10.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 51.02 112.341 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.43 31.51 54.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.467 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.527 HG21 ' CE1' ' A' ' 92' ' ' HIS . 29.5 mm -94.51 131.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 50.32 111.162 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 112' ' ' PHE . 1.2 tt -101.61 136.98 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 71.15 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 113' ' ' PHE . 5.7 t -105.95 -133.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 74.35 110.824 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -171.82 -34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.896 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 100' ' ' MET . . . 66.84 97.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.11 111.141 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.86 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.919 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.689 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -82.68 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.077 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 126.2 -63.42 0.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.462 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.72 -92.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.32 112.362 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -138.84 92.14 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.689 HG21 ' HB3' ' A' ' 103' ' ' ALA . 1.4 p -143.39 21.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.159 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 44.86 -91.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 52.43 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.95 -69.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 71.2 112.488 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 t 67.52 36.12 3.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 72.53 110.87 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -103.27 -97.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 73.12 110.943 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HE2' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.3 173.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 64.34 110.911 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER 178.21 57.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.897 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' A' ' 112' ' ' PHE . 66.7 mt -65.47 85.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.2 111.162 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.6 m -70.96 145.68 49.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.883 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.698 HG21 ' CD ' ' A' ' 143' ' ' GLU . 34.7 p -99.51 20.13 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.51 111.09 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -174.56 -167.84 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 72.21 111.101 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -78.46 134.01 37.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.842 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -134.27 49.74 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 53.11 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -63.21 -11.83 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.899 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -60.67 -26.28 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.883 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.403 HD22 ' NE2' ' A' ' 126' ' ' HIS . 25.5 mt -75.8 -29.92 58.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 60.25 110.924 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 124' ' ' GLY . 21.5 t0 49.83 81.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 71.02 110.859 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 17.31 62.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.689 -0.767 . . . . 25.31 112.505 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ASP . 22.1 tptp -103.57 -25.35 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 72.31 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.439 ' C ' HG23 ' A' ' 127' ' ' VAL . 64.6 m-70 -96.83 -6.96 34.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.834 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 87' ' ' ASN . 7.9 t 76.66 80.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.59 138.67 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.43 111.149 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -154.57 26.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 53.55 110.897 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.9 -179.01 15.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.506 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 140.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 62.22 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 22' ' ' PHE . 85.4 t -86.96 80.4 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 43.24 111.148 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -43.53 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 65.11 110.858 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.43 168.24 15.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.888 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 103.97 -0.09 44.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 51.14 112.46 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -33.44 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 61.3 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -51.13 -29.19 12.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 18' ' ' GLY . 24.7 mm -76.22 -40.44 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 60.51 111.09 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 65.4 t -49.49 -47.49 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.111 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -52.12 -33.41 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.11 110.852 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.41 82.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.21 111.099 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.619 ' HE2' HG21 ' A' ' 10' ' ' ILE . 12.6 mtm -77.34 -14.64 59.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.908 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.698 ' CD ' HG21 ' A' ' 116' ' ' THR . 17.9 mm-40 -86.44 14.27 6.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.9 1.2 2.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.869 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -105.06 -5.8 20.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.868 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.665 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -82.41 -151.26 9.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.54 112.474 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.1 m -145.94 -74.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.375 . . . . 43.01 110.847 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 75.54 110.86 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.87 2.67 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.886 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.85 -44.92 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 44.11 112.482 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.7 137.56 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 72.42 110.93 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.665 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.2 p -123.56 157.57 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.42 111.139 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.3 t -81.37 -17.24 49.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -135.2 -175.73 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.02 110.869 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -125.08 130.36 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 62.11 110.886 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.48 129.03 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 63.14 111.07 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 167.81 20.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 63.45 111.162 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.53 111.98 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.21 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -70.0 -50.99 36.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 51.0 111.085 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.34 162.85 33.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 63.51 110.9 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.4 p -165.73 168.18 16.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.24 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.46 -175.24 36.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 64.13 112.475 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 116.49 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 72.15 110.902 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.9 mm? -91.18 -39.64 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.933 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.864 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.804 0.335 . . . . 74.23 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.44 145.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.137 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.2 148.51 6.12 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.605 0.716 . . . . 55.24 110.924 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 126.11 12.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 63.15 112.336 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 164' ' ' LEU . 51.3 m -106.6 108.86 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 73.34 111.14 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG12 ' HG3' ' A' ' 163' ' ' GLN . 2.5 m -88.72 141.96 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.13 111.146 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -111.99 159.99 17.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 73.15 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.31 138.03 29.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.896 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.4 109.16 17.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.906 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.745 HD12 HG21 ' A' ' 138' ' ' ILE . 13.3 mt -94.49 148.32 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 71.44 111.138 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.34 164.53 28.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 71.43 111.04 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 17' ' ' LEU . 91.0 t -136.44 98.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.129 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 65.69 54.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.54 110.882 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.39 9.91 56.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.21 112.476 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 76.4 tt0 -123.72 107.24 31.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.642 0.734 . . . . 63.21 110.877 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.77 143.43 50.79 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.652 2.234 . . . . 72.34 112.379 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 12' ' ' VAL . 5.8 mp -98.84 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.9 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.67 -167.8 26.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 51.34 112.473 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.07 120.58 40.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 74.14 110.852 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 138' ' ' ILE . 38.4 t -109.23 102.47 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 72.45 111.132 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -110.24 147.19 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.88 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.83 109.04 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.907 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.29 127.88 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.846 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 129' ' ' PHE . 26.9 mt -89.28 136.12 33.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 54.54 110.972 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -78.68 65.3 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.61 66.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.093 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.19 -55.42 12.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 73.54 110.898 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -54.03 -60.58 3.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.911 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.0 m -99.37 101.18 12.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.596 0.712 . . . . 72.34 111.127 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -50.48 0.46 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.677 2.252 . . . . 70.01 112.366 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -44.68 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.895 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' ND2' ' A' ' 108' ' ' ASN . 3.6 m -86.04 23.13 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.138 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.78 -47.38 15.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 62.12 111.127 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.6 mt-10 -85.68 -24.29 27.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.15 110.876 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 34' ' ' GLU . 1.6 t-20 -28.29 -72.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.913 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 64.3 t80 -79.28 -30.19 42.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.52 110.876 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.0 ttp180 -49.27 -44.28 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.54 110.878 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.95 66.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 72.02 111.145 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 79.2 mt -69.11 -41.92 76.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.897 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -64.1 -45.1 90.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' OE1' ' A' ' 163' ' ' GLN . 33.0 p -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 62.11 111.102 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.53 88.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 74.34 112.474 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.02 31.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 74.31 110.924 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -126.27 -15.7 5.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.919 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 21.65 14.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 71.32 112.515 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -178.28 -167.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 72.12 110.844 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.89 -177.24 43.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 75.54 112.44 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 104.7 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 73.33 110.906 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 -66.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.05 110.899 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.79 26.09 7.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 43.2 112.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -76.19 -164.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 61.34 110.866 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.2 p -153.07 172.74 16.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 53.5 110.875 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.4 -75.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.87 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.72 23.53 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.856 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -139.16 17.73 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.883 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.07 143.22 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 55' ' ' ARG . 24.3 mt -127.49 103.39 22.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.674 0.749 . . . . 63.14 111.119 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.71 96.5 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.3 . . . . 63.14 112.318 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.19 -21.18 4.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.76 . . . . 71.21 112.485 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.06 -60.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.906 0.384 . . . . 72.4 110.878 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -167.63 -148.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 62.2 110.875 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -131.89 -58.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 65.74 118.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.878 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.81 151.08 17.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 65.12 112.476 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.13 175.59 19.35 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.481 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -118.7 59.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 43.13 110.864 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' O ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -174.62 -175.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.869 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -175.42 61.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 73.23 111.132 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.73 65.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.04 110.909 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -49.82 -72.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.851 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -94.02 35.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 60.03 110.859 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.16 57.69 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 71.14 112.486 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m 68.14 44.54 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 74.14 111.123 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.8 -174.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 72.22 112.474 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 127.84 28.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.737 . . . . 75.03 112.53 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -83.48 -178.19 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.327 . . . . 72.23 110.868 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . 4.9 p -87.02 -174.74 5.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.43 110.879 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.52 -31.51 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 72.11 111.173 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -87.33 42.32 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.882 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.42 -113.78 3.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 73.22 112.48 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.37 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 71.42 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -103.07 -171.08 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 64.33 110.894 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -131.44 169.53 15.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.88 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.71 169.85 11.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -61.38 -167.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.43 110.844 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -152.59 -55.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 61.44 110.839 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.38 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 63.22 110.898 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.17 56.5 1.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.833 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.6 -0.45 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 64.11 111.111 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 48.9 mt -114.67 132.4 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.923 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.69 126.68 40.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 72.43 110.931 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -53.44 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 63.14 110.882 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -95.02 4.61 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.166 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.02 -175.38 46.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.749 -0.739 . . . . 62.33 112.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 158.75 55.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.281 . . . . 63.52 112.347 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.15 -28.21 9.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 52.32 112.463 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.1 mm -57.81 124.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 64.31 111.14 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 113' ' ' PHE . 1.4 mp -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.883 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 112' ' ' PHE . 4.8 t -142.77 -152.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 63.51 110.857 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.4 mmt -141.11 135.34 30.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 63.42 110.858 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.881 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.91 -163.43 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.089 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.881 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 4.0 m120 116.61 -176.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.888 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.509 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -52.28 -41.28 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.12 111.053 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.58 -64.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 53.54 112.47 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 111.96 2.96 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.599 2.199 . . . . 62.25 112.353 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 42.47 61.56 1.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 42.23 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.418 HG22 ' HG3' ' A' ' 82' ' ' LYS . 16.0 p -152.5 54.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 70.14 111.176 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -45.01 -43.38 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 65.51 110.912 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.24 -164.32 19.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 71.02 112.489 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.445 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -117.65 -31.76 5.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 73.21 110.867 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.746 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 8.0 pt20 -55.51 149.02 14.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 64.24 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -160.95 158.05 27.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.861 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.0 p90 -114.4 -173.07 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 65.01 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.3 mt -113.51 -57.45 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.34 111.121 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.22 127.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -133.19 34.38 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.106 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.37 159.18 37.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 71.53 111.093 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -67.11 88.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.926 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 p -111.12 54.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.33 111.174 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.29 15.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.877 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 11.33 27.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 75.43 110.946 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 4.1 mt -109.26 -33.24 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 122' ' ' LEU . 4.3 t0 78.19 -42.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.857 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.61 2.78 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 72.21 112.515 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -62.94 -14.94 53.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 72.42 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -92.51 16.54 11.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.894 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.428 HG11 ' OD1' ' A' ' 108' ' ' ASN . 7.0 t 72.41 85.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.167 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 4.4 p -86.31 126.46 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.147 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE2' HD22 ' A' ' 24' ' ' LEU . 5.1 p90 -157.93 128.49 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.892 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 115.81 121.61 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 72.21 112.545 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -129.72 159.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 52.15 110.905 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.25 158.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 75.32 111.119 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -62.59 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.865 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.16 173.6 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 73.21 110.877 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.44 81.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 65.5 112.478 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -7.09 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 62.44 110.865 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -30.86 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.865 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.745 HG21 HD12 ' A' ' 10' ' ' ILE . 50.1 mm -65.69 -36.14 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 72.23 111.138 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 11.4 t -89.04 1.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 62.31 111.123 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -115.62 -64.0 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 60.44 110.854 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.25 -52.61 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 52.25 111.065 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 14.0 tmm? -51.9 -45.78 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 64.43 110.868 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -23.12 3.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.845 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.4 ttm-85 -63.28 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 75.51 110.877 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -92.91 20.13 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.885 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.73 68.14 0.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.1 112.447 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -27.35 135.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 72.43 110.837 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 13.6 mmm-85 -46.16 -63.68 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 71.5 110.903 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.81 -31.35 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 63.15 110.879 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.8 -167.69 22.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 75.53 112.521 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 mttt 61.72 103.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 72.3 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.5 p -77.68 144.35 37.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 65.24 111.15 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 p -60.9 -19.05 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.83 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -129.88 -168.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 61.41 110.905 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.4 108.46 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.44 110.894 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.95 99.87 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 73.42 111.143 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.15 157.1 23.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.32 111.121 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.12 126.01 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 65.42 111.185 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.31 -63.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.33 111.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -127.31 168.95 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 62.44 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.05 -176.1 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.35 110.847 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.97 -152.22 20.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.499 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -125.07 138.33 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.366 . . . . 71.54 110.854 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -116.92 143.98 45.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.963 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.85 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.814 0.34 . . . . 73.32 110.882 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.43 144.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.33 111.153 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -52.2 141.73 30.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.618 0.723 . . . . 75.1 110.862 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 128.44 16.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 63.52 112.351 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -115.52 125.95 53.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 73.32 111.197 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.9 m -113.22 156.74 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 72.01 111.142 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HB3' HD21 ' A' ' 164' ' ' LEU . 9.2 p90 -127.46 165.65 19.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.833 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.63 143.98 33.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 61.41 110.888 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.04 136.26 38.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 ' HB ' ' A' ' 20' ' ' VAL . 3.7 mm -107.19 136.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 71.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -143.26 162.86 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.12 111.095 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 156' ' ' ILE . 76.1 t -153.1 101.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.167 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 65.4 56.64 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.888 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.4 13.08 48.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.718 . . . . 54.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -124.04 113.42 28.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 72.32 110.903 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.8 153.32 68.87 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.674 2.249 . . . . 73.53 112.348 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HB3' HD12 ' A' ' 138' ' ' ILE . 1.7 mm? -112.51 -60.49 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.911 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.62 -164.33 27.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 43.35 112.468 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -108.99 121.49 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 75.23 110.853 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.796 ' HB ' HD11 ' A' ' 10' ' ' ILE . 74.7 t -119.37 111.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 65.2 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 p -111.09 152.61 26.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.11 110.869 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 112.9 15.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.889 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.33 137.39 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 53.22 110.881 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.783 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.5 113.35 26.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.92 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE2' HD11 ' A' ' 90' ' ' LEU . 4.2 m-85 -85.99 70.79 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 55.22 110.86 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -1.88 43.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.112 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.36 -48.22 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 65.3 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG2' HD23 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -60.52 -62.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.874 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -115.35 77.67 5.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.64 0.733 . . . . 70.34 111.117 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 72.85 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 74.44 112.371 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -177.11 -42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.14 110.892 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.547 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -82.55 -61.85 1.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 64.31 111.127 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . . . -91.43 22.17 4.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 75.21 111.115 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.37 12.67 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.876 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -121.5 -28.03 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 64.55 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -54.26 -26.75 30.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.883 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.23 -30.79 39.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 74.24 110.876 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.0 -26.67 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.03 111.077 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.08 19.44 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -118.02 -8.06 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.1 110.86 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -115.95 12.71 15.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 70.43 111.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.11 31.55 33.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 62.21 112.461 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.95 -34.18 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 54.33 110.898 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -61.49 -19.97 62.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 65.34 110.914 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.88 18.8 60.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 61.41 112.473 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.8 151.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 73.43 110.902 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.49 -179.58 16.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 41.5 112.485 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.13 102.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 74.15 110.9 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 -51.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.92 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.94 32.73 2.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 43.35 112.475 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.32 -169.46 2.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 72.22 110.893 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.1 p -152.86 148.77 27.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 65.15 110.864 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.82 -177.61 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.898 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -171.87 60.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 62.0 110.831 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.654 ' NH2' HD11 ' A' ' 57' ' ' ILE . 13.1 mmm180 -137.23 29.54 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.883 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.49 143.27 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 71.35 111.141 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.654 HD11 ' NH2' ' A' ' 55' ' ' ARG . 14.5 mt -139.77 96.5 8.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.622 0.725 . . . . 71.44 111.108 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.77 85.13 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.255 . . . . 73.2 112.314 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.47 -40.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 71.52 112.486 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -58.19 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 73.41 110.867 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.558 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.0 OUTLIER -173.97 -158.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 61.25 110.838 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.4 m -139.56 142.55 37.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.879 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' CD ' HG22 ' A' ' 68' ' ' THR . 2.1 tt0 -126.9 157.39 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.953 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.63 99.86 0.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 74.04 112.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.82 -132.58 11.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 74.51 112.491 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.9 -169.71 1.78 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.834 0.35 . . . . 74.4 110.918 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.38 132.83 29.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 63.3 110.893 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.48 HG22 ' CD ' ' A' ' 63' ' ' GLN . 14.1 t -117.24 -33.68 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 54.51 111.172 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -106.18 44.62 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 61.41 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 174.19 115.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 64.52 110.867 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 47.77 34.27 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 63.14 110.878 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.69 153.97 32.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.74 . . . . 73.32 112.487 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 p -142.55 141.13 31.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 74.53 111.183 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.16 173.07 30.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.03 112.499 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.71 -93.73 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 71.32 112.505 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt 64.68 152.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.805 0.336 . . . . 45.43 110.871 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.663 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 40.5 t -118.74 10.83 12.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.861 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER 75.4 -8.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.53 111.092 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -110.28 -18.12 13.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 62.03 110.938 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.37 -134.38 2.01 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 73.34 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -123.98 -33.84 3.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 74.22 110.888 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.42 163.95 10.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.879 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -144.28 135.6 25.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.2 110.883 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -51.02 162.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.21 110.903 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -75.29 92.67 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.882 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -51.67 51.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 177.51 167.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.891 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.34 110.907 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.38 -28.08 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 72.04 111.143 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -87.75 122.3 31.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.43 110.892 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -108.39 -166.55 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 70.25 110.891 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.456 ' CE1' HD12 ' A' ' 122' ' ' LEU . 11.8 m170 -99.88 -88.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.22 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.6 m 69.46 7.64 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.448 . . . . 74.51 111.121 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.22 168.78 30.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.02 112.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 171.34 14.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.269 . . . . 70.11 112.322 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 80.05 28.26 50.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.15 112.526 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 128' ' ' VAL . 37.7 mm -95.31 139.4 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 53.12 111.127 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.741 HD22 ' CE1' ' A' ' 112' ' ' PHE . 12.3 mt -106.54 142.29 36.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.905 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 m -116.89 -138.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 44.32 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.406 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 7.3 mmt -155.13 -59.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 62.04 110.872 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 65.04 146.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 53.31 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.584 ' CG ' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER 177.81 -73.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 75.53 110.882 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.506 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.43 -28.8 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 71.1 111.12 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.11 -76.72 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.72 -0.752 . . . . 41.02 112.429 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.79 107.62 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 73.23 112.331 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' PRO . 70.9 m-80 35.41 69.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.873 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.584 HG22 ' CG ' ' A' ' 102' ' ' ASN . 2.7 m -134.68 16.68 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 71.32 111.165 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.5 t30 39.45 -97.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.9 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 133.65 174.48 13.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 53.15 112.512 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 63.6 m -144.68 -43.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 71.34 110.901 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -91.47 92.55 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 63.01 110.889 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.741 ' CE1' HD22 ' A' ' 98' ' ' LEU . 32.7 p90 -82.91 147.06 28.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.53 110.858 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -111.46 131.73 55.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.51 123.17 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.1 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 68.1 m -74.72 130.97 40.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 54.11 110.862 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 61' ' ' MET . 28.9 p -91.71 -27.77 17.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.173 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 119' ' ' THR . . . -130.53 169.67 15.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 55.13 111.117 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -61.86 96.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 73.12 110.895 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.556 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 29.6 p -121.33 59.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.145 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -88.63 25.0 1.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 73.13 110.872 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.556 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.7 OUTLIER -89.22 10.5 21.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.945 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.633 HD13 ' CD2' ' A' ' 126' ' ' HIS . 10.9 mt -98.44 -41.56 7.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 71.21 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -58.37 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 74.35 110.899 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.23 59.99 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.702 -0.761 . . . . 72.31 112.468 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -103.33 -22.66 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 65.13 110.87 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CD2' HD13 ' A' ' 122' ' ' LEU . 18.6 m-70 -119.32 -20.78 7.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 63.43 110.891 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 16.1 t 80.74 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 55.43 111.104 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 97' ' ' ILE . 77.2 t -102.43 137.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 70.23 111.143 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.839 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -157.6 29.63 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 74.04 110.884 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.64 140.17 6.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.0 112.451 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -124.04 -165.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 70.11 110.904 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.465 HG23 ' CA ' ' A' ' 96' ' ' GLY . 21.7 t -96.68 134.13 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 75.41 111.13 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -90.62 -63.37 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.11 110.862 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -162.07 142.6 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.892 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.63 4.71 13.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 62.21 112.523 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.6 ttt -49.41 -33.24 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 54.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.1 -28.44 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.931 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 17' ' ' LEU . 31.0 mm -79.39 -38.4 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.03 111.115 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.8 t -48.08 -53.31 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.172 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.98 -32.02 14.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -66.02 -41.12 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.119 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.458 ' SD ' HD13 ' A' ' 156' ' ' ILE . 43.7 mtm -77.14 -17.15 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.41 110.858 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -90.16 29.47 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.882 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -129.15 17.43 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.4 110.86 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -136.65 46.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 74.12 112.469 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 146' ' ' GLY . 37.8 m 33.42 -100.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.04 110.856 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' ILE . 7.5 mmm-85 -161.52 -40.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 73.15 110.86 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.58 -7.03 57.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.2 110.903 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 109.34 -137.18 14.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.31 112.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 75.47 -55.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 65.41 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.35 140.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.4 111.156 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 0.33 20.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 70.5 110.859 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.14 161.04 36.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.878 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.48 112.76 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 43.43 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 11' ' ' ALA . 41.5 mt -98.35 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 72.24 111.168 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.66 174.2 6.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.122 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.36 145.12 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.14 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.21 -62.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.51 111.102 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -157.06 164.8 37.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.787 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.7 m -146.23 -165.55 2.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.863 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.34 28.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 72.54 112.489 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 mt-30 -108.65 136.48 48.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.353 . . . . 74.01 110.919 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 7' ' ' PHE . 41.7 mt -73.12 -41.04 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.11 110.909 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 71.34 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.362 . . . . 61.23 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.26 155.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.54 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -92.96 152.87 41.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 72.24 110.882 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 54.2 Cg_endo -69.77 147.11 62.07 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.686 2.257 . . . . 61.32 112.356 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 6' ' ' VAL . 1.9 m -140.01 165.8 26.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.33 111.173 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.96 132.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 65.13 111.136 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.5 162.86 13.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 63.34 110.906 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -143.67 138.58 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.884 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -101.41 71.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 60.44 110.827 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 156' ' ' ILE . 42.7 mm -50.47 136.09 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 63.42 111.145 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.37 152.69 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 52.41 111.126 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD23 ' A' ' 17' ' ' LEU . 2.0 t -127.27 94.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.24 111.159 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.01 32.33 21.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 74.03 110.896 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.47 -24.71 25.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 62.12 112.511 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -121.79 119.68 28.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.67 0.748 . . . . 71.44 110.884 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 162.67 41.16 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.732 2.288 . . . . 74.21 112.365 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' CG2' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -126.11 20.98 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 44.23 110.891 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 133.9 -164.33 24.43 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 60.1 112.49 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 174.47 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 75.23 110.866 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 135' ' ' GLY . 31.9 m -136.78 177.12 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.52 111.116 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -129.61 100.86 5.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.893 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -86.62 114.04 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.877 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.55 124.85 50.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.51 110.898 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 32.1 mt -88.19 126.66 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.937 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -76.38 67.08 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.1 110.888 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.03 -30.1 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.45 111.138 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -53.06 -56.46 16.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.874 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 90' ' ' LEU . 4.6 mptp? -81.95 -35.55 28.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.841 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 129' ' ' PHE . 16.6 m -128.32 80.35 72.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 63.31 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.07 17.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.27 . . . . 60.43 112.356 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.59 -69.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 61.4 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -42.26 -39.62 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 53.01 111.166 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -63.55 -67.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 53.4 111.071 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' ARG . 6.8 tt0 -41.62 -61.06 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 53.21 110.862 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -35.83 -43.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 44.21 110.881 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -75.24 -41.85 56.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.02 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' GLU . 9.0 tmm_? -51.62 -30.32 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 61.45 110.838 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.55 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.24 111.113 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.19 -41.44 81.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.923 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.9 p -58.88 -46.09 88.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.44 110.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -16.93 64.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.129 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.56 86.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 55.41 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -143.74 39.95 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 74.34 110.92 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 21.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.13 110.926 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.91 -33.69 3.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 64.33 112.486 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CZ ' HG21 ' A' ' 73' ' ' THR . 15.7 p90 -126.09 -167.53 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 72.2 110.865 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.6 -144.21 13.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.733 . . . . 72.51 112.496 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 -18.69 15.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 74.24 110.968 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.59 113.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 65.1 110.88 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -131.19 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 50.42 112.498 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.697 ' O ' HG22 ' A' ' 157' ' ' THR . 6.2 t 49.32 -166.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 65.33 110.817 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.7 p -143.52 -168.58 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -179.44 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.87 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -116.13 -57.52 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.1 110.855 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -145.79 164.6 31.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.15 110.909 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' A' ' 152' ' ' THR . 67.0 mt -153.42 124.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 72.12 111.171 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 1.3 pt -134.62 126.82 18.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.652 0.739 . . . . 61.42 111.132 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 138.44 37.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.622 2.215 . . . . 63.03 112.348 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.43 30.86 77.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 54.34 112.486 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.96 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 74.52 110.898 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -163.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.893 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 m -137.02 -69.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 61.42 110.865 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 62.81 148.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 65.33 110.897 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.61 167.18 21.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 53.2 112.469 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.44 -90.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 43.43 112.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.76 -168.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 62.54 110.865 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -134.75 32.92 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 75' ' ' GLY . 90.2 m -58.98 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 53.24 111.131 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 65.31 -152.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.45 110.875 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -152.9 27.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 75.1 110.839 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.86 -17.58 56.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 71.34 110.836 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.83 15.36 2.91 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.732 -0.746 . . . . 73.25 112.497 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.57 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 81.3 m -128.51 -51.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 64.1 111.14 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.95 178.02 43.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 54.42 112.451 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.544 ' H ' HG23 ' A' ' 68' ' ' THR . . . -79.11 109.25 2.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 70.11 112.504 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.37 -165.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.76 0.314 . . . . 61.3 110.914 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ILE . 47.6 p -77.87 137.46 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 43.31 110.861 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -33.59 -46.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.153 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 8.2 p90 -112.84 106.21 14.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 71.21 110.88 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.57 -168.86 51.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 73.43 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -71.33 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 74.01 110.902 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.06 155.56 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 53.4 110.913 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 179.41 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.881 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 173.96 9.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.848 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -71.79 179.96 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.883 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.72 -63.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.835 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.86 158.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.855 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 60.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 54.5 110.924 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -78.98 -3.34 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 70.14 111.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -115.94 71.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.882 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 154.57 24.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 53.04 110.866 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -63.82 83.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.845 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -77.08 -8.81 58.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 71.25 111.13 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.95 -174.35 45.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.54 112.492 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.07 66.68 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 71.42 112.329 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -27.96 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 53.43 112.496 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.18 120.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 72.42 111.131 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 99' ' ' SER . 4.1 tt -91.96 143.16 26.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.909 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.711 ' N ' HD23 ' A' ' 98' ' ' LEU . 21.0 t -148.83 -166.58 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 62.34 110.824 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.0 OUTLIER -101.81 148.52 25.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 75.54 110.872 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 107' ' ' THR . 3.1 t30 -145.5 -160.54 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.927 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.16 -45.59 16.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 75.24 111.081 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.04 -65.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 64.04 112.527 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 112.21 3.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.233 . . . . 64.2 112.333 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' PRO . 51.7 m-20 34.42 46.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 54.1 110.901 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 19.7 p -154.08 34.31 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.3 111.16 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -79.73 4.01 17.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.07 133.1 43.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 62.24 112.467 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.22 166.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 52.02 110.891 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 67.52 138.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 70.25 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -153.91 177.49 10.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 61.42 110.91 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.47 162.91 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.874 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.4 pt -145.39 134.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.507 ' SG ' HG23 ' A' ' 119' ' ' THR . 14.0 t -96.58 156.89 16.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 73.3 110.873 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -124.9 27.74 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 73.1 111.125 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.62 27.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 71.4 111.102 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.0 142.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.878 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.507 HG23 ' SG ' ' A' ' 115' ' ' CYS . 0.2 OUTLIER -140.57 48.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.13 111.195 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.72 -20.82 23.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 64.21 110.849 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -62.51 -22.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.904 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.455 HD22 ' HB ' ' A' ' 119' ' ' THR . 4.2 mp -76.41 -37.46 57.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.919 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t0 47.09 86.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 73.3 110.828 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.79 37.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 31.32 112.508 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -55.03 -32.91 62.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 74.32 110.911 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.621 ' C ' HG23 ' A' ' 127' ' ' VAL . 87.3 m-70 -145.57 43.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.871 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER 67.13 -153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.12 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 127' ' ' VAL . 14.2 p -176.94 144.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.22 111.122 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.619 ' CB ' HG21 ' A' ' 29' ' ' VAL . 4.1 p90 -176.5 95.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 63.02 110.881 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 132.54 161.48 9.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 54.41 112.468 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt 175.18 131.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 73.52 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.69 136.36 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.124 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -114.54 -39.41 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 75.52 110.883 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.24 160.94 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.33 110.896 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.655 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 59.05 81.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.3 112.473 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -12.29 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 70.43 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -75.06 -24.54 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 74.53 110.88 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.458 HD11 ' HA3' ' A' ' 18' ' ' GLY . 17.6 mm -64.19 -44.11 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 74.53 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -93.38 5.62 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.55 111.166 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -112.58 -64.36 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 70.22 110.849 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.27 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.23 111.077 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.34 -44.45 54.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.23 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.93 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 54.45 110.907 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.37 -29.97 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.37 -2.81 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 62.41 110.884 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.95 -152.75 14.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 52.44 112.44 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.7 t -161.92 156.13 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 72.42 110.858 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -71.53 -7.47 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 73.1 110.837 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -106.21 -19.61 13.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.862 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.15 -44.27 1.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 61.24 112.495 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -44.55 129.63 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.45 110.914 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 56' ' ' ILE . 49.2 p -98.62 118.17 34.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 53.01 111.118 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 p -54.2 -26.27 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 110.82 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -127.43 -163.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.943 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -131.0 127.75 38.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 64.53 110.943 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 10' ' ' ILE . 2.2 mp -98.84 125.21 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 73.04 111.145 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.13 141.69 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 75.2 111.139 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.07 100.53 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.185 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -66.31 -59.82 3.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.093 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.5 170.41 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.873 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -170.2 154.36 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.928 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.79 179.89 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.747 . . . . 51.43 112.478 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 1.1 mt-30 -82.62 -49.92 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 51.25 110.898 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 164' ' ' LEU . 2.7 mm? 65.04 115.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 64.33 110.936 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.11 110.917 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.889 0.376 . . . . 70.14 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.85 156.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.139 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -92.64 160.1 35.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.623 0.725 . . . . 71.1 110.859 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.52 69.02 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 61.21 112.349 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.1 m -136.18 150.13 48.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 50.2 111.142 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.92 137.24 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.15 111.079 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.625 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -113.32 157.87 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.867 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -141.66 136.34 30.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.878 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.1 m-20 -96.55 119.75 35.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 138' ' ' ILE . 13.3 mm -95.02 142.41 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.12 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.54 170.76 15.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 42.51 111.067 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 17' ' ' LEU . 2.6 m -146.99 96.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.25 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.74 36.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.03 110.857 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -12.42 66.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 65.12 112.486 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.56 131.55 30.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 73.44 110.921 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 153.18 69.08 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.257 . . . . 75.23 112.333 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.715 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.53 -68.21 0.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.58 28.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 50.05 112.528 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.76 134.26 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 70.34 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.603 HG22 ' HA3' ' A' ' 135' ' ' GLY . 53.3 t -136.59 139.99 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.076 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -123.53 152.66 41.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 53.12 110.87 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 132' ' ' VAL . 1.3 m-85 -119.54 -175.48 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 72.34 110.874 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -144.48 117.57 8.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 72.22 110.927 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.46 130.21 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 61.31 110.913 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 29' ' ' VAL . 67.6 m-85 -79.48 75.86 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.86 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -28.11 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.42 111.126 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -37.72 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 50.14 110.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HD2' HD12 ' A' ' 89' ' ' ILE . 19.0 mmtp -86.44 -31.97 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 65.22 110.889 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 7.9 m -132.84 84.98 48.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 73.22 111.11 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -40.38 5.37 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.228 . . . . 50.44 112.38 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -83.08 -44.89 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.864 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.415 HG21 ' CE ' ' A' ' 100' ' ' MET . 2.7 m -81.84 17.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 63.42 111.163 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -85.79 -44.14 12.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.41 111.139 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.4 mt-10 -81.81 -31.37 31.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 61.34 110.85 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 8.4 t30 -27.18 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 72.21 110.896 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -77.51 -34.21 54.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.869 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 1.8 ttp180 -47.83 -40.27 20.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 54.02 110.917 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.21 60.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.32 111.079 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 13.16 14.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.42 110.942 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -129.67 -20.29 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.8 p -101.19 -25.08 14.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 72.41 111.106 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.17 62.11 1.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.45 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.63 27.08 1.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 71.13 110.865 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -123.6 -11.03 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 61.35 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.86 -25.94 25.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 52.13 112.539 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -140.57 166.65 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 64.53 110.89 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.87 -176.68 41.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 73.01 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -99.58 3.29 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.956 0.408 . . . . 73.21 110.937 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -54.19 150.41 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 64.24 110.894 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 158' ' ' ILE . . . 49.51 63.61 3.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 74.53 112.544 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 m -153.6 -95.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 65.33 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 p -176.5 -172.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.899 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -124.18 -174.51 3.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.9 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.26 177.02 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 70.34 110.87 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 51.17 27.09 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.872 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mt -71.27 119.44 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.53 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.4 111.32 8.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 65.41 111.168 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 93.45 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.672 2.248 . . . . 71.23 112.335 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.96 -30.89 2.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 71.3 112.461 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -108.56 -65.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.52 110.9 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -171.82 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 72.32 110.849 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -121.17 -67.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.906 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 64.15 162.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.85 168.27 20.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.504 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.44 -92.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 62.53 112.48 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -178.9 -155.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 72.33 110.859 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -158.37 -39.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 73.51 110.885 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 3.1 p 47.7 -101.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 64.23 111.123 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -121.95 -176.09 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 71.33 110.86 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.62 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 71.24 110.81 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.65 -51.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 51.24 110.902 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 46.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 73.0 112.495 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.4 m -120.21 -48.88 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.369 . . . . 72.13 111.169 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.63 153.19 9.41 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.756 -0.735 . . . . 70.41 112.521 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 68' ' ' THR . . . -90.62 -155.52 31.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 53.12 112.456 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.93 -68.07 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 74.43 110.871 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.444 ' HB2' ' C ' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -125.31 129.31 49.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.856 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pt -61.75 -15.0 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 63.33 111.172 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.0 21.85 6.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 72.41 110.923 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 77' ' ' SER . . . 157.12 -136.15 4.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.495 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' C ' ' HB2' ' A' ' 77' ' ' SER . 27.2 mm-40 -104.57 -47.71 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.956 0.407 . . . . 60.23 110.883 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 175.01 10.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 54.33 110.866 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.51 175.0 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.897 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.97 152.12 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -56.61 166.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.864 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.37 -64.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 71.35 110.888 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.36 153.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 62.41 110.909 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 62.69 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.853 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 28' ' ' LYS . 1.5 mt -81.9 -4.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.34 111.177 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.734 ' O ' HG11 ' A' ' 128' ' ' VAL . 4.2 mt -120.49 77.38 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -58.82 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.939 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 86.29 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.861 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 p -108.33 17.78 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.41 111.113 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.62 164.97 31.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 61.43 112.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.63 30.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.265 . . . . 75.33 112.312 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . 75.98 26.38 64.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.729 . . . . 60.43 112.517 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -91.86 118.85 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 72.54 111.152 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 131' ' ' LYS . 1.2 mt -94.37 143.31 26.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.13 110.961 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 t -146.22 -127.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 61.35 110.821 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.61 118.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.42 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -106.79 88.87 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 61.3 111.089 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 49.5 t30 -153.74 95.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 71.13 110.873 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 71.26 -66.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 64.53 111.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.15 -73.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 60.32 112.491 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.3 Cg_endo -69.72 123.54 10.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 63.14 112.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' PRO . 4.2 m-20 31.06 60.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 54.54 110.901 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 108' ' ' ASN . 1.2 p -145.05 31.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 55.31 111.132 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.581 ' C ' ' O ' ' A' ' 107' ' ' THR . 35.6 t30 22.14 -100.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.41 110.911 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.96 145.12 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 72.24 112.514 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -121.4 -10.43 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 45.54 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.595 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.8 mt-30 -81.25 53.66 2.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 75.41 110.902 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -52.95 143.17 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.15 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -112.95 64.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 72.45 110.876 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 113' ' ' PHE . 55.5 mt -29.82 99.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.155 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -64.97 152.88 42.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 63.2 110.886 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.3 p -118.55 -1.82 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.115 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 119' ' ' THR . . . -149.46 159.4 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.129 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -53.73 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.03 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 117' ' ' ALA . 33.2 p -105.15 63.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.01 111.131 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 4.87 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.725 ' CH2' HG22 ' A' ' 119' ' ' THR . 6.5 p90 -84.21 7.52 18.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.933 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -93.37 -57.69 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.03 110.938 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.04 83.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.89 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.06 36.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 61.42 112.489 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tmtp? -73.56 -30.31 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 64.03 110.93 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.485 ' C ' HG23 ' A' ' 127' ' ' VAL . 19.2 m-70 -146.14 34.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 64.51 110.864 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER 56.21 -154.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.119 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.734 HG11 ' O ' ' A' ' 90' ' ' LEU . 7.1 p 178.89 147.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 70.44 111.129 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.798 ' HB2' HG21 ' A' ' 29' ' ' VAL . 15.4 p90 -177.5 115.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.876 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 102.86 141.71 11.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 63.53 112.48 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -158.76 148.24 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.41 110.901 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 22' ' ' PHE . 94.6 t -51.91 148.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 71.22 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -118.27 -60.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.34 110.906 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -128.5 125.61 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.15 110.893 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 20' ' ' VAL . . . 112.16 65.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 45.3 112.49 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.7 mmm -84.26 -0.47 52.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 73.43 110.877 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -30.39 63.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.848 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 142' ' ' MET . 13.1 mm -72.21 -37.17 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.3 111.154 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.0 t -91.69 20.48 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.51 111.144 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -139.28 -55.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 61.41 110.9 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.4 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 70.14 111.152 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 10.2 tmm? -48.0 -36.38 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 42.53 110.888 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.11 -32.69 55.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 72.04 110.885 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.423 ' HG3' ' CD1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -59.01 -18.41 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.869 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 144' ' ' ARG . 50.0 m-85 -82.59 1.12 39.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 74.33 110.889 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.819 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -90.79 -157.7 33.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 55.34 112.528 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 t -159.45 169.7 23.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 75.2 110.836 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -61.28 -48.5 81.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.888 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -5.66 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.35 110.909 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.46 -39.96 2.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.523 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -48.88 158.22 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 72.53 110.883 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.819 HG22 ' HA2' ' A' ' 146' ' ' GLY . 64.1 p -126.25 157.62 37.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 73.11 111.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.4 t -85.64 1.44 49.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.892 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.3 -168.67 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 64.24 110.893 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.16 120.48 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.22 110.939 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -84.55 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 73.12 111.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.38 136.68 51.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.3 111.202 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.619 HD11 ' CE2' ' A' ' 48' ' ' TYR . 5.7 mt -85.65 132.97 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 75.42 111.165 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -88.03 -58.23 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 74.4 111.129 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -167.79 168.45 12.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.896 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.7 m -146.81 164.48 32.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 61.42 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.51 171.83 44.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.761 . . . . 75.12 112.502 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -68.18 -35.7 78.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.887 0.375 . . . . 61.13 110.929 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.83 -60.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.24 110.929 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 73.25 110.885 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.818 0.342 . . . . 75.44 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.92 146.06 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.14 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.84 141.12 14.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 52.01 110.91 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.72 26.28 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.649 2.233 . . . . 74.41 112.364 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -112.78 112.07 23.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 111.144 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 24' ' ' LEU . 16.1 m -88.57 155.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.11 111.096 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.55 151.75 39.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.866 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 137.64 23.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 62.22 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -109.96 148.28 31.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.669 HD12 ' CG2' ' A' ' 138' ' ' ILE . 3.8 mt -120.13 134.44 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 62.41 111.146 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.27 156.35 42.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.129 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD23 ' A' ' 17' ' ' LEU . 59.1 t -135.27 120.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.44 111.159 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.71 41.34 7.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.875 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.44 62.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 24.23 112.472 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.07 125.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.657 0.741 . . . . 73.44 110.856 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 131.6 21.67 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.702 2.268 . . . . 71.51 112.372 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.76 -19.51 10.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.4 110.926 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.47 -179.58 39.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.747 . . . . 74.03 112.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -144.0 167.0 23.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.353 . . . . 71.22 110.854 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 135' ' ' GLY . 22.6 m -127.15 173.52 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.074 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 t -117.75 94.71 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.35 110.87 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.737 ' CE1' HD11 ' A' ' 114' ' ' ILE . 12.5 m-85 -84.21 120.34 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.848 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.91 146.47 26.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 62.33 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.68 HD11 HG11 ' A' ' 6' ' ' VAL . 11.4 mt -112.26 121.35 44.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.931 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 90' ' ' LEU . 3.9 m-85 -79.99 68.85 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.841 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.21 57.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.129 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.93 -65.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.11 110.852 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -52.43 -62.13 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.887 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.63 84.78 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 52.05 111.113 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 76.48 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 65.34 112.329 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 179.66 -65.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 62.1 110.85 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' CE2' ' A' ' 129' ' ' PHE . 52.1 m -50.92 -41.55 58.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 74.24 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.27 -26.24 51.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.085 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.14 -24.08 66.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.907 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -80.75 -66.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 65.31 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -49.57 -41.21 41.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.888 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -62.13 -33.46 74.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.889 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.4 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 60.14 111.067 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.87 -51.04 36.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 64.23 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 m -57.06 -48.12 79.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.859 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -79.25 -5.41 54.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 73.33 111.168 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.25 64.96 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 41.24 112.505 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -112.22 37.53 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 73.31 110.883 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.635 ' HD2' HD12 ' A' ' 78' ' ' ILE . 2.1 mtpm? -131.64 17.02 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.3 110.884 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.62 63.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 74.11 112.51 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.92 164.78 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 74.32 110.858 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.78 141.2 5.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 54.41 112.5 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HE1' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.45 138.66 9.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 61.35 110.925 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 -47.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.927 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.48 30.22 6.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.731 . . . . 75.1 112.455 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -112.48 -164.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 73.4 110.887 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.0 p -103.23 -178.8 3.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 70.43 110.874 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 158' ' ' ILE . 2.0 m-85 -88.54 177.32 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 74.32 110.851 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.36 -61.54 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 72.2 110.888 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -164.33 145.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 65.24 110.903 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -133.43 145.66 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.43 111.122 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -139.16 123.04 11.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 53.42 111.131 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.71 28.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.632 2.221 . . . . 74.11 112.338 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.17 24.44 68.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 72.34 112.505 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.94 -71.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 71.44 110.918 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.58 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -174.5 -163.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 72.42 110.88 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.57 143.34 16.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.32 110.893 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.41 152.27 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.875 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.49 146.48 16.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 64.02 112.491 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.86 156.93 7.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 44.43 112.503 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -70.07 69.08 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 75.35 110.884 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -150.93 67.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.858 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 t -83.26 -0.7 50.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.32 111.166 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -87.48 -72.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 44.51 110.855 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.86 -177.5 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.873 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.07 134.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 65.52 110.913 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.53 89.52 0.51 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 73.11 112.495 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.1 p -115.09 140.65 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.342 . . . . 52.41 111.154 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.52 151.85 5.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.793 -0.718 . . . . 73.21 112.521 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.33 106.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 63.11 112.513 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt 177.46 131.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.781 0.324 . . . . 71.41 110.906 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -71.18 174.41 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.846 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.635 HD12 ' HD2' ' A' ' 44' ' ' LYS . 20.0 pt -83.45 -32.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 72.44 111.139 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -81.36 3.12 25.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.22 -120.46 3.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.739 -0.744 . . . . 73.44 112.521 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -60.47 -164.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 61.24 110.89 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -107.97 164.27 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.902 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.55 146.66 47.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.876 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.38 172.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 72.33 110.862 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 124.19 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 54.04 110.863 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.12 -55.35 14.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.859 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.3 p30 179.65 172.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.32 110.886 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.41 41.05 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.51 110.863 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.522 HG21 ' HG3' ' A' ' 28' ' ' LYS . 3.8 mt -46.54 -33.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 71.54 111.157 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.76 HD11 ' CD2' ' A' ' 25' ' ' PHE . 22.0 mt -91.99 118.97 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 62.24 110.945 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.4 111.11 23.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.902 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.681 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -61.01 92.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 52.53 110.881 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 p -115.43 25.66 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.166 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.61 171.0 43.94 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 73.15 112.527 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 150.37 67.84 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.743 2.295 . . . . 75.1 112.36 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 -30.35 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 75.22 112.468 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 92' ' ' HIS . 43.9 mm -51.49 145.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.42 111.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 ' CE1' ' A' ' 129' ' ' PHE . 1.7 tt -104.82 133.07 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 75.2 110.881 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.75 137.34 54.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 71.32 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.9 mmt -88.07 178.48 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.864 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . 176.11 174.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 71.32 111.111 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 33.7 t-20 178.21 -66.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 53.12 110.837 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -157.34 23.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.23 111.081 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.73 -153.55 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 44.23 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.03 66.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 72.43 112.303 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 64.91 27.14 12.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 75.2 110.936 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 82' ' ' LYS . 26.3 p -147.11 67.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 62.42 111.122 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -88.21 7.21 33.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.959 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.85 130.74 36.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 63.54 112.501 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.1 p 48.13 -158.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 33.02 110.823 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 49.77 93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.932 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.69 163.77 18.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.1 110.841 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -138.85 139.98 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.858 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.737 HD11 ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -81.84 -41.65 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 75.24 111.093 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.6 m 70.78 99.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.88 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.9 p -91.83 27.42 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.146 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -173.04 -173.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 62.11 111.088 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 138.06 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.929 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.7 p -81.27 -150.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.131 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 168.65 -67.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -64.76 -19.87 66.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.949 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 126' ' ' HIS . 25.5 mt -88.16 140.24 29.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.916 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -154.98 -48.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.873 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.99 51.39 0.82 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 43.44 112.472 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HD2' HD22 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.5 29.74 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 72.45 110.92 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.493 ' CD2' HD13 ' A' ' 122' ' ' LEU . 29.3 m-70 -156.11 -50.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.859 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 15.8 t 80.04 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.0 133.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 65.02 111.154 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.53 ' CE1' HD22 ' A' ' 98' ' ' LEU . 4.6 p90 -151.01 17.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.889 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -135.29 -166.55 11.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 71.02 112.47 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER 175.08 172.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 72.41 110.89 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.634 HG11 ' HB2' ' A' ' 136' ' ' MET . 21.3 t -107.94 100.38 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.53 111.144 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -39.87 90.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 179.71 -168.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 110.915 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.714 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 62.68 14.69 51.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 42.22 112.507 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.634 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -55.58 -22.02 20.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 62.11 110.902 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -50.28 -30.26 11.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 51.24 110.886 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.669 ' CG2' HD12 ' A' ' 10' ' ' ILE . 16.7 mm -73.32 -39.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 61.13 111.147 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.671 HG12 ' OE1' ' A' ' 143' ' ' GLU . 53.3 t -48.33 -44.05 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 34.42 111.135 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.72 -47.4 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.53 110.892 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -27.51 62.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.2 111.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 10' ' ' ILE . 46.3 mtm -80.32 -39.76 28.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.671 ' OE1' HG12 ' A' ' 139' ' ' VAL . 2.5 pt-20 -87.44 30.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.22 110.878 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -122.48 -13.54 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.884 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -128.84 24.13 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.851 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -120.73 73.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 75.43 112.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 146' ' ' GLY . 24.0 p -24.37 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 75.11 110.87 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -49.62 -36.13 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.31 110.869 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -54.08 -25.6 22.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.917 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.57 -45.16 1.26 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.791 -0.719 . . . . 44.54 112.512 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 116.1 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 72.21 110.905 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -78.96 133.13 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 74.44 111.138 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -23.25 67.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 74.23 110.838 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.23 -169.33 2.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 73.21 110.908 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.1 OUTLIER -106.08 134.39 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 63.24 110.885 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -115.25 87.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.129 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.701 HG23 ' HD2' ' A' ' 155' ' ' LYS . 2.0 p -102.38 168.77 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.23 111.174 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.596 HD11 ' HE1' ' A' ' 53' ' ' PHE . 1.8 mp -113.4 118.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.11 111.162 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.33 -70.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 61.42 111.136 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -119.1 173.24 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 53.14 110.863 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.2 p -171.9 178.57 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.833 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.69 -143.9 15.4 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 63.23 112.517 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.5 tt0 -107.29 132.95 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.862 0.363 . . . . 73.14 110.924 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -59.78 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 70.2 110.902 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.884 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.795 0.331 . . . . 72.34 110.851 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.68 142.47 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 63.53 111.129 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.89 162.13 0.83 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 74.55 110.89 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 149.23 66.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 73.22 112.345 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.0 m -136.94 86.21 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 43.1 111.126 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.98 159.85 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.107 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.33 161.35 36.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.928 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.64 137.55 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.5 OUTLIER -110.42 100.16 9.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.858 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mm -75.44 144.88 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 72.4 111.18 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -124.7 154.1 41.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.35 111.131 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.577 HG21 HD23 ' A' ' 17' ' ' LEU . 4.8 t -129.16 98.84 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.24 111.121 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.54 54.98 8.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.1 110.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.08 7.93 52.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 62.21 112.469 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -140.05 95.76 8.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 74.12 110.856 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 161.65 45.12 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 70.15 112.289 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -128.31 25.94 5.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.916 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -162.69 21.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 75.44 112.441 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 -176.92 5.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 74.14 110.885 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 3.7 m -135.19 163.91 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 60.1 111.123 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -116.5 94.82 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.868 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.2 m-85 -89.63 116.79 28.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 63.42 110.881 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.34 113.68 26.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.923 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 129' ' ' PHE . 23.6 mt -79.94 139.71 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 75.1 110.941 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CG ' HD11 ' A' ' 90' ' ' LEU . 17.6 m-85 -86.97 60.22 6.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.433 . . . . 70.42 110.886 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.53 -25.26 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.087 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.9 -61.06 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -19.12 62.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.875 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.99 82.7 8.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.682 0.753 . . . . 64.22 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.62 24.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 63.14 112.3 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -58.52 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 73.22 110.925 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.524 HG21 ' CG1' ' A' ' 127' ' ' VAL . 12.7 m -52.0 -45.09 64.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 73.43 111.115 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.22 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.081 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.6 tp10 -57.47 -23.18 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.926 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.51 -71.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.874 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -48.72 -44.23 38.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.857 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.73 -33.18 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.837 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.73 -38.79 28.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.45 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.1 tt -89.33 20.06 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.922 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -112.39 -15.18 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 55.21 110.864 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 p -117.52 4.68 12.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 74.4 111.132 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.96 30.13 66.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 74.13 112.491 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -38.6 50.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.968 0.413 . . . . 63.25 110.906 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.82 -17.05 54.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 51.22 110.9 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.72 -26.36 24.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.34 159.61 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 71.45 110.843 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.636 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 176.3 -78.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 51.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -167.44 -64.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 73.11 110.96 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tptt 59.77 166.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 62.34 110.882 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 118.67 14.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 71.31 112.479 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 157' ' ' THR . 36.8 m -159.14 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 72.42 110.811 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -142.88 119.14 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 44.45 110.879 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.23 122.54 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.22 110.894 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.92 70.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.848 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.43 39.49 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 72.23 110.855 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 mt -96.26 140.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.23 111.139 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.438 HG13 ' HD2' ' A' ' 58' ' ' PRO . 2.0 tt -135.05 133.02 20.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.587 0.708 . . . . 63.14 111.184 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.8 125.21 11.86 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 50.11 112.375 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.33 26.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 75.01 112.514 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -156.73 -82.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 73.01 110.855 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -179.96 -150.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.34 110.848 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.9 m -146.79 144.22 29.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 72.01 110.91 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.49 164.64 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.878 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.22 -79.33 0.7 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.769 -0.729 . . . . 31.22 112.454 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.99 -150.66 22.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 71.13 112.488 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.11 155.07 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 74.11 110.884 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 62.77 158.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 74.05 110.902 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.38 -67.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 64.25 111.065 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -119.7 48.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 72.51 110.85 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' ARG . 11.1 m170 38.07 51.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.858 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.505 ' O ' HG23 ' A' ' 73' ' ' THR . 6.2 t-20 -152.42 121.08 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.1 110.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.67 102.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 75.35 112.486 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 71' ' ' ASN . 54.0 p -98.3 -64.03 1.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.841 0.353 . . . . 63.11 111.168 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.35 -92.37 0.97 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 75.15 112.505 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.47 23.61 1.69 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 55.33 112.516 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -56.91 -177.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 75.43 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -133.15 15.26 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 52.2 110.819 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER 83.9 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 73.15 111.184 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.93 -23.25 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 61.12 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.04 -156.68 26.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 64.41 112.503 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.95 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 71.04 110.908 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -155.84 155.34 32.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 71.05 110.917 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -119.55 145.91 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -64.57 152.98 40.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 72.54 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.8 93.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -58.56 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 75.51 110.885 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 175.44 175.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.4 110.909 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.58 43.52 2.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.3 mm -46.23 -32.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 53.33 111.147 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 25' ' ' PHE . 14.5 mt -91.0 147.71 22.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -126.33 -166.37 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.51 110.884 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -98.65 -88.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.35 10.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.163 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.59 141.07 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 63.45 112.488 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 156.68 62.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.31 112.318 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.52 -28.8 9.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 41.01 112.475 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 131' ' ' LYS . 50.3 mm -62.82 147.87 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 72.02 111.102 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 99' ' ' SER . 1.6 tm? -99.1 148.8 23.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.877 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.679 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -145.49 176.96 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.845 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.481 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 4.8 mmt -82.52 170.72 14.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.41 110.926 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' PHE . . . -140.38 100.12 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 61.12 111.083 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -161.0 -169.86 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.923 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -53.38 -32.84 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.23 -68.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 74.55 112.445 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' O ' HG23 ' A' ' 107' ' ' THR . 53.7 Cg_endo -69.73 120.52 7.3 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.2 112.345 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 11.9 m-20 32.96 58.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.52 110.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 105' ' ' PRO . 19.2 p -139.71 33.12 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.24 111.161 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 107' ' ' THR . 2.4 p30 23.89 -101.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 73.23 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 100' ' ' MET . . . 166.08 -165.25 38.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 63.31 112.468 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.45 13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 64.42 110.854 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 70.36 72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 63.21 110.941 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.703 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 175.59 122.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 61.54 110.87 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 112' ' ' PHE . 11.4 t80 178.83 47.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 73.02 110.847 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.59 HG12 HD23 ' A' ' 98' ' ' LEU . 58.8 mt -72.91 94.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.54 111.117 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.5 p -83.28 133.22 34.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.87 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -91.05 -10.38 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 34.42 111.145 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.16 149.43 47.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.16 131.98 46.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.4 110.895 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.05 47.14 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 61.22 111.093 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.02 -15.45 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.872 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -57.81 -20.21 34.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.955 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.28 -46.32 28.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 63.23 110.944 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.99 -58.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 63.51 110.851 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.0 64.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.43 112.508 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -105.47 -28.45 10.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 74.12 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.23 125.5 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.899 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 32' ' ' THR . 53.1 t -51.01 114.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 73.2 111.152 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -98.42 139.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 54.34 111.133 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.2 p90 -176.26 123.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.904 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.38 134.85 8.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.733 . . . . 62.23 112.491 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HB2' HD13 ' A' ' 97' ' ' ILE . 22.2 pttm -152.02 165.26 35.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 70.01 110.873 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 133' ' ' LYS . 9.8 p -72.84 159.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.158 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -124.49 -47.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.15 110.879 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.39 178.51 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 70.44 110.839 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 51.44 69.5 1.12 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.778 -0.725 . . . . 42.53 112.471 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.52 -1.16 40.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.333 . . . . 63.12 110.898 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -77.71 -27.12 50.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.859 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.492 ' HB ' HG12 ' A' ' 20' ' ' VAL . 35.0 mm -65.34 -44.38 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 139' ' ' VAL . 4.7 t -90.11 9.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.52 111.13 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.89 -66.38 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 72.22 110.868 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.83 -51.51 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 53.54 111.111 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.0 ttm -50.95 -44.43 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.875 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -52.8 -27.11 16.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.892 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -62.63 -23.09 66.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 62.02 110.909 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -78.65 2.46 19.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.12 110.904 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -73.16 -161.37 6.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 72.1 112.5 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.9 m -142.15 -77.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 71.44 110.849 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.893 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -92.94 14.93 16.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.938 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.41 -42.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.742 -0.742 . . . . 73.33 112.542 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 155.67 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 70.4 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 146' ' ' GLY . 75.0 p -130.24 157.85 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 53.31 111.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.1 p -79.01 -16.49 56.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.88 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.39 -169.72 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.912 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.55 40.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.893 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.51 127.39 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.23 111.146 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -134.13 143.49 47.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.134 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.91 104.97 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.1 111.157 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -64.25 -59.95 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.13 111.073 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -144.33 171.1 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 65.35 110.869 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.3 p -175.58 145.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.33 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.0 -178.92 36.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 63.13 112.529 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -81.4 122.78 27.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 70.01 110.88 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.817 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -94.92 -30.68 14.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.936 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.916 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.812 0.339 . . . . 71.12 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.19 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.32 111.115 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -89.58 144.27 31.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 75.12 110.902 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 124.57 11.23 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.273 . . . . 62.42 112.349 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -117.1 145.99 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.133 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.36 148.75 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 64.23 111.105 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -110.0 154.47 23.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.14 137.47 42.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.861 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.36 124.0 44.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.888 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.89 129.05 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.55 111.092 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -123.9 168.54 12.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.085 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.5 t -152.39 107.23 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 62.12 111.155 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.25 25.23 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 62.43 110.845 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.63 -14.04 65.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.03 112.499 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.82 139.28 21.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.73 . . . . 71.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.49 64.97 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.722 2.281 . . . . 74.04 112.374 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -66.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 63.52 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.29 -174.83 36.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 64.34 112.459 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -118.76 126.09 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 71.12 110.877 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 138' ' ' ILE . 24.2 t -121.14 119.72 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.173 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.3 p -107.14 148.93 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.895 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.3 105.72 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.93 162.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 74.33 110.909 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.94 119.24 35.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 51.21 110.909 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.85 84.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.91 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.43 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.59 -28.71 37.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.888 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' NZ ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -82.45 -71.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.903 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.7 m -101.46 99.5 11.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.56 0.695 . . . . 71.4 111.133 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.678 2.252 . . . . 63.15 112.361 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -43.22 66.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.9 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 32' ' ' THR . 6.4 m -85.8 21.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 44.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.05 -45.31 20.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 61.14 111.122 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ASN . 86.9 tt0 -83.57 -24.21 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.53 110.89 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' GLU . 15.6 t-20 -30.79 -70.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 53.1 110.896 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 39' ' ' LEU . 65.2 t80 -74.01 -32.42 63.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.1 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 2.7 ttm180 -50.82 -37.9 45.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 70.23 110.863 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.57 -29.99 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.718 HD12 ' HA ' ' A' ' 36' ' ' PHE . 63.6 mt -66.94 -51.65 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.912 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -65.35 -47.83 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 52.41 110.863 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 163' ' ' GLN . 80.8 p -68.83 -24.07 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 62.31 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.49 83.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 55.31 112.482 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 33.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.396 . . . . 74.02 110.895 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -124.73 27.58 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 23.41 110.887 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.09 14.34 68.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 53.54 112.502 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -174.91 173.86 2.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 71.13 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.61 153.93 7.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 51.04 112.484 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.97 137.88 41.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.947 0.403 . . . . 74.33 110.944 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -41.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.912 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.03 43.35 0.55 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 53.44 112.489 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.26 31.67 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.2 110.885 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.0 m 62.96 174.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.894 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -168.2 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 74.43 110.855 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 -59.75 1.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.14 110.878 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -155.68 -169.99 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 61.31 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -168.4 141.84 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.166 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 17.6 mt -134.87 95.89 15.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.66 0.743 . . . . 71.31 111.128 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.74 81.14 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.245 . . . . 65.42 112.346 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.45 -27.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 41.34 112.474 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -51.46 2.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.44 110.931 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.97 -159.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.853 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 36.8 m -129.46 -66.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.23 110.917 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 62' ' ' CYS . 14.6 tt0 64.34 136.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.9 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.75 161.9 13.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 65.43 112.495 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.17 91.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 61.41 112.512 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -108.38 -161.9 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 74.42 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 68' ' ' THR . 7.4 p90 -122.25 174.6 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 72.55 110.854 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 178.49 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 74.21 111.144 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 73.53 -154.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.02 110.902 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -175.69 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -23.32 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.931 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.56 -77.36 1.04 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 61.1 112.499 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 p -115.79 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 75.24 111.135 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.41 41.22 1.79 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 72.44 112.474 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 152.14 14.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 72.51 112.482 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.19 151.23 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 63.31 110.911 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -102.61 157.65 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 71.32 110.903 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -39.38 -38.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 64.32 111.159 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.78 49.96 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 62.32 110.935 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.45 -120.58 7.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.769 -0.729 . . . . 72.54 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.98 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 73.34 110.93 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.26 176.34 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.893 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.54 175.23 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.35 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.36 173.69 10.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 60.42 110.834 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.4 158.43 28.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.822 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.98 -58.59 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.05 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.97 150.93 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.893 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -125.01 68.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.9 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 89' ' ' ILE . 14.6 mt -83.19 0.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 43.13 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.453 HD21 ' NZ ' ' A' ' 28' ' ' LYS . 32.9 mt -121.56 83.18 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 53.13 110.941 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' THR . 33.9 mttm -70.17 141.14 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.899 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -55.7 91.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.838 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 91' ' ' LYS . 48.1 p -86.9 7.62 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 54.13 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.45 -165.32 30.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 52.53 112.438 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 166.04 28.91 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 71.41 112.358 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 80.13 -0.06 84.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 74.0 112.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.1 mm -83.18 141.43 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 71.24 111.148 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -116.29 141.4 48.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 71.03 110.95 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.819 ' O ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -150.22 30.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 53.11 110.86 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.819 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 ptp 34.1 120.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.11 110.891 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 110' ' ' SER . . . -46.91 170.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.117 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -174.49 174.77 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.904 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.0 24.7 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 62.52 111.089 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.5 -178.41 21.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.5 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.95 41.69 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.662 2.242 . . . . 65.05 112.357 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 67.63 27.87 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 p -150.55 50.92 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 64.4 111.156 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.88 1.81 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.914 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.93 88.58 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.468 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 5.0 m -145.75 -145.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.349 . . . . 72.23 110.833 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' OE1' HD13 ' A' ' 39' ' ' LEU . 4.4 tp-100 -109.77 -80.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 72.01 110.923 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.472 ' HB2' HD21 ' A' ' 98' ' ' LEU . 8.2 p90 178.94 137.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 64.34 110.868 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' ' C ' ' A' ' 114' ' ' ILE . 5.7 p90 -131.26 45.29 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.02 110.876 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 113' ' ' PHE . 79.1 mt -28.07 130.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 73.13 111.14 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 77.5 m -83.07 148.09 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.832 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.628 HG21 ' OE2' ' A' ' 143' ' ' GLU . 5.4 p -117.88 22.98 11.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 53.12 111.124 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.58 175.76 6.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.124 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 86.57 4.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.904 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.0 p -112.11 52.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 55.42 111.125 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -87.26 23.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 64.21 110.871 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 8.67 39.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 62.05 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.43 1.41 51.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 62.31 110.935 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 49.3 66.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 73.51 110.863 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 41.19 36.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 55.34 112.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -57.21 -32.87 66.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 75.21 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -108.67 156.82 19.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 71.43 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.56 94.49 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.097 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 49.6 t -74.46 136.07 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.156 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -163.84 26.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.936 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.54 -178.34 15.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 33.34 112.461 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.33 147.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 72.12 110.817 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' HA2' ' A' ' 96' ' ' GLY . 6.6 t -72.21 103.8 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.163 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -53.58 25.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.884 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -166.8 157.55 12.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.88 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.93 6.05 54.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.12 112.48 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.4 ' HB2' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.66 -31.15 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 61.14 110.886 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -52.04 -24.04 6.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.492 HD12 HG22 ' A' ' 20' ' ' VAL . 6.5 mt -81.84 -39.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 64.23 111.113 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.96 -44.65 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.34 111.159 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.62 -29.48 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.47 67.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 31.23 111.104 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -75.31 -23.35 57.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.847 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -89.56 29.21 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.73 3.75 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.821 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.16 13.5 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.822 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -89.06 -160.91 36.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.744 . . . . 51.34 112.514 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.1 t -154.13 18.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.52 110.849 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 46.91 59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 61.01 110.871 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -177.34 -36.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.93 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.75 -56.98 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 74.4 112.485 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.95 116.29 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 75.44 110.877 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.822 HG22 ' HA2' ' A' ' 146' ' ' GLY . 19.6 p -90.28 158.47 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.41 111.134 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 t -68.57 -21.66 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 75.33 110.866 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.47 -168.0 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 65.03 110.834 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.47 124.43 34.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.909 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 11' ' ' ALA . 2.7 mp -100.17 104.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 61.41 111.166 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -96.92 175.8 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 44.43 111.19 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.74 143.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 62.55 111.118 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.35 -59.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.0 111.098 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -154.78 164.5 38.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 75.04 110.845 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.0 m -144.79 -162.97 1.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.92 -155.54 22.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 34.24 112.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -108.24 134.9 50.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.346 . . . . 64.31 110.886 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 tp -55.35 -59.07 5.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.892 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.21 110.913 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 63.22 110.892 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.61 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 65.1 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.617 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -116.8 160.72 35.59 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 54.44 110.895 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 152.9 69.43 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 73.4 112.387 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 m -123.75 43.87 2.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 71.23 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -50.67 143.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.55 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -135.41 175.9 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.913 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -146.14 145.66 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.87 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -102.23 135.21 44.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 54.41 110.876 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.04 131.0 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 71.25 111.142 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.26 167.8 13.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.33 111.081 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.691 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -148.27 98.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.13 111.131 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.33 -12.09 70.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 61.13 112.513 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -95.84 131.81 28.44 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 74.44 110.894 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 145.57 57.87 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.754 2.302 . . . . 73.55 112.342 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.691 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.0 tp -114.9 -67.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.861 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.23 177.5 41.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 71.42 112.477 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 135.92 49.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.03 110.907 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.12 129.48 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 72.02 111.131 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.3 t -90.84 96.5 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.836 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.83 81.82 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.14 110.871 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 9.7 tt0 -57.51 143.49 40.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 73.01 110.897 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD21 ' HD2' ' A' ' 36' ' ' PHE . 11.3 mt -109.6 117.47 34.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 61.34 110.895 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.69 72.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.851 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 3' ' ' ASN . . . -76.82 -30.18 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 72.24 111.096 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -54.03 -60.33 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -64.69 -61.93 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.31 110.921 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.08 94.2 46.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 74.13 111.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -22.83 31.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 71.22 112.315 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -66.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 65.45 110.905 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 127' ' ' VAL . 60.5 p -52.84 -40.93 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.1 111.123 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.88 -71.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 61.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 37' ' ' ARG . 34.2 tt0 -40.66 -65.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.898 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.6 t30 -34.18 -45.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.884 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 39' ' ' LEU . 89.4 t80 -77.11 -38.92 51.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.894 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -51.89 -29.84 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 71.25 110.865 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.06 55.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 54.23 111.122 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 36' ' ' PHE . 57.8 mt -67.82 -54.45 18.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 63.4 110.877 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 t -52.91 -41.89 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.44 110.874 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 62.3 p -71.08 -21.6 62.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 73.43 111.143 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.78 91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.01 112.495 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 35.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 72.55 110.861 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -144.0 12.43 1.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.926 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.27 17.33 74.27 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 42.12 112.45 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -175.26 -166.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 65.53 110.926 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 130.77 -149.08 19.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.489 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -98.08 -26.16 14.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 75.43 110.93 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.32 139.33 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.856 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.69 60.23 5.94 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 73.32 112.531 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.463 ' H ' HD13 ' A' ' 158' ' ' ILE . 5.3 t -137.49 -165.93 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 72.41 110.88 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -157.21 168.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.24 110.869 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 156' ' ' ILE . 20.5 m-85 -81.47 120.69 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 53.52 110.905 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -93.69 -17.53 23.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -145.26 137.76 25.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.873 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.5 mt -150.33 121.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 71.12 111.128 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt -137.76 108.14 8.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 70.31 111.132 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 107.64 1.91 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 74.33 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 130.82 -34.13 2.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.537 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.22 -68.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 73.31 110.871 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -165.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 71.24 110.83 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.66 137.32 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.884 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -100.15 140.98 33.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.932 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.54 -43.97 9.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 74.51 112.465 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.67 -139.92 7.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.693 -0.765 . . . . 75.11 112.449 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 t0 179.4 136.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 64.14 110.84 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.93 29.8 7.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.858 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.725 HG22 ' HG2' ' A' ' 69' ' ' ARG . 18.3 m -150.48 -72.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 65.24 111.139 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.725 ' HG2' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -131.83 -163.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 73.03 110.884 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -173.45 -50.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 71.03 110.873 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -103.27 91.76 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.868 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.4 -50.54 0.89 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.751 . . . . 74.25 112.495 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.5 p -142.96 167.09 22.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.344 . . . . 74.53 111.145 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.25 175.0 21.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.734 -0.746 . . . . 60.3 112.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -133.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 52.43 112.531 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -175.5 176.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 75.42 110.839 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.03 -173.72 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.832 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -87.36 -32.03 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 65.45 111.157 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.37 82.36 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 54.44 110.943 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.29 -125.87 8.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 65.04 112.463 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -116.61 -85.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 73.54 110.903 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 175.0 9.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 64.01 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.74 155.26 40.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.25 110.832 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 168.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.898 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.29 130.62 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 70.43 110.869 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -50.31 18.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.869 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.76 159.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.908 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -105.4 29.84 6.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.875 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.636 HG21 ' HG3' ' A' ' 28' ' ' LYS . 22.0 mm -51.31 -27.53 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.15 103.3 15.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.893 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.7 107.34 19.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 64.02 110.883 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.63 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -58.42 98.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 74.31 110.847 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 42.36 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.115 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.33 178.93 23.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 41.5 112.521 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.29 19.25 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.241 . . . . 72.31 112.329 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA2' HD11 ' A' ' 114' ' ' ILE . . . 87.17 -34.75 3.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 43.04 112.503 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.63 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.6 mm -50.91 137.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 73.51 111.137 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 99' ' ' SER . 2.7 tt -98.38 128.64 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 64.43 110.93 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.549 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -134.42 -171.07 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 72.15 110.834 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.428 ' H ' ' HB3' ' A' ' 126' ' ' HIS . 9.5 mmt -116.63 -173.4 2.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 70.04 110.877 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 102' ' ' ASN . . . -101.35 -48.77 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 61.15 111.053 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HA ' HG23 ' A' ' 107' ' ' THR . 5.4 p-10 39.73 -165.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 62.01 110.906 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.557 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -158.86 22.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 72.34 111.103 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.3 -67.92 0.34 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 41.24 112.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.557 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.75 -156.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 74.14 112.315 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.22 87.31 7.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 102' ' ' ASN . 7.2 t -153.75 51.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.167 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -71.64 -4.88 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 70.43 110.895 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.65 76.04 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 74.51 112.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.0 p -127.3 -140.88 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 73.11 110.871 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -77.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.95 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.89 148.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.842 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.78 122.58 14.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.886 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' HA2' ' A' ' 96' ' ' GLY . 13.0 tt -123.95 137.46 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 71.13 111.124 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.83 148.48 22.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.888 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -92.68 -18.74 22.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 73.34 111.094 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.0 179.89 5.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 75.44 111.125 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -65.7 90.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.63 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.2 p -116.9 59.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 64.21 111.187 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.09 28.06 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.31 110.856 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.4 OUTLIER -91.81 10.63 27.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.91 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -23.65 17.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.913 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.8 OUTLIER 56.72 85.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 60.25 110.87 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.589 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 20.18 61.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 42.15 112.461 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -104.66 -14.36 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 75.42 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HB3' ' H ' ' A' ' 100' ' ' MET . 32.5 m-70 -110.99 -8.94 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.4 110.848 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 32' ' ' THR . 42.6 t 65.74 96.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 73.14 111.133 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 97' ' ' ILE . 24.8 t -83.12 130.36 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.139 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.11 27.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.888 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -152.72 -179.67 28.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 65.11 112.523 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.09 136.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 74.33 110.915 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . 1.4 t -63.32 119.07 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.165 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -89.47 -42.28 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 72.23 110.904 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.39 156.01 13.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 74.02 110.908 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.65 1.96 57.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.763 . . . . 71.35 112.51 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -29.1 8.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.33 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.93 -22.32 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.24 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.2 mm -89.84 -35.67 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 72.41 111.11 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.4 t -52.62 -22.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.12 111.149 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -84.29 -35.38 23.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.888 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.02 94.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 72.5 111.1 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.3 ptm -71.39 -37.15 71.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.893 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.04 34.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 74.45 110.922 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -10.86 6.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.912 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.17 14.59 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.861 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -106.77 71.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.707 -0.759 . . . . 71.35 112.525 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.553 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.73 131.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 52.45 110.843 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -46.25 -46.54 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.901 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -47.0 -37.9 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.07 -47.67 0.92 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 61.35 112.463 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 110.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 64.51 110.889 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.1 t -82.62 145.12 29.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 45.44 111.182 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -22.46 52.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.874 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -136.31 163.91 29.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.952 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.14 130.8 51.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.878 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 53' ' ' PHE . 3.8 mp -109.82 120.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.42 111.169 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.6 p -119.31 165.41 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 62.42 111.181 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 3.9 mp -90.37 -64.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 71.23 111.144 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 158' ' ' ILE . . . 93.93 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 55.42 111.127 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.59 147.08 15.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.24 110.874 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.2 p -176.24 -174.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.51 110.889 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.0 -163.73 28.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 62.55 112.484 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -81.39 120.07 24.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 64.11 110.908 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -91.91 -23.97 19.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.51 110.943 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.333 . . . . 73.11 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 89.1 t 62.38 104.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 73.01 111.137 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -60.19 151.93 64.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 63.14 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.728 ' O ' HD12 ' A' ' 24' ' ' LEU . 54.1 Cg_endo -69.73 117.25 4.97 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 65.32 112.34 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 22' ' ' PHE . 48.7 m -110.35 132.12 54.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 62.3 111.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.4 m -123.99 160.48 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 60.33 111.151 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -127.92 160.04 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.911 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HD2' HD12 ' A' ' 158' ' ' ILE . 5.9 m-85 -135.84 126.98 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.02 110.914 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.27 72.08 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.865 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.16 135.12 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.133 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -123.27 151.38 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 45.14 111.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.6 t -133.31 100.85 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t0 54.06 55.73 7.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.897 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.31 12.27 55.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 64.15 112.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 35.2 tt0 -142.87 94.22 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.645 0.736 . . . . 70.23 110.887 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.7 167.13 25.27 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.271 . . . . 74.05 112.386 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.78 30.05 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 70.53 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.0 -164.02 22.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 70.3 112.481 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 164.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 74.23 110.818 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 138' ' ' ILE . 32.3 m -128.8 171.8 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 74.12 111.107 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -149.84 148.58 29.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.04 110.858 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 5' ' ' THR . 3.9 m-85 -125.32 154.05 42.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.868 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -94.15 -53.28 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 62.54 110.874 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 4' ' ' PRO . 7.9 mt 73.81 122.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.936 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.722 ' CE2' HD22 ' A' ' 90' ' ' LEU . 60.4 m-85 -88.75 69.04 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.875 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.49 48.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 45.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.95 -34.25 26.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 61.42 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -31.42 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 65.53 110.879 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.8 67.6 79.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 61.11 111.138 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 54.2 Cg_endo -69.76 61.64 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 43.14 112.355 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.68 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 73.1 110.875 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.56 ' OG1' HG11 ' A' ' 127' ' ' VAL . 17.6 m -75.2 -60.5 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.4 111.152 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -88.43 -1.32 57.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.128 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 14.8 tm-20 -82.19 -19.99 38.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.886 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' HG21 ' A' ' 78' ' ' ILE . 8.2 p30 -101.28 -27.86 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 72.45 110.859 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -50.95 -29.47 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 45.44 110.899 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -31.17 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.869 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.2 -30.64 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 64.55 111.129 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD11 ' HA3' ' A' ' 47' ' ' GLY . 2.5 tt -84.47 5.46 27.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.954 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 m -108.15 -2.67 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 70.53 110.83 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -117.16 13.21 14.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 74.32 111.146 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.58 26.58 10.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.01 112.47 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -33.47 28.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -17.97 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 62.55 110.9 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.09 -63.27 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 41.51 112.463 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -102.29 148.99 24.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 62.44 110.828 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 39' ' ' LEU . . . 135.63 151.45 6.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.491 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 158' ' ' ILE . 8.1 t80 -49.56 103.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 64.24 110.921 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -139.55 -47.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.846 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.69 33.76 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 74.34 112.457 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -172.83 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 73.14 110.858 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.2 m -89.51 -172.09 3.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 75.33 110.874 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -75.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.02 110.876 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 41.42 -160.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.842 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.35 19.35 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.22 110.84 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.06 139.94 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 75.34 111.099 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -139.87 108.58 7.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 74.05 111.157 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 92.35 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 51.15 112.345 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.11 21.27 2.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.15 112.474 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.05 -66.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 73.33 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptp -163.54 -168.94 1.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.857 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.73 97.09 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.841 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.68 141.48 36.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.942 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.03 -50.22 70.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 54.15 112.525 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.03 109.05 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 73.34 112.506 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.59 6.69 22.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 60.31 110.893 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.5 t80 48.59 33.49 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.879 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.27 171.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 62.34 111.152 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 68.25 -179.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 71.23 110.901 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.66 48.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.885 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.09 -31.11 44.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 64.12 110.837 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.96 29.61 0.94 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 62.12 112.503 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -139.9 41.6 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 62.44 111.176 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.38 -69.01 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 52.01 112.461 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.65 -155.31 6.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 64.34 112.489 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -176.1 -163.78 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 73.53 110.932 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 148.84 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 44.44 110.879 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -44.14 -55.31 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.142 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -128.3 26.62 5.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 74.33 110.966 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.04 -167.25 17.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 24.43 112.485 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -118.24 -29.59 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 75.03 110.879 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -168.88 136.36 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.942 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -112.03 158.78 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.61 161.68 22.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.43 110.899 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -79.39 108.04 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.831 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.5 -52.64 12.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.857 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -178.9 168.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 71.1 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.91 72.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 64.05 110.936 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.4 mt -76.83 -3.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 72.34 111.139 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD22 ' CE2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -120.53 91.64 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.897 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -75.47 -167.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.901 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -95.05 72.54 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 74.13 110.858 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 p -69.63 -17.92 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 32.24 111.133 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.06 -177.11 43.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.24 112.476 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.82 52.08 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 61.23 112.326 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 104.12 22.35 8.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 52.14 112.476 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.539 ' C ' HD23 ' A' ' 98' ' ' LEU . 24.8 mm -99.36 137.25 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 62.21 111.153 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 112' ' ' PHE . 7.1 mt -111.11 148.18 33.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 54.33 110.898 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.664 ' O ' ' C ' ' A' ' 100' ' ' MET . 1.8 p -163.69 55.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.869 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.664 ' C ' ' O ' ' A' ' 99' ' ' SER . 3.0 mmt 7.96 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 61.14 110.861 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.07 110.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 54.05 111.095 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -142.54 -164.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.725 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -47.99 -51.85 22.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 43.12 111.126 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 124.96 -61.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 62.51 112.498 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 107' ' ' THR . 54.3 Cg_endo -69.76 100.0 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 45.21 112.335 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 63.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.919 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 103' ' ' ALA . 39.9 p -134.73 13.59 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.153 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 39.7 t30 42.28 -100.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 24.34 110.928 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.94 166.52 10.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 64.4 112.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.75 22.75 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 75.1 110.824 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.86 90.3 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 70.21 110.938 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.674 ' CD1' HD22 ' A' ' 98' ' ' LEU . 33.1 p90 -72.44 155.7 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.894 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 10.1 p90 -120.96 107.3 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 64.2 110.9 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.27 111.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.108 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.88 136.85 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 61.12 110.903 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.84 13.17 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.21 111.145 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.5 11.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.05 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.28 138.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 70.12 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.753 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.1 p -139.34 46.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 111.085 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -54.06 -25.39 21.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.753 ' CZ2' HG22 ' A' ' 119' ' ' THR . 21.0 p90 -62.43 -18.53 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 119' ' ' THR . 33.8 mt -82.58 -34.97 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.78 -10.0 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.879 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.18 52.46 1.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.777 -0.725 . . . . 75.23 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 -29.74 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 74.45 110.912 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -112.36 154.97 24.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 64.43 110.874 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.56 HG11 ' OG1' ' A' ' 32' ' ' THR . 6.6 p -50.08 109.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.095 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 90' ' ' LEU . 9.1 p -76.58 153.79 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 130' ' ' GLY . 4.8 p90 -177.02 178.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.5 110.884 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 43.61 114.15 0.0 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 73.31 112.516 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -119.53 35.41 4.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 73.24 110.913 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 96' ' ' GLY . 3.6 t 60.23 162.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 61.01 111.075 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 132' ' ' VAL . 5.4 tppt? -136.63 -58.08 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 71.15 110.923 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 175.29 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.934 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.37 81.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.705 -0.759 . . . . 70.34 112.446 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.9 tpt -91.62 -25.94 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 70.02 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.42 -30.72 53.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.03 110.892 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 20' ' ' VAL . 43.6 mm -44.07 -39.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.14 111.169 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.1 -52.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 61.12 111.134 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -45.83 -49.99 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.11 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 70.43 111.094 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 156' ' ' ILE . 9.6 ttm -50.3 -31.42 14.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 70.11 110.855 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.918 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -62.61 -14.21 40.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.883 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.87 3.65 47.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.28 -156.09 31.06 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 61.43 112.503 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 -165.99 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 63.41 110.9 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -84.4 -48.35 9.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.32 110.87 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -94.68 10.55 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.884 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.19 -150.77 17.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 51.1 112.481 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 65.04 142.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.12 110.91 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 p -114.41 141.46 47.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.082 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -18.0 63.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.838 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.12 -162.42 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.896 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -116.41 93.88 4.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.41 110.888 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' SD ' ' A' ' 142' ' ' MET . 6.6 mt -88.83 117.69 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 52.55 111.13 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.8 t -136.77 -178.36 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 54.22 111.143 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' OH ' ' A' ' 48' ' ' TYR . 35.5 mm -105.22 115.88 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -76.91 -62.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 70.45 111.117 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.06 167.27 20.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.41 110.834 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.13 -174.63 4.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 53.24 110.888 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.45 -160.93 24.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 73.01 112.49 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.0 mt-30 -110.35 137.01 48.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 71.31 110.925 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 5' ' ' THR . 3.6 mm? -47.91 -60.97 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 60.04 110.895 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.873 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.788 0.328 . . . . 75.25 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -139.44 146.23 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.32 111.156 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.51 156.55 1.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 65.14 110.924 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 151.16 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.667 2.245 . . . . 73.4 112.353 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -141.98 145.74 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 71.03 111.095 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 24' ' ' LEU . 22.9 m -136.82 163.21 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 60.21 111.107 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -135.8 162.71 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.881 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -139.32 131.79 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 15.2 t0 -101.58 75.54 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.872 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.1 146.36 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.31 111.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -138.94 164.77 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 42.13 111.118 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 156' ' ' ILE . 83.8 t -139.81 104.76 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 63.43 111.093 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 63.21 52.54 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.891 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.05 17.46 61.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 43.24 112.498 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.3 mm-40 -132.19 106.56 13.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 64.23 110.893 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.3 Cg_endo -69.75 138.85 38.82 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.664 2.243 . . . . 52.51 112.313 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.76 18.33 13.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 63.12 110.892 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.75 167.22 13.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 34.23 112.495 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.75 175.67 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 72.33 110.88 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 24.8 m -122.39 -176.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 63.05 111.114 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -134.77 86.31 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.85 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -84.83 127.23 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 63.11 110.88 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -104.03 145.42 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 61.4 110.914 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 6' ' ' VAL . 1.4 mt -110.11 113.65 26.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.908 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD2' HD21 ' A' ' 90' ' ' LEU . 15.9 m-85 -73.81 67.46 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 71.4 110.926 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.97 77.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.53 111.062 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.9 -54.77 14.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.32 110.845 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' HG21 ' A' ' 89' ' ' ILE . 3.2 mptp? -69.21 -60.83 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 62.23 110.891 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -121.14 95.89 48.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 52.3 111.097 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -23.13 31.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.253 . . . . 40.22 112.358 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -78.55 -51.19 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.02 110.955 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.508 HG22 ' CE1' ' A' ' 129' ' ' PHE . 18.1 m -64.85 -30.94 71.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.126 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.66 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.11 111.115 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.0 tt0 -56.47 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.948 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -29.29 -54.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.01 110.888 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 39' ' ' LEU . 34.0 t80 -77.07 -39.32 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.905 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -50.04 -31.75 13.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.42 110.901 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.91 -36.86 72.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 71.51 111.124 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 36' ' ' PHE . 30.7 mt -64.58 -43.86 92.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.899 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -59.16 -50.63 73.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.883 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 163' ' ' GLN . 30.7 p -74.91 -18.8 60.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 74.41 111.182 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.86 83.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 73.41 112.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.35 31.95 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 62.43 110.88 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -122.78 26.93 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.844 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 2.32 55.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 62.22 112.503 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -163.28 178.67 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.38 . . . . 73.1 110.885 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.34 131.96 3.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.461 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 161.43 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 73.43 110.924 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.96 -40.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.896 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.91 43.54 1.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 74.22 112.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.53 165.08 24.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.52 110.849 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -131.01 -179.56 5.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.831 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -113.63 -69.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.904 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' NE2' HG21 ' A' ' 152' ' ' THR . 0.0 OUTLIER 61.61 20.25 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.35 110.885 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -138.03 29.93 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.85 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -79.9 144.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 45.15 111.124 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 56' ' ' ILE . 16.6 mm -134.52 107.39 10.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 74.43 111.118 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 98.51 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.727 2.284 . . . . 43.21 112.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.13 -28.95 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 41.53 112.493 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.94 -63.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 73.15 110.913 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -176.94 -157.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 70.25 110.87 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 t -144.41 137.06 26.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 54.23 110.902 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 167.61 21.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.885 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.23 159.8 24.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 42.34 112.478 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 90.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 45.23 112.464 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.5 81.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 71.32 110.876 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -81.99 171.13 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.55 110.878 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.23 -49.18 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 64.05 111.172 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.5 tpt85 -88.93 -43.07 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 65.42 110.819 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -58.9 -164.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 65.53 110.839 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -34.47 78.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.869 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.27 145.43 37.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 72.14 112.468 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -131.55 -169.35 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 71.33 111.158 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.08 -24.74 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 31.24 112.487 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.91 76.99 0.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 70.42 112.493 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -118.79 179.6 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 70.44 110.88 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t -85.62 146.72 26.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 70.1 110.835 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 79' ' ' TYR . 2.1 pp -71.26 -41.87 74.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 44.35 111.15 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.41 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -97.07 -5.64 37.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.955 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 -143.33 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 55.43 112.437 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -118.9 -25.58 6.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 71.14 110.877 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -170.75 141.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -108.8 154.1 22.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.05 110.916 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -88.29 164.43 15.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.01 116.32 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 65.14 110.899 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.68 -49.58 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.871 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.93 140.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.924 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.15 70.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.53 110.917 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.4 mm -80.38 4.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 62.51 111.103 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -108.32 121.77 45.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.913 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 92' ' ' HIS . 14.3 mttp -123.81 82.85 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.891 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 93' ' ' THR . 5.0 m80 38.78 -160.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 65.4 110.863 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 97' ' ' ILE . 1.2 t 161.8 -38.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 73.04 111.16 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . 158.7 -163.6 33.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 71.54 112.486 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 128.54 16.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.31 112.372 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.17 -5.44 15.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 70.24 112.487 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 128' ' ' VAL . 1.7 mm -61.88 139.87 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.352 . . . . 74.34 111.108 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.6 tt -100.86 125.97 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.963 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.552 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -111.78 125.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.859 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -33.77 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 74.11 110.852 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . . . 62.84 155.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.124 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p30 172.0 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.888 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -78.18 -22.51 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.21 111.081 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.8 -64.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 54.53 112.506 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.1 Cg_endo -69.68 87.45 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 71.35 112.367 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 32.55 78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.87 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.94 15.53 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.5 111.175 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 43.73 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.871 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 73.56 132.97 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 70.43 112.448 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.9 p -129.18 77.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 44.01 110.825 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.55 ' OE1' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -93.85 -31.92 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 53.23 110.904 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER 71.97 69.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 62.52 110.86 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -90.82 111.03 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.908 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.538 HD11 ' CE1' ' A' ' 112' ' ' PHE . 96.5 mt -102.89 111.31 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 75.44 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.24 160.02 29.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.87 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.6 p -133.65 27.83 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.31 32.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 72.24 111.104 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 4.2 tttt 62.39 146.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 38.4 p -141.97 58.65 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 73.33 111.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 92' ' ' HIS . 8.1 tm-20 -49.56 -24.7 2.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 64.42 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -60.02 -36.03 76.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 74.2 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.57 106.32 18.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.905 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -43.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 72.53 110.859 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.23 -38.26 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 54.42 112.497 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -59.94 -35.83 75.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 72.24 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -131.81 140.13 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.83 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.79 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 72.7 t -74.14 -81.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.078 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.79 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 72.4 t 103.08 127.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 71.21 111.168 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.508 ' CE1' HG22 ' A' ' 32' ' ' THR . 29.5 p90 -147.55 18.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.27 146.43 16.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 64.45 112.458 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -156.42 140.05 15.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 75.41 110.861 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -48.65 109.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 74.51 111.152 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 -36.03 24.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.05 110.865 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.01 175.37 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 60.31 110.862 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 48.69 73.09 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 62.11 112.485 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -3.53 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.77 0.319 . . . . 75.11 110.88 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 88.6 m-20 -84.25 -34.64 23.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 71.32 110.84 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 50.2 mm -42.47 -41.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 62.31 111.168 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.79 -49.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.135 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 7.4 mm-40 -46.5 -50.27 17.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.873 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.48 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.59 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.9 ttm -50.38 -38.51 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 64.22 110.835 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.99 -27.62 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.909 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -62.66 -14.89 48.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.863 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -89.51 13.22 14.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.922 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.02 -156.34 28.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 34.12 112.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.5 t -166.87 169.79 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 71.14 110.828 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -54.0 -47.31 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 55.15 110.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 3.29 53.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.886 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.36 13.25 79.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 44.33 112.476 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.79 ' O ' HG22 ' A' ' 152' ' ' THR . 4.9 tppp? -45.55 -29.14 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.383 . . . . 75.34 110.957 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.795 HG23 ' N ' ' A' ' 153' ' ' SER . 0.6 OUTLIER 86.73 -169.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.136 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.795 ' N ' HG23 ' A' ' 152' ' ' THR . 23.3 t -137.7 -52.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.895 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 -168.09 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.3 110.892 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.67 111.13 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 74.24 110.9 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.59 HD13 ' SD ' ' A' ' 142' ' ' MET . 40.4 mt -107.24 101.76 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.1 111.164 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.4 p -113.64 168.66 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.22 111.132 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.95 106.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 63.33 111.162 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -55.0 -54.57 41.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 44.34 111.113 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.24 167.97 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.897 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -156.5 160.87 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 64.43 110.853 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.84 179.83 46.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 53.33 112.481 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 7.3 mt-30 -74.89 -37.89 62.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 74.41 110.902 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.41 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 63.33 110.951 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.881 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.829 0.347 . . . . 73.41 110.863 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.03 152.64 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -67.48 137.63 93.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.597 0.713 . . . . 70.33 110.885 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.54 51.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 61.4 112.343 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 86.6 m -127.75 148.38 50.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.43 111.136 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.44 160.04 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.33 111.135 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.5 162.25 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.829 -179.95 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.534 ' HD2' HD12 ' A' ' 158' ' ' ILE . 26.8 m-85 -139.32 136.43 34.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 63.05 110.889 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.77 69.85 1.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.897 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 158' ' ' ILE . 26.2 mm -51.52 129.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.0 111.105 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.48 163.12 16.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 52.12 111.093 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.856 HG22 HG22 ' A' ' 156' ' ' ILE . 53.5 t -140.89 104.99 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.125 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t0 51.49 53.23 13.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 53.14 110.875 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.15 10.09 55.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 72.24 112.43 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.2 tm-20 -142.57 96.52 6.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.635 0.731 . . . . 72.21 110.903 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.69 157.69 59.66 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 73.35 112.343 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.84 21.0 8.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.928 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.64 169.42 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 62.32 112.489 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.03 172.68 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 61.31 110.886 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.423 ' CG1' HG21 ' A' ' 138' ' ' ILE . 4.5 m -138.59 158.77 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.13 111.154 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.8 p -140.83 143.75 34.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 70.04 110.884 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -125.88 123.54 38.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 62.13 110.874 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -47.01 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.11 110.901 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 75.27 117.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 55.45 110.914 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -83.67 57.58 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.835 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -65.24 -26.33 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.134 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.1 -59.34 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 64.11 110.83 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -50.24 -57.73 7.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 62.43 110.88 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.767 ' HB ' HG22 ' A' ' 32' ' ' THR . 3.0 m -110.48 90.21 9.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.638 0.732 . . . . 71.31 111.142 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -19.33 36.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 2.24 . . . . 71.41 112.393 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -79.84 -58.25 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 63.43 110.873 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 29' ' ' VAL . 6.2 t -87.11 25.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 72.41 111.173 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -80.21 -42.25 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.42 111.093 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -76.85 -10.01 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.917 -179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' O ' HG21 ' A' ' 78' ' ' ILE . 29.7 t30 -42.41 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.35 110.891 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -81.42 -32.16 32.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 70.45 110.863 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.42 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 5.5 ttp85 -55.1 -39.98 69.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.839 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.52 -37.06 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 64.31 111.106 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.875 HD12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -91.74 33.46 1.03 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.896 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 t -151.2 -22.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' HG2' ' A' ' 163' ' ' GLN . 90.0 m -84.47 -42.14 15.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.52 111.163 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 151.28 -31.1 0.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 73.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 42' ' ' GLY . 8.4 tp10 -33.46 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 75.21 110.882 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 141.42 30.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.93 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.29 -30.49 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 73.12 112.458 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -47.07 -36.1 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 71.43 110.863 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.85 -146.37 3.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 53.0 112.486 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 136.45 43.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 75.25 110.915 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -162.62 -39.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 64.31 110.904 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.54 43.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 63.41 112.495 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.0 m -120.74 168.43 11.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 65.01 110.838 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -58.96 163.44 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 72.44 110.871 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.38 -70.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.89 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -163.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 71.22 110.823 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 51.82 35.74 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.899 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 156' ' ' ILE . 86.0 mt -90.11 135.38 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.146 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 tt -141.15 115.94 7.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 71.31 111.156 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.73 69.14 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.72 2.28 . . . . 54.32 112.326 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.54 69.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 52.22 112.495 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.61 -71.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 60.14 110.868 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -166.72 -159.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.23 110.851 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.45 -49.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.32 110.889 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 67.99 145.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.45 110.953 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.44 -67.12 1.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 54.33 112.484 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.15 -151.73 20.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 72.33 112.501 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.81 -166.72 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.885 0.374 . . . . 60.1 110.874 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -167.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.4 110.823 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 t -125.53 -46.71 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.35 111.142 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -116.65 31.84 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 65.34 110.87 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.31 149.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 61.1 110.88 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -145.63 158.39 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.3 110.925 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.07 27.3 19.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 43.51 112.519 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.4 p -121.84 -54.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 71.33 111.172 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.98 -148.06 18.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.747 -0.74 . . . . 54.51 112.468 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.31 36.99 3.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.754 . . . . 72.13 112.509 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -49.51 166.7 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 62.41 110.899 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 110' ' ' SER . 1.9 p -85.11 144.21 28.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.851 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 39' ' ' LEU . 1.8 pp -58.45 -13.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.13 111.078 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -20.34 13.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 75.22 110.959 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.72 -131.76 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.33 112.514 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -95.42 -36.52 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.926 0.393 . . . . 72.25 110.916 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.04 157.07 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 62.24 110.891 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -147.97 138.98 23.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.889 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 54.24 110.939 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.51 158.65 20.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 74.4 110.847 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -54.51 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.62 145.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.894 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -104.83 57.32 0.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.4 mm -74.32 -24.61 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.05 111.127 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HB2' HG13 ' A' ' 128' ' ' VAL . 8.4 mt -95.17 133.81 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.32 110.929 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.22 78.33 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 60.54 110.919 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' LYS . 19.9 m-70 33.23 -140.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 72.12 110.837 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 168.29 -51.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 62.1 111.106 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 93' ' ' THR . . . 178.08 -153.65 13.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 63.04 112.507 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 109.59 2.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 72.51 112.341 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 132' ' ' VAL . . . 132.06 -22.85 4.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 62.21 112.491 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 128' ' ' VAL . 5.0 mm -50.82 141.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 73.55 111.097 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.551 HD11 ' HD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -106.97 132.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 71.44 110.918 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.34 33.84 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.855 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 43.71 -159.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.32 110.901 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -170.52 138.98 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 74.4 111.143 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.4 m-20 166.39 -74.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 64.31 110.91 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.828 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -171.79 122.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 21.21 111.101 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.824 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.43 -37.78 61.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 53.01 112.49 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.824 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.8 84.91 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 71.55 112.324 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.6 m120 43.52 62.09 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.908 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.828 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -154.13 57.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 52.01 111.156 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.99 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.921 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.29 173.42 37.13 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.681 -0.771 . . . . 64.44 112.46 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -120.09 13.35 12.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 64.25 110.852 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -63.88 -165.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.948 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 114' ' ' ILE . 36.9 t80 -155.64 93.62 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.894 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.46 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.888 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 2.6 mt -121.54 138.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.128 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 m -83.38 162.16 21.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.868 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -135.18 15.58 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 73.15 111.165 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.75 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 53.14 111.117 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 61.88 156.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.861 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 36.7 p -108.35 -141.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 64.53 111.125 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 119' ' ' THR . 0.3 OUTLIER 161.7 -51.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.41 110.864 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -7.05 53.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 72.02 110.933 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.71 10.16 16.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.893 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.87 127.5 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.886 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.56 32.62 61.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.02 112.483 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 -66.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 70.22 110.904 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -125.4 160.43 29.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.857 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.723 HG11 HG21 ' A' ' 32' ' ' THR . 57.5 t -61.06 117.89 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 62.01 111.129 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.8 p -101.82 138.36 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 70.4 111.131 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -178.94 111.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.894 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.7 134.96 6.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 70.32 112.42 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -155.2 147.9 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 72.14 110.877 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.642 HG11 HG21 ' A' ' 139' ' ' VAL . 16.2 m -53.17 125.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.142 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -89.01 -49.09 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 63.53 110.872 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 172.59 11.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.866 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.35 0.83 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 52.12 112.495 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.416 ' HE1' HG21 ' A' ' 132' ' ' VAL . 7.0 tpt -84.58 3.83 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 73.11 110.901 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -32.9 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.921 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 142' ' ' MET . 45.8 mm -65.28 -38.45 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 73.32 111.093 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 132' ' ' VAL . 4.2 t -91.57 13.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 73.35 111.088 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -128.57 -66.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.02 110.854 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.92 15.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 75.24 111.11 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 8.5 tmm? -48.49 -36.95 16.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 55.32 110.923 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -53.85 -31.63 50.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 75.05 110.848 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -16.9 40.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.886 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -82.08 4.89 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 73.3 110.858 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.05 -163.86 34.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 63.04 112.469 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -157.98 20.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 70.21 110.819 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 47.05 60.97 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.83 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 174.96 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.865 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.22 -56.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 65.55 112.505 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 132.06 39.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.867 0.365 . . . . 74.31 110.879 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 56' ' ' ILE . 40.2 p -111.67 144.85 40.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.54 111.157 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 50.24 110.895 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -159.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.03 110.931 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -132.73 137.79 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 55.03 110.91 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.856 HG22 HG22 ' A' ' 12' ' ' VAL . 9.3 pt -126.44 136.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.13 111.107 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 159.15 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 63.35 111.136 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 10' ' ' ILE . 46.7 mm -83.12 104.84 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.31 111.145 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.23 -56.58 7.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 62.03 111.099 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.13 175.39 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 51.51 110.867 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.1 p -174.45 154.41 2.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 73.53 110.825 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.27 -176.57 46.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.45 112.498 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -73.62 -38.34 65.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 74.54 110.901 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mm? 71.29 -65.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.934 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.918 179.913 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 75.43 110.883 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.83 156.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.147 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.88 126.88 57.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 71.42 110.852 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 145.41 57.19 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.701 2.267 . . . . 51.4 112.374 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -132.64 123.41 26.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 75.43 111.132 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 m -100.42 151.06 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.118 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.23 153.54 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 138.79 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.888 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.747 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -101.42 152.59 20.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.888 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 9' ' ' ASP . 5.9 mm -129.51 135.75 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.101 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 157.56 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 HD23 ' A' ' 17' ' ' LEU . 15.0 m -140.94 111.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 62.14 111.14 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.27 25.56 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 65.3 110.913 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.97 -14.2 65.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.498 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' HG2' HG23 ' A' ' 12' ' ' VAL . 2.3 pt-20 -93.69 140.85 23.2 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 54.55 110.9 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.83 68.51 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.633 2.222 . . . . 75.4 112.356 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.726 HD23 HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -118.47 -66.2 1.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 61.24 110.921 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.42 -148.19 5.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 73.5 112.459 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 127.41 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 73.13 110.901 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -100.28 144.89 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.11 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -107.25 94.71 5.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 74.03 110.831 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.555 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 12.4 m-85 -88.21 126.3 35.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.883 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -107.8 145.87 32.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 110.906 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -114.93 119.28 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 62.02 110.93 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 m-85 -82.75 81.66 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 72.1 110.909 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.38 -2.66 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.12 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -80.02 -42.13 24.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.858 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -97.11 -24.22 15.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.89 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -140.44 82.74 15.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.682 0.753 . . . . 73.34 111.086 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -49.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.634 2.223 . . . . 74.52 112.343 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -55.95 11.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.33 110.89 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' CD2' ' A' ' 129' ' ' PHE . 1.3 m -50.77 -48.97 59.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 74.11 111.116 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -27.94 64.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 45.14 111.107 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -61.42 -31.02 70.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.861 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -66.27 -71.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.881 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HA ' HD12 ' A' ' 39' ' ' LEU . 46.6 t80 -48.54 -30.43 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.86 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -57.23 -40.94 78.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.3 110.836 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.729 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -79.51 -21.52 45.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 60.15 111.107 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 36' ' ' PHE . 74.1 mt -76.46 -40.47 50.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.04 110.892 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -72.22 -46.51 55.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 51.25 110.828 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -82.51 8.17 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 70.41 111.166 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.55 40.79 11.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 75.34 112.459 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 5.1 mm-40 -54.96 -27.36 43.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 75.01 110.891 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.844 ' HD2' HG23 ' A' ' 78' ' ' ILE . 6.8 mtpm? -113.46 -6.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.33 110.903 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 40.8 32.88 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 71.2 112.451 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -121.1 -18.75 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 62.52 110.873 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.58 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 64.51 112.496 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -156.09 15.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.942 0.401 . . . . 73.25 110.911 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -60.76 127.63 32.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 71.33 110.897 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.93 67.6 1.85 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 35.12 112.519 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 m -164.29 -94.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.795 0.331 . . . . 71.52 110.822 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.7 p -172.3 -168.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 71.53 110.853 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -178.21 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 64.24 110.893 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -114.02 -50.17 2.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.01 110.84 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -179.07 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.847 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER 175.03 122.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.31 111.107 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.697 HD12 ' CE ' ' A' ' 61' ' ' MET . 30.7 mt -133.47 112.91 13.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 63.43 111.129 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 82.08 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 74.35 112.363 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.19 -32.81 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.13 112.525 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -59.41 1.71 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 72.13 110.845 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.697 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -178.8 -166.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 64.54 110.919 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.1 129.0 19.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 71.03 110.903 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 132.62 51.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.914 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.96 141.65 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 61.44 112.544 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.78 165.25 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 71.11 112.472 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 177.15 86.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 42.32 110.846 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' THR . 22.1 p90 -116.49 178.46 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.14 110.826 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -173.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.23 111.176 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -103.87 144.48 31.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.859 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 172.12 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 60.33 110.865 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p30 171.83 33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 75.01 110.884 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.06 23.6 77.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.734 . . . . 64.21 112.458 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -145.89 115.87 7.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.37 . . . . 61.42 111.135 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.58 -169.52 0.51 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 70.02 112.489 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 68' ' ' THR . . . -59.12 172.21 4.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 72.45 112.497 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.37 172.45 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 64.03 110.856 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.613 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -124.04 26.33 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.873 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.844 HG23 ' HD2' ' A' ' 44' ' ' LYS . 57.0 mt 87.56 -59.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.185 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.46 28.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 61.42 110.912 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.93 166.69 13.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 25.34 112.488 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.71 -84.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.387 . . . . 63.34 110.877 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -124.51 152.22 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 72.01 110.914 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -115.26 168.58 9.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -86.39 159.68 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 71.24 110.89 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.83 116.01 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 65.43 110.854 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 -47.87 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 75.02 110.908 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 p30 175.52 174.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 74.13 110.875 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.74 38.21 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.35 110.91 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.65 -26.73 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 50.34 111.121 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.45 118.51 30.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.924 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -110.6 167.75 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.04 110.871 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.26 96.21 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 64.43 110.918 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -96.01 4.21 52.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.34 111.17 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 -161.25 23.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 64.24 112.536 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -57.14 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.662 2.241 . . . . 62.32 112.407 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -66.25 142.61 43.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 55.11 112.526 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -161.85 118.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.12 111.141 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -103.18 121.11 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 60.21 110.937 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 p -150.84 -161.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.825 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 mtp -112.63 99.66 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.865 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -83.58 73.0 10.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 55.04 111.095 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.65 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.87 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -141.53 -92.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 33.02 111.107 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 169.8 -61.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.41 112.484 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 107' ' ' THR . 54.1 Cg_endo -69.73 90.46 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.717 2.278 . . . . 74.41 112.359 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 37.82 42.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.22 110.902 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.5 p -139.17 39.63 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 54.14 111.123 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -92.73 177.34 6.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.12 110.935 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.43 -117.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 23.23 112.477 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.511 ' HB2' HD11 ' A' ' 39' ' ' LEU . 94.3 p -107.16 -165.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 61.04 110.861 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.712 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 mt-30 73.07 63.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.935 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -61.87 -178.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.888 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.71 129.97 8.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.92 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.555 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 59.0 mt -84.75 109.28 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 45.11 111.101 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.444 ' C ' ' H ' ' A' ' 117' ' ' ALA . 84.3 m -51.61 -33.64 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.51 -33.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 44.13 111.171 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . -138.63 173.57 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.44 111.099 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -69.39 88.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.3 110.895 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 115' ' ' CYS . 31.6 p -92.17 65.09 4.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.33 111.135 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -5.55 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.35 110.847 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.9 -5.13 39.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.918 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 126' ' ' HIS . 98.4 mt -89.35 -48.48 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.929 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.8 -85.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 73.14 110.847 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -118.49 109.34 1.75 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.686 -0.769 . . . . 74.44 112.472 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.48 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 73.12 110.911 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.692 ' CD2' HD13 ' A' ' 122' ' ' LEU . 4.3 m-70 -119.97 134.04 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.51 110.828 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.55 97.21 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.32 111.146 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.27 131.63 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 54.33 111.126 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.62 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.8 p90 -136.33 4.51 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 65.02 110.877 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.82 -161.33 9.11 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 51.44 112.459 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 177.2 -169.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 75.54 110.925 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.439 HG23 ' HA3' ' A' ' 96' ' ' GLY . 55.9 t -103.83 88.8 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 55.03 111.104 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -40.78 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.888 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.08 163.96 3.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 70.4 110.894 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.26 11.58 44.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 61.15 112.479 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -30.76 9.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 63.32 110.861 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -51.06 -26.42 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.926 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mm -78.83 -45.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.24 111.11 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 143' ' ' GLU . 45.9 t -50.22 -44.03 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.54 111.126 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.35 -29.68 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 70.34 110.904 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.43 -31.91 60.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 111.063 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 10' ' ' ILE . 8.1 mtm -75.67 -35.07 60.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.888 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.424 ' OE1' HG12 ' A' ' 139' ' ' VAL . 4.6 pt-20 -84.13 31.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.85 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -126.42 -13.26 6.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.906 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.35 17.65 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.61 -156.58 30.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.22 112.513 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.76 -64.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 71.05 110.888 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.39 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 72.22 110.9 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -111.28 11.79 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 70.22 110.915 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.27 15.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 54.25 112.446 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 75.53 -58.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 41.4 110.9 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 154' ' ' LYS . 2.5 m 71.12 145.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.35 111.145 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.45 1.83 56.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 63.22 110.876 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.544 ' H ' HG22 ' A' ' 152' ' ' THR . 1.8 mttt -141.01 165.71 26.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.916 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -106.23 115.92 31.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 64.1 110.916 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 156' ' ' ILE . 1.3 mp -87.96 105.87 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 55.33 111.126 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -106.93 167.85 9.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 62.31 111.093 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 83.0 mt -121.33 138.52 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 64.22 111.155 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.59 -56.4 3.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.02 111.118 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -158.81 166.92 30.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 73.45 110.844 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -145.72 -163.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.892 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 141.4 -150.37 21.82 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 65.33 112.496 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -106.25 134.38 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 72.03 110.909 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -57.78 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.01 110.94 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 75.22 110.876 179.915 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.839 0.352 . . . . 73.15 110.916 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.98 156.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 61.33 111.103 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -87.66 148.31 43.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.723 . . . . 74.14 110.903 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB2' HD12 ' A' ' 24' ' ' LEU . 54.3 Cg_endo -69.68 122.73 9.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.271 . . . . 75.4 112.367 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.601 HG22 HD21 ' A' ' 164' ' ' LEU . 37.5 m -114.01 135.92 53.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 61.4 111.157 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 26.1 m -121.33 157.66 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 51.43 111.103 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 164' ' ' LEU . 28.1 p90 -122.55 160.34 25.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.11 110.823 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -137.54 136.52 37.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.74 112.03 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 62.23 110.858 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -85.26 126.12 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 53.15 111.155 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.98 165.15 14.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.42 111.09 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.19 93.84 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 60.53 111.111 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.78 35.08 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.882 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -13.17 67.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.54 112.522 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.76 130.28 33.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.652 0.739 . . . . 73.31 110.917 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 151.61 69.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 74.14 112.332 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.662 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -118.74 -67.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 64.44 110.924 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.92 -141.15 3.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 32.03 112.492 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -150.53 127.29 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 60.22 110.908 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.85 122.3 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.13 111.164 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 68.9 p -104.13 150.4 24.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 71.3 110.888 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.519 ' O ' HG23 ' A' ' 5' ' ' THR . 5.2 m-85 -118.25 178.17 4.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.939 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 127.0 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.14 110.875 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 4' ' ' PRO . 96.5 mt -95.43 106.21 18.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 71.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 90' ' ' LEU . 13.7 m-85 -72.68 75.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 73.44 110.888 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.91 -34.35 62.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 64.52 111.087 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 51.11 110.868 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.5 -65.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.872 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.44 93.07 30.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.588 0.709 . . . . 72.0 111.146 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -25.27 29.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.709 2.273 . . . . 44.12 112.364 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -78.74 -57.9 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.912 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 m -61.4 -26.08 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 61.44 111.177 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.58 -56.29 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.094 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.7 tt0 -62.66 -56.98 12.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.827 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.1 t-20 -28.07 -56.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.879 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.37 -40.57 62.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.929 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -48.3 -32.75 7.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 75.01 110.903 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.638 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -71.7 -43.25 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 53.21 111.094 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.938 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.2 m -76.3 -44.56 36.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 71.51 110.894 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -79.52 -0.55 33.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 74.23 111.162 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.87 78.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.787 -0.72 . . . . 54.31 112.451 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 10.3 pt-20 -99.21 0.86 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 73.15 110.9 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -127.51 -0.4 6.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.96 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 41.32 29.32 0.38 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 63.05 112.52 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.03 -33.15 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 73.44 110.859 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 74.11 112.44 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.88 149.68 21.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 63.55 110.929 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.9 119.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 74.2 110.93 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.87 22.18 76.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 73.43 112.479 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 p -94.17 -166.87 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.899 0.38 . . . . 74.45 110.881 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.3 m -99.2 -168.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.58 126.14 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 64.22 110.856 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -51.2 -62.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 74.23 110.863 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 150' ' ' GLY . 26.3 ttm180 -149.57 167.28 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 65.32 110.859 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 156' ' ' ILE . 58.7 mt -141.86 127.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 60.24 111.125 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.604 HD12 ' CE ' ' A' ' 61' ' ' MET . 46.6 mt -140.48 90.92 9.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.653 0.74 . . . . 73.44 111.115 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 108.65 2.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.238 . . . . 74.55 112.398 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.62 -45.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 55.25 112.424 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 -71.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 74.3 110.876 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.604 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.81 -174.74 4.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.871 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.97 117.87 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 54.2 110.891 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -136.58 166.39 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.92 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.76 29.98 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.79 -0.719 . . . . 42.44 112.51 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.89 137.1 8.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 74.12 112.477 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 170.35 132.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 75.15 110.913 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -60.17 163.73 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.54 110.861 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.77 -39.89 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 74.34 111.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -101.8 -25.11 13.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.878 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -66.24 -9.88 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.15 110.854 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 67.73 92.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 72.43 110.852 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.4 170.49 36.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 61.34 112.483 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 74.0 p -141.63 95.41 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 75.43 111.144 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.19 -25.63 3.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 72.11 112.487 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.14 -151.07 18.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 74.13 112.5 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.47 -167.51 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 73.31 110.902 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 130.19 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.832 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 38' ' ' ALA . 2.3 pp -48.03 -34.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 71.21 111.122 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.58 19.87 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.901 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.79 -140.99 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 71.44 112.479 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -122.99 -25.69 4.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 75.3 110.903 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -168.69 160.23 10.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 63.43 110.918 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -132.95 162.97 30.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 65.02 110.896 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -80.34 156.97 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.886 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.97 105.09 13.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 72.54 110.883 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.72 -41.57 97.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.887 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 175.07 171.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.884 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -130.4 32.62 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.905 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -19.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 75.13 111.164 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.688 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -90.9 128.31 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.921 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -121.29 179.39 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.894 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -78.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.34 110.821 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 61.96 11.37 4.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.186 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.86 166.63 34.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.22 112.544 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 163.09 39.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 73.41 112.34 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.98 9.87 79.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 73.41 112.529 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -97.57 150.08 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 74.1 111.168 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 99' ' ' SER . 1.7 tt -107.53 142.92 36.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.971 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.655 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.78 132.23 47.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.869 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.8 mmt -64.25 -45.73 86.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 70.03 110.901 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 46.62 72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.127 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 13.0 p-10 -104.0 -163.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.891 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -51.41 -32.4 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.095 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 132.76 -54.46 0.78 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 72.13 112.499 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.6 Cg_endo -69.8 -100.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.32 112.291 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.2 91.46 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.924 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.7 p -150.22 28.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.162 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 0.9 OUTLIER 54.89 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.35 110.864 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.92 -90.75 0.22 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 73.32 112.45 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.7 t 76.54 33.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 73.42 110.86 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -90.0 -34.46 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.51 110.921 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 3.9 t80 79.92 65.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 63.45 110.86 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 99' ' ' SER . 27.5 t80 -96.74 95.11 7.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 63.3 110.843 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 19.4 mt -90.63 136.81 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 50.1 111.14 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.5 m -103.05 133.57 47.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.897 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.803 HG21 ' OE2' ' A' ' 143' ' ' GLU . 47.8 p -111.75 17.12 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.24 111.158 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.14 175.51 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 64.3 111.088 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.8 78.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 51.52 110.902 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.614 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 16.6 p -117.34 67.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 42.43 111.134 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.26 25.2 4.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.55 110.915 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.614 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -93.58 17.87 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.02 110.885 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -132.61 14.35 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 72.3 110.947 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.92 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.838 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.97 57.53 3.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 75.54 112.543 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -163.97 -52.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 64.3 110.915 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -104.83 133.41 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.4 110.839 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.32 101.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 53.21 111.126 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.02 138.68 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.138 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -161.82 25.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.889 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -118.65 -165.83 13.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 71.32 112.488 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 1.6 tttp 162.22 120.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 71.11 110.871 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.674 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.5 t -65.13 88.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 65.34 111.105 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -71.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 75.52 110.945 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.54 159.13 44.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 63.15 110.847 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.22 42.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 62.1 112.492 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.674 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.71 -30.41 13.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 65.1 110.885 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -53.62 -25.8 19.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 61.51 110.881 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.9 mm -90.23 -39.13 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.33 111.135 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.13 -23.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.4 111.17 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.05 -27.81 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 73.04 110.906 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.91 71.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 53.23 111.119 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.6 ptm -76.8 -15.61 59.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 50.22 110.919 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.803 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -88.99 27.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.31 110.856 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.11 0.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.04 110.902 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -121.08 6.86 10.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.33 110.913 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -117.28 45.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 63.34 112.476 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' GLY . 7.3 t 36.16 -147.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 64.02 110.834 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -139.59 7.92 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 65.31 110.905 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -16.96 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.851 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 55' ' ' ARG . . . 144.54 -57.5 0.53 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.13 112.46 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.89 133.88 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 54.21 110.904 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.6 p -113.19 138.68 49.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 63.33 111.18 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -24.16 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.836 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -165.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.916 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -126.65 125.03 41.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 70.25 110.901 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.574 HD13 HD11 ' A' ' 56' ' ' ILE . 3.5 mp -99.4 105.94 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.33 111.129 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.07 171.86 7.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 63.34 111.157 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.93 147.16 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 75.41 111.129 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.69 -59.05 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 65.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.81 167.41 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 62.42 110.889 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.1 m -145.61 -166.11 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.41 110.855 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.06 -177.73 16.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 62.31 112.546 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.1 pt20 -94.52 136.36 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.31 110.911 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.708 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.5 pt? -112.49 -34.81 5.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 61.35 110.917 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.87 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.856 0.36 . . . . 73.55 110.865 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -139.77 142.24 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 51.32 111.159 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -55.16 159.83 3.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 73.42 110.893 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 149.09 66.42 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.236 . . . . 74.12 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.71 49.84 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 74.51 111.107 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 6' ' ' VAL . 5.1 m -42.31 140.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 75.34 111.166 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 161' ' ' CYS . 0.1 OUTLIER -124.85 165.28 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 65.22 110.892 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -142.5 137.73 30.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 72.44 110.905 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -101.56 86.22 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.836 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.7 mm -57.71 145.06 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.147 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.04 155.87 46.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 41.52 111.09 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.4 t -134.99 109.51 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 54.1 111.086 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 t0 57.98 52.41 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 75.52 110.923 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.53 12.63 56.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.01 112.505 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.51 107.82 26.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.637 0.732 . . . . 65.11 110.899 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.5 Cg_endo -69.75 143.41 50.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 62.24 112.348 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 21.44 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.24 110.897 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.37 166.39 20.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.807 -0.711 . . . . 40.44 112.519 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -175.32 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 64.24 110.852 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 32.8 m -138.8 175.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.34 111.148 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 t -117.39 84.41 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.847 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -81.85 88.32 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 74.12 110.846 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.83 137.13 36.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 72.41 110.883 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.617 HD11 ' HD2' ' A' ' 36' ' ' PHE . 46.2 mt -111.82 144.99 40.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 29' ' ' VAL . 14.9 m-85 -91.59 67.24 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.24 110.872 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.66 -10.57 8.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.14 111.106 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -92.23 -35.08 14.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 42.52 110.864 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -86.92 -30.34 21.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 73.23 110.917 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.594 HG21 ' CG ' ' A' ' 129' ' ' PHE . 4.5 m -128.52 69.0 78.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.605 0.717 . . . . 73.11 111.14 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 60.08 1.62 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.696 2.264 . . . . 73.44 112.385 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.81 -63.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 71.33 110.896 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.93 -55.72 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 62.5 111.086 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . . . -79.63 -12.99 59.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.22 111.051 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.29 -35.74 81.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 62.31 110.875 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.26 -31.48 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.883 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' HD2' HD11 ' A' ' 24' ' ' LEU . 1.1 t80 -50.9 -27.28 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.876 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -62.26 -30.91 71.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 73.55 110.901 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.21 -24.81 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 74.53 111.125 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -99.58 26.61 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 72.45 110.887 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.93 -21.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.846 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -89.79 -30.64 17.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 35.24 111.135 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 135.32 -20.42 3.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 73.14 112.475 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -32.6 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 72.24 110.876 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 153.82 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.86 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.16 -33.01 0.43 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.466 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -55.05 -28.56 53.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 74.24 110.897 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -77.48 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 63.41 112.506 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 124.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.41 110.915 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -93.71 -77.45 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 71.32 110.89 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.6 -54.1 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 43.12 112.441 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.7 -164.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 72.13 110.841 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.695 ' HB3' HG22 ' A' ' 157' ' ' THR . 9.8 p -157.0 134.45 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 65.33 110.946 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CE1' HD11 ' A' ' 158' ' ' ILE . 12.7 m-85 -94.77 123.76 38.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 72.02 110.901 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.94 32.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 65.53 110.84 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -133.02 27.17 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.862 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.8 138.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.92 111.13 17.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.613 0.721 . . . . 72.24 111.16 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 90.33 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 72.53 112.366 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.28 4.86 13.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 52.11 112.455 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.72 -66.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 72.13 110.868 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.15 -166.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 63.11 110.867 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.1 t -152.89 108.51 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.1 110.886 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -97.42 163.6 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 54.13 110.919 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -142.31 144.95 14.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 60.54 112.491 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.6 84.96 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 60.01 112.487 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -144.34 46.13 1.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 61.24 110.86 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.59 -53.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 65.14 110.887 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.636 HG21 ' HG2' ' A' ' 111' ' ' GLN . 5.2 p -93.99 39.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.4 111.138 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.0 -68.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.908 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -179.43 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 64.5 110.847 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -88.0 -65.51 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 64.53 110.878 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 68' ' ' THR . . . 121.89 48.35 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 31.22 112.526 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -119.55 -23.03 6.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 72.3 111.115 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -119.08 -21.12 3.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 45.13 112.511 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 68' ' ' THR . . . -46.88 164.71 0.12 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 42.32 112.452 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.89 -171.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 61.15 110.896 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m -79.52 -171.81 2.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 52.25 110.881 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 38' ' ' ALA . 16.8 pt -92.85 -40.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.34 111.116 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -86.76 85.12 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 70.12 110.887 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.36 -107.77 3.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 63.34 112.44 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -91.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 74.1 110.869 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 150.58 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 63.15 110.855 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 154.41 39.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.853 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 106' ' ' ASN . 20.7 pm0 -62.87 160.5 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.23 110.853 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.7 -169.47 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 51.41 110.907 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -132.96 -59.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 75.1 110.877 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -171.2 149.86 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 71.43 110.851 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.3 64.41 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.902 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' ILE . 10.1 mt -78.16 2.31 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 72.53 111.147 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.74 132.65 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 74.22 110.942 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -110.06 123.34 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.88 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.19 91.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.877 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.9 p -129.58 21.9 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 61.21 111.183 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.26 167.48 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 71.13 112.445 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -44.94 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 54.22 112.308 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.79 40.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.26 141.7 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.44 111.162 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 99' ' ' SER . 4.2 tt -89.57 130.46 35.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.872 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 98' ' ' LEU . 1.7 t -128.41 -147.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.845 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tpt -152.43 143.14 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.02 110.868 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -117.73 149.16 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 54.12 111.121 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 161.75 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.881 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -55.63 -36.87 67.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 55.25 111.106 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.7 -65.15 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 44.05 112.521 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 106.86 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.717 2.278 . . . . 71.42 112.321 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 84' ' ' GLU . 2.2 p-10 42.76 56.87 3.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.908 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.99 33.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.156 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -74.29 -0.71 17.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.918 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.9 119.63 19.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 24.24 112.484 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 8.9 t 54.86 -166.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 71.52 110.852 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.636 ' HG2' HG21 ' A' ' 68' ' ' THR . 3.9 mm-40 64.04 118.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 75.54 110.905 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.4 156.87 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.2 110.855 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.76 154.6 36.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.882 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.17 105.5 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 75.35 111.153 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.24 146.38 53.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.86 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 p -96.14 19.99 10.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.35 111.111 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.24 177.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 75.54 111.138 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 131.63 51.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 62.02 110.902 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.16 41.05 3.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 71.13 111.145 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -49.02 -25.43 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 64.2 110.916 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -58.21 -32.62 68.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 64.41 110.952 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 mt -118.5 61.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 61.41 110.913 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -126.63 56.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.844 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 53.31 112.506 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 63.31 110.901 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -105.09 -16.35 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.843 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t 71.84 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.53 111.116 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 p -79.22 153.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.1 111.097 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 29' ' ' VAL . 44.1 p90 -176.91 129.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.34 110.836 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.39 149.21 12.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 63.25 112.513 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -162.6 162.96 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 73.13 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 132' ' ' VAL . 15.0 m -83.76 107.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.153 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -41.03 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 44.34 110.871 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 178.9 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.22 110.896 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.67 74.58 0.32 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 74.41 112.5 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -84.35 -18.39 36.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 43.15 110.87 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.94 -36.83 24.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 63.33 110.913 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 37.9 mm -40.39 -45.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.52 111.109 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.9 t -89.09 -50.66 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.3 111.124 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -49.33 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 70.5 110.88 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.86 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 32.22 111.106 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.593 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.5 ttm -50.84 -45.71 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 63.22 110.874 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -52.07 -23.74 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.898 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -63.77 -26.29 68.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.852 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.28 8.28 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.945 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.25 -146.25 20.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 63.12 112.451 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.01 161.36 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 62.23 110.835 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -50.76 -56.66 11.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 70.3 110.871 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -6.74 59.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.863 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.46 -150.37 16.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 54.14 112.476 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mttp 61.43 104.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 74.31 110.871 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.1 p -82.18 155.84 24.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 62.45 111.155 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -2.99 58.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.44 110.842 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -138.83 -175.43 4.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.905 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.68 104.93 13.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.904 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.593 HD13 ' SD ' ' A' ' 142' ' ' MET . 8.3 mt -95.34 127.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 63.31 111.122 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 52' ' ' CYS . 29.1 p -139.72 159.16 42.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.119 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.5 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -84.86 105.22 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.112 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -61.59 -56.57 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.104 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.0 177.16 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 54.32 110.831 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 17.0 p -176.88 155.74 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.42 110.891 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 -169.48 40.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.747 . . . . 72.4 112.5 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.27 126.26 35.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 72.41 110.891 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.81 138.26 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.897 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.853 179.935 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 64.3 110.878 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.61 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 62.34 111.119 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -95.82 151.76 38.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 75.4 110.895 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 134.69 28.55 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.65 2.233 . . . . 71.42 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 22' ' ' PHE . 6.9 m -122.16 140.44 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.119 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 3.2 m -125.19 159.46 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.01 111.104 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -133.44 155.08 50.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.873 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 158' ' ' ILE . 13.7 m-85 -135.2 134.36 40.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.866 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -90.66 108.91 20.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.828 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.05 119.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 45.33 111.133 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.93 167.58 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 61.45 111.099 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.61 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -150.68 91.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.121 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.1 32.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.816 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.19 -12.24 69.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 42.43 112.478 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.81 130.35 25.48 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.667 0.746 . . . . 62.2 110.891 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 152.95 69.43 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.683 2.255 . . . . 72.21 112.336 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.7 tp -114.52 -65.42 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.929 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.74 -178.01 36.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 33.04 112.464 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.7 125.98 54.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 72.25 110.832 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.52 143.97 38.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 74.43 111.12 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 23.3 p -129.99 155.26 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.888 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -125.7 165.57 18.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.913 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -120.97 124.69 45.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.888 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 129' ' ' PHE . 8.6 mt -93.42 126.82 38.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.936 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -83.07 82.31 8.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.917 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -4.59 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 60.32 111.087 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.23 -34.11 16.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 54.5 110.858 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.4 mttm -91.44 -28.48 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.917 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.55 79.31 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.625 0.726 . . . . 65.4 111.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.14 13.43 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 70.22 112.294 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -45.72 9.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 72.25 110.874 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -52.4 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 65.35 111.161 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.11 -77.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.113 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 29.7 tt0 -48.34 -66.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.876 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 19.8 t30 -28.23 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 65.54 110.916 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' GLU . 85.3 t80 -85.53 -42.0 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.87 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -54.52 -31.24 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.877 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.641 ' HB1' ' HE2' ' A' ' 44' ' ' LYS . . . -76.01 -43.57 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.23 111.11 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 39' ' ' LEU . 3.2 tm? -67.11 -39.2 86.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 73.24 110.905 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -35.26 76.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.857 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.04 -12.74 61.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 73.42 111.165 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 4.13 63.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.788 -0.72 . . . . 62.21 112.446 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.96 -1.65 36.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 61.54 110.933 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 2.1 mmtm -93.39 37.57 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 65.31 110.916 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.09 -45.46 3.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 40.33 112.502 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -155.89 -166.38 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 74.45 110.854 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 -107.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 65.15 112.511 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -162.84 123.49 2.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.414 . . . . 53.5 110.919 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -106.9 -26.74 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 73.41 110.909 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.94 -62.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.741 . . . . 74.51 112.489 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.65 -169.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.34 110.869 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 p -166.11 111.21 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 41.4 110.876 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -73.4 123.98 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.53 110.892 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -120.32 17.99 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.867 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -136.84 119.09 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HD13 ' A' ' 156' ' ' ILE . 88.0 mt -143.53 137.28 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.075 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 90.3 mt -146.8 95.38 4.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.666 0.746 . . . . 73.35 111.111 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.72 96.34 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 72.23 112.347 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.69 -35.17 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.47 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.32 -64.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 71.43 110.849 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.451 ' HE1' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -158.39 -169.5 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 70.04 110.895 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.32 -75.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 65.33 110.858 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 64.1 tt0 63.32 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.926 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.68 117.83 3.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 62.31 112.479 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.38 -131.08 4.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 62.23 112.478 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -126.69 156.2 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.861 0.362 . . . . 75.24 110.851 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' THR . 0.3 OUTLIER -69.14 -175.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.869 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 179.82 -55.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 52.21 111.144 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.34 15.3 9.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.89 -80.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.03 110.851 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -151.02 23.05 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.932 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.43 104.8 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 53.03 112.462 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -114.52 112.4 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 72.13 111.128 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.01 -141.96 12.46 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 54.54 112.508 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . -103.4 -112.34 3.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 72.53 112.478 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 0.8 OUTLIER 179.96 168.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 74.32 110.842 179.972 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 t -81.69 160.78 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 43.35 110.874 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' A' ' 44' ' ' LYS . 2.0 pp -88.35 -32.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 72.44 111.126 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 78' ' ' ILE . 30.4 m-85 -85.01 -6.29 59.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 75.24 110.9 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -121.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 63.11 112.512 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -112.34 -83.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 74.2 110.927 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.92 168.05 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.887 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.0 165.52 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 61.12 110.898 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -62.45 163.32 8.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 62.32 110.846 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 127' ' ' VAL . 25.6 t0 -80.33 161.41 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 62.21 110.886 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 -50.65 3.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.89 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p30 178.74 157.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.898 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.73 66.73 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.859 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.644 ' C ' HD22 ' A' ' 90' ' ' LEU . 14.0 mt -83.91 7.78 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.156 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.644 HD22 ' C ' ' A' ' 89' ' ' ILE . 4.1 mm? -127.29 127.53 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 64.31 110.936 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.28 133.28 56.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 65.34 110.904 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.464 ' HA ' HG21 ' A' ' 97' ' ' ILE . 3.0 m-70 -59.05 91.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.0 110.874 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.2 p -118.95 19.4 13.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 74.3 111.197 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.96 26.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.525 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -2.93 10.99 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.43 112.331 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.41 29.01 6.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.42 112.501 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 92' ' ' HIS . 20.8 mm -90.66 127.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 70.42 111.165 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.1 tt -90.3 124.13 34.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.874 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 42.9 t -115.5 160.73 19.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 71.23 110.854 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.76 115.24 29.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.874 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.97 150.53 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 62.13 111.11 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.72 -163.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.21 110.884 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -62.06 -12.68 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 41.33 111.083 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 121.69 -135.02 10.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 72.24 112.47 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 107' ' ' THR . 54.2 Cg_endo -69.71 147.52 63.35 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.735 2.29 . . . . 73.15 112.337 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.93 23.07 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.903 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.661 HG21 ' HB3' ' A' ' 103' ' ' ALA . 7.7 p -141.23 33.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.22 111.2 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER 11.49 -87.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.913 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 107.16 140.15 9.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 73.31 112.486 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -97.86 -33.33 11.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.334 . . . . 75.13 110.816 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -63.43 152.46 38.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.94 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 99' ' ' SER . 17.1 p90 -145.08 146.55 31.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 71.54 110.891 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -127.84 114.86 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 63.24 110.889 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.6 mt -67.02 101.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 52.13 111.149 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 54.7 m -57.85 126.98 29.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 72.51 110.901 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -88.19 -31.25 19.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 64.22 111.105 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 119' ' ' THR . . . -120.9 155.02 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.24 111.111 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -57.01 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.4 110.888 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.8 p -117.6 69.52 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 54.14 111.134 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.52 21.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.867 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.682 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.3 p90 -101.14 15.19 29.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 73.35 110.941 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 13.3 mt -129.73 17.05 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.34 110.937 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -63.15 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.54 110.862 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -46.75 -28.78 3.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 54.5 112.505 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -74.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 75.51 110.925 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -86.67 141.25 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.55 110.851 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.667 HG21 ' OD1' ' A' ' 85' ' ' ASP . 94.9 t -103.58 129.73 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 43.31 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -104.31 137.67 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.147 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 31.2 p90 -129.07 -32.87 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.902 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -109.92 161.05 13.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 75.12 112.495 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -155.57 148.68 24.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.349 . . . . 73.31 110.919 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.45 126.49 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 72.54 111.153 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -68.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.874 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 143.71 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 61.33 110.844 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.72 9.21 21.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 63.12 112.514 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.0 ttm -49.62 -28.03 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 62.3 110.884 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -50.63 -27.25 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.89 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.85 -35.72 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 73.54 111.113 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.78 -23.41 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.32 111.144 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.01 -25.14 32.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.906 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.29 57.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 62.01 111.12 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.8 ptm -76.97 -30.37 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 65.41 110.907 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -89.85 33.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.856 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 17.2 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.25 110.865 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -97.73 33.3 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 72.4 110.87 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.601 ' O ' ' C ' ' A' ' 147' ' ' SER . . . 64.88 -92.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 75.04 112.483 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.601 ' C ' ' O ' ' A' ' 146' ' ' GLY . 88.7 p 17.86 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 74.01 110.874 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -91.51 -24.62 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.52 110.888 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -105.01 -7.53 19.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.34 110.931 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.95 -39.81 2.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.759 . . . . 41.22 112.453 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -64.5 101.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 71.2 110.891 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 147' ' ' SER . 1.9 m -90.56 154.15 19.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 50.1 111.162 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.73 -17.76 63.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 74.4 110.848 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.26 -175.87 4.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.866 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -120.05 144.17 47.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.899 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 56' ' ' ILE . 2.5 mp -110.41 134.51 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.126 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -129.33 166.86 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.136 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 8' ' ' PHE . 30.9 mm -112.06 106.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 61.51 111.128 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -54.2 -57.23 11.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 51.3 111.13 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -160.26 174.63 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.859 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 11.4 p -175.35 169.6 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.894 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.02 -160.52 28.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 71.24 112.493 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -72.25 109.36 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.13 110.883 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.66 -48.33 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.52 110.914 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 70.42 110.878 179.943 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.351 . . . . 62.33 110.868 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.65 153.82 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 62.25 111.158 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -50.44 153.31 2.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.595 0.712 . . . . 75.11 110.943 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 141.07 44.29 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 54.31 112.332 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.728 HG22 HD21 ' A' ' 164' ' ' LEU . 49.9 m -126.29 101.55 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.54 111.135 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 24' ' ' LEU . 5.8 m -96.42 149.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.123 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.95 162.72 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.889 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.01 133.51 21.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.886 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.25 108.52 16.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.02 110.891 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 142' ' ' MET . 15.7 mm -87.48 139.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.34 111.161 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -120.7 155.87 32.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 60.31 111.123 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.0 96.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 52.41 111.125 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.87 56.04 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.884 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.75 11.63 54.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 72.14 112.446 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -142.44 92.17 7.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 74.41 110.886 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.17 64.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 73.11 112.358 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -115.61 23.93 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.866 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.66 -161.74 21.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 44.45 112.463 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 170.37 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 74.33 110.868 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG13 HG21 ' A' ' 138' ' ' ILE . 33.2 m -132.15 172.47 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.147 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -127.89 90.69 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.41 110.87 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -81.73 72.98 8.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.54 110.94 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.92 143.53 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.851 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 6' ' ' VAL . 16.5 mt -105.53 119.81 40.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 52.52 110.93 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -76.62 57.23 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.856 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -31.3 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.51 111.103 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.87 -63.14 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 74.21 110.893 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.29 -74.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.93 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 129' ' ' PHE . 2.4 m -85.15 110.77 31.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 63.3 111.107 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 74.12 112.344 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -57.67 -47.02 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.874 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -45.77 -41.9 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 61.13 111.142 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' CB ' HG23 ' A' ' 29' ' ' VAL . . . -107.5 21.72 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.086 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -93.16 -28.37 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.856 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HA ' HD13 ' A' ' 78' ' ' ILE . 26.8 p-10 -85.19 -41.08 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 65.51 110.88 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -32.75 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 61.2 110.905 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.96 -39.55 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.85 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.46 -17.97 26.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.13 111.164 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 78' ' ' ILE . 50.4 mt -85.02 9.98 13.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 71.23 110.895 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.4 m -126.35 -3.42 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.879 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.6 p -124.82 -4.98 7.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.24 111.143 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.15 71.85 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 73.11 112.485 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.27 34.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 73.23 110.861 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.6 -42.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.22 110.863 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 46' ' ' PHE . . . -137.67 30.53 2.58 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 75.03 112.44 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' CG ' ' C ' ' A' ' 45' ' ' GLY . 2.1 p90 40.11 63.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 74.1 110.879 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.94 21.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 70.22 112.497 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.17 -179.81 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.393 . . . . 62.12 110.885 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -166.24 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 64.24 110.875 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.75 44.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.507 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.15 155.17 32.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 61.13 110.826 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.67 127.52 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 74.11 110.898 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -148.61 122.08 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 53.22 110.87 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -140.81 73.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.13 110.869 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -121.18 21.86 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.88 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 ' HA ' ' A' ' 143' ' ' GLU . 4.7 mt -59.64 136.35 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.0 111.139 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.11 113.05 32.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 65.43 111.193 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 86.73 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 73.33 112.362 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.64 2.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 75.11 112.501 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.27 -72.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 73.1 110.917 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -178.22 -158.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.871 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.2 t -143.24 135.9 27.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.41 110.869 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 153.42 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.927 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -142.33 147.67 19.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 73.52 112.505 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.75 85.72 1.49 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 73.35 112.483 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 60.22 110.895 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 68' ' ' THR . 15.5 p90 -99.76 -176.45 3.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 73.2 110.871 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 179.76 -68.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.44 111.124 -179.857 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -103.87 154.55 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.851 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 171.22 -39.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.843 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 -35.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 62.44 110.89 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.76 -7.09 64.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 71.21 112.516 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m 72.26 36.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 70.42 111.134 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.55 151.87 7.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 70.43 112.527 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.65 -118.53 3.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 61.21 112.523 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.6 -71.95 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.312 . . . . 74.45 110.873 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.06 120.38 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 51.11 110.85 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.2 pt -49.18 -37.01 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 73.2 111.159 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.22 36.92 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.904 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.51 15.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 75.01 112.458 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -122.4 -24.15 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 73.34 110.895 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -169.36 147.1 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.903 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.94 158.16 34.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 61.23 110.943 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.92 162.52 28.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.1 110.926 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.63 108.39 13.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.886 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.52 -51.73 47.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.882 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t30 175.27 175.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.881 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.45 40.81 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.871 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.52 -27.12 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.115 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.59 133.62 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 55.32 110.913 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -114.19 -175.69 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 72.33 110.942 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.492 ' C ' HG23 ' A' ' 93' ' ' THR . 32.1 m170 -99.49 -86.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 73.23 110.868 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 67.09 6.32 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 42.54 111.104 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.37 159.48 20.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 51.04 112.483 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.429 ' CB ' ' HA ' ' A' ' 116' ' ' THR . 53.6 Cg_endo -69.71 169.69 18.26 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 75.41 112.354 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.26 8.85 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.743 . . . . 31.34 112.482 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 98' ' ' LEU . 10.6 mm -69.9 158.28 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 64.21 111.121 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 112' ' ' PHE . 10.9 mt -124.36 162.72 23.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.934 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -160.49 43.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.4 110.883 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 4.2 mmt 48.65 -166.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.883 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -179.61 78.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 54.2 111.105 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.521 ' HB3' HG22 ' A' ' 107' ' ' THR . 0.7 OUTLIER -123.34 -76.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.91 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -137.07 -41.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 55.22 111.127 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -75.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 73.21 112.51 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 102.2 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 54.34 112.312 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.59 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 73.41 110.851 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.0 m -154.55 59.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.119 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.578 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -80.37 -0.68 37.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 65.3 110.901 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 21.0 -136.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.758 . . . . 75.21 112.518 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 m -153.91 65.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.331 . . . . 72.31 110.87 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.738 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.0 tp-100 -93.71 -45.41 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 74.21 110.91 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.569 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 67.63 130.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 75.34 110.864 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -153.41 134.76 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.35 110.885 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.55 143.99 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 74.03 111.155 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 p -115.55 161.23 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 72.54 110.906 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 95' ' ' PRO . 3.2 m -127.91 30.63 5.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.34 111.088 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.24 22.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.23 111.11 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.12 134.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.916 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 68.1 p -131.45 41.47 3.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 71.13 111.122 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -48.97 -26.42 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 61.21 110.863 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -60.35 -36.77 78.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.912 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.27 31.99 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.934 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -114.63 41.92 2.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.897 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.15 30.9 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.501 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.34 -39.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 70.33 110.936 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -97.33 156.88 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.12 110.879 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.53 99.18 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.32 111.109 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 98' ' ' LEU . 91.9 t -63.64 124.93 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 70.21 111.156 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.664 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.4 t80 -155.43 81.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.91 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.56 166.5 39.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 43.35 112.476 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp 177.97 153.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 72.55 110.911 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 132' ' ' VAL . 2.9 p -105.39 87.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.2 111.151 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -51.35 -46.24 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 63.23 110.917 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 174.22 11.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.866 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.8 77.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 52.33 112.491 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -24.36 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.758 0.313 . . . . 70.24 110.9 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -76.53 -34.65 58.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.11 110.854 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.656 HG21 HG13 ' A' ' 20' ' ' VAL . 48.0 mm -45.4 -39.8 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.35 111.12 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.4 -52.23 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 71.3 111.149 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -49.39 -67.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.53 110.889 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -51.62 -54.42 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.51 111.099 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.701 ' SD ' HD13 ' A' ' 156' ' ' ILE . 11.6 ttm -51.12 -41.28 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 75.41 110.914 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.42 ' HA ' HG21 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -53.95 -23.22 12.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 72.41 110.89 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -65.55 -25.94 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.847 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -87.42 9.0 22.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 73.12 110.838 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.14 -171.14 40.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 62.01 112.501 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -158.5 149.39 20.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 42.43 110.832 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -49.89 -56.09 11.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.876 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -22.23 57.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.879 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.96 -36.2 3.94 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 73.03 112.479 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -50.55 160.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 55.31 110.866 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.9 p -121.22 156.98 31.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 62.54 111.13 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -26.47 62.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 45.15 110.879 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.29 -168.19 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 71.52 110.888 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -113.43 96.82 6.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.886 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.701 HD13 ' SD ' ' A' ' 142' ' ' MET . 19.6 mt -90.61 101.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.114 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 7.2 t -117.63 164.87 14.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.4 111.141 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.4 mt -88.53 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.144 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.62 -64.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.34 111.113 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -135.1 166.33 23.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.856 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -153.72 -174.84 5.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.834 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.9 -147.77 18.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.462 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.6 pt20 -126.61 136.73 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.875 0.369 . . . . 73.35 110.901 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.728 HD21 HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -80.17 -35.39 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 63.51 110.969 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 70.34 110.893 179.905 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.321 . . . . 53.23 110.879 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.1 t -109.95 134.48 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 51.25 111.178 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -59.28 159.14 16.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.603 0.716 . . . . 71.52 110.918 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 154.0 68.45 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 71.23 112.35 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 m -122.14 44.64 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 75.01 111.145 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' CG1' HD12 ' A' ' 24' ' ' LEU . 3.8 m -47.83 140.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 61.1 111.141 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -136.57 175.87 9.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.13 110.892 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -148.64 142.59 25.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 73.54 110.902 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' HD13 ' A' ' 158' ' ' ILE . 5.9 t70 -96.29 131.8 42.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 63.23 110.826 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.8 137.34 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 53.15 111.106 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.76 167.07 22.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 73.24 111.092 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -143.92 95.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.03 111.121 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 71.14 33.49 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.901 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.27 70.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 71.41 112.549 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -93.17 131.7 32.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.691 0.757 . . . . 74.32 110.849 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 147.33 62.18 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 64.14 112.323 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 12' ' ' VAL . 1.3 tp -113.37 -67.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 65.42 110.88 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.21 -146.66 4.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.5 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.27 125.86 12.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 72.51 110.864 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG1' HG13 ' A' ' 132' ' ' VAL . 22.8 t -116.45 135.24 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.158 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -88.76 100.61 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.841 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -87.81 73.6 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 72.4 110.852 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -51.47 151.78 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.878 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 ' CG1' ' A' ' 6' ' ' VAL . 5.4 mt -117.41 123.75 47.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 74.3 110.932 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.74 70.77 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 70.23 110.864 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.95 -8.68 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 73.14 111.084 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.23 -56.13 4.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 71.11 110.894 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -54.91 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 73.12 110.894 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.53 83.24 53.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.613 0.721 . . . . 72.14 111.103 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 63.11 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.23 . . . . 74.44 112.359 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -159.77 -67.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 62.2 110.914 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 m -53.33 -48.06 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 75.31 111.154 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.02 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 53.14 111.132 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -55.63 -28.27 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.23 110.904 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -54.2 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 60.23 110.922 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.09 -36.52 81.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 51.4 110.862 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -27.23 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 70.43 110.871 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.41 -35.03 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.31 111.133 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.3 tt -83.84 5.22 25.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.898 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -105.31 -13.99 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.869 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -116.59 8.23 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 71.11 111.159 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.03 21.72 39.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 71.24 112.487 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -34.31 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 73.32 110.893 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -13.35 62.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 62.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.62 -12.48 59.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 71.34 112.5 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 47' ' ' GLY . 19.5 m-85 -92.34 -28.08 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 64.22 110.842 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -35.51 125.89 0.74 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 55.22 112.472 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -100.48 33.13 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 75.51 110.979 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 146.74 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 53.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 157' ' ' THR . . . 119.05 -95.91 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 44.35 112.476 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.568 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -101.96 121.72 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 70.22 110.862 -179.707 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.0 p -174.21 -166.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 61.21 110.882 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 63.51 86.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 62.53 110.902 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -116.47 17.28 15.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.885 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -134.37 151.68 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 70.21 110.862 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 179.54 131.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.52 111.17 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 61' ' ' MET . 1.2 pt -138.06 109.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.674 0.75 . . . . 73.33 111.146 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.27 . . . . 54.34 112.333 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.96 -31.6 1.73 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.489 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CB ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.47 -64.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 73.25 110.863 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.433 ' HG2' HD11 ' A' ' 57' ' ' ILE . 3.6 ptt? -158.42 -156.32 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.908 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.2 m -131.44 -44.04 1.02 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 54.44 110.872 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.09 119.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 65.13 110.947 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.78 11.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 50.11 112.487 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.25 -157.61 27.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 74.51 112.498 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.3 -177.31 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 73.21 110.856 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -176.08 121.11 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 65.21 110.897 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.3 -76.01 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 74.34 111.123 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -144.43 116.35 8.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 73.35 110.858 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.4 20.41 2.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.839 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.81 50.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 62.41 110.854 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.63 24.62 2.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.51 112.471 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p 48.08 88.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.848 0.356 . . . . 72.54 111.105 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.54 56.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.752 . . . . 53.35 112.513 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 101.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.739 . . . . 73.41 112.452 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 172.98 2.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 74.1 110.882 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -128.38 15.27 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 65.32 110.888 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 82.75 -19.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 53.42 111.11 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -20.29 15.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.934 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.41 -88.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.31 112.462 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -138.69 -54.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 75.5 110.898 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 9.2 pttp -168.81 145.17 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.895 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.48 144.55 49.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.3 110.882 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.73 170.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 65.35 110.857 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.2 146.45 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.85 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -58.79 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 62.41 110.846 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 178.75 156.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.889 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -112.55 60.14 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.868 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.7 mm -78.51 -20.52 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.45 111.181 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -96.51 99.06 10.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 72.3 110.889 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.24 114.33 26.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 63.11 110.926 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.633 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -51.16 -95.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 73.3 110.83 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 93' ' ' THR . 0.5 OUTLIER 66.72 5.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.31 111.167 -179.86 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.84 153.27 24.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 50.13 112.49 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.72 63.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.264 . . . . 73.42 112.326 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 94.64 -17.95 58.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 51.02 112.482 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.633 HG21 ' HB3' ' A' ' 92' ' ' HIS . 12.7 mm -64.45 140.91 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 65.43 111.167 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.8 tt -90.79 126.67 36.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.894 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -122.72 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 mtm -69.17 175.29 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 52.55 110.878 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -166.92 147.38 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.31 111.103 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.6 m-20 163.5 -64.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 71.15 110.934 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.75 -106.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 74.32 111.103 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.606 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -156.59 -60.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 75.13 112.479 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.79 -104.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.262 . . . . 72.33 112.297 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -121.0 72.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 55.45 110.852 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -144.69 10.42 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.44 111.115 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 102' ' ' ASN . 9.4 p30 -99.86 179.51 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 52.32 110.832 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.17 24.53 2.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 75.44 112.473 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.49 -52.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 64.21 110.906 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -84.14 155.81 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 71.04 110.9 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -149.87 171.63 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.872 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -159.28 166.48 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 63.12 110.886 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 116' ' ' THR . 37.5 mt -121.4 114.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.51 111.12 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.8 p -65.15 -28.03 69.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 60.41 110.849 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 114' ' ' ILE . 1.4 p 49.31 22.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 71.42 111.141 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.4 176.14 6.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 71.21 111.077 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 104.63 12.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 65.31 110.874 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.795 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 66.2 p -132.45 63.8 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.21 111.16 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -90.13 22.63 3.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 62.52 110.881 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.795 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.5 OUTLIER -93.33 5.91 49.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.933 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 4.4 mt -97.59 -4.96 36.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.14 68.42 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.21 110.91 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.57 37.36 0.83 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.79 -0.719 . . . . 70.14 112.454 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 3.9 mmtp -55.46 -34.33 64.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 71.45 110.899 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -110.38 156.2 21.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.1 110.827 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.07 85.07 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.22 111.105 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 90' ' ' LEU . 17.5 t -65.25 118.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.03 111.109 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 17.96 4.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 74.41 110.869 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.74 178.2 28.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.503 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 170.09 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 74.05 110.934 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.64 HG13 ' CG1' ' A' ' 20' ' ' VAL . 94.4 t -97.75 84.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 74.22 111.11 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -62.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.14 110.908 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -138.02 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.829 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.29 10.46 68.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.21 112.467 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.64 27.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 74.31 110.856 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.55 -26.92 14.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 62.42 110.886 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.4 mm -80.02 -41.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 71.53 111.124 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 116' ' ' THR . 38.1 t -50.17 -45.19 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.115 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -32.77 67.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 52.21 110.85 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.77 92.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 64.13 111.079 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.1 mtm -71.62 -26.09 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 72.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.5 14.18 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 70.13 110.883 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -16.26 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.21 110.89 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -104.24 -8.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.864 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.53 -150.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 73.42 112.447 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -169.41 152.87 4.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 63.4 110.857 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -73.24 69.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 65.2 110.851 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 177.51 -26.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.86 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.4 -48.14 0.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 41.53 112.497 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.84 160.9 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 62.22 110.895 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -137.71 171.4 14.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.41 111.119 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 p -86.55 -4.01 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.842 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -137.85 -165.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 55.14 110.888 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.33 125.31 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 54.15 110.903 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.04 131.18 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.41 111.148 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -126.67 163.85 22.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 43.04 111.152 179.993 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 9' ' ' ASP . 41.8 mm -120.97 94.47 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.132 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.55 -48.63 76.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.4 111.1 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.64 -178.48 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.877 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 161' ' ' CYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 6.0 p -176.55 157.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.89 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.48 176.67 45.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 53.31 112.488 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.6 mt-30 -69.29 -36.71 77.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.813 0.339 . . . . 64.02 110.854 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.3 mm? 71.9 -21.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.898 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 163' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.846 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.815 0.341 . . . . 72.11 110.9 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.04 154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 52.41 111.131 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -89.79 151.32 45.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 75.5 110.826 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.81 109.27 2.28 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.671 2.247 . . . . 73.12 112.344 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.664 HG22 HD21 ' A' ' 164' ' ' LEU . 6.4 m -113.42 141.46 47.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 61.12 111.121 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 163' ' ' GLN . 6.4 m -126.9 148.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 70.41 111.141 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.794 ' HB3' HD22 ' A' ' 164' ' ' LEU . 11.5 p90 -118.69 147.79 43.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.908 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -129.06 131.41 47.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 63.25 110.895 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -97.12 75.54 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 61.12 110.892 179.991 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mm -49.74 141.41 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.146 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.92 151.49 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 70.23 111.111 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.6 t -134.19 108.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 72.2 111.181 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t0 51.47 52.25 15.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.919 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.22 50.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 63.01 112.463 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mm-40 -139.29 94.57 9.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.651 0.738 . . . . 73.13 110.878 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.83 157.75 59.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.251 . . . . 53.03 112.309 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -126.37 22.88 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 44.3 110.955 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.85 160.4 9.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 65.41 112.495 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 -179.68 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 64.33 110.917 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 138' ' ' ILE . 17.6 m -146.61 168.99 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 71.43 111.111 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -145.64 144.27 30.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.823 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 5' ' ' THR . 2.0 m-85 -127.68 138.62 52.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.904 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -111.36 113.56 26.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 53.23 110.896 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 33' ' ' ALA . 10.6 mt -80.2 129.74 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.903 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 72.16 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.43 110.868 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.51 -27.19 15.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.43 111.116 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.57 -44.01 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.845 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.51 -32.84 18.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.906 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.778 HG21 ' CB ' ' A' ' 129' ' ' PHE . 11.5 m -131.24 87.19 48.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 71.12 111.147 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.27 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 73.15 112.364 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -41.89 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -3.1 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 71.03 111.18 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -76.62 -37.47 56.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.33 111.141 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 35' ' ' ASN . 80.3 tt0 -92.79 -37.88 12.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 65.04 110.885 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -29.32 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.861 -179.904 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HA ' HD12 ' A' ' 39' ' ' LEU . 37.3 t80 -64.45 -32.75 74.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.857 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -51.75 -34.7 40.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.885 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.49 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.113 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' PHE . 13.4 mt -75.63 -52.02 11.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 63.53 110.856 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.9 m -59.39 -54.01 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.862 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.6 p -73.19 -27.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.34 111.15 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.96 92.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.722 . . . . 72.32 112.495 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.72 36.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 61.11 110.901 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -133.72 26.81 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.947 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.06 4.76 60.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 74.45 112.454 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -164.56 178.05 7.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 64.14 110.875 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.52 117.01 2.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 70.4 112.45 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.11 150.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 61.31 110.912 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -76.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 63.54 110.92 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.01 44.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 72.11 112.516 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -26.46 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 63.32 110.848 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p 178.13 176.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 65.44 110.931 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -103.2 -77.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.876 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.12 -80.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.55 110.9 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -164.82 110.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.878 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.716 HD12 ' CD1' ' A' ' 156' ' ' ILE . 5.1 mt -95.71 135.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 74.05 111.131 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.564 HD12 ' CE ' ' A' ' 61' ' ' MET . 12.7 mt -131.74 103.5 14.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 74.03 111.087 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.77 104.53 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 74.54 112.385 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.46 8.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 23.1 112.476 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.56 -66.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 70.21 110.94 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.564 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -179.17 -168.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 73.5 110.875 179.945 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.871 ' HB2' HG23 ' A' ' 114' ' ' ILE . 87.8 m -149.15 133.22 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.895 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.04 154.81 18.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.939 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.15 -179.92 38.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 53.05 112.525 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.35 44.66 5.52 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.738 . . . . 74.23 112.518 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -102.82 177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.863 0.363 . . . . 70.12 110.871 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -169.82 29.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 71.23 110.875 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -87.31 -168.08 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 60.21 111.134 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -96.58 -90.47 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.924 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.52 -76.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.85 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 p30 179.65 -32.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 64.12 110.859 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.31 30.62 1.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 43.03 112.496 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.9 p -99.94 -32.27 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 72.1 111.171 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.7 -123.83 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 63.34 112.482 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 68' ' ' THR . . . 100.5 120.45 4.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 71.15 112.485 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -175.73 177.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 74.1 110.885 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 142.27 27.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 70.45 110.852 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 79' ' ' TYR . 2.1 pp -40.67 -38.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 65.33 111.081 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' CD2' HD11 ' A' ' 78' ' ' ILE . 4.5 m-85 -85.89 49.24 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.877 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.16 -113.82 4.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 73.04 112.47 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.96 -161.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.393 . . . . 74.4 110.862 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.3 OUTLIER -101.08 -178.51 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 65.03 110.87 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -131.66 162.13 31.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.913 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -91.28 172.5 8.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 55.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.71 105.9 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 71.12 110.821 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -58.21 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 73.33 110.861 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 p30 -177.92 165.52 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.883 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.1 55.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 54.11 110.839 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mt -48.93 -26.32 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.5 111.194 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 73.3 mt -93.39 155.08 17.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.905 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -117.93 178.29 4.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 63.54 110.908 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -105.08 76.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 70.33 110.849 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 t -122.34 22.39 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.162 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' HD11 ' A' ' 97' ' ' ILE . . . -120.72 160.12 15.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.76 -0.733 . . . . 72.35 112.505 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.26 24.27 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 72.43 112.375 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.42 71.11 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 60.42 112.491 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HA3' ' A' ' 94' ' ' GLY . 42.5 mm -91.42 143.4 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 73.51 111.119 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 97' ' ' ILE . 8.0 mt -117.03 152.67 34.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.887 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 56.9 m -154.89 -101.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 70.14 110.877 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -176.4 124.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 74.54 110.874 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -102.58 80.76 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 53.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -137.32 -64.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.44 110.919 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -178.17 121.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 51.5 111.118 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.906 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -72.61 -29.48 65.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 60.34 112.482 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.906 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.7 Cg_endo -69.78 80.99 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.232 . . . . 71.21 112.367 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 p-10 39.29 53.96 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.892 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -159.03 39.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.2 111.142 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -74.77 160.27 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.941 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.99 -110.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.53 112.507 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.25 -162.14 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 72.32 110.851 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 mt-30 74.75 50.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 75.52 110.896 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 41.0 p90 -50.25 142.71 9.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.836 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 27.9 p90 -103.98 59.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.871 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 62' ' ' CYS . 9.3 tt -34.79 121.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.5 111.106 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 119' ' ' THR . 69.7 m -90.53 159.01 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 61.3 110.898 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -111.67 -9.69 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 71.04 111.163 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.87 161.38 40.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 62.22 111.085 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.24 115.92 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.15 110.9 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 122' ' ' LEU . 15.8 p -115.7 47.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 74.41 111.153 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.71 -17.54 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.926 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -55.65 -21.91 20.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 71.31 110.934 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.522 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -73.33 -56.25 5.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 72.02 110.923 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 73.03 -61.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.2 110.897 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.83 61.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.685 -0.769 . . . . 70.03 112.491 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -98.02 -27.79 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.43 110.913 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -143.44 138.1 29.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 61.34 110.812 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 87' ' ' ASN . 55.4 t -51.37 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.14 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.4 p -84.2 143.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 75.1 111.133 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.778 ' CB ' HG21 ' A' ' 29' ' ' VAL . 37.2 p90 -178.78 119.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.13 110.855 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.42 123.33 4.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 74.41 112.485 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -139.23 162.03 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 74.52 110.892 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 t -54.83 100.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.136 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -46.85 41.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 64.54 110.888 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -148.06 118.2 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.33 84.42 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 64.23 112.474 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 tpt -91.26 -21.52 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.789 0.328 . . . . 64.41 110.873 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -30.74 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 73.0 110.885 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 20' ' ' VAL . 38.2 mm -64.49 -41.76 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.31 111.117 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.7 t -91.65 11.39 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.085 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.8 -64.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 64.44 110.855 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.63 -57.28 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.33 111.083 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.7 tmm? -52.81 -37.86 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 55.44 110.888 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -24.59 32.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.878 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -68.39 -12.57 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.839 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -94.78 26.09 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 75.51 110.884 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -124.92 44.04 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 70.4 112.53 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 146' ' ' GLY . 29.8 t 29.57 -102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.384 . . . . 44.42 110.834 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -173.5 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 64.12 110.86 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -87.74 -6.45 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.895 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.68 -55.81 0.76 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.464 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 110.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.84 0.352 . . . . 73.22 110.848 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 146' ' ' GLY . 40.0 p -84.11 138.33 33.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.154 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.31 -28.92 63.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 65.53 110.854 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -137.07 -179.62 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.12 110.903 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 135.4 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.888 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.716 ' CD1' HD12 ' A' ' 56' ' ' ILE . 20.5 mt -117.17 87.66 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.04 111.128 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -108.68 157.16 18.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.02 111.175 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.4 mt -93.22 146.06 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 72.11 111.188 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -96.55 -61.22 1.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.114 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.09 154.6 48.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.0 m -146.16 -167.5 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 73.44 110.892 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.66 -162.93 23.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 72.25 112.501 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.646 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.3 tt0 -112.54 133.82 54.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 72.22 110.901 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.794 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -109.24 144.48 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 62.34 110.943 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.895 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.838 0.351 . . . . 64.42 110.896 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.9 t 59.62 99.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 70.52 111.127 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -58.59 154.91 32.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 73.4 110.907 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 154.8 67.33 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.233 . . . . 74.4 112.365 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 6' ' ' VAL . 2.8 m -120.55 163.01 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 61.45 111.109 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.587 ' CG2' HD11 ' A' ' 24' ' ' LEU . 1.3 t -144.11 140.68 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.23 111.176 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -126.34 144.36 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 62.11 110.864 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 8.0 m-85 -138.67 139.58 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 71.3 110.862 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.02 109.86 22.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 65.24 110.799 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.3 136.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.478 . . . . 70.41 111.157 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.32 161.91 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.099 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 17' ' ' LEU . 61.2 t -146.45 93.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 54.34 111.161 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.2 27.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.83 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.88 57.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 63.01 112.536 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.15 139.22 21.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.605 0.717 . . . . 64.53 110.891 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 152.93 69.49 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 64.23 112.401 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.5 tp -116.07 -68.39 0.92 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 73.13 110.929 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.81 -144.67 4.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 42.32 112.518 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.31 135.91 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.45 110.847 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.64 129.73 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.32 111.145 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 95.54 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.45 110.821 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 5.5 m-85 -87.56 119.81 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.54 110.875 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -101.07 147.88 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.917 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 37' ' ' ARG . 0.8 OUTLIER -121.06 120.18 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 65.14 110.911 -179.919 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.63 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.1 110.904 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.67 -2.47 56.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 65.34 111.104 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.05 -51.03 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.867 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -26.32 16.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.862 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.58 74.57 65.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.64 0.733 . . . . 74.33 111.142 179.858 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -44.6 1.98 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.251 . . . . 73.34 112.382 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -62.85 -50.22 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.92 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.504 ' OG1' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -65.03 -39.33 93.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 71.12 111.138 179.986 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.81 -68.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 74.01 111.07 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' ARG . 27.2 tt0 -48.42 -65.61 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.932 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 34' ' ' GLU . 4.2 t30 -29.93 -52.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 65.12 110.867 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.12 -41.56 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.53 110.885 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.589 ' HG3' HD13 ' A' ' 24' ' ' LEU . 5.0 ttm180 -52.06 -29.52 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 64.32 110.834 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -62.55 -32.55 73.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 44.32 111.098 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -94.01 35.3 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.877 -179.923 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.7 t -113.22 -12.29 13.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 74.04 110.853 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 p -121.32 18.14 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.159 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.34 27.8 8.39 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.747 -0.739 . . . . 64.21 112.528 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.04 -40.41 53.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.392 . . . . 75.24 110.882 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -62.08 -17.27 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.895 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.26 -66.24 3.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 63.03 112.492 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -93.3 148.02 22.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 75.5 110.917 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.8 -168.04 25.14 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.756 -0.735 . . . . 33.45 112.48 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' O ' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -86.11 139.7 30.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.931 0.396 . . . . 74.31 110.941 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -42.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.918 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.2 45.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 34.15 112.473 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.5 t -95.43 45.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 72.51 110.854 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.27 -176.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 70.45 110.881 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -176.53 134.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.859 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.22 66.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.862 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 8.26 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.2 110.86 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.63 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -57.75 150.63 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 73.14 111.125 179.991 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 148' ' ' ARG . 3.9 mt -140.29 95.64 8.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 54.4 111.14 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.77 87.6 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 53.42 112.332 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 71.41 112.516 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -59.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 72.34 110.908 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -157.22 -150.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 72.44 110.888 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.6 t -121.01 -53.68 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.32 110.896 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.08 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 71.03 110.943 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.26 -152.58 21.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.728 -0.748 . . . . 64.05 112.5 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.65 43.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 54.13 112.471 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.24 121.63 14.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.85 0.357 . . . . 55.15 110.866 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 178.65 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.883 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.7 p -126.54 100.17 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 72.13 111.159 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.89 169.46 8.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 74.11 110.896 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -51.03 -32.87 22.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 52.23 110.863 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -179.36 103.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.845 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' C ' HG23 ' A' ' 73' ' ' THR . . . -165.97 26.84 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 61.04 112.494 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.3 p 62.99 26.43 15.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 73.44 111.143 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.81 -116.22 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 71.53 112.512 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.43 -26.42 1.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 65.13 112.48 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.01 -157.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 71.22 110.893 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 167.01 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 61.2 110.826 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -51.41 -42.96 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.42 111.126 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.75 46.02 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 70.53 110.966 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.55 -95.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.749 . . . . 33.43 112.495 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -54.64 178.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 53.25 110.904 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' CD ' ' H ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -95.92 -172.07 2.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.9 179.962 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.11 164.46 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 71.11 110.866 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.27 179.33 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.13 110.859 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.89 129.73 34.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.43 110.84 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -88.24 -46.57 9.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.877 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.68 156.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 61.11 110.913 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.84 63.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.884 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.585 ' O ' HD23 ' A' ' 90' ' ' LEU . 24.0 mm -80.82 2.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.43 111.164 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 89' ' ' ILE . 59.8 mt -133.68 136.74 44.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.12 110.907 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -162.91 1.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.897 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -102.19 97.07 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 65.21 110.867 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -79.19 -21.43 46.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.44 111.154 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.02 -125.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 61.24 112.483 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.14 47.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.616 2.211 . . . . 35.44 112.345 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 67.05 121.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 64.25 112.47 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -176.4 130.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 71.04 111.135 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CB ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -106.61 122.84 47.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 63.51 110.888 179.888 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HE3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -133.51 -155.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 75.54 110.908 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.444 ' HE3' ' O ' ' A' ' 99' ' ' SER . 1.1 mmt -134.23 116.34 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.905 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . -56.46 -46.38 80.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 44.52 111.083 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 107' ' ' THR . 21.5 p30 39.14 -157.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 62.23 110.912 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.577 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -141.44 10.99 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.24 111.11 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.9 -65.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 64.32 112.512 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.577 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.78 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 53.55 112.314 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' A' ' 105' ' ' PRO . 79.6 m-20 -82.34 81.05 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 64.23 110.888 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 102' ' ' ASN . 5.3 t -153.22 56.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 51.43 111.111 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -46.89 -44.51 19.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 32.04 110.898 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 48.18 -164.74 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 33.25 112.452 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.96 87.82 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 72.04 110.866 -179.733 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 25.2 tt0 -161.15 51.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.924 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CB ' HD23 ' A' ' 98' ' ' LEU . 2.8 p90 -59.83 -172.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 70.1 110.898 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.62 106.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.927 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.464 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 76.8 mt -48.17 123.36 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.122 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 89.7 m -84.29 116.5 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.868 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -88.18 -30.69 19.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.11 111.155 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.13 161.02 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 71.21 111.085 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -62.22 102.3 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 50.03 110.921 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.823 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 18.6 p -113.89 46.0 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 71.13 111.175 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -16.79 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 72.53 110.827 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.823 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -64.12 -15.51 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.939 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.99 78.29 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.02 110.942 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.92 -47.79 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 54.33 110.871 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.87 45.17 3.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 45.41 112.499 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -145.25 -53.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 70.35 110.906 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -101.68 134.76 44.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.802 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.47 104.83 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 71.22 111.119 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 90.8 t -78.41 132.5 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.12 111.131 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.536 ' HA ' HG21 ' A' ' 29' ' ' VAL . 19.5 p90 -152.94 26.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.884 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -161.4 -170.53 26.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.466 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp 178.73 -169.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 64.32 110.926 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -116.35 81.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 73.22 111.139 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -49.2 -34.56 15.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.919 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -171.02 168.28 6.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.873 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.83 -1.6 58.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.714 -0.755 . . . . 71.02 112.466 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -33.54 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.22 110.934 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -50.58 -27.03 6.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 71.02 110.905 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 17.6 mm -81.58 -45.61 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.25 111.145 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.06 -51.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.121 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.01 -27.74 14.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 70.24 110.891 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -71.83 -47.57 52.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 75.5 111.109 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 156' ' ' ILE . 62.1 mtm -62.96 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 64.34 110.863 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 6.3 mm-40 -51.42 -71.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 75.22 110.898 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -60.0 -16.68 32.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.883 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 142' ' ' MET . 11.8 m-85 -92.51 2.16 56.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 72.01 110.854 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 56' ' ' ILE . . . -127.62 46.77 1.06 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 75.24 112.504 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 146' ' ' GLY . 8.1 t 34.89 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 61.12 110.886 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.9 mmm-85 -133.62 -35.44 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.14 110.903 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -99.45 -8.3 24.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.926 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.57 80.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 61.43 112.483 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -60.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 75.05 110.874 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 66.43 133.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 50.01 111.126 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -9.02 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.03 110.877 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.48 156.65 47.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 73.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.76 118.64 32.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 64.3 110.891 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.454 HD13 ' SD ' ' A' ' 142' ' ' MET . 12.7 mt -88.59 134.47 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 73.24 111.15 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.16 170.45 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 71.43 111.145 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 67.1 mt -118.7 111.36 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.156 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -60.59 -54.96 39.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 63.11 111.131 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -167.6 168.84 12.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.908 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.3 p -156.49 163.76 39.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 65.1 110.867 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.72 -178.85 47.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 74.32 112.456 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 9.5 mt-30 -69.32 -37.23 77.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 61.55 110.94 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.546 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.14 -62.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 65.22 110.885 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.1 110.877 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 64.33 110.852 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.9 155.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 51.15 111.104 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.37 149.25 37.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 75.34 110.9 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.81 19.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.681 2.254 . . . . 54.1 112.366 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.632 HG21 HD22 ' A' ' 164' ' ' LEU . 57.4 m -119.6 124.91 47.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.132 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.2 m -104.95 144.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 75.25 111.108 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -105.05 154.94 19.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.866 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.33 131.52 26.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.89 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.52 95.07 5.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.885 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.753 HD12 ' CG2' ' A' ' 138' ' ' ILE . 17.3 mt -78.92 141.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 62.42 111.144 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -122.83 159.94 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.1 111.122 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.31 106.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 75.24 111.095 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 51.45 55.44 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 62.2 110.879 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.51 9.84 33.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 22.41 112.512 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -136.0 93.84 14.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.685 0.755 . . . . 72.34 110.87 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 156.02 64.22 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.694 2.262 . . . . 64.12 112.313 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.18 26.99 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 71.52 110.942 179.972 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.9 169.28 12.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.488 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.58 171.52 12.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 72.04 110.845 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 138' ' ' ILE . 17.6 m -143.3 -176.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.44 111.158 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.7 p -148.11 154.77 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.824 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.36 134.1 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.1 tt0 -73.98 -55.03 6.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 70.1 110.888 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mt 76.8 124.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.961 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD2' HD13 ' A' ' 90' ' ' LEU . 81.6 m-85 -81.76 55.28 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 71.14 110.877 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -36.52 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.113 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.44 -51.61 66.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.878 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -60.49 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.891 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.55 82.51 6.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 74.2 111.135 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 60.94 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 41.23 112.355 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 -71.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 62.23 110.874 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.444 HG23 ' HE1' ' A' ' 100' ' ' MET . 27.3 m -58.34 -53.71 55.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 53.34 111.149 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -86.83 9.52 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.106 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -88.95 -24.54 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 61.51 110.872 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.57 -29.76 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.859 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' A' ' 39' ' ' LEU . 7.7 t80 -50.59 -28.4 8.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.868 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 41' ' ' THR . 15.0 ptp180 -56.66 -30.71 63.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 71.25 110.861 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.79 -31.79 19.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.42 111.081 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 78' ' ' ILE . 67.1 mt -65.19 -47.85 75.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 65.4 110.962 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -65.22 -37.41 87.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.857 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' ARG . 65.4 p -73.88 -19.66 60.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 73.13 111.184 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.6 91.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.741 . . . . 64.52 112.457 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.66 36.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.901 0.381 . . . . 64.51 110.886 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.99 6.63 2.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.32 110.886 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 9.7 84.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.22 112.526 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -174.16 -169.17 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 72.41 110.886 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.53 -80.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 65.33 112.507 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -176.8 110.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 74.33 110.889 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -179.03 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.938 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -45.2 104.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 34.12 112.507 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -159.74 54.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 62.22 110.865 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' H ' HG22 ' A' ' 157' ' ' THR . 18.8 m 52.3 -173.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 62.2 110.908 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -168.84 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.839 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -115.56 -77.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 72.14 110.857 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -135.44 143.38 45.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 54.35 110.875 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.6 mt -143.78 125.86 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.32 111.134 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.698 HD11 ' CE ' ' A' ' 61' ' ' MET . 1.1 pt -134.28 114.11 12.46 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 70.22 111.15 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 108.99 2.21 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.682 2.255 . . . . 73.15 112.334 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.2 -31.28 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 54.23 112.516 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.599 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -99.96 -63.2 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 75.11 110.854 -179.852 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.698 ' CE ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 179.81 -165.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.853 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.3 m -142.19 115.04 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.1 110.925 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -99.36 151.06 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 54.3 110.908 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.48 159.9 18.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 72.35 112.433 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.66 1.76 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.723 -0.751 . . . . 62.35 112.486 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 150.72 40.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 73.44 110.854 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 60.79 164.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 64.54 110.862 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 p -146.64 34.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 53.4 111.12 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 65.63 34.08 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.873 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -51.81 -38.98 57.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.897 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.52 40.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 73.12 110.915 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.49 168.06 39.93 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 75.34 112.483 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -115.02 92.02 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 54.42 111.168 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.23 179.91 17.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.529 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.12 159.24 15.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 65.11 112.474 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' SER . 16.6 ptpt -176.86 -173.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 72.02 110.921 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 61.2 p -87.75 -167.94 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.811 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 39' ' ' LEU . 2.6 pp -111.85 11.19 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.4 111.121 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -7.71 25.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.919 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.05 -84.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 75.11 112.451 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.4 -68.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 71.35 110.864 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -167.78 163.58 14.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 52.21 110.883 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.453 ' O ' ' ND2' ' A' ' 108' ' ' ASN . 0.0 OUTLIER -130.6 144.15 51.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.856 -179.972 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.13 159.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.878 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -64.6 -167.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.863 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -148.36 -67.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.41 110.893 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 127' ' ' VAL . 6.4 p30 -176.93 171.88 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 64.33 110.935 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.97 43.35 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.868 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.7 mt -51.01 -27.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 50.34 111.132 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 128' ' ' VAL . 3.8 mt -96.6 137.39 35.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 70.24 110.899 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.93 114.09 17.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.917 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -55.97 102.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.837 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.2 p -113.76 42.45 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.3 111.153 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.89 156.67 14.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 43.11 112.517 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 128.08 15.49 Favored 'Trans proline' 0 N--CA 1.466 -0.103 0 C-N-CA 122.69 2.26 . . . . 73.21 112.33 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.9 -22.1 8.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 63.41 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.9 mm -65.82 152.05 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 52.31 111.117 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.78 HD12 ' HA3' ' A' ' 130' ' ' GLY . 32.0 mt -96.12 132.18 41.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.4 110.941 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.0 m -119.67 138.66 53.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.816 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.522 ' CG ' HG12 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -77.57 172.48 13.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 62.01 110.86 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.592 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . . . -166.13 -175.07 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 52.44 111.094 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 12.0 t30 88.6 95.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.887 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . 66.18 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.08 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 121.49 -59.96 0.56 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.708 -0.758 . . . . 71.43 112.462 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.599 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 100.15 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 64.11 112.301 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.8 56.33 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.84 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -132.0 7.14 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.2 111.116 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 1.3 m-80 41.29 -92.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.913 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 97.43 139.16 10.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 55.14 112.472 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 p -100.61 -8.89 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 65.22 110.896 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 129.82 35.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.934 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.05 138.69 48.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 62.41 110.903 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.592 ' HE1' ' HB2' ' A' ' 101' ' ' ALA . 14.2 p90 -120.2 121.64 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.2 110.883 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mt -92.35 119.26 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.107 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -76.27 150.97 36.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.84 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -126.55 23.75 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.42 111.124 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.72 20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 65.13 111.111 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 64.97 135.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.891 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.518 HG22 ' CZ3' ' A' ' 121' ' ' TRP . 21.8 p -148.95 68.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 71.15 111.129 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -84.37 14.3 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.868 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.518 ' CZ3' HG22 ' A' ' 119' ' ' THR . 3.2 p90 -91.39 0.33 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 75.44 110.955 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.56 31.88 1.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 54.52 110.871 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -96.26 78.81 3.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.02 110.847 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.79 -41.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 34.41 112.485 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -35.75 73.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 64.21 110.898 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -117.37 159.3 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 62.11 110.831 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.797 HG13 ' N ' ' A' ' 128' ' ' VAL . 1.1 p -81.05 -159.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 54.23 111.087 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.797 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -165.36 144.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 54.25 111.128 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 27.7 p90 -175.99 115.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.905 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.78 ' HA3' HD12 ' A' ' 98' ' ' LEU . . . 114.87 114.5 3.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 71.25 112.488 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.39 143.14 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 52.41 110.861 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 139' ' ' VAL . 69.5 t -52.53 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.126 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -56.78 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 55.04 110.899 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.09 170.8 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.872 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 63.37 82.45 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 42.41 112.463 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 8.7 tpt -89.17 11.09 19.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 73.45 110.832 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.69 -34.3 16.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 71.2 110.905 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.753 ' CG2' HD12 ' A' ' 10' ' ' ILE . 39.4 mm -60.18 -38.38 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.116 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.5 t -90.63 -3.01 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 63.42 111.122 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -110.66 -71.83 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.44 110.9 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.75 -52.07 34.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 72.54 111.119 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.7 tmm? -51.43 -29.16 15.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.862 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.54 29.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 71.24 110.854 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -113.51 -14.39 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.884 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -105.77 -2.46 23.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -157.46 1.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 62.12 112.483 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 57' ' ' ILE . 4.8 t -163.79 141.77 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 60.14 110.868 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -57.46 -20.15 28.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.855 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.09 -17.87 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 63.45 110.902 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.93 -42.0 1.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.708 -0.758 . . . . 70.01 112.506 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -46.41 131.6 10.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 73.22 110.882 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.7 p -96.52 112.66 24.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.21 111.144 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -49.8 -28.1 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 33.22 110.841 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -125.11 -162.26 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 62.34 110.939 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.3 tppm? -128.37 129.25 45.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 63.01 110.909 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 10' ' ' ILE . 3.3 mp -112.36 92.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.42 111.133 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 25.0 p -103.17 148.66 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 55.03 111.142 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.425 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.8 mt -88.82 130.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.134 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.89 -64.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.08 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -127.02 170.63 12.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.35 110.816 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.48 -174.89 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.862 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.36 -148.59 19.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.1 OUTLIER -106.74 133.91 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 73.24 110.9 -179.866 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.632 HD22 HG21 ' A' ' 5' ' ' THR . 3.2 tp -56.78 -57.09 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.2 110.866 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.12 110.912 179.95 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.809 0.337 . . . . 73.42 110.887 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.35 138.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 50.21 111.121 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -57.41 157.28 13.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.65 0.738 . . . . 73.41 110.882 -179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 122.0 8.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 74.35 112.318 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 14.4 m -100.85 55.99 0.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 71.22 111.128 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -52.26 154.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.077 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -136.56 170.8 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.861 -179.988 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -142.0 143.88 33.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.902 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.45 115.95 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.35 110.86 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -85.73 123.07 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 43.15 111.129 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.19 13.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.31 111.097 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.7 m -144.21 101.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.05 111.109 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 3.7 t0 76.71 45.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.901 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 24.02 70.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 72.32 112.452 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -135.27 148.7 67.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 73.52 110.92 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 140.13 41.91 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.68 2.253 . . . . 43.12 112.358 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.4 tp -127.39 -38.12 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.913 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.24 -178.51 45.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 43.45 112.482 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 162.25 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.51 110.847 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.54 147.6 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 73.25 111.119 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.23 97.82 11.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.911 -179.867 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -85.0 59.61 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.12 110.846 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.79 115.45 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.865 -179.9 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.542 HD21 ' CD2' ' A' ' 36' ' ' PHE . 5.9 mt -81.83 133.2 35.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.927 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 90' ' ' LEU . 71.2 m-85 -75.8 67.31 2.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.855 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.18 -14.82 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 73.44 111.095 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.09 -60.26 2.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.854 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -67.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 51.53 110.924 -179.995 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 3.2 m -105.95 114.46 62.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 64.14 111.107 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' LYS . 53.7 Cg_endo -69.77 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 63.53 112.319 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' PRO . 7.9 mtmm -38.33 -54.68 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.849 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 55.8 m -39.51 -58.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 73.4 111.145 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.98 30.85 4.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 70.03 111.074 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -97.24 -30.64 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.846 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.03 -35.53 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.13 110.9 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CD2' HD21 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.22 -31.62 6.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.932 179.981 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -35.82 70.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.872 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.29 -21.75 27.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 53.52 111.133 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 36' ' ' PHE . 73.7 mt -70.23 -51.36 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 63.43 110.892 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -68.18 -44.69 75.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 74.12 110.885 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -74.96 -24.07 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 41.45 111.157 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.34 94.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.486 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.76 47.53 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.948 0.404 . . . . 61.05 110.933 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 33.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 75.2 110.868 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.63 -3.4 49.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 74.53 112.495 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -163.0 -168.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 73.13 110.862 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.69 137.39 4.81 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.679 -0.772 . . . . 73.1 112.468 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -85.21 144.27 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.951 0.405 . . . . 74.25 110.94 -179.833 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -57.66 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.869 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -114.26 -76.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 71.51 112.513 179.916 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t 68.82 123.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 43.22 110.841 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.51 -171.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 72.24 110.849 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 152' ' ' THR . 27.1 p90 -104.81 -170.82 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 62.23 110.922 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -60.09 1.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.11 110.828 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -151.66 160.14 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.842 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.1 mt -136.82 130.52 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 73.13 111.151 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -130.22 110.23 16.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.601 0.715 . . . . 75.22 111.149 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.7 Cg_endo -69.83 101.72 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.609 2.206 . . . . 73.32 112.337 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.62 22.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.697 -0.764 . . . . 53.41 112.511 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HG21 ' A' ' 119' ' ' THR . 0.1 OUTLIER -138.5 -63.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 74.23 110.912 -179.878 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -168.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 60.53 110.846 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.796 ' HB2' HG23 ' A' ' 114' ' ' ILE . 9.0 m -150.04 131.5 14.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.92 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -111.92 139.57 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.899 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.61 -159.31 27.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.762 -0.732 . . . . 53.02 112.519 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.51 20.03 76.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 72.42 112.516 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.74 102.39 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 71.04 110.864 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -100.83 40.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.861 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.07 150.34 48.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.3 111.189 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 70' ' ' HIS . 0.0 OUTLIER 70.86 2.32 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 65.32 110.919 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 69' ' ' ARG . 73.0 t60 -37.13 -67.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.89 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -172.62 70.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.51 110.873 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.76 35.54 92.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 72.35 112.506 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.7 p -128.29 -58.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 73.23 111.149 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.96 -176.82 45.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.777 -0.725 . . . . 72.21 112.469 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.36 110.7 3.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 43.41 112.492 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.19 -167.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.771 0.32 . . . . 64.52 110.926 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.61 -179.44 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 71.23 110.843 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.5 pt -81.26 -39.17 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 64.31 111.134 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -96.68 93.93 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 63.21 110.941 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.36 -119.51 5.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 24.42 112.453 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -84.5 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 63.24 110.903 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 152.66 44.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.926 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.71 148.81 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.924 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -49.17 157.77 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 73.51 110.892 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.08 144.17 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 61.32 110.892 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -61.24 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.0 110.858 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.64 167.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.02 110.902 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.46 60.6 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.01 110.875 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 89' ' ' ILE . 30.6 mm -73.37 -6.86 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 72.12 111.165 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -117.99 81.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 70.3 110.922 179.911 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -66.93 161.54 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.882 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -71.41 75.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.834 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -70.93 -12.28 61.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.41 111.153 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.14 -170.09 43.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 70.45 112.483 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 128.04 15.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.694 2.263 . . . . 74.44 112.339 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.88 -31.4 3.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 73.43 112.511 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.0 mm -61.27 139.54 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.366 . . . . 70.32 111.129 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 112' ' ' PHE . 50.6 mt -108.28 159.64 16.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.938 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 m -158.96 33.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.858 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.493 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.6 OUTLIER 47.17 -167.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.15 110.877 179.928 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.544 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -172.46 75.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 60.42 111.165 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -116.23 -73.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.88 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.64 -36.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.2 111.122 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.06 -69.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 61.11 112.512 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.6 Cg_endo -69.74 108.53 2.1 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 73.22 112.33 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 45.52 38.39 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 73.11 110.879 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p -138.04 56.79 1.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 63.03 111.152 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -39.34 -57.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 73.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.8 -170.84 50.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.13 112.46 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.493 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 34.2 t -144.68 25.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 61.14 110.826 -179.722 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.7 tt0 -79.65 -100.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 73.13 110.88 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 170.66 179.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 52.51 110.888 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.62 38.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 61.23 110.905 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 62' ' ' CYS . 8.0 tt -58.27 91.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 65.4 111.14 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.9 142.11 54.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.907 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.624 HG21 ' CD ' ' A' ' 143' ' ' GLU . 11.4 p -111.4 22.34 15.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 64.23 111.154 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 119' ' ' THR . . . -176.75 161.24 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 54.24 111.116 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 95.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.42 110.914 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 117' ' ' ALA . 34.5 p -125.12 59.46 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 34.44 111.119 -179.971 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.22 30.63 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.2 110.929 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.479 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.6 OUTLIER -92.47 7.27 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.4 110.902 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.11 -10.16 28.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 71.01 110.915 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.59 78.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 75.12 110.876 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 38.82 50.54 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 63.23 112.481 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -58.27 -33.01 68.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 72.14 110.886 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -143.85 177.68 8.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.877 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -61.91 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 73.15 111.12 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.666 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.6 p -174.47 138.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.149 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 3.7 p90 178.6 102.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 73.25 110.843 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.56 127.11 3.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 62.42 112.485 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.71 21.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 63.31 110.892 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.644 HG11 HG21 ' A' ' 139' ' ' VAL . 25.5 m -49.56 159.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 61.52 111.138 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -160.86 -39.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.35 110.904 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -63.54 1.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.881 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.19 105.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 50.41 112.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -6.78 33.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.776 0.322 . . . . 71.52 110.869 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -57.61 -20.39 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.87 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.8 mm -91.74 -45.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.41 111.105 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.644 HG21 HG11 ' A' ' 132' ' ' VAL . 95.9 t -54.71 -20.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.12 111.115 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -83.92 -32.88 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 63.1 110.925 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.59 -31.28 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.123 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -86.02 -9.48 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.88 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.624 ' CD ' HG21 ' A' ' 116' ' ' THR . 4.0 mm-40 -89.88 28.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.869 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -145.17 8.04 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.891 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.66 2.28 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.903 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -110.17 72.57 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.769 -0.729 . . . . 73.33 112.516 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.564 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.7 134.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 50.14 110.877 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 27.2 mmm-85 -47.96 -44.91 30.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.34 110.857 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -49.11 -27.45 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 51.33 110.867 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.46 -37.59 2.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.723 . . . . 75.23 112.507 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.66 140.39 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 71.14 110.916 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.626 HG22 ' HA2' ' A' ' 146' ' ' GLY . 68.1 p -118.13 147.92 42.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 60.44 111.134 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -21.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 54.03 110.815 -179.807 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -131.9 -168.35 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 55.13 110.853 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -132.14 132.15 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 60.3 110.922 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 127.38 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.04 111.128 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.86 168.75 18.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 42.23 111.136 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mt -129.26 113.62 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 65.15 111.139 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.53 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 54.44 111.073 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.92 -178.44 6.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.846 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.62 178.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.52 110.925 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.4 -163.63 33.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 62.4 112.476 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.56 123.3 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 72.32 110.946 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -98.93 -74.84 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 63.22 110.892 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.919 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.805 0.336 . . . . 73.42 110.858 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.78 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.03 111.124 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.9 150.85 48.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 71.25 110.875 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.79 153.19 69.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 74.12 112.34 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.49 162.7 32.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.161 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 0.1 OUTLIER -150.05 132.91 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 53.42 111.156 179.886 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -110.98 161.9 15.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.884 179.98 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.1 m-85 -143.52 133.06 23.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 73.44 110.85 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -98.25 82.29 2.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.35 110.88 179.936 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.7 142.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.54 111.098 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -139.31 159.94 40.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.124 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 156' ' ' ILE . 96.9 t -137.64 99.63 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 44.44 111.124 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.29 33.61 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.54 110.862 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.45 -15.0 64.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.732 . . . . 62.52 112.467 -179.955 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.52 109.66 51.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.597 0.713 . . . . 64.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 145.04 55.83 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.671 2.247 . . . . 64.32 112.358 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.88 -66.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 61.2 110.857 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.82 -172.03 30.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 63.02 112.491 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 121.76 42.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 75.25 110.849 -179.816 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.892 HG22 HG21 ' A' ' 138' ' ' ILE . 1.3 t -109.45 105.86 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 54.15 111.112 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 79.1 p -98.84 142.06 30.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 72.45 110.826 -179.829 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.61 162.87 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.874 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 56.9 tt0 -106.61 139.97 40.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 54.35 110.896 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 41.3 mt -111.05 107.37 16.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 55.42 110.935 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -85.22 71.61 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 62.52 110.878 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.3 -24.55 64.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 64.22 111.082 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.57 -34.44 76.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 64.2 110.912 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -103.31 -32.16 9.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.917 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -128.4 67.19 75.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 65.15 111.161 179.888 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -3.37 11.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.667 2.245 . . . . 73.2 112.371 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -42.87 8.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.6 p -85.59 -41.09 15.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.164 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.97 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 60.14 111.082 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.7 tt0 -53.15 -64.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 64.11 110.893 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 34' ' ' GLU . 7.2 t30 -31.66 -46.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.41 110.905 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -78.75 -43.29 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.893 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -55.38 -33.23 63.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.884 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.68 77.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 62.42 111.153 179.896 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -85.98 39.24 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.927 179.997 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p -112.98 -15.15 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 75.33 110.808 -179.872 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.2 p -123.17 10.52 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.12 111.135 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.46 61.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 72.42 112.467 179.983 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -81.07 -26.49 36.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.93 0.395 . . . . 55.35 110.89 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -67.56 -10.14 49.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.55 110.925 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.29 -18.51 36.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 72.12 112.472 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -85.74 -31.03 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 75.25 110.854 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.32 -176.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 45.22 112.496 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.733 ' HB2' HD11 ' A' ' 39' ' ' LEU . 2.4 t80 -175.48 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.946 0.403 . . . . 75.24 110.932 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 48' ' ' TYR . 6.1 ptmt -27.08 111.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 50.25 110.863 179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.94 -60.99 0.57 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 71.33 112.445 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 42.62 -159.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 62.32 110.84 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 35.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.898 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -59.37 132.55 54.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.878 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -129.51 63.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.831 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.0 tpm_? -119.05 -92.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.43 110.873 -179.935 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' ARG . 6.3 mm 55.82 115.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.12 111.148 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 61' ' ' MET . 8.1 tt -143.28 102.0 5.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 74.25 111.153 179.872 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.6 Cg_endo -69.81 98.64 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 74.14 112.305 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.99 -56.11 0.29 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.704 -0.76 . . . . 63.42 112.448 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -105.46 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 54.31 110.899 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -144.3 -159.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 53.01 110.9 179.939 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.11 -56.44 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 72.52 110.92 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 65.6 151.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.861 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 149.74 15.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.754 . . . . 70.53 112.476 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.29 39.6 59.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 74.24 112.496 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.86 37.74 1.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 70.45 110.874 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.2 t80 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.908 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -113.3 37.19 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.12 111.118 -179.888 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -97.49 -82.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 61.35 110.932 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.7 -37.94 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 64.04 110.899 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.92 -64.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.14 110.896 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.8 81.06 0.33 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 45.5 112.437 179.979 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.4 p 50.69 58.42 5.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 73.14 111.123 -179.909 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.76 -150.05 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 42.04 112.461 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.71 -166.03 35.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.477 -179.927 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -172.87 171.08 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 54.33 110.935 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -97.94 161.95 13.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 62.54 110.885 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -8.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 72.41 111.08 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.46 20.6 5.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 63.21 110.905 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.26 -132.11 2.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.41 112.477 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -114.06 -33.2 5.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 73.23 110.893 -179.911 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.34 177.53 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 55.04 110.887 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.31 165.6 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 61.14 110.832 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -85.64 -176.14 5.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.879 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -91.61 122.97 34.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 73.01 110.853 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -40.81 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.843 -179.882 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.6 p30 177.94 161.38 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.844 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -113.33 34.3 4.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.876 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 mt -62.53 -22.42 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 71.34 111.141 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.662 HD12 ' CG1' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -94.12 110.72 22.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.917 179.883 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.502 ' O ' HD11 ' A' ' 97' ' ' ILE . 2.2 mtpp -109.31 -174.65 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.945 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -98.4 -77.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 73.5 110.898 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.1 16.89 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.124 -179.947 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.28 -168.72 36.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.34 112.499 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.667 2.244 . . . . 60.34 112.346 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 66.08 117.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 60.33 112.486 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.662 HD12 HG11 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -168.19 122.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 74.22 111.082 -179.96 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 tt -97.91 116.0 29.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.897 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.38 176.7 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 65.05 110.85 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 5.3 mmt -115.36 104.93 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 64.51 110.844 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -69.3 152.29 45.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.105 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.677 ' HB2' HG23 ' A' ' 107' ' ' THR . 42.2 p-10 -179.8 -168.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 73.51 110.915 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -84.38 -20.76 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 44.14 111.1 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 123.49 -62.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.496 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.68 96.42 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 75.21 112.37 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 25.37 78.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.22 110.875 -179.979 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -155.27 30.13 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 71.02 111.183 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 3.3 p30 -97.19 178.97 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.925 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.53 42.22 2.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 70.44 112.517 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -138.97 -90.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 51.52 110.863 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.785 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -93.71 171.39 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.11 110.91 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -138.93 147.39 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.44 110.891 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -117.65 141.07 48.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.884 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.3 136.64 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.112 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.35 123.99 34.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.4 110.861 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 p -99.24 -25.81 14.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 111.133 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.22 23.12 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 62.33 111.09 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.36 136.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 72.05 110.896 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.623 ' HB ' HD22 ' A' ' 122' ' ' LEU . 1.7 p -131.01 51.65 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 65.31 111.172 179.963 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.04 -19.0 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 63.45 110.925 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -57.79 -19.71 30.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 70.23 110.925 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.623 HD22 ' HB ' ' A' ' 119' ' ' THR . 0.0 OUTLIER -76.27 -63.0 1.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.924 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.78 -59.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.837 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.99 49.89 0.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 72.34 112.515 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -105.44 -24.36 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.14 110.932 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -139.32 139.57 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.4 110.87 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.3 t -77.71 104.37 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 64.2 111.159 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.662 ' CG1' HD12 ' A' ' 90' ' ' LEU . 78.4 t -90.36 135.28 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.147 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.465 ' CB ' HG21 ' A' ' 29' ' ' VAL . 33.6 p90 -150.65 16.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.874 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . -150.3 -169.76 16.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.729 . . . . 51.23 112.485 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -179.81 -165.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 65.12 110.85 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 136' ' ' MET . 75.0 t -100.99 98.92 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.135 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -55.59 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.71 160.73 38.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.14 110.879 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.33 33.93 42.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 72.44 112.479 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' MET . . . . . 0.498 ' HA ' HG11 ' A' ' 132' ' ' VAL . 10.1 mmm -50.08 -28.79 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.34 . . . . 63.42 110.88 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.33 110.916 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.892 HG21 HG22 ' A' ' 20' ' ' VAL . 45.6 mm -42.24 -37.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 74.24 111.163 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.45 -51.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 53.34 111.131 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -48.64 -49.87 35.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.828 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.6 -52.63 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 73.53 111.088 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.663 ' SD ' HD13 ' A' ' 156' ' ' ILE . 6.8 ttm -50.71 -46.3 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 71.14 110.848 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 58' ' ' PRO . 3.0 pt-20 -52.03 -23.06 4.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 73.34 110.85 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -63.39 -22.98 67.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.912 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -85.6 14.71 5.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.887 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.76 -155.4 31.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.718 . . . . 63.44 112.435 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.78 -168.5 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.904 0.383 . . . . 70.52 110.855 -179.76 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -80.13 -43.97 20.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 71.1 110.862 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -101.21 -7.84 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 71.52 110.874 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.11 -152.02 17.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.477 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 60.43 101.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 75.21 110.905 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 p -80.63 159.47 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.12 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.61 -19.91 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 74.24 110.866 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -138.29 -179.44 5.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 73.43 110.864 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.83 106.07 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 71.32 110.947 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' A' ' 142' ' ' MET . 61.8 mt -92.35 102.78 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 70.54 111.13 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.7 p -117.07 167.65 10.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 73.3 111.099 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.3 mt -90.95 134.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 75.01 111.107 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.34 -62.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 65.31 111.094 179.789 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -140.17 165.07 28.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.433 . . . . 61.31 110.827 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 33.4 m -142.67 166.27 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.884 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.82 179.8 46.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 51.23 112.452 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.2 mt-30 -93.61 -57.65 2.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 75.31 110.924 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.99 150.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.945 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.888 179.916 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 72.23 110.874 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.39 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.109 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.83 153.46 47.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 73.34 110.882 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 24' ' ' LEU . 53.5 Cg_endo -69.75 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.64 2.227 . . . . 62.24 112.317 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.4 m -126.96 142.07 51.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.165 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 163' ' ' GLN . 5.0 m -124.37 157.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 62.15 111.082 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -114.0 154.84 26.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.906 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.25 138.62 35.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 63.02 110.898 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.62 113.12 26.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 52.43 110.887 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.43 121.73 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.149 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -108.71 163.01 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.088 179.823 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -153.07 105.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.115 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.79 31.71 9.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.842 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.65 -17.42 52.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.493 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.5 136.5 23.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.679 0.752 . . . . 61.24 110.844 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 155.03 66.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 50.55 112.296 -179.989 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.04 -60.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.967 179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.61 -170.94 35.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.732 -0.746 . . . . 20.23 112.494 179.889 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -124.64 127.51 47.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 74.22 110.874 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.618 ' CG1' HG13 ' A' ' 132' ' ' VAL . 8.0 t -129.87 129.85 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.159 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 p -109.19 154.49 22.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.878 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 135.06 52.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.41 110.848 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.36 131.95 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.51 110.868 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 4' ' ' PRO . 36.5 mt -96.18 118.51 32.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 52.04 110.937 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 90' ' ' LEU . 47.6 m-85 -80.12 55.33 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.88 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.35 -28.24 11.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 63.13 111.094 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.63 -47.47 70.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 70.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 89' ' ' ILE . 1.1 mttt -95.78 -32.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.867 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -124.22 74.64 59.59 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.667 0.746 . . . . 74.14 111.168 179.877 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -51.14 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.698 2.265 . . . . 71.41 112.32 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -43.22 84.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.894 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.496 HG21 ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -69.01 -60.89 2.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.119 -179.987 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -33.76 -67.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.22 111.141 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' ARG . 79.3 tt0 -58.67 -58.79 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.874 -179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.0 t30 -32.85 -53.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.912 -179.971 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -79.2 -29.07 42.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 63.34 110.913 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 4.7 ttp180 -52.31 -32.99 40.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.859 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.25 -25.14 61.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.082 179.944 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 27.31 3.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.916 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -152.5 -25.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.87 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.5 p -81.82 -43.99 17.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 65.43 111.081 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 155.05 -27.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.11 112.455 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 42' ' ' GLY . 1.1 mt-10 -30.71 -74.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 63.24 110.897 -179.851 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.64 144.38 31.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 60.41 110.9 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.79 22.1 7.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.722 -0.752 . . . . 75.13 112.513 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.52 -8.0 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 74.42 110.896 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.97 -101.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.489 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 63.43 110.876 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? 57.6 169.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 74.44 110.912 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.54 118.53 8.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 73.53 112.506 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.6 p -159.33 -82.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 74.41 110.812 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 155' ' ' LYS . 5.9 p -177.57 173.82 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 61.12 110.883 -179.921 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.36 -171.24 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.834 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.74 -55.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 65.34 110.855 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.92 144.01 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.844 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -152.36 120.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.34 111.158 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.46 109.07 19.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.72 . . . . 72.43 111.183 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 97.92 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.655 2.236 . . . . 73.31 112.39 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.45 -5.06 23.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.526 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -66.52 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 74.43 110.835 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.06 -168.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 73.24 110.837 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.7 m -142.74 128.93 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.862 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -123.67 157.15 34.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 64.44 110.924 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.65 -157.57 30.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.11 112.459 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.78 37.56 16.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 73.11 112.45 -179.908 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.14 82.33 2.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 50.25 110.865 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -99.91 44.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.891 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.65 -75.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.24 111.193 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 155.0 31.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 65.12 110.859 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -72.46 -5.45 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.817 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -166.56 33.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 41.33 110.927 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -118.4 -22.14 3.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.22 112.461 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p 50.83 76.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.818 0.342 . . . . 75.45 111.168 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.83 -83.46 1.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 65.0 112.527 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.99 143.28 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 45.44 112.467 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -176.49 179.49 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.792 0.329 . . . . 73.44 110.896 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.61 177.68 8.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 65.21 110.871 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.17 -34.06 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 73.31 111.102 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.29 -7.3 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.882 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.19 -169.72 42.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 45.31 112.455 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.42 -90.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 40.11 110.877 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.9 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -154.66 160.33 41.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.857 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.9 175.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 71.34 110.914 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.19 149.13 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.902 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -94.83 -46.68 6.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.887 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 177.93 157.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 62.42 110.875 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.22 37.25 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.876 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.71 HG21 ' HG2' ' A' ' 28' ' ' LYS . 23.4 mm -55.39 -22.67 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.43 111.139 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.503 HD11 ' CD2' ' A' ' 25' ' ' PHE . 4.4 mm? -85.57 116.62 23.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.903 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -107.0 104.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.926 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.712 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.33 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 179.882 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.8 p -113.78 26.88 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 72.32 111.177 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 163.64 35.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 51.1 112.492 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 140.7 43.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.712 2.275 . . . . 61.01 112.349 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.95 45.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 72.13 112.465 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 92' ' ' HIS . 13.0 mm -70.45 146.21 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 65.25 111.096 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.0 mt -121.27 166.0 14.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.903 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.51 -170.99 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.891 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.496 ' HE1' HG21 ' A' ' 32' ' ' THR . 1.9 tpp -92.55 114.15 26.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.863 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -101.49 140.0 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 70.41 111.085 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 1.2 m-20 168.09 -75.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.915 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.46 29.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.109 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.51 -172.52 14.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 54.32 112.523 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -49.69 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.675 2.25 . . . . 54.53 112.327 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -48.7 -20.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.03 110.879 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.671 ' O ' ' C ' ' A' ' 108' ' ' ASN . 29.8 p -124.05 44.36 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.097 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.671 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.9 OUTLIER 1.96 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 72.45 110.901 179.98 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 79.49 91.56 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 52.44 112.491 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.91 121.47 34.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 72.33 110.893 -179.754 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -64.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 64.52 110.929 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.82 167.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.86 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -176.11 66.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.34 110.881 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.496 HG22 HG22 ' A' ' 116' ' ' THR . 6.6 mt -78.3 108.5 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 65.43 111.089 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.7 m -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 73.43 110.86 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.496 HG22 HG22 ' A' ' 114' ' ' ILE . 1.8 p 60.62 10.57 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 74.53 111.176 -179.812 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.66 -170.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.116 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -79.78 125.32 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.911 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.553 HG23 ' CD2' ' A' ' 92' ' ' HIS . 9.7 t -142.45 45.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 65.42 111.134 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.75 -10.75 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 62.03 110.906 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -57.93 -26.74 62.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.54 110.904 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.68 49.82 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 70.45 110.906 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -71.57 -40.76 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.897 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.1 81.73 0.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 50.31 112.549 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -160.17 -57.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 62.43 110.873 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -112.08 142.06 44.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.834 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' HB ' ' HE3' ' A' ' 100' ' ' MET . 81.5 t -65.71 100.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 64.12 111.179 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.26 136.51 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 52.1 111.115 179.93 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -177.46 128.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.888 179.951 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 120.69 4.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 62.04 112.524 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 152.23 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 72.53 110.88 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.618 HG13 ' CG1' ' A' ' 20' ' ' VAL . 34.3 t -44.35 141.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 53.42 111.133 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -132.79 -41.79 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.891 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -66.23 -78.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.879 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.79 115.77 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 60.04 112.49 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.68 -9.23 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.14 110.885 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -50.3 -25.06 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 63.42 110.861 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.99 -45.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 71.31 111.084 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.4 t -54.86 -20.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.24 111.09 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.65 -28.08 24.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.02 110.86 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -33.63 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 61.5 111.117 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptm -73.79 -21.19 60.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 50.04 110.92 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.38 26.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 54.44 110.881 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 -20.7 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.898 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.83 15.37 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.12 110.877 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.08 -142.81 9.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 72.54 112.462 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 p -162.61 147.91 12.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 55.43 110.832 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -75.7 68.51 2.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 52.52 110.899 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 179.62 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.862 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.62 -60.47 0.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 53.13 112.483 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 107.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 74.41 110.931 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -79.97 139.44 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.176 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -27.82 67.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 52.11 110.875 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.13 -165.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.906 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 52' ' ' CYS . 2.8 tppm? -131.57 112.09 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.871 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.6 mp -92.43 128.8 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.146 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 7.9 p -133.3 175.08 9.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 53.34 111.165 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -118.63 106.36 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.24 111.144 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.15 -61.5 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.121 179.825 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -134.9 179.32 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.81 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.1 p -172.81 -179.31 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 54.33 110.866 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 146.8 -169.46 27.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 74.54 112.546 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.418 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.8 mt-30 -95.11 138.79 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 61.51 110.895 -179.838 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -50.27 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.943 179.969 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.865 179.947 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.341 . . . . 74.14 110.868 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.33 142.6 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.134 179.974 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.68 161.06 0.92 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.601 0.715 . . . . 54.31 110.861 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 146.53 60.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.234 . . . . 74.45 112.322 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -130.4 72.28 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 72.22 111.144 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.43 151.9 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.11 111.108 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.477 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -130.76 162.06 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.862 179.97 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -136.6 132.9 35.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.861 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 14.1 t70 -107.44 87.82 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.31 110.886 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.559 HG21 ' HE1' ' A' ' 142' ' ' MET . 17.7 mm -71.02 150.42 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.11 111.111 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.41 163.68 29.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 52.14 111.115 179.762 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.9 96.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 54.02 111.168 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t0 68.8 53.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.52 110.851 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.48 14.77 62.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 24.11 112.495 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -128.59 105.27 19.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 64.3 110.894 -179.821 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.74 138.82 38.79 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.734 2.289 . . . . 72.3 112.304 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.87 28.57 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.89 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.41 -158.71 14.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 72.23 112.489 179.863 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.1 179.99 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 73.54 110.919 -179.89 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 11.4 m -139.44 170.08 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 75.21 111.142 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -118.43 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.891 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.7 m-85 -79.8 63.98 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 65.14 110.865 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -49.27 133.92 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.895 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 129' ' ' PHE . 12.9 mt -104.16 132.31 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.957 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -75.77 82.51 2.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.24 110.864 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -8.84 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 54.52 111.127 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.21 -57.37 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 71.12 110.797 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -57.22 -65.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.914 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 129' ' ' PHE . 2.9 m -110.99 95.14 22.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 23.53 111.106 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 53.8 Cg_endo -69.84 -19.24 35.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.694 2.263 . . . . 75.12 112.304 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -61.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 41.41 110.928 179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -57.3 -26.12 60.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 62.22 111.128 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.34 2.38 44.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 63.54 111.06 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.2 tt0 -91.01 -22.62 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.876 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.5 ' ND2' HG23 ' A' ' 78' ' ' ILE . 12.3 t-20 -79.89 -68.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 60.45 110.898 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -46.74 -45.68 19.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 65.05 110.869 179.988 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 3.3 ppt_? -54.47 -32.32 57.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.888 -179.931 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.36 -35.15 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.134 179.88 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 78' ' ' ILE . 86.7 mt -66.57 -28.78 68.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 64.45 110.869 -179.914 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -38.1 82.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 53.54 110.855 -179.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.7 p -86.38 11.42 12.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.42 111.164 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 41.2 51.29 4.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 52.15 112.506 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.59 32.79 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 71.32 110.941 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 10.34 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.893 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.31 30.63 8.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 60.12 112.495 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.44 158.63 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 62.25 110.855 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.35 159.08 12.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.32 112.467 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.95 103.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.397 . . . . 73.34 110.971 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 -44.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 71.54 110.858 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.92 31.97 2.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 63.22 112.496 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 t -100.28 -169.69 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 71.41 110.904 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -80.85 -166.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 72.43 110.89 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -94.95 -167.09 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.851 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -74.92 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 72.41 110.886 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -173.39 91.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 62.01 110.853 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.738 HD12 ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -77.08 144.35 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.139 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 61' ' ' MET . 6.3 tt -149.91 100.29 3.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 71.22 111.062 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.71 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.714 2.276 . . . . 41.41 112.311 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.52 -46.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 71.05 112.444 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -69.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 74.31 110.919 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.526 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -155.07 -148.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 42.42 110.903 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.5 m -132.53 -49.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 55.05 110.895 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.9 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.37 148.87 20.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 50.31 112.483 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.64 174.83 18.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 61.11 112.467 -179.911 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -104.38 -48.12 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.372 . . . . 64.42 110.861 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.568 ' HB2' HG22 ' A' ' 73' ' ' THR . 9.4 m-85 -125.62 -84.97 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 70.31 110.911 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.794 HG21 ' HA ' ' A' ' 102' ' ' ASN . 0.2 OUTLIER 69.66 -70.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 74.41 111.167 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -38.17 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.843 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -50.89 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 71.35 110.819 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.78 38.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.02 110.849 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 73' ' ' THR . . . 76.81 -148.96 35.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 55.15 112.502 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER 72.73 4.36 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 72.43 111.155 -179.89 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.66 ' HA3' HG23 ' A' ' 68' ' ' THR . . . -78.46 -158.63 12.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.758 . . . . 74.23 112.466 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.2 96.47 1.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 61.34 112.524 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.33 -166.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 72.23 110.863 -179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.46 125.92 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.11 110.89 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.5 HG23 ' ND2' ' A' ' 35' ' ' ASN . 2.0 pp -45.3 -40.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 74.13 111.115 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -117.44 29.73 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -147.64 7.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 71.24 112.49 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.56 -33.61 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.961 0.41 . . . . 74.25 110.884 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.31 137.92 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.896 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.602 ' HE2' HD21 ' A' ' 108' ' ' ASN . 28.0 p90 -118.65 161.56 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.88 179.981 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.2 160.54 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.861 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.79 168.23 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.903 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.43 ' HG3' ' ND2' ' A' ' 87' ' ' ASN . 1.2 tp10 -132.64 -68.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.45 110.863 -179.914 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.43 ' ND2' ' HG3' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -172.18 163.26 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.929 -179.954 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.84 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 89' ' ' ILE . 15.9 mt -77.53 -7.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.14 111.162 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.423 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 2.2 mt -114.42 139.09 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.43 110.898 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -171.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 179.852 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -115.01 91.18 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.02 110.904 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -107.19 21.75 17.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.44 111.143 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.72 -163.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 63.02 112.509 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 62.14 112.356 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -49.65 151.42 4.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 52.14 112.46 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER 172.6 124.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 53.1 111.149 -179.955 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -96.87 105.25 17.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.887 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 100' ' ' MET . 1.3 t -121.19 22.89 10.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.875 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.56 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.9 mmt 53.06 123.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 71.32 110.906 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -107.4 68.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 73.53 111.085 179.926 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.794 ' HA ' HG21 ' A' ' 68' ' ' THR . 2.4 m120 -115.9 -82.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.906 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -133.72 -70.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 72.24 111.102 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.67 -125.26 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 23.13 112.522 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.53 6.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.739 2.292 . . . . 73.55 112.349 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.94 23.42 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 62.22 110.86 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.564 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.9 p -154.75 46.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.151 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.602 HD21 ' HE2' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -88.28 11.65 16.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.873 179.995 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 24.67 -122.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 72.12 112.498 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.75 31.19 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 62.04 110.887 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -167.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.45 110.897 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -165.87 127.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.881 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.753 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -111.46 34.53 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.32 110.857 -179.917 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.576 ' C ' ' O ' ' A' ' 113' ' ' PHE . 24.7 mt -21.6 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 52.14 111.124 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' MET . 14.1 m -82.57 162.46 21.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 55.42 110.837 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 -17.48 11.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.14 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 119' ' ' THR . . . -126.63 146.81 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 75.34 111.081 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.43 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 52.44 110.891 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 117' ' ' ALA . 61.4 p -114.27 69.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.094 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.42 17.02 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 75.33 110.889 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.712 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.7 p90 -98.83 1.02 45.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.05 110.9 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.06 28.21 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.906 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -105.4 95.71 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 70.31 110.888 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.35 -42.59 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 75.53 112.459 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -31.74 25.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 73.15 110.929 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -98.16 139.73 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 65.21 110.795 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -60.14 176.74 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 75.11 111.123 179.963 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.561 ' H ' HG22 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -168.82 146.19 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 75.14 111.133 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 4.4 p90 -179.19 38.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.879 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.89 175.28 35.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.729 -0.748 . . . . 74.33 112.506 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -179.17 -166.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 64.53 110.879 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -121.73 125.03 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.11 111.107 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -111.02 -37.51 5.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.867 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -132.1 142.18 49.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.33 110.875 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.32 37.06 5.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 74.31 112.447 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -29.21 27.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 65.33 110.856 -179.966 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.52 -39.53 18.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 65.32 110.869 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.2 mm -39.63 -41.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.41 111.115 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.3 t -88.18 -51.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 71.04 111.074 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -50.59 -59.92 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.883 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.76 -58.94 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 60.14 111.157 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.649 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 5.8 ttm -50.55 -39.0 48.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.941 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -53.65 -24.89 15.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 72.35 110.919 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -65.48 -12.26 50.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.83 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -84.22 4.44 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 62.02 110.854 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.02 -158.14 28.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 65.11 112.483 -179.969 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -148.77 -89.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 74.45 110.84 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -154.98 -52.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.03 110.864 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -105.52 13.89 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 60.55 110.877 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.85 -162.77 12.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 40.24 112.465 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 66.73 140.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 75.51 110.897 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.3 p -123.48 154.35 39.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 75.53 111.127 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.48 -3.86 57.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.874 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.68 165.24 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 53.34 110.888 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.77 114.82 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.33 110.874 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.591 HD13 ' SD ' ' A' ' 142' ' ' MET . 43.5 mt -103.36 106.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 61.34 111.099 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 156.24 24.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 55.2 111.129 179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 mm -84.12 148.26 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 74.42 111.131 179.893 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -97.86 -59.28 1.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 60.25 111.072 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -167.55 163.25 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 52.35 110.838 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.0 m -147.68 176.6 9.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.887 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.55 -168.24 41.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 63.55 112.49 -179.857 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.2 mt-30 -87.27 -38.95 15.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 61.44 110.91 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.8 mm? 75.31 -54.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 71.13 110.886 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.871 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mmm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.342 . . . . 72.11 110.92 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 165' ' ' GLU . 0.4 OUTLIER 61.34 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.143 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m-20 -96.85 156.57 36.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 61.34 110.856 -179.932 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 147.42 62.91 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.707 2.272 . . . . 54.33 112.314 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 22' ' ' PHE . 8.0 m -147.18 141.27 26.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 63.52 111.142 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.55 147.74 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 71.13 111.142 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -111.78 145.64 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.892 -179.95 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 m-85 -138.27 139.63 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.14 110.866 -179.928 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -108.44 119.62 40.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.21 110.851 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.8 mm -89.03 116.6 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 70.21 111.135 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.68 154.58 17.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.31 111.117 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.89 104.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 72.32 111.112 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.21 37.06 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 71.21 110.861 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.23 80.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 43.31 112.48 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 149.63 71.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 71.33 110.884 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 150.93 68.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.653 2.235 . . . . 72.43 112.34 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.11 -57.59 1.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 62.02 110.879 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 -147.19 5.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 44.44 112.44 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -149.77 124.82 10.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 75.1 110.841 -179.796 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 8' ' ' PHE . 35.6 m -113.37 141.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 70.43 111.094 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -121.69 146.25 47.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 73.24 110.893 -179.859 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' THR . 7.8 m-85 -130.66 136.16 48.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.32 110.894 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.17 111.14 23.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.87 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 129' ' ' PHE . 86.1 mt -82.7 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 43.12 110.899 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 26.1 m-85 -83.17 79.68 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.893 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.59 -1.36 24.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 34.45 111.115 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.52 -47.68 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.899 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.9 mttt -83.88 -27.89 28.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.898 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.53 73.84 35.02 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.578 0.704 . . . . 64.03 111.127 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -9.58 26.45 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.63 2.22 . . . . 62.5 112.362 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -53.66 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.867 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -58.18 -51.48 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.168 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.7 -26.32 67.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.3 111.096 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.9 -34.57 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.897 -179.922 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.01 -57.74 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.885 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -50.89 -38.84 52.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.872 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.12 70.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 73.12 110.925 -179.922 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.36 -33.68 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 71.21 111.118 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD11 ' HA2' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -87.43 23.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.42 110.923 -179.943 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -118.29 -8.45 10.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 55.14 110.871 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 162' ' ' GLY . 17.8 p -117.96 7.48 12.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 63.11 111.16 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.67 29.59 54.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 54.01 112.477 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -34.98 26.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.381 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.32 47.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 74.21 110.899 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.53 56.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 74.12 112.467 179.977 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -179.8 153.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.383 . . . . 64.23 110.849 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 166.2 -140.34 6.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 24.33 112.447 -179.963 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -101.88 -27.99 12.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.973 0.416 . . . . 70.42 110.93 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.38 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.909 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.27 40.38 45.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 52.42 112.481 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 t -122.56 -171.2 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 41.24 110.874 -179.746 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -167.38 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.859 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 156' ' ' ILE . 0.8 OUTLIER -109.41 170.49 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.892 -179.842 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -118.09 -69.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 61.22 110.853 179.955 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 172.35 13.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 65.43 110.876 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -154.58 147.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 52.02 111.114 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.716 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -132.75 120.83 16.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.662 0.744 . . . . 75.24 111.133 179.872 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 109.06 2.21 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.34 112.355 179.879 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 25.32 18.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 64.11 112.527 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.34 -63.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 74.5 110.871 -179.868 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.485 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -177.74 -166.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.897 179.925 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.86 -70.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.887 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 64.86 126.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.878 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.09 -173.82 20.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 73.11 112.495 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.16 69.09 1.39 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 73.41 112.462 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -122.94 71.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 73.14 110.88 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 t80 177.18 -69.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.874 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.662 HG21 ' HA2' ' A' ' 74' ' ' GLY . 54.8 m 61.47 -85.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 63.24 111.124 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' N ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -125.94 -179.2 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.11 110.859 -179.957 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -43.76 -76.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 65.54 110.836 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -121.72 -78.72 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.876 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' C ' HG23 ' A' ' 73' ' ' THR . . . -74.9 177.77 47.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 72.25 112.521 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.409 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.5 p 65.15 39.09 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 71.35 111.167 -179.852 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.662 ' HA2' HG21 ' A' ' 68' ' ' THR . . . -144.93 -92.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 74.03 112.467 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . -77.95 100.76 1.63 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.726 . . . . 54.34 112.515 -179.898 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.2 ptpt 176.38 -169.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 72.14 110.906 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.94 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 70.31 110.873 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -42.17 -46.84 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.145 179.964 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.468 ' N ' HG23 ' A' ' 78' ' ' ILE . 19.1 m-85 -122.38 49.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.915 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.62 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 65.41 112.453 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.05 -75.82 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 73.52 110.915 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.716 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -130.21 168.46 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 71.44 110.901 179.902 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -145.48 151.66 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.13 110.873 179.969 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -54.8 157.91 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.872 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.55 112.78 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.84 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.51 -46.89 85.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.884 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -177.06 168.66 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 61.41 110.877 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.31 42.6 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.41 110.889 179.994 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -53.39 -23.49 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.41 111.113 179.955 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 128' ' ' VAL . 10.4 mt -94.67 145.95 24.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.958 179.873 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -122.06 -174.93 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 54.5 110.892 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -116.17 79.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.816 179.924 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -119.99 24.9 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 72.05 111.17 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.51 150.34 20.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 63.53 112.465 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -3.5 12.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.735 2.29 . . . . 72.01 112.34 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.45 49.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 73.13 112.477 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.68 135.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 71.41 111.173 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 129' ' ' PHE . 5.4 tt -90.05 122.78 33.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 65.53 110.933 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.478 ' HG ' ' HE2' ' A' ' 113' ' ' PHE . 13.2 t -123.67 164.83 18.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.848 -179.862 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.4 mtp -104.78 124.31 49.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.898 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -91.1 122.55 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 42.42 111.078 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 107' ' ' THR . 8.2 t30 175.85 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 73.53 110.894 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -59.72 -164.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.091 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -108.34 -66.91 0.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.51 112.522 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.581 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.74 130.91 20.2 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.662 2.241 . . . . 65.41 112.356 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.5 p30 22.84 67.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 65.34 110.91 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.847 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 6.9 p -150.62 52.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 74.42 111.151 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.442 ' ND2' ' CD2' ' A' ' 83' ' ' PHE . 4.6 m-20 -50.48 -56.04 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.89 -179.968 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.4 -172.62 52.06 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 61.54 112.518 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.1 p -112.77 -21.86 10.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 74.15 110.864 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.4 mm-40 -60.3 145.22 48.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 72.4 110.873 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.36 162.72 34.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.831 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' A' ' 99' ' ' SER . 15.1 p90 -148.84 132.02 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.45 110.913 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.73 121.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.41 111.161 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.69 128.76 33.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 55.21 110.878 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 61' ' ' MET . 6.9 p -90.43 -14.37 33.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.219 -179.91 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.06 160.16 43.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.164 179.833 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -53.29 132.97 39.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 64.14 110.885 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.2 p -138.35 52.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.03 111.13 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -50.63 -22.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 54.22 110.891 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -58.73 -35.79 73.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 61.42 110.894 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.24 101.62 14.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.887 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -151.09 -79.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.837 179.831 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.74 -27.95 29.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 52.4 112.477 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -73.42 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 73.12 110.926 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -99.5 149.77 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 64.24 110.836 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.2 t -64.37 -151.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.13 111.126 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.4 p 175.94 141.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.51 111.138 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.665 ' O ' HD22 ' A' ' 98' ' ' LEU . 3.1 p90 -175.51 124.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.887 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 98' ' ' LEU . . . 108.12 153.47 17.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.504 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -171.77 151.92 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 71.21 110.911 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.5 112.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 55.32 111.176 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.62 -49.97 8.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.932 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -159.45 145.32 16.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.898 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.95 16.56 27.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 42.33 112.481 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -29.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.34 110.852 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -49.57 -29.96 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 52.14 110.953 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.51 -50.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.41 111.099 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.61 -45.92 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 53.53 111.123 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -51.37 -40.45 59.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.891 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.33 -34.19 77.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 40.14 111.101 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.52 -29.13 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.9 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.59 26.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.03 110.872 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.43 -23.79 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.855 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -100.77 6.35 43.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 60.55 110.856 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -154.94 29.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 71.34 112.494 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 t -167.51 150.85 6.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 63.53 110.806 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -77.9 65.78 3.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.42 110.853 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.9 p30 167.82 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 65.14 110.896 -179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.3 172.75 13.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 65.51 112.473 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.51 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.42 110.879 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -91.06 41.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 52.3 111.134 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 74.01 -50.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.84 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.26 -168.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 65.1 110.921 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HE2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -110.55 134.77 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 70.12 110.924 179.861 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 53' ' ' PHE . 17.8 mt -100.38 104.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 53.24 111.114 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.601 HG23 ' HE2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -97.49 178.56 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 73.45 111.133 179.971 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.6 mm -128.38 143.94 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 51.13 111.083 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.17 -65.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.116 179.771 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.47 164.17 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 71.4 110.88 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 59.1 m -144.9 -173.61 4.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 34.21 110.882 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 140.52 -158.31 26.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.04 112.482 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.99 136.33 47.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.861 0.362 . . . . 63.42 110.914 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 164' ' ' LEU . 3.7 tt -93.06 -44.34 8.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 61.32 110.889 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 2' ' ' VAL . 6.9 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 61.32 110.888 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.807 0.337 . . . . 43.3 110.865 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -98.34 133.92 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 63.35 111.125 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -53.99 158.59 3.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.677 0.751 . . . . 64.35 110.852 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 120.71 7.45 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.68 2.253 . . . . 33.31 112.313 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -107.86 68.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 71.14 111.171 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -47.86 155.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 61.41 111.159 179.885 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.66 160.21 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.889 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -144.94 135.05 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.849 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -97.42 78.44 2.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 72.02 110.877 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 17' ' ' LEU . 2.7 mm -56.72 146.21 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.55 111.162 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -134.65 170.48 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.076 179.861 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 156' ' ' ILE . 79.5 t -146.66 96.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 64.45 111.116 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t0 65.84 41.98 3.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.05 -16.19 52.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 73.11 112.523 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -97.42 110.02 52.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.65 0.738 . . . . 73.2 110.91 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.75 144.85 55.43 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 63.41 112.328 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.671 HD13 HG23 ' A' ' 138' ' ' ILE . 4.1 mt -81.29 -44.54 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 53.22 110.952 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.8 35.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 61.02 112.489 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 62.39 147.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 74.43 110.826 -179.893 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 138' ' ' ILE . 36.5 t -105.41 -103.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 63.51 111.079 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 164.64 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.858 -179.859 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.85 111.68 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 64.41 110.932 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -88.22 144.46 26.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 113.18 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.868 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -76.53 66.28 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.892 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.23 77.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.1 111.075 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.57 -65.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.894 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.612 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -51.91 -78.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 65.02 110.891 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 129' ' ' PHE . 17.4 m -72.13 117.72 60.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 53.42 111.1 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -87.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 74.51 112.33 179.942 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -36.79 84.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.849 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -4.46 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 64.12 111.112 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -76.9 -48.54 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' C ' ' A' ' 35' ' ' ASN . 22.2 pt-20 -78.2 -38.12 44.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.849 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -28.97 -67.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.898 -179.935 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HA ' HD12 ' A' ' 39' ' ' LEU . 71.9 t80 -74.91 -34.71 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.909 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 2.6 ttp180 -49.36 -38.68 29.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.843 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -71.55 -35.1 70.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 55.33 111.119 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 36' ' ' PHE . 14.0 mt -68.5 -45.35 72.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.03 110.911 179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.38 94.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.868 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -72.41 -15.52 61.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.168 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 54.17 82.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.463 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.54 31.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 74.44 110.947 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -138.87 22.62 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.11 110.93 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 -40.42 3.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 74.21 112.486 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -127.98 -164.01 1.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.23 110.889 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.92 145.71 11.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 64.02 112.515 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -50.72 102.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 65.32 110.947 -179.781 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.77 -61.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 50.23 110.876 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.47 30.13 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.477 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -76.08 -171.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 74.21 110.87 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.0 m -87.03 -174.44 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 62.31 110.885 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.59 -167.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.887 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -115.73 -92.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 71.24 110.842 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.638 ' HD3' HD11 ' A' ' 57' ' ' ILE . 13.1 ttm180 -135.01 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 72.3 110.872 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 156' ' ' ILE . 70.6 mt 61.19 104.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.54 111.189 -179.929 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' HD3' ' A' ' 55' ' ' ARG . 44.2 mt -139.72 98.78 7.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.582 0.706 . . . . 64.43 111.1 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.3 Cg_endo -69.84 96.13 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.652 2.235 . . . . 72.22 112.321 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.77 -46.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 55.03 112.489 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -67.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 62.31 110.87 -179.84 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.61 -153.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 54.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 p -150.74 153.39 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 74.24 110.924 -179.94 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 1.3 tp60 -88.25 -168.84 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.24 -65.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.51 112.493 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.5 66.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 73.01 112.501 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -79.41 168.24 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 65.52 110.889 -179.969 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.0 34.66 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.892 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.3 p -112.01 -75.11 0.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 74.1 111.125 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.0 165.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.852 -179.988 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 12.1 m80 72.68 43.35 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.882 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.33 -74.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.898 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 134.64 65.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 42.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.3 p -133.9 -164.4 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 74.31 111.143 -179.898 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.09 -178.92 15.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 61.22 112.453 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.7 -118.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 75.4 112.448 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -158.9 170.72 21.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 65.35 110.892 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.74 179.31 7.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.814 -179.861 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' ALA . 23.2 pt -96.63 -36.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.03 111.1 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -87.6 -20.21 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.889 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.22 -173.53 26.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 63.22 112.505 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -19.45 37.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 53.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -175.91 149.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.964 179.967 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -117.03 166.48 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.893 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 4.1 pt-20 -90.41 159.66 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.853 -179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -71.42 141.56 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.15 110.871 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -57.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.902 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -173.0 145.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.43 110.86 -179.951 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.39 52.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.34 110.843 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mt -82.69 3.86 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 73.14 111.093 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD21 ' HG2' ' A' ' 28' ' ' LYS . 2.7 mm? -113.51 97.73 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.92 179.909 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 131.02 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.883 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -53.81 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 70.44 110.882 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -84.27 -12.63 54.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.118 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.64 -170.09 43.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 72.45 112.5 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 53.8 Cg_endo -69.75 142.43 47.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.627 2.218 . . . . 55.03 112.375 -179.984 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.74 -21.24 25.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.787 -0.72 . . . . 64.31 112.478 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.37 149.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 63.22 111.142 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.692 HD12 ' CA ' ' A' ' 130' ' ' GLY . 2.8 mt -119.84 145.96 46.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.945 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -155.8 35.23 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 60.24 110.877 -179.884 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.9 mmt 39.2 -149.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 62.42 110.899 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 100' ' ' MET . . . 166.63 86.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.32 111.062 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -110.1 -71.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.855 -179.942 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -146.02 -39.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.35 111.108 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 128.31 -61.14 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.751 . . . . 74.15 112.516 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.78 100.06 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 75.01 112.325 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.548 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER 25.28 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.873 179.972 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' ALA . 6.6 t -140.63 29.32 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 70.01 111.139 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 t30 51.59 -99.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 54.14 110.895 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 102' ' ' ASN . . . 146.47 -85.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.457 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.56 20.98 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 64.24 110.873 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -87.52 -38.25 16.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 62.02 110.881 -179.965 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 114' ' ' ILE . 66.3 t80 68.65 84.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.929 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.0 129.1 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.872 -179.888 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -117.39 118.65 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.25 111.127 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 115' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 18.9 p -86.0 147.01 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 35.53 110.881 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -107.78 33.81 3.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.33 111.151 -179.897 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -170.2 -177.92 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 54.11 111.084 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -82.68 90.98 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.882 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.603 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.0 p -116.39 64.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 72.21 111.185 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 18.61 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 72.32 110.912 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -97.9 13.8 29.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.921 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 3.5 mt -125.01 -4.25 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 72.03 110.908 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -79.97 53.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.862 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.32 26.17 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 74.31 112.485 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -168.79 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 75.41 110.93 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.94 154.51 17.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 55.41 110.903 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 129' ' ' PHE . 53.9 t -86.95 107.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 65.21 111.117 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.719 HG22 ' HB3' ' A' ' 99' ' ' SER . 39.7 t -93.5 135.02 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 64.13 111.106 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 29' ' ' VAL . 11.6 p90 -170.93 58.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 63.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.692 ' CA ' HD12 ' A' ' 98' ' ' LEU . . . -128.93 179.32 16.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 64.32 112.483 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 176.31 147.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 73.04 110.871 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -112.28 94.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.087 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -75.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.909 179.894 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.17 -166.2 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.872 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.84 69.03 1.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.43 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -7.1 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.758 0.314 . . . . 73.22 110.866 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -31.31 61.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 52.45 110.846 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.684 HG21 HG22 ' A' ' 20' ' ' VAL . 21.2 mm -73.74 -39.19 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 54.44 111.133 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 139' ' ' VAL . 15.5 t -82.36 -1.48 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 70.11 111.169 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -118.24 -59.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 65.03 110.909 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.81 -56.13 22.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.51 111.128 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 2.0 ttm -51.43 -49.47 61.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.9 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -24.61 28.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.42 110.91 -179.963 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -66.67 -13.64 61.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 75.15 110.871 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -90.36 19.5 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.43 110.861 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.78 -158.75 31.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.743 . . . . 74.34 112.482 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -146.82 -77.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 62.43 110.852 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.35 110.912 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.1 -14.68 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.88 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.27 -34.41 2.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.25 112.479 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 127.84 15.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 72.04 110.872 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -110.01 149.56 29.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.52 111.121 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -68.9 -25.27 64.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 43.45 110.849 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.02 -166.92 1.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 40.21 110.909 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.9 OUTLIER -121.83 116.9 25.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 74.01 110.908 179.917 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.615 HD13 ' CD1' ' A' ' 56' ' ' ILE . 4.1 mp -95.37 128.34 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 63.05 111.114 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 155' ' ' LYS . 82.4 p -138.59 149.53 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.081 179.991 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.669 HD13 ' CE1' ' A' ' 48' ' ' TYR . 3.0 mp -88.99 105.94 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 61.34 111.144 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.08 76.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 62.02 111.102 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -156.61 177.99 10.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.53 110.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.3 p -174.54 159.81 3.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.24 110.873 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.51 -179.95 37.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.54 112.49 -179.942 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.57 -43.81 22.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 73.02 110.904 -179.85 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.86 -172.46 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 62.3 110.913 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 64.43 110.877 179.889 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.813 0.339 . . . . 75.32 110.872 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.4 t -142.24 145.83 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 62.04 111.069 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -65.71 140.87 97.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.623 0.725 . . . . 73.24 110.911 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.73 69.36 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 60.0 112.321 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 58.0 m -138.59 90.29 2.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 33.2 111.147 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -74.22 162.56 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 63.31 111.103 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -133.45 157.24 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 71.4 110.909 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -140.87 139.99 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.43 110.91 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 6.7 m-20 -95.46 99.53 11.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.45 110.927 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 mm -71.7 113.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.125 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.46 161.33 15.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.1 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.91 110.93 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 61.52 111.13 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.7 43.87 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.855 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.82 9.11 65.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 51.53 112.497 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -114.91 132.29 23.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.594 0.712 . . . . 71.34 110.912 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.28 11.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 64.1 112.328 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.58 -36.92 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.919 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.21 -137.89 4.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.756 . . . . 75.12 112.471 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.87 149.74 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.851 0.358 . . . . 64.55 110.837 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 134' ' ' GLU . 5.4 t -148.91 136.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.134 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -114.78 161.66 17.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.869 -179.834 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.76 149.51 46.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.905 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -92.0 107.9 19.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.877 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.664 HD12 ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -81.06 130.18 34.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.875 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -84.73 63.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.44 110.902 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.19 -2.48 31.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.44 111.096 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.89 -55.04 3.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.845 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.3 110.937 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 33' ' ' ALA . 4.7 m -110.84 80.48 2.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.587 0.708 . . . . 75.12 111.131 179.865 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 56.25 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 74.45 112.387 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -161.7 -67.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.915 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.682 HG21 HG11 ' A' ' 127' ' ' VAL . 10.0 t -72.48 -16.58 61.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 54.52 111.139 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 24' ' ' LEU . . . -82.47 -36.39 26.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 71.2 111.106 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -63.98 -156.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.886 -179.929 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 65.37 -73.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 33.11 110.876 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.6 t80 -50.07 -34.41 21.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.881 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.68 71.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.45 110.876 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.2 -41.47 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 55.22 111.134 179.887 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.76 -19.32 63.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 63.51 110.912 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -101.18 -7.67 22.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 75.3 110.887 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 99.8 m -105.69 -22.65 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 75.32 111.179 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 69.74 1.36 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 42.41 112.5 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.96 34.16 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 64.45 110.87 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 18.85 2.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.53 110.902 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.13 -32.04 5.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 54.51 112.448 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.85 -177.55 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.362 . . . . 75.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.47 39.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.733 . . . . 62.24 112.536 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.71 -69.26 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 73.33 110.907 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 55.5 179.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.845 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -37.97 100.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 53.52 112.506 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 154.17 42.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 73.21 110.824 -179.729 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.8 p -65.76 161.17 21.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 74.41 110.885 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.88 174.97 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.888 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.91 166.37 17.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.874 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 65.68 112.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.828 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.8 mt -151.05 122.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 75.45 111.136 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 7.1 mt -130.6 103.76 16.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 71.55 111.098 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.5 Cg_endo -69.69 85.76 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.67 2.246 . . . . 71.45 112.379 179.817 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.46 -17.08 2.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 52.44 112.519 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.87 -57.89 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 62.44 110.905 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -162.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.33 110.874 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.93 -72.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 65.42 110.867 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 62.87 153.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.913 -179.9 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.26 179.38 16.2 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 41.43 112.467 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.71 120.71 6.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 63.13 112.477 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -149.86 155.1 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.373 . . . . 74.03 110.846 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 179.85 175.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 74.51 110.907 -179.925 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 76' ' ' LYS . 5.0 t -176.84 59.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.51 111.131 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.58 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.839 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -47.05 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.851 -179.997 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.21 40.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 54.5 110.871 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.69 -137.8 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 54.42 112.49 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -144.53 135.29 24.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 74.31 111.12 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.6 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 65.15 112.476 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.01 -9.73 54.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 34.33 112.522 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' H ' HG21 ' A' ' 68' ' ' THR . 16.8 ptpt -93.29 171.79 8.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 74.14 110.918 179.987 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.1 p -81.92 -167.4 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 63.14 110.881 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.3 pp -109.55 12.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.173 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -129.61 20.74 5.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.911 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.46 -122.34 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 74.12 112.505 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.99 -20.0 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.33 110.892 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -176.11 -175.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 63.3 110.927 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -151.52 154.27 36.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.885 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -71.2 163.26 27.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.854 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.8 123.96 33.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 75.33 110.896 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -48.8 55.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 51.12 110.849 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.3 p30 179.38 175.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.891 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.52 37.6 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -56.55 -23.36 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 55.01 111.11 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HG13 ' A' ' 128' ' ' VAL . 7.2 mt -104.02 134.58 47.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 45.21 110.894 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -120.04 -172.34 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 70.14 110.92 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -97.47 80.34 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 70.32 110.892 179.866 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.7 p -60.68 -22.53 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.42 111.137 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.91 -149.1 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 50.11 112.494 179.945 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 162.7 41.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.625 2.217 . . . . 74.34 112.332 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.33 23.02 76.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 73.2 112.495 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.05 116.83 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 72.22 111.125 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 130' ' ' GLY . 1.4 mt -86.38 136.07 33.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.888 179.948 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -133.77 -153.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 44.52 110.866 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mmt -153.59 158.08 40.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 61.02 110.895 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -108.5 -169.42 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 50.34 111.103 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 32.4 t30 89.43 102.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 63.43 110.893 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.52 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 52.51 -108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.087 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 168.86 -62.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 64.14 112.538 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.8 Cg_endo -69.82 99.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.679 2.253 . . . . 74.42 112.331 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.21 47.0 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 64.3 110.914 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -147.73 71.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.13 111.166 -179.966 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.552 ' CG ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -91.39 31.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 53.45 110.908 179.975 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . -27.57 -95.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 64.12 112.499 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 t -151.66 -167.6 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 70.22 110.857 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.13 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.89 -179.998 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -101.69 139.46 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.867 -179.936 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -111.35 104.6 13.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.893 -179.937 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.39 136.18 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 75.01 111.094 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.19 153.75 20.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.866 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -130.53 -33.87 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 62.23 111.166 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.41 15.76 26.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.085 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 126.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 75.44 110.852 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -143.05 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 41.33 111.127 179.994 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.36 17.14 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.01 110.89 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -29.22 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 64.44 110.926 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -99.4 23.72 8.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.949 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -89.72 42.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 65.22 110.877 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.21 33.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 55.31 112.515 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.19 -49.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 73.44 110.901 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -96.55 158.09 15.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.845 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.5 t -81.8 -168.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.143 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.4 p -172.39 103.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 73.23 111.165 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.68 82.38 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.92 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.558 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 140.03 135.73 3.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 75.01 112.49 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.99 144.49 31.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 73.32 110.976 -179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.43 115.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 73.53 111.106 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -64.49 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 55.51 110.911 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -141.73 146.41 36.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 73.41 110.945 179.905 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.9 10.29 35.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.515 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 ttt -50.07 -28.69 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 70.41 110.848 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -51.5 -25.08 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.936 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.72 -37.34 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.142 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -53.97 -21.77 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 75.21 111.136 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -85.91 -34.32 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.877 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.22 -47.24 83.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 52.21 111.125 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.9 ptm -69.36 -22.11 63.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.91 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -88.45 23.34 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 65.53 110.891 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 -11.46 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.877 -179.922 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.6 11.47 33.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.03 110.877 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.1 -142.18 11.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 53.14 112.484 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t -159.16 139.63 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 64.13 110.843 -179.724 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.69 80.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.13 110.859 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 173.81 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 64.11 110.881 -179.975 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.02 -61.79 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 54.33 112.509 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.23 143.95 10.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 73.52 110.869 -179.973 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.4 p -116.04 133.89 55.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 71.12 111.147 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.17 -1.6 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.41 110.868 -179.898 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -136.78 -171.15 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.33 110.913 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -133.35 153.82 51.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mt -135.39 118.97 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.55 111.129 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.4 p -115.04 169.32 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 51.21 111.168 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.405 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 39.6 mm -110.38 133.33 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.45 111.089 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.635 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -82.67 -58.49 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.52 111.112 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.19 170.67 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 62.14 110.873 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 66.8 m -150.09 166.65 29.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 63.21 110.896 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.17 -178.32 48.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 21.2 112.45 -179.931 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.2 mt-30 -80.08 -32.52 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 73.12 110.955 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER 73.49 -60.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 60.14 110.916 179.971 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 55.2 110.831 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.327 . . . . 71.11 110.922 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.27 156.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 54.13 111.132 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.2 m-20 -66.61 128.98 94.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.65 21.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 63.03 112.334 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -126.19 145.04 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 71.23 111.123 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 10.5 m -125.15 147.53 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 55.12 111.139 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.6 p90 -103.62 148.56 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.839 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.06 130.64 20.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.903 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.6 t0 -108.59 119.94 41.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.849 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' CE ' ' A' ' 142' ' ' MET . 12.2 mm -101.82 149.25 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.43 111.097 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.73 26.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.143 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 156' ' ' ILE . 58.9 t -139.1 101.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 63.53 111.117 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.6 t0 78.68 27.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.849 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.21 -15.63 62.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.795 -0.716 . . . . 24.11 112.518 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 136.71 21.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 73.44 110.859 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 162.95 40.12 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.673 2.249 . . . . 62.1 112.319 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -110.23 -52.79 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 53.5 110.895 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 19' ' ' ARG . . . 162.29 -15.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 74.31 112.481 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 71.52 147.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.906 0.384 . . . . 74.43 110.846 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.553 HG13 HG21 ' A' ' 138' ' ' ILE . 26.4 m -115.8 -176.17 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 71.51 111.094 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 133' ' ' LYS . 3.7 m -123.67 87.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.4 110.845 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -84.32 121.63 27.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 63.54 110.928 -179.993 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.04 153.26 20.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 64.33 110.85 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 mt -119.99 126.81 51.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 74.41 110.937 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE2' HD11 ' A' ' 90' ' ' LEU . 21.0 m-85 -89.34 70.48 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.856 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -22.75 67.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.13 111.107 179.914 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.25 -61.08 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.888 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -33.07 30.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.933 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -126.39 79.4 70.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 75.34 111.165 179.876 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -45.41 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 74.24 112.368 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -59.38 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.1 110.904 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' OD1' ' A' ' 108' ' ' ASN . 1.5 m -55.15 -61.88 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 64.42 111.128 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -36.41 11.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 72.32 111.122 179.867 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -67.13 -52.15 45.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 71.32 110.933 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.18 -39.88 31.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.934 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 10.4 t80 -76.24 -29.66 57.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.875 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -44.05 97.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.885 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.46 -25.87 62.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.3 111.071 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 43.0 mt -76.72 -55.63 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 73.22 110.921 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -56.75 -48.96 76.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.0 p -77.44 -13.99 59.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 71.31 111.111 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.17 71.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 72.24 112.48 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.08 33.51 5.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.408 . . . . 62.03 110.927 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.39 0.51 6.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.908 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.0 -2.88 58.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 74.33 112.529 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -166.56 171.98 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 74.51 110.88 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.78 -172.0 24.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 75.33 112.476 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -82.1 129.34 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 72.22 110.915 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -134.93 -48.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 70.42 110.894 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -166.61 51.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 63.15 112.487 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 157' ' ' THR . 16.5 t -71.41 -92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 75.21 110.861 -179.707 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 51' ' ' SER . 0.6 OUTLIER 167.52 139.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 62.35 110.915 -179.914 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -130.3 162.22 29.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 54.44 110.905 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.09 52.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 60.41 110.833 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -135.06 35.44 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.32 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.55 148.08 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.153 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 148' ' ' ARG . 1.5 tt -143.97 110.91 5.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.627 0.727 . . . . 72.11 111.108 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 53.7 Cg_endo -69.76 118.88 5.95 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 71.44 112.361 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.44 -30.27 7.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 61.31 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.08 -66.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.3 110.855 -179.885 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.4 ' H ' HG23 ' A' ' 57' ' ' ILE . 1.7 ptt? -176.52 -152.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 61.55 110.857 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.77 137.91 25.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 44.41 110.886 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.48 157.21 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.04 110.943 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.39 35.08 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 74.51 112.463 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.89 29.82 8.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 62.23 112.497 -179.87 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.66 83.37 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.81 0.338 . . . . 71.51 110.859 -179.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -94.66 31.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 71.4 110.849 -179.888 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.11 108.76 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.144 -179.923 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 tpt85 68.76 142.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.41 110.868 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -87.32 25.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 54.53 110.863 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.59 -39.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.866 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.24 54.48 0.41 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.697 -0.764 . . . . 64.15 112.455 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.4 p -112.35 3.88 17.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 63.34 111.133 -179.899 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.15 -137.57 6.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.681 -0.771 . . . . 62.14 112.479 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.85 71.58 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.747 . . . . 50.52 112.47 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 141.3 32.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 63.41 110.916 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 m -105.69 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.15 110.826 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.17 -44.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.11 111.127 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -101.28 75.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 73.33 110.934 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.49 -127.77 8.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 71.14 112.494 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -111.19 -85.25 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 60.34 110.913 -179.932 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -123.48 145.92 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.875 179.966 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.43 171.02 7.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 72.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.48 161.5 27.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.904 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -69.27 152.88 44.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 73.04 110.899 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.44 -56.67 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 70.23 110.894 -179.888 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -177.46 143.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.5 110.875 -179.968 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.15 41.91 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.885 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 87' ' ' ASN . 9.2 mt -75.27 -22.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 60.32 111.147 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.31 99.46 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 72.2 110.88 179.89 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.1 101.5 13.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.9 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CB ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.34 95.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.54 110.858 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.7 37.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 60.23 111.155 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 173.16 158.87 18.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 73.3 112.484 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 135.81 31.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.661 2.241 . . . . 63.05 112.326 -179.913 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.84 -22.15 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 64.12 112.498 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 ' CB ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -50.62 152.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 75.11 111.154 -179.976 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -118.87 126.85 52.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.938 179.886 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 128' ' ' VAL . 82.1 p -153.47 86.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.2 110.826 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -38.45 155.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 63.41 110.858 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.77 19.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.13 111.042 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.873 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.809 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.12 -24.91 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 63.43 111.054 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . 117.13 -78.46 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 61.41 112.495 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 107' ' ' THR . 53.4 Cg_endo -69.8 128.58 16.2 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 62.41 112.348 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' PRO . 19.5 m-20 29.24 55.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 73.52 110.921 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 103' ' ' ALA . 18.4 p -140.98 42.66 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 72.21 111.121 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.683 ' C ' ' O ' ' A' ' 107' ' ' THR . 23.4 t30 0.83 -82.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.883 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 119.44 168.42 13.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 54.21 112.507 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -132.88 -39.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 51.5 110.839 -179.75 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -84.05 72.71 10.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 64.52 110.897 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.94 -171.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 75.52 110.874 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.91 150.7 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.893 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.8 mt -106.37 114.72 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 60.33 111.144 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.7 m -75.8 132.9 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.861 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.8 p -99.45 11.99 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.2 111.151 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.25 179.28 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.107 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -74.43 119.63 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 73.4 110.902 179.976 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.744 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 73.3 p -132.34 59.03 1.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 72.23 111.149 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.47 -11.87 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.91 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.744 ' CZ2' HG22 ' A' ' 119' ' ' THR . 41.8 p90 -82.99 5.75 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 73.23 110.894 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 82.0 mt -122.51 34.91 5.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.93 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.11 -86.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 63.13 110.86 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.95 78.08 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.741 . . . . 42.42 112.495 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -45.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 73.12 110.881 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 126' ' ' HIS . . . . . 0.444 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 36.7 m-70 -112.57 -25.53 9.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.859 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 24.9 t 73.6 95.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 72.24 111.102 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 99' ' ' SER . 99.0 t -75.32 140.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.119 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CB ' HG21 ' A' ' 29' ' ' VAL . 43.4 p90 -139.01 -29.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 72.41 110.88 -179.95 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.78 -168.33 43.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.489 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 170.01 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.325 . . . . 65.32 110.907 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.67 141.14 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.12 111.19 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 21' ' ' SER . 13.3 tppt? -118.07 -37.22 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.87 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.87 175.57 13.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.881 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.15 78.8 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 63.33 112.475 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.29 -24.11 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 61.22 110.88 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 138' ' ' ILE . 26.1 m120 -77.64 -39.49 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 74.12 110.846 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.553 HG21 HG13 ' A' ' 20' ' ' VAL . 50.0 mm -38.1 -46.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 73.44 111.177 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -88.79 -51.48 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.03 111.132 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 20.5 mm-40 -46.66 -57.0 5.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.855 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.98 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 53.43 111.074 179.964 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.581 ' CE ' HG21 ' A' ' 10' ' ' ILE . 4.5 ttm -52.86 -43.98 66.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 74.11 110.894 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -55.46 -19.77 10.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 64.14 110.884 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -66.7 -20.06 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.861 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -90.89 15.13 11.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.23 110.879 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -94.18 -159.06 33.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 63.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.42 169.7 21.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.22 110.871 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 57' ' ' ILE . 25.1 mmm180 -57.08 -36.96 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.27 12.94 19.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 61.41 110.878 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.85 -85.7 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 22.33 112.443 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 152' ' ' THR . 4.3 mttp 62.6 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 52.43 110.914 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 151' ' ' LYS . 1.4 t 163.29 67.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 72.41 111.117 179.979 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -48.16 82.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.866 -179.873 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -126.37 177.44 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.912 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.89 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 12' ' ' VAL . 21.1 pt -131.6 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 44.31 111.133 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 51' ' ' SER . 1.3 m -134.34 159.41 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.134 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 53' ' ' PHE . 47.0 mt -91.85 115.92 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.11 111.16 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.76 -53.54 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 45.03 111.087 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -141.37 175.56 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.34 110.85 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.8 p -166.53 175.34 8.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.912 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.33 -156.44 26.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 61.13 112.431 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 1.6 tt0 -103.97 144.55 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 72.03 110.898 -179.842 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -57.71 -62.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.912 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 64.5 110.931 179.865 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 74.44 110.852 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.6 t -140.4 142.31 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 72.42 111.136 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.66 153.24 42.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 72.25 110.913 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 154.52 67.8 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.726 2.284 . . . . 72.31 112.35 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -128.36 45.93 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 63.15 111.157 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.69 144.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.34 111.173 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.631 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -128.87 164.94 22.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.22 110.86 -179.939 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.82 148.56 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 75.12 110.907 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.748 ' O ' HD13 ' A' ' 10' ' ' ILE . 25.6 m-20 -108.57 157.22 18.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 64.31 110.889 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 9' ' ' ASP . 8.6 mm -129.97 129.69 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 55.04 111.156 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.44 167.39 15.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.1 111.084 179.821 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 15' ' ' GLU . 12.8 m -152.85 106.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 72.33 111.135 179.946 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.02 23.03 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.35 110.88 179.894 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 -10.32 65.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 51.1 112.494 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HG2' HG23 ' A' ' 12' ' ' VAL . 4.0 pt-20 -101.54 138.56 19.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 62.13 110.916 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 151.99 69.0 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 62.33 112.337 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.8 tp -121.02 -70.97 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.54 110.929 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.41 179.2 35.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 74.43 112.463 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 73.2 110.91 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.85 84.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.31 111.079 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -66.07 94.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.5 110.834 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 25.9 p90 -106.83 114.28 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 74.35 110.899 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.91 146.7 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 33.31 110.869 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' A' ' 129' ' ' PHE . 20.2 mt -108.13 128.41 54.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 75.23 110.943 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -70.84 79.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.889 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.696 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . . . -73.44 -11.18 60.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 51.12 111.116 179.92 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.38 -58.96 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 65.34 110.883 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -50.65 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.936 179.966 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 5.0 m -66.04 128.36 93.77 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 52.45 111.131 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.686 2.257 . . . . 60.24 112.358 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -40.91 64.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 61.51 110.939 179.887 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 54.9 m -57.12 -11.28 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 71.22 111.144 179.961 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 26' ' ' ALA . . . -74.93 -45.43 42.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 75.1 111.1 179.872 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 35' ' ' ASN . 28.9 tt0 -91.42 -49.18 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 70.33 110.917 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.549 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -25.63 -51.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 65.4 110.924 -179.948 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -81.54 -45.04 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.875 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' GLU . 2.9 ptt85 -51.21 -27.16 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.913 -179.946 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.609 ' HB1' ' CD ' ' A' ' 43' ' ' GLU . . . -75.69 -49.2 19.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 62.2 111.11 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.8 tm? -71.32 -10.67 60.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 62.4 110.936 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -8.2 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.879 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 37' ' ' ARG . 19.8 p -102.22 -13.75 17.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 55.42 111.155 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 45.83 8.65 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 60.52 112.526 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.609 ' CD ' ' HB1' ' A' ' 38' ' ' ALA . 8.4 pt-20 -98.38 -21.75 16.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 75.43 110.903 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -89.27 17.97 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 71.3 110.923 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.45 26.01 63.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 75.45 112.473 179.945 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 178.68 168.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 62.24 110.832 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.38 -129.59 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 61.22 112.478 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -93.92 -72.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 75.11 110.918 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 1.7 tptt 59.62 166.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 62.04 110.882 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -36.99 104.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 62.53 112.492 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 m -132.53 -108.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 71.54 110.872 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.7 p 172.77 150.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 51.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -90.53 -71.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.874 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.75 5.82 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.44 110.87 -179.971 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 94.79 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 75.02 110.877 -179.872 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 62' ' ' CYS . 2.5 mt -147.77 139.84 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.54 111.187 179.931 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -140.07 139.37 21.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.609 0.719 . . . . 54.54 111.118 179.913 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 128.4 15.98 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.677 2.251 . . . . 54.13 112.335 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 117' ' ' ALA . . . 67.18 48.22 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.06 -80.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 61.42 110.862 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -165.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.899 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.404 ' HB2' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -149.59 147.46 28.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.31 110.864 -179.991 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.66 127.36 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.911 -179.886 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -38.28 -67.56 0.51 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.489 -179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.87 134.03 1.91 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 73.13 112.505 -179.888 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.14 78.16 1.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 53.51 110.875 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -94.28 36.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.868 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.38 100.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.117 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -35.38 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.884 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -48.76 -46.3 41.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.15 110.817 -179.98 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.46 -33.09 13.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.02 110.862 -179.936 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.24 -133.63 7.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 42.02 112.463 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.3 p -136.02 136.02 39.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 53.3 111.172 -179.886 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.19 -95.67 1.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 65.11 112.5 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.4 125.21 5.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 62.2 112.472 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -176.23 -173.88 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 63.04 110.902 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.5 m -81.18 143.79 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.861 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 39' ' ' LEU . 15.4 pt -83.88 -39.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.153 179.936 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -88.83 -6.78 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.73 -138.18 2.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.768 -0.73 . . . . 71.01 112.493 179.96 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -122.6 -29.59 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.419 . . . . 73.35 110.896 -179.851 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -174.67 137.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 73.14 110.924 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.43 138.43 54.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.881 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 175.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.886 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.46 -168.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.846 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.17 -61.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.853 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -171.22 154.01 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 71.32 110.888 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.02 79.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.873 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.621 ' O ' HD23 ' A' ' 90' ' ' LEU . 10.4 mm -86.77 14.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.136 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 89' ' ' ILE . 5.7 mt -131.33 99.69 4.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 73.4 110.906 179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.09 125.74 33.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.868 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.423 ' HA ' HG13 ' A' ' 97' ' ' ILE . 1.3 m80 -49.03 97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.838 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -116.39 22.71 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 75.24 111.109 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 166.22 26.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.43 112.462 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 132.81 24.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 73.4 112.4 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 121.7 -23.74 7.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.51 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 92' ' ' HIS . 33.3 mm -57.58 149.99 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.341 . . . . 63.45 111.136 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 112' ' ' PHE . 6.7 mp -120.86 143.14 49.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.913 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.08 39.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.851 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.497 ' SD ' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER 59.01 168.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.1 110.862 179.936 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.64 76.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.1 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -144.04 -80.09 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 73.13 110.884 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -125.81 -146.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 63.33 111.123 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.622 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -140.29 -64.18 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 61.12 112.516 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.5 Cg_endo -69.8 106.08 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.21 112.368 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 39.86 68.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.884 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -152.78 35.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.173 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.656 ' C ' ' O ' ' A' ' 107' ' ' THR . 1.6 m120 7.46 -87.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.54 110.94 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 128.8 -41.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.2 112.5 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.3 OUTLIER 76.68 -39.03 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.32 110.856 -179.734 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -62.67 -159.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.02 110.905 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.761 ' HB2' HD23 ' A' ' 98' ' ' LEU . 11.8 p90 -170.72 140.87 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 65.03 110.86 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 4.3 p90 -131.29 102.11 5.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.927 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.446 HG23 ' HA2' ' A' ' 96' ' ' GLY . 12.4 mt -64.59 103.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 73.43 111.157 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.6 m -60.47 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 54.1 110.888 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.94 13.83 27.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 51.14 111.124 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 119' ' ' THR . . . -169.63 153.86 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 71.2 111.101 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -56.91 99.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.12 110.942 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.6 p -117.7 63.19 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 72.45 111.117 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 2.14 5.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 64.22 110.882 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.466 ' CZ2' HG22 ' A' ' 119' ' ' THR . 26.0 p90 -91.78 2.99 56.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.938 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.65 37.97 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.54 110.887 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -125.87 70.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.886 179.851 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.08 -49.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 71.2 112.471 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.13 -31.99 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 73.22 110.87 -179.935 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.25 145.15 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.846 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.1 m -79.0 109.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 74.32 111.177 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 90' ' ' LEU . 9.0 p -75.35 144.61 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.54 111.133 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.758 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 2.0 t80 174.5 100.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.884 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.616 ' C ' HD13 ' A' ' 98' ' ' LEU . . . 123.74 144.08 6.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 63.5 112.479 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -154.72 -179.77 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 75.25 110.911 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 12.1 t -108.36 85.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 74.42 111.136 179.88 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.83 -50.3 68.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.921 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.9 163.56 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.859 179.961 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.17 -4.44 64.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.52 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.37 -34.38 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 74.13 110.869 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.93 -24.24 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 62.24 110.89 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.21 -41.06 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.21 111.078 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.03 -37.96 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 74.41 111.121 179.852 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.85 -20.87 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 72.52 110.853 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.17 -38.97 26.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -65.23 -29.8 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.886 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.64 -50.32 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.906 -179.965 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -17.05 52.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.3 -16.47 29.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.906 -179.946 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.99 -158.97 21.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 72.22 112.491 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -149.57 -162.2 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 74.13 110.804 -179.705 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -92.45 -42.74 9.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.892 -179.908 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -101.01 15.28 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.12 110.935 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.68 -157.87 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 61.44 112.463 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm 60.85 159.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 74.32 110.916 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -133.26 161.37 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.31 111.152 179.965 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.39 -19.26 43.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 73.21 110.817 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -135.37 161.08 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.32 110.889 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -90.86 128.18 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.919 179.875 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mt -101.16 134.92 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 72.12 111.133 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 155' ' ' LYS . 4.2 p -136.59 163.89 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 75.31 111.175 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.1 mp -124.71 132.89 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.094 179.923 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.06 -58.34 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 74.35 111.122 179.799 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -151.81 179.03 8.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.34 110.881 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.9 p -176.15 165.44 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 142.83 -171.59 24.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 75.4 112.428 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -68.7 118.51 11.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 72.43 110.933 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.4 mm? -92.32 -44.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.916 -179.964 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.873 179.897 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 74.12 110.867 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.14 155.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 54.03 111.126 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.47 141.37 42.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 74.12 110.848 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.7 Cg_endo -69.75 127.79 15.11 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 73.32 112.347 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -102.19 148.78 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 55.32 111.144 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -120.21 139.02 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 53.12 111.158 179.868 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -117.42 143.95 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.849 -179.936 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -140.07 127.63 21.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 65.21 110.855 -179.929 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 34.6 t0 -101.0 79.6 2.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.858 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.32 139.11 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.5 111.116 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -127.17 158.66 36.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 111.091 179.763 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.34 97.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.09 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t0 54.61 54.96 8.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.32 110.891 179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.82 13.06 60.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 62.32 112.456 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -142.48 93.02 7.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.684 0.754 . . . . 72.1 110.862 -179.885 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 152.43 69.28 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.688 2.259 . . . . 72.02 112.316 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.74 25.13 9.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.906 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.21 -173.68 20.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.504 179.912 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 170.3 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 71.24 110.846 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG13 HG13 ' A' ' 138' ' ' ILE . 35.2 m -137.33 177.6 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.119 179.957 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 p -136.63 138.79 41.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 23.54 110.894 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -114.52 149.55 36.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.878 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.52 128.63 53.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 74.24 110.916 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 6' ' ' VAL . 6.6 mt -94.85 116.79 29.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 54.31 110.915 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 11.1 m-85 -82.61 67.47 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.893 179.92 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.072 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -36.54 74.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 62.41 110.919 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -89.83 -28.39 19.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 64.12 110.946 179.965 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -147.24 83.69 7.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.638 0.732 . . . . 73.0 111.138 179.834 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.28 37.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 54.44 112.348 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -34.75 19.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.925 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -75.07 -53.74 8.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.119 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.17 -37.95 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.45 111.148 179.887 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.64 -30.66 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.35 110.869 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.32 -61.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.851 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.01 -29.8 9.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.13 110.871 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.95 85.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.826 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.912 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -81.32 -19.03 43.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 53.4 111.132 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 110' ' ' SER . 87.8 mt -78.9 -61.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 65.41 110.924 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -51.48 -45.65 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.886 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.43 -9.87 56.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 74.43 111.089 -179.902 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.12 73.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.528 -179.973 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -47.8 -53.47 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.383 . . . . 64.55 110.876 -179.868 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -167.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 63.01 110.903 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.98 17.38 55.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.512 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -146.35 -168.32 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 74.23 110.89 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.72 144.02 7.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 42.12 112.508 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.22 120.67 5.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 75.11 110.96 -179.81 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -41.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.01 110.9 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 30.64 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 62.22 112.508 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -77.21 162.12 27.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 72.22 110.84 -179.723 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 m -75.06 -168.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.914 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.692 ' CE1' HD11 ' A' ' 158' ' ' ILE . 2.2 m-85 -140.16 135.74 32.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.876 -179.864 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.12 -179.11 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.04 110.858 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER 66.83 20.69 10.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.45 110.879 -179.875 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.475 HD12 ' OG1' ' A' ' 152' ' ' THR . 18.6 mt -69.45 123.47 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 74.2 111.118 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 55' ' ' ARG . 2.9 mp -138.92 103.44 7.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 60.24 111.155 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 76.08 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 45.31 112.337 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.02 -25.63 0.31 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 62.4 112.489 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.34 -64.19 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.05 110.876 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 -161.57 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 62.54 110.899 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.5 m -137.47 -64.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 40.5 110.882 -179.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.97 152.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.904 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.13 -179.93 48.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 55.54 112.448 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.35 29.38 16.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 74.1 112.514 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -65.72 120.12 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 73.45 110.915 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.33 -167.84 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.04 110.871 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.2 -52.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.126 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.02 162.37 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.853 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.94 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 64.55 110.872 -179.994 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -129.52 -161.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 55.5 110.9 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.89 41.32 2.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 62.43 112.491 179.938 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.6 p -129.79 -49.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 75.33 111.145 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.43 138.11 9.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.77 . . . . 75.51 112.467 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.25 -153.17 3.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 70.34 112.494 -179.851 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.16 -70.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 64.24 110.881 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -116.55 131.91 56.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 55.12 110.839 -179.884 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.912 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -49.35 -34.15 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.171 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD12 ' A' ' 78' ' ' ILE . 7.5 m-85 -128.31 55.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 71.23 110.923 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.82 -139.7 8.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.448 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.94 -82.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.385 . . . . 65.11 110.893 -179.846 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.797 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.29 -177.42 4.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 52.41 110.89 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.52 179.74 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.91 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 160.43 22.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.895 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -74.14 111.2 9.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.903 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.31 -52.35 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.917 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 178.8 165.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.861 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.05 40.22 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.864 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.6 mt -52.48 -29.02 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.52 111.116 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.69 118.07 31.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.917 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -105.43 171.1 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.885 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.8 95.35 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.851 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 p -112.11 34.63 4.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.85 41.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.715 -0.755 . . . . 71.4 112.481 179.952 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 150.31 67.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 74.21 112.348 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.0 128.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 52.2 112.482 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -178.0 131.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 75.55 111.146 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.0 tt -89.36 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 61.41 110.899 179.913 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 128' ' ' VAL . 31.1 p -109.74 -152.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.841 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 4.2 mtt -160.51 104.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.899 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.89 161.76 13.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.126 179.915 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER 172.14 -45.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.868 -179.936 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.909 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -172.21 -34.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 71.25 111.084 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.15 -80.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.743 -0.741 . . . . 43.14 112.494 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' O ' HG23 ' A' ' 107' ' ' THR . 53.6 Cg_endo -69.78 120.4 7.19 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 73.51 112.323 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 39.65 36.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 73.54 110.876 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.909 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 69.6 p -144.81 61.55 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 74.11 111.122 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 109' ' ' GLY . 3.0 m120 -82.16 -6.38 59.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 61.31 110.907 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 29.45 -138.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 72.44 112.492 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 39' ' ' LEU . 9.2 m -147.7 29.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 74.43 110.856 -179.711 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -107.18 83.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.3 110.95 -179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -80.66 176.98 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.878 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.64 -175.83 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.4 110.884 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.73 117.11 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.44 111.112 179.986 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.41 153.51 21.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 75.44 110.878 179.953 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.3 p -131.16 12.24 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 111.155 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.76 6.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 50.32 111.096 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.62 131.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.893 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.615 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.6 p -142.03 54.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 61.44 111.153 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.19 -17.88 5.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 62.35 110.919 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 121' ' ' TRP . . . . . 0.615 ' CZ2' HG22 ' A' ' 119' ' ' THR . 20.4 p90 -69.1 -18.47 63.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 72.14 110.922 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 50.7 mt -89.8 -6.8 55.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.902 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -47.77 -51.68 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 74.23 110.884 179.84 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.02 52.23 3.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 52.53 112.512 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -159.65 -50.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 50.22 110.868 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -110.13 143.25 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.827 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 76.4 t -48.97 -87.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 64.4 111.142 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 ' NE2' ' A' ' 92' ' ' HIS . 17.1 t 82.77 123.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 51.41 111.135 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.464 ' HB3' HG21 ' A' ' 29' ' ' VAL . 14.6 p90 -161.35 36.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 70.31 110.858 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.76 173.3 36.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 41.31 112.485 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -173.83 156.23 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 74.41 110.907 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.1 t -51.05 108.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.4 111.139 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -34.06 54.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.31 110.935 179.89 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -151.51 169.77 21.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 73.23 110.864 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 78.97 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 52.41 112.508 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.5 tpt -87.17 0.87 54.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 62.14 110.881 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -88.59 -34.32 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 71.41 110.891 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.572 HG13 HG13 ' A' ' 20' ' ' VAL . 30.7 mm -60.95 -40.28 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 72.1 111.143 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 139' ' ' VAL . 13.9 t -87.32 0.13 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 43.25 111.131 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -112.78 -69.71 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.893 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.06 -51.6 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 63.22 111.131 179.942 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 5.3 tmm? -44.31 -39.95 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.45 110.902 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.02 59.64 1.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 65.11 110.874 -179.914 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.94 -12.4 4.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.1 110.898 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.0 21.65 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.876 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -97.93 65.11 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 25.41 112.501 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.603 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.8 OUTLIER -18.64 120.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 52.34 110.867 -179.721 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -47.54 -43.31 24.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.855 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -45.68 -35.34 4.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.1 -60.86 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.719 . . . . 63.22 112.482 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 125.94 19.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 53.04 110.87 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.497 HG23 ' HA2' ' A' ' 146' ' ' GLY . 2.2 m -85.89 139.94 30.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 65.24 111.135 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -67.66 -22.72 65.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.829 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -124.59 -164.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 54.11 110.916 179.906 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 112.16 13.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 74.23 110.913 179.872 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 mt -99.06 90.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.24 111.154 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -91.14 153.61 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 65.43 111.114 -179.976 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -94.22 128.28 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.124 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.13 -63.08 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.41 111.106 179.804 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.26 162.17 41.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 74.1 110.873 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.06 -179.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 63.41 110.921 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.46 -156.63 25.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 62.21 112.492 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -120.02 140.58 50.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 74.41 110.874 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.08 132.66 53.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.1 110.913 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 64.44 110.959 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 75.04 110.82 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.5 OUTLIER 62.55 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.11 111.125 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' VAL . 13.0 m-20 -88.47 144.63 34.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 64.55 110.864 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 132.26 22.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.684 2.256 . . . . 63.0 112.338 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.442 HG21 HD22 ' A' ' 164' ' ' LEU . 21.6 m -116.51 142.28 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 75.24 111.097 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.79 137.8 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -101.34 156.23 17.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.857 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.52 143.69 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.901 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.35 143.03 37.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.879 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -115.43 120.3 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.149 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 163.28 13.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 53.25 111.064 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.653 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.88 96.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 72.13 111.145 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.33 31.39 6.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.14 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.24 65.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 63.34 112.475 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -96.22 132.91 25.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.648 0.737 . . . . 74.35 110.874 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.65 65.32 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 72.13 112.351 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.6 tp -121.97 -72.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.903 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.64 -148.24 4.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 74.34 112.526 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.75 126.6 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 63.52 110.874 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.33 125.26 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 70.24 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.1 p -113.47 159.16 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.884 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.69 126.67 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.904 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.0 tm-20 -59.46 -48.36 81.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 71.01 110.916 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 7.1 mt 69.51 126.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.22 110.935 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CG ' HD21 ' A' ' 90' ' ' LEU . 81.8 m-85 -88.6 74.14 8.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.902 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.8 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.4 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.01 -37.59 12.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.896 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 3.2 mmtp -75.11 -27.7 59.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 129' ' ' PHE . 2.7 m -131.67 68.7 81.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 52.22 111.095 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 58.87 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.698 2.265 . . . . 34.11 112.378 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.59 -72.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.31 110.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 86.3 m -58.95 -53.91 53.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 64.12 111.14 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -77.42 -9.39 58.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 62.13 111.118 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -74.17 -24.75 59.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.849 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -90.5 -34.41 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.869 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' HD2' HD11 ' A' ' 24' ' ' LEU . 3.8 t80 -50.77 -28.71 9.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.928 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.36 76.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 62.42 110.874 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.96 -28.69 25.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.12 111.119 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.1 tt -89.12 13.1 13.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.951 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -117.22 -11.99 10.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 51.42 110.852 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.491 HG22 ' HA2' ' A' ' 162' ' ' GLY . 71.1 p -116.63 -0.06 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.184 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.56 10.66 60.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.44 112.516 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.16 -36.79 85.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 74.24 110.846 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -15.23 62.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 71.24 110.921 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.01 -18.66 30.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.746 . . . . 34.44 112.472 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.481 ' O ' ' C ' ' A' ' 47' ' ' GLY . 9.6 m-85 -87.42 -24.95 24.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.38 . . . . 64.53 110.841 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -30.9 135.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 64.34 112.457 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -76.46 -43.86 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.96 0.409 . . . . 65.24 110.941 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.67 93.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 72.24 110.889 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.9 63.18 0.84 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 73.14 112.462 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 53.04 110.834 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.3 p -144.7 -172.74 3.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 65.12 110.896 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.45 167.09 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 70.43 110.878 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -46.96 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.858 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -146.04 153.05 40.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.863 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 HG21 ' A' ' 152' ' ' THR . 63.5 mt -144.81 130.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.12 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.458 HD12 ' HE3' ' A' ' 61' ' ' MET . 3.1 mt -134.78 104.65 10.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 75.54 111.145 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.76 98.43 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 62.02 112.32 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.5 -22.51 3.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 62.21 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.27 -60.65 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 65.22 110.865 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.458 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -173.45 -160.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 61.34 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 65.3 m -133.36 -73.0 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 74.21 110.907 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 61.8 160.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.894 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 53.35 112.459 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.819 0.342 . . . . 75.31 110.931 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 t -132.71 137.48 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 73.02 110.843 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -70.32 -27.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 73.25 111.153 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -122.98 41.29 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.79 -136.58 5.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 63.21 112.513 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.82 -74.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 63.04 110.896 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 160.4 32.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.878 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 147.04 35.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.873 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.61 158.65 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 64.33 110.914 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.29 127.19 32.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.45 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -57.76 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.03 110.895 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -179.76 177.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.47 36.95 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.883 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -50.49 -25.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 64.33 111.158 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 28' ' ' LYS . 2.6 mt -73.07 122.75 22.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.92 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -77.23 160.2 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.04 110.872 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -86.53 107.23 18.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.862 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 p -142.93 164.82 29.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.128 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.03 144.19 4.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 62.45 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.01 27.5 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.251 . . . . 73.45 112.326 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.57 73.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 33.35 112.458 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -84.87 161.91 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 75.02 111.121 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.44 HD21 ' CD2' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -102.84 128.83 49.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.916 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 128' ' ' VAL . 47.1 t -143.75 -116.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.816 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.427 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 0.8 OUTLIER 178.24 143.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.34 110.856 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 101.67 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.04 111.095 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 -167.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 74.2 110.929 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 1.057 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -54.65 -37.29 65.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.05 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 107' ' ' THR . . . 114.5 -65.12 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 75.31 112.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.655 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.71 120.88 7.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.252 . . . . 75.34 112.379 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 105' ' ' PRO . 10.0 p-10 26.53 64.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 61.01 110.915 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 1.057 HG21 ' HB3' ' A' ' 103' ' ' ALA . 5.5 t -163.22 54.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 52.31 111.124 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 24.8 m120 -40.11 -52.29 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.23 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.48 -167.79 53.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 63.54 112.501 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -118.81 -20.17 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 45.22 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -51.44 150.9 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.15 110.948 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' CD2' HD21 ' A' ' 98' ' ' LEU . 1.9 p90 -160.47 175.03 13.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.5 110.893 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -144.98 179.02 7.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.12 110.873 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 32.8 mm -102.24 -63.73 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 63.31 111.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER 79.37 112.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.2 110.921 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 t -98.8 -13.52 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 75.34 111.175 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.61 159.06 30.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 70.02 111.087 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -71.51 102.62 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.66 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 34.9 p -121.36 70.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.44 111.184 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -84.65 22.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.841 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 119' ' ' THR . 3.9 p90 -103.87 9.72 36.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.29 -30.98 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.04 110.93 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.26 165.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.851 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.22 -24.74 30.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 65.33 112.471 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -104.9 -33.56 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 73.13 110.904 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -119.73 170.29 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.819 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.02 112.88 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 64.02 111.129 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.449 ' CG2' HD13 ' A' ' 97' ' ' ILE . 9.6 p -84.94 144.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.41 111.149 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 31.6 p90 -178.65 112.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.41 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 144.04 -166.11 27.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 64.25 112.484 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt 172.87 -174.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 54.52 110.95 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.69 86.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.35 111.15 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -47.5 -74.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.865 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -150.78 146.99 26.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 71.3 110.868 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.36 26.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 41.4 112.51 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.3 -30.14 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 64.01 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -50.76 -25.94 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.03 110.864 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.2 mm -86.33 -38.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.156 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.2 t -51.32 -23.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.2 111.125 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.28 -43.48 15.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.857 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.13 -48.33 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.13 111.131 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.5 ptm -64.08 -20.15 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.46 29.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 74.53 110.873 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.69 -23.18 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.831 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.32 1.33 57.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 72.4 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.71 -147.29 10.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.755 -0.736 . . . . 44.44 112.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.1 134.35 6.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 72.13 110.858 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -70.59 76.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 71.45 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.71 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.21 110.859 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.54 -60.5 0.43 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 72.2 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -61.63 155.18 23.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 64.31 110.966 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 56' ' ' ILE . 63.2 p -124.91 129.42 50.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 70.42 111.166 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.3 -31.69 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 73.14 110.893 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -169.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.895 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -137.88 126.07 23.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 70.13 110.865 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.14 127.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 71.15 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.31 43.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.3 111.192 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.0 142.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.088 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.57 -64.98 1.01 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 31.33 111.078 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.77 178.12 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.5 110.858 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.63 -176.34 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.914 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 137.07 -146.46 18.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 63.3 112.477 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 128.14 53.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 73.4 110.917 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 5' ' ' THR . 1.6 tp -54.51 -56.53 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.905 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 53.12 110.923 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.807 0.337 . . . . 75.35 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.78 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.153 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.35 157.4 38.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 73.32 110.854 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.28 69.21 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.274 . . . . 74.11 112.34 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 13.8 m -130.34 55.57 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.145 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 24' ' ' LEU . 15.4 m -49.26 147.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.169 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.521 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -140.55 163.51 32.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 73.41 110.876 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -141.76 146.17 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 72.12 110.882 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -93.98 163.32 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.841 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 mm -132.5 102.66 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.12 111.142 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -105.04 158.0 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 63.13 111.149 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 12' ' ' VAL . 22.5 t -138.31 99.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.34 111.134 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.68 42.65 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.891 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.88 -8.08 67.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 33.55 112.504 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.0 tt0 -100.22 101.38 14.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.746 . . . . 73.53 110.844 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.81 126.89 13.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 74.31 112.298 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -83.87 -43.73 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 71.4 110.909 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.02 -151.32 20.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.42 112.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 156.83 21.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.812 0.339 . . . . 74.1 110.901 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.62 76.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 74.03 111.151 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.65 165.44 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.14 110.89 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -152.67 122.53 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.897 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 39.7 tt0 -47.89 137.03 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 61.31 110.88 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -108.22 120.93 43.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 74.5 110.948 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -76.36 57.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 53.11 110.847 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -28.17 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 22.3 111.067 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.75 -61.29 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.51 110.845 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.921 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.928 HG23 ' HB2' ' A' ' 33' ' ' ALA . 5.4 m -72.75 120.05 78.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.32 111.13 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -87.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.674 2.25 . . . . 74.3 112.382 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -44.58 68.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.898 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -46.07 -28.46 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 73.23 111.121 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.928 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -79.87 -63.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 53.21 111.067 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' ARG . 15.6 tt0 -57.98 -64.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.865 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 34' ' ' GLU . 14.2 t-20 -31.53 -51.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.873 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.01 -40.95 62.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.91 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -52.62 -25.01 9.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.2 110.88 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.37 -43.48 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 35.41 111.109 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 ' O ' HD23 ' A' ' 39' ' ' LEU . 8.0 tt -64.73 -13.98 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 64.42 110.914 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -6.2 31.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 54.25 110.826 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.2 p -101.62 -21.25 14.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.53 111.126 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.76 -17.12 54.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 65.52 112.502 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.59 -37.13 48.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 72.43 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -23.13 35.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.865 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.33 -4.55 40.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 72.23 112.515 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -164.02 167.13 20.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 70.43 110.842 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.31 20.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 73.41 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 108.11 16.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 75.12 110.936 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -69.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.852 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.79 32.67 2.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.33 112.47 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.13 -168.2 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 73.3 110.84 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 m -114.17 -168.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.24 -173.29 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 71.21 110.913 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -102.96 -74.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -154.64 103.52 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 74.32 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.88 128.27 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 61.44 111.17 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 148' ' ' ARG . 5.0 tt -136.11 106.85 9.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 72.31 111.144 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.76 105.72 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.697 2.265 . . . . 71.15 112.306 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.62 -49.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 42.2 112.511 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.27 -66.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 75.15 110.86 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -162.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.12 110.872 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.8 m -149.94 98.38 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 62.52 110.907 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -90.68 170.09 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 71.3 110.889 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 71.04 112.46 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.79 0.329 . . . . 71.4 110.903 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 177.6 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.844 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 35' ' ' ASN . 30.1 pt -86.9 -34.45 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 54.13 111.115 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.01 72.42 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.903 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.48 -130.02 10.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 70.04 112.501 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.78 -77.5 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 73.15 110.877 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.801 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -136.78 -177.34 4.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 64.22 110.903 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.23 174.91 11.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.22 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.7 158.61 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 61.2 110.853 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 119.48 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.44 110.872 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -47.46 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.863 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.53 167.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.12 110.875 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.48 37.11 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.872 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.79 -22.19 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.43 111.139 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 128' ' ' VAL . 70.3 mt -98.09 90.6 4.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.93 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -63.23 171.98 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 70.35 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.408 ' CD2' HG21 ' A' ' 97' ' ' ILE . 21.5 m80 -90.29 95.25 10.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 72.1 110.86 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 94' ' ' GLY . 18.2 p -131.14 149.56 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 60.33 111.117 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' THR . . . 56.17 155.07 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 41.13 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.37 24.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 64.41 112.348 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.592 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 84.28 -10.55 60.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 72.42 112.541 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 92' ' ' HIS . 6.2 mm -47.67 133.51 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 64.43 111.139 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -120.97 145.9 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 63.34 110.884 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 t -149.79 -133.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.821 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.542 ' HE3' HG23 ' A' ' 32' ' ' THR . 5.2 mtt -145.65 112.62 6.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 74.03 110.862 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -95.01 74.37 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 72.43 111.132 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -107.36 -75.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.91 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -134.99 -84.62 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 65.33 111.077 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.84 -83.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 43.12 112.481 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 107' ' ' THR . 53.9 Cg_endo -69.77 113.9 3.53 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.677 2.251 . . . . 63.12 112.351 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 34.47 46.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.32 110.896 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.6 p -142.26 46.74 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 55.23 111.143 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.73 176.52 8.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.13 110.913 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.82 -127.04 1.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 62.13 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -101.76 -171.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 63.44 110.917 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.2 mt-30 72.3 64.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.32 110.913 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -72.48 149.39 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.877 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 5.4 p90 -114.6 120.49 40.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.54 110.847 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.57 132.63 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.101 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.11 127.84 33.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 71.4 110.915 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 p -99.62 -31.35 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 65.02 111.155 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.06 24.77 5.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 72.44 111.089 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.69 135.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.547 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 67.0 p -139.97 61.25 1.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.137 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.06 3.61 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.547 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -86.29 1.44 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.14 110.919 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 pp -139.81 43.64 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.909 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.49 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.845 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 125' ' ' LYS . . . -50.11 140.53 17.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 70.15 112.469 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 1.0 OUTLIER 78.41 61.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.13 110.875 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.431 ' C ' HG23 ' A' ' 127' ' ' VAL . 2.3 m-70 -163.14 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.23 110.846 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.431 HG23 ' C ' ' A' ' 126' ' ' HIS . 5.4 t 74.67 86.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 64.4 111.095 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.482 ' O ' HD12 ' A' ' 90' ' ' LEU . 25.0 t -90.91 133.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.159 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.642 ' CB ' HG21 ' A' ' 29' ' ' VAL . 46.8 p90 -151.64 22.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.44 110.852 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -140.7 174.07 22.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 54.53 112.494 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.68 130.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 53.03 110.895 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' CA ' ' A' ' 96' ' ' GLY . 44.7 t -51.77 129.36 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.42 111.129 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -112.28 -59.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.844 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -139.82 140.99 36.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.888 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.7 1.78 43.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 75.44 112.445 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.56 -31.13 9.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 54.33 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -49.69 -26.72 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.89 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.34 -36.28 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 75.35 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.07 -22.75 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 62.45 111.137 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -83.75 -34.24 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 71.13 110.849 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.0 81.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.5 ptm -72.21 -11.87 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.51 110.951 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.92 25.2 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -16.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 71.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.66 -6.03 40.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.55 -166.05 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 73.4 112.452 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -140.04 -75.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 63.13 110.883 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -179.95 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 72.23 110.908 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -92.79 24.02 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.35 110.873 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.49 9.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 51.1 112.521 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.64 149.1 36.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 61.04 110.859 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -130.85 168.05 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 73.1 111.149 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.2 t -92.04 -2.49 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -140.95 -167.55 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 72.23 110.893 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.45 119.83 17.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 64.51 110.895 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.2 125.57 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 62.44 111.162 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -119.61 172.36 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 70.5 111.14 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.15 108.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.131 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -63.43 -60.28 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.14 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -148.9 177.2 9.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 64.22 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 10.7 p -178.17 163.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.909 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 147.11 -169.61 28.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.47 117.51 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 70.11 110.927 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.5 mm? -99.11 -69.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.54 110.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 1.2 tm-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 62.23 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 73.13 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.23 148.25 24.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 52.03 111.133 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.37 143.12 5.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 62.54 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 112.68 3.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 64.23 112.378 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.632 HG22 HD21 ' A' ' 164' ' ' LEU . 24.7 m -115.93 133.81 55.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 72.4 111.125 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.765 HG12 ' HG3' ' A' ' 163' ' ' GLN . 17.2 m -124.08 150.15 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 72.2 111.152 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.738 ' HB3' HD22 ' A' ' 164' ' ' LEU . 35.0 p90 -108.48 160.83 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.53 110.87 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.94 130.09 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.31 110.895 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.04 95.68 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 71.24 110.903 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.556 HD12 HG22 ' A' ' 138' ' ' ILE . 15.7 mt -75.62 151.91 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 63.42 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -129.52 168.49 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.01 111.051 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 17' ' ' LEU . 2.9 m -149.73 109.78 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.098 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.19 34.93 2.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.919 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 10.99 84.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 24.15 112.457 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.4 pt-20 -120.3 147.53 45.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.672 0.749 . . . . 62.25 110.876 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.21 56.63 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 62.03 112.336 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 12' ' ' VAL . 18.7 tp -132.97 8.32 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.11 110.969 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -166.15 12.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 24.34 112.494 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.96 151.35 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 72.12 110.888 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 25.9 m -124.95 170.2 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 52.44 111.146 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.436 ' OG ' HD21 ' A' ' 164' ' ' LEU . 14.0 t -122.72 151.33 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.15 110.875 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 5' ' ' THR . 20.0 m-85 -126.4 134.43 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 53.35 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -108.79 105.72 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.902 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.12 138.6 31.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -90.72 83.3 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.842 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.93 0.92 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.2 -34.23 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.15 110.866 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.2 mttm -97.51 -27.14 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 70.25 110.912 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.56 79.46 24.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 73.21 111.138 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -19.25 36.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 72.03 112.336 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -43.65 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 52.22 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.492 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -74.65 -53.19 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 73.4 111.122 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.65 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 75.13 111.099 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.98 -38.16 37.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.906 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.33 -61.86 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 72.34 110.903 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -51.51 -25.23 6.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.21 110.889 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -36.12 83.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.61 -21.05 35.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 110' ' ' SER . 83.1 mt -75.29 -60.44 2.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.929 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 64.02 110.896 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -84.53 -12.78 53.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 44.14 83.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 51.11 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.8 32.03 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 73.0 110.909 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.1 32.54 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 61.34 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.68 13.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 52.12 112.482 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.75 -170.54 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 75.01 110.848 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.57 176.6 37.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 72.02 112.502 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.68 -18.07 63.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 73.41 110.894 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.38 136.55 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 64.41 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.4 58.58 8.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.443 ' OG ' HD13 ' A' ' 158' ' ' ILE . 82.7 p -145.07 -166.27 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 44.11 110.888 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.96 169.06 24.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.869 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.56 ' CE1' HD11 ' A' ' 158' ' ' ILE . 53.6 m-85 -104.18 -67.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.35 110.86 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 59.65 20.64 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.23 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -146.97 115.63 6.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.23 156.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.97 112.88 8.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 75.21 111.112 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 86.31 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 71.31 112.384 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.75 9.05 8.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 65.12 112.487 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -69.98 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.51 110.867 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.95 -164.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 55.22 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.608 ' HB3' HG23 ' A' ' 114' ' ' ILE . 19.0 t -151.48 121.57 7.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.869 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -92.91 134.71 34.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.943 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 52.54 112.5 -179.965 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.826 0.346 . . . . 72.42 110.854 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.82 -179.13 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.83 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.78 -5.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 64.51 111.156 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.99 28.1 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.41 110.9 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.0 -126.18 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 74.42 112.458 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -144.49 13.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 73.24 110.908 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -171.44 126.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -119.03 143.83 46.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.1 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -66.43 156.5 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.899 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -78.03 134.68 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.35 110.884 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -61.98 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.14 110.902 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -173.94 148.21 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.892 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.52 49.97 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 28' ' ' LYS . 32.6 mm -72.5 -15.93 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.149 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -104.75 137.7 42.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.14 110.88 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -129.0 104.89 7.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.914 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.706 ' CB ' HG21 ' A' ' 97' ' ' ILE . 11.9 p80 -67.63 103.57 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.816 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.3 p -130.58 39.63 3.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 73.42 111.13 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.8 163.8 32.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.482 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 146.26 59.6 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.738 2.292 . . . . 74.3 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.02 13.71 65.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.71 -0.757 . . . . 70.33 112.474 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.754 HD13 ' HB3' ' A' ' 131' ' ' LYS . 28.6 mm -89.27 138.61 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 63.15 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 98' ' ' LEU . 6.1 tt -93.99 114.6 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 75.14 110.896 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -113.66 140.29 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 64.53 110.864 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.451 ' HE3' ' CG2' ' A' ' 32' ' ' THR . 3.5 mmt -69.55 145.5 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.44 110.849 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -138.14 139.05 39.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 50.24 111.124 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' OD1' HG22 ' A' ' 107' ' ' THR . 0.4 OUTLIER 174.63 -69.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 72.21 110.908 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -136.42 -40.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 64.54 111.114 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.76 -69.02 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 52.34 112.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -104.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.265 . . . . 71.5 112.356 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -90.77 62.95 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -156.84 68.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.2 111.122 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -44.66 -60.73 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 62.32 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.59 43.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 63.34 112.448 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.422 ' HB2' HD13 ' A' ' 39' ' ' LEU . 2.7 p -129.04 9.94 5.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 72.03 110.851 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -72.26 -166.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.11 110.931 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD12 ' A' ' 98' ' ' LEU . 1.9 t80 -143.87 128.16 17.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.908 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 99' ' ' SER . 32.8 t80 -123.25 106.85 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 63.55 110.888 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 62' ' ' CYS . 7.5 tt -120.55 103.8 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 71.42 111.181 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -85.44 153.11 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 61.01 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 28.95 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.119 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.93 165.11 5.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 43.23 111.067 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -61.78 96.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -122.9 62.43 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 71.11 111.155 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.53 25.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.3 110.902 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 119' ' ' THR . 4.2 m-90 -69.9 -22.88 63.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.934 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.512 HD13 ' NE2' ' A' ' 126' ' ' HIS . 63.0 mt -116.63 34.68 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -86.99 44.42 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 73.12 110.844 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.06 52.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.776 -0.726 . . . . 71.3 112.526 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -171.34 -45.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 72.41 110.894 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.512 ' NE2' HD13 ' A' ' 122' ' ' LEU . 2.0 m-70 -98.49 142.34 30.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 61.12 110.863 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.78 90.61 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 63.31 111.1 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 90' ' ' LEU . 2.8 p -82.53 143.56 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.151 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.492 ' CZ ' HG22 ' A' ' 32' ' ' THR . 2.5 p90 -176.51 134.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.875 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.31 137.99 9.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 54.03 112.487 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.754 ' HB3' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -149.37 172.05 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 54.31 110.907 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.96 139.04 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 72.2 111.105 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -117.9 -29.85 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 54.01 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.56 158.33 36.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 58.71 85.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 55.24 112.484 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.6 mmm -92.04 -24.15 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 72.54 110.848 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 1.9 p-10 -80.57 -34.53 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.52 110.877 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 10' ' ' ILE . 46.6 mm -39.42 -48.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 65.32 111.132 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 114' ' ' ILE . 91.7 t -90.36 -50.8 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 60.41 111.135 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 12.1 mm-40 -44.68 -59.77 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.88 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.74 78.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.03 111.082 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.522 ' SD ' HD13 ' A' ' 156' ' ' ILE . 8.1 tmm? -50.08 -45.04 52.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 73.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -27.76 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 64.34 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -63.31 -25.45 68.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -90.52 21.92 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.1 110.872 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.89 -159.03 21.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 53.21 112.52 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -155.47 147.59 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 71.41 110.836 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -76.34 64.24 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.43 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -176.19 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.63 -52.47 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 71.35 112.454 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.04 112.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 61.11 110.905 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 154' ' ' LYS . 28.1 m -77.88 127.96 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 62.3 111.166 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -46.15 -32.07 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 33.33 110.86 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.589 ' H ' HG22 ' A' ' 152' ' ' THR . 2.8 mttt -133.51 -178.56 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 61.04 110.871 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -98.82 107.28 19.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 55.45 110.938 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.0 mt -98.3 108.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.43 111.147 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.1 t -119.24 156.93 29.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.34 111.148 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 53' ' ' PHE . 3.5 mp -83.48 139.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.73 -59.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.124 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.74 161.81 41.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.64 -168.59 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.32 110.894 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.68 -165.58 26.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 74.44 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.765 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.2 mt-30 -113.09 138.82 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 62.43 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -121.36 156.2 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.913 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.852 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.797 0.332 . . . . 40.53 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.59 141.64 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.23 111.111 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.62 145.83 37.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 72.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 121.59 8.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 72.42 112.301 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 164' ' ' LEU . 37.8 m -106.64 128.04 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.557 ' CG1' HD11 ' A' ' 24' ' ' LEU . 3.3 m -111.73 141.99 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.23 111.164 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.809 ' HB3' HD22 ' A' ' 164' ' ' LEU . 4.8 p90 -122.35 160.22 25.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.902 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 161' ' ' CYS . 11.3 m-85 -142.03 143.1 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.929 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.21 82.07 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.835 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.9 147.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.24 150.56 41.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.32 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 17' ' ' LEU . 67.0 t -135.81 97.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 73.1 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.87 24.41 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.187 -0.46 . . . . 45.04 110.841 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.09 59.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.48 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -108.34 143.0 26.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 74.55 110.881 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 152.82 68.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.661 2.241 . . . . 75.14 112.339 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 12' ' ' VAL . 17.5 tp -129.63 -0.38 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.31 110.905 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.588 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 138.48 171.71 12.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 51.51 112.508 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -105.99 127.41 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 60.3 110.855 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 138' ' ' ILE . 34.0 t -113.18 100.18 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.31 111.137 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.8 p -102.17 142.44 33.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.819 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.52 104.5 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.891 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -51.86 167.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 72.21 110.833 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.557 HD11 ' CG1' ' A' ' 6' ' ' VAL . 59.9 mt -117.46 126.85 53.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 74.5 110.93 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 90' ' ' LEU . 23.0 m-85 -77.33 59.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.899 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.06 -7.51 52.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 73.31 111.121 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.85 -65.05 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.02 110.93 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -61.22 2.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.2 m -109.53 83.29 2.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 55.32 111.121 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.97 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 52.42 112.351 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.31 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -47.17 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.52 111.11 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.31 -33.96 59.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.5 111.096 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.61 -31.75 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.51 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.671 ' ND2' HG23 ' A' ' 78' ' ' ILE . 11.3 t-20 -77.49 -67.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.1 110.908 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.18 -43.33 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.849 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HB3' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -63.36 -29.61 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.22 110.861 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.89 -43.33 20.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 35.24 111.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.98 -38.41 82.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.907 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -69.55 -47.88 62.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 51.1 110.893 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.1 p -72.34 -13.52 61.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 72.25 111.121 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.51 69.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 75.12 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.1 41.56 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 74.21 110.932 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 78' ' ' ILE . 5.9 mtpm? -130.09 -2.63 4.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.914 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.73 -14.06 65.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 73.31 112.488 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -33.85 76.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 65.53 110.936 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 48' ' ' TYR . . . 85.27 -141.32 19.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 71.11 112.482 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 1.3 t80 82.56 85.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 72.2 110.884 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 -47.95 4.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -125.29 113.33 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.53 112.512 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 p -88.11 -168.61 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 64.1 110.833 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 p -139.52 96.0 3.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 64.14 110.911 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HZ ' HD11 ' A' ' 158' ' ' ILE . 34.2 m-85 -81.37 107.11 13.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.11 110.858 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.29 29.84 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 73.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.05 24.4 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.21 110.887 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.43 141.73 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.13 111.107 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HE3' ' A' ' 61' ' ' MET . 4.4 mt -131.95 110.36 14.34 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 74.35 111.15 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 89.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.657 2.238 . . . . 74.45 112.403 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.7 14.86 4.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 75.31 112.5 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 -64.51 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 75.34 110.87 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.559 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -177.16 -169.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 72.14 110.883 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.8 m -146.4 142.91 28.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 62.22 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 140.37 51.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.925 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 44.32 112.466 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.833 0.349 . . . . 73.11 110.874 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -87.92 -174.9 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 62.14 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 44' ' ' LYS . 27.9 pt -80.35 -32.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 75.43 111.126 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -89.19 44.29 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 71.22 110.932 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 -109.17 2.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 52.51 112.494 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -52.56 174.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.395 . . . . 75.42 110.851 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -97.3 -172.19 2.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 71.42 110.883 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.89 145.17 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.853 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -60.61 176.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 74.02 110.882 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.4 126.4 40.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 72.53 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.27 -48.71 26.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -175.19 149.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 71.42 110.862 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.02 46.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.881 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -62.37 -14.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 64.03 111.163 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -119.43 125.67 49.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 65.4 110.893 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -164.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.24 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.437 ' CE1' HG21 ' A' ' 128' ' ' VAL . 65.6 m80 -97.42 65.39 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 65.22 110.897 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -20.05 53.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.21 111.126 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.23 174.77 46.55 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.667 2.245 . . . . 61.22 112.379 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 126.02 -30.6 4.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 41.24 112.485 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 98' ' ' LEU . 14.1 mm -62.8 158.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 70.4 111.114 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.615 HD23 ' CD2' ' A' ' 112' ' ' PHE . 5.8 mp -107.05 147.97 29.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.893 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.57 150.03 49.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 38.1 mmt -79.37 106.38 11.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.1 110.844 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.67 73.57 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.08 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 34.3 t-20 -105.02 -81.79 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.924 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 102' ' ' ASN . . . 176.8 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 61.5 111.129 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.31 171.34 38.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 65.11 112.476 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 54.11 112.335 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 65.58 32.41 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.456 HG22 ' HG3' ' A' ' 82' ' ' LYS . 29.2 p -148.02 69.52 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 72.12 111.13 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.55 18.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 73.21 110.911 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 107' ' ' THR . . . -63.74 -144.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.8 -0.714 . . . . 74.41 112.434 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 t 51.68 -150.92 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 72.35 110.897 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -116.52 -77.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 64.15 110.931 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.615 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 176.53 172.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 70.03 110.852 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 138.66 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.68 114.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 64.12 111.119 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.5 p -71.43 -27.23 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 61.45 110.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 57.53 17.08 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 62.3 111.132 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 119' ' ' THR . . . -167.56 137.48 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 75.01 111.09 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -51.21 129.99 25.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 63.14 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 117' ' ' ALA . 71.6 p -131.5 59.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 64.42 111.144 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -51.24 -24.0 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 63.32 110.893 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -63.13 -30.29 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 64.51 110.914 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.8 mt -111.68 64.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -110.74 15.89 21.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.809 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.64 31.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 63.22 112.487 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -126.17 -62.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 72.54 110.874 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -98.0 121.72 40.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 72.32 110.854 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 127' ' ' VAL . 29.9 t -58.45 96.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.32 111.095 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 98' ' ' LEU . 40.0 t -86.79 128.22 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 72.52 111.071 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HA ' HD22 ' A' ' 90' ' ' LEU . 12.5 p90 -158.5 43.33 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.862 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -119.19 -168.45 14.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.34 112.467 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.463 ' H ' HD13 ' A' ' 98' ' ' LEU . 17.5 ttpp 178.48 150.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 74.22 110.909 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 96' ' ' GLY . 79.4 t -92.26 85.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 74.52 111.114 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -66.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.52 110.892 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.02 123.11 13.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.44 73.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 44.03 112.497 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -93.55 -28.69 15.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 60.43 110.859 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -70.07 -34.91 73.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 73.31 110.903 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.588 HD11 ' HA3' ' A' ' 18' ' ' GLY . 29.1 mm -66.77 -38.01 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.35 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.0 t -81.46 -0.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 54.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -117.7 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 41.41 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.45 -57.94 10.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 54.21 111.072 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.4 ttm -50.7 -29.97 12.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 65.22 110.89 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.866 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -62.45 -13.47 30.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.856 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.18 17.1 3.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.11 110.89 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.15 -146.07 19.61 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.489 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -152.51 -87.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 70.31 110.883 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -156.04 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.874 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.12 19.94 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.44 110.871 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.56 -157.72 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 44.42 112.548 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.7 mttt 63.15 101.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 63.24 110.896 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.582 HG21 HD12 ' A' ' 156' ' ' ILE . 33.8 p -84.02 155.45 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.34 111.148 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -17.21 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 62.13 110.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -126.92 -165.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.883 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.55 106.24 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 44.24 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' THR . 16.4 mt -94.03 122.73 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 73.04 111.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.4 p -139.02 169.52 17.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HZ ' ' A' ' 53' ' ' PHE . 20.1 mt -107.04 99.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.52 111.165 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.53 8.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 45.05 111.127 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -133.15 168.64 18.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.2 110.845 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.405 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 14.1 p -176.95 -167.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 61.3 110.864 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.82 -152.06 16.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 44.02 112.512 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.69 129.72 55.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 72.53 110.913 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 5' ' ' THR . 1.5 pt? -100.06 -29.45 12.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.898 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.03 110.864 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 74.32 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.93 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 64.13 111.134 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -97.76 159.39 31.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 71.4 110.895 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 148.57 65.44 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 71.21 112.378 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.472 ' C ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.51 173.74 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 61.33 111.118 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.573 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -167.2 143.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -124.36 154.57 40.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.83 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -135.98 132.49 36.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 65.55 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.23 108.39 19.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.824 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mm -80.96 110.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.22 111.169 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -113.15 172.66 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 70.41 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.27 94.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.32 111.08 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 72.09 56.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.858 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.51 11.63 57.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 52.04 112.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -123.69 107.37 31.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 53.44 110.875 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.81 138.56 37.95 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.634 2.223 . . . . 74.53 112.349 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -103.31 -53.23 2.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.5 -154.23 9.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 75.4 112.491 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 168.12 24.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 71.43 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 -177.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.21 111.123 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -130.09 96.88 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 65.24 110.826 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -93.34 115.26 27.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 70.2 110.909 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -113.32 113.88 25.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 42.2 110.884 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 129' ' ' PHE . 23.8 mt -80.25 140.01 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.55 110.894 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 29' ' ' VAL . 45.0 m-85 -88.37 82.58 6.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.3 110.848 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -29.86 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.41 111.104 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.28 -28.19 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 54.24 110.831 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.845 ' HG3' HD21 ' A' ' 90' ' ' LEU . 5.0 mmtt -96.88 -34.55 11.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.898 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 129' ' ' PHE . 15.5 m -131.9 88.79 40.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 71.24 111.152 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.63 12.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.661 2.241 . . . . 73.31 112.336 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.92 -48.48 11.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 32' ' ' THR . 21.6 m -76.7 7.93 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 73.55 111.132 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -81.18 -40.98 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 72.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 35' ' ' ASN . 13.5 pt-20 -90.76 -32.6 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 61.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' GLU . 54.4 t-20 -30.87 -70.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.881 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -71.44 -30.95 66.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 63.23 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.427 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.5 tmm_? -50.21 -43.1 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 73.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -68.06 -32.34 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 71.32 111.122 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.746 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.8 21.56 12.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.903 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.573 ' OG ' HG11 ' A' ' 6' ' ' VAL . 36.2 t -127.61 -26.67 2.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.2 110.843 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -109.89 -16.53 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 64.14 111.098 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.63 86.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 72.53 112.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -170.23 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 73.2 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 20.73 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.12 110.9 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 -26.18 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 64.0 112.465 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -147.86 -176.34 5.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 73.23 110.871 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.92 -144.49 16.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 43.01 112.494 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.84 174.22 6.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.988 0.423 . . . . 73.23 110.918 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 14.43 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.927 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -158.82 44.36 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 72.11 112.494 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -89.99 133.53 34.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 73.14 110.873 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.7 m -51.89 172.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 73.21 110.866 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 73.37 1.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.838 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -70.61 175.24 5.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.54 110.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.88 104.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.827 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.1 mt -148.51 132.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.33 111.135 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' SD ' ' A' ' 61' ' ' MET . 7.8 pt -154.17 109.14 2.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 73.33 111.147 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 126.69 13.61 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.654 2.236 . . . . 61.12 112.347 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.45 3.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 72.44 112.491 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.4 -75.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 75.01 110.843 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.551 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.22 -164.5 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 53.42 110.927 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.4 m -125.51 -70.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 51.25 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 65.37 153.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 63.34 110.951 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 73.42 112.527 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.827 0.346 . . . . 74.14 110.886 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 t -145.16 120.0 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 71.32 110.856 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 pp -55.84 -19.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 75.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 -22.0 14.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.24 -112.8 0.35 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.729 -0.748 . . . . 55.45 112.501 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -108.96 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 73.43 110.872 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -159.96 155.77 26.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.882 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -112.65 171.27 7.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 70.44 110.849 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.71 142.49 30.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 51.45 110.878 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.62 141.84 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.2 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -102.91 -64.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.841 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.29 165.81 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.864 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.17 45.69 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.894 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.9 mt -68.88 -11.27 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.23 111.123 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 28' ' ' LYS . 8.0 mt -98.18 70.12 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -61.35 130.32 45.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.869 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.97 90.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 74.15 110.83 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 p -99.28 31.69 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 54.21 111.163 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.69 177.47 26.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 54.13 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.24 7.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.252 . . . . 62.03 112.34 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.33 14.07 66.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.33 112.457 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -86.99 125.49 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 73.51 111.174 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 129' ' ' PHE . 3.1 tt -93.05 137.81 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.53 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 98' ' ' LEU . 13.8 t -141.67 -130.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 55.32 110.826 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 5.9 mmt -149.94 -175.05 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.13 110.844 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -169.05 147.28 3.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.137 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.8 m-20 166.5 -78.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 54.11 110.878 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.98 -35.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 71.13 111.156 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.77 -127.19 2.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 64.22 112.499 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 149.03 66.25 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.34 112.352 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 51.5 29.3 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 103' ' ' ALA . 3.1 m -132.87 21.79 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.139 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 107' ' ' THR . 3.2 m120 29.49 -98.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.865 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.91 169.31 13.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 71.23 112.522 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.57 11.65 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 70.15 110.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -175.26 156.58 2.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 52.42 110.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.423 ' HE2' HD11 ' A' ' 114' ' ' ILE . 13.6 p90 -111.82 150.18 30.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.45 110.867 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 114' ' ' ILE . 18.6 p90 -108.92 67.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.54 110.886 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 113' ' ' PHE . 36.0 mt -32.19 115.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.44 111.148 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.0 m -84.13 149.26 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.843 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.4 p -113.71 18.56 17.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.144 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -166.19 -176.59 3.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.42 111.108 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -77.53 104.47 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.45 110.907 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -126.79 55.51 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 73.52 111.137 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 21.99 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.867 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -94.94 11.03 33.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 75.44 110.881 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.08 25.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 70.12 110.923 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -58.17 -65.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.873 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.87 83.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.14 112.464 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 179.38 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 62.11 110.863 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -126.89 162.5 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.861 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -76.26 -166.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.18 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.688 ' H ' HG12 ' A' ' 127' ' ' VAL . 8.2 p -170.34 141.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.32 111.143 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.813 ' O ' HD22 ' A' ' 98' ' ' LEU . 2.6 p90 -177.66 110.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . 121.1 145.98 7.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 73.41 112.464 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -157.68 139.53 14.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.689 HG11 ' HG2' ' A' ' 136' ' ' MET . 25.2 t -58.45 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.132 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -32.83 65.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.96 178.31 8.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 73.04 110.866 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.17 57.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 53.42 112.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.689 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 75.42 110.851 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -54.55 -22.38 12.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 35.23 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 34.9 mm -78.11 -41.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 50.32 111.178 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -53.75 -47.2 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.25 111.136 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.23 -29.09 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.98 -26.7 61.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.42 111.129 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.2 mtm -73.48 -49.3 27.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.67 39.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 72.53 110.896 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -16.42 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.818 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -130.52 13.09 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 54.32 110.926 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.45 44.82 1.44 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.733 . . . . 45.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t 37.45 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 52.01 110.877 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.464 ' C ' HG22 ' A' ' 57' ' ' ILE . 13.3 mmm-85 -141.36 18.08 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.892 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -128.79 -18.54 3.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 64.24 110.866 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.51 -59.55 0.48 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 75.32 112.444 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.78 158.48 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.879 0.371 . . . . 73.21 110.885 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.77 154.01 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 75.14 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -21.48 59.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 64.3 110.825 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -132.28 165.93 23.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 75.44 110.877 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -108.47 124.07 49.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 74.42 110.881 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 4.4 mp -97.61 107.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.55 111.135 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.647 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -105.54 145.1 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 64.45 111.114 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.444 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -90.29 139.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.4 111.137 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.92 -57.76 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 52.23 111.123 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -167.2 169.08 12.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.11 110.852 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.0 m -146.95 168.87 20.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 72.1 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.45 178.48 35.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 70.22 112.495 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -47.2 48.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 71.44 110.859 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 61.72 108.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 73.34 110.844 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 62.34 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.75 143.88 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 70.42 111.094 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -54.76 134.75 65.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.664 0.745 . . . . 75.34 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 73.55 112.323 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 22' ' ' PHE . 62.2 m -115.05 138.79 50.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.146 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.49 147.65 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.136 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -107.98 146.23 32.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.21 133.12 45.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.33 110.879 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.82 127.6 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 64.05 110.89 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.34 120.15 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 71.23 111.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -127.35 158.22 37.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 45.4 111.104 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.9 m -129.01 106.71 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.14 111.129 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 71.17 35.44 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 74.12 110.863 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.19 -6.69 78.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 65.12 112.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 10.4 tp10 -98.06 136.42 21.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 75.43 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 133.72 26.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.718 2.279 . . . . 51.33 112.333 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.3 tp -116.81 -34.94 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.31 110.924 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -176.87 43.51 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 75.51 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.27 152.62 50.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 75.11 110.886 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 173.86 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 51.22 111.128 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.0 p -139.72 143.56 37.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.883 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 5' ' ' THR . 3.0 m-85 -122.48 133.18 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.886 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -101.87 123.15 45.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 55.44 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 33' ' ' ALA . 12.2 mt -88.45 124.35 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 70.34 110.898 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 90' ' ' LEU . 25.2 m-85 -77.01 62.86 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.835 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.25 -29.36 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 63.05 111.093 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.52 -45.6 91.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.22 110.847 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HD2' HD12 ' A' ' 89' ' ' ILE . 34.0 mmtm -90.14 -31.19 17.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 53.31 110.915 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.9 m -129.8 84.9 59.64 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.624 0.726 . . . . 75.45 111.092 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -31.33 20.86 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.719 2.279 . . . . 63.42 112.32 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -46.24 10.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 61.34 110.869 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -6.73 42.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.01 111.168 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.761 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -77.08 -40.56 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.31 111.072 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 35' ' ' ASN . 51.6 mt-10 -92.46 -44.31 8.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 72.23 110.88 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.7 t30 -28.0 -64.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.936 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.777 ' HA ' HD12 ' A' ' 39' ' ' LEU . 66.5 t80 -72.0 -37.32 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.0 tmm_? -51.02 -35.64 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.863 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -66.72 -32.4 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 61.2 111.121 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 36' ' ' PHE . 8.2 mt -72.78 -54.31 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 51.34 110.882 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 m -56.37 -50.62 71.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.879 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 62.4 p -72.89 -26.92 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.14 111.171 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.75 101.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 75.32 112.482 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -149.53 34.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 72.4 110.886 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -131.7 3.55 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 65.2 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.32 15.96 63.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 71.4 112.498 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -174.69 173.96 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 72.22 110.906 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.89 -172.43 15.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 43.21 112.482 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.36 144.66 27.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.97 0.415 . . . . 63.22 110.89 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.49 -60.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.936 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.4 45.77 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 73.44 112.42 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -93.59 -171.04 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 70.3 110.831 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.8 m -87.65 -167.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.893 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.29 -174.09 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 71.23 110.842 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.3 -76.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 65.41 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.11 162.71 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.877 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.667 HD11 HD12 ' A' ' 156' ' ' ILE . 48.5 mt -149.83 129.9 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 63.35 111.077 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 60' ' ' PHE . 1.2 pt -143.94 117.94 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.641 0.734 . . . . 71.44 111.14 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.8 Cg_endo -69.69 130.63 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.73 2.287 . . . . 62.43 112.349 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.68 21.7 79.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 53.34 112.48 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -137.62 -69.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 74.41 110.857 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.541 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.52 -170.53 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 70.32 110.904 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.51 107.72 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 62.34 110.847 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.41 179.74 4.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 64.21 110.901 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 33.21 112.513 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.793 0.33 . . . . 62.22 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 4.0 t -127.14 107.97 10.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.875 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 35' ' ' ASN . 8.2 pt -56.5 -19.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.13 111.135 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.64 28.94 7.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 72.1 110.919 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.16 -137.65 5.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 34.44 112.47 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.443 ' C ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -109.95 -34.78 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.909 0.385 . . . . 70.53 110.899 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -178.91 146.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.55 110.897 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 160.39 16.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 72.43 110.903 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.7 166.58 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -59.17 -174.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 63.4 110.938 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.85 -63.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 71.54 110.884 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -177.74 161.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.882 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 68.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.866 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 28' ' ' LYS . 12.7 mt -78.16 -1.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.15 111.168 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB2' HG11 ' A' ' 128' ' ' VAL . 1.1 mt -119.24 111.67 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 53.55 110.904 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.65 175.08 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 44.21 110.922 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -96.85 83.76 3.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 63.15 110.822 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 21.67 13.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.24 111.162 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.79 145.76 12.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 70.32 112.495 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 115' ' ' CYS . 53.2 Cg_endo -69.82 -9.64 26.58 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 72.51 112.315 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -100.98 -20.02 15.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 73.11 112.507 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.56 141.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 63.34 111.145 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 114' ' ' ILE . 17.3 mt -116.17 162.94 16.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.25 110.891 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 t -151.48 -142.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.891 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -152.12 133.73 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.21 110.89 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.16 103.44 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.071 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 1.9 p30 -131.97 -179.53 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 70.13 110.863 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.585 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -64.17 -34.5 78.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.128 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 119.76 -62.86 0.47 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 60.33 112.471 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.9 Cg_endo -69.75 94.61 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 2.269 . . . . 54.23 112.332 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 43.17 56.64 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 109' ' ' GLY . 4.2 m -121.26 -1.68 9.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 65.43 111.117 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 47.18 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 62.44 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 115.68 126.73 4.08 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 71.53 112.486 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.15 -31.0 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.32 110.86 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.76 145.01 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.925 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CE2' HD13 ' A' ' 98' ' ' LEU . 2.8 p90 -131.62 179.64 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 75.31 110.936 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -150.5 130.7 13.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 64.43 110.908 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 45.2 mt -48.1 -87.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 75.41 111.126 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.49 ' C ' HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER 160.96 -61.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 63.54 110.875 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 115' ' ' CYS . 1.4 p 67.85 -1.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 54.03 111.16 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.95 151.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 53.43 111.111 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -55.5 132.5 48.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.875 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -129.95 52.62 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.164 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 64.42 110.86 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.25 -36.57 81.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.939 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.55 74.5 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.927 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -157.65 55.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.855 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.56 -44.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 70.04 112.494 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -64.74 -42.98 94.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.81 0.338 . . . . 51.03 110.868 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -112.83 166.07 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.813 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -68.57 -149.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 44.41 111.128 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.643 ' O ' HG11 ' A' ' 29' ' ' VAL . 9.2 p -171.84 157.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.21 111.116 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' ' O ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER 179.4 167.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.903 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 57.03 142.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 61.51 112.462 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -154.4 133.09 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 73.25 110.885 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -44.94 114.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.116 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -88.43 -75.23 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 72.15 110.914 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -138.14 142.63 40.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 72.01 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.47 8.8 26.32 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 74.04 112.476 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.4 ttt -48.35 -32.33 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 61.11 110.882 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -49.31 -28.52 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 71.03 110.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.1 mm -78.21 -40.55 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 75.31 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.3 t -51.0 -47.15 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 64.13 111.142 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.96 -36.24 65.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.24 110.929 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.24 80.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 50.13 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.9 mtm -70.88 -19.13 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -89.41 21.79 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 -20.49 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 72.14 110.875 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -102.4 -6.02 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.54 110.937 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.11 3.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 60.34 112.513 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.17 135.28 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 72.13 110.849 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 36.5 mmm-85 -70.94 79.69 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.01 110.864 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 175.77 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.26 -61.91 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 64.1 112.474 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -74.51 -178.07 3.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 50.12 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.7 22.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 73.2 111.155 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -21.64 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.819 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -131.76 -164.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 55.24 110.876 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 119.7 19.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.52 110.934 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.667 HD12 HD11 ' A' ' 56' ' ' ILE . 49.7 mt -92.71 101.44 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 71.22 111.121 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.8 162.75 13.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.169 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.43 142.92 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.53 111.102 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -102.23 -55.35 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 70.43 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -142.93 179.43 7.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -170.97 -167.01 0.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 70.13 110.906 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 41' ' ' THR . . . 137.16 -148.16 19.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 51.55 112.475 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -112.08 136.91 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.13 110.869 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 tp -54.12 -57.0 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 70.31 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 62.43 110.935 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.355 . . . . 51.54 110.883 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 60.14 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.37 158.95 31.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.656 0.741 . . . . 52.2 110.865 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.77 65.08 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.684 2.256 . . . . 70.41 112.348 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -131.44 57.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.11 111.148 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.427 HG13 HD12 ' A' ' 24' ' ' LEU . 5.4 m -49.05 147.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.151 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -138.25 164.99 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.878 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -144.84 138.35 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.51 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.694 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.2 t0 -101.79 91.27 4.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 156' ' ' ILE . 9.4 mm -59.76 143.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.53 111.151 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.63 163.39 22.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.136 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.4 t -151.8 104.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 73.13 111.14 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 52.39 46.32 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.841 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.6 10.97 83.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 34.35 112.469 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -133.66 109.1 12.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.738 . . . . 72.22 110.903 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.3 Cg_endo -69.75 168.92 20.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 63.45 112.374 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.06 -58.45 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.927 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.24 -167.64 27.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 41.41 112.49 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -100.24 127.75 46.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 61.35 110.909 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 138' ' ' ILE . 7.7 t -101.65 120.16 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.124 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -94.93 84.28 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.32 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.54 95.51 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 55.12 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -78.41 153.64 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.5 110.866 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 129' ' ' PHE . 18.3 mt -115.06 133.21 56.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 55.11 110.888 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -81.54 78.64 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.13 110.879 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.9 -7.0 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 51.11 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -61.31 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 63.42 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.63 -60.01 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.57 83.2 4.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.632 0.729 . . . . 75.45 111.105 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 60.23 112.342 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 179.38 -59.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 70.14 110.908 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.547 HG23 ' CE ' ' A' ' 100' ' ' MET . 51.1 m -56.31 -48.57 76.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.02 87.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.33 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.85 -30.11 9.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.85 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.62 -61.27 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 64.42 110.907 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.9 -33.65 57.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.837 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.97 69.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.32 110.894 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.39 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 70.22 111.118 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.2 tt -78.12 -2.6 38.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t -98.93 -8.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 61.23 110.848 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.6 p -115.96 8.02 14.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.3 37.0 30.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.734 . . . . 62.24 112.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -110.02 30.96 6.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 74.41 110.92 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.675 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -128.27 32.13 4.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 52.51 110.89 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.3 -45.1 2.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.45 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -138.91 167.04 22.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 72.31 110.892 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.67 -108.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.758 . . . . 74.42 112.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -177.25 124.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.389 . . . . 75.1 110.965 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -26.44 13.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.889 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.68 -67.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.741 . . . . 35.04 112.494 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 157' ' ' THR . 3.4 t 45.42 -160.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 63.21 110.844 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -166.4 162.55 17.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 33.21 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HE1' HD11 ' A' ' 158' ' ' ILE . 22.8 m-85 -101.78 -78.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.868 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.74 25.82 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.872 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.94 21.42 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.66 138.87 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.106 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 HD12 ' CE ' ' A' ' 61' ' ' MET . 11.7 mt -121.24 102.72 42.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.708 . . . . 74.35 111.127 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 77.89 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.702 2.268 . . . . 72.41 112.31 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.12 -40.82 0.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 63.14 112.494 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -64.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 72.31 110.917 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.4 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.96 -167.48 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.88 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 t -143.45 129.56 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -152.92 164.28 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 60.42 110.895 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 64.41 112.54 179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.8 0.333 . . . . 72.34 110.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.07 -177.4 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.35 110.855 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.675 HD12 ' HD2' ' A' ' 44' ' ' LYS . 25.2 pt -93.36 -38.09 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.41 111.144 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -80.22 -13.26 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.927 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.84 -172.32 45.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 72.33 112.529 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.73 -96.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 65.11 110.898 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -121.44 176.71 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.89 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -149.42 153.94 38.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.915 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 164.03 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.871 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.04 145.75 25.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 75.05 110.838 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -52.32 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.874 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -179.0 163.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 53.34 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.03 36.99 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.877 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.6 mm -53.19 -26.63 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 71.41 111.172 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.36 112.59 21.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 74.23 110.872 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 93' ' ' THR . 4.7 mmtt -103.04 93.83 5.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 75.1 110.926 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.816 ' HB3' HG21 ' A' ' 97' ' ' ILE . 4.6 p80 -64.8 108.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 54.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' LYS . 13.3 p -128.09 33.81 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.11 111.159 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.58 174.63 44.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 53.5 112.487 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 160.2 50.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 74.13 112.333 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 14.54 76.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 65.04 112.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 92' ' ' HIS . 44.7 mm -99.98 137.5 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 62.32 111.154 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 99' ' ' SER . 3.1 tt -100.12 138.31 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.889 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.667 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -121.56 131.89 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.866 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.547 ' CE ' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.34 -27.17 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.902 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.67 167.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 60.13 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER 169.42 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 63.41 110.867 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' H ' HG23 ' A' ' 107' ' ' THR . . . -106.25 -20.14 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 62.4 111.116 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 130.41 -58.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.492 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.75 83.52 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 73.44 112.366 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 27.06 82.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.2 110.926 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 103' ' ' ALA . 1.8 t -156.87 54.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.54 111.158 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -54.33 -40.87 68.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 60.42 110.914 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.76 -152.0 39.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 63.32 112.459 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.9 m -134.21 65.14 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 42.02 110.866 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -155.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.54 110.947 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 29.9 t80 -177.4 75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.41 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 1.5 t80 -90.33 129.01 36.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 73.33 110.882 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 61.7 mt -107.55 130.59 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.166 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.5 t -99.98 136.71 39.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -120.39 -20.46 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 71.14 111.115 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.86 179.01 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 64.35 111.113 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 87.98 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 73.1 110.888 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.534 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 8.4 p -122.5 62.61 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.155 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 23.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 50.53 110.869 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.534 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -94.65 19.5 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.1 11.2 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 65.11 110.931 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.8 -63.44 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 53.4 110.837 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.31 57.7 3.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.659 -0.781 . . . . 64.13 112.521 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -156.81 -52.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 61.54 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -113.98 148.26 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.01 110.867 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.8 t -90.8 107.53 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.53 111.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 92' ' ' HIS . 35.7 t -83.22 140.61 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 72.45 111.172 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 24' ' ' LEU . 9.3 p90 -159.93 33.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -126.16 -166.88 12.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 63.23 112.456 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER 167.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 75.23 110.935 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.415 HG11 ' HG2' ' A' ' 136' ' ' MET . 44.9 t -112.73 93.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.157 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -52.0 -48.1 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.891 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.67 -175.85 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 73.0 110.922 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 53.17 71.48 0.68 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 64.11 112.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.415 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -89.53 3.38 52.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 74.21 110.913 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -79.15 -28.46 42.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.87 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.71 HG21 ' CG2' ' A' ' 20' ' ' VAL . 23.4 mm -68.58 -36.62 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 73.1 111.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -94.68 6.06 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.127 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -119.13 -62.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.865 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.09 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.31 111.082 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.5 tmm? -52.35 -37.02 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.862 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -24.48 18.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.97 -11.23 36.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.879 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -86.06 22.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 64.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.93 -160.0 32.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 64.31 112.467 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.7 p -151.44 -71.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 75.12 110.853 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.72 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 70.41 110.861 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -105.74 15.1 27.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.21 110.938 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.82 -38.32 3.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 70.14 112.479 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -50.44 120.56 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 73.42 110.891 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 p -95.02 158.75 15.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 30.12 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -15.94 57.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.846 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.6 170.45 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 54.01 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -98.49 123.3 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.914 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 10' ' ' ILE . 3.7 mp -105.93 130.63 57.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.45 111.154 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 51' ' ' SER . 67.2 p -138.56 157.62 45.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.164 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 ' HE1' ' A' ' 53' ' ' PHE . 4.2 mp -90.78 93.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.119 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -50.77 -57.83 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 75.41 111.071 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.54 162.48 41.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 75.51 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.5 p -156.01 160.56 40.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 75.43 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.84 45.25 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 75.43 112.482 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.7 mt-30 -68.18 -36.56 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 54.14 110.911 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.8 mm? 73.86 -58.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 75.1 110.873 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.11 110.918 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 51.3 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -126.05 143.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.1 111.122 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -53.51 145.34 28.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 34.01 110.895 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.4 Cg_endo -69.77 129.4 17.51 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 74.11 112.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 m -119.98 147.3 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.25 111.132 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.593 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -128.45 165.09 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 44.45 111.11 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CD1' HD21 ' A' ' 164' ' ' LEU . 5.6 p90 -122.54 153.79 38.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.866 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 158' ' ' ILE . 5.5 t80 -136.09 128.88 31.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.905 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 34.7 m-20 -95.32 126.56 40.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.872 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.508 HD12 ' HE1' ' A' ' 142' ' ' MET . 4.2 mm -99.53 119.36 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.33 111.169 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.0 163.13 15.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 65.43 111.124 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -147.67 92.84 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.03 111.129 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.05 31.12 4.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.85 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.12 -12.99 65.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 74.04 112.512 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -97.9 126.86 39.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.652 0.739 . . . . 74.32 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.4 69.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 74.2 112.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.551 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.76 -67.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.916 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.8 -159.6 10.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 63.22 112.506 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -127.99 124.27 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 74.42 110.903 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.8 t -113.11 90.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 72.42 111.13 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 77.8 p -85.16 147.8 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.823 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CD2' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.68 140.02 40.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 74.32 110.884 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 6.1 tt0 -91.21 161.97 14.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.895 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 4' ' ' PRO . 61.2 mt -114.9 119.57 37.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.907 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 90' ' ' LEU . 16.9 m-85 -74.85 61.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 75.53 110.902 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.98 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 74.41 111.137 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.91 -65.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -74.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 65.4 110.899 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 33' ' ' ALA . 12.9 m -84.58 116.71 66.39 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 72.04 111.162 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.706 2.271 . . . . 72.45 112.331 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -66.28 -43.69 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.918 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -48.24 -27.96 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.152 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -80.17 -39.27 29.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 53.02 111.104 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.92 -156.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 61.14 110.878 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.472 HD21 HD12 ' A' ' 78' ' ' ILE . 1.3 t30 69.85 -68.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.31 110.903 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.01 -29.03 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.909 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -52.03 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.89 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 43' ' ' GLU . . . -78.95 -28.09 43.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.41 111.082 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -89.08 19.47 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.929 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' HG11 ' A' ' 6' ' ' VAL . 31.8 t -144.8 -31.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 61.14 110.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -103.94 -32.97 9.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 74.53 111.097 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 120.08 2.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 53.15 112.513 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 177.41 -47.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 55.42 110.884 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -83.85 -11.37 57.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.907 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.77 7.52 35.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 74.53 112.515 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' C ' ' A' ' 47' ' ' GLY . 2.6 m-85 -93.02 -24.77 18.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 64.44 110.871 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -29.05 130.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 50.51 112.467 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -95.2 34.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.933 0.397 . . . . 73.12 110.915 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.98 147.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.873 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.05 62.15 4.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 62.31 112.476 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -125.82 -168.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 72.34 110.906 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 m -120.85 -169.69 1.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.3 110.896 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.06 127.75 55.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 65.5 110.839 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -63.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.813 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -157.58 -179.51 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.45 110.841 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 152' ' ' THR . 65.8 mt -150.55 136.22 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.142 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -140.27 105.41 6.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.573 0.701 . . . . 75.02 111.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.4 Cg_endo -69.77 159.4 53.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 62.02 112.31 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.93 -34.53 3.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.508 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -111.18 -82.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 73.53 110.86 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 175.13 119.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.861 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.41 177.29 8.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.04 174.55 10.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 51.23 110.919 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 64.03 112.508 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.792 0.329 . . . . 74.41 110.934 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -83.68 5.76 23.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.33 110.858 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 39' ' ' LEU . 2.5 mt 83.0 -43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 71.42 111.106 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -72.65 70.24 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.939 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.43 -72.25 2.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 32.34 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.0 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 65.02 110.835 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.75 162.94 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 72.45 110.896 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -141.22 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.01 110.865 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.79 164.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 63.31 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -77.85 113.04 15.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 51.13 110.858 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -56.28 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.848 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.08 149.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 64.24 110.894 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -111.84 58.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.854 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.97 -10.96 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.42 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -104.11 137.33 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.92 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -128.34 -172.89 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 71.3 110.892 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -95.18 -89.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 73.11 110.881 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m 76.54 -15.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 44.44 111.178 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.34 163.22 36.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 74.54 112.485 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 118' ' ' LYS . 53.8 Cg_endo -69.79 143.19 49.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.619 2.213 . . . . 70.22 112.392 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.16 -41.28 2.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.737 -0.744 . . . . 74.34 112.457 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.6 mm -50.42 150.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 71.43 111.152 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -123.18 161.11 25.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.13 110.886 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.746 ' OG ' HG22 ' A' ' 128' ' ' VAL . 4.2 m -158.8 -129.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 73.23 110.894 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.0 mtp -142.83 -159.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 54.34 110.92 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . 173.38 81.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.32 111.084 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 107' ' ' THR . 2.0 t30 -104.13 -158.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.24 42.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 52.3 111.085 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.73 168.82 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 71.2 112.468 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.72 166.67 26.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 72.11 112.335 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 56.35 34.13 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 54.04 110.871 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 105' ' ' PRO . 16.3 p -137.67 26.66 2.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.1 t30 50.62 -97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 73.33 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.74 -85.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.727 . . . . 62.42 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 t 71.0 36.76 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 74.22 110.872 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 9.1 tp-100 -92.22 -34.95 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 74.32 110.894 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.627 ' CE2' HD11 ' A' ' 114' ' ' ILE . 60.0 t80 68.57 75.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 63.4 110.908 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -108.49 129.67 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -120.47 121.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 73.41 111.169 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' MET . 6.5 p -73.91 136.92 43.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.14 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.577 HG21 ' OE1' ' A' ' 143' ' ' GLU . 13.1 t -109.89 -16.58 13.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 64.02 111.134 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.65 24.57 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 42.11 111.116 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 1.2 tmtt? 58.17 103.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.2 p -121.38 71.63 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 72.4 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.45 20.34 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.835 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -9.01 58.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.929 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -86.51 -47.87 8.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 72.33 110.918 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -56.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.851 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.58 47.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.693 -0.765 . . . . 74.43 112.507 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -96.73 -31.02 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 70.55 110.932 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -132.36 124.87 29.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.825 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.8 t -49.37 111.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.23 111.103 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.746 HG22 ' OG ' ' A' ' 99' ' ' SER . 20.9 t -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.24 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.718 ' HB2' HG21 ' A' ' 29' ' ' VAL . 19.6 p90 -165.66 34.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.31 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -122.41 -173.22 14.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.717 . . . . 53.34 112.508 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 174.57 144.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 62.25 110.928 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.12 90.22 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.15 111.154 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -50.92 -59.96 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.52 110.856 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.55 142.0 10.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 61.44 110.863 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.48 2.99 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.484 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.18 -32.19 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 74.31 110.827 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -50.4 -27.95 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 72.02 110.925 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 24.5 mm -80.09 -40.81 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.25 111.141 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -48.83 -52.82 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.23 111.162 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.78 -30.59 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.2 110.868 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -70.98 -42.69 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 62.13 111.121 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.508 ' HE1' HD12 ' A' ' 10' ' ' ILE . 19.1 mtm -62.81 -30.12 71.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.859 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.577 ' OE1' HG21 ' A' ' 116' ' ' THR . 14.7 mm-40 -58.13 -55.07 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.31 110.874 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -22.5 66.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.84 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.94 -6.28 59.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.869 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.427 ' HA3' ' CG2' ' A' ' 56' ' ' ILE . . . -89.94 -157.35 33.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 54.45 112.537 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 p -164.49 142.59 6.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 74.21 110.86 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 38.5 mmm-85 -74.63 73.31 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.922 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 175.93 -33.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.919 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.17 -67.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 73.42 112.491 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.45 159.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 74.13 110.92 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 56' ' ' ILE . 77.0 p -131.19 156.67 44.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.8 t -77.41 -18.05 57.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 70.21 110.879 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -134.22 -165.67 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 75.15 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -138.63 136.08 35.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.915 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.49 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.4 mt -106.02 119.04 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 65.14 111.128 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 26.5 p -106.01 163.69 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.152 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.55 HG23 ' CE1' ' A' ' 8' ' ' PHE . 4.3 mt -106.48 134.83 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.24 111.113 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -89.63 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.03 111.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.76 171.95 16.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.0 m -151.86 122.8 7.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 72.21 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -150.36 178.13 28.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 40.2 112.471 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 123.07 24.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 75.24 110.935 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -95.04 -58.88 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.11 110.887 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 55.5 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.846 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.34 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 62.53 111.071 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.91 157.27 39.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.729 . . . . 60.34 110.892 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.98 52.42 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 73.33 112.33 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 164' ' ' LEU . 96.9 m -138.44 93.87 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 70.31 111.145 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 2.4 m -77.03 143.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.108 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.525 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -132.26 162.51 30.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.888 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.56 ' HD1' HG23 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -149.84 152.84 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 62.31 110.911 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -109.35 114.75 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.855 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 tt -86.01 147.83 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.125 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -141.14 164.26 30.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.51 111.131 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 156' ' ' ILE . 61.6 t -138.33 105.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.137 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 66.88 50.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 60.14 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.19 20.6 67.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 60.4 112.496 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 tt0 -134.4 107.29 11.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 54.11 110.886 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.81 141.76 45.91 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 62.31 112.306 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.63 24.9 7.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.3 110.898 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.53 -167.26 14.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.738 . . . . 52.31 112.474 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -178.72 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 75.01 110.832 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.524 HG12 ' HB ' ' A' ' 138' ' ' ILE . 2.9 m -137.32 161.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.21 111.093 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 133' ' ' LYS . 30.6 t -114.44 91.79 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 70.5 110.832 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 13.8 m-85 -83.52 102.49 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 72.24 110.873 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.27 111.06 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.892 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.745 HD22 ' CE2' ' A' ' 129' ' ' PHE . 27.4 mt -85.51 140.66 30.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 62.31 110.935 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.65 81.3 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.842 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.71 -3.69 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.04 111.122 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -87.47 -38.33 16.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.52 110.832 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.96 -23.76 17.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 62.35 110.921 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.59 73.06 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 75.45 111.11 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -6.81 19.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.272 . . . . 45.4 112.374 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 -51.84 5.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 62.04 110.902 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.54 HG22 ' HE2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -77.96 -53.77 7.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 61.51 111.066 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -31.41 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.24 111.079 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.44 -56.47 8.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.835 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HA ' HG12 ' A' ' 78' ' ' ILE . 1.8 t30 -47.86 -39.61 19.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 71.45 110.865 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 39' ' ' LEU . 1.4 t80 -77.83 -32.77 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 71.4 110.888 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -35.98 81.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.858 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.31 67.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 51.03 111.124 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 36' ' ' PHE . 46.1 mt -70.3 -32.56 70.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.14 110.906 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -60.14 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.884 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.1 p -72.91 -17.01 61.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.34 111.089 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.19 44.53 93.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.722 -0.751 . . . . 71.15 112.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -28.85 69.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 74.45 110.886 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -70.72 -125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 64.54 110.882 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.06 18.18 3.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 44.44 112.45 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -165.57 -174.55 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 74.41 110.848 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.21 124.61 2.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 73.23 112.488 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.9 155.61 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.993 0.425 . . . . 74.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -157.01 -38.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 64.01 110.898 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.25 27.7 12.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 54.43 112.488 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 170.56 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 51.3 110.894 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -140.53 153.1 46.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 70.25 110.861 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.92 134.32 53.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.885 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -141.37 34.22 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.869 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -138.31 33.17 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.921 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 27.7 mt -82.71 140.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.42 111.096 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.38 113.62 23.37 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.596 0.712 . . . . 63.44 111.107 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 54.2 Cg_endo -69.73 81.38 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 73.44 112.356 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.81 0.24 4.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.748 -0.739 . . . . 75.14 112.498 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.337 . . . . 74.21 110.852 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.25 -160.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 63.1 110.889 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 82.4 m -136.96 -41.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 64.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 65.28 150.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 61.42 112.512 -179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 120.793 0.33 . . . . 74.01 110.876 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.28 157.2 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 45.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -67.52 -11.84 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 64.11 111.14 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.27 13.8 20.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 75.52 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.47 -162.85 23.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.485 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.1 -42.55 60.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 74.34 110.939 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -177.24 173.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 65.11 110.846 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.53 168.29 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.866 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.69 162.6 16.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.895 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.01 149.42 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.7 -63.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.857 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -176.39 173.7 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.844 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 45.65 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.73 -25.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 71.31 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.644 ' O ' HG11 ' A' ' 128' ' ' VAL . 5.9 mt -91.94 119.28 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 71.02 110.937 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.782 ' O ' HG23 ' A' ' 93' ' ' THR . 7.9 mtpp -100.86 112.42 24.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.852 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -58.94 99.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 61.3 110.841 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 91' ' ' LYS . 6.2 p -127.45 36.25 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.159 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.11 39.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 61.04 112.533 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.62 23.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 72.44 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.01 22.58 72.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 64.22 112.481 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 92' ' ' HIS . 23.4 mm -95.39 117.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 70.23 111.15 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 112' ' ' PHE . 4.7 tt -83.78 121.47 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.891 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 8.0 t -119.58 142.63 48.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.33 110.889 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.54 ' HE2' HG22 ' A' ' 32' ' ' THR . 2.6 mmt -81.74 102.75 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 61.41 110.882 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -84.91 146.38 27.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.15 111.109 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER 165.97 -166.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 61.44 110.854 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.22 -52.96 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.093 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.05 -87.75 0.27 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.727 -0.749 . . . . 63.21 112.455 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 125.19 11.86 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 55.01 112.351 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 45.6 36.12 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.85 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -146.77 56.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 52.32 111.158 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -50.99 -52.91 38.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.52 110.827 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.38 -168.58 54.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 64.22 112.488 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 t -119.85 -5.7 10.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 60.22 110.835 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -64.76 156.62 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.876 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -149.4 162.37 40.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.874 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -160.57 140.5 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 62.41 110.869 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.729 HG21 ' CG1' ' A' ' 139' ' ' VAL . 3.7 mt -91.88 125.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 63.34 111.122 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.4 m -74.49 -32.4 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 72.42 110.919 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 m 55.86 14.69 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.52 111.138 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.53 167.99 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 63.24 111.108 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -63.35 133.44 54.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 5.6 p -145.34 43.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.164 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -66.11 -10.21 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 52.43 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.857 ' CZ2' HG22 ' A' ' 119' ' ' THR . 9.8 p90 -75.9 -9.6 58.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.923 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.17 -17.98 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 64.32 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 124' ' ' GLY . 11.0 m-20 51.64 70.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.818 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.17 43.76 0.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 51.14 112.481 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -73.8 133.32 43.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.349 . . . . 74.4 110.955 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.589 ' C ' HG23 ' A' ' 127' ' ' VAL . 4.9 m-70 64.53 28.95 13.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.32 110.851 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 60.85 -163.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.147 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 90' ' ' LEU . 13.1 p -179.13 145.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.745 ' CE2' HD22 ' A' ' 24' ' ' LEU . 2.0 p90 -176.68 125.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.91 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.86 145.92 14.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.554 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -165.74 151.72 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.23 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 133' ' ' LYS . 1.3 p -55.76 168.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 42.53 111.095 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 132' ' ' VAL . 2.2 tptp -147.81 -39.89 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.01 110.902 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -132.26 155.37 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.879 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.24 78.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 63.14 112.49 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -2.22 47.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 72.53 110.901 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.26 -29.96 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.912 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 20' ' ' VAL . 47.4 mm -63.99 -43.79 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.729 ' CG1' HG21 ' A' ' 114' ' ' ILE . 9.3 t -88.2 6.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 23.45 111.156 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.06 -69.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.87 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.53 67.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 55.41 111.123 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 15.6 tmm? -49.67 -35.44 21.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.88 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.49 54.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.3 110.836 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -141.31 0.32 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.859 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.69 15.96 26.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 63.55 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -95.12 -155.72 31.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 73.34 112.458 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.24 -169.23 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 73.54 110.881 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -77.77 -32.58 52.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.863 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -106.09 1.33 26.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.34 110.912 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.03 -146.25 16.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 61.33 112.455 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 64.78 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 63.5 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 54' ' ' HIS . 59.3 p -82.56 146.01 29.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 64.32 111.154 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -21.99 62.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -135.19 -179.17 5.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.1 110.896 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -97.86 101.44 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 73.12 110.871 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 12' ' ' VAL . 4.5 mp -96.44 122.02 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.104 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.18 159.49 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.53 111.174 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.56 HG23 ' HD1' ' A' ' 8' ' ' PHE . 42.0 mt -87.88 116.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 70.53 111.143 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.28 -52.19 20.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 52.32 111.09 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -143.38 -179.59 6.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 65.22 110.866 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 5.1 p -171.23 -172.85 1.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.23 110.858 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.29 -149.21 20.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 34.42 112.455 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -127.55 141.95 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 72.53 110.926 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.1 pt? -128.82 166.6 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 45.14 110.856 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 61.53 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 74.44 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.17 156.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.33 111.101 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -93.63 157.21 38.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 62.32 110.908 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 151.83 69.13 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.678 2.252 . . . . 64.42 112.364 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -138.98 151.32 46.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 74.43 111.101 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.574 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -141.8 151.97 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 73.55 111.136 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -127.1 156.77 41.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.888 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -137.92 137.29 37.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 64.12 110.9 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -92.47 114.09 26.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.886 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' A' ' 142' ' ' MET . 7.3 mm -82.49 114.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.32 111.132 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.76 148.77 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 72.41 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.03 98.6 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.178 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.95 24.27 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.873 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.02 -21.62 45.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.471 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.36 150.2 36.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.637 0.732 . . . . 64.45 110.869 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.5 68.28 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 70.12 112.355 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 17' ' ' LEU . 4.1 tp -125.53 -39.65 2.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 40.21 110.876 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 165.73 -176.5 41.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 70.41 112.455 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.15 167.1 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 63.31 110.869 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 27.2 m -130.15 -179.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 62.41 111.106 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -131.59 95.66 3.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.831 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.622 ' HE1' HG22 ' A' ' 132' ' ' VAL . 15.7 m-85 -91.78 138.15 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.854 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' C ' HD23 ' A' ' 24' ' ' LEU . 24.2 tt0 -116.45 156.06 27.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 74.34 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -116.08 118.07 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.896 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . 23.9 m-85 -78.59 77.93 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.21 110.869 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.1 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 72.35 111.083 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.02 -46.84 41.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 50.13 110.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.535 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.4 mttt -87.72 -18.49 29.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.885 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -155.44 84.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.633 0.73 . . . . 73.25 111.143 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -27.65 26.29 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 73.21 112.341 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -76.47 -57.36 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 71.25 110.89 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.7 m -51.7 -43.55 62.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.34 111.195 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.45 78.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.45 111.139 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -53.96 -25.01 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.4 110.848 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -66.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.935 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HD2' HD22 ' A' ' 24' ' ' LEU . 5.9 t80 -52.59 -39.7 61.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.918 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 64.31 110.877 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -90.48 -33.8 15.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 64.43 111.138 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -92.13 26.12 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.959 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.574 ' OG ' HG11 ' A' ' 6' ' ' VAL . 34.3 t -121.2 -5.69 9.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 63.04 110.872 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.8 p -118.47 15.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.13 111.183 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.98 24.81 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 60.42 112.488 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -83.78 -21.89 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 72.34 110.884 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 17.64 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.22 110.96 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.33 -52.5 4.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 53.23 112.493 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.03 155.92 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 74.24 110.898 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 -136.69 3.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 72.2 112.507 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -22.55 17.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.393 . . . . 55.15 110.865 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.63 112.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 74.51 110.879 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.77 55.55 20.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 54.22 112.479 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 m -113.85 3.85 15.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 44.25 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m 50.61 -168.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 65.44 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 56' ' ' ILE . 2.8 m-85 -111.41 154.37 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 64.14 110.887 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -93.34 -64.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.841 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.5 148.12 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 74.3 110.922 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CD2' ' A' ' 53' ' ' PHE . 55.2 mt -142.49 117.81 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 75.01 111.142 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.758 HD12 ' CE ' ' A' ' 61' ' ' MET . 59.5 mt -128.42 99.9 23.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 75.02 111.148 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.79 93.71 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.215 . . . . 73.32 112.384 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.43 -26.18 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 51.31 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.55 -56.54 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 73.31 110.843 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.758 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -174.49 -165.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 53.42 110.85 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 61' ' ' MET . 0.7 OUTLIER -146.32 144.9 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 54.43 110.834 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -94.52 -168.71 1.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 71.41 110.897 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 54.05 112.518 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.808 0.337 . . . . 73.23 110.879 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.405 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 5.2 t -105.03 126.39 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 42.32 110.888 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.839 HD13 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -63.88 -13.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.116 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.48 -16.38 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.941 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.31 -107.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 54.15 112.504 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.405 ' C ' ' HB3' ' A' ' 77' ' ' SER . 1.1 pt-20 -109.45 -55.76 2.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 71.54 110.913 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -166.74 151.09 7.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.904 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.09 144.13 51.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.9 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -52.98 153.52 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.876 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.04 136.38 33.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 73.42 110.865 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.14 -55.32 6.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.854 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.613 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.9 p30 -176.83 -173.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -132.34 38.49 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 54.25 110.885 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.535 HG21 ' HG2' ' A' ' 28' ' ' LYS . 4.3 mt -51.34 -25.16 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.31 111.125 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.42 HD23 ' CD ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -84.61 110.58 18.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 64.5 110.897 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -98.68 -166.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.93 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CD2' HG21 ' A' ' 97' ' ' ILE . 79.7 m80 -102.09 -98.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.34 110.865 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 65.6 7.1 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.55 111.141 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.51 163.36 30.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 75.52 112.499 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.72 10.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 51.02 112.341 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.43 31.51 54.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.467 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.712 HG21 ' CD2' ' A' ' 92' ' ' HIS . 29.5 mm -94.51 131.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 50.32 111.162 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 112' ' ' PHE . 1.2 tt -101.61 136.98 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 71.15 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 113' ' ' PHE . 5.7 t -105.95 -133.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 74.35 110.824 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -171.82 -34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.896 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 100' ' ' MET . . . 66.84 97.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.11 111.141 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.86 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.919 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.689 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -82.68 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.077 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 126.2 -63.42 0.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.462 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.72 -92.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.32 112.362 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -138.84 92.14 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.689 HG21 ' HB3' ' A' ' 103' ' ' ALA . 1.4 p -143.39 21.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.159 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 44.86 -91.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 52.43 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.95 -69.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 71.2 112.488 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 t 67.52 36.12 3.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 72.53 110.87 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -103.27 -97.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 73.12 110.943 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HE2' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.3 173.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 64.34 110.911 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER 178.21 57.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.897 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' A' ' 112' ' ' PHE . 66.7 mt -65.47 85.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.2 111.162 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.6 m -70.96 145.68 49.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.883 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.698 HG21 ' CD ' ' A' ' 143' ' ' GLU . 34.7 p -99.51 20.13 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.51 111.09 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -174.56 -167.84 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 72.21 111.101 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -78.46 134.01 37.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.842 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -134.27 49.74 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 53.11 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -63.21 -11.83 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.899 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -60.67 -26.28 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.883 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.403 HD22 ' NE2' ' A' ' 126' ' ' HIS . 25.5 mt -75.8 -29.92 58.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 60.25 110.924 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 124' ' ' GLY . 21.5 t0 49.83 81.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 71.02 110.859 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 17.31 62.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.689 -0.767 . . . . 25.31 112.505 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ASP . 22.1 tptp -103.57 -25.35 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 72.31 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.439 ' C ' HG23 ' A' ' 127' ' ' VAL . 64.6 m-70 -96.83 -6.96 34.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.834 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 87' ' ' ASN . 7.9 t 76.66 80.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.59 138.67 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.43 111.149 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -154.57 26.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 53.55 110.897 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.9 -179.01 15.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.506 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 140.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 62.22 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 22' ' ' PHE . 85.4 t -86.96 80.4 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 43.24 111.148 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -43.53 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 65.11 110.858 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.43 168.24 15.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.888 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 103.97 -0.09 44.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 51.14 112.46 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -33.44 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 61.3 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -51.13 -29.19 12.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 18' ' ' GLY . 24.7 mm -76.22 -40.44 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 60.51 111.09 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 65.4 t -49.49 -47.49 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.111 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -52.12 -33.41 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.11 110.852 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.41 82.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.21 111.099 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.619 ' HE2' HG21 ' A' ' 10' ' ' ILE . 12.6 mtm -77.34 -14.64 59.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.908 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.698 ' CD ' HG21 ' A' ' 116' ' ' THR . 17.9 mm-40 -86.44 14.27 6.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.9 1.2 2.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.869 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -105.06 -5.8 20.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.868 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.665 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -82.41 -151.26 9.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.54 112.474 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.1 m -145.94 -74.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.375 . . . . 43.01 110.847 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 75.54 110.86 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.87 2.67 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.886 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.85 -44.92 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 44.11 112.482 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.7 137.56 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 72.42 110.93 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.665 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.2 p -123.56 157.57 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.42 111.139 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.3 t -81.37 -17.24 49.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -135.2 -175.73 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.02 110.869 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -125.08 130.36 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 62.11 110.886 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.48 129.03 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 63.14 111.07 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 167.81 20.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 63.45 111.162 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.53 111.98 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.21 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -70.0 -50.99 36.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 51.0 111.085 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.34 162.85 33.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 63.51 110.9 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.4 p -165.73 168.18 16.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.24 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.46 -175.24 36.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 64.13 112.475 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 116.49 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 72.15 110.902 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.9 mm? -91.18 -39.64 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.933 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.864 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.804 0.335 . . . . 74.23 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.44 145.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.137 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.2 148.51 6.12 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.605 0.716 . . . . 55.24 110.924 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 126.11 12.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 63.15 112.336 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 164' ' ' LEU . 51.3 m -106.6 108.86 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 73.34 111.14 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.493 HG12 ' HG3' ' A' ' 163' ' ' GLN . 2.5 m -88.72 141.96 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.13 111.146 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.528 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -111.99 159.99 17.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 73.15 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.31 138.03 29.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.896 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.4 109.16 17.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.906 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.745 HD12 HG21 ' A' ' 138' ' ' ILE . 13.3 mt -94.49 148.32 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 71.44 111.138 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.34 164.53 28.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 71.43 111.04 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 17' ' ' LEU . 91.0 t -136.44 98.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.129 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 65.69 54.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.54 110.882 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.39 9.91 56.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.21 112.476 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 76.4 tt0 -123.72 107.24 31.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.642 0.734 . . . . 63.21 110.877 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.77 143.43 50.79 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.652 2.234 . . . . 72.34 112.379 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 12' ' ' VAL . 5.8 mp -98.84 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.9 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.67 -167.8 26.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 51.34 112.473 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.07 120.58 40.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 74.14 110.852 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 138' ' ' ILE . 38.4 t -109.23 102.47 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 72.45 111.132 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -110.24 147.19 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.88 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.83 109.04 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.907 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.29 127.88 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.846 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 129' ' ' PHE . 26.9 mt -89.28 136.12 33.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 54.54 110.972 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -78.68 65.3 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.61 66.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.093 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.19 -55.42 12.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 73.54 110.898 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -54.03 -60.58 3.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.911 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.0 m -99.37 101.18 12.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.596 0.712 . . . . 72.34 111.127 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -50.48 0.46 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.677 2.252 . . . . 70.01 112.366 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -44.68 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.895 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' ND2' ' A' ' 108' ' ' ASN . 3.6 m -86.04 23.13 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.138 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.78 -47.38 15.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 62.12 111.127 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.6 mt-10 -85.68 -24.29 27.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.15 110.876 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 34' ' ' GLU . 1.6 t-20 -28.29 -72.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.913 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 64.3 t80 -79.28 -30.19 42.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.52 110.876 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.0 ttp180 -49.27 -44.28 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.54 110.878 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.95 66.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 72.02 111.145 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 79.2 mt -69.11 -41.92 76.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.897 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -64.1 -45.1 90.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' OE1' ' A' ' 163' ' ' GLN . 33.0 p -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 62.11 111.102 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.53 88.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 74.34 112.474 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.02 31.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 74.31 110.924 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -126.27 -15.7 5.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.919 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 21.65 14.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 71.32 112.515 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -178.28 -167.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 72.12 110.844 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.89 -177.24 43.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 75.54 112.44 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 104.7 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 73.33 110.906 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 -66.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.05 110.899 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.79 26.09 7.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 43.2 112.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -76.19 -164.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 61.34 110.866 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.2 p -153.07 172.74 16.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 53.5 110.875 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.4 -75.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.87 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.72 23.53 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.856 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -139.16 17.73 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.883 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.07 143.22 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 55' ' ' ARG . 24.3 mt -127.49 103.39 22.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.674 0.749 . . . . 63.14 111.119 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.71 96.5 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.3 . . . . 63.14 112.318 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.19 -21.18 4.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.76 . . . . 71.21 112.485 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.06 -60.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.906 0.384 . . . . 72.4 110.878 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -167.63 -148.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 62.2 110.875 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -131.89 -58.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 65.74 118.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.878 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 65.12 112.476 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.788 0.327 . . . . 72.23 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . 4.9 p -87.02 -174.74 5.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.43 110.879 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.52 -31.51 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 72.11 111.173 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -87.33 42.32 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.882 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.42 -113.78 3.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 73.22 112.48 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.37 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 71.42 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -103.07 -171.08 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 64.33 110.894 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -131.44 169.53 15.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.88 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.71 169.85 11.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -61.38 -167.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.43 110.844 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -152.59 -55.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 61.44 110.839 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.38 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 63.22 110.898 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.17 56.5 1.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.833 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.6 -0.45 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 64.11 111.111 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 48.9 mt -114.67 132.4 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.923 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.69 126.68 40.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 72.43 110.931 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -53.44 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 63.14 110.882 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -95.02 4.61 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.166 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.02 -175.38 46.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.749 -0.739 . . . . 62.33 112.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 158.75 55.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.281 . . . . 63.52 112.347 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.15 -28.21 9.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 52.32 112.463 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.1 mm -57.81 124.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 64.31 111.14 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 113' ' ' PHE . 1.4 mp -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.883 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 112' ' ' PHE . 4.8 t -142.77 -152.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 63.51 110.857 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.4 mmt -141.11 135.34 30.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 63.42 110.858 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.881 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.91 -163.43 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.089 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.881 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 4.0 m120 116.61 -176.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.888 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.509 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -52.28 -41.28 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.12 111.053 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.58 -64.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 53.54 112.47 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 111.96 2.96 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.599 2.199 . . . . 62.25 112.353 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 42.47 61.56 1.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 42.23 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.418 HG22 ' HG3' ' A' ' 82' ' ' LYS . 16.0 p -152.5 54.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 70.14 111.176 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -45.01 -43.38 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 65.51 110.912 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.24 -164.32 19.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 71.02 112.489 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.445 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -117.65 -31.76 5.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 73.21 110.867 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.746 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 8.0 pt20 -55.51 149.02 14.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 64.24 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -160.95 158.05 27.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.861 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.0 p90 -114.4 -173.07 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 65.01 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.3 mt -113.51 -57.45 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.34 111.121 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.22 127.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -133.19 34.38 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.106 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.37 159.18 37.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 71.53 111.093 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -67.11 88.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.926 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 p -111.12 54.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.33 111.174 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.29 15.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.877 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 11.33 27.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 75.43 110.946 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 4.1 mt -109.26 -33.24 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 122' ' ' LEU . 4.3 t0 78.19 -42.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.857 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.61 2.78 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 72.21 112.515 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -62.94 -14.94 53.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 72.42 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -92.51 16.54 11.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.894 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.428 HG11 ' OD1' ' A' ' 108' ' ' ASN . 7.0 t 72.41 85.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.167 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 4.4 p -86.31 126.46 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.147 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE2' HD22 ' A' ' 24' ' ' LEU . 5.1 p90 -157.93 128.49 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.892 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 115.81 121.61 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 72.21 112.545 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -129.72 159.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 52.15 110.905 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.25 158.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 75.32 111.119 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -62.59 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.865 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.16 173.6 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 73.21 110.877 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.44 81.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 65.5 112.478 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -7.09 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 62.44 110.865 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -30.86 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.865 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.745 HG21 HD12 ' A' ' 10' ' ' ILE . 50.1 mm -65.69 -36.14 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 72.23 111.138 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 11.4 t -89.04 1.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 62.31 111.123 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -115.62 -64.0 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 60.44 110.854 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.25 -52.61 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 52.25 111.065 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 14.0 tmm? -51.9 -45.78 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 64.43 110.868 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -23.12 3.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.845 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.4 ttm-85 -63.28 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 75.51 110.877 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -92.91 20.13 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.885 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.73 68.14 0.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.1 112.447 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -27.35 135.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 72.43 110.837 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 13.6 mmm-85 -46.16 -63.68 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 71.5 110.903 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.81 -31.35 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 63.15 110.879 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.8 -167.69 22.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 75.53 112.521 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 mttt 61.72 103.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 72.3 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.5 p -77.68 144.35 37.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 65.24 111.15 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 p -60.9 -19.05 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.83 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -129.88 -168.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 61.41 110.905 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.4 108.46 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.44 110.894 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.95 99.87 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 73.42 111.143 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.15 157.1 23.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.32 111.121 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.12 126.01 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 65.42 111.185 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.31 -63.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.33 111.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -127.31 168.95 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 62.44 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.05 -176.1 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.35 110.847 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.97 -152.22 20.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.499 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -125.07 138.33 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.366 . . . . 71.54 110.854 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -116.92 143.98 45.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.963 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.85 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.814 0.34 . . . . 73.32 110.882 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.43 144.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.33 111.153 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -52.2 141.73 30.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.618 0.723 . . . . 75.1 110.862 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 128.44 16.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 63.52 112.351 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -115.52 125.95 53.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 73.32 111.197 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.9 m -113.22 156.74 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 72.01 111.142 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HB3' HD21 ' A' ' 164' ' ' LEU . 9.2 p90 -127.46 165.65 19.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.833 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.63 143.98 33.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 61.41 110.888 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.04 136.26 38.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 ' HB ' ' A' ' 20' ' ' VAL . 3.7 mm -107.19 136.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 71.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -143.26 162.86 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.12 111.095 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 156' ' ' ILE . 76.1 t -153.1 101.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.167 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 65.4 56.64 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.888 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.4 13.08 48.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.718 . . . . 54.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -124.04 113.42 28.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 72.32 110.903 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.8 153.32 68.87 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.674 2.249 . . . . 73.53 112.348 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HB3' HD12 ' A' ' 138' ' ' ILE . 1.7 mm? -112.51 -60.49 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.911 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.62 -164.33 27.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 43.35 112.468 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -108.99 121.49 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 75.23 110.853 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.796 ' HB ' HD11 ' A' ' 10' ' ' ILE . 74.7 t -119.37 111.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 65.2 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 p -111.09 152.61 26.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.11 110.869 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 112.9 15.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.889 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.33 137.39 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 53.22 110.881 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.783 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.5 113.35 26.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.92 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE2' HD11 ' A' ' 90' ' ' LEU . 4.2 m-85 -85.99 70.79 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 55.22 110.86 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -1.88 43.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.112 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.36 -48.22 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 65.3 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG2' HD23 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -60.52 -62.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.874 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -115.35 77.67 5.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.64 0.733 . . . . 70.34 111.117 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 72.85 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 74.44 112.371 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -177.11 -42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.14 110.892 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.547 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -82.55 -61.85 1.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 64.31 111.127 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . . . -91.43 22.17 4.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 75.21 111.115 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.37 12.67 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.876 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -121.5 -28.03 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 64.55 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -54.26 -26.75 30.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.883 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.23 -30.79 39.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 74.24 110.876 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.0 -26.67 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.03 111.077 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.08 19.44 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -118.02 -8.06 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.1 110.86 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -115.95 12.71 15.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 70.43 111.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.11 31.55 33.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 62.21 112.461 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.95 -34.18 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 54.33 110.898 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -61.49 -19.97 62.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 65.34 110.914 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.88 18.8 60.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 61.41 112.473 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.8 151.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 73.43 110.902 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.49 -179.58 16.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 41.5 112.485 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.13 102.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 74.15 110.9 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 -51.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.92 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.94 32.73 2.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 43.35 112.475 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.32 -169.46 2.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 72.22 110.893 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.1 p -152.86 148.77 27.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 65.15 110.864 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.82 -177.61 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.898 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -171.87 60.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 62.0 110.831 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.654 ' NH2' HD11 ' A' ' 57' ' ' ILE . 13.1 mmm180 -137.23 29.54 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.883 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.49 143.27 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 71.35 111.141 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.654 HD11 ' NH2' ' A' ' 55' ' ' ARG . 14.5 mt -139.77 96.5 8.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.622 0.725 . . . . 71.44 111.108 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.77 85.13 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.255 . . . . 73.2 112.314 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.47 -40.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 71.52 112.486 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -58.19 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 73.41 110.867 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.558 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.0 OUTLIER -173.97 -158.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 61.25 110.838 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.4 m -139.56 142.55 37.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.879 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -126.9 157.39 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.953 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 74.04 112.486 -179.989 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' N ' ' HG ' ' A' ' 110' ' ' SER . 4.7 ttpt . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.805 0.336 . . . . 45.43 110.871 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.663 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 40.5 t -118.74 10.83 12.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.861 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER 75.4 -8.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.53 111.092 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -110.28 -18.12 13.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 62.03 110.938 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.37 -134.38 2.01 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 73.34 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -123.98 -33.84 3.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 74.22 110.888 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.42 163.95 10.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.879 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -144.28 135.6 25.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.2 110.883 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -51.02 162.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.21 110.903 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -75.29 92.67 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.882 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -51.67 51.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 177.51 167.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.891 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.34 110.907 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.38 -28.08 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 72.04 111.143 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -87.75 122.3 31.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.43 110.892 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -108.39 -166.55 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 70.25 110.891 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.456 ' CE1' HD12 ' A' ' 122' ' ' LEU . 11.8 m170 -99.88 -88.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.22 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.6 m 69.46 7.64 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.448 . . . . 74.51 111.121 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.22 168.78 30.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.02 112.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 171.34 14.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.269 . . . . 70.11 112.322 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 80.05 28.26 50.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.15 112.526 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 128' ' ' VAL . 37.7 mm -95.31 139.4 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 53.12 111.127 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.741 HD22 ' CE1' ' A' ' 112' ' ' PHE . 12.3 mt -106.54 142.29 36.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.905 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 m -116.89 -138.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 44.32 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.406 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 7.3 mmt -155.13 -59.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 62.04 110.872 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 65.04 146.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 53.31 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.584 ' CG ' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER 177.81 -73.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 75.53 110.882 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.506 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.43 -28.8 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 71.1 111.12 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.11 -76.72 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.72 -0.752 . . . . 41.02 112.429 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.79 107.62 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 73.23 112.331 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' PRO . 70.9 m-80 35.41 69.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.873 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.584 HG22 ' CG ' ' A' ' 102' ' ' ASN . 2.7 m -134.68 16.68 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 71.32 111.165 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.5 t30 39.45 -97.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.9 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 133.65 174.48 13.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 53.15 112.512 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.489 ' HG ' ' N ' ' A' ' 76' ' ' LYS . 63.6 m -144.68 -43.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 71.34 110.901 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -91.47 92.55 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 63.01 110.889 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.741 ' CE1' HD22 ' A' ' 98' ' ' LEU . 32.7 p90 -82.91 147.06 28.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.53 110.858 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -111.46 131.73 55.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.51 123.17 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.1 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 68.1 m -74.72 130.97 40.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 54.11 110.862 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 61' ' ' MET . 28.9 p -91.71 -27.77 17.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.173 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 119' ' ' THR . . . -130.53 169.67 15.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 55.13 111.117 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -61.86 96.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 73.12 110.895 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.556 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 29.6 p -121.33 59.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.145 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -88.63 25.0 1.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 73.13 110.872 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.556 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.7 OUTLIER -89.22 10.5 21.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.945 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.633 HD13 ' CD2' ' A' ' 126' ' ' HIS . 10.9 mt -98.44 -41.56 7.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 71.21 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -58.37 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 74.35 110.899 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.23 59.99 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.702 -0.761 . . . . 72.31 112.468 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -103.33 -22.66 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 65.13 110.87 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CD2' HD13 ' A' ' 122' ' ' LEU . 18.6 m-70 -119.32 -20.78 7.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 63.43 110.891 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 16.1 t 80.74 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 55.43 111.104 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 97' ' ' ILE . 77.2 t -102.43 137.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 70.23 111.143 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.839 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -157.6 29.63 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 74.04 110.884 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.64 140.17 6.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.0 112.451 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -124.04 -165.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 70.11 110.904 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.465 HG23 ' CA ' ' A' ' 96' ' ' GLY . 21.7 t -96.68 134.13 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 75.41 111.13 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -90.62 -63.37 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.11 110.862 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -162.07 142.6 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.892 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.63 4.71 13.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 62.21 112.523 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.6 ttt -49.41 -33.24 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 54.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.1 -28.44 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.931 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 17' ' ' LEU . 31.0 mm -79.39 -38.4 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.03 111.115 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.8 t -48.08 -53.31 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.172 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.98 -32.02 14.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -66.02 -41.12 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.119 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.458 ' SD ' HD13 ' A' ' 156' ' ' ILE . 43.7 mtm -77.14 -17.15 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.41 110.858 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -90.16 29.47 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.882 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -129.15 17.43 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.4 110.86 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -136.65 46.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 74.12 112.469 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 146' ' ' GLY . 37.8 m 33.42 -100.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.04 110.856 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' ILE . 7.5 mmm-85 -161.52 -40.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 73.15 110.86 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.58 -7.03 57.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.2 110.903 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 109.34 -137.18 14.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.31 112.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 75.47 -55.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 65.41 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.35 140.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.4 111.156 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 0.33 20.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 70.5 110.859 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.14 161.04 36.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.878 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.48 112.76 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 43.43 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 11' ' ' ALA . 41.5 mt -98.35 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 72.24 111.168 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.66 174.2 6.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.122 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.36 145.12 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.14 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.21 -62.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.51 111.102 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -157.06 164.8 37.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.787 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.7 m -146.23 -165.55 2.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.863 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.34 28.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 72.54 112.489 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 mt-30 -108.65 136.48 48.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.353 . . . . 74.01 110.919 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 7' ' ' PHE . 41.7 mt -73.12 -41.04 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.11 110.909 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 71.34 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.362 . . . . 61.23 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.26 155.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.54 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -92.96 152.87 41.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 72.24 110.882 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 54.2 Cg_endo -69.77 147.11 62.07 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.686 2.257 . . . . 61.32 112.356 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 6' ' ' VAL . 1.9 m -140.01 165.8 26.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.33 111.173 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.96 132.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 65.13 111.136 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.5 162.86 13.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 63.34 110.906 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -143.67 138.58 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.884 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -101.41 71.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 60.44 110.827 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 156' ' ' ILE . 42.7 mm -50.47 136.09 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 63.42 111.145 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.37 152.69 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 52.41 111.126 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD23 ' A' ' 17' ' ' LEU . 2.0 t -127.27 94.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.24 111.159 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.01 32.33 21.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 74.03 110.896 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.47 -24.71 25.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 62.12 112.511 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -121.79 119.68 28.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.67 0.748 . . . . 71.44 110.884 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 162.67 41.16 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.732 2.288 . . . . 74.21 112.365 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' CG2' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -126.11 20.98 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 44.23 110.891 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 133.9 -164.33 24.43 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 60.1 112.49 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 174.47 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 75.23 110.866 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 135' ' ' GLY . 31.9 m -136.78 177.12 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.52 111.116 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -129.61 100.86 5.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.893 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -86.62 114.04 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.877 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.55 124.85 50.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.51 110.898 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 32.1 mt -88.19 126.66 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.937 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -76.38 67.08 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.1 110.888 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.03 -30.1 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.45 111.138 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -53.06 -56.46 16.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.874 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 90' ' ' LEU . 4.6 mptp? -81.95 -35.55 28.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.841 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 129' ' ' PHE . 16.6 m -128.32 80.35 72.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 63.31 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.07 17.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.27 . . . . 60.43 112.356 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.59 -69.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 61.4 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -42.26 -39.62 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 53.01 111.166 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -63.55 -67.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 53.4 111.071 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' ARG . 6.8 tt0 -41.62 -61.06 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 53.21 110.862 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -35.83 -43.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 44.21 110.881 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -75.24 -41.85 56.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.02 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' GLU . 9.0 tmm_? -51.62 -30.32 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 61.45 110.838 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.55 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.24 111.113 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.19 -41.44 81.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.923 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.9 p -58.88 -46.09 88.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.44 110.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -16.93 64.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.129 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.56 86.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 55.41 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -143.74 39.95 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 74.34 110.92 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 21.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.13 110.926 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.91 -33.69 3.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 64.33 112.486 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -126.09 -167.53 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 72.2 110.865 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.6 -144.21 13.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.733 . . . . 72.51 112.496 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 -18.69 15.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 74.24 110.968 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.59 113.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 65.1 110.88 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -131.19 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 50.42 112.498 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.697 ' O ' HG22 ' A' ' 157' ' ' THR . 6.2 t 49.32 -166.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 65.33 110.817 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.7 p -143.52 -168.58 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -179.44 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.87 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -116.13 -57.52 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.1 110.855 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -145.79 164.6 31.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.15 110.909 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' A' ' 152' ' ' THR . 67.0 mt -153.42 124.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 72.12 111.171 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 1.3 pt -134.62 126.82 18.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.652 0.739 . . . . 61.42 111.132 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 138.44 37.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.622 2.215 . . . . 63.03 112.348 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.43 30.86 77.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 54.34 112.486 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.96 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 74.52 110.898 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -163.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.893 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 m -137.02 -69.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 61.42 110.865 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 62.81 148.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 65.33 110.897 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 53.2 112.469 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.76 0.314 . . . . 61.3 110.914 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ILE . 47.6 p -77.87 137.46 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 43.31 110.861 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -33.59 -46.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.153 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 8.2 p90 -112.84 106.21 14.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 71.21 110.88 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.57 -168.86 51.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 73.43 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -71.33 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 74.01 110.902 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.06 155.56 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 53.4 110.913 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 179.41 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.881 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 173.96 9.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.848 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -71.79 179.96 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.883 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.72 -63.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.835 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.86 158.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.855 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 60.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 54.5 110.924 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -78.98 -3.34 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 70.14 111.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -115.94 71.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.882 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 154.57 24.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 53.04 110.866 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -63.82 83.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.845 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -77.08 -8.81 58.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 71.25 111.13 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.95 -174.35 45.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.54 112.492 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.07 66.68 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 71.42 112.329 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -27.96 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 53.43 112.496 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.18 120.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 72.42 111.131 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 99' ' ' SER . 4.1 tt -91.96 143.16 26.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.909 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.711 ' N ' HD23 ' A' ' 98' ' ' LEU . 21.0 t -148.83 -166.58 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 62.34 110.824 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.0 OUTLIER -101.81 148.52 25.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 75.54 110.872 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 107' ' ' THR . 3.1 t30 -145.5 -160.54 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.927 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.16 -45.59 16.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 75.24 111.081 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.04 -65.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 64.04 112.527 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 112.21 3.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.233 . . . . 64.2 112.333 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' PRO . 51.7 m-20 34.42 46.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 54.1 110.901 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 19.7 p -154.08 34.31 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.3 111.16 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -79.73 4.01 17.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.07 133.1 43.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 62.24 112.467 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.22 166.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 52.02 110.891 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 67.52 138.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 70.25 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -153.91 177.49 10.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 61.42 110.91 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.47 162.91 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.874 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.4 pt -145.39 134.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.507 ' SG ' HG23 ' A' ' 119' ' ' THR . 14.0 t -96.58 156.89 16.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 73.3 110.873 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -124.9 27.74 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 73.1 111.125 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.62 27.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 71.4 111.102 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.0 142.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.878 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.507 HG23 ' SG ' ' A' ' 115' ' ' CYS . 0.2 OUTLIER -140.57 48.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.13 111.195 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.72 -20.82 23.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 64.21 110.849 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -62.51 -22.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.904 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.455 HD22 ' HB ' ' A' ' 119' ' ' THR . 4.2 mp -76.41 -37.46 57.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.919 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t0 47.09 86.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 73.3 110.828 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.79 37.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 31.32 112.508 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -55.03 -32.91 62.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 74.32 110.911 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.621 ' C ' HG23 ' A' ' 127' ' ' VAL . 87.3 m-70 -145.57 43.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.871 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER 67.13 -153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.12 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 127' ' ' VAL . 14.2 p -176.94 144.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.22 111.122 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.619 ' CB ' HG21 ' A' ' 29' ' ' VAL . 4.1 p90 -176.5 95.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 63.02 110.881 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 132.54 161.48 9.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 54.41 112.468 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt 175.18 131.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 73.52 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.69 136.36 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.124 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -114.54 -39.41 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 75.52 110.883 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.24 160.94 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.33 110.896 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.655 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 59.05 81.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.3 112.473 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -12.29 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 70.43 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -75.06 -24.54 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 74.53 110.88 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.458 HD11 ' HA3' ' A' ' 18' ' ' GLY . 17.6 mm -64.19 -44.11 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 74.53 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -93.38 5.62 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.55 111.166 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -112.58 -64.36 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 70.22 110.849 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.27 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.23 111.077 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.34 -44.45 54.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.23 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.93 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 54.45 110.907 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.37 -29.97 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.37 -2.81 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 62.41 110.884 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.95 -152.75 14.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 52.44 112.44 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.7 t -161.92 156.13 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 72.42 110.858 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -71.53 -7.47 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 73.1 110.837 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -106.21 -19.61 13.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.862 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.15 -44.27 1.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 61.24 112.495 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -44.55 129.63 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.45 110.914 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 56' ' ' ILE . 49.2 p -98.62 118.17 34.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 53.01 111.118 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 p -54.2 -26.27 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 110.82 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -127.43 -163.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.943 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -131.0 127.75 38.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 64.53 110.943 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 10' ' ' ILE . 2.2 mp -98.84 125.21 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 73.04 111.145 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.13 141.69 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 75.2 111.139 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.07 100.53 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.185 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -66.31 -59.82 3.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.093 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.5 170.41 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.873 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -170.2 154.36 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.928 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.79 179.89 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.747 . . . . 51.43 112.478 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 1.1 mt-30 -82.62 -49.92 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 51.25 110.898 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 164' ' ' LEU . 2.7 mm? 65.04 115.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 64.33 110.936 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.11 110.917 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.889 0.376 . . . . 70.14 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.85 156.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.139 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -92.64 160.1 35.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.623 0.725 . . . . 71.1 110.859 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.52 69.02 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 61.21 112.349 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.1 m -136.18 150.13 48.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 50.2 111.142 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.92 137.24 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.15 111.079 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.625 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -113.32 157.87 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.867 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -141.66 136.34 30.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.878 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.615 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.1 m-20 -96.55 119.75 35.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 138' ' ' ILE . 13.3 mm -95.02 142.41 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.12 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.54 170.76 15.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 42.51 111.067 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 17' ' ' LEU . 2.6 m -146.99 96.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.25 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.74 36.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.03 110.857 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -12.42 66.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 65.12 112.486 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.56 131.55 30.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 73.44 110.921 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 153.18 69.08 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.257 . . . . 75.23 112.333 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.715 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.53 -68.21 0.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.58 28.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 50.05 112.528 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.76 134.26 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 70.34 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.603 HG22 ' HA3' ' A' ' 135' ' ' GLY . 53.3 t -136.59 139.99 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.076 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -123.53 152.66 41.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 53.12 110.87 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 132' ' ' VAL . 1.3 m-85 -119.54 -175.48 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 72.34 110.874 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -144.48 117.57 8.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 72.22 110.927 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.46 130.21 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 61.31 110.913 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 29' ' ' VAL . 67.6 m-85 -79.48 75.86 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.86 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -28.11 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.42 111.126 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -37.72 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 50.14 110.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HD2' HD12 ' A' ' 89' ' ' ILE . 19.0 mmtp -86.44 -31.97 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 65.22 110.889 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 7.9 m -132.84 84.98 48.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 73.22 111.11 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -40.38 5.37 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.228 . . . . 50.44 112.38 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -83.08 -44.89 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.864 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.415 HG21 ' CE ' ' A' ' 100' ' ' MET . 2.7 m -81.84 17.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 63.42 111.163 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -85.79 -44.14 12.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.41 111.139 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.4 mt-10 -81.81 -31.37 31.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 61.34 110.85 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 8.4 t30 -27.18 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 72.21 110.896 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -77.51 -34.21 54.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.869 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.426 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 1.8 ttp180 -47.83 -40.27 20.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 54.02 110.917 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.21 60.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.32 111.079 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 13.16 14.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.42 110.942 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -129.67 -20.29 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.8 p -101.19 -25.08 14.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 72.41 111.106 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.17 62.11 1.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.45 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.63 27.08 1.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 71.13 110.865 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -123.6 -11.03 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 61.35 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.86 -25.94 25.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 52.13 112.539 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -140.57 166.65 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 64.53 110.89 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.87 -176.68 41.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 73.01 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -99.58 3.29 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.956 0.408 . . . . 73.21 110.937 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -54.19 150.41 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 64.24 110.894 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 158' ' ' ILE . . . 49.51 63.61 3.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 74.53 112.544 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 m -153.6 -95.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 65.33 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 p -176.5 -172.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.899 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -124.18 -174.51 3.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.9 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.26 177.02 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 70.34 110.87 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 51.17 27.09 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.872 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mt -71.27 119.44 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.53 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.4 111.32 8.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 65.41 111.168 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 93.45 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.672 2.248 . . . . 71.23 112.335 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.96 -30.89 2.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 71.3 112.461 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -108.56 -65.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.52 110.9 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -171.82 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 72.32 110.849 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -121.17 -67.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.906 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 64.15 162.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.504 179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.786 0.327 . . . . 74.43 110.871 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.444 ' HB2' ' C ' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -125.31 129.31 49.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.856 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pt -61.75 -15.0 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 63.33 111.172 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.0 21.85 6.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 72.41 110.923 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 77' ' ' SER . . . 157.12 -136.15 4.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.495 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.408 ' C ' ' HB2' ' A' ' 77' ' ' SER . 27.2 mm-40 -104.57 -47.71 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.956 0.407 . . . . 60.23 110.883 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 175.01 10.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 54.33 110.866 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.51 175.0 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.897 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.97 152.12 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -56.61 166.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.864 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.37 -64.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 71.35 110.888 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.36 153.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 62.41 110.909 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 62.69 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.853 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 28' ' ' LYS . 1.5 mt -81.9 -4.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.34 111.177 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.734 ' O ' HG11 ' A' ' 128' ' ' VAL . 4.2 mt -120.49 77.38 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -58.82 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.939 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 86.29 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.861 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 p -108.33 17.78 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.41 111.113 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.62 164.97 31.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 61.43 112.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.63 30.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.265 . . . . 75.33 112.312 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . 75.98 26.38 64.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.729 . . . . 60.43 112.517 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -91.86 118.85 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 72.54 111.152 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 131' ' ' LYS . 1.2 mt -94.37 143.31 26.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.13 110.961 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 t -146.22 -127.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 61.35 110.821 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.61 118.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.42 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -106.79 88.87 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 61.3 111.089 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 49.5 t30 -153.74 95.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 71.13 110.873 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 71.26 -66.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 64.53 111.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.15 -73.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 60.32 112.491 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.3 Cg_endo -69.72 123.54 10.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 63.14 112.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' PRO . 4.2 m-20 31.06 60.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 54.54 110.901 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 108' ' ' ASN . 1.2 p -145.05 31.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 55.31 111.132 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.581 ' C ' ' O ' ' A' ' 107' ' ' THR . 35.6 t30 22.14 -100.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.41 110.911 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.96 145.12 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 72.24 112.514 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -121.4 -10.43 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 45.54 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.595 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.8 mt-30 -81.25 53.66 2.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 75.41 110.902 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -52.95 143.17 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.15 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -112.95 64.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 72.45 110.876 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 113' ' ' PHE . 55.5 mt -29.82 99.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.155 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -64.97 152.88 42.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 63.2 110.886 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.3 p -118.55 -1.82 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.115 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 119' ' ' THR . . . -149.46 159.4 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.129 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -53.73 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.03 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 117' ' ' ALA . 33.2 p -105.15 63.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.01 111.131 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 4.87 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.725 ' CH2' HG22 ' A' ' 119' ' ' THR . 6.5 p90 -84.21 7.52 18.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.933 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -93.37 -57.69 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.03 110.938 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.04 83.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.89 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.06 36.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 61.42 112.489 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tmtp? -73.56 -30.31 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 64.03 110.93 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.485 ' C ' HG23 ' A' ' 127' ' ' VAL . 19.2 m-70 -146.14 34.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 64.51 110.864 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER 56.21 -154.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.119 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.734 HG11 ' O ' ' A' ' 90' ' ' LEU . 7.1 p 178.89 147.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 70.44 111.129 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.798 ' HB2' HG21 ' A' ' 29' ' ' VAL . 15.4 p90 -177.5 115.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.876 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 102.86 141.71 11.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 63.53 112.48 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -158.76 148.24 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.41 110.901 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 22' ' ' PHE . 94.6 t -51.91 148.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 71.22 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -118.27 -60.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.34 110.906 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -128.5 125.61 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.15 110.893 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 20' ' ' VAL . . . 112.16 65.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 45.3 112.49 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.7 mmm -84.26 -0.47 52.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 73.43 110.877 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -30.39 63.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.848 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 142' ' ' MET . 13.1 mm -72.21 -37.17 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.3 111.154 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.0 t -91.69 20.48 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.51 111.144 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -139.28 -55.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 61.41 110.9 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.4 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 70.14 111.152 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 10.2 tmm? -48.0 -36.38 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 42.53 110.888 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.11 -32.69 55.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 72.04 110.885 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . 0.423 ' HG3' ' CD1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -59.01 -18.41 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.869 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 144' ' ' ARG . 50.0 m-85 -82.59 1.12 39.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 74.33 110.889 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.819 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -90.79 -157.7 33.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 55.34 112.528 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 t -159.45 169.7 23.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 75.2 110.836 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -61.28 -48.5 81.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.888 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -5.66 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.35 110.909 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.46 -39.96 2.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.523 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -48.88 158.22 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 72.53 110.883 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.819 HG22 ' HA2' ' A' ' 146' ' ' GLY . 64.1 p -126.25 157.62 37.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 73.11 111.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.4 t -85.64 1.44 49.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.892 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.3 -168.67 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 64.24 110.893 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.16 120.48 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.22 110.939 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -84.55 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 73.12 111.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.38 136.68 51.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.3 111.202 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.619 HD11 ' CE2' ' A' ' 48' ' ' TYR . 5.7 mt -85.65 132.97 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 75.42 111.165 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -88.03 -58.23 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 74.4 111.129 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -167.79 168.45 12.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.896 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.7 m -146.81 164.48 32.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 61.42 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.51 171.83 44.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.761 . . . . 75.12 112.502 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -68.18 -35.7 78.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.887 0.375 . . . . 61.13 110.929 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.83 -60.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.24 110.929 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 73.25 110.885 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.818 0.342 . . . . 75.44 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.92 146.06 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.14 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.84 141.12 14.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 52.01 110.91 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.72 26.28 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.649 2.233 . . . . 74.41 112.364 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -112.78 112.07 23.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 111.144 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 24' ' ' LEU . 16.1 m -88.57 155.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.11 111.096 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.55 151.75 39.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.866 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 137.64 23.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 62.22 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -109.96 148.28 31.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.669 HD12 ' CG2' ' A' ' 138' ' ' ILE . 3.8 mt -120.13 134.44 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 62.41 111.146 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.27 156.35 42.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.129 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD23 ' A' ' 17' ' ' LEU . 59.1 t -135.27 120.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.44 111.159 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.71 41.34 7.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.875 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.44 62.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 24.23 112.472 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.07 125.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.657 0.741 . . . . 73.44 110.856 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 131.6 21.67 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.702 2.268 . . . . 71.51 112.372 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.76 -19.51 10.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.4 110.926 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.47 -179.58 39.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.747 . . . . 74.03 112.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -144.0 167.0 23.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.353 . . . . 71.22 110.854 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 135' ' ' GLY . 22.6 m -127.15 173.52 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.074 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 t -117.75 94.71 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.35 110.87 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.737 ' CE1' HD11 ' A' ' 114' ' ' ILE . 12.5 m-85 -84.21 120.34 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.848 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.91 146.47 26.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 62.33 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.68 HD11 HG11 ' A' ' 6' ' ' VAL . 11.4 mt -112.26 121.35 44.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.931 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 90' ' ' LEU . 3.9 m-85 -79.99 68.85 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.841 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.21 57.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.129 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.93 -65.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.11 110.852 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -52.43 -62.13 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.887 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.63 84.78 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 52.05 111.113 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 76.48 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 65.34 112.329 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 179.66 -65.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 62.1 110.85 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' CE2' ' A' ' 129' ' ' PHE . 52.1 m -50.92 -41.55 58.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 74.24 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.27 -26.24 51.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.085 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.14 -24.08 66.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.907 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -80.75 -66.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 65.31 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -49.57 -41.21 41.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.888 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -62.13 -33.46 74.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.889 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.4 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 60.14 111.067 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.87 -51.04 36.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 64.23 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 m -57.06 -48.12 79.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.859 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -79.25 -5.41 54.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 73.33 111.168 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.25 64.96 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 41.24 112.505 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -112.22 37.53 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 73.31 110.883 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.635 ' HD2' HD12 ' A' ' 78' ' ' ILE . 2.1 mtpm? -131.64 17.02 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.3 110.884 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.62 63.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 74.11 112.51 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.92 164.78 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 74.32 110.858 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.78 141.2 5.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 54.41 112.5 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HE1' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.45 138.66 9.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 61.35 110.925 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 -47.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.927 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.48 30.22 6.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.731 . . . . 75.1 112.455 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -112.48 -164.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 73.4 110.887 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.0 p -103.23 -178.8 3.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 70.43 110.874 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 158' ' ' ILE . 2.0 m-85 -88.54 177.32 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 74.32 110.851 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.36 -61.54 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 72.2 110.888 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -164.33 145.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 65.24 110.903 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.472 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -133.43 145.66 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.43 111.122 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -139.16 123.04 11.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 53.42 111.131 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.71 28.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.632 2.221 . . . . 74.11 112.338 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.17 24.44 68.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 72.34 112.505 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.94 -71.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 71.44 110.918 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.58 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -174.5 -163.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 72.42 110.88 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.57 143.34 16.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.32 110.893 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.41 152.27 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.875 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 64.02 112.491 179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.634 ' N ' ' HG ' ' A' ' 110' ' ' SER . 5.1 ptpt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.781 0.324 . . . . 71.41 110.906 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -71.18 174.41 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.846 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.635 HD12 ' HD2' ' A' ' 44' ' ' LYS . 20.0 pt -83.45 -32.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 72.44 111.139 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -81.36 3.12 25.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.22 -120.46 3.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.739 -0.744 . . . . 73.44 112.521 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -60.47 -164.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 61.24 110.89 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -107.97 164.27 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.902 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.55 146.66 47.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.876 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.38 172.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 72.33 110.862 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 124.19 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 54.04 110.863 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.12 -55.35 14.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.859 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.3 p30 179.65 172.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.32 110.886 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.41 41.05 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.51 110.863 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.522 HG21 ' HG3' ' A' ' 28' ' ' LYS . 3.8 mt -46.54 -33.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 71.54 111.157 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.76 HD11 ' CD2' ' A' ' 25' ' ' PHE . 22.0 mt -91.99 118.97 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 62.24 110.945 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.4 111.11 23.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.902 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.681 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -61.01 92.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 52.53 110.881 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 p -115.43 25.66 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.166 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.61 171.0 43.94 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 73.15 112.527 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 150.37 67.84 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.743 2.295 . . . . 75.1 112.36 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 -30.35 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 75.22 112.468 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 92' ' ' HIS . 43.9 mm -51.49 145.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.42 111.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 ' CE1' ' A' ' 129' ' ' PHE . 1.7 tt -104.82 133.07 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 75.2 110.881 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.75 137.34 54.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 71.32 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.9 mmt -88.07 178.48 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.864 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . 176.11 174.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 71.32 111.111 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 33.7 t-20 178.21 -66.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 53.12 110.837 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -157.34 23.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.23 111.081 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.73 -153.55 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 44.23 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.03 66.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 72.43 112.303 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 64.91 27.14 12.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 75.2 110.936 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 82' ' ' LYS . 26.3 p -147.11 67.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 62.42 111.122 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -88.21 7.21 33.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.959 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.85 130.74 36.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 63.54 112.501 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.634 ' HG ' ' N ' ' A' ' 76' ' ' LYS . 55.1 p 48.13 -158.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 33.02 110.823 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 49.77 93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.932 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.69 163.77 18.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.1 110.841 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -138.85 139.98 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.858 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.737 HD11 ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -81.84 -41.65 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 75.24 111.093 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.6 m 70.78 99.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.88 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.9 p -91.83 27.42 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.146 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -173.04 -173.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 62.11 111.088 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 138.06 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.929 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.7 p -81.27 -150.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.131 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 168.65 -67.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -64.76 -19.87 66.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.949 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 126' ' ' HIS . 25.5 mt -88.16 140.24 29.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.916 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -154.98 -48.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.873 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.99 51.39 0.82 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 43.44 112.472 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HD2' HD22 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.5 29.74 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 72.45 110.92 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.493 ' CD2' HD13 ' A' ' 122' ' ' LEU . 29.3 m-70 -156.11 -50.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.859 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 15.8 t 80.04 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.0 133.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 65.02 111.154 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.53 ' CE1' HD22 ' A' ' 98' ' ' LEU . 4.6 p90 -151.01 17.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.889 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -135.29 -166.55 11.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 71.02 112.47 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER 175.08 172.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 72.41 110.89 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.634 HG11 ' HB2' ' A' ' 136' ' ' MET . 21.3 t -107.94 100.38 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.53 111.144 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -39.87 90.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 179.71 -168.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 110.915 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.714 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 62.68 14.69 51.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 42.22 112.507 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.634 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -55.58 -22.02 20.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 62.11 110.902 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -50.28 -30.26 11.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 51.24 110.886 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.669 ' CG2' HD12 ' A' ' 10' ' ' ILE . 16.7 mm -73.32 -39.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 61.13 111.147 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.671 HG12 ' OE1' ' A' ' 143' ' ' GLU . 53.3 t -48.33 -44.05 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 34.42 111.135 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.72 -47.4 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.53 110.892 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -27.51 62.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.2 111.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 10' ' ' ILE . 46.3 mtm -80.32 -39.76 28.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.671 ' OE1' HG12 ' A' ' 139' ' ' VAL . 2.5 pt-20 -87.44 30.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.22 110.878 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -122.48 -13.54 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.884 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -128.84 24.13 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.851 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -120.73 73.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 75.43 112.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 146' ' ' GLY . 24.0 p -24.37 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 75.11 110.87 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -49.62 -36.13 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.31 110.869 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -54.08 -25.6 22.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.917 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.57 -45.16 1.26 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.791 -0.719 . . . . 44.54 112.512 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 116.1 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 72.21 110.905 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -78.96 133.13 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 74.44 111.138 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -23.25 67.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 74.23 110.838 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.23 -169.33 2.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 73.21 110.908 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.1 OUTLIER -106.08 134.39 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 63.24 110.885 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -115.25 87.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.129 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.701 HG23 ' HD2' ' A' ' 155' ' ' LYS . 2.0 p -102.38 168.77 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.23 111.174 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.596 HD11 ' HE1' ' A' ' 53' ' ' PHE . 1.8 mp -113.4 118.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.11 111.162 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.33 -70.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 61.42 111.136 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -119.1 173.24 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 53.14 110.863 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.2 p -171.9 178.57 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.833 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.69 -143.9 15.4 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 63.23 112.517 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.5 tt0 -107.29 132.95 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.862 0.363 . . . . 73.14 110.924 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -59.78 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 70.2 110.902 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.884 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.795 0.331 . . . . 72.34 110.851 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.68 142.47 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 63.53 111.129 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.89 162.13 0.83 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 74.55 110.89 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 149.23 66.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 73.22 112.345 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.0 m -136.94 86.21 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 43.1 111.126 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.98 159.85 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.107 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.33 161.35 36.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.928 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.64 137.55 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.5 OUTLIER -110.42 100.16 9.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.858 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mm -75.44 144.88 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 72.4 111.18 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -124.7 154.1 41.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.35 111.131 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.577 HG21 HD23 ' A' ' 17' ' ' LEU . 4.8 t -129.16 98.84 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.24 111.121 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.54 54.98 8.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.1 110.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.08 7.93 52.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 62.21 112.469 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -140.05 95.76 8.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 74.12 110.856 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 161.65 45.12 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 70.15 112.289 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -128.31 25.94 5.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.916 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -162.69 21.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 75.44 112.441 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 -176.92 5.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 74.14 110.885 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.638 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 3.7 m -135.19 163.91 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 60.1 111.123 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -116.5 94.82 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.868 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.2 m-85 -89.63 116.79 28.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 63.42 110.881 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.34 113.68 26.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.923 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 129' ' ' PHE . 23.6 mt -79.94 139.71 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 75.1 110.941 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CG ' HD11 ' A' ' 90' ' ' LEU . 17.6 m-85 -86.97 60.22 6.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.433 . . . . 70.42 110.886 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.53 -25.26 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.087 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.9 -61.06 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -19.12 62.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.875 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.99 82.7 8.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.682 0.753 . . . . 64.22 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.62 24.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 63.14 112.3 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -58.52 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 73.22 110.925 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.524 HG21 ' CG1' ' A' ' 127' ' ' VAL . 12.7 m -52.0 -45.09 64.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 73.43 111.115 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.22 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.081 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.6 tp10 -57.47 -23.18 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.926 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.51 -71.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.874 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -48.72 -44.23 38.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.857 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.73 -33.18 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.837 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.73 -38.79 28.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.45 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.1 tt -89.33 20.06 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.922 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -112.39 -15.18 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 55.21 110.864 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 p -117.52 4.68 12.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 74.4 111.132 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.96 30.13 66.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 74.13 112.491 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -38.6 50.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.968 0.413 . . . . 63.25 110.906 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.82 -17.05 54.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 51.22 110.9 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.72 -26.36 24.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.34 159.61 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 71.45 110.843 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.636 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 176.3 -78.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 51.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -167.44 -64.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 73.11 110.96 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tptt 59.77 166.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 62.34 110.882 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 118.67 14.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 71.31 112.479 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 157' ' ' THR . 36.8 m -159.14 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 72.42 110.811 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -142.88 119.14 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 44.45 110.879 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.23 122.54 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.22 110.894 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.92 70.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.848 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.43 39.49 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 72.23 110.855 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 mt -96.26 140.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.23 111.139 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.438 HG13 ' HD2' ' A' ' 58' ' ' PRO . 2.0 tt -135.05 133.02 20.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.587 0.708 . . . . 63.14 111.184 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.8 125.21 11.86 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 50.11 112.375 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.33 26.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 75.01 112.514 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -156.73 -82.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 73.01 110.855 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -179.96 -150.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.34 110.848 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.9 m -146.79 144.22 29.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 72.01 110.91 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.49 164.64 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.878 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.769 -0.729 . . . . 31.22 112.454 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.804 0.335 . . . . 75.43 110.912 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -133.15 15.26 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 52.2 110.819 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER 83.9 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 73.15 111.184 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.93 -23.25 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 61.12 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.04 -156.68 26.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 64.41 112.503 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.95 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 71.04 110.908 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -155.84 155.34 32.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 71.05 110.917 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -119.55 145.91 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -64.57 152.98 40.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 72.54 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.8 93.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -58.56 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 75.51 110.885 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 175.44 175.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.4 110.909 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.58 43.52 2.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.3 mm -46.23 -32.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 53.33 111.147 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 25' ' ' PHE . 14.5 mt -91.0 147.71 22.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -126.33 -166.37 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.51 110.884 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -98.65 -88.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.35 10.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.163 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.59 141.07 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 63.45 112.488 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 156.68 62.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.31 112.318 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.52 -28.8 9.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 41.01 112.475 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 131' ' ' LYS . 50.3 mm -62.82 147.87 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 72.02 111.102 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 99' ' ' SER . 1.6 tm? -99.1 148.8 23.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.877 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.679 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -145.49 176.96 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.845 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.481 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 4.8 mmt -82.52 170.72 14.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.41 110.926 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' PHE . . . -140.38 100.12 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 61.12 111.083 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -161.0 -169.86 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.923 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -53.38 -32.84 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.23 -68.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 74.55 112.445 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.714 ' O ' HG23 ' A' ' 107' ' ' THR . 53.7 Cg_endo -69.73 120.52 7.3 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.2 112.345 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 11.9 m-20 32.96 58.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.52 110.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 105' ' ' PRO . 19.2 p -139.71 33.12 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.24 111.161 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 107' ' ' THR . 2.4 p30 23.89 -101.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 73.23 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 100' ' ' MET . . . 166.08 -165.25 38.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 63.31 112.468 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.45 13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 64.42 110.854 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 70.36 72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 63.21 110.941 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.703 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 175.59 122.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 61.54 110.87 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 112' ' ' PHE . 11.4 t80 178.83 47.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 73.02 110.847 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.59 HG12 HD23 ' A' ' 98' ' ' LEU . 58.8 mt -72.91 94.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.54 111.117 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.5 p -83.28 133.22 34.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.87 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -91.05 -10.38 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 34.42 111.145 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.16 149.43 47.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.16 131.98 46.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.4 110.895 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.05 47.14 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 61.22 111.093 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.02 -15.45 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.872 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -57.81 -20.21 34.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.955 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.28 -46.32 28.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 63.23 110.944 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.99 -58.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 63.51 110.851 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.0 64.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.43 112.508 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -105.47 -28.45 10.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 74.12 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.23 125.5 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.899 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 32' ' ' THR . 53.1 t -51.01 114.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 73.2 111.152 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -98.42 139.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 54.34 111.133 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.2 p90 -176.26 123.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.904 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.38 134.85 8.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.733 . . . . 62.23 112.491 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HB2' HD13 ' A' ' 97' ' ' ILE . 22.2 pttm -152.02 165.26 35.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 70.01 110.873 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 133' ' ' LYS . 9.8 p -72.84 159.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.158 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -124.49 -47.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.15 110.879 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.39 178.51 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 70.44 110.839 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 51.44 69.5 1.12 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.778 -0.725 . . . . 42.53 112.471 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.52 -1.16 40.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.333 . . . . 63.12 110.898 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -77.71 -27.12 50.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.859 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.492 ' HB ' HG12 ' A' ' 20' ' ' VAL . 35.0 mm -65.34 -44.38 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 139' ' ' VAL . 4.7 t -90.11 9.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.52 111.13 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.89 -66.38 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 72.22 110.868 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.83 -51.51 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 53.54 111.111 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.0 ttm -50.95 -44.43 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.875 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -52.8 -27.11 16.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.892 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -62.63 -23.09 66.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 62.02 110.909 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -78.65 2.46 19.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.12 110.904 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -73.16 -161.37 6.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 72.1 112.5 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.9 m -142.15 -77.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 71.44 110.849 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.893 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -92.94 14.93 16.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.938 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.41 -42.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.742 -0.742 . . . . 73.33 112.542 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 155.67 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 70.4 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 146' ' ' GLY . 75.0 p -130.24 157.85 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 53.31 111.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.1 p -79.01 -16.49 56.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.88 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.39 -169.72 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.912 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.55 40.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.893 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.51 127.39 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.23 111.146 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -134.13 143.49 47.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.134 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.91 104.97 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.1 111.157 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -64.25 -59.95 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.13 111.073 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -144.33 171.1 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 65.35 110.869 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.3 p -175.58 145.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.33 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.0 -178.92 36.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 63.13 112.529 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -81.4 122.78 27.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 70.01 110.88 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.817 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -94.92 -30.68 14.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.936 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.916 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.812 0.339 . . . . 71.12 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.19 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.32 111.115 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -89.58 144.27 31.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 75.12 110.902 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 124.57 11.23 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.273 . . . . 62.42 112.349 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -117.1 145.99 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.133 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.36 148.75 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 64.23 111.105 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -110.0 154.47 23.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.14 137.47 42.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.861 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.36 124.0 44.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.888 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.89 129.05 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.55 111.092 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -123.9 168.54 12.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.085 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.5 t -152.39 107.23 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 62.12 111.155 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.25 25.23 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 62.43 110.845 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.63 -14.04 65.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.03 112.499 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.82 139.28 21.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.73 . . . . 71.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.49 64.97 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.722 2.281 . . . . 74.04 112.374 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -66.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 63.52 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.29 -174.83 36.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 64.34 112.459 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -118.76 126.09 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 71.12 110.877 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 138' ' ' ILE . 24.2 t -121.14 119.72 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.173 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.3 p -107.14 148.93 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.895 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.3 105.72 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.93 162.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 74.33 110.909 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.94 119.24 35.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 51.21 110.909 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.85 84.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.91 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.43 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.59 -28.71 37.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.888 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.453 ' NZ ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -82.45 -71.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.903 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.7 m -101.46 99.5 11.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.56 0.695 . . . . 71.4 111.133 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.678 2.252 . . . . 63.15 112.361 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -43.22 66.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.9 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 32' ' ' THR . 6.4 m -85.8 21.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 44.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.05 -45.31 20.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 61.14 111.122 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ASN . 86.9 tt0 -83.57 -24.21 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.53 110.89 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -30.79 -70.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 53.1 110.896 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 39' ' ' LEU . 65.2 t80 -74.01 -32.42 63.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.1 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 2.7 ttm180 -50.82 -37.9 45.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 70.23 110.863 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.57 -29.99 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.718 HD12 ' HA ' ' A' ' 36' ' ' PHE . 63.6 mt -66.94 -51.65 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.912 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -65.35 -47.83 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 52.41 110.863 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 163' ' ' GLN . 80.8 p -68.83 -24.07 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 62.31 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.49 83.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 55.31 112.482 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 33.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.396 . . . . 74.02 110.895 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -124.73 27.58 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 23.41 110.887 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.09 14.34 68.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 53.54 112.502 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -174.91 173.86 2.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 71.13 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.61 153.93 7.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 51.04 112.484 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.97 137.88 41.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.947 0.403 . . . . 74.33 110.944 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -41.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.912 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.03 43.35 0.55 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 53.44 112.489 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.26 31.67 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.2 110.885 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.0 m 62.96 174.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.894 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -168.2 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 74.43 110.855 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 -59.75 1.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.14 110.878 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -155.68 -169.99 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 61.31 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -168.4 141.84 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.166 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 17.6 mt -134.87 95.89 15.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.66 0.743 . . . . 71.31 111.128 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.74 81.14 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.245 . . . . 65.42 112.346 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.45 -27.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 41.34 112.474 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -51.46 2.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.44 110.931 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.97 -159.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.853 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 36.8 m -129.46 -66.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.23 110.917 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 62' ' ' CYS . 14.6 tt0 64.34 136.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.9 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 65.43 112.495 180.0 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.754 0.311 . . . . 63.31 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -102.61 157.65 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 71.32 110.903 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -39.38 -38.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 64.32 111.159 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.78 49.96 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 62.32 110.935 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.45 -120.58 7.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.769 -0.729 . . . . 72.54 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.98 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 73.34 110.93 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.26 176.34 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.893 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.54 175.23 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.35 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.36 173.69 10.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 60.42 110.834 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.4 158.43 28.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.822 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.98 -58.59 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.05 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.97 150.93 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.893 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -125.01 68.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.9 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 89' ' ' ILE . 14.6 mt -83.19 0.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 43.13 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.453 HD21 ' NZ ' ' A' ' 28' ' ' LYS . 32.9 mt -121.56 83.18 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 53.13 110.941 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' THR . 33.9 mttm -70.17 141.14 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.899 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -55.7 91.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.838 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 91' ' ' LYS . 48.1 p -86.9 7.62 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 54.13 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.45 -165.32 30.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 52.53 112.438 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 166.04 28.91 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 71.41 112.358 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 80.13 -0.06 84.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 74.0 112.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.1 mm -83.18 141.43 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 71.24 111.148 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -116.29 141.4 48.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 71.03 110.95 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.819 ' O ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -150.22 30.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 53.11 110.86 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.819 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 ptp 34.1 120.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.11 110.891 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 110' ' ' SER . . . -46.91 170.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.117 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -174.49 174.77 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.904 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.0 24.7 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 62.52 111.089 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.5 -178.41 21.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.5 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.95 41.69 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.662 2.242 . . . . 65.05 112.357 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 67.63 27.87 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 p -150.55 50.92 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 64.4 111.156 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -80.88 1.81 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.914 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.93 88.58 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.468 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 5.0 m -145.75 -145.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.349 . . . . 72.23 110.833 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.527 ' OE1' HD13 ' A' ' 39' ' ' LEU . 4.4 tp-100 -109.77 -80.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 72.01 110.923 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.472 ' HB2' HD21 ' A' ' 98' ' ' LEU . 8.2 p90 178.94 137.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 64.34 110.868 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' ' C ' ' A' ' 114' ' ' ILE . 5.7 p90 -131.26 45.29 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.02 110.876 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 113' ' ' PHE . 79.1 mt -28.07 130.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 73.13 111.14 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 77.5 m -83.07 148.09 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.832 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.628 HG21 ' OE2' ' A' ' 143' ' ' GLU . 5.4 p -117.88 22.98 11.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 53.12 111.124 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.58 175.76 6.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.124 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 86.57 4.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.904 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.0 p -112.11 52.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 55.42 111.125 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -87.26 23.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 64.21 110.871 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 8.67 39.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 62.05 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.43 1.41 51.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 62.31 110.935 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 49.3 66.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 73.51 110.863 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 41.19 36.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 55.34 112.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -57.21 -32.87 66.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 75.21 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -108.67 156.82 19.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 71.43 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.56 94.49 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.097 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 49.6 t -74.46 136.07 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.156 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -163.84 26.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.936 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.54 -178.34 15.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 33.34 112.461 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.33 147.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 72.12 110.817 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' HA2' ' A' ' 96' ' ' GLY . 6.6 t -72.21 103.8 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.163 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -53.58 25.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.884 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -166.8 157.55 12.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.88 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.93 6.05 54.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.12 112.48 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.4 ' HB2' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.66 -31.15 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 61.14 110.886 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -52.04 -24.04 6.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.492 HD12 HG22 ' A' ' 20' ' ' VAL . 6.5 mt -81.84 -39.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 64.23 111.113 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.96 -44.65 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.34 111.159 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.62 -29.48 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.47 67.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 31.23 111.104 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -75.31 -23.35 57.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.847 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -89.56 29.21 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.73 3.75 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.821 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.16 13.5 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.822 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -89.06 -160.91 36.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.744 . . . . 51.34 112.514 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.1 t -154.13 18.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.52 110.849 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 46.91 59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 61.01 110.871 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -177.34 -36.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.93 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.75 -56.98 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 74.4 112.485 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.95 116.29 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 75.44 110.877 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.822 HG22 ' HA2' ' A' ' 146' ' ' GLY . 19.6 p -90.28 158.47 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.41 111.134 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 t -68.57 -21.66 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 75.33 110.866 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.47 -168.0 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 65.03 110.834 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.47 124.43 34.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.909 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 11' ' ' ALA . 2.7 mp -100.17 104.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 61.41 111.166 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -96.92 175.8 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 44.43 111.19 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.74 143.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 62.55 111.118 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.35 -59.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.0 111.098 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -154.78 164.5 38.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 75.04 110.845 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.0 m -144.79 -162.97 1.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.92 -155.54 22.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 34.24 112.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -108.24 134.9 50.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.346 . . . . 64.31 110.886 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 tp -55.35 -59.07 5.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.892 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.21 110.913 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 63.22 110.892 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.61 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 65.1 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.617 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -116.8 160.72 35.59 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 54.44 110.895 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 152.9 69.43 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 73.4 112.387 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 m -123.75 43.87 2.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 71.23 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -50.67 143.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.55 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -135.41 175.9 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.913 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -146.14 145.66 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.87 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -102.23 135.21 44.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 54.41 110.876 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.04 131.0 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 71.25 111.142 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.26 167.8 13.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.33 111.081 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.691 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -148.27 98.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.13 111.131 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.33 -12.09 70.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 61.13 112.513 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -95.84 131.81 28.44 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 74.44 110.894 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 145.57 57.87 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.754 2.302 . . . . 73.55 112.342 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.691 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.0 tp -114.9 -67.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.861 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.23 177.5 41.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 71.42 112.477 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 135.92 49.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.03 110.907 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.12 129.48 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 72.02 111.131 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.3 t -90.84 96.5 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.836 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.83 81.82 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.14 110.871 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 9.7 tt0 -57.51 143.49 40.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 73.01 110.897 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.406 HD21 ' HD2' ' A' ' 36' ' ' PHE . 11.3 mt -109.6 117.47 34.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 61.34 110.895 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.69 72.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.851 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 3' ' ' ASN . . . -76.82 -30.18 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 72.24 111.096 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -54.03 -60.33 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -64.69 -61.93 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.31 110.921 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.08 94.2 46.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 74.13 111.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -22.83 31.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 71.22 112.315 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -66.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 65.45 110.905 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 127' ' ' VAL . 60.5 p -52.84 -40.93 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.1 111.123 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.88 -71.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 61.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 37' ' ' ARG . 34.2 tt0 -40.66 -65.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.898 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.6 t30 -34.18 -45.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.884 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 39' ' ' LEU . 89.4 t80 -77.11 -38.92 51.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.894 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -51.89 -29.84 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 71.25 110.865 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.06 55.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 54.23 111.122 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 36' ' ' PHE . 57.8 mt -67.82 -54.45 18.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 63.4 110.877 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 t -52.91 -41.89 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.44 110.874 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 62.3 p -71.08 -21.6 62.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 73.43 111.143 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.78 91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.01 112.495 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 35.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 72.55 110.861 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -144.0 12.43 1.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.926 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.27 17.33 74.27 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 42.12 112.45 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -175.26 -166.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 65.53 110.926 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 130.77 -149.08 19.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.489 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -98.08 -26.16 14.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 75.43 110.93 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.32 139.33 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.856 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.69 60.23 5.94 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 73.32 112.531 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.463 ' H ' HD13 ' A' ' 158' ' ' ILE . 5.3 t -137.49 -165.93 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 72.41 110.88 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -157.21 168.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.24 110.869 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 156' ' ' ILE . 20.5 m-85 -81.47 120.69 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 53.52 110.905 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -93.69 -17.53 23.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -145.26 137.76 25.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.873 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.5 mt -150.33 121.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 71.12 111.128 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt -137.76 108.14 8.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 70.31 111.132 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 107.64 1.91 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 74.33 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 130.82 -34.13 2.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.537 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.22 -68.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 73.31 110.871 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -165.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 71.24 110.83 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.66 137.32 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.884 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -100.15 140.98 33.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.932 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 74.51 112.465 -179.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.831 0.348 . . . . 75.42 110.839 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.03 -173.72 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.832 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -87.36 -32.03 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 65.45 111.157 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.37 82.36 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 54.44 110.943 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.29 -125.87 8.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 65.04 112.463 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -116.61 -85.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 73.54 110.903 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 175.0 9.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 64.01 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.74 155.26 40.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.25 110.832 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 168.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.898 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.29 130.62 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 70.43 110.869 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -50.31 18.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.869 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.76 159.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.908 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.419 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -105.4 29.84 6.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.875 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.636 HG21 ' HG3' ' A' ' 28' ' ' LYS . 22.0 mm -51.31 -27.53 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.15 103.3 15.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.893 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.7 107.34 19.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 64.02 110.883 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.63 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -58.42 98.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 74.31 110.847 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 42.36 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.115 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.33 178.93 23.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 41.5 112.521 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.29 19.25 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.241 . . . . 72.31 112.329 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA2' HD11 ' A' ' 114' ' ' ILE . . . 87.17 -34.75 3.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 43.04 112.503 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.63 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.6 mm -50.91 137.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 73.51 111.137 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 99' ' ' SER . 2.7 tt -98.38 128.64 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 64.43 110.93 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.549 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -134.42 -171.07 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 72.15 110.834 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.428 ' H ' ' HB3' ' A' ' 126' ' ' HIS . 9.5 mmt -116.63 -173.4 2.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 70.04 110.877 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 102' ' ' ASN . . . -101.35 -48.77 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 61.15 111.053 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HA ' HG23 ' A' ' 107' ' ' THR . 5.4 p-10 39.73 -165.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 62.01 110.906 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.557 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -158.86 22.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 72.34 111.103 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.3 -67.92 0.34 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 41.24 112.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.557 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.75 -156.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 74.14 112.315 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.22 87.31 7.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 102' ' ' ASN . 7.2 t -153.75 51.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.167 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -71.64 -4.88 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 70.43 110.895 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.65 76.04 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 74.51 112.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.0 p -127.3 -140.88 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 73.11 110.871 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -77.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.95 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.89 148.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.842 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.78 122.58 14.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.886 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' HA2' ' A' ' 96' ' ' GLY . 13.0 tt -123.95 137.46 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 71.13 111.124 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.83 148.48 22.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.888 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -92.68 -18.74 22.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 73.34 111.094 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.0 179.89 5.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 75.44 111.125 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -65.7 90.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.63 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.2 p -116.9 59.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 64.21 111.187 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.09 28.06 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.31 110.856 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.4 OUTLIER -91.81 10.63 27.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.91 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -23.65 17.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.913 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.8 OUTLIER 56.72 85.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 60.25 110.87 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.589 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 20.18 61.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 42.15 112.461 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -104.66 -14.36 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 75.42 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HB3' ' H ' ' A' ' 100' ' ' MET . 32.5 m-70 -110.99 -8.94 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.4 110.848 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 32' ' ' THR . 42.6 t 65.74 96.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 73.14 111.133 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 97' ' ' ILE . 24.8 t -83.12 130.36 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.139 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.11 27.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.888 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -152.72 -179.67 28.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 65.11 112.523 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.09 136.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 74.33 110.915 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . 1.4 t -63.32 119.07 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.165 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -89.47 -42.28 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 72.23 110.904 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.39 156.01 13.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 74.02 110.908 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.65 1.96 57.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.763 . . . . 71.35 112.51 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -29.1 8.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.33 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.93 -22.32 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.24 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.2 mm -89.84 -35.67 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 72.41 111.11 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.4 t -52.62 -22.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.12 111.149 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -84.29 -35.38 23.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.888 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.02 94.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 72.5 111.1 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.3 ptm -71.39 -37.15 71.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.893 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.04 34.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 74.45 110.922 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -10.86 6.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.912 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.17 14.59 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.861 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -106.77 71.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.707 -0.759 . . . . 71.35 112.525 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.553 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.73 131.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 52.45 110.843 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -46.25 -46.54 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.901 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -47.0 -37.9 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.07 -47.67 0.92 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 61.35 112.463 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 110.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 64.51 110.889 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.1 t -82.62 145.12 29.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 45.44 111.182 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -22.46 52.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.874 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -136.31 163.91 29.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.952 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.14 130.8 51.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.878 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 53' ' ' PHE . 3.8 mp -109.82 120.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.42 111.169 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.6 p -119.31 165.41 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 62.42 111.181 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 3.9 mp -90.37 -64.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 71.23 111.144 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 158' ' ' ILE . . . 93.93 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 55.42 111.127 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.59 147.08 15.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.24 110.874 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.2 p -176.24 -174.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.51 110.889 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.0 -163.73 28.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 62.55 112.484 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -81.39 120.07 24.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 64.11 110.908 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -91.91 -23.97 19.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.51 110.943 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.333 . . . . 73.11 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 89.1 t 62.38 104.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 73.01 111.137 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -60.19 151.93 64.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 63.14 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.728 ' O ' HD12 ' A' ' 24' ' ' LEU . 54.1 Cg_endo -69.73 117.25 4.97 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 65.32 112.34 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 22' ' ' PHE . 48.7 m -110.35 132.12 54.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 62.3 111.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.4 m -123.99 160.48 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 60.33 111.151 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -127.92 160.04 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.911 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HD2' HD12 ' A' ' 158' ' ' ILE . 5.9 m-85 -135.84 126.98 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.02 110.914 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.27 72.08 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.865 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.16 135.12 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.133 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -123.27 151.38 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 45.14 111.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.6 t -133.31 100.85 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t0 54.06 55.73 7.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.897 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.31 12.27 55.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 64.15 112.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 35.2 tt0 -142.87 94.22 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.645 0.736 . . . . 70.23 110.887 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.7 167.13 25.27 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.271 . . . . 74.05 112.386 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.78 30.05 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 70.53 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.0 -164.02 22.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 70.3 112.481 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 164.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 74.23 110.818 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 138' ' ' ILE . 32.3 m -128.8 171.8 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 74.12 111.107 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -149.84 148.58 29.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.04 110.858 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 5' ' ' THR . 3.9 m-85 -125.32 154.05 42.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.868 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -94.15 -53.28 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 62.54 110.874 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 4' ' ' PRO . 7.9 mt 73.81 122.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.936 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.722 ' CE2' HD22 ' A' ' 90' ' ' LEU . 60.4 m-85 -88.75 69.04 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.875 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.49 48.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 45.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.95 -34.25 26.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 61.42 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -31.42 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 65.53 110.879 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.8 67.6 79.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 61.11 111.138 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 54.2 Cg_endo -69.76 61.64 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 43.14 112.355 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.68 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 73.1 110.875 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.56 ' OG1' HG11 ' A' ' 127' ' ' VAL . 17.6 m -75.2 -60.5 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.4 111.152 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -88.43 -1.32 57.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.128 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 14.8 tm-20 -82.19 -19.99 38.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.886 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' HG21 ' A' ' 78' ' ' ILE . 8.2 p30 -101.28 -27.86 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 72.45 110.859 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -50.95 -29.47 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 45.44 110.899 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -31.17 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.869 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.2 -30.64 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 64.55 111.129 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.423 HD11 ' HA3' ' A' ' 47' ' ' GLY . 2.5 tt -84.47 5.46 27.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.954 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 m -108.15 -2.67 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 70.53 110.83 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -117.16 13.21 14.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 74.32 111.146 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.58 26.58 10.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.01 112.47 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -33.47 28.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -17.97 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 62.55 110.9 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.09 -63.27 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 41.51 112.463 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -102.29 148.99 24.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 62.44 110.828 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 39' ' ' LEU . . . 135.63 151.45 6.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.491 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 158' ' ' ILE . 8.1 t80 -49.56 103.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 64.24 110.921 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -139.55 -47.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.846 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.69 33.76 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 74.34 112.457 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -172.83 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 73.14 110.858 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.2 m -89.51 -172.09 3.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 75.33 110.874 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -75.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.02 110.876 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 41.42 -160.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.842 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.35 19.35 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.22 110.84 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.06 139.94 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 75.34 111.099 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -139.87 108.58 7.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 74.05 111.157 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 92.35 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 51.15 112.345 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.11 21.27 2.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.15 112.474 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.05 -66.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 73.33 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptp -163.54 -168.94 1.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.857 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.73 97.09 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.841 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.68 141.48 36.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.942 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 54.15 112.525 -179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.79 0.329 . . . . 73.53 110.932 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 148.84 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 44.44 110.879 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -44.14 -55.31 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.142 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -128.3 26.62 5.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 74.33 110.966 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.04 -167.25 17.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 24.43 112.485 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -118.24 -29.59 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 75.03 110.879 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -168.88 136.36 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.942 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -112.03 158.78 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.61 161.68 22.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.43 110.899 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -79.39 108.04 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.831 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.5 -52.64 12.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.857 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -178.9 168.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 71.1 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.91 72.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 64.05 110.936 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.4 mt -76.83 -3.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 72.34 111.139 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD22 ' CE2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -120.53 91.64 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.897 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -75.47 -167.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.901 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -95.05 72.54 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 74.13 110.858 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 p -69.63 -17.92 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 32.24 111.133 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.06 -177.11 43.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.24 112.476 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.82 52.08 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 61.23 112.326 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 104.12 22.35 8.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 52.14 112.476 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.539 ' C ' HD23 ' A' ' 98' ' ' LEU . 24.8 mm -99.36 137.25 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 62.21 111.153 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 112' ' ' PHE . 7.1 mt -111.11 148.18 33.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 54.33 110.898 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.664 ' O ' ' C ' ' A' ' 100' ' ' MET . 1.8 p -163.69 55.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.869 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.664 ' C ' ' O ' ' A' ' 99' ' ' SER . 3.0 mmt 7.96 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 61.14 110.861 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.07 110.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 54.05 111.095 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -142.54 -164.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.725 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -47.99 -51.85 22.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 43.12 111.126 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 124.96 -61.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 62.51 112.498 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 107' ' ' THR . 54.3 Cg_endo -69.76 100.0 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 45.21 112.335 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 63.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.919 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 103' ' ' ALA . 39.9 p -134.73 13.59 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.153 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 42.28 -100.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 24.34 110.928 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.94 166.52 10.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 64.4 112.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.75 22.75 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 75.1 110.824 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.86 90.3 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 70.21 110.938 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.674 ' CD1' HD22 ' A' ' 98' ' ' LEU . 33.1 p90 -72.44 155.7 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.894 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 10.1 p90 -120.96 107.3 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 64.2 110.9 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.27 111.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.108 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.88 136.85 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 61.12 110.903 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.84 13.17 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.21 111.145 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.5 11.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.05 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.28 138.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 70.12 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.753 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.1 p -139.34 46.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 111.085 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -54.06 -25.39 21.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.753 ' CZ2' HG22 ' A' ' 119' ' ' THR . 21.0 p90 -62.43 -18.53 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 119' ' ' THR . 33.8 mt -82.58 -34.97 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.78 -10.0 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.879 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.18 52.46 1.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.777 -0.725 . . . . 75.23 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 -29.74 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 74.45 110.912 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -112.36 154.97 24.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 64.43 110.874 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.56 HG11 ' OG1' ' A' ' 32' ' ' THR . 6.6 p -50.08 109.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.095 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 90' ' ' LEU . 9.1 p -76.58 153.79 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 130' ' ' GLY . 4.8 p90 -177.02 178.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.5 110.884 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 43.61 114.15 0.0 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 73.31 112.516 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -119.53 35.41 4.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 73.24 110.913 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 96' ' ' GLY . 3.6 t 60.23 162.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 61.01 111.075 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 132' ' ' VAL . 5.4 tppt? -136.63 -58.08 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 71.15 110.923 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 175.29 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.934 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.37 81.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.705 -0.759 . . . . 70.34 112.446 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.9 tpt -91.62 -25.94 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 70.02 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.42 -30.72 53.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.03 110.892 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 20' ' ' VAL . 43.6 mm -44.07 -39.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.14 111.169 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.1 -52.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 61.12 111.134 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -45.83 -49.99 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.11 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 70.43 111.094 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 156' ' ' ILE . 9.6 ttm -50.3 -31.42 14.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 70.11 110.855 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.918 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -62.61 -14.21 40.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.883 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.87 3.65 47.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.28 -156.09 31.06 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 61.43 112.503 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 -165.99 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 63.41 110.9 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -84.4 -48.35 9.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.32 110.87 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -94.68 10.55 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.884 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.19 -150.77 17.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 51.1 112.481 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 65.04 142.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.12 110.91 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 p -114.41 141.46 47.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.082 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -18.0 63.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.838 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.12 -162.42 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.896 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -116.41 93.88 4.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.41 110.888 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' SD ' ' A' ' 142' ' ' MET . 6.6 mt -88.83 117.69 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 52.55 111.13 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.8 t -136.77 -178.36 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 54.22 111.143 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' OH ' ' A' ' 48' ' ' TYR . 35.5 mm -105.22 115.88 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -76.91 -62.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 70.45 111.117 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.06 167.27 20.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.41 110.834 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.13 -174.63 4.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 53.24 110.888 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.45 -160.93 24.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 73.01 112.49 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.0 mt-30 -110.35 137.01 48.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 71.31 110.925 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 5' ' ' THR . 3.6 mm? -47.91 -60.97 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 60.04 110.895 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.873 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.788 0.328 . . . . 75.25 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -139.44 146.23 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.32 111.156 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.51 156.55 1.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 65.14 110.924 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 151.16 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.667 2.245 . . . . 73.4 112.353 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -141.98 145.74 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 71.03 111.095 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 24' ' ' LEU . 22.9 m -136.82 163.21 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 60.21 111.107 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -135.8 162.71 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.881 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -139.32 131.79 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 15.2 t0 -101.58 75.54 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.872 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.1 146.36 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.31 111.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -138.94 164.77 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 42.13 111.118 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 156' ' ' ILE . 83.8 t -139.81 104.76 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 63.43 111.093 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 63.21 52.54 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.891 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.05 17.46 61.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 43.24 112.498 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.3 mm-40 -132.19 106.56 13.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 64.23 110.893 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.3 Cg_endo -69.75 138.85 38.82 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.664 2.243 . . . . 52.51 112.313 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.76 18.33 13.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 63.12 110.892 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.75 167.22 13.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 34.23 112.495 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.75 175.67 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 72.33 110.88 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 24.8 m -122.39 -176.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 63.05 111.114 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -134.77 86.31 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.85 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -84.83 127.23 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 63.11 110.88 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -104.03 145.42 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 61.4 110.914 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 6' ' ' VAL . 1.4 mt -110.11 113.65 26.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.908 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD2' HD21 ' A' ' 90' ' ' LEU . 15.9 m-85 -73.81 67.46 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 71.4 110.926 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.97 77.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.53 111.062 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.9 -54.77 14.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.32 110.845 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' HG21 ' A' ' 89' ' ' ILE . 3.2 mptp? -69.21 -60.83 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 62.23 110.891 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -121.14 95.89 48.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 52.3 111.097 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -23.13 31.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.253 . . . . 40.22 112.358 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -78.55 -51.19 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.02 110.955 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.508 HG22 ' CE1' ' A' ' 129' ' ' PHE . 18.1 m -64.85 -30.94 71.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.126 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.66 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.11 111.115 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.0 tt0 -56.47 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.948 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -29.29 -54.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.01 110.888 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 39' ' ' LEU . 34.0 t80 -77.07 -39.32 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.905 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -50.04 -31.75 13.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.42 110.901 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.91 -36.86 72.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 71.51 111.124 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 36' ' ' PHE . 30.7 mt -64.58 -43.86 92.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.899 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -59.16 -50.63 73.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.883 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 163' ' ' GLN . 30.7 p -74.91 -18.8 60.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 74.41 111.182 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.86 83.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 73.41 112.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.35 31.95 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 62.43 110.88 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -122.78 26.93 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.844 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 2.32 55.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 62.22 112.503 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -163.28 178.67 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.38 . . . . 73.1 110.885 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.34 131.96 3.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.461 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 161.43 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 73.43 110.924 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.96 -40.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.896 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.91 43.54 1.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 74.22 112.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.53 165.08 24.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.52 110.849 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -131.01 -179.56 5.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.831 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -113.63 -69.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.904 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.737 ' CE1' HG21 ' A' ' 152' ' ' THR . 0.1 OUTLIER 61.61 20.25 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.35 110.885 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -138.03 29.93 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.85 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -79.9 144.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 45.15 111.124 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 56' ' ' ILE . 16.6 mm -134.52 107.39 10.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 74.43 111.118 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 98.51 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.727 2.284 . . . . 43.21 112.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.13 -28.95 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 41.53 112.493 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.94 -63.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 73.15 110.913 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -176.94 -157.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 70.25 110.87 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 t -144.41 137.06 26.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 54.23 110.902 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 167.61 21.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.885 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 42.34 112.478 179.994 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.793 0.33 . . . . 70.44 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t -85.62 146.72 26.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 70.1 110.835 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 79' ' ' TYR . 2.1 pp -71.26 -41.87 74.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 44.35 111.15 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.41 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -97.07 -5.64 37.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.955 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 -143.33 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 55.43 112.437 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -118.9 -25.58 6.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 71.14 110.877 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -170.75 141.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -108.8 154.1 22.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.05 110.916 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -88.29 164.43 15.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.01 116.32 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 65.14 110.899 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.68 -49.58 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.871 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.93 140.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.924 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.15 70.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.53 110.917 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.4 mm -80.38 4.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 62.51 111.103 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -108.32 121.77 45.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.913 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 92' ' ' HIS . 14.3 mttp -123.81 82.85 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.891 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 93' ' ' THR . 5.0 m80 38.78 -160.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 65.4 110.863 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 97' ' ' ILE . 1.2 t 161.8 -38.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 73.04 111.16 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . 158.7 -163.6 33.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 71.54 112.486 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 128.54 16.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.31 112.372 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.17 -5.44 15.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 70.24 112.487 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 128' ' ' VAL . 1.7 mm -61.88 139.87 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.352 . . . . 74.34 111.108 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.6 tt -100.86 125.97 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.963 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.552 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -111.78 125.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.859 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -33.77 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 74.11 110.852 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . . . 62.84 155.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.124 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p30 172.0 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.888 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -78.18 -22.51 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.21 111.081 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.8 -64.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 54.53 112.506 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.1 Cg_endo -69.68 87.45 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 71.35 112.367 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 32.55 78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.87 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.94 15.53 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.5 111.175 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 43.73 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.871 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 73.56 132.97 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 70.43 112.448 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.9 p -129.18 77.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 44.01 110.825 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.55 ' OE1' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -93.85 -31.92 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 53.23 110.904 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER 71.97 69.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 62.52 110.86 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -90.82 111.03 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.908 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.538 HD11 ' CE1' ' A' ' 112' ' ' PHE . 96.5 mt -102.89 111.31 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 75.44 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.24 160.02 29.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.87 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.6 p -133.65 27.83 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.31 32.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 72.24 111.104 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 4.2 tttt 62.39 146.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 38.4 p -141.97 58.65 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 73.33 111.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 92' ' ' HIS . 8.1 tm-20 -49.56 -24.7 2.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 64.42 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -60.02 -36.03 76.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 74.2 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.57 106.32 18.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.905 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -43.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 72.53 110.859 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.23 -38.26 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 54.42 112.497 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -59.94 -35.83 75.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 72.24 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -131.81 140.13 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.83 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.79 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 72.7 t -74.14 -81.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.078 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.79 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 72.4 t 103.08 127.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 71.21 111.168 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.508 ' CE1' HG22 ' A' ' 32' ' ' THR . 29.5 p90 -147.55 18.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.27 146.43 16.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 64.45 112.458 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -156.42 140.05 15.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 75.41 110.861 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -48.65 109.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 74.51 111.152 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 -36.03 24.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.05 110.865 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.01 175.37 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 60.31 110.862 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 48.69 73.09 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 62.11 112.485 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -3.53 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.77 0.319 . . . . 75.11 110.88 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 88.6 m-20 -84.25 -34.64 23.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 71.32 110.84 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 50.2 mm -42.47 -41.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 62.31 111.168 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.79 -49.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.135 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 7.4 mm-40 -46.5 -50.27 17.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.873 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.48 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.59 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.9 ttm -50.38 -38.51 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 64.22 110.835 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.99 -27.62 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.909 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -62.66 -14.89 48.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.863 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -89.51 13.22 14.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.922 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.02 -156.34 28.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 34.12 112.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.5 t -166.87 169.79 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 71.14 110.828 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -54.0 -47.31 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 55.15 110.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 3.29 53.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.886 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.36 13.25 79.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 44.33 112.476 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.79 ' O ' HG22 ' A' ' 152' ' ' THR . 4.9 tppp? -45.55 -29.14 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.383 . . . . 75.34 110.957 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.795 HG23 ' N ' ' A' ' 153' ' ' SER . 0.6 OUTLIER 86.73 -169.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.136 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.795 ' N ' HG23 ' A' ' 152' ' ' THR . 23.3 t -137.7 -52.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.895 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 -168.09 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.3 110.892 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.67 111.13 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 74.24 110.9 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.59 HD13 ' SD ' ' A' ' 142' ' ' MET . 40.4 mt -107.24 101.76 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.1 111.164 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.4 p -113.64 168.66 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.22 111.132 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.95 106.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 63.33 111.162 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -55.0 -54.57 41.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 44.34 111.113 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.24 167.97 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.897 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -156.5 160.87 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 64.43 110.853 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.84 179.83 46.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 53.33 112.481 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 7.3 mt-30 -74.89 -37.89 62.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 74.41 110.902 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.41 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 63.33 110.951 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.881 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.829 0.347 . . . . 73.41 110.863 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.03 152.64 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -67.48 137.63 93.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.597 0.713 . . . . 70.33 110.885 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.54 51.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 61.4 112.343 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 86.6 m -127.75 148.38 50.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.43 111.136 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.44 160.04 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.33 111.135 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.5 162.25 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.829 -179.95 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.534 ' HD2' HD12 ' A' ' 158' ' ' ILE . 26.8 m-85 -139.32 136.43 34.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 63.05 110.889 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.77 69.85 1.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.897 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 158' ' ' ILE . 26.2 mm -51.52 129.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.0 111.105 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.48 163.12 16.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 52.12 111.093 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.856 HG22 HG22 ' A' ' 156' ' ' ILE . 53.5 t -140.89 104.99 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.125 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t0 51.49 53.23 13.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 53.14 110.875 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.15 10.09 55.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 72.24 112.43 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.2 tm-20 -142.57 96.52 6.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.635 0.731 . . . . 72.21 110.903 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.69 157.69 59.66 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 73.35 112.343 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.84 21.0 8.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.928 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.64 169.42 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 62.32 112.489 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.03 172.68 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 61.31 110.886 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.423 ' CG1' HG21 ' A' ' 138' ' ' ILE . 4.5 m -138.59 158.77 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.13 111.154 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.8 p -140.83 143.75 34.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 70.04 110.884 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -125.88 123.54 38.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 62.13 110.874 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -47.01 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.11 110.901 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 75.27 117.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 55.45 110.914 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -83.67 57.58 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.835 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -65.24 -26.33 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.134 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.1 -59.34 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 64.11 110.83 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -50.24 -57.73 7.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 62.43 110.88 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.767 ' HB ' HG22 ' A' ' 32' ' ' THR . 3.0 m -110.48 90.21 9.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.638 0.732 . . . . 71.31 111.142 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -19.33 36.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 2.24 . . . . 71.41 112.393 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -79.84 -58.25 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 63.43 110.873 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 29' ' ' VAL . 6.2 t -87.11 25.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 72.41 111.173 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -80.21 -42.25 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.42 111.093 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -76.85 -10.01 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.917 -179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.429 ' O ' HG21 ' A' ' 78' ' ' ILE . 29.7 t30 -42.41 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.35 110.891 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -81.42 -32.16 32.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 70.45 110.863 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.42 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 5.5 ttp85 -55.1 -39.98 69.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.839 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.52 -37.06 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 64.31 111.106 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.875 HD12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -91.74 33.46 1.03 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.896 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 t -151.2 -22.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' HG2' ' A' ' 163' ' ' GLN . 90.0 m -84.47 -42.14 15.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.52 111.163 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 151.28 -31.1 0.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 73.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 42' ' ' GLY . 8.4 tp10 -33.46 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 75.21 110.882 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 141.42 30.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.93 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.29 -30.49 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 73.12 112.458 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -47.07 -36.1 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 71.43 110.863 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.85 -146.37 3.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 53.0 112.486 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 136.45 43.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 75.25 110.915 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -162.62 -39.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 64.31 110.904 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.54 43.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 63.41 112.495 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.0 m -120.74 168.43 11.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 65.01 110.838 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -58.96 163.44 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 72.44 110.871 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.38 -70.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.89 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -163.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 71.22 110.823 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 51.82 35.74 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.899 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 156' ' ' ILE . 86.0 mt -90.11 135.38 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.146 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 tt -141.15 115.94 7.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 71.31 111.156 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.73 69.14 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.72 2.28 . . . . 54.32 112.326 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.54 69.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 52.22 112.495 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.61 -71.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 60.14 110.868 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -166.72 -159.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.23 110.851 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.45 -49.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.32 110.889 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 67.99 145.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.45 110.953 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 54.33 112.484 -179.929 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.805 0.336 . . . . 62.41 110.899 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 110' ' ' SER . 1.9 p -85.11 144.21 28.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.851 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 39' ' ' LEU . 1.8 pp -58.45 -13.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.13 111.078 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -20.34 13.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 75.22 110.959 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.72 -131.76 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.33 112.514 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -95.42 -36.52 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.926 0.393 . . . . 72.25 110.916 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.04 157.07 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 62.24 110.891 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -147.97 138.98 23.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.889 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 54.24 110.939 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.51 158.65 20.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 74.4 110.847 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -54.51 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.62 145.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.894 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -104.83 57.32 0.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.4 mm -74.32 -24.61 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.05 111.127 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HB2' HG13 ' A' ' 128' ' ' VAL . 8.4 mt -95.17 133.81 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.32 110.929 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.22 78.33 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 60.54 110.919 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' LYS . 21.9 m80 33.23 -140.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 72.12 110.837 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 168.29 -51.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 62.1 111.106 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 93' ' ' THR . . . 178.08 -153.65 13.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 63.04 112.507 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 109.59 2.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 72.51 112.341 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 132' ' ' VAL . . . 132.06 -22.85 4.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 62.21 112.491 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 128' ' ' VAL . 5.0 mm -50.82 141.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 73.55 111.097 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.551 HD11 ' HD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -106.97 132.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 71.44 110.918 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.34 33.84 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.855 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 43.71 -159.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.32 110.901 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -170.52 138.98 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 74.4 111.143 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.4 m-20 166.39 -74.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 64.31 110.91 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.828 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -171.79 122.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 21.21 111.101 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.824 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.43 -37.78 61.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 53.01 112.49 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.824 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.8 84.91 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 71.55 112.324 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.6 m120 43.52 62.09 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.908 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.828 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -154.13 57.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 52.01 111.156 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.99 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.921 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.29 173.42 37.13 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.681 -0.771 . . . . 64.44 112.46 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -120.09 13.35 12.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 64.25 110.852 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -63.88 -165.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.948 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 114' ' ' ILE . 36.9 t80 -155.64 93.62 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.894 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.46 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.888 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 2.6 mt -121.54 138.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.128 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 m -83.38 162.16 21.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.868 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -135.18 15.58 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 73.15 111.165 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.75 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 53.14 111.117 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 61.88 156.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.861 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 36.7 p -108.35 -141.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 64.53 111.125 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 119' ' ' THR . 0.3 OUTLIER 161.7 -51.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.41 110.864 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -7.05 53.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 72.02 110.933 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.71 10.16 16.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.893 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.87 127.5 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.886 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.56 32.62 61.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.02 112.483 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 -66.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 70.22 110.904 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -125.4 160.43 29.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.857 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.723 HG11 HG21 ' A' ' 32' ' ' THR . 57.5 t -61.06 117.89 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 62.01 111.129 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.8 p -101.82 138.36 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 70.4 111.131 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -178.94 111.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.894 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.7 134.96 6.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 70.32 112.42 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -155.2 147.9 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 72.14 110.877 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.642 HG11 HG21 ' A' ' 139' ' ' VAL . 16.2 m -53.17 125.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.142 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -89.01 -49.09 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 63.53 110.872 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 172.59 11.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.866 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.35 0.83 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 52.12 112.495 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.416 ' HE1' HG21 ' A' ' 132' ' ' VAL . 7.0 tpt -84.58 3.83 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 73.11 110.901 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -32.9 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.921 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 142' ' ' MET . 45.8 mm -65.28 -38.45 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 73.32 111.093 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 132' ' ' VAL . 4.2 t -91.57 13.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 73.35 111.088 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -128.57 -66.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.02 110.854 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.92 15.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 75.24 111.11 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 8.5 tmm? -48.49 -36.95 16.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 55.32 110.923 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -53.85 -31.63 50.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 75.05 110.848 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -16.9 40.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.886 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -82.08 4.89 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 73.3 110.858 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.05 -163.86 34.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 63.04 112.469 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -157.98 20.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 70.21 110.819 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 47.05 60.97 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.83 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 t30 174.96 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.865 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.22 -56.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 65.55 112.505 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 132.06 39.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.867 0.365 . . . . 74.31 110.879 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 56' ' ' ILE . 40.2 p -111.67 144.85 40.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.54 111.157 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 50.24 110.895 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -159.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.03 110.931 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -132.73 137.79 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 55.03 110.91 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.856 HG22 HG22 ' A' ' 12' ' ' VAL . 9.3 pt -126.44 136.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.13 111.107 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 159.15 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 63.35 111.136 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 10' ' ' ILE . 46.7 mm -83.12 104.84 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.31 111.145 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.23 -56.58 7.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 62.03 111.099 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.13 175.39 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 51.51 110.867 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.1 p -174.45 154.41 2.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 73.53 110.825 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.27 -176.57 46.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.45 112.498 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -73.62 -38.34 65.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 74.54 110.901 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mm? 71.29 -65.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.934 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.918 179.913 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 75.43 110.883 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.83 156.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.147 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.88 126.88 57.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 71.42 110.852 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 145.41 57.19 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.701 2.267 . . . . 51.4 112.374 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -132.64 123.41 26.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 75.43 111.132 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 m -100.42 151.06 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.118 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.23 153.54 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 138.79 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.888 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.747 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -101.42 152.59 20.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.888 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 9' ' ' ASP . 5.9 mm -129.51 135.75 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.101 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 157.56 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 HD23 ' A' ' 17' ' ' LEU . 15.0 m -140.94 111.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 62.14 111.14 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.27 25.56 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 65.3 110.913 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.97 -14.2 65.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.498 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.533 ' HG2' HG23 ' A' ' 12' ' ' VAL . 2.3 pt-20 -93.69 140.85 23.2 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 54.55 110.9 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.83 68.51 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.633 2.222 . . . . 75.4 112.356 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.726 HD23 HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -118.47 -66.2 1.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 61.24 110.921 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.42 -148.19 5.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 73.5 112.459 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 127.41 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 73.13 110.901 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -100.28 144.89 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.11 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -107.25 94.71 5.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 74.03 110.831 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.555 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 12.4 m-85 -88.21 126.3 35.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.883 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -107.8 145.87 32.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 110.906 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -114.93 119.28 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 62.02 110.93 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 m-85 -82.75 81.66 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 72.1 110.909 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.38 -2.66 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.12 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -80.02 -42.13 24.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.858 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -97.11 -24.22 15.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.89 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -140.44 82.74 15.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.682 0.753 . . . . 73.34 111.086 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -49.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.634 2.223 . . . . 74.52 112.343 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -55.95 11.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.33 110.89 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' CD2' ' A' ' 129' ' ' PHE . 1.3 m -50.77 -48.97 59.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 74.11 111.116 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -27.94 64.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 45.14 111.107 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -61.42 -31.02 70.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.861 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.622 HD22 HD12 ' A' ' 78' ' ' ILE . 2.8 t-20 -66.27 -71.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.881 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HA ' HD12 ' A' ' 39' ' ' LEU . 46.6 t80 -48.54 -30.43 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.86 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -57.23 -40.94 78.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.3 110.836 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.729 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -79.51 -21.52 45.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 60.15 111.107 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 36' ' ' PHE . 74.1 mt -76.46 -40.47 50.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.04 110.892 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -72.22 -46.51 55.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 51.25 110.828 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -82.51 8.17 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 70.41 111.166 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.55 40.79 11.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 75.34 112.459 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 5.1 mm-40 -54.96 -27.36 43.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 75.01 110.891 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.844 ' HD2' HG23 ' A' ' 78' ' ' ILE . 6.8 mtpm? -113.46 -6.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.33 110.903 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 40.8 32.88 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 71.2 112.451 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -121.1 -18.75 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 62.52 110.873 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.58 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 64.51 112.496 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -156.09 15.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.942 0.401 . . . . 73.25 110.911 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -60.76 127.63 32.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 71.33 110.897 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.93 67.6 1.85 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 35.12 112.519 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 m -164.29 -94.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.795 0.331 . . . . 71.52 110.822 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.7 p -172.3 -168.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 71.53 110.853 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -178.21 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 64.24 110.893 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -114.02 -50.17 2.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.01 110.84 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -179.07 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.847 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER 175.03 122.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.31 111.107 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.697 HD12 ' CE ' ' A' ' 61' ' ' MET . 30.7 mt -133.47 112.91 13.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 63.43 111.129 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 82.08 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 74.35 112.363 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.19 -32.81 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.13 112.525 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -59.41 1.71 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 72.13 110.845 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.697 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -178.8 -166.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 64.54 110.919 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.1 129.0 19.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 71.03 110.903 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 132.62 51.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.914 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 61.44 112.544 -179.995 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.796 0.332 . . . . 64.03 110.856 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.613 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -124.04 26.33 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.873 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.844 HG23 ' HD2' ' A' ' 44' ' ' LYS . 57.0 mt 87.56 -59.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.185 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.46 28.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 61.42 110.912 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.93 166.69 13.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 25.34 112.488 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.71 -84.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.387 . . . . 63.34 110.877 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -124.51 152.22 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 72.01 110.914 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -115.26 168.58 9.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -86.39 159.68 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 71.24 110.89 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.83 116.01 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 65.43 110.854 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 -47.87 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 75.02 110.908 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 p30 175.52 174.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 74.13 110.875 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.74 38.21 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.35 110.91 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.65 -26.73 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 50.34 111.121 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.45 118.51 30.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.924 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -110.6 167.75 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.04 110.871 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.26 96.21 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 64.43 110.918 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -96.01 4.21 52.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.34 111.17 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 -161.25 23.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 64.24 112.536 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -57.14 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.662 2.241 . . . . 62.32 112.407 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -66.25 142.61 43.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 55.11 112.526 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -161.85 118.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.12 111.141 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -103.18 121.11 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 60.21 110.937 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 p -150.84 -161.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.825 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 mtp -112.63 99.66 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.865 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -83.58 73.0 10.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 55.04 111.095 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.65 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.87 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -141.53 -92.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 33.02 111.107 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 169.8 -61.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.41 112.484 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 107' ' ' THR . 54.1 Cg_endo -69.73 90.46 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.717 2.278 . . . . 74.41 112.359 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 37.82 42.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.22 110.902 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.5 p -139.17 39.63 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 54.14 111.123 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.73 177.34 6.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.12 110.935 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.43 -117.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 23.23 112.477 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.511 ' HB2' HD11 ' A' ' 39' ' ' LEU . 94.3 p -107.16 -165.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 61.04 110.861 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.712 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 mt-30 73.07 63.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.935 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -61.87 -178.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.888 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.71 129.97 8.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.92 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.555 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 59.0 mt -84.75 109.28 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 45.11 111.101 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.444 ' C ' ' H ' ' A' ' 117' ' ' ALA . 84.3 m -51.61 -33.64 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.51 -33.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 44.13 111.171 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . -138.63 173.57 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.44 111.099 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -69.39 88.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.3 110.895 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 115' ' ' CYS . 31.6 p -92.17 65.09 4.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.33 111.135 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -5.55 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.35 110.847 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.9 -5.13 39.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.918 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 126' ' ' HIS . 98.4 mt -89.35 -48.48 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.929 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.8 -85.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 73.14 110.847 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -118.49 109.34 1.75 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.686 -0.769 . . . . 74.44 112.472 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.48 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 73.12 110.911 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.692 ' CD2' HD13 ' A' ' 122' ' ' LEU . 4.3 m-70 -119.97 134.04 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.51 110.828 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.55 97.21 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.32 111.146 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.27 131.63 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 54.33 111.126 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.62 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.8 p90 -136.33 4.51 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 65.02 110.877 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.82 -161.33 9.11 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 51.44 112.459 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 177.2 -169.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 75.54 110.925 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.439 HG23 ' HA3' ' A' ' 96' ' ' GLY . 55.9 t -103.83 88.8 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 55.03 111.104 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -40.78 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.888 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.08 163.96 3.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 70.4 110.894 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.26 11.58 44.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 61.15 112.479 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -30.76 9.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 63.32 110.861 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -51.06 -26.42 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.926 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mm -78.83 -45.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.24 111.11 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 143' ' ' GLU . 45.9 t -50.22 -44.03 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.54 111.126 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.35 -29.68 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 70.34 110.904 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.43 -31.91 60.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 111.063 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 10' ' ' ILE . 8.1 mtm -75.67 -35.07 60.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.888 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.424 ' OE1' HG12 ' A' ' 139' ' ' VAL . 4.6 pt-20 -84.13 31.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.85 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -126.42 -13.26 6.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.906 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.35 17.65 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.61 -156.58 30.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.22 112.513 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.76 -64.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 71.05 110.888 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.39 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 72.22 110.9 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.28 11.79 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 70.22 110.915 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.27 15.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 54.25 112.446 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 75.53 -58.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 41.4 110.9 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 154' ' ' LYS . 2.5 m 71.12 145.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.35 111.145 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.45 1.83 56.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 63.22 110.876 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.544 ' H ' HG22 ' A' ' 152' ' ' THR . 1.8 mttt -141.01 165.71 26.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.916 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -106.23 115.92 31.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 64.1 110.916 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 156' ' ' ILE . 1.3 mp -87.96 105.87 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 55.33 111.126 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -106.93 167.85 9.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 62.31 111.093 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 83.0 mt -121.33 138.52 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 64.22 111.155 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.59 -56.4 3.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.02 111.118 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -158.81 166.92 30.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 73.45 110.844 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -145.72 -163.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.892 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 141.4 -150.37 21.82 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 65.33 112.496 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -106.25 134.38 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 72.03 110.909 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -57.78 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.01 110.94 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 75.22 110.876 179.915 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.839 0.352 . . . . 73.15 110.916 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.98 156.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 61.33 111.103 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -87.66 148.31 43.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.723 . . . . 74.14 110.903 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB2' HD12 ' A' ' 24' ' ' LEU . 54.3 Cg_endo -69.68 122.73 9.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.271 . . . . 75.4 112.367 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.601 HG22 HD21 ' A' ' 164' ' ' LEU . 37.5 m -114.01 135.92 53.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 61.4 111.157 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 26.1 m -121.33 157.66 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 51.43 111.103 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 164' ' ' LEU . 28.1 p90 -122.55 160.34 25.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.11 110.823 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -137.54 136.52 37.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.74 112.03 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 62.23 110.858 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -85.26 126.12 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 53.15 111.155 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.98 165.15 14.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.42 111.09 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.19 93.84 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 60.53 111.111 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.78 35.08 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.882 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -13.17 67.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.54 112.522 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.76 130.28 33.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.652 0.739 . . . . 73.31 110.917 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 151.61 69.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 74.14 112.332 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.662 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -118.74 -67.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 64.44 110.924 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.92 -141.15 3.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 32.03 112.492 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -150.53 127.29 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 60.22 110.908 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.85 122.3 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.13 111.164 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 68.9 p -104.13 150.4 24.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 71.3 110.888 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.519 ' O ' HG23 ' A' ' 5' ' ' THR . 5.2 m-85 -118.25 178.17 4.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.939 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 127.0 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.14 110.875 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 4' ' ' PRO . 96.5 mt -95.43 106.21 18.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 71.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 90' ' ' LEU . 13.7 m-85 -72.68 75.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 73.44 110.888 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.91 -34.35 62.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 64.52 111.087 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 51.11 110.868 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.5 -65.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.872 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.44 93.07 30.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.588 0.709 . . . . 72.0 111.146 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -25.27 29.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.709 2.273 . . . . 44.12 112.364 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -78.74 -57.9 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.912 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 m -61.4 -26.08 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 61.44 111.177 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.58 -56.29 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.094 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.7 tt0 -62.66 -56.98 12.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.827 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.1 t-20 -28.07 -56.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.879 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.37 -40.57 62.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.929 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -48.3 -32.75 7.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 75.01 110.903 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.638 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -71.7 -43.25 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 53.21 111.094 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.938 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.2 m -76.3 -44.56 36.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 71.51 110.894 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -79.52 -0.55 33.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 74.23 111.162 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.87 78.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.787 -0.72 . . . . 54.31 112.451 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 10.3 pt-20 -99.21 0.86 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 73.15 110.9 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -127.51 -0.4 6.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.96 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 41.32 29.32 0.38 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 63.05 112.52 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.03 -33.15 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 73.44 110.859 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 74.11 112.44 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.88 149.68 21.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 63.55 110.929 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.9 119.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 74.2 110.93 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.87 22.18 76.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 73.43 112.479 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 p -94.17 -166.87 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.899 0.38 . . . . 74.45 110.881 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.3 m -99.2 -168.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.58 126.14 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 64.22 110.856 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -51.2 -62.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 74.23 110.863 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 150' ' ' GLY . 26.3 ttm180 -149.57 167.28 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 65.32 110.859 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 156' ' ' ILE . 58.7 mt -141.86 127.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 60.24 111.125 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.604 HD12 ' CE ' ' A' ' 61' ' ' MET . 46.6 mt -140.48 90.92 9.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.653 0.74 . . . . 73.44 111.115 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 108.65 2.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.238 . . . . 74.55 112.398 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.62 -45.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 55.25 112.424 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 -71.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 74.3 110.876 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.604 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.81 -174.74 4.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.871 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.97 117.87 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 54.2 110.891 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -136.58 166.39 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.92 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.79 -0.719 . . . . 42.44 112.51 -179.955 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.773 0.32 . . . . 73.31 110.902 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 130.19 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.832 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 38' ' ' ALA . 2.3 pp -48.03 -34.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 71.21 111.122 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.58 19.87 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.901 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.79 -140.99 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 71.44 112.479 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -122.99 -25.69 4.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 75.3 110.903 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -168.69 160.23 10.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 63.43 110.918 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -132.95 162.97 30.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 65.02 110.896 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -80.34 156.97 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.886 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.97 105.09 13.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 72.54 110.883 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.72 -41.57 97.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.887 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 175.07 171.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.884 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -130.4 32.62 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.905 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -19.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 75.13 111.164 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.688 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -90.9 128.31 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.921 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -121.29 179.39 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.894 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -78.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.34 110.821 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 61.96 11.37 4.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.186 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.86 166.63 34.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.22 112.544 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 163.09 39.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 73.41 112.34 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.98 9.87 79.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 73.41 112.529 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -97.57 150.08 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 74.1 111.168 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 99' ' ' SER . 1.7 tt -107.53 142.92 36.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.971 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.655 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.78 132.23 47.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.869 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.8 mmt -64.25 -45.73 86.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 70.03 110.901 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 46.62 72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.127 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 13.0 p-10 -104.0 -163.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.891 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -51.41 -32.4 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.095 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 132.76 -54.46 0.78 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 72.13 112.499 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.6 Cg_endo -69.8 -100.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.32 112.291 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.2 91.46 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.924 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.7 p -150.22 28.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.162 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 0.4 OUTLIER 54.89 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.35 110.864 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.92 -90.75 0.22 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 73.32 112.45 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.7 t 76.54 33.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 73.42 110.86 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -90.0 -34.46 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.51 110.921 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 3.9 t80 79.92 65.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 63.45 110.86 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 99' ' ' SER . 27.5 t80 -96.74 95.11 7.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 63.3 110.843 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 19.4 mt -90.63 136.81 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 50.1 111.14 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.5 m -103.05 133.57 47.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.897 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.803 HG21 ' OE2' ' A' ' 143' ' ' GLU . 47.8 p -111.75 17.12 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.24 111.158 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.14 175.51 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 64.3 111.088 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.8 78.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 51.52 110.902 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.614 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 16.6 p -117.34 67.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 42.43 111.134 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.26 25.2 4.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.55 110.915 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.614 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -93.58 17.87 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.02 110.885 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -132.61 14.35 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 72.3 110.947 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.92 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.838 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.97 57.53 3.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 75.54 112.543 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -163.97 -52.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 64.3 110.915 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -104.83 133.41 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.4 110.839 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.32 101.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 53.21 111.126 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.02 138.68 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.138 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -161.82 25.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.889 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -118.65 -165.83 13.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 71.32 112.488 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 1.6 tttp 162.22 120.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 71.11 110.871 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.674 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.5 t -65.13 88.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 65.34 111.105 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -71.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 75.52 110.945 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.54 159.13 44.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 63.15 110.847 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.22 42.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 62.1 112.492 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.674 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.71 -30.41 13.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 65.1 110.885 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -53.62 -25.8 19.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 61.51 110.881 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.9 mm -90.23 -39.13 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.33 111.135 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.13 -23.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.4 111.17 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.05 -27.81 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 73.04 110.906 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.91 71.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 53.23 111.119 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.6 ptm -76.8 -15.61 59.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 50.22 110.919 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.803 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -88.99 27.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.31 110.856 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.11 0.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.04 110.902 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -121.08 6.86 10.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.33 110.913 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -117.28 45.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 63.34 112.476 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' GLY . 7.3 t 36.16 -147.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 64.02 110.834 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -139.59 7.92 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 65.31 110.905 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -16.96 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.851 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 55' ' ' ARG . . . 144.54 -57.5 0.53 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.13 112.46 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.89 133.88 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 54.21 110.904 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.6 p -113.19 138.68 49.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 63.33 111.18 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -24.16 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.836 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -165.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.916 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -126.65 125.03 41.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 70.25 110.901 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.574 HD13 HD11 ' A' ' 56' ' ' ILE . 3.5 mp -99.4 105.94 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.33 111.129 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.07 171.86 7.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 63.34 111.157 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.93 147.16 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 75.41 111.129 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.69 -59.05 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 65.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.81 167.41 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 62.42 110.889 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.1 m -145.61 -166.11 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.41 110.855 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.06 -177.73 16.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 62.31 112.546 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.1 pt20 -94.52 136.36 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.31 110.911 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.708 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.5 pt? -112.49 -34.81 5.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 61.35 110.917 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.426 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.87 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.856 0.36 . . . . 73.55 110.865 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -139.77 142.24 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 51.32 111.159 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -55.16 159.83 3.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 73.42 110.893 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 149.09 66.42 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.236 . . . . 74.12 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.71 49.84 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 74.51 111.107 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 6' ' ' VAL . 5.1 m -42.31 140.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 75.34 111.166 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 161' ' ' CYS . 0.1 OUTLIER -124.85 165.28 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 65.22 110.892 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -142.5 137.73 30.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 72.44 110.905 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -101.56 86.22 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.836 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.7 mm -57.71 145.06 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.147 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.04 155.87 46.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 41.52 111.09 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.4 t -134.99 109.51 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 54.1 111.086 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 t0 57.98 52.41 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 75.52 110.923 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.53 12.63 56.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.01 112.505 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.51 107.82 26.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.637 0.732 . . . . 65.11 110.899 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.5 Cg_endo -69.75 143.41 50.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 62.24 112.348 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 21.44 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.24 110.897 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.37 166.39 20.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.807 -0.711 . . . . 40.44 112.519 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -175.32 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 64.24 110.852 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 32.8 m -138.8 175.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.34 111.148 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 t -117.39 84.41 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.847 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -81.85 88.32 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 74.12 110.846 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.83 137.13 36.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 72.41 110.883 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.617 HD11 ' HD2' ' A' ' 36' ' ' PHE . 46.2 mt -111.82 144.99 40.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 29' ' ' VAL . 14.9 m-85 -91.59 67.24 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.24 110.872 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.66 -10.57 8.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.14 111.106 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -92.23 -35.08 14.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 42.52 110.864 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -86.92 -30.34 21.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 73.23 110.917 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.594 HG21 ' CG ' ' A' ' 129' ' ' PHE . 4.5 m -128.52 69.0 78.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.605 0.717 . . . . 73.11 111.14 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 60.08 1.62 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.696 2.264 . . . . 73.44 112.385 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.81 -63.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 71.33 110.896 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.93 -55.72 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 62.5 111.086 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . . . -79.63 -12.99 59.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.22 111.051 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.29 -35.74 81.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 62.31 110.875 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.26 -31.48 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.883 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' HD2' HD11 ' A' ' 24' ' ' LEU . 1.1 t80 -50.9 -27.28 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.876 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -62.26 -30.91 71.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 73.55 110.901 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.21 -24.81 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 74.53 111.125 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -99.58 26.61 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 72.45 110.887 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.93 -21.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.846 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -89.79 -30.64 17.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 35.24 111.135 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 135.32 -20.42 3.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 73.14 112.475 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -32.6 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 72.24 110.876 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 153.82 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.86 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.16 -33.01 0.43 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.466 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -55.05 -28.56 53.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 74.24 110.897 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -77.48 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 63.41 112.506 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 124.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.41 110.915 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -93.71 -77.45 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 71.32 110.89 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.6 -54.1 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 43.12 112.441 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.7 -164.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 72.13 110.841 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.695 ' HB3' HG22 ' A' ' 157' ' ' THR . 9.8 p -157.0 134.45 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 65.33 110.946 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CE1' HD11 ' A' ' 158' ' ' ILE . 12.7 m-85 -94.77 123.76 38.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 72.02 110.901 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.94 32.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 65.53 110.84 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -133.02 27.17 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.862 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.8 138.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.92 111.13 17.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.613 0.721 . . . . 72.24 111.16 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 90.33 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 72.53 112.366 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.28 4.86 13.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 52.11 112.455 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.72 -66.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 72.13 110.868 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.15 -166.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 63.11 110.867 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.1 t -152.89 108.51 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.1 110.886 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -97.42 163.6 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 54.13 110.919 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 60.54 112.491 -179.944 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.795 0.331 . . . . 61.15 110.896 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m -79.52 -171.81 2.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 52.25 110.881 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 38' ' ' ALA . 16.8 pt -92.85 -40.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.34 111.116 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -86.76 85.12 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 70.12 110.887 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.36 -107.77 3.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 63.34 112.44 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -91.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 74.1 110.869 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 150.58 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 63.15 110.855 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 154.41 39.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.853 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 106' ' ' ASN . 20.7 pm0 -62.87 160.5 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.23 110.853 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.7 -169.47 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 51.41 110.907 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -132.96 -59.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 75.1 110.877 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -171.2 149.86 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 71.43 110.851 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.3 64.41 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.902 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' ILE . 10.1 mt -78.16 2.31 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 72.53 111.147 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.74 132.65 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 74.22 110.942 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -110.06 123.34 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.88 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.19 91.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.877 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.9 p -129.58 21.9 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 61.21 111.183 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.26 167.48 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 71.13 112.445 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -44.94 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 54.22 112.308 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.79 40.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.26 141.7 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.44 111.162 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 99' ' ' SER . 4.2 tt -89.57 130.46 35.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.872 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 98' ' ' LEU . 1.7 t -128.41 -147.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.845 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tpt -152.43 143.14 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.02 110.868 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -117.73 149.16 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 54.12 111.121 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 161.75 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.881 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.622 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -55.63 -36.87 67.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 55.25 111.106 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.7 -65.15 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 44.05 112.521 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 106.86 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.717 2.278 . . . . 71.42 112.321 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 84' ' ' GLU . 6.0 p30 42.76 56.87 3.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.908 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.99 33.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.156 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -74.29 -0.71 17.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.918 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.9 119.63 19.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 24.24 112.484 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 8.9 t 54.86 -166.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 71.52 110.852 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.411 ' HB2' ' O ' ' A' ' 110' ' ' SER . 3.9 mm-40 64.04 118.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 75.54 110.905 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.4 156.87 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.2 110.855 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.76 154.6 36.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.882 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.17 105.5 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 75.35 111.153 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.24 146.38 53.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.86 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 p -96.14 19.99 10.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.35 111.111 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.24 177.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 75.54 111.138 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 131.63 51.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 62.02 110.902 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.16 41.05 3.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 71.13 111.145 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -49.02 -25.43 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 64.2 110.916 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -58.21 -32.62 68.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 64.41 110.952 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 mt -118.5 61.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 61.41 110.913 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -126.63 56.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.844 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 53.31 112.506 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 63.31 110.901 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -105.09 -16.35 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.843 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t 71.84 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.53 111.116 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 p -79.22 153.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.1 111.097 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 29' ' ' VAL . 44.1 p90 -176.91 129.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.34 110.836 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.39 149.21 12.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 63.25 112.513 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -162.6 162.96 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 73.13 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 132' ' ' VAL . 15.0 m -83.76 107.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.153 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -41.03 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 44.34 110.871 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 178.9 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.22 110.896 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.67 74.58 0.32 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 74.41 112.5 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -84.35 -18.39 36.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 43.15 110.87 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.94 -36.83 24.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 63.33 110.913 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 37.9 mm -40.39 -45.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.52 111.109 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.9 t -89.09 -50.66 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.3 111.124 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -49.33 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 70.5 110.88 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.86 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 32.22 111.106 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.593 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.5 ttm -50.84 -45.71 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 63.22 110.874 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -52.07 -23.74 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.898 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -63.77 -26.29 68.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.852 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.28 8.28 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.945 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.25 -146.25 20.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 63.12 112.451 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.01 161.36 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 62.23 110.835 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -50.76 -56.66 11.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 70.3 110.871 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -6.74 59.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.863 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.46 -150.37 16.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 54.14 112.476 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mttp 61.43 104.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 74.31 110.871 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.1 p -82.18 155.84 24.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 62.45 111.155 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -2.99 58.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.44 110.842 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -138.83 -175.43 4.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.905 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.68 104.93 13.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.904 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.593 HD13 ' SD ' ' A' ' 142' ' ' MET . 8.3 mt -95.34 127.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 63.31 111.122 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 52' ' ' CYS . 29.1 p -139.72 159.16 42.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.119 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.5 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -84.86 105.22 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.112 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -61.59 -56.57 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.104 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.0 177.16 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 54.32 110.831 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 17.0 p -176.88 155.74 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.42 110.891 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 -169.48 40.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.747 . . . . 72.4 112.5 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.27 126.26 35.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 72.41 110.891 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.81 138.26 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.897 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.853 179.935 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 64.3 110.878 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.61 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 62.34 111.119 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -95.82 151.76 38.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 75.4 110.895 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 134.69 28.55 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.65 2.233 . . . . 71.42 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 22' ' ' PHE . 6.9 m -122.16 140.44 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.119 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 3.2 m -125.19 159.46 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.01 111.104 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -133.44 155.08 50.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.873 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 158' ' ' ILE . 13.7 m-85 -135.2 134.36 40.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.866 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -90.66 108.91 20.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.828 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.05 119.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 45.33 111.133 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.93 167.58 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 61.45 111.099 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.61 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -150.68 91.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.121 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.1 32.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.816 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.19 -12.24 69.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 42.43 112.478 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.81 130.35 25.48 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.667 0.746 . . . . 62.2 110.891 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 152.95 69.43 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.683 2.255 . . . . 72.21 112.336 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.61 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.7 tp -114.52 -65.42 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.929 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.74 -178.01 36.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 33.04 112.464 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.7 125.98 54.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 72.25 110.832 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.52 143.97 38.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 74.43 111.12 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 23.3 p -129.99 155.26 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.888 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -125.7 165.57 18.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.913 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -120.97 124.69 45.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.888 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 129' ' ' PHE . 8.6 mt -93.42 126.82 38.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.936 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -83.07 82.31 8.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.917 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -4.59 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 60.32 111.087 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.23 -34.11 16.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 54.5 110.858 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.4 mttm -91.44 -28.48 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.917 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.55 79.31 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.625 0.726 . . . . 65.4 111.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.14 13.43 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 70.22 112.294 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -45.72 9.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 72.25 110.874 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -52.4 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 65.35 111.161 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.11 -77.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.113 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 29.7 tt0 -48.34 -66.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.876 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 19.8 t30 -28.23 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 65.54 110.916 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' GLU . 85.3 t80 -85.53 -42.0 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.87 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -54.52 -31.24 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.877 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.641 ' HB1' ' HE2' ' A' ' 44' ' ' LYS . . . -76.01 -43.57 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.23 111.11 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 39' ' ' LEU . 3.2 tm? -67.11 -39.2 86.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 73.24 110.905 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -35.26 76.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.857 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.04 -12.74 61.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 73.42 111.165 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 4.13 63.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.788 -0.72 . . . . 62.21 112.446 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.96 -1.65 36.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 61.54 110.933 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 2.1 mmtm -93.39 37.57 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 65.31 110.916 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.09 -45.46 3.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 40.33 112.502 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -155.89 -166.38 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 74.45 110.854 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 -107.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 65.15 112.511 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -162.84 123.49 2.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.414 . . . . 53.5 110.919 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -106.9 -26.74 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 73.41 110.909 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.94 -62.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.741 . . . . 74.51 112.489 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.65 -169.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.34 110.869 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 p -166.11 111.21 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 41.4 110.876 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -73.4 123.98 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.53 110.892 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -120.32 17.99 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.867 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -136.84 119.09 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HD13 ' A' ' 156' ' ' ILE . 88.0 mt -143.53 137.28 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.075 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 90.3 mt -146.8 95.38 4.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.666 0.746 . . . . 73.35 111.111 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.72 96.34 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 72.23 112.347 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.69 -35.17 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.47 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.32 -64.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 71.43 110.849 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.451 ' HE1' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -158.39 -169.5 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 70.04 110.895 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.32 -75.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 65.33 110.858 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 64.1 tt0 63.32 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.926 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 62.31 112.479 179.999 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.847 0.356 . . . . 74.32 110.842 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 t -81.69 160.78 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 43.35 110.874 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' A' ' 44' ' ' LYS . 2.0 pp -88.35 -32.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 72.44 111.126 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 78' ' ' ILE . 30.4 m-85 -85.01 -6.29 59.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 75.24 110.9 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -121.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 63.11 112.512 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -112.34 -83.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 74.2 110.927 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.92 168.05 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.887 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.0 165.52 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 61.12 110.898 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -62.45 163.32 8.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 62.32 110.846 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 127' ' ' VAL . 25.6 t0 -80.33 161.41 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 62.21 110.886 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 -50.65 3.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.89 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p30 178.74 157.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.898 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.73 66.73 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.859 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.644 ' C ' HD22 ' A' ' 90' ' ' LEU . 14.0 mt -83.91 7.78 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.156 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.644 HD22 ' C ' ' A' ' 89' ' ' ILE . 4.1 mm? -127.29 127.53 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 64.31 110.936 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.28 133.28 56.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 65.34 110.904 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.464 ' HA ' HG21 ' A' ' 97' ' ' ILE . 3.0 m-70 -59.05 91.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.0 110.874 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.2 p -118.95 19.4 13.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 74.3 111.197 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.96 26.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.525 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -2.93 10.99 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.43 112.331 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.41 29.01 6.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.42 112.501 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 92' ' ' HIS . 20.8 mm -90.66 127.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 70.42 111.165 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.1 tt -90.3 124.13 34.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.874 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 42.9 t -115.5 160.73 19.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 71.23 110.854 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.76 115.24 29.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.874 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.97 150.53 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 62.13 111.11 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.72 -163.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.21 110.884 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -62.06 -12.68 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 41.33 111.083 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 121.69 -135.02 10.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 72.24 112.47 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 107' ' ' THR . 54.2 Cg_endo -69.71 147.52 63.35 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.735 2.29 . . . . 73.15 112.337 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.93 23.07 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.903 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.661 HG21 ' HB3' ' A' ' 103' ' ' ALA . 7.7 p -141.23 33.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.22 111.2 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER 11.49 -87.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.913 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 107.16 140.15 9.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 73.31 112.486 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -97.86 -33.33 11.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.334 . . . . 75.13 110.816 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -63.43 152.46 38.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.94 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 99' ' ' SER . 17.1 p90 -145.08 146.55 31.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 71.54 110.891 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -127.84 114.86 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 63.24 110.889 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.6 mt -67.02 101.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 52.13 111.149 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 54.7 m -57.85 126.98 29.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 72.51 110.901 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -88.19 -31.25 19.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 64.22 111.105 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 119' ' ' THR . . . -120.9 155.02 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.24 111.111 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -57.01 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.4 110.888 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.8 p -117.6 69.52 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 54.14 111.134 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.52 21.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.867 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.682 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.3 p90 -101.14 15.19 29.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 73.35 110.941 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 13.3 mt -129.73 17.05 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.34 110.937 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -63.15 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.54 110.862 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -46.75 -28.78 3.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 54.5 112.505 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -74.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 75.51 110.925 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -86.67 141.25 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.55 110.851 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.667 HG21 ' OD1' ' A' ' 85' ' ' ASP . 94.9 t -103.58 129.73 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 43.31 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -104.31 137.67 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.147 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 31.2 p90 -129.07 -32.87 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.902 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -109.92 161.05 13.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 75.12 112.495 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -155.57 148.68 24.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.349 . . . . 73.31 110.919 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.45 126.49 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 72.54 111.153 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -68.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.874 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 143.71 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 61.33 110.844 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.72 9.21 21.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 63.12 112.514 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.0 ttm -49.62 -28.03 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 62.3 110.884 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -50.63 -27.25 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.89 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.85 -35.72 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 73.54 111.113 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.78 -23.41 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.32 111.144 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.01 -25.14 32.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.906 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.29 57.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 62.01 111.12 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.8 ptm -76.97 -30.37 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 65.41 110.907 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -89.85 33.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.856 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 17.2 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.25 110.865 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -97.73 33.3 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 72.4 110.87 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.601 ' O ' ' C ' ' A' ' 147' ' ' SER . . . 64.88 -92.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 75.04 112.483 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.601 ' C ' ' O ' ' A' ' 146' ' ' GLY . 88.7 p 17.86 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 74.01 110.874 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -91.51 -24.62 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.52 110.888 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -105.01 -7.53 19.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.34 110.931 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.95 -39.81 2.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.759 . . . . 41.22 112.453 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -64.5 101.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 71.2 110.891 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 147' ' ' SER . 1.9 m -90.56 154.15 19.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 50.1 111.162 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.73 -17.76 63.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 74.4 110.848 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.26 -175.87 4.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.866 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -120.05 144.17 47.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.899 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 56' ' ' ILE . 2.5 mp -110.41 134.51 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.126 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -129.33 166.86 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.136 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 8' ' ' PHE . 30.9 mm -112.06 106.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 61.51 111.128 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -54.2 -57.23 11.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 51.3 111.13 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -160.26 174.63 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.859 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 11.4 p -175.35 169.6 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.894 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.02 -160.52 28.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 71.24 112.493 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -72.25 109.36 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.13 110.883 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.66 -48.33 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.52 110.914 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 70.42 110.878 179.943 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.351 . . . . 62.33 110.868 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.65 153.82 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 62.25 111.158 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -50.44 153.31 2.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.595 0.712 . . . . 75.11 110.943 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 141.07 44.29 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 54.31 112.332 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.728 HG22 HD21 ' A' ' 164' ' ' LEU . 49.9 m -126.29 101.55 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.54 111.135 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 24' ' ' LEU . 5.8 m -96.42 149.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.123 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.95 162.72 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.889 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.01 133.51 21.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.886 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.25 108.52 16.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.02 110.891 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 142' ' ' MET . 15.7 mm -87.48 139.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.34 111.161 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -120.7 155.87 32.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 60.31 111.123 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.0 96.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 52.41 111.125 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.87 56.04 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.884 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.75 11.63 54.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 72.14 112.446 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -142.44 92.17 7.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 74.41 110.886 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.17 64.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 73.11 112.358 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -115.61 23.93 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.866 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.66 -161.74 21.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 44.45 112.463 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 170.37 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 74.33 110.868 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG13 HG21 ' A' ' 138' ' ' ILE . 33.2 m -132.15 172.47 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.147 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -127.89 90.69 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.41 110.87 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -81.73 72.98 8.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.54 110.94 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.92 143.53 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.851 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 6' ' ' VAL . 16.5 mt -105.53 119.81 40.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 52.52 110.93 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -76.62 57.23 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.856 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -31.3 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.51 111.103 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.87 -63.14 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 74.21 110.893 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.29 -74.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.93 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 129' ' ' PHE . 2.4 m -85.15 110.77 31.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 63.3 111.107 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 74.12 112.344 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -57.67 -47.02 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.874 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -45.77 -41.9 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 61.13 111.142 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' CB ' HG23 ' A' ' 29' ' ' VAL . . . -107.5 21.72 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.086 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -93.16 -28.37 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.856 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HA ' HD13 ' A' ' 78' ' ' ILE . 26.8 p-10 -85.19 -41.08 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 65.51 110.88 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -32.75 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 61.2 110.905 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.96 -39.55 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.85 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.46 -17.97 26.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.13 111.164 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 78' ' ' ILE . 50.4 mt -85.02 9.98 13.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 71.23 110.895 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.4 m -126.35 -3.42 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.879 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.6 p -124.82 -4.98 7.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.24 111.143 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.15 71.85 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 73.11 112.485 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.27 34.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 73.23 110.861 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.6 -42.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.22 110.863 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 46' ' ' PHE . . . -137.67 30.53 2.58 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 75.03 112.44 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' CG ' ' C ' ' A' ' 45' ' ' GLY . 2.1 p90 40.11 63.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 74.1 110.879 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.94 21.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 70.22 112.497 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.17 -179.81 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.393 . . . . 62.12 110.885 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -166.24 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 64.24 110.875 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.75 44.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.507 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.15 155.17 32.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 61.13 110.826 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.67 127.52 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 74.11 110.898 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -148.61 122.08 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 53.22 110.87 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -140.81 73.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.13 110.869 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -121.18 21.86 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.88 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 ' HA ' ' A' ' 143' ' ' GLU . 4.7 mt -59.64 136.35 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.0 111.139 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.11 113.05 32.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 65.43 111.193 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 86.73 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 73.33 112.362 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.64 2.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 75.11 112.501 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.27 -72.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 73.1 110.917 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -178.22 -158.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.871 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.2 t -143.24 135.9 27.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.41 110.869 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 153.42 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.927 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 73.52 112.505 -179.982 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.754 0.312 . . . . 74.45 110.873 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.06 120.38 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 51.11 110.85 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.2 pt -49.18 -37.01 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 73.2 111.159 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.22 36.92 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.904 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.51 15.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 75.01 112.458 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -122.4 -24.15 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 73.34 110.895 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -169.36 147.1 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.903 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.94 158.16 34.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 61.23 110.943 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.92 162.52 28.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.1 110.926 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.63 108.39 13.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.886 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.52 -51.73 47.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.882 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t30 175.27 175.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.881 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.45 40.81 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.871 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.52 -27.12 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.115 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.59 133.62 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 55.32 110.913 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -114.19 -175.69 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 72.33 110.942 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.492 ' C ' HG23 ' A' ' 93' ' ' THR . 32.1 m170 -99.49 -86.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 73.23 110.868 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 67.09 6.32 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 42.54 111.104 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.37 159.48 20.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 51.04 112.483 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.429 ' CB ' ' HA ' ' A' ' 116' ' ' THR . 53.6 Cg_endo -69.71 169.69 18.26 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 75.41 112.354 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.26 8.85 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.743 . . . . 31.34 112.482 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 98' ' ' LEU . 10.6 mm -69.9 158.28 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 64.21 111.121 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 112' ' ' PHE . 10.9 mt -124.36 162.72 23.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.934 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -160.49 43.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.4 110.883 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 4.2 mmt 48.65 -166.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.883 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -179.61 78.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 54.2 111.105 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.521 ' HB3' HG22 ' A' ' 107' ' ' THR . 0.7 OUTLIER -123.34 -76.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.91 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -137.07 -41.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 55.22 111.127 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -75.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 73.21 112.51 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 102.2 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 54.34 112.312 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.59 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 73.41 110.851 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.0 m -154.55 59.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.119 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.578 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -80.37 -0.68 37.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 65.3 110.901 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 21.0 -136.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.758 . . . . 75.21 112.518 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 m -153.91 65.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.331 . . . . 72.31 110.87 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.738 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.0 tp-100 -93.71 -45.41 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 74.21 110.91 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.569 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 67.63 130.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 75.34 110.864 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -153.41 134.76 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.35 110.885 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.55 143.99 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 74.03 111.155 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 p -115.55 161.23 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 72.54 110.906 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 95' ' ' PRO . 3.2 m -127.91 30.63 5.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.34 111.088 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.24 22.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.23 111.11 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.12 134.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.916 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 68.1 p -131.45 41.47 3.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 71.13 111.122 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -48.97 -26.42 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 61.21 110.863 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -60.35 -36.77 78.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.912 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.27 31.99 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.934 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -114.63 41.92 2.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.897 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.15 30.9 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.501 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.34 -39.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 70.33 110.936 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -97.33 156.88 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.12 110.879 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.53 99.18 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.32 111.109 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 98' ' ' LEU . 91.9 t -63.64 124.93 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 70.21 111.156 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.664 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.4 t80 -155.43 81.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.91 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.56 166.5 39.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 43.35 112.476 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp 177.97 153.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 72.55 110.911 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 132' ' ' VAL . 2.9 p -105.39 87.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.2 111.151 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -51.35 -46.24 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 63.23 110.917 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 174.22 11.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.866 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.8 77.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 52.33 112.491 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -24.36 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.758 0.313 . . . . 70.24 110.9 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -76.53 -34.65 58.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.11 110.854 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.656 HG21 HG13 ' A' ' 20' ' ' VAL . 48.0 mm -45.4 -39.8 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.35 111.12 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.4 -52.23 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 71.3 111.149 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -49.39 -67.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.53 110.889 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -51.62 -54.42 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.51 111.099 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.701 ' SD ' HD13 ' A' ' 156' ' ' ILE . 11.6 ttm -51.12 -41.28 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 75.41 110.914 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.42 ' HA ' HG21 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -53.95 -23.22 12.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 72.41 110.89 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -65.55 -25.94 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.847 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -87.42 9.0 22.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 73.12 110.838 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.14 -171.14 40.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 62.01 112.501 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -158.5 149.39 20.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 42.43 110.832 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -49.89 -56.09 11.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.876 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -22.23 57.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.879 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.96 -36.2 3.94 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 73.03 112.479 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -50.55 160.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 55.31 110.866 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.9 p -121.22 156.98 31.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 62.54 111.13 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -26.47 62.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 45.15 110.879 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.29 -168.19 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 71.52 110.888 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -113.43 96.82 6.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.886 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.701 HD13 ' SD ' ' A' ' 142' ' ' MET . 19.6 mt -90.61 101.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.114 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 7.2 t -117.63 164.87 14.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.4 111.141 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.4 mt -88.53 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.144 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.62 -64.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.34 111.113 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -135.1 166.33 23.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.856 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -153.72 -174.84 5.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.834 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.9 -147.77 18.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.462 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.6 pt20 -126.61 136.73 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.875 0.369 . . . . 73.35 110.901 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.728 HD21 HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -80.17 -35.39 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 63.51 110.969 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 70.34 110.893 179.905 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.321 . . . . 53.23 110.879 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.1 t -109.95 134.48 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 51.25 111.178 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -59.28 159.14 16.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.603 0.716 . . . . 71.52 110.918 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 154.0 68.45 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 71.23 112.35 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 m -122.14 44.64 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 75.01 111.145 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.575 ' CG1' HD12 ' A' ' 24' ' ' LEU . 3.8 m -47.83 140.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 61.1 111.141 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -136.57 175.87 9.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.13 110.892 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -148.64 142.59 25.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 73.54 110.902 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' HD13 ' A' ' 158' ' ' ILE . 5.9 t70 -96.29 131.8 42.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 63.23 110.826 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.8 137.34 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 53.15 111.106 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.76 167.07 22.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 73.24 111.092 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -143.92 95.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.03 111.121 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 71.14 33.49 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.901 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.27 70.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 71.41 112.549 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -93.17 131.7 32.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.691 0.757 . . . . 74.32 110.849 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 147.33 62.18 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 64.14 112.323 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 12' ' ' VAL . 1.3 tp -113.37 -67.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 65.42 110.88 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.21 -146.66 4.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.5 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.27 125.86 12.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 72.51 110.864 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG1' HG13 ' A' ' 132' ' ' VAL . 22.8 t -116.45 135.24 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.158 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -88.76 100.61 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.841 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -87.81 73.6 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 72.4 110.852 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -51.47 151.78 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.878 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 ' CG1' ' A' ' 6' ' ' VAL . 5.4 mt -117.41 123.75 47.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 74.3 110.932 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.74 70.77 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 70.23 110.864 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.95 -8.68 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 73.14 111.084 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.23 -56.13 4.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 71.11 110.894 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -54.91 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 73.12 110.894 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.53 83.24 53.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.613 0.721 . . . . 72.14 111.103 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 63.11 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.23 . . . . 74.44 112.359 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -159.77 -67.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 62.2 110.914 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 m -53.33 -48.06 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 75.31 111.154 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.02 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 53.14 111.132 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -55.63 -28.27 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.23 110.904 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -54.2 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 60.23 110.922 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.09 -36.52 81.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 51.4 110.862 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -27.23 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 70.43 110.871 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.41 -35.03 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.31 111.133 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.3 tt -83.84 5.22 25.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.898 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -105.31 -13.99 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.869 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -116.59 8.23 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 71.11 111.159 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.03 21.72 39.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 71.24 112.487 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -34.31 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 73.32 110.893 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -13.35 62.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 62.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.62 -12.48 59.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 71.34 112.5 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 47' ' ' GLY . 19.5 m-85 -92.34 -28.08 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 64.22 110.842 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -35.51 125.89 0.74 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 55.22 112.472 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -100.48 33.13 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 75.51 110.979 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 146.74 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 53.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 157' ' ' THR . . . 119.05 -95.91 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 44.35 112.476 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.568 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -101.96 121.72 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 70.22 110.862 -179.707 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.0 p -174.21 -166.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 61.21 110.882 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 63.51 86.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 62.53 110.902 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -116.47 17.28 15.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.885 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -134.37 151.68 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 70.21 110.862 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 179.54 131.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.52 111.17 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 61' ' ' MET . 1.2 pt -138.06 109.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.674 0.75 . . . . 73.33 111.146 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.27 . . . . 54.34 112.333 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.96 -31.6 1.73 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.489 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CB ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.47 -64.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 73.25 110.863 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.433 ' HG2' HD11 ' A' ' 57' ' ' ILE . 3.6 ptt? -158.42 -156.32 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.908 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.2 m -131.44 -44.04 1.02 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 54.44 110.872 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.09 119.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 65.13 110.947 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 50.11 112.487 -179.973 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 74.1 110.882 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -128.38 15.27 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 65.32 110.888 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 82.75 -19.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 53.42 111.11 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -20.29 15.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.934 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.41 -88.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.31 112.462 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -138.69 -54.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 75.5 110.898 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 9.2 pttp -168.81 145.17 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.895 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.48 144.55 49.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.3 110.882 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.73 170.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 65.35 110.857 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.2 146.45 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.85 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -58.79 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 62.41 110.846 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 178.75 156.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.889 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -112.55 60.14 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.868 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.7 mm -78.51 -20.52 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.45 111.181 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -96.51 99.06 10.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 72.3 110.889 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.24 114.33 26.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 63.11 110.926 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.633 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -51.16 -95.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 73.3 110.83 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 93' ' ' THR . 0.5 OUTLIER 66.72 5.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.31 111.167 -179.86 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.84 153.27 24.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 50.13 112.49 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.72 63.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.264 . . . . 73.42 112.326 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 94.64 -17.95 58.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 51.02 112.482 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.633 HG21 ' HB3' ' A' ' 92' ' ' HIS . 12.7 mm -64.45 140.91 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 65.43 111.167 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.8 tt -90.79 126.67 36.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.894 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -122.72 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 mtm -69.17 175.29 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 52.55 110.878 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -166.92 147.38 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.31 111.103 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.6 m-20 163.5 -64.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 71.15 110.934 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.75 -106.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 74.32 111.103 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.606 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -156.59 -60.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 75.13 112.479 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.79 -104.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.262 . . . . 72.33 112.297 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -121.0 72.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 55.45 110.852 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -144.69 10.42 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.44 111.115 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 102' ' ' ASN . 9.4 p30 -99.86 179.51 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 52.32 110.832 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.17 24.53 2.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 75.44 112.473 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.49 -52.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 64.21 110.906 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -84.14 155.81 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 71.04 110.9 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -149.87 171.63 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.872 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -159.28 166.48 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 63.12 110.886 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 116' ' ' THR . 37.5 mt -121.4 114.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.51 111.12 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.8 p -65.15 -28.03 69.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 60.41 110.849 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 114' ' ' ILE . 1.4 p 49.31 22.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 71.42 111.141 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.4 176.14 6.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 71.21 111.077 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 104.63 12.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 65.31 110.874 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.795 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 66.2 p -132.45 63.8 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.21 111.16 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -90.13 22.63 3.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 62.52 110.881 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.795 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.5 OUTLIER -93.33 5.91 49.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.933 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 4.4 mt -97.59 -4.96 36.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.14 68.42 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.21 110.91 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.57 37.36 0.83 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.79 -0.719 . . . . 70.14 112.454 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 3.9 mmtp -55.46 -34.33 64.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 71.45 110.899 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -110.38 156.2 21.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.1 110.827 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.07 85.07 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.22 111.105 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 90' ' ' LEU . 17.5 t -65.25 118.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.03 111.109 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 17.96 4.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 74.41 110.869 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.74 178.2 28.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.503 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 170.09 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 74.05 110.934 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.64 HG13 ' CG1' ' A' ' 20' ' ' VAL . 94.4 t -97.75 84.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 74.22 111.11 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -62.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.14 110.908 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -138.02 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.829 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.29 10.46 68.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.21 112.467 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.64 27.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 74.31 110.856 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.55 -26.92 14.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 62.42 110.886 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.4 mm -80.02 -41.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 71.53 111.124 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 116' ' ' THR . 38.1 t -50.17 -45.19 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.115 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -32.77 67.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 52.21 110.85 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.77 92.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 64.13 111.079 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.1 mtm -71.62 -26.09 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 72.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.5 14.18 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 70.13 110.883 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -16.26 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.21 110.89 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -104.24 -8.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.864 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.53 -150.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 73.42 112.447 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -169.41 152.87 4.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 63.4 110.857 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -73.24 69.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 65.2 110.851 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 177.51 -26.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.86 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.4 -48.14 0.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 41.53 112.497 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.84 160.9 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 62.22 110.895 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -137.71 171.4 14.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.41 111.119 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 p -86.55 -4.01 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.842 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -137.85 -165.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 55.14 110.888 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.33 125.31 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 54.15 110.903 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.04 131.18 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.41 111.148 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -126.67 163.85 22.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 43.04 111.152 179.993 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 9' ' ' ASP . 41.8 mm -120.97 94.47 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.132 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.55 -48.63 76.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.4 111.1 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.64 -178.48 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.877 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 6.0 p -176.55 157.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.89 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.48 176.67 45.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 53.31 112.488 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.6 mt-30 -69.29 -36.71 77.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.813 0.339 . . . . 64.02 110.854 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.3 mm? 71.9 -21.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.898 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 163' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.846 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.815 0.341 . . . . 72.11 110.9 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.04 154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 52.41 111.131 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -89.79 151.32 45.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 75.5 110.826 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.81 109.27 2.28 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.671 2.247 . . . . 73.12 112.344 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.664 HG22 HD21 ' A' ' 164' ' ' LEU . 6.4 m -113.42 141.46 47.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 61.12 111.121 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 163' ' ' GLN . 6.4 m -126.9 148.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 70.41 111.141 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.794 ' HB3' HD22 ' A' ' 164' ' ' LEU . 11.5 p90 -118.69 147.79 43.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.908 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -129.06 131.41 47.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 63.25 110.895 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -97.12 75.54 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 61.12 110.892 179.991 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mm -49.74 141.41 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.146 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.92 151.49 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 70.23 111.111 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.6 t -134.19 108.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 72.2 111.181 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t0 51.47 52.25 15.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.919 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.22 50.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 63.01 112.463 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mm-40 -139.29 94.57 9.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.651 0.738 . . . . 73.13 110.878 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.83 157.75 59.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.251 . . . . 53.03 112.309 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -126.37 22.88 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 44.3 110.955 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.85 160.4 9.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 65.41 112.495 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 -179.68 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 64.33 110.917 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 138' ' ' ILE . 17.6 m -146.61 168.99 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 71.43 111.111 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -145.64 144.27 30.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.823 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 5' ' ' THR . 2.0 m-85 -127.68 138.62 52.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.904 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -111.36 113.56 26.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 53.23 110.896 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 33' ' ' ALA . 10.6 mt -80.2 129.74 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.903 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 72.16 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.43 110.868 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.51 -27.19 15.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.43 111.116 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.57 -44.01 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.845 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.51 -32.84 18.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.906 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.778 HG21 ' CB ' ' A' ' 129' ' ' PHE . 11.5 m -131.24 87.19 48.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 71.12 111.147 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.27 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 73.15 112.364 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -41.89 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -3.1 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 71.03 111.18 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.718 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -76.62 -37.47 56.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.33 111.141 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 35' ' ' ASN . 80.3 tt0 -92.79 -37.88 12.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 65.04 110.885 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -29.32 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.861 -179.904 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HA ' HD12 ' A' ' 39' ' ' LEU . 37.3 t80 -64.45 -32.75 74.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.857 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -51.75 -34.7 40.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.885 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.49 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.113 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' PHE . 13.4 mt -75.63 -52.02 11.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 63.53 110.856 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.9 m -59.39 -54.01 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.862 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.6 p -73.19 -27.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.34 111.15 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.96 92.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.722 . . . . 72.32 112.495 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.72 36.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 61.11 110.901 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -133.72 26.81 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.947 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.06 4.76 60.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 74.45 112.454 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -164.56 178.05 7.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 64.14 110.875 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.52 117.01 2.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 70.4 112.45 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.11 150.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 61.31 110.912 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -76.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 63.54 110.92 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.01 44.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 72.11 112.516 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -26.46 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 63.32 110.848 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p 178.13 176.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 65.44 110.931 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -103.2 -77.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.876 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.12 -80.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.55 110.9 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -164.82 110.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.878 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.716 HD12 ' CD1' ' A' ' 156' ' ' ILE . 5.1 mt -95.71 135.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 74.05 111.131 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.564 HD12 ' CE ' ' A' ' 61' ' ' MET . 12.7 mt -131.74 103.5 14.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 74.03 111.087 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.77 104.53 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 74.54 112.385 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.46 8.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 23.1 112.476 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.56 -66.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 70.21 110.94 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.564 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -179.17 -168.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 73.5 110.875 179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.871 ' HB2' HG23 ' A' ' 114' ' ' ILE . 87.8 m -149.15 133.22 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.895 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.04 154.81 18.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.939 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 53.05 112.525 -179.976 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.797 0.332 . . . . 74.1 110.885 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 142.27 27.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 70.45 110.852 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 79' ' ' TYR . 2.1 pp -40.67 -38.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 65.33 111.081 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' CD2' HD11 ' A' ' 78' ' ' ILE . 4.5 m-85 -85.89 49.24 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.877 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.16 -113.82 4.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 73.04 112.47 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.96 -161.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.393 . . . . 74.4 110.862 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.3 OUTLIER -101.08 -178.51 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 65.03 110.87 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -131.66 162.13 31.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.913 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -91.28 172.5 8.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 55.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.71 105.9 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 71.12 110.821 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -58.21 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 73.33 110.861 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 p30 -177.92 165.52 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.883 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.1 55.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 54.11 110.839 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mt -48.93 -26.32 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.5 111.194 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 73.3 mt -93.39 155.08 17.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.905 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -117.93 178.29 4.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 63.54 110.908 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -105.08 76.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 70.33 110.849 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 t -122.34 22.39 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.162 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' HD11 ' A' ' 97' ' ' ILE . . . -120.72 160.12 15.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.76 -0.733 . . . . 72.35 112.505 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.26 24.27 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 72.43 112.375 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.42 71.11 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 60.42 112.491 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HA3' ' A' ' 94' ' ' GLY . 42.5 mm -91.42 143.4 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 73.51 111.119 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 97' ' ' ILE . 8.0 mt -117.03 152.67 34.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.887 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 56.9 m -154.89 -101.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 70.14 110.877 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -176.4 124.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 74.54 110.874 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -102.58 80.76 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 53.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -137.32 -64.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.44 110.919 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.679 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -178.17 121.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 51.5 111.118 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.906 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -72.61 -29.48 65.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 60.34 112.482 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.906 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.7 Cg_endo -69.78 80.99 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.232 . . . . 71.21 112.367 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 p-10 39.29 53.96 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.892 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -159.03 39.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.2 111.142 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -74.77 160.27 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.941 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.99 -110.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.53 112.507 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.25 -162.14 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 72.32 110.851 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 mt-30 74.75 50.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 75.52 110.896 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 41.0 p90 -50.25 142.71 9.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.836 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 27.9 p90 -103.98 59.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.871 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 62' ' ' CYS . 9.3 tt -34.79 121.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.5 111.106 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 119' ' ' THR . 69.7 m -90.53 159.01 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 61.3 110.898 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -111.67 -9.69 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 71.04 111.163 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.87 161.38 40.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 62.22 111.085 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.24 115.92 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.15 110.9 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 122' ' ' LEU . 15.8 p -115.7 47.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 74.41 111.153 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.71 -17.54 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.926 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -55.65 -21.91 20.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 71.31 110.934 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.522 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -73.33 -56.25 5.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 72.02 110.923 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 73.03 -61.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.2 110.897 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.83 61.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.685 -0.769 . . . . 70.03 112.491 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -98.02 -27.79 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.43 110.913 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -143.44 138.1 29.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 61.34 110.812 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 87' ' ' ASN . 55.4 t -51.37 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.14 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.4 p -84.2 143.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 75.1 111.133 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.778 ' CB ' HG21 ' A' ' 29' ' ' VAL . 37.2 p90 -178.78 119.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.13 110.855 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.42 123.33 4.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 74.41 112.485 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -139.23 162.03 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 74.52 110.892 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 t -54.83 100.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.136 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -46.85 41.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 64.54 110.888 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -148.06 118.2 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.33 84.42 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 64.23 112.474 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 tpt -91.26 -21.52 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.789 0.328 . . . . 64.41 110.873 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -30.74 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 73.0 110.885 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 20' ' ' VAL . 38.2 mm -64.49 -41.76 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.31 111.117 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.7 t -91.65 11.39 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.085 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.8 -64.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 64.44 110.855 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.63 -57.28 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.33 111.083 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.7 tmm? -52.81 -37.86 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 55.44 110.888 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -24.59 32.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.878 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -68.39 -12.57 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.839 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -94.78 26.09 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 75.51 110.884 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -124.92 44.04 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 70.4 112.53 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 146' ' ' GLY . 29.8 t 29.57 -102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.384 . . . . 44.42 110.834 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -173.5 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 64.12 110.86 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -87.74 -6.45 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.895 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.68 -55.81 0.76 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.464 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 110.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.84 0.352 . . . . 73.22 110.848 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 146' ' ' GLY . 40.0 p -84.11 138.33 33.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.154 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.31 -28.92 63.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 65.53 110.854 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -137.07 -179.62 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.12 110.903 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 135.4 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.888 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.716 ' CD1' HD12 ' A' ' 56' ' ' ILE . 20.5 mt -117.17 87.66 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.04 111.128 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -108.68 157.16 18.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.02 111.175 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.4 mt -93.22 146.06 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 72.11 111.188 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -96.55 -61.22 1.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.114 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.09 154.6 48.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.0 m -146.16 -167.5 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 73.44 110.892 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.66 -162.93 23.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 72.25 112.501 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.646 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.3 tt0 -112.54 133.82 54.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 72.22 110.901 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.794 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -109.24 144.48 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 62.34 110.943 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.895 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.838 0.351 . . . . 64.42 110.896 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.9 t 59.62 99.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 70.52 111.127 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -58.59 154.91 32.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 73.4 110.907 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 154.8 67.33 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.233 . . . . 74.4 112.365 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 6' ' ' VAL . 2.8 m -120.55 163.01 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 61.45 111.109 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.587 ' CG2' HD11 ' A' ' 24' ' ' LEU . 1.3 t -144.11 140.68 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.23 111.176 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -126.34 144.36 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 62.11 110.864 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 8.0 m-85 -138.67 139.58 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 71.3 110.862 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.02 109.86 22.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 65.24 110.799 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.3 136.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.478 . . . . 70.41 111.157 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.32 161.91 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.099 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 17' ' ' LEU . 61.2 t -146.45 93.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 54.34 111.161 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.2 27.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.83 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.88 57.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 63.01 112.536 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.15 139.22 21.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.605 0.717 . . . . 64.53 110.891 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 152.93 69.49 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 64.23 112.401 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.5 tp -116.07 -68.39 0.92 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 73.13 110.929 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.81 -144.67 4.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 42.32 112.518 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.31 135.91 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.45 110.847 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.64 129.73 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.32 111.145 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 95.54 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.45 110.821 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 5.5 m-85 -87.56 119.81 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.54 110.875 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -101.07 147.88 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.917 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 37' ' ' ARG . 0.8 OUTLIER -121.06 120.18 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 65.14 110.911 -179.919 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.63 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.1 110.904 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.67 -2.47 56.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 65.34 111.104 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.05 -51.03 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.867 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -26.32 16.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.862 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.58 74.57 65.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.64 0.733 . . . . 74.33 111.142 179.858 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -44.6 1.98 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.251 . . . . 73.34 112.382 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -62.85 -50.22 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.92 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.504 ' OG1' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -65.03 -39.33 93.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 71.12 111.138 179.986 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.81 -68.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 74.01 111.07 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' ARG . 27.2 tt0 -48.42 -65.61 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.932 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 34' ' ' GLU . 4.2 t30 -29.93 -52.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 65.12 110.867 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.12 -41.56 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.53 110.885 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.589 ' HG3' HD13 ' A' ' 24' ' ' LEU . 5.0 ttm180 -52.06 -29.52 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 64.32 110.834 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -62.55 -32.55 73.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 44.32 111.098 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -94.01 35.3 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.877 -179.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.7 t -113.22 -12.29 13.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 74.04 110.853 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 p -121.32 18.14 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.159 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.34 27.8 8.39 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.747 -0.739 . . . . 64.21 112.528 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.04 -40.41 53.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.392 . . . . 75.24 110.882 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -62.08 -17.27 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.895 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.26 -66.24 3.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 63.03 112.492 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -93.3 148.02 22.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 75.5 110.917 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.8 -168.04 25.14 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.756 -0.735 . . . . 33.45 112.48 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.442 ' O ' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -86.11 139.7 30.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.931 0.396 . . . . 74.31 110.941 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -42.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.918 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.2 45.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 34.15 112.473 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.5 t -95.43 45.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 72.51 110.854 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.27 -176.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 70.45 110.881 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -176.53 134.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.859 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.22 66.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.862 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 8.26 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.2 110.86 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.63 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -57.75 150.63 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 73.14 111.125 179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 148' ' ' ARG . 3.9 mt -140.29 95.64 8.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 54.4 111.14 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.77 87.6 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 53.42 112.332 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 71.41 112.516 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -59.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 72.34 110.908 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -157.22 -150.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 72.44 110.888 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.6 t -121.01 -53.68 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.32 110.896 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.08 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 71.03 110.943 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 C-N-CA 120.728 -0.748 . . . . 64.05 112.5 -179.976 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.797 0.332 . . . . 71.22 110.893 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 167.01 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 61.2 110.826 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -51.41 -42.96 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.42 111.126 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.75 46.02 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 70.53 110.966 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.55 -95.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.749 . . . . 33.43 112.495 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -54.64 178.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 53.25 110.904 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' CD ' ' H ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -95.92 -172.07 2.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.9 179.962 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.11 164.46 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 71.11 110.866 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.27 179.33 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.13 110.859 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.89 129.73 34.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.43 110.84 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -88.24 -46.57 9.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.877 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 p30 177.68 156.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 61.11 110.913 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.84 63.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.884 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.585 ' O ' HD23 ' A' ' 90' ' ' LEU . 24.0 mm -80.82 2.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.43 111.164 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 89' ' ' ILE . 59.8 mt -133.68 136.74 44.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.12 110.907 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -162.91 1.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.897 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -102.19 97.07 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 65.21 110.867 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -79.19 -21.43 46.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.44 111.154 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.02 -125.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 61.24 112.483 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.14 47.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.616 2.211 . . . . 35.44 112.345 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 67.05 121.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 64.25 112.47 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -176.4 130.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 71.04 111.135 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CB ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -106.61 122.84 47.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 63.51 110.888 179.888 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HE3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -133.51 -155.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 75.54 110.908 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.444 ' HE3' ' O ' ' A' ' 99' ' ' SER . 1.1 mmt -134.23 116.34 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.905 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . -56.46 -46.38 80.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 44.52 111.083 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 107' ' ' THR . 21.5 p30 39.14 -157.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 62.23 110.912 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.577 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -141.44 10.99 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.24 111.11 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.9 -65.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 64.32 112.512 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.577 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.78 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 53.55 112.314 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' A' ' 105' ' ' PRO . 79.6 m-20 -82.34 81.05 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 64.23 110.888 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 102' ' ' ASN . 5.3 t -153.22 56.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 51.43 111.111 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.89 -44.51 19.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 32.04 110.898 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 48.18 -164.74 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 33.25 112.452 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.96 87.82 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 72.04 110.866 -179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 25.2 tt0 -161.15 51.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.924 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CB ' HD23 ' A' ' 98' ' ' LEU . 2.8 p90 -59.83 -172.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 70.1 110.898 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.62 106.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.927 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.464 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 76.8 mt -48.17 123.36 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.122 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 89.7 m -84.29 116.5 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.868 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -88.18 -30.69 19.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.11 111.155 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.13 161.02 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 71.21 111.085 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -62.22 102.3 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 50.03 110.921 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.823 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 18.6 p -113.89 46.0 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 71.13 111.175 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -16.79 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 72.53 110.827 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.823 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -64.12 -15.51 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.939 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.99 78.29 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.02 110.942 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.92 -47.79 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 54.33 110.871 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.87 45.17 3.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 45.41 112.499 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -145.25 -53.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 70.35 110.906 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -101.68 134.76 44.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.802 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.47 104.83 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 71.22 111.119 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 90.8 t -78.41 132.5 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.12 111.131 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.536 ' HA ' HG21 ' A' ' 29' ' ' VAL . 19.5 p90 -152.94 26.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.884 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -161.4 -170.53 26.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.466 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp 178.73 -169.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 64.32 110.926 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -116.35 81.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 73.22 111.139 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -49.2 -34.56 15.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.919 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -171.02 168.28 6.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.873 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.83 -1.6 58.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.714 -0.755 . . . . 71.02 112.466 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -33.54 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.22 110.934 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -50.58 -27.03 6.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 71.02 110.905 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 17.6 mm -81.58 -45.61 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.25 111.145 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.06 -51.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.121 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.01 -27.74 14.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 70.24 110.891 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -71.83 -47.57 52.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 75.5 111.109 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 156' ' ' ILE . 62.1 mtm -62.96 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 64.34 110.863 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 6.3 mm-40 -51.42 -71.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 75.22 110.898 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -60.0 -16.68 32.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.883 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 142' ' ' MET . 11.8 m-85 -92.51 2.16 56.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 72.01 110.854 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 56' ' ' ILE . . . -127.62 46.77 1.06 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 75.24 112.504 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 146' ' ' GLY . 8.1 t 34.89 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 61.12 110.886 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.9 mmm-85 -133.62 -35.44 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.14 110.903 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -99.45 -8.3 24.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.926 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.57 80.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 61.43 112.483 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -60.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 75.05 110.874 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 66.43 133.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 50.01 111.126 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -9.02 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.03 110.877 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.48 156.65 47.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 73.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.76 118.64 32.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 64.3 110.891 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.454 HD13 ' SD ' ' A' ' 142' ' ' MET . 12.7 mt -88.59 134.47 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 73.24 111.15 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.16 170.45 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 71.43 111.145 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 67.1 mt -118.7 111.36 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.156 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -60.59 -54.96 39.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 63.11 111.131 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -167.6 168.84 12.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.908 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.3 p -156.49 163.76 39.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 65.1 110.867 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.72 -178.85 47.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 74.32 112.456 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 9.5 mt-30 -69.32 -37.23 77.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 61.55 110.94 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.546 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.14 -62.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 65.22 110.885 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.1 110.877 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 64.33 110.852 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.9 155.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 51.15 111.104 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.37 149.25 37.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 75.34 110.9 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.81 19.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.681 2.254 . . . . 54.1 112.366 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.632 HG21 HD22 ' A' ' 164' ' ' LEU . 57.4 m -119.6 124.91 47.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.132 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.2 m -104.95 144.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 75.25 111.108 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -105.05 154.94 19.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.866 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.33 131.52 26.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.89 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.52 95.07 5.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.885 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.753 HD12 ' CG2' ' A' ' 138' ' ' ILE . 17.3 mt -78.92 141.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 62.42 111.144 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -122.83 159.94 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.1 111.122 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.31 106.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 75.24 111.095 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 51.45 55.44 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 62.2 110.879 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.51 9.84 33.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 22.41 112.512 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -136.0 93.84 14.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.685 0.755 . . . . 72.34 110.87 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 156.02 64.22 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.694 2.262 . . . . 64.12 112.313 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.18 26.99 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 71.52 110.942 179.972 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.9 169.28 12.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.488 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.58 171.52 12.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 72.04 110.845 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 138' ' ' ILE . 17.6 m -143.3 -176.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.44 111.158 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.7 p -148.11 154.77 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.824 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.36 134.1 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.1 tt0 -73.98 -55.03 6.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 70.1 110.888 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mt 76.8 124.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.961 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD2' HD13 ' A' ' 90' ' ' LEU . 81.6 m-85 -81.76 55.28 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 71.14 110.877 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -36.52 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.113 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.44 -51.61 66.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.878 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -60.49 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.891 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.55 82.51 6.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 74.2 111.135 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 60.94 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 41.23 112.355 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 -71.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 62.23 110.874 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.66 HG23 ' HE3' ' A' ' 100' ' ' MET . 27.3 m -58.34 -53.71 55.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 53.34 111.149 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -86.83 9.52 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.106 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -88.95 -24.54 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 61.51 110.872 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.57 -29.76 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.859 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' A' ' 39' ' ' LEU . 7.7 t80 -50.59 -28.4 8.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.868 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 41' ' ' THR . 15.0 ptp180 -56.66 -30.71 63.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 71.25 110.861 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.79 -31.79 19.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.42 111.081 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 78' ' ' ILE . 67.1 mt -65.19 -47.85 75.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 65.4 110.962 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -65.22 -37.41 87.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.857 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' ARG . 65.4 p -73.88 -19.66 60.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 73.13 111.184 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.6 91.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.741 . . . . 64.52 112.457 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.66 36.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.901 0.381 . . . . 64.51 110.886 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.99 6.63 2.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.32 110.886 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 9.7 84.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.22 112.526 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -174.16 -169.17 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 72.41 110.886 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.53 -80.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 65.33 112.507 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -176.8 110.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 74.33 110.889 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -179.03 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.938 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.425 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -45.2 104.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 34.12 112.507 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -159.74 54.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 62.22 110.865 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' H ' HG22 ' A' ' 157' ' ' THR . 18.8 m 52.3 -173.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 62.2 110.908 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -168.84 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.839 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -115.56 -77.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 72.14 110.857 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -135.44 143.38 45.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 54.35 110.875 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.6 mt -143.78 125.86 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.32 111.134 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.698 HD11 ' CE ' ' A' ' 61' ' ' MET . 1.1 pt -134.28 114.11 12.46 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 70.22 111.15 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 108.99 2.21 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.682 2.255 . . . . 73.15 112.334 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.2 -31.28 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 54.23 112.516 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.599 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -99.96 -63.2 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 75.11 110.854 -179.852 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.698 ' CE ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 179.81 -165.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.853 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.3 m -142.19 115.04 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.1 110.925 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -99.36 151.06 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 54.3 110.908 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 72.35 112.433 -179.911 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' SER . 16.6 ptpt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.754 0.312 . . . . 72.02 110.921 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 61.2 p -87.75 -167.94 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.811 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 39' ' ' LEU . 2.6 pp -111.85 11.19 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.4 111.121 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -7.71 25.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.919 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.05 -84.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 75.11 112.451 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.4 -68.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 71.35 110.864 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -167.78 163.58 14.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 52.21 110.883 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.6 144.15 51.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.856 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.13 159.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.878 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -64.6 -167.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.863 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -148.36 -67.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.41 110.893 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 127' ' ' VAL . 6.4 p30 -176.93 171.88 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 64.33 110.935 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.97 43.35 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.868 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.7 mt -51.01 -27.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 50.34 111.132 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 128' ' ' VAL . 3.8 mt -96.6 137.39 35.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 70.24 110.899 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.93 114.09 17.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.917 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.455 ' CE1' ' HB3' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -55.97 102.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.837 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.2 p -113.76 42.45 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.3 111.153 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.89 156.67 14.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 43.11 112.517 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 128.08 15.49 Favored 'Trans proline' 0 N--CA 1.466 -0.103 0 C-N-CA 122.69 2.26 . . . . 73.21 112.33 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.9 -22.1 8.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 63.41 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.9 mm -65.82 152.05 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 52.31 111.117 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.78 HD12 ' HA3' ' A' ' 130' ' ' GLY . 32.0 mt -96.12 132.18 41.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.4 110.941 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.0 m -119.67 138.66 53.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.816 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.66 ' HE3' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -77.57 172.48 13.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 62.01 110.86 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.592 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . . . -166.13 -175.07 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 52.44 111.094 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 12.0 t30 88.6 95.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.887 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.599 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . 66.18 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.08 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 121.49 -59.96 0.56 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.708 -0.758 . . . . 71.43 112.462 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.599 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 100.15 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 64.11 112.301 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.8 56.33 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.84 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -132.0 7.14 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.2 111.116 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 41.29 -92.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.913 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 97.43 139.16 10.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 55.14 112.472 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 p -100.61 -8.89 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 65.22 110.896 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 129.82 35.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.934 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.05 138.69 48.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 62.41 110.903 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.592 ' HE1' ' HB2' ' A' ' 101' ' ' ALA . 14.2 p90 -120.2 121.64 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.2 110.883 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mt -92.35 119.26 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.107 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -76.27 150.97 36.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.84 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -126.55 23.75 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.42 111.124 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.72 20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 65.13 111.111 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 64.97 135.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.891 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.518 HG22 ' CZ3' ' A' ' 121' ' ' TRP . 21.8 p -148.95 68.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 71.15 111.129 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -84.37 14.3 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.868 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.518 ' CZ3' HG22 ' A' ' 119' ' ' THR . 3.2 p90 -91.39 0.33 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 75.44 110.955 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.56 31.88 1.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 54.52 110.871 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.455 ' HB3' ' CE1' ' A' ' 92' ' ' HIS . 22.5 p-10 -96.26 78.81 3.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.02 110.847 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.79 -41.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 34.41 112.485 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -35.75 73.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 64.21 110.898 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -117.37 159.3 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 62.11 110.831 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.797 HG13 ' N ' ' A' ' 128' ' ' VAL . 1.1 p -81.05 -159.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 54.23 111.087 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.797 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -165.36 144.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 54.25 111.128 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 27.7 p90 -175.99 115.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.905 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.78 ' HA3' HD12 ' A' ' 98' ' ' LEU . . . 114.87 114.5 3.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 71.25 112.488 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.39 143.14 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 52.41 110.861 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 139' ' ' VAL . 69.5 t -52.53 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.126 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -56.78 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 55.04 110.899 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.09 170.8 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.872 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 63.37 82.45 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 42.41 112.463 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 8.7 tpt -89.17 11.09 19.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 73.45 110.832 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.69 -34.3 16.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 71.2 110.905 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.753 ' CG2' HD12 ' A' ' 10' ' ' ILE . 39.4 mm -60.18 -38.38 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.116 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.5 t -90.63 -3.01 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 63.42 111.122 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -110.66 -71.83 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.44 110.9 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.75 -52.07 34.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 72.54 111.119 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.7 tmm? -51.43 -29.16 15.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.862 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.54 29.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 71.24 110.854 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -113.51 -14.39 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.884 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -105.77 -2.46 23.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -157.46 1.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 62.12 112.483 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 57' ' ' ILE . 4.8 t -163.79 141.77 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 60.14 110.868 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -57.46 -20.15 28.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.855 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.09 -17.87 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 63.45 110.902 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.93 -42.0 1.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.708 -0.758 . . . . 70.01 112.506 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -46.41 131.6 10.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 73.22 110.882 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.7 p -96.52 112.66 24.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.21 111.144 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -49.8 -28.1 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 33.22 110.841 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -125.11 -162.26 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 62.34 110.939 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.3 tppm? -128.37 129.25 45.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 63.01 110.909 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 10' ' ' ILE . 3.3 mp -112.36 92.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.42 111.133 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 25.0 p -103.17 148.66 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 55.03 111.142 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.425 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.8 mt -88.82 130.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.134 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.89 -64.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.08 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -127.02 170.63 12.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.35 110.816 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.48 -174.89 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.862 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.36 -148.59 19.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -106.74 133.91 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 73.24 110.9 -179.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.632 HD22 HG21 ' A' ' 5' ' ' THR . 3.2 tp -56.78 -57.09 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.2 110.866 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.12 110.912 179.95 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.809 0.337 . . . . 73.42 110.887 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.35 138.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 50.21 111.121 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.41 157.28 13.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.65 0.738 . . . . 73.41 110.882 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 122.0 8.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 74.35 112.318 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 14.4 m -100.85 55.99 0.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 71.22 111.128 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -52.26 154.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.077 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -136.56 170.8 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.861 -179.988 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -142.0 143.88 33.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.902 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.45 115.95 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.35 110.86 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -85.73 123.07 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 43.15 111.129 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.19 13.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.31 111.097 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.7 m -144.21 101.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.05 111.109 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 3.7 t0 76.71 45.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.901 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 24.02 70.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 72.32 112.452 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -135.27 148.7 67.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 73.52 110.92 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 140.13 41.91 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.68 2.253 . . . . 43.12 112.358 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.4 tp -127.39 -38.12 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.913 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.24 -178.51 45.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 43.45 112.482 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 162.25 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.51 110.847 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.54 147.6 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 73.25 111.119 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.23 97.82 11.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.911 -179.867 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -85.0 59.61 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.12 110.846 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.79 115.45 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.865 -179.9 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.542 HD21 ' CD2' ' A' ' 36' ' ' PHE . 5.9 mt -81.83 133.2 35.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.927 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 90' ' ' LEU . 71.2 m-85 -75.8 67.31 2.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.855 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.18 -14.82 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 73.44 111.095 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.09 -60.26 2.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.854 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -67.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 51.53 110.924 -179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 3.2 m -105.95 114.46 62.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 64.14 111.107 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' LYS . 53.7 Cg_endo -69.77 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 63.53 112.319 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' PRO . 7.9 mtmm -38.33 -54.68 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.849 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 55.8 m -39.51 -58.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 73.4 111.145 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.98 30.85 4.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 70.03 111.074 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -97.24 -30.64 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.846 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.03 -35.53 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.13 110.9 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CD2' HD21 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.22 -31.62 6.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.932 179.981 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -35.82 70.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.872 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.29 -21.75 27.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 53.52 111.133 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 36' ' ' PHE . 73.7 mt -70.23 -51.36 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 63.43 110.892 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -68.18 -44.69 75.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 74.12 110.885 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -74.96 -24.07 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 41.45 111.157 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.34 94.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.486 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.76 47.53 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.948 0.404 . . . . 61.05 110.933 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 33.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 75.2 110.868 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.63 -3.4 49.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 74.53 112.495 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -163.0 -168.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 73.13 110.862 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.69 137.39 4.81 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.679 -0.772 . . . . 73.1 112.468 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -85.21 144.27 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.951 0.405 . . . . 74.25 110.94 -179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -57.66 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.869 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -114.26 -76.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 71.51 112.513 179.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t 68.82 123.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 43.22 110.841 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.51 -171.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 72.24 110.849 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 152' ' ' THR . 27.1 p90 -104.81 -170.82 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 62.23 110.922 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -60.09 1.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.11 110.828 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -151.66 160.14 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.842 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.1 mt -136.82 130.52 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 73.13 111.151 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -130.22 110.23 16.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.601 0.715 . . . . 75.22 111.149 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.7 Cg_endo -69.83 101.72 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.609 2.206 . . . . 73.32 112.337 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.62 22.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.697 -0.764 . . . . 53.41 112.511 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HG21 ' A' ' 119' ' ' THR . 0.1 OUTLIER -138.5 -63.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 74.23 110.912 -179.878 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -168.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 60.53 110.846 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.796 ' HB2' HG23 ' A' ' 114' ' ' ILE . 9.0 m -150.04 131.5 14.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.92 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -111.92 139.57 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.899 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.762 -0.732 . . . . 53.02 112.519 -179.989 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.771 0.32 . . . . 64.52 110.926 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.61 -179.44 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 71.23 110.843 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.5 pt -81.26 -39.17 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 64.31 111.134 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -96.68 93.93 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 63.21 110.941 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.36 -119.51 5.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 24.42 112.453 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -84.5 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 63.24 110.903 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 152.66 44.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.926 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.71 148.81 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.924 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -49.17 157.77 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 73.51 110.892 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.08 144.17 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 61.32 110.892 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -61.24 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.0 110.858 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.64 167.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.02 110.902 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.46 60.6 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.01 110.875 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 89' ' ' ILE . 30.6 mm -73.37 -6.86 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 72.12 111.165 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -117.99 81.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 70.3 110.922 179.911 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -66.93 161.54 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.882 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -71.41 75.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.834 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -70.93 -12.28 61.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.41 111.153 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.14 -170.09 43.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 70.45 112.483 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 128.04 15.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.694 2.263 . . . . 74.44 112.339 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.88 -31.4 3.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 73.43 112.511 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.0 mm -61.27 139.54 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.366 . . . . 70.32 111.129 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 112' ' ' PHE . 50.6 mt -108.28 159.64 16.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.938 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 m -158.96 33.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.858 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.493 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.6 OUTLIER 47.17 -167.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.15 110.877 179.928 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.544 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -172.46 75.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 60.42 111.165 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -116.23 -73.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.88 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.64 -36.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.2 111.122 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.06 -69.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 61.11 112.512 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.6 Cg_endo -69.74 108.53 2.1 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 73.22 112.33 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 45.52 38.39 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 73.11 110.879 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p -138.04 56.79 1.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 63.03 111.152 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -39.34 -57.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 73.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.8 -170.84 50.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.13 112.46 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.493 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 34.2 t -144.68 25.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 61.14 110.826 -179.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.544 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.7 tt0 -79.65 -100.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 73.13 110.88 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 170.66 179.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 52.51 110.888 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.62 38.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 61.23 110.905 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 62' ' ' CYS . 8.0 tt -58.27 91.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 65.4 111.14 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.9 142.11 54.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.907 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.624 HG21 ' CD ' ' A' ' 143' ' ' GLU . 11.4 p -111.4 22.34 15.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 64.23 111.154 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 119' ' ' THR . . . -176.75 161.24 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 54.24 111.116 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 95.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.42 110.914 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 117' ' ' ALA . 34.5 p -125.12 59.46 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 34.44 111.119 -179.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.22 30.63 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.2 110.929 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.479 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.6 OUTLIER -92.47 7.27 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.4 110.902 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.11 -10.16 28.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 71.01 110.915 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.59 78.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 75.12 110.876 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 38.82 50.54 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 63.23 112.481 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -58.27 -33.01 68.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 72.14 110.886 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -143.85 177.68 8.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.877 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -61.91 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 73.15 111.12 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.666 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.6 p -174.47 138.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.149 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 3.7 p90 178.6 102.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 73.25 110.843 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.56 127.11 3.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 62.42 112.485 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.71 21.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 63.31 110.892 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.644 HG11 HG21 ' A' ' 139' ' ' VAL . 25.5 m -49.56 159.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 61.52 111.138 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -160.86 -39.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.35 110.904 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -63.54 1.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.881 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.19 105.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 50.41 112.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -6.78 33.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.776 0.322 . . . . 71.52 110.869 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -57.61 -20.39 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.87 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.8 mm -91.74 -45.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.41 111.105 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.644 HG21 HG11 ' A' ' 132' ' ' VAL . 95.9 t -54.71 -20.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.12 111.115 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -83.92 -32.88 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 63.1 110.925 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.59 -31.28 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.123 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -86.02 -9.48 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.88 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.624 ' CD ' HG21 ' A' ' 116' ' ' THR . 4.0 mm-40 -89.88 28.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.869 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -145.17 8.04 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.891 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.66 2.28 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.903 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -110.17 72.57 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.769 -0.729 . . . . 73.33 112.516 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.564 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.7 134.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 50.14 110.877 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 27.2 mmm-85 -47.96 -44.91 30.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.34 110.857 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -49.11 -27.45 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 51.33 110.867 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.46 -37.59 2.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.723 . . . . 75.23 112.507 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.66 140.39 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 71.14 110.916 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.626 HG22 ' HA2' ' A' ' 146' ' ' GLY . 68.1 p -118.13 147.92 42.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 60.44 111.134 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -21.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 54.03 110.815 -179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -131.9 -168.35 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 55.13 110.853 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -132.14 132.15 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 60.3 110.922 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 127.38 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.04 111.128 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.86 168.75 18.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 42.23 111.136 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mt -129.26 113.62 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 65.15 111.139 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.53 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 54.44 111.073 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.92 -178.44 6.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.846 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.62 178.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.52 110.925 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.4 -163.63 33.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 62.4 112.476 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.56 123.3 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 72.32 110.946 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -98.93 -74.84 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 63.22 110.892 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.919 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.805 0.336 . . . . 73.42 110.858 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.78 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.03 111.124 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.9 150.85 48.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 71.25 110.875 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.79 153.19 69.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 74.12 112.34 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.49 162.7 32.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.161 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 0.1 OUTLIER -150.05 132.91 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 53.42 111.156 179.886 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -110.98 161.9 15.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.884 179.98 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.1 m-85 -143.52 133.06 23.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 73.44 110.85 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -98.25 82.29 2.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.35 110.88 179.936 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.7 142.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.54 111.098 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -139.31 159.94 40.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.124 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 156' ' ' ILE . 96.9 t -137.64 99.63 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 44.44 111.124 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.29 33.61 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.54 110.862 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.45 -15.0 64.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.732 . . . . 62.52 112.467 -179.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.52 109.66 51.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.597 0.713 . . . . 64.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 145.04 55.83 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.671 2.247 . . . . 64.32 112.358 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.88 -66.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 61.2 110.857 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.82 -172.03 30.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 63.02 112.491 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 121.76 42.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 75.25 110.849 -179.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.892 HG22 HG21 ' A' ' 138' ' ' ILE . 1.3 t -109.45 105.86 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 54.15 111.112 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 79.1 p -98.84 142.06 30.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 72.45 110.826 -179.829 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.61 162.87 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.874 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 56.9 tt0 -106.61 139.97 40.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 54.35 110.896 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 41.3 mt -111.05 107.37 16.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 55.42 110.935 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -85.22 71.61 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 62.52 110.878 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.3 -24.55 64.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 64.22 111.082 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.57 -34.44 76.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 64.2 110.912 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -103.31 -32.16 9.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.917 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -128.4 67.19 75.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 65.15 111.161 179.888 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -3.37 11.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.667 2.245 . . . . 73.2 112.371 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -42.87 8.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.6 p -85.59 -41.09 15.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.164 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.97 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 60.14 111.082 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.7 tt0 -53.15 -64.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 64.11 110.893 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 34' ' ' GLU . 7.2 t30 -31.66 -46.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.41 110.905 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -78.75 -43.29 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.893 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -55.38 -33.23 63.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.884 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.68 77.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 62.42 111.153 179.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -85.98 39.24 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.927 179.997 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p -112.98 -15.15 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 75.33 110.808 -179.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.2 p -123.17 10.52 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.12 111.135 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.46 61.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 72.42 112.467 179.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -81.07 -26.49 36.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.93 0.395 . . . . 55.35 110.89 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -67.56 -10.14 49.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.55 110.925 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.29 -18.51 36.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 72.12 112.472 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -85.74 -31.03 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 75.25 110.854 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.32 -176.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 45.22 112.496 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.733 ' HB2' HD11 ' A' ' 39' ' ' LEU . 2.4 t80 -175.48 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.946 0.403 . . . . 75.24 110.932 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 48' ' ' TYR . 6.1 ptmt -27.08 111.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 50.25 110.863 179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.94 -60.99 0.57 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 71.33 112.445 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 42.62 -159.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 62.32 110.84 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 35.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.898 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -59.37 132.55 54.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.878 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -129.51 63.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.831 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.0 tpm_? -119.05 -92.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.43 110.873 -179.935 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' ARG . 6.3 mm 55.82 115.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.12 111.148 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 61' ' ' MET . 8.1 tt -143.28 102.0 5.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 74.25 111.153 179.872 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.6 Cg_endo -69.81 98.64 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 74.14 112.305 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.99 -56.11 0.29 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.704 -0.76 . . . . 63.42 112.448 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -105.46 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 54.31 110.899 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -144.3 -159.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 53.01 110.9 179.939 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.11 -56.44 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 72.52 110.92 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 65.6 151.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.861 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.754 . . . . 70.53 112.476 -179.929 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.777 0.322 . . . . 54.33 110.935 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -97.94 161.95 13.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 62.54 110.885 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -8.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 72.41 111.08 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.46 20.6 5.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 63.21 110.905 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.26 -132.11 2.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.41 112.477 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -114.06 -33.2 5.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 73.23 110.893 -179.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.34 177.53 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 55.04 110.887 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.31 165.6 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 61.14 110.832 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -85.64 -176.14 5.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.879 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -91.61 122.97 34.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 73.01 110.853 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -40.81 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.843 -179.882 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.6 p30 177.94 161.38 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.844 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -113.33 34.3 4.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.876 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 mt -62.53 -22.42 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 71.34 111.141 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.662 HD12 ' CG1' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -94.12 110.72 22.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.917 179.883 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.502 ' O ' HD11 ' A' ' 97' ' ' ILE . 2.2 mtpp -109.31 -174.65 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.945 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -98.4 -77.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 73.5 110.898 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.1 16.89 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.124 -179.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.28 -168.72 36.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.34 112.499 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.667 2.244 . . . . 60.34 112.346 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 66.08 117.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 60.33 112.486 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.662 HD12 HG11 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -168.19 122.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 74.22 111.082 -179.96 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 tt -97.91 116.0 29.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.897 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.38 176.7 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 65.05 110.85 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 5.3 mmt -115.36 104.93 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 64.51 110.844 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -69.3 152.29 45.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.105 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.677 ' HB2' HG23 ' A' ' 107' ' ' THR . 42.2 p-10 -179.8 -168.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 73.51 110.915 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -84.38 -20.76 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 44.14 111.1 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 123.49 -62.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.496 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.68 96.42 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 75.21 112.37 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 25.37 78.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.22 110.875 -179.979 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -155.27 30.13 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 71.02 111.183 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 3.3 p30 -97.19 178.97 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.925 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.53 42.22 2.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 70.44 112.517 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -138.97 -90.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 51.52 110.863 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.785 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -93.71 171.39 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.11 110.91 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -138.93 147.39 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.44 110.891 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -117.65 141.07 48.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.884 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.3 136.64 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.112 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.35 123.99 34.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.4 110.861 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 p -99.24 -25.81 14.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 111.133 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.22 23.12 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 62.33 111.09 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.36 136.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 72.05 110.896 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.623 ' HB ' HD22 ' A' ' 122' ' ' LEU . 1.7 p -131.01 51.65 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 65.31 111.172 179.963 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.04 -19.0 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 63.45 110.925 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -57.79 -19.71 30.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 70.23 110.925 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.623 HD22 ' HB ' ' A' ' 119' ' ' THR . 0.0 OUTLIER -76.27 -63.0 1.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.924 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.78 -59.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.837 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.99 49.89 0.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 72.34 112.515 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -105.44 -24.36 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.14 110.932 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -139.32 139.57 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.4 110.87 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.3 t -77.71 104.37 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 64.2 111.159 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.662 ' CG1' HD12 ' A' ' 90' ' ' LEU . 78.4 t -90.36 135.28 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.147 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.465 ' CB ' HG21 ' A' ' 29' ' ' VAL . 33.6 p90 -150.65 16.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.874 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . -150.3 -169.76 16.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.729 . . . . 51.23 112.485 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -179.81 -165.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 65.12 110.85 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 136' ' ' MET . 75.0 t -100.99 98.92 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.135 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -55.59 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.71 160.73 38.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.14 110.879 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.33 33.93 42.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 72.44 112.479 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . 0.498 ' HA ' HG11 ' A' ' 132' ' ' VAL . 10.1 mmm -50.08 -28.79 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.34 . . . . 63.42 110.88 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.33 110.916 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.892 HG21 HG22 ' A' ' 20' ' ' VAL . 45.6 mm -42.24 -37.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 74.24 111.163 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.45 -51.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 53.34 111.131 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -48.64 -49.87 35.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.828 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.6 -52.63 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 73.53 111.088 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.663 ' SD ' HD13 ' A' ' 156' ' ' ILE . 6.8 ttm -50.71 -46.3 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 71.14 110.848 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 58' ' ' PRO . 3.0 pt-20 -52.03 -23.06 4.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 73.34 110.85 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -63.39 -22.98 67.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.912 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -85.6 14.71 5.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.887 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.76 -155.4 31.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.718 . . . . 63.44 112.435 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.78 -168.5 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.904 0.383 . . . . 70.52 110.855 -179.76 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -80.13 -43.97 20.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 71.1 110.862 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -101.21 -7.84 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 71.52 110.874 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.11 -152.02 17.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.477 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 60.43 101.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 75.21 110.905 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 p -80.63 159.47 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.12 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.61 -19.91 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 74.24 110.866 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -138.29 -179.44 5.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 73.43 110.864 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.83 106.07 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 71.32 110.947 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' A' ' 142' ' ' MET . 61.8 mt -92.35 102.78 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 70.54 111.13 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.7 p -117.07 167.65 10.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 73.3 111.099 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.3 mt -90.95 134.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 75.01 111.107 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.34 -62.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 65.31 111.094 179.789 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -140.17 165.07 28.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.433 . . . . 61.31 110.827 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 33.4 m -142.67 166.27 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.884 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.82 179.8 46.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 51.23 112.452 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.2 mt-30 -93.61 -57.65 2.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 75.31 110.924 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.99 150.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.945 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.888 179.916 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 72.23 110.874 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.39 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.109 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.83 153.46 47.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 73.34 110.882 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 24' ' ' LEU . 53.5 Cg_endo -69.75 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.64 2.227 . . . . 62.24 112.317 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.4 m -126.96 142.07 51.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.165 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 163' ' ' GLN . 5.0 m -124.37 157.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 62.15 111.082 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -114.0 154.84 26.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.906 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.25 138.62 35.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 63.02 110.898 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.62 113.12 26.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 52.43 110.887 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.43 121.73 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.149 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -108.71 163.01 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.088 179.823 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -153.07 105.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.115 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.79 31.71 9.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.842 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.65 -17.42 52.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.493 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.5 136.5 23.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.679 0.752 . . . . 61.24 110.844 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 155.03 66.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 50.55 112.296 -179.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.04 -60.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.967 179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.61 -170.94 35.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.732 -0.746 . . . . 20.23 112.494 179.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -124.64 127.51 47.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 74.22 110.874 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.618 ' CG1' HG13 ' A' ' 132' ' ' VAL . 8.0 t -129.87 129.85 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.159 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 p -109.19 154.49 22.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.878 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 135.06 52.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.41 110.848 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.36 131.95 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.51 110.868 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 4' ' ' PRO . 36.5 mt -96.18 118.51 32.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 52.04 110.937 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 90' ' ' LEU . 47.6 m-85 -80.12 55.33 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.88 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.35 -28.24 11.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 63.13 111.094 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.63 -47.47 70.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 70.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 89' ' ' ILE . 1.1 mttt -95.78 -32.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.867 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -124.22 74.64 59.59 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.667 0.746 . . . . 74.14 111.168 179.877 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -51.14 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.698 2.265 . . . . 71.41 112.32 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -43.22 84.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.894 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.496 HG21 ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -69.01 -60.89 2.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.119 -179.987 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -33.76 -67.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.22 111.141 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' ARG . 79.3 tt0 -58.67 -58.79 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.874 -179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.0 t30 -32.85 -53.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.912 -179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -79.2 -29.07 42.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 63.34 110.913 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 4.7 ttp180 -52.31 -32.99 40.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.859 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.25 -25.14 61.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.082 179.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 27.31 3.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.916 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -152.5 -25.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.87 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.5 p -81.82 -43.99 17.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 65.43 111.081 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 155.05 -27.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.11 112.455 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 42' ' ' GLY . 1.1 mt-10 -30.71 -74.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 63.24 110.897 -179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.64 144.38 31.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 60.41 110.9 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.79 22.1 7.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.722 -0.752 . . . . 75.13 112.513 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.52 -8.0 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 74.42 110.896 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.97 -101.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.489 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 63.43 110.876 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? 57.6 169.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 74.44 110.912 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.54 118.53 8.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 73.53 112.506 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.6 p -159.33 -82.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 74.41 110.812 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 155' ' ' LYS . 5.9 p -177.57 173.82 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 61.12 110.883 -179.921 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.36 -171.24 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.834 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.74 -55.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 65.34 110.855 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.92 144.01 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.844 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -152.36 120.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.34 111.158 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.46 109.07 19.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.72 . . . . 72.43 111.183 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 97.92 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.655 2.236 . . . . 73.31 112.39 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.45 -5.06 23.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.526 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -66.52 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 74.43 110.835 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.06 -168.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 73.24 110.837 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.7 m -142.74 128.93 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.862 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -123.67 157.15 34.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 64.44 110.924 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.11 112.459 -179.968 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.792 0.329 . . . . 73.44 110.896 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.61 177.68 8.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 65.21 110.871 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.17 -34.06 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 73.31 111.102 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.29 -7.3 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.882 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.19 -169.72 42.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 45.31 112.455 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.42 -90.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 40.11 110.877 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.9 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -154.66 160.33 41.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.857 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.9 175.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 71.34 110.914 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.19 149.13 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.902 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -94.83 -46.68 6.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.887 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 157.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 62.42 110.875 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.22 37.25 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.876 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.71 HG21 ' HG2' ' A' ' 28' ' ' LYS . 23.4 mm -55.39 -22.67 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.43 111.139 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.503 HD11 ' CD2' ' A' ' 25' ' ' PHE . 4.4 mm? -85.57 116.62 23.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.903 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -107.0 104.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.926 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.712 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.33 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 179.882 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.8 p -113.78 26.88 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 72.32 111.177 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 163.64 35.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 51.1 112.492 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 140.7 43.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.712 2.275 . . . . 61.01 112.349 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.95 45.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 72.13 112.465 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 92' ' ' HIS . 13.0 mm -70.45 146.21 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 65.25 111.096 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.0 mt -121.27 166.0 14.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.903 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.51 -170.99 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.891 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.496 ' HE1' HG21 ' A' ' 32' ' ' THR . 1.9 tpp -92.55 114.15 26.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.863 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -101.49 140.0 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 70.41 111.085 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 1.2 m-20 168.09 -75.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.915 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.46 29.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.109 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.51 -172.52 14.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 54.32 112.523 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -49.69 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.675 2.25 . . . . 54.53 112.327 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -48.7 -20.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.03 110.879 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.671 ' O ' ' C ' ' A' ' 108' ' ' ASN . 29.8 p -124.05 44.36 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.097 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.671 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.9 OUTLIER 1.96 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 72.45 110.901 179.98 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 79.49 91.56 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 52.44 112.491 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.91 121.47 34.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 72.33 110.893 -179.754 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -64.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 64.52 110.929 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.82 167.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.86 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -176.11 66.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.34 110.881 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.496 HG22 HG22 ' A' ' 116' ' ' THR . 6.6 mt -78.3 108.5 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 65.43 111.089 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.7 m -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 73.43 110.86 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.496 HG22 HG22 ' A' ' 114' ' ' ILE . 1.8 p 60.62 10.57 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 74.53 111.176 -179.812 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.66 -170.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.116 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -79.78 125.32 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.911 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.553 HG23 ' CD2' ' A' ' 92' ' ' HIS . 9.7 t -142.45 45.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 65.42 111.134 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.75 -10.75 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 62.03 110.906 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -57.93 -26.74 62.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.54 110.904 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.68 49.82 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 70.45 110.906 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -71.57 -40.76 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.897 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.1 81.73 0.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 50.31 112.549 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -160.17 -57.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 62.43 110.873 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -112.08 142.06 44.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.834 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.424 ' HB ' ' HE3' ' A' ' 100' ' ' MET . 81.5 t -65.71 100.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 64.12 111.179 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.26 136.51 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 52.1 111.115 179.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -177.46 128.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.888 179.951 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 120.69 4.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 62.04 112.524 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 152.23 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 72.53 110.88 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.618 HG13 ' CG1' ' A' ' 20' ' ' VAL . 34.3 t -44.35 141.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 53.42 111.133 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -132.79 -41.79 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.891 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -66.23 -78.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.879 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.79 115.77 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 60.04 112.49 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.68 -9.23 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.14 110.885 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -50.3 -25.06 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 63.42 110.861 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.99 -45.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 71.31 111.084 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.4 t -54.86 -20.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.24 111.09 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.65 -28.08 24.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.02 110.86 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -33.63 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 61.5 111.117 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptm -73.79 -21.19 60.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 50.04 110.92 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.38 26.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 54.44 110.881 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 -20.7 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.898 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.83 15.37 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.12 110.877 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.08 -142.81 9.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 72.54 112.462 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 p -162.61 147.91 12.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 55.43 110.832 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -75.7 68.51 2.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 52.52 110.899 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.1 p30 179.62 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.862 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.62 -60.47 0.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 53.13 112.483 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 107.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 74.41 110.931 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -79.97 139.44 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.176 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -27.82 67.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 52.11 110.875 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.13 -165.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.906 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 52' ' ' CYS . 2.8 tppm? -131.57 112.09 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.871 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.6 mp -92.43 128.8 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.146 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 7.9 p -133.3 175.08 9.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 53.34 111.165 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -118.63 106.36 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.24 111.144 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.15 -61.5 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.121 179.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -134.9 179.32 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.81 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.1 p -172.81 -179.31 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 54.33 110.866 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 146.8 -169.46 27.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 74.54 112.546 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.418 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.8 mt-30 -95.11 138.79 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 61.51 110.895 -179.838 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -50.27 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.943 179.969 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.865 179.947 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.341 . . . . 74.14 110.868 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.33 142.6 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.134 179.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.68 161.06 0.92 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.601 0.715 . . . . 54.31 110.861 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 146.53 60.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.234 . . . . 74.45 112.322 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -130.4 72.28 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 72.22 111.144 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.43 151.9 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.11 111.108 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.477 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -130.76 162.06 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.862 179.97 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -136.6 132.9 35.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.861 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 14.1 t70 -107.44 87.82 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.31 110.886 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.559 HG21 ' HE1' ' A' ' 142' ' ' MET . 17.7 mm -71.02 150.42 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.11 111.111 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.41 163.68 29.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 52.14 111.115 179.762 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.9 96.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 54.02 111.168 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t0 68.8 53.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.52 110.851 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.48 14.77 62.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 24.11 112.495 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -128.59 105.27 19.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 64.3 110.894 -179.821 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.74 138.82 38.79 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.734 2.289 . . . . 72.3 112.304 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.87 28.57 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.89 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.41 -158.71 14.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 72.23 112.489 179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.1 179.99 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 73.54 110.919 -179.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 11.4 m -139.44 170.08 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 75.21 111.142 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -118.43 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.891 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.7 m-85 -79.8 63.98 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 65.14 110.865 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -49.27 133.92 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.895 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 129' ' ' PHE . 12.9 mt -104.16 132.31 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.957 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -75.77 82.51 2.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.24 110.864 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -8.84 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 54.52 111.127 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.21 -57.37 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 71.12 110.797 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -57.22 -65.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.914 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 129' ' ' PHE . 2.9 m -110.99 95.14 22.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 23.53 111.106 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 53.8 Cg_endo -69.84 -19.24 35.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.694 2.263 . . . . 75.12 112.304 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -61.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 41.41 110.928 179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -57.3 -26.12 60.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 62.22 111.128 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.34 2.38 44.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 63.54 111.06 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.2 tt0 -91.01 -22.62 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.876 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.5 ' ND2' HG23 ' A' ' 78' ' ' ILE . 12.3 t-20 -79.89 -68.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 60.45 110.898 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -46.74 -45.68 19.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 65.05 110.869 179.988 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 3.3 ppt_? -54.47 -32.32 57.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.888 -179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.36 -35.15 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.134 179.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 78' ' ' ILE . 86.7 mt -66.57 -28.78 68.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 64.45 110.869 -179.914 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -38.1 82.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 53.54 110.855 -179.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.7 p -86.38 11.42 12.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.42 111.164 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 41.2 51.29 4.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 52.15 112.506 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.59 32.79 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 71.32 110.941 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 10.34 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.893 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.31 30.63 8.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 60.12 112.495 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.44 158.63 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 62.25 110.855 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.35 159.08 12.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.32 112.467 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.95 103.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.397 . . . . 73.34 110.971 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 -44.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 71.54 110.858 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.92 31.97 2.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 63.22 112.496 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 t -100.28 -169.69 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 71.41 110.904 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -80.85 -166.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 72.43 110.89 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -94.95 -167.09 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.851 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -74.92 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 72.41 110.886 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -173.39 91.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 62.01 110.853 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.738 HD12 ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -77.08 144.35 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.139 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 61' ' ' MET . 6.3 tt -149.91 100.29 3.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 71.22 111.062 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.71 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.714 2.276 . . . . 41.41 112.311 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.52 -46.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 71.05 112.444 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -69.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 74.31 110.919 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.526 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -155.07 -148.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 42.42 110.903 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.5 m -132.53 -49.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 55.05 110.895 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.9 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 50.31 112.483 -179.974 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.85 0.357 . . . . 72.23 110.863 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.46 125.92 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.11 110.89 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.5 HG23 ' ND2' ' A' ' 35' ' ' ASN . 2.0 pp -45.3 -40.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 74.13 111.115 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -117.44 29.73 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -147.64 7.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 71.24 112.49 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.56 -33.61 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.961 0.41 . . . . 74.25 110.884 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.31 137.92 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.896 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -118.65 161.56 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.88 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.2 160.54 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.861 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.79 168.23 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.903 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -132.64 -68.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.45 110.863 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.18 163.26 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.929 -179.954 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.84 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 89' ' ' ILE . 15.9 mt -77.53 -7.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.14 111.162 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.423 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 2.2 mt -114.42 139.09 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.43 110.898 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -171.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 179.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -115.01 91.18 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.02 110.904 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -107.19 21.75 17.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.44 111.143 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.72 -163.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 63.02 112.509 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 62.14 112.356 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -49.65 151.42 4.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 52.14 112.46 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER 172.6 124.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 53.1 111.149 -179.955 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -96.87 105.25 17.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.887 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 100' ' ' MET . 1.3 t -121.19 22.89 10.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.875 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.56 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.9 mmt 53.06 123.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 71.32 110.906 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -107.4 68.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 73.53 111.085 179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -115.9 -82.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.906 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -133.72 -70.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 72.24 111.102 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.67 -125.26 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 23.13 112.522 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.53 6.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.739 2.292 . . . . 73.55 112.349 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.94 23.42 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 62.22 110.86 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.564 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.9 p -154.75 46.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.151 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.554 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -88.28 11.65 16.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.873 179.995 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 24.67 -122.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 72.12 112.498 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.75 31.19 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 62.04 110.887 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -167.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.45 110.897 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -165.87 127.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.881 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.753 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -111.46 34.53 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.32 110.857 -179.917 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.576 ' C ' ' O ' ' A' ' 113' ' ' PHE . 24.7 mt -21.6 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 52.14 111.124 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' MET . 14.1 m -82.57 162.46 21.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 55.42 110.837 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 -17.48 11.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.14 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 119' ' ' THR . . . -126.63 146.81 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 75.34 111.081 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.43 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 52.44 110.891 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 117' ' ' ALA . 61.4 p -114.27 69.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.094 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.42 17.02 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 75.33 110.889 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.712 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.7 p90 -98.83 1.02 45.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.05 110.9 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.06 28.21 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.906 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -105.4 95.71 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 70.31 110.888 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.35 -42.59 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 75.53 112.459 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -31.74 25.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 73.15 110.929 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -98.16 139.73 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 65.21 110.795 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -60.14 176.74 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 75.11 111.123 179.963 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.561 ' H ' HG22 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -168.82 146.19 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 75.14 111.133 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 4.4 p90 -179.19 38.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.879 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.89 175.28 35.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.729 -0.748 . . . . 74.33 112.506 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -179.17 -166.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 64.53 110.879 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -121.73 125.03 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.11 111.107 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -111.02 -37.51 5.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.867 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -132.1 142.18 49.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.33 110.875 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.32 37.06 5.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 74.31 112.447 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -29.21 27.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 65.33 110.856 -179.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.52 -39.53 18.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 65.32 110.869 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.2 mm -39.63 -41.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.41 111.115 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.3 t -88.18 -51.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 71.04 111.074 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -50.59 -59.92 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.883 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.76 -58.94 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 60.14 111.157 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.649 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 5.8 ttm -50.55 -39.0 48.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.941 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -53.65 -24.89 15.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 72.35 110.919 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -65.48 -12.26 50.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.83 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -84.22 4.44 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 62.02 110.854 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.02 -158.14 28.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 65.11 112.483 -179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -148.77 -89.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 74.45 110.84 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -154.98 -52.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.03 110.864 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.52 13.89 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 60.55 110.877 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.85 -162.77 12.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 40.24 112.465 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 66.73 140.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 75.51 110.897 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.3 p -123.48 154.35 39.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 75.53 111.127 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.48 -3.86 57.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.874 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.68 165.24 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 53.34 110.888 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.77 114.82 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.33 110.874 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.591 HD13 ' SD ' ' A' ' 142' ' ' MET . 43.5 mt -103.36 106.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 61.34 111.099 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 156.24 24.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 55.2 111.129 179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 mm -84.12 148.26 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 74.42 111.131 179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -97.86 -59.28 1.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 60.25 111.072 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -167.55 163.25 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 52.35 110.838 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.0 m -147.68 176.6 9.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.887 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.55 -168.24 41.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 63.55 112.49 -179.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.2 mt-30 -87.27 -38.95 15.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 61.44 110.91 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.8 mm? 75.31 -54.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 71.13 110.886 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.871 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mmm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.342 . . . . 72.11 110.92 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 165' ' ' GLU . 0.4 OUTLIER 61.34 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.143 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m-20 -96.85 156.57 36.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 61.34 110.856 -179.932 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 147.42 62.91 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.707 2.272 . . . . 54.33 112.314 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 22' ' ' PHE . 8.0 m -147.18 141.27 26.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 63.52 111.142 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.55 147.74 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 71.13 111.142 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -111.78 145.64 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.892 -179.95 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 m-85 -138.27 139.63 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.14 110.866 -179.928 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -108.44 119.62 40.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.21 110.851 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.8 mm -89.03 116.6 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 70.21 111.135 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.68 154.58 17.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.31 111.117 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.89 104.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 72.32 111.112 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.21 37.06 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 71.21 110.861 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.23 80.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 43.31 112.48 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 149.63 71.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 71.33 110.884 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 150.93 68.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.653 2.235 . . . . 72.43 112.34 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.11 -57.59 1.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 62.02 110.879 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 -147.19 5.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 44.44 112.44 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -149.77 124.82 10.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 75.1 110.841 -179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 8' ' ' PHE . 35.6 m -113.37 141.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 70.43 111.094 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -121.69 146.25 47.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 73.24 110.893 -179.859 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' THR . 7.8 m-85 -130.66 136.16 48.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.32 110.894 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.17 111.14 23.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.87 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 129' ' ' PHE . 86.1 mt -82.7 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 43.12 110.899 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 26.1 m-85 -83.17 79.68 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.893 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.59 -1.36 24.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 34.45 111.115 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.52 -47.68 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.899 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.9 mttt -83.88 -27.89 28.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.898 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.53 73.84 35.02 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.578 0.704 . . . . 64.03 111.127 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -9.58 26.45 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.63 2.22 . . . . 62.5 112.362 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -53.66 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.867 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -58.18 -51.48 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.168 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.7 -26.32 67.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.3 111.096 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.9 -34.57 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.897 -179.922 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.01 -57.74 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.885 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -50.89 -38.84 52.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.872 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.12 70.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 73.12 110.925 -179.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.36 -33.68 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 71.21 111.118 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.44 HD11 ' HA2' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -87.43 23.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.42 110.923 -179.943 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -118.29 -8.45 10.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 55.14 110.871 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 162' ' ' GLY . 17.8 p -117.96 7.48 12.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 63.11 111.16 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.67 29.59 54.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 54.01 112.477 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -34.98 26.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.381 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.32 47.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 74.21 110.899 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.53 56.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 74.12 112.467 179.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -179.8 153.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.383 . . . . 64.23 110.849 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 166.2 -140.34 6.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 24.33 112.447 -179.963 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -101.88 -27.99 12.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.973 0.416 . . . . 70.42 110.93 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.38 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.909 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.27 40.38 45.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 52.42 112.481 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 t -122.56 -171.2 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 41.24 110.874 -179.746 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -167.38 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.859 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 156' ' ' ILE . 0.8 OUTLIER -109.41 170.49 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.892 -179.842 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -118.09 -69.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 61.22 110.853 179.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 172.35 13.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 65.43 110.876 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -154.58 147.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 52.02 111.114 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.716 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -132.75 120.83 16.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.662 0.744 . . . . 75.24 111.133 179.872 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 109.06 2.21 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.34 112.355 179.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 25.32 18.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 64.11 112.527 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.34 -63.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 74.5 110.871 -179.868 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.485 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -177.74 -166.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.897 179.925 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.86 -70.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.887 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 64.86 126.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.878 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 73.11 112.495 -179.955 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.823 0.344 . . . . 72.14 110.906 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.94 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 70.31 110.873 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -42.17 -46.84 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.145 179.964 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.468 ' N ' HG23 ' A' ' 78' ' ' ILE . 19.1 m-85 -122.38 49.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.915 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.62 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 65.41 112.453 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.05 -75.82 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 73.52 110.915 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.716 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -130.21 168.46 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 71.44 110.901 179.902 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -145.48 151.66 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.13 110.873 179.969 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -54.8 157.91 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.872 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.55 112.78 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.84 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.51 -46.89 85.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.884 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -177.06 168.66 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 61.41 110.877 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.31 42.6 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.41 110.889 179.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -53.39 -23.49 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.41 111.113 179.955 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 128' ' ' VAL . 10.4 mt -94.67 145.95 24.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.958 179.873 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -122.06 -174.93 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 54.5 110.892 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -116.17 79.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.816 179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -119.99 24.9 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 72.05 111.17 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.51 150.34 20.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 63.53 112.465 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -3.5 12.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.735 2.29 . . . . 72.01 112.34 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.45 49.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 73.13 112.477 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.68 135.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 71.41 111.173 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 129' ' ' PHE . 5.4 tt -90.05 122.78 33.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 65.53 110.933 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.478 ' HG ' ' HE2' ' A' ' 113' ' ' PHE . 13.2 t -123.67 164.83 18.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.848 -179.862 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.4 mtp -104.78 124.31 49.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.898 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -91.1 122.55 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 42.42 111.078 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 107' ' ' THR . 8.2 t30 175.85 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 73.53 110.894 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -59.72 -164.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.091 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -108.34 -66.91 0.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.51 112.522 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.581 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.74 130.91 20.2 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.662 2.241 . . . . 65.41 112.356 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.5 p30 22.84 67.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 65.34 110.91 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.847 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 6.9 p -150.62 52.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 74.42 111.151 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -50.48 -56.04 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.89 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.4 -172.62 52.06 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 61.54 112.518 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.1 p -112.77 -21.86 10.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 74.15 110.864 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.4 mm-40 -60.3 145.22 48.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 72.4 110.873 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.36 162.72 34.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.831 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' A' ' 99' ' ' SER . 15.1 p90 -148.84 132.02 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.45 110.913 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.73 121.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.41 111.161 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.69 128.76 33.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 55.21 110.878 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 61' ' ' MET . 6.9 p -90.43 -14.37 33.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.219 -179.91 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.06 160.16 43.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.164 179.833 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -53.29 132.97 39.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 64.14 110.885 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.2 p -138.35 52.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.03 111.13 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -50.63 -22.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 54.22 110.891 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -58.73 -35.79 73.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 61.42 110.894 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.24 101.62 14.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.887 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -151.09 -79.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.837 179.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.74 -27.95 29.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 52.4 112.477 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -73.42 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 73.12 110.926 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -99.5 149.77 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 64.24 110.836 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.2 t -64.37 -151.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.13 111.126 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.4 p 175.94 141.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.51 111.138 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.665 ' O ' HD22 ' A' ' 98' ' ' LEU . 3.1 p90 -175.51 124.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.887 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 98' ' ' LEU . . . 108.12 153.47 17.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.504 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -171.77 151.92 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 71.21 110.911 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.5 112.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 55.32 111.176 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.62 -49.97 8.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.932 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -159.45 145.32 16.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.898 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.95 16.56 27.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 42.33 112.481 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -29.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.34 110.852 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -49.57 -29.96 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 52.14 110.953 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.51 -50.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.41 111.099 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.61 -45.92 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 53.53 111.123 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -51.37 -40.45 59.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.891 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.33 -34.19 77.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 40.14 111.101 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.52 -29.13 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.9 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.59 26.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.03 110.872 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.43 -23.79 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.855 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -100.77 6.35 43.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 60.55 110.856 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -154.94 29.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 71.34 112.494 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 t -167.51 150.85 6.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 63.53 110.806 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -77.9 65.78 3.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.42 110.853 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 167.82 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 65.14 110.896 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.3 172.75 13.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 65.51 112.473 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.51 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.42 110.879 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -91.06 41.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 52.3 111.134 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 74.01 -50.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.84 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.26 -168.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 65.1 110.921 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HE2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -110.55 134.77 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 70.12 110.924 179.861 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 53' ' ' PHE . 17.8 mt -100.38 104.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 53.24 111.114 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.601 HG23 ' HE2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -97.49 178.56 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 73.45 111.133 179.971 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.6 mm -128.38 143.94 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 51.13 111.083 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.17 -65.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.116 179.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.47 164.17 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 71.4 110.88 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 59.1 m -144.9 -173.61 4.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 34.21 110.882 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 140.52 -158.31 26.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.04 112.482 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 136.33 47.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.861 0.362 . . . . 63.42 110.914 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 164' ' ' LEU . 3.7 tt -93.06 -44.34 8.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 61.32 110.889 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 2' ' ' VAL . 6.9 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 61.32 110.888 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.807 0.337 . . . . 43.3 110.865 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -98.34 133.92 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 63.35 111.125 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -53.99 158.59 3.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.677 0.751 . . . . 64.35 110.852 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 120.71 7.45 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.68 2.253 . . . . 33.31 112.313 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -107.86 68.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 71.14 111.171 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -47.86 155.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 61.41 111.159 179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.66 160.21 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.889 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -144.94 135.05 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.849 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -97.42 78.44 2.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 72.02 110.877 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 17' ' ' LEU . 2.7 mm -56.72 146.21 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.55 111.162 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -134.65 170.48 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.076 179.861 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 156' ' ' ILE . 79.5 t -146.66 96.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 64.45 111.116 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t0 65.84 41.98 3.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.05 -16.19 52.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 73.11 112.523 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -97.42 110.02 52.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.65 0.738 . . . . 73.2 110.91 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.75 144.85 55.43 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 63.41 112.328 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.671 HD13 HG23 ' A' ' 138' ' ' ILE . 4.1 mt -81.29 -44.54 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 53.22 110.952 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.8 35.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 61.02 112.489 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 62.39 147.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 74.43 110.826 -179.893 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 138' ' ' ILE . 36.5 t -105.41 -103.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 63.51 111.079 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 164.64 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.858 -179.859 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.85 111.68 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 64.41 110.932 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -88.22 144.46 26.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 113.18 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.868 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -76.53 66.28 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.892 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.23 77.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.1 111.075 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.57 -65.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.894 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.612 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -51.91 -78.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 65.02 110.891 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 129' ' ' PHE . 17.4 m -72.13 117.72 60.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 53.42 111.1 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -87.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 74.51 112.33 179.942 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -36.79 84.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.849 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -4.46 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 64.12 111.112 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -76.9 -48.54 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' C ' ' A' ' 35' ' ' ASN . 22.2 pt-20 -78.2 -38.12 44.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.849 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -28.97 -67.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.898 -179.935 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HA ' HD12 ' A' ' 39' ' ' LEU . 71.9 t80 -74.91 -34.71 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.909 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 2.6 ttp180 -49.36 -38.68 29.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.843 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -71.55 -35.1 70.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 55.33 111.119 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 36' ' ' PHE . 14.0 mt -68.5 -45.35 72.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.03 110.911 179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.38 94.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.868 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -72.41 -15.52 61.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.168 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 54.17 82.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.463 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.54 31.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 74.44 110.947 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -138.87 22.62 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.11 110.93 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 -40.42 3.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 74.21 112.486 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -127.98 -164.01 1.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.23 110.889 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.92 145.71 11.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 64.02 112.515 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -50.72 102.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 65.32 110.947 -179.781 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.77 -61.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 50.23 110.876 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.47 30.13 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.477 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -76.08 -171.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 74.21 110.87 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.0 m -87.03 -174.44 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 62.31 110.885 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.59 -167.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.887 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -115.73 -92.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 71.24 110.842 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.638 ' HD3' HD11 ' A' ' 57' ' ' ILE . 13.1 ttm180 -135.01 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 72.3 110.872 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 156' ' ' ILE . 70.6 mt 61.19 104.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.54 111.189 -179.929 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' HD3' ' A' ' 55' ' ' ARG . 44.2 mt -139.72 98.78 7.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.582 0.706 . . . . 64.43 111.1 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.3 Cg_endo -69.84 96.13 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.652 2.235 . . . . 72.22 112.321 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.77 -46.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 55.03 112.489 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -67.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 62.31 110.87 -179.84 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.61 -153.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 54.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 p -150.74 153.39 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 74.24 110.924 -179.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 1.3 tp60 -88.25 -168.84 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.51 112.493 -179.979 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.761 0.315 . . . . 65.35 110.892 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.74 179.31 7.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.814 -179.861 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' ALA . 23.2 pt -96.63 -36.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.03 111.1 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -87.6 -20.21 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.889 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.22 -173.53 26.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 63.22 112.505 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -19.45 37.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 53.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -175.91 149.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.964 179.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -117.03 166.48 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.893 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 4.1 pt-20 -90.41 159.66 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.853 -179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -71.42 141.56 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.15 110.871 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -57.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.902 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -173.0 145.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.43 110.86 -179.951 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.39 52.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.34 110.843 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mt -82.69 3.86 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 73.14 111.093 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.612 HD21 ' HG2' ' A' ' 28' ' ' LYS . 2.7 mm? -113.51 97.73 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.92 179.909 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 131.02 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.883 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -53.81 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 70.44 110.882 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -84.27 -12.63 54.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.118 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.64 -170.09 43.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 72.45 112.5 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 53.8 Cg_endo -69.75 142.43 47.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.627 2.218 . . . . 55.03 112.375 -179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.74 -21.24 25.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.787 -0.72 . . . . 64.31 112.478 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.37 149.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 63.22 111.142 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.692 HD12 ' CA ' ' A' ' 130' ' ' GLY . 2.8 mt -119.84 145.96 46.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.945 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -155.8 35.23 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 60.24 110.877 -179.884 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.9 mmt 39.2 -149.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 62.42 110.899 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 100' ' ' MET . . . 166.63 86.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.32 111.062 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -110.1 -71.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.855 -179.942 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -146.02 -39.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.35 111.108 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 128.31 -61.14 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.751 . . . . 74.15 112.516 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.78 100.06 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 75.01 112.325 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.548 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER 25.28 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.873 179.972 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' ALA . 6.6 t -140.63 29.32 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 70.01 111.139 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 t30 51.59 -99.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 54.14 110.895 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 102' ' ' ASN . . . 146.47 -85.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.457 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.56 20.98 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 64.24 110.873 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -87.52 -38.25 16.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 62.02 110.881 -179.965 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 114' ' ' ILE . 66.3 t80 68.65 84.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.929 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.0 129.1 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.872 -179.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -117.39 118.65 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.25 111.127 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 18.9 p -86.0 147.01 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 35.53 110.881 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -107.78 33.81 3.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.33 111.151 -179.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -170.2 -177.92 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 54.11 111.084 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -82.68 90.98 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.882 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.603 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.0 p -116.39 64.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 72.21 111.185 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 18.61 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 72.32 110.912 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -97.9 13.8 29.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.921 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 3.5 mt -125.01 -4.25 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 72.03 110.908 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -79.97 53.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.862 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.32 26.17 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 74.31 112.485 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -168.79 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 75.41 110.93 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.94 154.51 17.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 55.41 110.903 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 129' ' ' PHE . 53.9 t -86.95 107.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 65.21 111.117 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.719 HG22 ' HB3' ' A' ' 99' ' ' SER . 39.7 t -93.5 135.02 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 64.13 111.106 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 29' ' ' VAL . 11.6 p90 -170.93 58.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 63.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.692 ' CA ' HD12 ' A' ' 98' ' ' LEU . . . -128.93 179.32 16.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 64.32 112.483 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 176.31 147.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 73.04 110.871 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -112.28 94.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.087 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -75.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.909 179.894 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.17 -166.2 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.872 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.84 69.03 1.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.43 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -7.1 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.758 0.314 . . . . 73.22 110.866 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -31.31 61.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 52.45 110.846 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.684 HG21 HG22 ' A' ' 20' ' ' VAL . 21.2 mm -73.74 -39.19 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 54.44 111.133 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 139' ' ' VAL . 15.5 t -82.36 -1.48 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 70.11 111.169 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -118.24 -59.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 65.03 110.909 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.81 -56.13 22.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.51 111.128 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 2.0 ttm -51.43 -49.47 61.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.9 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -24.61 28.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.42 110.91 -179.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -66.67 -13.64 61.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 75.15 110.871 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -90.36 19.5 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.43 110.861 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.78 -158.75 31.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.743 . . . . 74.34 112.482 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -146.82 -77.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 62.43 110.852 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.35 110.912 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.1 -14.68 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.88 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.27 -34.41 2.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.25 112.479 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 127.84 15.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 72.04 110.872 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -110.01 149.56 29.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.52 111.121 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -68.9 -25.27 64.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 43.45 110.849 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.02 -166.92 1.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 40.21 110.909 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.9 OUTLIER -121.83 116.9 25.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 74.01 110.908 179.917 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.615 HD13 ' CD1' ' A' ' 56' ' ' ILE . 4.1 mp -95.37 128.34 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 63.05 111.114 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 155' ' ' LYS . 82.4 p -138.59 149.53 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.081 179.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.669 HD13 ' CE1' ' A' ' 48' ' ' TYR . 3.0 mp -88.99 105.94 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 61.34 111.144 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.08 76.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 62.02 111.102 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -156.61 177.99 10.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.53 110.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.3 p -174.54 159.81 3.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.24 110.873 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.51 -179.95 37.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.54 112.49 -179.942 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.57 -43.81 22.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 73.02 110.904 -179.85 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.86 -172.46 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 62.3 110.913 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 64.43 110.877 179.889 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.813 0.339 . . . . 75.32 110.872 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.4 t -142.24 145.83 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 62.04 111.069 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.71 140.87 97.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.623 0.725 . . . . 73.24 110.911 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.73 69.36 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 60.0 112.321 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 58.0 m -138.59 90.29 2.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 33.2 111.147 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -74.22 162.56 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 63.31 111.103 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -133.45 157.24 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 71.4 110.909 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -140.87 139.99 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.43 110.91 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.635 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 6.7 m-20 -95.46 99.53 11.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.45 110.927 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 mm -71.7 113.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.125 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.46 161.33 15.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.1 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.91 110.93 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 61.52 111.13 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.7 43.87 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.855 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.82 9.11 65.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 51.53 112.497 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -114.91 132.29 23.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.594 0.712 . . . . 71.34 110.912 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.28 11.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 64.1 112.328 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.58 -36.92 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.919 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.21 -137.89 4.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.756 . . . . 75.12 112.471 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.87 149.74 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.851 0.358 . . . . 64.55 110.837 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 134' ' ' GLU . 5.4 t -148.91 136.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.134 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -114.78 161.66 17.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.869 -179.834 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.76 149.51 46.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.905 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -92.0 107.9 19.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.877 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.664 HD12 ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -81.06 130.18 34.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.875 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -84.73 63.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.44 110.902 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.19 -2.48 31.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.44 111.096 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.89 -55.04 3.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.845 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.3 110.937 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 33' ' ' ALA . 4.7 m -110.84 80.48 2.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.587 0.708 . . . . 75.12 111.131 179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 56.25 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 74.45 112.387 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -161.7 -67.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.915 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.682 HG21 HG11 ' A' ' 127' ' ' VAL . 10.0 t -72.48 -16.58 61.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 54.52 111.139 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 24' ' ' LEU . . . -82.47 -36.39 26.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 71.2 111.106 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -63.98 -156.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.886 -179.929 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 65.37 -73.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 33.11 110.876 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.6 t80 -50.07 -34.41 21.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.881 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.68 71.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.45 110.876 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.2 -41.47 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 55.22 111.134 179.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.76 -19.32 63.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 63.51 110.912 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -101.18 -7.67 22.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 75.3 110.887 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 99.8 m -105.69 -22.65 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 75.32 111.179 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 69.74 1.36 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 42.41 112.5 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.96 34.16 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 64.45 110.87 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 18.85 2.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.53 110.902 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.13 -32.04 5.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 54.51 112.448 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.85 -177.55 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.362 . . . . 75.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.47 39.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.733 . . . . 62.24 112.536 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.71 -69.26 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 73.33 110.907 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 55.5 179.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.845 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -37.97 100.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 53.52 112.506 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 154.17 42.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 73.21 110.824 -179.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.8 p -65.76 161.17 21.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 74.41 110.885 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.88 174.97 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.888 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.91 166.37 17.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.874 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 65.68 112.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.828 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.8 mt -151.05 122.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 75.45 111.136 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 7.1 mt -130.6 103.76 16.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 71.55 111.098 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.5 Cg_endo -69.69 85.76 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.67 2.246 . . . . 71.45 112.379 179.817 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.46 -17.08 2.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 52.44 112.519 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.87 -57.89 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 62.44 110.905 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -162.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.33 110.874 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.93 -72.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 65.42 110.867 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 62.87 153.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.913 -179.9 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 41.43 112.467 -179.943 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.804 0.335 . . . . 74.14 110.918 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.1 p -81.92 -167.4 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 63.14 110.881 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.3 pp -109.55 12.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.173 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -129.61 20.74 5.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.911 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.46 -122.34 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 74.12 112.505 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.99 -20.0 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.33 110.892 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -176.11 -175.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 63.3 110.927 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -151.52 154.27 36.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.885 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -71.2 163.26 27.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.854 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.8 123.96 33.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 75.33 110.896 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -48.8 55.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 51.12 110.849 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.3 p30 179.38 175.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.891 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.52 37.6 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -56.55 -23.36 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 55.01 111.11 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HG13 ' A' ' 128' ' ' VAL . 7.2 mt -104.02 134.58 47.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 45.21 110.894 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -120.04 -172.34 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 70.14 110.92 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -97.47 80.34 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 70.32 110.892 179.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.7 p -60.68 -22.53 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.42 111.137 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.91 -149.1 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 50.11 112.494 179.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 162.7 41.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.625 2.217 . . . . 74.34 112.332 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.33 23.02 76.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 73.2 112.495 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.05 116.83 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 72.22 111.125 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 130' ' ' GLY . 1.4 mt -86.38 136.07 33.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.888 179.948 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -133.77 -153.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 44.52 110.866 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mmt -153.59 158.08 40.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 61.02 110.895 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -108.5 -169.42 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 50.34 111.103 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 32.4 t30 89.43 102.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 63.43 110.893 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.52 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 52.51 -108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.087 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 168.86 -62.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 64.14 112.538 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.8 Cg_endo -69.82 99.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.679 2.253 . . . . 74.42 112.331 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.21 47.0 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 64.3 110.914 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -147.73 71.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.13 111.166 -179.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.552 ' CG ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -91.39 31.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 53.45 110.908 179.975 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . -27.57 -95.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 64.12 112.499 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 t -151.66 -167.6 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 70.22 110.857 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.13 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.89 -179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -101.69 139.46 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.867 -179.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -111.35 104.6 13.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.893 -179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.39 136.18 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 75.01 111.094 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.19 153.75 20.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.866 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -130.53 -33.87 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 62.23 111.166 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.41 15.76 26.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.085 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 126.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 75.44 110.852 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -143.05 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 41.33 111.127 179.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.36 17.14 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.01 110.89 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -29.22 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 64.44 110.926 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -99.4 23.72 8.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.949 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -89.72 42.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 65.22 110.877 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.21 33.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 55.31 112.515 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.19 -49.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 73.44 110.901 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -96.55 158.09 15.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.845 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.5 t -81.8 -168.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.143 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.4 p -172.39 103.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 73.23 111.165 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.68 82.38 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.92 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.558 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 140.03 135.73 3.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 75.01 112.49 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.99 144.49 31.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 73.32 110.976 -179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.43 115.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 73.53 111.106 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -64.49 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 55.51 110.911 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -141.73 146.41 36.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 73.41 110.945 179.905 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.9 10.29 35.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.515 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 ttt -50.07 -28.69 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 70.41 110.848 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -51.5 -25.08 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.936 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.72 -37.34 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.142 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -53.97 -21.77 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 75.21 111.136 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -85.91 -34.32 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.877 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.22 -47.24 83.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 52.21 111.125 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.9 ptm -69.36 -22.11 63.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.91 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -88.45 23.34 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 65.53 110.891 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 -11.46 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.877 -179.922 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.6 11.47 33.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.03 110.877 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.1 -142.18 11.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 53.14 112.484 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t -159.16 139.63 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 64.13 110.843 -179.724 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.69 80.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.13 110.859 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 173.81 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 64.11 110.881 -179.975 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.02 -61.79 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 54.33 112.509 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.23 143.95 10.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 73.52 110.869 -179.973 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.4 p -116.04 133.89 55.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 71.12 111.147 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.17 -1.6 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.41 110.868 -179.898 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -136.78 -171.15 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.33 110.913 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -133.35 153.82 51.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mt -135.39 118.97 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.55 111.129 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.4 p -115.04 169.32 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 51.21 111.168 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.405 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 39.6 mm -110.38 133.33 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.45 111.089 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.635 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -82.67 -58.49 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.52 111.112 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.19 170.67 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 62.14 110.873 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 66.8 m -150.09 166.65 29.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 63.21 110.896 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.17 -178.32 48.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 21.2 112.45 -179.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.2 mt-30 -80.08 -32.52 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 73.12 110.955 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER 73.49 -60.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 60.14 110.916 179.971 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 55.2 110.831 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.327 . . . . 71.11 110.922 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.27 156.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 54.13 111.132 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.61 128.98 94.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.65 21.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 63.03 112.334 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -126.19 145.04 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 71.23 111.123 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 10.5 m -125.15 147.53 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 55.12 111.139 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.6 p90 -103.62 148.56 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.839 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.06 130.64 20.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.903 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.6 t0 -108.59 119.94 41.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.849 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' CE ' ' A' ' 142' ' ' MET . 12.2 mm -101.82 149.25 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.43 111.097 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.73 26.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.143 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 156' ' ' ILE . 58.9 t -139.1 101.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 63.53 111.117 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.6 t0 78.68 27.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.849 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.21 -15.63 62.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.795 -0.716 . . . . 24.11 112.518 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 136.71 21.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 73.44 110.859 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 162.95 40.12 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.673 2.249 . . . . 62.1 112.319 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -110.23 -52.79 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 53.5 110.895 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 19' ' ' ARG . . . 162.29 -15.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 74.31 112.481 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 71.52 147.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.906 0.384 . . . . 74.43 110.846 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.553 HG13 HG21 ' A' ' 138' ' ' ILE . 26.4 m -115.8 -176.17 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 71.51 111.094 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 133' ' ' LYS . 3.7 m -123.67 87.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.4 110.845 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -84.32 121.63 27.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 63.54 110.928 -179.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.04 153.26 20.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 64.33 110.85 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 mt -119.99 126.81 51.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 74.41 110.937 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE2' HD11 ' A' ' 90' ' ' LEU . 21.0 m-85 -89.34 70.48 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.856 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -22.75 67.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.13 111.107 179.914 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.25 -61.08 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.888 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -33.07 30.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.933 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -126.39 79.4 70.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 75.34 111.165 179.876 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -45.41 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 74.24 112.368 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -59.38 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.1 110.904 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' OD1' ' A' ' 108' ' ' ASN . 1.5 m -55.15 -61.88 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 64.42 111.128 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -36.41 11.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 72.32 111.122 179.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -67.13 -52.15 45.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 71.32 110.933 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.18 -39.88 31.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.934 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 10.4 t80 -76.24 -29.66 57.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.875 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -44.05 97.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.885 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.46 -25.87 62.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.3 111.071 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 43.0 mt -76.72 -55.63 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 73.22 110.921 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -56.75 -48.96 76.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.0 p -77.44 -13.99 59.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 71.31 111.111 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.17 71.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 72.24 112.48 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.08 33.51 5.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.408 . . . . 62.03 110.927 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.39 0.51 6.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.908 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.0 -2.88 58.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 74.33 112.529 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -166.56 171.98 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 74.51 110.88 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.78 -172.0 24.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 75.33 112.476 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -82.1 129.34 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 72.22 110.915 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -134.93 -48.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 70.42 110.894 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -166.61 51.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 63.15 112.487 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 157' ' ' THR . 16.5 t -71.41 -92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 75.21 110.861 -179.707 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 51' ' ' SER . 0.6 OUTLIER 167.52 139.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 62.35 110.915 -179.914 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -130.3 162.22 29.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 54.44 110.905 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -178.09 52.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 60.41 110.833 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -135.06 35.44 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.32 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.55 148.08 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.153 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 148' ' ' ARG . 1.5 tt -143.97 110.91 5.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.627 0.727 . . . . 72.11 111.108 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 53.7 Cg_endo -69.76 118.88 5.95 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 71.44 112.361 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.44 -30.27 7.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 61.31 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.08 -66.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.3 110.855 -179.885 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.4 ' H ' HG23 ' A' ' 57' ' ' ILE . 1.7 ptt? -176.52 -152.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 61.55 110.857 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.77 137.91 25.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 44.41 110.886 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.48 157.21 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.04 110.943 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 74.51 112.463 -179.984 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.741 0.305 . . . . 63.41 110.916 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 m -105.69 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.15 110.826 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.17 -44.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.11 111.127 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -101.28 75.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 73.33 110.934 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.49 -127.77 8.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 71.14 112.494 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -111.19 -85.25 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 60.34 110.913 -179.932 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -123.48 145.92 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.875 179.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.43 171.02 7.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 72.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.48 161.5 27.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.904 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -69.27 152.88 44.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 73.04 110.899 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.44 -56.67 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 70.23 110.894 -179.888 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -177.46 143.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.5 110.875 -179.968 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.15 41.91 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.885 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 87' ' ' ASN . 9.2 mt -75.27 -22.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 60.32 111.147 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.653 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.31 99.46 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 72.2 110.88 179.89 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.1 101.5 13.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.9 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CB ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.34 95.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.54 110.858 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.7 37.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 60.23 111.155 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 173.16 158.87 18.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 73.3 112.484 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 135.81 31.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.661 2.241 . . . . 63.05 112.326 -179.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.84 -22.15 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 64.12 112.498 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 ' CB ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -50.62 152.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 75.11 111.154 -179.976 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -118.87 126.85 52.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.938 179.886 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 128' ' ' VAL . 82.1 p -153.47 86.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.2 110.826 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -38.45 155.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 63.41 110.858 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.77 19.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.13 111.042 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.873 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.809 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.12 -24.91 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 63.43 111.054 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . 117.13 -78.46 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 61.41 112.495 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 107' ' ' THR . 53.4 Cg_endo -69.8 128.58 16.2 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 62.41 112.348 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' PRO . 19.5 m-20 29.24 55.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 73.52 110.921 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 103' ' ' ALA . 18.4 p -140.98 42.66 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 72.21 111.121 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.683 ' C ' ' O ' ' A' ' 107' ' ' THR . 23.4 t30 0.83 -82.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.883 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 119.44 168.42 13.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 54.21 112.507 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -132.88 -39.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 51.5 110.839 -179.75 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -84.05 72.71 10.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 64.52 110.897 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.94 -171.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 75.52 110.874 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.91 150.7 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.893 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.8 mt -106.37 114.72 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 60.33 111.144 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.7 m -75.8 132.9 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.861 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.8 p -99.45 11.99 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.2 111.151 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.25 179.28 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.107 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -74.43 119.63 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 73.4 110.902 179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.744 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 73.3 p -132.34 59.03 1.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 72.23 111.149 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.47 -11.87 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.91 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.744 ' CZ2' HG22 ' A' ' 119' ' ' THR . 41.8 p90 -82.99 5.75 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 73.23 110.894 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 82.0 mt -122.51 34.91 5.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.93 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.11 -86.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 63.13 110.86 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.95 78.08 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.741 . . . . 42.42 112.495 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -45.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 73.12 110.881 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . 0.444 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 36.7 m-70 -112.57 -25.53 9.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.859 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 24.9 t 73.6 95.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 72.24 111.102 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 99' ' ' SER . 99.0 t -75.32 140.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.119 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CB ' HG21 ' A' ' 29' ' ' VAL . 43.4 p90 -139.01 -29.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 72.41 110.88 -179.95 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.78 -168.33 43.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.489 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 170.01 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.325 . . . . 65.32 110.907 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.67 141.14 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.12 111.19 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 21' ' ' SER . 13.3 tppt? -118.07 -37.22 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.87 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.87 175.57 13.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.881 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.15 78.8 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 63.33 112.475 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.29 -24.11 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 61.22 110.88 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 138' ' ' ILE . 26.1 m120 -77.64 -39.49 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 74.12 110.846 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.553 HG21 HG13 ' A' ' 20' ' ' VAL . 50.0 mm -38.1 -46.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 73.44 111.177 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -88.79 -51.48 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.03 111.132 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 20.5 mm-40 -46.66 -57.0 5.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.855 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.98 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 53.43 111.074 179.964 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.581 ' CE ' HG21 ' A' ' 10' ' ' ILE . 4.5 ttm -52.86 -43.98 66.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 74.11 110.894 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -55.46 -19.77 10.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 64.14 110.884 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -66.7 -20.06 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.861 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -90.89 15.13 11.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.23 110.879 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -94.18 -159.06 33.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 63.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.42 169.7 21.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.22 110.871 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 57' ' ' ILE . 25.1 mmm180 -57.08 -36.96 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.27 12.94 19.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 61.41 110.878 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.85 -85.7 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 22.33 112.443 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 152' ' ' THR . 4.3 mttp 62.6 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 52.43 110.914 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 151' ' ' LYS . 1.4 t 163.29 67.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 72.41 111.117 179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -48.16 82.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.866 -179.873 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -126.37 177.44 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.912 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.89 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 12' ' ' VAL . 21.1 pt -131.6 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 44.31 111.133 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 51' ' ' SER . 1.3 m -134.34 159.41 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.134 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 53' ' ' PHE . 47.0 mt -91.85 115.92 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.11 111.16 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.76 -53.54 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 45.03 111.087 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -141.37 175.56 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.34 110.85 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.8 p -166.53 175.34 8.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.912 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.33 -156.44 26.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 61.13 112.431 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 1.6 tt0 -103.97 144.55 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 72.03 110.898 -179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -57.71 -62.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.912 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 64.5 110.931 179.865 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 74.44 110.852 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.6 t -140.4 142.31 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 72.42 111.136 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.66 153.24 42.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 72.25 110.913 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 154.52 67.8 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.726 2.284 . . . . 72.31 112.35 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -128.36 45.93 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 63.15 111.157 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.69 144.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.34 111.173 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.631 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -128.87 164.94 22.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.22 110.86 -179.939 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.82 148.56 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 75.12 110.907 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.748 ' O ' HD13 ' A' ' 10' ' ' ILE . 25.6 m-20 -108.57 157.22 18.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 64.31 110.889 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 9' ' ' ASP . 8.6 mm -129.97 129.69 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 55.04 111.156 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.44 167.39 15.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.1 111.084 179.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 15' ' ' GLU . 12.8 m -152.85 106.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 72.33 111.135 179.946 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.02 23.03 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.35 110.88 179.894 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 -10.32 65.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 51.1 112.494 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HG2' HG23 ' A' ' 12' ' ' VAL . 4.0 pt-20 -101.54 138.56 19.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 62.13 110.916 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 151.99 69.0 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 62.33 112.337 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.8 tp -121.02 -70.97 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.54 110.929 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.41 179.2 35.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 74.43 112.463 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 73.2 110.91 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.85 84.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.31 111.079 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -66.07 94.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.5 110.834 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 25.9 p90 -106.83 114.28 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 74.35 110.899 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.91 146.7 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 33.31 110.869 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' A' ' 129' ' ' PHE . 20.2 mt -108.13 128.41 54.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 75.23 110.943 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -70.84 79.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.889 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.696 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . . . -73.44 -11.18 60.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 51.12 111.116 179.92 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.38 -58.96 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 65.34 110.883 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -50.65 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.936 179.966 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 5.0 m -66.04 128.36 93.77 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 52.45 111.131 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.686 2.257 . . . . 60.24 112.358 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -40.91 64.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 61.51 110.939 179.887 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 54.9 m -57.12 -11.28 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 71.22 111.144 179.961 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 26' ' ' ALA . . . -74.93 -45.43 42.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 75.1 111.1 179.872 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 35' ' ' ASN . 28.9 tt0 -91.42 -49.18 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 70.33 110.917 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.549 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -25.63 -51.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 65.4 110.924 -179.948 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -81.54 -45.04 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.875 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' GLU . 2.9 ptt85 -51.21 -27.16 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.913 -179.946 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.609 ' HB1' ' CD ' ' A' ' 43' ' ' GLU . . . -75.69 -49.2 19.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 62.2 111.11 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.8 tm? -71.32 -10.67 60.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 62.4 110.936 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -8.2 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.879 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 37' ' ' ARG . 19.8 p -102.22 -13.75 17.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 55.42 111.155 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 45.83 8.65 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 60.52 112.526 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.609 ' CD ' ' HB1' ' A' ' 38' ' ' ALA . 8.4 pt-20 -98.38 -21.75 16.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 75.43 110.903 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -89.27 17.97 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 71.3 110.923 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.45 26.01 63.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 75.45 112.473 179.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 178.68 168.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 62.24 110.832 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.38 -129.59 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 61.22 112.478 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -93.92 -72.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 75.11 110.918 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 1.7 tptt 59.62 166.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 62.04 110.882 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -36.99 104.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 62.53 112.492 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 m -132.53 -108.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 71.54 110.872 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.7 p 172.77 150.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 51.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -90.53 -71.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.874 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.75 5.82 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.44 110.87 -179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 94.79 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 75.02 110.877 -179.872 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 62' ' ' CYS . 2.5 mt -147.77 139.84 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.54 111.187 179.931 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -140.07 139.37 21.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.609 0.719 . . . . 54.54 111.118 179.913 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 128.4 15.98 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.677 2.251 . . . . 54.13 112.335 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 117' ' ' ALA . . . 67.18 48.22 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.06 -80.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 61.42 110.862 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -165.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.899 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.404 ' HB2' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -149.59 147.46 28.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.31 110.864 -179.991 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.66 127.36 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.911 -179.886 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.489 -179.948 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.716 ' N ' ' HG ' ' A' ' 110' ' ' SER . 17.6 ptpt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.793 0.33 . . . . 63.04 110.902 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.5 m -81.18 143.79 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.861 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 39' ' ' LEU . 15.4 pt -83.88 -39.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.153 179.936 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -88.83 -6.78 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.73 -138.18 2.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.768 -0.73 . . . . 71.01 112.493 179.96 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -122.6 -29.59 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.419 . . . . 73.35 110.896 -179.851 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -174.67 137.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 73.14 110.924 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.43 138.43 54.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.881 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 175.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.886 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.46 -168.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.846 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.17 -61.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.853 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -171.22 154.01 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 71.32 110.888 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.02 79.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.873 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.621 ' O ' HD23 ' A' ' 90' ' ' LEU . 10.4 mm -86.77 14.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.136 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 89' ' ' ILE . 5.7 mt -131.33 99.69 4.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 73.4 110.906 179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.09 125.74 33.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.868 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.423 ' HA ' HG13 ' A' ' 97' ' ' ILE . 1.3 m80 -49.03 97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.838 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -116.39 22.71 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 75.24 111.109 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 166.22 26.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.43 112.462 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 132.81 24.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 73.4 112.4 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 121.7 -23.74 7.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.51 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 92' ' ' HIS . 33.3 mm -57.58 149.99 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.341 . . . . 63.45 111.136 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 112' ' ' PHE . 6.7 mp -120.86 143.14 49.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.913 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.08 39.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.851 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.497 ' SD ' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER 59.01 168.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.1 110.862 179.936 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.64 76.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.1 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -144.04 -80.09 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 73.13 110.884 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -125.81 -146.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 63.33 111.123 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.622 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -140.29 -64.18 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 61.12 112.516 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.5 Cg_endo -69.8 106.08 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.21 112.368 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 39.86 68.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.884 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -152.78 35.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.173 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.656 ' C ' ' O ' ' A' ' 107' ' ' THR . 1.6 m120 7.46 -87.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.54 110.94 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 128.8 -41.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.2 112.5 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.716 ' HG ' ' N ' ' A' ' 76' ' ' LYS . 0.3 OUTLIER 76.68 -39.03 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.32 110.856 -179.734 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -62.67 -159.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.02 110.905 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.761 ' HB2' HD23 ' A' ' 98' ' ' LEU . 11.8 p90 -170.72 140.87 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 65.03 110.86 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 4.3 p90 -131.29 102.11 5.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.927 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.446 HG23 ' HA2' ' A' ' 96' ' ' GLY . 12.4 mt -64.59 103.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 73.43 111.157 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.6 m -60.47 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 54.1 110.888 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.94 13.83 27.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 51.14 111.124 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 119' ' ' THR . . . -169.63 153.86 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 71.2 111.101 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -56.91 99.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.12 110.942 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.6 p -117.7 63.19 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 72.45 111.117 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 2.14 5.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 64.22 110.882 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.466 ' CZ2' HG22 ' A' ' 119' ' ' THR . 26.0 p90 -91.78 2.99 56.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.938 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.65 37.97 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.54 110.887 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -125.87 70.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.886 179.851 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.08 -49.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 71.2 112.471 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.13 -31.99 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 73.22 110.87 -179.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.25 145.15 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.846 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.1 m -79.0 109.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 74.32 111.177 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 90' ' ' LEU . 9.0 p -75.35 144.61 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.54 111.133 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.758 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 2.0 t80 174.5 100.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.884 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.616 ' C ' HD13 ' A' ' 98' ' ' LEU . . . 123.74 144.08 6.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 63.5 112.479 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -154.72 -179.77 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 75.25 110.911 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 12.1 t -108.36 85.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 74.42 111.136 179.88 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.83 -50.3 68.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.921 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.9 163.56 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.859 179.961 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.17 -4.44 64.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.52 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.37 -34.38 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 74.13 110.869 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.93 -24.24 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 62.24 110.89 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.21 -41.06 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.21 111.078 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.03 -37.96 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 74.41 111.121 179.852 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.85 -20.87 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 72.52 110.853 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.17 -38.97 26.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -65.23 -29.8 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.886 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.64 -50.32 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.906 -179.965 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -17.05 52.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.3 -16.47 29.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.906 -179.946 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.99 -158.97 21.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 72.22 112.491 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -149.57 -162.2 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 74.13 110.804 -179.705 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -92.45 -42.74 9.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.892 -179.908 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -101.01 15.28 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.12 110.935 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.68 -157.87 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 61.44 112.463 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm 60.85 159.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 74.32 110.916 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -133.26 161.37 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.31 111.152 179.965 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.39 -19.26 43.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 73.21 110.817 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -135.37 161.08 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.32 110.889 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -90.86 128.18 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.919 179.875 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mt -101.16 134.92 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 72.12 111.133 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 155' ' ' LYS . 4.2 p -136.59 163.89 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 75.31 111.175 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.1 mp -124.71 132.89 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.094 179.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.06 -58.34 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 74.35 111.122 179.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -151.81 179.03 8.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.34 110.881 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.9 p -176.15 165.44 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 142.83 -171.59 24.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 75.4 112.428 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -68.7 118.51 11.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 72.43 110.933 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.4 mm? -92.32 -44.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.916 -179.964 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.873 179.897 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 74.12 110.867 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.14 155.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 54.03 111.126 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.47 141.37 42.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 74.12 110.848 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.7 Cg_endo -69.75 127.79 15.11 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 73.32 112.347 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -102.19 148.78 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 55.32 111.144 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -120.21 139.02 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 53.12 111.158 179.868 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -117.42 143.95 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.849 -179.936 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -140.07 127.63 21.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 65.21 110.855 -179.929 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 34.6 t0 -101.0 79.6 2.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.858 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.32 139.11 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.5 111.116 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -127.17 158.66 36.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 111.091 179.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.34 97.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.09 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t0 54.61 54.96 8.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.32 110.891 179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.82 13.06 60.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 62.32 112.456 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -142.48 93.02 7.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.684 0.754 . . . . 72.1 110.862 -179.885 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 152.43 69.28 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.688 2.259 . . . . 72.02 112.316 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.74 25.13 9.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.906 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.21 -173.68 20.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.504 179.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 170.3 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 71.24 110.846 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.572 HG13 HG13 ' A' ' 138' ' ' ILE . 35.2 m -137.33 177.6 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.119 179.957 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 p -136.63 138.79 41.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 23.54 110.894 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -114.52 149.55 36.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.878 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.52 128.63 53.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 74.24 110.916 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 6' ' ' VAL . 6.6 mt -94.85 116.79 29.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 54.31 110.915 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 11.1 m-85 -82.61 67.47 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.893 179.92 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.072 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -36.54 74.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 62.41 110.919 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -89.83 -28.39 19.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 64.12 110.946 179.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -147.24 83.69 7.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.638 0.732 . . . . 73.0 111.138 179.834 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.28 37.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 54.44 112.348 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -34.75 19.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.925 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -75.07 -53.74 8.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.119 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.17 -37.95 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.45 111.148 179.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.64 -30.66 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.35 110.869 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.32 -61.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.851 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.01 -29.8 9.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.13 110.871 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.95 85.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.826 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.912 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -81.32 -19.03 43.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 53.4 111.132 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 110' ' ' SER . 87.8 mt -78.9 -61.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 65.41 110.924 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -51.48 -45.65 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.886 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.43 -9.87 56.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 74.43 111.089 -179.902 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.12 73.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.528 -179.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -47.8 -53.47 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.383 . . . . 64.55 110.876 -179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -167.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 63.01 110.903 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.98 17.38 55.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.512 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -146.35 -168.32 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 74.23 110.89 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.72 144.02 7.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 42.12 112.508 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.22 120.67 5.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 75.11 110.96 -179.81 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -41.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.01 110.9 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 30.64 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 62.22 112.508 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -77.21 162.12 27.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 72.22 110.84 -179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 m -75.06 -168.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.914 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.692 ' CE1' HD11 ' A' ' 158' ' ' ILE . 2.2 m-85 -140.16 135.74 32.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.876 -179.864 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.12 -179.11 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.04 110.858 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER 66.83 20.69 10.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.45 110.879 -179.875 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.475 HD12 ' OG1' ' A' ' 152' ' ' THR . 18.6 mt -69.45 123.47 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 74.2 111.118 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 55' ' ' ARG . 2.9 mp -138.92 103.44 7.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 60.24 111.155 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 76.08 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 45.31 112.337 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.02 -25.63 0.31 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 62.4 112.489 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.34 -64.19 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.05 110.876 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 -161.57 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 62.54 110.899 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.5 m -137.47 -64.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 40.5 110.882 -179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.97 152.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.904 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 55.54 112.448 -179.976 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.845 0.355 . . . . 64.24 110.881 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -116.55 131.91 56.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 55.12 110.839 -179.884 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.912 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -49.35 -34.15 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.171 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD12 ' A' ' 78' ' ' ILE . 7.5 m-85 -128.31 55.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 71.23 110.923 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.82 -139.7 8.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.448 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.94 -82.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.385 . . . . 65.11 110.893 -179.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.797 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.29 -177.42 4.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 52.41 110.89 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.52 179.74 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.91 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 160.43 22.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.895 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -74.14 111.2 9.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.903 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.31 -52.35 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.917 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 178.8 165.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.861 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.05 40.22 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.864 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.6 mt -52.48 -29.02 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.52 111.116 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.69 118.07 31.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.917 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -105.43 171.1 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.885 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.8 95.35 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.851 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 p -112.11 34.63 4.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.85 41.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.715 -0.755 . . . . 71.4 112.481 179.952 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 150.31 67.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 74.21 112.348 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.0 128.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 52.2 112.482 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -178.0 131.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 75.55 111.146 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.0 tt -89.36 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 61.41 110.899 179.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 128' ' ' VAL . 31.1 p -109.74 -152.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.841 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 4.2 mtt -160.51 104.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.899 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.89 161.76 13.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.126 179.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER 172.14 -45.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.868 -179.936 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.909 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -172.21 -34.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 71.25 111.084 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.15 -80.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.743 -0.741 . . . . 43.14 112.494 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.623 ' O ' HG23 ' A' ' 107' ' ' THR . 53.6 Cg_endo -69.78 120.4 7.19 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 73.51 112.323 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 39.65 36.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 73.54 110.876 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.909 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 69.6 p -144.81 61.55 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 74.11 111.122 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 109' ' ' GLY . 3.0 m-80 -82.16 -6.38 59.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 61.31 110.907 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 29.45 -138.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 72.44 112.492 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 39' ' ' LEU . 9.2 m -147.7 29.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 74.43 110.856 -179.711 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -107.18 83.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.3 110.95 -179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -80.66 176.98 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.878 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.64 -175.83 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.4 110.884 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.73 117.11 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.44 111.112 179.986 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.41 153.51 21.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 75.44 110.878 179.953 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.3 p -131.16 12.24 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 111.155 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.76 6.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 50.32 111.096 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.62 131.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.893 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.615 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.6 p -142.03 54.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 61.44 111.153 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.19 -17.88 5.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 62.35 110.919 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' TRP . . . . . 0.615 ' CZ2' HG22 ' A' ' 119' ' ' THR . 20.4 p90 -69.1 -18.47 63.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 72.14 110.922 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 50.7 mt -89.8 -6.8 55.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.902 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -47.77 -51.68 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 74.23 110.884 179.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.02 52.23 3.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 52.53 112.512 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -159.65 -50.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 50.22 110.868 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -110.13 143.25 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.827 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 76.4 t -48.97 -87.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 64.4 111.142 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 ' NE2' ' A' ' 92' ' ' HIS . 17.1 t 82.77 123.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 51.41 111.135 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.464 ' HB3' HG21 ' A' ' 29' ' ' VAL . 14.6 p90 -161.35 36.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 70.31 110.858 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.76 173.3 36.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 41.31 112.485 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -173.83 156.23 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 74.41 110.907 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.1 t -51.05 108.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.4 111.139 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -34.06 54.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.31 110.935 179.89 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -151.51 169.77 21.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 73.23 110.864 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 78.97 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 52.41 112.508 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.5 tpt -87.17 0.87 54.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 62.14 110.881 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -88.59 -34.32 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 71.41 110.891 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.572 HG13 HG13 ' A' ' 20' ' ' VAL . 30.7 mm -60.95 -40.28 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 72.1 111.143 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 139' ' ' VAL . 13.9 t -87.32 0.13 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 43.25 111.131 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -112.78 -69.71 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.893 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.06 -51.6 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 63.22 111.131 179.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 142' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 5.3 tmm? -44.31 -39.95 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.45 110.902 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.02 59.64 1.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 65.11 110.874 -179.914 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.94 -12.4 4.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.1 110.898 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.0 21.65 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.876 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -97.93 65.11 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 25.41 112.501 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.603 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.8 OUTLIER -18.64 120.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 52.34 110.867 -179.721 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -47.54 -43.31 24.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.855 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -45.68 -35.34 4.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.1 -60.86 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.719 . . . . 63.22 112.482 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 125.94 19.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 53.04 110.87 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.497 HG23 ' HA2' ' A' ' 146' ' ' GLY . 2.2 m -85.89 139.94 30.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 65.24 111.135 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -67.66 -22.72 65.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.829 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -124.59 -164.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 54.11 110.916 179.906 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 112.16 13.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 74.23 110.913 179.872 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 mt -99.06 90.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.24 111.154 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -91.14 153.61 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 65.43 111.114 -179.976 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -94.22 128.28 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.124 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.13 -63.08 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.41 111.106 179.804 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.26 162.17 41.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 74.1 110.873 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.06 -179.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 63.41 110.921 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.46 -156.63 25.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 62.21 112.492 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -120.02 140.58 50.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 74.41 110.874 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.08 132.66 53.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.1 110.913 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 64.44 110.959 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.828 0.347 . . . . 75.04 110.82 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.408 HG13 ' N ' ' A' ' 3' ' ' ASN . 0.5 OUTLIER 62.55 157.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 75.11 111.125 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 2' ' ' VAL . 13.0 m-20 -88.47 144.63 34.03 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.616 0.722 . . . . 64.55 110.864 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 132.26 22.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.684 2.256 . . . . 63.0 112.338 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.442 HG21 HD22 ' A' ' 164' ' ' LEU . 21.6 m -116.51 142.28 47.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 75.24 111.097 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.79 137.8 51.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.25 111.136 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -101.34 156.23 17.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 71.44 110.857 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -142.52 143.69 32.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 71.54 110.901 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.35 143.03 37.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 74.03 110.879 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 14.2 mm -115.43 120.3 64.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.216 -0.447 . . . . 74.32 111.149 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -107.53 163.28 13.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 53.25 111.064 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.653 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.88 96.76 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.466 . . . . 72.13 111.145 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 67.33 31.39 6.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 73.14 110.879 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.86 -14.24 65.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 63.34 112.475 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -96.22 132.91 25.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.648 0.737 . . . . 74.35 110.874 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 155.65 65.32 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 72.13 112.351 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.6 tp -121.97 -72.03 0.7 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.903 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -155.64 -148.24 4.97 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.78 -0.724 . . . . 74.34 112.526 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.75 126.6 12.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.844 0.354 . . . . 63.52 110.874 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t -124.33 125.26 70.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 70.24 111.138 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.1 p -113.47 159.16 19.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.142 -0.481 . . . . 74.25 110.884 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 22' ' ' PHE . 0.2 OUTLIER -131.69 126.67 35.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.904 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 3.0 tm-20 -59.46 -48.36 81.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.142 -0.481 . . . . 71.01 110.916 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 7.1 mt 69.51 126.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.117 -0.492 . . . . 74.22 110.935 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.485 ' CG ' HD21 ' A' ' 90' ' ' LEU . 81.8 m-85 -88.6 74.14 8.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 72.24 110.902 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.8 54.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.4 111.135 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -93.01 -37.59 12.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.19 -0.459 . . . . 74.43 110.896 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.567 ' HB2' HD11 ' A' ' 90' ' ' LEU . 3.2 mmtp -75.11 -27.7 59.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 74.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.489 HG21 ' CB ' ' A' ' 129' ' ' PHE . 2.7 m -131.67 68.7 81.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.581 0.705 . . . . 52.22 111.095 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 58.87 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.698 2.265 . . . . 34.11 112.378 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.59 -72.49 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 64.31 110.929 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.457 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 86.3 m -58.95 -53.91 53.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 64.12 111.14 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.784 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -77.42 -9.39 58.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 62.13 111.118 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -74.17 -24.75 59.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.849 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -90.5 -34.41 15.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 71.2 110.869 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' HD2' HD11 ' A' ' 24' ' ' LEU . 3.8 t80 -50.77 -28.71 9.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 71.4 110.928 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -35.36 76.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 62.42 110.874 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.96 -28.69 25.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 72.12 111.119 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD11 ' CE2' ' A' ' 67' ' ' PHE . 1.1 tt -89.12 13.1 13.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.14 110.951 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 14.6 m -117.22 -11.99 10.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 51.42 110.852 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.491 HG22 ' HA2' ' A' ' 162' ' ' GLY . 71.1 p -116.63 -0.06 12.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 75.41 111.184 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 68.56 10.66 60.92 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.754 -0.736 . . . . 72.44 112.516 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -64.16 -36.79 85.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 74.24 110.846 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -15.23 62.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.203 -0.453 . . . . 71.24 110.921 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.01 -18.66 30.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.746 . . . . 34.44 112.472 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.764 ' CG ' HG21 ' A' ' 73' ' ' THR . 9.6 m-85 -87.42 -24.95 24.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.38 . . . . 64.53 110.841 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.481 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -30.9 135.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.746 -0.74 . . . . 64.34 112.457 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.2 t80 -76.46 -43.86 38.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.96 0.409 . . . . 65.24 110.941 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.67 93.91 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 72.24 110.889 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.9 63.18 0.84 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 73.14 112.462 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.52 -168.43 1.31 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.821 0.343 . . . . 53.04 110.834 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.3 p -144.7 -172.74 3.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.108 -0.496 . . . . 65.12 110.896 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -100.45 167.09 10.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 70.43 110.878 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -109.25 -46.96 3.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.858 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -146.04 153.05 40.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 74.31 110.863 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.691 HD12 HG21 ' A' ' 152' ' ' THR . 63.5 mt -144.81 130.39 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 75.12 111.113 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.458 HD12 ' HE3' ' A' ' 61' ' ' MET . 3.1 mt -134.78 104.65 10.75 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.602 0.715 . . . . 75.54 111.145 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.76 98.43 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.659 2.239 . . . . 62.02 112.32 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.5 -22.51 3.35 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 62.21 112.5 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.27 -60.65 1.67 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.839 0.352 . . . . 65.22 110.865 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.458 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -173.45 -160.44 0.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.147 -0.479 . . . . 61.34 110.902 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 65.3 m -133.36 -73.0 0.5 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.264 -0.426 . . . . 74.21 110.907 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 61.8 160.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.894 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 112.71 55.09 0.46 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.702 -0.761 . . . . 53.35 112.459 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -135.0 122.73 2.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 61.41 112.43 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -151.08 -172.16 4.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.831 0.348 . . . . 74.4 110.91 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.497 ' CE2' HD11 ' A' ' 39' ' ' LEU . 14.5 p90 -154.77 47.26 0.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 73.25 110.843 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 75' ' ' GLY . 59.6 p -79.7 122.92 27.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.465 . . . . 71.32 111.134 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.02 171.86 9.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 73.13 110.867 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.474 ' O ' ' C ' ' A' ' 71' ' ' ASN . 27.5 p-80 -67.58 -35.0 78.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.882 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' C ' ' O ' ' A' ' 70' ' ' HIS . 23.5 t-20 -32.41 -78.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 71.51 110.867 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.7 42.24 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.736 -0.745 . . . . 30.15 112.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.764 HG21 ' CG ' ' A' ' 46' ' ' PHE . 53.7 p -117.86 -51.56 2.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.847 0.356 . . . . 75.12 111.165 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.73 176.65 22.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 72.13 112.503 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' H ' HG22 ' A' ' 68' ' ' THR . . . -94.05 112.65 4.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 62.21 112.512 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.89 -79.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 75.31 110.931 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.1 t -132.71 137.48 46.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 73.02 110.843 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 tt -70.32 -27.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 73.25 111.153 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -122.98 41.29 3.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.891 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 148.79 -136.58 5.92 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.782 -0.723 . . . . 63.21 112.513 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -116.82 -74.85 0.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.915 0.388 . . . . 63.04 110.896 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 160.4 32.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.878 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -142.47 147.04 35.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.32 110.873 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.61 158.65 2.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.121 -0.491 . . . . 64.33 110.914 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -82.29 127.19 32.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.465 . . . . 73.45 110.913 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.48 -57.76 3.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.03 110.895 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -179.76 177.3 0.7 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.142 -0.481 . . . . 75.14 110.926 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.47 36.95 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.883 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 90.1 mt -50.49 -25.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.479 . . . . 64.33 111.158 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 28' ' ' LYS . 2.6 mt -73.07 122.75 22.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 72.02 110.92 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -77.23 160.2 29.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 73.04 110.872 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.448 ' CD2' ' HB2' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -86.53 107.23 18.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.862 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 p -142.93 164.82 29.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 71.22 111.128 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.03 144.19 4.65 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.756 -0.735 . . . . 62.45 112.465 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -10.01 27.5 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.677 2.251 . . . . 73.45 112.326 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -154.57 73.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 33.35 112.458 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.449 HD13 ' CG2' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -84.87 161.91 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 75.02 111.121 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.44 HD21 ' CD2' ' A' ' 112' ' ' PHE . 1.0 OUTLIER -102.84 128.83 49.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.916 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.43 ' HB2' HG23 ' A' ' 128' ' ' VAL . 47.1 t -143.75 -116.86 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.14 110.816 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.427 ' HE1' ' HB3' ' A' ' 108' ' ' ASN . 0.8 OUTLIER 178.24 143.37 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 71.34 110.856 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -116.77 101.67 8.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.04 111.095 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.1 -167.47 1.96 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 74.2 110.929 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 1.057 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -54.65 -37.29 65.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.05 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.489 ' H ' HG23 ' A' ' 107' ' ' THR . . . 114.5 -65.12 0.29 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 75.31 112.522 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.655 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.71 120.88 7.6 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.677 2.252 . . . . 75.34 112.379 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.541 ' C ' ' O ' ' A' ' 105' ' ' PRO . 10.0 p-10 26.53 64.87 0.07 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.238 -0.437 . . . . 61.01 110.915 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 1.057 HG21 ' HB3' ' A' ' 103' ' ' ALA . 5.5 t -163.22 54.39 0.18 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 52.31 111.124 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.427 ' HB3' ' HE1' ' A' ' 100' ' ' MET . 24.8 m120 -40.11 -52.29 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 65.23 110.923 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 72.48 -167.79 53.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.782 -0.723 . . . . 63.54 112.501 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.6 p -118.81 -20.17 8.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.814 0.34 . . . . 45.22 110.855 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -51.44 150.9 3.32 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 62.15 110.948 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' CD2' HD21 ' A' ' 98' ' ' LEU . 1.9 p90 -160.47 175.03 13.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.5 110.893 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -144.98 179.02 7.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.12 110.873 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 32.8 mm -102.24 -63.73 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 63.31 111.109 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 114' ' ' ILE . 0.9 OUTLIER 79.37 112.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 71.2 110.921 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.6 t -98.8 -13.52 20.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 75.34 111.175 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -123.61 159.06 30.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 70.02 111.087 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -71.51 102.62 2.74 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 62.14 110.895 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.66 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 34.9 p -121.36 70.4 0.93 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 73.44 111.184 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.448 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -84.65 22.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 73.12 110.841 -179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.66 ' CZ2' HG22 ' A' ' 119' ' ' THR . 3.9 p90 -103.87 9.72 36.71 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 74.21 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 49.1 mt -105.29 -30.98 9.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.266 -0.425 . . . . 72.04 110.93 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.26 165.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.851 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 98.22 -24.74 30.6 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.693 -0.765 . . . . 65.33 112.471 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.5 mmtp -104.9 -33.56 8.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.797 0.332 . . . . 73.13 110.904 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -119.73 170.29 9.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.819 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 37.7 t -97.02 112.88 29.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 64.02 111.129 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.449 ' CG2' HD13 ' A' ' 97' ' ' ILE . 9.6 p -84.94 144.54 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.41 111.149 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.784 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 31.6 p90 -178.65 112.99 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 64.41 110.876 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.416 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 144.04 -166.11 27.17 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.79 -0.719 . . . . 64.25 112.484 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.9 ptpt 172.87 -174.94 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.821 0.343 . . . . 54.52 110.95 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -109.69 86.59 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 74.35 111.15 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -47.5 -74.52 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.865 179.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -150.78 146.99 26.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 71.3 110.868 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.75 4.36 26.39 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.749 -0.739 . . . . 41.4 112.51 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.0 ttt -48.3 -30.14 4.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.806 0.336 . . . . 64.01 110.865 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -50.76 -25.94 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 71.03 110.864 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.2 mm -86.33 -38.35 12.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.153 -0.476 . . . . 74.1 111.156 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.2 t -51.32 -23.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 74.2 111.125 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -83.28 -43.48 15.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 71.13 110.857 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.13 -48.33 64.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 75.13 111.131 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 5.5 ptm -64.08 -20.15 65.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.456 . . . . 72.45 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -91.46 29.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.261 -0.427 . . . . 74.53 110.873 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.69 -23.18 0.87 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 74.11 110.831 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -93.32 1.33 57.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 72.4 110.9 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -86.71 -147.29 10.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.755 -0.736 . . . . 44.44 112.513 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -161.1 134.35 6.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 72.13 110.858 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.9 mmm-85 -70.59 76.67 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 71.45 110.872 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 178.71 -33.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 71.21 110.859 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 149.54 -60.5 0.43 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.703 -0.761 . . . . 72.2 112.463 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp -61.63 155.18 23.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.813 0.34 . . . . 64.31 110.966 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.691 HG21 HD12 ' A' ' 56' ' ' ILE . 63.2 p -124.91 129.42 50.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.256 -0.429 . . . . 70.42 111.166 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.3 -31.69 9.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 73.14 110.893 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.7 -169.35 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 75.42 110.895 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -137.88 126.07 23.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 70.13 110.865 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -86.14 127.13 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 71.15 111.113 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.24 156.31 43.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 75.3 111.192 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.9 mm -108.0 142.07 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 71.41 111.088 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -101.57 -64.98 1.01 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 31.33 111.078 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -132.77 178.12 7.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 71.5 110.858 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -166.63 -176.34 3.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 71.42 110.914 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.491 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 137.07 -146.46 18.38 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.732 -0.747 . . . . 63.3 112.477 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -106.56 128.14 53.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.813 0.339 . . . . 73.4 110.917 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 5' ' ' THR . 1.6 tp -54.51 -56.53 17.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.905 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 53.12 110.923 179.93 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.807 0.337 . . . . 75.35 110.885 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.78 155.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 74.54 111.153 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -93.35 157.4 38.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.619 0.724 . . . . 73.32 110.854 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 153.28 69.21 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.712 2.274 . . . . 74.11 112.34 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 13.8 m -130.34 55.57 1.8 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.145 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 24' ' ' LEU . 15.4 m -49.26 147.86 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 74.41 111.169 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.521 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -140.55 163.51 32.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 73.41 110.876 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -141.76 146.17 35.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 72.12 110.882 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -93.98 163.32 13.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.147 -0.479 . . . . 71.33 110.841 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 20.9 mm -132.5 102.66 5.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.217 -0.447 . . . . 72.12 111.142 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.469 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -105.04 158.0 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.215 -0.448 . . . . 63.13 111.149 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 12' ' ' VAL . 22.5 t -138.31 99.67 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 71.34 111.134 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.68 42.65 3.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 70.42 110.891 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.88 -8.08 67.73 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.743 -0.741 . . . . 33.55 112.504 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.435 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.0 tt0 -100.22 101.38 14.4 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.668 0.746 . . . . 73.53 110.844 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.81 126.89 13.81 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.644 2.229 . . . . 74.31 112.298 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.1 mp -83.87 -43.73 15.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 71.4 110.909 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.02 -151.32 20.58 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.42 112.484 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.38 156.83 21.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.812 0.339 . . . . 74.1 110.901 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.0 t -147.62 76.75 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 74.03 111.151 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 p -72.65 165.44 24.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 64.14 110.89 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' HB3' ' HA ' ' A' ' 132' ' ' VAL . 0.1 OUTLIER -152.67 122.53 6.96 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 75.3 110.897 -179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 39.7 tt0 -47.89 137.03 10.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 61.31 110.88 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.44 HD12 HG22 ' A' ' 6' ' ' VAL . 0.9 OUTLIER -108.22 120.93 43.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.143 -0.48 . . . . 74.5 110.948 179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -76.36 57.63 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.225 -0.443 . . . . 53.11 110.847 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -28.17 68.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 22.3 111.067 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.75 -61.29 2.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 75.51 110.845 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -52.19 -77.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 72.03 110.921 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.928 HG23 ' HB2' ' A' ' 33' ' ' ALA . 5.4 m -72.75 120.05 78.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.666 0.746 . . . . 72.32 111.13 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.74 -87.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.674 2.25 . . . . 74.3 112.382 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.1 -44.58 68.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 72.45 110.898 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.542 HG23 ' HE3' ' A' ' 100' ' ' MET . 0.9 OUTLIER -46.07 -28.46 1.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.434 . . . . 73.23 111.121 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.928 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -79.87 -63.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 53.21 111.067 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' O ' ' N ' ' A' ' 37' ' ' ARG . 15.6 tt0 -57.98 -64.15 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.25 110.865 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 34' ' ' GLU . 14.2 t-20 -31.53 -51.63 0.21 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 63.33 110.873 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -74.01 -40.95 62.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 73.14 110.91 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.656 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -52.62 -25.01 9.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 62.2 110.88 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.37 -43.48 27.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 35.41 111.109 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.696 HD11 ' CZ ' ' A' ' 67' ' ' PHE . 8.0 tt -64.73 -13.98 56.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 64.42 110.914 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -6.2 31.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 54.25 110.826 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.656 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.2 p -101.62 -21.25 14.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.53 111.126 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.76 -17.12 54.59 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.74 . . . . 65.52 112.502 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.59 -37.13 48.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 72.43 110.901 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -23.13 35.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 71.44 110.865 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 105.33 -4.55 40.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 72.23 112.515 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.7 p90 -164.02 167.13 20.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 70.43 110.842 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.18 -149.31 20.42 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.777 -0.725 . . . . 73.41 112.508 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 108.11 16.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.96 0.409 . . . . 75.12 110.936 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.48 -69.99 0.79 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 71.21 110.852 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.79 32.67 2.74 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.33 112.47 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.13 -168.2 2.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.869 0.366 . . . . 73.3 110.84 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.7 m -114.17 -168.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 74.0 110.903 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.24 -173.29 3.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 71.21 110.913 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -102.96 -74.71 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 73.35 110.885 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 21.6 mtm180 -154.64 103.52 2.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.427 . . . . 74.32 110.883 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 49.6 mt -85.88 128.27 39.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 61.44 111.17 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.434 HD12 ' O ' ' A' ' 148' ' ' ARG . 5.0 tt -136.11 106.85 9.53 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.598 0.713 . . . . 72.31 111.144 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.76 105.72 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.697 2.265 . . . . 71.15 112.306 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 136.62 -49.47 0.87 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.74 -0.743 . . . . 42.2 112.511 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.27 -66.57 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.361 . . . . 75.15 110.86 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -162.9 0.58 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 65.12 110.872 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 15.8 m -149.94 98.38 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.454 . . . . 62.52 110.907 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -90.68 170.09 10.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.43 . . . . 71.3 110.889 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.43 -160.25 31.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.706 -0.759 . . . . 71.04 112.46 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.64 -4.17 79.84 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.722 -0.751 . . . . 71.11 112.465 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -54.14 110.75 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.87 0.367 . . . . 74.24 110.89 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.696 ' CZ ' HD11 ' A' ' 39' ' ' LEU . 52.8 p90 -119.37 13.68 12.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 61.55 110.837 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.454 HG23 ' HA2' ' A' ' 75' ' ' GLY . 12.1 t -177.79 35.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 51.43 111.122 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.76 -40.7 14.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 63.14 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 25.5 m170 -77.24 56.74 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 51.44 110.86 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 173.12 -55.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 75.35 110.896 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -92.29 17.55 56.9 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.803 -0.713 . . . . 61.44 112.438 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.1 m 44.21 64.72 1.22 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 75.51 111.139 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.16 133.84 7.8 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.754 -0.736 . . . . 61.23 112.46 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' HA2' HG23 ' A' ' 68' ' ' THR . . . -62.44 -161.14 0.21 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.746 -0.74 . . . . 52.11 112.499 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -174.96 -177.71 1.13 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.329 . . . . 71.4 110.903 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.15 177.6 8.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 73.43 110.844 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.445 HD13 ' O ' ' A' ' 35' ' ' ASN . 30.1 pt -86.9 -34.45 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.119 -0.491 . . . . 54.13 111.115 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -94.01 72.42 4.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.903 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 95.48 -130.02 10.12 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.757 -0.735 . . . . 70.04 112.501 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -98.78 -77.5 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.881 0.372 . . . . 73.15 110.877 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.801 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -136.78 -177.34 4.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.115 -0.493 . . . . 64.22 110.903 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -147.23 174.91 11.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 74.22 110.918 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -81.7 158.61 24.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 61.2 110.853 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.92 119.48 20.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.44 110.872 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -47.46 73.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 75.04 110.863 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 179.53 167.26 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 73.12 110.875 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.48 37.11 4.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.52 110.872 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 8.1 mt -57.79 -22.19 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 74.43 111.139 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 128' ' ' VAL . 70.3 mt -98.09 90.6 4.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 71.43 110.93 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt -63.23 171.98 2.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 70.35 110.87 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.408 ' CD2' HG21 ' A' ' 97' ' ' ILE . 21.5 m80 -90.29 95.25 10.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 72.1 110.86 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.431 ' O ' ' O ' ' A' ' 94' ' ' GLY . 18.2 p -131.14 149.56 52.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 60.33 111.117 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 93' ' ' THR . . . 56.17 155.07 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 41.13 112.488 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 167.37 24.57 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.668 2.245 . . . . 64.41 112.348 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.592 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 84.28 -10.55 60.86 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.752 -0.737 . . . . 72.42 112.541 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.408 HG21 ' CD2' ' A' ' 92' ' ' HIS . 6.2 mm -47.67 133.51 4.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 64.43 111.139 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.426 ' HB2' ' HA3' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -120.97 145.9 47.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.475 . . . . 63.34 110.884 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.5 t -149.79 -133.74 0.06 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 74.22 110.821 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.542 ' HE3' HG23 ' A' ' 32' ' ' THR . 5.2 mtt -145.65 112.62 6.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.076 -0.511 . . . . 74.03 110.862 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -95.01 74.37 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 72.43 111.132 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -107.36 -75.39 0.63 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.21 110.91 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.801 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -134.99 -84.62 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 65.33 111.077 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 174.84 -83.16 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 43.12 112.481 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.541 ' O ' HG23 ' A' ' 107' ' ' THR . 53.9 Cg_endo -69.77 113.9 3.53 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.677 2.251 . . . . 63.12 112.351 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.443 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.5 OUTLIER 34.47 46.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 62.32 110.896 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.801 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.6 p -142.26 46.74 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.451 . . . . 55.23 111.143 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -83.73 176.52 8.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 71.13 110.913 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 174.82 -127.04 1.24 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.785 -0.722 . . . . 62.13 112.503 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 m -101.76 -171.19 1.94 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.823 0.344 . . . . 63.44 110.917 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.466 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.2 mt-30 72.3 64.31 0.13 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.32 110.913 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -72.48 149.39 44.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 71.52 110.877 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 5.4 p90 -114.6 120.49 40.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 63.54 110.847 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 26.9 mt -82.57 132.63 30.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 74.32 111.101 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.1 m -82.11 127.84 33.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.112 -0.495 . . . . 71.4 110.915 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 p -99.62 -31.35 11.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 65.02 111.155 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.06 24.77 5.96 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 72.44 111.089 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.69 135.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 74.54 110.867 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.547 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 67.0 p -139.97 61.25 1.54 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.214 -0.448 . . . . 73.1 111.137 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -73.06 3.61 5.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.915 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.547 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -86.29 1.44 50.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 72.14 110.919 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.1 pp -139.81 43.64 1.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.909 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -60.49 -82.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.845 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.434 ' O ' ' CB ' ' A' ' 125' ' ' LYS . . . -50.11 140.53 17.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.758 -0.734 . . . . 70.15 112.469 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.434 ' CB ' ' O ' ' A' ' 124' ' ' GLY . 1.0 OUTLIER 78.41 61.31 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.13 110.875 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.431 ' C ' HG23 ' A' ' 127' ' ' VAL . 2.3 m-70 -163.14 -48.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 63.23 110.846 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.431 HG23 ' C ' ' A' ' 126' ' ' HIS . 5.4 t 74.67 86.8 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.445 . . . . 64.4 111.095 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.482 ' O ' HD12 ' A' ' 90' ' ' LEU . 25.0 t -90.91 133.08 33.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 61.34 111.159 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.642 ' CB ' HG21 ' A' ' 29' ' ' VAL . 46.8 p90 -151.64 22.9 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 75.44 110.852 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.426 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -140.7 174.07 22.82 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.757 -0.735 . . . . 54.53 112.494 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.68 130.63 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.799 0.333 . . . . 53.03 110.895 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.592 HG23 ' CA ' ' A' ' 96' ' ' GLY . 44.7 t -51.77 129.36 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 62.42 111.129 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.422 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -112.28 -59.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 60.43 110.844 179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -139.82 140.99 36.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.888 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.7 1.78 43.09 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.751 -0.738 . . . . 75.44 112.445 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.469 ' SD ' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.56 -31.13 9.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.747 0.308 . . . . 54.33 110.927 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -49.69 -26.72 3.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 74.43 110.89 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.34 -36.28 9.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 75.35 111.13 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 93.8 t -53.07 -22.75 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 62.45 111.137 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -83.75 -34.24 24.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 71.13 110.849 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.79 -44.0 81.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 64.53 111.115 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.5 ptm -72.21 -11.87 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.216 -0.447 . . . . 70.51 110.951 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -91.92 25.2 2.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.12 110.892 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -16.53 1.78 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 71.41 110.905 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -95.66 -6.03 40.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.884 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -67.55 -166.05 3.0 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.739 -0.743 . . . . 73.4 112.452 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 16.5 t -140.04 -75.93 0.34 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.867 0.365 . . . . 63.13 110.883 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.434 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -179.95 -42.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 72.23 110.908 -179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -92.79 24.02 3.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 64.35 110.873 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.48 -28.49 9.89 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.714 -0.755 . . . . 51.1 112.521 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.64 149.1 36.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 61.04 110.859 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -130.85 168.05 17.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 73.1 111.149 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.2 t -92.04 -2.49 56.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -140.95 -167.55 2.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 72.23 110.893 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.45 119.83 17.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 64.51 110.895 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.2 125.57 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.419 . . . . 62.44 111.162 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.469 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -119.61 172.36 7.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 70.5 111.14 179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.0 mm -117.15 108.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.15 111.131 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.428 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -63.43 -60.28 3.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.24 111.14 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -148.9 177.2 9.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 64.22 110.833 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 10.7 p -178.17 163.45 1.68 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.03 110.909 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 147.11 -169.61 28.12 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.747 -0.74 . . . . 53.32 112.512 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.47 117.51 17.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.822 0.344 . . . . 70.11 110.927 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.521 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.5 mm? -99.11 -69.74 0.75 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.236 -0.438 . . . . 74.54 110.958 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 1.2 tm-20 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 62.23 110.915 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.825 0.345 . . . . 73.13 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 95.8 t -121.23 148.25 24.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.23 -0.441 . . . . 52.03 111.133 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -47.37 143.12 5.48 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.637 0.732 . . . . 62.54 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 112.68 3.15 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 64.23 112.378 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.632 HG22 HD21 ' A' ' 164' ' ' LEU . 24.7 m -115.93 133.81 55.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 72.4 111.125 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.765 HG12 ' HG3' ' A' ' 163' ' ' GLN . 17.2 m -124.08 150.15 28.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 72.2 111.152 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.738 ' HB3' HD22 ' A' ' 164' ' ' LEU . 35.0 p90 -108.48 160.83 15.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 74.53 110.87 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -143.94 130.09 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 74.31 110.895 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -110.04 95.68 5.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.123 -0.489 . . . . 71.24 110.903 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.556 HD12 HG22 ' A' ' 138' ' ' ILE . 15.7 mt -75.62 151.91 6.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 63.42 111.104 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -129.52 168.49 16.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 65.01 111.051 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.419 HG22 ' HB2' ' A' ' 17' ' ' LEU . 2.9 m -149.73 109.78 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 74.05 111.098 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 70.19 34.93 2.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.466 . . . . 72.23 110.919 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 10.99 84.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.759 -0.734 . . . . 24.15 112.457 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HG2' HG23 ' A' ' 12' ' ' VAL . 1.4 pt-20 -120.3 147.53 45.25 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.672 0.749 . . . . 62.25 110.876 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 145.21 56.63 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.674 2.249 . . . . 62.03 112.336 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' HB2' HG22 ' A' ' 12' ' ' VAL . 18.7 tp -132.97 8.32 4.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.212 -0.449 . . . . 64.11 110.969 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 114.39 -166.15 12.13 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.737 -0.744 . . . . 24.34 112.494 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.96 151.35 28.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.85 0.357 . . . . 72.12 110.888 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 138' ' ' ILE . 25.9 m -124.95 170.2 15.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.176 -0.465 . . . . 52.44 111.146 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.436 ' OG ' HD21 ' A' ' 164' ' ' LEU . 14.0 t -122.72 151.33 41.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 73.15 110.875 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.581 ' O ' HG23 ' A' ' 5' ' ' THR . 20.0 m-85 -126.4 134.43 51.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 53.35 110.916 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -108.79 105.72 15.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.902 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.6 mt -87.12 138.6 31.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.882 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -90.72 83.3 5.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.163 -0.471 . . . . 73.03 110.842 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.93 0.92 22.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 61.44 111.104 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -87.2 -34.23 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.212 -0.449 . . . . 71.15 110.866 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.2 mttm -97.51 -27.14 14.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 70.25 110.912 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.56 79.46 24.39 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.599 0.714 . . . . 73.21 111.138 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.8 -19.25 36.17 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.684 2.256 . . . . 72.03 112.336 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.54 -43.65 31.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 52.22 110.917 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.492 HG22 ' CZ ' ' A' ' 129' ' ' PHE . 0.3 OUTLIER -74.65 -53.19 9.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 73.4 111.122 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -53.74 -21.65 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 75.13 111.099 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -78.98 -38.16 37.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 74.53 110.906 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -71.33 -61.86 1.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 72.34 110.903 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 17.7 t80 -51.51 -25.23 6.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 64.21 110.889 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -36.12 83.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 75.34 110.867 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.61 -21.05 35.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.24 111.104 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.422 HD13 ' HB2' ' A' ' 110' ' ' SER . 83.1 mt -75.29 -60.44 2.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.929 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -55.96 -41.45 74.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 64.02 110.896 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.8 p -84.53 -12.78 53.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 73.33 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 44.14 83.66 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 51.11 112.495 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -131.8 32.03 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.91 0.386 . . . . 73.0 110.909 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -130.1 32.54 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 61.34 110.903 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 92.61 -26.68 13.0 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 52.12 112.482 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.4 p90 -147.75 -170.54 3.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 75.01 110.848 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.57 176.6 37.18 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.732 -0.747 . . . . 72.02 112.502 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -63.68 -18.07 63.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.93 0.395 . . . . 73.41 110.894 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.38 136.55 7.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 64.41 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.4 58.58 8.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.719 -0.753 . . . . 63.24 112.509 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.443 ' OG ' HD13 ' A' ' 158' ' ' ILE . 82.7 p -145.07 -166.27 2.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.826 0.346 . . . . 44.11 110.888 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.96 169.06 24.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.162 -0.472 . . . . 65.31 110.869 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.56 ' CE1' HD11 ' A' ' 158' ' ' ILE . 53.6 m-85 -104.18 -67.82 0.88 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.35 110.86 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 59.65 20.64 9.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.12 -0.491 . . . . 62.23 110.857 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.1 tpp85 -146.97 115.63 6.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.898 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -156.23 156.35 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.225 -0.443 . . . . 74.2 111.128 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.3 mt -137.97 112.88 8.95 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.634 0.73 . . . . 75.21 111.112 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 86.31 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.693 2.262 . . . . 71.31 112.384 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.75 9.05 8.57 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.724 -0.751 . . . . 65.12 112.487 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -129.22 -69.98 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 73.51 110.867 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.95 -164.54 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 55.22 110.885 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.608 ' HB3' HG23 ' A' ' 114' ' ' ILE . 19.0 t -151.48 121.57 7.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.869 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -92.91 134.71 34.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 72.23 110.943 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -56.38 -50.59 61.55 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.778 -0.725 . . . . 52.54 112.5 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.72 -91.87 2.24 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 72.43 112.461 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 p30 177.36 65.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.84 0.352 . . . . 74.41 110.828 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -148.68 -74.93 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 73.12 110.887 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.421 HG21 ' HB1' ' A' ' 101' ' ' ALA . 99.6 m -55.61 114.27 1.79 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 74.1 111.166 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.0 tpt85 -113.62 -27.48 7.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 61.13 110.831 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 177.41 35.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.896 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -177.03 -40.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 71.31 110.888 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 65.68 139.63 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 40.31 112.517 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.9 p -110.2 -33.74 6.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 64.51 111.116 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -166.07 -163.01 18.76 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.705 -0.76 . . . . 75.34 112.462 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . 159.03 -21.25 0.29 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.739 . . . . 70.14 112.502 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER 66.9 139.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 72.42 110.854 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.82 -179.13 3.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 75.22 110.83 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.2 pt -78.78 -5.76 8.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 64.51 111.156 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -137.99 28.1 2.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.199 -0.455 . . . . 73.41 110.9 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.0 -126.18 3.02 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 74.42 112.458 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -144.49 13.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 73.24 110.908 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -171.44 126.55 0.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 72.21 110.929 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 21.9 t80 -119.03 143.83 46.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.211 -0.45 . . . . 62.1 110.9 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -66.43 156.5 34.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 75.12 110.899 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 23.4 m-20 -78.03 134.68 37.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 71.35 110.884 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.25 -61.98 1.58 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 72.14 110.902 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -173.94 148.21 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.892 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.52 49.97 1.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 75.21 110.909 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.745 HG21 ' HG2' ' A' ' 28' ' ' LYS . 32.6 mm -72.5 -15.93 17.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 74.32 111.149 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.533 ' HB3' HG13 ' A' ' 128' ' ' VAL . 1.0 OUTLIER -104.75 137.7 42.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 71.14 110.88 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.7 mtpp -129.0 104.89 7.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.914 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.706 ' CB ' HG21 ' A' ' 97' ' ' ILE . 11.9 p80 -67.63 103.57 1.4 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 71.13 110.816 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.3 p -130.58 39.63 3.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 73.42 111.13 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.8 163.8 32.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.718 -0.753 . . . . 74.42 112.482 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 146.26 59.6 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.738 2.292 . . . . 74.3 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.02 13.71 65.91 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.71 -0.757 . . . . 70.33 112.474 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.754 HD13 ' HB3' ' A' ' 131' ' ' LYS . 28.6 mm -89.27 138.61 18.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.832 0.349 . . . . 63.15 111.123 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 98' ' ' LEU . 6.1 tt -93.99 114.6 26.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.469 . . . . 75.14 110.896 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 113' ' ' PHE . 0.1 OUTLIER -113.66 140.29 48.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.173 -0.467 . . . . 64.53 110.864 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.451 ' HE3' ' CG2' ' A' ' 32' ' ' THR . 3.5 mmt -69.55 145.5 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 74.44 110.849 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.482 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -138.14 139.05 39.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 50.24 111.124 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' OD1' HG22 ' A' ' 107' ' ' THR . 0.4 OUTLIER 174.63 -69.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.255 -0.429 . . . . 72.21 110.908 -179.911 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.62 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -136.42 -40.49 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 64.54 111.114 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.76 -69.02 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.723 -0.751 . . . . 52.34 112.448 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.72 -104.58 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.698 2.265 . . . . 71.5 112.356 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -90.77 62.95 5.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 75.12 110.887 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.62 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -156.84 68.9 0.58 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 74.2 111.122 -179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -44.66 -60.73 1.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 62.32 110.873 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.59 43.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.72 -0.753 . . . . 63.34 112.448 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.422 ' HB2' HD13 ' A' ' 39' ' ' LEU . 2.7 p -129.04 9.94 5.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.806 0.336 . . . . 72.03 110.851 -179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.482 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -72.26 -166.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 64.11 110.931 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.419 ' CZ ' HD12 ' A' ' 98' ' ' LEU . 1.9 t80 -143.87 128.16 17.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.908 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.426 ' HB3' ' O ' ' A' ' 99' ' ' SER . 32.8 t80 -123.25 106.85 11.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 63.55 110.888 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.608 HG23 ' HB3' ' A' ' 62' ' ' CYS . 7.5 tt -120.55 103.8 14.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.119 -0.491 . . . . 71.42 111.181 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -85.44 153.11 22.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 61.01 110.91 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.55 28.95 7.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 73.35 111.119 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.93 165.11 5.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.216 -0.447 . . . . 43.23 111.067 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.4 tttt -61.78 96.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 51.24 110.904 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.457 HG22 ' CE3' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -122.9 62.43 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 71.11 111.155 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.53 25.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.194 -0.457 . . . . 73.3 110.902 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.457 ' CE3' HG22 ' A' ' 119' ' ' THR . 4.2 m-90 -69.9 -22.88 63.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 72.3 110.934 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.512 HD13 ' NE2' ' A' ' 126' ' ' HIS . 63.0 mt -116.63 34.68 4.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 74.42 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.6 p-10 -86.99 44.42 1.17 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 73.12 110.844 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -175.06 52.41 0.13 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.776 -0.726 . . . . 71.3 112.526 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 tppt? -171.34 -45.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 72.41 110.894 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.512 ' NE2' HD13 ' A' ' 122' ' ' LEU . 2.0 m-70 -98.49 142.34 30.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.259 -0.428 . . . . 61.12 110.863 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.6 t -74.78 90.61 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 63.31 111.1 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 90' ' ' LEU . 2.8 p -82.53 143.56 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 75.14 111.151 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.492 ' CZ ' HG22 ' A' ' 32' ' ' THR . 2.5 p90 -176.51 134.66 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 73.33 110.875 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 96.31 137.99 9.65 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.717 -0.754 . . . . 54.03 112.487 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.754 ' HB3' HD13 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -149.37 172.05 15.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.817 0.341 . . . . 54.31 110.907 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.0 p -85.96 139.04 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 72.2 111.105 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 2.9 ptmt -117.9 -29.85 5.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 54.01 110.874 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.56 158.33 36.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.201 -0.454 . . . . 63.14 110.879 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.409 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 58.71 85.61 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 55.24 112.484 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.6 mmm -92.04 -24.15 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.764 0.316 . . . . 72.54 110.848 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.407 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 1.9 p-10 -80.57 -34.53 35.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 73.52 110.877 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.556 HG22 HD12 ' A' ' 10' ' ' ILE . 46.6 mm -39.42 -48.07 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 65.32 111.132 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 114' ' ' ILE . 91.7 t -90.36 -50.8 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 60.41 111.135 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 12.1 mm-40 -44.68 -59.77 2.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.152 -0.476 . . . . 74.14 110.88 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.27 -47.74 78.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 72.03 111.082 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.522 ' SD ' HD13 ' A' ' 156' ' ' ILE . 8.1 tmm? -50.08 -45.04 52.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.445 . . . . 73.31 110.894 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.98 -27.76 14.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 64.34 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 12.8 ttt85 -63.31 -25.45 68.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 74.41 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -90.52 21.92 3.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 62.1 110.872 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -106.89 -159.03 21.52 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.704 -0.76 . . . . 53.21 112.52 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 3.3 t -155.47 147.59 23.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.865 0.364 . . . . 71.41 110.836 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 25.2 mmm-85 -76.34 64.24 2.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 63.43 110.869 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -176.19 -35.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 75.12 110.844 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 143.63 -52.47 0.62 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.684 -0.769 . . . . 71.35 112.454 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.04 112.13 0.74 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.856 0.36 . . . . 61.11 110.905 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.589 HG22 ' H ' ' A' ' 154' ' ' LYS . 28.1 m -77.88 127.96 33.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 62.3 111.166 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.4 m -46.15 -32.07 2.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 33.33 110.86 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.589 ' H ' HG22 ' A' ' 152' ' ' THR . 2.8 mttt -133.51 -178.56 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.128 -0.487 . . . . 61.04 110.871 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.8 tptp -98.82 107.28 19.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 55.45 110.938 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.522 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.0 mt -98.3 108.73 22.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 73.43 111.147 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.479 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 1.1 t -119.24 156.93 29.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.34 111.148 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.56 HD11 ' CE1' ' A' ' 53' ' ' PHE . 3.5 mp -83.48 139.99 16.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 75.21 111.139 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -96.73 -59.03 1.9 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 74.13 111.124 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -154.74 161.81 41.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 73.33 110.862 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 63.5 m -146.64 -168.59 3.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 73.32 110.894 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.68 -165.58 26.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 74.44 112.523 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.765 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.2 mt-30 -113.09 138.82 49.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.841 0.353 . . . . 62.43 110.944 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.738 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -121.36 156.2 33.13 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 73.33 110.913 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.852 179.961 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.797 0.332 . . . . 40.53 110.902 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 61.5 t -109.59 141.64 24.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 74.23 111.111 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -54.62 145.83 37.91 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.635 0.731 . . . . 72.0 110.905 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 121.59 8.28 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.715 2.277 . . . . 72.42 112.301 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.818 HG22 HD21 ' A' ' 164' ' ' LEU . 37.8 m -106.64 128.04 53.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.184 -0.462 . . . . 74.42 111.138 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.557 ' CG1' HD11 ' A' ' 24' ' ' LEU . 3.3 m -111.73 141.99 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 63.23 111.164 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.809 ' HB3' HD22 ' A' ' 164' ' ' LEU . 4.8 p90 -122.35 160.22 25.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.475 . . . . 74.23 110.902 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 161' ' ' CYS . 11.3 m-85 -142.03 143.1 32.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.929 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -109.21 82.07 1.54 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.199 -0.455 . . . . 73.11 110.835 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.1 mm -53.9 147.43 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 73.23 111.095 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -121.24 150.56 41.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 72.32 111.126 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.477 HG21 HD22 ' A' ' 17' ' ' LEU . 67.0 t -135.81 97.39 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 73.1 111.121 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.87 24.41 11.28 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.187 -0.46 . . . . 45.04 110.841 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.18 -15.09 59.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 64.31 112.48 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -108.34 143.0 26.55 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.646 0.736 . . . . 74.55 110.881 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 152.82 68.97 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.661 2.241 . . . . 75.14 112.339 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD22 HG21 ' A' ' 12' ' ' VAL . 17.5 tp -129.63 -0.38 4.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.31 110.905 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.588 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 138.48 171.71 12.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.773 -0.727 . . . . 51.51 112.508 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ptt-85 -105.99 127.41 53.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.849 0.357 . . . . 60.3 110.855 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG2' HG21 ' A' ' 138' ' ' ILE . 34.0 t -113.18 100.18 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 71.31 111.137 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.8 p -102.17 142.44 33.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 71.35 110.819 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -144.52 104.5 4.06 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.12 -0.491 . . . . 72.35 110.891 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -51.86 167.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.112 -0.495 . . . . 72.21 110.833 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.557 HD11 ' CG1' ' A' ' 6' ' ' VAL . 59.9 mt -117.46 126.85 53.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.11 -0.495 . . . . 74.5 110.93 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.683 ' CZ ' HD21 ' A' ' 90' ' ' LEU . 23.0 m-85 -77.33 59.02 1.75 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 73.03 110.899 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.06 -7.51 52.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 73.31 111.121 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -83.85 -65.05 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 74.02 110.93 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -53.18 -61.22 2.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.911 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.413 ' O ' HG23 ' A' ' 29' ' ' VAL . 6.2 m -109.53 83.29 2.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.648 0.737 . . . . 55.32 111.121 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 78.97 0.97 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 52.42 112.351 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 176.31 -64.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.869 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.08 -47.17 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 60.52 111.11 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -54.31 -33.96 59.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.5 111.096 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.61 -31.75 38.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.51 110.926 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.671 ' ND2' HG23 ' A' ' 78' ' ' ILE . 11.3 t-20 -77.49 -67.31 0.73 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 74.1 110.908 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.18 -43.33 52.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 74.13 110.849 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.552 ' HB3' HD13 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -63.36 -29.61 70.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 60.22 110.861 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.498 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.89 -43.33 20.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 35.24 111.131 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.98 -38.41 82.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.41 110.907 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.1 m -69.55 -47.88 62.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 51.1 110.893 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.1 p -72.34 -13.52 61.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.493 . . . . 72.25 111.121 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.51 69.82 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 75.12 112.506 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.1 41.56 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.931 0.396 . . . . 74.21 110.932 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.789 ' HD2' HD12 ' A' ' 78' ' ' ILE . 5.9 mtpm? -130.09 -2.63 4.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.168 -0.469 . . . . 73.11 110.914 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.73 -14.06 65.11 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 73.31 112.488 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.64 -33.85 76.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 65.53 110.936 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 48' ' ' TYR . . . 85.27 -141.32 19.01 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.741 . . . . 71.11 112.482 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CB ' ' O ' ' A' ' 47' ' ' GLY . 1.3 t80 82.56 85.23 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.94 0.4 . . . . 72.2 110.884 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.17 -47.95 4.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.098 -0.501 . . . . 73.32 110.871 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -125.29 113.33 1.89 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.725 -0.75 . . . . 53.53 112.512 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.3 p -88.11 -168.61 2.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.855 0.36 . . . . 64.1 110.833 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 p -139.52 96.0 3.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.116 -0.493 . . . . 64.14 110.911 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' HZ ' HD11 ' A' ' 158' ' ' ILE . 34.2 m-85 -81.37 107.11 13.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.448 . . . . 64.11 110.858 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -133.29 29.84 3.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 73.53 110.873 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.05 24.4 3.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 75.21 110.887 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.1 mt -76.43 141.73 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 75.13 111.107 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.559 HD12 ' HE3' ' A' ' 61' ' ' MET . 4.4 mt -131.95 110.36 14.34 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.606 0.717 . . . . 74.35 111.15 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.71 89.78 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.657 2.238 . . . . 74.45 112.403 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.7 14.86 4.14 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.748 . . . . 75.31 112.5 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 -64.51 0.34 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.877 0.37 . . . . 75.34 110.87 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.559 ' HE3' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -177.16 -169.46 0.24 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.097 -0.501 . . . . 72.14 110.883 179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 13.8 m -146.4 142.91 28.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 62.22 110.874 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.34 140.37 51.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 71.4 110.925 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 65' ' ' GLY . . . -116.93 109.16 1.86 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.78 -0.724 . . . . 44.32 112.466 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 64' ' ' GLY . . . 37.47 43.62 1.11 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.702 -0.761 . . . . 73.03 112.498 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -53.25 137.99 33.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.854 0.359 . . . . 72.31 110.848 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -71.36 175.01 5.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 75.51 110.93 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.1 p -90.57 -81.08 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 62.24 111.176 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 52.88 92.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 52.41 110.872 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -47.24 102.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 73.42 110.861 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -179.68 -53.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.925 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.85 -71.33 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.748 -0.739 . . . . 64.54 112.506 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.9 m -110.32 -41.07 4.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 74.22 111.157 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.43 161.34 21.8 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.742 -0.742 . . . . 65.11 112.475 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 128.27 114.81 1.83 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.728 -0.748 . . . . 51.54 112.481 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 3.7 ptmt -111.57 174.78 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.833 0.349 . . . . 73.11 110.874 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.3 t -87.92 -174.9 4.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 62.14 110.835 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 44' ' ' LYS . 27.9 pt -80.35 -32.78 13.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.125 -0.489 . . . . 75.43 111.126 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 54.5 m-85 -89.19 44.29 1.2 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 71.22 110.932 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 67.21 -109.17 2.76 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 52.51 112.494 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -52.56 174.75 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.928 0.395 . . . . 75.42 110.851 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.456 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -97.3 -172.19 2.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 71.42 110.883 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.89 145.17 41.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.853 179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -60.61 176.17 0.4 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 74.02 110.882 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -95.4 126.4 40.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 72.53 110.853 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -74.27 -48.71 26.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 62.12 110.885 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -175.19 149.27 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 71.42 110.862 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.02 46.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 72.43 110.881 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 89' ' ' ILE . 0.3 OUTLIER -62.37 -14.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 64.03 111.163 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -119.43 125.67 49.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 65.4 110.893 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.75 -164.81 1.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 64.24 110.891 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.437 ' CE1' HG21 ' A' ' 128' ' ' VAL . 65.6 m80 -97.42 65.39 1.93 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 65.22 110.897 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.71 -20.05 53.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 74.21 111.126 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.23 174.77 46.55 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.734 -0.746 . . . . 73.13 112.48 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 133.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.667 2.245 . . . . 61.22 112.379 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 126.02 -30.6 4.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.746 -0.74 . . . . 41.24 112.485 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 98' ' ' LEU . 14.1 mm -62.8 158.96 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.911 0.386 . . . . 70.4 111.114 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.615 HD23 ' CD2' ' A' ' 112' ' ' PHE . 5.8 mp -107.05 147.97 29.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.15 110.893 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.57 150.03 49.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 63.0 110.843 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 38.1 mmt -79.37 106.38 11.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.12 -0.491 . . . . 75.1 110.844 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -98.67 73.57 2.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.08 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 103' ' ' ALA . 34.3 t-20 -105.02 -81.79 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 71.21 110.924 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 102' ' ' ASN . . . 176.8 93.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 61.5 111.129 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 78.31 171.34 38.35 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 65.11 112.476 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 161.19 46.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 54.11 112.335 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 65.58 32.41 9.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 74.21 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.456 HG22 ' HG3' ' A' ' 82' ' ' LYS . 29.2 p -148.02 69.52 1.12 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 72.12 111.13 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.55 18.46 0.23 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.21 -0.45 . . . . 73.21 110.911 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 107' ' ' THR . . . -63.74 -144.16 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.8 -0.714 . . . . 74.41 112.434 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 t 51.68 -150.92 0.27 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 72.35 110.897 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.415 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -116.52 -77.89 0.57 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.158 -0.473 . . . . 64.15 110.931 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.615 ' CD2' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 176.53 172.94 0.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 70.03 110.852 -179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -156.58 138.66 14.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.128 -0.487 . . . . 72.44 110.891 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.4 mt -98.68 114.26 35.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 64.12 111.119 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 19.5 p -71.43 -27.23 63.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 61.45 110.903 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.4 p 57.53 17.08 3.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 62.3 111.132 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 119' ' ' THR . . . -167.56 137.48 2.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.247 -0.433 . . . . 75.01 111.09 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -51.21 129.99 25.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 63.14 110.916 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 117' ' ' ALA . 71.6 p -131.5 59.29 1.7 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 64.42 111.144 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 11.7 tm-20 -51.24 -24.0 3.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 63.32 110.893 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 5.1 m-90 -63.13 -30.29 71.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 64.51 110.914 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 24.8 mt -111.68 64.84 0.62 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.896 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -110.74 15.89 21.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 72.31 110.809 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -150.64 31.41 1.02 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.731 -0.747 . . . . 63.22 112.487 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -126.17 -62.41 1.16 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 72.54 110.874 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -98.0 121.72 40.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 72.32 110.854 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.437 ' O ' HG12 ' A' ' 127' ' ' VAL . 29.9 t -58.45 96.31 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 71.32 111.095 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.569 HG13 ' O ' ' A' ' 98' ' ' LEU . 40.0 t -86.79 128.22 39.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.459 . . . . 72.52 111.071 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.661 ' HA ' HD22 ' A' ' 90' ' ' LEU . 12.5 p90 -158.5 43.33 0.27 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.862 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.421 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -119.19 -168.45 14.03 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.751 -0.737 . . . . 73.34 112.467 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.463 ' H ' HD13 ' A' ' 98' ' ' LEU . 17.5 ttpp 178.48 150.5 0.25 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.834 0.35 . . . . 74.22 110.909 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 96' ' ' GLY . 79.4 t -92.26 85.63 2.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 74.52 111.114 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.91 -66.77 0.34 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 74.52 110.892 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -143.02 123.11 13.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.878 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.44 73.25 0.12 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 44.03 112.497 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -93.55 -28.69 15.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.789 0.328 . . . . 60.43 110.859 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -70.07 -34.91 73.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 73.31 110.903 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.588 HD11 ' HA3' ' A' ' 18' ' ' GLY . 29.1 mm -66.77 -38.01 80.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 63.35 111.139 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.482 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.0 t -81.46 -0.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 54.0 111.14 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 mm-40 -117.7 -65.37 1.19 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 41.41 110.859 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.45 -57.94 10.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 54.21 111.072 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.487 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.4 ttm -50.7 -29.97 12.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.266 -0.425 . . . . 65.22 110.89 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -34.54 78.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.204 -0.453 . . . . 72.43 110.866 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 mtp180 -62.45 -13.47 30.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 73.33 110.856 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -86.18 17.1 3.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 71.11 110.89 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.15 -146.07 19.61 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 71.23 112.489 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -152.51 -87.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.854 0.359 . . . . 70.31 110.883 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -156.04 -45.26 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 74.13 110.874 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -115.12 19.94 15.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 70.44 110.871 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 111.56 -157.72 14.78 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.773 -0.727 . . . . 44.42 112.548 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 15.7 mttt 63.15 101.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.904 0.383 . . . . 63.24 110.896 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.582 HG21 HD12 ' A' ' 156' ' ' ILE . 33.8 p -84.02 155.45 22.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.232 -0.44 . . . . 73.34 111.148 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -74.98 -17.21 60.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 62.13 110.869 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.5 mmtt -126.92 -165.92 1.52 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.883 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -115.55 106.24 13.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 44.24 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.582 HD12 HG21 ' A' ' 152' ' ' THR . 16.4 mt -94.03 122.73 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.444 . . . . 73.04 111.141 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.4 p -139.02 169.52 17.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 72.01 111.146 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.543 HD11 ' HZ ' ' A' ' 53' ' ' PHE . 20.1 mt -107.04 99.2 8.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 72.52 111.165 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.89 -57.53 8.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.216 -0.447 . . . . 45.05 111.127 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -133.15 168.64 18.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.2 110.845 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.405 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 14.1 p -176.95 -167.74 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 61.3 110.864 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.82 -152.06 16.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.76 -0.733 . . . . 44.02 112.512 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -108.69 129.72 55.35 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 72.53 110.913 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.818 HD21 HG22 ' A' ' 5' ' ' THR . 1.5 pt? -100.06 -29.45 12.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 72.23 110.898 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.03 110.864 179.948 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mmm . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.882 0.372 . . . . 74.32 110.872 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.93 155.83 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 64.13 111.134 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -97.76 159.39 31.08 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.57 0.7 . . . . 71.4 110.895 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 148.57 65.44 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.67 2.247 . . . . 71.21 112.378 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 ' C ' HG22 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -135.51 173.74 11.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 61.33 111.118 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.573 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -167.2 143.45 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 64.34 111.108 179.924 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -124.36 154.57 40.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 72.24 110.83 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -135.98 132.49 36.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.099 -0.5 . . . . 65.55 110.896 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -89.23 108.39 19.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 74.12 110.824 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.2 mm -80.96 110.11 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 64.22 111.169 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -113.15 172.66 6.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 70.41 111.133 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.27 94.91 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.249 -0.432 . . . . 72.32 111.08 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 72.09 56.25 0.16 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.151 -0.477 . . . . 74.42 110.858 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.51 11.63 57.1 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 52.04 112.422 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -123.69 107.37 31.53 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.638 0.732 . . . . 53.44 110.875 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.8 Cg_endo -69.81 138.56 37.95 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.634 2.223 . . . . 74.53 112.349 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.9 mt -103.31 -53.23 2.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 73.54 110.871 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -169.5 -154.23 9.04 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.711 -0.757 . . . . 75.4 112.491 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 168.12 24.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.87 0.367 . . . . 71.43 110.883 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.81 -177.26 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 72.21 111.123 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.1 t -130.09 96.88 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 65.24 110.826 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -93.34 115.26 27.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.168 -0.469 . . . . 70.2 110.909 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.402 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 0.8 OUTLIER -113.32 113.88 25.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 42.2 110.884 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.682 HD22 ' CD2' ' A' ' 129' ' ' PHE . 23.8 mt -80.25 140.01 36.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 73.55 110.894 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.491 ' O ' HG22 ' A' ' 29' ' ' VAL . 45.0 m-85 -88.37 82.58 6.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 70.3 110.848 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -29.86 71.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 62.41 111.104 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.28 -28.19 68.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.247 -0.433 . . . . 54.24 110.831 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.845 ' HG3' HD21 ' A' ' 90' ' ' LEU . 5.0 mmtt -96.88 -34.55 11.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 73.31 110.898 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.776 HG21 ' CB ' ' A' ' 129' ' ' PHE . 15.5 m -131.9 88.79 40.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 71.24 111.152 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -35.63 12.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.661 2.241 . . . . 73.31 112.336 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -81.92 -48.48 11.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 73.03 110.882 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 32' ' ' THR . 21.6 m -76.7 7.93 4.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.226 -0.443 . . . . 73.55 111.132 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.722 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -81.18 -40.98 23.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 72.44 111.125 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' O ' ' C ' ' A' ' 35' ' ' ASN . 13.5 pt-20 -90.76 -32.6 16.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.215 -0.448 . . . . 61.0 110.864 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.477 ' C ' ' O ' ' A' ' 34' ' ' GLU . 54.4 t-20 -30.87 -70.71 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.01 110.881 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -71.44 -30.95 66.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 63.23 110.89 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.427 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.5 tmm_? -50.21 -43.1 52.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.488 . . . . 73.51 110.923 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -68.06 -32.34 72.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 71.32 111.122 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.746 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.5 OUTLIER -99.8 21.56 12.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 74.22 110.903 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.573 ' OG ' HG11 ' A' ' 6' ' ' VAL . 36.2 t -127.61 -26.67 2.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 75.2 110.843 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -109.89 -16.53 13.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 64.14 111.098 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.63 86.75 1.22 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 72.53 112.475 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -170.23 46.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.919 0.39 . . . . 73.2 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.79 20.73 3.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.12 110.9 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.92 -26.18 2.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.795 -0.717 . . . . 64.0 112.465 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -147.86 -176.34 5.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.913 0.387 . . . . 73.23 110.871 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 133.92 -144.49 16.45 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 43.01 112.494 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -168.84 174.22 6.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.988 0.423 . . . . 73.23 110.918 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.95 14.43 0.82 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.122 -0.49 . . . . 74.24 110.927 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.444 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -158.82 44.36 0.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.719 -0.753 . . . . 72.11 112.494 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 59.8 p -89.99 133.53 34.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 73.14 110.873 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 64.7 m -51.89 172.03 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.119 -0.491 . . . . 73.21 110.866 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -121.97 73.37 1.08 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 73.51 110.838 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -70.61 175.24 5.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.149 -0.478 . . . . 72.54 110.842 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.88 104.32 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.827 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.1 mt -148.51 132.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 61.33 111.135 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.551 HD11 ' SD ' ' A' ' 61' ' ' MET . 7.8 pt -154.17 109.14 2.45 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.578 0.704 . . . . 73.33 111.147 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.76 126.69 13.61 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.654 2.236 . . . . 61.12 112.347 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 123.1 -36.45 3.07 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.742 -0.742 . . . . 72.44 112.491 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -109.4 -75.16 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.875 0.369 . . . . 75.01 110.843 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.551 ' SD ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -148.22 -164.5 2.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 53.42 110.927 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 39.4 m -125.51 -70.38 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 51.25 110.878 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 65.37 153.81 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 63.34 110.951 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.82 -154.9 25.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.751 -0.737 . . . . 73.42 112.527 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.83 65.21 2.77 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.755 -0.736 . . . . 71.33 112.456 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -80.3 162.92 24.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.838 0.351 . . . . 61.52 110.895 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.648 ' CD1' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -145.35 -170.43 3.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.231 -0.441 . . . . 72.24 110.864 -179.906 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.744 HG22 ' C ' ' A' ' 73' ' ' THR . 3.3 p 68.44 36.84 2.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 63.42 111.147 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 -69.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.238 -0.437 . . . . 75.0 110.881 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -74.61 -18.67 60.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 74.23 110.905 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -115.71 -54.87 2.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 65.25 110.886 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.23 4.93 23.56 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.771 -0.728 . . . . 72.13 112.494 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.744 ' C ' HG22 ' A' ' 68' ' ' THR . 5.1 t -125.26 156.22 38.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.862 0.363 . . . . 44.33 111.154 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 141.53 -36.18 1.74 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.73 -0.748 . . . . 61.43 112.444 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.05 74.87 1.16 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 63.03 112.473 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.9 ptpt 178.42 -98.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.827 0.346 . . . . 74.14 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.8 t -145.16 120.0 9.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.244 -0.435 . . . . 71.32 110.856 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.746 HG21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 pp -55.84 -19.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 75.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.58 -22.0 14.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 74.12 110.948 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.24 -112.8 0.35 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.729 -0.748 . . . . 55.45 112.501 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -108.96 -66.33 1.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.923 0.392 . . . . 73.43 110.872 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.9 pttt -159.96 155.77 26.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.31 110.882 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -112.65 171.27 7.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 70.44 110.849 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -83.71 142.49 30.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 51.45 110.878 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -57.62 141.84 46.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 73.2 110.854 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -102.91 -64.97 1.03 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.44 110.841 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -176.29 165.81 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.864 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -130.17 45.69 2.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 75.12 110.894 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.401 ' O ' HG22 ' A' ' 89' ' ' ILE . 32.9 mt -68.88 -11.27 14.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.23 111.123 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.845 HD21 ' HG3' ' A' ' 28' ' ' LYS . 8.0 mt -98.18 70.12 2.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.946 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mptp? -61.35 130.32 45.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 74.3 110.869 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.97 90.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 74.15 110.83 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.1 p -99.28 31.69 3.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.214 -0.448 . . . . 54.21 111.163 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 152.69 177.47 26.35 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 54.13 112.454 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 176.24 7.07 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.677 2.252 . . . . 62.03 112.34 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.33 14.07 66.02 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.719 -0.753 . . . . 71.33 112.457 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.8 mm -86.99 125.49 40.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.823 0.344 . . . . 73.51 111.174 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.813 HD22 ' O ' ' A' ' 129' ' ' PHE . 3.1 tt -93.05 137.81 32.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 62.53 110.927 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.475 ' N ' HD23 ' A' ' 98' ' ' LEU . 13.8 t -141.67 -130.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 55.32 110.826 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.411 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 5.9 mmt -149.94 -175.05 4.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 54.13 110.844 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -169.05 147.28 3.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 74.31 111.137 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.8 m-20 166.5 -78.69 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 54.11 110.878 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.734 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.98 -35.68 1.61 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 71.13 111.156 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.77 -127.19 2.84 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.706 -0.759 . . . . 64.22 112.499 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 149.03 66.25 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 70.34 112.352 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 51.5 29.3 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 72.1 110.92 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 103' ' ' ALA . 3.1 m -132.87 21.79 4.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.168 -0.469 . . . . 64.32 111.139 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.499 ' C ' ' O ' ' A' ' 107' ' ' THR . 3.2 m120 29.49 -98.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.461 . . . . 75.22 110.865 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 144.91 169.31 13.31 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 71.23 112.522 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.57 11.65 8.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 70.15 110.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -175.26 156.58 2.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 52.42 110.934 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.423 ' HE2' HD11 ' A' ' 114' ' ' ILE . 13.6 p90 -111.82 150.18 30.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 54.45 110.867 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.466 ' O ' ' C ' ' A' ' 114' ' ' ILE . 18.6 p90 -108.92 67.84 0.66 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 74.54 110.886 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' C ' ' O ' ' A' ' 113' ' ' PHE . 36.0 mt -32.19 115.6 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 75.44 111.148 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 66.0 m -84.13 149.26 26.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 72.43 110.843 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.4 p -113.71 18.56 17.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.144 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -166.19 -176.59 3.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 63.42 111.108 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -77.53 104.47 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 72.45 110.907 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 24.8 p -126.79 55.51 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 73.52 111.137 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -90.06 21.99 3.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.219 -0.446 . . . . 74.45 110.867 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -94.94 11.03 33.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.129 -0.487 . . . . 75.44 110.881 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.08 25.28 1.76 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.247 -0.433 . . . . 70.12 110.923 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -58.17 -65.87 0.58 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.873 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -65.87 83.99 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.752 -0.737 . . . . 71.14 112.464 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 179.38 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.798 0.332 . . . . 62.11 110.863 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -126.89 162.5 25.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 74.24 110.861 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -76.26 -166.25 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.41 111.18 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.688 ' H ' HG12 ' A' ' 127' ' ' VAL . 8.2 p -170.34 141.1 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 74.32 111.143 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.813 ' O ' HD22 ' A' ' 98' ' ' LEU . 2.6 p90 -177.66 110.19 0.07 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 73.13 110.886 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . 121.1 145.98 7.37 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.744 . . . . 73.41 112.464 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 pttt -157.68 139.53 14.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.804 0.335 . . . . 62.33 110.931 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.689 HG11 ' HG2' ' A' ' 136' ' ' MET . 25.2 t -58.45 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 75.41 111.132 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -32.83 65.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 75.33 110.928 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.96 178.31 8.99 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.25 -0.432 . . . . 73.04 110.866 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 66.15 12.17 57.21 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.719 -0.753 . . . . 53.42 112.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.689 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -56.88 -34.56 67.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.789 0.328 . . . . 75.42 110.851 -179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -54.55 -22.38 12.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 35.23 110.884 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 34.9 mm -78.11 -41.62 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 50.32 111.178 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -53.75 -47.2 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.161 -0.472 . . . . 63.25 111.136 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -54.23 -29.09 45.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 71.42 110.918 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.98 -26.7 61.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 61.42 111.129 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.2 mtm -73.48 -49.3 27.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 72.52 110.891 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.67 39.42 0.35 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 72.53 110.896 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.53 -16.42 5.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 74.33 110.818 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -130.52 13.09 5.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.234 -0.439 . . . . 54.32 110.926 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -102.45 44.82 1.44 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.733 . . . . 45.0 112.463 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t 37.45 -149.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.848 0.356 . . . . 52.01 110.877 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.464 ' C ' HG22 ' A' ' 57' ' ' ILE . 13.3 mmm-85 -141.36 18.08 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 75.32 110.892 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -128.79 -18.54 3.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 64.24 110.866 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.51 -59.55 0.48 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.739 -0.743 . . . . 75.32 112.444 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -55.78 158.48 3.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.879 0.371 . . . . 73.21 110.885 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -132.77 154.01 50.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.22 -0.446 . . . . 75.14 111.163 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.01 -21.48 59.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 64.3 110.825 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -132.28 165.93 23.05 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 75.44 110.877 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -108.47 124.07 49.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 74.42 110.881 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 4.4 mp -97.61 107.16 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 75.55 111.135 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.647 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -105.54 145.1 31.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 64.45 111.114 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.444 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 3.7 mt -90.29 139.85 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 73.4 111.137 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.92 -57.76 2.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 52.23 111.123 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -167.2 169.08 12.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 71.11 110.852 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 82.0 m -146.95 168.87 20.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 72.1 110.882 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -159.45 178.48 35.56 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.731 -0.747 . . . . 70.22 112.495 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -47.2 48.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.835 0.35 . . . . 71.44 110.859 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 2.3 mm? 61.72 108.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 62.43 110.919 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.435 . . . . 73.34 110.844 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 ttp . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.802 0.334 . . . . 62.34 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.0 t -134.75 143.88 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 70.42 111.094 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 29.9 m-20 -54.76 134.75 65.26 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.664 0.745 . . . . 75.34 110.901 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 119.23 6.21 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.703 2.268 . . . . 73.55 112.323 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 22' ' ' PHE . 62.2 m -115.05 138.79 50.47 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.146 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.6 m -122.49 147.65 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 74.44 111.136 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -107.98 146.23 32.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.886 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.21 133.12 45.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.103 -0.499 . . . . 73.33 110.879 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.82 127.6 42.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 64.05 110.89 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.34 120.15 52.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 71.23 111.147 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 15' ' ' GLU . . . -127.35 158.22 37.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 45.4 111.104 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 12' ' ' VAL . 5.9 m -129.01 106.71 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 73.14 111.129 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 71.17 35.44 1.59 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 74.12 110.863 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.19 -6.69 78.62 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 65.12 112.52 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.407 ' O ' ' HB1' ' A' ' 11' ' ' ALA . 10.4 tp10 -98.06 136.42 21.04 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.643 0.735 . . . . 75.43 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 133.72 26.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.718 2.279 . . . . 51.33 112.333 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.595 ' O ' HD12 ' A' ' 17' ' ' LEU . 3.3 tp -116.81 -34.94 4.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 64.31 110.924 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 169.8 -176.87 43.51 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.727 -0.749 . . . . 75.51 112.463 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.27 152.62 50.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.877 0.37 . . . . 75.11 110.886 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 m -136.69 173.86 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 51.22 111.128 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.0 p -139.72 143.56 37.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.5 110.883 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.419 ' O ' HG23 ' A' ' 5' ' ' THR . 3.0 m-85 -122.48 133.18 54.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 75.31 110.886 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -101.87 123.15 45.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 55.44 110.879 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.761 HD13 ' O ' ' A' ' 33' ' ' ALA . 12.2 mt -88.45 124.35 33.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 70.34 110.898 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.505 ' CE2' HD22 ' A' ' 90' ' ' LEU . 25.2 m-85 -77.01 62.86 2.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 74.43 110.835 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.455 ' HA ' ' HB2' ' A' ' 33' ' ' ALA . . . -50.25 -29.36 9.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 63.05 111.093 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.52 -45.6 91.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.22 110.847 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.476 ' HD2' HD12 ' A' ' 89' ' ' ILE . 34.0 mmtm -90.14 -31.19 17.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.245 -0.434 . . . . 53.31 110.915 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.643 HG11 ' O ' ' A' ' 128' ' ' VAL . 2.9 m -129.8 84.9 59.64 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.624 0.726 . . . . 75.45 111.092 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -31.33 20.86 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.719 2.279 . . . . 63.42 112.32 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.83 -46.24 10.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 61.34 110.869 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.57 -6.73 42.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.01 111.168 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.761 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -77.08 -40.56 45.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 63.31 111.072 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 35' ' ' ASN . 51.6 mt-10 -92.46 -44.31 8.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 72.23 110.88 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.505 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.7 t30 -28.0 -64.5 0.09 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 71.25 110.936 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.777 ' HA ' HD12 ' A' ' 39' ' ' LEU . 66.5 t80 -72.0 -37.32 69.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.887 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.0 tmm_? -51.02 -35.64 35.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 74.41 110.863 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.478 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -66.72 -32.4 73.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 61.2 111.121 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD12 ' HA ' ' A' ' 36' ' ' PHE . 8.2 mt -72.78 -54.31 9.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 51.34 110.882 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 37.3 m -56.37 -50.62 71.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 73.52 110.879 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.419 ' HA ' ' HA2' ' A' ' 162' ' ' GLY . 62.4 p -72.89 -26.92 61.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 64.14 111.171 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 60.75 101.35 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.692 -0.766 . . . . 75.32 112.482 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -149.53 34.17 0.71 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.919 0.39 . . . . 72.4 110.886 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -131.7 3.55 4.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 65.2 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 86.32 15.96 63.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.739 -0.743 . . . . 71.4 112.498 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 26.7 p90 -174.69 173.96 2.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.868 0.366 . . . . 72.22 110.906 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.89 -172.43 15.88 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.772 -0.727 . . . . 43.21 112.482 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -86.36 144.66 27.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.97 0.415 . . . . 63.22 110.89 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.49 -60.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.936 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -138.4 45.77 1.02 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.76 . . . . 73.44 112.42 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.0 m -93.59 -171.04 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.865 0.364 . . . . 70.3 110.831 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.8 m -87.65 -167.47 1.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 73.33 110.893 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -101.29 -174.09 2.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 71.23 110.842 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -107.3 -76.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.131 -0.486 . . . . 65.41 110.871 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -138.11 162.71 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 74.03 110.877 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.667 HD11 HD12 ' A' ' 156' ' ' ILE . 48.5 mt -149.83 129.9 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 63.35 111.077 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.588 HD12 ' HB3' ' A' ' 60' ' ' PHE . 1.2 pt -143.94 117.94 5.94 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.641 0.734 . . . . 71.44 111.14 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.423 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.8 Cg_endo -69.69 130.63 19.76 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.73 2.287 . . . . 62.43 112.349 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 72.68 21.7 79.47 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 53.34 112.48 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -137.62 -69.67 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.857 0.36 . . . . 74.41 110.857 -179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.541 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -170.52 -170.53 0.94 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 70.32 110.904 179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -162.51 107.72 1.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.257 -0.429 . . . . 62.34 110.847 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.41 179.74 4.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 64.21 110.901 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -170.64 175.78 44.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.761 -0.733 . . . . 33.21 112.513 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.37 58.66 8.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.73 . . . . 72.41 112.463 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -67.9 84.53 0.21 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.822 0.344 . . . . 65.1 110.849 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.8 -176.13 3.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.879 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 m 64.19 44.88 4.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.136 -0.483 . . . . 74.2 111.118 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.28 -175.65 3.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 75.03 110.867 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.484 ' O ' ' C ' ' A' ' 71' ' ' ASN . 6.9 p80 -50.92 -29.68 12.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 75.44 110.827 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 70' ' ' HIS . 13.3 t30 -30.47 -76.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 72.22 110.904 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.16 -83.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.741 -0.742 . . . . 71.22 112.474 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.3 m -120.47 124.4 45.33 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.789 0.328 . . . . 43.25 111.136 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.2 -48.37 0.48 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.728 -0.749 . . . . 74.23 112.47 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 176.55 -87.21 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.753 -0.736 . . . . 73.4 112.521 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 67.84 -75.32 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.793 0.33 . . . . 62.22 110.892 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.443 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 4.0 t -127.14 107.97 10.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 73.24 110.875 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.499 HG21 ' O ' ' A' ' 35' ' ' ASN . 8.2 pt -56.5 -19.1 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.13 111.135 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -122.64 28.94 7.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.201 -0.454 . . . . 72.1 110.919 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 161.16 -137.65 5.04 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 34.44 112.47 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.443 ' C ' ' HB3' ' A' ' 77' ' ' SER . 0.2 OUTLIER -109.95 -34.78 6.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.909 0.385 . . . . 70.53 110.899 -179.89 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.8 pttp -178.91 146.51 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 75.55 110.897 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.09 160.39 16.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 72.43 110.903 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.7 166.58 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 74.33 110.879 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -59.17 -174.17 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 63.4 110.938 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -158.85 -63.65 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 71.54 110.884 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -177.74 161.9 1.69 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 75.22 110.882 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 68.32 1.46 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.866 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 28' ' ' LYS . 12.7 mt -78.16 -1.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 73.15 111.168 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.578 ' HB2' HG11 ' A' ' 128' ' ' VAL . 1.1 mt -119.24 111.67 18.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 53.55 110.904 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.65 175.08 7.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 44.21 110.922 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.8 m80 -96.85 83.76 3.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 63.15 110.822 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -115.93 21.67 13.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.24 111.162 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.79 145.76 12.64 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.732 -0.747 . . . . 70.32 112.495 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 115' ' ' CYS . 53.2 Cg_endo -69.82 -9.64 26.58 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.685 2.257 . . . . 72.51 112.315 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -100.98 -20.02 15.35 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.741 -0.743 . . . . 73.11 112.507 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.7 mm -57.56 141.67 14.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.829 0.347 . . . . 63.34 111.145 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 114' ' ' ILE . 17.3 mt -116.17 162.94 16.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 61.25 110.891 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.3 t -151.48 -142.49 0.12 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.891 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 6.3 mmt -152.12 133.73 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.135 -0.484 . . . . 74.21 110.89 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -100.16 103.44 14.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.197 -0.456 . . . . 72.32 111.071 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.452 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 1.9 p30 -131.97 -179.53 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 70.13 110.863 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.585 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -64.17 -34.5 78.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 53.43 111.128 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.417 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 119.76 -62.86 0.47 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.742 -0.742 . . . . 60.33 112.471 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.9 Cg_endo -69.75 94.61 0.53 Allowed 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.704 2.269 . . . . 54.23 112.332 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 43.17 56.64 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 73.05 110.913 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 109' ' ' GLY . 4.2 m -121.26 -1.68 9.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 65.43 111.117 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m120 47.18 -88.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 62.44 110.932 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 115.68 126.73 4.08 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.729 . . . . 71.53 112.486 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -96.15 -31.0 13.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.785 0.326 . . . . 73.32 110.86 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -83.76 145.01 28.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 73.23 110.925 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.416 ' CE2' HD13 ' A' ' 98' ' ' LEU . 2.8 p90 -131.62 179.64 5.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.46 . . . . 75.31 110.936 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -150.5 130.7 13.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.456 . . . . 64.43 110.908 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' ' CB ' ' A' ' 115' ' ' CYS . 45.2 mt -48.1 -87.52 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.142 -0.481 . . . . 75.41 111.126 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.49 ' C ' HG23 ' A' ' 116' ' ' THR . 0.5 OUTLIER 160.96 -61.95 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.165 -0.471 . . . . 63.54 110.875 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.49 HG23 ' C ' ' A' ' 115' ' ' CYS . 1.4 p 67.85 -1.39 1.71 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 54.03 111.16 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.479 ' HB2' ' O ' ' A' ' 116' ' ' THR . . . 174.95 151.45 0.11 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 53.43 111.111 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 ptmt -55.5 132.5 48.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.223 -0.444 . . . . 74.53 110.875 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 117' ' ' ALA . 69.5 p -129.95 52.62 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.164 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.3 tm-20 -49.45 -25.08 2.33 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 64.42 110.86 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -67.25 -36.57 81.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.171 -0.468 . . . . 72.32 110.939 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.2 mp -99.55 74.5 1.89 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.261 -0.427 . . . . 71.12 110.927 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 57.0 p-10 -157.65 55.87 0.49 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 63.14 110.855 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -168.56 -44.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.73 -0.748 . . . . 70.04 112.494 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -64.74 -42.98 94.8 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.81 0.338 . . . . 51.03 110.868 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -112.83 166.07 11.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.436 . . . . 73.14 110.813 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.563 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER -68.57 -149.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.159 -0.473 . . . . 44.41 111.128 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.643 ' O ' HG11 ' A' ' 29' ' ' VAL . 9.2 p -171.84 157.49 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 73.21 111.116 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.481 ' O ' ' O ' ' A' ' 130' ' ' GLY . 0.3 OUTLIER 179.4 167.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.2 110.903 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 57.03 142.74 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 61.51 112.462 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' O ' ' HG3' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -154.4 133.09 12.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.821 0.343 . . . . 73.25 110.885 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -44.94 114.48 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 64.41 111.116 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -88.43 -75.23 0.43 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 72.15 110.914 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -138.14 142.63 40.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 72.01 110.892 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.47 8.8 26.32 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.755 -0.736 . . . . 74.04 112.476 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 2.4 ttt -48.35 -32.33 7.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 61.11 110.882 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -49.31 -28.52 4.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 71.03 110.85 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.1 mm -78.21 -40.55 25.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.463 . . . . 75.31 111.146 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 49.3 t -51.0 -47.15 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 64.13 111.142 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -54.96 -36.24 65.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 63.24 110.929 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.51 -37.24 80.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 50.13 111.091 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 25.9 mtm -70.88 -19.13 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 73.3 110.876 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -89.41 21.79 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 74.33 110.921 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.38 -20.49 2.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 72.14 110.875 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -102.4 -6.02 23.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.54 110.937 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -73.01 -157.11 3.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.741 . . . . 60.34 112.513 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.17 135.28 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.879 0.371 . . . . 72.13 110.849 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 36.5 mmm-85 -70.94 79.69 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.138 -0.483 . . . . 72.01 110.864 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 175.77 -44.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 61.43 110.902 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 158.26 -61.91 0.32 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.773 -0.727 . . . . 64.1 112.474 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -74.51 -178.07 3.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 50.12 110.898 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -145.32 167.7 22.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 73.2 111.155 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.92 -21.64 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 73.42 110.819 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -131.76 -164.93 1.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 55.24 110.876 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -133.75 119.7 19.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.52 110.934 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.667 HD12 HD11 ' A' ' 56' ' ' ILE . 49.7 mt -92.71 101.44 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.438 . . . . 71.22 111.121 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.8 162.75 13.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 73.45 111.169 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 46.1 mm -109.43 142.92 20.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.439 . . . . 74.53 111.102 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -102.23 -55.35 2.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 70.43 111.09 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -142.93 179.43 7.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.926 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -170.97 -167.01 0.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.221 -0.445 . . . . 70.13 110.906 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 41' ' ' THR . . . 137.16 -148.16 19.63 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 51.55 112.475 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -112.08 136.91 50.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.13 110.869 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.1 tp -54.12 -57.0 12.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 70.31 110.924 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 62.43 110.935 179.866 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.847 0.355 . . . . 51.54 110.883 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 60.14 111.12 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.37 158.95 31.75 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.656 0.741 . . . . 52.2 110.865 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 155.77 65.08 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.684 2.256 . . . . 70.41 112.348 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -131.44 57.46 1.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 72.11 111.148 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.427 HG13 HD12 ' A' ' 24' ' ' LEU . 5.4 m -49.05 147.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.151 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.597 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -138.25 164.99 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.34 110.878 -179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -144.84 138.35 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.487 . . . . 73.51 110.902 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.694 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 1.2 t0 -101.79 91.27 4.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 62.32 110.883 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 156' ' ' ILE . 9.4 mm -59.76 143.23 14.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 74.53 111.151 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -125.63 163.39 22.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 54.23 111.136 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.4 t -151.8 104.54 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.247 -0.433 . . . . 73.13 111.14 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 52.39 46.32 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.841 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.6 10.97 83.05 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.728 . . . . 34.35 112.469 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -133.66 109.1 12.07 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.738 . . . . 72.22 110.903 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.3 Cg_endo -69.75 168.92 20.15 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.678 2.252 . . . . 63.45 112.374 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.06 -58.45 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 74.15 110.927 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.24 -167.64 27.2 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.746 -0.74 . . . . 41.41 112.49 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.7 tmm_? -100.24 127.75 46.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 61.35 110.909 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.71 ' CG2' HG21 ' A' ' 138' ' ' ILE . 7.7 t -101.65 120.16 50.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 74.22 111.124 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.8 t -94.93 84.28 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 63.32 110.835 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -94.54 95.51 8.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 55.12 110.9 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -78.41 153.64 31.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.481 . . . . 75.5 110.866 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.439 HD22 ' CE2' ' A' ' 129' ' ' PHE . 18.3 mt -115.06 133.21 56.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.148 -0.478 . . . . 55.11 110.888 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -81.54 78.64 8.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 64.13 110.879 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.9 -7.0 58.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 51.11 111.08 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.09 -61.31 1.99 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 63.42 110.879 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -53.63 -60.01 3.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 73.24 110.869 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.4 m -111.57 83.2 4.18 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.632 0.729 . . . . 75.45 111.105 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.72 78.52 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.714 2.276 . . . . 60.23 112.342 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 179.38 -59.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 70.14 110.908 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.547 HG23 ' CE ' ' A' ' 100' ' ' MET . 51.1 m -56.31 -48.57 76.43 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 65.33 111.157 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.02 87.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 63.33 111.1 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -49.85 -30.11 9.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.85 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -77.62 -61.27 2.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 64.42 110.907 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -53.9 -33.65 57.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 74.54 110.837 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.28 -27.97 69.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 65.32 110.894 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.0 -38.39 11.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 70.22 111.118 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 39' ' ' LEU . 5.2 tt -78.12 -2.6 38.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 74.44 110.924 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 29.1 t -98.93 -8.48 25.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 61.23 110.848 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 63.6 p -115.96 8.02 14.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 74.34 111.127 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.3 37.0 30.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.734 . . . . 62.24 112.456 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -110.02 30.96 6.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.904 0.383 . . . . 74.41 110.92 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.675 ' HD2' HD12 ' A' ' 78' ' ' ILE . 0.1 OUTLIER -128.27 32.13 4.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 52.51 110.89 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.3 -45.1 2.98 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.751 -0.738 . . . . 52.45 112.459 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -138.91 167.04 22.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.828 0.347 . . . . 72.31 110.892 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.67 -108.32 0.33 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.758 . . . . 74.42 112.468 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -177.25 124.25 0.14 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.389 . . . . 75.1 110.965 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.25 -26.44 13.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.163 -0.471 . . . . 74.14 110.889 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.68 -67.0 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.743 -0.741 . . . . 35.04 112.494 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.48 ' O ' HG22 ' A' ' 157' ' ' THR . 3.4 t 45.42 -160.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.842 0.353 . . . . 63.21 110.844 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.3 p -166.4 162.55 17.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 33.21 110.889 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.403 ' HE1' HD11 ' A' ' 158' ' ' ILE . 22.8 m-85 -101.78 -78.49 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.868 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 56.74 25.82 10.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 74.34 110.872 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -134.94 21.42 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 72.44 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.0 mt -76.66 138.87 19.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 72.33 111.106 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 HD12 ' CE ' ' A' ' 61' ' ' MET . 11.7 mt -121.24 102.72 42.86 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.588 0.708 . . . . 74.35 111.127 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 77.89 1.05 Allowed 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.702 2.268 . . . . 72.41 112.31 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.12 -40.82 0.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 63.14 112.494 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -64.08 1.08 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.82 0.343 . . . . 72.31 110.917 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.4 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -161.96 -167.48 1.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.88 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 t -143.45 129.56 19.69 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 74.13 110.881 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -152.92 164.28 38.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 60.42 110.895 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 159.21 39.35 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.769 -0.729 . . . . 64.41 112.54 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -143.19 8.73 2.17 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 45.03 112.516 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -78.57 156.5 29.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.892 0.377 . . . . 65.15 110.854 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -50.67 168.37 0.05 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.196 -0.456 . . . . 74.24 110.862 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.9 t -101.07 30.85 3.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.116 -0.493 . . . . 64.53 111.145 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.19 -164.14 0.93 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.895 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -166.72 -38.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 54.1 110.864 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -67.33 -55.05 15.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 63.14 110.863 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.452 ' C ' HG23 ' A' ' 73' ' ' THR . . . -161.62 160.23 32.1 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.678 -0.773 . . . . 73.24 112.411 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.452 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.4 p 66.22 32.83 7.69 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.824 0.345 . . . . 73.43 111.145 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.01 76.07 1.05 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.728 -0.749 . . . . 61.4 112.469 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.95 53.82 0.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.73 -0.748 . . . . 72.1 112.496 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -88.12 -179.78 6.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.8 0.333 . . . . 72.34 110.901 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.07 -177.4 6.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.217 -0.447 . . . . 72.35 110.855 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.675 HD12 ' HD2' ' A' ' 44' ' ' LYS . 25.2 pt -93.36 -38.09 9.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.132 -0.485 . . . . 70.41 111.144 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -80.22 -13.26 59.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.927 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 176.84 -172.32 45.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.743 -0.741 . . . . 72.33 112.529 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -58.73 -96.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.886 0.374 . . . . 65.11 110.898 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -121.44 176.71 5.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 63.41 110.89 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.487 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -149.42 153.94 38.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.915 179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.81 164.03 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.162 -0.472 . . . . 74.41 110.871 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -88.04 145.75 25.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 75.05 110.838 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -87.78 -52.32 5.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 70.32 110.874 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -179.0 163.34 1.33 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.159 -0.473 . . . . 53.34 110.921 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -107.03 36.99 2.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.877 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 89' ' ' ILE . 3.6 mm -53.19 -26.63 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 71.41 111.172 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -86.36 112.59 21.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.145 -0.48 . . . . 74.23 110.872 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' O ' HG23 ' A' ' 93' ' ' THR . 4.7 mmtt -103.04 93.83 5.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 75.1 110.926 179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.816 ' HB3' HG21 ' A' ' 97' ' ' ILE . 4.6 p80 -64.8 108.1 1.64 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 54.4 110.867 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 91' ' ' LYS . 13.3 p -128.09 33.81 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.11 111.159 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 178.58 174.63 44.98 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.759 -0.734 . . . . 53.5 112.487 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 160.2 50.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 74.13 112.333 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.43 14.54 76.05 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 65.04 112.479 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.816 HG21 ' HB3' ' A' ' 92' ' ' HIS . 44.7 mm -99.98 137.5 27.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.881 0.372 . . . . 62.32 111.154 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 99' ' ' SER . 3.1 tt -100.12 138.31 37.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 72.34 110.889 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.667 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -121.56 131.89 54.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 71.23 110.866 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.547 ' CE ' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -71.34 -27.17 63.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 74.43 110.902 179.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 61.67 167.99 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 60.13 111.087 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.405 ' HB2' HG23 ' A' ' 107' ' ' THR . 0.5 OUTLIER 169.42 -174.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.242 -0.435 . . . . 63.41 110.867 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' H ' HG23 ' A' ' 107' ' ' THR . . . -106.25 -20.14 13.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 62.4 111.116 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.489 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 130.41 -58.93 0.7 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.492 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.4 Cg_endo -69.75 83.52 0.69 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.641 2.227 . . . . 73.44 112.366 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.527 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.0 OUTLIER 27.06 82.98 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 70.2 110.926 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.528 HG23 ' H ' ' A' ' 103' ' ' ALA . 1.8 t -156.87 54.09 0.52 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 71.54 111.158 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -54.33 -40.87 68.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 60.42 110.914 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 60.76 -152.0 39.93 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.747 -0.74 . . . . 63.32 112.459 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.9 m -134.21 65.14 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.852 0.358 . . . . 42.02 110.866 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.49 -155.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.49 . . . . 71.54 110.947 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 29.9 t80 -177.4 75.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 73.41 110.91 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.494 ' CD1' ' C ' ' A' ' 113' ' ' PHE . 1.5 t80 -90.33 129.01 36.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 73.33 110.882 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 61.7 mt -107.55 130.59 59.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.4 111.166 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 2.5 t -99.98 136.71 39.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.889 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 p -120.39 -20.46 7.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 71.14 111.115 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -125.86 179.01 5.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 64.35 111.113 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.66 87.98 3.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 73.1 110.888 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.534 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 8.4 p -122.5 62.61 0.97 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 73.43 111.155 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.72 23.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 50.53 110.869 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.534 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -94.65 19.5 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mt -132.1 11.2 4.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.229 -0.442 . . . . 65.11 110.931 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -48.8 -63.44 1.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.46 . . . . 53.4 110.837 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.31 57.7 3.68 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.659 -0.781 . . . . 64.13 112.521 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tppt? -156.81 -52.36 0.08 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.82 0.343 . . . . 61.54 110.909 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 19.6 m-70 -113.98 148.26 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 64.01 110.867 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 77.8 t -90.8 107.53 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 71.53 111.076 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.784 HG21 ' HB3' ' A' ' 92' ' ' HIS . 35.7 t -83.22 140.61 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 72.45 111.172 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.439 ' CE2' HD22 ' A' ' 24' ' ' LEU . 9.3 p90 -159.93 33.65 0.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.14 110.833 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -126.16 -166.88 12.34 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.755 -0.736 . . . . 63.23 112.456 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 0.0 OUTLIER 167.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.783 0.325 . . . . 75.23 110.935 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.415 HG11 ' HG2' ' A' ' 136' ' ' MET . 44.9 t -112.73 93.85 2.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 64.43 111.157 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -52.0 -48.1 64.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.142 -0.481 . . . . 74.51 110.891 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -158.67 -175.85 5.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 73.0 110.922 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 53.17 71.48 0.68 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.709 -0.758 . . . . 64.11 112.485 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.415 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -89.53 3.38 52.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.835 0.35 . . . . 74.21 110.913 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -79.15 -28.46 42.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 64.3 110.87 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.71 HG21 ' CG2' ' A' ' 20' ' ' VAL . 23.4 mm -68.58 -36.62 75.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 73.1 111.153 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -94.68 6.06 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.127 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 -119.13 -62.0 1.57 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.32 110.865 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -53.09 50.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 53.31 111.082 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.413 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.5 tmm? -52.35 -37.02 55.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 74.52 110.862 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.15 -24.48 18.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.889 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 35.2 ttp180 -64.97 -11.23 36.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.879 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -86.06 22.35 1.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 64.22 110.866 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.93 -160.0 32.69 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.731 . . . . 64.31 112.467 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 61.7 p -151.44 -71.54 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.887 0.375 . . . . 75.12 110.853 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 177.72 -33.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.114 -0.494 . . . . 70.41 110.861 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -105.74 15.1 27.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.21 110.938 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 95.82 -38.32 3.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.75 -0.738 . . . . 70.14 112.479 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 13.9 mttm -50.44 120.56 4.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.811 0.338 . . . . 73.42 110.891 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 34.6 p -95.02 158.75 15.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 30.12 111.136 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.83 -15.94 57.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.846 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.6 170.45 15.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 54.01 110.899 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -98.49 123.3 42.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 64.4 110.914 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.413 HG23 HG23 ' A' ' 10' ' ' ILE . 3.7 mp -105.93 130.63 57.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 75.45 111.154 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 51' ' ' SER . 67.2 p -138.56 157.62 45.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 71.21 111.164 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.403 HD11 ' HE1' ' A' ' 53' ' ' PHE . 4.2 mp -90.78 93.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 75.32 111.119 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.694 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -50.77 -57.83 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.14 -0.482 . . . . 75.41 111.071 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -154.54 162.48 41.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.264 -0.425 . . . . 75.51 110.914 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.5 p -156.01 160.56 40.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.436 . . . . 75.43 110.854 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.55 172.84 45.25 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.733 -0.746 . . . . 75.43 112.482 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.7 mt-30 -68.18 -36.56 79.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.858 0.361 . . . . 54.14 110.911 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.636 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.8 mm? 73.86 -58.03 0.6 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 75.1 110.873 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.11 110.918 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 39.2 mtm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.866 0.365 . . . . 51.3 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -126.05 143.98 37.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 64.1 111.122 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -53.51 145.34 28.89 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.619 0.723 . . . . 34.01 110.895 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.4 Cg_endo -69.77 129.4 17.51 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 74.11 112.354 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.7 m -119.98 147.3 44.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 72.25 111.132 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.593 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.0 OUTLIER -128.45 165.09 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 44.45 111.11 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.421 ' CD1' HD21 ' A' ' 164' ' ' LEU . 5.6 p90 -122.54 153.79 38.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.866 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 158' ' ' ILE . 5.5 t80 -136.09 128.88 31.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.905 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.563 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 34.7 m-20 -95.32 126.56 40.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 73.22 110.872 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.508 HD12 ' HE1' ' A' ' 142' ' ' MET . 4.2 mm -99.53 119.36 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.33 111.169 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.0 163.13 15.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 65.43 111.124 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.551 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -147.67 92.84 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 64.03 111.129 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.05 31.12 4.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 61.03 110.85 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.12 -12.99 65.26 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.7 -0.762 . . . . 74.04 112.512 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -97.9 126.86 39.04 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.652 0.739 . . . . 74.32 110.899 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 152.4 69.17 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.718 2.279 . . . . 74.2 112.302 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.551 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.76 -67.28 1.0 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.224 -0.444 . . . . 73.22 110.916 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.8 -159.6 10.94 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.759 -0.734 . . . . 63.22 112.506 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 ttm180 -127.99 124.27 36.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.818 0.342 . . . . 74.42 110.903 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 36.8 t -113.11 90.92 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 72.42 111.13 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 77.8 p -85.16 147.8 26.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 74.34 110.823 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CD2' HG23 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -137.68 140.02 40.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 74.32 110.884 -179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HB2' ' HG2' ' A' ' 133' ' ' LYS . 6.1 tt0 -91.21 161.97 14.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.3 110.895 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD12 ' HG2' ' A' ' 4' ' ' PRO . 61.2 mt -114.9 119.57 37.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.141 -0.481 . . . . 73.44 110.907 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CE2' HD11 ' A' ' 90' ' ' LEU . 16.9 m-85 -74.85 61.35 1.01 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 75.53 110.902 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.11 -38.98 65.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.492 . . . . 74.41 111.137 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -53.91 -65.58 0.54 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.194 -0.457 . . . . 72.24 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.38 -74.38 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 65.4 110.899 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 33' ' ' ALA . 12.9 m -84.58 116.71 66.39 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 72.04 111.162 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.706 2.271 . . . . 72.45 112.331 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.3 mtmm -66.28 -43.69 85.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 75.12 110.918 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.424 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -48.24 -27.96 2.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.152 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.891 ' HB2' HG23 ' A' ' 29' ' ' VAL . . . -80.17 -39.27 29.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.209 -0.451 . . . . 53.02 111.104 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -64.92 -156.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 61.14 110.878 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.472 HD21 HD12 ' A' ' 78' ' ' ILE . 1.3 t30 69.85 -68.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 54.31 110.903 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -55.01 -29.03 56.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.181 -0.463 . . . . 72.21 110.909 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -52.03 28.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 71.44 110.89 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 43' ' ' GLU . . . -78.95 -28.09 43.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 62.41 111.082 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.749 HD13 HD11 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -89.08 19.47 4.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 75.32 110.929 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' HG11 ' A' ' 6' ' ' VAL . 31.8 t -144.8 -31.83 0.42 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 61.14 110.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -103.94 -32.97 9.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 74.53 111.097 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.79 120.08 2.91 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.77 -0.729 . . . . 53.15 112.513 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.1 OUTLIER 177.41 -47.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.886 0.374 . . . . 55.42 110.884 -179.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' HG21 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -83.85 -11.37 57.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 72.1 110.907 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.77 7.52 35.87 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.72 -0.752 . . . . 74.53 112.515 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' C ' ' A' ' 47' ' ' GLY . 2.6 m-85 -93.02 -24.77 18.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.908 0.385 . . . . 64.44 110.871 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.504 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -29.05 130.64 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.736 -0.745 . . . . 50.51 112.467 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -95.2 34.52 1.4 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.933 0.397 . . . . 73.12 110.915 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.98 147.08 1.08 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 74.13 110.873 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.05 62.15 4.16 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.704 -0.76 . . . . 62.31 112.476 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -125.82 -168.06 1.79 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.84 0.353 . . . . 72.34 110.906 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.4 m -120.85 -169.69 1.87 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.127 -0.488 . . . . 74.3 110.896 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -110.06 127.75 55.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 65.5 110.839 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.47 -63.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 72.51 110.813 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -157.58 -179.51 8.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.45 110.841 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.549 HD12 HG21 ' A' ' 152' ' ' THR . 65.8 mt -150.55 136.22 11.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 64.42 111.142 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 66.6 mt -140.27 105.41 6.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.573 0.701 . . . . 75.02 111.138 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.404 ' HG2' ' HG2' ' A' ' 148' ' ' ARG . 53.4 Cg_endo -69.77 159.4 53.55 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.663 2.242 . . . . 62.02 112.31 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 88.93 -34.53 3.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.508 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.535 ' O ' ' HB3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -111.18 -82.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.862 0.363 . . . . 73.53 110.86 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER 175.13 119.31 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 73.31 110.861 179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.5 p -77.41 177.29 8.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -144.04 174.55 10.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 51.23 110.919 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.18 150.3 18.73 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.734 -0.746 . . . . 64.03 112.508 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -92.32 114.79 4.67 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 61.44 112.5 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -83.64 -167.06 1.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.875 0.369 . . . . 71.24 110.869 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.496 ' CE1' HD11 ' A' ' 39' ' ' LEU . 54.8 p90 -96.68 -173.58 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 65.22 110.881 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.565 HG22 ' H ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -170.76 -71.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 73.14 111.138 -179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -98.5 132.9 43.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 74.35 110.86 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 173.0 -35.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 74.31 110.877 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.75 -33.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 71.04 110.881 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.17 -12.55 76.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.748 -0.739 . . . . 74.23 112.47 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.3 m 71.91 43.04 0.58 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.796 0.331 . . . . 65.41 111.145 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 124.8 162.56 11.41 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.731 -0.747 . . . . 71.34 112.454 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.565 ' H ' HG22 ' A' ' 68' ' ' THR . . . -86.54 138.46 15.77 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.746 -0.74 . . . . 64.35 112.484 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.31 -169.52 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.792 0.329 . . . . 74.41 110.934 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.545 ' O ' HD12 ' A' ' 78' ' ' ILE . 0.3 OUTLIER -83.68 5.76 23.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 74.33 110.858 -179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.749 HD11 HD13 ' A' ' 39' ' ' LEU . 2.5 mt 83.0 -43.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 71.42 111.106 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -72.65 70.24 0.93 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 74.41 110.939 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.43 -72.25 2.55 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.713 -0.756 . . . . 32.34 112.515 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -175.0 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.949 0.404 . . . . 65.02 110.835 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.75 162.94 17.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.108 -0.496 . . . . 72.45 110.896 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -141.22 152.7 44.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.01 110.865 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.79 164.04 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 63.31 110.887 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -77.85 113.04 15.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 51.13 110.858 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.02 -56.28 24.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 75.21 110.848 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 179.08 149.8 0.27 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 64.24 110.894 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -111.84 58.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 74.43 110.854 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.0 mt -80.97 -10.96 12.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 73.42 111.12 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.56 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -104.11 137.33 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.92 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.8 mttm -128.34 -172.89 2.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 71.3 110.892 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -95.18 -89.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 73.11 110.881 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 m 76.54 -15.71 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 44.44 111.178 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.34 163.22 36.98 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.698 -0.763 . . . . 74.54 112.485 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD3' ' HB2' ' A' ' 118' ' ' LYS . 53.8 Cg_endo -69.79 143.19 49.92 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.619 2.213 . . . . 70.22 112.392 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.16 -41.28 2.08 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.737 -0.744 . . . . 74.34 112.457 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 38.6 mm -50.42 150.96 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.886 0.374 . . . . 71.43 111.152 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.604 ' O ' HG13 ' A' ' 128' ' ' VAL . 0.3 OUTLIER -123.18 161.11 25.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 71.13 110.886 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.746 ' OG ' HG22 ' A' ' 128' ' ' VAL . 4.2 m -158.8 -129.31 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.183 -0.462 . . . . 73.23 110.894 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.501 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.0 mtp -142.83 -159.53 0.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.481 . . . . 54.34 110.92 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.676 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . 173.38 81.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 73.32 111.084 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.451 ' HB3' ' OG1' ' A' ' 107' ' ' THR . 2.0 t30 -104.13 -158.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 73.32 110.911 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -102.24 42.9 1.1 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.167 -0.47 . . . . 52.3 111.085 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 129.73 168.82 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.714 -0.755 . . . . 71.2 112.468 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.728 ' O ' HG23 ' A' ' 107' ' ' THR . 53.8 Cg_endo -69.72 166.67 26.76 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.708 2.272 . . . . 72.11 112.335 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 56.35 34.13 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 54.04 110.871 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.728 HG23 ' O ' ' A' ' 105' ' ' PRO . 16.3 p -137.67 26.66 2.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 72.0 111.144 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 28.1 t30 50.62 -97.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.26 -0.427 . . . . 73.33 110.883 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 139.74 -85.62 0.21 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.727 . . . . 62.42 112.49 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 3.4 t 71.0 36.76 1.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.85 0.357 . . . . 74.22 110.872 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 9.1 tp-100 -92.22 -34.95 14.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.083 -0.508 . . . . 74.32 110.894 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.627 ' CE2' HD11 ' A' ' 114' ' ' ILE . 60.0 t80 68.57 75.75 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 63.4 110.908 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' CE1' ' HG3' ' A' ' 61' ' ' MET . 0.0 OUTLIER -108.49 129.67 55.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 73.22 110.896 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.627 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -120.47 121.15 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 73.41 111.169 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.426 ' HA ' ' HB2' ' A' ' 61' ' ' MET . 6.5 p -73.91 136.92 43.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 62.14 110.902 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.577 HG21 ' OE1' ' A' ' 143' ' ' GLU . 13.1 t -109.89 -16.58 13.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 64.02 111.134 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.65 24.57 5.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 42.11 111.116 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.427 ' HB2' ' HD3' ' A' ' 95' ' ' PRO . 1.2 tmtt? 58.17 103.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.929 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 67.2 p -121.38 71.63 0.97 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 72.4 111.115 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.45 20.34 2.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 73.41 110.835 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.78 -9.01 58.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.929 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.443 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.3 OUTLIER -86.51 -47.87 8.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 72.33 110.918 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -56.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.851 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.58 47.3 0.51 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.693 -0.765 . . . . 74.43 112.507 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.4 tppt? -96.73 -31.02 12.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.351 . . . . 70.55 110.932 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -132.36 124.87 29.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.202 -0.454 . . . . 72.41 110.825 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 24.8 t -49.37 111.33 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 71.23 111.103 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.746 HG22 ' OG ' ' A' ' 99' ' ' SER . 20.9 t -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 73.24 111.156 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.718 ' HB2' HG21 ' A' ' 29' ' ' VAL . 19.6 p90 -165.66 34.49 0.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 74.31 110.854 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.514 ' HA3' ' HB2' ' A' ' 98' ' ' LEU . . . -122.41 -173.22 14.22 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.793 -0.717 . . . . 53.34 112.508 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 174.57 144.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.803 0.335 . . . . 62.25 110.928 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.1 t -93.12 90.22 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.21 -0.45 . . . . 71.15 111.154 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.412 ' HG2' ' HB2' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -50.92 -59.96 3.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 73.52 110.856 179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.55 142.0 10.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 61.44 110.863 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 122.48 2.99 9.62 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 75.23 112.484 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.18 -32.19 9.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.764 0.316 . . . . 74.31 110.827 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 42.7 m-20 -50.4 -27.95 7.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 72.02 110.925 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.432 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 24.5 mm -80.09 -40.81 20.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.25 111.141 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 61.6 t -48.83 -52.82 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 70.23 111.162 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -51.78 -30.59 23.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 71.2 110.868 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -70.98 -42.69 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 62.13 111.121 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.508 ' HE1' HD12 ' A' ' 10' ' ' ILE . 19.1 mtm -62.81 -30.12 71.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.859 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.577 ' OE1' HG21 ' A' ' 116' ' ' THR . 14.7 mm-40 -58.13 -55.07 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.264 -0.426 . . . . 74.31 110.874 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.26 -22.5 66.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.84 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -82.94 -6.28 59.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.869 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' HA3' ' CG2' ' A' ' 56' ' ' ILE . . . -89.94 -157.35 33.18 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.762 -0.732 . . . . 54.45 112.537 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.1 p -164.49 142.59 6.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.909 0.385 . . . . 74.21 110.86 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG2' ' HG2' ' A' ' 58' ' ' PRO . 38.5 mmm-85 -74.63 73.31 1.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 75.42 110.922 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 175.93 -33.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 75.45 110.919 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 139.17 -67.03 0.52 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.723 -0.751 . . . . 73.42 112.491 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.45 159.98 0.44 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.862 0.363 . . . . 74.13 110.92 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.549 HG21 HD12 ' A' ' 56' ' ' ILE . 77.0 p -131.19 156.67 44.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.24 -0.436 . . . . 65.13 111.174 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 29.8 t -77.41 -18.05 57.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 70.21 110.879 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 tptt -134.22 -165.67 1.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 75.15 110.905 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.6 tppm? -138.63 136.08 35.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 73.13 110.915 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.49 HD13 ' SD ' ' A' ' 142' ' ' MET . 38.4 mt -106.02 119.04 54.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 65.14 111.128 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 26.5 p -106.01 163.69 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 74.44 111.152 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.55 HG23 ' CE1' ' A' ' 8' ' ' PHE . 4.3 mt -106.48 134.83 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 74.24 111.113 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.563 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -89.63 -64.32 1.16 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 70.03 111.084 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -162.76 171.95 16.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 73.15 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.0 m -151.86 122.8 7.56 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 72.21 110.888 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -150.36 178.13 28.01 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 40.2 112.471 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.77 123.07 24.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.826 0.346 . . . . 75.24 110.935 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.421 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -95.04 -58.88 2.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 54.11 110.887 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 55.5 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 72.43 110.846 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.802 0.334 . . . . 63.34 110.887 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.37 155.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.211 -0.449 . . . . 62.53 111.071 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.91 157.27 39.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.632 0.729 . . . . 60.34 110.892 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 143.98 52.42 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.686 2.257 . . . . 73.33 112.33 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.456 ' O ' HD23 ' A' ' 164' ' ' LEU . 96.9 m -138.44 93.87 2.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 70.31 111.145 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 2.4 m -77.03 143.39 13.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.03 111.108 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.525 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -132.26 162.51 30.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 74.34 110.888 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.56 ' HD1' HG23 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -149.84 152.84 35.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 62.31 110.911 -179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -109.35 114.75 28.68 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.153 -0.476 . . . . 75.45 110.855 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 tt -86.01 147.83 5.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 70.32 111.125 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -141.14 164.26 30.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 75.51 111.131 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.834 HG22 HG13 ' A' ' 156' ' ' ILE . 61.6 t -138.33 105.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 73.21 111.137 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.5 t0 66.88 50.62 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 60.14 110.852 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.19 20.6 67.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 60.4 112.496 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.416 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 28.8 tt0 -134.4 107.29 11.08 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.634 0.73 . . . . 54.11 110.886 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.81 141.76 45.91 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.69 2.26 . . . . 62.31 112.306 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -125.63 24.9 7.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.183 -0.462 . . . . 71.3 110.898 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.53 -167.26 14.32 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.749 -0.738 . . . . 52.31 112.474 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -178.72 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 75.01 110.832 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.524 HG12 ' HB ' ' A' ' 138' ' ' ILE . 2.9 m -137.32 161.26 34.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.181 -0.463 . . . . 73.21 111.093 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 133' ' ' LYS . 30.6 t -114.44 91.79 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 70.5 110.832 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.476 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 13.8 m-85 -83.52 102.49 12.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.117 -0.492 . . . . 72.24 110.873 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.27 111.06 21.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.183 -0.462 . . . . 64.02 110.892 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.745 HD22 ' CE2' ' A' ' 129' ' ' PHE . 27.4 mt -85.51 140.66 30.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.454 . . . . 62.31 110.935 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -89.65 81.3 6.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.34 110.842 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.71 -3.69 51.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 72.04 111.122 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -87.47 -38.33 16.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 74.52 110.832 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -94.96 -23.76 17.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 62.35 110.921 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.59 73.06 49.1 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.622 0.725 . . . . 75.45 111.11 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -6.81 19.48 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.707 2.272 . . . . 45.4 112.374 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.82 -51.84 5.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 62.04 110.902 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.54 HG22 ' HE2' ' A' ' 100' ' ' MET . 0.2 OUTLIER -77.96 -53.77 7.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.208 -0.451 . . . . 61.51 111.066 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -31.41 4.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 73.24 111.079 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -68.44 -56.47 8.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 70.43 110.835 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' HA ' HG12 ' A' ' 78' ' ' ILE . 1.8 t30 -47.86 -39.61 19.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 71.45 110.865 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.412 ' HA ' HD12 ' A' ' 39' ' ' LEU . 1.4 t80 -77.83 -32.77 52.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.454 . . . . 71.4 110.888 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.75 -35.98 81.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.858 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.31 67.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 51.03 111.124 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 36' ' ' PHE . 46.1 mt -70.3 -32.56 70.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 54.14 110.906 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.99 -60.14 2.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 74.34 110.884 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.1 p -72.91 -17.01 61.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 75.34 111.089 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.19 44.53 93.2 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.722 -0.751 . . . . 71.15 112.503 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -28.85 69.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.906 0.384 . . . . 74.45 110.886 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -70.72 -125.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 64.54 110.882 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -139.06 18.18 3.15 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.757 -0.735 . . . . 44.44 112.45 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -165.57 -174.55 3.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.912 0.387 . . . . 74.41 110.848 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 135.21 124.61 2.45 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.729 -0.748 . . . . 73.23 112.488 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -47.9 155.61 0.41 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.993 0.425 . . . . 74.0 110.907 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -157.01 -38.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.106 -0.497 . . . . 64.01 110.898 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.25 27.7 12.2 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.735 -0.745 . . . . 54.43 112.488 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.44 170.56 11.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 51.3 110.894 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 6.1 p -140.53 153.1 46.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.159 -0.473 . . . . 70.25 110.861 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -111.92 134.32 53.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.885 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.548 ' HA ' HG23 ' A' ' 152' ' ' THR . 0.7 OUTLIER -141.37 34.22 1.67 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 74.11 110.869 -179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.2 tpm_? -138.31 33.17 2.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.921 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 62' ' ' CYS . 27.7 mt -82.71 140.24 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.42 111.096 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 17.8 mt -126.38 113.62 23.37 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.596 0.712 . . . . 63.44 111.107 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 54.2 Cg_endo -69.73 81.38 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.662 2.241 . . . . 73.44 112.356 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 132.81 0.24 4.39 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.748 -0.739 . . . . 75.14 112.498 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.17 0.91 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.809 0.337 . . . . 74.21 110.852 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -177.25 -160.64 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 63.1 110.889 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 56' ' ' ILE . 82.4 m -136.96 -41.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 64.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 65.28 150.64 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.14 110.912 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.22 88.63 0.45 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 61.42 112.512 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 58.13 87.44 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.69 -0.767 . . . . 52.21 112.507 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -169.93 80.55 0.11 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.821 0.343 . . . . 44.42 110.883 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -50.56 -71.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.255 -0.43 . . . . 75.45 110.915 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.11 115.44 10.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.145 -0.48 . . . . 70.34 111.166 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -99.73 51.89 0.92 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 73.52 110.881 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -70.62 78.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 72.12 110.88 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 70.91 -72.54 0.11 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 73.52 110.884 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.7 86.6 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.716 -0.754 . . . . 73.23 112.455 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.3 p -114.48 119.93 38.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 75.43 111.172 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -115.53 -131.48 4.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.756 -0.735 . . . . 51.45 112.467 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -142.02 -177.15 16.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.702 -0.761 . . . . 75.22 112.486 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -62.72 166.29 5.63 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.793 0.33 . . . . 74.01 110.876 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.28 157.2 17.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.197 -0.456 . . . . 45.43 110.91 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 35' ' ' ASN . 1.1 pt -67.52 -11.84 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.149 -0.478 . . . . 64.11 111.14 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -112.27 13.8 20.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.469 . . . . 75.52 110.886 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 131.47 -162.85 23.73 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.773 -0.727 . . . . 74.23 112.485 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.1 -42.55 60.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.973 0.416 . . . . 74.34 110.939 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.4 pttt -177.24 173.51 1.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 65.11 110.846 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -125.53 168.29 13.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 71.21 110.866 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -87.69 162.6 16.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.103 -0.499 . . . . 62.43 110.895 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -70.01 149.42 47.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.893 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.7 -63.44 1.42 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.857 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -176.39 173.7 2.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 73.45 110.844 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.46 45.65 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 74.34 110.902 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 54.8 mt -50.73 -25.06 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 71.31 111.163 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.644 ' O ' HG11 ' A' ' 128' ' ' VAL . 5.9 mt -91.94 119.28 31.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 71.02 110.937 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.782 ' O ' HG23 ' A' ' 93' ' ' THR . 7.9 mtpp -100.86 112.42 24.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 53.33 110.852 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.773 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -58.94 99.54 0.05 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 61.3 110.841 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 91' ' ' LYS . 6.2 p -127.45 36.25 4.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 54.32 111.159 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.46 172.11 39.29 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.719 . . . . 61.04 112.533 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 167.62 23.9 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.717 2.278 . . . . 72.44 112.323 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.01 22.58 72.42 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.761 . . . . 64.22 112.481 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.773 HG21 ' HB3' ' A' ' 92' ' ' HIS . 23.4 mm -95.39 117.49 39.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.878 0.371 . . . . 70.23 111.15 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.523 HD21 ' HB2' ' A' ' 112' ' ' PHE . 4.7 tt -83.78 121.47 27.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 74.13 110.891 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 8.0 t -119.58 142.63 48.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 72.33 110.889 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.54 ' HE2' HG22 ' A' ' 32' ' ' THR . 2.6 mmt -81.74 102.75 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 61.41 110.882 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.427 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -84.91 146.38 27.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 72.15 111.109 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER 165.97 -166.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 61.44 110.854 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.669 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -47.22 -52.96 14.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 71.44 111.093 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 133.05 -87.75 0.27 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.727 -0.749 . . . . 63.21 112.455 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 125.19 11.86 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.693 2.262 . . . . 55.01 112.351 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 45.6 36.12 2.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.85 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.669 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.2 p -146.77 56.34 1.14 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 52.32 111.158 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -50.99 -52.91 38.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 75.52 110.827 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.38 -168.58 54.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.755 -0.736 . . . . 64.22 112.488 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.1 t -119.85 -5.7 10.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 60.22 110.835 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -64.76 156.62 29.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 71.25 110.876 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.523 ' HB2' HD21 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -149.4 162.37 40.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.874 -179.928 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -160.57 140.5 11.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.128 -0.487 . . . . 62.41 110.869 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.729 HG21 ' CG1' ' A' ' 139' ' ' VAL . 3.7 mt -91.88 125.81 44.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 63.34 111.122 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.4 m -74.49 -32.4 62.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 72.42 110.919 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 m 55.86 14.69 1.42 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 74.52 111.138 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -172.53 167.99 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 63.24 111.108 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -63.35 133.44 54.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.43 . . . . 73.42 110.87 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 5.6 p -145.34 43.88 1.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 74.21 111.164 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -66.11 -10.21 38.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 52.43 110.869 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.857 ' CZ2' HG22 ' A' ' 119' ' ' THR . 9.8 p90 -75.9 -9.6 58.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 74.52 110.923 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 63.5 mt -80.17 -17.98 50.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.265 -0.425 . . . . 64.32 110.896 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' A' ' 124' ' ' GLY . 11.0 m-20 51.64 70.52 0.54 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.52 110.818 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 37.17 43.76 0.99 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.749 -0.739 . . . . 51.14 112.481 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.4 mmtp -73.8 133.32 43.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.832 0.349 . . . . 74.4 110.955 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.589 ' C ' HG23 ' A' ' 127' ' ' VAL . 4.9 m-70 64.53 28.95 13.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 74.32 110.851 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.589 HG23 ' C ' ' A' ' 126' ' ' HIS . 0.3 OUTLIER 60.85 -163.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 73.15 111.147 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.644 HG11 ' O ' ' A' ' 90' ' ' LEU . 13.1 p -179.13 145.77 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 74.42 111.145 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.745 ' CE2' HD22 ' A' ' 24' ' ' LEU . 2.0 p90 -176.68 125.02 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 73.13 110.91 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 104.86 145.92 14.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.696 -0.764 . . . . 74.54 112.554 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 11.0 ptmt -165.74 151.72 9.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.788 0.328 . . . . 73.23 110.912 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.474 HG22 ' H ' ' A' ' 133' ' ' LYS . 1.3 p -55.76 168.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 42.53 111.095 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 132' ' ' VAL . 2.2 tptp -147.81 -39.89 0.18 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.466 . . . . 71.01 110.902 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -132.26 155.37 48.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 74.44 110.879 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.24 78.53 0.12 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.748 -0.739 . . . . 63.14 112.49 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.12 -2.22 47.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 72.53 110.901 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -78.26 -29.96 48.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 74.02 110.912 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.524 ' HB ' HG12 ' A' ' 20' ' ' VAL . 47.4 mm -63.99 -43.79 97.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 73.14 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.729 ' CG1' HG21 ' A' ' 114' ' ' ILE . 9.3 t -88.2 6.07 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 23.45 111.156 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -118.06 -69.88 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.87 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.04 -51.53 67.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 55.41 111.123 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.417 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 15.6 tmm? -49.67 -35.44 21.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 65.13 110.88 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -75.49 54.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 63.3 110.836 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -141.31 0.32 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.484 . . . . 74.43 110.859 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -105.69 15.96 26.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 63.55 110.914 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.405 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -95.12 -155.72 31.57 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 73.34 112.458 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -158.24 -169.23 2.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 73.54 110.881 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -77.77 -32.58 52.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 73.43 110.863 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -106.09 1.33 26.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 63.34 110.912 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.03 -146.25 16.04 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.746 -0.74 . . . . 61.33 112.455 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 tttm 64.78 116.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.862 0.363 . . . . 63.5 110.894 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.548 HG23 ' HA ' ' A' ' 54' ' ' HIS . 59.3 p -82.56 146.01 29.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 64.32 111.154 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.28 -21.99 62.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 71.44 110.856 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 34.2 mttt -135.19 -179.17 5.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 75.1 110.896 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -97.86 101.44 12.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 73.12 110.871 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.834 HG13 HG22 ' A' ' 12' ' ' VAL . 4.5 mp -96.44 122.02 47.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 74.05 111.104 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -137.18 159.49 41.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 73.53 111.174 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.56 HG23 ' HD1' ' A' ' 8' ' ' PHE . 42.0 mt -87.88 116.15 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 70.53 111.143 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.28 -52.19 20.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 52.32 111.09 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -143.38 -179.59 6.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 65.22 110.866 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' PHE . 5.1 p -171.23 -172.85 1.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 63.23 110.858 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.29 -149.21 20.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.739 -0.743 . . . . 34.42 112.455 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.6 OUTLIER -127.55 141.95 51.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.813 0.339 . . . . 72.53 110.926 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.1 pt? -128.82 166.6 18.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.264 -0.425 . . . . 45.14 110.856 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 61.53 110.862 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.761 0.315 . . . . 74.44 110.875 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.17 156.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 72.33 111.101 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 21.9 m-20 -93.63 157.21 38.73 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.65 0.738 . . . . 62.32 110.908 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 151.83 69.13 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.678 2.252 . . . . 64.42 112.364 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -138.98 151.32 46.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.231 -0.441 . . . . 74.43 111.101 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.574 HG11 ' OG ' ' A' ' 40' ' ' SER . 0.3 OUTLIER -141.8 151.97 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.199 -0.455 . . . . 73.55 111.136 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.502 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -127.1 156.77 41.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.888 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 34.7 m-85 -137.92 137.29 37.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 64.12 110.9 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -92.47 114.09 26.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 71.05 110.886 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.619 HG21 ' HE2' ' A' ' 142' ' ' MET . 7.3 mm -82.49 114.87 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 70.32 111.132 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.76 148.77 23.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 72.41 111.076 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 1.6 m -142.03 98.6 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 72.41 111.178 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 73.95 24.27 2.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 74.1 110.873 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.02 -21.62 45.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.734 -0.746 . . . . 71.4 112.471 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -97.36 150.2 36.54 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 121.637 0.732 . . . . 64.45 110.869 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 150.5 68.28 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.695 2.263 . . . . 70.12 112.355 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.634 ' O ' HD12 ' A' ' 17' ' ' LEU . 4.1 tp -125.53 -39.65 2.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 40.21 110.876 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.457 ' HA3' HD12 ' A' ' 138' ' ' ILE . . . 165.73 -176.5 41.19 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 70.41 112.455 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.15 167.1 22.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 63.31 110.869 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 135' ' ' GLY . 27.2 m -130.15 -179.45 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.207 -0.451 . . . . 62.41 111.106 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.2 t -131.59 95.66 3.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.175 -0.466 . . . . 75.0 110.831 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.622 ' HE1' HG22 ' A' ' 132' ' ' VAL . 15.7 m-85 -91.78 138.15 31.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.854 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' C ' HD23 ' A' ' 24' ' ' LEU . 24.2 tt0 -116.45 156.06 27.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.134 -0.484 . . . . 74.34 110.884 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.473 HD23 ' C ' ' A' ' 23' ' ' GLU . 0.4 OUTLIER -116.08 118.07 31.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.137 -0.483 . . . . 72.14 110.896 -179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG23 ' A' ' 29' ' ' VAL . 23.9 m-85 -78.59 77.93 5.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.474 . . . . 74.21 110.869 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.78 -11.1 59.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.148 -0.478 . . . . 72.35 111.083 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -74.02 -46.84 41.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 50.13 110.877 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.535 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.4 mttt -87.72 -18.49 29.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 73.13 110.885 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 25' ' ' PHE . 1.0 OUTLIER -155.44 84.55 3.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.633 0.73 . . . . 73.25 111.143 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.74 -27.65 26.29 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.66 2.24 . . . . 73.21 112.341 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 20.0 mmtm -76.47 -57.36 3.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 71.25 110.89 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 76.7 m -51.7 -43.55 62.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 73.34 111.195 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.61 -34.45 78.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.45 111.139 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 0.4 OUTLIER -53.96 -25.01 18.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.174 -0.466 . . . . 64.4 110.848 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.09 -66.37 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 74.31 110.935 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HD2' HD22 ' A' ' 24' ' ' LEU . 5.9 t80 -52.59 -39.7 61.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 72.13 110.918 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.414 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.82 -30.19 69.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.479 . . . . 64.31 110.877 -179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.839 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -90.48 -33.8 15.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 64.43 111.138 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' HB2' HG21 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -92.13 26.12 2.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.959 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.574 ' OG ' HG11 ' A' ' 6' ' ' VAL . 34.3 t -121.2 -5.69 9.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.199 -0.455 . . . . 63.04 110.872 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.8 p -118.47 15.79 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.13 111.183 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.98 24.81 6.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.72 -0.752 . . . . 60.42 112.488 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.7 pt-20 -83.78 -21.89 32.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.918 0.39 . . . . 72.34 110.884 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.96 17.64 6.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 73.22 110.96 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.33 -52.5 4.33 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.748 -0.739 . . . . 53.23 112.493 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -117.03 155.92 28.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.906 0.384 . . . . 74.24 110.898 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 -136.69 3.26 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.746 -0.74 . . . . 72.2 112.507 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -22.55 17.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.926 0.393 . . . . 55.15 110.865 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -42.63 112.85 0.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.108 -0.496 . . . . 74.51 110.879 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.77 55.55 20.08 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.743 -0.741 . . . . 54.22 112.479 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.9 m -113.85 3.85 15.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.874 0.369 . . . . 44.25 110.85 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.4 m 50.61 -168.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 65.44 110.945 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 56' ' ' ILE . 2.8 m-85 -111.41 154.37 24.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 64.14 110.887 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -93.34 -64.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.152 -0.476 . . . . 75.11 110.841 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.5 148.12 47.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 74.3 110.922 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CD2' ' A' ' 53' ' ' PHE . 55.2 mt -142.49 117.81 5.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.246 -0.434 . . . . 75.01 111.142 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.758 HD12 ' CE ' ' A' ' 61' ' ' MET . 59.5 mt -128.42 99.9 23.36 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.625 0.726 . . . . 75.02 111.148 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.79 93.71 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.622 2.215 . . . . 73.32 112.384 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 143.43 -26.18 2.14 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.755 -0.736 . . . . 51.31 112.482 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -112.55 -56.54 2.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 73.31 110.843 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.758 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -174.49 -165.08 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 53.42 110.85 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.486 ' N ' ' HG2' ' A' ' 61' ' ' MET . 0.7 OUTLIER -146.32 144.9 30.11 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 54.43 110.834 -179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -94.52 -168.71 1.89 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 71.41 110.897 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.84 -73.01 0.11 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.728 -0.749 . . . . 54.05 112.518 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.22 -144.42 11.01 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.769 . . . . 53.14 112.466 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -147.35 -169.51 3.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.361 . . . . 61.23 110.852 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -174.77 -35.55 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.54 110.901 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 74' ' ' GLY . 10.6 t -54.07 132.44 42.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.125 -0.489 . . . . 74.33 111.162 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.8 mtt-85 57.88 178.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 73.13 110.901 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -69.11 -32.74 72.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 63.43 110.848 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -82.46 -77.7 0.22 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 63.51 110.913 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 138.58 -104.72 0.45 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 65.33 112.434 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 p 60.33 34.14 20.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.845 0.355 . . . . 62.04 111.109 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 68' ' ' THR . . . 128.71 -175.94 18.49 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.771 -0.728 . . . . 62.45 112.493 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.78 136.76 10.48 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.761 -0.733 . . . . 54.1 112.489 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.6 -162.84 0.97 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.808 0.337 . . . . 73.23 110.879 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.405 ' HB3' ' C ' ' A' ' 81' ' ' GLU . 5.2 t -105.03 126.39 52.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 42.32 110.888 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.839 HD13 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -63.88 -13.49 13.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 73.13 111.116 179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -106.48 -16.38 14.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 73.42 110.941 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 173.31 -107.7 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.781 -0.723 . . . . 54.15 112.504 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.405 ' C ' ' HB3' ' A' ' 77' ' ' SER . 1.1 pt-20 -109.45 -55.76 2.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.948 0.404 . . . . 71.54 110.913 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.0 pttm -166.74 151.09 7.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 74.23 110.904 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.09 144.13 51.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.9 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -52.98 153.52 3.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.876 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.04 136.38 33.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.112 -0.495 . . . . 73.42 110.865 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.14 -55.32 6.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.854 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.613 ' O ' HG13 ' A' ' 127' ' ' VAL . 1.9 p30 -176.83 -173.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 72.34 110.861 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -132.34 38.49 3.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.159 -0.473 . . . . 54.25 110.885 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.535 HG21 ' HG2' ' A' ' 28' ' ' LYS . 4.3 mt -51.34 -25.16 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 72.31 111.125 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.42 HD23 ' CD ' ' A' ' 28' ' ' LYS . 0.1 OUTLIER -84.61 110.58 18.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.462 . . . . 64.5 110.897 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -98.68 -166.67 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 74.44 110.93 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CD2' HG21 ' A' ' 97' ' ' ILE . 79.7 m80 -102.09 -98.39 0.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.431 . . . . 73.34 110.865 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 65.6 7.1 4.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 72.55 111.141 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 179.51 163.36 30.19 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.763 -0.732 . . . . 75.52 112.499 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 173.72 10.56 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.689 2.259 . . . . 51.02 112.341 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.43 31.51 54.28 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.753 -0.737 . . . . 73.33 112.467 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.712 HG21 ' CD2' ' A' ' 92' ' ' HIS . 29.5 mm -94.51 131.59 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.845 0.355 . . . . 50.32 111.162 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.493 HD11 ' CE1' ' A' ' 112' ' ' PHE . 1.2 tt -101.61 136.98 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 71.15 110.868 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.546 ' HB3' ' HB2' ' A' ' 113' ' ' PHE . 5.7 t -105.95 -133.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 74.35 110.824 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -171.82 -34.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 74.22 110.896 179.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 100' ' ' MET . . . 66.84 97.79 0.05 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 73.11 111.141 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -115.86 -174.8 2.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.919 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.689 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -82.68 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.077 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.412 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 126.2 -63.42 0.59 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.736 -0.745 . . . . 71.02 112.462 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 54.0 Cg_endo -69.72 -92.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.686 2.257 . . . . 73.32 112.362 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -138.84 92.14 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.11 110.871 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.689 HG21 ' HB3' ' A' ' 103' ' ' ALA . 1.4 p -143.39 21.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 74.51 111.159 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 44.86 -91.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 52.43 110.838 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.95 -69.69 0.51 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.734 -0.746 . . . . 71.2 112.488 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 12.9 t 67.52 36.12 3.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.821 0.343 . . . . 72.53 110.87 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -103.27 -97.82 0.3 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 73.12 110.943 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.596 ' HE2' HD11 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.3 173.61 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 64.34 110.911 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.546 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 0.3 OUTLIER 178.21 57.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 75.52 110.897 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.596 HD11 ' HE2' ' A' ' 112' ' ' PHE . 66.7 mt -65.47 85.08 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 73.2 111.162 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 56.6 m -70.96 145.68 49.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 74.31 110.883 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.698 HG21 ' CD ' ' A' ' 143' ' ' GLU . 34.7 p -99.51 20.13 14.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.202 -0.454 . . . . 73.51 111.09 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -174.56 -167.84 0.34 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.238 -0.437 . . . . 72.21 111.101 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.2 ptmm? -78.46 134.01 37.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.842 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 2.7 p -134.27 49.74 2.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 53.11 111.151 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -63.21 -11.83 23.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.183 -0.462 . . . . 64.25 110.899 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.2 m-90 -60.67 -26.28 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.194 -0.457 . . . . 75.11 110.883 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.403 HD22 ' NE2' ' A' ' 126' ' ' HIS . 25.5 mt -75.8 -29.92 58.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 60.25 110.924 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 124' ' ' GLY . 21.5 t0 49.83 81.26 0.06 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 71.02 110.859 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.618 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 17.31 62.25 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.689 -0.767 . . . . 25.31 112.505 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 123' ' ' ASP . 22.1 tptp -103.57 -25.35 13.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.82 0.343 . . . . 72.31 110.911 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.439 ' C ' HG23 ' A' ' 127' ' ' VAL . 64.6 m-70 -96.83 -6.96 34.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 74.33 110.834 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 87' ' ' ASN . 7.9 t 76.66 80.48 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.25 -0.432 . . . . 75.25 111.113 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 55.4 t -75.59 138.67 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 72.43 111.149 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -154.57 26.43 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 53.55 110.897 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -128.9 -179.01 15.66 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.756 -0.735 . . . . 52.23 112.506 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 179.87 140.21 0.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.849 0.357 . . . . 62.22 110.89 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 22' ' ' PHE . 85.4 t -86.96 80.4 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 43.24 111.148 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.58 -43.53 12.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 65.11 110.858 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -166.43 168.24 15.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.276 -0.42 . . . . 73.51 110.888 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 20' ' ' VAL . . . 103.97 -0.09 44.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.75 -0.738 . . . . 51.14 112.46 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.89 -33.44 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.765 0.317 . . . . 61.3 110.879 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -51.13 -29.19 12.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 62.31 110.901 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.457 HD12 ' HA3' ' A' ' 18' ' ' GLY . 24.7 mm -76.22 -40.44 36.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 60.51 111.09 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 65.4 t -49.49 -47.49 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 74.53 111.111 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -52.12 -33.41 39.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 74.11 110.852 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.41 82.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 70.21 111.099 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.619 ' HE2' HG21 ' A' ' 10' ' ' ILE . 12.6 mtm -77.34 -14.64 59.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.908 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.698 ' CD ' HG21 ' A' ' 116' ' ' THR . 17.9 mm-40 -86.44 14.27 6.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 74.13 110.9 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -136.9 1.2 2.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.869 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -105.06 -5.8 20.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 71.42 110.868 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.665 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -82.41 -151.26 9.46 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.54 112.474 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.1 m -145.94 -74.99 0.22 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.375 . . . . 43.01 110.847 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.23 -41.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 75.54 110.86 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -95.87 2.67 53.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 61.4 110.886 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 121.85 -44.92 1.27 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.742 -0.742 . . . . 44.11 112.482 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -47.7 137.56 9.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.362 . . . . 72.42 110.93 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.665 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.2 p -123.56 157.57 33.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 72.42 111.139 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 30.3 t -81.37 -17.24 49.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.35 110.86 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -135.2 -175.73 4.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 74.02 110.869 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -125.08 130.36 52.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 62.11 110.886 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.4 mp -104.48 129.03 57.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 63.14 111.07 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.32 167.81 20.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 63.45 111.162 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 38.3 mm -106.53 111.98 37.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.449 . . . . 73.21 111.095 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.596 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -70.0 -50.99 36.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 51.0 111.085 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -160.34 162.85 33.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 63.51 110.9 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.4 p -165.73 168.18 16.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.219 -0.446 . . . . 73.24 110.88 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 159.46 -175.24 36.37 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.77 -0.729 . . . . 64.13 112.475 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.05 116.49 13.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.831 0.348 . . . . 72.15 110.902 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.502 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.9 mm? -91.18 -39.64 12.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 72.23 110.933 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.5 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 61.14 110.864 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmt? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.804 0.335 . . . . 74.23 110.88 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -139.44 145.22 27.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 74.45 111.137 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.2 148.51 6.12 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.605 0.716 . . . . 55.24 110.924 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 126.11 12.95 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.712 2.275 . . . . 63.15 112.336 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.695 ' O ' HD23 ' A' ' 164' ' ' LEU . 51.3 m -106.6 108.86 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 73.34 111.14 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.493 HG12 ' HG3' ' A' ' 163' ' ' GLN . 2.5 m -88.72 141.96 13.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 43.13 111.146 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.528 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.8 p90 -111.99 159.99 17.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.472 . . . . 73.15 110.893 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -143.31 138.03 29.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.896 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -115.4 109.16 17.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.906 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.745 HD12 HG21 ' A' ' 138' ' ' ILE . 13.3 mt -94.49 148.32 5.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.189 -0.46 . . . . 71.44 111.138 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -137.34 164.53 28.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 71.43 111.04 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.526 HG23 HD13 ' A' ' 17' ' ' LEU . 91.0 t -136.44 98.71 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.129 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.0 t0 65.69 54.11 1.12 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 72.54 110.882 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.39 9.91 56.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 74.21 112.476 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.427 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 76.4 tt0 -123.72 107.24 31.53 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.642 0.734 . . . . 63.21 110.877 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.77 143.43 50.79 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.652 2.234 . . . . 72.34 112.379 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.526 HD13 HG23 ' A' ' 12' ' ' VAL . 5.8 mp -98.84 -56.79 2.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 74.31 110.9 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.67 -167.8 26.85 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.728 -0.748 . . . . 51.34 112.473 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -103.07 120.58 40.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 74.14 110.852 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.72 HG21 HG21 ' A' ' 138' ' ' ILE . 38.4 t -109.23 102.47 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 72.45 111.132 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -110.24 147.19 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 73.43 110.88 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -143.83 109.04 5.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.126 -0.488 . . . . 75.44 110.907 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -60.29 127.88 33.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.846 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.755 HD22 ' CE2' ' A' ' 129' ' ' PHE . 26.9 mt -89.28 136.12 33.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 54.54 110.972 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -78.68 65.3 3.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.873 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.77 -27.61 66.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 62.42 111.093 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -68.19 -55.42 12.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 73.54 110.898 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.426 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -54.03 -60.58 3.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.31 110.911 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.695 ' O ' HG23 ' A' ' 29' ' ' VAL . 33.0 m -99.37 101.18 12.22 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.596 0.712 . . . . 72.34 111.127 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -50.48 0.46 Allowed 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.677 2.252 . . . . 70.01 112.366 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.79 -44.68 63.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 74.45 110.895 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' ND2' ' A' ' 108' ' ' ASN . 3.6 m -86.04 23.13 1.56 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 64.02 111.138 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.78 -47.38 15.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.225 -0.443 . . . . 62.12 111.127 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.6 mt-10 -85.68 -24.29 27.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 74.15 110.876 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' C ' ' O ' ' A' ' 34' ' ' GLU . 1.6 t-20 -28.29 -72.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.913 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 64.3 t80 -79.28 -30.19 42.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.52 110.876 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.463 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 7.0 ttp180 -49.27 -44.28 43.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 74.54 110.878 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.95 66.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 72.02 111.145 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 79.2 mt -69.11 -41.92 76.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.19 -0.459 . . . . 74.31 110.897 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 5.9 m -64.1 -45.1 90.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 73.12 110.902 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' OE1' ' A' ' 163' ' ' GLN . 33.0 p -71.13 -23.38 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.483 . . . . 62.11 111.102 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.53 88.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 74.34 112.474 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.02 31.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.94 0.4 . . . . 74.31 110.924 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -126.27 -15.7 5.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 74.52 110.919 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.58 21.65 14.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 71.32 112.515 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -178.28 -167.14 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.898 0.38 . . . . 72.12 110.844 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.89 -177.24 43.11 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 75.54 112.44 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.01 104.7 0.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.955 0.407 . . . . 73.33 110.906 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 -66.59 0.54 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 74.05 110.899 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.79 26.09 7.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.758 -0.734 . . . . 43.2 112.476 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 t -76.19 -164.98 0.43 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.822 0.344 . . . . 61.34 110.866 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.2 p -153.07 172.74 16.41 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.166 -0.47 . . . . 53.5 110.875 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -99.4 -75.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.474 . . . . 73.35 110.87 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.72 23.53 2.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.856 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' CZ ' HD11 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -139.16 17.73 2.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.209 -0.45 . . . . 75.42 110.883 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -58.07 143.22 12.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.172 -0.467 . . . . 75.42 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 55' ' ' ARG . 24.3 mt -127.49 103.39 22.38 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.674 0.749 . . . . 63.14 111.119 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.9 Cg_endo -69.71 96.5 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.751 2.3 . . . . 63.14 112.318 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 133.19 -21.18 4.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.705 -0.76 . . . . 71.21 112.485 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.06 -60.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.906 0.384 . . . . 72.4 110.878 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -167.63 -148.13 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 62.2 110.875 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 35.8 m -131.89 -58.85 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 73.31 110.889 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 65.74 118.13 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 72.3 110.878 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.81 151.08 17.05 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.719 -0.753 . . . . 65.12 112.476 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 113.13 175.59 19.35 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.763 -0.732 . . . . 71.44 112.481 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -118.7 59.18 0.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.844 0.354 . . . . 43.13 110.864 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' O ' HG23 ' A' ' 68' ' ' THR . 0.1 OUTLIER -174.62 -175.05 0.89 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 73.34 110.869 -179.926 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -175.42 61.08 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.113 -0.494 . . . . 73.23 111.132 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.73 65.99 0.64 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 73.04 110.909 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -49.82 -72.51 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 74.33 110.851 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -94.02 35.0 1.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 60.03 110.859 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -140.16 57.69 0.6 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 71.14 112.486 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.4 m 68.14 44.54 1.41 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.822 0.344 . . . . 74.14 111.123 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.8 -174.76 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.782 -0.723 . . . . 72.22 112.474 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.75 127.84 28.72 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.737 . . . . 75.03 112.53 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -83.48 -178.19 6.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.327 . . . . 72.23 110.868 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . 4.9 p -87.02 -174.74 5.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 64.43 110.879 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.3 pt -80.52 -31.51 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 72.11 111.173 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -87.33 42.32 1.03 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 72.41 110.882 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 81.42 -113.78 3.7 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.706 -0.759 . . . . 73.22 112.48 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -59.37 -167.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.864 0.364 . . . . 71.42 110.924 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER -103.07 -171.08 1.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 64.33 110.894 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -131.44 169.53 15.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.25 110.88 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -87.71 169.85 11.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.902 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -61.38 -167.08 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 64.43 110.844 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -152.59 -55.21 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 61.44 110.839 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.38 130.69 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 63.22 110.898 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -96.17 56.5 1.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.833 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.6 -0.45 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 64.11 111.111 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 48.9 mt -114.67 132.4 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.923 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.69 126.68 40.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.229 -0.442 . . . . 72.43 110.931 179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.8 m-70 -53.44 95.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 63.14 110.882 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.6 p -95.02 4.61 53.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 73.32 111.166 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.02 -175.38 46.53 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.749 -0.739 . . . . 62.33 112.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 158.75 55.9 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.721 2.281 . . . . 63.52 112.347 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 92.15 -28.21 9.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.773 -0.727 . . . . 52.32 112.463 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.1 mm -57.81 124.91 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.852 0.358 . . . . 64.31 111.14 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 113' ' ' PHE . 1.4 mp -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 73.04 110.883 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.509 ' O ' ' HB2' ' A' ' 112' ' ' PHE . 4.8 t -142.77 -152.58 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 63.51 110.857 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.4 mmt -141.11 135.34 30.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 63.42 110.858 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.881 ' O ' ' HB2' ' A' ' 102' ' ' ASN . . . -91.91 -163.43 1.04 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 74.52 111.089 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.881 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 4.0 m120 116.61 -176.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 63.24 110.888 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.509 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -52.28 -41.28 62.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 74.12 111.053 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 123.58 -64.02 0.54 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.746 -0.74 . . . . 53.54 112.47 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.509 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 111.96 2.96 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.599 2.199 . . . . 62.25 112.353 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 42.47 61.56 1.99 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.171 -0.468 . . . . 42.23 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.418 HG22 ' HG3' ' A' ' 82' ' ' LYS . 16.0 p -152.5 54.93 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 70.14 111.176 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.623 ' ND2' HG21 ' A' ' 32' ' ' THR . 0.1 OUTLIER -45.01 -43.38 9.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 65.51 110.912 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 61.24 -164.32 19.31 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.72 -0.752 . . . . 71.02 112.489 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.445 ' HB2' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -117.65 -31.76 5.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.85 0.357 . . . . 73.21 110.867 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.746 ' HG3' ' HB3' ' A' ' 101' ' ' ALA . 8.0 pt20 -55.51 149.02 14.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 64.24 110.9 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 99' ' ' SER . 0.1 OUTLIER -160.95 158.05 27.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.21 110.861 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.568 ' O ' HD23 ' A' ' 98' ' ' LEU . 20.0 p90 -114.4 -173.07 2.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.471 . . . . 65.01 110.902 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 41.3 mt -113.51 -57.45 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 74.34 111.121 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 76.22 127.72 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 74.45 110.878 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.0 p -133.19 34.38 3.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.256 -0.429 . . . . 61.32 111.106 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -157.37 159.18 37.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 71.53 111.093 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -67.11 88.31 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 74.32 110.926 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 26.7 p -111.12 54.18 0.69 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 61.33 111.174 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -79.29 15.19 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.18 -0.464 . . . . 74.45 110.877 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.06 11.33 27.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.188 -0.46 . . . . 75.43 110.946 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 123' ' ' ASP . 4.1 mt -109.26 -33.24 6.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 75.25 110.943 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.421 ' CB ' ' O ' ' A' ' 122' ' ' LEU . 4.3 t0 78.19 -42.18 0.34 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 72.42 110.857 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 101.17 40.61 2.78 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 72.21 112.515 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.6 mtpp -62.94 -14.94 53.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.862 0.363 . . . . 72.42 110.903 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -92.51 16.54 11.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 64.43 110.894 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.428 HG11 ' OD1' ' A' ' 108' ' ' ASN . 7.0 t 72.41 85.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 71.03 111.167 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 4.4 p -86.31 126.46 40.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 73.33 111.147 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.755 ' CE2' HD22 ' A' ' 24' ' ' LEU . 5.1 p90 -157.93 128.49 6.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 73.52 110.892 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 115.81 121.61 3.4 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.762 -0.732 . . . . 72.21 112.545 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -129.72 159.05 37.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 52.15 110.905 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.3 p -64.25 158.4 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 75.32 111.119 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.89 -62.59 1.47 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 74.21 110.865 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.16 173.6 11.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.244 -0.434 . . . . 73.21 110.877 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.44 81.58 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.791 -0.719 . . . . 65.5 112.478 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.54 -7.09 42.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 62.44 110.865 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.13 -30.86 62.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.865 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.745 HG21 HD12 ' A' ' 10' ' ' ILE . 50.1 mm -65.69 -36.14 76.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.187 -0.461 . . . . 72.23 111.138 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.48 ' O ' HG12 ' A' ' 139' ' ' VAL . 11.4 t -89.04 1.59 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 62.31 111.123 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 -115.62 -64.0 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 60.44 110.854 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.25 -52.61 64.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 52.25 111.065 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.488 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 14.0 tmm? -51.9 -45.78 64.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.262 -0.426 . . . . 64.43 110.868 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 -23.12 3.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.845 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 34.4 ttm-85 -63.28 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.469 . . . . 75.51 110.877 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -92.91 20.13 6.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.42 110.885 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.529 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -110.73 68.14 0.22 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.755 -0.736 . . . . 74.1 112.447 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.529 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -27.35 135.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 72.43 110.837 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.448 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 13.6 mmm-85 -46.16 -63.68 0.93 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.5 . . . . 71.5 110.903 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.81 -31.35 16.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 63.15 110.879 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.8 -167.69 22.12 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.739 -0.743 . . . . 75.53 112.521 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.5 mttt 61.72 103.99 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.848 0.356 . . . . 72.3 110.867 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.5 p -77.68 144.35 37.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.251 -0.432 . . . . 65.24 111.15 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.1 p -60.9 -19.05 59.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 75.22 110.83 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.431 ' HB3' HG13 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -129.88 -168.5 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 61.41 110.905 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.4 108.46 17.25 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 61.44 110.894 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.8 mt -88.95 99.87 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 73.42 111.143 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.15 157.1 23.07 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 63.32 111.121 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.7 mt -95.12 126.01 47.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 65.42 111.185 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.31 -63.12 1.37 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 63.33 111.111 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -127.31 168.95 14.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 62.44 110.832 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -164.05 -176.1 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 71.35 110.847 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.97 -152.22 20.07 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.759 -0.734 . . . . 74.22 112.499 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.493 ' HG3' HG12 ' A' ' 6' ' ' VAL . 0.3 OUTLIER -125.07 138.33 54.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.87 0.366 . . . . 71.54 110.854 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.695 HD23 ' O ' ' A' ' 5' ' ' THR . 1.0 OUTLIER -116.92 143.98 45.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.963 179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.85 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.814 0.34 . . . . 73.32 110.882 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.43 144.67 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.226 -0.443 . . . . 73.33 111.153 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -52.2 141.73 30.08 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.618 0.723 . . . . 75.1 110.862 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 128.44 16.08 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 63.52 112.351 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 63.1 m -115.52 125.95 53.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 73.32 111.197 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.9 m -113.22 156.74 14.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 72.01 111.142 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.478 ' HB3' HD21 ' A' ' 164' ' ' LEU . 9.2 p90 -127.46 165.65 19.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 74.2 110.833 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.63 143.98 33.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 61.41 110.888 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -98.04 136.26 38.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 71.15 110.893 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.796 HD11 ' HB ' ' A' ' 20' ' ' VAL . 3.7 mm -107.19 136.74 41.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 71.51 111.127 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.589 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -143.26 162.86 34.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 62.12 111.095 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 HG22 HG12 ' A' ' 156' ' ' ILE . 76.1 t -153.1 101.8 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 73.43 111.167 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 65.4 56.64 0.95 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 72.51 110.888 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.4 13.08 48.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.793 -0.718 . . . . 54.34 112.512 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -124.04 113.42 28.21 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.629 0.728 . . . . 72.32 110.903 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.9 Cg_endo -69.8 153.32 68.87 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.674 2.249 . . . . 73.53 112.348 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HB3' HD12 ' A' ' 138' ' ' ILE . 1.7 mm? -112.51 -60.49 1.86 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.911 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.62 -164.33 27.06 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.772 -0.727 . . . . 43.35 112.468 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.2 ttp180 -108.99 121.49 45.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.876 0.37 . . . . 75.23 110.853 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.796 ' HB ' HD11 ' A' ' 10' ' ' ILE . 74.7 t -119.37 111.96 35.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.456 . . . . 65.2 111.119 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.5 p -111.09 152.61 26.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 71.11 110.869 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -127.5 112.9 15.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.15 -0.477 . . . . 72.11 110.889 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -47.33 137.39 8.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 53.22 110.881 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.783 ' CD1' ' HB1' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -105.5 113.35 26.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 74.14 110.92 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CE2' HD11 ' A' ' 90' ' ' LEU . 4.2 m-85 -85.99 70.79 10.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 55.22 110.86 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.52 -1.88 43.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 70.44 111.112 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.36 -48.22 8.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 65.3 110.91 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.436 ' HG2' HD23 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -60.52 -62.71 1.66 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 72.1 110.874 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.446 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -115.35 77.67 5.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.64 0.733 . . . . 70.34 111.117 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 72.85 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.677 2.251 . . . . 74.44 112.371 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.547 ' HG2' ' N ' ' A' ' 32' ' ' THR . 0.0 OUTLIER -177.11 -42.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 75.14 110.892 179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.547 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -82.55 -61.85 1.77 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 64.31 111.127 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.839 ' HB2' ' CD1' ' A' ' 129' ' ' PHE . . . -91.43 22.17 4.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 75.21 111.115 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -108.37 12.67 26.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.876 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -121.5 -28.03 4.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.13 -0.486 . . . . 64.55 110.868 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -54.26 -26.75 30.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.883 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 28.3 ptt85 -53.23 -30.79 39.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.49 . . . . 74.24 110.876 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.0 -26.67 26.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.03 111.077 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -93.08 19.44 7.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 74.51 110.888 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.2 m -118.02 -8.06 10.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 62.1 110.86 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.0 p -115.95 12.71 15.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 70.43 111.166 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.11 31.55 33.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 62.21 112.461 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -84.95 -34.18 22.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.905 0.383 . . . . 54.33 110.898 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HE2' ' HB ' ' A' ' 78' ' ' ILE . 0.2 OUTLIER -61.49 -19.97 62.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 65.34 110.914 179.926 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.88 18.8 60.66 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.742 -0.742 . . . . 61.41 112.473 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.8 151.79 0.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.861 0.363 . . . . 73.43 110.902 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 120.49 -179.58 16.41 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.742 -0.742 . . . . 41.5 112.485 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.13 102.51 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.923 0.392 . . . . 74.15 110.9 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.07 -51.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.92 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -136.94 32.73 2.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 43.35 112.475 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.32 -169.46 2.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.825 0.345 . . . . 72.22 110.893 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.1 p -152.86 148.77 27.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.459 . . . . 65.15 110.864 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -127.82 -177.61 4.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.489 . . . . 74.44 110.898 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -171.87 60.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 62.0 110.831 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.654 ' NH2' HD11 ' A' ' 57' ' ' ILE . 13.1 mmm180 -137.23 29.54 2.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 73.15 110.883 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.49 143.27 15.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.464 . . . . 71.35 111.141 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.654 HD11 ' NH2' ' A' ' 55' ' ' ARG . 14.5 mt -139.77 96.5 8.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.622 0.725 . . . . 71.44 111.108 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.77 85.13 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.682 2.255 . . . . 73.2 112.314 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.47 -40.65 0.48 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.772 -0.728 . . . . 71.52 112.486 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -109.22 -58.19 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.349 . . . . 73.41 110.867 -179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.558 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.0 OUTLIER -173.97 -158.75 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 61.25 110.838 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 60.4 m -139.56 142.55 37.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 63.52 110.879 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.48 ' CD ' HG22 ' A' ' 68' ' ' THR . 2.1 tt0 -126.9 157.39 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 75.31 110.953 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.63 99.86 0.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.759 . . . . 74.04 112.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.82 -132.58 11.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.742 -0.742 . . . . 74.51 112.491 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -99.9 -169.71 1.78 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.834 0.35 . . . . 74.4 110.918 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -51.38 132.83 29.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 63.3 110.893 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.48 HG22 ' CD ' ' A' ' 63' ' ' GLN . 14.1 t -117.24 -33.68 4.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 54.51 111.172 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -106.18 44.62 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 61.41 110.855 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 174.19 115.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 64.52 110.867 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 47.77 34.27 3.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 63.14 110.878 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -82.69 153.97 32.01 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.747 -0.74 . . . . 73.32 112.487 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 9.5 p -142.55 141.13 31.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.793 0.33 . . . . 74.53 111.183 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.16 173.07 30.03 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.729 -0.748 . . . . 71.03 112.499 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 139.71 -93.73 0.2 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.734 -0.746 . . . . 71.32 112.505 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt 64.68 152.37 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.805 0.336 . . . . 45.43 110.871 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.663 ' O ' ' CG1' ' A' ' 78' ' ' ILE . 40.5 t -118.74 10.83 12.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.205 -0.452 . . . . 71.42 110.861 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.663 ' CG1' ' O ' ' A' ' 77' ' ' SER . 0.5 OUTLIER 75.4 -8.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 73.53 111.092 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 17.9 t80 -110.28 -18.12 13.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.208 -0.451 . . . . 62.03 110.938 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.37 -134.38 2.01 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.765 -0.731 . . . . 73.34 112.502 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -123.98 -33.84 3.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.942 0.401 . . . . 74.22 110.888 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.42 163.95 10.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.109 -0.496 . . . . 72.25 110.879 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -144.28 135.6 25.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 64.2 110.883 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.6 pm0 -51.02 162.91 0.24 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.122 -0.49 . . . . 74.21 110.903 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 -75.29 92.67 2.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 73.13 110.882 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -51.67 51.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.895 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.4 p30 177.51 167.63 0.64 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.149 -0.478 . . . . 73.34 110.891 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -122.95 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 64.34 110.907 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 3.4 mt -52.38 -28.08 11.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 72.04 111.143 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.544 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -87.75 122.3 31.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 74.43 110.892 179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -108.39 -166.55 1.14 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 70.25 110.891 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.456 ' CE1' HD12 ' A' ' 122' ' ' LEU . 11.8 m170 -99.88 -88.22 0.35 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.215 -0.448 . . . . 73.22 110.837 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.6 m 69.46 7.64 6.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.448 . . . . 74.51 111.121 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.22 168.78 30.82 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.02 112.455 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 171.34 14.61 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.269 . . . . 70.11 112.322 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.465 ' CA ' HG23 ' A' ' 132' ' ' VAL . . . 80.05 28.26 50.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.756 -0.735 . . . . 64.15 112.526 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.509 HG23 HG11 ' A' ' 128' ' ' VAL . 37.7 mm -95.31 139.4 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.831 0.348 . . . . 53.12 111.127 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.741 HD22 ' CE1' ' A' ' 112' ' ' PHE . 12.3 mt -106.54 142.29 36.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 74.13 110.905 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 6.4 m -116.89 -138.21 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 44.32 110.889 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.406 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 7.3 mmt -155.13 -59.28 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 62.04 110.872 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 65.04 146.06 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 53.31 111.108 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.584 ' CG ' HG22 ' A' ' 107' ' ' THR . 0.2 OUTLIER 177.81 -73.35 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.439 . . . . 75.53 110.882 -179.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.506 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.43 -28.8 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 71.1 111.12 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.11 -76.72 0.29 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.72 -0.752 . . . . 41.02 112.429 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.79 107.62 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.649 2.233 . . . . 73.23 112.331 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 105' ' ' PRO . 70.9 m-80 35.41 69.96 0.16 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.225 -0.443 . . . . 75.35 110.873 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.584 HG22 ' CG ' ' A' ' 102' ' ' ASN . 2.7 m -134.68 16.68 3.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 71.32 111.165 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 24.5 t30 39.45 -97.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.14 110.9 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' ' OD1' ' A' ' 102' ' ' ASN . . . 133.65 174.48 13.56 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 53.15 112.512 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 63.6 m -144.68 -43.03 0.24 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.892 0.377 . . . . 71.34 110.901 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 8.6 mp0 -91.47 92.55 8.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.104 -0.498 . . . . 63.01 110.889 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.741 ' CE1' HD22 ' A' ' 98' ' ' LEU . 32.7 p90 -82.91 147.06 28.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 64.53 110.858 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -111.46 131.73 55.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 73.43 110.911 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 18.0 mt -84.51 123.17 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.1 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 68.1 m -74.72 130.97 40.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 54.11 110.862 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.558 HG23 ' HA ' ' A' ' 61' ' ' MET . 28.9 p -91.71 -27.77 17.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 72.51 111.173 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 119' ' ' THR . . . -130.53 169.67 15.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 55.13 111.117 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -61.86 96.98 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.233 -0.44 . . . . 73.12 110.895 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.556 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 29.6 p -121.33 59.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 74.43 111.145 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -88.63 25.0 1.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 73.13 110.872 -179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.556 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.7 OUTLIER -89.22 10.5 21.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 73.42 110.945 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.633 HD13 ' CD2' ' A' ' 126' ' ' HIS . 10.9 mt -98.44 -41.56 7.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.241 -0.436 . . . . 71.21 110.89 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.92 -58.37 0.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.435 . . . . 74.35 110.899 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.23 59.99 0.14 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.702 -0.761 . . . . 72.31 112.468 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.1 mmtp -103.33 -22.66 13.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.781 0.324 . . . . 65.13 110.87 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.633 ' CD2' HD13 ' A' ' 122' ' ' LEU . 18.6 m-70 -119.32 -20.78 7.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 63.43 110.891 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 16.1 t 80.74 104.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.212 -0.449 . . . . 55.43 111.104 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 97' ' ' ILE . 77.2 t -102.43 137.92 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 70.23 111.143 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.839 ' CD1' ' HB2' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -157.6 29.63 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 74.04 110.884 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.64 140.17 6.27 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.723 -0.751 . . . . 54.0 112.451 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 mtmp? -124.04 -165.3 1.34 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.803 0.335 . . . . 70.11 110.904 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.465 HG23 ' CA ' ' A' ' 96' ' ' GLY . 21.7 t -96.68 134.13 35.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 75.41 111.13 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 4.8 tppt? -90.62 -63.37 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 71.11 110.862 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -162.07 142.6 10.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 72.34 110.892 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 118.63 4.71 13.02 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.771 -0.728 . . . . 62.21 112.523 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.6 ttt -49.41 -33.24 13.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.779 0.323 . . . . 54.0 110.902 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -51.1 -28.44 10.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.32 110.931 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.608 HD12 ' HB3' ' A' ' 17' ' ' LEU . 31.0 mm -79.39 -38.4 19.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 75.03 111.115 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 47.8 t -48.08 -53.31 5.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.172 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.98 -32.02 14.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.128 -0.487 . . . . 74.12 110.846 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -66.02 -41.12 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 61.23 111.119 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.458 ' SD ' HD13 ' A' ' 156' ' ' ILE . 43.7 mtm -77.14 -17.15 58.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 72.41 110.858 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -90.16 29.47 1.23 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 71.13 110.899 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.18 9.73 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 72.14 110.882 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -129.15 17.43 6.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 74.4 110.86 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.465 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -136.65 46.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 74.12 112.469 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.465 ' C ' ' O ' ' A' ' 146' ' ' GLY . 37.8 m 33.42 -100.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.859 0.361 . . . . 72.04 110.856 -179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.651 ' O ' HG23 ' A' ' 57' ' ' ILE . 7.5 mmm-85 -161.52 -40.23 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.099 -0.5 . . . . 73.15 110.86 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -78.58 -7.03 57.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.2 110.903 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 109.34 -137.18 14.05 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.752 -0.737 . . . . 75.31 112.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.6 mttp 75.47 -55.56 0.62 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.886 0.374 . . . . 65.41 110.915 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 73.35 140.15 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 71.4 111.156 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -108.8 0.33 20.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 70.5 110.859 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -135.14 161.04 36.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.878 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.48 112.76 25.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 43.43 110.919 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.589 HG23 ' O ' ' A' ' 11' ' ' ALA . 41.5 mt -98.35 100.3 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.259 -0.428 . . . . 72.24 111.168 179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.66 174.2 6.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 73.33 111.122 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 23.1 mm -120.36 145.12 27.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.192 -0.458 . . . . 74.31 111.14 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.21 -62.04 1.29 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.174 -0.466 . . . . 74.51 111.102 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -157.06 164.8 37.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 72.3 110.787 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.7 m -146.23 -165.55 2.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 71.11 110.863 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.64 -166.34 28.73 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 72.54 112.489 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 13.6 mt-30 -108.65 136.48 48.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.353 . . . . 74.01 110.919 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.478 HD21 ' HB3' ' A' ' 7' ' ' PHE . 41.7 mt -73.12 -41.04 64.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 72.11 110.909 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 71.34 110.892 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.362 . . . . 61.23 110.843 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.26 155.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 73.54 111.15 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -92.96 152.87 41.82 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.653 0.74 . . . . 72.24 110.882 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 54.2 Cg_endo -69.77 147.11 62.07 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.686 2.257 . . . . 61.32 112.356 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.466 HG22 ' H ' ' A' ' 6' ' ' VAL . 1.9 m -140.01 165.8 26.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 75.33 111.173 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.466 ' H ' HG22 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.96 132.85 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 65.13 111.136 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -109.5 162.86 13.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.178 -0.464 . . . . 63.34 110.906 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -143.67 138.58 29.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 72.32 110.884 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -101.41 71.95 1.39 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.151 -0.477 . . . . 60.44 110.827 179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 156' ' ' ILE . 42.7 mm -50.47 136.09 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 63.42 111.145 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -108.37 152.69 24.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 52.41 111.126 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD23 ' A' ' 17' ' ' LEU . 2.0 t -127.27 94.8 2.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.24 111.159 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 60.01 32.33 21.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 74.03 110.896 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.47 -24.71 25.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.746 -0.74 . . . . 62.12 112.511 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -121.79 119.68 28.92 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.67 0.748 . . . . 71.44 110.884 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 162.67 41.16 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.732 2.288 . . . . 74.21 112.365 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.538 HD23 ' CG2' ' A' ' 12' ' ' VAL . 0.4 OUTLIER -126.11 20.98 7.49 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 44.23 110.891 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HD11 ' A' ' 138' ' ' ILE . . . 133.9 -164.33 24.43 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.763 -0.732 . . . . 60.1 112.49 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.51 174.47 13.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.806 0.336 . . . . 75.23 110.866 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.655 HG12 ' O ' ' A' ' 135' ' ' GLY . 31.9 m -136.78 177.12 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 61.52 111.116 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 t -129.61 100.86 5.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 75.02 110.893 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -86.62 114.04 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.43 110.877 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -105.55 124.85 50.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.152 -0.476 . . . . 74.51 110.898 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HB3' ' HB1' ' A' ' 33' ' ' ALA . 32.1 mt -88.19 126.66 35.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 74.42 110.937 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -76.38 67.08 2.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 72.1 110.888 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -49.03 -30.1 5.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 70.45 111.138 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -53.06 -56.46 16.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 64.43 110.874 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.683 ' HB2' HD11 ' A' ' 90' ' ' LEU . 4.6 mptp? -81.95 -35.55 28.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.439 . . . . 74.32 110.841 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.619 HG21 ' CB ' ' A' ' 129' ' ' PHE . 16.6 m -128.32 80.35 72.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 63.31 111.129 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -33.07 17.39 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.706 2.27 . . . . 60.43 112.356 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mtmm -84.59 -69.35 0.65 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 61.4 110.87 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -42.26 -39.62 2.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 53.01 111.166 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 24' ' ' LEU . . . -63.55 -67.72 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 53.4 111.071 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' ARG . 6.8 tt0 -41.62 -61.06 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 53.21 110.862 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -35.83 -43.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 44.21 110.881 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -75.24 -41.85 56.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 74.02 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' GLU . 9.0 tmm_? -51.62 -30.32 20.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 61.45 110.838 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.55 67.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 75.24 111.113 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.1 mt -68.19 -41.44 81.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.923 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 89.9 p -58.88 -46.09 88.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 71.44 110.881 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -16.93 64.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 73.33 111.129 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.56 86.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.71 -0.757 . . . . 55.41 112.474 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -143.74 39.95 1.39 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.942 0.401 . . . . 74.34 110.92 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -144.6 21.57 1.66 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.126 -0.488 . . . . 62.13 110.926 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.91 -33.69 3.93 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.766 -0.731 . . . . 64.33 112.486 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.57 ' CZ ' HG21 ' A' ' 73' ' ' THR . 15.7 p90 -126.09 -167.53 1.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.908 0.385 . . . . 72.2 110.865 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 143.6 -144.21 13.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.733 . . . . 72.51 112.496 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.11 -18.69 15.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.986 0.422 . . . . 74.24 110.968 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.59 113.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 65.1 110.88 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 89.34 -131.19 10.58 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.749 -0.739 . . . . 50.42 112.498 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.697 ' O ' HG22 ' A' ' 157' ' ' THR . 6.2 t 49.32 -166.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.866 0.365 . . . . 65.33 110.817 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.7 p -143.52 -168.58 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.153 -0.476 . . . . 73.0 110.907 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -95.08 -179.44 4.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.222 -0.445 . . . . 72.34 110.87 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -116.13 -57.52 2.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 74.1 110.855 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -145.79 164.6 31.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 74.15 110.909 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.577 ' HB ' HG22 ' A' ' 152' ' ' THR . 67.0 mt -153.42 124.53 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 72.12 111.171 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 1.3 pt -134.62 126.82 18.29 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.652 0.739 . . . . 61.42 111.132 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 138.44 37.77 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.622 2.215 . . . . 63.03 112.348 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.43 30.86 77.58 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.745 -0.741 . . . . 54.34 112.486 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.539 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.96 -70.31 0.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.826 0.346 . . . . 74.52 110.898 -179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -176.0 -163.37 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.893 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 5.0 m -137.02 -69.39 0.47 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 61.42 110.865 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 62.81 148.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.241 -0.436 . . . . 65.33 110.897 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.61 167.18 21.57 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.712 -0.756 . . . . 53.2 112.469 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -51.44 -90.33 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.744 -0.741 . . . . 43.43 112.486 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 176.76 -168.44 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.816 0.341 . . . . 62.54 110.865 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -134.75 32.92 3.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.913 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.544 HG23 ' H ' ' A' ' 75' ' ' GLY . 90.2 m -58.98 -76.59 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 53.24 111.131 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 65.31 -152.58 0.26 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 74.45 110.875 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -152.9 27.13 0.54 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.452 . . . . 75.1 110.839 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -61.86 -17.58 56.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 71.34 110.836 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.83 15.36 2.91 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.732 -0.746 . . . . 73.25 112.497 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.57 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 81.3 m -128.51 -51.75 1.27 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.331 . . . . 64.1 111.14 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 90.95 178.02 43.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 54.42 112.451 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.544 ' H ' HG23 ' A' ' 68' ' ' THR . . . -79.11 109.25 2.82 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.757 -0.735 . . . . 70.11 112.504 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.37 -165.77 0.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.76 0.314 . . . . 61.3 110.914 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' ILE . 47.6 p -77.87 137.46 38.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.248 -0.433 . . . . 43.31 110.861 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' SER . 0.9 OUTLIER -33.59 -46.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.127 -0.488 . . . . 74.22 111.153 179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.587 ' CG ' ' O ' ' A' ' 79' ' ' TYR . 8.2 p90 -112.84 106.21 14.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 71.21 110.88 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.57 -168.86 51.85 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.74 -0.743 . . . . 73.43 112.506 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -71.33 -100.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 74.01 110.902 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.436 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.06 155.56 44.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 53.4 110.913 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -115.53 179.41 3.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.446 . . . . 73.23 110.881 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -86.65 173.96 9.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.157 -0.474 . . . . 65.44 110.848 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 8.6 p30 -71.79 179.96 2.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.883 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -137.72 -63.3 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 72.25 110.835 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -176.86 158.97 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 73.23 110.855 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -131.21 60.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.176 -0.465 . . . . 54.5 110.924 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 mt -78.98 -3.34 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 70.14 111.116 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 28' ' ' LYS . 0.5 OUTLIER -115.94 71.52 0.78 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 75.1 110.882 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.47 154.57 24.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 53.04 110.866 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -63.82 83.42 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 63.22 110.845 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -77.08 -8.81 58.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 71.25 111.13 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.95 -174.35 45.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.54 112.492 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.82 155.07 66.68 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.694 2.263 . . . . 71.42 112.329 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.58 -27.96 11.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.741 -0.742 . . . . 53.43 112.496 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 36.9 mm -49.18 120.51 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.864 0.364 . . . . 72.42 111.131 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.711 HD23 ' N ' ' A' ' 99' ' ' SER . 4.1 tt -91.96 143.16 26.77 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.153 -0.476 . . . . 75.22 110.909 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.711 ' N ' HD23 ' A' ' 98' ' ' LEU . 21.0 t -148.83 -166.58 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 62.34 110.824 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.414 ' HA ' ' HE3' ' A' ' 100' ' ' MET . 0.0 OUTLIER -101.81 148.52 25.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.126 -0.488 . . . . 75.54 110.872 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.203 -0.453 . . . . 73.31 111.096 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 107' ' ' THR . 3.1 t30 -145.5 -160.54 1.15 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 74.52 110.927 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.84 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -46.16 -45.59 16.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.461 . . . . 75.24 111.081 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.04 -65.31 0.32 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 64.04 112.527 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.629 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 112.21 3.03 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.65 2.233 . . . . 64.2 112.333 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.439 ' C ' ' O ' ' A' ' 105' ' ' PRO . 51.7 m-20 34.42 46.63 0.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 54.1 110.901 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.84 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 19.7 p -154.08 34.31 0.43 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.177 -0.465 . . . . 72.3 111.16 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.3 p30 -79.73 4.01 17.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.02 110.875 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.07 133.1 43.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 62.24 112.467 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 62.22 166.29 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 52.02 110.891 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 67.52 138.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 70.25 110.947 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -153.91 177.49 10.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 61.42 110.91 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -159.47 162.91 35.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 74.14 110.874 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 15.4 pt -145.39 134.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.54 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.507 ' SG ' HG23 ' A' ' 119' ' ' THR . 14.0 t -96.58 156.89 16.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 73.3 110.873 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 p -124.9 27.74 6.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 73.1 111.125 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.62 27.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 71.4 111.102 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.0 142.44 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 72.23 110.878 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.507 HG23 ' SG ' ' A' ' 115' ' ' CYS . 0.2 OUTLIER -140.57 48.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 73.13 111.195 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -56.72 -20.82 23.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.46 . . . . 64.21 110.849 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.6 m-90 -62.51 -22.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.904 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.455 HD22 ' HB ' ' A' ' 119' ' ' THR . 4.2 mp -76.41 -37.46 57.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.239 -0.437 . . . . 55.43 110.919 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t0 47.09 86.56 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 73.3 110.828 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.79 37.08 1.23 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.707 -0.759 . . . . 31.32 112.508 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.1 tptp -55.03 -32.91 62.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.846 0.355 . . . . 74.32 110.911 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.621 ' C ' HG23 ' A' ' 127' ' ' VAL . 87.3 m-70 -145.57 43.28 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.232 -0.44 . . . . 72.43 110.871 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.0 OUTLIER 67.13 -153.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.235 -0.439 . . . . 72.32 111.12 179.973 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.644 ' H ' HG12 ' A' ' 127' ' ' VAL . 14.2 p -176.94 144.15 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.22 111.122 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.619 ' CB ' HG21 ' A' ' 29' ' ' VAL . 4.1 p90 -176.5 95.51 0.05 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 63.02 110.881 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . 132.54 161.48 9.97 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.755 -0.736 . . . . 54.41 112.468 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 10.6 ptmt 175.18 131.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.816 0.341 . . . . 73.52 110.872 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.1 p -51.69 136.36 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 74.14 111.124 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.3 mmtt -114.54 -39.41 3.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 75.52 110.883 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -133.24 160.94 35.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 75.33 110.896 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.655 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 59.05 81.45 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.766 -0.73 . . . . 72.3 112.473 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.67 -12.29 51.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.799 0.333 . . . . 70.43 110.913 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -75.06 -24.54 58.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.23 -0.441 . . . . 74.53 110.88 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.458 HD11 ' HA3' ' A' ' 18' ' ' GLY . 17.6 mm -64.19 -44.11 97.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.464 . . . . 74.53 111.144 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.488 ' O ' HG12 ' A' ' 139' ' ' VAL . 6.7 t -93.38 5.62 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 52.55 111.166 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -112.58 -64.36 1.31 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 70.22 110.849 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.66 -50.27 73.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 53.23 111.077 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -50.34 -44.45 54.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 72.23 110.851 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.29 -28.93 8.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 54.45 110.907 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 55.0 ttp180 -59.37 -29.97 68.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.173 -0.467 . . . . 71.21 110.864 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -78.37 -2.81 40.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.192 -0.458 . . . . 62.41 110.884 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.95 -152.75 14.95 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.757 -0.735 . . . . 52.44 112.44 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 3.7 t -161.92 156.13 22.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.84 0.352 . . . . 72.42 110.858 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -71.53 -7.47 47.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 73.1 110.837 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -106.21 -19.61 13.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 74.13 110.862 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.15 -44.27 1.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.797 -0.716 . . . . 61.24 112.495 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -44.55 129.63 6.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.851 0.358 . . . . 72.45 110.914 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.577 HG22 ' HB ' ' A' ' 56' ' ' ILE . 49.2 p -98.62 118.17 34.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 53.01 111.118 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.7 p -54.2 -26.27 27.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 74.42 110.82 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.456 ' HE2' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -127.43 -163.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.943 179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -131.0 127.75 38.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 64.53 110.943 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 HG23 ' A' ' 10' ' ' ILE . 2.2 mp -98.84 125.21 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.429 . . . . 73.04 111.145 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.697 HG22 ' O ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.13 141.69 49.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 75.2 111.139 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.8 mp -83.07 100.53 6.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 75.34 111.185 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.603 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -66.31 -59.82 3.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 74.03 111.093 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -139.5 170.41 15.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.439 . . . . 64.25 110.873 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -170.2 154.36 4.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.168 -0.469 . . . . 74.25 110.928 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.79 179.89 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.732 -0.747 . . . . 51.43 112.478 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 1.1 mt-30 -82.62 -49.92 9.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.831 0.348 . . . . 51.25 110.898 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 164' ' ' LEU . 2.7 mm? 65.04 115.46 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 64.33 110.936 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 72.11 110.917 179.952 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.889 0.376 . . . . 70.14 110.911 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.85 156.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 75.2 111.139 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -92.64 160.1 35.12 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.623 0.725 . . . . 71.1 110.859 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 151.52 69.02 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.67 2.247 . . . . 61.21 112.349 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 56.1 m -136.18 150.13 48.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 50.2 111.142 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.92 137.24 24.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 73.15 111.079 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.625 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -113.32 157.87 21.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 74.33 110.867 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -141.66 136.34 30.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.878 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.615 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 3.1 m-20 -96.55 119.75 35.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 71.23 110.912 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.432 HG13 HD12 ' A' ' 138' ' ' ILE . 13.3 mm -95.02 142.41 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 74.14 111.12 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.54 170.76 15.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 42.51 111.067 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.715 HG22 HD13 ' A' ' 17' ' ' LEU . 2.6 m -146.99 96.29 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 70.25 111.092 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.74 36.07 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 75.03 110.857 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.24 -12.42 66.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.717 -0.754 . . . . 65.12 112.486 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -94.56 131.55 30.65 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.646 0.736 . . . . 73.44 110.921 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 153.18 69.08 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.686 2.257 . . . . 75.23 112.333 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.715 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -117.53 -68.21 0.93 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.444 . . . . 74.33 110.912 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.47 -168.58 28.87 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.789 -0.719 . . . . 50.05 112.528 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.76 134.26 54.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.859 0.361 . . . . 70.34 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.603 HG22 ' HA3' ' A' ' 135' ' ' GLY . 53.3 t -136.59 139.99 44.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.19 -0.459 . . . . 75.31 111.076 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -123.53 152.66 41.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.468 . . . . 53.12 110.87 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' CD2' HG22 ' A' ' 132' ' ' VAL . 1.3 m-85 -119.54 -175.48 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 72.34 110.874 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -144.48 117.57 8.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.468 . . . . 72.22 110.927 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -89.46 130.21 35.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 61.31 110.913 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.451 ' O ' HG22 ' A' ' 29' ' ' VAL . 67.6 m-85 -79.48 75.86 6.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.86 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.35 -28.11 64.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.124 -0.489 . . . . 73.42 111.126 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -37.72 79.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 50.14 110.891 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HD2' HD12 ' A' ' 89' ' ' ILE . 19.0 mmtp -86.44 -31.97 21.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 65.22 110.889 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.801 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 7.9 m -132.84 84.98 48.0 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.637 0.732 . . . . 73.22 111.11 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -40.38 5.37 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.643 2.228 . . . . 50.44 112.38 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.1 mtmm -83.08 -44.89 14.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 70.33 110.864 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.415 HG21 ' CE ' ' A' ' 100' ' ' MET . 2.7 m -81.84 17.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 63.42 111.163 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.801 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -85.79 -44.14 12.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 72.41 111.139 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.4 mt-10 -81.81 -31.37 31.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 61.34 110.85 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 8.4 t30 -27.18 -70.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.462 . . . . 72.21 110.896 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -77.51 -34.21 54.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 73.45 110.869 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.426 ' CB ' ' HA ' ' A' ' 34' ' ' GLU . 1.8 ttp180 -47.83 -40.27 20.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 54.02 110.917 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.85 -34.21 60.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 73.32 111.079 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.64 13.16 14.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 73.42 110.942 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.2 p -129.67 -20.29 3.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.864 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 37' ' ' ARG . 77.8 p -101.19 -25.08 14.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.459 . . . . 72.41 111.106 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.17 62.11 1.24 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 75.23 112.45 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -144.63 27.08 1.38 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 71.13 110.865 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -123.6 -11.03 7.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 61.35 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.86 -25.94 25.38 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.742 -0.742 . . . . 52.13 112.539 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -140.57 166.65 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 64.53 110.89 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.87 -176.68 41.24 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.776 -0.726 . . . . 73.01 112.522 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.619 ' CE2' HD11 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -99.58 3.29 45.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.956 0.408 . . . . 73.21 110.937 -179.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.3 tttt -54.19 150.41 8.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 64.24 110.894 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.426 ' H ' ' HB ' ' A' ' 158' ' ' ILE . . . 49.51 63.61 3.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.747 -0.739 . . . . 74.53 112.544 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.5 m -153.6 -95.33 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.844 0.354 . . . . 65.33 110.884 -179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 p -176.5 -172.8 0.48 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.142 -0.481 . . . . 75.1 110.899 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -124.18 -174.51 3.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.177 -0.465 . . . . 75.31 110.9 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.26 177.02 7.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.141 -0.482 . . . . 70.34 110.87 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.5 mmm-85 51.17 27.09 3.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.872 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.8 mt -71.27 119.44 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 72.53 111.121 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 mt -138.4 111.32 8.38 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.587 0.708 . . . . 65.41 111.168 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.69 93.45 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.672 2.248 . . . . 71.23 112.335 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.96 -30.89 2.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.715 -0.755 . . . . 71.3 112.461 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -108.56 -65.72 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.863 0.363 . . . . 74.52 110.9 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.96 -171.82 3.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.141 -0.482 . . . . 72.32 110.849 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 7.1 m -121.17 -67.4 0.97 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 64.53 110.906 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 64.15 162.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 74.5 110.905 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.85 168.27 20.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.736 -0.745 . . . . 74.21 112.504 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -48.44 -92.82 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.731 -0.747 . . . . 62.53 112.48 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -178.9 -155.47 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.877 0.37 . . . . 72.33 110.859 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.9 p90 -158.37 -39.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.119 -0.491 . . . . 73.51 110.885 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.401 ' HA ' ' HA3' ' A' ' 75' ' ' GLY . 3.1 p 47.7 -101.99 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.48 . . . . 64.23 111.123 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -121.95 -176.09 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 71.33 110.86 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 179.62 -30.45 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.479 . . . . 71.24 110.81 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.65 -51.16 1.6 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 51.24 110.902 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 152.0 46.09 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.723 -0.751 . . . . 73.0 112.495 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.4 m -120.21 -48.88 2.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.876 0.369 . . . . 72.13 111.169 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 118.63 153.19 9.41 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.756 -0.735 . . . . 70.41 112.521 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 68' ' ' THR . . . -90.62 -155.52 31.47 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 53.12 112.456 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 69.93 -68.07 0.21 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.786 0.327 . . . . 74.43 110.871 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.444 ' HB2' ' C ' ' A' ' 80' ' ' GLY . 0.4 OUTLIER -125.31 129.31 49.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 63.53 110.856 -179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pt -61.75 -15.0 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 63.33 111.172 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -128.0 21.85 6.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 72.41 110.923 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' C ' ' HB2' ' A' ' 77' ' ' SER . . . 157.12 -136.15 4.77 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.783 -0.722 . . . . 75.34 112.495 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.408 ' C ' ' HB2' ' A' ' 77' ' ' SER . 27.2 mm-40 -104.57 -47.71 4.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.956 0.407 . . . . 60.23 110.883 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.34 175.01 10.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 54.33 110.866 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -138.51 175.0 9.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.897 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -89.97 152.12 21.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 72.34 110.858 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -56.61 166.03 1.02 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.161 -0.472 . . . . 73.31 110.864 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -127.37 -64.12 1.01 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 71.35 110.888 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -178.36 153.65 0.76 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.473 . . . . 62.41 110.909 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -122.92 62.69 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 73.42 110.853 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.439 HD12 ' HD2' ' A' ' 28' ' ' LYS . 1.5 mt -81.9 -4.75 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.171 -0.468 . . . . 72.34 111.177 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.734 ' O ' HG11 ' A' ' 128' ' ' VAL . 4.2 mt -120.49 77.38 1.27 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.902 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -58.82 -172.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.939 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -101.72 86.29 2.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 74.55 110.861 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 p -108.33 17.78 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 74.41 111.113 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 177.62 164.97 31.94 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.722 -0.751 . . . . 61.43 112.486 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 165.63 30.27 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.698 2.265 . . . . 75.33 112.312 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' O ' ' HA ' ' A' ' 131' ' ' LYS . . . 75.98 26.38 64.63 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.768 -0.729 . . . . 60.43 112.517 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 14.8 mm -91.86 118.85 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.819 0.342 . . . . 72.54 111.152 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 131' ' ' LYS . 1.2 mt -94.37 143.31 26.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 52.13 110.961 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 21.5 t -146.22 -127.11 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 61.35 110.821 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.415 ' CE ' HG21 ' A' ' 32' ' ' THR . 0.0 OUTLIER -162.61 118.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 75.42 110.868 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.595 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -106.79 88.87 2.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 61.3 111.089 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 103' ' ' ALA . 49.5 t30 -153.74 95.69 1.91 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 71.13 110.873 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.508 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 71.26 -66.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 64.53 111.052 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 127.15 -73.41 0.45 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.71 -0.757 . . . . 60.32 112.491 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.482 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.3 Cg_endo -69.72 123.54 10.21 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.731 2.288 . . . . 63.14 112.341 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.482 ' C ' ' O ' ' A' ' 105' ' ' PRO . 4.2 m-20 31.06 60.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.447 . . . . 54.54 110.901 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.581 ' O ' ' C ' ' A' ' 108' ' ' ASN . 1.2 p -145.05 31.69 1.13 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.145 -0.479 . . . . 55.31 111.132 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.581 ' C ' ' O ' ' A' ' 107' ' ' THR . 35.6 t30 22.14 -100.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.243 -0.435 . . . . 74.41 110.911 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 107.96 145.12 11.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.729 -0.748 . . . . 72.24 112.514 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 t -121.4 -10.43 8.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.798 0.332 . . . . 45.54 110.821 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.595 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 2.8 mt-30 -81.25 53.66 2.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 75.41 110.902 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 20.1 p90 -52.95 143.17 17.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 61.15 110.916 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.516 ' CD2' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -112.95 64.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 72.45 110.876 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.491 ' C ' ' O ' ' A' ' 113' ' ' PHE . 55.5 mt -29.82 99.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 74.43 111.155 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 58.8 m -64.97 152.88 42.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.193 -0.458 . . . . 63.2 110.886 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.3 p -118.55 -1.82 11.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.34 111.115 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.746 ' O ' HG23 ' A' ' 119' ' ' THR . . . -149.46 159.4 44.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 74.33 111.129 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 34.8 tttt -53.73 99.03 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 74.03 110.913 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.746 HG23 ' O ' ' A' ' 117' ' ' ALA . 33.2 p -105.15 63.95 0.71 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.01 111.131 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 4.87 5.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.888 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.725 ' CH2' HG22 ' A' ' 119' ' ' THR . 6.5 p90 -84.21 7.52 18.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 75.34 110.933 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 122' ' ' LEU . 0.2 OUTLIER -93.37 -57.69 2.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.03 110.938 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 58.04 83.07 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.188 -0.46 . . . . 72.34 110.89 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 40.06 36.34 0.84 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.735 -0.745 . . . . 61.42 112.489 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.2 tmtp? -73.56 -30.31 62.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.852 0.358 . . . . 64.03 110.93 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.485 ' C ' HG23 ' A' ' 127' ' ' VAL . 19.2 m-70 -146.14 34.27 0.99 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 64.51 110.864 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.3 OUTLIER 56.21 -154.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 74.34 111.119 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.734 HG11 ' O ' ' A' ' 90' ' ' LEU . 7.1 p 178.89 147.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 70.44 111.129 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.798 ' HB2' HG21 ' A' ' 29' ' ' VAL . 15.4 p90 -177.5 115.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 64.11 110.876 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.415 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 102.86 141.71 11.7 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.754 -0.736 . . . . 63.53 112.48 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.434 ' N ' HD12 ' A' ' 98' ' ' LEU . 0.0 OUTLIER -158.76 148.24 19.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 72.41 110.901 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.4 HG22 ' CD2' ' A' ' 22' ' ' PHE . 94.6 t -51.91 148.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 71.22 111.108 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -118.27 -60.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 72.34 110.906 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.516 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -128.5 125.61 38.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 74.15 110.893 179.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.603 ' HA3' HG22 ' A' ' 20' ' ' VAL . . . 112.16 65.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 45.3 112.49 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.7 mmm -84.26 -0.47 52.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.765 0.317 . . . . 73.43 110.877 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.09 -30.39 63.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 73.14 110.848 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 142' ' ' MET . 13.1 mm -72.21 -37.17 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 72.3 111.154 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.423 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.0 t -91.69 20.48 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 74.51 111.144 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -139.28 -55.07 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 61.41 110.9 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -77.61 -61.4 2.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 70.14 111.152 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.498 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 10.2 tmm? -48.0 -36.38 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 42.53 110.888 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -54.11 -32.69 55.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.442 . . . . 72.04 110.885 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.423 ' HG3' ' CD1' ' A' ' 145' ' ' PHE . 0.1 OUTLIER -59.01 -18.41 34.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 71.34 110.869 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.423 ' CD1' ' HG3' ' A' ' 144' ' ' ARG . 50.0 m-85 -82.59 1.12 39.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.152 -0.477 . . . . 74.33 110.889 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.819 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -90.79 -157.7 33.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 55.34 112.528 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 11.1 t -159.45 169.7 23.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.896 0.379 . . . . 75.2 110.836 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -61.28 -48.5 81.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.109 -0.496 . . . . 74.23 110.888 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -71.85 -5.66 36.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 75.35 110.909 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.46 -39.96 2.63 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.523 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -48.88 158.22 0.34 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.855 0.36 . . . . 72.53 110.883 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.819 HG22 ' HA2' ' A' ' 146' ' ' GLY . 64.1 p -126.25 157.62 37.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 73.11 111.176 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 13.4 t -85.64 1.44 49.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 73.23 110.892 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.3 -168.67 2.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.094 -0.503 . . . . 64.24 110.893 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.16 120.48 20.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 72.22 110.939 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.9 mp -84.55 134.36 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.252 -0.431 . . . . 73.12 111.094 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.38 136.68 51.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 74.3 111.202 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.619 HD11 ' CE2' ' A' ' 48' ' ' TYR . 5.7 mt -85.65 132.97 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 75.42 111.165 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.615 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -88.03 -58.23 2.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.121 -0.491 . . . . 74.4 111.129 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -167.79 168.45 12.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 52.14 110.896 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 9.7 m -146.81 164.48 32.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 61.42 110.883 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -174.51 171.83 44.89 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.703 -0.761 . . . . 75.12 112.502 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 0.7 OUTLIER -68.18 -35.7 78.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.887 0.375 . . . . 61.13 110.929 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.83 -60.84 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 63.24 110.929 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 73.25 110.885 179.91 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttp . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.818 0.342 . . . . 75.44 110.89 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -137.92 146.06 27.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 75.01 111.14 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -49.84 141.12 14.51 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.629 0.728 . . . . 52.01 110.91 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 133.72 26.28 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.649 2.233 . . . . 74.41 112.364 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.3 m -112.78 112.07 23.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 111.144 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.68 HG11 HD11 ' A' ' 24' ' ' LEU . 16.1 m -88.57 155.09 3.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 74.11 111.096 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -121.55 151.75 39.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.866 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -147.33 137.64 23.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 62.22 110.865 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -109.96 148.28 31.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 72.32 110.87 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.669 HD12 ' CG2' ' A' ' 138' ' ' ILE . 3.8 mt -120.13 134.44 63.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 62.41 111.146 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -127.27 156.35 42.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 74.11 111.129 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD23 ' A' ' 17' ' ' LEU . 59.1 t -135.27 120.15 28.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 71.44 111.159 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 63.71 41.34 7.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 75.4 110.875 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.21 10.44 62.42 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 24.23 112.472 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.07 125.51 24.73 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.657 0.741 . . . . 73.44 110.856 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.7 131.6 21.67 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.702 2.268 . . . . 71.51 112.372 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -115.76 -19.51 10.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 72.4 110.926 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 164.47 -179.58 39.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.732 -0.747 . . . . 74.03 112.528 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 ppt_? -144.0 167.0 23.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.84 0.353 . . . . 71.22 110.854 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.714 HG12 ' O ' ' A' ' 135' ' ' GLY . 22.6 m -127.15 173.52 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 71.25 111.074 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 t -117.75 94.71 4.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.134 -0.484 . . . . 74.35 110.87 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.737 ' CE1' HD11 ' A' ' 114' ' ' ILE . 12.5 m-85 -84.21 120.34 26.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 73.3 110.848 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.91 146.47 26.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 62.33 110.851 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.68 HD11 HG11 ' A' ' 6' ' ' VAL . 11.4 mt -112.26 121.35 44.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.931 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 90' ' ' LEU . 3.9 m-85 -79.99 68.85 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 73.33 110.841 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.69 -8.21 57.6 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.168 -0.469 . . . . 73.22 111.129 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -79.93 -65.68 0.97 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 62.11 110.852 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.522 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -52.43 -62.13 1.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 72.24 110.887 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.0 m -109.63 84.78 3.38 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.616 0.722 . . . . 52.05 111.113 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 76.48 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.66 2.24 . . . . 65.34 112.329 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.8 mttm 179.66 -65.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.451 . . . . 62.1 110.85 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 ' CE2' ' A' ' 129' ' ' PHE . 52.1 m -50.92 -41.55 58.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.256 -0.429 . . . . 74.24 111.152 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.27 -26.24 51.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.085 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -62.14 -24.08 66.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 73.1 110.907 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -80.75 -66.99 0.81 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 65.31 110.893 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.432 ' CZ ' HD11 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -49.57 -41.21 41.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 73.14 110.888 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -62.13 -33.46 74.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.13 -0.486 . . . . 74.23 110.889 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.82 -32.4 46.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 60.14 111.067 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 77.7 mt -69.87 -51.04 36.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 64.23 110.932 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 m -57.06 -48.12 79.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 72.43 110.859 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 51.3 p -79.25 -5.41 54.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.486 . . . . 73.33 111.168 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 40.25 64.96 1.03 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.726 -0.75 . . . . 41.24 112.505 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -112.22 37.53 2.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.95 0.405 . . . . 73.31 110.883 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.635 ' HD2' HD12 ' A' ' 78' ' ' ILE . 2.1 mtpm? -131.64 17.02 4.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 75.3 110.884 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.76 14.62 63.21 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.71 -0.757 . . . . 74.11 112.51 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -174.92 164.78 3.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 74.32 110.858 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 125.78 141.2 5.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 54.41 112.5 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.438 ' HE1' HD13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -48.45 138.66 9.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.002 0.429 . . . . 61.35 110.925 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.26 -47.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 73.43 110.927 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -115.48 30.22 6.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.766 -0.731 . . . . 75.1 112.455 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 m -112.48 -164.81 0.94 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.844 0.354 . . . . 73.4 110.887 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 17.0 p -103.23 -178.8 3.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.163 -0.471 . . . . 70.43 110.874 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.596 ' HE1' HD11 ' A' ' 158' ' ' ILE . 2.0 m-85 -88.54 177.32 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 74.32 110.851 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -99.36 -61.54 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.111 -0.495 . . . . 72.2 110.888 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -164.33 145.14 8.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.456 . . . . 65.24 110.903 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.472 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.1 OUTLIER -133.43 145.66 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.43 111.122 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.581 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -139.16 123.04 11.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.632 0.729 . . . . 53.42 111.131 179.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 134.71 28.59 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.632 2.221 . . . . 74.11 112.338 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.17 24.44 68.83 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.767 -0.73 . . . . 72.34 112.505 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -138.94 -71.73 0.4 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 71.44 110.918 -179.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.58 ' CG ' HD11 ' A' ' 57' ' ' ILE . 0.4 OUTLIER -174.5 -163.3 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 72.42 110.88 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -158.57 143.34 16.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.44 . . . . 70.32 110.893 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -134.41 152.27 51.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 75.0 110.875 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.49 146.48 16.23 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.692 -0.766 . . . . 64.02 112.491 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.86 156.93 7.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.721 -0.752 . . . . 44.43 112.503 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -70.07 69.08 0.33 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 75.35 110.884 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -150.93 67.89 0.94 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.858 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.2 t -83.26 -0.7 50.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.32 111.166 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 19.7 tpt180 -87.48 -72.25 0.53 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 44.51 110.855 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -178.86 -177.5 0.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.873 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 64.07 134.79 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.228 -0.442 . . . . 65.52 110.913 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -114.53 89.52 0.51 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.742 -0.742 . . . . 73.11 112.495 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.1 p -115.09 140.65 48.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.342 . . . . 52.41 111.154 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 152.52 151.85 5.79 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.793 -0.718 . . . . 73.21 112.521 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.33 106.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.723 -0.751 . . . . 63.11 112.513 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 5.1 ptpt 177.46 131.66 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.781 0.324 . . . . 71.41 110.906 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 5.2 t -71.18 174.41 6.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.846 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.635 HD12 ' HD2' ' A' ' 44' ' ' LYS . 20.0 pt -83.45 -32.9 9.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 72.44 111.139 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -81.36 3.12 25.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 75.1 110.938 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 125.22 -120.46 3.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.739 -0.744 . . . . 73.44 112.521 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -60.47 -164.3 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 61.24 110.89 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.455 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -107.97 164.27 12.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 73.24 110.902 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.55 146.66 47.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.229 -0.441 . . . . 73.42 110.876 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -52.38 172.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.482 . . . . 72.33 110.862 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.23 124.19 35.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.104 -0.498 . . . . 54.04 110.863 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -67.12 -55.35 14.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 74.13 110.859 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.3 p30 179.65 172.69 0.94 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.32 110.886 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.41 41.05 3.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.166 -0.47 . . . . 71.51 110.863 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.522 HG21 ' HG3' ' A' ' 28' ' ' LYS . 3.8 mt -46.54 -33.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 71.54 111.157 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.76 HD11 ' CD2' ' A' ' 25' ' ' PHE . 22.0 mt -91.99 118.97 31.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.459 . . . . 62.24 110.945 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.4 111.11 23.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.902 179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.681 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -61.01 92.73 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.283 -0.417 . . . . 52.53 110.881 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 p -115.43 25.66 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 71.2 111.166 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -176.61 171.0 43.94 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 73.15 112.527 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 150.37 67.84 Favored 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 122.743 2.295 . . . . 75.1 112.36 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 98.54 -30.35 9.8 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.767 -0.73 . . . . 75.22 112.468 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.681 HG21 ' HB3' ' A' ' 92' ' ' HIS . 43.9 mm -51.49 145.13 2.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.865 0.364 . . . . 73.42 111.113 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 ' CE1' ' A' ' 129' ' ' PHE . 1.7 tt -104.82 133.07 50.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 75.2 110.881 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.75 137.34 54.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 71.32 110.883 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.457 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 2.9 mmt -88.07 178.48 6.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 73.14 110.864 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . 176.11 174.73 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 71.32 111.111 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 101' ' ' ALA . 33.7 t-20 178.21 -66.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 53.12 110.837 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -157.34 23.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 71.23 111.081 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.73 -153.55 16.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.711 -0.757 . . . . 44.23 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 149.03 66.38 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.669 2.246 . . . . 72.43 112.303 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 64.91 27.14 12.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.196 -0.457 . . . . 75.2 110.936 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 82' ' ' LYS . 26.3 p -147.11 67.56 1.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 62.42 111.122 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -88.21 7.21 33.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 75.53 110.959 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -64.85 130.74 36.54 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.715 -0.755 . . . . 63.54 112.501 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 55.1 p 48.13 -158.5 0.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.797 0.332 . . . . 33.02 110.823 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.628 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 2.1 mm-40 49.77 93.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 74.32 110.932 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.69 163.77 18.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.1 110.841 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -138.85 139.98 38.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.092 -0.504 . . . . 73.14 110.858 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.737 HD11 ' CE1' ' A' ' 22' ' ' PHE . 0.4 OUTLIER -81.84 -41.65 18.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 75.24 111.093 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 12.6 m 70.78 99.44 0.06 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.173 -0.467 . . . . 74.2 110.88 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.9 p -91.83 27.42 2.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 74.12 111.146 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -173.04 -173.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 62.11 111.088 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 138.06 32.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.929 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 12.7 p -81.27 -150.34 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 72.12 111.131 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 168.65 -67.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.51 110.875 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 18.7 p90 -64.76 -19.87 66.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 71.42 110.949 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 126' ' ' HIS . 25.5 mt -88.16 140.24 29.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 74.04 110.916 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -154.98 -48.11 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 74.21 110.873 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.99 51.39 0.82 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.748 -0.739 . . . . 43.44 112.472 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HD2' HD22 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -146.5 29.74 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.823 0.344 . . . . 72.45 110.92 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.493 ' CD2' HD13 ' A' ' 122' ' ' LEU . 29.3 m-70 -156.11 -50.25 0.08 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 73.31 110.859 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 15.8 t 80.04 99.06 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 74.24 111.102 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 70.5 t -84.0 133.99 27.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.132 -0.485 . . . . 65.02 111.154 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.53 ' CE1' HD22 ' A' ' 98' ' ' LEU . 4.6 p90 -151.01 17.91 0.77 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 71.43 110.889 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -135.29 -166.55 11.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.752 -0.737 . . . . 71.02 112.47 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.459 ' HG2' HD13 ' A' ' 97' ' ' ILE . 0.5 OUTLIER 175.08 172.06 0.26 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.851 0.358 . . . . 72.41 110.89 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.634 HG11 ' HB2' ' A' ' 136' ' ' MET . 21.3 t -107.94 100.38 10.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 73.53 111.144 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.89 -39.87 90.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 75.24 110.897 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 179.71 -168.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 62.11 110.915 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.714 ' O ' HG12 ' A' ' 20' ' ' VAL . . . 62.68 14.69 51.79 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.781 -0.723 . . . . 42.22 112.507 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.634 ' HB2' HG11 ' A' ' 132' ' ' VAL . 0.1 OUTLIER -55.58 -22.02 20.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 62.11 110.902 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -50.28 -30.26 11.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 51.24 110.886 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.669 ' CG2' HD12 ' A' ' 10' ' ' ILE . 16.7 mm -73.32 -39.95 56.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 61.13 111.147 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.671 HG12 ' OE1' ' A' ' 143' ' ' GLU . 53.3 t -48.33 -44.05 12.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 34.42 111.135 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -62.72 -47.4 83.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.182 -0.463 . . . . 72.53 110.892 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.49 -27.51 62.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 73.2 111.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.556 ' SD ' HD13 ' A' ' 10' ' ' ILE . 46.3 mtm -80.32 -39.76 28.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 72.14 110.852 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.671 ' OE1' HG12 ' A' ' 139' ' ' VAL . 2.5 pt-20 -87.44 30.89 0.76 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.454 . . . . 74.22 110.878 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 -122.48 -13.54 7.99 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 71.14 110.884 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -128.84 24.13 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 74.55 110.851 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.56 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -120.73 73.73 0.34 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.699 -0.762 . . . . 75.43 112.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.56 ' C ' ' O ' ' A' ' 146' ' ' GLY . 24.0 p -24.37 136.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.894 0.378 . . . . 75.11 110.87 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 -49.62 -36.13 23.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.132 -0.486 . . . . 74.31 110.869 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -54.08 -25.6 22.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 74.45 110.917 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.57 -45.16 1.26 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.791 -0.719 . . . . 44.54 112.512 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.94 116.1 2.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.817 0.342 . . . . 72.21 110.905 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.6 p -78.96 133.13 36.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 74.44 111.138 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.08 -23.25 67.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 74.23 110.838 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.23 -169.33 2.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 73.21 110.908 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.701 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.1 OUTLIER -106.08 134.39 49.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.22 -0.446 . . . . 63.24 110.885 179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 62.0 mt -115.25 87.08 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 73.13 111.129 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.701 HG23 ' HD2' ' A' ' 155' ' ' LYS . 2.0 p -102.38 168.77 9.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.23 111.174 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.596 HD11 ' HE1' ' A' ' 53' ' ' PHE . 1.8 mp -113.4 118.87 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 73.11 111.162 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.33 -70.38 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 61.42 111.136 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -119.1 173.24 7.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 53.14 110.863 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.2 p -171.9 178.57 2.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.833 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.69 -143.9 15.4 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.797 -0.716 . . . . 63.23 112.517 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.5 tt0 -107.29 132.95 52.54 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.862 0.363 . . . . 73.14 110.924 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.64 -59.78 4.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 70.2 110.902 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 75.2 110.884 179.963 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.2 mmt . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.795 0.331 . . . . 72.34 110.851 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.0 t -135.68 142.47 39.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 63.53 111.129 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.89 162.13 0.83 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.604 0.716 . . . . 74.55 110.89 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 149.23 66.67 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.695 2.264 . . . . 73.22 112.345 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.0 m -136.94 86.21 2.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.207 -0.451 . . . . 43.1 111.126 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 m -76.98 159.85 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 61.53 111.107 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.817 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.33 161.35 36.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.475 . . . . 71.31 110.928 -179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -147.64 137.55 22.82 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.166 -0.47 . . . . 72.4 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.5 OUTLIER -110.42 100.16 9.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.126 -0.488 . . . . 73.14 110.858 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.8 mm -75.44 144.88 11.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.169 -0.469 . . . . 72.4 111.18 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -124.7 154.1 41.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.35 111.131 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.577 HG21 HD23 ' A' ' 17' ' ' LEU . 4.8 t -129.16 98.84 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 75.24 111.121 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 54.54 54.98 8.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 73.1 110.901 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.08 7.93 52.28 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.78 -0.724 . . . . 62.21 112.469 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -140.05 95.76 8.39 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.598 0.714 . . . . 74.12 110.856 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 161.65 45.12 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.677 2.251 . . . . 70.15 112.289 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -128.31 25.94 5.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.461 . . . . 71.21 110.916 179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.7 -162.69 21.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 75.44 112.441 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 -176.92 5.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 74.14 110.885 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 3.7 m -135.19 163.91 34.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 60.1 111.123 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.7 t -116.5 94.82 4.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 75.15 110.868 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.638 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.2 m-85 -89.63 116.79 28.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.096 -0.502 . . . . 63.42 110.881 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.34 113.68 26.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 74.34 110.923 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' A' ' 129' ' ' PHE . 23.6 mt -79.94 139.71 36.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.134 -0.485 . . . . 75.1 110.941 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.478 ' CG ' HD11 ' A' ' 90' ' ' LEU . 17.6 m-85 -86.97 60.22 6.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.246 -0.433 . . . . 70.42 110.886 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.53 -25.26 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.23 111.087 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -62.9 -61.06 2.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 75.24 110.891 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.4 -19.12 62.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 74.22 110.875 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -146.99 82.7 8.34 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.682 0.753 . . . . 64.22 111.152 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -28.62 24.8 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 63.14 112.3 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -58.52 3.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 73.22 110.925 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.524 HG21 ' CG1' ' A' ' 127' ' ' VAL . 12.7 m -52.0 -45.09 64.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 73.43 111.115 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.22 -31.19 70.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.24 111.081 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.6 tp10 -57.47 -23.18 48.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 75.41 110.926 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -78.51 -71.09 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 73.41 110.874 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -48.72 -44.23 38.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 75.23 110.857 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -60.73 -33.18 72.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 73.02 110.837 -179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.73 -38.79 28.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.45 111.116 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.747 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.1 tt -89.33 20.06 4.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 74.43 110.922 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.1 t -112.39 -15.18 13.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 55.21 110.864 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.2 p -117.52 4.68 12.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 74.4 111.132 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 58.96 30.13 66.09 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.777 -0.725 . . . . 74.13 112.491 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -38.6 50.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.968 0.413 . . . . 63.25 110.906 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.402 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.82 -17.05 54.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.12 -0.491 . . . . 51.22 110.9 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.72 -26.36 24.34 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 73.23 112.49 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -136.34 159.61 41.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 71.45 110.843 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.636 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 176.3 -78.11 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.743 -0.741 . . . . 51.0 112.491 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -167.44 -64.0 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.005 0.431 . . . . 73.11 110.96 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 tptt 59.77 166.16 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 62.34 110.882 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -63.01 118.67 14.68 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.732 -0.747 . . . . 71.31 112.479 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.572 ' N ' HG22 ' A' ' 157' ' ' THR . 36.8 m -159.14 -85.86 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 72.42 110.811 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 9.1 t -142.88 119.14 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 44.45 110.879 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -150.23 122.54 8.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 75.22 110.894 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -161.92 70.98 0.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 71.41 110.848 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -131.43 39.49 3.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 72.23 110.855 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 39.1 mt -96.26 140.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 74.23 111.139 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.438 HG13 ' HD2' ' A' ' 58' ' ' PRO . 2.0 tt -135.05 133.02 20.54 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.587 0.708 . . . . 63.14 111.184 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.438 ' HD2' HG13 ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.8 125.21 11.86 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.65 2.233 . . . . 50.11 112.375 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 77.45 39.33 26.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.73 . . . . 75.01 112.514 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -156.73 -82.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.851 0.358 . . . . 73.01 110.855 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -179.96 -150.23 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.34 110.848 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 19.9 m -146.79 144.22 29.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 72.01 110.91 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.49 164.64 14.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 70.33 110.878 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -77.22 -79.33 0.7 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.769 -0.729 . . . . 31.22 112.454 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 150.99 -150.66 22.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 71.13 112.488 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -125.11 155.07 40.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.835 0.35 . . . . 74.11 110.884 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 62.77 158.36 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 74.05 110.902 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.38 -67.3 0.07 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 64.25 111.065 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.402 ' O ' ' C ' ' A' ' 70' ' ' HIS . 0.6 OUTLIER -119.7 48.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.214 -0.448 . . . . 72.51 110.85 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.402 ' C ' ' O ' ' A' ' 69' ' ' ARG . 11.1 m170 38.07 51.41 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.858 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.505 ' O ' HG23 ' A' ' 73' ' ' THR . 6.2 t-20 -152.42 121.08 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 63.1 110.893 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -50.67 102.02 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.743 . . . . 75.35 112.486 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 71' ' ' ASN . 54.0 p -98.3 -64.03 1.07 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.841 0.353 . . . . 63.11 111.168 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.35 -92.37 0.97 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.725 -0.75 . . . . 75.15 112.505 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -146.47 23.61 1.69 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.736 -0.745 . . . . 55.33 112.516 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.7 ptmt -56.91 -177.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.804 0.335 . . . . 75.43 110.912 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.471 ' O ' HG22 ' A' ' 78' ' ' ILE . 0.9 OUTLIER -133.15 15.26 4.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.445 . . . . 52.2 110.819 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.747 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.0 OUTLIER 83.9 -20.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.148 -0.478 . . . . 73.15 111.184 179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -97.93 -23.25 15.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.475 . . . . 61.12 110.933 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.04 -156.68 26.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.764 -0.731 . . . . 64.41 112.503 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -47.95 -75.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.935 0.398 . . . . 71.04 110.908 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -155.84 155.34 32.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.472 . . . . 71.05 110.917 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -119.55 145.91 45.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 75.1 110.908 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.6 pm0 -64.57 152.98 40.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.48 . . . . 72.54 110.866 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.8 93.24 0.38 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 75.11 110.9 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.89 -58.56 5.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 75.51 110.885 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.8 t30 175.44 175.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 75.4 110.909 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.58 43.52 2.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 73.34 110.921 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 89' ' ' ILE . 2.3 mm -46.23 -32.23 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.121 -0.491 . . . . 53.33 111.147 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD11 ' CG ' ' A' ' 25' ' ' PHE . 14.5 mt -91.0 147.71 22.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.135 -0.484 . . . . 75.44 110.924 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -126.33 -166.37 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.227 -0.442 . . . . 75.51 110.884 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 47.1 m80 -98.65 -88.88 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.873 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 65.35 10.67 6.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.33 111.163 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 170.59 141.07 3.18 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.757 -0.735 . . . . 63.45 112.488 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 156.68 62.79 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.714 2.276 . . . . 72.31 112.318 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 110.52 -28.8 9.69 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.732 -0.746 . . . . 41.01 112.475 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 131' ' ' LYS . 50.3 mm -62.82 147.87 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.836 0.35 . . . . 72.02 111.102 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.679 HD13 ' N ' ' A' ' 99' ' ' SER . 1.6 tm? -99.1 148.8 23.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 74.42 110.877 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.679 ' N ' HD13 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -145.49 176.96 9.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 75.42 110.845 -179.917 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.481 ' HB3' ' HA3' ' A' ' 109' ' ' GLY . 4.8 mmt -82.52 170.72 14.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 72.41 110.926 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 112' ' ' PHE . . . -140.38 100.12 3.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.267 -0.424 . . . . 61.12 111.083 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.456 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 0.1 OUTLIER -161.0 -169.86 2.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 73.42 110.923 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.652 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -53.38 -32.84 51.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.105 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.23 -68.86 0.38 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.78 -0.724 . . . . 74.55 112.445 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.714 ' O ' HG23 ' A' ' 107' ' ' THR . 53.7 Cg_endo -69.73 120.52 7.3 Favored 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.657 2.238 . . . . 73.2 112.345 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.453 ' C ' ' O ' ' A' ' 105' ' ' PRO . 11.9 m-20 32.96 58.68 0.44 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.52 110.903 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.714 HG23 ' O ' ' A' ' 105' ' ' PRO . 19.2 p -139.71 33.12 2.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 63.24 111.161 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.555 ' C ' ' O ' ' A' ' 107' ' ' THR . 2.4 p30 23.89 -101.79 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 73.23 110.856 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 100' ' ' MET . . . 166.08 -165.25 38.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 63.31 112.468 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -122.45 13.13 10.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 64.42 110.854 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 29.1 mm-40 70.36 72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.135 -0.484 . . . . 63.21 110.941 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.703 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 175.59 122.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 61.54 110.87 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 112' ' ' PHE . 11.4 t80 178.83 47.89 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 73.02 110.847 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.59 HG12 HD23 ' A' ' 98' ' ' LEU . 58.8 mt -72.91 94.3 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 72.54 111.117 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.5 p -83.28 133.22 34.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 71.2 110.87 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -91.05 -10.38 42.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 34.42 111.145 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -137.16 149.43 47.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 75.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.7 ptmt -55.16 131.98 46.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.203 -0.453 . . . . 73.4 110.895 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.05 47.14 2.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.194 -0.457 . . . . 61.22 111.093 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -58.02 -15.45 9.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.872 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 12.7 m-90 -57.81 -20.21 34.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.162 -0.472 . . . . 70.32 110.955 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.5 mp -76.28 -46.32 28.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.235 -0.439 . . . . 63.23 110.944 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 73.99 -58.76 0.58 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.207 -0.451 . . . . 63.51 110.851 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -177.0 64.06 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 63.43 112.508 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 14.6 tppt? -105.47 -28.45 10.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 74.12 110.895 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -129.23 125.5 37.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.195 -0.457 . . . . 73.24 110.899 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 32' ' ' THR . 53.1 t -51.01 114.56 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 73.2 111.152 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.3 p -98.42 139.86 19.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 54.34 111.133 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' CE1' HG22 ' A' ' 32' ' ' THR . 6.2 p90 -176.26 123.59 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 72.14 110.904 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 105.38 134.85 8.06 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.733 . . . . 62.23 112.491 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.442 ' HB2' HD13 ' A' ' 97' ' ' ILE . 22.2 pttm -152.02 165.26 35.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.856 0.36 . . . . 70.01 110.873 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.429 HG22 ' N ' ' A' ' 133' ' ' LYS . 9.8 p -72.84 159.87 5.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.201 -0.454 . . . . 74.01 111.158 179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -124.49 -47.53 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 72.15 110.879 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -133.39 178.51 6.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.445 . . . . 70.44 110.839 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 51.44 69.5 1.12 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.778 -0.725 . . . . 42.53 112.471 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.52 -1.16 40.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.798 0.333 . . . . 63.12 110.898 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -77.71 -27.12 50.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 73.44 110.859 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.492 ' HB ' HG12 ' A' ' 20' ' ' VAL . 35.0 mm -65.34 -44.38 94.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 73.42 111.152 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.478 ' O ' HG12 ' A' ' 139' ' ' VAL . 4.7 t -90.11 9.52 2.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 75.52 111.13 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -119.89 -66.38 1.07 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.141 -0.481 . . . . 72.22 110.868 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.83 -51.51 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 53.54 111.111 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 4.0 ttm -50.95 -44.43 60.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 74.43 110.875 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -52.8 -27.11 16.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.892 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -62.63 -23.09 66.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 62.02 110.909 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -78.65 2.46 19.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 72.12 110.904 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.476 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -73.16 -161.37 6.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 72.1 112.5 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 63.9 m -142.15 -77.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 71.44 110.849 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 175.75 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.893 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -92.94 14.93 16.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 63.53 110.938 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.41 -42.78 1.83 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.742 -0.742 . . . . 73.33 112.542 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.52 155.67 2.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 70.4 110.94 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.476 HG22 ' HA2' ' A' ' 146' ' ' GLY . 75.0 p -130.24 157.85 41.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.252 -0.431 . . . . 53.31 111.175 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 23.1 p -79.01 -16.49 56.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 64.22 110.88 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -130.39 -169.72 2.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.49 . . . . 72.33 110.912 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.23 149.55 40.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 75.13 110.893 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 11.3 mt -125.51 127.39 71.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 73.23 111.146 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -134.13 143.49 47.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 74.32 111.134 180.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 42.9 mm -84.91 104.97 13.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 74.1 111.157 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.539 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -64.25 -59.95 3.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.13 111.073 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -144.33 171.1 14.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 65.35 110.869 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 19.3 p -175.58 145.05 0.7 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.181 -0.463 . . . . 65.33 110.88 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 161.0 -178.92 36.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.786 -0.721 . . . . 63.13 112.529 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -81.4 122.78 27.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.866 0.365 . . . . 70.01 110.88 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.817 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -94.92 -30.68 14.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 53.2 110.936 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 73.11 110.916 179.904 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.812 0.339 . . . . 71.12 110.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.19 155.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 64.32 111.115 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -89.58 144.27 31.72 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.638 0.732 . . . . 75.12 110.902 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 124.57 11.23 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.71 2.273 . . . . 62.42 112.349 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.7 m -117.1 145.99 43.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 73.24 111.133 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.7 m -126.36 148.75 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 64.23 111.105 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -110.0 154.47 23.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 65.32 110.902 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.14 137.47 42.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 74.14 110.861 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.36 124.0 44.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.31 110.888 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.2 mm -101.89 129.05 53.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 74.55 111.092 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.649 ' O ' HG23 ' A' ' 156' ' ' ILE . . . -123.9 168.54 12.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 74.23 111.085 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.5 t -152.39 107.23 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 62.12 111.155 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 70.25 25.23 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.142 -0.481 . . . . 62.43 110.845 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.63 -14.04 65.49 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.713 -0.756 . . . . 73.03 112.499 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.82 139.28 21.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.632 0.73 . . . . 71.32 110.905 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 148.49 64.97 Favored 'Trans proline' 0 C--O 1.232 0.216 0 C-N-CA 122.722 2.281 . . . . 74.04 112.374 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.46 -66.78 1.05 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.257 -0.429 . . . . 63.52 110.887 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.29 -174.83 36.06 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.72 -0.752 . . . . 64.34 112.459 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 1.2 ptt-85 -118.76 126.09 51.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.873 0.368 . . . . 71.12 110.877 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.492 HG22 HD12 ' A' ' 138' ' ' ILE . 24.2 t -121.14 119.72 60.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 75.0 111.173 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.3 p -107.14 148.93 28.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.04 110.895 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -139.3 105.72 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.127 -0.488 . . . . 71.12 110.913 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -51.93 162.3 0.46 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 74.33 110.909 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.7 mt -115.94 119.24 35.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.48 . . . . 51.21 110.909 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.85 84.89 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.886 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -79.22 -15.91 57.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 72.43 111.08 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.59 -28.71 37.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 73.22 110.888 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.453 ' NZ ' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -82.45 -71.48 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.903 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.717 ' O ' HG23 ' A' ' 29' ' ' VAL . 30.7 m -101.46 99.5 11.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.56 0.695 . . . . 71.4 111.133 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -48.77 0.65 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.678 2.252 . . . . 63.15 112.361 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -43.22 66.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 74.25 110.9 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 32' ' ' THR . 6.4 m -85.8 21.23 1.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 44.0 111.125 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.488 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -79.05 -45.31 20.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 61.14 111.122 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 35' ' ' ASN . 86.9 tt0 -83.57 -24.21 31.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.225 -0.443 . . . . 63.53 110.89 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.7 OUTLIER -30.79 -70.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.148 -0.478 . . . . 53.1 110.896 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.718 ' HA ' HD12 ' A' ' 39' ' ' LEU . 65.2 t80 -74.01 -32.42 63.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.177 -0.465 . . . . 72.1 110.926 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 34' ' ' GLU . 2.7 ttm180 -50.82 -37.9 45.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.499 . . . . 70.23 110.863 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.57 -29.99 61.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 72.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.718 HD12 ' HA ' ' A' ' 36' ' ' PHE . 63.6 mt -66.94 -51.65 52.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.54 110.912 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 m -65.35 -47.83 75.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 52.41 110.863 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.451 HG22 ' HG2' ' A' ' 163' ' ' GLN . 80.8 p -68.83 -24.07 64.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 62.31 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 52.49 83.62 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.742 . . . . 55.31 112.482 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -141.16 33.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.933 0.396 . . . . 74.02 110.895 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm -124.73 27.58 6.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 23.41 110.887 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.09 14.34 68.23 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.757 -0.735 . . . . 53.54 112.502 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.2 p90 -174.91 173.86 2.63 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.853 0.359 . . . . 71.13 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 131.61 153.93 7.63 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.783 -0.722 . . . . 51.04 112.484 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.97 137.88 41.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.947 0.403 . . . . 74.33 110.944 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.49 -41.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.127 -0.488 . . . . 73.11 110.912 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -156.03 43.35 0.55 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 53.44 112.489 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -103.26 31.67 4.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.812 0.339 . . . . 75.2 110.885 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 34.0 m 62.96 174.24 0.15 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.894 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -95.36 -168.2 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 74.43 110.855 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.63 -59.75 1.66 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.139 -0.482 . . . . 73.14 110.878 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 12.3 ptp180 -155.68 -169.99 3.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 61.31 110.897 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -168.4 141.84 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 74.31 111.166 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.41 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 17.6 mt -134.87 95.89 15.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.66 0.743 . . . . 71.31 111.128 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.9 Cg_endo -69.74 81.14 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.668 2.245 . . . . 65.42 112.346 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.45 -27.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 41.34 112.474 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.41 -51.46 2.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.868 0.366 . . . . 72.44 110.931 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -172.97 -159.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 71.44 110.853 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.415 ' O ' ' HB3' ' A' ' 63' ' ' GLN . 36.8 m -129.46 -66.6 0.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 72.23 110.917 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 62' ' ' CYS . 14.6 tt0 64.34 136.73 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.9 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -108.75 161.9 13.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.745 -0.74 . . . . 65.43 112.495 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.17 91.74 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.766 -0.73 . . . . 61.41 112.512 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -108.38 -161.9 0.79 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.82 0.343 . . . . 74.42 110.83 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.526 ' O ' HG23 ' A' ' 68' ' ' THR . 7.4 p90 -122.25 174.6 6.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 72.55 110.854 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.526 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 178.49 -76.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.478 . . . . 74.21 111.144 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 73.53 -154.34 0.06 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 75.02 110.902 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 p-80 -175.69 -50.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 71.44 110.856 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.8 -23.32 11.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.931 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -107.56 -77.36 1.04 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.709 -0.758 . . . . 61.1 112.499 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 47.3 p -115.79 -65.04 1.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 75.24 111.135 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 106.41 41.22 1.79 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.795 -0.717 . . . . 72.44 112.474 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.25 152.14 14.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.705 -0.76 . . . . 72.51 112.482 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -161.19 151.23 17.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.754 0.311 . . . . 63.31 110.911 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.8 t -102.61 157.65 16.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.274 -0.421 . . . . 71.32 110.903 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -39.38 -38.11 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 64.32 111.159 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -86.78 49.96 1.91 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.187 -0.461 . . . . 62.32 110.935 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 73.45 -120.58 7.09 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.769 -0.729 . . . . 72.54 112.483 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -62.98 -155.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.846 0.355 . . . . 73.34 110.93 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.26 176.34 5.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 74.33 110.893 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -143.54 175.23 10.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 75.35 110.894 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.36 173.69 10.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 60.42 110.834 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.4 158.43 28.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.131 -0.486 . . . . 73.31 110.822 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.98 -58.59 1.89 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 73.05 110.936 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -177.97 150.93 0.64 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.147 -0.479 . . . . 74.12 110.893 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -125.01 68.18 1.12 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 71.4 110.9 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.473 ' O ' HG22 ' A' ' 89' ' ' ILE . 14.6 mt -83.19 0.79 4.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.153 -0.476 . . . . 43.13 111.119 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.453 HD21 ' NZ ' ' A' ' 28' ' ' LYS . 32.9 mt -121.56 83.18 2.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 53.13 110.941 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.444 ' O ' HG23 ' A' ' 93' ' ' THR . 33.9 mttm -70.17 141.14 52.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.899 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -55.7 91.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 72.32 110.838 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 91' ' ' LYS . 48.1 p -86.9 7.62 26.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 54.13 111.171 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 151.45 -165.32 30.43 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.733 -0.746 . . . . 52.53 112.438 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 166.04 28.91 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.665 2.243 . . . . 71.41 112.358 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.488 ' HA2' HG23 ' A' ' 132' ' ' VAL . . . 80.13 -0.06 84.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.759 -0.734 . . . . 74.0 112.502 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.1 mm -83.18 141.43 14.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.894 0.378 . . . . 71.24 111.148 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -116.29 141.4 48.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 71.03 110.95 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.819 ' O ' ' O ' ' A' ' 100' ' ' MET . 0.1 OUTLIER -150.22 30.16 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 53.11 110.86 -179.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.819 ' O ' ' O ' ' A' ' 99' ' ' SER . 2.6 ptp 34.1 120.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 71.11 110.891 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.413 ' HB3' ' CB ' ' A' ' 110' ' ' SER . . . -46.91 170.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 73.24 111.117 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 p-10 -174.49 174.77 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.904 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -131.0 24.7 4.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.464 . . . . 62.52 111.089 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 142.5 -178.41 21.01 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.78 -0.724 . . . . 72.13 112.5 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 139.95 41.69 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.662 2.242 . . . . 65.05 112.357 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-20 67.63 27.87 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.874 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 15.2 p -150.55 50.92 0.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 64.4 111.156 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -80.88 1.81 29.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 64.51 110.914 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -66.93 88.58 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.747 . . . . 73.14 112.468 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.413 ' CB ' ' HB3' ' A' ' 101' ' ' ALA . 5.0 m -145.75 -145.56 0.17 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.834 0.349 . . . . 72.23 110.833 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' OE1' HD13 ' A' ' 39' ' ' LEU . 4.4 tp-100 -109.77 -80.87 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.116 -0.493 . . . . 72.01 110.923 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.472 ' HB2' HD21 ' A' ' 98' ' ' LEU . 8.2 p90 178.94 137.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 64.34 110.868 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.519 ' O ' ' C ' ' A' ' 114' ' ' ILE . 5.7 p90 -131.26 45.29 2.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 75.02 110.876 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.519 ' C ' ' O ' ' A' ' 113' ' ' PHE . 79.1 mt -28.07 130.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.109 -0.496 . . . . 73.13 111.14 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 77.5 m -83.07 148.09 27.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 73.23 110.832 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.628 HG21 ' OE2' ' A' ' 143' ' ' GLU . 5.4 p -117.88 22.98 11.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 53.12 111.124 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -168.58 175.76 6.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 74.14 111.124 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 86.57 4.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 73.34 110.904 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 19.0 p -112.11 52.81 0.75 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 55.42 111.125 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -87.26 23.99 1.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 64.21 110.871 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -93.53 8.67 39.79 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.127 -0.488 . . . . 62.05 110.894 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 6.6 mt -96.43 1.41 51.64 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.429 . . . . 62.31 110.935 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 t0 49.3 66.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.481 . . . . 73.51 110.863 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 41.19 36.48 1.32 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.716 -0.754 . . . . 55.34 112.518 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -57.21 -32.87 66.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.824 0.345 . . . . 75.21 110.881 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -108.67 156.82 19.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 71.43 110.833 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 71.9 t -85.56 94.49 4.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 64.45 111.097 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 49.6 t -74.46 136.07 26.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.53 111.156 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.0 p90 -163.84 26.0 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 75.43 110.936 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.54 -178.34 15.58 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 33.34 112.461 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.33 147.29 0.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.887 0.375 . . . . 72.12 110.817 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.488 HG23 ' HA2' ' A' ' 96' ' ' GLY . 6.6 t -72.21 103.8 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 74.53 111.163 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.86 -53.58 25.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.207 -0.451 . . . . 73.31 110.884 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -166.8 157.55 12.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 71.2 110.88 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.93 6.05 54.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.703 -0.76 . . . . 72.12 112.48 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.4 ' HB2' HG11 ' A' ' 132' ' ' VAL . 1.8 ttt -49.66 -31.15 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.766 0.317 . . . . 61.14 110.886 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -52.04 -24.04 6.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.891 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.492 HD12 HG22 ' A' ' 20' ' ' VAL . 6.5 mt -81.84 -39.26 16.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.216 -0.447 . . . . 64.23 111.113 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.1 t -50.96 -44.65 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 73.34 111.159 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -56.62 -29.48 62.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 75.34 110.896 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.63 -35.47 67.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 31.23 111.104 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.459 ' SD ' HG21 ' A' ' 156' ' ' ILE . 0.0 OUTLIER -75.31 -23.35 57.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.847 179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.628 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -89.56 29.21 1.16 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 73.45 110.913 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.73 3.75 2.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 73.11 110.821 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -118.16 13.5 13.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.34 110.884 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.822 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -89.06 -160.91 36.98 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.744 . . . . 51.34 112.514 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 28.1 t -154.13 18.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.854 0.359 . . . . 72.52 110.849 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 28.3 mmm-85 46.91 59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 61.01 110.871 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -177.34 -36.92 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.194 -0.457 . . . . 65.24 110.93 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 146.75 -56.98 0.51 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.689 -0.767 . . . . 74.4 112.485 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -67.95 116.29 8.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 75.44 110.877 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.822 HG22 ' HA2' ' A' ' 146' ' ' GLY . 19.6 p -90.28 158.47 17.16 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 73.41 111.134 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 t -68.57 -21.66 64.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 75.33 110.866 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -136.47 -168.0 2.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 65.03 110.834 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.47 124.43 34.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 72.2 110.909 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.649 HG23 ' O ' ' A' ' 11' ' ' ALA . 2.7 mp -100.17 104.51 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 61.41 111.166 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.424 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -96.92 175.8 6.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.46 . . . . 44.43 111.19 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 64.4 mt -122.74 143.15 36.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 62.55 111.118 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -95.35 -59.75 1.82 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 74.0 111.098 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -154.78 164.5 38.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 75.04 110.845 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 23.0 m -144.79 -162.97 1.6 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 64.21 110.875 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 136.92 -155.54 22.76 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.753 -0.737 . . . . 34.24 112.518 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.451 ' HG2' HG22 ' A' ' 41' ' ' THR . 0.0 OUTLIER -108.24 134.9 50.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.828 0.346 . . . . 64.31 110.886 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 3.4 tp -55.35 -59.07 5.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.197 -0.456 . . . . 74.22 110.892 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 71.21 110.913 179.945 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.811 0.339 . . . . 63.22 110.892 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.61 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 65.1 111.118 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.617 ' OD1' ' HB3' ' A' ' 26' ' ' ALA . 0.9 OUTLIER -116.8 160.72 35.59 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.645 0.736 . . . . 54.44 110.895 179.973 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.76 152.9 69.43 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.705 2.27 . . . . 73.4 112.387 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.7 m -123.75 43.87 2.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 71.23 111.172 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -50.67 143.21 2.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 73.55 111.128 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -135.41 175.9 9.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.34 110.913 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -146.14 145.66 30.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.195 -0.457 . . . . 74.24 110.87 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -102.23 135.21 44.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 54.41 110.876 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.5 mm -103.04 131.0 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 71.25 111.142 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -123.26 167.8 13.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 72.33 111.081 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.691 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -148.27 98.42 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 73.13 111.131 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.75 32.54 8.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 61.23 110.868 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.33 -12.09 70.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.727 -0.749 . . . . 61.13 112.513 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 37.1 mm-40 -95.84 131.81 28.44 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.654 0.74 . . . . 74.44 110.894 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 145.57 57.87 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.754 2.302 . . . . 73.55 112.342 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.691 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.0 tp -114.9 -67.91 0.96 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 64.4 110.861 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.23 177.5 41.19 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.751 -0.737 . . . . 71.42 112.477 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.88 135.92 49.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 74.03 110.907 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 40.0 t -117.12 129.48 73.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.443 . . . . 72.02 111.131 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.3 t -90.84 96.5 10.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.836 -179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -86.83 81.82 8.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 73.14 110.871 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HB2' ' HG3' ' A' ' 133' ' ' LYS . 9.7 tt0 -57.51 143.49 40.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.158 -0.473 . . . . 73.01 110.897 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.406 HD21 ' HD2' ' A' ' 36' ' ' PHE . 11.3 mt -109.6 117.47 34.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 61.34 110.895 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 -74.69 72.46 1.99 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 63.21 110.851 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.617 ' HB3' ' OD1' ' A' ' 3' ' ' ASN . . . -76.82 -30.18 56.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 72.24 111.096 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -54.03 -60.33 3.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.174 -0.466 . . . . 70.52 110.827 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 89' ' ' ILE . 0.0 OUTLIER -64.69 -61.93 1.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 64.31 110.921 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.7 m -118.08 94.2 46.1 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.626 0.727 . . . . 74.13 111.13 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 -22.83 31.12 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.691 2.261 . . . . 71.22 112.315 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.26 -66.55 0.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 65.45 110.905 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 HG21 HG11 ' A' ' 127' ' ' VAL . 60.5 p -52.84 -40.93 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 74.1 111.123 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -65.88 -71.67 0.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 61.4 111.079 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.491 ' O ' ' N ' ' A' ' 37' ' ' ARG . 34.2 tt0 -40.66 -65.73 0.39 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.197 -0.456 . . . . 74.44 110.898 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 34' ' ' GLU . 3.6 t30 -34.18 -45.51 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 71.13 110.884 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 39' ' ' LEU . 89.4 t80 -77.11 -38.92 51.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 72.34 110.894 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -51.89 -29.84 21.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 71.25 110.865 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.03 -30.06 55.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 54.23 111.122 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.523 HD12 ' HA ' ' A' ' 36' ' ' PHE . 57.8 mt -67.82 -54.45 18.99 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 63.4 110.877 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 t -52.91 -41.89 64.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 70.44 110.874 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 62.3 p -71.08 -21.6 62.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.111 -0.495 . . . . 73.43 111.143 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.78 91.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 74.01 112.495 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.61 35.95 0.87 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.877 0.37 . . . . 72.55 110.861 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -144.0 12.43 1.62 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 65.13 110.926 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.27 17.33 74.27 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.726 -0.749 . . . . 42.12 112.45 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -175.26 -166.78 0.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.869 0.366 . . . . 65.53 110.926 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' HA2' HD22 ' A' ' 39' ' ' LEU . . . 130.77 -149.08 19.01 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.77 -0.729 . . . . 74.51 112.489 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -98.08 -26.16 14.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.972 0.415 . . . . 75.43 110.93 -179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.4 ttpt -48.32 139.33 8.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 74.12 110.856 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.69 60.23 5.94 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.715 -0.755 . . . . 73.32 112.531 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.463 ' H ' HD13 ' A' ' 158' ' ' ILE . 5.3 t -137.49 -165.93 1.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 72.41 110.88 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 7.9 p -157.21 168.47 27.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 63.24 110.869 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.623 ' CE2' HG21 ' A' ' 156' ' ' ILE . 20.5 m-85 -81.47 120.69 25.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 53.52 110.905 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -93.69 -17.53 23.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 74.4 110.841 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 18.7 tpp85 -145.26 137.76 25.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.873 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.5 mt -150.33 121.66 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.223 -0.444 . . . . 71.12 111.128 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.2 tt -137.76 108.14 8.4 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.621 0.724 . . . . 70.31 111.132 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 107.64 1.91 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.705 2.27 . . . . 74.33 112.309 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 130.82 -34.13 2.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.773 -0.727 . . . . 72.41 112.537 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -102.22 -68.39 0.83 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.868 0.366 . . . . 73.31 110.871 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -165.04 0.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.499 . . . . 71.24 110.83 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 43.2 t -151.66 137.32 17.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 75.41 110.884 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -100.15 140.98 33.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 74.43 110.932 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.54 -43.97 9.84 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.751 -0.738 . . . . 74.51 112.465 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.67 -139.92 7.45 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.693 -0.765 . . . . 75.11 112.449 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.0 t0 179.4 136.03 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.85 0.357 . . . . 64.14 110.84 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -111.93 29.8 7.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.858 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.725 HG22 ' HG2' ' A' ' 69' ' ' ARG . 18.3 m -150.48 -72.97 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.118 -0.492 . . . . 65.24 111.139 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.725 ' HG2' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -131.83 -163.67 1.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 73.03 110.884 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -173.45 -50.06 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 71.03 110.873 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -103.27 91.76 4.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.203 -0.453 . . . . 75.44 110.868 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 130.4 -50.54 0.89 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.724 -0.751 . . . . 74.25 112.495 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 42.5 p -142.96 167.09 22.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.821 0.344 . . . . 74.53 111.145 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -105.25 175.0 21.72 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.734 -0.746 . . . . 60.3 112.455 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.39 -133.01 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.725 -0.75 . . . . 52.43 112.531 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -175.5 176.38 1.97 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.831 0.348 . . . . 75.42 110.839 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -84.03 -173.72 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 73.22 110.832 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 20.0 pt -87.36 -32.03 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.134 -0.484 . . . . 65.45 111.157 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -101.37 82.36 2.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.459 . . . . 54.44 110.943 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.29 -125.87 8.46 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 65.04 112.463 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -116.61 -85.07 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.909 0.385 . . . . 73.54 110.903 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.55 175.0 9.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.155 -0.475 . . . . 64.01 110.882 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.74 155.26 40.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 73.25 110.832 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.31 168.85 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 74.45 110.898 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -80.29 130.62 35.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.185 -0.462 . . . . 70.43 110.869 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -74.47 -50.31 18.79 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.869 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 5.0 p30 178.76 159.13 0.56 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.908 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' HB3' ' HA3' ' A' ' 124' ' ' GLY . 0.1 OUTLIER -105.4 29.84 6.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 73.33 110.875 -179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.636 HG21 ' HG3' ' A' ' 28' ' ' LYS . 22.0 mm -51.31 -27.53 6.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 72.0 111.134 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -92.15 103.3 15.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 75.32 110.893 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.7 107.34 19.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.222 -0.445 . . . . 64.02 110.883 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.63 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -58.42 98.42 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 74.31 110.847 179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.69 42.36 1.42 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 63.42 111.115 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 148.33 178.93 23.88 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.773 -0.727 . . . . 41.5 112.521 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 169.29 19.25 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.661 2.241 . . . . 72.31 112.329 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.659 ' HA2' HD11 ' A' ' 114' ' ' ILE . . . 87.17 -34.75 3.54 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 43.04 112.503 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.63 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.6 mm -50.91 137.1 9.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.854 0.359 . . . . 73.51 111.137 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' N ' ' A' ' 99' ' ' SER . 2.7 tt -98.38 128.64 44.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 64.43 110.93 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.549 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -134.42 -171.07 2.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 72.15 110.834 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.428 ' H ' ' HB3' ' A' ' 126' ' ' HIS . 9.5 mmt -116.63 -173.4 2.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.094 -0.503 . . . . 70.04 110.877 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.466 ' O ' ' O ' ' A' ' 102' ' ' ASN . . . -101.35 -48.77 4.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 61.15 111.053 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.524 ' HA ' HG23 ' A' ' 107' ' ' THR . 5.4 p-10 39.73 -165.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 62.01 110.906 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.557 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -158.86 22.07 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.466 . . . . 72.34 111.103 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.3 -67.92 0.34 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.73 -0.748 . . . . 41.24 112.469 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.557 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.7 Cg_endo -69.75 -156.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 74.14 112.315 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -87.22 87.31 7.4 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.193 -0.458 . . . . 75.23 110.916 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.524 HG23 ' HA ' ' A' ' 102' ' ' ASN . 7.2 t -153.75 51.46 0.69 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 72.11 111.167 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -71.64 -4.88 29.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 70.43 110.895 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.65 76.04 1.76 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 74.51 112.457 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.0 p -127.3 -140.88 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.802 0.334 . . . . 73.11 110.871 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.52 -77.58 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.95 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.444 ' CZ ' HG22 ' A' ' 114' ' ' ILE . 0.0 OUTLIER 170.89 148.27 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.842 -179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -141.78 122.58 14.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 73.01 110.886 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.659 HD11 ' HA2' ' A' ' 96' ' ' GLY . 13.0 tt -123.95 137.46 56.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.49 . . . . 71.13 111.124 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 27.1 p -96.83 148.48 22.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.888 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -92.68 -18.74 22.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 73.34 111.094 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -131.0 179.89 5.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.266 -0.425 . . . . 75.44 111.125 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 tttt -65.7 90.81 0.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 73.3 110.895 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.63 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 27.2 p -116.9 59.5 0.75 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.213 -0.449 . . . . 64.21 111.187 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.09 28.06 1.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 73.31 110.856 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.63 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.4 OUTLIER -91.81 10.63 27.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.173 -0.467 . . . . 73.53 110.91 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.51 -23.65 17.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 62.2 110.913 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.589 ' O ' ' C ' ' A' ' 124' ' ' GLY . 0.8 OUTLIER 56.72 85.49 0.08 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.181 -0.463 . . . . 60.25 110.87 179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.589 ' C ' ' O ' ' A' ' 123' ' ' ASP . . . 20.18 61.13 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.803 -0.713 . . . . 42.15 112.461 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -104.66 -14.36 15.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 75.42 110.864 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.428 ' HB3' ' H ' ' A' ' 100' ' ' MET . 32.5 m-70 -110.99 -8.94 14.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 73.4 110.848 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 32' ' ' THR . 42.6 t 65.74 96.27 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 73.14 111.133 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.507 HG11 HG23 ' A' ' 97' ' ' ILE . 24.8 t -83.12 130.36 35.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.159 -0.473 . . . . 73.11 111.139 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -142.11 27.25 1.79 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 72.31 110.888 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 98' ' ' LEU . . . -152.72 -179.67 28.47 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 65.11 112.523 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -179.09 136.98 0.13 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.819 0.343 . . . . 74.33 110.915 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 132' ' ' VAL . 1.4 t -63.32 119.07 6.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.454 . . . . 75.24 111.165 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.41 ' HG3' ' HB2' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -89.47 -42.28 11.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.18 -0.464 . . . . 72.23 110.904 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.39 156.01 13.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 74.02 110.908 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.65 1.96 57.53 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.697 -0.763 . . . . 71.35 112.51 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.13 -29.1 8.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 74.33 110.9 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -53.93 -22.32 9.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 73.24 110.865 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 22.2 mm -89.84 -35.67 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 72.41 111.11 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.4 t -52.62 -22.03 3.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.12 111.149 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -84.29 -35.38 23.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.888 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -40.02 94.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 72.5 111.1 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.3 ptm -71.39 -37.15 71.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 74.12 110.893 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -85.04 34.99 0.56 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 74.45 110.922 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -126.78 -10.86 6.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 74.25 110.912 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.1 m-85 -124.17 14.59 9.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 75.45 110.861 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -106.77 71.36 0.21 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.707 -0.759 . . . . 71.35 112.525 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.553 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.73 131.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.86 0.362 . . . . 52.45 110.843 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.4 mmm-85 -46.25 -46.54 17.82 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.146 -0.479 . . . . 60.43 110.901 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -47.0 -37.9 9.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 74.23 110.902 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 138.07 -47.67 0.92 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.731 -0.747 . . . . 61.35 112.463 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.98 110.22 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 64.51 110.889 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 7.1 t -82.62 145.12 29.85 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 45.44 111.182 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.07 -22.46 52.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.23 -0.441 . . . . 72.3 110.874 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.5 mttt -136.31 163.91 29.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.162 -0.472 . . . . 75.34 110.952 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -104.14 130.8 51.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.45 . . . . 74.23 110.878 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.623 HG21 ' CE2' ' A' ' 53' ' ' PHE . 3.8 mp -109.82 120.05 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.42 111.169 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 33.6 p -119.31 165.41 14.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 62.42 111.181 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.734 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 3.9 mp -90.37 -64.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 71.23 111.144 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 158' ' ' ILE . . . 93.93 -60.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 55.42 111.127 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -160.59 147.08 15.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 53.24 110.874 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 3.2 p -176.24 -174.45 0.62 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.237 -0.438 . . . . 75.51 110.889 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 145.0 -163.73 28.0 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.751 -0.738 . . . . 62.55 112.484 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -81.39 120.07 24.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.799 0.333 . . . . 64.11 110.908 -179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mt -91.91 -23.97 19.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 75.11 110.92 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.218 -0.446 . . . . 74.51 110.943 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.6 tpp . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.8 0.333 . . . . 73.11 110.874 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 89.1 t 62.38 104.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 73.01 111.137 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 -60.19 151.93 64.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.601 0.715 . . . . 63.14 110.894 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.728 ' O ' HD12 ' A' ' 24' ' ' LEU . 54.1 Cg_endo -69.73 117.25 4.97 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.669 2.246 . . . . 65.32 112.34 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 22' ' ' PHE . 48.7 m -110.35 132.12 54.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.273 -0.421 . . . . 62.3 111.132 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.42 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.4 m -123.99 160.48 27.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 60.33 111.151 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 27.9 p90 -127.92 160.04 33.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 54.12 110.911 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' HD2' HD12 ' A' ' 158' ' ' ILE . 5.9 m-85 -135.84 126.98 28.05 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.163 -0.471 . . . . 75.02 110.914 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.27 72.08 2.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.129 -0.487 . . . . 74.25 110.865 179.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mp -49.16 135.12 6.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 74.31 111.133 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . . . -123.27 151.38 42.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 45.14 111.118 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 99.6 t -133.31 100.85 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.157 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t0 54.06 55.73 7.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.464 . . . . 63.43 110.897 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.31 12.27 55.07 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.753 -0.737 . . . . 64.15 112.482 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 35.2 tt0 -142.87 94.22 6.53 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.645 0.736 . . . . 70.23 110.887 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.7 167.13 25.27 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.706 2.271 . . . . 74.05 112.386 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.78 30.05 4.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 70.53 110.941 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 129.0 -164.02 22.2 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 70.3 112.481 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 164.28 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.905 0.383 . . . . 74.23 110.818 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.718 HG13 HG21 ' A' ' 138' ' ' ILE . 32.3 m -128.8 171.8 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 74.12 111.107 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.8 p -149.84 148.58 29.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 62.04 110.858 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.672 ' O ' HG23 ' A' ' 5' ' ' THR . 3.9 m-85 -125.32 154.05 42.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 71.41 110.868 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -94.15 -53.28 4.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 62.54 110.874 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.728 HD12 ' O ' ' A' ' 4' ' ' PRO . 7.9 mt 73.81 122.69 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 74.41 110.936 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.722 ' CE2' HD22 ' A' ' 90' ' ' LEU . 60.4 m-85 -88.75 69.04 8.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 74.53 110.875 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.46 -19.49 48.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.111 -0.495 . . . . 45.41 111.098 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.95 -34.25 26.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 61.42 110.853 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.97 -31.42 22.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 65.53 110.879 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.8 67.6 79.78 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.676 0.751 . . . . 61.11 111.138 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.428 ' HA ' ' HB2' ' A' ' 34' ' ' GLU . 54.2 Cg_endo -69.76 61.64 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.704 2.269 . . . . 43.14 112.355 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.68 -49.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 73.1 110.875 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.56 ' OG1' HG11 ' A' ' 127' ' ' VAL . 17.6 m -75.2 -60.5 2.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 72.4 111.152 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.615 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -88.43 -1.32 57.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.128 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 30' ' ' PRO . 14.8 tm-20 -82.19 -19.99 38.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 74.24 110.886 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.47 ' HB2' HG21 ' A' ' 78' ' ' ILE . 8.2 p30 -101.28 -27.86 12.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.103 -0.499 . . . . 72.45 110.859 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -50.95 -29.47 12.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 45.44 110.899 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -31.17 62.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 74.41 110.869 -179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.2 -30.64 19.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 64.55 111.129 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.423 HD11 ' HA3' ' A' ' 47' ' ' GLY . 2.5 tt -84.47 5.46 27.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 71.34 110.954 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 72.0 m -108.15 -2.67 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 70.53 110.83 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -117.16 13.21 14.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.474 . . . . 74.32 111.146 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 50.58 26.58 10.48 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.715 -0.755 . . . . 74.01 112.47 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -33.47 28.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.948 0.404 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.09 -17.97 60.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 62.55 110.9 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.09 -63.27 0.74 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.7 -0.762 . . . . 41.51 112.463 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -102.29 148.99 24.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.936 0.398 . . . . 62.44 110.828 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' HA3' HD11 ' A' ' 39' ' ' LEU . . . 135.63 151.45 6.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.491 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' OH ' HD11 ' A' ' 158' ' ' ILE . 8.1 t80 -49.56 103.98 0.06 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.902 0.382 . . . . 64.24 110.921 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -139.55 -47.98 0.47 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.163 -0.471 . . . . 72.42 110.846 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -131.69 33.76 2.69 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.755 -0.736 . . . . 74.34 112.457 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.76 -172.83 3.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.814 0.34 . . . . 73.14 110.858 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 14.2 m -89.51 -172.09 3.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.165 -0.47 . . . . 75.33 110.874 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -125.96 -75.73 0.59 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.02 110.876 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 41.42 -160.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.181 -0.463 . . . . 62.43 110.842 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.35 19.35 2.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 62.22 110.84 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.06 139.94 16.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 75.34 111.099 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.4 mt -139.87 108.58 7.04 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.654 0.74 . . . . 74.05 111.157 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 92.35 0.51 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.709 2.272 . . . . 51.15 112.345 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 124.11 21.27 2.35 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 73.15 112.474 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -148.05 -66.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.862 0.363 . . . . 73.33 110.911 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 19.8 ptp -163.54 -168.94 1.79 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 74.24 110.857 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -151.73 97.09 2.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 70.21 110.841 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -79.68 141.48 36.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 73.44 110.942 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -60.03 -50.22 70.09 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.695 -0.764 . . . . 54.15 112.525 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 159.03 109.05 0.26 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.761 . . . . 73.34 112.506 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -84.59 6.69 22.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.849 0.357 . . . . 60.31 110.893 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 6.5 t80 48.59 33.49 4.19 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.879 -179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.27 171.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 62.34 111.152 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 68.25 -179.15 0.22 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 71.23 110.901 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 179.66 48.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 72.34 110.885 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -79.09 -31.11 44.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 64.12 110.837 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.96 29.61 0.94 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.735 -0.745 . . . . 62.12 112.503 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 t -139.9 41.6 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.856 0.36 . . . . 62.44 111.176 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -72.38 -69.01 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.779 -0.724 . . . . 52.01 112.461 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -138.65 -155.31 6.69 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.768 -0.73 . . . . 64.34 112.489 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -176.1 -163.78 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 73.53 110.932 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.92 148.84 23.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 44.44 110.879 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' A' ' 35' ' ' ASN . 0.4 OUTLIER -44.14 -55.31 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 75.24 111.142 179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -128.3 26.62 5.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 74.33 110.966 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -156.04 -167.25 17.17 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.709 -0.758 . . . . 24.43 112.485 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -118.24 -29.59 5.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.93 0.395 . . . . 75.03 110.879 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.2 pttm -168.88 136.36 1.93 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.471 . . . . 73.23 110.942 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -112.03 158.78 19.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 73.13 110.868 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -82.61 161.68 22.15 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 75.43 110.899 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -79.39 108.04 12.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 74.23 110.831 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -73.5 -52.64 12.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.191 -0.459 . . . . 71.44 110.857 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -178.9 168.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.145 -0.48 . . . . 71.1 110.864 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.91 72.01 1.39 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 64.05 110.936 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.444 ' O ' HG22 ' A' ' 89' ' ' ILE . 16.4 mt -76.83 -3.91 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.494 . . . . 72.34 111.139 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD22 ' CE2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -120.53 91.64 3.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.17 -0.468 . . . . 65.41 110.897 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -75.47 -167.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 63.13 110.901 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 35.0 m80 -95.05 72.54 3.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 74.13 110.858 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.8 p -69.63 -17.92 63.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 32.24 111.133 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -175.06 -177.11 43.9 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.712 -0.756 . . . . 62.24 112.476 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 143.82 52.08 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.709 2.273 . . . . 61.23 112.326 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.576 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 104.12 22.35 8.82 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.711 -0.756 . . . . 52.14 112.476 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.539 ' C ' HD23 ' A' ' 98' ' ' LEU . 24.8 mm -99.36 137.25 27.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.857 0.36 . . . . 62.21 111.153 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.674 HD22 ' CD1' ' A' ' 112' ' ' PHE . 7.1 mt -111.11 148.18 33.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 54.33 110.898 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.664 ' O ' ' C ' ' A' ' 100' ' ' MET . 1.8 p -163.69 55.43 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 64.15 110.869 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.664 ' C ' ' O ' ' A' ' 99' ' ' SER . 3.0 mmt 7.96 90.96 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 61.14 110.861 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.07 110.34 1.34 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 54.05 111.095 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -142.54 -164.97 1.94 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 71.23 110.888 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.725 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -47.99 -51.85 22.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.147 -0.478 . . . . 43.12 111.126 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.441 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 124.96 -61.68 0.6 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.713 -0.756 . . . . 62.51 112.498 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.681 ' O ' HG23 ' A' ' 107' ' ' THR . 54.3 Cg_endo -69.76 100.0 0.79 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.705 2.27 . . . . 45.21 112.335 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 38.42 63.62 0.84 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.24 -0.436 . . . . 71.33 110.919 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.725 HG21 ' HB3' ' A' ' 103' ' ' ALA . 39.9 p -134.73 13.59 3.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 63.21 111.153 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 42.28 -100.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 24.34 110.928 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.94 166.52 10.73 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.756 -0.735 . . . . 64.4 112.523 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.75 22.75 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.759 0.314 . . . . 75.1 110.824 -179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.86 90.3 0.52 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 70.21 110.938 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.674 ' CD1' HD22 ' A' ' 98' ' ' LEU . 33.1 p90 -72.44 155.7 39.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 73.02 110.894 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.448 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 10.1 p90 -120.96 107.3 12.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 64.2 110.9 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.2 mt -63.27 111.74 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 72.52 111.108 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 63.1 m -71.88 136.85 47.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.133 -0.485 . . . . 61.12 110.903 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.84 13.17 8.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 71.21 111.145 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.5 11.44 0.78 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 74.05 111.102 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.28 138.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 70.12 110.945 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.753 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 71.1 p -139.34 46.38 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 72.42 111.085 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 13.8 tm-20 -54.06 -25.39 21.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.205 -0.452 . . . . 74.22 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.753 ' CZ2' HG22 ' A' ' 119' ' ' THR . 21.0 p90 -62.43 -18.53 61.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 74.24 110.949 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.425 HD12 ' HB ' ' A' ' 119' ' ' THR . 33.8 mt -82.58 -34.97 27.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.938 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 75.78 -10.0 1.34 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.177 -0.465 . . . . 75.42 110.879 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 96.18 52.46 1.61 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.777 -0.725 . . . . 75.23 112.481 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.49 -29.74 2.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.841 0.353 . . . . 74.45 110.912 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -112.36 154.97 24.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.214 -0.448 . . . . 64.43 110.874 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.56 HG11 ' OG1' ' A' ' 32' ' ' THR . 6.6 p -50.08 109.8 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.095 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 90' ' ' LEU . 9.1 p -76.58 153.79 5.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.143 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.642 ' O ' ' O ' ' A' ' 130' ' ' GLY . 4.8 p90 -177.02 178.38 1.14 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.194 -0.457 . . . . 54.5 110.884 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 129' ' ' PHE . . . 43.61 114.15 0.0 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.744 -0.741 . . . . 73.31 112.516 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -119.53 35.41 4.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.818 0.342 . . . . 73.24 110.913 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 96' ' ' GLY . 3.6 t 60.23 162.45 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 61.01 111.075 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 132' ' ' VAL . 5.4 tppt? -136.63 -58.08 0.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 71.15 110.923 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 175.29 9.68 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 74.5 110.934 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.37 81.4 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.705 -0.759 . . . . 70.34 112.446 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.9 tpt -91.62 -25.94 18.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 70.02 110.877 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.42 -30.72 53.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 75.03 110.892 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.718 HG21 HG13 ' A' ' 20' ' ' VAL . 43.6 mm -44.07 -39.24 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 73.14 111.169 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 97.0 t -93.1 -52.35 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.484 . . . . 61.12 111.134 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -45.83 -49.99 14.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 73.22 110.902 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.14 -55.11 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.147 -0.479 . . . . 70.43 111.094 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.652 ' SD ' HD13 ' A' ' 156' ' ' ILE . 9.6 ttm -50.3 -31.42 14.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 70.11 110.855 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -54.5 -32.95 58.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.249 -0.432 . . . . 72.31 110.918 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 27.7 mtm105 -62.61 -14.21 40.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.883 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -87.87 3.65 47.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 73.24 110.88 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -96.28 -156.09 31.06 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.729 -0.748 . . . . 61.43 112.503 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.09 -165.99 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.837 0.351 . . . . 63.41 110.9 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -84.4 -48.35 9.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 63.32 110.87 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 21.3 p30 -94.68 10.55 34.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 74.12 110.884 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 104.19 -150.77 17.43 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 51.1 112.481 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 6.0 mttm 65.04 142.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.888 0.375 . . . . 73.12 110.91 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.3 p -114.41 141.46 47.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.21 -0.45 . . . . 73.45 111.082 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.31 -18.0 63.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.179 -0.464 . . . . 74.45 110.838 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.12 -162.42 1.18 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.464 . . . . 72.12 110.896 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -116.41 93.88 4.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.237 -0.438 . . . . 72.41 110.888 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.652 HD13 ' SD ' ' A' ' 142' ' ' MET . 6.6 mt -88.83 117.69 32.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 52.55 111.13 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.8 t -136.77 -178.36 5.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 54.22 111.143 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.544 HD11 ' OH ' ' A' ' 48' ' ' TYR . 35.5 mm -105.22 115.88 47.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 74.24 111.121 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -76.91 -62.06 1.77 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.183 -0.462 . . . . 70.45 111.117 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -134.06 167.27 20.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 74.41 110.834 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.3 m -159.13 -174.63 4.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.48 . . . . 53.24 110.888 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.45 -160.93 24.62 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.756 -0.735 . . . . 73.01 112.49 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 27.0 mt-30 -110.35 137.01 48.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.846 0.355 . . . . 71.31 110.925 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.597 HD23 HG22 ' A' ' 5' ' ' THR . 3.6 mm? -47.91 -60.97 2.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 60.04 110.895 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.22 -0.445 . . . . 75.13 110.873 179.947 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 tmm? . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.788 0.328 . . . . 75.25 110.88 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 87.1 t -139.44 146.23 25.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.263 -0.426 . . . . 71.32 111.156 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -49.51 156.55 1.1 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.599 0.714 . . . . 65.14 110.924 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 151.16 69.04 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.667 2.245 . . . . 73.4 112.353 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 99.3 m -141.98 145.74 34.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.215 -0.448 . . . . 71.03 111.095 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.54 HG13 HD11 ' A' ' 24' ' ' LEU . 22.9 m -136.82 163.21 33.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.463 . . . . 60.21 111.107 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.598 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -135.8 162.71 32.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 72.13 110.881 -179.991 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -139.32 131.79 28.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.133 -0.485 . . . . 75.34 110.917 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 15.2 t0 -101.58 75.54 1.6 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.16 -0.473 . . . . 73.22 110.872 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.5 mm -56.1 146.36 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 74.31 111.133 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -138.94 164.77 28.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.215 -0.448 . . . . 42.13 111.118 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.538 HG22 HG12 ' A' ' 156' ' ' ILE . 83.8 t -139.81 104.76 2.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 63.43 111.093 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 t0 63.21 52.54 2.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.891 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.05 17.46 61.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.748 -0.739 . . . . 43.24 112.498 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.421 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 5.3 mm-40 -132.19 106.56 13.55 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.61 0.719 . . . . 64.23 110.893 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.3 Cg_endo -69.75 138.85 38.82 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.664 2.243 . . . . 52.51 112.313 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.76 18.33 13.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.181 -0.463 . . . . 63.12 110.892 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 121.75 167.22 13.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.769 -0.729 . . . . 34.23 112.495 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.75 175.67 5.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.865 0.364 . . . . 72.33 110.88 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 24.8 m -122.39 -176.84 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 63.05 111.114 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -134.77 86.31 2.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.85 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -84.83 127.23 34.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 63.11 110.88 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 23.8 tp10 -104.03 145.42 30.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 61.4 110.914 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.54 HD11 HG13 ' A' ' 6' ' ' VAL . 1.4 mt -110.11 113.65 26.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 73.41 110.908 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CD2' HD21 ' A' ' 90' ' ' LEU . 15.9 m-85 -73.81 67.46 1.2 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 71.4 110.926 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.69 -35.97 77.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.15 -0.477 . . . . 71.53 111.062 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -48.9 -54.77 14.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.32 110.845 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.432 ' HG3' HG21 ' A' ' 89' ' ' ILE . 3.2 mptp? -69.21 -60.83 2.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 62.23 110.891 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -121.14 95.89 48.52 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.596 0.712 . . . . 52.3 111.097 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 54.0 Cg_endo -69.79 -23.13 31.0 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.679 2.253 . . . . 40.22 112.358 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.9 mtmm -78.55 -51.19 10.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.203 -0.453 . . . . 73.02 110.955 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.508 HG22 ' CE1' ' A' ' 129' ' ' PHE . 18.1 m -64.85 -30.94 71.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 74.14 111.126 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.45 -56.66 6.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 71.11 111.115 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.504 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.0 tt0 -56.47 -60.72 3.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 70.4 110.948 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -29.29 -54.6 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 62.01 110.888 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' HA ' HD12 ' A' ' 39' ' ' LEU . 34.0 t80 -77.07 -39.32 50.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 74.4 110.905 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -50.04 -31.75 13.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.42 110.901 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.91 -36.86 72.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 71.51 111.124 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.435 HD12 ' HA ' ' A' ' 36' ' ' PHE . 30.7 mt -64.58 -43.86 92.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 62.4 110.899 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 39.5 t -59.16 -50.63 73.29 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.184 -0.462 . . . . 73.45 110.883 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.441 HG22 ' HG2' ' A' ' 163' ' ' GLN . 30.7 p -74.91 -18.8 60.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.116 -0.493 . . . . 74.41 111.182 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.86 83.46 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.766 -0.73 . . . . 73.41 112.47 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.35 31.95 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.369 . . . . 62.43 110.88 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -122.78 26.93 7.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 75.51 110.844 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.62 2.32 55.65 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.713 -0.756 . . . . 62.22 112.503 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -163.28 178.67 7.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.38 . . . . 73.1 110.885 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 128.34 131.96 3.5 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 74.31 112.461 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -54.47 161.43 1.42 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 73.43 110.924 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -145.96 -40.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 71.2 110.896 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.91 43.54 1.54 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 74.22 112.45 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.53 165.08 24.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.873 0.368 . . . . 75.52 110.849 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 p -131.01 -179.56 5.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.113 -0.494 . . . . 74.23 110.831 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -113.63 -69.33 0.87 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.904 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.737 ' CE1' HG21 ' A' ' 152' ' ' THR . 0.1 OUTLIER 61.61 20.25 11.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 72.35 110.885 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.1 ttm-85 -138.03 29.93 2.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.184 -0.462 . . . . 73.44 110.85 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.689 ' O ' HD13 ' A' ' 57' ' ' ILE . 0.3 OUTLIER -79.9 144.83 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 45.15 111.124 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 56' ' ' ILE . 16.6 mm -134.52 107.39 10.97 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.667 0.746 . . . . 74.43 111.118 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 98.51 0.69 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.727 2.284 . . . . 43.21 112.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 125.13 -28.95 4.99 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.755 -0.736 . . . . 41.53 112.493 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -103.94 -63.36 1.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.886 0.374 . . . . 73.15 110.913 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -176.94 -157.8 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.488 . . . . 70.25 110.87 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.9 t -144.41 137.06 26.76 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.228 -0.442 . . . . 54.23 110.902 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.87 167.61 21.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.158 -0.474 . . . . 74.32 110.885 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -136.23 159.8 24.48 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.713 -0.756 . . . . 42.34 112.478 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -58.38 90.1 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.729 -0.748 . . . . 45.23 112.464 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 174.5 81.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.908 0.385 . . . . 71.32 110.876 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -81.99 171.13 14.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 74.55 110.878 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -129.23 -49.18 1.19 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 64.05 111.172 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.5 tpt85 -88.93 -43.07 11.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.458 . . . . 65.42 110.819 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 42.0 m-70 -58.9 -164.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 65.53 110.839 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.93 -34.47 78.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 73.34 110.869 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -72.27 145.43 37.64 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.741 -0.742 . . . . 72.14 112.468 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.4 t -131.55 -169.35 2.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.858 0.361 . . . . 71.33 111.158 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.08 -24.74 5.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.775 -0.726 . . . . 31.24 112.487 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.91 76.99 0.69 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 70.42 112.493 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 1.5 ptmt -118.79 179.6 4.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.793 0.33 . . . . 70.44 110.88 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.1 t -85.62 146.72 26.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 70.1 110.835 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 79' ' ' TYR . 2.1 pp -71.26 -41.87 74.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 44.35 111.15 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.41 ' N ' HD12 ' A' ' 78' ' ' ILE . 0.6 OUTLIER -97.07 -5.64 37.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.955 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -149.45 -143.33 3.74 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.7 -0.762 . . . . 55.43 112.437 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -118.9 -25.58 6.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.911 0.386 . . . . 71.14 110.877 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.1 pttt -170.75 141.49 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.9 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -108.8 154.1 22.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.05 110.916 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 13.9 pm0 -88.29 164.43 15.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 72.41 110.896 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.01 116.32 15.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 65.14 110.899 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -85.68 -49.58 7.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 71.42 110.871 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.93 140.38 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 74.31 110.924 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -100.15 70.98 1.58 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 73.53 110.917 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.539 ' O ' HG22 ' A' ' 89' ' ' ILE . 19.4 mm -80.38 4.36 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 62.51 111.103 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.552 HD21 ' CD2' ' A' ' 25' ' ' PHE . 0.7 OUTLIER -108.32 121.77 45.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 71.31 110.913 179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 92' ' ' HIS . 14.3 mttp -123.81 82.85 2.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 75.02 110.891 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.51 ' C ' HG22 ' A' ' 93' ' ' THR . 5.0 m80 38.78 -160.31 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 65.4 110.863 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.577 HG22 HD11 ' A' ' 97' ' ' ILE . 1.2 t 161.8 -38.41 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 73.04 111.16 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.404 ' HA2' ' HB2' ' A' ' 118' ' ' LYS . . . 158.7 -163.6 33.19 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.725 -0.75 . . . . 71.54 112.486 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 128.54 16.13 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.656 2.237 . . . . 64.31 112.372 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 118.17 -5.44 15.53 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 70.24 112.487 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.735 HD12 HG11 ' A' ' 128' ' ' VAL . 1.7 mm -61.88 139.87 20.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.838 0.352 . . . . 74.34 111.108 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.563 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.6 tt -100.86 125.97 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 73.12 110.963 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.552 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -111.78 125.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 65.33 110.859 -179.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.02 -33.77 76.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.093 -0.503 . . . . 74.11 110.852 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.55 ' HB2' ' OE1' ' A' ' 111' ' ' GLN . . . 62.84 155.34 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 72.4 111.124 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.0 p30 172.0 -174.96 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.888 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -78.18 -22.51 48.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.479 . . . . 73.21 111.081 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.8 -64.9 0.56 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.765 -0.731 . . . . 54.53 112.506 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.1 Cg_endo -69.68 87.45 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 71.35 112.367 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 32.55 78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 71.11 110.87 179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.521 ' O ' ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.94 15.53 6.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 62.5 111.175 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 20.5 t-20 43.73 -89.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 71.32 110.871 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 73.56 132.97 0.22 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.762 -0.733 . . . . 70.43 112.448 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 59.9 p -129.18 77.2 1.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.78 0.324 . . . . 44.01 110.825 -179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.55 ' OE1' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -93.85 -31.92 14.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 53.23 110.904 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.538 ' CE1' HD11 ' A' ' 114' ' ' ILE . 0.4 OUTLIER 71.97 69.01 0.15 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.454 . . . . 62.52 110.86 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -90.82 111.03 22.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.908 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.538 HD11 ' CE1' ' A' ' 112' ' ' PHE . 96.5 mt -102.89 111.31 32.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 75.44 111.107 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.3 m -77.24 160.02 29.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.175 -0.466 . . . . 71.53 110.87 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.6 p -133.65 27.83 3.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 75.13 111.163 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.31 32.58 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 72.24 111.104 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HB2' ' HA2' ' A' ' 94' ' ' GLY . 4.2 tttt 62.39 146.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 55.34 110.868 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 38.4 p -141.97 58.65 1.48 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.242 -0.436 . . . . 73.33 111.15 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 92' ' ' HIS . 8.1 tm-20 -49.56 -24.7 2.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.221 -0.445 . . . . 64.42 110.905 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 8.7 m-90 -60.02 -36.03 76.36 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.118 -0.492 . . . . 74.2 110.908 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.9 mp -99.57 106.32 18.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 72.34 110.905 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -137.49 -43.77 0.55 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 72.53 110.859 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -89.23 -38.26 6.81 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.744 -0.741 . . . . 54.42 112.497 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.5 tptp -59.94 -35.83 75.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.834 0.349 . . . . 72.24 110.889 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.5 m-70 -131.81 140.13 49.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.13 110.83 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.79 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 72.7 t -74.14 -81.14 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 73.21 111.078 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.79 ' HB ' ' O ' ' A' ' 127' ' ' VAL . 72.4 t 103.08 127.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 71.21 111.168 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.508 ' CE1' HG22 ' A' ' 32' ' ' THR . 29.5 p90 -147.55 18.94 1.18 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 75.42 110.854 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.27 146.43 16.71 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 64.45 112.458 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -156.42 140.05 15.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.855 0.359 . . . . 75.41 110.861 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 45.5 t -48.65 109.81 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 74.51 111.152 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.36 -36.03 24.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 74.05 110.865 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -148.01 175.37 11.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.441 . . . . 60.31 110.862 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 48.69 73.09 0.37 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.705 -0.76 . . . . 62.11 112.485 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.39 -3.53 55.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.77 0.319 . . . . 75.11 110.88 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.408 ' HA ' ' HB2' ' A' ' 140' ' ' GLU . 88.6 m-20 -84.25 -34.64 23.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 71.32 110.84 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 50.2 mm -42.47 -41.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 62.31 111.168 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 91.1 t -95.79 -49.61 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 75.43 111.135 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.408 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 7.4 mm-40 -46.5 -50.27 17.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 73.33 110.873 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.79 -51.48 13.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 74.03 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.59 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.9 ttm -50.38 -38.51 42.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 64.22 110.835 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -52.99 -27.62 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 73.13 110.909 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -62.66 -14.89 48.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 72.42 110.863 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -89.51 13.22 14.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.2 110.922 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.02 -156.34 28.14 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.715 -0.755 . . . . 34.12 112.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 12.5 t -166.87 169.79 12.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 71.14 110.828 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.6 mmm180 -54.0 -47.31 71.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.106 -0.497 . . . . 55.15 110.873 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -89.73 3.29 53.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.886 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.36 13.25 79.93 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.742 -0.742 . . . . 44.33 112.476 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.79 ' O ' HG22 ' A' ' 152' ' ' THR . 4.9 tppp? -45.55 -29.14 1.09 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.905 0.383 . . . . 75.34 110.957 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.795 HG23 ' N ' ' A' ' 153' ' ' SER . 0.6 OUTLIER 86.73 -169.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.193 -0.458 . . . . 71.51 111.136 179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.795 ' N ' HG23 ' A' ' 152' ' ' THR . 23.3 t -137.7 -52.81 0.65 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 75.3 110.895 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 -168.09 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 72.3 110.892 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.67 111.13 23.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 74.24 110.9 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.59 HD13 ' SD ' ' A' ' 142' ' ' MET . 40.4 mt -107.24 101.76 12.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 75.1 111.164 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.4 p -113.64 168.66 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 75.22 111.132 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.5 mt -93.95 106.47 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 63.33 111.162 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -55.0 -54.57 41.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 44.34 111.113 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -164.24 167.97 19.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.213 -0.449 . . . . 72.22 110.897 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 21.2 p -156.5 160.87 39.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 64.43 110.853 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.84 179.83 46.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.731 -0.747 . . . . 53.33 112.481 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.585 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 7.3 mt-30 -74.89 -37.89 62.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.829 0.347 . . . . 74.41 110.902 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.598 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.41 -62.76 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 63.33 110.951 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 64.52 110.881 179.941 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mmm . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.829 0.347 . . . . 73.41 110.863 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.1 p -148.03 152.64 12.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.455 . . . . 71.31 111.12 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -67.48 137.63 93.52 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.597 0.713 . . . . 70.33 110.885 179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 143.54 51.18 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.668 2.245 . . . . 61.4 112.343 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 163' ' ' GLN . 86.6 m -127.75 148.38 50.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 63.43 111.136 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -133.44 160.04 42.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.451 . . . . 72.33 111.135 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.559 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -137.5 162.25 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 75.44 110.829 -179.95 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.534 ' HD2' HD12 ' A' ' 158' ' ' ILE . 26.8 m-85 -139.32 136.43 34.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 63.05 110.889 -179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.77 69.85 1.85 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.897 179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 158' ' ' ILE . 26.2 mm -51.52 129.08 10.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 74.0 111.105 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.48 163.12 16.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 52.12 111.093 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.856 HG22 HG22 ' A' ' 156' ' ' ILE . 53.5 t -140.89 104.99 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.176 -0.465 . . . . 75.53 111.125 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.7 t0 51.49 53.23 13.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 53.14 110.875 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.15 10.09 55.78 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.74 -0.743 . . . . 72.24 112.43 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.2 tm-20 -142.57 96.52 6.22 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.635 0.731 . . . . 72.21 110.903 -179.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 54.2 Cg_endo -69.69 157.69 59.66 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.708 2.272 . . . . 73.35 112.343 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -124.84 21.0 8.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 72.42 110.928 179.949 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 135.64 169.42 11.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.775 -0.726 . . . . 62.32 112.489 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.03 172.68 7.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 61.31 110.886 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.423 ' CG1' HG21 ' A' ' 138' ' ' ILE . 4.5 m -138.59 158.77 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 75.13 111.154 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.8 p -140.83 143.75 34.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.163 -0.471 . . . . 70.04 110.884 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -125.88 123.54 38.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 62.13 110.874 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.28 -47.01 87.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 63.11 110.901 -179.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 75.27 117.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 55.45 110.914 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -83.67 57.58 4.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 64.43 110.835 179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.471 ' HB1' ' HB1' ' A' ' 33' ' ' ALA . . . -65.24 -26.33 68.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.21 111.134 179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -61.1 -59.34 5.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 64.11 110.83 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -50.24 -57.73 7.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 62.43 110.88 -179.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.767 ' HB ' HG22 ' A' ' 32' ' ' THR . 3.0 m -110.48 90.21 9.95 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.638 0.732 . . . . 71.31 111.142 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -19.33 36.3 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.66 2.24 . . . . 71.41 112.393 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 21.0 mmtm -79.84 -58.25 3.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 63.43 110.873 179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.767 HG22 ' HB ' ' A' ' 29' ' ' VAL . 6.2 t -87.11 25.78 1.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.199 -0.455 . . . . 72.41 111.173 -179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -80.21 -42.25 23.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.457 . . . . 73.42 111.093 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.625 ' HG3' HD11 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -76.85 -10.01 59.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 73.14 110.917 -179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' O ' HG21 ' A' ' 78' ' ' ILE . 29.7 t30 -42.41 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 71.35 110.891 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -81.42 -32.16 32.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.19 -0.459 . . . . 70.45 110.863 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.42 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 5.5 ttp85 -55.1 -39.98 69.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 73.23 110.839 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.52 -37.06 71.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 64.31 111.106 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.875 HD12 HG22 ' A' ' 78' ' ' ILE . 0.2 OUTLIER -91.74 33.46 1.03 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 74.24 110.896 -179.977 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.7 t -151.2 -22.66 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 64.15 110.849 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.553 HG23 ' HG2' ' A' ' 163' ' ' GLN . 90.0 m -84.47 -42.14 15.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.52 111.163 -179.914 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 151.28 -31.1 0.96 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.742 -0.742 . . . . 73.0 112.475 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' ' 42' ' ' GLY . 8.4 tp10 -33.46 -75.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 75.21 110.882 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.33 141.42 30.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 74.31 110.93 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -129.29 -30.49 0.67 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.751 -0.738 . . . . 73.12 112.458 179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -47.07 -36.1 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.898 0.38 . . . . 71.43 110.863 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.85 -146.37 3.3 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 53.0 112.486 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.59 136.45 43.96 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 75.25 110.915 -179.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -162.62 -39.49 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.095 -0.502 . . . . 64.31 110.904 179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -151.54 43.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 63.41 112.495 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.0 m -120.74 168.43 11.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.824 0.345 . . . . 65.01 110.838 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 55.9 m -58.96 163.44 3.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 72.44 110.871 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.38 -70.08 0.83 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.89 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 63.59 -163.45 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 71.22 110.823 180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 51.82 35.74 16.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.24 110.899 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 156' ' ' ILE . 86.0 mt -90.11 135.38 26.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 74.23 111.146 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.4 tt -141.15 115.94 7.17 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.572 0.701 . . . . 71.31 111.156 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 151.73 69.14 Favored 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.72 2.28 . . . . 54.32 112.326 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 58.09 33.54 69.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.734 -0.746 . . . . 52.22 112.495 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.61 -71.26 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.906 0.384 . . . . 60.14 110.868 -179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -166.72 -159.79 0.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 75.23 110.851 179.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.45 -49.78 1.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.231 -0.441 . . . . 73.32 110.889 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 67.99 145.94 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 75.45 110.953 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -79.44 -67.12 1.61 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.759 -0.734 . . . . 54.33 112.484 -179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.15 -151.73 20.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.747 -0.739 . . . . 72.33 112.501 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -141.81 -166.72 2.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.885 0.374 . . . . 60.1 110.874 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.42 -167.29 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.4 110.823 -179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 1.9 t -125.53 -46.71 1.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 73.35 111.142 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -116.65 31.84 6.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 65.34 110.87 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 65.31 149.24 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 61.1 110.88 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -145.63 158.39 43.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 73.3 110.925 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -98.07 27.3 19.84 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.729 -0.748 . . . . 43.51 112.519 179.94 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 64.4 p -121.84 -54.12 1.95 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.844 0.354 . . . . 71.33 111.172 -179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.98 -148.06 18.87 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.747 -0.74 . . . . 54.51 112.468 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.31 36.99 3.89 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.718 -0.754 . . . . 72.13 112.509 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 14.9 mtmt -49.51 166.7 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 62.41 110.899 -179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.418 ' HA ' ' HB3' ' A' ' 110' ' ' SER . 1.9 p -85.11 144.21 28.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 71.22 110.851 -179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.875 HG22 HD12 ' A' ' 39' ' ' LEU . 1.8 pp -58.45 -13.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 64.13 111.078 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -20.34 13.5 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.218 -0.446 . . . . 75.22 110.959 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.72 -131.76 1.63 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.738 -0.744 . . . . 74.33 112.514 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -95.42 -36.52 11.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.926 0.393 . . . . 72.25 110.916 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.04 157.07 1.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 62.24 110.891 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -147.97 138.98 23.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.249 -0.432 . . . . 72.3 110.889 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.23 -174.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 54.24 110.939 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -84.51 158.65 20.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 74.4 110.847 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -54.51 2.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 73.31 110.87 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.62 145.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 74.23 110.894 -179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -104.83 57.32 0.69 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.877 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.4 mm -74.32 -24.61 19.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 73.05 111.127 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.69 ' HB2' HG13 ' A' ' 128' ' ' VAL . 8.4 mt -95.17 133.81 38.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 73.32 110.929 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' C ' ' A' ' 92' ' ' HIS . 0.1 OUTLIER -112.22 78.33 1.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.173 -0.467 . . . . 60.54 110.919 179.845 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.461 ' C ' ' O ' ' A' ' 91' ' ' LYS . 21.9 m80 33.23 -140.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.252 -0.431 . . . . 72.12 110.837 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 94' ' ' GLY . 0.9 OUTLIER 168.29 -51.64 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 62.1 111.106 -179.891 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.434 ' N ' HG22 ' A' ' 93' ' ' THR . . . 178.08 -153.65 13.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.746 -0.74 . . . . 63.04 112.507 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 109.59 2.34 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.678 2.252 . . . . 72.51 112.341 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.527 ' HA3' HG22 ' A' ' 132' ' ' VAL . . . 132.06 -22.85 4.2 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 62.21 112.491 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.454 HG23 HG23 ' A' ' 128' ' ' VAL . 5.0 mm -50.82 141.28 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.889 0.376 . . . . 73.55 111.097 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.551 HD11 ' HD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -106.97 132.28 53.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 71.44 110.918 179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.34 33.84 2.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 75.33 110.855 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER 43.71 -159.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 73.32 110.901 179.941 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.745 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -170.52 138.98 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 74.4 111.143 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.425 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 1.4 m-20 166.39 -74.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 64.31 110.91 -179.979 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.828 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -171.79 122.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.195 -0.457 . . . . 21.21 111.101 179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.824 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -54.43 -37.78 61.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.77 -0.728 . . . . 53.01 112.49 -179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.824 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.8 84.91 0.64 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.707 2.271 . . . . 71.55 112.324 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 30.6 m120 43.52 62.09 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.908 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.828 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 0.2 OUTLIER -154.13 57.99 0.72 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 52.01 111.156 -179.948 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -39.99 -75.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.921 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 95.29 173.42 37.13 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.681 -0.771 . . . . 64.44 112.46 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG23 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -120.09 13.35 12.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.829 0.347 . . . . 64.25 110.852 -179.771 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.745 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.7 OUTLIER -63.88 -165.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 73.43 110.948 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CZ ' HD12 ' A' ' 114' ' ' ILE . 36.9 t80 -155.64 93.62 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 72.31 110.894 -179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -112.18 122.46 47.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.888 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD12 ' CZ ' ' A' ' 112' ' ' PHE . 2.6 mt -121.54 138.52 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.128 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.4 m -83.38 162.16 21.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.868 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -135.18 15.58 3.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 73.15 111.165 -179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -160.75 26.03 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 53.14 111.117 179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.7 tttt 61.88 156.09 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.219 -0.446 . . . . 74.3 110.861 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.487 ' O ' ' CB ' ' A' ' 120' ' ' GLU . 36.7 p -108.35 -141.63 0.38 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 64.53 111.125 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 119' ' ' THR . 0.3 OUTLIER 161.7 -51.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 64.41 110.864 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.9 -7.05 53.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.178 -0.465 . . . . 72.02 110.933 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 9.3 mp -86.71 10.16 16.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.247 -0.433 . . . . 72.12 110.893 -179.993 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -69.87 127.5 33.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.886 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 72.56 32.62 61.68 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.772 -0.728 . . . . 72.02 112.483 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.17 -66.64 0.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 70.22 110.904 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -125.4 160.43 29.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 75.13 110.857 179.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.723 HG11 HG21 ' A' ' 32' ' ' THR . 57.5 t -61.06 117.89 3.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 62.01 111.129 179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.69 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.8 p -101.82 138.36 26.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 70.4 111.131 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -178.94 111.59 0.05 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.194 -0.457 . . . . 74.23 110.894 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.7 134.96 6.28 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.734 -0.746 . . . . 70.32 112.42 179.962 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -155.2 147.9 24.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.786 0.327 . . . . 72.14 110.877 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.642 HG11 HG21 ' A' ' 139' ' ' VAL . 16.2 m -53.17 125.26 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 74.33 111.142 179.87 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 29.3 mmtt -89.01 -49.09 6.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.183 -0.462 . . . . 63.53 110.872 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -129.29 172.59 11.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.866 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 62.03 71.35 0.83 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.741 -0.742 . . . . 52.12 112.495 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.416 ' HE1' HG21 ' A' ' 132' ' ' VAL . 7.0 tpt -84.58 3.83 34.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.83 0.348 . . . . 73.11 110.901 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -82.91 -32.9 27.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.921 -179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 142' ' ' MET . 45.8 mm -65.28 -38.45 82.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 73.32 111.093 179.922 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.642 HG21 HG11 ' A' ' 132' ' ' VAL . 4.2 t -91.57 13.28 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 73.35 111.088 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -128.57 -66.08 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 65.02 110.854 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.17 -56.92 15.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 75.24 111.11 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 8.5 tmm? -48.49 -36.95 16.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.464 . . . . 55.32 110.923 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -53.85 -31.63 50.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.233 -0.44 . . . . 75.05 110.848 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.41 -16.9 40.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.886 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -82.08 4.89 21.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 73.3 110.858 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.05 -163.86 34.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 63.04 112.469 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.3 m -157.98 20.59 0.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.872 0.368 . . . . 70.21 110.819 -179.727 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.8 mmm-85 47.05 60.97 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.83 -179.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.4 t30 174.96 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.21 110.865 -179.942 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 151.22 -56.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.763 -0.732 . . . . 65.55 112.505 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 132.06 39.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.867 0.365 . . . . 74.31 110.879 -179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.561 HG21 HD12 ' A' ' 56' ' ' ILE . 40.2 p -111.67 144.85 40.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 74.54 111.157 179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.51 -28.26 69.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 50.24 110.895 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.21 -159.08 0.94 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.03 110.931 179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -132.73 137.79 47.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 55.03 110.91 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.856 HG22 HG22 ' A' ' 12' ' ' VAL . 9.3 pt -126.44 136.14 61.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.13 111.107 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.82 159.15 42.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 63.35 111.136 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.574 HD13 HD13 ' A' ' 10' ' ' ILE . 46.7 mm -83.12 104.84 12.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 73.31 111.145 179.876 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.591 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -69.23 -56.58 7.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.227 -0.442 . . . . 62.03 111.099 179.788 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.13 175.39 9.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 51.51 110.867 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 18.1 p -174.45 154.41 2.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.456 . . . . 73.53 110.825 -179.847 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -178.27 -176.57 46.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.692 -0.766 . . . . 62.45 112.498 -179.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.553 ' HG2' HG23 ' A' ' 41' ' ' THR . 0.8 OUTLIER -73.62 -38.34 65.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.834 0.35 . . . . 74.54 110.901 -179.903 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.559 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.2 mm? 71.29 -65.27 0.35 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 62.32 110.934 -179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 74.51 110.918 179.913 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtp . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.81 0.338 . . . . 75.43 110.883 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.83 156.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 73.44 111.147 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -88.88 126.88 57.97 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.649 0.738 . . . . 71.42 110.852 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 145.41 57.19 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.701 2.267 . . . . 51.4 112.374 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -132.64 123.41 26.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.24 -0.437 . . . . 75.43 111.132 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.7 m -100.42 151.06 5.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.217 -0.447 . . . . 73.43 111.118 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -105.23 153.54 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.884 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.62 138.79 36.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.474 . . . . 74.23 110.888 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.747 ' O ' HD13 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -101.42 152.59 20.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 74.42 110.888 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 9' ' ' ASP . 5.9 mm -129.51 135.75 60.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 72.5 111.101 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.17 157.56 46.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 73.12 111.146 179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.726 HG22 HD23 ' A' ' 17' ' ' LEU . 15.0 m -140.94 111.39 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 62.14 111.14 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.27 25.56 5.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 65.3 110.913 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.97 -14.2 65.81 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.752 -0.737 . . . . 70.52 112.498 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.533 ' HG2' HG23 ' A' ' 12' ' ' VAL . 2.3 pt-20 -93.69 140.85 23.2 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.622 0.725 . . . . 54.55 110.9 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.8 150.83 68.51 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.633 2.222 . . . . 75.4 112.356 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.726 HD23 HG22 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -118.47 -66.2 1.1 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 61.24 110.921 179.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.42 -148.19 5.41 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.747 . . . . 73.5 112.459 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.44 127.41 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.788 0.328 . . . . 73.13 110.901 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.9 t -100.28 144.89 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 71.23 111.11 179.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 t -107.25 94.71 5.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 74.03 110.831 -179.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.555 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 12.4 m-85 -88.21 126.3 35.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 73.4 110.883 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -107.8 145.87 32.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 63.43 110.906 -179.942 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -114.93 119.28 36.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.183 -0.462 . . . . 62.02 110.93 -179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' O ' HG23 ' A' ' 29' ' ' VAL . 38.1 m-85 -82.75 81.66 8.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.455 . . . . 72.1 110.909 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.38 -2.66 32.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 73.24 111.12 179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -80.02 -42.13 24.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 72.1 110.858 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -97.11 -24.22 15.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 73.31 110.89 179.983 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.62 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -140.44 82.74 15.94 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.682 0.753 . . . . 73.34 111.086 179.913 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 -49.36 0.56 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.634 2.223 . . . . 74.52 112.343 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.35 -55.95 11.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.33 110.89 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' CD2' ' A' ' 129' ' ' PHE . 1.3 m -50.77 -48.97 59.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 74.11 111.116 179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.06 -27.94 64.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 45.14 111.107 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -61.42 -31.02 70.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 72.32 110.861 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.622 HD22 HD12 ' A' ' 78' ' ' ILE . 2.8 t-20 -66.27 -71.75 0.18 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 53.44 110.881 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.619 ' HA ' HD12 ' A' ' 39' ' ' LEU . 46.6 t80 -48.54 -30.43 5.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 74.31 110.86 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -57.23 -40.94 78.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 73.3 110.836 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.729 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -79.51 -21.52 45.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.191 -0.459 . . . . 60.15 111.107 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.619 HD12 ' HA ' ' A' ' 36' ' ' PHE . 74.1 mt -76.46 -40.47 50.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 75.04 110.892 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.6 m -72.22 -46.51 55.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 51.25 110.828 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.8 p -82.51 8.17 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 70.41 111.166 -179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.55 40.79 11.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 75.34 112.459 179.906 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.562 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 5.1 mm-40 -54.96 -27.36 43.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.924 0.392 . . . . 75.01 110.891 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.844 ' HD2' HG23 ' A' ' 78' ' ' ILE . 6.8 mtpm? -113.46 -6.04 13.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 73.33 110.903 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 40.8 32.88 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 71.2 112.451 179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -121.1 -18.75 7.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.933 0.397 . . . . 62.52 110.873 -179.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.58 -95.54 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.753 -0.737 . . . . 64.51 112.496 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -156.09 15.68 0.34 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.942 0.401 . . . . 73.25 110.911 -179.795 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttt -60.76 127.63 32.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 71.33 110.897 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.93 67.6 1.85 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.73 -0.748 . . . . 35.12 112.519 179.976 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 m -164.29 -94.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.795 0.331 . . . . 71.52 110.822 -179.759 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.7 p -172.3 -168.3 0.53 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.134 -0.484 . . . . 71.53 110.853 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -102.24 -178.21 3.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 64.24 110.893 -179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -114.02 -50.17 2.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.469 . . . . 71.01 110.84 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -179.07 6.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 73.33 110.847 -179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.475 HG22 ' O ' ' A' ' 56' ' ' ILE . 0.1 OUTLIER 175.03 122.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.177 -0.465 . . . . 72.31 111.107 179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.697 HD12 ' CE ' ' A' ' 61' ' ' MET . 30.7 mt -133.47 112.91 13.02 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.654 0.74 . . . . 63.43 111.129 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 82.08 0.78 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.696 2.264 . . . . 74.35 112.363 179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.19 -32.81 1.14 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.789 -0.719 . . . . 74.13 112.525 -179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -59.41 1.71 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.871 0.367 . . . . 72.13 110.845 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.697 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -178.8 -166.62 0.1 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 64.54 110.919 179.97 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.5 m -143.1 129.0 19.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.224 -0.444 . . . . 71.03 110.903 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.26 132.62 51.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 74.3 110.914 -179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -124.96 141.65 13.27 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.728 -0.749 . . . . 61.44 112.544 -179.995 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 60.78 165.25 0.23 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.755 -0.736 . . . . 71.11 112.472 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 177.15 86.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.835 0.35 . . . . 42.32 110.846 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.54 ' O ' HG23 ' A' ' 68' ' ' THR . 22.1 p90 -116.49 178.46 4.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 74.14 110.826 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.1 OUTLIER -173.57 -84.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 74.23 111.176 -179.919 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.7 ttt180 -103.87 144.48 31.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.859 179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 172.12 26.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 60.33 110.865 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.3 p30 171.83 33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.209 -0.451 . . . . 75.01 110.884 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.06 23.6 77.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.734 . . . . 64.21 112.458 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 17.4 p -145.89 115.87 7.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.876 0.37 . . . . 61.42 111.135 -179.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.58 -169.52 0.51 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.728 -0.749 . . . . 70.02 112.489 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' CA ' ' HA ' ' A' ' 68' ' ' THR . . . -59.12 172.21 4.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.73 -0.748 . . . . 72.45 112.497 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -175.37 172.45 2.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 64.03 110.856 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.613 ' O ' ' HB ' ' A' ' 78' ' ' ILE . 0.0 OUTLIER -124.04 26.33 7.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.873 -179.885 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.844 HG23 ' HD2' ' A' ' 44' ' ' LYS . 57.0 mt 87.56 -59.41 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 74.42 111.185 179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -85.46 28.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 61.42 110.912 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 118.93 166.69 13.57 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.743 -0.742 . . . . 25.34 112.488 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -46.71 -84.93 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.387 . . . . 63.34 110.877 -179.847 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.404 ' CG ' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -124.51 152.22 43.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 72.01 110.914 179.948 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -115.26 168.58 9.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.907 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -86.39 159.68 19.29 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.159 -0.473 . . . . 71.24 110.89 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -72.83 116.01 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 65.43 110.854 179.982 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 -47.87 11.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 75.02 110.908 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.2 p30 175.52 174.96 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.49 . . . . 74.13 110.875 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -131.74 38.21 3.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 64.35 110.91 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 11.0 mt -52.65 -26.73 10.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.098 -0.501 . . . . 50.34 111.121 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.45 118.51 30.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.924 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -110.6 167.75 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.185 -0.461 . . . . 74.04 110.871 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -77.26 96.21 4.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.445 . . . . 64.43 110.918 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 17.2 p -96.01 4.21 52.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 73.34 111.17 -179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.7 -161.25 23.53 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.77 -0.729 . . . . 64.24 112.536 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 -57.14 0.12 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.662 2.241 . . . . 62.32 112.407 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.478 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -66.25 142.61 43.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 55.11 112.526 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 96' ' ' GLY . 1.0 OUTLIER -161.85 118.83 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.862 0.363 . . . . 71.12 111.141 -179.986 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.555 HD23 ' HB2' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -103.18 121.11 41.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.457 . . . . 60.21 110.937 179.894 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 4.0 p -150.84 -161.59 1.37 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 73.33 110.825 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 mtp -112.63 99.66 8.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.122 -0.49 . . . . 73.52 110.865 179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 111' ' ' GLN . . . -83.58 73.0 10.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.237 -0.438 . . . . 55.04 111.095 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -114.65 -75.64 0.59 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 74.14 110.87 -179.903 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.626 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -141.53 -92.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 33.02 111.107 179.875 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 169.8 -61.66 0.18 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 72.41 112.484 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.559 ' O ' HG23 ' A' ' 107' ' ' THR . 54.1 Cg_endo -69.73 90.46 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.717 2.278 . . . . 74.41 112.359 -179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 37.82 42.05 0.38 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 71.22 110.902 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.626 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 22.5 p -139.17 39.63 2.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 54.14 111.123 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.73 177.34 6.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.264 -0.425 . . . . 72.12 110.935 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -178.43 -117.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.765 -0.731 . . . . 23.23 112.477 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.511 ' HB2' HD11 ' A' ' 39' ' ' LEU . 94.3 p -107.16 -165.96 1.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.836 0.351 . . . . 61.04 110.861 -179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.712 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 13.0 mt-30 73.07 63.0 0.1 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.139 -0.482 . . . . 74.22 110.935 -179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.555 ' HB2' HD23 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -61.87 -178.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 72.22 110.888 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -156.71 129.97 8.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.92 -179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.555 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 59.0 mt -84.75 109.28 17.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.129 -0.487 . . . . 45.11 111.101 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.444 ' C ' ' H ' ' A' ' 117' ' ' ALA . 84.3 m -51.61 -33.64 33.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 73.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 75.51 -33.53 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 44.13 111.171 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 115' ' ' CYS . . . -138.63 173.57 11.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 73.44 111.099 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -69.39 88.13 0.46 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.3 110.895 179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.418 HG23 ' HB3' ' A' ' 115' ' ' CYS . 31.6 p -92.17 65.09 4.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 72.33 111.135 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -5.55 45.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 74.35 110.847 -179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -73.9 -5.13 39.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.172 -0.467 . . . . 64.21 110.918 -179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.692 HD13 ' CD2' ' A' ' 126' ' ' HIS . 98.4 mt -89.35 -48.48 7.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.929 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 58.8 -85.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 73.14 110.847 179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -118.49 109.34 1.75 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.686 -0.769 . . . . 74.44 112.472 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.48 -41.61 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.79 0.329 . . . . 73.12 110.911 -179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.692 ' CD2' HD13 ' A' ' 122' ' ' LEU . 4.3 m-70 -119.97 134.04 55.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 75.51 110.828 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 69.0 t -83.55 97.21 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 73.32 111.146 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 86.6 t -75.27 131.63 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 54.33 111.126 179.928 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.62 ' CB ' HG21 ' A' ' 29' ' ' VAL . 22.8 p90 -136.33 4.51 2.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 65.02 110.877 -179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -145.82 -161.33 9.11 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.736 -0.745 . . . . 51.44 112.459 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 177.2 -169.51 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.789 0.328 . . . . 75.54 110.925 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.439 HG23 ' HA3' ' A' ' 96' ' ' GLY . 55.9 t -103.83 88.8 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 55.03 111.104 179.862 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.75 -40.78 66.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.172 -0.467 . . . . 73.01 110.888 179.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -175.08 163.96 3.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.454 . . . . 70.4 110.894 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.26 11.58 44.89 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.728 -0.748 . . . . 61.15 112.479 -179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.68 -30.76 9.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 63.32 110.861 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -51.06 -26.42 6.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 75.14 110.926 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.2 mm -78.83 -45.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 71.24 111.11 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.424 HG12 ' OE1' ' A' ' 143' ' ' GLU . 45.9 t -50.22 -44.03 22.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 71.54 111.126 179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -58.35 -29.68 66.15 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 70.34 110.904 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.43 -31.91 60.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 53.43 111.063 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.411 ' SD ' HG21 ' A' ' 10' ' ' ILE . 8.1 mtm -75.67 -35.07 60.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 75.11 110.888 179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.424 ' OE1' HG12 ' A' ' 139' ' ' VAL . 4.6 pt-20 -84.13 31.69 0.5 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 73.31 110.85 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 16.7 tpt180 -126.42 -13.26 6.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 75.11 110.906 -179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -105.35 17.65 23.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 74.22 110.868 -179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -97.61 -156.58 30.25 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.769 -0.729 . . . . 70.22 112.513 -179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -146.76 -64.65 0.29 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 71.05 110.888 -179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 176.39 -34.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.137 -0.483 . . . . 72.22 110.9 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.28 11.79 21.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 70.22 110.915 -179.939 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.27 15.51 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.689 -0.767 . . . . 54.25 112.446 179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 75.53 -58.97 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 41.4 110.9 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' H ' ' A' ' 154' ' ' LYS . 2.5 m 71.12 145.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 75.35 111.145 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.45 1.83 56.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.245 -0.434 . . . . 63.22 110.876 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.544 ' H ' HG22 ' A' ' 152' ' ' THR . 1.8 mttt -141.01 165.71 26.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.098 -0.501 . . . . 72.13 110.916 179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.0 mmpt? -106.23 115.92 31.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.258 -0.428 . . . . 64.1 110.916 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.451 ' O ' HG22 ' A' ' 156' ' ' ILE . 1.3 mp -87.96 105.87 15.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 55.33 111.126 179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -106.93 167.85 9.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 62.31 111.093 -179.997 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 83.0 mt -121.33 138.52 51.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 64.22 111.155 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -89.59 -56.4 3.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 55.02 111.118 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -158.81 166.92 30.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.242 -0.436 . . . . 73.45 110.844 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 46.4 m -145.72 -163.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 71.41 110.892 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 141.4 -150.37 21.82 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.723 -0.751 . . . . 65.33 112.496 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -106.25 134.38 49.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.841 0.353 . . . . 72.03 110.909 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.31 -57.78 11.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 64.01 110.94 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 54.5 tt0 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.453 . . . . 75.22 110.876 179.915 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 42.4 mtm . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.839 0.352 . . . . 73.15 110.916 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.98 156.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 61.33 111.103 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.6 m-20 -87.66 148.31 43.62 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.723 . . . . 74.14 110.903 179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HB2' HD12 ' A' ' 24' ' ' LEU . 54.3 Cg_endo -69.68 122.73 9.42 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.706 2.271 . . . . 75.4 112.367 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.601 HG22 HD21 ' A' ' 164' ' ' LEU . 37.5 m -114.01 135.92 53.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 61.4 111.157 -179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 26.1 m -121.33 157.66 24.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.227 -0.442 . . . . 51.43 111.103 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.708 ' HB3' HD22 ' A' ' 164' ' ' LEU . 28.1 p90 -122.55 160.34 25.86 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 74.11 110.823 -179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -137.54 136.52 37.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.501 . . . . 74.04 110.897 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -96.74 112.03 23.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 62.23 110.858 179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -85.26 126.12 40.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.177 -0.465 . . . . 53.15 111.155 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.98 165.15 14.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.42 111.09 179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.662 HG22 HD13 ' A' ' 17' ' ' LEU . 2.4 m -146.19 93.84 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.236 -0.438 . . . . 60.53 111.111 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 68.78 35.08 3.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.459 . . . . 72.21 110.882 179.911 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.2 -13.17 67.77 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.738 -0.744 . . . . 53.54 112.522 -179.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -94.76 130.28 33.64 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.652 0.739 . . . . 73.31 110.917 -179.877 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 151.61 69.09 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.69 2.26 . . . . 74.14 112.332 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.662 HD13 HG22 ' A' ' 12' ' ' VAL . 1.2 tp -118.74 -67.27 1.0 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 64.44 110.924 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.92 -141.15 3.05 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 32.03 112.492 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.1 ttm-85 -150.53 127.29 10.97 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.854 0.359 . . . . 60.22 110.908 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.85 122.3 68.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.13 111.164 179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 68.9 p -104.13 150.4 24.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 71.3 110.888 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.519 ' O ' HG23 ' A' ' 5' ' ' THR . 5.2 m-85 -118.25 178.17 4.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.13 110.939 179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.07 127.0 46.25 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 73.14 110.875 -179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 4' ' ' PRO . 96.5 mt -95.43 106.21 18.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.152 -0.476 . . . . 71.4 110.918 179.986 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CE2' HD11 ' A' ' 90' ' ' LEU . 13.7 m-85 -72.68 75.45 1.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 73.44 110.888 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.91 -34.35 62.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 64.52 111.087 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.92 -62.58 1.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 51.11 110.868 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -63.5 -65.38 0.69 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 74.44 110.872 -179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 1.5 m -114.44 93.07 30.51 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.588 0.709 . . . . 72.0 111.146 179.874 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 -25.27 29.07 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.709 2.273 . . . . 44.12 112.364 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 5.9 mtmm -78.74 -57.9 3.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.912 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 47.0 m -61.4 -26.08 67.62 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.222 -0.444 . . . . 61.44 111.177 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.58 -56.29 6.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 72.54 111.094 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 35' ' ' ASN . 21.7 tt0 -62.66 -56.98 12.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 71.11 110.827 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.1 t-20 -28.07 -56.09 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 72.4 110.879 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.37 -40.57 62.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 61.34 110.929 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -48.3 -32.75 7.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.497 . . . . 75.01 110.903 -179.934 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.638 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -71.7 -43.25 66.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 53.21 111.094 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.58 -27.52 69.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 73.21 110.938 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 33.2 m -76.3 -44.56 36.4 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.174 -0.466 . . . . 71.51 110.894 -179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 59.1 p -79.52 -0.55 33.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.501 . . . . 74.23 111.162 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 43.87 78.44 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.787 -0.72 . . . . 54.31 112.451 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' OE2' ' HB1' ' A' ' 38' ' ' ALA . 10.3 pt-20 -99.21 0.86 44.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 73.15 110.9 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.6 mttm -127.51 -0.4 6.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 75.3 110.96 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 41.32 29.32 0.38 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.702 -0.761 . . . . 63.05 112.52 179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -117.03 -33.15 4.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.84 0.352 . . . . 73.44 110.859 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.8 -152.88 0.15 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 74.11 112.44 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -92.88 149.68 21.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.902 0.382 . . . . 63.55 110.929 -179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.9 119.55 0.12 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.483 . . . . 74.2 110.93 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.87 22.18 76.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.779 -0.724 . . . . 73.43 112.479 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 p -94.17 -166.87 1.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.899 0.38 . . . . 74.45 110.881 -179.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 22.3 m -99.2 -168.13 1.58 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 75.24 110.903 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -107.58 126.14 52.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 64.22 110.856 -179.857 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -51.2 -62.48 1.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 74.23 110.863 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.415 ' HG2' ' HA2' ' A' ' 150' ' ' GLY . 26.3 ttm180 -149.57 167.28 26.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 65.32 110.859 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.574 HD11 HD13 ' A' ' 156' ' ' ILE . 58.7 mt -141.86 127.09 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 60.24 111.125 179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.604 HD12 ' CE ' ' A' ' 61' ' ' MET . 46.6 mt -140.48 90.92 9.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.653 0.74 . . . . 73.44 111.115 179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 108.65 2.12 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.658 2.238 . . . . 74.55 112.398 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 139.62 -45.16 1.03 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.686 -0.769 . . . . 55.25 112.424 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -97.56 -71.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.844 0.354 . . . . 74.3 110.876 -179.844 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.604 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -146.81 -174.74 4.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 74.3 110.871 179.95 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.97 117.87 7.18 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.445 . . . . 54.2 110.891 -179.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -136.58 166.39 23.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.2 110.92 -179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -174.76 29.98 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.79 -0.719 . . . . 42.44 112.51 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.89 137.1 8.6 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 74.12 112.477 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 170.35 132.3 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 75.15 110.913 -179.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -60.17 163.73 4.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 75.54 110.861 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.77 -39.89 0.41 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.143 -0.48 . . . . 74.34 111.109 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -101.8 -25.11 13.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.878 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -66.24 -9.88 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.15 110.854 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 67.73 92.71 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.447 . . . . 72.43 110.852 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.4 170.49 36.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 61.34 112.483 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 74.0 p -141.63 95.41 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.859 0.361 . . . . 75.43 111.144 -179.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 132.19 -25.63 3.84 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.764 -0.731 . . . . 72.11 112.487 179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 118.14 -151.07 18.04 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 74.13 112.5 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -167.47 -167.51 0.9 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.773 0.32 . . . . 73.31 110.902 -179.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.98 130.19 54.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 74.33 110.832 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.638 HG21 ' HB3' ' A' ' 38' ' ' ALA . 2.3 pp -48.03 -34.37 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 71.21 111.122 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -118.58 19.87 13.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.901 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.79 -140.99 3.62 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.758 -0.734 . . . . 71.44 112.479 179.976 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -122.99 -25.69 4.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.904 0.383 . . . . 75.3 110.903 -179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 0.0 OUTLIER -168.69 160.23 10.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 63.43 110.918 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -132.95 162.97 30.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 65.02 110.896 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -80.34 156.97 26.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.465 . . . . 72.13 110.886 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 65.3 t0 -82.97 105.09 13.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.175 -0.466 . . . . 72.54 110.883 179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -61.72 -41.57 97.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.461 . . . . 75.42 110.887 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 175.07 171.99 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 74.11 110.884 -179.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -130.4 32.62 4.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.186 -0.461 . . . . 65.41 110.905 -179.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.29 -19.72 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 75.13 111.164 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.688 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.5 OUTLIER -90.9 128.31 36.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 74.43 110.921 179.899 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -121.29 179.39 4.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 73.12 110.894 179.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.36 -78.15 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.444 . . . . 72.34 110.821 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.2 p 61.96 11.37 4.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.186 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.86 166.63 34.17 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 74.22 112.544 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 163.09 39.57 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.698 2.265 . . . . 73.41 112.34 -179.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.98 9.87 79.79 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.71 -0.757 . . . . 73.41 112.529 180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 8.7 mm -97.57 150.08 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.881 0.372 . . . . 74.1 111.168 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.655 HD23 ' N ' ' A' ' 99' ' ' SER . 1.7 tt -107.53 142.92 36.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 75.12 110.971 179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.655 ' N ' HD23 ' A' ' 98' ' ' LEU . 0.4 OUTLIER -128.78 132.23 47.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.869 -179.873 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.8 mmt -64.25 -45.73 86.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 70.03 110.901 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . 46.62 72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 74.34 111.127 179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 13.0 p-10 -104.0 -163.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.891 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.432 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -51.41 -32.4 26.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.095 179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.575 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 132.76 -54.46 0.78 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.756 -0.735 . . . . 72.13 112.499 -179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.575 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.6 Cg_endo -69.8 -100.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 64.32 112.291 -179.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -136.2 91.46 2.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 74.34 110.924 -179.957 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 109' ' ' GLY . 1.7 p -150.22 28.89 0.73 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.162 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' A' ' 102' ' ' ASN . 0.4 OUTLIER 54.89 -87.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 71.35 110.864 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 135.92 -90.75 0.22 Allowed Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.71 -0.757 . . . . 73.32 112.45 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.412 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 1.7 t 76.54 33.98 0.49 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.373 . . . . 73.42 110.86 -179.686 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.446 ' O ' ' CB ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -90.0 -34.46 15.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 70.51 110.921 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.611 ' CZ ' HD11 ' A' ' 114' ' ' ILE . 3.9 t80 79.92 65.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.452 . . . . 63.45 110.86 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.414 ' HB3' ' CB ' ' A' ' 99' ' ' SER . 27.5 t80 -96.74 95.11 7.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 63.3 110.843 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.611 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 19.4 mt -90.63 136.81 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 50.1 111.14 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.5 m -103.05 133.57 47.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.897 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.803 HG21 ' OE2' ' A' ' 143' ' ' GLU . 47.8 p -111.75 17.12 20.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 73.24 111.158 -179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.14 175.51 13.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 64.3 111.088 179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.8 78.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 51.52 110.902 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.614 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 16.6 p -117.34 67.62 0.74 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 42.43 111.134 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.26 25.2 4.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.245 -0.434 . . . . 72.55 110.915 179.977 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.614 ' CZ2' HG22 ' A' ' 119' ' ' THR . 2.2 p90 -93.58 17.87 10.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.164 -0.471 . . . . 75.02 110.885 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HG ' ' HD1' ' A' ' 121' ' ' TRP . 0.2 OUTLIER -132.61 14.35 4.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 72.3 110.947 179.978 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -51.92 -63.83 1.01 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 71.13 110.838 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -75.97 57.53 3.12 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.73 -0.748 . . . . 75.54 112.543 -179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -163.97 -52.83 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 64.3 110.915 -179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -104.83 133.41 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.44 . . . . 74.4 110.839 179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 66.2 t -80.32 101.02 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 53.21 111.126 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.02 138.68 20.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 62.43 111.138 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -161.82 25.34 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.44 110.889 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 131' ' ' LYS . . . -118.65 -165.83 13.39 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.778 -0.725 . . . . 71.32 112.488 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 130' ' ' GLY . 1.6 tttp 162.22 120.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.826 0.346 . . . . 71.11 110.871 -180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.674 HG11 ' HG2' ' A' ' 136' ' ' MET . 55.5 t -65.13 88.38 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 65.34 111.105 179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -71.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.466 . . . . 75.52 110.945 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.54 159.13 44.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.222 -0.445 . . . . 63.15 110.847 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 104.63 5.22 42.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.746 -0.74 . . . . 62.1 112.492 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.674 ' HG2' HG11 ' A' ' 132' ' ' VAL . 0.0 OUTLIER -50.71 -30.41 13.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.789 0.328 . . . . 65.1 110.885 -179.969 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.9 m120 -53.62 -25.8 19.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 61.51 110.881 -179.929 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 23.9 mm -90.23 -39.13 11.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 64.33 111.135 179.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 95.2 t -54.13 -23.12 9.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 73.4 111.17 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.05 -27.81 30.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 73.04 110.906 -179.982 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -71.25 -39.91 71.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 53.23 111.119 179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.6 ptm -76.8 -15.61 59.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 50.22 110.919 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.803 ' OE2' HG21 ' A' ' 116' ' ' THR . 5.2 mm-40 -88.99 27.47 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 70.31 110.856 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -142.11 0.81 1.39 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 74.04 110.902 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -121.08 6.86 10.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 75.33 110.913 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -117.28 45.24 1.3 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 63.34 112.476 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' GLY . 7.3 t 36.16 -147.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 64.02 110.834 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 30.9 mmm-85 -139.59 7.92 2.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 65.31 110.905 -179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.99 -16.96 5.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 74.32 110.851 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.415 ' HA2' ' HG2' ' A' ' 55' ' ' ARG . . . 144.54 -57.5 0.53 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.731 -0.747 . . . . 74.13 112.46 -179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.89 133.88 17.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 54.21 110.904 -179.96 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 146' ' ' GLY . 70.6 p -113.19 138.68 49.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 63.33 111.18 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.66 -24.16 65.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 73.22 110.836 -179.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -165.62 1.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 71.43 110.916 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -126.65 125.03 41.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.217 -0.447 . . . . 70.25 110.901 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.574 HD13 HD11 ' A' ' 56' ' ' ILE . 3.5 mp -99.4 105.94 18.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.33 111.129 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.07 171.86 7.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 63.34 111.157 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 96.7 mt -118.93 147.16 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.265 -0.425 . . . . 75.41 111.129 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -100.69 -59.05 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 65.0 111.109 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -156.81 167.41 30.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 62.42 110.889 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 38.1 m -145.61 -166.11 2.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 72.41 110.855 -179.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 121.06 -177.73 16.38 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.711 -0.757 . . . . 62.31 112.546 -179.86 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.1 pt20 -94.52 136.36 34.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.825 0.345 . . . . 64.31 110.911 -179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.708 HD22 ' HB3' ' A' ' 7' ' ' PHE . 1.5 pt? -112.49 -34.81 5.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 61.35 110.917 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.426 ' N ' ' HG ' ' A' ' 164' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.185 -0.461 . . . . 73.24 110.87 179.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 ptt? . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.856 0.36 . . . . 73.55 110.865 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 88.6 t -139.77 142.24 32.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 51.32 111.159 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -55.16 159.83 3.79 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.594 0.711 . . . . 73.42 110.893 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 149.09 66.42 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.653 2.236 . . . . 74.12 112.35 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.71 49.84 2.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.435 . . . . 74.51 111.107 -179.979 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 6' ' ' VAL . 5.1 m -42.31 140.49 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.469 . . . . 75.34 111.166 179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.43 ' CE1' ' HA ' ' A' ' 161' ' ' CYS . 0.1 OUTLIER -124.85 165.28 18.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 65.22 110.892 -179.969 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -142.5 137.73 30.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.133 -0.485 . . . . 72.44 110.905 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -101.56 86.22 2.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.836 179.992 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.7 mm -57.71 145.06 9.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 74.41 111.147 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -140.04 155.87 46.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 41.52 111.09 179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 86.4 t -134.99 109.51 11.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.21 -0.45 . . . . 54.1 111.086 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 t0 57.98 52.41 7.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.471 . . . . 75.52 110.923 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.53 12.63 56.77 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.778 -0.725 . . . . 75.01 112.505 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -125.51 107.82 26.56 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.637 0.732 . . . . 65.11 110.899 -179.869 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.5 Cg_endo -69.75 143.41 50.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.68 2.253 . . . . 62.24 112.348 179.993 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -123.26 21.44 9.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 64.24 110.897 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 109.37 166.39 20.28 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.807 -0.711 . . . . 40.44 112.519 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.58 -175.32 2.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 64.24 110.852 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.69 HG13 HG21 ' A' ' 138' ' ' ILE . 32.8 m -138.8 175.52 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.209 -0.45 . . . . 75.34 111.148 179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.8 t -117.39 84.41 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.847 -179.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.4 m-85 -81.85 88.32 6.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.495 . . . . 74.12 110.846 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -79.83 137.13 36.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 72.41 110.883 -179.949 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.617 HD11 ' HD2' ' A' ' 36' ' ' PHE . 46.2 mt -111.82 144.99 40.21 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.442 ' O ' HG22 ' A' ' 29' ' ' VAL . 14.9 m-85 -91.59 67.24 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 75.24 110.872 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.66 -10.57 8.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 73.14 111.106 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -92.23 -35.08 14.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.204 -0.453 . . . . 42.52 110.864 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -86.92 -30.34 21.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.463 . . . . 73.23 110.917 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.594 HG21 ' CG ' ' A' ' 129' ' ' PHE . 4.5 m -128.52 69.0 78.75 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.605 0.717 . . . . 73.11 111.14 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.68 60.08 1.62 Allowed 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.696 2.264 . . . . 73.44 112.385 179.908 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.81 -63.19 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.222 -0.444 . . . . 71.33 110.896 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.93 -55.72 23.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.229 -0.441 . . . . 62.5 111.086 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB2' ' CE2' ' A' ' 129' ' ' PHE . . . -79.63 -12.99 59.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 53.22 111.051 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -66.29 -35.74 81.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 62.31 110.875 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -89.26 -31.48 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 74.45 110.883 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' HD2' HD11 ' A' ' 24' ' ' LEU . 1.1 t80 -50.9 -27.28 7.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 74.51 110.876 -179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -62.26 -30.91 71.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.092 -0.503 . . . . 73.55 110.901 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.59 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -80.21 -24.81 39.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.137 -0.483 . . . . 74.53 111.125 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -99.58 26.61 5.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 72.45 110.887 -179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.93 -21.92 0.26 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 64.41 110.846 -179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 95.1 m -89.79 -30.64 17.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 35.24 111.135 -179.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 135.32 -20.42 3.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 73.14 112.475 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' C ' ' O ' ' A' ' 42' ' ' GLY . 0.1 OUTLIER -32.6 -74.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.926 0.393 . . . . 72.24 110.876 -179.884 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.0 153.82 21.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 73.44 110.86 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -132.16 -33.01 0.43 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 62.33 112.466 179.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.4 p90 -55.05 -28.56 53.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.894 0.378 . . . . 74.24 110.897 -179.861 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -60.24 -77.48 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.699 -0.763 . . . . 63.41 112.506 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 177.87 124.52 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.909 0.385 . . . . 74.41 110.915 -179.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 9.7 tppt? -93.71 -77.45 0.45 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.121 -0.491 . . . . 71.32 110.89 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -78.6 -54.1 4.4 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.769 -0.729 . . . . 43.12 112.441 179.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 51.7 -164.73 0.06 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.873 0.368 . . . . 72.13 110.841 -179.733 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.695 ' HB3' HG22 ' A' ' 157' ' ' THR . 9.8 p -157.0 134.45 10.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 65.33 110.946 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.5 ' CE1' HD11 ' A' ' 158' ' ' ILE . 12.7 m-85 -94.77 123.76 38.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 72.02 110.901 -179.853 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -141.94 32.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 65.53 110.84 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -133.02 27.17 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 72.43 110.862 -179.879 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.8 138.85 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 65.31 111.102 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.92 111.13 17.16 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.613 0.721 . . . . 72.24 111.16 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 90.33 0.52 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.682 2.255 . . . . 72.53 112.366 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 118.28 4.86 13.55 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.732 -0.747 . . . . 52.11 112.455 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.72 -66.02 0.81 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.876 0.369 . . . . 72.13 110.868 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -175.15 -166.29 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 63.11 110.867 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 8.1 t -152.89 108.51 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 71.1 110.886 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -97.42 163.6 12.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 54.13 110.919 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -142.31 144.95 14.79 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.721 -0.752 . . . . 60.54 112.491 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.6 84.96 0.38 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 60.01 112.487 -179.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -144.34 46.13 1.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.845 0.355 . . . . 61.24 110.86 -179.981 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -175.59 -53.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.213 -0.449 . . . . 65.14 110.887 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.636 HG21 ' HG2' ' A' ' 111' ' ' GLN . 5.2 p -93.99 39.25 1.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 65.4 111.138 -179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 70.0 -68.33 0.2 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 64.35 110.908 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -179.43 -34.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 64.5 110.847 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.1 m-80 -88.0 -65.51 1.01 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 64.53 110.878 -179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.413 ' HA2' ' HB ' ' A' ' 68' ' ' THR . . . 121.89 48.35 0.27 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.769 -0.729 . . . . 31.22 112.526 -179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.3 t -119.55 -23.03 6.72 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.837 0.351 . . . . 72.3 111.115 -179.831 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -119.08 -21.12 3.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.793 -0.717 . . . . 45.13 112.511 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.446 ' HA3' HG22 ' A' ' 68' ' ' THR . . . -46.88 164.71 0.12 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 42.32 112.452 -179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.89 -171.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.795 0.331 . . . . 61.15 110.896 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.2 m -79.52 -171.81 2.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 52.25 110.881 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.59 HD13 ' HB3' ' A' ' 38' ' ' ALA . 16.8 pt -92.85 -40.42 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.124 -0.489 . . . . 75.34 111.116 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -86.76 85.12 7.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.484 . . . . 70.12 110.887 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.36 -107.77 3.13 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.755 -0.736 . . . . 63.34 112.44 179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.01 -91.76 0.52 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.943 0.401 . . . . 74.1 110.869 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.67 150.58 50.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.49 . . . . 63.15 110.855 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -123.81 154.41 39.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.1 110.853 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 106' ' ' ASN . 20.7 pm0 -62.87 160.5 14.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.481 . . . . 64.23 110.853 -179.937 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.7 -169.47 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 51.41 110.907 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -132.96 -59.2 0.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 75.1 110.877 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -171.2 149.86 2.89 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 71.43 110.851 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.3 64.41 0.71 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 73.54 110.902 -179.998 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.468 ' O ' HG22 ' A' ' 89' ' ' ILE . 10.1 mt -78.16 2.31 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 72.53 111.147 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.6 mt -113.74 132.65 55.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.489 . . . . 74.22 110.942 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -110.06 123.34 49.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 64.21 110.88 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -61.19 91.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 75.04 110.877 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 19.9 p -129.58 21.9 5.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 61.21 111.183 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -112.26 167.48 12.4 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.75 -0.738 . . . . 71.13 112.445 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.76 -44.94 1.78 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.706 2.271 . . . . 54.22 112.308 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -128.79 40.53 1.69 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.735 -0.745 . . . . 74.03 112.472 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 4.5 mm -65.26 141.7 17.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 75.44 111.162 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 99' ' ' SER . 4.2 tt -89.57 130.46 35.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 75.02 110.872 179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.5 ' N ' HD23 ' A' ' 98' ' ' LEU . 1.7 t -128.41 -147.23 0.34 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 73.42 110.845 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 1.5 tpt -152.43 143.14 22.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 72.02 110.868 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.48 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -117.73 149.16 41.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.431 . . . . 54.12 111.121 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 0.4 OUTLIER 161.75 -169.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 75.43 110.881 -179.902 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.622 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -55.63 -36.87 67.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 55.25 111.106 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.7 -65.15 0.33 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 44.05 112.521 -179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.81 106.86 1.74 Allowed 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.717 2.278 . . . . 71.42 112.321 -179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.403 ' CB ' ' HA ' ' A' ' 84' ' ' GLU . 6.0 p30 42.76 56.87 3.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 73.43 110.908 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.99 33.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 74.31 111.156 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.8 p30 -74.29 -0.71 17.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 73.13 110.918 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -59.9 119.63 19.19 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.756 -0.735 . . . . 24.24 112.484 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 111' ' ' GLN . 8.9 t 54.86 -166.43 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 71.52 110.852 -179.761 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.636 ' HG2' HG21 ' A' ' 68' ' ' THR . 3.9 mm-40 64.04 118.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 75.54 110.905 -179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -153.4 156.87 39.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 74.2 110.855 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.0 p90 -151.76 154.6 36.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.111 -0.495 . . . . 74.43 110.882 -179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 28.4 mt -117.17 105.5 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.131 -0.486 . . . . 75.35 111.153 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.24 146.38 53.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 72.43 110.86 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.3 p -96.14 19.99 10.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 71.35 111.111 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.24 177.06 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 75.54 111.138 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.8 131.63 51.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.26 -0.427 . . . . 62.02 110.902 179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.16 41.05 3.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.227 -0.442 . . . . 71.13 111.145 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.5 tm-20 -49.02 -25.43 2.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 64.2 110.916 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -58.21 -32.62 68.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.164 -0.471 . . . . 64.41 110.952 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.1 mt -118.5 61.65 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.231 -0.441 . . . . 61.41 110.913 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 45.7 p-10 -126.63 56.98 1.45 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 75.15 110.844 179.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 166.64 60.92 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.742 -0.742 . . . . 53.31 112.506 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 -34.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 63.31 110.901 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.7 m-70 -105.09 -16.35 14.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 74.55 110.843 179.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 5.3 t 71.84 94.77 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 72.53 111.116 179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 14.6 p -79.22 153.55 4.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.133 -0.485 . . . . 73.1 111.097 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 29' ' ' VAL . 44.1 p90 -176.91 129.29 0.17 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 72.34 110.836 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.39 149.21 12.13 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.781 -0.723 . . . . 63.25 112.513 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 18.2 pttm -162.6 162.96 27.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 73.13 110.894 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 132' ' ' VAL . 15.0 m -83.76 107.69 15.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.459 . . . . 72.11 111.153 179.849 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.52 -41.03 85.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 44.34 110.871 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.76 178.9 7.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 64.22 110.896 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.67 74.58 0.32 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 74.41 112.5 -179.983 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.8 tpt -84.35 -18.39 36.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.809 0.338 . . . . 43.15 110.87 -179.952 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.94 -36.83 24.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 63.33 110.913 -179.984 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.69 HG21 HG13 ' A' ' 20' ' ' VAL . 37.9 mm -40.39 -45.37 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 72.52 111.109 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.9 t -89.09 -50.66 13.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 70.3 111.124 179.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -49.33 -63.3 1.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 70.5 110.88 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -56.83 -51.86 67.34 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 32.22 111.106 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.593 ' SD ' HD13 ' A' ' 156' ' ' ILE . 4.5 ttm -50.84 -45.71 59.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 63.22 110.874 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -52.07 -23.74 5.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.227 -0.442 . . . . 72.23 110.898 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 22.3 ttm180 -63.77 -26.29 68.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.852 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.28 8.28 11.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 75.55 110.945 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -98.25 -146.25 20.27 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.731 -0.747 . . . . 63.12 112.451 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -172.01 161.36 5.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.868 0.366 . . . . 62.23 110.835 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -50.76 -56.66 11.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 70.3 110.871 -179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -6.74 59.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 73.51 110.863 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.46 -150.37 16.81 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.741 -0.743 . . . . 54.14 112.476 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.0 mttp 61.43 104.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 74.31 110.871 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 75.1 p -82.18 155.84 24.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.254 -0.43 . . . . 62.45 111.155 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.49 -2.99 58.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 64.44 110.842 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -138.83 -175.43 4.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.155 -0.475 . . . . 74.25 110.905 179.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -111.68 104.93 13.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 75.44 110.904 179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.593 HD13 ' SD ' ' A' ' 142' ' ' MET . 8.3 mt -95.34 127.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 63.31 111.122 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.695 HG22 ' HB3' ' A' ' 52' ' ' CYS . 29.1 p -139.72 159.16 42.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 73.41 111.119 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.5 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -84.86 105.22 13.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 74.22 111.112 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -61.59 -56.57 18.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 75.2 111.104 179.75 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -148.0 177.16 9.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 54.32 110.831 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.43 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 17.0 p -176.88 155.74 1.27 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 64.42 110.891 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 179.95 -169.48 40.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.73 -0.747 . . . . 72.4 112.5 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.27 126.26 35.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.828 0.347 . . . . 72.41 110.891 -179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -112.81 138.26 49.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.469 . . . . 74.34 110.897 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 30.7 tp10 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.853 179.935 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 tpp . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.814 0.34 . . . . 64.3 110.878 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.61 157.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 62.34 111.119 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -95.82 151.76 38.61 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.628 0.728 . . . . 75.4 110.895 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 134.69 28.55 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.65 2.233 . . . . 71.42 112.355 179.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 22' ' ' PHE . 6.9 m -122.16 140.44 52.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 74.44 111.119 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 ' HA ' HD23 ' A' ' 164' ' ' LEU . 3.2 m -125.19 159.46 32.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 73.01 111.104 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.3 OUTLIER -133.44 155.08 50.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.873 -179.928 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.42 ' CD2' HG21 ' A' ' 158' ' ' ILE . 13.7 m-85 -135.2 134.36 40.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 75.55 110.866 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.691 ' HB2' ' HB3' ' A' ' 159' ' ' ALA . 3.5 m-20 -90.66 108.91 20.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.828 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 12.3 mm -77.05 119.5 25.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 45.33 111.133 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -111.93 167.58 10.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.471 . . . . 61.45 111.099 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.61 ' CG2' HD13 ' A' ' 17' ' ' LEU . 2.2 m -150.68 91.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 74.34 111.121 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 73.1 32.79 1.26 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 72.23 110.816 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.19 -12.24 69.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.768 -0.729 . . . . 42.43 112.478 -179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -100.81 130.35 25.48 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.667 0.746 . . . . 62.2 110.891 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 152.95 69.43 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.683 2.255 . . . . 72.21 112.336 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.61 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.7 tp -114.52 -65.42 1.19 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.929 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.74 -178.01 36.22 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.742 -0.742 . . . . 33.04 112.464 179.892 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -114.7 125.98 54.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 72.25 110.832 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.1 t -131.52 143.97 38.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 74.43 111.12 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 23.3 p -129.99 155.26 46.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.888 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.598 ' O ' HG23 ' A' ' 5' ' ' THR . 0.4 OUTLIER -125.7 165.57 18.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.913 -179.945 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -120.97 124.69 45.5 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 74.34 110.888 -179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 129' ' ' PHE . 8.6 mt -93.42 126.82 38.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.145 -0.48 . . . . 71.52 110.936 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -83.07 82.31 8.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.917 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.74 -4.59 55.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 60.32 111.087 179.963 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -89.23 -34.11 16.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.2 -0.454 . . . . 54.5 110.858 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.411 ' HB3' HD12 ' A' ' 89' ' ' ILE . 11.4 mttm -91.44 -28.48 17.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.917 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.55 79.31 11.45 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.625 0.726 . . . . 65.4 111.144 179.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 -4.14 13.43 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.698 2.266 . . . . 70.22 112.294 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.95 -45.72 9.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.432 . . . . 72.25 110.874 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.2 -52.4 7.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 65.35 111.161 179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -41.11 -77.22 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 75.31 111.113 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' C ' ' A' ' 35' ' ' ASN . 29.7 tt0 -48.34 -66.24 0.43 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.187 -0.46 . . . . 75.41 110.876 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 34' ' ' GLU . 19.8 t30 -28.23 -45.58 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.154 -0.476 . . . . 65.54 110.916 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' GLU . 85.3 t80 -85.53 -42.0 14.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 70.11 110.87 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -54.52 -31.24 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 71.42 110.877 -179.892 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.641 ' HB1' ' HE2' ' A' ' 44' ' ' LYS . . . -76.01 -43.57 43.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 74.23 111.11 179.917 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.565 HD13 ' O ' ' A' ' 39' ' ' LEU . 3.2 tm? -67.11 -39.2 86.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.253 -0.43 . . . . 73.24 110.905 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.05 -35.26 76.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 71.22 110.857 -179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.04 -12.74 61.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 73.42 111.165 -179.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.34 4.13 63.52 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.788 -0.72 . . . . 62.21 112.446 179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.96 -1.65 36.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 61.54 110.933 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HE2' ' HB1' ' A' ' 38' ' ' ALA . 2.1 mmtm -93.39 37.57 1.05 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.481 . . . . 65.31 110.916 179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 80.09 -45.46 3.0 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.749 -0.739 . . . . 40.33 112.502 179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -155.89 -166.38 2.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.897 0.379 . . . . 74.45 110.854 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 147.21 -107.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 65.15 112.511 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -162.84 123.49 2.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.414 . . . . 53.5 110.919 -179.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -106.9 -26.74 11.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 73.41 110.909 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -129.94 -62.02 0.1 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.745 -0.741 . . . . 74.51 112.489 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.65 -169.49 0.14 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.898 0.38 . . . . 74.34 110.869 -179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.2 p -166.11 111.21 0.83 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 41.4 110.876 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -73.4 123.98 24.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 74.53 110.892 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -120.32 17.99 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 75.12 110.867 179.986 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 11.8 tpp180 -136.84 119.09 15.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 75.13 110.855 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.647 HD11 HD13 ' A' ' 156' ' ' ILE . 88.0 mt -143.53 137.28 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 75.33 111.075 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.4 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 90.3 mt -146.8 95.38 4.52 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.666 0.746 . . . . 73.35 111.111 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.7 Cg_endo -69.72 96.34 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.718 2.279 . . . . 72.23 112.347 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 147.69 -35.17 1.22 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.756 -0.735 . . . . 74.25 112.47 179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.32 -64.88 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.865 0.364 . . . . 71.43 110.849 -179.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.451 ' HE1' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -158.39 -169.5 2.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.491 . . . . 70.04 110.895 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 85.2 m -123.32 -75.7 0.6 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.302 -0.408 . . . . 65.33 110.858 -179.894 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.451 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 64.1 tt0 63.32 154.33 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 63.41 110.926 -179.858 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.68 117.83 3.53 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.748 -0.739 . . . . 62.31 112.479 179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.38 -131.08 4.36 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.734 -0.745 . . . . 62.23 112.478 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -126.69 156.2 41.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.861 0.362 . . . . 75.24 110.851 -179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' THR . 0.3 OUTLIER -69.14 -175.98 0.84 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.51 110.869 -179.929 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.495 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 179.82 -55.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.093 -0.503 . . . . 52.21 111.144 -179.914 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.34 15.3 9.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 74.0 110.893 -179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -71.89 -80.63 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 74.03 110.851 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -151.02 23.05 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 74.23 110.932 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.43 104.8 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.741 . . . . 53.03 112.462 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 20.2 p -114.52 112.4 22.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.823 0.344 . . . . 72.13 111.128 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -101.01 -141.96 12.46 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.759 -0.734 . . . . 54.54 112.508 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . -103.4 -112.34 3.67 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 72.53 112.478 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 0.8 OUTLIER 179.96 168.12 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.847 0.356 . . . . 74.32 110.842 179.972 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 13.1 t -81.69 160.78 23.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 43.35 110.874 -179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.534 HD13 ' CD ' ' A' ' 44' ' ' LYS . 2.0 pp -88.35 -32.04 5.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 72.44 111.126 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.476 ' CE2' HD11 ' A' ' 78' ' ' ILE . 30.4 m-85 -85.01 -6.29 59.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.481 . . . . 75.24 110.9 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 177.02 -121.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.738 -0.744 . . . . 63.11 112.512 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -112.34 -83.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.951 0.405 . . . . 74.2 110.927 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.92 168.05 20.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 72.33 110.887 179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -145.0 165.52 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 61.12 110.898 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.0 pm0 -62.45 163.32 8.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 62.32 110.846 -179.899 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.667 ' OD1' HG21 ' A' ' 127' ' ' VAL . 25.6 t0 -80.33 161.41 25.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 62.21 110.886 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -104.97 -50.65 3.21 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.45 . . . . 70.21 110.89 -179.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.0 p30 178.74 157.38 0.49 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.55 110.898 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.73 66.73 0.75 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 74.31 110.859 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.644 ' C ' HD22 ' A' ' 90' ' ' LEU . 14.0 mt -83.91 7.78 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 72.22 111.156 179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.644 HD22 ' C ' ' A' ' 89' ' ' ILE . 4.1 mm? -127.29 127.53 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 64.31 110.936 179.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -117.28 133.28 56.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.244 -0.435 . . . . 65.34 110.904 179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.464 ' HA ' HG21 ' A' ' 97' ' ' ILE . 3.0 m-70 -59.05 91.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 72.0 110.874 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 38.2 p -118.95 19.4 13.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.192 -0.458 . . . . 74.3 111.197 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -157.76 155.96 26.89 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 71.43 112.525 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -2.93 10.99 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.708 2.272 . . . . 71.43 112.331 -179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -118.41 29.01 6.58 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.42 112.501 -179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.464 HG21 ' HA ' ' A' ' 92' ' ' HIS . 20.8 mm -90.66 127.04 43.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.356 . . . . 70.42 111.165 -179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' O ' HG23 ' A' ' 128' ' ' VAL . 2.1 tt -90.3 124.13 34.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 71.42 110.874 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 112' ' ' PHE . 42.9 t -115.5 160.73 19.56 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 71.23 110.854 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -106.76 115.24 29.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.131 -0.486 . . . . 75.33 110.874 179.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -94.97 150.53 20.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.275 -0.421 . . . . 62.13 111.11 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.72 -163.28 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 61.21 110.884 -179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.661 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -62.06 -12.68 20.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 41.33 111.083 179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.414 ' HA3' ' HD2' ' A' ' 105' ' ' PRO . . . 121.69 -135.02 10.25 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.691 -0.766 . . . . 72.24 112.47 -179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' O ' HG23 ' A' ' 107' ' ' THR . 54.2 Cg_endo -69.71 147.52 63.35 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.735 2.29 . . . . 73.15 112.337 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.1 t30 63.93 23.07 13.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 75.34 110.903 -179.978 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.661 HG21 ' HB3' ' A' ' 103' ' ' ALA . 7.7 p -141.23 33.85 1.7 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 55.22 111.2 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.653 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.8 OUTLIER 11.49 -87.72 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 71.05 110.913 -179.961 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 107.16 140.15 9.52 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 73.31 112.486 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p -97.86 -33.33 11.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.8 0.334 . . . . 75.13 110.816 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -63.43 152.46 38.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 52.31 110.94 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 99' ' ' SER . 17.1 p90 -145.08 146.55 31.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 71.54 110.891 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 27.5 p90 -127.84 114.86 17.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 63.24 110.889 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 24.6 mt -67.02 101.91 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 52.13 111.149 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 54.7 m -57.85 126.98 29.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.203 -0.453 . . . . 72.51 110.901 179.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.2 p -88.19 -31.25 19.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.445 . . . . 64.22 111.105 -179.826 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' O ' HG23 ' A' ' 119' ' ' THR . . . -120.9 155.02 35.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 74.24 111.111 179.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -57.01 94.53 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.4 110.888 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.8 p -117.6 69.52 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 54.14 111.134 179.968 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.52 21.26 1.84 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.153 -0.476 . . . . 73.13 110.867 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.682 ' CZ2' HG22 ' A' ' 119' ' ' THR . 5.3 p90 -101.14 15.19 29.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.165 -0.47 . . . . 73.35 110.941 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.44 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 13.3 mt -129.73 17.05 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 63.34 110.937 179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -63.15 -65.15 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.451 . . . . 74.54 110.862 179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -46.75 -28.78 3.89 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.738 . . . . 54.5 112.505 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.76 -74.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.794 0.33 . . . . 75.51 110.925 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -86.67 141.25 29.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 71.55 110.851 179.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.667 HG21 ' OD1' ' A' ' 85' ' ' ASP . 94.9 t -103.58 129.73 55.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 43.31 111.133 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.585 HG13 ' HB2' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -104.31 137.67 32.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.172 -0.467 . . . . 72.34 111.147 179.918 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 24' ' ' LEU . 31.2 p90 -129.07 -32.87 2.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 72.13 110.902 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -109.92 161.05 13.11 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.739 -0.743 . . . . 75.12 112.495 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -155.57 148.68 24.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.832 0.349 . . . . 73.31 110.919 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 73.3 t -49.45 126.49 4.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 72.54 111.153 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -96.19 -68.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.178 -0.464 . . . . 74.44 110.874 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.58 143.71 37.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 61.33 110.844 179.99 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 111.72 9.21 21.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 63.12 112.514 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.0 ttm -49.62 -28.03 5.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 62.3 110.884 179.964 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -50.63 -27.25 6.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 71.33 110.89 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.1 mm -87.85 -35.72 8.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 73.54 111.113 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.78 -23.41 11.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.219 -0.446 . . . . 74.32 111.144 179.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -83.01 -25.14 32.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 74.12 110.906 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.9 -38.29 57.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 62.01 111.12 179.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.8 ptm -76.97 -30.37 55.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 65.41 110.907 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -89.85 33.75 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.223 -0.444 . . . . 74.54 110.856 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 17.2 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 75.25 110.865 -179.935 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -97.73 33.3 2.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 72.4 110.87 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.601 ' O ' ' C ' ' A' ' 147' ' ' SER . . . 64.88 -92.86 0.14 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.77 -0.729 . . . . 75.04 112.483 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.601 ' C ' ' O ' ' A' ' 146' ' ' GLY . 88.7 p 17.86 78.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.871 0.367 . . . . 74.01 110.874 -179.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 22.1 mmm-85 -91.51 -24.62 19.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 75.52 110.888 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -105.01 -7.53 19.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 71.34 110.931 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 122.95 -39.81 2.16 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.705 -0.759 . . . . 41.22 112.453 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.0 ttpp -64.5 101.09 0.41 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.856 0.36 . . . . 71.2 110.891 -179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.45 ' HA ' ' HB3' ' A' ' 147' ' ' SER . 1.9 m -90.56 154.15 19.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.435 . . . . 50.1 111.162 179.97 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.73 -17.76 63.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 74.4 110.848 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -143.26 -175.87 4.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 74.44 110.866 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -120.05 144.17 47.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 71.41 110.899 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.647 HD13 HD11 ' A' ' 56' ' ' ILE . 2.5 mp -110.41 134.51 52.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 72.32 111.126 179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -129.33 166.86 18.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.42 111.136 179.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.42 HG21 ' CD2' ' A' ' 8' ' ' PHE . 30.9 mm -112.06 106.97 21.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.247 -0.433 . . . . 61.51 111.128 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.691 ' HB3' ' HB2' ' A' ' 9' ' ' ASP . . . -54.2 -57.23 11.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 51.3 111.13 179.807 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -160.26 174.63 13.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 74.31 110.859 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 11.4 p -175.35 169.6 3.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 74.23 110.894 -179.885 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 147.02 -160.52 28.28 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.756 -0.735 . . . . 71.24 112.493 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.4 mt-30 -72.25 109.36 5.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.817 0.341 . . . . 62.13 110.883 -179.841 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 6' ' ' VAL . 0.3 OUTLIER -66.66 -48.33 69.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 74.52 110.914 -179.99 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 70.42 110.878 179.943 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.2 mtm . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.836 0.351 . . . . 62.33 110.868 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 2.1 p -149.65 153.82 10.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.233 -0.44 . . . . 62.25 111.158 179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -50.44 153.31 2.7 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.595 0.712 . . . . 75.11 110.943 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 141.07 44.29 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.69 2.26 . . . . 54.31 112.332 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.728 HG22 HD21 ' A' ' 164' ' ' LEU . 49.9 m -126.29 101.55 6.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 63.54 111.135 -179.962 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.681 HG11 HD11 ' A' ' 24' ' ' LEU . 5.8 m -96.42 149.78 4.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 74.32 111.123 179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -112.95 162.72 15.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 52.01 110.889 179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -145.01 133.51 21.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 73.01 110.886 -179.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -115.25 108.52 16.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 74.02 110.891 179.962 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.415 HG21 ' HE1' ' A' ' 142' ' ' MET . 15.7 mm -87.48 139.73 16.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 74.34 111.161 179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.413 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -120.7 155.87 32.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 60.31 111.123 179.831 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 80.4 t -136.0 96.04 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.254 -0.43 . . . . 52.41 111.125 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 56.87 56.04 5.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.884 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.75 11.63 54.51 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.748 -0.739 . . . . 72.14 112.446 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -142.44 92.17 7.43 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.665 0.745 . . . . 74.41 110.886 -179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 156.17 64.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.684 2.256 . . . . 73.11 112.358 179.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -115.61 23.93 11.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.44 110.866 -179.995 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 127.66 -161.74 21.65 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 44.45 112.463 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.28 170.37 15.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.877 0.37 . . . . 74.33 110.868 -179.88 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG13 HG21 ' A' ' 138' ' ' ILE . 33.2 m -132.15 172.47 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 71.13 111.147 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -127.89 90.69 3.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 74.41 110.87 -179.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -81.73 72.98 8.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.54 110.94 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.7 tm-20 -52.92 143.53 16.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 73.54 110.851 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.681 HD11 HG11 ' A' ' 6' ' ' VAL . 16.5 mt -105.53 119.81 40.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 52.52 110.93 179.986 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -76.62 57.23 1.22 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.34 110.856 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.3 -31.3 21.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 71.51 111.103 179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -59.87 -63.14 1.41 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.253 -0.431 . . . . 74.21 110.893 179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -57.29 -74.14 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 74.14 110.93 179.971 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 129' ' ' PHE . 2.4 m -85.15 110.77 31.16 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.617 0.722 . . . . 63.3 111.107 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.71 -89.84 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.731 2.287 . . . . 74.12 112.344 179.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mtmm -57.67 -47.02 83.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 65.42 110.874 179.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.476 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 0.9 OUTLIER -45.77 -41.9 11.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 61.13 111.142 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' CB ' HG23 ' A' ' 29' ' ' VAL . . . -107.5 21.72 17.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 72.14 111.086 179.891 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -93.16 -28.37 16.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 74.32 110.856 -179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.492 ' HA ' HD13 ' A' ' 78' ' ' ILE . 26.8 p-10 -85.19 -41.08 15.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 65.51 110.88 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -47.13 -32.75 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 61.2 110.905 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -57.96 -39.55 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 63.5 110.85 -179.91 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.46 -17.97 26.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 73.13 111.164 179.904 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 78' ' ' ILE . 50.4 mt -85.02 9.98 13.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.466 . . . . 71.23 110.895 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.4 m -126.35 -3.42 6.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.196 -0.456 . . . . 73.02 110.879 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.6 p -124.82 -4.98 7.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.109 -0.496 . . . . 73.24 111.143 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 46.15 71.85 0.46 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.714 -0.755 . . . . 73.11 112.485 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -145.27 34.39 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 73.23 110.861 -179.883 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.6 -42.1 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.22 110.863 179.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.446 ' C ' ' CG ' ' A' ' 46' ' ' PHE . . . -137.67 30.53 2.58 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.73 -0.748 . . . . 75.03 112.44 -179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' CG ' ' C ' ' A' ' 45' ' ' GLY . 2.1 p90 40.11 63.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.925 0.393 . . . . 74.1 110.879 -179.876 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.47 -172.94 21.03 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.734 -0.746 . . . . 70.22 112.497 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -75.17 -179.81 4.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.924 0.393 . . . . 62.12 110.885 -179.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -166.24 -34.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.088 -0.505 . . . . 64.24 110.875 179.926 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -144.75 44.27 0.91 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 71.24 112.507 179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -77.15 155.17 32.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.874 0.369 . . . . 61.13 110.826 -179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.8 p -95.67 127.52 41.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.483 . . . . 74.11 110.898 179.997 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -148.61 122.08 9.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 53.22 110.87 -179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -140.81 73.15 1.41 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 73.13 110.869 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.6 mtm180 -121.18 21.86 11.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.88 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.42 HG21 ' HA ' ' A' ' 143' ' ' GLU . 4.7 mt -59.64 136.35 23.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 72.0 111.139 179.963 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.1 mt -121.11 113.05 32.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.614 0.721 . . . . 65.43 111.193 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 86.73 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.704 2.269 . . . . 73.33 112.362 179.911 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 119.56 26.64 2.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.752 -0.737 . . . . 75.11 112.501 -179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.27 -72.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.836 0.35 . . . . 73.1 110.917 -179.853 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -178.22 -158.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 65.14 110.871 179.943 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 17.2 t -143.24 135.9 27.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 70.41 110.869 -179.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.33 153.42 37.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 71.23 110.927 -179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -142.33 147.67 19.21 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 73.52 112.505 -179.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.75 85.72 1.49 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.728 -0.749 . . . . 73.35 112.483 -179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.86 -165.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 60.22 110.895 179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.498 ' O ' HG23 ' A' ' 68' ' ' THR . 15.5 p90 -99.76 -176.45 3.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 73.2 110.871 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.498 HG23 ' O ' ' A' ' 67' ' ' PHE . 0.0 OUTLIER 179.76 -68.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 74.44 111.124 -179.857 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -103.87 154.55 19.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 73.21 110.851 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER 171.22 -39.07 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 75.22 110.843 179.973 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -177.92 -35.32 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.199 -0.455 . . . . 62.44 110.89 -179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.76 -7.09 64.72 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.715 -0.755 . . . . 71.21 112.516 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m 72.26 36.81 1.03 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.864 0.364 . . . . 70.42 111.134 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 126.55 151.87 7.93 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 70.43 112.527 179.95 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -112.65 -118.53 3.58 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 61.21 112.523 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.6 -71.95 0.12 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.754 0.312 . . . . 74.45 110.873 -179.987 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -111.06 120.38 42.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 51.11 110.85 -179.871 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.492 HD13 ' HA ' ' A' ' 35' ' ' ASN . 11.2 pt -49.18 -37.01 9.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.484 . . . . 73.2 111.159 179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -119.22 36.92 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 74.22 110.904 -179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 175.26 -153.51 15.6 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 75.01 112.458 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -122.4 -24.15 5.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.899 0.38 . . . . 73.34 110.895 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.7 pttm -169.36 147.1 3.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 73.04 110.903 179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.94 158.16 34.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 61.23 110.943 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -74.92 162.52 28.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 72.1 110.926 -179.948 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -79.63 108.39 13.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 73.5 110.886 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.52 -51.73 47.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 72.31 110.882 -179.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.5 t30 175.27 175.88 0.21 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 72.42 110.881 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.45 40.81 3.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 73.02 110.871 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mm -50.52 -27.12 4.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.465 . . . . 72.43 111.115 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 48.5 mt -86.59 133.62 33.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.211 -0.449 . . . . 55.32 110.913 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.9 mmtm -114.19 -175.69 2.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 72.33 110.942 179.827 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.492 ' C ' HG23 ' A' ' 93' ' ' THR . 32.1 m170 -99.49 -86.56 0.37 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 73.23 110.868 179.91 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.492 HG23 ' C ' ' A' ' 92' ' ' HIS . 1.2 p 67.09 6.32 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 42.54 111.104 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.37 159.48 20.01 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 51.04 112.483 179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.429 ' CB ' ' HA ' ' A' ' 116' ' ' THR . 53.6 Cg_endo -69.71 169.69 18.26 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.703 2.269 . . . . 75.41 112.354 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 93.92 -29.26 8.85 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.741 -0.743 . . . . 31.34 112.482 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.407 HG22 ' N ' ' A' ' 98' ' ' LEU . 10.6 mm -69.9 158.28 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.837 0.351 . . . . 64.21 111.121 -179.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 112' ' ' PHE . 10.9 mt -124.36 162.72 23.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 72.13 110.934 179.875 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.458 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.7 OUTLIER -160.49 43.76 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 63.4 110.883 -179.932 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.491 ' HA ' ' H ' ' A' ' 112' ' ' PHE . 4.2 mmt 48.65 -166.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 70.32 110.883 179.982 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -179.61 78.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.264 -0.425 . . . . 54.2 111.105 179.941 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.521 ' HB3' HG22 ' A' ' 107' ' ' THR . 0.7 OUTLIER -123.34 -76.85 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 73.43 110.91 -179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.735 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -137.07 -41.45 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 55.22 111.127 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.39 -75.98 0.33 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.712 -0.756 . . . . 73.21 112.51 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 102.2 1.0 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.714 2.276 . . . . 54.34 112.312 -179.965 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 54.59 41.01 32.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 73.41 110.851 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.735 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 3.0 m -154.55 59.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 75.14 111.119 179.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.578 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -80.37 -0.68 37.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.214 -0.448 . . . . 65.3 110.901 179.948 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 21.0 -136.93 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.707 -0.758 . . . . 75.21 112.518 179.992 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.5 m -153.91 65.32 0.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.794 0.331 . . . . 72.31 110.87 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.738 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.0 tp-100 -93.71 -45.41 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 74.21 110.91 -179.942 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.569 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 67.63 130.84 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 75.34 110.864 -179.946 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.532 ' O ' HD23 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -153.41 134.76 14.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 71.35 110.885 -179.928 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -114.55 143.99 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 74.03 111.155 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 3.2 p -115.55 161.23 18.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.458 . . . . 72.54 110.906 179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 95' ' ' PRO . 3.2 m -127.91 30.63 5.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.217 -0.447 . . . . 72.34 111.088 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -163.24 22.75 0.08 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 74.23 111.11 179.858 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.12 134.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 72.11 110.916 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 68.1 p -131.45 41.47 3.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 71.13 111.122 -180.0 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -48.97 -26.42 2.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.235 -0.438 . . . . 61.21 110.863 -179.981 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 11.8 m-90 -60.35 -36.77 78.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.912 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.27 31.99 1.4 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 72.34 110.934 179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -114.63 41.92 2.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 74.21 110.897 179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -149.15 30.9 1.19 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.748 -0.739 . . . . 63.52 112.501 -179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -162.34 -39.73 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.824 0.345 . . . . 70.33 110.936 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -97.33 156.88 16.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 65.12 110.879 179.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 94.2 t -88.53 99.18 8.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.217 -0.447 . . . . 63.32 111.109 -179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 98' ' ' LEU . 91.9 t -63.64 124.93 19.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.183 -0.462 . . . . 70.21 111.156 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.664 ' HB2' HG21 ' A' ' 29' ' ' VAL . 1.4 t80 -155.43 81.96 1.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.91 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.56 166.5 39.52 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.714 -0.755 . . . . 43.35 112.476 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.9 ttpp 177.97 153.76 0.31 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.797 0.332 . . . . 72.55 110.911 179.999 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 132' ' ' VAL . 2.9 p -105.39 87.88 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 71.2 111.151 179.87 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -51.35 -46.24 62.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.147 -0.479 . . . . 63.23 110.917 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.7 174.22 11.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.46 . . . . 65.21 110.866 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 61.8 77.86 0.18 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.753 -0.737 . . . . 52.33 112.491 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 -24.36 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.758 0.313 . . . . 70.24 110.9 179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -76.53 -34.65 58.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.426 . . . . 74.11 110.854 -179.942 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.656 HG21 HG13 ' A' ' 20' ' ' VAL . 48.0 mm -45.4 -39.8 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 63.35 111.12 179.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 96.4 t -90.4 -52.23 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 71.3 111.149 179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -49.39 -67.59 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 74.53 110.889 -179.994 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -51.62 -54.42 27.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 75.51 111.099 179.925 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.701 ' SD ' HD13 ' A' ' 156' ' ' ILE . 11.6 ttm -51.12 -41.28 59.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 75.41 110.914 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.42 ' HA ' HG21 ' A' ' 56' ' ' ILE . 0.0 OUTLIER -53.95 -23.22 12.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 72.41 110.89 -179.981 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 57.4 ttp85 -65.55 -25.94 67.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 73.24 110.847 -179.864 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -87.42 9.0 22.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 73.12 110.838 -179.928 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.14 -171.14 40.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.775 -0.726 . . . . 62.01 112.501 -179.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 5.3 m -158.5 149.39 20.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.862 0.363 . . . . 42.43 110.832 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -49.89 -56.09 11.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.876 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.73 -22.23 57.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.222 -0.444 . . . . 70.1 110.879 -179.96 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 115.96 -36.2 3.94 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.785 -0.721 . . . . 73.03 112.479 179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -50.55 160.62 0.4 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.877 0.37 . . . . 55.31 110.866 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 47.9 p -121.22 156.98 31.27 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.182 -0.463 . . . . 62.54 111.13 179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -26.47 62.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 45.15 110.879 -179.865 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -128.29 -168.19 1.87 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.129 -0.487 . . . . 71.52 110.888 179.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -113.43 96.82 6.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.886 179.853 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.701 HD13 ' SD ' ' A' ' 142' ' ' MET . 19.6 mt -90.61 101.42 12.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 75.35 111.114 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 7.2 t -117.63 164.87 14.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 65.4 111.141 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 68.4 mt -88.53 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 74.44 111.144 179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.62 -64.96 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 45.34 111.113 179.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -135.1 166.33 23.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.2 -0.454 . . . . 73.14 110.856 179.988 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 6.4 m -153.72 -174.84 5.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.834 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 130.9 -147.77 18.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 74.42 112.462 -179.931 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 2.6 pt20 -126.61 136.73 52.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.875 0.369 . . . . 73.35 110.901 -179.902 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.728 HD21 HG22 ' A' ' 5' ' ' THR . 0.4 OUTLIER -80.17 -35.39 36.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 63.51 110.969 -179.985 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 70.34 110.893 179.905 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.775 0.321 . . . . 53.23 110.879 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 72.1 t -109.95 134.48 51.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 51.25 111.178 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -59.28 159.14 16.56 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.603 0.716 . . . . 71.52 110.918 -179.995 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 154.0 68.45 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.249 . . . . 71.23 112.35 179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.2 m -122.14 44.64 2.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 75.01 111.145 -179.96 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.575 ' CG1' HD12 ' A' ' 24' ' ' LEU . 3.8 m -47.83 140.89 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 61.1 111.141 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.487 ' CE1' HD21 ' A' ' 164' ' ' LEU . 0.8 OUTLIER -136.57 175.87 9.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.454 . . . . 72.13 110.892 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -148.64 142.59 25.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.097 -0.501 . . . . 73.54 110.902 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.598 ' O ' HD13 ' A' ' 158' ' ' ILE . 5.9 t70 -96.29 131.8 42.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 63.23 110.826 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 17.3 mm -95.8 137.34 24.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.458 . . . . 53.15 111.106 -179.986 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -136.76 167.07 22.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.473 . . . . 73.24 111.092 179.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.699 HG22 HD13 ' A' ' 17' ' ' LEU . 2.1 m -143.92 95.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.465 . . . . 75.03 111.121 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 71.14 33.49 2.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 63.5 110.901 179.921 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.22 -12.27 70.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.73 -0.748 . . . . 71.41 112.549 -179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 26.5 tp10 -93.17 131.7 32.38 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.691 0.757 . . . . 74.32 110.849 -179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 147.33 62.18 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.667 2.244 . . . . 64.14 112.323 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.699 HD13 HG22 ' A' ' 12' ' ' VAL . 1.3 tp -113.37 -67.62 0.99 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 65.42 110.88 -179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.21 -146.66 4.74 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 72.14 112.5 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -147.27 125.86 12.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.845 0.355 . . . . 72.51 110.864 -179.872 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.64 ' CG1' HG13 ' A' ' 132' ' ' VAL . 22.8 t -116.45 135.24 57.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.158 179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.8 t -88.76 100.61 13.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.157 -0.474 . . . . 61.43 110.841 -179.791 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -87.81 73.6 9.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 72.4 110.852 -179.929 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -51.47 151.78 2.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.152 -0.476 . . . . 73.24 110.878 -179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.575 HD12 ' CG1' ' A' ' 6' ' ' VAL . 5.4 mt -117.41 123.75 47.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 74.3 110.932 -179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -81.74 70.77 8.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 70.23 110.864 179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.95 -8.68 59.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 73.14 111.084 179.919 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -80.23 -56.13 4.43 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 71.11 110.894 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.4 -54.91 40.0 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 73.12 110.894 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -123.53 83.24 53.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.613 0.721 . . . . 72.14 111.103 179.885 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 63.11 1.81 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.644 2.23 . . . . 74.44 112.359 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 16.3 mmtm -159.77 -67.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 62.2 110.914 179.9 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 29.8 m -53.33 -48.06 68.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 75.31 111.154 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -56.77 -36.02 69.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 53.14 111.132 179.864 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -55.63 -28.27 54.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 72.23 110.904 -179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.38 -54.2 7.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.497 . . . . 60.23 110.922 -179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.09 -36.52 81.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 51.4 110.862 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.47 -27.23 56.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 70.43 110.871 -179.915 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -92.41 -35.03 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 75.31 111.133 179.913 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.729 ' HB2' HD12 ' A' ' 78' ' ' ILE . 1.3 tt -83.84 5.22 25.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.898 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 54.7 p -105.31 -13.99 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 71.33 110.869 -179.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 t -116.59 8.23 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 71.11 111.159 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.03 21.72 39.49 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 71.24 112.487 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.31 -34.31 68.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.894 0.378 . . . . 73.32 110.893 -179.832 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -13.35 62.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.18 -0.464 . . . . 62.0 110.881 179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 85.62 -12.48 59.04 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.773 -0.727 . . . . 71.34 112.5 179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.419 ' O ' ' C ' ' A' ' 47' ' ' GLY . 19.5 m-85 -92.34 -28.08 17.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.888 0.375 . . . . 64.22 110.842 -179.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 46' ' ' PHE . . . -35.51 125.89 0.74 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 55.22 112.472 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.3 t80 -100.48 33.13 2.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.956 0.408 . . . . 75.51 110.979 -179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.02 146.74 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.101 -0.499 . . . . 53.13 110.898 179.91 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.571 ' O ' HG22 ' A' ' 157' ' ' THR . . . 119.05 -95.91 0.63 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 44.35 112.476 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.568 ' HA ' HG22 ' A' ' 157' ' ' THR . 0.3 OUTLIER -101.96 121.72 42.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 70.22 110.862 -179.707 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.0 p -174.21 -166.57 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.12 -0.491 . . . . 61.21 110.882 -179.962 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER 63.51 86.82 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 62.53 110.902 -179.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -116.47 17.28 15.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 74.11 110.885 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 50.8 mmm-85 -134.37 151.68 51.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 70.21 110.862 -179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 179.54 131.16 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.52 111.17 179.955 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' HG2' ' A' ' 61' ' ' MET . 1.2 pt -138.06 109.05 8.29 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.674 0.75 . . . . 73.33 111.146 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.5 Cg_endo -69.79 92.98 0.52 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.706 2.27 . . . . 54.34 112.333 179.895 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 144.96 -31.6 1.73 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.751 -0.738 . . . . 74.13 112.489 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.422 ' CB ' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -111.47 -64.12 1.33 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 73.25 110.863 -179.831 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.433 ' HG2' HD11 ' A' ' 57' ' ' ILE . 3.6 ptt? -158.42 -156.32 0.54 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.103 -0.499 . . . . 74.12 110.908 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 76.2 m -131.44 -44.04 1.02 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.278 -0.419 . . . . 54.44 110.872 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.09 119.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 65.13 110.947 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.75 132.78 11.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.734 -0.746 . . . . 50.11 112.487 -179.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.25 -157.61 27.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.72 -0.752 . . . . 74.51 112.498 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -152.3 -177.31 6.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.819 0.343 . . . . 73.21 110.856 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -176.08 121.11 0.17 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.443 . . . . 65.21 110.897 -179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -123.3 -76.01 0.59 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 74.34 111.123 -179.891 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -144.43 116.35 8.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 73.35 110.858 -179.955 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -85.4 20.41 2.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.239 -0.437 . . . . 74.34 110.839 179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 70.81 50.01 0.36 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 62.41 110.854 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.63 24.62 2.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.758 -0.734 . . . . 63.51 112.471 179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 72.1 p 48.08 88.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.848 0.356 . . . . 72.54 111.105 -179.95 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -155.54 56.81 0.4 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.72 -0.752 . . . . 53.35 112.513 179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -55.19 101.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.747 -0.739 . . . . 73.41 112.452 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.14 172.98 2.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.812 0.339 . . . . 74.1 110.882 -179.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 78' ' ' ILE . 0.9 OUTLIER -128.38 15.27 6.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 65.32 110.888 -179.884 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.729 HD12 ' HB2' ' A' ' 39' ' ' LEU . 0.1 OUTLIER 82.75 -19.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.109 -0.496 . . . . 53.42 111.11 179.933 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.55 -20.29 15.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.47 . . . . 72.14 110.934 -179.995 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 172.41 -88.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 74.31 112.462 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -138.69 -54.28 0.6 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.921 0.391 . . . . 75.5 110.898 -179.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.408 ' HB2' ' HA ' ' A' ' 107' ' ' THR . 9.2 pttp -168.81 145.17 3.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 75.24 110.895 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -133.48 144.55 49.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 65.3 110.882 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.73 170.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 65.35 110.857 -179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -81.2 146.45 30.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.85 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -91.23 -58.79 2.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.462 . . . . 62.41 110.846 -179.902 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.7 p30 178.75 156.46 0.46 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 73.21 110.889 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -112.55 60.14 0.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.173 -0.467 . . . . 74.43 110.868 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 34.7 mm -78.51 -20.52 13.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 73.45 111.181 179.914 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 128' ' ' VAL . 0.2 OUTLIER -96.51 99.06 10.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.467 . . . . 72.3 110.889 179.928 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -92.24 114.33 26.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 63.11 110.926 179.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.633 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -51.16 -95.47 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 73.3 110.83 179.938 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.661 HG23 ' O ' ' A' ' 93' ' ' THR . 0.5 OUTLIER 66.72 5.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 65.31 111.167 -179.86 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -150.84 153.27 24.9 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.744 -0.741 . . . . 50.13 112.49 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 147.72 63.79 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.697 2.264 . . . . 73.42 112.326 -179.982 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.492 ' O ' HG23 ' A' ' 132' ' ' VAL . . . 94.64 -17.95 58.09 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.719 -0.753 . . . . 51.02 112.482 179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.633 HG21 ' HB3' ' A' ' 92' ' ' HIS . 12.7 mm -64.45 140.91 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.823 0.344 . . . . 65.43 111.167 -179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' HG22 ' A' ' 128' ' ' VAL . 3.8 tt -90.79 126.67 36.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 72.32 110.894 179.908 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.3 t -122.72 142.27 50.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 64.23 110.846 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 4.5 mtm -69.17 175.29 3.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 52.55 110.878 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -166.92 147.38 5.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.31 111.103 179.922 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 2.6 m-20 163.5 -64.43 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.248 -0.433 . . . . 71.15 110.934 -179.909 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -141.75 -106.7 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 74.32 111.103 179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.606 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -156.59 -60.28 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.732 -0.747 . . . . 75.13 112.479 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.606 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.79 -104.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.692 2.262 . . . . 72.33 112.297 -179.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -121.0 72.8 0.99 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 55.45 110.852 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.408 ' HA ' ' HB2' ' A' ' 82' ' ' LYS . 0.1 OUTLIER -144.69 10.42 1.39 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 64.44 111.115 -179.939 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' HA ' ' HB2' ' A' ' 102' ' ' ASN . 9.4 p30 -99.86 179.51 4.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 52.32 110.832 -179.973 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 121.17 24.53 2.44 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.686 -0.769 . . . . 75.44 112.473 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.49 -52.21 0.17 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 64.21 110.906 -179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.498 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 0.8 OUTLIER -84.14 155.81 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 71.04 110.9 -179.963 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -149.87 171.63 16.47 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 73.1 110.872 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 12.4 p90 -159.28 166.48 31.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.122 -0.49 . . . . 63.12 110.886 -179.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.534 HG22 HG23 ' A' ' 116' ' ' THR . 37.5 mt -121.4 114.11 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.157 -0.474 . . . . 63.51 111.12 179.956 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 20.8 p -65.15 -28.03 69.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 60.41 110.849 179.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.534 HG23 HG22 ' A' ' 114' ' ' ILE . 1.4 p 49.31 22.79 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 71.42 111.141 -179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -167.4 176.14 6.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.247 -0.433 . . . . 71.21 111.077 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 104.63 12.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 65.31 110.874 179.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.795 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 66.2 p -132.45 63.8 1.62 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 75.21 111.16 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.412 ' HB3' ' HA ' ' A' ' 93' ' ' THR . 0.0 OUTLIER -90.13 22.63 3.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 62.52 110.881 179.996 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.795 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.5 OUTLIER -93.33 5.91 49.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 74.15 110.933 -179.991 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 125' ' ' LYS . 4.4 mt -97.59 -4.96 36.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.257 -0.429 . . . . 74.43 110.899 179.95 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 51.14 68.42 0.79 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 64.21 110.91 179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 39.57 37.36 0.83 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.79 -0.719 . . . . 70.14 112.454 -179.908 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 122' ' ' LEU . 3.9 mmtp -55.46 -34.33 64.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 71.45 110.899 179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -110.38 156.2 21.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 73.1 110.827 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 85.5 t -87.07 85.07 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 72.22 111.105 179.993 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 90' ' ' LEU . 17.5 t -65.25 118.97 8.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 74.03 111.109 179.951 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -133.37 17.96 4.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.47 . . . . 74.41 110.869 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -150.74 178.2 28.32 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.763 -0.732 . . . . 75.01 112.503 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.76 170.09 2.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.831 0.348 . . . . 74.05 110.934 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.64 HG13 ' CG1' ' A' ' 20' ' ' VAL . 94.4 t -97.75 84.94 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 74.22 111.11 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.0 -62.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 71.14 110.908 179.88 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.445 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -138.02 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.176 -0.466 . . . . 75.41 110.829 -179.984 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 88.29 10.46 68.37 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.711 -0.757 . . . . 75.21 112.467 -179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.18 -30.64 27.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.785 0.326 . . . . 74.31 110.856 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -52.55 -26.92 14.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.247 -0.433 . . . . 62.42 110.886 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 20.4 mm -80.02 -41.75 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 71.53 111.124 179.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.492 HG11 HG22 ' A' ' 116' ' ' THR . 38.1 t -50.17 -45.19 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 75.32 111.115 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -57.71 -32.77 67.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 52.21 110.85 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.77 92.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.171 -0.468 . . . . 64.13 111.079 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 21.1 mtm -71.62 -26.09 62.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 72.0 110.872 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -84.5 14.18 4.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 70.13 110.883 -179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.45 -16.26 8.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.143 -0.481 . . . . 73.21 110.89 -179.92 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -104.24 -8.98 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 71.24 110.864 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -70.53 -150.57 0.62 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 73.42 112.447 -179.941 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.4 t -169.41 152.87 4.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.871 0.367 . . . . 63.4 110.857 -179.747 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -73.24 69.39 1.09 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 65.2 110.851 -179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 177.51 -26.44 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 72.43 110.86 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.4 -48.14 0.98 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.748 -0.739 . . . . 41.53 112.497 179.968 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.84 160.9 22.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.838 0.351 . . . . 62.22 110.895 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 1.3 p -137.71 171.4 14.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 64.41 111.119 179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 12.8 p -86.55 -4.01 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 74.31 110.842 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -137.85 -165.94 1.87 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 55.14 110.888 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.33 125.31 13.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 54.15 110.903 179.863 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.9 mp -87.04 131.18 35.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 71.41 111.148 179.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.571 HG22 ' O ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -126.67 163.85 22.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 43.04 111.152 179.993 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.598 HD13 ' O ' ' A' ' 9' ' ' ASP . 41.8 mm -120.97 94.47 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 74.54 111.132 179.899 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -56.55 -48.63 76.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 64.4 111.1 179.798 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -155.64 -178.48 7.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.262 -0.427 . . . . 74.14 110.877 -179.993 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . 0.404 ' HA ' ' CE1' ' A' ' 7' ' ' PHE . 6.0 p -176.55 157.92 1.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.19 -0.459 . . . . 72.25 110.89 -179.946 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -172.48 176.67 45.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.74 -0.743 . . . . 53.31 112.488 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.588 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.6 mt-30 -69.29 -36.71 77.32 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.813 0.339 . . . . 64.02 110.854 -179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 1.3 mm? 71.9 -21.4 0.22 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 75.02 110.898 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 163' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 70.11 110.846 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.815 0.341 . . . . 72.11 110.9 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 65.04 154.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 52.41 111.131 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 m-20 -89.79 151.32 45.39 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.619 0.723 . . . . 75.5 110.826 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.81 109.27 2.28 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.671 2.247 . . . . 73.12 112.344 179.914 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.664 HG22 HD21 ' A' ' 164' ' ' LEU . 6.4 m -113.42 141.46 47.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 61.12 111.121 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 163' ' ' GLN . 6.4 m -126.9 148.92 31.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 70.41 111.141 179.877 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.794 ' HB3' HD22 ' A' ' 164' ' ' LEU . 11.5 p90 -118.69 147.79 43.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 72.21 110.908 -179.968 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -129.06 131.41 47.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 63.25 110.895 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -97.12 75.54 2.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.472 . . . . 61.12 110.892 179.991 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 28.4 mm -49.74 141.41 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 62.42 111.146 -179.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.92 151.49 52.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 70.23 111.111 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 73.6 t -134.19 108.71 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 72.2 111.181 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.1 t0 51.47 52.25 15.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 73.43 110.919 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.04 10.22 50.69 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.771 -0.728 . . . . 63.01 112.463 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 2.6 mm-40 -139.29 94.57 9.59 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.651 0.738 . . . . 73.13 110.878 -179.896 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 15' ' ' GLU . 53.4 Cg_endo -69.83 157.75 59.2 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.677 2.251 . . . . 53.03 112.309 -179.975 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.5 pp -126.37 22.88 7.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 44.3 110.955 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 133.85 160.4 9.3 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.72 -0.753 . . . . 65.41 112.495 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.47 -179.68 3.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.809 0.338 . . . . 64.33 110.917 -179.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.535 ' CG1' HG21 ' A' ' 138' ' ' ILE . 17.6 m -146.61 168.99 5.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.45 . . . . 71.43 111.111 179.974 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 84.4 p -145.64 144.27 30.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 73.44 110.823 -179.84 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.446 ' O ' HG23 ' A' ' 5' ' ' THR . 2.0 m-85 -127.68 138.62 52.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.084 -0.507 . . . . 64.25 110.904 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -111.36 113.56 26.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 53.23 110.896 -179.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.718 HD13 ' O ' ' A' ' 33' ' ' ALA . 10.6 mt -80.2 129.74 34.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 62.15 110.903 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -82.3 72.16 9.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 62.43 110.868 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.51 -27.19 15.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 63.43 111.116 179.904 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -62.57 -44.01 97.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.246 -0.434 . . . . 74.44 110.845 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -88.51 -32.84 18.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 72.14 110.906 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.778 HG21 ' CB ' ' A' ' 129' ' ' PHE . 11.5 m -131.24 87.19 48.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.622 0.725 . . . . 71.12 111.147 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -47.27 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.667 2.245 . . . . 73.15 112.364 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.22 -41.89 47.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 64.0 110.897 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -3.1 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 71.03 111.18 179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.718 ' O ' HD13 ' A' ' 24' ' ' LEU . . . -76.62 -37.47 56.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 64.33 111.141 179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 35' ' ' ASN . 80.3 tt0 -92.79 -37.88 12.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 65.04 110.885 -179.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.5 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -29.32 -76.24 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 73.21 110.861 -179.904 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.611 ' HA ' HD12 ' A' ' 39' ' ' LEU . 37.3 t80 -64.45 -32.75 74.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 72.22 110.857 -179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -51.75 -34.7 40.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 72.33 110.885 -179.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.88 -27.49 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 61.24 111.113 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 36' ' ' PHE . 13.4 mt -75.63 -52.02 11.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 63.53 110.856 -179.955 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 73.9 m -59.39 -54.01 51.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 74.03 110.862 -179.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.6 p -73.19 -27.44 61.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.118 -0.492 . . . . 74.34 111.15 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.96 92.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.785 -0.722 . . . . 72.32 112.495 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -149.72 36.79 0.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.921 0.391 . . . . 61.11 110.901 -179.837 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 5.6 mmmm -133.72 26.81 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.187 -0.46 . . . . 64.31 110.947 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.06 4.76 60.23 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 74.45 112.454 179.927 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -164.56 178.05 7.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.923 0.392 . . . . 64.14 110.875 -179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 122.52 117.01 2.38 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.751 -0.738 . . . . 70.4 112.45 179.982 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -48.11 150.66 1.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 61.31 110.912 -179.812 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.96 -76.05 0.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.143 -0.48 . . . . 63.54 110.92 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -154.01 44.63 0.58 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 72.11 112.516 179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.32 -26.46 33.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.856 0.36 . . . . 63.32 110.848 -179.69 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.5 p 178.13 176.13 0.48 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.104 -0.498 . . . . 65.44 110.931 -179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -103.2 -77.09 0.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.876 -179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 168.12 -80.97 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 74.55 110.9 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -164.82 110.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 73.34 110.878 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.716 HD12 ' CD1' ' A' ' 156' ' ' ILE . 5.1 mt -95.71 135.0 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 74.05 111.131 179.998 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.564 HD12 ' CE ' ' A' ' 61' ' ' MET . 12.7 mt -131.74 103.5 14.59 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 74.03 111.087 179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.0 Cg_endo -69.77 104.53 1.34 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.67 2.247 . . . . 74.54 112.385 179.826 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.07 16.46 8.41 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.765 -0.731 . . . . 23.1 112.476 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.56 -66.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.866 0.365 . . . . 70.21 110.94 -179.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.564 ' CE ' HD12 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -179.17 -168.27 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 73.5 110.875 179.945 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.871 ' HB2' HG23 ' A' ' 114' ' ' ILE . 87.8 m -149.15 133.22 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 73.52 110.895 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.04 154.81 18.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 71.42 110.939 -179.873 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 163.15 -179.92 38.05 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.762 -0.732 . . . . 53.05 112.525 -179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.35 44.66 5.52 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.751 -0.738 . . . . 74.23 112.518 -179.896 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -102.82 177.97 4.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.863 0.363 . . . . 70.12 110.871 -179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -169.82 29.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 71.23 110.875 -179.892 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 75' ' ' GLY . 0.2 OUTLIER -87.31 -168.08 2.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 60.21 111.134 -179.889 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -96.58 -90.47 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 75.25 110.924 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -52.52 -76.45 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.85 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.0 p30 179.65 -32.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 64.12 110.859 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -149.31 30.62 1.18 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.748 . . . . 43.03 112.496 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.9 p -99.94 -32.27 11.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 72.1 111.171 -179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -106.7 -123.83 5.16 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.771 -0.728 . . . . 63.34 112.482 179.979 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.436 ' H ' HG23 ' A' ' 68' ' ' THR . . . 100.5 120.45 4.56 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.718 -0.753 . . . . 71.15 112.485 -179.922 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -175.73 177.58 1.69 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.797 0.332 . . . . 74.1 110.885 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -89.87 142.27 27.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 70.45 110.852 -179.86 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.402 HD11 ' CD2' ' A' ' 79' ' ' TYR . 2.1 pp -40.67 -38.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 65.33 111.081 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' CD2' HD11 ' A' ' 78' ' ' ILE . 4.5 m-85 -85.89 49.24 1.74 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.451 . . . . 63.4 110.877 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 72.16 -113.82 4.68 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.737 -0.744 . . . . 73.04 112.47 179.949 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -61.96 -161.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.924 0.393 . . . . 74.4 110.862 -179.855 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.622 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.3 OUTLIER -101.08 -178.51 3.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.141 -0.481 . . . . 65.03 110.87 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -131.66 162.13 31.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.235 -0.438 . . . . 74.43 110.913 179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -91.28 172.5 8.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.178 -0.465 . . . . 55.22 110.866 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -71.71 105.9 3.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.492 . . . . 71.12 110.821 179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.14 -58.21 3.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 73.33 110.861 -179.904 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.659 ' O ' HG22 ' A' ' 127' ' ' VAL . 2.6 p30 -177.92 165.52 1.99 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 75.13 110.883 -179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -142.1 55.31 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 54.11 110.839 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 10.4 mt -48.93 -26.32 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 72.5 111.194 179.903 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.755 ' HB2' HG13 ' A' ' 128' ' ' VAL . 73.3 mt -93.39 155.08 17.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.148 -0.478 . . . . 65.5 110.905 179.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.2 mtpp -117.93 178.29 4.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.186 -0.461 . . . . 63.54 110.908 179.826 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -105.08 76.8 1.26 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 70.33 110.849 179.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.3 t -122.34 22.39 10.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 71.41 111.162 -179.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.592 ' HA3' HD11 ' A' ' 97' ' ' ILE . . . -120.72 160.12 15.22 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.76 -0.733 . . . . 72.35 112.505 -179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 -29.26 24.27 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.664 2.243 . . . . 72.43 112.375 -179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -132.42 71.11 0.51 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.754 -0.736 . . . . 60.42 112.491 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.592 HD11 ' HA3' ' A' ' 94' ' ' GLY . 42.5 mm -91.42 143.4 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.816 0.341 . . . . 73.51 111.119 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.549 HD23 ' C ' ' A' ' 97' ' ' ILE . 8.0 mt -117.03 152.67 34.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 75.14 110.887 179.879 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.415 ' HB2' ' CE1' ' A' ' 113' ' ' PHE . 56.9 m -154.89 -101.23 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 70.14 110.877 -179.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -176.4 124.37 0.18 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.095 -0.502 . . . . 74.54 110.874 179.92 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -102.58 80.76 1.96 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 53.23 111.136 179.882 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -137.32 -64.31 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.472 . . . . 65.44 110.919 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.679 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -178.17 121.01 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 51.5 111.118 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.906 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . -72.61 -29.48 65.59 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.736 -0.745 . . . . 60.34 112.482 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.906 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.7 Cg_endo -69.78 80.99 0.85 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.647 2.232 . . . . 71.21 112.367 -179.954 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.415 ' O ' HG23 ' A' ' 107' ' ' THR . 5.6 p-10 39.29 53.96 2.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 72.22 110.892 -179.992 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.622 HG22 ' HG3' ' A' ' 82' ' ' LYS . 0.6 OUTLIER -159.03 39.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.2 111.142 -179.973 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -74.77 160.27 30.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 73.31 110.941 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.99 -110.68 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 74.53 112.507 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -127.25 -162.14 1.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.859 0.361 . . . . 72.32 110.851 -179.778 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.408 ' O ' ' HB3' ' A' ' 101' ' ' ALA . 4.1 mt-30 74.75 50.11 0.09 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.095 -0.502 . . . . 75.52 110.896 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.463 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 41.0 p90 -50.25 142.71 9.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 72.41 110.836 -179.918 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 27.9 p90 -103.98 59.81 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 71.31 110.871 -179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.871 HG23 ' HB2' ' A' ' 62' ' ' CYS . 9.3 tt -34.79 121.39 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 71.5 111.106 179.979 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.462 ' SG ' HG21 ' A' ' 119' ' ' THR . 69.7 m -90.53 159.01 16.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.216 -0.447 . . . . 61.3 110.898 179.946 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.2 p -111.67 -9.69 14.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 71.04 111.163 -179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -145.87 161.38 40.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 62.22 111.085 179.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.24 115.92 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 73.15 110.9 179.926 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.522 ' HB ' HD23 ' A' ' 122' ' ' LEU . 15.8 p -115.7 47.52 1.34 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 74.41 111.153 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.6 tm-20 -55.71 -17.54 6.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 73.25 110.926 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 14.1 m-90 -55.65 -21.91 20.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 71.31 110.934 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.522 HD23 ' HB ' ' A' ' 119' ' ' THR . 3.8 mm? -73.33 -56.25 5.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.206 -0.452 . . . . 72.02 110.923 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 73.03 -61.85 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 75.2 110.897 179.921 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -172.83 61.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.685 -0.769 . . . . 70.03 112.491 -179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 tptp -98.02 -27.79 14.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.848 0.356 . . . . 72.43 110.913 -179.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -143.44 138.1 29.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 61.34 110.812 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.659 HG22 ' O ' ' A' ' 87' ' ' ASN . 55.4 t -51.37 106.38 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 63.43 111.14 179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 90' ' ' LEU . 1.4 p -84.2 143.27 12.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.461 . . . . 75.1 111.133 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.778 ' CB ' HG21 ' A' ' 29' ' ' VAL . 37.2 p90 -178.78 119.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 75.13 110.855 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 110.42 123.33 4.52 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.69 -0.767 . . . . 74.41 112.485 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -139.23 162.03 35.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 74.52 110.892 -179.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 24.1 t -54.83 100.05 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.439 . . . . 75.12 111.136 179.86 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.92 -46.85 41.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 64.54 110.888 179.902 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -148.06 118.2 7.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 73.12 110.865 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 117.33 84.42 1.03 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.741 -0.743 . . . . 64.23 112.474 -179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 tpt -91.26 -21.52 21.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.789 0.328 . . . . 64.41 110.873 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.83 -30.74 59.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 73.0 110.885 -179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.535 HG21 ' CG1' ' A' ' 20' ' ' VAL . 38.2 mm -64.49 -41.76 93.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 70.31 111.117 179.923 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.448 ' O ' HG12 ' A' ' 139' ' ' VAL . 3.7 t -91.65 11.39 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.196 -0.456 . . . . 63.24 111.085 179.908 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -121.8 -64.05 1.25 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 64.44 110.855 -179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.63 -57.28 9.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 73.33 111.083 179.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 1.7 tmm? -52.81 -37.86 60.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 55.44 110.888 -179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.51 -24.59 32.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.239 -0.437 . . . . 73.25 110.878 -179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.2 ttp85 -68.39 -12.57 61.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 74.01 110.839 -179.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -94.78 26.09 3.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 75.51 110.884 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.689 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -124.92 44.04 1.31 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.749 -0.739 . . . . 70.4 112.53 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.503 ' C ' ' O ' ' A' ' 146' ' ' GLY . 29.8 t 29.57 -102.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.905 0.384 . . . . 44.42 110.834 -179.751 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.1 mmm-85 -173.5 -34.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 64.12 110.86 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -87.74 -6.45 58.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 75.42 110.895 -179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 130.68 -55.81 0.76 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 74.41 112.464 -179.993 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.65 110.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.84 0.352 . . . . 73.22 110.848 -179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.689 HG22 ' HA2' ' A' ' 146' ' ' GLY . 40.0 p -84.11 138.33 33.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.233 -0.44 . . . . 74.01 111.154 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.31 -28.92 63.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 65.53 110.854 -179.839 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -137.07 -179.62 5.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 72.12 110.903 179.93 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.43 135.4 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.888 179.859 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.716 ' CD1' HD12 ' A' ' 56' ' ' ILE . 20.5 mt -117.17 87.66 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 74.04 111.128 179.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 62.6 p -108.68 157.16 18.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.177 -0.465 . . . . 74.02 111.175 179.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 1.4 mt -93.22 146.06 6.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 72.11 111.188 179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -96.55 -61.22 1.46 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 73.51 111.114 179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.09 154.6 48.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 74.0 110.881 179.937 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 26.0 m -146.16 -167.5 2.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.24 -0.437 . . . . 73.44 110.892 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 131.66 -162.93 23.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 72.25 112.501 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.646 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.3 tt0 -112.54 133.82 54.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.362 . . . . 72.22 110.901 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.794 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.5 OUTLIER -109.24 144.48 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 62.34 110.943 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 73.42 110.895 179.914 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.4 mmt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.838 0.351 . . . . 64.42 110.896 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.9 t 59.62 99.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 70.52 111.127 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -58.59 154.91 32.21 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.604 0.716 . . . . 73.4 110.907 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 154.8 67.33 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.65 2.233 . . . . 74.4 112.365 179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 6' ' ' VAL . 2.8 m -120.55 163.01 18.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.169 -0.468 . . . . 61.45 111.109 -179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.587 ' CG2' HD11 ' A' ' 24' ' ' LEU . 1.3 t -144.11 140.68 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 73.23 111.176 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.546 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -126.34 144.36 50.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 62.11 110.864 -179.947 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.593 ' CE2' HD13 ' A' ' 158' ' ' ILE . 8.0 m-85 -138.67 139.58 38.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 71.3 110.862 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.538 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -98.02 109.86 22.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 65.24 110.799 -179.969 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.1 mm -80.3 136.78 22.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.147 -0.478 . . . . 70.41 111.157 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -124.32 161.91 24.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.162 -0.472 . . . . 63.53 111.099 179.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 17' ' ' LEU . 61.2 t -146.45 93.92 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 54.34 111.161 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 75.2 27.57 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 73.13 110.83 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 98.62 -17.88 57.74 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.764 -0.731 . . . . 63.01 112.536 -179.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -95.15 139.22 21.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.605 0.717 . . . . 64.53 110.891 -179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 152.93 69.49 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.705 2.27 . . . . 64.23 112.401 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 HD13 ' CG2' ' A' ' 12' ' ' VAL . 1.5 tp -116.07 -68.39 0.92 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.263 -0.426 . . . . 73.13 110.929 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -162.81 -144.67 4.09 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.742 -0.742 . . . . 42.32 112.518 179.898 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.31 135.91 29.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.898 0.38 . . . . 74.45 110.847 -179.835 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.3 t -109.64 129.73 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 74.32 111.145 179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 t -93.65 95.54 9.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 74.45 110.821 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.464 ' HZ ' HD11 ' A' ' 114' ' ' ILE . 5.5 m-85 -87.56 119.81 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 71.54 110.875 -179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -101.07 147.88 25.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 74.42 110.917 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.589 HD13 ' HG3' ' A' ' 37' ' ' ARG . 0.8 OUTLIER -121.06 120.18 34.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.161 -0.472 . . . . 65.14 110.911 -179.919 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -83.63 88.15 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.46 . . . . 63.1 110.904 179.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.67 -2.47 56.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 65.34 111.104 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -80.05 -51.03 9.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 74.54 110.867 179.942 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.11 -26.32 16.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 74.13 110.862 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.536 HG21 ' HA ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -134.58 74.57 65.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.64 0.733 . . . . 74.33 111.142 179.858 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 -44.6 1.98 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.251 . . . . 73.34 112.382 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 3.7 mtmm -62.85 -50.22 71.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.24 110.92 179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.504 ' OG1' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -65.03 -39.33 93.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 71.12 111.138 179.986 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.81 -68.23 0.36 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.226 -0.443 . . . . 74.01 111.07 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' N ' ' A' ' 37' ' ' ARG . 27.2 tt0 -48.42 -65.61 0.54 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 73.12 110.932 -179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 34' ' ' GLU . 4.2 t30 -29.93 -52.27 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 65.12 110.867 -179.915 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -73.12 -41.56 63.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 74.53 110.885 -179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.589 ' HG3' HD13 ' A' ' 24' ' ' LEU . 5.0 ttm180 -52.06 -29.52 21.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.119 -0.491 . . . . 64.32 110.834 -179.888 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.618 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -62.55 -32.55 73.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 44.32 111.098 179.919 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.635 HD13 ' O ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -94.01 35.3 1.17 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.877 -179.923 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 6' ' ' VAL . 16.7 t -113.22 -12.29 13.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 74.04 110.853 -179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.4 p -121.32 18.14 11.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.12 111.159 -179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 49.34 27.8 8.39 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.747 -0.739 . . . . 64.21 112.528 179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -76.04 -40.41 53.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.922 0.392 . . . . 75.24 110.882 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' HG22 ' A' ' 78' ' ' ILE . 0.0 OUTLIER -62.08 -17.27 57.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 65.22 110.895 179.994 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.26 -66.24 3.52 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 63.03 112.492 179.929 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -93.3 148.02 22.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.926 0.393 . . . . 75.5 110.917 -179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 139.8 -168.04 25.14 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.756 -0.735 . . . . 33.45 112.48 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.442 ' O ' HD11 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -86.11 139.7 30.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.931 0.396 . . . . 74.31 110.941 -179.821 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -163.11 -42.98 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.16 -0.473 . . . . 72.51 110.918 179.902 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -158.2 45.98 0.46 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.727 -0.749 . . . . 34.15 112.473 179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.5 t -95.43 45.98 1.1 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 72.51 110.854 -179.744 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 53.27 -176.01 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 70.45 110.881 -179.975 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -176.53 134.45 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 63.25 110.859 -179.837 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.22 66.36 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.862 179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -141.49 8.26 1.97 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 70.2 110.86 -179.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.63 HG22 ' HA3' ' A' ' 146' ' ' GLY . 0.0 OUTLIER -57.75 150.63 4.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 73.14 111.125 179.991 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 148' ' ' ARG . 3.9 mt -140.29 95.64 8.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.608 0.718 . . . . 54.4 111.14 179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.437 ' HB3' ' HB3' ' A' ' 143' ' ' GLU . 53.5 Cg_endo -69.77 87.6 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.666 2.244 . . . . 53.42 112.332 179.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 159.87 -27.55 0.35 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.759 -0.734 . . . . 71.41 112.516 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -59.94 1.12 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.85 0.357 . . . . 72.34 110.908 -179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' ILE . 0.0 OUTLIER -157.22 -150.42 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 72.44 110.888 179.961 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.6 t -121.01 -53.68 2.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 64.32 110.896 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 65.08 122.59 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 71.03 110.943 -179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.26 -152.58 21.8 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.728 -0.748 . . . . 64.05 112.5 -179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 57.61 21.65 43.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 54.13 112.471 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.24 121.63 14.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.85 0.357 . . . . 55.15 110.866 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 178.65 -33.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 73.32 110.883 -179.889 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.7 p -126.54 100.17 6.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 72.13 111.159 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.8 mpt_? -104.89 169.46 8.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 74.11 110.896 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -51.03 -32.87 22.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 52.23 110.863 -179.99 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -179.36 103.7 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.845 -179.913 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' C ' HG23 ' A' ' 73' ' ' THR . . . -165.97 26.84 0.17 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.731 -0.747 . . . . 61.04 112.494 179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.427 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.3 p 62.99 26.43 15.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.827 0.346 . . . . 73.44 111.143 -179.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -83.81 -116.22 0.64 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 71.53 112.512 179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.43 -26.42 1.81 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.728 . . . . 65.13 112.48 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 63.01 -157.91 0.33 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.797 0.332 . . . . 71.22 110.893 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 14.4 m -91.69 167.01 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 61.2 110.826 -179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.618 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -51.41 -42.96 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 75.42 111.126 179.931 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.75 46.02 1.33 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 70.53 110.966 -180.0 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.55 -95.91 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.728 -0.749 . . . . 33.43 112.495 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -54.64 178.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.9 0.381 . . . . 53.25 110.904 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' CD ' ' H ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -95.92 -172.07 2.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 74.15 110.9 179.962 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.404 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -137.11 164.46 28.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 71.11 110.866 179.925 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.27 179.33 6.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 72.13 110.859 -179.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -80.89 129.73 34.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 74.43 110.84 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.2 tp10 -88.24 -46.57 9.12 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 73.51 110.877 -179.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 10.1 p30 177.68 156.49 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.46 . . . . 61.11 110.913 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -117.84 63.77 0.75 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 74.41 110.884 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.585 ' O ' HD23 ' A' ' 90' ' ' LEU . 24.0 mm -80.82 2.08 2.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 62.43 111.164 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 89' ' ' ILE . 59.8 mt -133.68 136.74 44.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.13 -0.486 . . . . 70.12 110.907 179.926 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.44 -162.91 1.11 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 74.31 110.897 179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -102.19 97.07 7.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 65.21 110.867 179.869 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -79.19 -21.43 46.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 72.44 111.154 -179.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 162.02 -125.09 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.743 -0.741 . . . . 61.24 112.483 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 142.14 47.14 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.616 2.211 . . . . 35.44 112.345 -179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.455 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 67.05 121.51 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.765 -0.731 . . . . 64.25 112.47 179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -176.4 130.79 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.855 0.359 . . . . 71.04 111.135 -179.959 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD23 ' CB ' ' A' ' 112' ' ' PHE . 0.8 OUTLIER -106.61 122.84 47.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 63.51 110.888 179.888 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HE3' ' A' ' 100' ' ' MET . 0.2 OUTLIER -133.51 -155.85 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.445 . . . . 75.54 110.908 -179.979 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.444 ' HE3' ' O ' ' A' ' 99' ' ' SER . 1.1 mmt -134.23 116.34 15.22 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 71.34 110.905 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' O ' ' A' ' 111' ' ' GLN . . . -56.46 -46.38 80.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 44.52 111.083 179.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.485 ' HB2' HG23 ' A' ' 107' ' ' THR . 21.5 p30 39.14 -157.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.254 -0.43 . . . . 62.23 110.912 -179.918 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.577 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -141.44 10.99 2.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 64.24 111.11 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.9 -65.61 0.4 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.723 -0.751 . . . . 64.32 112.512 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.577 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.8 Cg_endo -69.78 -152.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.711 2.274 . . . . 53.55 112.314 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' H ' ' HB2' ' A' ' 105' ' ' PRO . 79.6 m-20 -82.34 81.05 8.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 64.23 110.888 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 102' ' ' ASN . 5.3 t -153.22 56.77 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 51.43 111.111 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -46.89 -44.51 19.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 32.04 110.898 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 48.18 -164.74 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.734 -0.746 . . . . 33.25 112.452 179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.96 87.82 2.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.809 0.338 . . . . 72.04 110.866 -179.733 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.509 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 25.2 tt0 -161.15 51.05 0.25 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.924 -179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.447 ' CB ' HD23 ' A' ' 98' ' ' LEU . 2.8 p90 -59.83 -172.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 70.1 110.898 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -158.62 106.87 1.91 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.171 -0.468 . . . . 75.1 110.927 -179.934 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.464 HD11 ' HZ ' ' A' ' 22' ' ' PHE . 76.8 mt -48.17 123.36 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.141 -0.481 . . . . 74.52 111.122 -179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 89.7 m -84.29 116.5 23.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 74.12 110.868 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 41.9 p -88.18 -30.69 19.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.11 111.155 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -122.13 161.02 23.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.2 -0.454 . . . . 71.21 111.085 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -62.22 102.3 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 50.03 110.921 179.928 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.823 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 18.6 p -113.89 46.0 1.38 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 71.13 111.175 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -16.79 9.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 72.53 110.827 -179.951 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.823 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.9 OUTLIER -64.12 -15.51 59.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.939 -179.942 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 11.5 mt -112.99 78.29 1.12 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 72.02 110.942 179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -113.92 -47.79 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.18 -0.464 . . . . 54.33 110.871 179.832 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -87.87 45.17 3.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 45.41 112.499 -179.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -145.25 -53.76 0.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.799 0.333 . . . . 70.35 110.906 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 38.5 m-70 -101.68 134.76 44.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.802 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 70.1 t -83.47 104.83 12.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 71.22 111.119 179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 98' ' ' LEU . 90.8 t -78.41 132.5 32.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 73.12 111.131 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.536 ' HA ' HG21 ' A' ' 29' ' ' VAL . 19.5 p90 -152.94 26.02 0.55 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.884 -179.981 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 98' ' ' LEU . . . -161.4 -170.53 26.2 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.701 -0.762 . . . . 71.23 112.466 -179.95 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.7 ttpp 178.73 -169.43 0.1 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.841 0.353 . . . . 64.32 110.926 -179.951 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 16.4 t -116.35 81.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.441 . . . . 73.22 111.139 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.2 ttmm -49.2 -34.56 15.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.919 179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -171.02 168.28 6.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 74.54 110.873 179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 98.83 -1.6 58.1 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.714 -0.755 . . . . 71.02 112.466 -179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.94 -33.54 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 70.22 110.934 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 41.7 m-20 -50.58 -27.03 6.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.472 . . . . 71.02 110.905 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.464 ' O ' ' HB3' ' A' ' 141' ' ' ALA . 17.6 mm -81.58 -45.61 20.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 72.25 111.145 179.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 53.2 t -50.06 -51.19 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.121 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -52.01 -27.74 14.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 70.24 110.891 -179.968 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 138' ' ' ILE . . . -71.83 -47.57 52.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.494 . . . . 75.5 111.109 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.454 ' SD ' HD13 ' A' ' 156' ' ' ILE . 62.1 mtm -62.96 -24.51 67.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.179 -0.464 . . . . 64.34 110.863 -179.979 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.437 ' HB3' ' HB3' ' A' ' 58' ' ' PRO . 6.3 mm-40 -51.42 -71.71 0.06 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 75.22 110.898 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -60.0 -16.68 32.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.167 -0.47 . . . . 74.22 110.883 -179.963 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.406 ' HB2' ' HA ' ' A' ' 142' ' ' MET . 11.8 m-85 -92.51 2.16 56.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 72.01 110.854 -179.873 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.63 ' HA3' HG22 ' A' ' 56' ' ' ILE . . . -127.62 46.77 1.06 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.704 -0.76 . . . . 75.24 112.504 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 146' ' ' GLY . 8.1 t 34.89 -146.68 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.872 0.368 . . . . 61.12 110.886 -179.736 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.9 mmm-85 -133.62 -35.44 0.99 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 72.14 110.903 -179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -99.45 -8.3 24.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 75.01 110.926 -179.995 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.57 80.35 0.91 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.754 -0.736 . . . . 61.43 112.483 179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.97 -60.42 0.63 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.817 0.341 . . . . 75.05 110.874 179.991 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 66.43 133.43 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 50.01 111.126 179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.03 -9.02 26.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 63.03 110.877 -179.878 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -137.48 156.65 47.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 73.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.76 118.64 32.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 64.3 110.891 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.454 HD13 ' SD ' ' A' ' 142' ' ' MET . 12.7 mt -88.59 134.47 28.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 73.24 111.15 179.857 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.16 170.45 14.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 71.43 111.145 179.97 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.593 HD13 ' CE2' ' A' ' 8' ' ' PHE . 67.1 mt -118.7 111.36 33.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 72.33 111.156 179.92 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.538 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -60.59 -54.96 39.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 63.11 111.131 179.828 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -167.6 168.84 12.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 75.52 110.908 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 13.3 p -156.49 163.76 39.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.438 . . . . 65.1 110.867 -179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -177.72 -178.85 47.59 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.73 -0.748 . . . . 74.32 112.456 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.527 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 9.5 mt-30 -69.32 -37.23 77.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.822 0.344 . . . . 61.55 110.94 -179.875 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.546 HD21 ' CD1' ' A' ' 7' ' ' PHE . 2.5 mm? 71.14 -62.43 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 65.22 110.885 179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 74.1 110.877 179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.827 0.346 . . . . 64.33 110.852 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.9 155.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 51.15 111.104 179.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -104.37 149.25 37.15 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.604 0.716 . . . . 75.34 110.9 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.77 130.81 19.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.681 2.254 . . . . 54.1 112.366 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.632 HG21 HD22 ' A' ' 164' ' ' LEU . 57.4 m -119.6 124.91 47.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.132 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 3.2 m -104.95 144.66 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 75.25 111.108 179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -105.05 154.94 19.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 73.41 110.866 -179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -140.33 131.52 26.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 73.21 110.89 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.52 95.07 5.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.885 179.942 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.753 HD12 ' CG2' ' A' ' 138' ' ' ILE . 17.3 mt -78.92 141.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 62.42 111.144 -179.988 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -122.83 159.94 27.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.154 -0.475 . . . . 70.1 111.122 179.834 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.8 t -133.31 106.29 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 75.24 111.095 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.7 t0 51.45 55.44 9.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 62.2 110.879 179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.51 9.84 33.39 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 22.41 112.512 -179.923 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -136.0 93.84 14.96 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.685 0.755 . . . . 72.34 110.87 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 156.02 64.22 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.694 2.262 . . . . 64.12 112.313 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.512 HD12 ' H ' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -127.18 26.99 5.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.207 -0.451 . . . . 71.52 110.942 179.972 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 124.9 169.28 12.94 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.74 -0.743 . . . . 61.32 112.488 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.58 171.52 12.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.869 0.366 . . . . 72.04 110.845 -179.863 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 138' ' ' ILE . 17.6 m -143.3 -176.93 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 61.44 111.158 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 59.7 p -148.11 154.77 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 74.53 110.824 -179.811 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -124.36 134.1 53.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 75.34 110.878 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 24' ' ' LEU . 2.1 tt0 -73.98 -55.03 6.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 70.1 110.888 -179.924 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 3.3 mt 76.8 124.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 64.42 110.961 -179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CD2' HD13 ' A' ' 90' ' ' LEU . 81.6 m-85 -81.76 55.28 2.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 71.14 110.877 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -36.52 79.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 72.43 111.113 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -62.44 -51.61 66.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.184 -0.462 . . . . 74.32 110.878 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.5 -60.49 3.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.207 -0.451 . . . . 74.03 110.891 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.3 m -113.55 82.51 6.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.589 0.709 . . . . 74.2 111.135 179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 60.94 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.704 2.269 . . . . 41.23 112.355 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.5 -71.9 0.1 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 62.23 110.874 179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.66 HG23 ' HE3' ' A' ' 100' ' ' MET . 27.3 m -58.34 -53.71 55.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 53.34 111.149 179.999 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HB2' ' CD2' ' A' ' 129' ' ' PHE . . . -86.83 9.52 18.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 71.5 111.106 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -88.95 -24.54 22.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 61.51 110.872 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.57 -29.76 14.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.859 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.469 ' HA ' HD12 ' A' ' 39' ' ' LEU . 7.7 t80 -50.59 -28.4 8.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 74.4 110.868 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.44 ' O ' HG23 ' A' ' 41' ' ' THR . 15.0 ptp180 -56.66 -30.71 63.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.151 -0.477 . . . . 71.25 110.861 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.79 -31.79 19.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 72.42 111.081 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 78' ' ' ILE . 67.1 mt -65.19 -47.85 75.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.235 -0.438 . . . . 65.4 110.962 179.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 1.4 m -65.22 -37.41 87.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.469 . . . . 74.42 110.857 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.44 HG23 ' O ' ' A' ' 37' ' ' ARG . 65.4 p -73.88 -19.66 60.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.122 -0.49 . . . . 73.13 111.184 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 53.6 91.44 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.743 -0.741 . . . . 64.52 112.457 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.66 36.21 0.63 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.901 0.381 . . . . 64.51 110.886 -179.902 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.99 6.63 2.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.135 -0.484 . . . . 75.32 110.886 -179.98 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 82.74 9.7 84.22 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.762 -0.732 . . . . 71.22 112.526 -179.996 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -174.16 -169.17 0.45 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.883 0.373 . . . . 72.41 110.886 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 127.53 -80.2 0.36 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 65.33 112.507 -179.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -176.8 110.61 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.977 0.418 . . . . 74.33 110.889 -179.85 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.6 -179.03 5.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 74.54 110.938 179.877 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.425 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -45.2 104.23 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.694 -0.765 . . . . 34.12 112.507 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 63.3 p -159.74 54.93 0.37 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.862 0.363 . . . . 62.22 110.865 -179.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' H ' HG22 ' A' ' 157' ' ' THR . 18.8 m 52.3 -173.39 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.172 -0.467 . . . . 62.2 110.908 -179.921 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -109.19 -168.84 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.231 -0.44 . . . . 74.43 110.839 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -115.56 -77.04 0.57 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 72.14 110.857 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -135.44 143.38 45.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 54.35 110.875 -179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 52.6 mt -143.78 125.86 11.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 64.32 111.134 179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.698 HD11 ' CE ' ' A' ' 61' ' ' MET . 1.1 pt -134.28 114.11 12.46 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 70.22 111.15 179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.8 108.99 2.21 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.682 2.255 . . . . 73.15 112.334 179.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 122.2 -31.28 4.95 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.763 -0.732 . . . . 54.23 112.516 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.599 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.2 OUTLIER -99.96 -63.2 1.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.857 0.361 . . . . 75.11 110.854 -179.852 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.698 ' CE ' HD11 ' A' ' 57' ' ' ILE . 0.0 OUTLIER 179.81 -165.25 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 75.12 110.853 179.975 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 36.3 m -142.19 115.04 8.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 63.1 110.925 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -99.36 151.06 21.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 54.3 110.908 -179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -123.48 159.9 18.06 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.687 -0.768 . . . . 72.35 112.433 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -105.37 100.66 1.76 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.723 -0.751 . . . . 62.35 112.486 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.97 150.72 40.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.815 0.341 . . . . 73.44 110.854 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 60.79 164.44 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 64.54 110.862 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.9 p -146.64 34.34 0.94 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.485 . . . . 53.4 111.12 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 65.63 34.08 7.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.24 110.873 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -51.81 -38.98 57.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.897 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -176.52 40.09 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 73.12 110.915 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.49 168.06 39.93 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.754 -0.736 . . . . 75.34 112.483 179.975 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 95.0 m -115.02 92.02 3.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.833 0.349 . . . . 54.42 111.168 -179.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 137.23 179.91 17.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.751 -0.738 . . . . 72.13 112.529 -179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -120.12 159.24 15.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 65.11 112.474 -179.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 77' ' ' SER . 16.6 ptpt -176.86 -173.35 0.48 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.754 0.312 . . . . 72.02 110.921 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 76' ' ' LYS . 61.2 p -87.75 -167.94 2.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 73.34 110.811 -179.842 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.517 HG23 HD21 ' A' ' 39' ' ' LEU . 2.6 pp -111.85 11.19 8.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 64.4 111.121 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.77 -7.71 25.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.145 -0.479 . . . . 72.43 110.919 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 147.05 -84.72 0.18 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.756 -0.735 . . . . 75.11 112.451 179.969 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.4 -68.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.919 0.39 . . . . 71.35 110.864 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -167.78 163.58 14.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.462 . . . . 52.21 110.883 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -130.6 144.15 51.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.44 110.856 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.13 159.62 0.27 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 73.01 110.878 -179.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -64.6 -167.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 73.33 110.863 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -148.36 -67.35 0.24 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 75.41 110.893 -179.92 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.62 ' O ' HG23 ' A' ' 127' ' ' VAL . 6.4 p30 -176.93 171.88 2.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 64.33 110.935 -179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -129.97 43.35 3.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 65.45 110.868 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.7 mt -51.01 -27.8 5.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 50.34 111.132 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.59 ' HB2' HG13 ' A' ' 128' ' ' VAL . 3.8 mt -96.6 137.39 35.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.177 -0.465 . . . . 70.24 110.899 179.922 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -126.93 114.09 17.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 75.52 110.917 179.827 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.455 ' CE1' ' HB3' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -55.97 102.04 0.07 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 74.13 110.837 179.895 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.2 p -113.76 42.45 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 72.3 111.153 -179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.89 156.67 14.61 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.749 -0.739 . . . . 43.11 112.517 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.8 128.08 15.49 Favored 'Trans proline' 0 N--CA 1.466 -0.103 0 C-N-CA 122.69 2.26 . . . . 73.21 112.33 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 120.9 -22.1 8.17 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.723 -0.751 . . . . 63.41 112.504 -179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.403 HG21 ' HB3' ' A' ' 92' ' ' HIS . 20.9 mm -65.82 152.05 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 52.31 111.117 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.78 HD12 ' HA3' ' A' ' 130' ' ' GLY . 32.0 mt -96.12 132.18 41.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 74.4 110.941 179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 9.0 m -119.67 138.66 53.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 74.42 110.816 -179.915 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.66 ' HE3' HG23 ' A' ' 32' ' ' THR . 0.0 OUTLIER -77.57 172.48 13.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 62.01 110.86 179.924 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.592 ' HB2' ' HE1' ' A' ' 113' ' ' PHE . . . -166.13 -175.07 3.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 52.44 111.094 179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 12.0 t30 88.6 95.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.887 -179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.599 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . 66.18 -75.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 73.24 111.08 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.478 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 121.49 -59.96 0.56 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.708 -0.758 . . . . 71.43 112.462 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.599 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.3 Cg_endo -69.83 100.15 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.676 2.251 . . . . 64.11 112.301 -179.909 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 60.6 m-80 44.8 56.33 5.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 64.41 110.84 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -132.0 7.14 4.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 73.2 111.116 179.999 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m120 41.29 -92.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 74.24 110.913 179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.483 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 97.43 139.16 10.53 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.759 -0.734 . . . . 55.14 112.472 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.2 p -100.61 -8.89 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.839 0.352 . . . . 65.22 110.896 -179.786 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 129.82 35.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.089 -0.505 . . . . 73.54 110.934 -179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -132.05 138.69 48.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 62.41 110.903 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.592 ' HE1' ' HB2' ' A' ' 101' ' ' ALA . 14.2 p90 -120.2 121.64 39.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.481 . . . . 74.2 110.883 -179.858 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 mt -92.35 119.26 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.107 -179.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -76.27 150.97 36.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.215 -0.448 . . . . 74.45 110.84 179.97 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 17.7 p -126.55 23.75 6.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 72.42 111.124 -179.871 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -161.72 20.63 0.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.448 . . . . 65.13 111.111 179.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER 64.97 135.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 71.23 110.891 179.989 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.518 HG22 ' CZ3' ' A' ' 121' ' ' TRP . 21.8 p -148.95 68.84 1.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 71.15 111.129 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -84.37 14.3 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 75.25 110.868 -179.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.518 ' CZ3' HG22 ' A' ' 119' ' ' THR . 3.2 p90 -91.39 0.33 57.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.161 -0.472 . . . . 75.44 110.955 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.56 31.88 1.48 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 54.52 110.871 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.455 ' HB3' ' CE1' ' A' ' 92' ' ' HIS . 22.5 p-10 -96.26 78.81 3.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 74.02 110.847 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -173.79 -41.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.763 -0.732 . . . . 34.41 112.485 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.61 -35.75 73.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.828 0.347 . . . . 64.21 110.898 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -117.37 159.3 22.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 62.11 110.831 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.797 HG13 ' N ' ' A' ' 128' ' ' VAL . 1.1 p -81.05 -159.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.202 -0.454 . . . . 54.23 111.087 179.998 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.797 ' N ' HG13 ' A' ' 127' ' ' VAL . 0.9 OUTLIER -165.36 144.32 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 54.25 111.128 179.951 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.632 ' CD2' ' HB2' ' A' ' 33' ' ' ALA . 27.7 p90 -175.99 115.32 0.13 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.487 . . . . 64.34 110.905 179.994 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.78 ' HA3' HD12 ' A' ' 98' ' ' LEU . . . 114.87 114.5 3.01 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.714 -0.755 . . . . 71.25 112.488 -179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.39 143.14 50.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.871 0.367 . . . . 52.41 110.861 -179.981 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.447 HG21 HG21 ' A' ' 139' ' ' VAL . 69.5 t -52.53 98.01 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 74.44 111.126 179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.44 -56.78 16.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 55.04 110.899 179.912 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.09 170.8 15.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.872 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.405 ' HA3' HG12 ' A' ' 20' ' ' VAL . . . 63.37 82.45 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.719 -0.753 . . . . 42.41 112.463 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 8.7 tpt -89.17 11.09 19.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.722 0.296 . . . . 73.45 110.832 -179.988 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -89.69 -34.3 16.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 71.2 110.905 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.753 ' CG2' HD12 ' A' ' 10' ' ' ILE . 39.4 mm -60.18 -38.38 76.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.139 -0.482 . . . . 73.24 111.116 179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 139' ' ' VAL . 14.5 t -90.63 -3.01 10.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 63.42 111.122 179.866 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.2 mm-40 -110.66 -71.83 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 74.44 110.9 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -49.75 -52.07 34.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 72.54 111.119 179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.443 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 13.7 tmm? -51.43 -29.16 15.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 74.21 110.862 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -79.54 29.7 0.24 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.278 -0.419 . . . . 71.24 110.854 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 15.6 ttp85 -113.51 -14.39 12.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 73.31 110.884 -179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -105.77 -2.46 23.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 -179.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -69.37 -157.46 1.48 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.752 -0.737 . . . . 62.12 112.483 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.524 ' O ' HG22 ' A' ' 57' ' ' ILE . 4.8 t -163.79 141.77 7.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.867 0.365 . . . . 60.14 110.868 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -57.46 -20.15 28.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.145 -0.48 . . . . 72.51 110.855 -179.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.09 -17.87 25.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 63.45 110.902 -179.946 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 116.93 -42.0 1.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.708 -0.758 . . . . 70.01 112.506 179.986 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 26.7 tttm -46.41 131.6 10.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.894 0.378 . . . . 73.22 110.882 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 43.7 p -96.52 112.66 24.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 70.21 111.144 179.961 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 50.1 m -49.8 -28.1 5.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 33.22 110.841 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -125.11 -162.26 1.09 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 62.34 110.939 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.441 ' HG3' HG23 ' A' ' 157' ' ' THR . 1.3 tppm? -128.37 129.25 45.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 63.01 110.909 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 10' ' ' ILE . 3.3 mp -112.36 92.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.223 -0.444 . . . . 73.42 111.133 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.528 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 25.0 p -103.17 148.66 25.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 55.03 111.142 179.974 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.425 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.8 mt -88.82 130.5 38.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 72.24 111.134 179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -91.89 -64.79 1.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.194 -0.457 . . . . 72.34 111.08 179.841 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -127.02 170.63 12.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.35 110.816 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.48 -174.89 2.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 74.53 110.862 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 135.36 -148.59 19.66 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.721 -0.752 . . . . 52.32 112.44 -179.939 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 0.0 OUTLIER -106.74 133.91 50.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 73.24 110.9 -179.866 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.632 HD22 HG21 ' A' ' 5' ' ' THR . 3.2 tp -56.78 -57.09 13.98 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.2 110.866 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.12 110.912 179.95 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.809 0.337 . . . . 73.42 110.887 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.0 t -137.35 138.39 45.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 50.21 111.121 179.939 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -57.41 157.28 13.44 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.65 0.738 . . . . 73.41 110.882 -179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 122.0 8.68 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.683 2.256 . . . . 74.35 112.318 179.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.464 ' HB ' ' H ' ' A' ' 165' ' ' GLU . 14.4 m -100.85 55.99 0.87 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.181 -0.463 . . . . 71.22 111.128 -179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -52.26 154.98 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 73.52 111.077 179.918 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.2 OUTLIER -136.56 170.8 15.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 74.12 110.861 -179.988 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.49 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.2 OUTLIER -142.0 143.88 33.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.128 -0.487 . . . . 71.23 110.902 -179.914 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -104.45 115.95 31.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.179 -0.464 . . . . 75.35 110.86 179.95 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.7 mm -85.73 123.07 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 43.15 111.129 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.19 13.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 65.31 111.097 179.818 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' CB ' ' A' ' 13' ' ' ASP . 1.7 m -144.21 101.92 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 72.05 111.109 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 3.7 t0 76.71 45.61 0.09 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 70.55 110.901 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 24.02 70.6 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 72.32 112.452 -179.944 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -135.27 148.7 67.4 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 73.52 110.92 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 140.13 41.91 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.68 2.253 . . . . 43.12 112.358 -179.986 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.623 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.4 tp -127.39 -38.12 1.97 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.236 -0.438 . . . . 74.13 110.913 179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 173.24 -178.51 45.17 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.741 -0.742 . . . . 43.45 112.482 179.876 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.63 162.25 35.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.849 0.357 . . . . 73.51 110.847 -179.819 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.5 m -142.54 147.6 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 73.25 111.119 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.23 97.82 11.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.911 -179.867 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -85.0 59.61 5.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.12 110.846 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HB2' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -49.79 115.45 1.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 71.34 110.865 -179.9 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.542 HD21 ' CD2' ' A' ' 36' ' ' PHE . 5.9 mt -81.83 133.2 35.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.123 -0.489 . . . . 74.11 110.927 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.553 ' CD2' HD13 ' A' ' 90' ' ' LEU . 71.2 m-85 -75.8 67.31 2.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 74.03 110.855 179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.18 -14.82 57.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.126 -0.488 . . . . 73.44 111.095 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.09 -60.26 2.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.24 -0.436 . . . . 73.44 110.854 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.07 -67.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 51.53 110.924 -179.995 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.512 ' HB ' ' HB ' ' A' ' 32' ' ' THR . 3.2 m -105.95 114.46 62.65 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.686 0.755 . . . . 64.14 111.107 179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 31' ' ' LYS . 53.7 Cg_endo -69.77 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.705 2.27 . . . . 63.53 112.319 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 30' ' ' PRO . 7.9 mtmm -38.33 -54.68 1.42 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 73.32 110.849 179.939 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.512 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 55.8 m -39.51 -58.09 1.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.255 -0.429 . . . . 73.4 111.145 -180.0 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -102.98 30.85 4.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 70.03 111.074 179.839 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.9 tp10 -97.24 -30.64 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.24 -0.436 . . . . 73.41 110.846 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -91.03 -35.53 14.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.465 . . . . 64.13 110.9 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.542 ' CD2' HD21 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -48.22 -31.62 6.06 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.932 179.981 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -35.82 70.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.131 -0.486 . . . . 75.43 110.872 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.29 -21.75 27.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 53.52 111.133 179.881 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.532 HD12 ' CD1' ' A' ' 36' ' ' PHE . 73.7 mt -70.23 -51.36 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.207 -0.451 . . . . 63.43 110.892 -179.967 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.3 m -68.18 -44.69 75.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.165 -0.47 . . . . 74.12 110.885 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 48.2 p -74.96 -24.07 58.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.142 -0.481 . . . . 41.45 111.157 -179.912 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 59.34 94.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.486 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -158.76 47.53 0.33 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.948 0.404 . . . . 61.05 110.933 -179.845 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.92 33.92 1.96 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.473 . . . . 75.2 110.868 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.63 -3.4 49.45 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.765 -0.731 . . . . 74.53 112.495 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -163.0 -168.66 1.81 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 73.13 110.862 -179.892 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 124.69 137.39 4.81 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.679 -0.772 . . . . 73.1 112.468 -179.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.9 p90 -85.21 144.27 28.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.951 0.405 . . . . 74.25 110.94 -179.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.36 -57.66 2.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 75.51 110.869 179.946 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.419 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -114.26 -76.23 0.69 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.786 -0.721 . . . . 71.51 112.513 179.916 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.3 t 68.82 123.06 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.902 0.382 . . . . 43.22 110.841 -179.744 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.0 p -59.51 -171.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 72.24 110.849 -179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.439 ' CZ ' HG21 ' A' ' 152' ' ' THR . 27.1 p90 -104.81 -170.82 1.82 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.477 . . . . 62.23 110.922 -179.928 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.57 -60.09 1.89 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.11 110.828 -179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -151.66 160.14 43.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.23 110.842 -179.862 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.1 mt -136.82 130.52 46.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.178 -0.465 . . . . 73.13 111.151 179.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -130.22 110.23 16.63 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.601 0.715 . . . . 75.22 111.149 179.836 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 148' ' ' ARG . 53.7 Cg_endo -69.83 101.72 0.95 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.609 2.206 . . . . 73.32 112.337 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.45 15.62 22.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.697 -0.764 . . . . 53.41 112.511 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.446 ' O ' HG21 ' A' ' 119' ' ' THR . 0.1 OUTLIER -138.5 -63.85 0.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.844 0.354 . . . . 74.23 110.912 -179.878 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.73 -168.39 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.161 -0.472 . . . . 60.53 110.846 179.986 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.796 ' HB2' HG23 ' A' ' 114' ' ' ILE . 9.0 m -150.04 131.5 14.75 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.19 -0.459 . . . . 74.55 110.92 -179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -111.92 139.57 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 72.23 110.899 -179.843 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.61 -159.31 27.05 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.762 -0.732 . . . . 53.02 112.519 -179.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.51 20.03 76.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.699 -0.762 . . . . 72.42 112.516 -179.915 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.74 102.39 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.823 0.344 . . . . 71.04 110.864 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -100.83 40.12 1.31 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 73.21 110.861 -179.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -66.07 150.34 48.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 73.3 111.189 -179.957 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 70' ' ' HIS . 0.0 OUTLIER 70.86 2.32 4.14 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 65.32 110.919 -179.926 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.419 ' C ' ' O ' ' A' ' 69' ' ' ARG . 73.0 t60 -37.13 -67.71 0.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 73.31 110.89 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 t30 -172.62 70.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 73.51 110.873 -179.937 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.76 35.54 92.04 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.794 -0.717 . . . . 72.35 112.506 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 68.7 p -128.29 -58.03 1.21 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.786 0.327 . . . . 73.23 111.149 -179.903 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 87.96 -176.82 45.99 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.777 -0.725 . . . . 72.21 112.469 179.966 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.36 110.7 3.31 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.737 -0.744 . . . . 43.41 112.492 -179.887 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.19 -167.34 0.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.771 0.32 . . . . 64.52 110.926 179.992 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -82.61 -179.44 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 71.23 110.843 -179.853 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 15.5 pt -81.26 -39.17 17.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.125 -0.488 . . . . 64.31 111.134 179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -96.68 93.93 7.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.469 . . . . 63.21 110.941 -179.994 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.36 -119.51 5.17 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.723 -0.751 . . . . 24.42 112.453 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -128.43 -84.5 0.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.892 0.377 . . . . 63.24 110.903 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.32 152.66 44.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 75.3 110.926 179.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.71 148.81 43.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.924 179.945 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -49.17 157.77 0.42 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.454 . . . . 73.51 110.892 -179.899 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -68.08 144.17 55.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 61.32 110.892 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.85 -61.24 1.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.221 -0.445 . . . . 74.0 110.858 -179.892 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -179.64 167.99 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 73.02 110.902 -179.927 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -129.46 60.6 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 75.01 110.875 179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' ' 89' ' ' ILE . 30.6 mm -73.37 -6.86 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.136 -0.484 . . . . 72.12 111.165 179.929 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.553 HD13 ' CD2' ' A' ' 25' ' ' PHE . 0.8 OUTLIER -117.99 81.52 1.68 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 70.3 110.922 179.911 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.1 mmtm -66.93 161.54 23.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.461 . . . . 75.25 110.882 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -71.41 75.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 74.12 110.834 179.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.7 p -70.93 -12.28 61.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 74.41 111.153 -179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 175.14 -170.09 43.09 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.697 -0.763 . . . . 70.45 112.483 179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 128.04 15.48 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.694 2.263 . . . . 74.44 112.339 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 126.88 -31.4 3.92 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.781 -0.723 . . . . 73.43 112.511 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.0 mm -61.27 139.54 20.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.366 . . . . 70.32 111.129 -179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.424 HD21 ' CE2' ' A' ' 112' ' ' PHE . 50.6 mt -108.28 159.64 16.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 64.14 110.938 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 2.6 m -158.96 33.84 0.21 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 63.24 110.858 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.493 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 0.6 OUTLIER 47.17 -167.6 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 73.15 110.877 179.928 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.544 ' HB3' ' CG ' ' A' ' 111' ' ' GLN . . . -172.46 75.85 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 60.42 111.165 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -116.23 -73.67 0.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 75.43 110.88 -179.883 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.642 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -147.64 -36.65 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 61.2 111.122 179.836 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 118.06 -69.78 0.31 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.719 -0.753 . . . . 61.11 112.512 -179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.529 ' HD2' ' C ' ' A' ' 103' ' ' ALA . 53.6 Cg_endo -69.74 108.53 2.1 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.705 2.27 . . . . 73.22 112.33 -179.932 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 45.52 38.39 3.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.243 -0.435 . . . . 73.11 110.879 -179.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.642 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 1.1 p -138.04 56.79 1.73 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.186 -0.461 . . . . 63.03 111.152 179.962 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -39.34 -57.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 73.23 110.893 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 82.8 -170.84 50.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 74.13 112.46 179.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.493 ' HA ' ' HE2' ' A' ' 100' ' ' MET . 34.2 t -144.68 25.78 1.45 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.828 0.347 . . . . 61.14 110.826 -179.722 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.544 ' CG ' ' HB3' ' A' ' 101' ' ' ALA . 4.7 tt0 -79.65 -100.53 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 73.13 110.88 -179.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.424 ' CE2' HD21 ' A' ' 98' ' ' LEU . 0.0 OUTLIER 170.66 179.91 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 52.51 110.888 -179.936 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -170.62 38.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 61.23 110.905 -179.905 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.796 HG23 ' HB2' ' A' ' 62' ' ' CYS . 8.0 tt -58.27 91.59 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 65.4 111.14 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 74.3 m -68.9 142.11 54.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 74.04 110.907 179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.624 HG21 ' CD ' ' A' ' 143' ' ' GLU . 11.4 p -111.4 22.34 15.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 64.23 111.154 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.483 ' O ' HG23 ' A' ' 119' ' ' THR . . . -176.75 161.24 2.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 54.24 111.116 179.88 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 95.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 75.42 110.914 179.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 117' ' ' ALA . 34.5 p -125.12 59.46 1.24 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 34.44 111.119 -179.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.22 30.63 2.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.2 110.929 179.981 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.479 ' CZ2' HG22 ' A' ' 119' ' ' THR . 0.6 OUTLIER -92.47 7.27 43.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 72.4 110.902 -179.979 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 14.2 mt -96.11 -10.16 28.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 71.01 110.915 -179.973 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 51.59 78.42 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 75.12 110.876 179.875 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 38.82 50.54 2.56 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.794 -0.717 . . . . 63.23 112.481 -179.925 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -58.27 -33.01 68.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.846 0.355 . . . . 72.14 110.886 -179.98 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.8 m-70 -143.85 177.68 8.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 71.24 110.877 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -61.91 -162.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 73.15 111.12 179.993 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.666 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.6 p -174.47 138.46 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 75.43 111.149 179.912 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.507 ' CG ' ' O ' ' A' ' 129' ' ' PHE . 3.7 p90 178.6 102.98 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 73.25 110.843 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 118.56 127.11 3.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.739 -0.743 . . . . 62.42 112.485 -179.978 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -159.01 151.71 21.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.805 0.336 . . . . 63.31 110.892 179.979 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.644 HG11 HG21 ' A' ' 139' ' ' VAL . 25.5 m -49.56 159.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 61.52 111.138 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 11.3 mttm -160.86 -39.6 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 72.35 110.904 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -63.54 1.26 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.206 -0.452 . . . . 72.24 110.881 179.99 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -166.19 105.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.723 -0.751 . . . . 50.41 112.471 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -69.53 -6.78 33.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.776 0.322 . . . . 71.52 110.869 -179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 29.7 m-20 -57.61 -20.39 32.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 54.32 110.87 -179.949 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 35.8 mm -91.74 -45.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 74.41 111.105 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.644 HG21 HG11 ' A' ' 132' ' ' VAL . 95.9 t -54.71 -20.95 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 71.12 111.115 179.927 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -83.92 -32.88 24.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 63.1 110.925 179.991 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -55.59 -31.28 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.123 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -86.02 -9.48 56.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 61.34 110.88 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.624 ' CD ' HG21 ' A' ' 116' ' ' THR . 4.0 mm-40 -89.88 28.94 1.26 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.869 -179.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -145.17 8.04 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 55.44 110.891 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -132.66 2.28 3.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.02 110.903 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.626 ' HA2' HG22 ' A' ' 152' ' ' THR . . . -110.17 72.57 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.769 -0.729 . . . . 73.33 112.516 -179.931 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.564 ' C ' ' O ' ' A' ' 146' ' ' GLY . 1.1 m -23.7 134.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.867 0.365 . . . . 50.14 110.877 -179.723 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.441 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 27.2 mmm-85 -47.96 -44.91 30.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.104 -0.498 . . . . 72.34 110.857 -179.944 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -49.11 -27.45 3.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 51.33 110.867 -179.922 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 129.46 -37.59 2.16 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.783 -0.723 . . . . 75.23 112.507 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -61.66 140.39 58.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.89 0.376 . . . . 71.14 110.916 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.626 HG22 ' HA2' ' A' ' 146' ' ' GLY . 68.1 p -118.13 147.92 42.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.254 -0.43 . . . . 60.44 111.134 -179.978 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -76.32 -21.03 56.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 54.03 110.815 -179.807 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -131.9 -168.35 2.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 55.13 110.853 179.984 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -132.14 132.15 42.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.173 -0.467 . . . . 60.3 110.922 179.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 3.6 mp -98.71 127.38 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 71.04 111.128 179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -133.86 168.75 18.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 42.23 111.136 179.991 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 8' ' ' PHE . 2.4 mt -129.26 113.62 28.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 65.15 111.139 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -60.15 -51.53 69.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 54.44 111.073 179.84 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.92 -178.44 6.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 71.14 110.846 -179.997 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 1.7 p -176.62 178.76 1.22 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 54.52 110.925 -179.889 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 158.4 -163.63 33.06 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 62.4 112.476 -179.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -81.56 123.3 28.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.801 0.334 . . . . 72.32 110.946 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 7' ' ' PHE . 0.4 OUTLIER -98.93 -74.84 0.57 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 63.22 110.892 -179.942 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' H ' ' HB ' ' A' ' 5' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.465 . . . . 74.35 110.919 179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.805 0.336 . . . . 73.42 110.858 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 62.78 156.53 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 74.03 111.124 179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -87.9 150.85 48.75 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.637 0.732 . . . . 71.25 110.875 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 24' ' ' LEU . 53.8 Cg_endo -69.79 153.19 69.09 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.685 2.256 . . . . 74.12 112.34 179.982 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.49 162.7 32.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 70.43 111.161 -179.951 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 0.1 OUTLIER -150.05 132.91 6.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 53.42 111.156 179.886 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -110.98 161.9 15.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.884 179.98 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CE2' HD13 ' A' ' 158' ' ' ILE . 6.1 m-85 -143.52 133.06 23.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 73.44 110.85 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -98.25 82.29 2.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 63.35 110.88 179.936 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 mp -58.7 142.15 14.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 74.54 111.098 -179.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -139.31 159.94 40.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 74.23 111.124 179.77 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG22 HG12 ' A' ' 156' ' ' ILE . 96.9 t -137.64 99.63 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 44.44 111.124 -179.976 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.29 33.61 8.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.157 -0.474 . . . . 74.54 110.862 179.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.45 -15.0 64.1 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.764 -0.732 . . . . 62.52 112.467 -179.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -97.52 109.66 51.41 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.597 0.713 . . . . 64.42 110.912 -179.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.7 Cg_endo -69.78 145.04 55.83 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.671 2.247 . . . . 64.32 112.358 -179.991 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.2 mp -98.88 -66.58 0.89 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 61.2 110.857 -179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -163.82 -172.03 30.79 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.733 -0.746 . . . . 63.02 112.491 179.94 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.89 121.76 42.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.823 0.344 . . . . 75.25 110.849 -179.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.892 HG22 HG21 ' A' ' 138' ' ' ILE . 1.3 t -109.45 105.86 19.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 54.15 111.112 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 79.1 p -98.84 142.06 30.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 72.45 110.826 -179.829 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -119.61 162.87 18.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 75.33 110.874 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 56.9 tt0 -106.61 139.97 40.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 54.35 110.896 -179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 4' ' ' PRO . 41.3 mt -111.05 107.37 16.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 55.42 110.935 179.971 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -85.22 71.61 10.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.441 . . . . 62.52 110.878 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.3 -24.55 64.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 64.22 111.082 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.57 -34.44 76.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.233 -0.439 . . . . 64.2 110.912 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 9.1 mttm -103.31 -32.16 9.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 71.02 110.917 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.1 OUTLIER -128.4 67.19 75.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.591 0.71 . . . . 65.15 111.161 179.888 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.7 -3.37 11.85 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.667 2.245 . . . . 73.2 112.371 179.937 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.0 -42.87 8.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 75.41 110.884 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 82.6 p -85.59 -41.09 15.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.259 -0.428 . . . . 74.11 111.164 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -48.97 -73.56 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 60.14 111.082 179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' O ' ' C ' ' A' ' 35' ' ' ASN . 16.7 tt0 -53.15 -64.88 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 64.11 110.893 -179.94 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 34' ' ' GLU . 7.2 t30 -31.66 -46.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 64.41 110.905 -179.914 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -78.75 -43.29 25.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.04 110.893 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.467 ' N ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -55.38 -33.23 63.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 72.12 110.884 -179.888 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.74 -46.68 77.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.201 -0.454 . . . . 62.42 111.153 179.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 48' ' ' TYR . 0.3 OUTLIER -85.98 39.24 0.8 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.2 -0.454 . . . . 75.02 110.927 179.997 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 4.8 p -112.98 -15.15 12.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 75.33 110.808 -179.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.2 p -123.17 10.52 9.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 61.12 111.135 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 57.79 29.46 61.63 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.776 -0.726 . . . . 72.42 112.467 179.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -81.07 -26.49 36.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.93 0.395 . . . . 55.35 110.89 -179.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tppm? -67.56 -10.14 49.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 63.55 110.925 179.943 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 87.29 -18.51 36.66 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 72.12 112.472 179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -85.74 -31.03 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.867 0.365 . . . . 75.25 110.854 -179.844 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 52.32 -176.61 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.73 -0.748 . . . . 45.22 112.496 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.733 ' HB2' HD11 ' A' ' 39' ' ' LEU . 2.4 t80 -175.48 -35.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.946 0.403 . . . . 75.24 110.932 -179.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' A' ' 48' ' ' TYR . 6.1 ptmt -27.08 111.08 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.12 -0.491 . . . . 50.25 110.863 179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 138.94 -60.99 0.57 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 71.33 112.445 179.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.8 t 42.62 -159.72 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 62.32 110.84 -179.766 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.47 35.07 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 74.22 110.898 -179.985 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -59.37 132.55 54.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 74.23 110.878 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -129.51 63.29 1.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 75.03 110.831 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' O ' ' O ' ' A' ' 56' ' ' ILE . 4.0 tpm_? -119.05 -92.02 0.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 71.43 110.873 -179.935 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.429 ' O ' ' O ' ' A' ' 55' ' ' ARG . 6.3 mm 55.82 115.29 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 73.12 111.148 -179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 61' ' ' MET . 8.1 tt -143.28 102.0 5.17 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.63 0.729 . . . . 74.25 111.153 179.872 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HB3' ' HG3' ' A' ' 143' ' ' GLU . 53.6 Cg_endo -69.81 98.64 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.708 2.272 . . . . 74.14 112.305 179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.99 -56.11 0.29 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.704 -0.76 . . . . 63.42 112.448 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -105.46 -69.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.835 0.35 . . . . 54.31 110.899 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.557 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -144.3 -159.64 1.02 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 53.01 110.9 179.939 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.3 m -121.11 -56.44 1.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 72.52 110.92 -179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 65.6 151.8 0.06 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 74.23 110.861 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -166.94 149.74 15.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.754 . . . . 70.53 112.476 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 53.29 39.6 59.08 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.69 -0.767 . . . . 74.24 112.496 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.86 37.74 1.67 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 70.45 110.874 -179.985 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 12.2 t80 177.94 -32.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 73.11 110.908 -179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 p -113.3 37.19 3.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 74.12 111.118 -179.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -97.49 -82.48 0.41 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 61.35 110.932 179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -37.94 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 64.04 110.899 179.955 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 174.92 -64.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 71.14 110.896 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -130.8 81.06 0.33 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 45.5 112.437 179.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 19.4 p 50.69 58.42 5.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.814 0.34 . . . . 73.14 111.123 -179.909 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -144.76 -150.05 5.15 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 42.04 112.461 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.71 -166.03 35.32 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 64.42 112.477 -179.927 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 13.8 ptpt -172.87 171.08 4.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.777 0.322 . . . . 54.33 110.935 -179.983 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 p -97.94 161.95 13.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 62.54 110.885 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -76.5 -8.48 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.113 -0.494 . . . . 72.41 111.08 179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -129.46 20.6 5.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 63.21 110.905 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 162.26 -132.11 2.71 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.756 -0.735 . . . . 73.41 112.477 179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 58.5 mm-40 -114.06 -33.2 5.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.923 0.392 . . . . 73.23 110.893 -179.911 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.34 177.53 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 55.04 110.887 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.31 165.6 26.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 61.14 110.832 -179.993 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 19.1 pm0 -85.64 -176.14 5.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 74.41 110.879 -179.91 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -91.61 122.97 34.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.164 -0.471 . . . . 73.01 110.853 179.99 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.5 -40.81 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 75.42 110.843 -179.882 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 11.6 p30 177.94 161.38 0.56 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 52.21 110.844 -179.933 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -113.33 34.3 4.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 64.04 110.876 179.977 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 mt -62.53 -22.42 29.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.166 -0.47 . . . . 71.34 111.141 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.662 HD12 ' CG1' ' A' ' 128' ' ' VAL . 0.2 OUTLIER -94.12 110.72 22.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 74.11 110.917 179.883 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.502 ' O ' HD11 ' A' ' 97' ' ' ILE . 2.2 mtpp -109.31 -174.65 2.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 74.0 110.945 179.772 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -98.4 -77.56 0.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 73.5 110.898 179.916 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 67.1 16.89 10.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.124 -179.947 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 161.28 -168.72 36.63 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.761 -0.733 . . . . 73.34 112.499 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 162.66 41.21 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.667 2.244 . . . . 60.34 112.346 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 97' ' ' ILE . . . 66.08 117.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.772 -0.728 . . . . 60.33 112.486 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.662 HD12 HG11 ' A' ' 128' ' ' VAL . 0.6 OUTLIER -168.19 122.58 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.369 . . . . 74.22 111.082 -179.96 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.4 tt -97.91 116.0 29.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.475 . . . . 72.34 110.897 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -130.38 176.7 7.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 65.05 110.85 -179.944 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.403 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 5.3 mmt -115.36 104.93 12.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 64.51 110.844 179.994 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.785 ' HB3' ' HG2' ' A' ' 111' ' ' GLN . . . -69.3 152.29 45.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.243 -0.435 . . . . 71.0 111.105 179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.677 ' HB2' HG23 ' A' ' 107' ' ' THR . 42.2 p-10 -179.8 -168.48 0.11 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.243 -0.435 . . . . 73.51 110.915 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.655 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -84.38 -20.76 31.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 44.14 111.1 179.874 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 123.49 -62.26 0.56 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.714 -0.755 . . . . 65.35 112.496 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.544 ' O ' ' C ' ' A' ' 106' ' ' ASN . 53.9 Cg_endo -69.68 96.42 0.58 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 75.21 112.37 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.544 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.4 OUTLIER 25.37 78.63 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.446 . . . . 73.22 110.875 -179.979 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.677 HG23 ' HB2' ' A' ' 102' ' ' ASN . 0.7 OUTLIER -155.27 30.13 0.39 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.141 -0.481 . . . . 71.02 111.183 179.988 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.513 ' HA ' ' HB3' ' A' ' 102' ' ' ASN . 3.3 p30 -97.19 178.97 5.07 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.925 179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 103.53 42.22 2.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 70.44 112.517 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 10.9 t -138.97 -90.44 0.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.804 0.335 . . . . 51.52 110.863 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.785 ' HG2' ' HB3' ' A' ' 101' ' ' ALA . 0.0 OUTLIER -93.71 171.39 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 70.11 110.91 -179.956 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 3.8 p90 -138.93 147.39 42.22 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 71.44 110.891 -179.9 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -117.65 141.07 48.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 74.44 110.884 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.3 136.64 41.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 74.42 111.112 179.963 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 7.5 m -90.35 123.99 34.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 72.4 110.861 179.921 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 32.9 p -99.24 -25.81 14.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 64.25 111.133 -179.879 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -129.22 23.12 5.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 62.33 111.09 179.899 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.36 136.99 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 72.05 110.896 -179.998 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.623 ' HB ' HD22 ' A' ' 122' ' ' LEU . 1.7 p -131.01 51.65 2.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 65.31 111.172 179.963 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.04 -19.0 6.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 63.45 110.925 -179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -57.79 -19.71 30.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 70.23 110.925 -179.966 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.623 HD22 ' HB ' ' A' ' 119' ' ' THR . 0.0 OUTLIER -76.27 -63.0 1.42 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 72.11 110.924 179.949 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 73.78 -59.0 0.57 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.453 . . . . 71.22 110.837 179.828 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -146.99 49.89 0.61 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.728 -0.749 . . . . 72.34 112.515 -179.902 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -105.44 -24.36 12.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 72.14 110.932 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 10.9 m-70 -139.32 139.57 37.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 72.4 110.87 179.862 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 72.3 t -77.71 104.37 5.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 64.2 111.159 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.662 ' CG1' HD12 ' A' ' 90' ' ' LEU . 78.4 t -90.36 135.28 26.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 74.42 111.147 179.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.465 ' CB ' HG21 ' A' ' 29' ' ' VAL . 33.6 p90 -150.65 16.32 0.79 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 72.02 110.874 -179.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 23' ' ' GLU . . . -150.3 -169.76 16.75 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.768 -0.729 . . . . 51.23 112.485 -179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -179.81 -165.89 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.875 0.369 . . . . 65.12 110.85 179.98 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 136' ' ' MET . 75.0 t -100.99 98.92 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 74.14 111.135 179.9 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.99 -55.59 10.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.17 -0.468 . . . . 65.0 110.884 179.909 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.71 160.73 38.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 71.14 110.879 -179.989 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 77.33 33.93 42.46 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.744 -0.741 . . . . 72.44 112.479 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . 0.498 ' HA ' HG11 ' A' ' 132' ' ' VAL . 10.1 mmm -50.08 -28.79 7.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.34 . . . . 63.42 110.88 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -73.9 -40.33 63.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 63.33 110.916 -179.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.892 HG21 HG22 ' A' ' 20' ' ' VAL . 45.6 mm -42.24 -37.17 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.122 -0.49 . . . . 74.24 111.163 179.88 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -92.45 -51.64 11.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.143 -0.48 . . . . 53.34 111.131 179.856 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -48.64 -49.87 35.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 73.1 110.828 -179.981 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.6 -52.63 20.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 73.53 111.088 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.663 ' SD ' HD13 ' A' ' 156' ' ' ILE . 6.8 ttm -50.71 -46.3 58.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 71.14 110.848 -179.996 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.463 ' HG3' ' HB3' ' A' ' 58' ' ' PRO . 3.0 pt-20 -52.03 -23.06 4.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 73.34 110.85 -179.941 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 32.3 ttm180 -63.39 -22.98 67.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.15 -0.477 . . . . 72.13 110.912 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -85.6 14.71 5.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 75.51 110.887 -179.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.76 -155.4 31.07 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.718 . . . . 63.44 112.435 -179.896 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.78 -168.5 2.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.904 0.383 . . . . 70.52 110.855 -179.76 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.4 mmm-85 -80.13 -43.97 20.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 71.1 110.862 -179.887 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -101.21 -7.84 22.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.456 . . . . 71.52 110.874 -179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.11 -152.02 17.14 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 72.42 112.477 179.98 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? 60.43 101.63 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.839 0.352 . . . . 75.21 110.905 -179.938 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 9.7 p -80.63 159.47 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.24 -0.436 . . . . 74.23 111.12 -179.979 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.61 -19.91 63.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.246 -0.434 . . . . 74.24 110.866 -179.837 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.1 mttp -138.29 -179.44 5.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.093 -0.503 . . . . 73.43 110.864 179.999 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -98.83 106.07 18.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 71.32 110.947 179.818 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.663 HD13 ' SD ' ' A' ' 142' ' ' MET . 61.8 mt -92.35 102.78 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 70.54 111.13 179.884 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 15.7 p -117.07 167.65 10.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.15 -0.477 . . . . 73.3 111.099 179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.459 HD13 ' CE2' ' A' ' 8' ' ' PHE . 4.3 mt -90.95 134.48 29.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.462 . . . . 75.01 111.107 179.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.657 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -91.34 -62.67 1.39 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 65.31 111.094 179.789 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -140.17 165.07 28.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.246 -0.433 . . . . 61.31 110.827 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 33.4 m -142.67 166.27 25.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 74.33 110.884 -179.923 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -175.82 179.8 46.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.701 -0.761 . . . . 51.23 112.452 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 5.2 mt-30 -93.61 -57.65 2.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.844 0.354 . . . . 75.31 110.924 -179.897 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 65.99 150.86 0.05 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.157 -0.474 . . . . 74.45 110.945 -179.962 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.888 179.916 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.3 mmm . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.809 0.338 . . . . 72.23 110.874 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.39 155.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.109 179.902 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -89.83 153.46 47.47 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.653 0.739 . . . . 73.34 110.882 179.99 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 24' ' ' LEU . 53.5 Cg_endo -69.75 123.78 10.44 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.64 2.227 . . . . 62.24 112.317 179.952 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 49.4 m -126.96 142.07 51.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 75.3 111.165 179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.418 HG12 ' HG3' ' A' ' 163' ' ' GLN . 5.0 m -124.37 157.38 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.228 -0.442 . . . . 62.15 111.082 179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -114.0 154.84 26.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 74.55 110.906 179.979 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -140.25 138.62 35.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 63.02 110.898 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -102.62 113.12 26.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 52.43 110.887 179.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 16.5 mm -80.43 121.73 34.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 74.25 111.149 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.49 ' HB3' ' OG1' ' A' ' 157' ' ' THR . . . -108.71 163.01 13.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 64.23 111.088 179.823 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -153.07 105.5 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 71.12 111.115 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 65.79 31.71 9.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 74.53 110.842 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.65 -17.42 52.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.735 -0.745 . . . . 62.21 112.493 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -94.5 136.5 23.19 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.679 0.752 . . . . 61.24 110.844 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 155.03 66.82 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.698 2.265 . . . . 50.55 112.296 -179.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -121.04 -60.47 1.64 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 75.44 110.967 179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -170.61 -170.94 35.47 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.732 -0.746 . . . . 20.23 112.494 179.889 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -124.64 127.51 47.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.803 0.335 . . . . 74.22 110.874 -179.841 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.618 ' CG1' HG13 ' A' ' 132' ' ' VAL . 8.0 t -129.87 129.85 66.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.32 111.159 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.7 p -109.19 154.49 22.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 64.31 110.878 -179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -125.17 135.06 52.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 74.41 110.848 -179.918 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -86.36 131.95 34.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 70.51 110.868 -179.89 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 4' ' ' PRO . 36.5 mt -96.18 118.51 32.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 52.04 110.937 -179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.503 ' CD2' HD11 ' A' ' 90' ' ' LEU . 47.6 m-85 -80.12 55.33 2.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 74.51 110.88 179.945 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -51.35 -28.24 11.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.156 -0.474 . . . . 63.13 111.094 179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -53.63 -47.47 70.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 70.0 110.894 179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.71 ' HG2' HG21 ' A' ' 89' ' ' ILE . 1.1 mttt -95.78 -32.27 12.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 75.44 110.867 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG21 ' HB2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -124.22 74.64 59.59 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.667 0.746 . . . . 74.14 111.168 179.877 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -51.14 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.698 2.265 . . . . 71.41 112.32 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.68 -43.22 84.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 70.35 110.894 179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.496 HG21 ' HE1' ' A' ' 100' ' ' MET . 0.1 OUTLIER -69.01 -60.89 2.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 71.33 111.119 -179.987 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' THR . . . -33.76 -67.26 0.13 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 72.22 111.141 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 37' ' ' ARG . 79.3 tt0 -58.67 -58.79 7.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 71.23 110.874 -179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' C ' ' O ' ' A' ' 34' ' ' GLU . 2.0 t30 -32.85 -53.82 0.35 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 74.15 110.912 -179.971 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -79.2 -29.07 42.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 63.34 110.913 -180.0 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 34' ' ' GLU . 4.7 ttp180 -52.31 -32.99 40.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 70.31 110.859 -179.929 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.25 -25.14 61.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 74.1 111.082 179.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.48 27.31 3.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 73.34 110.916 -179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 2.0 t -152.5 -25.89 0.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 74.14 110.87 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 37' ' ' ARG . 26.5 p -81.82 -43.99 17.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 65.43 111.081 -179.925 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 43' ' ' GLU . . . 155.05 -27.07 0.63 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.727 -0.749 . . . . 74.11 112.455 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' C ' ' O ' ' A' ' 42' ' ' GLY . 1.1 mt-10 -30.71 -74.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.95 0.405 . . . . 63.24 110.897 -179.851 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.64 144.38 31.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.503 . . . . 60.41 110.9 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -122.79 22.1 7.35 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.722 -0.752 . . . . 75.13 112.513 179.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -132.52 -8.0 3.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.874 0.369 . . . . 74.42 110.896 -179.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -55.97 -101.84 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.775 -0.726 . . . . 71.44 112.489 -179.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.14 -74.15 0.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.981 0.42 . . . . 63.43 110.876 -179.777 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? 57.6 169.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.105 -0.498 . . . . 74.44 110.912 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -53.54 118.53 8.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.712 -0.756 . . . . 73.53 112.506 179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.6 p -159.33 -82.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.867 0.365 . . . . 74.41 110.812 -179.704 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.403 ' HB2' ' HD2' ' A' ' 155' ' ' LYS . 5.9 p -177.57 173.82 1.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.111 -0.495 . . . . 61.12 110.883 -179.921 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -93.36 -171.24 2.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.216 -0.447 . . . . 73.43 110.834 -179.844 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -134.74 -55.42 0.83 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.503 . . . . 65.34 110.855 179.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.92 144.01 51.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 72.54 110.844 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 58.6 mt -152.36 120.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.34 111.158 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 2.6 mt -128.46 109.07 19.19 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.613 0.72 . . . . 72.43 111.183 179.872 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.74 97.92 0.66 Allowed 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.655 2.236 . . . . 73.31 112.39 179.902 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.45 -5.06 23.18 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.526 -179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -118.56 -66.52 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.831 0.348 . . . . 74.43 110.835 -179.841 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.06 -168.35 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 73.24 110.837 179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 25.7 m -142.74 128.93 19.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.862 -179.984 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -123.67 157.15 34.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 64.44 110.924 -179.88 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 166.65 -157.57 30.11 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 73.11 112.459 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.78 37.56 16.19 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.72 -0.753 . . . . 73.11 112.45 -179.908 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.14 82.33 2.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.876 0.37 . . . . 50.25 110.865 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.2 p90 -99.91 44.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.2 -0.455 . . . . 74.12 110.891 -179.919 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -126.65 -75.55 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 63.24 111.193 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.45 155.0 31.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 65.12 110.859 -179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -72.46 -5.45 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 75.35 110.817 -179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -166.56 33.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 41.33 110.927 -179.914 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -118.4 -22.14 3.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.758 -0.734 . . . . 65.22 112.461 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.8 p 50.83 76.72 0.14 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.818 0.342 . . . . 75.45 111.168 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -90.83 -83.46 1.41 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 65.0 112.527 179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 67.99 143.28 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.734 -0.746 . . . . 45.44 112.467 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -176.49 179.49 1.16 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.792 0.329 . . . . 73.44 110.896 -179.989 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -83.61 177.68 8.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.253 -0.43 . . . . 65.21 110.871 -179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -90.17 -34.06 6.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.117 -0.492 . . . . 73.31 111.102 179.946 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -83.29 -7.3 59.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 74.25 110.882 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.19 -169.72 42.09 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 45.31 112.455 179.956 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -62.42 -90.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.907 0.384 . . . . 40.11 110.877 -179.839 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.21 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 71.55 110.9 179.961 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -154.66 160.33 41.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 72.55 110.857 179.942 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -54.9 175.46 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.495 . . . . 71.34 110.914 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.2 p30 -88.19 149.13 24.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 71.34 110.902 179.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -94.83 -46.68 6.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.887 -179.871 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 177.93 157.26 0.4 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 62.42 110.875 -179.97 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.22 37.25 4.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.471 . . . . 75.32 110.876 -179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.71 HG21 ' HG2' ' A' ' 28' ' ' LYS . 23.4 mm -55.39 -22.67 12.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.496 . . . . 73.43 111.139 179.953 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.503 HD11 ' CD2' ' A' ' 25' ' ' PHE . 4.4 mm? -85.57 116.62 23.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.164 -0.471 . . . . 73.41 110.903 179.904 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -107.0 104.25 13.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 71.03 110.926 179.808 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.712 ' HB3' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -59.33 96.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 74.42 110.89 179.882 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 46.8 p -113.78 26.88 9.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.241 -0.436 . . . . 72.32 111.177 -179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.08 163.64 35.37 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.754 -0.736 . . . . 51.1 112.492 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 140.7 43.35 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.712 2.275 . . . . 61.01 112.349 -179.968 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 105.51 -9.95 45.54 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 72.13 112.465 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 92' ' ' HIS . 13.0 mm -70.45 146.21 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.9 0.381 . . . . 65.25 111.096 -179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 62.0 mt -121.27 166.0 14.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 72.43 110.903 179.934 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.51 -170.99 2.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 72.42 110.891 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.496 ' HE1' HG21 ' A' ' 32' ' ' THR . 1.9 tpp -92.55 114.15 26.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.455 . . . . 73.42 110.863 179.968 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.4 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -101.49 140.0 36.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 70.41 111.085 179.963 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' CG ' ' HA3' ' A' ' 109' ' ' GLY . 1.2 m-20 168.09 -75.23 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 74.01 110.915 -179.899 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -170.46 29.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 72.12 111.109 179.864 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.51 -172.52 14.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.729 -0.748 . . . . 54.32 112.523 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.73 -49.69 0.54 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.675 2.25 . . . . 54.53 112.327 -179.936 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -48.7 -20.81 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 75.03 110.879 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.671 ' O ' ' C ' ' A' ' 108' ' ' ASN . 29.8 p -124.05 44.36 2.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.47 . . . . 62.31 111.097 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.671 ' C ' ' O ' ' A' ' 107' ' ' THR . 0.9 OUTLIER 1.96 -86.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.443 . . . . 72.45 110.901 179.98 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.41 ' HA3' ' CG ' ' A' ' 102' ' ' ASN . . . 79.49 91.56 0.4 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.73 -0.747 . . . . 52.44 112.491 179.964 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.91 121.47 34.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.81 0.338 . . . . 72.33 110.893 -179.754 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -64.3 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.143 -0.48 . . . . 64.52 110.929 -179.949 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 173.82 167.64 0.19 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 73.22 110.86 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -176.11 66.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 74.34 110.881 -179.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.496 HG22 HG22 ' A' ' 116' ' ' THR . 6.6 mt -78.3 108.5 11.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.465 . . . . 65.43 111.089 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 13.7 m -67.86 -35.17 78.08 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 73.43 110.86 179.909 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.496 HG22 HG22 ' A' ' 114' ' ' ILE . 1.8 p 60.62 10.57 2.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 74.53 111.176 -179.812 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -178.66 -170.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.116 179.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.5 tttm -79.78 125.32 29.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 74.43 110.911 179.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.553 HG23 ' CD2' ' A' ' 92' ' ' HIS . 9.7 t -142.45 45.78 1.62 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 65.42 111.134 179.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -58.75 -10.75 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 62.03 110.906 179.991 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 10.4 m-90 -57.93 -26.74 62.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 75.54 110.904 -179.97 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 65.6 mt -117.68 49.82 1.19 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 70.45 110.906 179.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -71.57 -40.76 69.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 74.34 110.897 179.784 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -114.1 81.73 0.3 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 50.31 112.549 -179.973 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -160.17 -57.24 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.804 0.335 . . . . 62.43 110.873 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -112.08 142.06 44.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.455 . . . . 74.32 110.834 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.424 ' HB ' ' HE3' ' A' ' 100' ' ' MET . 81.5 t -65.71 100.91 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.476 . . . . 64.12 111.179 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 65.6 t -76.26 136.51 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 52.1 111.115 179.93 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HB2' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -177.46 128.48 0.15 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 74.35 110.888 179.951 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 99.11 120.69 4.41 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.73 -0.748 . . . . 62.04 112.524 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.7 152.23 32.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.848 0.356 . . . . 72.53 110.88 -179.976 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.618 HG13 ' CG1' ' A' ' 20' ' ' VAL . 34.3 t -44.35 141.59 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 53.42 111.133 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -132.79 -41.79 0.93 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.16 -0.473 . . . . 71.34 110.891 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -66.23 -78.78 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 73.45 110.879 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.79 115.77 0.68 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.706 -0.759 . . . . 60.04 112.49 -179.971 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 1.5 ttt -67.68 -9.23 41.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.824 0.345 . . . . 72.14 110.885 -179.965 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 52.4 m-20 -50.3 -25.06 3.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 63.42 110.861 -179.953 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 27.2 mm -91.99 -45.48 14.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 71.31 111.084 179.974 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 89.4 t -54.86 -20.95 6.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 74.24 111.09 179.893 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -85.65 -28.08 24.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 73.02 110.86 -179.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.44 -33.63 73.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 61.5 111.117 179.94 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 6.3 ptm -73.79 -21.19 60.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 50.04 110.92 179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -88.38 26.37 1.45 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.216 -0.447 . . . . 54.44 110.881 -179.939 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.49 -20.7 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 73.42 110.898 -179.894 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -95.83 15.37 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 71.12 110.877 -179.944 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -109.08 -142.81 9.93 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 72.54 112.462 -179.917 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.0 p -162.61 147.91 12.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.851 0.358 . . . . 55.43 110.832 -179.708 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 32.6 mmm-85 -75.7 68.51 2.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 52.52 110.899 -179.957 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.1 p30 179.62 -32.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.171 -0.468 . . . . 73.41 110.862 -179.952 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.62 -60.47 0.53 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.743 -0.742 . . . . 53.13 112.483 179.958 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.54 107.87 0.19 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.852 0.358 . . . . 74.41 110.931 179.995 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 3.5 t -79.97 139.44 37.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 74.15 111.176 -179.994 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.42 -27.82 67.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.234 -0.439 . . . . 52.11 110.875 -179.864 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.13 -165.01 1.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.906 179.932 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.403 ' HD2' ' HB2' ' A' ' 52' ' ' CYS . 2.8 tppm? -131.57 112.09 12.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 74.23 110.871 179.868 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 156' ' ' ILE . 3.6 mp -92.43 128.8 43.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 71.32 111.146 179.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.49 ' OG1' ' HB3' ' A' ' 11' ' ' ALA . 7.9 p -133.3 175.08 9.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.474 . . . . 53.34 111.165 179.947 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 4.6 mt -118.63 106.36 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 63.24 111.144 179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.15 -61.5 2.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 72.44 111.121 179.825 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -134.9 179.32 6.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.182 -0.463 . . . . 71.44 110.81 -179.981 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 2.1 p -172.81 -179.31 2.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 54.33 110.866 -179.873 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 146.8 -169.46 27.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.793 -0.717 . . . . 74.54 112.546 -179.941 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.418 ' HG3' HG12 ' A' ' 6' ' ' VAL . 1.8 mt-30 -95.11 138.79 32.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.852 0.358 . . . . 61.51 110.895 -179.838 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -50.27 -61.06 2.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 64.23 110.943 179.969 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 23.0 tp10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 61.33 110.865 179.947 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.815 0.341 . . . . 74.14 110.868 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 90.6 t -132.33 142.6 42.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 73.1 111.134 179.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -51.68 161.06 0.92 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.601 0.715 . . . . 54.31 110.861 -179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 146.53 60.16 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.65 2.234 . . . . 74.45 112.322 179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 31.6 m -130.4 72.28 1.49 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.468 . . . . 72.22 111.144 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 m -65.43 151.9 9.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 61.11 111.108 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.477 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.0 OUTLIER -130.76 162.06 30.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.862 179.97 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -136.6 132.9 35.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.105 -0.498 . . . . 73.33 110.861 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 14.1 t70 -107.44 87.82 2.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 71.31 110.886 179.979 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.559 HG21 ' HE1' ' A' ' 142' ' ' MET . 17.7 mm -71.02 150.42 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.11 111.111 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -135.41 163.68 29.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 52.14 111.115 179.762 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 m -132.9 96.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.244 -0.434 . . . . 54.02 111.168 179.989 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 t0 68.8 53.77 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 70.52 110.851 179.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.48 14.77 62.81 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.772 -0.728 . . . . 24.11 112.495 -179.922 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -128.59 105.27 19.06 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.631 0.729 . . . . 64.3 110.894 -179.821 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 54.0 Cg_endo -69.74 138.82 38.79 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.734 2.289 . . . . 72.3 112.304 -179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.87 28.57 8.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.89 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 115.41 -158.71 14.2 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.739 -0.743 . . . . 72.23 112.489 179.863 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.1 179.99 7.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.813 0.339 . . . . 73.54 110.919 -179.89 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.742 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 11.4 m -139.44 170.08 16.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 75.21 111.142 179.958 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.3 t -118.43 84.66 2.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 73.13 110.891 -179.869 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.742 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 16.7 m-85 -79.8 63.98 4.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 65.14 110.865 -179.919 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.9 tm-20 -49.27 133.92 18.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 71.31 110.895 -179.931 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 HD22 ' CD2' ' A' ' 129' ' ' PHE . 12.9 mt -104.16 132.31 50.55 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.19 -0.459 . . . . 74.2 110.957 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -75.77 82.51 2.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 75.24 110.864 179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -78.98 -8.84 59.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 54.52 111.127 179.908 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.21 -57.37 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.461 . . . . 71.12 110.797 -179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -57.22 -65.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 71.54 110.914 -179.983 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.511 HG21 ' HB3' ' A' ' 129' ' ' PHE . 2.9 m -110.99 95.14 22.98 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.621 0.724 . . . . 23.53 111.106 179.913 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 29' ' ' VAL . 53.8 Cg_endo -69.84 -19.24 35.99 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.694 2.263 . . . . 75.12 112.304 179.983 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.01 -61.5 1.67 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 41.41 110.928 179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.9 m -57.3 -26.12 60.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.235 -0.439 . . . . 62.22 111.128 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -85.34 2.38 44.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 63.54 111.06 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' HA ' ' HG2' ' A' ' 37' ' ' ARG . 11.2 tt0 -91.01 -22.62 20.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 74.31 110.876 -179.925 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.5 ' ND2' HG23 ' A' ' 78' ' ' ILE . 12.3 t-20 -79.89 -68.42 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 60.45 110.898 -179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE2' HD11 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -46.74 -45.68 19.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 65.05 110.869 179.988 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' GLU . 3.3 ppt_? -54.47 -32.32 57.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 70.12 110.888 -179.931 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.36 -35.15 35.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 63.44 111.134 179.88 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 78' ' ' ILE . 86.7 mt -66.57 -28.78 68.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.204 -0.453 . . . . 64.45 110.869 -179.914 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -68.01 -38.1 82.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 53.54 110.855 -179.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.7 p -86.38 11.42 12.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 72.42 111.164 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 41.2 51.29 4.37 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.747 -0.739 . . . . 52.15 112.506 179.995 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -96.59 32.79 1.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.969 0.414 . . . . 71.32 110.941 -179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.5 10.34 2.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 74.24 110.893 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.31 30.63 8.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 60.12 112.495 179.979 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -176.44 158.63 1.84 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.865 0.364 . . . . 62.25 110.855 -179.879 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.35 159.08 12.63 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.714 -0.755 . . . . 73.32 112.467 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -50.95 103.11 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.933 0.397 . . . . 73.34 110.971 -179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.4 -44.62 0.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.166 -0.47 . . . . 71.54 110.858 179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -139.92 31.97 2.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.754 -0.736 . . . . 63.22 112.496 179.956 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 9.1 t -100.28 -169.69 1.76 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.821 0.343 . . . . 71.41 110.904 -179.791 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 15.5 p -80.85 -166.61 1.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.148 -0.478 . . . . 72.43 110.89 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -94.95 -167.09 1.57 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 73.21 110.851 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.96 -74.92 0.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 72.41 110.886 179.985 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -173.39 91.64 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 62.01 110.853 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.738 HD12 ' CE2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -77.08 144.35 11.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 63.12 111.139 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 61' ' ' MET . 6.3 tt -149.91 100.29 3.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.651 0.738 . . . . 71.22 111.062 179.849 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.79 107.71 1.92 Allowed 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.714 2.276 . . . . 41.41 112.311 179.878 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.52 -46.24 0.63 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 71.05 112.444 179.946 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -112.73 -69.43 0.87 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.881 0.372 . . . . 74.31 110.919 -179.889 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.526 ' O ' HG23 ' A' ' 57' ' ' ILE . 0.0 OUTLIER -155.07 -148.49 0.24 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.475 . . . . 42.42 110.903 179.94 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 18.5 m -132.53 -49.51 0.91 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.241 -0.436 . . . . 55.05 110.895 -179.953 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.16 156.55 0.06 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.45 110.9 -179.857 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.37 148.87 20.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.765 -0.731 . . . . 50.31 112.483 -179.974 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 115.64 174.83 18.02 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.723 -0.751 . . . . 61.11 112.467 -179.911 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -104.38 -48.12 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.88 0.372 . . . . 64.42 110.861 -179.958 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.568 ' HB2' HG22 ' A' ' 73' ' ' THR . 9.4 m-85 -125.62 -84.97 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 70.31 110.911 -179.892 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.794 HG21 ' HA ' ' A' ' 102' ' ' ASN . 0.2 OUTLIER 69.66 -70.05 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 74.41 111.167 -179.922 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.62 -38.17 23.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 73.41 110.843 -179.955 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -50.89 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 71.35 110.819 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.78 38.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.02 110.849 -179.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.547 ' O ' HG22 ' A' ' 73' ' ' THR . . . 76.81 -148.96 35.72 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.722 -0.751 . . . . 55.15 112.502 179.996 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 73' ' ' THR . 0.4 OUTLIER 72.73 4.36 4.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.886 0.374 . . . . 72.43 111.155 -179.89 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.66 ' HA3' HG23 ' A' ' 68' ' ' THR . . . -78.46 -158.63 12.08 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.709 -0.758 . . . . 74.23 112.466 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -77.2 96.47 1.23 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.724 -0.75 . . . . 61.34 112.524 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -65.33 -166.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.85 0.357 . . . . 72.23 110.863 -179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.46 125.92 36.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 71.11 110.89 -179.922 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.5 HG23 ' ND2' ' A' ' 35' ' ' ASN . 2.0 pp -45.3 -40.6 2.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.129 -0.487 . . . . 74.13 111.115 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -117.44 29.73 7.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 74.04 110.898 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -178.2 -147.64 7.04 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.751 -0.738 . . . . 71.24 112.49 179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.56 -33.61 2.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.961 0.41 . . . . 74.25 110.884 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.31 137.92 8.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 75.34 110.896 179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 28.0 p90 -118.65 161.56 19.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.88 179.981 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -92.2 160.54 15.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.43 110.861 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -68.79 168.23 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.903 179.967 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -132.64 -68.54 0.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 73.45 110.863 -179.914 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -172.18 163.26 5.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.142 -0.481 . . . . 71.14 110.929 -179.954 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.71 79.45 1.78 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 65.03 110.84 -179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 89' ' ' ILE . 15.9 mt -77.53 -7.75 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.484 . . . . 74.14 111.162 179.946 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.423 ' HB2' ' CG1' ' A' ' 128' ' ' VAL . 2.2 mt -114.42 139.09 49.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.461 . . . . 71.43 110.898 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.71 -171.01 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.194 -0.457 . . . . 70.24 110.853 179.852 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 4.5 m170 -115.01 91.18 3.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 75.02 110.904 179.921 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 p -107.19 21.75 17.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.44 111.143 -179.879 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.72 -163.28 15.06 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 63.02 112.509 179.991 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -86.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.702 2.268 . . . . 62.14 112.356 -179.965 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' O ' HG12 ' A' ' 97' ' ' ILE . . . -49.65 151.42 4.08 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 52.14 112.46 179.987 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 97' ' ' ILE . 0.3 OUTLIER 172.6 124.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 53.1 111.149 -179.955 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.482 HD11 ' CE2' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -96.87 105.25 17.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 71.51 110.887 179.959 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.56 ' O ' ' O ' ' A' ' 100' ' ' MET . 1.3 t -121.19 22.89 10.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 72.02 110.875 -179.933 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.56 ' O ' ' O ' ' A' ' 99' ' ' SER . 6.9 mmt 53.06 123.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.088 -0.505 . . . . 71.32 110.906 179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.753 ' HB2' ' HB3' ' A' ' 113' ' ' PHE . . . -107.4 68.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.268 -0.424 . . . . 73.53 111.085 179.926 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.794 ' HA ' HG21 ' A' ' 68' ' ' THR . 2.4 m120 -115.9 -82.55 0.62 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.906 -179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.564 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -133.72 -70.88 0.51 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 72.24 111.102 179.882 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 178.67 -125.26 0.97 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.734 -0.746 . . . . 23.13 112.522 -179.934 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 119.53 6.46 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.739 2.292 . . . . 73.55 112.349 -179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 71.94 23.42 3.54 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.281 -0.418 . . . . 62.22 110.86 179.98 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.564 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 17.9 p -154.75 46.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 73.14 111.151 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.554 ' O ' ' C ' ' A' ' 109' ' ' GLY . 0.2 OUTLIER -88.28 11.65 16.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.873 179.995 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.554 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 24.67 -122.82 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.738 -0.744 . . . . 72.12 112.498 179.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -146.75 31.19 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.836 0.35 . . . . 62.04 110.887 -179.774 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.56 -167.52 1.77 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 75.45 110.897 -179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -165.87 127.97 1.97 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.15 110.881 -179.939 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.753 ' HB3' ' HB2' ' A' ' 101' ' ' ALA . 0.1 OUTLIER -111.46 34.53 4.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 73.32 110.857 -179.917 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.576 ' C ' ' O ' ' A' ' 113' ' ' PHE . 24.7 mt -21.6 113.84 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 52.14 111.124 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' MET . 14.1 m -82.57 162.46 21.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 55.42 110.837 179.977 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.2 t -114.02 -17.48 11.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 72.24 111.14 -179.872 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.757 ' O ' HG23 ' A' ' 119' ' ' THR . . . -126.63 146.81 50.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 75.34 111.081 179.915 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -52.43 100.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 52.44 110.891 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.757 HG23 ' O ' ' A' ' 117' ' ' ALA . 61.4 p -114.27 69.67 0.71 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 63.15 111.094 -179.978 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -86.42 17.02 4.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.457 . . . . 75.33 110.889 179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.712 ' CZ2' HG22 ' A' ' 119' ' ' THR . 8.7 p90 -98.83 1.02 45.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 75.05 110.9 -179.962 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.06 28.21 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.221 -0.445 . . . . 71.23 110.906 179.988 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.3 p30 -105.4 95.71 6.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 70.31 110.888 179.84 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 171.35 -42.59 0.18 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.728 -0.749 . . . . 75.53 112.459 -179.918 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.01 -31.74 25.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.818 0.342 . . . . 73.15 110.929 -179.967 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 23.8 m-70 -98.16 139.73 33.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 65.21 110.795 179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.561 HG22 ' H ' ' A' ' 128' ' ' VAL . 0.5 OUTLIER -60.14 176.74 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 75.11 111.123 179.963 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.561 ' H ' HG22 ' A' ' 127' ' ' VAL . 0.4 OUTLIER -168.82 146.19 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.463 . . . . 75.14 111.133 179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HB3' HG21 ' A' ' 29' ' ' VAL . 4.4 p90 -179.19 38.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 63.44 110.879 179.982 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -158.89 175.28 35.9 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.729 -0.748 . . . . 74.33 112.506 -179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.3 ptmt -179.17 -166.89 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.846 0.355 . . . . 64.53 110.879 -179.996 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 87.3 t -121.73 125.03 72.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 73.11 111.107 179.896 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 14.8 mttt -111.02 -37.51 5.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.461 . . . . 44.31 110.867 179.919 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -132.1 142.18 49.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.441 . . . . 74.33 110.875 179.988 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 93.32 37.06 5.72 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 74.31 112.447 -179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.89 -29.21 27.03 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 65.33 110.856 -179.966 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -84.52 -39.53 18.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.272 -0.422 . . . . 65.32 110.869 -179.945 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.649 ' O ' ' HB2' ' A' ' 142' ' ' MET . 48.2 mm -39.63 -41.65 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 64.41 111.115 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 94.3 t -88.18 -51.31 12.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.134 -0.484 . . . . 71.04 111.074 179.89 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -50.59 -59.92 3.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 72.41 110.883 179.999 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -57.76 -58.94 6.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 60.14 111.157 179.926 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.649 ' HB2' ' O ' ' A' ' 138' ' ' ILE . 5.8 ttm -50.55 -39.0 48.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 64.23 110.941 179.939 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -53.65 -24.89 15.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 72.35 110.919 -179.94 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -65.48 -12.26 50.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.109 -0.496 . . . . 74.15 110.83 -179.907 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -84.22 4.44 30.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.205 -0.452 . . . . 62.02 110.854 -179.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.02 -158.14 28.93 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.726 -0.75 . . . . 65.11 112.483 -179.969 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 4.1 m -148.77 -89.87 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.888 0.375 . . . . 74.45 110.84 -179.716 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 20.3 mmm180 -154.98 -52.64 0.09 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 72.03 110.864 -179.929 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -105.52 13.89 29.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 60.55 110.877 -179.929 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 114.85 -162.77 12.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.72 -0.753 . . . . 40.24 112.465 179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.6 mttp 66.73 140.57 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.839 0.352 . . . . 75.51 110.897 -179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 48.3 p -123.48 154.35 39.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 75.53 111.127 179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -83.48 -3.86 57.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.231 -0.44 . . . . 72.24 110.874 -179.9 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -141.68 165.24 28.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 53.34 110.888 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.77 114.82 26.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.33 110.874 179.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.591 HD13 ' SD ' ' A' ' 142' ' ' MET . 43.5 mt -103.36 106.48 20.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.246 -0.434 . . . . 61.34 111.099 179.848 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -114.4 156.24 24.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 55.2 111.129 179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.8 mm -84.12 148.26 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 74.42 111.131 179.893 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -97.86 -59.28 1.8 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 60.25 111.072 179.829 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -167.55 163.25 14.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 52.35 110.838 179.976 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 58.0 m -147.68 176.6 9.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.23 110.887 -179.949 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 171.55 -168.24 41.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.735 -0.745 . . . . 63.55 112.49 -179.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 6.2 mt-30 -87.27 -38.95 15.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.861 0.362 . . . . 61.44 110.91 -179.887 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.597 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 2.8 mm? 75.31 -54.55 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 71.13 110.886 -179.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 74.41 110.871 179.925 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.9 mmm . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.819 0.342 . . . . 72.11 110.92 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.461 HG11 ' HG3' ' A' ' 165' ' ' GLU . 0.4 OUTLIER 61.34 159.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 71.22 111.143 179.977 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.422 ' N ' HG13 ' A' ' 2' ' ' VAL . 2.0 m-20 -96.85 156.57 36.34 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.621 0.724 . . . . 61.34 110.856 -179.932 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.75 147.42 62.91 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.707 2.272 . . . . 54.33 112.314 179.954 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.568 HG23 ' O ' ' A' ' 22' ' ' PHE . 8.0 m -147.18 141.27 26.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 63.52 111.142 -179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 m -123.55 147.74 27.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 71.13 111.142 179.889 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -111.78 145.64 39.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.473 . . . . 74.41 110.892 -179.95 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.425 ' O ' HG22 ' A' ' 20' ' ' VAL . 3.5 m-85 -138.27 139.63 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 75.14 110.866 -179.928 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -108.44 119.62 40.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.147 -0.479 . . . . 65.21 110.851 179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 25.8 mm -89.03 116.6 30.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 70.21 111.135 179.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.68 154.58 17.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.465 . . . . 74.31 111.117 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.1 m -139.89 104.63 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 72.32 111.112 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.21 37.06 1.0 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.147 -0.478 . . . . 71.21 110.861 179.929 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.69 17.23 80.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.778 -0.725 . . . . 43.31 112.48 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.88 149.63 71.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.628 0.728 . . . . 71.33 110.884 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 150.93 68.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.653 2.235 . . . . 72.43 112.34 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 15.4 tp -124.11 -57.59 1.59 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 62.02 110.879 179.972 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -166.76 -147.19 5.14 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.694 -0.765 . . . . 44.44 112.44 179.947 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.2 tmm_? -149.77 124.82 10.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.899 0.38 . . . . 75.1 110.841 -179.796 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 8' ' ' PHE . 35.6 m -113.37 141.61 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 70.43 111.094 179.983 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.0 p -121.69 146.25 47.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 73.24 110.893 -179.859 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.568 ' O ' HG23 ' A' ' 5' ' ' THR . 7.8 m-85 -130.66 136.16 48.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.32 110.894 -179.933 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -103.17 111.14 23.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 73.22 110.87 -179.923 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.572 HD22 ' CE2' ' A' ' 129' ' ' PHE . 86.1 mt -82.7 132.36 35.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 43.12 110.899 -179.973 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.42 ' CD2' HD21 ' A' ' 90' ' ' LEU . 26.1 m-85 -83.17 79.68 9.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 75.42 110.893 179.939 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.59 -1.36 24.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 34.45 111.115 179.922 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -87.52 -47.68 8.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.899 179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' HG2' HG21 ' A' ' 89' ' ' ILE . 5.9 mttt -83.88 -27.89 28.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 74.11 110.898 179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.53 73.84 35.02 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.578 0.704 . . . . 64.03 111.127 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -9.58 26.45 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.63 2.22 . . . . 62.5 112.362 179.965 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.35 -53.66 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 74.34 110.867 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.0 m -58.18 -51.48 69.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.436 . . . . 74.42 111.168 -179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.7 -26.32 67.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 62.3 111.096 179.89 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -54.9 -34.57 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 74.43 110.897 -179.922 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -81.01 -57.74 3.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 72.21 110.885 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -50.89 -38.84 52.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 64.2 110.872 -179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -29.12 70.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.482 . . . . 73.12 110.925 -179.922 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.36 -33.68 15.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.133 -0.485 . . . . 71.21 111.118 179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.44 HD11 ' HA2' ' A' ' 47' ' ' GLY . 0.6 OUTLIER -87.43 23.96 1.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 64.42 110.923 -179.943 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.5 m -118.29 -8.45 10.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 55.14 110.871 -179.912 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.544 HG22 ' HA2' ' A' ' 162' ' ' GLY . 17.8 p -117.96 7.48 12.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.106 -0.497 . . . . 63.11 111.16 -179.923 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 55.67 29.59 54.56 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.701 -0.761 . . . . 54.01 112.477 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.87 -34.98 26.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.899 0.381 . . . . 71.13 110.93 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -10.32 47.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 74.21 110.899 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 91.52 14.53 56.85 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.736 -0.745 . . . . 74.12 112.467 179.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -179.8 153.3 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.903 0.383 . . . . 64.23 110.849 -179.855 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 39' ' ' LEU . . . 166.2 -140.34 6.29 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.727 -0.749 . . . . 24.33 112.447 -179.963 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -101.88 -27.99 12.67 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.973 0.416 . . . . 70.42 110.93 -179.805 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.84 147.38 9.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.48 . . . . 74.13 110.909 179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 51.27 40.38 45.12 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.724 -0.751 . . . . 52.42 112.481 179.883 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 t -122.56 -171.2 2.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.85 0.357 . . . . 41.24 110.874 -179.746 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.09 -167.38 1.17 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.186 -0.461 . . . . 75.04 110.859 -179.935 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' CE2' HD12 ' A' ' 156' ' ' ILE . 0.8 OUTLIER -109.41 170.49 8.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 73.24 110.892 -179.842 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -118.09 -69.3 0.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 61.22 110.853 179.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.81 172.35 13.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 65.43 110.876 -179.909 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -154.58 147.06 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.469 . . . . 52.02 111.114 179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.716 HD12 ' HB3' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -132.75 120.83 16.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.662 0.744 . . . . 75.24 111.133 179.872 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 109.06 2.21 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.684 2.256 . . . . 72.34 112.355 179.879 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.59 25.32 18.58 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 64.11 112.527 -179.969 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.716 ' HB3' HD12 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -145.34 -63.99 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.838 0.351 . . . . 74.5 110.871 -179.868 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.485 ' HA ' HG23 ' A' ' 116' ' ' THR . 0.9 OUTLIER -177.74 -166.58 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 74.22 110.897 179.925 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 50.6 m -129.86 -70.09 0.65 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 71.43 110.887 -179.91 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 64.86 126.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 63.34 110.878 -179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.09 -173.82 20.76 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.758 -0.734 . . . . 73.11 112.495 -179.955 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.16 69.09 1.39 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.741 -0.742 . . . . 73.41 112.462 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -122.94 71.76 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.862 0.363 . . . . 73.14 110.88 179.986 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 7.0 t80 177.18 -69.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 72.44 110.874 -179.916 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.662 HG21 ' HA2' ' A' ' 74' ' ' GLY . 54.8 m 61.47 -85.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 63.24 111.124 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.404 ' N ' HG22 ' A' ' 68' ' ' THR . 0.0 OUTLIER -125.94 -179.2 4.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.11 110.859 -179.957 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -43.76 -76.33 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 65.54 110.836 -179.983 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -121.72 -78.72 0.6 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 72.12 110.876 -179.944 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' C ' HG23 ' A' ' 73' ' ' THR . . . -74.9 177.77 47.27 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.745 -0.74 . . . . 72.25 112.521 179.944 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.409 HG23 ' C ' ' A' ' 72' ' ' GLY . 1.5 p 65.15 39.09 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.875 0.369 . . . . 71.35 111.167 -179.852 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.662 ' HA2' HG21 ' A' ' 68' ' ' THR . . . -144.93 -92.33 0.14 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 74.03 112.467 179.954 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 76' ' ' LYS . . . -77.95 100.76 1.63 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.774 -0.726 . . . . 54.34 112.515 -179.898 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.491 ' HB3' ' O ' ' A' ' 75' ' ' GLY . 17.2 ptpt 176.38 -169.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.823 0.344 . . . . 72.14 110.906 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -94.94 150.52 20.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 70.31 110.873 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.468 HG23 ' N ' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -42.17 -46.84 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.145 179.964 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.468 ' N ' HG23 ' A' ' 78' ' ' ILE . 19.1 m-85 -122.38 49.8 1.56 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.31 110.915 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 149.36 -140.62 8.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.711 -0.757 . . . . 65.41 112.453 179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.05 -75.82 0.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.914 0.388 . . . . 73.52 110.915 -179.865 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.716 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -130.21 168.46 16.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.481 . . . . 71.44 110.901 179.902 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -145.48 151.66 38.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 70.13 110.873 179.969 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -54.8 157.91 2.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 75.43 110.872 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -89.55 112.78 24.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 65.02 110.84 179.997 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -58.51 -46.89 85.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 75.21 110.884 -179.921 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -177.06 168.66 2.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.12 -0.491 . . . . 61.41 110.877 -179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -126.31 42.6 3.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.41 110.889 179.994 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.429 HG21 ' HG2' ' A' ' 28' ' ' LYS . 0.3 OUTLIER -53.39 -23.49 7.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 73.41 111.113 179.955 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.636 ' HB2' HG13 ' A' ' 128' ' ' VAL . 10.4 mt -94.67 145.95 24.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.205 -0.452 . . . . 74.0 110.958 179.873 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -122.06 -174.93 3.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.19 -0.459 . . . . 54.5 110.892 179.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -116.17 79.23 1.28 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 75.54 110.816 179.924 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.0 t -119.99 24.9 10.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.462 . . . . 72.05 111.17 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -134.51 150.34 20.04 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.728 -0.749 . . . . 63.53 112.465 -179.974 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -3.5 12.12 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.735 2.29 . . . . 72.01 112.34 -179.94 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -142.45 49.19 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.702 -0.761 . . . . 73.13 112.477 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 20.7 mm -85.68 135.66 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.842 0.353 . . . . 71.41 111.173 -179.987 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.665 HD22 ' O ' ' A' ' 129' ' ' PHE . 5.4 tt -90.05 122.78 33.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 65.53 110.933 179.926 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.478 ' HG ' ' HE2' ' A' ' 113' ' ' PHE . 13.2 t -123.67 164.83 18.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.848 -179.862 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 8.4 mtp -104.78 124.31 49.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 74.13 110.898 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.465 ' HB3' ' HB3' ' A' ' 111' ' ' GLN . . . -91.1 122.55 33.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 42.42 111.078 179.961 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 107' ' ' THR . 8.2 t30 175.85 -161.97 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 73.53 110.894 -179.966 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.847 ' HB3' ' CB ' ' A' ' 107' ' ' THR . . . -59.72 -164.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 73.44 111.091 179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.581 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -108.34 -66.91 0.6 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.718 -0.753 . . . . 72.51 112.522 -179.969 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.581 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.9 Cg_endo -69.74 130.91 20.2 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.662 2.241 . . . . 65.41 112.356 -179.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.565 ' C ' ' O ' ' A' ' 105' ' ' PRO . 1.5 p30 22.84 67.17 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.192 -0.458 . . . . 65.34 110.91 179.999 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.847 ' CB ' ' HB3' ' A' ' 103' ' ' ALA . 6.9 p -150.62 52.62 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.134 -0.485 . . . . 74.42 111.151 -179.924 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -50.48 -56.04 13.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.435 . . . . 75.31 110.89 -179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 74.4 -172.62 52.06 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.711 -0.756 . . . . 61.54 112.518 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 72.1 p -112.77 -21.86 10.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.827 0.346 . . . . 74.15 110.864 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.465 ' HB3' ' HB3' ' A' ' 101' ' ' ALA . 5.4 mm-40 -60.3 145.22 48.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 72.4 110.873 -179.955 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -141.36 162.72 34.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 71.4 110.831 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.478 ' HE2' ' HG ' ' A' ' 99' ' ' SER . 15.1 p90 -148.84 132.02 16.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 64.45 110.913 -179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 77.8 mt -78.73 121.94 32.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 73.41 111.161 179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -78.69 128.76 33.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 55.21 110.878 179.964 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 61' ' ' MET . 6.9 p -90.43 -14.37 33.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 75.14 111.219 -179.91 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -152.06 160.16 43.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 73.02 111.164 179.833 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.4 ptmt -53.29 132.97 39.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.26 -0.427 . . . . 64.14 110.885 179.999 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 40.2 p -138.35 52.59 1.82 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 71.03 111.13 179.978 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 15.4 tm-20 -50.63 -22.03 1.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.272 -0.422 . . . . 54.22 110.891 179.981 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 9.6 m-90 -58.73 -35.79 73.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.172 -0.467 . . . . 61.42 110.894 -179.966 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.24 101.62 14.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 73.44 110.887 -179.992 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -151.09 -79.32 0.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 73.21 110.837 179.831 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -52.74 -27.95 29.33 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.748 -0.739 . . . . 52.4 112.477 -179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -73.42 0.21 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.768 0.318 . . . . 73.12 110.926 -179.986 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 6.3 m-70 -99.5 149.77 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.287 -0.415 . . . . 64.24 110.836 179.886 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.2 t -64.37 -151.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 61.13 111.126 179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.636 HG13 ' HB2' ' A' ' 90' ' ' LEU . 2.4 p 175.94 141.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 72.51 111.138 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.665 ' O ' HD22 ' A' ' 98' ' ' LEU . 3.1 p90 -175.51 124.94 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 74.02 110.887 -179.981 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' A' ' 98' ' ' LEU . . . 108.12 153.47 17.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 73.02 112.504 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.3 pttm -171.77 151.92 2.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.861 0.362 . . . . 71.21 110.911 179.998 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.7 t -48.5 112.09 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.446 . . . . 55.32 111.176 179.857 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.62 -49.97 8.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 75.13 110.932 179.917 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -159.45 145.32 16.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 73.22 110.898 179.946 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 99.95 16.56 27.88 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.687 -0.768 . . . . 42.33 112.481 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -46.09 -29.72 1.62 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.767 0.318 . . . . 72.34 110.852 -179.937 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 51.3 m-20 -49.57 -29.96 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 52.14 110.953 -179.97 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.1 mm -69.51 -50.08 53.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 64.41 111.099 179.913 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.7 t -47.61 -45.92 10.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 53.53 111.123 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -51.37 -40.45 59.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 74.32 110.891 -179.975 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.33 -34.19 77.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 40.14 111.101 179.938 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.52 -29.13 61.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 65.43 110.9 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -87.59 26.09 1.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 63.03 110.872 -179.895 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.43 -23.79 1.63 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 74.25 110.855 -179.883 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -100.77 6.35 43.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.453 . . . . 60.55 110.856 -179.92 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.86 -154.94 29.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.752 . . . . 71.34 112.494 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.9 t -167.51 150.85 6.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 63.53 110.806 -179.73 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 24.9 mmm-85 -77.9 65.78 3.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.143 -0.48 . . . . 75.42 110.853 -179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 167.82 -26.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 65.14 110.896 -179.967 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 133.3 172.75 13.05 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.747 -0.74 . . . . 65.51 112.473 179.935 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.51 105.75 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.852 0.358 . . . . 73.42 110.879 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.9 p -91.06 41.1 1.05 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 52.3 111.134 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 74.01 -50.83 0.69 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.84 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -123.26 -168.15 1.72 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 65.1 110.921 179.942 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.601 ' HE2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -110.55 134.77 52.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 70.12 110.924 179.861 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.71 HD12 ' CE2' ' A' ' 53' ' ' PHE . 17.8 mt -100.38 104.78 16.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.438 . . . . 53.24 111.114 179.889 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.601 HG23 ' HE2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -97.49 178.56 5.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.449 . . . . 73.45 111.133 179.971 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 43.6 mm -128.38 143.94 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 51.13 111.083 179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -94.17 -65.34 0.99 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 53.25 111.116 179.771 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -147.47 164.17 34.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.194 -0.457 . . . . 71.4 110.88 -179.982 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 59.1 m -144.9 -173.61 4.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 34.21 110.882 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.544 ' HA2' HG22 ' A' ' 41' ' ' THR . . . 140.52 -158.31 26.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.724 -0.751 . . . . 74.04 112.482 -179.882 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.99 136.33 47.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.861 0.362 . . . . 63.42 110.914 -179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.491 ' C ' HD23 ' A' ' 164' ' ' LEU . 3.7 tt -93.06 -44.34 8.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.438 . . . . 61.32 110.889 -179.957 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 2' ' ' VAL . 6.9 tp10 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 61.32 110.888 179.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.5 tpt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.807 0.337 . . . . 43.3 110.865 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 54.1 t -98.34 133.92 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 63.35 111.125 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -53.99 158.59 3.4 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.677 0.751 . . . . 64.35 110.852 -179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 120.71 7.45 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.68 2.253 . . . . 33.31 112.313 179.968 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 33.0 m -107.86 68.58 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 71.14 111.171 179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 m -47.86 155.9 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 61.41 111.159 179.885 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -135.66 160.21 39.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 75.13 110.889 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -144.94 135.05 23.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.169 -0.469 . . . . 73.44 110.849 -179.922 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -97.42 78.44 2.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.138 -0.483 . . . . 72.02 110.877 179.952 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.568 HG22 HD12 ' A' ' 17' ' ' LEU . 2.7 mm -56.72 146.21 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 74.55 111.162 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 16' ' ' PRO . . . -134.65 170.48 15.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.459 . . . . 74.41 111.076 179.861 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.447 HG22 HG13 ' A' ' 156' ' ' ILE . 79.5 t -146.66 96.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 64.45 111.116 179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.9 t0 65.84 41.98 3.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 179.911 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.05 -16.19 52.68 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.744 -0.741 . . . . 73.11 112.523 -179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -97.42 110.02 52.78 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.65 0.738 . . . . 73.2 110.91 -179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 53.5 Cg_endo -69.75 144.85 55.43 Favored 'Trans proline' 0 C--O 1.231 0.166 0 C-N-CA 122.703 2.269 . . . . 63.41 112.328 -179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.671 HD13 HG23 ' A' ' 138' ' ' ILE . 4.1 mt -81.29 -44.54 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 53.22 110.952 179.958 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.8 35.46 0.35 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 61.02 112.489 179.876 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 62.39 147.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.889 0.376 . . . . 74.43 110.826 -179.893 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 HG21 ' A' ' 138' ' ' ILE . 36.5 t -105.41 -103.82 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 63.51 111.079 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 164.64 81.07 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.205 -0.452 . . . . 75.13 110.858 -179.859 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.85 111.68 23.37 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.123 -0.49 . . . . 64.41 110.932 -179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -88.22 144.46 26.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.162 -0.472 . . . . 75.32 110.888 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.17 113.18 24.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.868 -179.959 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -76.53 66.28 2.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 74.42 110.892 179.921 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.81 -35.23 77.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 75.1 111.075 179.929 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.57 -65.46 0.56 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 62.01 110.894 179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.612 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -51.91 -78.9 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 65.02 110.891 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG21 ' CD2' ' A' ' 129' ' ' PHE . 17.4 m -72.13 117.72 60.81 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.598 0.713 . . . . 53.42 111.1 179.9 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -87.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.712 2.275 . . . . 74.51 112.33 179.942 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.33 -36.79 84.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.849 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -4.46 2.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 64.12 111.112 -179.968 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 29' ' ' VAL . . . -76.9 -48.54 17.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 71.04 111.075 179.86 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.514 ' O ' ' C ' ' A' ' 35' ' ' ASN . 22.2 pt-20 -78.2 -38.12 44.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 72.34 110.849 -179.902 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -28.97 -67.23 0.08 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 72.34 110.898 -179.935 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.795 ' HA ' HD12 ' A' ' 39' ' ' LEU . 71.9 t80 -74.91 -34.71 62.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.909 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 34' ' ' GLU . 2.6 ttp180 -49.36 -38.68 29.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.843 -179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HB3' HD13 ' A' ' 78' ' ' ILE . . . -71.55 -35.1 70.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 55.33 111.119 179.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.795 HD12 ' HA ' ' A' ' 36' ' ' PHE . 14.0 mt -68.5 -45.35 72.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 75.03 110.911 179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.8 -45.38 94.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 75.03 110.868 -179.927 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.4 p -72.41 -15.52 61.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 73.42 111.168 -179.961 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 54.17 82.81 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.774 -0.727 . . . . 75.41 112.463 179.956 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.54 31.23 1.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.95 0.405 . . . . 74.44 110.947 -179.886 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -138.87 22.62 2.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.136 -0.484 . . . . 72.11 110.93 179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 88.68 -40.42 3.07 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.757 -0.735 . . . . 74.21 112.486 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -127.98 -164.01 1.33 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.857 0.36 . . . . 74.23 110.889 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 107.92 145.71 11.99 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.767 -0.73 . . . . 64.02 112.515 -179.941 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.669 ' CE1' HD13 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -50.72 102.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.383 . . . . 65.32 110.947 -179.781 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -129.77 -61.32 1.01 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.142 -0.481 . . . . 50.23 110.876 179.924 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.47 30.13 3.19 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.72 -0.752 . . . . 64.23 112.477 179.932 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -76.08 -171.11 1.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.874 0.369 . . . . 74.21 110.87 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 76.0 m -87.03 -174.44 4.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.124 -0.489 . . . . 62.31 110.885 -179.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -65.59 -167.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 73.31 110.887 -179.905 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' GLN . 0.4 OUTLIER -115.73 -92.95 0.5 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 71.24 110.842 -179.98 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.638 ' HD3' HD11 ' A' ' 57' ' ' ILE . 13.1 ttm180 -135.01 -46.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.195 -0.457 . . . . 72.3 110.872 -179.889 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.615 ' CD1' HD13 ' A' ' 156' ' ' ILE . 70.6 mt 61.19 104.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 74.54 111.189 -179.929 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.638 HD11 ' HD3' ' A' ' 55' ' ' ARG . 44.2 mt -139.72 98.78 7.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.582 0.706 . . . . 64.43 111.1 179.905 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 53.3 Cg_endo -69.84 96.13 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.652 2.235 . . . . 72.22 112.321 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.77 -46.59 0.61 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.77 -0.729 . . . . 55.03 112.489 179.982 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -106.09 -67.16 0.95 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 62.31 110.87 -179.84 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -172.61 -153.48 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 54.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 4.1 p -150.74 153.39 35.43 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.264 -0.426 . . . . 74.24 110.924 -179.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 54' ' ' HIS . 1.3 tp60 -88.25 -168.84 2.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.944 -179.913 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.24 -65.9 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.73 -0.748 . . . . 64.51 112.493 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.5 66.45 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.718 -0.753 . . . . 73.01 112.501 -179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -79.41 168.24 19.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.8 0.333 . . . . 65.52 110.889 -179.969 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -126.0 34.66 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 74.33 110.892 -179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.3 p -112.01 -75.11 0.62 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 74.1 111.125 -179.933 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 64.0 165.0 0.14 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.23 -0.441 . . . . 72.43 110.852 -179.988 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 72.68 43.35 0.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.882 -179.993 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 168.33 -74.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 64.01 110.898 -179.89 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 134.64 65.72 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.752 -0.737 . . . . 42.0 112.474 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.3 p -133.9 -164.4 1.49 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.809 0.338 . . . . 74.31 111.143 -179.898 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -123.09 -178.92 15.63 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.718 -0.753 . . . . 61.22 112.453 -179.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.7 -118.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.737 -0.744 . . . . 75.4 112.448 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 4.1 ptmt -158.9 170.72 21.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.761 0.315 . . . . 65.35 110.892 -179.963 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.74 179.31 7.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.814 -179.861 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.625 HD13 ' HB3' ' A' ' 38' ' ' ALA . 23.2 pt -96.63 -36.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.03 111.1 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.5 m-85 -87.6 -20.21 26.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.214 -0.448 . . . . 74.55 110.889 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -158.22 -173.53 26.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.791 -0.718 . . . . 63.22 112.505 -179.985 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.8 -19.45 37.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.941 0.4 . . . . 53.24 110.923 -179.916 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.4 pttt -175.91 149.81 0.95 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.964 179.967 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -117.03 166.48 12.15 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.249 -0.432 . . . . 73.32 110.893 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.402 ' HA ' ' HB2' ' A' ' 106' ' ' ASN . 4.1 pt-20 -90.41 159.66 16.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 74.41 110.853 -179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -71.42 141.56 50.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 72.15 110.871 179.948 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.04 -57.98 1.98 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 71.43 110.902 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -173.0 145.03 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 65.43 110.86 -179.951 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -104.39 52.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 71.34 110.843 -179.981 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 mt -82.69 3.86 2.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.147 -0.478 . . . . 73.14 111.093 179.981 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.612 HD21 ' HG2' ' A' ' 28' ' ' LYS . 2.7 mm? -113.51 97.73 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.206 -0.452 . . . . 72.13 110.92 179.909 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.24 131.02 40.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 72.43 110.883 179.842 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 13.8 m80 -53.81 94.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 70.44 110.882 179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.9 p -84.27 -12.63 54.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 72.32 111.118 -179.903 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 174.64 -170.09 43.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.723 -0.751 . . . . 72.45 112.5 179.945 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 115' ' ' CYS . 53.8 Cg_endo -69.75 142.43 47.97 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.627 2.218 . . . . 55.03 112.375 -179.984 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 109.74 -21.24 25.91 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.787 -0.72 . . . . 64.31 112.478 179.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.6 mm -63.37 149.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.833 0.349 . . . . 63.22 111.142 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.692 HD12 ' CA ' ' A' ' 130' ' ' GLY . 2.8 mt -119.84 145.96 46.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.155 -0.475 . . . . 72.34 110.945 179.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.719 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.7 OUTLIER -155.8 35.23 0.35 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 60.24 110.877 -179.884 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.608 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.9 mmt 39.2 -149.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 62.42 110.899 179.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 100' ' ' MET . . . 166.63 86.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 62.32 111.062 179.912 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.445 ' HB2' ' HA2' ' A' ' 109' ' ' GLY . 1.0 OUTLIER -110.1 -71.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.855 -179.942 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.456 ' C ' ' HD2' ' A' ' 105' ' ' PRO . . . -146.02 -39.04 0.23 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 75.35 111.108 179.908 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 128.31 -61.14 0.66 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.724 -0.751 . . . . 74.15 112.516 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.548 ' O ' ' C ' ' A' ' 106' ' ' ASN . 54.0 Cg_endo -69.78 100.06 0.79 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.716 2.277 . . . . 75.01 112.325 -179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.548 ' C ' ' O ' ' A' ' 105' ' ' PRO . 0.3 OUTLIER 25.28 79.18 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.873 179.972 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' ALA . 6.6 t -140.63 29.32 1.94 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.444 . . . . 70.01 111.139 -179.972 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 36.5 t30 51.59 -99.13 0.07 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 54.14 110.895 179.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.445 ' HA2' ' HB2' ' A' ' 102' ' ' ASN . . . 146.47 -85.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.708 -0.758 . . . . 75.34 112.457 179.938 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.56 20.98 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.809 0.338 . . . . 64.24 110.873 -179.697 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.414 ' O ' ' HB3' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -87.52 -38.25 16.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 62.02 110.881 -179.965 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 114' ' ' ILE . 66.3 t80 68.65 84.19 0.15 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.237 -0.438 . . . . 71.34 110.929 -179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.0 129.1 55.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 74.1 110.872 -179.888 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.539 HD11 ' CE2' ' A' ' 112' ' ' PHE . 0.5 OUTLIER -117.39 118.65 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 62.25 111.127 179.992 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 18.9 p -86.0 147.01 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 35.53 110.881 179.95 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.3 m -107.78 33.81 3.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.177 -0.465 . . . . 71.33 111.151 -179.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -170.2 -177.92 2.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 54.11 111.084 179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -82.68 90.98 6.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 74.41 110.882 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.603 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 33.0 p -116.39 64.01 0.71 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.264 -0.425 . . . . 72.21 111.185 179.94 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -86.04 18.61 2.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 72.32 110.912 -179.995 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.603 ' CZ2' HG22 ' A' ' 119' ' ' THR . 6.4 p90 -97.9 13.8 29.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.153 -0.476 . . . . 75.43 110.921 -179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 3.5 mt -125.01 -4.25 7.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 72.03 110.908 -179.993 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -79.97 53.79 1.76 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 73.35 110.862 179.851 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -147.32 26.17 1.55 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.695 -0.764 . . . . 74.31 112.485 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tppm? -168.79 -36.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.824 0.345 . . . . 75.41 110.93 -179.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -95.94 154.51 17.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 55.41 110.903 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.441 HG12 ' CD1' ' A' ' 129' ' ' PHE . 53.9 t -86.95 107.67 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 65.21 111.117 -179.997 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.719 HG22 ' HB3' ' A' ' 99' ' ' SER . 39.7 t -93.5 135.02 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 64.13 111.106 179.965 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.692 ' CD2' HG21 ' A' ' 29' ' ' VAL . 11.6 p90 -170.93 58.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 63.33 110.876 179.986 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.692 ' CA ' HD12 ' A' ' 98' ' ' LEU . . . -128.93 179.32 16.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.768 -0.729 . . . . 64.32 112.483 -179.955 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? 176.31 147.75 0.1 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.845 0.355 . . . . 73.04 110.871 -179.964 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 64.6 t -112.28 94.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 74.11 111.087 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.99 -75.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.47 . . . . 75.21 110.909 179.894 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -127.17 -166.2 1.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 74.21 110.872 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.84 69.03 1.4 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.761 -0.733 . . . . 73.43 112.43 179.965 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.14 -7.1 52.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.758 0.314 . . . . 73.22 110.866 -179.999 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -75.05 -31.31 61.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 52.45 110.846 -179.904 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.684 HG21 HG22 ' A' ' 20' ' ' VAL . 21.2 mm -73.74 -39.19 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 54.44 111.133 179.937 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 139' ' ' VAL . 15.5 t -82.36 -1.48 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 70.11 111.169 179.848 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -118.24 -59.5 1.89 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.48 . . . . 65.03 110.909 -179.995 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.81 -56.13 22.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 75.51 111.128 179.894 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.429 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 2.0 ttm -51.43 -49.47 61.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.476 . . . . 71.42 110.9 179.978 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -24.61 28.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.2 -0.454 . . . . 74.42 110.91 -179.963 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 23.9 ttm-85 -66.67 -13.64 61.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 75.15 110.871 -179.92 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -90.36 19.5 5.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 61.43 110.861 -179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.78 -158.75 31.04 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.739 -0.743 . . . . 74.34 112.482 -179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 32.9 t -146.82 -77.8 0.17 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.868 0.366 . . . . 62.43 110.852 -179.728 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 177.43 -32.46 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.149 -0.478 . . . . 73.35 110.912 -179.942 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -106.1 -14.68 15.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 71.25 110.88 -179.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 132.27 -34.41 2.52 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.775 -0.726 . . . . 70.25 112.479 179.966 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 127.84 15.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.833 0.349 . . . . 72.04 110.872 -179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 2.1 m -110.01 149.56 29.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 71.52 111.121 179.994 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 3.8 p -68.9 -25.27 64.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 43.45 110.849 -179.859 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.02 -166.92 1.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.125 -0.489 . . . . 40.21 110.909 179.96 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.478 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.9 OUTLIER -121.83 116.9 25.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 74.01 110.908 179.917 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.615 HD13 ' CD1' ' A' ' 56' ' ' ILE . 4.1 mp -95.37 128.34 46.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.247 -0.433 . . . . 63.05 111.114 179.874 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.478 HG23 ' HD2' ' A' ' 155' ' ' LYS . 82.4 p -138.59 149.53 45.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.152 -0.476 . . . . 74.11 111.081 179.991 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.669 HD13 ' CE1' ' A' ' 48' ' ' TYR . 3.0 mp -88.99 105.94 16.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 61.34 111.144 179.91 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.02 -49.08 76.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 62.02 111.102 179.844 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -156.61 177.99 10.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 71.53 110.898 179.946 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 27.3 p -174.54 159.81 3.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.164 -0.471 . . . . 72.24 110.873 -179.889 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -162.51 -179.95 37.42 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.712 -0.756 . . . . 64.54 112.49 -179.942 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -79.57 -43.81 22.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.817 0.341 . . . . 73.02 110.904 -179.85 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 61.86 -172.46 0.15 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.209 -0.451 . . . . 62.3 110.913 -179.978 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 64.43 110.877 179.889 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.813 0.339 . . . . 75.32 110.872 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 94.4 t -142.24 145.83 23.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 62.04 111.069 179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.71 140.87 97.55 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.623 0.725 . . . . 73.24 110.911 179.979 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.77 152.73 69.36 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.702 2.268 . . . . 60.0 112.321 179.948 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.402 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 58.0 m -138.59 90.29 2.44 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 33.2 111.147 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.4 m -74.22 162.56 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 63.31 111.103 179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -133.45 157.24 46.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 71.4 110.909 -179.992 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -140.87 139.99 34.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.43 110.91 -179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.635 ' CB ' ' HB3' ' A' ' 159' ' ' ALA . 6.7 m-20 -95.46 99.53 11.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 74.45 110.927 179.943 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 19.7 mm -71.7 113.39 8.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 74.13 111.125 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -110.46 161.33 15.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.1 179.796 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.1 m -143.91 110.93 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 61.52 111.13 179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 65.7 43.87 3.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 71.34 110.855 179.903 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.82 9.11 65.26 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.732 -0.746 . . . . 51.53 112.497 -179.939 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 58.8 tt0 -114.91 132.29 23.05 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.594 0.712 . . . . 71.34 110.912 -179.879 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 125.28 11.94 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.669 2.246 . . . . 64.1 112.328 -179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 tp -94.58 -36.92 11.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.444 . . . . 63.13 110.919 179.959 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 165.21 -137.89 4.94 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.756 . . . . 75.12 112.471 179.886 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.87 149.74 23.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.851 0.358 . . . . 64.55 110.837 -179.798 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 134' ' ' GLU . 5.4 t -148.91 136.61 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 62.11 111.134 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.459 ' HA ' ' HA ' ' A' ' 7' ' ' PHE . 0.3 OUTLIER -114.78 161.66 17.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 72.21 110.869 -179.834 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -137.76 149.51 46.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 72.44 110.905 -179.961 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -92.0 107.9 19.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.55 110.877 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.664 HD12 ' HB1' ' A' ' 33' ' ' ALA . 0.1 OUTLIER -81.06 130.18 34.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 64.3 110.875 -179.969 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -84.73 63.53 8.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 73.44 110.902 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.19 -2.48 31.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 75.44 111.096 179.958 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -93.89 -55.04 3.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.845 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.52 -59.13 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.23 -0.441 . . . . 75.3 110.937 179.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 33' ' ' ALA . 4.7 m -110.84 80.48 2.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.587 0.708 . . . . 75.12 111.131 179.865 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 56.25 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.647 2.231 . . . . 74.45 112.387 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.8 mtmm -161.7 -67.27 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.223 -0.444 . . . . 75.01 110.915 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.682 HG21 HG11 ' A' ' 127' ' ' VAL . 10.0 t -72.48 -16.58 61.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 54.52 111.139 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.664 ' HB1' HD12 ' A' ' 24' ' ' LEU . . . -82.47 -36.39 26.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 71.2 111.106 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -63.98 -156.11 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 74.02 110.886 -179.929 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 65.37 -73.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 33.11 110.876 -179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' N ' ' O ' ' A' ' 34' ' ' GLU . 8.6 t80 -50.07 -34.41 21.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 74.12 110.881 -179.99 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -40.68 71.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 74.45 110.876 -179.87 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -91.2 -41.47 10.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 55.22 111.134 179.887 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.3 tt -62.76 -19.32 63.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 63.51 110.912 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 43.2 t -101.18 -7.67 22.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 75.3 110.887 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 99.8 m -105.69 -22.65 12.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.495 . . . . 75.32 111.179 -179.972 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.98 69.74 1.36 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.737 -0.744 . . . . 42.41 112.5 179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -153.96 34.16 0.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.931 0.396 . . . . 64.45 110.87 -179.868 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.2 18.85 2.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 74.53 110.902 179.935 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 90.13 -32.04 5.09 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 54.51 112.448 179.91 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -148.85 -177.55 5.86 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.859 0.362 . . . . 75.0 110.909 -179.849 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 166.62 178.47 39.22 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.762 -0.733 . . . . 62.24 112.536 179.989 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -65.71 -69.26 0.31 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.94 0.4 . . . . 73.33 110.907 -179.761 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? 55.5 179.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 75.45 110.845 179.882 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.405 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -37.97 100.08 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.706 -0.759 . . . . 53.52 112.506 179.932 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.6 154.17 42.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.884 0.373 . . . . 73.21 110.824 -179.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 24.8 p -65.76 161.17 21.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.087 -0.506 . . . . 74.41 110.885 -179.998 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -119.88 174.97 6.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 72.34 110.888 -179.881 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -165.91 166.37 17.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 73.54 110.874 179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 65.68 112.76 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.828 -179.94 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 32.8 mt -151.05 122.35 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.475 . . . . 75.45 111.136 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.418 ' HA ' ' HD2' ' A' ' 58' ' ' PRO . 7.1 mt -130.6 103.76 16.11 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.642 0.734 . . . . 71.55 111.098 179.875 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 57' ' ' ILE . 54.5 Cg_endo -69.69 85.76 0.59 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.67 2.246 . . . . 71.45 112.379 179.817 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 140.46 -17.08 2.89 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.798 -0.715 . . . . 52.44 112.519 -179.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -118.87 -57.89 2.0 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 62.44 110.905 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.64 -162.73 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 72.33 110.874 179.934 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.2 m -129.93 -72.08 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.214 -0.448 . . . . 65.42 110.867 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 62.87 153.92 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 74.03 110.913 -179.9 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.26 179.38 16.2 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.753 -0.737 . . . . 41.43 112.467 -179.943 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -99.71 120.71 6.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.779 -0.724 . . . . 63.13 112.477 -179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -149.86 155.1 39.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.882 0.373 . . . . 74.03 110.846 -179.971 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 179.85 175.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 74.51 110.907 -179.925 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.457 HG21 ' H ' ' A' ' 76' ' ' LYS . 5.0 t -176.84 59.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 73.51 111.131 -179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.02 -30.58 12.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.445 . . . . 72.34 110.839 179.994 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -47.05 -78.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 73.33 110.851 -179.997 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 179.21 40.36 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 54.5 110.871 -179.928 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -134.69 -137.8 3.82 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.714 -0.755 . . . . 54.42 112.49 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.5 t -144.53 135.29 24.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.809 0.337 . . . . 74.31 111.12 -179.837 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -179.6 -81.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.711 -0.757 . . . . 65.15 112.476 179.906 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.01 -9.73 54.48 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 34.33 112.522 -179.925 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.457 ' H ' HG21 ' A' ' 68' ' ' THR . 16.8 ptpt -93.29 171.79 8.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.804 0.335 . . . . 74.14 110.918 179.987 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 84.1 p -81.92 -167.4 1.52 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 63.14 110.881 -179.932 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.429 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.3 pp -109.55 12.35 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 73.44 111.173 179.895 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -129.61 20.74 5.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.173 -0.467 . . . . 74.33 110.911 -179.973 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 142.46 -122.34 1.94 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.767 -0.73 . . . . 74.12 112.505 179.97 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -116.99 -20.0 9.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 72.33 110.892 -179.878 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -176.11 -175.33 0.7 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.136 -0.483 . . . . 63.3 110.927 179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' N ' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -151.52 154.27 36.18 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 71.24 110.885 179.939 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -71.2 163.26 27.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 72.11 110.854 -179.892 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -88.8 123.96 33.7 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.125 -0.489 . . . . 75.33 110.896 179.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.24 -48.8 55.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.218 -0.446 . . . . 51.12 110.849 -179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 4.3 p30 179.38 175.43 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 74.44 110.891 -179.955 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -118.52 37.6 4.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.449 . . . . 74.23 110.927 -179.981 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 36.9 mm -56.55 -23.36 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 55.01 111.11 179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.697 ' HB2' HG13 ' A' ' 128' ' ' VAL . 7.2 mt -104.02 134.58 47.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 45.21 110.894 179.95 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.7 mttm -120.04 -172.34 2.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 70.14 110.92 179.828 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -97.47 80.34 2.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.241 -0.436 . . . . 70.32 110.892 179.866 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 31.7 p -60.68 -22.53 63.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 75.42 111.137 -179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.91 -149.1 13.71 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.777 -0.725 . . . . 50.11 112.494 179.945 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 162.7 41.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.625 2.217 . . . . 74.34 112.332 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.33 23.02 76.75 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.669 -0.777 . . . . 73.2 112.495 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 9.8 mm -95.05 116.83 37.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.87 0.367 . . . . 72.22 111.125 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 130' ' ' GLY . 1.4 mt -86.38 136.07 33.27 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 71.34 110.888 179.948 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 8.4 t -133.77 -153.94 0.57 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.482 . . . . 44.52 110.866 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 3.1 mmt -153.59 158.08 40.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 61.02 110.895 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.572 ' O ' ' CB ' ' A' ' 102' ' ' ASN . . . -108.5 -169.42 1.5 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 50.34 111.103 179.929 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.572 ' CB ' ' O ' ' A' ' 101' ' ' ALA . 32.4 t30 89.43 102.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 63.43 110.893 -179.947 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.52 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . 52.51 -108.08 0.38 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 74.53 111.087 179.882 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.424 ' N ' ' HD2' ' A' ' 105' ' ' PRO . . . 168.86 -62.57 0.19 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.748 -0.739 . . . . 64.14 112.538 -179.912 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 104' ' ' GLY . 53.8 Cg_endo -69.82 99.84 0.78 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.679 2.253 . . . . 74.42 112.331 -179.971 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 62.21 47.0 5.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.438 . . . . 64.3 110.914 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.52 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 0.6 OUTLIER -147.73 71.13 1.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.149 -0.478 . . . . 75.13 111.166 -179.966 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.552 ' CG ' HG21 ' A' ' 127' ' ' VAL . 0.0 OUTLIER -91.39 31.48 1.15 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 53.45 110.908 179.975 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . -27.57 -95.45 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.716 -0.754 . . . . 64.12 112.499 179.991 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 7.5 t -151.66 -167.6 2.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 70.22 110.857 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 72.13 96.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 73.3 110.89 -179.998 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -101.69 139.46 37.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 75.12 110.867 -179.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 13.9 p90 -111.35 104.6 13.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 72.31 110.893 -179.937 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 31.2 mt -72.39 136.18 26.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 75.01 111.094 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.9 m -103.19 153.75 20.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.111 -0.495 . . . . 73.44 110.866 179.942 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.3 m -130.53 -33.87 1.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.459 . . . . 62.23 111.166 -179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -100.41 15.76 26.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 72.32 111.085 179.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 65.3 126.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 75.44 110.852 179.938 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 72.1 p -143.05 76.51 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 41.33 111.127 179.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.36 17.14 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 75.01 110.89 179.988 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -80.4 -29.22 37.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 64.44 110.926 -179.965 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.432 ' N ' HD13 ' A' ' 122' ' ' LEU . 0.4 OUTLIER -99.4 23.72 8.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 74.44 110.949 179.978 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.8 p-10 -89.72 42.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 65.22 110.877 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -162.21 33.31 0.33 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.793 -0.718 . . . . 55.31 112.515 -179.896 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -160.19 -49.3 0.05 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.83 0.348 . . . . 73.44 110.901 -179.984 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.6 m-70 -96.55 158.09 15.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 75.13 110.845 179.902 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.8 HG12 ' H ' ' A' ' 128' ' ' VAL . 1.5 t -81.8 -168.64 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 72.3 111.143 179.976 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.8 ' H ' HG12 ' A' ' 127' ' ' VAL . 2.4 p -172.39 103.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.454 . . . . 73.23 111.165 179.955 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -129.68 82.38 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.92 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.558 ' C ' HD12 ' A' ' 98' ' ' LEU . . . 140.03 135.73 3.27 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.765 -0.731 . . . . 75.01 112.49 -179.967 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -143.99 144.49 31.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.802 0.334 . . . . 73.32 110.976 -179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 74.8 t -49.43 115.9 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.268 -0.423 . . . . 73.53 111.106 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -64.49 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 55.51 110.911 179.891 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.409 ' O ' HG13 ' A' ' 20' ' ' VAL . 0.9 OUTLIER -141.73 146.41 36.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 73.41 110.945 179.905 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.9 10.29 35.23 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.733 -0.746 . . . . 72.22 112.515 -179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.2 ttt -50.07 -28.69 7.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 70.41 110.848 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -51.5 -25.08 5.92 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.252 -0.431 . . . . 72.25 110.936 -179.96 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.6 mm -90.72 -37.34 9.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.142 179.875 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.4 t -53.97 -21.77 6.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 75.21 111.136 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -85.91 -34.32 20.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.144 -0.48 . . . . 73.22 110.877 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.22 -47.24 83.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 52.21 111.125 179.912 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 13.9 ptm -69.36 -22.11 63.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.242 -0.436 . . . . 73.5 110.91 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -88.45 23.34 2.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 65.53 110.891 -179.938 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.76 -11.46 1.55 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.877 -179.922 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -95.6 11.47 33.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 74.03 110.877 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -103.1 -142.18 11.95 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 53.14 112.484 -179.933 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.2 t -159.16 139.63 12.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.86 0.362 . . . . 64.13 110.843 -179.724 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 mmm-85 -69.69 80.16 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 74.13 110.859 -179.935 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 173.81 -29.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 64.11 110.881 -179.975 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 135.02 -61.79 0.63 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.778 -0.725 . . . . 54.33 112.509 -179.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -51.23 143.95 10.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.839 0.352 . . . . 73.52 110.869 -179.973 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 10.4 p -116.04 133.89 55.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.44 . . . . 71.12 111.147 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.17 -1.6 45.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 64.41 110.868 -179.898 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -136.78 -171.15 2.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.468 . . . . 73.33 110.913 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.6 tppm? -133.35 153.82 51.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 71.43 110.905 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.5 mt -135.39 118.97 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 73.55 111.129 179.908 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.4 p -115.04 169.32 9.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 51.21 111.168 179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.405 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 39.6 mm -110.38 133.33 56.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 74.45 111.089 179.974 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.635 ' HB3' ' CB ' ' A' ' 9' ' ' ASP . . . -82.67 -58.49 2.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 75.52 111.112 179.779 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -160.19 170.67 20.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.453 . . . . 62.14 110.873 179.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 66.8 m -150.09 166.65 29.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.22 -0.446 . . . . 63.21 110.896 -179.871 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -179.17 -178.32 48.22 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.735 -0.745 . . . . 21.2 112.45 -179.931 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.61 ' O ' ' HB2' ' A' ' 164' ' ' LEU . 3.2 mt-30 -80.08 -32.52 39.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 73.12 110.955 -179.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.61 ' HB2' ' O ' ' A' ' 163' ' ' GLN . 0.4 OUTLIER 73.49 -60.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.454 . . . . 60.14 110.916 179.971 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 55.2 110.831 179.953 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 tmm? . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.788 0.327 . . . . 71.11 110.922 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 63.27 156.44 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.225 -0.443 . . . . 54.13 111.132 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.61 128.98 94.11 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.628 0.728 . . . . 75.5 110.827 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 131.65 21.66 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.687 2.258 . . . . 63.03 112.334 179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 64.3 m -126.19 145.04 50.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.234 -0.439 . . . . 71.23 111.123 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 163' ' ' GLN . 10.5 m -125.15 147.53 29.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 55.12 111.139 179.881 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.673 ' HB3' HD22 ' A' ' 164' ' ' LEU . 2.6 p90 -103.62 148.56 25.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 73.35 110.839 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -144.06 130.64 20.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 73.43 110.903 -179.959 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.6 t0 -108.59 119.94 41.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 74.01 110.849 179.977 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.581 HG21 ' CE ' ' A' ' 142' ' ' MET . 12.2 mm -101.82 149.25 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 75.43 111.097 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -134.57 164.73 26.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.177 -0.465 . . . . 72.22 111.143 179.768 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 1.044 HG22 HG22 ' A' ' 156' ' ' ILE . 58.9 t -139.1 101.52 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 63.53 111.117 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.435 ' CB ' ' O ' ' A' ' 12' ' ' VAL . 1.6 t0 78.68 27.97 0.45 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.849 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.21 -15.63 62.57 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.795 -0.716 . . . . 24.11 112.518 -179.908 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 136.71 21.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.669 0.747 . . . . 73.44 110.859 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 162.95 40.12 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.673 2.249 . . . . 62.1 112.319 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 10.2 mt -110.23 -52.79 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 53.5 110.895 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.554 ' O ' ' HB3' ' A' ' 19' ' ' ARG . . . 162.29 -15.8 0.14 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.742 -0.742 . . . . 74.31 112.481 179.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.554 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 0.0 OUTLIER 71.52 147.18 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.906 0.384 . . . . 74.43 110.846 -179.92 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.553 HG13 HG21 ' A' ' 138' ' ' ILE . 26.4 m -115.8 -176.17 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.462 . . . . 71.51 111.094 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 133' ' ' LYS . 3.7 m -123.67 87.43 2.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 74.4 110.845 -179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -84.32 121.63 27.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.148 -0.478 . . . . 63.54 110.928 -179.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -102.04 153.26 20.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 64.33 110.85 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.3 mt -119.99 126.81 51.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 74.41 110.937 -179.959 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.653 ' CE2' HD11 ' A' ' 90' ' ' LEU . 21.0 m-85 -89.34 70.48 8.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 75.43 110.856 179.963 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.48 -22.75 67.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 72.13 111.107 179.914 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -57.25 -61.08 2.72 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.888 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.08 -33.07 30.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.184 -0.462 . . . . 73.13 110.933 179.95 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.499 HG21 ' CB ' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -126.39 79.4 70.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.664 0.745 . . . . 75.34 111.165 179.876 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 -45.41 1.63 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 74.24 112.368 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -62.01 -59.38 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.1 110.904 179.901 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' OD1' ' A' ' 108' ' ' ASN . 1.5 m -55.15 -61.88 2.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.253 -0.43 . . . . 64.42 111.128 179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -47.69 -36.41 11.19 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 72.32 111.122 179.867 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 76.3 tt0 -67.13 -52.15 45.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.446 . . . . 71.32 110.933 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -49.18 -39.88 31.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.181 -0.463 . . . . 65.45 110.934 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.554 ' HA ' HD12 ' A' ' 39' ' ' LEU . 10.4 t80 -76.24 -29.66 57.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 74.32 110.875 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.72 -44.05 97.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.885 -179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.46 -25.87 62.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 74.3 111.071 179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 36' ' ' PHE . 43.0 mt -76.72 -55.63 5.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 73.22 110.921 -179.957 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 57.7 m -56.75 -48.96 76.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 74.13 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 57.0 p -77.44 -13.99 59.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 71.31 111.111 -179.923 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 48.17 71.07 0.62 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.797 -0.716 . . . . 72.24 112.48 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -121.08 33.51 5.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.956 0.408 . . . . 62.03 110.927 -179.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -126.39 0.51 6.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 74.5 110.908 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 99.0 -2.88 58.29 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 74.33 112.529 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -166.56 171.98 11.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.896 0.379 . . . . 74.51 110.88 -179.858 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 142.78 -172.0 24.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.757 -0.735 . . . . 75.33 112.476 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -82.1 129.34 34.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 72.22 110.915 -179.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -134.93 -48.6 0.74 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 70.42 110.894 179.865 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.432 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -166.61 51.78 0.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.695 -0.764 . . . . 63.15 112.487 179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 157' ' ' THR . 16.5 t -71.41 -92.75 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.81 0.338 . . . . 75.21 110.861 -179.707 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 51' ' ' SER . 0.6 OUTLIER 167.52 139.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.162 -0.472 . . . . 62.35 110.915 -179.914 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.528 ' CE2' HD11 ' A' ' 158' ' ' ILE . 9.4 m-85 -130.3 162.22 29.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 54.44 110.905 -179.892 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -178.09 52.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 60.41 110.833 -179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 32.2 ttm-85 -135.06 35.44 3.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.444 . . . . 72.32 110.846 -179.898 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -87.55 148.08 4.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.181 -0.463 . . . . 72.42 111.153 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.513 HD12 ' O ' ' A' ' 148' ' ' ARG . 1.5 tt -143.97 110.91 5.17 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.627 0.727 . . . . 72.11 111.108 179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 146' ' ' GLY . 53.7 Cg_endo -69.76 118.88 5.95 Favored 'Trans proline' 0 C--N 1.34 0.13 0 C-N-CA 122.701 2.267 . . . . 71.44 112.361 179.86 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 113.44 -30.27 7.38 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.732 -0.747 . . . . 61.31 112.484 179.997 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -106.08 -66.19 1.01 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.828 0.347 . . . . 70.3 110.855 -179.885 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.4 ' H ' HG23 ' A' ' 57' ' ' ILE . 1.7 ptt? -176.52 -152.69 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.149 -0.478 . . . . 61.55 110.857 179.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.77 137.91 25.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 44.41 110.886 -179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.48 157.21 34.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 72.04 110.943 -179.879 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 168.95 -161.39 35.08 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.709 -0.758 . . . . 74.51 112.463 -179.984 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.89 29.82 8.59 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.749 -0.739 . . . . 62.23 112.497 -179.87 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -96.66 83.37 3.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.81 0.338 . . . . 71.51 110.859 -179.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -94.66 31.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 71.4 110.849 -179.888 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.11 108.76 2.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.182 -0.463 . . . . 74.12 111.144 -179.923 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 13.1 tpt85 68.76 142.69 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.249 -0.432 . . . . 74.41 110.868 -179.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -87.32 25.73 1.35 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 54.53 110.863 179.983 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.59 -39.39 0.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.866 -179.919 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.24 54.48 0.41 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.697 -0.764 . . . . 64.15 112.455 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 75.4 p -112.35 3.88 17.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.822 0.344 . . . . 63.34 111.133 -179.899 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -116.15 -137.57 6.13 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.681 -0.771 . . . . 62.14 112.479 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 110.85 71.58 0.65 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.73 -0.747 . . . . 50.52 112.47 -179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.75 141.3 32.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.741 0.305 . . . . 63.41 110.916 -179.999 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 71.9 m -105.69 -178.69 3.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.221 -0.445 . . . . 73.15 110.826 -179.859 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.7 pp -74.17 -44.48 49.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 72.11 111.127 179.939 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -101.28 75.22 1.62 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.182 -0.463 . . . . 73.33 110.934 -179.991 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 89.49 -127.77 8.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.807 -0.711 . . . . 71.14 112.494 179.973 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -111.19 -85.25 0.56 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.882 0.372 . . . . 60.34 110.913 -179.932 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.528 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -123.48 145.92 48.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 73.11 110.875 179.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -107.43 171.02 7.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 72.0 110.899 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.48 161.5 27.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 73.43 110.904 -179.941 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -69.27 152.88 44.5 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.196 -0.457 . . . . 73.04 110.899 179.982 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.44 -56.67 2.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.266 -0.424 . . . . 70.23 110.894 -179.888 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.446 ' HB3' HD12 ' A' ' 89' ' ' ILE . 0.6 OUTLIER -177.46 143.68 0.37 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 74.5 110.875 -179.968 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -97.15 41.91 1.1 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 71.24 110.885 -179.98 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 87' ' ' ASN . 9.2 mt -75.27 -22.33 16.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 60.32 111.147 179.981 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.9 OUTLIER -83.31 99.46 10.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 72.2 110.88 179.89 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.1 101.5 13.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.44 110.9 179.798 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.701 ' CB ' HG21 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -60.34 95.2 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.54 110.858 179.903 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.7 37.28 1.96 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.26 -0.427 . . . . 60.23 111.155 -179.916 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.559 ' O ' HG23 ' A' ' 97' ' ' ILE . . . 173.16 158.87 18.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 73.3 112.484 179.997 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 135.81 31.35 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.661 2.241 . . . . 63.05 112.326 -179.913 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 121.84 -22.15 7.75 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 64.12 112.498 179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 ' CB ' ' A' ' 92' ' ' HIS . 0.2 OUTLIER -50.62 152.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.828 0.346 . . . . 75.11 111.154 -179.976 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -118.87 126.85 52.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 74.22 110.938 179.886 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HB3' HG22 ' A' ' 128' ' ' VAL . 82.1 p -153.47 86.0 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 64.2 110.826 -179.936 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -38.45 155.87 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 63.41 110.858 179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -130.46 166.77 19.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 75.13 111.042 179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -79.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 74.22 110.873 -179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.809 ' HB3' HG21 ' A' ' 107' ' ' THR . . . -129.12 -24.91 2.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 63.43 111.054 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.418 ' N ' ' OG1' ' A' ' 107' ' ' THR . . . 117.13 -78.46 0.29 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.778 -0.725 . . . . 61.41 112.495 -179.973 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 107' ' ' THR . 53.4 Cg_endo -69.8 128.58 16.2 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.656 2.237 . . . . 62.41 112.348 -179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.488 ' C ' ' O ' ' A' ' 105' ' ' PRO . 19.5 m-20 29.24 55.64 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 73.52 110.921 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.809 HG21 ' HB3' ' A' ' 103' ' ' ALA . 18.4 p -140.98 42.66 1.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.128 -0.487 . . . . 72.21 111.121 -179.921 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.683 ' C ' ' O ' ' A' ' 107' ' ' THR . 23.4 t30 0.83 -82.87 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 72.31 110.883 179.954 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 119.44 168.42 13.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 54.21 112.507 179.989 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 m -132.88 -39.66 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.805 0.336 . . . . 51.5 110.839 -179.75 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -84.05 72.71 10.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.468 . . . . 64.52 110.897 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -63.94 -171.12 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.232 -0.44 . . . . 75.52 110.874 -179.969 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -159.91 150.7 19.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 72.3 110.893 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 68.8 mt -106.37 114.72 46.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.13 -0.486 . . . . 60.33 111.144 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 70.7 m -75.8 132.9 40.7 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.16 -0.473 . . . . 75.5 110.861 179.958 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 42.8 p -99.45 11.99 37.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 73.2 111.151 -179.857 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.25 179.28 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.201 -0.454 . . . . 61.14 111.107 179.838 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -74.43 119.63 18.89 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 73.4 110.902 179.976 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.744 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 73.3 p -132.34 59.03 1.73 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 72.23 111.149 179.96 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -61.47 -11.87 12.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 71.5 110.91 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.744 ' CZ2' HG22 ' A' ' 119' ' ' THR . 41.8 p90 -82.99 5.75 21.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 73.23 110.894 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.447 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 82.0 mt -122.51 34.91 5.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 74.31 110.93 179.971 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -75.11 -86.74 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.183 -0.462 . . . . 63.13 110.86 179.869 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -73.95 78.08 0.94 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.745 -0.741 . . . . 42.42 112.495 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.47 -45.44 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.342 . . . . 73.12 110.881 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . 0.444 ' O ' ' HB ' ' A' ' 127' ' ' VAL . 36.7 m-70 -112.57 -25.53 9.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 72.12 110.859 179.929 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 126' ' ' HIS . 24.9 t 73.6 95.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.233 -0.44 . . . . 72.24 111.102 179.972 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.591 HG22 ' HB3' ' A' ' 99' ' ' SER . 99.0 t -75.32 140.08 18.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 71.21 111.119 179.899 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.499 ' CB ' HG21 ' A' ' 29' ' ' VAL . 43.4 p90 -139.01 -29.55 0.76 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.481 . . . . 72.41 110.88 -179.95 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.78 -168.33 43.49 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 74.34 112.489 -179.925 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.58 170.01 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.784 0.325 . . . . 65.32 110.907 -179.949 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -104.67 141.14 20.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 62.12 111.19 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 21' ' ' SER . 13.3 tppt? -118.07 -37.22 3.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 71.12 110.87 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.87 175.57 13.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 73.43 110.881 -179.988 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.15 78.8 0.12 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.786 -0.721 . . . . 63.33 112.475 -179.988 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -91.29 -24.11 19.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.766 0.317 . . . . 61.22 110.88 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.4 ' O ' ' C ' ' A' ' 138' ' ' ILE . 26.1 m120 -77.64 -39.49 44.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.433 . . . . 74.12 110.846 -179.966 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.553 HG21 HG13 ' A' ' 20' ' ' VAL . 50.0 mm -38.1 -46.54 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 73.44 111.177 179.961 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 70.2 t -88.79 -51.48 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.132 -0.485 . . . . 71.03 111.132 179.839 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 137' ' ' ASN . 20.5 mm-40 -46.66 -57.0 5.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.133 -0.485 . . . . 73.24 110.855 -179.978 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.98 76.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 53.43 111.074 179.964 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.581 ' CE ' HG21 ' A' ' 10' ' ' ILE . 4.5 ttm -52.86 -43.98 66.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 74.11 110.894 -179.998 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -55.46 -19.77 10.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 64.14 110.884 -179.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 28.7 ttm-85 -66.7 -20.06 65.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 74.22 110.861 -179.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 31.7 m-85 -90.89 15.13 11.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 64.23 110.879 -179.912 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 58' ' ' PRO . . . -94.18 -159.06 33.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.777 -0.725 . . . . 63.0 112.474 -179.953 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -151.42 169.7 21.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.83 0.348 . . . . 74.22 110.871 -179.755 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' O ' HD12 ' A' ' 57' ' ' ILE . 25.1 mmm180 -57.08 -36.96 71.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.152 -0.476 . . . . 74.42 110.859 -179.92 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.27 12.94 19.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 61.41 110.878 -179.926 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 74.85 -85.7 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.724 -0.75 . . . . 22.33 112.443 179.946 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.462 ' O ' ' HB ' ' A' ' 152' ' ' THR . 4.3 mttp 62.6 -89.22 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.871 0.367 . . . . 52.43 110.914 -179.935 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 151' ' ' LYS . 1.4 t 163.29 67.72 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 72.41 111.117 179.979 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -59.03 -48.16 82.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 73.43 110.866 -179.873 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 7.7 mttt -126.37 177.44 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 73.14 110.912 179.95 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 131.29 56.98 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.203 -0.453 . . . . 72.34 110.89 179.911 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 1.044 HG22 HG22 ' A' ' 12' ' ' VAL . 21.1 pt -131.6 135.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 44.31 111.133 179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 51' ' ' SER . 1.3 m -134.34 159.41 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 74.33 111.134 179.987 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.528 HD11 ' CE2' ' A' ' 53' ' ' PHE . 47.0 mt -91.85 115.92 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 75.11 111.16 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.76 -53.54 13.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 45.03 111.087 179.828 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -141.37 175.56 9.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 73.34 110.85 179.993 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 17.8 p -166.53 175.34 8.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 73.11 110.912 -179.938 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 148.33 -156.44 26.89 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.707 -0.759 . . . . 61.13 112.431 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' VAL . 1.6 tt0 -103.97 144.55 31.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 72.03 110.898 -179.842 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.673 HD22 ' HB3' ' A' ' 7' ' ' PHE . 0.2 OUTLIER -57.71 -62.41 1.82 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 74.11 110.912 -179.98 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.239 -0.437 . . . . 64.5 110.931 179.865 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 74.44 110.852 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 81.6 t -140.4 142.31 31.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 72.42 111.136 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -58.66 153.24 42.18 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.652 0.739 . . . . 72.25 110.913 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 154.52 67.8 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.726 2.284 . . . . 72.31 112.35 179.931 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -128.36 45.93 2.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 63.15 111.157 -179.979 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.0 m -47.69 144.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.217 -0.447 . . . . 75.34 111.173 179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.631 ' CD1' HD21 ' A' ' 164' ' ' LEU . 0.1 OUTLIER -128.87 164.94 22.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.206 -0.452 . . . . 64.22 110.86 -179.939 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -144.82 148.56 34.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 75.12 110.907 -179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.748 ' O ' HD13 ' A' ' 10' ' ' ILE . 25.6 m-20 -108.57 157.22 18.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 64.31 110.889 179.966 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.748 HD13 ' O ' ' A' ' 9' ' ' ASP . 8.6 mm -129.97 129.69 65.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 55.04 111.156 179.977 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -125.44 167.39 15.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 71.1 111.084 179.821 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 15' ' ' GLU . 12.8 m -152.85 106.51 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 72.33 111.135 179.946 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.02 23.03 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.459 . . . . 44.35 110.88 179.894 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.98 -10.32 65.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.74 -0.743 . . . . 51.1 112.494 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.599 ' HG2' HG23 ' A' ' 12' ' ' VAL . 4.0 pt-20 -101.54 138.56 19.91 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.662 0.744 . . . . 62.13 110.916 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 151.99 69.0 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.692 2.261 . . . . 62.33 112.337 -179.951 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.564 HD13 ' CG2' ' A' ' 12' ' ' VAL . 2.8 tp -121.02 -70.97 0.76 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 72.54 110.929 -179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.41 179.2 35.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.719 -0.753 . . . . 74.43 112.463 179.887 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.76 123.63 49.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.85 0.357 . . . . 73.2 110.91 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 96.0 t -95.85 84.95 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 64.31 111.079 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -66.07 94.16 0.23 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 74.5 110.834 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.452 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 25.9 p90 -106.83 114.28 28.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.131 -0.486 . . . . 74.35 110.899 179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -86.91 146.7 26.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 33.31 110.869 -179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.758 HD22 ' CZ ' ' A' ' 129' ' ' PHE . 20.2 mt -108.13 128.41 54.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.13 -0.486 . . . . 75.23 110.943 -179.996 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -70.84 79.45 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 75.25 110.889 179.969 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.696 ' HA ' ' HB1' ' A' ' 33' ' ' ALA . . . -73.44 -11.18 60.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.125 -0.489 . . . . 51.12 111.116 179.92 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.38 -58.96 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 65.34 110.883 179.985 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.564 ' HG2' HD21 ' A' ' 90' ' ' LEU . 0.3 OUTLIER -50.65 -78.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.936 179.966 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.694 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 5.0 m -66.04 128.36 93.77 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.601 0.715 . . . . 52.45 111.131 179.854 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -88.18 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.686 2.257 . . . . 60.24 112.358 179.95 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.12 -40.91 64.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 61.51 110.939 179.887 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.521 ' HB ' ' HB ' ' A' ' 29' ' ' VAL . 54.9 m -57.12 -11.28 1.52 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 71.22 111.144 179.961 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.696 ' HB1' ' HA ' ' A' ' 26' ' ' ALA . . . -74.93 -45.43 42.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.236 -0.438 . . . . 75.1 111.1 179.872 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.549 ' O ' ' C ' ' A' ' 35' ' ' ASN . 28.9 tt0 -91.42 -49.18 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 70.33 110.917 -179.98 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.549 ' C ' ' O ' ' A' ' 34' ' ' GLU . 0.2 OUTLIER -25.63 -51.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 65.4 110.924 -179.948 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -81.54 -45.04 16.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 71.13 110.875 -179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' GLU . 2.9 ptt85 -51.21 -27.16 8.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 75.41 110.913 -179.946 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.609 ' HB1' ' CD ' ' A' ' 43' ' ' GLU . . . -75.69 -49.2 19.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 62.2 111.11 179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.8 tm? -71.32 -10.67 60.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.439 . . . . 62.4 110.936 -179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.88 -8.2 34.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.157 -0.474 . . . . 73.11 110.879 -179.889 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 37' ' ' ARG . 19.8 p -102.22 -13.75 17.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 55.42 111.155 -179.922 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.14 45.83 8.65 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.746 -0.74 . . . . 60.52 112.526 179.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.609 ' CD ' ' HB1' ' A' ' 38' ' ' ALA . 8.4 pt-20 -98.38 -21.75 16.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.95 0.405 . . . . 75.43 110.903 -179.841 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm -89.27 17.97 5.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 71.3 110.923 179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.45 26.01 63.74 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.751 -0.738 . . . . 75.45 112.473 179.945 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER 178.68 168.7 0.88 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.934 0.397 . . . . 62.24 110.832 -179.898 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 157.38 -129.59 2.41 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.692 -0.766 . . . . 61.22 112.478 -179.992 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -93.92 -72.23 0.62 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.966 0.412 . . . . 75.11 110.918 -179.824 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 50' ' ' GLY . 1.7 tptt 59.62 166.98 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 62.04 110.882 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.402 ' HA2' ' HB ' ' A' ' 158' ' ' ILE . . . -36.99 104.52 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.768 -0.73 . . . . 62.53 112.492 179.969 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 46.5 m -132.53 -108.07 0.25 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.848 0.356 . . . . 71.54 110.872 -179.741 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 2.7 p 172.77 150.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.481 . . . . 51.0 110.867 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -90.53 -71.64 0.61 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.874 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 71.75 5.82 5.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 72.44 110.87 -179.971 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.75 94.79 2.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 75.02 110.877 -179.872 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.404 HG12 ' HB2' ' A' ' 62' ' ' CYS . 2.5 mt -147.77 139.84 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 73.54 111.187 179.931 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.544 HG22 ' O ' ' A' ' 147' ' ' SER . 0.1 OUTLIER -140.07 139.37 21.13 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.609 0.719 . . . . 54.54 111.118 179.913 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 128.4 15.98 Favored 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.677 2.251 . . . . 54.13 112.335 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 117' ' ' ALA . . . 67.18 48.22 60.28 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.758 -0.734 . . . . 73.43 112.513 179.98 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -158.06 -80.0 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.829 0.347 . . . . 61.42 110.862 -179.832 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 178.23 -165.8 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 74.14 110.899 -179.994 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.404 ' HB2' HG12 ' A' ' 56' ' ' ILE . 0.5 OUTLIER -149.59 147.46 28.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 64.31 110.864 -179.991 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -104.66 127.36 52.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 73.21 110.911 -179.886 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -38.28 -67.56 0.51 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.738 -0.744 . . . . 71.42 112.489 -179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.87 134.03 1.91 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.742 -0.742 . . . . 73.13 112.505 -179.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -101.14 78.16 1.88 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.861 0.362 . . . . 53.51 110.875 179.956 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -94.28 36.21 1.15 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 63.2 110.868 -179.903 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 66.38 100.32 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 74.43 111.117 -179.93 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.34 -35.38 11.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 74.52 110.884 -180.0 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -48.76 -46.3 41.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 73.15 110.817 -179.98 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -93.46 -33.09 13.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.02 110.862 -179.936 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -106.24 -133.63 7.51 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.73 . . . . 42.02 112.463 -179.986 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 57.3 p -136.02 136.02 39.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.761 0.315 . . . . 53.3 111.172 -179.886 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -121.19 -95.67 1.42 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.757 . . . . 65.11 112.5 179.993 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -122.4 125.21 5.97 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 62.2 112.472 -179.942 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -176.23 -173.88 0.58 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.793 0.33 . . . . 63.04 110.902 -179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 12.5 m -81.18 143.79 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 75.24 110.861 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG21 ' HB2' ' A' ' 39' ' ' LEU . 15.4 pt -83.88 -39.57 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 74.43 111.153 179.936 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -88.83 -6.78 57.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.464 . . . . 72.33 110.92 -179.937 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -154.73 -138.18 2.55 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.768 -0.73 . . . . 71.01 112.493 179.96 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -122.6 -29.59 4.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.979 0.419 . . . . 73.35 110.896 -179.851 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.4 pttp -174.67 137.52 0.47 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 73.14 110.924 179.934 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -121.43 138.43 54.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 75.51 110.881 -179.99 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.92 175.05 0.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 70.12 110.886 -179.899 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -70.46 -168.63 0.25 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.172 -0.467 . . . . 74.01 110.846 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -153.17 -61.69 0.15 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.169 -0.469 . . . . 71.21 110.853 -179.848 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -171.22 154.01 3.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.14 -0.482 . . . . 71.32 110.888 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -134.02 79.58 1.82 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 74.43 110.873 -179.929 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.621 ' O ' HD23 ' A' ' 90' ' ' LEU . 10.4 mm -86.77 14.61 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 73.43 111.136 179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 89' ' ' ILE . 5.7 mt -131.33 99.69 4.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 73.4 110.906 179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.09 125.74 33.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.868 179.84 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.423 ' HA ' HG13 ' A' ' 97' ' ' ILE . 1.3 m80 -49.03 97.3 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 64.21 110.838 179.902 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.0 p -116.39 22.71 12.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.176 -0.465 . . . . 75.24 111.109 -179.907 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 167.94 166.22 26.65 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.714 -0.755 . . . . 74.43 112.462 179.948 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.78 132.81 24.08 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.644 2.229 . . . . 73.4 112.4 -179.94 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.566 ' O ' HD12 ' A' ' 98' ' ' LEU . . . 121.7 -23.74 7.37 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 62.22 112.51 -179.931 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.423 HG13 ' HA ' ' A' ' 92' ' ' HIS . 33.3 mm -57.58 149.99 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.817 0.341 . . . . 63.45 111.136 -179.957 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.761 HD23 ' HB2' ' A' ' 112' ' ' PHE . 6.7 mp -120.86 143.14 49.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 73.14 110.913 179.908 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.08 39.59 0.36 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 65.24 110.851 -179.926 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.497 ' SD ' HG23 ' A' ' 127' ' ' VAL . 0.0 OUTLIER 59.01 168.76 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.485 . . . . 73.1 110.862 179.936 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -146.64 76.75 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 73.12 111.1 179.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -144.04 -80.09 0.19 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 73.13 110.884 -179.92 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.868 ' HB3' ' HB ' ' A' ' 107' ' ' THR . . . -125.81 -146.12 0.34 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 63.33 111.123 179.893 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.622 ' H ' ' HD2' ' A' ' 105' ' ' PRO . . . -140.29 -64.18 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.728 -0.749 . . . . 61.12 112.516 -179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.622 ' HD2' ' H ' ' A' ' 104' ' ' GLY . 53.5 Cg_endo -69.8 106.08 1.61 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.21 112.368 -179.972 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 39.86 68.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.884 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.868 ' HB ' ' HB3' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -152.78 35.06 0.49 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 64.45 111.173 179.982 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.656 ' C ' ' O ' ' A' ' 107' ' ' THR . 1.6 m120 7.46 -87.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 62.54 110.94 179.978 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 107' ' ' THR . . . 128.8 -41.02 1.62 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.75 -0.738 . . . . 75.2 112.5 179.981 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 109' ' ' GLY . 0.3 OUTLIER 76.68 -39.03 0.33 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.817 0.342 . . . . 73.32 110.856 -179.734 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 109' ' ' GLY . 0.4 OUTLIER -62.67 -159.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 71.02 110.905 -179.951 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.761 ' HB2' HD23 ' A' ' 98' ' ' LEU . 11.8 p90 -170.72 140.87 1.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 65.03 110.86 -179.998 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . 0.497 ' CG ' ' O ' ' A' ' 113' ' ' PHE . 4.3 p90 -131.29 102.11 5.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.927 -179.982 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.446 HG23 ' HA2' ' A' ' 96' ' ' GLY . 12.4 mt -64.59 103.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 73.43 111.157 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 11.6 m -60.47 128.75 38.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.192 -0.458 . . . . 54.1 110.888 179.959 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.8 p -96.94 13.83 27.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 51.14 111.124 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.72 ' O ' HG23 ' A' ' 119' ' ' THR . . . -169.63 153.86 5.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 71.2 111.101 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.1 tttt -56.91 99.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 73.12 110.942 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.72 HG23 ' O ' ' A' ' 117' ' ' ALA . 30.6 p -117.7 63.19 0.74 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 72.45 111.117 -179.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 2.14 5.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.439 . . . . 64.22 110.882 179.967 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.466 ' CZ2' HG22 ' A' ' 119' ' ' THR . 26.0 p90 -91.78 2.99 56.13 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.938 -179.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 2.6 tp -134.65 37.97 3.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.54 110.887 -179.943 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -125.87 70.1 1.2 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 75.23 110.886 179.851 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -158.08 -49.13 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.724 -0.75 . . . . 71.2 112.471 -179.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 40.4 mttp -78.13 -31.99 50.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.78 0.324 . . . . 73.22 110.87 -179.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -95.25 145.15 25.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 74.23 110.846 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.539 ' O ' HG23 ' A' ' 127' ' ' VAL . 26.1 m -79.0 109.73 14.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 74.32 111.177 179.954 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.562 HG11 ' O ' ' A' ' 90' ' ' LEU . 9.0 p -75.35 144.61 11.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 75.54 111.133 179.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.758 ' CZ ' HD22 ' A' ' 24' ' ' LEU . 2.0 t80 174.5 100.0 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 73.31 110.884 179.999 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.616 ' C ' HD13 ' A' ' 98' ' ' LEU . . . 123.74 144.08 6.43 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.728 -0.749 . . . . 63.5 112.479 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -154.72 -179.77 8.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.782 0.325 . . . . 75.25 110.911 179.996 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 22' ' ' PHE . 12.1 t -108.36 85.83 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 74.42 111.136 179.88 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -54.83 -50.3 68.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 75.44 110.921 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -139.9 163.56 32.33 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 72.11 110.859 179.961 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 96.17 -4.44 64.98 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.52 -179.915 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.37 -34.38 23.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 74.13 110.869 -179.976 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.93 -24.24 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.243 -0.435 . . . . 62.24 110.89 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -84.21 -41.06 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 62.21 111.078 179.955 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 54.2 t -53.03 -37.96 28.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 74.41 111.121 179.852 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.85 -20.87 66.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 72.52 110.853 -179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -81.17 -38.97 26.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.935 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.0 mtm -65.23 -29.8 70.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.187 -0.46 . . . . 71.11 110.886 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -57.64 -50.32 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.242 -0.436 . . . . 75.24 110.906 -179.965 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.35 -17.05 52.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 74.21 110.912 -179.938 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -90.3 -16.47 29.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.906 -179.946 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.99 -158.97 21.35 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 72.22 112.491 -179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.544 ' O ' HG22 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -149.57 -162.2 1.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.921 0.391 . . . . 74.13 110.804 -179.705 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -92.45 -42.74 9.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 75.24 110.892 -179.908 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -101.01 15.28 29.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 75.12 110.935 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 105.68 -157.87 16.02 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.706 -0.759 . . . . 61.44 112.463 -179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm 60.85 159.64 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.848 0.356 . . . . 74.32 110.916 -179.978 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -133.26 161.37 34.65 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.221 -0.445 . . . . 73.31 111.152 179.965 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.39 -19.26 43.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.249 -0.432 . . . . 73.21 110.817 -179.821 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -135.37 161.08 36.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.32 110.889 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HD2' HG23 ' A' ' 157' ' ' THR . 0.0 OUTLIER -90.86 128.18 36.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 74.21 110.919 179.875 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 mt -101.16 134.92 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.262 -0.426 . . . . 72.12 111.133 179.888 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.676 HG23 ' HD2' ' A' ' 155' ' ' LYS . 4.2 p -136.59 163.89 29.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 75.31 111.175 179.955 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.402 ' HB ' ' HA2' ' A' ' 50' ' ' GLY . 2.1 mp -124.71 132.89 70.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 75.41 111.094 179.923 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.06 -58.34 3.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 74.35 111.122 179.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -151.81 179.03 8.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.26 -0.427 . . . . 63.34 110.881 179.967 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 12.9 p -176.15 165.44 2.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 65.5 110.889 -179.97 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.478 ' O ' HD23 ' A' ' 164' ' ' LEU . . . 142.83 -171.59 24.79 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.677 -0.773 . . . . 75.4 112.428 -179.912 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -68.7 118.51 11.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.82 0.343 . . . . 72.43 110.933 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.631 HD21 ' CD1' ' A' ' 7' ' ' PHE . 1.4 mm? -92.32 -44.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 75.11 110.916 -179.964 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 75.44 110.873 179.897 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 mmm . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 74.12 110.867 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 64.14 155.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 54.03 111.126 179.96 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -83.47 141.37 42.15 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 74.12 110.848 -179.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.474 ' HG2' HD12 ' A' ' 24' ' ' LEU . 53.7 Cg_endo -69.75 127.79 15.11 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.669 2.246 . . . . 73.32 112.347 179.951 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.5 m -102.19 148.78 25.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 55.32 111.144 -179.984 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.545 HG21 HD21 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -120.21 139.02 48.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 53.12 111.158 179.868 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -117.42 143.95 45.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 72.44 110.849 -179.936 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -140.07 127.63 21.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.138 -0.483 . . . . 65.21 110.855 -179.929 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 159' ' ' ALA . 34.6 t0 -101.0 79.6 2.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.145 -0.48 . . . . 72.32 110.858 179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 39.6 mm -57.32 139.11 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 71.5 111.116 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 157' ' ' THR . . . -127.17 158.66 36.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 73.43 111.091 179.763 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 90.5 t -135.34 97.86 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 74.14 111.09 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.8 t0 54.61 54.96 8.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 64.32 110.891 179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.82 13.06 60.79 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.767 -0.73 . . . . 62.32 112.456 -179.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -142.48 93.02 7.13 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.684 0.754 . . . . 72.1 110.862 -179.885 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.77 152.43 69.28 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.688 2.259 . . . . 72.02 112.316 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.74 25.13 9.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 74.32 110.906 179.979 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 131.21 -173.68 20.27 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.706 -0.759 . . . . 72.34 112.504 179.912 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.15 170.3 17.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.894 0.378 . . . . 71.24 110.846 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.572 HG13 HG13 ' A' ' 138' ' ' ILE . 35.2 m -137.33 177.6 5.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.215 -0.448 . . . . 73.12 111.119 179.957 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 53.2 p -136.63 138.79 41.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 23.54 110.894 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -114.52 149.55 36.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 71.23 110.878 -179.917 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -120.52 128.63 53.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 74.24 110.916 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.545 HD21 HG21 ' A' ' 6' ' ' VAL . 6.6 mt -94.85 116.79 29.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 54.31 110.915 -179.964 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 129' ' ' PHE . 11.1 m-85 -82.61 67.47 8.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 72.42 110.893 179.92 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.83 -29.09 70.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 71.24 111.072 179.949 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -58.61 -36.54 74.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 62.41 110.919 179.951 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 10.6 mmtt -89.83 -28.39 19.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 64.12 110.946 179.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.464 HG21 ' HB3' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -147.24 83.69 7.68 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.638 0.732 . . . . 73.0 111.138 179.834 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 -17.28 37.77 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.71 2.273 . . . . 54.44 112.348 179.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.86 -34.75 19.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 74.33 110.925 179.946 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.8 m -75.07 -53.74 8.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 72.4 111.119 179.958 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.17 -37.95 72.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 63.45 111.148 179.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -52.64 -30.66 32.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 74.35 110.869 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -78.32 -61.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.851 -179.896 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -50.01 -29.8 9.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 62.13 110.871 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.75 -36.95 85.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 74.42 110.826 -179.889 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.912 ' HB3' HG21 ' A' ' 78' ' ' ILE . . . -81.32 -19.03 43.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 53.4 111.132 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' CB ' ' A' ' 110' ' ' SER . 87.8 mt -78.9 -61.85 1.88 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 65.41 110.924 -179.948 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.8 m -51.48 -45.65 62.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 71.23 110.886 -179.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 37.0 p -85.43 -9.87 56.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.107 -0.497 . . . . 74.43 111.089 -179.902 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 47.12 73.46 0.31 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.725 -0.75 . . . . 60.32 112.528 -179.973 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -47.8 -53.47 15.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.903 0.383 . . . . 64.55 110.876 -179.868 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.86 -167.16 0.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 63.01 110.903 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.98 17.38 55.62 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.754 -0.736 . . . . 75.22 112.512 179.898 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 7.8 p90 -146.35 -168.32 2.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.857 0.36 . . . . 74.23 110.89 -179.907 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.72 144.02 7.58 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 42.12 112.508 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.22 120.67 5.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.952 0.406 . . . . 75.11 110.96 -179.81 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.68 -41.71 0.36 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 74.01 110.9 179.923 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.44 30.64 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.73 -0.748 . . . . 62.22 112.508 179.939 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.3 m -77.21 162.12 27.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 72.22 110.84 -179.723 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 m -75.06 -168.14 0.71 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.914 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.692 ' CE1' HD11 ' A' ' 158' ' ' ILE . 2.2 m-85 -140.16 135.74 32.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 74.41 110.876 -179.864 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -144.12 -179.11 6.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 74.04 110.858 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 57' ' ' ILE . 0.3 OUTLIER 66.83 20.69 10.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.194 -0.457 . . . . 72.45 110.879 -179.875 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.475 HD12 ' OG1' ' A' ' 152' ' ' THR . 18.6 mt -69.45 123.47 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 74.2 111.118 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 55' ' ' ARG . 2.9 mp -138.92 103.44 7.49 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.598 0.713 . . . . 60.24 111.155 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 76.08 1.17 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.691 2.26 . . . . 45.31 112.337 179.904 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.02 -25.63 0.31 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.725 -0.75 . . . . 62.4 112.489 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -117.34 -64.19 1.34 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 72.05 110.876 -179.876 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.48 -161.57 1.13 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 62.54 110.899 179.997 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 31.5 m -137.47 -64.79 0.55 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.218 -0.446 . . . . 40.5 110.882 -179.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 67.97 152.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 74.0 110.904 -179.877 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 179.13 -179.93 48.82 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 55.54 112.448 -179.976 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 50.35 29.38 16.37 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.719 -0.753 . . . . 74.1 112.514 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -65.72 120.12 12.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.84 0.353 . . . . 73.45 110.915 -179.993 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.8 p90 -147.33 -167.84 2.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 74.04 110.871 -179.865 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -173.2 -52.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 70.13 111.126 -179.894 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -105.02 162.37 13.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 73.34 110.853 -179.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 178.94 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.186 -0.461 . . . . 64.55 110.872 -179.994 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -129.52 -161.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 55.5 110.9 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -89.89 41.32 2.99 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.754 -0.736 . . . . 62.43 112.491 179.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 58.6 p -129.79 -49.99 1.14 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.832 0.348 . . . . 75.33 111.145 -179.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.43 138.11 9.48 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.682 -0.77 . . . . 75.51 112.467 179.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.25 -153.17 3.71 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.697 -0.763 . . . . 70.34 112.494 -179.851 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 71.16 -70.81 0.15 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.845 0.355 . . . . 64.24 110.881 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.6 t -116.55 131.91 56.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 55.12 110.839 -179.884 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.912 HG21 ' HB3' ' A' ' 38' ' ' ALA . 1.0 OUTLIER -49.35 -34.15 7.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 74.2 111.171 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.667 ' CD2' HD12 ' A' ' 78' ' ' ILE . 7.5 m-85 -128.31 55.58 1.67 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 71.23 110.923 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.82 -139.7 8.65 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 74.44 112.448 179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -113.94 -82.6 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.91 0.385 . . . . 65.11 110.893 -179.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.797 ' HG3' HG22 ' A' ' 107' ' ' THR . 0.0 OUTLIER -128.29 -177.42 4.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.123 -0.489 . . . . 52.41 110.89 179.949 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -149.52 179.74 7.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 72.55 110.91 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.24 160.43 22.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 71.33 110.895 -179.926 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -74.14 111.2 9.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.464 . . . . 75.34 110.903 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -70.31 -52.35 23.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 73.45 110.917 -179.922 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 6.8 p30 178.8 165.24 0.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 72.13 110.861 -179.975 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -121.05 40.22 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 72.12 110.864 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 78.6 mt -52.48 -29.02 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 73.52 111.116 179.955 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -95.69 118.07 31.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 75.23 110.917 179.899 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -105.43 171.1 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.31 110.885 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.672 ' NE2' HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -121.8 95.35 4.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 74.34 110.851 179.882 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 p -112.11 34.63 4.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 64.0 111.106 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 173.6 -168.85 41.87 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.715 -0.755 . . . . 71.4 112.481 179.952 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.81 150.31 67.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.687 2.258 . . . . 74.21 112.348 -179.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 65.0 128.5 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.731 -0.747 . . . . 52.2 112.482 -179.985 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -178.0 131.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 75.55 111.146 -179.969 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.644 ' O ' HG13 ' A' ' 128' ' ' VAL . 2.0 tt -89.36 111.06 21.81 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.176 -0.465 . . . . 61.41 110.899 179.913 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 128' ' ' VAL . 31.1 p -109.74 -152.43 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.205 -0.452 . . . . 72.44 110.841 -179.915 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.41 ' HE2' ' HA ' ' A' ' 110' ' ' SER . 4.2 mtt -160.51 104.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.899 179.963 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -101.89 161.76 13.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 73.44 111.126 179.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER 172.14 -45.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.868 -179.936 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.909 ' HB3' ' OG1' ' A' ' 107' ' ' THR . . . -172.21 -34.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.469 . . . . 71.25 111.084 179.867 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 119.15 -80.14 0.32 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.743 -0.741 . . . . 43.14 112.494 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.623 ' O ' HG23 ' A' ' 107' ' ' THR . 53.6 Cg_endo -69.78 120.4 7.19 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.692 2.261 . . . . 73.51 112.323 -179.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 39.65 36.43 0.25 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 73.54 110.876 179.994 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.909 ' OG1' ' HB3' ' A' ' 103' ' ' ALA . 69.6 p -144.81 61.55 1.32 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.472 . . . . 74.11 111.122 -179.993 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.493 ' O ' ' C ' ' A' ' 109' ' ' GLY . 3.0 m-80 -82.16 -6.38 59.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 61.31 110.907 179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 108' ' ' ASN . . . 29.45 -138.24 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.722 -0.751 . . . . 72.44 112.492 179.928 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.469 ' CB ' HD11 ' A' ' 39' ' ' LEU . 9.2 m -147.7 29.64 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.822 0.344 . . . . 74.43 110.856 -179.711 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -107.18 83.46 1.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 73.3 110.95 -179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -80.66 176.98 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.41 110.878 -179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -141.64 -175.83 4.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 71.4 110.884 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -130.73 117.11 37.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.135 -0.484 . . . . 73.44 111.112 179.986 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' CYS . . . . . . . . . . . . . 26.7 p -104.41 153.51 21.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.127 -0.488 . . . . 75.44 110.878 179.953 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.3 p -131.16 12.24 5.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 73.32 111.155 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.84 -0.76 6.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 50.32 111.096 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 70.62 131.53 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.227 -0.442 . . . . 73.11 110.893 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.615 HG22 ' CZ2' ' A' ' 121' ' ' TRP . 28.6 p -142.03 54.17 1.47 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 61.44 111.153 179.985 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -55.19 -17.88 5.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.176 -0.465 . . . . 62.35 110.919 179.967 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' TRP . . . . . 0.615 ' CZ2' HG22 ' A' ' 119' ' ' THR . 20.4 p90 -69.1 -18.47 63.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.104 -0.498 . . . . 72.14 110.922 -179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.485 ' HG ' ' CD1' ' A' ' 121' ' ' TRP . 50.7 mt -89.8 -6.8 55.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 74.42 110.902 -179.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -47.77 -51.68 21.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 74.23 110.884 179.84 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -79.02 52.23 3.97 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.786 -0.721 . . . . 52.53 112.512 -179.96 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -159.65 -50.58 0.06 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.789 0.328 . . . . 50.22 110.868 -179.924 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -110.13 143.25 40.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 73.21 110.827 179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.512 ' O ' ' HB ' ' A' ' 128' ' ' VAL . 76.4 t -48.97 -87.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 64.4 111.142 179.949 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.672 HG21 ' NE2' ' A' ' 92' ' ' HIS . 17.1 t 82.77 123.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 51.41 111.135 179.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.464 ' HB3' HG21 ' A' ' 29' ' ' VAL . 14.6 p90 -161.35 36.28 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 70.31 110.858 -179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -159.76 173.3 36.46 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.759 -0.734 . . . . 41.31 112.485 -179.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -173.83 156.23 2.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.864 0.364 . . . . 74.41 110.907 179.978 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 47.1 t -51.05 108.4 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.468 . . . . 75.4 111.139 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.49 -34.06 54.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.476 . . . . 73.31 110.935 179.89 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -151.51 169.77 21.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 73.23 110.864 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.83 78.97 0.11 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.715 -0.755 . . . . 52.41 112.508 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 9.5 tpt -87.17 0.87 54.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.781 0.324 . . . . 62.14 110.881 -179.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -88.59 -34.32 17.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.444 . . . . 71.41 110.891 -179.945 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.572 HG13 HG13 ' A' ' 20' ' ' VAL . 30.7 mm -60.95 -40.28 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 72.1 111.143 179.908 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.491 ' O ' HG12 ' A' ' 139' ' ' VAL . 13.9 t -87.32 0.13 6.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 43.25 111.131 179.873 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -112.78 -69.71 0.85 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 74.33 110.893 -179.997 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -52.06 -51.6 56.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 63.22 111.131 179.942 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.467 ' HB3' ' O ' ' A' ' 138' ' ' ILE . 5.3 tmm? -44.31 -39.95 4.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.476 . . . . 71.45 110.902 179.942 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -76.02 59.64 1.32 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 65.11 110.874 -179.914 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.94 -12.4 4.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 64.1 110.898 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -135.0 21.65 3.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.168 -0.469 . . . . 73.43 110.876 -179.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.603 ' O ' ' C ' ' A' ' 147' ' ' SER . . . -97.93 65.11 0.84 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 25.41 112.501 179.992 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.603 ' C ' ' O ' ' A' ' 146' ' ' GLY . 0.8 OUTLIER -18.64 120.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.885 0.374 . . . . 52.34 110.867 -179.721 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 36.7 mmm-85 -47.54 -43.31 24.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 74.42 110.855 -179.88 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -45.68 -35.34 4.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 75.21 110.881 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 142.1 -60.86 0.54 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.791 -0.719 . . . . 63.22 112.482 179.991 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.16 125.94 19.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.883 0.373 . . . . 53.04 110.87 -179.984 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.497 HG23 ' HA2' ' A' ' 146' ' ' GLY . 2.2 m -85.89 139.94 30.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 65.24 111.135 179.967 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.2 t -67.66 -22.72 65.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 64.32 110.829 -179.835 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.412 ' H ' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -124.59 -164.96 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 54.11 110.916 179.906 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -129.97 112.16 13.23 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.215 -0.448 . . . . 74.23 110.913 179.872 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 9.2 mt -99.06 90.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 74.24 111.154 179.883 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.544 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 0.2 OUTLIER -91.14 153.61 19.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 65.43 111.114 -179.976 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 53' ' ' PHE . 42.3 mm -94.22 128.28 45.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.23 111.124 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 9' ' ' ASP . . . -81.13 -63.08 1.48 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.121 -0.49 . . . . 72.41 111.106 179.804 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -150.26 162.17 41.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 74.1 110.873 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 161' ' ' CYS . . . . . . . . . . . . . 14.8 m -141.06 -179.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 63.41 110.921 -179.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 140.46 -156.63 25.31 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.745 -0.741 . . . . 62.21 112.492 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -120.02 140.58 50.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 74.41 110.874 -179.855 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.08 132.66 53.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 74.1 110.913 -179.995 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.466 . . . . 64.44 110.959 179.977 . . . . . . . . 1 1 . 1 stop_ save_